Citrus Sinensis ID: 036583
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 817 | 2.2.26 [Sep-21-2011] | |||||||
| Q8RWZ5 | 821 | G-type lectin S-receptor- | yes | no | 0.982 | 0.978 | 0.658 | 0.0 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.947 | 0.887 | 0.352 | 1e-129 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.933 | 0.875 | 0.347 | 1e-120 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.847 | 0.834 | 0.377 | 1e-117 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.844 | 0.833 | 0.363 | 1e-113 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.833 | 0.854 | 0.350 | 1e-100 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.798 | 0.798 | 0.319 | 9e-91 | |
| Q94C25 | 452 | Probable receptor-like pr | no | no | 0.424 | 0.767 | 0.425 | 1e-81 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.821 | 0.796 | 0.307 | 2e-80 | |
| Q9ZR08 | 852 | G-type lectin S-receptor- | no | no | 0.894 | 0.857 | 0.301 | 6e-79 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1092 bits (2824), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 542/823 (65%), Positives = 653/823 (79%), Gaps = 20/823 (2%)
Query: 11 GFFLV---SLILISKTCMASIQSIGKILPGFQGAQMTFIDKNGLFLLSNNSDFAFGFRTT 67
G F+V L+ + A + SIG I PGF G+QM +I+ +G+FL SNNS F FGF TT
Sbjct: 3 GVFIVIVTCLVFLPDPLRAGVASIGSITPGFGGSQMNYINNDGIFLESNNSAFGFGFVTT 62
Query: 68 ENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVSLQKGGSVVWSVNPSGA 127
++ VTLF L I+HK+S+ +IW+ANR SPV+NSD FVF +G V ++ G+ VW ++ SG
Sbjct: 63 QDSVTLFTLSIIHKSSTKLIWSANRASPVSNSDKFVFDDNGNVVME--GTEVWRLDNSGK 120
Query: 128 SVSAMELRDSGNLVLLGNDNKVLWQSFSHPTDTLISNQDFTQGMKLVSAPSTNNLSYVLE 187
+ S +ELRDSGNLV++ D +W+SF HPTDTLI+NQ F +GMKL S+PS++N++Y LE
Sbjct: 121 NASRIELRDSGNLVVVSVDGTSIWESFDHPTDTLITNQAFKEGMKLTSSPSSSNMTYALE 180
Query: 188 IKSGDVVLSAGFPTPQPYWSMGREERKTINKGGGEVTSASLSANSWRFYDNNKIFLWQFI 247
IKSGD+VLS TPQ YWSM + INK GG VTS+SL NSWRF+D ++ LWQF+
Sbjct: 181 IKSGDMVLSVNSLTPQVYWSMANARERIINKDGGVVTSSSLLGNSWRFFDQKQVLLWQFV 240
Query: 248 FSDNTDGNATWIAVLANDGFISFYNLQDGEPSTASNTKIPNSPCSTPEPCDAYYICSGIN 307
FSDN D N TWIAVL N+G ISF NL G + S+TKIP+ C TPEPC YY+CSG
Sbjct: 241 FSDNKDDNTTWIAVLGNNGVISFSNLGSGASAADSSTKIPSDLCGTPEPCGPYYVCSGSK 300
Query: 308 KCQCPSVISS--QNCKTGIASPCDHSKGST----ELVSAGDGLNYFALGFVPP-SSKADL 360
C C S +S +CKTGI SPC +K + +LVSAGDG++YFALG+ PP S K DL
Sbjct: 301 VCGCVSGLSRARSDCKTGITSPCKKTKDNATLPLQLVSAGDGVDYFALGYAPPFSKKTDL 360
Query: 361 NGCKKACLGNCSCLAMFFQNSSGNCFLFDRIGSLQSS-NQGSGFVSYIKILSNGGSDTNN 419
+ CK+ C NCSCL +FFQNSSGNCFLFD IGS ++S N GSGFVSYIKI S G +N
Sbjct: 361 DSCKEFCHNNCSCLGLFFQNSSGNCFLFDYIGSFKTSGNGGSGFVSYIKIASTGSGGGDN 420
Query: 420 GGSGSNKKHFPVVVIIVLSTSVVILGLLYVAIRYVRKKRKAPESPQETSEEDNFLENLSG 479
+ KHFP VVIIV+ T +I L++VA R ++K+ E+PQE+SEEDNFLENLSG
Sbjct: 421 --GEDDGKHFPYVVIIVVVTVFIIAVLIFVAFRIHKRKKMILEAPQESSEEDNFLENLSG 478
Query: 480 MPVRFTYRDLQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVS 539
MP+RF Y+DLQ+ATNNFSVKLGQGGFGSVY+G LPDG+RLAVKKLEGIGQGKKEFRAEVS
Sbjct: 479 MPIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVS 538
Query: 540 IIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIF-KKNQEFLLDWETRFNIALG 598
IIGSIHHLHLV+LRGFCAEG HRLLAYEF++ GSL++WIF KK+ + LLDW+TRFNIALG
Sbjct: 539 IIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALG 598
Query: 599 TAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR 658
TAKGLAYLHEDCD RI+HCDIKPEN+LLDDN++AKVSDFGLAKLMTREQSHVFTT+RGTR
Sbjct: 599 TAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTR 658
Query: 659 GYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKL 718
GYLAPEWITNYAISEKSDVYSYGMVLLE+IGGRKN+DP+ETS+K HFPS+AFK MEEGKL
Sbjct: 659 GYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHFPSFAFKKMEEGKL 718
Query: 719 RNILDSRL-NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQPPTCSP 777
+I+D ++ N+D +RV A+K ALWC+QEDM RPSM+KVVQMLEG+ PV QPP+ S
Sbjct: 719 MDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPSSST 778
Query: 778 LGARLYSSFFRSISEEG---TSSGPSDCNSDAYLSAVRLSGPR 817
+G+RLYSSFF+SISE+G TSSGPSDCNS+ YLSAVRLSGPR
Sbjct: 779 MGSRLYSSFFKSISEDGGATTSSGPSDCNSENYLSAVRLSGPR 821
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 461 bits (1187), Expect = e-129, Method: Compositional matrix adjust.
Identities = 307/872 (35%), Positives = 449/872 (51%), Gaps = 98/872 (11%)
Query: 23 TCMASIQSIGKILPGFQGAQMTFIDKN-GLFLLSNNSDFAFGFRTTEND--VTLFLLVIM 79
+C +SI+ + P F + + F+D + G FLLS NS F G + D T F ++
Sbjct: 22 SCASSIEFV---YPNFTASNLRFVDSSKGAFLLSRNSIFKAGLFSPGGDDSSTGFYFSVV 78
Query: 80 HKASSTIIWTANRGSPVANSDNFVFKKDGEVSLQKGGSV--VWSVNPSGASVSAMELRDS 137
H S + IW++NR SPV++S G ++ G S VWS + V ++ L D+
Sbjct: 79 HVDSGSTIWSSNRDSPVSSSGTMNLTPQGISVIEDGKSQIPVWSTPVLASPVKSLRLTDA 138
Query: 138 GNLVLLGNDNKVLWQSFSHPTDTLISNQDFTQGMKLVSAPSTNNLS---YVLEIKSGDVV 194
GNL+LL + N LW+SF PTD+++ Q GM L + S ++ S Y + D +
Sbjct: 139 GNLLLLDHLNVSLWESFDFPTDSIVLGQRLKLGMFLSGSVSRSDFSTGDYKFLVGESDGL 198
Query: 195 LSAGFPTPQPYWSMGREERKTINKGGG----EVTSASLSANSWRFYDNNKIFLWQFIFSD 250
+ Q YW + R ++ VT++ L+ + N + + +
Sbjct: 199 MQW---RGQNYWKLRMHIRANVDSNFPVEYLTVTTSGLALMA----RNGTVVVVRVALPP 251
Query: 251 NTDGNATWIAVLANDGFISFYNLQDGEPSTASNTKIPNSPCSTPEPCDAYYICSGIN--- 307
++D V D F + + + P C P C +C+ N
Sbjct: 252 SSD-----FRVAKMDSSGKFIVSRFSGKNLVTEFSGPMDSCQIPFVCGKLGLCNLDNASE 306
Query: 308 --KCQCPSVISSQNCKTGIASPCDHS--------KGSTELVSAGDGLNYFALGFVPPSSK 357
C CP + K G+ P S + + G G++YF+ F P
Sbjct: 307 NQSCSCPDEMRMDAGK-GVCVPVSQSLSLPVSCEARNISYLELGLGVSYFSTHFTDPVEH 365
Query: 358 A-DLNGCKKACLGNCSCLAMFFQNSSGNCFLF-DRIGSL---QSSNQGSGFVSYIKI--- 409
L C C NCSCL +F++N+S +C+L D GSL ++S + + Y+K+
Sbjct: 366 GLPLLACHDICSKNCSCLGVFYENTSRSCYLVKDSFGSLSLVKNSPENHDLIGYVKLSIR 425
Query: 410 LSNGGSDTNNGGSGSNKKHFPVVVIIVLSTS----VVILGLLY----VAIRYVRKKRKAP 461
+N NN GS+ FPV+ +++L S ++ LGLL+ +RY + K
Sbjct: 426 KTNAQPPGNNNRGGSS---FPVIALVLLPCSGFFLLIALGLLWWRRCAVMRYSSIREKQV 482
Query: 462 ESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAV 521
P D ++ G+P +F + +L+ AT NF +++G GGFGSVY+G LPD T +AV
Sbjct: 483 TRPGSFESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAV 542
Query: 522 KKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFK 580
KK+ G G++EF E++IIG+I H +LVKLRGFCA G LL YE+M +GSL+K +F
Sbjct: 543 KKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFS 602
Query: 581 KNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLA 640
N +L+W+ RF+IALGTA+GLAYLH CDQ+IIHCD+KPEN+LL D++ K+SDFGL+
Sbjct: 603 GNGP-VLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLS 661
Query: 641 KLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETS 700
KL+ +E+S +FTT+RGTRGYLAPEWITN AISEK+DVYSYGMVLLE++ GRKN S
Sbjct: 662 KLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSFRSRS 721
Query: 701 DK-------------------AHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKV 741
+ +FP YA M E+G+ + D RL S V++
Sbjct: 722 NSVTEDNNQNHSSTTTTSTGLVYFPLYALDMHEQGRYMELADPRLEGRVTSQEAEKLVRI 781
Query: 742 ALWCVQEDMSLRPSMTKVVQMLEGICPVPQPPTCSPLGARLYSSFFRSIS---------- 791
AL CV E+ +LRP+M VV M EG P+ P S R Y F S
Sbjct: 782 ALCCVHEEPALRPTMAAVVGMFEGSIPLGNPRMESLNFLRFYGLRFAESSMVEGQNGESE 841
Query: 792 ------EEGTSSGPSDCNSDAYLSAVRLSGPR 817
E ++SG S S +Y+++ +SGPR
Sbjct: 842 TMVFHRRESSNSGGSR-QSASYIASQEVSGPR 872
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 432 bits (1111), Expect = e-120, Method: Compositional matrix adjust.
Identities = 295/848 (34%), Positives = 437/848 (51%), Gaps = 85/848 (10%)
Query: 6 LIHLIGFFLVSLILISKTCMASIQSIGKILPGFQGAQMTFIDKNGLFLLSNNSDFAFGFR 65
L FFLVSL A+ IG G+++ + N ++ S N FA GF
Sbjct: 13 LFSFFCFFLVSL--------ATEPHIG------LGSKLKASEPNRAWV-SANGTFAIGF- 56
Query: 66 TTENDVTLFLLVIMHK---ASSTIIWTANRGSPVANSDNFVFKKDGEVSLQKGGSVVWSV 122
T FLL I TI+W+ NR SPV + G + L +VVW+
Sbjct: 57 TRFKPTDRFLLSIWFAQLPGDPTIVWSPNRNSPVTKEAVLELEATGNLVLSDQNTVVWTS 116
Query: 123 NPSGASVSAMELRDSGNLVLLGND---NKVLWQSFSHPTDTLISNQDFTQGMKLVSAPS- 178
N S V + + +SGN +LLG + +WQSFS P+DTL+ NQ T ++L S PS
Sbjct: 117 NTSNHGVESAVMSESGNFLLLGTEVTAGPTIWQSFSQPSDTLLPNQPLTVSLELTSNPSP 176
Query: 179 TNNLSYVLEIKSGDVVLSAGFP---TPQPYWSMGREERKTINKGGGEVTSASLSANSWRF 235
+ + Y L++ LS G P+ + I+ G+VT+ S++
Sbjct: 177 SRHGHYSLKMLQQHTSLSLGLTYNINLDPHANYSYWSGPDISNVTGDVTAVLDDTGSFKI 236
Query: 236 YDNNKIFLWQFIFSDNTDGNATW---------------IAVLANDGFISFYNLQDGEPST 280
+++ + D N + VL N+G + Y +
Sbjct: 237 VYGESSIGAVYVYKNPVDDNRNYNNSSNLGLTKNPVLRRLVLENNGNLRLYRWDND--MN 294
Query: 281 ASNTKIPNSPCSTPEPCDAYYIC-SGI---------NKCQC-------PSVISSQNC--K 321
S+ +P + PCD IC +G+ C C P +++ C
Sbjct: 295 GSSQWVPEW-AAVSNPCDIAGICGNGVCNLDRTKKNADCLCLPGSVKLPDQENAKLCSDN 353
Query: 322 TGIASPCD---HSKGSTELVSAGDGLNYFALGFVPP--SSKADLNGCKKACLGNCSCLAM 376
+ + C+ + GS ++ + + YF+ V S +++ C + CL +C C+A
Sbjct: 354 SSLVQECESNINRNGSFKISTVQETNYYFSERSVIENISDISNVRKCGEMCLSDCKCVAS 413
Query: 377 FF--QNSSGNCFLFDRIGSLQSSNQGSGFVSYIKILSNGGSDTNNGGSGSNKKH---FPV 431
+ + C++ + + GS + + S++NN S S K H V
Sbjct: 414 VYGLDDEKPYCWILKSLNFGGFRDPGSTLFVKTRANESYPSNSNNNDSKSRKSHGLRQKV 473
Query: 432 VVIIVLSTSVVILGLLYVAIRYVRKKRKAPESPQETSEEDNFLENLSGMPVRFTYRDLQT 491
+VI ++ +V++ LL + + Y +++ + + S L PV FTYRDLQ
Sbjct: 474 LVIPIVVGMLVLVALLGMLLYYNLDRKRTLKRAAKNSLI------LCDSPVSFTYRDLQN 527
Query: 492 ATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLE-GIGQGKKEFRAEVSIIGSIHHLHLV 550
TNNFS LG GGFG+VY+G + T +AVK+L+ + G++EF EV+ IGS+HH++LV
Sbjct: 528 CTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEVNTIGSMHHMNLV 587
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEF-LLDWETRFNIALGTAKGLAYLHED 609
+L G+C+E +HRLL YE+M NGSLDKWIF Q LLDW TRF IA+ TA+G+AY HE
Sbjct: 588 RLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGIAYFHEQ 647
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNY 669
C RIIHCDIKPEN+LLDDN+ KVSDFGLAK+M RE SHV T +RGTRGYLAPEW++N
Sbjct: 648 CRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVVTMIRGTRGYLAPEWVSNR 707
Query: 670 AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729
I+ K+DVYSYGM+LLEI+GGR+N D + ++ +P +A+K + G +D RL
Sbjct: 708 PITVKADVYSYGMLLLEIVGGRRNLDMSYDAEDFFYPGWAYKELTNGTSLKAVDKRLQGV 767
Query: 730 EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG----ICPVPQPPTCSPLGARLYSS 785
+ + V A+KVA WC+Q+++S+RPSM +VV++LEG I P P T L
Sbjct: 768 AEEEEVVKALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLPPMPQTILELIEEGLED 827
Query: 786 FFRSISEE 793
+R++ E
Sbjct: 828 VYRAMRRE 835
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 422 bits (1085), Expect = e-117, Method: Compositional matrix adjust.
Identities = 282/748 (37%), Positives = 405/748 (54%), Gaps = 56/748 (7%)
Query: 55 SNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVSLQK 114
S NS F+ F + + + L + A S IW+A V + + G + L
Sbjct: 44 SPNSTFSVSFVPSPSPNSF--LAAVSFAGSVPIWSAG---TVDSRGSLRLHTSGSLRLTN 98
Query: 115 G-GSVVWSVNPSGASVSAMELRDSGNLVLLGNDNKVLWQSFSHPTDTLISNQDFTQGMKL 173
G G+ VW V++ + D+G +LL N + +W SF +PTDT++ +Q+FT G L
Sbjct: 99 GSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSVPVWSSFDNPTDTIVQSQNFTAGKIL 158
Query: 174 VSAPSTNNLSYVLEIKSGDVVLSAGFPTPQPYWSMGREERKTINKGGGEVTSASLSANSW 233
S S+ LE +SG++ L + T YW+ G + N + SL N
Sbjct: 159 RSGL----YSFQLE-RSGNLTLR--WNTSAIYWNHGLNSSFSSNLSSPRL---SLQTNGV 208
Query: 234 -RFYDNNKIFLWQFIFS-DNTDGNATWIAVLANDGFISFYNLQDGEPSTASNTKIPNSPC 291
+++N + + ++S D D N L +DG + Y+ S + N+ N+
Sbjct: 209 VSIFESNLLGGAEIVYSGDYGDSNTFRFLKLDDDGNLRIYS------SASRNSGPVNAHW 262
Query: 292 STPEPCDAYYICSGINKCQCPSVISSQNCKT---GIASPCDHSKGSTELVSAGD-GLNYF 347
S + C Y C C +C + D KG V D N
Sbjct: 263 SAVDQCLVYGYCGNFGICSYNDTNPICSCPSRNFDFVDVNDRRKGCKRKVELSDCSGNTT 322
Query: 348 ALGFV---------PPSSKADLNG---CKKACLGNCSCLA-MFFQNSSGNCFLFDRIGSL 394
L V P+S++ G C+ CL + CLA + + SGNC+ GS
Sbjct: 323 MLDLVHTRLFTYEDDPNSESFFAGSSPCRANCLSSVLCLASVSMSDGSGNCWQ-KHPGSF 381
Query: 395 QSSNQGSGF--VSYIKI----LSNGGSDTNNGGSGSNKKHFPVVVIIVLSTSVVILGLLY 448
+ Q SY+K+ ++N G ++K H +V + V++ +LGL+
Sbjct: 382 FTGYQWPSVPSTSYVKVCGPVVANTLERATKGDDNNSKVHLWIVAVAVIAG---LLGLVA 438
Query: 449 VAI-RYVRKKRKAPESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSVKLGQGGFGS 507
V I + RK P +S LE SG PV+FTY++LQ T +F KLG GGFG+
Sbjct: 439 VEIGLWWCCCRKNPRFGTLSSHY-TLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGT 497
Query: 508 VYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567
VY+GVL + T +AVK+LEGI QG+K+FR EV+ I S HHL+LV+L GFC++G HRLL YE
Sbjct: 498 VYRGVLTNRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYE 557
Query: 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD 627
FM NGSLD ++F + L WE RFNIALGTAKG+ YLHE+C I+HCDIKPEN+L+D
Sbjct: 558 FMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVD 617
Query: 628 DNYHAKVSDFGLAKLMT-REQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLE 686
DN+ AKVSDFGLAKL+ ++ + +++RGTRGYLAPEW+ N I+ KSDVYSYGMVLLE
Sbjct: 618 DNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLE 677
Query: 687 IIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSD--RVFTAVKVALW 744
++ G++NFD +E ++ F +A++ E+G + ILD+RL+ D+ D +V VK + W
Sbjct: 678 LVSGKRNFDVSEKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFW 737
Query: 745 CVQEDMSLRPSMTKVVQMLEGICPVPQP 772
C+QE RP+M KVVQMLEGI + P
Sbjct: 738 CIQEQPLQRPTMGKVVQMLEGITEIKNP 765
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 409 bits (1050), Expect = e-113, Method: Compositional matrix adjust.
Identities = 280/770 (36%), Positives = 418/770 (54%), Gaps = 80/770 (10%)
Query: 53 LLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFK-KDGEVS 111
++S++ + GF + ++ + + S TI+W ANR V++ ++ VFK +G +
Sbjct: 38 IVSSDGTYEMGFFKPGSSSNFYIGMWYKQLSQTILWVANRDKAVSDKNSSVFKISNGNLI 97
Query: 112 LQKGG--SVVWSVN-PSGASVSAME--LRDSGNLVLLGNDN----KVLWQSFSHPTDTLI 162
L G + VWS S +SVSA+E L+D GNLVL + VLWQSF HP DT +
Sbjct: 98 LLDGNYQTPVWSTGLNSTSSVSALEAVLQDDGNLVLRTGGSSLSANVLWQSFDHPGDTWL 157
Query: 163 SNQDFTQGMKLVSAPSTNNLSYVLEIKSGDVVLSAGFPTPQP-YWSMGREER---KTINK 218
G+K+ T + KS P P +S+ +E K +
Sbjct: 158 P------GVKIRLDKRTGKSQRLTSWKS--------LEDPSPGLFSLELDESTAYKILWN 203
Query: 219 GGGEVTSASLSANSWRFYDN------NKIFLWQFIFSDNTDGNATWIA---------VLA 263
G E S+ R +D+ N I+ + F FS+ TD T+ V+
Sbjct: 204 GSNEYWSSGPWNPQSRIFDSVPEMRLNYIYNFSF-FSNTTDSYFTYSIYNQLNVSRFVMD 262
Query: 264 NDGFISFYNLQDGEPSTASNTKIPNSPCSTPEPCDAYYICSGINK--CQCPSVISSQNCK 321
G I + +G + P C C ++ ICS ++ C+CP + K
Sbjct: 263 VSGQIKQFTWLEGNKAWNLFWSQPRQQCQVYRYCGSFGICSDKSEPFCRCPQGFRPMSQK 322
Query: 322 TGIASPCDHSKG---STEL-VSAGDGLNYFALGFVPPS------SKADLNGCKKACLGNC 371
D+S G TEL S GD +F L + + ++ L+ C AC G+C
Sbjct: 323 DWDLK--DYSAGCVRKTELQCSRGDINQFFRLPNMKLADNSEVLTRTSLSICASACQGDC 380
Query: 372 SCLAMFFQNSSGNCFLFDR----IGSLQSSNQGSGFVSYIKILSNGGSDTNNGGSGSNKK 427
SC A + S C ++ + + L+ N G + Y+++ SD N G+
Sbjct: 381 SCKAYAYDEGSSKCLVWSKDVLNLQQLEDENS-EGNIFYLRL---AASDVPNVGASGKSN 436
Query: 428 HFPVVVIIVLSTSVVILGLLYVAIRYVRKKRKAPESPQETSEEDNFLENLSGMPVRFTYR 487
+ ++ VL + LG++ + + V + + E+ + G F+YR
Sbjct: 437 NKGLIFGAVLGS----LGVIVLVLLVVILILRYRRRKRMRGEKGD------GTLSAFSYR 486
Query: 488 DLQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHL 547
+LQ AT NFS KLG GGFGSV++G LPD + +AVK+LEGI QG+K+FR EV IG+I H+
Sbjct: 487 ELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEVVTIGTIQHV 546
Query: 548 HLVKLRGFCAEGTHRLLAYEFMANGSLDKWIF--KKNQEFLLDWETRFNIALGTAKGLAY 605
+LV+LRGFC+EG+ +LL Y++M NGSLD +F + ++ +L W+ RF IALGTA+GLAY
Sbjct: 547 NLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAY 606
Query: 606 LHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEW 665
LH++C IIHCDIKPEN+LLD + KV+DFGLAKL+ R+ S V TT+RGTRGYLAPEW
Sbjct: 607 LHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEW 666
Query: 666 ITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMM-EEGKLRNILDS 724
I+ AI+ K+DVYSYGM+L E++ GR+N + +E FPS+A ++ ++G +R+++D
Sbjct: 667 ISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATILTKDGDIRSLVDP 726
Query: 725 RLNIDEQS-DRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQPP 773
RL D + V A KVA WC+Q++ S RP+M++VVQ+LEG+ V PP
Sbjct: 727 RLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPP 776
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 368 bits (945), Expect = e-100, Method: Compositional matrix adjust.
Identities = 268/764 (35%), Positives = 390/764 (51%), Gaps = 83/764 (10%)
Query: 41 AQMTFIDKNGLFLLSNNSDFAFGFRTTENDVTLFLLVIMHKA--SSTIIWTANRGSPVAN 98
Q I K +LS + F GF +T N + + L I + + + T +W ANR PV++
Sbjct: 21 VQSKVIIKGNQTILSFKAIFRLGFFSTTNGSSNWYLGISYASMPTPTHVWVANRIRPVSD 80
Query: 99 SDNFVFKKDGE----VSLQKGGSVVWSVNPSGASVSAMELRDSGNLVLLGNDNKVLWQSF 154
D+ + VS + G VVW + ++GNL+L+ +D +WQSF
Sbjct: 81 PDSSTLELTSTGYLIVSNLRDG-VVWQTDNKQPGTD-FRFSETGNLILINDDGSPVWQSF 138
Query: 155 SHPTDTLISNQDFTQGMKLVSAPSTNNLS---YVLEIKSGDVVLSAGFPTPQPYWSMGRE 211
+PTDT + + T + S S + S Y L + + PYWS G
Sbjct: 139 DNPTDTWLPGMNVTGLTAMTSWRSLFDPSPGFYSLRLSPSFNEFQLVYKGTTPYWSTGNW 198
Query: 212 ERKTINKGGGEVTSASLSANSWRFYDNNKIF----LWQFI--FSDNTDGNATWIAVLAND 265
+ G E+T + +RF+ N W + ++ T V AN
Sbjct: 199 TGEAF-VGVPEMTIPYI----YRFHFVNPYTPTASFWYIVPPLDSVSEPRLTRFMVGAN- 252
Query: 266 GFISFYNLQDGEPSTASNTKI---PNSPCSTPEPCDAYYICSG--INKCQCPSVISSQNC 320
G + Y +P T S P PC C CS + C C +N
Sbjct: 253 GQLKQYTW---DPQTQSWNMFWLQPEDPCRVYNLCGQLGFCSSELLKPCACIRGFRPRND 309
Query: 321 KTGIASPCDHSKG-STELVSAGDGLNYF-ALGFVPPSSKADLN-------GCKKACLGNC 371
+ D+S G E +G+ + F A+G + ++ C K CLGN
Sbjct: 310 AAWRSD--DYSDGCRRENGDSGEKSDTFEAVGDLRYDGDVKMSRLQVSKSSCAKTCLGNS 367
Query: 372 SCLAMFFQNSSGNCFLFDRIGSLQSSNQGSGFVSYIKILSNGGSDTNNGGSGSNKKHFPV 431
SC+ + + S C KIL ++ N G+ K +
Sbjct: 368 SCVGFYHKEKSNLC----------------------KILLESPNNLKNS-KGNISKSIII 404
Query: 432 VVIIVLSTSVVILGLLYVAIRYVRKKRKAPESPQETSEEDNF-LENLSGMPVRFTYRDLQ 490
+ +V S SV+ LL I R +++ Q+ ED F + NL F++++LQ
Sbjct: 405 LCSVVGSISVLGFTLLVPLILLKRSRKRKKTRKQD---EDGFAVLNLK----VFSFKELQ 457
Query: 491 TATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHL 549
+ATN FS K+G GGFG+V++G LP T +AVK+LE G G+ EFRAEV IG+I H++L
Sbjct: 458 SATNGFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLERPGSGESEFRAEVCTIGNIQHVNL 517
Query: 550 VKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED 609
V+LRGFC+E HRLL Y++M GSL ++ + + + LL WETRF IALGTAKG+AYLHE
Sbjct: 518 VRLRGFCSENLHRLLVYDYMPQGSLSSYLSRTSPK-LLSWETRFRIALGTAKGIAYLHEG 576
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNY 669
C IIHCDIKPEN+LLD +Y+AKVSDFGLAKL+ R+ S V T+RGT GY+APEWI+
Sbjct: 577 CRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRVLATMRGTWGYVAPEWISGL 636
Query: 670 AISEKSDVYSYGMVLLEIIGGRKNFDPNETS--------DKAHFPSYAFKMMEEGKLRNI 721
I+ K+DVYS+GM LLE+IGGR+N N + +K FP +A + + +G + ++
Sbjct: 637 PITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPEKWFFPPWAAREIIQGNVDSV 696
Query: 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765
+DSRLN + ++ V VA+WC+Q++ +RP+M VV+MLEG
Sbjct: 697 VDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTVVKMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 335 bits (859), Expect = 9e-91, Method: Compositional matrix adjust.
Identities = 241/755 (31%), Positives = 369/755 (48%), Gaps = 103/755 (13%)
Query: 85 TIIWTANRGSPV-ANSDNFVFKKDGEVSLQK-GGSVVWSVNPSG-ASVSAMELRDSGNLV 141
TI+W+AN PV A +KDG + L G+ VW + + V L D+GNLV
Sbjct: 85 TIVWSANPDRPVHARRSALTLQKDGNMVLTDYDGAAVWRADGNNFTGVQRARLLDTGNLV 144
Query: 142 LLGNDNKVLWQSFSHPTDTLISNQDFTQGMKLVSAPSTNNLS---YVLEIKSGDVVLSAG 198
+ + +WQSF PTDT + Q T +LV P+T + S Y+ S VLS
Sbjct: 145 IEDSGGNTVWQSFDSPTDTFLPTQLITAATRLV--PTTQSRSPGNYIFRF-SDLSVLSLI 201
Query: 199 FPTPQP---YW-----SMGREERKTINKGG-GEVTSASLSANSWRFYDNNKIFLWQFIFS 249
+ PQ YW ++ ++ R N G +T + + A+S F D + + S
Sbjct: 202 YHVPQVSDIYWPDPDQNLYQDGRNQYNSTRLGMLTDSGVLASS-DFADGQAL-----VAS 255
Query: 250 DNTDGNATWIAVLANDGFISFYNLQDGEPSTASNTKIPNSPCSTPEPCDAYYIC--SGIN 307
D G + L DG + Y++ D + S + + PC+ C IC S
Sbjct: 256 DVGPGVKRRLT-LDPDGNLRLYSMNDSDGSWSVSMVAMTQPCNIHGLCGPNGICHYSPTP 314
Query: 308 KCQCPSVISSQN-------CKTGIASPCD-HSKGSTELVS-------AGDGLNYFALGFV 352
C CP +++N C + + CD + K S V D + ++
Sbjct: 315 TCSCPPGYATRNPGNWTEGCMAIVNTTCDRYDKRSMRFVRLPNTDFWGSDQQHLLSVS-- 372
Query: 353 PPSSKADLNGCKKACLGNCSCLAMFFQNSSGNCFLFDRIGSLQSSNQGSGFVSYIKI--- 409
L C+ C+ +C+C +Q +G+C+ + S ++ Y+K+
Sbjct: 373 -------LRTCRDICISDCTCKGFQYQEGTGSCYPKAYLFSGRTYPTSDVRTIYLKLPTG 425
Query: 410 --LSNG---------------------------GSDTNNGGSGSNKKHFP---VVVIIVL 437
+SN D + G G +K + + V+
Sbjct: 426 VSVSNALIPRSDVFDSVPRRLDCDRMNKSIREPFPDVHKTGGGESKWFYFYGFIAAFFVV 485
Query: 438 STSVVILGLLYVAIRYVRKKRKAPESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFS 497
S + +V R +R P E + + ++ R++YR+L AT F
Sbjct: 486 EVSFISFAWFFVLKRELR--------PSELWASEKGYKAMTSNFRRYSYRELVKATRKFK 537
Query: 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCA 557
V+LG+G G+VY+GVL D +AVKKLE + QGK+ F+AE+S+IG I+H++LV++ GFC+
Sbjct: 538 VELGRGESGTVYKGVLEDDRHVAVKKLENVRQGKEVFQAELSVIGRINHMNLVRIWGFCS 597
Query: 558 EGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHC 617
EG+HRLL E++ NGSL +F + LLDWE RFNIALG AKGLAYLH +C + +IHC
Sbjct: 598 EGSHRLLVSEYVENGSLANILFSEGGNILLDWEGRFNIALGVAKGLAYLHHECLEWVIHC 657
Query: 618 DIKPENVLLDDNYHAKVSDFGLAKLMTREQS-HVFTTLRGTRGYLAPEWITNYAISEKSD 676
D+KPEN+LLD + K++DFGL KL+ R S + +RGT GY+APEW+++ I+ K D
Sbjct: 658 DVKPENILLDQAFEPKITDFGLVKLLNRGGSTQNVSHVRGTLGYIAPEWVSSLPITAKVD 717
Query: 677 VYSYGMVLLEIIGGRKNFDPNETSDKAH--------FPSYAFKMMEEGKLRNILDSRLNI 728
VYSYG+VLLE++ G + + +D+ H S + E+ + LDS+LN
Sbjct: 718 VYSYGVVLLELLTGTRVSELVGGTDEVHSMLRKLVRMLSAKLEGEEQSWIDGYLDSKLNR 777
Query: 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQML 763
+ T +K+A+ C++ED S RP+M VQ L
Sbjct: 778 PVNYVQARTLIKLAVSCLEEDRSKRPTMEHAVQTL 812
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94C25|Y5005_ARATH Probable receptor-like protein kinase At5g20050 OS=Arabidopsis thaliana GN=At5g20050 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 305 bits (781), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 156/367 (42%), Positives = 234/367 (63%), Gaps = 20/367 (5%)
Query: 427 KHFPVVVIIVLSTSVVILGLLYVAIRYVRKKR----KAPESPQETSEEDNFLENLSGMPV 482
K F ++ + +S + ++ L + RY ++++ + +E E +FL ++G+P
Sbjct: 32 KTFYLIAGVDISLILAVICFLIIRSRYNKERKLLVSRFASEGRELRIEYSFLRKVAGVPT 91
Query: 483 RFTYRDLQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIG 542
+F DL+ AT+ F +G+GG GSV++GVL DG+++AVK++EG +G++EFR+EV+ I
Sbjct: 92 KFKLEDLEEATDGFRSLIGKGGSGSVFKGVLKDGSQVAVKRIEGEEKGEREFRSEVAAIA 151
Query: 543 SIHHLHLVKLRGFCAEGTH---RLLAYEFMANGSLDKWIF------KKNQEFLLDWETRF 593
S+ H +LV+L G+ + + R L Y+++ N SLD WIF ++ L WE R+
Sbjct: 152 SVQHKNLVRLYGYSSSTSANRPRFLVYDYIVNSSLDIWIFPDRGNRGRSGGGCLSWEQRY 211
Query: 594 NIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT 653
+A+ AK LAYLH DC +I+H D+KPEN+LLD+N+ A V+DFGL+KL+ R++S V T
Sbjct: 212 QVAIDVAKALAYLHHDCRSKILHLDVKPENILLDENFRAVVTDFGLSKLIARDESRVLTD 271
Query: 654 LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA-----HFPSY 708
+RGTRGYLAPEW+ + ISEKSDVYSYG+VLLE+IGGR++ E + +FP
Sbjct: 272 IRGTRGYLAPEWLLEHGISEKSDVYSYGIVLLEMIGGRRSISRVEVKETKKKKLEYFPRI 331
Query: 709 AFKMMEEGKLRNILDSRL--NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
+ M E K+ I+D RL + + V V VALWC+QE RP MT V++MLEG
Sbjct: 332 VNQKMRERKIMEIVDQRLIEVNEVDEEEVMKLVCVALWCIQEKSKKRPDMTMVIEMLEGR 391
Query: 767 CPVPQPP 773
PV +PP
Sbjct: 392 VPVNEPP 398
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 300 bits (769), Expect = 2e-80, Method: Compositional matrix adjust.
Identities = 243/789 (30%), Positives = 362/789 (45%), Gaps = 118/789 (14%)
Query: 53 LLSNNSDFAFGFRTTENDVTLFLLVIMHKAS---STIIWTANRGSPVANSDNFV-FKKDG 108
LL + F FGF T N T V + T++W AN+ SP+ ++ + +DG
Sbjct: 47 LLCKSGIFRFGFFTPVNSTTRLRYVGIWYEKIPIQTVVWVANKDSPINDTSGVISIYQDG 106
Query: 109 EVSLQKG-GSVVWSVN---PSGASVSAMELRDSGNLVLLGNDN--KVLWQSFSHPTDTLI 162
+++ G +VWS N P + + ++L DSGNL+L N N ++LW+SF HP D+ +
Sbjct: 107 NLAVTDGRNRLVWSTNVSVPVAPNATWVQLMDSGNLMLQDNRNNGEILWESFKHPYDSFM 166
Query: 163 SNQDF-TQG-----MKLVS-----APSTNNLSYVLEIKSGDVVLSAGFPTPQ-------- 203
T G +KL S PST N + + A F P+
Sbjct: 167 PRMTLGTDGRTGGNLKLTSWTSHDDPSTGNYTAGI----------APFTFPELLIWKNNV 216
Query: 204 PYWSMGREERKTINKGGGEVTSASLSANSWRFYDNNKIFLWQFIFSDNTDGNATWIAVLA 263
P W G G+V + +S F D F+ N+D T A
Sbjct: 217 PTWRSG--------PWNGQVFIGLPNMDSLLFLDG---------FNLNSDNQGTISMSYA 259
Query: 264 NDGFISFYNLQ------DGEPSTASNT-----KIPNSPCSTPEPCDAYYIC-SGINK-CQ 310
ND F+ +NL + ST+ T K P + C C + C +G N C+
Sbjct: 260 NDSFMYHFNLDPEGIIYQKDWSTSMRTWRIGVKFPYTDCDAYGRCGRFGSCHAGENPPCK 319
Query: 311 CPSVISSQN------------CKTGIASPCDHSKGSTELVSA--GDGLNYFALGFVPPS- 355
C +N C C+ + + DG VP S
Sbjct: 320 CVKGFVPKNNTEWNGGNWSNGCMRKAPLQCERQRNVSNGGGGGKADGFLKLQKMKVPISA 379
Query: 356 --SKADLNGCKKACLGNCSCLAMFFQNSSGNCFLFDRIGSLQSSNQGSGFVSYIKILSNG 413
S+A C K CL NCSC A + G C L+ S GSG +I++
Sbjct: 380 ERSEASEQVCPKVCLDNCSCTAYAYDRGIG-CMLWSGDLVDMQSFLGSGIDLFIRV---- 434
Query: 414 GSDTNNGGSGSNKKHFPVVVIIVLSTSVVILGLLYVAIRYVRKKRKAPESPQETSEEDNF 473
K H + V+I V+L + RK +K P ++ S E F
Sbjct: 435 -------AHSELKTHSNLAVMIAAPVIGVMLIAAVCVLLACRKYKKRPAPAKDRSAELMF 487
Query: 474 LE---------------NLSGMPVRFTYRDLQTATNNFSV--KLGQGGFGSVYQGVLPDG 516
L +P+ F ++ L T+T++FS+ KLGQGGFG VY+G LP+G
Sbjct: 488 KRMEALTSDNESASNQIKLKELPL-FEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEG 546
Query: 517 TRLAVKKL-EGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLD 575
+AVK+L GQG +E EV +I + H +LVKL G C EG R+L YE+M SLD
Sbjct: 547 QEIAVKRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLD 606
Query: 576 KWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVS 635
++F ++ +LDW+TRFNI G +GL YLH D +IIH D+K N+LLD+N + K+S
Sbjct: 607 AYLFDPMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKIS 666
Query: 636 DFGLAKLMTREQSHVFT-TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNF 694
DFGLA++ + T + GT GY++PE+ SEKSDV+S G++ LEII GR+N
Sbjct: 667 DFGLARIFRANEDEANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNS 726
Query: 695 DPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRP 754
++ + + +YA+K+ +G+ ++ D + + V + L CVQE + RP
Sbjct: 727 SSHKEENNLNLLAYAWKLWNDGEAASLADPAVFDKCFEKEIEKCVHIGLLCVQEVANDRP 786
Query: 755 SMTKVVQML 763
+++ V+ ML
Sbjct: 787 NVSNVIWML 795
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 296 bits (757), Expect = 6e-79, Method: Compositional matrix adjust.
Identities = 255/845 (30%), Positives = 390/845 (46%), Gaps = 114/845 (13%)
Query: 12 FFLVSLILISK-TCMASIQSIGKILPGFQGAQMTFIDKNGLFLLSNNSDFAFGFRTT--E 68
FF + L+ I + C ++Q + F+G+ + D +G L+S F GF T
Sbjct: 6 FFYMFLLHIRRLDCFVAVQDSKTL---FKGSTL-INDSHGETLVSAGQRFELGFFTPNGS 61
Query: 69 NDVTLFLLVIMHKASS-TIIWTANRGSPVAN-SDNFVFKKDGEVS-LQKGGSVVWS--VN 123
+D +L + + T++W ANR SPV + S F KDG + + G V W V
Sbjct: 62 SDERRYLGIWFYNLHPLTVVWVANRESPVLDRSCIFTISKDGNLEVIDSKGRVYWDTGVK 121
Query: 124 PSGASVSAM-ELRDSGNLVLL--GNDNKVLWQSFSHPTDTLISNQDFTQGMKLVS----- 175
PS S M +L D+GNLVL+ GN+ V+WQSF +PTDT + + M L S
Sbjct: 122 PSSVSAERMVKLMDNGNLVLISDGNEANVVWQSFQNPTDTFLPGMRMDENMTLSSWRSFN 181
Query: 176 APSTNNLSYVLEIK-------------------SGDVVLSAGFPTPQPYWSMGREERKTI 216
PS N ++ ++ + SG + S P Y+ E T+
Sbjct: 182 DPSHGNFTFQMDQEEDKQFIIWKRSMRYWKSGISGKFIGSDEMPYAISYFLSNFTETVTV 241
Query: 217 NKGGGEVTSASLSANSWRFYDNNKIFLWQFIFSDNTDGNATWIAVLANDGFISFYNLQDG 276
+ SL N+ RF +++ G ++ L DG
Sbjct: 242 HNASVPPLFTSLYTNT-RF-------------------------TMSSSGQAQYFRL-DG 274
Query: 277 EPSTASNTKIPNSPCSTPEPCDAYYICSGINK--CQC-----PSVISSQNCKTGIASPCD 329
E A P CS C + C+ N+ C+C P+ + K + C
Sbjct: 275 ERFWAQIWAEPRDECSVYNACGNFGSCNSKNEEMCKCLPGFRPNFLEKW-VKGDFSGGCS 333
Query: 330 HSK---GSTELVSAGDGLNYFALGFVPPSSKADLNG---CKKACLGNCSCLAMFFQ---- 379
G +V LN + P S+ D + C+ CL NC C A ++
Sbjct: 334 RESRICGKDGVVVGDMFLNLSVVEVGSPDSQFDAHNEKECRAECLNNCQCQAYSYEEVDI 393
Query: 380 -NSSGNCFLF-DRIGSLQSSNQGSGFVSYIKILSNGGSDTNNGGSGSNKKHFPVVVIIVL 437
S+ C+++ + + +L+ GS V + + GS G + PVV+IIV+
Sbjct: 394 LQSNTKCWIWLEDLNNLKEGYLGSRNVFIRVAVPDIGSHVERGRGRYGEAKTPVVLIIVV 453
Query: 438 S-TSVVILGLLYVAIRYVRKKRK-----------------APESPQETSEEDNFLENLS- 478
+ TS IL +L YV +R+ + +E E F ++ S
Sbjct: 454 TFTSAAILVVLSSTASYVFLQRRKVNKELGSIPRGVHLCDSERHIKELIESGRFKQDDSQ 513
Query: 479 GMPV-RFTYRDLQTATNNFSV--KLGQGGFGSVYQGVLPDGTRLAVKKLEGI-GQGKKEF 534
G+ V F + AT+NFS KLGQGGFG VY+G+ P +AVK+L GQG +EF
Sbjct: 514 GIDVPSFELETILYATSNFSNANKLGQGGFGPVYKGMFPGDQEIAVKRLSRCSGQGLEEF 573
Query: 535 RAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFN 594
+ EV +I + H +LV+L G+C G +LL YE+M + SLD +IF + LDW+ R N
Sbjct: 574 KNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEYMPHKSLDFFIFDRKLCQRLDWKMRCN 633
Query: 595 IALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT- 653
I LG A+GL YLH+D RIIH D+K N+LLD+ + K+SDFGLA++ ++ T
Sbjct: 634 IILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARIFGGSETSANTNR 693
Query: 654 LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMM 713
+ GT GY++PE+ S KSDV+S+G+V++E I G++N +E +A+ +
Sbjct: 694 VVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTGFHEPEKSLSLLGHAWDLW 753
Query: 714 EEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQML----EGICPV 769
+ + +LD L +++ + V L CVQED + RP+M+ VV ML P
Sbjct: 754 KAERGIELLDQALQESCETEGFLKCLNVGLLCVQEDPNDRPTMSNVVFMLGSSEAATLPT 813
Query: 770 PQPPT 774
P+ P
Sbjct: 814 PKQPA 818
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 817 | ||||||
| 224092482 | 816 | predicted protein [Populus trichocarpa] | 0.990 | 0.991 | 0.749 | 0.0 | |
| 224143149 | 776 | predicted protein [Populus trichocarpa] | 0.947 | 0.997 | 0.725 | 0.0 | |
| 225430295 | 815 | PREDICTED: G-type lectin S-receptor-like | 0.963 | 0.965 | 0.719 | 0.0 | |
| 255548908 | 769 | s-receptor kinase, putative [Ricinus com | 0.940 | 0.998 | 0.731 | 0.0 | |
| 356518250 | 817 | PREDICTED: G-type lectin S-receptor-like | 0.987 | 0.987 | 0.684 | 0.0 | |
| 356562038 | 812 | PREDICTED: G-type lectin S-receptor-like | 0.984 | 0.990 | 0.680 | 0.0 | |
| 356509918 | 816 | PREDICTED: G-type lectin S-receptor-like | 0.988 | 0.990 | 0.682 | 0.0 | |
| 449437142 | 776 | PREDICTED: G-type lectin S-receptor-like | 0.937 | 0.987 | 0.687 | 0.0 | |
| 356554268 | 810 | PREDICTED: G-type lectin S-receptor-like | 0.962 | 0.970 | 0.682 | 0.0 | |
| 297802800 | 825 | lectin protein kinase family protein [Ar | 0.982 | 0.973 | 0.659 | 0.0 |
| >gi|224092482|ref|XP_002309629.1| predicted protein [Populus trichocarpa] gi|222855605|gb|EEE93152.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1273 bits (3294), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 610/814 (74%), Positives = 698/814 (85%), Gaps = 5/814 (0%)
Query: 6 LIHLIGFFLVSLILISKTCMASIQSIGKILPGFQGAQMTFIDKNGLFLLSNNSDFAFGFR 65
LI +G + ++L+ + C A +Q +G I PGFQG+QMT+I+ NGLFL+SNNS+FAFGF
Sbjct: 6 LIRFMGSISLFVLLLPEGCKAGVQHVGTIYPGFQGSQMTWINLNGLFLISNNSNFAFGFS 65
Query: 66 TTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVSLQKGGSVVWSVNPS 125
TT+ DVT FLLV++H SS +IW+ANRGSPV+ SD F+F DG+VSLQKG +VVW+ +
Sbjct: 66 TTQ-DVTQFLLVVVHMGSSKVIWSANRGSPVSYSDKFIFGGDGKVSLQKGEAVVWTADTG 124
Query: 126 GASVSAMELRDSGNLVLLGNDNKVLWQSFSHPTDTLISNQDFTQGMKLVSAPSTNNLSYV 185
G VSA+E++DSGNLVLLGN VLWQSFSHPTDTLISNQDF GMKLVS P++N L+++
Sbjct: 125 GKRVSAIEMQDSGNLVLLGNGGSVLWQSFSHPTDTLISNQDFVDGMKLVSDPNSNKLTHI 184
Query: 186 LEIKSGDVVLSAGFPTPQPYWSMGREERKTINKGGGEVTSASLSANSWRFYDNNKIFLWQ 245
LEIKSGD++LSAGF TPQPYWS+ +E R TI+KGGG+ ASLS NSW+FYD NK+FL Q
Sbjct: 185 LEIKSGDMMLSAGFQTPQPYWSIQKERRMTIDKGGGKPAVASLSGNSWKFYDGNKVFLSQ 244
Query: 246 FIFSDNTDGNATWIAVLANDGFISFYNLQDGEPSTASNTKIPNSPCSTPEPCDAYYICSG 305
FIFSD+TD N TWIAVL NDGFISFYNL DG + S TKIP+ PCS PEPCDA+Y+CSG
Sbjct: 245 FIFSDSTDANGTWIAVLGNDGFISFYNLDDG--GSDSQTKIPSDPCSRPEPCDAHYVCSG 302
Query: 306 INKCQCPSVISSQ-NCKTGIASPCDHSKGSTELVSAGDGLNYFALGFVPPSSKADLNGCK 364
N CQCPS +S++ NC+T + S CD S GSTELVSAGD LNYFALGFVPPSS DL GCK
Sbjct: 303 NNVCQCPSGLSNRLNCQTEVVSSCDGSNGSTELVSAGDRLNYFALGFVPPSSITDLEGCK 362
Query: 365 KACLGNCSCLAMFFQNSSGNCFLFDRIGSLQSSNQGSGFVSYIKILSNGGSDTNNGGSGS 424
AC GNCSCLA FF NSSGNCFLF IGS Q+SN GS FV+YIK+ S+GGS +N GG GS
Sbjct: 363 SACHGNCSCLAFFFHNSSGNCFLFSDIGSFQNSNAGSSFVAYIKVSSDGGSGSNAGGDGS 422
Query: 425 NKKHFPVVVIIVLSTSVVILGLLYVAIRYVRKKRKAPESPQETSEEDNFLENLSGMPVRF 484
+K FP+VVIIV+ T +VI GLLY+A RY RKK+K ESP TSE+DNFLE LSGMP+RF
Sbjct: 423 GEKSFPIVVIIVIGTLIVICGLLYMAFRYHRKKKKMLESPPNTSEDDNFLETLSGMPIRF 482
Query: 485 TYRDLQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSI 544
+YRDLQTATNNFSVKLGQGGFGSVYQG LPDGT+LAVKKLEG+GQGKKEFRAEVSIIGSI
Sbjct: 483 SYRDLQTATNNFSVKLGQGGFGSVYQGALPDGTQLAVKKLEGMGQGKKEFRAEVSIIGSI 542
Query: 545 HHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKN-QEFLLDWETRFNIALGTAKGL 603
HH HLV+++GFCAEGTHRLLAYEFMANGSLDKWIFK+N +EFLLDWETRFNIA+GTAKGL
Sbjct: 543 HHHHLVRIKGFCAEGTHRLLAYEFMANGSLDKWIFKRNKEEFLLDWETRFNIAVGTAKGL 602
Query: 604 AYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAP 663
AYLHEDCD +IIHCDIKPENVLLD + AKVSDFGLAKLM REQSHVFTTLRGTRGYLAP
Sbjct: 603 AYLHEDCDVKIIHCDIKPENVLLDGQFLAKVSDFGLAKLMNREQSHVFTTLRGTRGYLAP 662
Query: 664 EWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723
EWITNYAISEKSDVYSYGM+LLEIIGGRKNFDP E+S+K+HFPSYAFKMMEEGKL+ ILD
Sbjct: 663 EWITNYAISEKSDVYSYGMLLLEIIGGRKNFDPTESSEKSHFPSYAFKMMEEGKLKEILD 722
Query: 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQPPTCSPLGARLY 783
S+L +D DRV T++KVALWC+QEDM+LRPSMTKVV MLEG+ PVP PPT SPLG+RLY
Sbjct: 723 SKLRLDNDDDRVSTSIKVALWCIQEDMNLRPSMTKVVHMLEGLSPVPLPPTSSPLGSRLY 782
Query: 784 SSFFRSISEEGTSSGPSDCNSDAYLSAVRLSGPR 817
SSFF+S SEEGTSSGPSDCNSDAYLSAVRLSGPR
Sbjct: 783 SSFFKSTSEEGTSSGPSDCNSDAYLSAVRLSGPR 816
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224143149|ref|XP_002324861.1| predicted protein [Populus trichocarpa] gi|222866295|gb|EEF03426.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1204 bits (3114), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 588/810 (72%), Positives = 666/810 (82%), Gaps = 36/810 (4%)
Query: 10 IGFFLVSLILISKTCMASIQSIGKILPGFQGAQMTFIDKNGLFLLSNNSDFAFGFRTTEN 69
+G V ++L C A IQS+GKI PG QG+ MT+I+ +GLFL SNNSDFAFGF TTE
Sbjct: 1 MGSISVFVLLFPGGCKAGIQSVGKIYPGLQGSAMTWINLDGLFLRSNNSDFAFGFTTTE- 59
Query: 70 DVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVSLQKGGSVVWSVNPSGASV 129
DVT FLL I+H SS +IW+ANRGSPV+NSD F+F +DG+VSLQKG VVW+ + G V
Sbjct: 60 DVTQFLLTIVHLGSSKVIWSANRGSPVSNSDKFIFGEDGKVSLQKGEDVVWAADTGGKRV 119
Query: 130 SAMELRDSGNLVLLGNDNKVLWQSFSHPTDTLISNQDFTQGMKLVSAPSTNNLSYVLEIK 189
SA+E++DSGNLVLLGND VLWQSFSHPT+TLISNQDF GMKLVS P++NNL+++LEIK
Sbjct: 120 SAIEMQDSGNLVLLGNDTSVLWQSFSHPTNTLISNQDFVDGMKLVSDPNSNNLTHILEIK 179
Query: 190 SGDVVLSAGFPTPQPYWSMGREERKTINKGGGEVTSASLSANSWRFYDNNKIFLWQFIFS 249
SGD++LSAGF TPQPYWS+ +E R TIN+GGG+V ASL NSWRFYD NK+FL QFIFS
Sbjct: 180 SGDMILSAGFQTPQPYWSVQKESRITINQGGGKVAVASLIGNSWRFYDGNKVFLSQFIFS 239
Query: 250 DNTDGNATWIAVLANDGFISFYNLQDGEPSTASNTKIPNSPCSTPEPCDAYYICSGINKC 309
D+ D +ATWIAVL NDGFISFYNL E AS TKIP+ PCS PEPCDA+++CSG N C
Sbjct: 240 DSVDASATWIAVLGNDGFISFYNLD--ESGGASQTKIPSDPCSRPEPCDAHFVCSGNNVC 297
Query: 310 QCPSVISSQ-NCKTGIASPCDHSKGSTELVSAGDGLNYFALGFVPPSSKADLNGCKKACL 368
QCPS +S++ NC+TGI S CD S STEL
Sbjct: 298 QCPSGLSTRSNCQTGIVSTCDGSHDSTEL------------------------------- 326
Query: 369 GNCSCLAMFFQNSSGNCFLFDRIGSLQSSNQGSGFVSYIKILSNGGSDTNNGGSGSNKKH 428
NCSCLA FFQNSSGNCFLF IGS Q+S G FV+YIK+LS+GGS +N GG GS+KK
Sbjct: 327 SNCSCLAFFFQNSSGNCFLFSDIGSFQNSKAGPSFVAYIKVLSDGGSGSNAGGDGSSKKS 386
Query: 429 FPVVVIIVLSTSVVILGLLYVAIRYVRKKRKAPESPQETSEEDNFLENLSGMPVRFTYRD 488
FP+VVIIV++T + I GLLY+A RY R+K+K PESP+ETSEEDNFLE LSGMP+RF YRD
Sbjct: 387 FPIVVIIVIATLITICGLLYLAFRYHRRKKKMPESPRETSEEDNFLETLSGMPIRFGYRD 446
Query: 489 LQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLH 548
LQTATNNFSVKLGQGGFGSVYQG LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHH H
Sbjct: 447 LQTATNNFSVKLGQGGFGSVYQGALPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHHH 506
Query: 549 LVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKN-QEFLLDWETRFNIALGTAKGLAYLH 607
LV+L+GFCAEGTHRLLAYEFMANGSLDKWIFK+N +EFLLDWE RFNIA+GTAKGLAYLH
Sbjct: 507 LVRLKGFCAEGTHRLLAYEFMANGSLDKWIFKRNNEEFLLDWEARFNIAVGTAKGLAYLH 566
Query: 608 EDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWIT 667
EDCD +IIHCDIKPENVLLD + AKVSDFGLAKLM REQSHVFTTLRGTRGYLAPEWIT
Sbjct: 567 EDCDVKIIHCDIKPENVLLDGQFLAKVSDFGLAKLMNREQSHVFTTLRGTRGYLAPEWIT 626
Query: 668 NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727
NYAISEKSDVYSYGM+LLEIIGGRKNF E+S+K+HFPSYAFKMMEEGKLR ILDS+L
Sbjct: 627 NYAISEKSDVYSYGMLLLEIIGGRKNFIATESSEKSHFPSYAFKMMEEGKLREILDSKLR 686
Query: 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQPPTCSPLGARLYSSFF 787
D+ +RV T++KVALWC+QEDM LRPSMTKVVQMLEG+ PVP PPT SPLG RLYSSFF
Sbjct: 687 FDKDDERVSTSIKVALWCIQEDMHLRPSMTKVVQMLEGLSPVPLPPTSSPLGPRLYSSFF 746
Query: 788 RSISEEGTSSGPSDCNSDAYLSAVRLSGPR 817
+SIS EGTSSGPSD NSDAYLSAV+LSGPR
Sbjct: 747 KSISGEGTSSGPSDSNSDAYLSAVQLSGPR 776
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225430295|ref|XP_002282684.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1185 bits (3065), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 577/802 (71%), Positives = 670/802 (83%), Gaps = 15/802 (1%)
Query: 22 KTCMASIQSIGKILPGFQGAQMTFIDKNGLFLLSNNSDFAFGFRTTENDVTLFLLVIMHK 81
+TCMAS+Q GK+ PGF+G+QM +ID +G FLLSNNSDFAFGF T NDV LFLLV++H
Sbjct: 23 ETCMASVQRHGKVEPGFEGSQMNWIDNDGHFLLSNNSDFAFGFEAT-NDVQLFLLVVIHL 81
Query: 82 ASSTIIWTANRGSPVANSDNFVFKKDGEVSLQKGGSVVWSVNPSGASVSAMELRDSGNLV 141
A+ IIWTANRGSPV NSD FVF G V LQKG VWS + +G +VSA+E++DSGNLV
Sbjct: 82 AAKKIIWTANRGSPVQNSDKFVFDDKGRVFLQKGNRTVWSPDTAGKAVSAIEMQDSGNLV 141
Query: 142 LLGNDNKVLWQSFSHPTDTLISNQDFTQGMKLVSAPSTNNLSYVLEIKSGDVVLSAGFPT 201
L+GN+ + +WQSF HPTDTL+S Q+F +GMKL S + +N+SY LEIKSG+++L AG+ T
Sbjct: 142 LVGNEGQPIWQSFDHPTDTLLSYQNFKEGMKLESDLTNDNISYYLEIKSGNMILYAGYRT 201
Query: 202 PQPYWSMGREERKTINKGGGEVTSASLSANSWRFYDNNKIFLWQFIFSDNTDGNATWIAV 261
PQPYWSM +E K + K G V SAS+ NSWRFYD NK LWQF+ S N D N+TW A
Sbjct: 202 PQPYWSMKKENLKIVEKDGDPV-SASIEGNSWRFYDRNKALLWQFVLSQNGDTNSTWAAT 260
Query: 262 LANDGFISFYNLQDGEPSTASNTKIPNSPCSTPEPCDAYYICSGINKCQCPSVISSQ-NC 320
L +DGFISF L DG S +IP CS+P C+AYYICS N+CQCPSV+SS+ NC
Sbjct: 261 LGSDGFISFTTLSDGGISQVQK-QIPGDSCSSPGFCEAYYICSS-NRCQCPSVLSSRPNC 318
Query: 321 KTGIASPCDHSKGSTELVSAGDGLNYFALGFVPPS-SKADLNGCKKACLGNCSCLAMFFQ 379
TGI SPC K STELV+AGDG NYFA+ F+ PS DLNGCK +CL NCSCLA FF+
Sbjct: 319 NTGIVSPC---KDSTELVNAGDGFNYFAIEFISPSLPDTDLNGCKNSCLSNCSCLASFFK 375
Query: 380 NSSGNCFLFDRIGSLQSSNQGSGFVSYIKILSNGGSDTN--NGGSGSNKKHFPVVVIIVL 437
NS+GNCFLFD +G LQS++ G GF YIK+ S+GGSD N G G +KKHFP VVII +
Sbjct: 376 NSTGNCFLFDSVGGLQSTD-GQGFAMYIKVSSSGGSDVNPGGDGGGGSKKHFPYVVIIAV 434
Query: 438 STSVVILGLLYVAIRYVRKKRKAPESPQE-TSEEDNFLENLSGMPVRFTYRDLQTATNNF 496
ST +VI+GL+YV RY R+K K+PESP + TSEEDNFLE+LSGMP+RF+Y+DLQTAT+NF
Sbjct: 435 STVLVIIGLVYVGFRYSRRK-KSPESPHDHTSEEDNFLESLSGMPIRFSYKDLQTATDNF 493
Query: 497 SVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFC 556
SVKLGQGGFGSVY+G LPDGT+LAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKL+GFC
Sbjct: 494 SVKLGQGGFGSVYRGALPDGTQLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLKGFC 553
Query: 557 AEGTHRLLAYEFMANGSLDKWIFKKNQE-FLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
AEG+HRLLAYEFMANGSLD+WIF+KN+E F+LDW TRFNIALGTAKGL+YLHEDCD +II
Sbjct: 554 AEGSHRLLAYEFMANGSLDRWIFRKNREGFMLDWNTRFNIALGTAKGLSYLHEDCDAKII 613
Query: 616 HCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKS 675
HCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKS
Sbjct: 614 HCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKS 673
Query: 676 DVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRV 735
DVYSYGMVLLEIIGGRKN+DP+E S+K+HFP+YAFKMMEEGKLR++LDSRL +DE+ +RV
Sbjct: 674 DVYSYGMVLLEIIGGRKNYDPSEISEKSHFPTYAFKMMEEGKLRDLLDSRLEVDEEDERV 733
Query: 736 FTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQPPTCSPLGARLYSSFFRSISEEGT 795
TA+KVA+WC+QEDM RPSM KVVQMLEG+C VPQPPT S +G+R YS FF+SISEEGT
Sbjct: 734 STAIKVAMWCIQEDMHQRPSMMKVVQMLEGLCAVPQPPTTSQMGSRFYSGFFKSISEEGT 793
Query: 796 SSGPSDCNSDAYLSAVRLSGPR 817
SSGPSDCNSDAYLSAVRLSGPR
Sbjct: 794 SSGPSDCNSDAYLSAVRLSGPR 815
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255548908|ref|XP_002515510.1| s-receptor kinase, putative [Ricinus communis] gi|223545454|gb|EEF46959.1| s-receptor kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1140 bits (2948), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 568/776 (73%), Positives = 658/776 (84%), Gaps = 8/776 (1%)
Query: 43 MTFIDKNGLFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNF 102
M +IDKNGLFL+SNNS+FAFGFR T+ D TLFLLVI+H + IW+ANRGSPV+NSD F
Sbjct: 1 MNWIDKNGLFLVSNNSNFAFGFRATQEDATLFLLVIIHLKTLKAIWSANRGSPVSNSDKF 60
Query: 103 VFKKDGEVSLQKGGSVVWSVNPSGASVSAMELRDSGNLVLLGNDNKVLWQSFSHPTDTLI 162
F DG VSL+KGG+ VW+ + G VSA+EL+DSGNLVLLGND+ V+WQSFSHPTDTLI
Sbjct: 61 FFGNDGHVSLRKGGNPVWTPDTGGERVSAIELQDSGNLVLLGNDSIVIWQSFSHPTDTLI 120
Query: 163 SNQDFTQGMKLVSAPSTNNLSYVLEIKSGDVVLSAGFPTPQPYWSMGREERKTINKGGGE 222
SNQ+F +GMKLVS PS NNL+YVLEIKSGD++LSAGF PQPYWSM + RKTINK G
Sbjct: 121 SNQEFLEGMKLVSDPSPNNLTYVLEIKSGDMILSAGFRIPQPYWSMKNDNRKTINKDGEG 180
Query: 223 VTSASLSANSWRFYDNNKIFLWQFIFSDNTDGNATWIAVLANDGFISFYNLQDGEPSTAS 282
VT ASL NSWRFYD NK+ LWQFIF +T+ NATWIA++ DGFISF NL + TA+
Sbjct: 181 VTLASLDGNSWRFYDRNKVLLWQFIFEHSTE-NATWIAIIGGDGFISFRNLDN--EGTAA 237
Query: 283 NTKIPNSPCSTPEPCDAYYICSGINKCQCPSVISS-QNCKTGIASPCDHSKGSTELVSAG 341
+ KIP+ CS PE C A+ IC+ N CQCPS +S+ NC TGI S C+ SK STELVSAG
Sbjct: 238 DIKIPSDTCSRPEACAAHLICAVNNICQCPSALSTFTNCNTGIVSSCNSSKASTELVSAG 297
Query: 342 DGLNYFALGFVPPSSKADLNGCKKACLGNCSCLAMFFQNSSGNCFLFDRIGSLQSSNQGS 401
+GL+YFALGFV PSSK +L GCK +C NCSCLA+FFQNS+G+CFLFD+IGS ++S GS
Sbjct: 298 NGLDYFALGFVSPSSKTNLEGCKSSCRNNCSCLALFFQNSTGDCFLFDQIGSFRNSGSGS 357
Query: 402 GFVSYIKILSNGGSDTNNGGSGSNKKHFPVVVIIVLSTSVVILGLLYVAIRYVRKKRKAP 461
F +YIKILSN GS G +G K+ FP VVIIV++T +VI GLLYVA RY + K++ P
Sbjct: 358 SFDAYIKILSNRGS----GVTGRRKEDFPYVVIIVVATIIVICGLLYVAFRYFKNKKRFP 413
Query: 462 ESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAV 521
ESP +TSE+DNFLE+LSGMP+R++YRDLQTATNNFSVKLG GGFGSVYQGVLPDGTRLAV
Sbjct: 414 ESPHDTSEDDNFLESLSGMPLRYSYRDLQTATNNFSVKLGHGGFGSVYQGVLPDGTRLAV 473
Query: 522 KKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKK 581
KKLEGIGQG+KEFRAEVSIIGSIHH HLV+L+GFCAEGTHRLLAYEFMANGSLDKWIF++
Sbjct: 474 KKLEGIGQGRKEFRAEVSIIGSIHHHHLVRLKGFCAEGTHRLLAYEFMANGSLDKWIFRR 533
Query: 582 NQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK 641
N+E LLDWETRFNIALGTAKGLAYLHEDCD +IIHCDIKPENVLLDDN+ AKVSDFGLAK
Sbjct: 534 NKEELLDWETRFNIALGTAKGLAYLHEDCDVKIIHCDIKPENVLLDDNFIAKVSDFGLAK 593
Query: 642 LMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSD 701
LMTREQSHVFTTLRGTRGYLAPEW+TNYAISEKSDVYSYGM+LLEII GRKNF E+S+
Sbjct: 594 LMTREQSHVFTTLRGTRGYLAPEWLTNYAISEKSDVYSYGMLLLEIISGRKNFVATESSE 653
Query: 702 KAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761
K+HFPS+AFKMME GK+R ILDS L +DE +R+ A+KVALWC+QEDM LRPSM KVVQ
Sbjct: 654 KSHFPSFAFKMMERGKVREILDSALMLDETDERISDAIKVALWCIQEDMHLRPSMPKVVQ 713
Query: 762 MLEGICPVPQPPTCSPLGARLYSSFFRSISEEGTSSGPSDCNSDAYLSAVRLSGPR 817
ML+G+C VPQPPT SPLG RL+S+F +S SEEG+SSGPSDCNS+AYLS+V+LSGPR
Sbjct: 714 MLDGLCTVPQPPTSSPLGYRLFSTFLKSTSEEGSSSGPSDCNSEAYLSSVQLSGPR 769
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356518250|ref|XP_003527792.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1135 bits (2935), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 560/818 (68%), Positives = 668/818 (81%), Gaps = 11/818 (1%)
Query: 5 NLIHLIGFFLVSLILISKTCMASIQSIGKILPG-FQGAQMTFIDKNGLFLLSNNSDFAFG 63
+ H+ G +L L+ K C+A Q G++LPG G+QM +ID++G FL+S FAFG
Sbjct: 6 SFFHITG----TLFLLCKVCLAGSQYSGRVLPGVLNGSQMNWIDRDGKFLVSKKVQFAFG 61
Query: 64 FRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVSLQKGGSVVWSVN 123
F TT ND T FLL I+H A++ +IWTANR PVANSDNFVF + G LQK G++VWS +
Sbjct: 62 FVTTTNDTTKFLLAIIHVATTRVIWTANRAVPVANSDNFVFDEKGNAFLQKDGTLVWSTS 121
Query: 124 PSGASVSAMELRDSGNLVLLGNDNK-VLWQSFSHPTDTLISNQDFTQGMKLVSAPSTNNL 182
S VS+MEL D+GNLVLLG DN V+WQSFSHPTDTL+ Q+FT+GMKL+S PS+NNL
Sbjct: 122 TSNKGVSSMELLDTGNLVLLGIDNSTVIWQSFSHPTDTLLPTQEFTEGMKLISDPSSNNL 181
Query: 183 SYVLEIKSGDVVLSAGFPTPQPYWSMGREERKTINKGGGEVTSASLSANSWRFYDNNKIF 242
++VLEIKSG+VVL+AGF TPQPYW+M ++ R+ INKGG V SA++S NSWRFYD +K
Sbjct: 182 THVLEIKSGNVVLTAGFRTPQPYWTMQKDNRRVINKGGDAVASANISGNSWRFYDKSKSL 241
Query: 243 LWQFIFSDNTDGNATWIAVLANDGFISFYNLQDGEPSTASNTKIPNSPCSTPEPCDAYYI 302
LWQFIFS + NATWIAVL +DGFI+F NL DG + AS T IP C+TPEPCDAY I
Sbjct: 242 LWQFIFSADQGTNATWIAVLGSDGFITFSNLNDGGSNAASPTTIPQDSCATPEPCDAYTI 301
Query: 303 CSG-INKCQCPSVISSQNCKTGIASPCD-HSKGSTELVSAGDGLNYFALGFVPPSSKADL 360
C+G +C CPSVI S CK G SPC S+ S +LV A DGL+YFAL F+ P SK DL
Sbjct: 302 CTGDQRRCSCPSVIPS--CKPGFDSPCGGDSEKSIQLVKADDGLDYFALQFLQPFSKTDL 359
Query: 361 NGCKKACLGNCSCLAMFFQNSSGNCFLFDRIGSLQSSNQGSGFVSYIKILSNGGSDTNNG 420
GC+ +C GNCSCLA+FF SSG+CFL D +GS Q + SG+VSYIK+ ++GG+ T +G
Sbjct: 360 AGCQSSCRGNCSCLALFFHRSSGDCFLLDSVGSFQKPDSDSGYVSYIKVSTDGGAGTGSG 419
Query: 421 GSGSNKKHFPVVVIIVLSTSVVILGLLYVAIRYVRKKRKAPESPQETSEEDNFLENLSGM 480
G G KH VVV+IV+ VVI GL++ +RY R+K++ PESP+E SEEDNFLENL+GM
Sbjct: 420 GGGGVHKHTIVVVVIVIIALVVICGLVFGGVRYHRRKQRLPESPREGSEEDNFLENLTGM 479
Query: 481 PVRFTYRDLQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSI 540
P+R++Y+DL+ ATNNFSVKLGQGGFGSVY+GVLPDGT+LAVKKLEGIGQGKKEFRAEVSI
Sbjct: 480 PIRYSYKDLEAATNNFSVKLGQGGFGSVYKGVLPDGTQLAVKKLEGIGQGKKEFRAEVSI 539
Query: 541 IGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQ-EFLLDWETRFNIALGT 599
IGSIHHLHLV+L+GFCA+GTHRLLAYE+++NGSLDKWIFKKN+ EF LDW+TRFNIALGT
Sbjct: 540 IGSIHHLHLVRLKGFCADGTHRLLAYEYLSNGSLDKWIFKKNKGEFQLDWDTRFNIALGT 599
Query: 600 AKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRG 659
AKGLAYLHEDCD +I+HCDIKPENVLLDD++ AKVSDFGLAKLM REQSHVFTTLRGTRG
Sbjct: 600 AKGLAYLHEDCDSKIVHCDIKPENVLLDDHFMAKVSDFGLAKLMNREQSHVFTTLRGTRG 659
Query: 660 YLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLR 719
YLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKN+DP+++S+K+HFP+YA+KMMEEGKLR
Sbjct: 660 YLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNYDPSKSSEKSHFPTYAYKMMEEGKLR 719
Query: 720 NILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQPPTCSPLG 779
+I DS L IDE DR A+KVALWC+QEDMS+RPSMT+VVQMLEGIC VP PPT S LG
Sbjct: 720 DIFDSELKIDENDDRFQCAIKVALWCIQEDMSMRPSMTRVVQMLEGICIVPNPPTSSSLG 779
Query: 780 ARLYSSFFRSISEEGTSSGPSDCNSDAYLSAVRLSGPR 817
+RLY++ F+S SE TSSGPSDCNSDAYLSAVRLSGPR
Sbjct: 780 SRLYATVFKSSSEGATSSGPSDCNSDAYLSAVRLSGPR 817
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356562038|ref|XP_003549282.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1127 bits (2915), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 555/816 (68%), Positives = 656/816 (80%), Gaps = 12/816 (1%)
Query: 5 NLIHLIGFFLVSLILISKTCMASIQSIGKILPGFQGAQMTFIDKNGLFLLSNNSDFAFGF 64
+L + L+ ++L S+ + S Q++GK+ PG +G+QM +ID+ G+ L S N +F FG
Sbjct: 6 SLFSAMDTLLLCILLSSEVVLTSYQNVGKVYPGIEGSQMNWIDRYGILLESYNGEFGFGL 65
Query: 65 RTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVSLQKGGSVVWSVNP 124
TT ND TLFLL I+H + ++W ANR PV+NSD FVF + G V L KG SVVWS
Sbjct: 66 VTTANDSTLFLLAIVHMHTPKLVWVANRELPVSNSDKFVFDEKGNVILHKGESVVWSTYT 125
Query: 125 SGASVSAMELRDSGNLVLLGNDNKVLWQSFSHPTDTLISNQDFTQGMKLVSAPSTNNLSY 184
SG VS+MEL+D+GNLVLLGND++V+WQSFSHPTDTL+ QDF +GMKLVS P NNL+Y
Sbjct: 126 SGKGVSSMELKDTGNLVLLGNDSRVIWQSFSHPTDTLLPMQDFIEGMKLVSEPGPNNLTY 185
Query: 185 VLEIKSGDVVLSAGFPTPQPYWSMGREERKTI-NKGGGEVTSASLSANSWRFYDNNKIFL 243
VLEI+SG V+LS G TPQPYWSM ++ RK I NK G V SA+L ANSWRFYD K L
Sbjct: 186 VLEIESGSVILSTGLQTPQPYWSMKKDSRKKIVNKNGDVVASATLDANSWRFYDETKSLL 245
Query: 244 WQFIFSDNTDGNATWIAVLANDGFISFYNLQDGEPSTASNTKIPNSPCSTPEPCDAYYIC 303
W+ F++ +D NATWIAVL +DGFI+F NL G AS T+IP CSTPEPCD Y IC
Sbjct: 246 WELDFAEESDANATWIAVLGSDGFITFSNLLSGGSIVASPTRIPQDSCSTPEPCDPYNIC 305
Query: 304 SGINKCQCPSVISSQ-NCKTGIASPCDHSKGSTELVSAGDGLNYFALGFVPPSSKADLNG 362
SG KC CPSV+SS+ NCK G SPC+ SK + ELV A D LNYFALGFVPPSSK DL G
Sbjct: 306 SGEKKCTCPSVLSSRPNCKPGFVSPCN-SKSTIELVKADDRLNYFALGFVPPSSKTDLIG 364
Query: 363 CKKACLGNCSCLAMFFQNSSGNCFLFDRIGSLQSSNQGSGFVSYIKILSNGGSDTNNGGS 422
CK +C NCSCLAMFF +SSGNCFLFDRIGS + S++ SG VSYIK++S+ G DT + S
Sbjct: 365 CKTSCSANCSCLAMFFNSSSGNCFLFDRIGSFEKSDKDSGLVSYIKVVSSEG-DTRD--S 421
Query: 423 GSNKKHFPVVVIIVLSTSVVILGLLYVAIRYVRKKRKAPESPQETSEEDNFLENLSGMPV 482
GS+K VVVIIV+ T VI G+L+VA R RKK ESPQE SE+D+FLE+L+GMP+
Sbjct: 422 GSSKMQTIVVVIIVIVTLFVISGMLFVAHRCFRKKEDLLESPQEDSEDDSFLESLTGMPI 481
Query: 483 RFTYRDLQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIG 542
R++Y DL+TAT+NFSV+LG+GGFGSVY+GVLPDGT+LAVKKLEGIGQGKKEFR EVSIIG
Sbjct: 482 RYSYTDLETATSNFSVRLGEGGFGSVYKGVLPDGTQLAVKKLEGIGQGKKEFRVEVSIIG 541
Query: 543 SIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKN-QEFLLDWETRFNIALGTAK 601
SIHH HLV+L+GFCAEG+HR+LAYE+MANGSLDKWIF KN +EF+LDW+TR+NIALGTAK
Sbjct: 542 SIHHHHLVRLKGFCAEGSHRVLAYEYMANGSLDKWIFNKNKEEFVLDWDTRYNIALGTAK 601
Query: 602 GLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL 661
GLAYLHEDCD +IIHCDIKPENVLLDDN+ KVSDFGLAKLMTREQSHVFTTLRGTRGYL
Sbjct: 602 GLAYLHEDCDSKIIHCDIKPENVLLDDNFRVKVSDFGLAKLMTREQSHVFTTLRGTRGYL 661
Query: 662 APEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721
APEWITN +ISEKSDVYSYGMVLLEIIGGRKN+DP+ETS+K+HFPS+AFKM+EEG +R I
Sbjct: 662 APEWITNCSISEKSDVYSYGMVLLEIIGGRKNYDPSETSEKSHFPSFAFKMVEEGNVREI 721
Query: 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQPPTCSPLGAR 781
LDS++ E +RV AV VALWC+QEDMSLRPSMTKVVQMLEG+C V +PPTCS LG+R
Sbjct: 722 LDSKVETYENDERVHIAVNVALWCIQEDMSLRPSMTKVVQMLEGLCTVHKPPTCSVLGSR 781
Query: 782 LYSSFFRSISEEGTSSGPSDCNSDAYLSAVRLSGPR 817
YS+ SE GTSSGPSDCNS+A LSAVRLSGPR
Sbjct: 782 FYST-----SEVGTSSGPSDCNSEANLSAVRLSGPR 812
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356509918|ref|XP_003523689.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1118 bits (2891), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 558/817 (68%), Positives = 664/817 (81%), Gaps = 9/817 (1%)
Query: 7 IHLIGFFLV-SLILISKTCMASIQSIGKILPGF-QGAQMTFIDKNGLFLLSNNSDFAFGF 64
IH F + +L L+ K C+A IQ G + PG G+QM +ID++G FL+S FAF F
Sbjct: 3 IHWPFFHITGTLFLLCKVCLAGIQYSGSVSPGIINGSQMNWIDRDGKFLVSKEGQFAFAF 62
Query: 65 RTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVSLQKGGSVVWSVNP 124
T ND T FLL I+H A+ +IWTANR PVANSDNFVF + G L+K G++VWS N
Sbjct: 63 VATANDSTKFLLAIVHVATERVIWTANRAVPVANSDNFVFDEKGNAFLEKDGTLVWSTNT 122
Query: 125 SGASVSAMELRDSGNLVLLGNDNK-VLWQSFSHPTDTLISNQDFTQGMKLVSAPSTNNLS 183
S VS+MEL D+GNLVLLG+DN V+WQSF+HPTDTL+ Q+FT+GMKL+S PSTNNL+
Sbjct: 123 SNKGVSSMELLDTGNLVLLGSDNSTVIWQSFNHPTDTLLPTQEFTEGMKLISDPSTNNLT 182
Query: 184 YVLEIKSGDVVLSAGFPTPQPYWSMGREERKTINKGGGEVTSASLSANSWRFYDNNKIFL 243
+ LEIKSG+VVL+AGF T QPYW+M ++ RK INK G V SA++S NSWRFY +K L
Sbjct: 183 HFLEIKSGNVVLTAGFRTLQPYWTMQKDNRKVINKDGDAVASANISGNSWRFYGKSKSLL 242
Query: 244 WQFIFSDNTDGNATWIAVLANDGFISFYNLQDGEPSTASNTKIPNSPCSTPEPCDAYYIC 303
WQFIFS + NATWIAVL +DGFI+F NL GE S A++ +IP C+TPEPCDAY IC
Sbjct: 243 WQFIFSTDQGTNATWIAVLGSDGFITFSNLNGGE-SNAASQRIPQDSCATPEPCDAYTIC 301
Query: 304 SGINKCQCPSVISSQNCKTGIASPCD-HSKGSTELVSAGDGLNYFALGFVPPSSKADLNG 362
+G +C CPSVI S CK G SPC S+ S +LV A DGL+YFAL F+ P S DL G
Sbjct: 302 TGNQRCSCPSVIPS--CKPGFDSPCGGDSEKSIQLVKADDGLDYFALQFLQPFSITDLAG 359
Query: 363 CKKACLGNCSCLAMFFQNSSGNCFLFDRIGSLQSSNQGSGFVSYIKILSNGGSDTNNGGS 422
C+ +C GNCSCLA+FF SSG+CFL + +GS Q + SG+VSYIK+ + GG+ T +GGS
Sbjct: 360 CQSSCRGNCSCLALFFHISSGDCFLLNSVGSFQKPDSDSGYVSYIKVSTVGGAGTGSGGS 419
Query: 423 GSNKKHFPVVVIIVLSTSVVILGLLYVAIRYVRKKRKAPESPQETSEEDNFLENLSGMPV 482
G KH VVV+IV+ T +VI GL++ +RY R+K++ PESP++ SEEDNFLENL+GMP+
Sbjct: 420 GGGNKHTIVVVVIVIITLLVICGLVFGGVRYHRRKQRLPESPRDGSEEDNFLENLTGMPI 479
Query: 483 RFTYRDLQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIG 542
R++Y+DL+TATNNFSVKLGQGGFGSVY+G LPDGT+LAVKKLEGIGQGKKEFRAEVSIIG
Sbjct: 480 RYSYKDLETATNNFSVKLGQGGFGSVYKGALPDGTQLAVKKLEGIGQGKKEFRAEVSIIG 539
Query: 543 SIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQ-EFLLDWETRFNIALGTAK 601
SIHHLHLV+LRGFCA+GTHRLLAYE+++NGSLDKWIFKKN+ EFLLDW+TRFNIALGTAK
Sbjct: 540 SIHHLHLVRLRGFCADGTHRLLAYEYLSNGSLDKWIFKKNKGEFLLDWDTRFNIALGTAK 599
Query: 602 GLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL 661
GLAYLHEDCD +I+HCDIKPENVLLDD++ AKVSDFGLAKLM REQSHVFTTLRGTRGYL
Sbjct: 600 GLAYLHEDCDSKIVHCDIKPENVLLDDHFMAKVSDFGLAKLMNREQSHVFTTLRGTRGYL 659
Query: 662 APEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721
APEWITNYAISEKSDVYSYGMVLLEIIGGRKN+DP E+S+K+HFP+YAFKMMEEGKLR+I
Sbjct: 660 APEWITNYAISEKSDVYSYGMVLLEIIGGRKNYDPRESSEKSHFPTYAFKMMEEGKLRDI 719
Query: 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQPPTCSPLGAR 781
DS L IDE DR A+KVALWC+QEDMS+RPSMT+VVQMLEGIC VP+PPT S LG+R
Sbjct: 720 FDSELEIDENDDRFQCAIKVALWCIQEDMSMRPSMTRVVQMLEGICIVPKPPTSSSLGSR 779
Query: 782 LYSSFFRSISEEG-TSSGPSDCNSDAYLSAVRLSGPR 817
LY++ F+S SEEG TSS PSDCNSDAYLSAVRLSGPR
Sbjct: 780 LYATMFKSSSEEGATSSAPSDCNSDAYLSAVRLSGPR 816
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449437142|ref|XP_004136351.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1111 bits (2874), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 540/785 (68%), Positives = 638/785 (81%), Gaps = 19/785 (2%)
Query: 43 MTFIDKNGLFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNF 102
M +ID NGLFL+SNNS F FGF TT+ DVT+FLL ++H +S ++W+ANR PVANSD F
Sbjct: 1 MNWIDNNGLFLMSNNSKFGFGFVTTQ-DVTMFLLAVIHTSSLRVVWSANRAFPVANSDEF 59
Query: 103 VFKKDGEVSLQKGGSVVWSVNPSGASVSAMELRDSGNLVLLGN--DNKVLWQSFSHPTDT 160
F + G L+KG VVWS N S VS++EL++SGNLVL N DN+++W+SFSHPTDT
Sbjct: 60 TFDEKGNAMLKKGSVVVWSTNSSDKGVSSLELQNSGNLVLRANNSDNEIVWESFSHPTDT 119
Query: 161 LISNQDFTQGMKLVSAPSTNN-LSYVLEIKSGDVVLSAGFPTPQPYWSMGREERKTINKG 219
L+S QDF +GM+LVS S NN +SY LE+KSGD+ LSAGF +PQ YWSM +E RKT+NK
Sbjct: 120 LLSGQDFVEGMRLVSDLSNNNNMSYFLEMKSGDMTLSAGFQSPQTYWSMAKENRKTVNKN 179
Query: 220 GGEVTSASLSANSWRFYDNNKIFLWQFIFSDNTDGNATWIAVLANDGFISFYNLQDGEPS 279
GG V SA+L NSW+FYD +K+ LWQFIFS+ + NATWIAVL +DGF+SFYNLQD
Sbjct: 180 GGAVYSATLDTNSWKFYDRSKVLLWQFIFSNVANENATWIAVLGDDGFVSFYNLQDS--G 237
Query: 280 TASNTKIPNSPCSTPEPCDAYYICSGINKCQCPSVISSQ-NCKTGIASPCDHSKGSTELV 338
AS T+IP CSTPEPC Y+IC NKCQCPSV+S+ +C+ GI SPC S GS +L
Sbjct: 238 AASTTRIPEDSCSTPEPCGPYFICYSGNKCQCPSVLSTNPSCQPGIVSPCHQSNGSIKLA 297
Query: 339 SAGDGLNYFALGFVPPSSKADLNGCKKACLGNCSCLAMFFQNSSGNCFLFDRIGSLQSSN 398
A G+ YFAL F+P +S DLNGCK AC+ NCSC A+FF+N +GNCFL D +GS Q+SN
Sbjct: 298 YA-TGVKYFALEFLPSTSTTDLNGCKNACMSNCSCRALFFENLTGNCFLLDDVGSFQNSN 356
Query: 399 QGSGFVSYIKILSNGGSDT-----NNGGSGSNKKHFPVVVIIVLSTSVVILGLLYVAIRY 453
+ S FVSYIK+ +NGGS NGG S+ +V II++ T VI GLLY+A Y
Sbjct: 357 EDSNFVSYIKVSNNGGSGDNNGGSRNGGMNSH-----IVAIIIVFTGFVICGLLYLAFCY 411
Query: 454 VRKKRKAPESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSVKLGQGGFGSVYQGVL 513
++K+K P +P ETSE+DNFL+ L+G P+R++Y +LQTATNNFS+KLGQGGFGSVYQG+L
Sbjct: 412 YKRKKKLPGTPHETSEDDNFLDGLTGAPIRYSYDNLQTATNNFSMKLGQGGFGSVYQGLL 471
Query: 514 PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGS 573
PDGTR+AVKKLE +GQGKKEFRAEVSIIGSIHH+HLV+L+G+CAEG+H+LLAYE+M NGS
Sbjct: 472 PDGTRVAVKKLEAVGQGKKEFRAEVSIIGSIHHVHLVRLKGYCAEGSHKLLAYEYMGNGS 531
Query: 574 LDKWIFKKNQE-FLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHA 632
LDKWIF+KN+E FLLDW TRFNIALGTAKGLAYLHEDCD +IIHCDIKPENVLLDD + A
Sbjct: 532 LDKWIFRKNKEDFLLDWNTRFNIALGTAKGLAYLHEDCDVKIIHCDIKPENVLLDDKFLA 591
Query: 633 KVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRK 692
KVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRK
Sbjct: 592 KVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRK 651
Query: 693 NFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSL 752
NFD ETS+K HFPSYAFKMMEEGKL NILDS L I +RVFTA+KVALWC+QEDM L
Sbjct: 652 NFDSTETSEKCHFPSYAFKMMEEGKLENILDSNLAIKNGDERVFTAIKVALWCIQEDMHL 711
Query: 753 RPSMTKVVQMLEGICPVPQPPTCSPLGARLYSSFFRSISEEGTSSGPSDCNSDAYLSAVR 812
RP MT+VVQMLEG+C VP PPT SPLG+RL+SSFF+SISE GTSS PSDCNSDAYLSA++
Sbjct: 712 RPPMTRVVQMLEGLCAVPPPPTSSPLGSRLFSSFFKSISEGGTSSWPSDCNSDAYLSAMK 771
Query: 813 LSGPR 817
LSGPR
Sbjct: 772 LSGPR 776
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356554268|ref|XP_003545470.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1111 bits (2874), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 546/800 (68%), Positives = 646/800 (80%), Gaps = 14/800 (1%)
Query: 21 SKTCMASIQSIGKILPGFQGAQMTFIDKNGLFLLSNNSDFAFGFRTTENDVTLFLLVIMH 80
S+ + S ++GK+ P +G+QM +ID++G+ L+SN +F FG TT ND TLFLL I+H
Sbjct: 22 SEVVLTSFLNVGKVYPRIEGSQMNWIDRDGILLVSNKGEFGFGLVTTANDSTLFLLAIVH 81
Query: 81 KASSTIIWTANRGSPVANSDNFVFKKDGEVSLQKGGSVVWSVNPSGASVSAMELRDSGNL 140
K S+ ++W ANR PV+NSD FVF + G V L KG SVVWS + SG VS+MEL+D+GNL
Sbjct: 82 KYSNKVVWVANRALPVSNSDKFVFDEKGNVILHKGESVVWSSDTSGKGVSSMELKDTGNL 141
Query: 141 VLLGNDNKVLWQSFSHPTDTLISNQDFTQGMKLVSAPSTNNLSYVLEIKSGDVVLSAGFP 200
VLLGND++V+WQSF HPTDTL+ QDF +GMKLVS P NNL+YVLEI+SG+V+LS G
Sbjct: 142 VLLGNDSRVIWQSFRHPTDTLLPMQDFNEGMKLVSEPGPNNLTYVLEIESGNVILSTGLQ 201
Query: 201 TPQPYWSMGREERK-TINKGGGEVTSASLSANSWRFYDNNKIFLWQFIFSDNTDGNATWI 259
TPQPYWSM ++ RK INK G VTSA+L+ANSWRFYD K LW+ F++ +D NATWI
Sbjct: 202 TPQPYWSMKKDSRKKIINKNGDVVTSATLNANSWRFYDETKSMLWELDFAEESDANATWI 261
Query: 260 AVLANDGFISFYNLQDGEPSTASNTKIPNSPCSTPEPCDAYYICSGINKCQCPSVISSQ- 318
A L +DGFI+F NL G AS+T+IP CSTPE CD Y ICSG KC CPSV+SS+
Sbjct: 262 AGLGSDGFITFSNLLSGGSIVASSTRIPQDSCSTPESCDPYNICSGDKKCTCPSVLSSRP 321
Query: 319 NCKTGIASPCDHSKGSTELVSAGDGLNYFALGFVPPSSKADLNGCKKACLGNCSCLAMFF 378
NC+ G SPC+ SK +TELV DGLNYFALGFVPPSSK DL GCK +C NCSCLAMFF
Sbjct: 322 NCQPGNVSPCN-SKSTTELVKVDDGLNYFALGFVPPSSKTDLIGCKTSCSANCSCLAMFF 380
Query: 379 QNSSGNCFLFDRIGSLQSSNQGSGFVSYIKILSNGGSDTNNGGSGSNKKHFPVVVIIVLS 438
+SSGNCFL DRIGS + S++ SG VSYIK++S+ G + S+K VVVIIV+
Sbjct: 381 NSSSGNCFLLDRIGSFEKSDKDSGLVSYIKVVSSEGDIRD-----SSKMQIIVVVIIVIF 435
Query: 439 TSVVILGLLYVAIRYVRKKRKAPESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSV 498
T VI G+L+VA R RKK+ PESPQE E+D+FLE+L+GMP+R++Y DL+TAT+NFSV
Sbjct: 436 TLFVISGMLFVAHRCFRKKQDLPESPQEDLEDDSFLESLTGMPIRYSYNDLETATSNFSV 495
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558
KLG+GGFGSVY+GVLPDGT+LAVKKLEGIGQGKKEF EVSIIGSIHH HLV+L+GFCAE
Sbjct: 496 KLGEGGFGSVYKGVLPDGTQLAVKKLEGIGQGKKEFWVEVSIIGSIHHHHLVRLKGFCAE 555
Query: 559 GTHRLLAYEFMANGSLDKWIFKKN-QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHC 617
G+HRLLAYE+MANGSLDKWIF KN +EF+LDW+TR+NIALGTAKGLAYLHEDCD +IIHC
Sbjct: 556 GSHRLLAYEYMANGSLDKWIFNKNIEEFVLDWDTRYNIALGTAKGLAYLHEDCDSKIIHC 615
Query: 618 DIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDV 677
DIKPENVLLDDN+ KVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN AISEKSDV
Sbjct: 616 DIKPENVLLDDNFMVKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNCAISEKSDV 675
Query: 678 YSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFT 737
YSYGMVLLEIIG RKN+DP+ETS+K+HFPS+AF+MMEEG LR ILDS++ E +RV
Sbjct: 676 YSYGMVLLEIIGARKNYDPSETSEKSHFPSFAFRMMEEGNLREILDSKVETYENDERVHI 735
Query: 738 AVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQPPTCSPLGARLYSSFFRSISEEGTSS 797
AVKVALWC+QEDMSLRPSMTKVVQMLEG+C V +P CS LG+R YS+ SE GTSS
Sbjct: 736 AVKVALWCIQEDMSLRPSMTKVVQMLEGLCIVHKPAICSVLGSRFYST-----SEVGTSS 790
Query: 798 GPSDCNSDAYLSAVRLSGPR 817
GPSDCNS+A LSAVRLSGPR
Sbjct: 791 GPSDCNSEANLSAVRLSGPR 810
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297802800|ref|XP_002869284.1| lectin protein kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297315120|gb|EFH45543.1| lectin protein kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1106 bits (2861), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 541/820 (65%), Positives = 656/820 (80%), Gaps = 17/820 (2%)
Query: 13 FLVSLILISKTCMASIQSIGKILPGFQGAQMTFIDKNGLFLLSNNSDFAFGFRTTENDVT 72
F+ L+ + +A + SIGKI+PGF G+QM +I+ +G+FL SNNSDF FGF TT++ VT
Sbjct: 8 FVTCLVFLPDPLLAGVASIGKIIPGFGGSQMNYINNDGIFLESNNSDFGFGFVTTQDSVT 67
Query: 73 LFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVSLQK--GGSVVWSVNPSGASVS 130
LF L I+HK+S+ +IW+ANR SPV+NSD VF+ +G V L++ GG+ VW ++ SG + S
Sbjct: 68 LFTLSIIHKSSTKLIWSANRASPVSNSDKLVFEDNGNVVLRREDGGTEVWRLDNSGKNAS 127
Query: 131 AMELRDSGNLVLLGNDNKVLWQSFSHPTDTLISNQDFTQGMKLVSAPSTNNLSYVLEIKS 190
MELRDSGNLV++ D +W+SF HPTDTLI+NQ F +GMKL S+PS++N++Y LEIKS
Sbjct: 128 RMELRDSGNLVVVSVDGTSIWESFDHPTDTLITNQAFKEGMKLTSSPSSSNMTYALEIKS 187
Query: 191 GDVVLSAGFPTPQPYWSMGREERKTINKGGGEVTSASLSANSWRFYDNNKIFLWQFIFSD 250
GD+VLS TPQ YWSMG + INK GG VTS+SL NSWRF+D ++ LWQF+FSD
Sbjct: 188 GDMVLSVNSLTPQVYWSMGNSRERIINKDGGVVTSSSLLGNSWRFFDQKQVLLWQFVFSD 247
Query: 251 NTDGNATWIAVLANDGFISFYNLQDGEPSTASNTKIPNSPCSTPEPCDAYYICSGINKCQ 310
N D N TWIAVL N+G ISF NL G + S+TKIP+ C TPEPC YY+CSG C
Sbjct: 248 NKDDNTTWIAVLGNNGVISFSNLGSGTSAADSSTKIPSDLCGTPEPCGPYYVCSGSKVCG 307
Query: 311 CPSVISS--QNCKTGIASPCDHSKGST----ELVSAGDGLNYFALGFVPP-SSKADLNGC 363
C S +S +CKTGI SPC +K + +LV+AGDG++YFALGF PP S K DL+ C
Sbjct: 308 CVSGLSRARSDCKTGITSPCKKTKDNATLPLQLVNAGDGVDYFALGFAPPFSKKTDLDSC 367
Query: 364 KKACLGNCSCLAMFFQNSSGNCFLFDRIGSLQSS-NQGSGFVSYIKILSNGGSDTNNGGS 422
K+ C NCSCL +FFQNSSGNCFLFD +GS ++S N GSGFVSYIKI S S
Sbjct: 368 KEFCNNNCSCLGLFFQNSSGNCFLFDWVGSFKTSGNGGSGFVSYIKIAST--SSGGGDNG 425
Query: 423 GSNKKHFPVVVIIVLSTSVVILGLLYVAIRYVRKKRKAPESPQETSEEDNFLENLSGMPV 482
+ KHFP +VII++ T +I L++VA R ++K+ E+PQE+SEEDNFLENLSGMP+
Sbjct: 426 EDDGKHFPYIVIIIVVTIFIIAVLIFVAFRIHKRKKMILEAPQESSEEDNFLENLSGMPI 485
Query: 483 RFTYRDLQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIG 542
RF Y+DLQ+ATNNFSVKLGQGGFGSVY+G LPDG+RLAVKKLEGIGQGKKEFRAEVSIIG
Sbjct: 486 RFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVSIIG 545
Query: 543 SIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIF-KKNQEFLLDWETRFNIALGTAK 601
SIHHLHLV+LRGFCAEG HRLLAYEF++ GSL++WIF KK+ + LLDW+TRFNIALGTAK
Sbjct: 546 SIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAK 605
Query: 602 GLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL 661
GLAYLHEDCD RI+HCDIKPEN+LLDDN++AKVSDFGLAKLMTREQSHVFTT+RGTRGYL
Sbjct: 606 GLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGYL 665
Query: 662 APEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721
APEWITNYAISEKSDVYSYGMVLLE+IGGRKN+DP+ETS+K HFPS+AFK MEEGKL +I
Sbjct: 666 APEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHFPSFAFKKMEEGKLMDI 725
Query: 722 LDSRL-NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQPPTCSPLGA 780
+D ++ N+D +RV A+K ALWC+QEDM RPSM+KVVQMLEG+ PV QPP+ S +G+
Sbjct: 726 VDGKMKNVDVNDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPSSSTMGS 785
Query: 781 RLYSSFFRSISEEG---TSSGPSDCNSDAYLSAVRLSGPR 817
RLYSSFF+SISE+G TSSGPSDCNS+ YLSAVRLSGPR
Sbjct: 786 RLYSSFFKSISEDGGGTTSSGPSDCNSENYLSAVRLSGPR 825
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 817 | ||||||
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.982 | 0.978 | 0.645 | 6.4e-289 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.293 | 0.275 | 0.569 | 7.3e-121 | |
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.412 | 0.406 | 0.523 | 2.3e-112 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.903 | 0.891 | 0.353 | 6.3e-108 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.367 | 0.361 | 0.425 | 1.9e-86 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.363 | 0.349 | 0.405 | 2.8e-77 | |
| TAIR|locus:2147635 | 452 | AT5G20050 [Arabidopsis thalian | 0.385 | 0.696 | 0.469 | 1.5e-76 | |
| TAIR|locus:2197649 | 821 | AT1G61360 [Arabidopsis thalian | 0.363 | 0.361 | 0.424 | 2.7e-76 | |
| TAIR|locus:2197734 | 814 | AT1G61370 [Arabidopsis thalian | 0.587 | 0.589 | 0.329 | 1.6e-75 | |
| TAIR|locus:2197664 | 804 | AT1G61490 [Arabidopsis thalian | 0.505 | 0.513 | 0.358 | 6.7e-73 |
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2775 (981.9 bits), Expect = 6.4e-289, P = 6.4e-289
Identities = 531/823 (64%), Positives = 637/823 (77%)
Query: 11 GFFLV---SLILISKTCMASIQSIGKILPGFQGAQMTFIDKNGLFLLSNNSDFAFGFRTT 67
G F+V L+ + A + SIG I PGF G+QM +I+ +G+FL SNNS F FGF TT
Sbjct: 3 GVFIVIVTCLVFLPDPLRAGVASIGSITPGFGGSQMNYINNDGIFLESNNSAFGFGFVTT 62
Query: 68 ENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVSLQKGGSVVWSVNPSGA 127
++ VTLF L I+HK+S+ +IW+ANR SPV+NSD FVF +G V ++ G+ VW ++ SG
Sbjct: 63 QDSVTLFTLSIIHKSSTKLIWSANRASPVSNSDKFVFDDNGNVVME--GTEVWRLDNSGK 120
Query: 128 SVSAMELRDSGNLVLLGNDNKVLWQSFSHPTDTLISNQDFTQGMKLVSAPSTNNLSYVLE 187
+ S +ELRDSGNLV++ D +W+SF HPTDTLI+NQ F +GMKL S+PS++N++Y LE
Sbjct: 121 NASRIELRDSGNLVVVSVDGTSIWESFDHPTDTLITNQAFKEGMKLTSSPSSSNMTYALE 180
Query: 188 IKSGDVVLSAGFPTPQPYWSMGREERKTINKGGGEVTSASLSANSWRFYDNNKIFLWQFI 247
IKSGD+VLS TPQ YWSM + INK GG VTS+SL NSWRF+D ++ LWQF+
Sbjct: 181 IKSGDMVLSVNSLTPQVYWSMANARERIINKDGGVVTSSSLLGNSWRFFDQKQVLLWQFV 240
Query: 248 FSDNTDGNATWIAVLANDGFISFYNLQDGEPSTASNTKIPNSPCSTPEPCDAYYICSGIN 307
FSDN D N TWIAVL N+G ISF NL G + S+TKIP+ C TPEPC YY+CSG
Sbjct: 241 FSDNKDDNTTWIAVLGNNGVISFSNLGSGASAADSSTKIPSDLCGTPEPCGPYYVCSGSK 300
Query: 308 KCQCPSVISS--QNCKTGIASPCDHSKGST----ELVSAGDGLNYFALGFVPP-SSKADL 360
C C S +S +CKTGI SPC +K + +LVSAGDG++YFALG+ PP S K DL
Sbjct: 301 VCGCVSGLSRARSDCKTGITSPCKKTKDNATLPLQLVSAGDGVDYFALGYAPPFSKKTDL 360
Query: 361 NGCKKACLGNCSCLAMFFQNSSGNCFLFDRIGSLQSS-NQGSGFVSYIKILXXXXXXXXX 419
+ CK+ C NCSCL +FFQNSSGNCFLFD IGS ++S N GSGFVSYIKI
Sbjct: 361 DSCKEFCHNNCSCLGLFFQNSSGNCFLFDYIGSFKTSGNGGSGFVSYIKIASTGSGGGDN 420
Query: 420 XXXXXXKKHFPXXXXXXXXXXXXXXXXXYVAIRYVRKKRKAPESPQETSEEDNFLENLSG 479
KHFP +VA R ++K+ E+PQE+SEEDNFLENLSG
Sbjct: 421 GEDDG--KHFPYVVIIVVVTVFIIAVLIFVAFRIHKRKKMILEAPQESSEEDNFLENLSG 478
Query: 480 MPVRFTYRDLQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVS 539
MP+RF Y+DLQ+ATNNFSVKLGQGGFGSVY+G LPDG+RLAVKKLEGIGQGKKEFRAEVS
Sbjct: 479 MPIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVS 538
Query: 540 IIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIF-KKNQEFLLDWETRFNIALG 598
IIGSIHHLHLV+LRGFCAEG HRLLAYEF++ GSL++WIF KK+ + LLDW+TRFNIALG
Sbjct: 539 IIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALG 598
Query: 599 TAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR 658
TAKGLAYLHEDCD RI+HCDIKPEN+LLDDN++AKVSDFGLAKLMTREQSHVFTT+RGTR
Sbjct: 599 TAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTR 658
Query: 659 GYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKL 718
GYLAPEWITNYAISEKSDVYSYGMVLLE+IGGRKN+DP+ETS+K HFPS+AFK MEEGKL
Sbjct: 659 GYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHFPSFAFKKMEEGKL 718
Query: 719 RNILDSRL-NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQPPTCSP 777
+I+D ++ N+D +RV A+K ALWC+QEDM RPSM+KVVQMLEG+ PV QPP+ S
Sbjct: 719 MDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPSSST 778
Query: 778 LGARLYSSFFRSISEEG---TSSGPSDCNSDAYLSAVRLSGPR 817
+G+RLYSSFF+SISE+G TSSGPSDCNS+ YLSAVRLSGPR
Sbjct: 779 MGSRLYSSFFKSISEDGGATTSSGPSDCNSENYLSAVRLSGPR 821
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 749 (268.7 bits), Expect = 7.3e-121, Sum P(3) = 7.3e-121
Identities = 140/246 (56%), Positives = 190/246 (77%)
Query: 451 IRY--VRKKRKAPESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSVKLGQGGFGSV 508
+RY +R+K+ E+ + +F ++ G+P +F + +L+ AT NF +++G GGFGSV
Sbjct: 472 MRYSSIREKQVTRPGSFESGDLGSF--HIPGLPQKFEFEELEQATENFKMQIGSGGFGSV 529
Query: 509 YQGVLPDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567
Y+G LPD T +AVKK+ G G++EF E++IIG+I H +LVKLRGFCA G LL YE
Sbjct: 530 YKGTLPDETLIAVKKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYE 589
Query: 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD 627
+M +GSL+K +F N +L+W+ RF+IALGTA+GLAYLH CDQ+IIHCD+KPEN+LL
Sbjct: 590 YMNHGSLEKTLFSGNGP-VLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLH 648
Query: 628 DNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEI 687
D++ K+SDFGL+KL+ +E+S +FTT+RGTRGYLAPEWITN AISEK+DVYSYGMVLLE+
Sbjct: 649 DHFQPKISDFGLSKLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLEL 708
Query: 688 IGGRKN 693
+ GRKN
Sbjct: 709 VSGRKN 714
|
|
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 912 (326.1 bits), Expect = 2.3e-112, Sum P(2) = 2.3e-112
Identities = 179/342 (52%), Positives = 238/342 (69%)
Query: 468 SEEDNFLENLSGMPVRFTYRDLQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGI 527
S LE SG PV+FTY++LQ T +F KLG GGFG+VY+GVL + T +AVK+LEGI
Sbjct: 458 SSHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGI 517
Query: 528 GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLL 587
QG+K+FR EV+ I S HHL+LV+L GFC++G HRLL YEFM NGSLD ++F + L
Sbjct: 518 EQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFL 577
Query: 588 DWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT-RE 646
WE RFNIALGTAKG+ YLHE+C I+HCDIKPEN+L+DDN+ AKVSDFGLAKL+ ++
Sbjct: 578 TWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKD 637
Query: 647 QSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFP 706
+ +++RGTRGYLAPEW+ N I+ KSDVYSYGMVLLE++ G++NFD +E ++ F
Sbjct: 638 NRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFS 697
Query: 707 SYAFKMMEEGKLRNILDSRLNIDEQSD--RVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764
+A++ E+G + ILD+RL+ D+ D +V VK + WC+QE RP+M KVVQMLE
Sbjct: 698 IWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLE 757
Query: 765 GICPVPQPPTCSPLGARLYSSFFRSISEEG--TSSGPSDCNS 804
GI + P + +S S S +SGP+ +S
Sbjct: 758 GITEIKNPLCPKTISEVSFSGNSMSTSHASMFVASGPTRSSS 799
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1067 (380.7 bits), Expect = 6.3e-108, P = 6.3e-108
Identities = 286/809 (35%), Positives = 424/809 (52%)
Query: 53 LLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFK-KDGEVS 111
++S++ + GF + ++ + + S TI+W ANR V++ ++ VFK +G +
Sbjct: 38 IVSSDGTYEMGFFKPGSSSNFYIGMWYKQLSQTILWVANRDKAVSDKNSSVFKISNGNLI 97
Query: 112 LQKGG--SVVWSVN-PSGASVSAME--LRDSGNLVL-LGNDN---KVLWQSFSHPTDTLI 162
L G + VWS S +SVSA+E L+D GNLVL G + VLWQSF HP DT +
Sbjct: 98 LLDGNYQTPVWSTGLNSTSSVSALEAVLQDDGNLVLRTGGSSLSANVLWQSFDHPGDTWL 157
Query: 163 ------------SNQDFTQGMKLVSAPSTNNLSYVLEIKSGDVVLSAGFPTPQPYWSMGR 210
+Q T K + PS S L+ + +L G YWS G
Sbjct: 158 PGVKIRLDKRTGKSQRLTS-WKSLEDPSPGLFSLELDESTAYKILWNG---SNEYWSSGP 213
Query: 211 EERKTINKGGGEVTSASLS-ANSWRFYDNNKIFLWQFIFSDNTDGNATWIAVLANDGFIS 269
++ + V L+ ++ F+ N F +S N + V+ G I
Sbjct: 214 WNPQS--RIFDSVPEMRLNYIYNFSFFSNTTDSY--FTYSIYNQLNVSRF-VMDVSGQIK 268
Query: 270 FYNLQDGEPSTASNTKIPNSPCSTPEPCDAYYICSGINK--CQCPSVISSQNCKTGIASP 327
+ +G + P C C ++ ICS ++ C+CP + K
Sbjct: 269 QFTWLEGNKAWNLFWSQPRQQCQVYRYCGSFGICSDKSEPFCRCPQGFRPMSQKDWDLK- 327
Query: 328 CDHSKG---STEL-VSAGDGLNYFALGFVPPSSKAD------LNGCKKACLGNCSCLAMF 377
D+S G TEL S GD +F L + + ++ L+ C AC G+CSC A
Sbjct: 328 -DYSAGCVRKTELQCSRGDINQFFRLPNMKLADNSEVLTRTSLSICASACQGDCSCKAYA 386
Query: 378 FQNSSGNCFLFDR-IGSLQS--SNQGSGFVSYIKILXXXXXXXXXXXXXXXKKHFPXXXX 434
+ S C ++ + + +LQ G + Y+++ K
Sbjct: 387 YDEGSSKCLVWSKDVLNLQQLEDENSEGNIFYLRLAASDVPNVGASGKSNNKGLIFGAVL 446
Query: 435 XXXXXXXXXXXXXYVAIRYVRKKRKAPESPQETSEEDNFLENLSGMPVRFTYRDLQTATN 494
+ +RY R+KR E T LS F+YR+LQ AT
Sbjct: 447 GSLGVIVLVLLVVILILRYRRRKRMRGEKGDGT---------LSA----FSYRELQNATK 493
Query: 495 NFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRG 554
NFS KLG GGFGSV++G LPD + +AVK+LEGI QG+K+FR EV IG+I H++LV+LRG
Sbjct: 494 NFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEVVTIGTIQHVNLVRLRG 553
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIF--KKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
FC+EG+ +LL Y++M NGSLD +F + ++ +L W+ RF IALGTA+GLAYLH++C
Sbjct: 554 FCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRD 613
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAIS 672
IIHCDIKPEN+LLD + KV+DFGLAKL+ R+ S V TT+RGTRGYLAPEWI+ AI+
Sbjct: 614 CIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEWISGVAIT 673
Query: 673 EKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMM-EEGKLRNILDSRLNIDEQ 731
K+DVYSYGM+L E++ GR+N + +E FPS+A ++ ++G +R+++D RL D
Sbjct: 674 AKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATILTKDGDIRSLVDPRLEGDAV 733
Query: 732 S-DRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQPPTCSPLGARLYSS----F 786
+ V A KVA WC+Q++ S RP+M++VVQ+LEG+ V PP + A + S F
Sbjct: 734 DIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFPRSIQALVVSDEDVVF 793
Query: 787 F-RSISEEGTSSGPSDCNSDAYLSAVRLS 814
F S S +S + +S + S+ +++
Sbjct: 794 FTESSSSSSHNSSQNHKHSSSSSSSKKMT 822
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 602 (217.0 bits), Expect = 1.9e-86, Sum P(4) = 1.9e-86
Identities = 131/308 (42%), Positives = 186/308 (60%)
Query: 477 LSGMPVRFTYRDLQTATNNFSV--KLGQGGFGSVYQGVLPDGTRLAVKKLEGI-GQGKKE 533
L +P+ F ++ L ATNNFS+ KLGQGGFG+VY+G L +G +AVK+L GQG +E
Sbjct: 494 LKELPL-FEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEE 552
Query: 534 FRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRF 593
F EV +I + H +LV+L GFC EG R+L YEFM LD ++F ++ LLDW+TRF
Sbjct: 553 FVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRF 612
Query: 594 NIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT 653
NI G +GL YLH D +IIH D+K N+LLD+N + K+SDFGLA++ + V T
Sbjct: 613 NIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVSTV 672
Query: 654 -LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKM 712
+ GT GY+APE+ SEKSDV+S G++LLEI+ GR+N + +YA+K+
Sbjct: 673 RVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNLSAYAWKL 732
Query: 713 MEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI---CPV 769
G+ ++D + + + + V V L CVQ+ + RPS+ V+ ML P
Sbjct: 733 WNTGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSENSNLPE 792
Query: 770 PQPPTCSP 777
P+ P P
Sbjct: 793 PKQPAFIP 800
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 587 (211.7 bits), Expect = 2.8e-77, Sum P(3) = 2.8e-77
Identities = 124/306 (40%), Positives = 185/306 (60%)
Query: 476 NLSGMPVRFTYRDLQTATNNFSVK--LGQGGFGSVYQGVLPDGTRLAVKKLEG-IGQGKK 532
N S +PV F+ + ATN+F + LG+GGFG VY+GVL DG +AVK+L G GQG
Sbjct: 510 NTSELPV-FSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVD 568
Query: 533 EFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETR 592
EF+ E+ +I + H +LV+L G C EG ++L YE+M N SLD ++F + ++ L+DW+ R
Sbjct: 569 EFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLR 628
Query: 593 FNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT 652
F+I G A+GL YLH D RIIH D+K NVLLD + K+SDFG+A++ Q+ T
Sbjct: 629 FSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANT 688
Query: 653 T-LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFK 711
+ GT GY++PE+ S KSDVYS+G++LLEI+ G++N +S+ YA+
Sbjct: 689 VRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLR-SSEHGSLIGYAWY 747
Query: 712 MMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG---ICP 768
+ G+ ++D ++ + + VA+ CVQ+ + RP+M V+ MLE
Sbjct: 748 LYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLA 807
Query: 769 VPQPPT 774
P+ PT
Sbjct: 808 APRQPT 813
|
|
| TAIR|locus:2147635 AT5G20050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 771 (276.5 bits), Expect = 1.5e-76, P = 1.5e-76
Identities = 156/332 (46%), Positives = 222/332 (66%)
Query: 458 RKAPESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSVKLGQGGFGSVYQGVLPDGT 517
R A E +E E +FL ++G+P +F DL+ AT+ F +G+GG GSV++GVL DG+
Sbjct: 68 RFASEG-RELRIEYSFLRKVAGVPTKFKLEDLEEATDGFRSLIGKGGSGSVFKGVLKDGS 126
Query: 518 RLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTH---RLLAYEFMANGSL 574
++AVK++EG +G++EFR+EV+ I S+ H +LV+L G+ + + R L Y+++ N SL
Sbjct: 127 QVAVKRIEGEEKGEREFRSEVAAIASVQHKNLVRLYGYSSSTSANRPRFLVYDYIVNSSL 186
Query: 575 DKWIFK------KNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD 628
D WIF ++ L WE R+ +A+ AK LAYLH DC +I+H D+KPEN+LLD+
Sbjct: 187 DIWIFPDRGNRGRSGGGCLSWEQRYQVAIDVAKALAYLHHDCRSKILHLDVKPENILLDE 246
Query: 629 NYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEII 688
N+ A V+DFGL+KL+ R++S V T +RGTRGYLAPEW+ + ISEKSDVYSYG+VLLE+I
Sbjct: 247 NFRAVVTDFGLSKLIARDESRVLTDIRGTRGYLAPEWLLEHGISEKSDVYSYGIVLLEMI 306
Query: 689 GGRKNF---DPNETSDKA--HFPSYAFKMMEEGKLRNILDSRL-NIDE-QSDRVFTAVKV 741
GGR++ + ET K +FP + M E K+ I+D RL ++E + V V V
Sbjct: 307 GGRRSISRVEVKETKKKKLEYFPRIVNQKMRERKIMEIVDQRLIEVNEVDEEEVMKLVCV 366
Query: 742 ALWCVQEDMSLRPSMTKVVQMLEGICPVPQPP 773
ALWC+QE RP MT V++MLEG PV +PP
Sbjct: 367 ALWCIQEKSKKRPDMTMVIEMLEGRVPVNEPP 398
|
|
| TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 598 (215.6 bits), Expect = 2.7e-76, Sum P(3) = 2.7e-76
Identities = 129/304 (42%), Positives = 186/304 (61%)
Query: 475 ENLSGMPVRFTYRDLQTATNNFSV--KLGQGGFGSVYQGVLPDGTRLAVKKLEGIG-QGK 531
+++SG+ F DLQTATNNFSV KLGQGGFG+VY+G L DG +AVK+L QG
Sbjct: 478 QDVSGLNF-FEIHDLQTATNNFSVLNKLGQGGFGTVYKGKLQDGKEIAVKRLTSSSVQGT 536
Query: 532 KEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWET 591
+EF E+ +I + H +L++L G C +G +LL YE+M N SLD +IF ++ +DW T
Sbjct: 537 EEFMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYMVNKSLDIFIFDLKKKLEIDWAT 596
Query: 592 RFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651
RFNI G A+GL YLH D R++H D+K N+LLD+ + K+SDFGLA+L Q
Sbjct: 597 RFNIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDEKMNPKISDFGLARLFHGNQHQDS 656
Query: 652 T-TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAF 710
T ++ GT GY++PE+ SEKSD+YS+G+++LEII G++ + D + SYA+
Sbjct: 657 TGSVVGTLGYMSPEYAWTGTFSEKSDIYSFGVLMLEIITGKEISSFSYGKDNKNLLSYAW 716
Query: 711 KMMEEGKLRNILDSRLNIDEQSDRVFTA--VKVALWCVQEDMSLRPSMTKVVQMLEGICP 768
E N+LD L+ + + V V + L CVQ RP++ +V+ ML
Sbjct: 717 DSWSENGGVNLLDQDLDDSDSVNSVEAGRCVHIGLLCVQHQAIDRPNIKQVMSMLTSTTD 776
Query: 769 VPQP 772
+P+P
Sbjct: 777 LPKP 780
|
|
| TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 627 (225.8 bits), Expect = 1.6e-75, Sum P(2) = 1.6e-75
Identities = 170/516 (32%), Positives = 247/516 (47%)
Query: 282 SNTKIPNSPCSTPEPCDAYYICSGIN--KCQC-----PSVISSQN-------CKTGIASP 327
++ + P S C C + +C N KC+C P N C
Sbjct: 277 TDLEAPVSSCDVYNTCGPFGLCIRSNPPKCECLKGFVPKSDEEWNKRNWTGGCMRRTNLS 336
Query: 328 CDHSKGSTELVSAGDGLNYFALGFVPPS-----SKADLNGCKKACLGNCSCLAMFFQNSS 382
CD + +T + GD + A PP S + C++ CLGNCSC A +
Sbjct: 337 CDVNSSATAQANNGDIFDIVA-NVKPPDFYEYLSLINEEDCQQRCLGNCSCTAFSYIEQI 395
Query: 383 GNCFLFDRIGSLQSSNQGSGFVSYIKILXXXXXXXXXXXXXXXKKHFPXXXXXXXXXXXX 442
G C +++R L Q FV+ + L K
Sbjct: 396 G-CLVWNR--ELVDVMQ---FVAGGETLSIRLASSELAGSNRVK--IIVASIVSISVFMI 447
Query: 443 XXXXXYVAIRYVRKKRKAPESPQETSEEDNFLENLSGMPVRF-TYRDLQTATNNFSV--K 499
Y RY K+ + P ETS+ D + E L V F + + T TNNFS+ K
Sbjct: 448 LVFASYWYWRYKAKQNDSNPIPLETSQ-DAWREQLKPQDVNFFDMQTILTITNNFSMENK 506
Query: 500 LGQGGFGSVYQGVLPDGTRLAVKKLEGI-GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558
LGQGGFG VY+G L DG +A+K+L GQG +EF E+ +I + H +LV+L G C E
Sbjct: 507 LGQGGFGPVYKGNLQDGKEIAIKRLSSTSGQGLEEFMNEIILISKLQHRNLVRLLGCCIE 566
Query: 559 GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCD 618
G +LL YEFMAN SL+ +IF ++ LDW RF I G A GL YLH D R++H D
Sbjct: 567 GEEKLLIYEFMANKSLNTFIFDSTKKLELDWPKRFEIIQGIACGLLYLHRDSCLRVVHRD 626
Query: 619 IKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLR--GTRGYLAPEWITNYAISEKSD 676
+K N+LLD+ + K+SDFGLA++ Q H T R GT GY++PE+ SEKSD
Sbjct: 627 MKVSNILLDEEMNPKISDFGLARMFQGTQ-HQANTRRVVGTLGYMSPEYAWTGMFSEKSD 685
Query: 677 VYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVF 736
+Y++G++LLEII G++ + +A+ E ++LD ++ V
Sbjct: 686 IYAFGVLLLEIITGKRISSFTIGEEGKTLLEFAWDSWCESGGSDLLDQDISSSGSESEVA 745
Query: 737 TAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQP 772
V++ L C+Q+ RP++ +V+ ML +P+P
Sbjct: 746 RCVQIGLLCIQQQAGDRPNIAQVMSMLTTTMDLPKP 781
|
|
| TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 599 (215.9 bits), Expect = 6.7e-73, Sum P(2) = 6.7e-73
Identities = 154/430 (35%), Positives = 226/430 (52%)
Query: 351 FVPPSSKADLNGCKKACLGNCSCLAMFFQNSSGNCFLFDRIGSLQSSNQGSGFVSYIKIL 410
F S D C ++CL NCSCLA + + G C ++++ +L + Q F + +IL
Sbjct: 356 FYEYESSVDAEECHQSCLHNCSCLAFAYIHGIG-CLIWNQ--NLMDAVQ---FSAGGEIL 409
Query: 411 XXXXXXXXXXXXXXXKKHFPXXXXXXXXXXXXXXXXXYVAIRYVRKKRKAPESPQETSEE 470
K + RY R K KA + ++
Sbjct: 410 SIRLAHSELGGNKRNK--IIVASTVSLSLFVILTSAAFGFWRY-RVKHKA-YTLKDAWRN 465
Query: 471 DNFLENLSGMPVRFTYRDLQTATNNFSV--KLGQGGFGSVYQGVLPDGTRLAVKKLEGI- 527
D + + G+ F +QTATNNFS+ KLGQGGFGSVY+G L DG +AVK+L
Sbjct: 466 DLKSKEVPGLEF-FEMNTIQTATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKQLSSSS 524
Query: 528 GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLL 587
GQGK+EF E+ +I + H +LV++ G C EG +LL YEFM N SLD ++F ++ +
Sbjct: 525 GQGKEEFMNEIVLISKLQHRNLVRVLGCCIEGEEKLLIYEFMLNKSLDTFVFDARKKLEV 584
Query: 588 DWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647
DW RF+I G A+GL YLH D ++IH D+K N+LLD+ + K+SDFGLA++ Q
Sbjct: 585 DWPKRFDIVQGIARGLLYLHRDSRLKVIHRDLKVSNILLDEKMNPKISDFGLARMYEGTQ 644
Query: 648 SHVFTT-LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFP 706
T + GT GY++PE+ SEKSD+YS+G++LLEII G K + +
Sbjct: 645 CQDKTRRVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISRFSYGEEGKTLL 704
Query: 707 SYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
+YA++ E K ++LD L + V V++ L CVQ + RP+ +++ ML
Sbjct: 705 AYAWESWGETKGIDLLDQDLADSCRPLEVGRCVQIGLLCVQHQPADRPNTLELLAMLTTT 764
Query: 767 CPVPQP--PT 774
+P P PT
Sbjct: 765 SDLPSPKQPT 774
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8RWZ5 | SD25_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6585 | 0.9828 | 0.9780 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00061861 | hypothetical protein (816 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 817 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-56 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-47 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-37 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-28 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-26 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-23 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 7e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-23 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-22 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 3e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-22 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 7e-22 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-18 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-11 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 1e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-10 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 4e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-04 | |
| smart00605 | 94 | smart00605, CW, CW domain | 6e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.001 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 7e-56
Identities = 85/270 (31%), Positives = 128/270 (47%), Gaps = 26/270 (9%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEF---RAEVSIIGSIHHLHLVKLRG 554
KLG G FG+VY+ G +AVK L+ + K+ R E+ I+ + H ++V+L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
+ H L E+ G L ++ + L + IAL +GL YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHS---NGI 119
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI-TNYAISE 673
IH D+KPEN+LLD+N K++DFGLAK + + S TT GT Y+APE +
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS-LTTFVGTPWYMAPEVLLGGNGYGP 178
Query: 674 KSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSD 733
K DV+S G++L E++ G+ F D+ +R IL L DE
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSGENILDQLQ------------LIRRILGPPLEFDEPKW 226
Query: 734 RVF--TAVKVALWCVQEDMSLRPSMTKVVQ 761
A + C+ +D S RP+ +++Q
Sbjct: 227 SSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 5e-50
Identities = 71/193 (36%), Positives = 106/193 (54%), Gaps = 11/193 (5%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVKKL--EGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFC 556
LG+GGFG+VY G ++A+K + E +E E+ I+ ++H ++VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 557 AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIH 616
+ H L E+ GSL + + + L + I L +GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 617 CDIKPENVLLD-DNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPE-WITNYAISEK 674
D+KPEN+LLD DN K++DFGL+KL+T + T+ GT Y+APE + SEK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 675 SDVYSYGMVLLEI 687
SD++S G++L E+
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 2e-47
Identities = 72/250 (28%), Positives = 120/250 (48%), Gaps = 26/250 (10%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL--EGIGQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
KLG+G FG VY G +A+K + + I + ++ E+ I+ + H ++V+L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
+ L E+ G L + K + L + E RF L YLH + I+
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARF-YLRQILSALEYLH---SKGIV 119
Query: 616 HCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKS 675
H D+KPEN+LLD++ H K++DFGLA+ + + TT GT Y+APE + +
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPEVLLGKGYGKAV 177
Query: 676 DVYSYGMVLLEIIGGRKNFDPNET---------SDKAHFPSYAFKMMEEGK--LRNIL-- 722
D++S G++L E++ G+ F ++ K FP + + E K +R +L
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVK 237
Query: 723 --DSRLNIDE 730
+ RL +E
Sbjct: 238 DPEKRLTAEE 247
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 3e-47
Identities = 78/274 (28%), Positives = 133/274 (48%), Gaps = 30/274 (10%)
Query: 499 KLGQGGFGSVYQGVL---PDGTRL--AVKKL--EGIGQGKKEFRAEVSIIGSIHHLHLVK 551
KLG+G FG VY+G L DG + AVK L + Q +EF E I+ + H ++VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 552 LRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCD 611
L G C E ++ E+M G L ++ +KN+ L + AL A+G+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLE---S 121
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAI 671
+ IH D+ N L+ +N K+SDFGL++ + + + + ++APE +
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKF 181
Query: 672 SEKSDVYSYGMVLLEII-GGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730
+ KSDV+S+G++L EI G + + ++ + +++G RL
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE-------VLEYLKKGY-------RLPKPP 227
Query: 731 Q-SDRVFTAVKVALWCVQEDMSLRPSMTKVVQML 763
++ K+ L C ED RP+ +++V++L
Sbjct: 228 NCPPELY---KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 3e-47
Identities = 76/280 (27%), Positives = 127/280 (45%), Gaps = 43/280 (15%)
Query: 499 KLGQGGFGSVYQGVL---PDGTRL--AVKKL--EGIGQGKKEFRAEVSIIGSIHHLHLVK 551
KLG+G FG VY+G L ++ AVK L + Q +EF E I+ + H ++VK
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 552 LRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCD 611
L G C E + E+M G L ++ +KN+ L + AL A+G+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKL-SLSDLLSFALQIARGMEYLE---S 120
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAI 671
+ IH D+ N L+ +N K+SDFGL++ + + + + ++APE +
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF 180
Query: 672 SEKSDVYSYGMVLLEII-------GGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724
+ KSDV+S+G++L EI G N + + ++ G
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-------------VLEYLKNGY------- 220
Query: 725 RLNIDEQ-SDRVFTAVKVALWCVQEDMSLRPSMTKVVQML 763
RL ++ + L C ED RP+ +++V++L
Sbjct: 221 RLPQPPNCPPELY---DLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 1e-44
Identities = 81/280 (28%), Positives = 133/280 (47%), Gaps = 42/280 (15%)
Query: 499 KLGQGGFGSVYQGVL---PDGTRL--AVKKL-EGIG-QGKKEFRAEVSIIGSIHHLHLVK 551
KLG+G FG VY+G L +GT AVK L EG + ++EF E SI+ + H ++V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 552 LRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCD 611
L G C +G + E+M G L F + L + +AL AKG+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLD--FLRKHGEKLTLKDLLQMALQIAKGMEYLE---S 120
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRG---YLAPEWITN 668
+ +H D+ N L+ +N K+SDFGL++ + + + G + ++APE + +
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWMAPESLKD 178
Query: 669 YAISEKSDVYSYGMVLLEII-GGR---KNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724
+ KSDV+S+G++L EI G E +++E+G
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE----------VLELLEDGY------- 221
Query: 725 RLNIDEQ-SDRVFTAVKVALWCVQEDMSLRPSMTKVVQML 763
RL E D ++ ++ L C D RP+ +++V+ L
Sbjct: 222 RLPRPENCPDELY---ELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 7e-43
Identities = 78/288 (27%), Positives = 133/288 (46%), Gaps = 49/288 (17%)
Query: 499 KLGQGGFGSVYQGVLPDG----TRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKL 552
KLG+G FG VY+G L T +AVK L+ + +K+F E ++ + H ++V+L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFL------LDWETRFNIALGTAKGLAYL 606
G C E L E+M G L ++ K F L + + A+ AKG+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 607 HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT-----LRGTRGYL 661
++ +H D+ N L+ ++ K+SDFGL++ + + + T +R ++
Sbjct: 122 AS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----WM 174
Query: 662 APEWITNYAISEKSDVYSYGMVLLEII-GGRK---NFDPNETSDKAHFPSYAFKMMEEGK 717
APE + + + KSDV+S+G++L EI G E + + +G
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV----------LEYLRKG- 223
Query: 718 LRNILDSRLNIDEQ-SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764
RL E D ++ ++ L C Q D RP+ +++V+ LE
Sbjct: 224 ------YRLPKPEYCPDELY---ELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 9e-37
Identities = 66/205 (32%), Positives = 103/205 (50%), Gaps = 23/205 (11%)
Query: 499 KLGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQGKKEFRA---EVSIIGSIHHLHLVKLRG 554
LG+G FGSVY + D G +AVK +E G ++E A E+ I+ S+ H ++V+ G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 555 FC--AEGTHRLLAYEFMANGSLDKWI--FKKNQEFLLDWETRFNIALGTA---KGLAYLH 607
E + E+++ GSL + F K E + I T +GLAYLH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV--------IRKYTRQILEGLAYLH 118
Query: 608 EDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM-TREQSHVFTTLRGTRGYLAPEWI 666
I+H DIK N+L+D + K++DFG AK + E ++RGT ++APE I
Sbjct: 119 S---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 667 TNYAISEKSDVYSYGMVLLEIIGGR 691
+D++S G ++E+ G+
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 70/254 (27%), Positives = 119/254 (46%), Gaps = 37/254 (14%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKK--LEGIGQGKKEF-RAEVSIIGSIHHLHLVKLRG 554
++G+G FG VY DG +K+ L + + ++E EV I+ ++H +++K
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQ-------EFLLDWETRFNIALGTAKGLAYLH 607
E + E+ G L + I K+ + E +LDW + L L YLH
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCLA----LKYLH 120
Query: 608 EDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWIT 667
++I+H DIKP+N+ L N K+ DFG++K+++ T+ GT YL+PE
Sbjct: 121 ---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA-KTVVGTPYYLSPELCQ 176
Query: 668 NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEG----------K 717
N + KSD++S G VL E+ + F + + A K+++ +
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHPF------EGENLLELALKILKGQYPPIPSQYSSE 230
Query: 718 LRNILDSRLNIDEQ 731
LRN++ S L D +
Sbjct: 231 LRNLVSSLLQKDPE 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 498 VKLGQGGFGSVYQG-VLPDGTRLAVKKLEGIGQGKKEF-RAEVSIIGSIHHLHLVKLRGF 555
K+G+GGFG VY+ G +A+K ++ + KKE E+ I+ H ++VK G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIA---LGTAKGLAYLHEDCDQ 612
+ + EF + GSL + NQ IA KGL YLH
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-----IAYVCKELLKGLEYLHS---N 117
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAIS 672
IIH DIK N+LL + K+ DFGL+ ++ ++ T+ GT ++APE I
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR--NTMVGTPYWMAPEVINGKPYD 175
Query: 673 EKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHF 705
K+D++S G+ +E+ G+ + KA F
Sbjct: 176 YKADIWSLGITAIELAEGKPPY-SELPPMKALF 207
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 9e-31
Identities = 82/272 (30%), Positives = 121/272 (44%), Gaps = 23/272 (8%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKE----FRAEVSIIGSI-HHLHLVKLR 553
KLG+G FG VY D +A+K L + K + F E+ I+ S+ H ++VKL
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
F + L E++ GSL+ + K ++ L I L YLH +
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KG 121
Query: 614 IIHCDIKPENVLLDDNYH-AKVSDFGLAKLMTREQSHV-----FTTLRGTRGYLAPEWIT 667
IIH DIKPEN+LLD + K+ DFGLAKL+ S +T GT GY+APE +
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 668 ---NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724
S SD++S G+ L E++ G P E + S K++ E ++ S
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLP---PFEGEKNSSATSQTLKIILELPTPSLA-S 237
Query: 725 RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSM 756
L+ A + + +D R S
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 25/217 (11%)
Query: 496 FSVKLGQGGFGSVYQG---VLPDGTRL--AVKKL--EGIGQGKKEFRAEVSIIGSIHHLH 548
F +LG+G FG V L D T AVK L G Q + +F E+ I+ ++ H +
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 549 LVKLRGFCAEGTHR---LLAYEFMANGSLDKWI-FKKNQEFLLDWETRFNIALGTAKGLA 604
+VK +G E L E++ +GSL ++ ++Q ++ + + KG+
Sbjct: 68 IVKYKG-VCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKRLLLFSSQICKGMD 123
Query: 605 YLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRG----Y 660
YL QR IH D+ N+L++ K+SDFGLAK++ + + ++ +
Sbjct: 124 YLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP--EDKDYYYVKEPGESPIFW 178
Query: 661 LAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDP 696
APE + S SDV+S+G+ L E+ G + P
Sbjct: 179 YAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 63/188 (33%), Positives = 102/188 (54%), Gaps = 9/188 (4%)
Query: 500 LGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG 559
+G+G FG V G G ++AVK L+ + F AE S++ ++ H +LV+L G +G
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72
Query: 560 THRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDI 619
+ E+MA GSL ++ + + ++ + AL +G+ YL E + +H D+
Sbjct: 73 NPLYIVTEYMAKGSLVDYLRSRGRA-VITLAQQLGFALDVCEGMEYLEE---KNFVHRDL 128
Query: 620 KPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYS 679
NVL+ ++ AKVSDFGLAK ++ Q ++ T APE + S KSDV+S
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSDVWS 184
Query: 680 YGMVLLEI 687
+G++L EI
Sbjct: 185 FGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 66/213 (30%), Positives = 114/213 (53%), Gaps = 19/213 (8%)
Query: 500 LGQGGFGSVYQGV-LPDGTR----LAVKKL--EGIGQGKKEFRAEVSIIGSIHHLHLVKL 552
LG G FG+VY+GV +P+G + +A+K L E + KE E ++ S+ H H+V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
G C +L+ + M G L ++ +N + + + N + AKG++YL E +
Sbjct: 75 LGICLSSQVQLIT-QLMPLGCLLDYV--RNHKDNIGSQYLLNWCVQIAKGMSYLEE---K 128
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNY 669
R++H D+ NVL+ H K++DFGLAKL+ ++ G + ++A E I +
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE--GGKVPIKWMALESILHR 186
Query: 670 AISEKSDVYSYGMVLLEIIG-GRKNFDPNETSD 701
+ KSDV+SYG+ + E++ G K ++ +
Sbjct: 187 IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 23/206 (11%)
Query: 496 FSVKLGQGGFGSVYQGV-LPDGTRLAVKK--LEGIGQGK-KEFRAEVSIIGSIHHLHLVK 551
+G+G FG VY+G+ L G +A+K+ LE I + K E+ ++ ++ H ++VK
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 552 LRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIAL------GTAKGLAY 605
G + E+ NGSL + I KK F +L +GLAY
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQ-IIKKF--------GPFPESLVAVYVYQVLQGLAY 114
Query: 606 LHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEW 665
LHE Q +IH DIK N+L + K++DFG+A + + S ++ GT ++APE
Sbjct: 115 LHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEV 170
Query: 666 ITNYAISEKSDVYSYGMVLLEIIGGR 691
I S SD++S G ++E++ G
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 64/197 (32%), Positives = 105/197 (53%), Gaps = 20/197 (10%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGK-KEFRAEVSIIGSIHHLHLVKLRGFCA 557
KLG G FG V++G+ + R+A+K L+ K ++F+ EV + + H HL+ L C+
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 558 EGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETR-------FNIALGTAKGLAYLHEDC 610
G + E M GSL FL E + ++A A+G+AYL E
Sbjct: 73 VGEPVYIITELMEKGSL--------LAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE-- 122
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYA 670
Q IH D+ N+L+ ++ KV+DFGLA+L+ +E ++ + + + APE ++
Sbjct: 123 -QNSIHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDKKIPYKWTAPEAASHGT 180
Query: 671 ISEKSDVYSYGMVLLEI 687
S KSDV+S+G++L E+
Sbjct: 181 FSTKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 24/200 (12%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558
KLG G FG V+ G T++AVK L+ + F E I+ + H LV+L C+E
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 559 GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRF-------NIALGTAKGLAYLHEDCD 611
+ E+M+ GSL +FL E + ++A A+G+AYL
Sbjct: 73 EEPIYIVTEYMSKGSL--------LDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES--- 121
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITN 668
+ IH D+ N+L+ +N K++DFGLA+L+ E +T G + + APE
Sbjct: 122 RNYIHRDLAARNILVGENLVCKIADFGLARLI--EDDE-YTAREGAKFPIKWTAPEAANY 178
Query: 669 YAISEKSDVYSYGMVLLEII 688
+ KSDV+S+G++L EI+
Sbjct: 179 GRFTIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 10/193 (5%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558
KLG G FG V++G+ + T +AVK L+ K+F AE I+ + H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 559 GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCD 618
+ E M GSL +++ + L ++A A G+AYL Q IH D
Sbjct: 73 EEPIYIVTELMKYGSLLEYL-QGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRD 128
Query: 619 IKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNYAISEKS 675
+ NVL+ +N KV+DFGLA+++ + ++ G + + APE S KS
Sbjct: 129 LAARNVLVGENNICKVADFGLARVI---KEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 676 DVYSYGMVLLEII 688
DV+S+G++L EI+
Sbjct: 186 DVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 16/198 (8%)
Query: 500 LGQGGFGSVYQGVL--PDGTRL--AVKKLEGIGQGKK--EFRAEVSIIGSIHHLHLVKLR 553
+G G FG V +G L P + A+K L+ K+ +F E SI+G H ++++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
G + ++ E+M NGSLDK++ + + +F + G A G+ YL E
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDGKF--TVGQLVGMLRGIASGMKYLSEMN--- 126
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNYA 670
+H D+ N+L++ N KVSDFGL++ + +TT +G + + APE I
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRR-LEDSEATYTT-KGGKIPIRWTAPEAIAYRK 184
Query: 671 ISEKSDVYSYGMVLLEII 688
+ SDV+S+G+V+ E++
Sbjct: 185 FTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 72/200 (36%), Positives = 101/200 (50%), Gaps = 25/200 (12%)
Query: 500 LGQGGFGSVYQGV--LPDGTRL--AVKKL--EGIGQGKKEFRAEVSIIGSIHHLHLVKLR 553
LG G FGSV +GV + G + AVK L E I GKKEF E S++ + H +V+L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEF----LLDWETRFNIALGTAKGLAYLHED 609
G C +G +L E G L K++ KK +E L + A A G+AYL
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYL-KKRREIPVSDLKEL------AHQVAMGMAYLES- 113
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWI 666
+ +H D+ NVLL + + AK+SDFG+++ + S + R + APE I
Sbjct: 114 --KHFVHRDLAARNVLLVNRHQAKISDFGMSRAL-GAGSDYYRATTAGRWPLKWYAPECI 170
Query: 667 TNYAISEKSDVYSYGMVLLE 686
S KSDV+SYG+ L E
Sbjct: 171 NYGKFSSKSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 60/223 (26%), Positives = 112/223 (50%), Gaps = 12/223 (5%)
Query: 496 FSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
++G G FG V+ G + ++A+K + +++F E ++ + H LV+L G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
C E + L +EFM +G L ++ + Q ET + L +G+AYL +I
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 616 HCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNYAIS 672
H D+ N L+ +N KVSDFG+ + + +Q +T+ GT+ + +PE + S
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWSSPEVFSFSKYS 179
Query: 673 EKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMME 714
KSDV+S+G+++ E+ G+ ++ S+ + F++ +
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK 222
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (271), Expect = 3e-26
Identities = 76/233 (32%), Positives = 106/233 (45%), Gaps = 42/233 (18%)
Query: 500 LGQGGFGSVYQGV--LPDGTRLAVKKLEGIGQGKKE---------FRAEVSIIGSIHHLH 548
LG+G FG V V G A+K L+ KK+ E +I+ I+H
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVLK-----KKKIIKRKEVEHTLTERNILSRINHPF 54
Query: 549 LVKLRGFCAEGTHRLLAY---EFMANGSLDKWIFKKNQEFLLD-WETRFNIA-LGTAKGL 603
+VKL A T L Y E+ G L + ++E RF A + A L
Sbjct: 55 IVKL--HYAFQTEEKL-YLVLEYAPGGELFSHL---SKEGRFSEERARFYAAEIVLA--L 106
Query: 604 AYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAP 663
YLH II+ D+KPEN+LLD + H K++DFGLAK ++ E S T GT YLAP
Sbjct: 107 EYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT-NTFCGTPEYLAP 162
Query: 664 EWITNYAISEKSDVYSYGMVLLEIIGGRKNF---DPNET-----SDKAHFPSY 708
E + + D +S G++L E++ G+ F D E D FP +
Sbjct: 163 EVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEF 215
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 71/210 (33%), Positives = 99/210 (47%), Gaps = 24/210 (11%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKL----EGIGQGKKEFRAEVSIIGSIHHLHLVKLRG 554
+LG+G GSV + L + + K K+ R E+ I S ++VK G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR-ELEINKSCKSPYIVKYYG 66
Query: 555 -FCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFN------IALGTAKGLAYL 606
F E + + +A E+ GSLD I+KK + R IA KGL+YL
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDS-IYKK----VKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 607 HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI 666
H ++IIH DIKP N+LL K+ DFG++ + + FT GT Y+APE I
Sbjct: 122 HS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPERI 175
Query: 667 TNYAISEKSDVYSYGMVLLEIIGGRKNFDP 696
S SDV+S G+ LLE+ R F P
Sbjct: 176 QGKPYSITSDVWSLGLTLLEVAQNRFPFPP 205
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 61/193 (31%), Positives = 102/193 (52%), Gaps = 11/193 (5%)
Query: 499 KLGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCA 557
KLG G +G VY+GV +AVK L+ +EF E +++ I H +LV+L G C
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 558 EGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHC 617
+ EFM G+L ++ + N++ ++ +A + + YL + + IH
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK---KNFIHR 128
Query: 618 DIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNYAISEK 674
D+ N L+ +N+ KV+DFGL++LMT + +T G + + APE + S K
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 675 SDVYSYGMVLLEI 687
SDV+++G++L EI
Sbjct: 186 SDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 84/278 (30%), Positives = 125/278 (44%), Gaps = 42/278 (15%)
Query: 499 KLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRG- 554
LGQG G VY+ P G A+KK+ G +K+ E+ + S ++VK G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKK---NQEFLLDWETRFNIALGTAKGLAYLHEDCD 611
F EG + E+M GSL + K + L IA KGL YLH
Sbjct: 68 FYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPVLAY------IARQILKGLDYLHTK-- 118
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAI 671
+ IIH DIKP N+L++ K++DFG++K++ T GT Y++PE I +
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-QCNTFVGTVTYMSPERIQGESY 177
Query: 672 SEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS---RLNI 728
S +D++S G+ LLE G+ F P F++M+ I D L
Sbjct: 178 SYAADIWSLGLTLLECALGKFPFLPPGQPSF-------FELMQA-----ICDGPPPSLPA 225
Query: 729 DEQSD--RVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764
+E S R F + C+Q+D RPS ++L+
Sbjct: 226 EEFSPEFRDFISA-----CLQKDPKKRPS---AAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 73/281 (25%), Positives = 127/281 (45%), Gaps = 43/281 (15%)
Query: 495 NFSV--KLGQGGFGSVYQ-GVLPDGTRLAVKKLEGIGQGKKEFRA----EVSIIGSIHHL 547
+F V KLG+G +GSVY+ L D A+K+++ +KE R E+ I+ S++H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKE-REDAVNEIRILASVNHP 59
Query: 548 HLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFK-KNQEFLLDWETRFNIALGTAKGLAYL 606
+++ + +G + E+ G L K I K K + L+ + + I + +GL L
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 607 HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI 666
HE Q+I+H D+K N+LL N K+ D G++K++ ++ T GT Y+APE
Sbjct: 120 HE---QKILHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQIGTPHYMAPEVW 173
Query: 667 TNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI----- 721
S KSD++S G +L E+ F+ + M++ + +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEA--------------RSMQDLRYKVQRGKYP 219
Query: 722 -LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761
+ + D Q +Q LRP+ K++
Sbjct: 220 PIPPIYSQDLQ--------NFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 44/218 (20%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL---EGIGQGKKEFRAEVSIIGSIHHLHLVKLRG 554
K+G G FG VY V L G +AVK++ + + KE E+ ++ + H +LVK G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 555 -------------FCAEGTHRLLAYEFMANGS-LDKWIFKKNQEFLLDWETRFNIALGTA 600
+C+ GT L E + +G LD+ + + LL
Sbjct: 67 VEVHREKVYIFMEYCSGGT---LE-ELLEHGRILDEHVIRVYTLQLL------------- 109
Query: 601 KGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT---TLRGT 657
+GLAYLH I+H DIKP N+ LD N K+ DFG A + + + +L GT
Sbjct: 110 EGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166
Query: 658 RGYLAPEWITNYAISEK---SDVYSYGMVLLEIIGGRK 692
Y+APE IT +D++S G V+LE+ G++
Sbjct: 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 495 NFSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLR 553
K+G+G G VY+ G +A+KK+ Q K+ E+ I+ H ++V
Sbjct: 22 KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYY 81
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDW-ETRFN------IALGTAKGLAYL 606
G + E+M GSL ++ R N + +GL YL
Sbjct: 82 DSYLVGDELWVVMEYMDGGSLTD---------IITQNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 607 HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI 666
H Q +IH DIK +N+LL + K++DFG A +T+E+S ++ GT ++APE I
Sbjct: 133 HS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR-NSVVGTPYWMAPEVI 188
Query: 667 TNYAISEKSDVYSYGMVLLEIIGG 690
K D++S G++ +E+ G
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 73/278 (26%), Positives = 134/278 (48%), Gaps = 38/278 (13%)
Query: 500 LGQGGFGSVYQGVLPDGTR----LAVKKLEG--IGQGKKEFRAEVSIIGSIHHLHLVKLR 553
+G G FG V++G+L R +A+K L+ + +++F +E SI+G H ++++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIA---LGTAKGLAYLHEDC 610
G + ++ E+M NG+LDK++ + EF + + + G A G+ YL
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEF-----SSYQLVGMLRGIAAGMKYL---S 124
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRG--YLAPEWITN 668
D +H D+ N+L++ N KVSDFGL++++ + +TT G + APE I
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 669 YAISEKSDVYSYGMVLLEII--GGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726
+ SDV+S+G+V+ E++ G R +D M ++ ++
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWD-----------------MSNHEVMKAINDGF 227
Query: 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764
+ D ++ L C Q+D + RP +V +L+
Sbjct: 228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 79/277 (28%), Positives = 137/277 (49%), Gaps = 36/277 (12%)
Query: 500 LGQGGFGSVYQGVLP-DGTR---LAVKKLEG--IGQGKKEFRAEVSIIGSIHHLHLVKLR 553
+G G FG V G L G R +A+K L+ + +++F +E SI+G H +++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
G + ++ E+M NGSLD ++ K + +F + + G A G+ YL D
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVI--QLVGMLRGIASGMKYL---SDMG 126
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNYA 670
+H D+ N+L++ N KVSDFGL++++ + +TT RG + + APE I
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT-RGGKIPIRWTAPEAIAYRK 185
Query: 671 ISEKSDVYSYGMVLLEII--GGRKNFDPNETSDKAHFPSYAFKMMEEG-KLRNILDSRLN 727
+ SDV+SYG+V+ E++ G R ++ + K +EEG +L +D
Sbjct: 186 FTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--------VIKAIEEGYRLPAPMDCPAA 237
Query: 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764
+ + + L C Q+D + RP ++V +L+
Sbjct: 238 LHQ----------LMLDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 7e-23
Identities = 42/86 (48%), Positives = 52/86 (60%), Gaps = 3/86 (3%)
Query: 85 TIIWTANRGSPVANSD-NFVFKKDGEVSLQKG-GSVVWSVNPSG-ASVSAMELRDSGNLV 141
T++W ANR +P+ +S + + DG + L G G VVWS N SG S L+D GNLV
Sbjct: 3 TVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGNLV 62
Query: 142 LLGNDNKVLWQSFSHPTDTLISNQDF 167
L N KVLWQSF HPTDTL+ Q
Sbjct: 63 LYDNSGKVLWQSFDHPTDTLLPGQKD 88
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 7e-23
Identities = 62/195 (31%), Positives = 102/195 (52%), Gaps = 10/195 (5%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCA 557
KLG+G +GSVY+ + G +A+K + + + +E E+SI+ ++VK G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 558 EGTHRLLAYEFMANGS-LDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIH 616
+ T + E+ GS D I K + L + E I T KGL YLH + IH
Sbjct: 69 KNTDLWIVMEYCGAGSVSD--IMKITNKTLTEEEIAA-ILYQTLKGLEYLH---SNKKIH 122
Query: 617 CDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSD 676
DIK N+LL++ AK++DFG++ +T + T+ GT ++APE I + K+D
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR-NTVIGTPFWMAPEVIQEIGYNNKAD 181
Query: 677 VYSYGMVLLEIIGGR 691
++S G+ +E+ G+
Sbjct: 182 IWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 9e-23
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 35/212 (16%)
Query: 500 LGQGGFGSVYQGVLPD------GTRLAVKKL---EGIGQGKKEFRAEVSIIGSIHHLHLV 550
LGQG FG VY+G+ TR+A+K + + + + EF E S++ + H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRE-RIEFLNEASVMKEFNCHHVV 72
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLDKWIFKK--NQEFL-----LDWETRFNIALGTAKGL 603
+L G + G L+ E MA G L ++ + E + +A A G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 604 AYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT---LRGTRGY 660
AYL ++ +H D+ N ++ ++ K+ DFG MTR+ ++ T +G +G
Sbjct: 133 AYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFG----MTRD---IYETDYYRKGGKGL 182
Query: 661 L-----APEWITNYAISEKSDVYSYGMVLLEI 687
L APE + + + KSDV+S+G+VL E+
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 12/202 (5%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRA---EVSIIGSIHHLHLVKLRG 554
+LG G G V + + P G +AVK + + + + E+ I+ + ++V G
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIR-LEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
+ E+M GSLDK K + + IA+ KGL YLHE +I
Sbjct: 67 AFYNNGDISICMEYMDGGSLDK--ILKEVQGRIPERILGKIAVAVLKGLTYLHEK--HKI 122
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEK 674
IH D+KP N+L++ K+ DFG++ + + F GT Y+APE I S K
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSSYMAPERIQGNDYSVK 179
Query: 675 SDVYSYGMVLLEIIGGRKNFDP 696
SD++S G+ L+E+ GR + P
Sbjct: 180 SDIWSLGLSLIELATGRFPYPP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 75/277 (27%), Positives = 132/277 (47%), Gaps = 34/277 (12%)
Query: 500 LGQGGFGSVYQGVL-PDGTR---LAVKKLEG--IGQGKKEFRAEVSIIGSIHHLHLVKLR 553
+G G FG V +G L G R +A+K L+ + +++F +E SI+G H +++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
G + ++ EFM NG+LD ++ + + +F + + G A G+ YL E
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYLSE---MN 126
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH-VFTTLRGTR---GYLAPEWITNY 669
+H D+ N+L++ N KVSDFGL++ + + S +T+ G + + APE I
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 670 AISEKSDVYSYGMVLLEII--GGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727
+ SDV+SYG+V+ E++ G R +D M + N ++
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERPYWD-----------------MSNQDVINAIEQDYR 229
Query: 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764
+ D ++ L C Q+D + RP ++V L+
Sbjct: 230 LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL--EGIGQGKKE-FRAEVSIIGSIHHLHLVK-LR 553
+G+G FG+V + DG L K++ + + +K+ +EV+I+ + H ++V+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 554 GFCAEGTHRLLAY-EFMANGSLDKWIFKKNQEFL-LDWETRFNIALGTAKGLAYLH--ED 609
L E+ G L + I K +E ++ E + I L H D
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNY 669
++H D+KP N+ LD N + K+ DFGLAK++ + S T GT Y++PE + +
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA-KTYVGTPYYMSPEQLNHM 185
Query: 670 AISEKSDVYSYGMVLLEI 687
+ EKSD++S G ++ E+
Sbjct: 186 SYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 3e-22
Identities = 39/116 (33%), Positives = 57/116 (49%), Gaps = 2/116 (1%)
Query: 44 TFIDKNGLFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFV 103
+ +G L+S+ S F GF + L++ +S T++W ANR +P +S
Sbjct: 1 SNPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLT 60
Query: 104 FKKDGE-VSLQKGGSVVWSVNPSGA-SVSAMELRDSGNLVLLGNDNKVLWQSFSHP 157
+ DG V G+VVWS N + + L D GNLVL +D LWQSF +P
Sbjct: 61 LQSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 37/215 (17%)
Query: 500 LGQGGFGSVYQG----VLPDG--TRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVK 551
LG+G FG V+ G + P+ +AVK L+ +K+F E ++ + H ++VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 552 LRGFCAEGTHRLLAYEFMANGSLDKW-----------IFKKNQEFLLDWETRFNIALGTA 600
G C EG ++ +E+M +G L+K+ + L IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 601 KGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT----LRG 656
G+ YL Q +H D+ N L+ + K+ DFG M+R+ V+TT + G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFG----MSRD---VYTTDYYRVGG 182
Query: 657 TR----GYLAPEWITNYAISEKSDVYSYGMVLLEI 687
++ PE I + +SDV+S+G+VL EI
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 62/196 (31%), Positives = 95/196 (48%), Gaps = 16/196 (8%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVK--KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFC 556
K+G+G FG VY+GVL T +AVK + K++F E I+ H ++VKL G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 557 AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIH 616
+ + E + GSL ++ KK L + ++L A G+ YL IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 617 CDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRG-----YLAPEWITNYAI 671
D+ N L+ +N K+SDFG M+RE+ T+ + APE +
Sbjct: 117 RDLAARNCLVGENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 672 SEKSDVYSYGMVLLEI 687
+ +SDV+SYG++L E
Sbjct: 173 TSESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 7e-22
Identities = 58/193 (30%), Positives = 102/193 (52%), Gaps = 11/193 (5%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558
KLG G FG V+ G T++A+K L+ + F AE +++ + H LV+L +
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 559 GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCD 618
++ E+M NGSL ++ K + L ++A A+G+A++ + IH D
Sbjct: 73 EPIYIIT-EYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRD 127
Query: 619 IKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNYAISEKS 675
++ N+L+ + K++DFGLA+L+ + +T G + + APE I + KS
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 676 DVYSYGMVLLEII 688
DV+S+G++L EI+
Sbjct: 185 DVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 7e-22
Identities = 43/115 (37%), Positives = 62/115 (53%), Gaps = 3/115 (2%)
Query: 44 TFIDKNGLFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFV 103
+ +G L+S NS F GF T + L++ +S T++W ANR +PV++S
Sbjct: 1 SNTLSSGQTLVSGNSLFELGFFTLIMQN-DYNLILYKSSSRTVVWVANRDNPVSDSCTLT 59
Query: 104 FKKDGEVSLQKG-GSVVWSVNPSGA-SVSAMELRDSGNLVLLGNDNKVLWQSFSH 156
+ DG + L G G VVWS N +GA + L D GNLV+ +D LWQSF +
Sbjct: 60 LQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 8e-22
Identities = 65/212 (30%), Positives = 116/212 (54%), Gaps = 29/212 (13%)
Query: 500 LGQGGFGSVYQGV-LPDGTRL----AVKKLEGIGQGK--KEFRAEVSIIGSIHHLHLVKL 552
LG G FG+VY+G+ +P+G ++ A+K+L K KE E ++ S+ + H+ +L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQE-----FLLDWETRFNIALGTAKGLAYLH 607
G C T +L+ + M G L ++ +++++ +LL+W + AKG+ YL
Sbjct: 75 LGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNW------CVQIAKGMNYLE 126
Query: 608 EDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPE 664
E +R++H D+ NVL+ H K++DFGLAKL+ ++ G + ++A E
Sbjct: 127 E---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA--EGGKVPIKWMALE 181
Query: 665 WITNYAISEKSDVYSYGMVLLEIIG-GRKNFD 695
I + + +SDV+SYG+ + E++ G K +D
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 8e-22
Identities = 88/298 (29%), Positives = 132/298 (44%), Gaps = 57/298 (19%)
Query: 500 LGQGGFGSV----YQGVLPDGTR--LAVKKLEGIGQGKKE----FRAEVSIIGSIHHLHL 549
LG+G FGSV Y L D T +AVKKL+ E F E+ I+ S+ H ++
Sbjct: 12 LGKGNFGSVELCRYDP-LQDNTGEVVAVKKLQ---HSTAEHLRDFEREIEILKSLQHDNI 67
Query: 550 VKLRGFC-AEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLH 607
VK +G C + G L L E++ GSL ++ +K++E LD A KG+ YL
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL-QKHRE-RLDHRKLLLYASQICKGMEYLG 125
Query: 608 EDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL--------MTRE--QSHVFTTLRGT 657
+R +H D+ N+L++ K+ DFGL K+ RE +S +F
Sbjct: 126 S---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF------ 176
Query: 658 RGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAF-KMMEEG 716
+ APE +T S SDV+S+G+VL E+ SDK+ P F +MM
Sbjct: 177 --WYAPESLTESKFSVASDVWSFGVVLYELF---------TYSDKSCSPPAEFMRMMGND 225
Query: 717 K--------LRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
K L +L + + + C D S RPS +++ +E I
Sbjct: 226 KQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 58/204 (28%), Positives = 104/204 (50%), Gaps = 9/204 (4%)
Query: 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRA---EVSIIGSIHHLHLVKLR 553
K+G+G FG V++ V D A+K+++ ++E E ++ + ++++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
+ + E+ NG L K + K + L + + + GLA+LH ++
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHS---KK 121
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISE 673
I+H DIK N+ LD + K+ D G+AKL++ + ++ T+ GT YL+PE + +E
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 674 KSDVYSYGMVLLEIIGGRKNFDPN 697
KSDV++ G+VL E G+ FD N
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDAN 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 69/209 (33%), Positives = 113/209 (54%), Gaps = 23/209 (11%)
Query: 500 LGQGGFGSVYQGV-LPDGTRL----AVKKL-EGIG-QGKKEFRAEVSIIGSIHHLHLVKL 552
LG G FG+VY+G+ +P+G + A+K L E G + EF E I+ S+ H HLV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKN----QEFLLDWETRFNIALGTAKGLAYLHE 608
G C T +L+ + M +G L ++ + + LL+W + AKG+ YL E
Sbjct: 75 LGVCLSPTIQLVT-QLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE 127
Query: 609 DCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT-REQSHVFTTLRGTRGYLAPEWIT 667
+R++H D+ NVL+ H K++DFGLA+L+ E+ + + ++A E I
Sbjct: 128 ---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 668 NYAISEKSDVYSYGMVLLEIIG-GRKNFD 695
+ +SDV+SYG+ + E++ G K +D
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 39/220 (17%)
Query: 500 LGQGGFGSVYQ----GVLP--DGTRLAVKKL--EGIGQGKKEFRAEVSIIGSIHHLHLVK 551
+GQG FG V+Q G+LP T +AVK L E + +F+ E +++ H ++VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 552 LRGFCAEGTHRLLAYEFMANGSLDKWIFK---KNQEFLLDWETR---------------- 592
L G CA G L +E+MA G L++++ + Q L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 593 FNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM-----TREQ 647
IA A G+AYL E ++ +H D+ N L+ +N K++DFGL++ + +
Sbjct: 133 LCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 648 SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEI 687
+ +R ++ PE I + +SDV++YG+VL EI
Sbjct: 190 ENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 7e-21
Identities = 87/278 (31%), Positives = 136/278 (48%), Gaps = 44/278 (15%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGK------KEFRAEVSIIGSIHHLHLVKL 552
LG G FGSVY+G+ L DG AVK++ G+ K+ E++++ + H ++V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTA---KGLAYLHED 609
G E + + E + GSL K + KK F I L T GL YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAK-LLKKYGSF-----PEPVIRLYTRQILLGLEYLH-- 119
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWIT-- 667
D+ +H DIK N+L+D N K++DFG+AK + E S + +G+ ++APE I
Sbjct: 120 -DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV-EFSFA-KSFKGSPYWMAPEVIAQQ 176
Query: 668 -NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726
Y ++ +D++S G +LE+ G+ + E + FK+ +L I D L
Sbjct: 177 GGYGLA--ADIWSLGCTVLEMATGKPPWSQLE------GVAAVFKIGRSKELPPIPDH-L 227
Query: 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764
+ DE D + L C+Q D SLRP+ ++LE
Sbjct: 228 S-DEAKDFI-------LKCLQRDPSLRPTAA---ELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 68/210 (32%), Positives = 106/210 (50%), Gaps = 17/210 (8%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRA----EVSIIGSIHHLHLVKLRG 554
LG G GSV + +P GT +A KK+ IG K R E+ I+ ++V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMA-KKVVHIG-AKSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 555 -FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
F E + + EFM GSLD+ I+KK ++ + IA+ +GL YL+ R
Sbjct: 71 AFLNEN-NICMCMEFMDCGSLDR-IYKKGGPIPVEILGK--IAVAVVEGLTYLYNV--HR 124
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISE 673
I+H DIKP N+L++ K+ DFG++ + + + T GT Y++PE I +
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELI---NSIADTFVGTSTYMSPERIQGGKYTV 181
Query: 674 KSDVYSYGMVLLEIIGGRKNFDPNETSDKA 703
KSDV+S G+ ++E+ G+ F + D
Sbjct: 182 KSDVWSLGISIIELALGKFPFAFSNIDDDG 211
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 63/191 (32%), Positives = 98/191 (51%), Gaps = 15/191 (7%)
Query: 500 LGQGGFGSVYQGVLPDGTRLAVK--KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCA 557
+G+G FG V G G ++AVK K + Q F AE S++ + H +LV+L G
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 558 EGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIH 616
E L + E+MA GSL ++ + + +L + +L + + YL + +H
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEAN---NFVH 125
Query: 617 CDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSD 676
D+ NVL+ ++ AKVSDFGL T+E S T + + APE + S KSD
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGL----TKEASSTQDTGKLPVKWTAPEALREKKFSTKSD 181
Query: 677 VYSYGMVLLEI 687
V+S+G++L EI
Sbjct: 182 VWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 55/196 (28%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 500 LGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG 559
LG G FG V+ G +A+K + + +F E ++ + H +LV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71
Query: 560 THRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDI 619
+ E+MANG L + + ++ L E ++ + + YL + IH D+
Sbjct: 72 RPIFIVTEYMANGCLLN--YLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDL 126
Query: 620 KPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNYAISEKSD 676
N L+ ++ KVSDFGLA+ + +Q +T+ +GT+ + PE S KSD
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 677 VYSYGMVLLEIIGGRK 692
V+S+G+++ E+ K
Sbjct: 184 VWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 62/196 (31%), Positives = 105/196 (53%), Gaps = 16/196 (8%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558
KLG G FG V+ G + T++AVK L+ + F E +++ ++ H LV+L +
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 559 GTHRLLAYEFMANGSLDKWIFKKNQE---FLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
+ E+MA GSL F K+ E LL F+ + A+G+AY+ + I
Sbjct: 73 EEPIYIITEYMAKGSLLD--FLKSDEGGKVLLPKLIDFSAQI--AEGMAYIER---KNYI 125
Query: 616 HCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNYAIS 672
H D++ NVL+ ++ K++DFGLA+++ + +T G + + APE I + +
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFT 182
Query: 673 EKSDVYSYGMVLLEII 688
KSDV+S+G++L EI+
Sbjct: 183 IKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 499 KLGQGGFGSVYQ-GVLPDGTRLAVKKL------EGIGQGKKEFRAEVSIIGSIHHLHLVK 551
++G+G G V++ G +A+KK+ GI + E+ + + H ++VK
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP---NQALREIKALQACQHPYVVK 63
Query: 552 LRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCD 611
L G+ +L E+M + + + + + L + + + + KG+AY+H +
Sbjct: 64 LLDVFPHGSGFVLVMEYMPSDLSE--VLRDEERPLPEAQVK-SYMRMLLKGVAYMHAN-- 118
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI---TN 668
I+H D+KP N+L+ + K++DFGLA+L + E+ +++ TR Y APE +
Sbjct: 119 -GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 669 YAISEKSDVYSYGMVLLEIIGGRKNFD 695
Y D+++ G + E++ G F
Sbjct: 178 Y--DPGVDLWAVGCIFAELLNGSPLFP 202
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 49/226 (21%)
Query: 496 FSVKLGQGGFGSVYQG--VLPDG----TRLAVKKL--EGIGQGKKEFRAEVSIIGSIHHL 547
F +LG+G FG VY+G P+ T +A+K L + ++EFR E ++ + H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 548 HLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFL--------------------- 586
++V L G C + + +E++A+G L EFL
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDL--------HEFLVRNSPHSDVGAESGDETVKSS 120
Query: 587 LDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM--- 643
LD +IA+ A G+ YL +H D+ N L+ + K+SDFGL++ +
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177
Query: 644 --TREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEI 687
R QS +R ++ PE I + +SD++S+G+VL EI
Sbjct: 178 DYYRVQSKSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 7e-20
Identities = 64/211 (30%), Positives = 111/211 (52%), Gaps = 20/211 (9%)
Query: 488 DLQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVK--KLEGIGQGKKEFRAEVSIIGSIH 545
+LQ T +G+G FG+V QG G ++AVK K + Q F E +++ +H
Sbjct: 4 NLQKLT--LGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLH 57
Query: 546 HLHLVKLRG-FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLA 604
H +LV+L G G + + E M+ G+L ++ + + L+ +L A+G+
Sbjct: 58 HKNLVRLLGVILHNGLY--IVMELMSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGME 114
Query: 605 YLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPE 664
YL ++++H D+ N+L+ ++ AKVSDFGLA++ + + ++ T APE
Sbjct: 115 YLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APE 167
Query: 665 WITNYAISEKSDVYSYGMVLLEIIG-GRKNF 694
+ + S KSDV+SYG++L E+ GR +
Sbjct: 168 ALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 60/195 (30%), Positives = 101/195 (51%), Gaps = 11/195 (5%)
Query: 496 FSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
VKLGQG FG V+ G TR+A+K L+ + F E ++ + H LV+L
Sbjct: 10 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
+E ++ E+M+ GSL ++ K L ++A A G+AY+ +
Sbjct: 70 VSEEPIYIVT-EYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYV 124
Query: 616 HCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNYAIS 672
H D++ N+L+ +N KV+DFGLA+L+ + + +T +G + + APE +
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 673 EKSDVYSYGMVLLEI 687
KSDV+S+G++L E+
Sbjct: 182 IKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 500 LGQGGFGSVYQGVLPDGTRLAVKKLE----GIGQGKKEFRA---EVSIIGSIHHLHLVKL 552
LG+G +G+VY G+ G +AVK++E + +KE+ EV ++ S+ H+++V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWI--FKKNQEFLLDWETRFNIALGTAKGLAYLHEDC 610
G C + + EF+ GS+ + F E + T+ G+AYLH +C
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-----QILDGVAYLHNNC 122
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM-----TREQSHVFTTLRGTRGYLAPEW 665
++H DIK NV+L N K+ DFG A+ + S++ ++ GT ++APE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 666 ITNYAISEKSDVYSYGMVLLEIIGGR 691
I KSD++S G + E+ G+
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 65/194 (33%), Positives = 99/194 (51%), Gaps = 17/194 (8%)
Query: 500 LGQGGFGSVYQGVLPDGTRLAVKKL-EGIGQGKK-EFRAEVSIIGSIHHLHLVKLRGFCA 557
LG+G FG V++G L D T +AVK E + Q K +F +E I+ H ++VKL G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 558 EGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLH-EDCDQRIIH 616
+ + E + G ++ KK E +F AL A G+AYL ++C IH
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF--ALDAAAGMAYLESKNC----IH 116
Query: 617 CDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR----GYLAPEWITNYAIS 672
D+ N L+ +N K+SDFG M+R++ + G + + APE + S
Sbjct: 117 RDLAARNCLVGENNVLKISDFG----MSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 673 EKSDVYSYGMVLLE 686
+SDV+SYG++L E
Sbjct: 173 SESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 77/292 (26%), Positives = 130/292 (44%), Gaps = 45/292 (15%)
Query: 500 LGQGGFGSV----YQGVLPD-GTRLAVKKLE-GIGQGKKE-FRAEVSIIGSIHHLHLVKL 552
LG+G FG V Y G +AVK L+ GQ ++ E++I+ +++H ++VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 553 RGFCAEGTHR--LLAYEFMANGSLDKWIFKKN---QEFLLDWETRFNIALGTAKGLAYLH 607
+G C+E + L E++ GSL ++ K + LL A +G+AYLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL-------FAQQICEGMAYLH 124
Query: 608 EDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM--------TRE--QSHVFTTLRGT 657
Q IH D+ NVLLD++ K+ DFGLAK + RE S VF
Sbjct: 125 S---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF------ 175
Query: 658 RGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFK--MMEE 715
+ A E + S SDV+S+G+ L E++ + D ++ K K M
Sbjct: 176 --WYAVECLKENKFSYASDVWSFGVTLYELL---THCDSKQSPPKKFEEMIGPKQGQMTV 230
Query: 716 GKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767
+L +L+ + + + + C + + RP+ ++ +L+ +
Sbjct: 231 VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 29/211 (13%)
Query: 499 KLGQGGFGSVY----QGVLPDGTRL--AVKKL-EGIGQGKKEFRAEVSIIGSIHHLHLVK 551
+LG+G FG V+ + P+ ++ AVK L + +K+F E ++ ++ H H+VK
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 552 LRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETR----------FNIALGTAK 601
G C EG ++ +E+M +G L+K++ + +L E +IA A
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 602 GLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM-----TREQSHVFTTLRG 656
G+ YL Q +H D+ N L+ +N K+ DFG+++ + R H +R
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR- 187
Query: 657 TRGYLAPEWITNYAISEKSDVYSYGMVLLEI 687
++ PE I + +SDV+S G+VL EI
Sbjct: 188 ---WMPPESIMYRKFTTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 501 GQGGFGSVYQGVLPD-GTRLAVK---KLEGIGQGK-KEFRAEVSIIGSIHHLHLVKLR-G 554
G+G FG V D A+K K + + +G + E I+ ++H LV L
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
F E + L + + G L ++ + +F + + +F I L YLH + I
Sbjct: 69 FQDE-ENMYLVVDLLLGGDL-RYHLSQKVKFSEE-QVKFWIC-EIVLALEYLHS---KGI 121
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEK 674
IH DIKP+N+LLD+ H ++DF +A +T + + T+ GT GY+APE + S
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVA 179
Query: 675 SDVYSYGMVLLEIIGGRKNFD 695
D +S G+ E + G++ +
Sbjct: 180 VDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 70/270 (25%), Positives = 116/270 (42%), Gaps = 27/270 (10%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKK--LEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
+G G VY + LP+ ++A+K+ LE E R EV + +H ++VK
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
G L +++ GSL + LD + KGL YLH I
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQI 124
Query: 616 HCDIKPENVLLDDNYHAKVSDFG----LAKLMTREQSHVFTTLRGTRGYLAPEWITN-YA 670
H DIK N+LL ++ K++DFG LA R V T GT ++APE + +
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDR-TRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 671 ISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730
K+D++S+G+ +E+ G + + +P M+ L+N L
Sbjct: 184 YDFKADIWSFGITAIELATGAAPY--------SKYPPMKVLML---TLQND-PPSLETGA 231
Query: 731 QSDRVFTAVK--VALWCVQEDMSLRPSMTK 758
+ + + ++L C+Q+D S RP+ +
Sbjct: 232 DYKKYSKSFRKMISL-CLQKDPSKRPTAEE 260
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 72/277 (25%), Positives = 123/277 (44%), Gaps = 25/277 (9%)
Query: 493 TNNFSV--KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRA----EVSIIGSIH 545
NF + K+G+G F VY+ + L DG +A+KK++ + R E+ ++ +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 546 HLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFK-KNQEFLLDWETRFNIALGTAKGLA 604
H +++K E + E G L + I K Q+ L+ T + + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 605 YLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPE 664
++H +RI+H DIKP NV + K+ D GL + + + + +L GT Y++PE
Sbjct: 121 HMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH-SLVGTPYYMSPE 176
Query: 665 WITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724
I + KSD++S G +L E+ + F DK + S K +E+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLYSL-CKKIEKCDY-----P 226
Query: 725 RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761
L D S+ + V C+ D RP ++ V+Q
Sbjct: 227 PLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 5e-19
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 499 KLGQGGFGSVYQG--VLPDGTRL--AVKKL--EGIGQGKKEFRAEVSIIGSIHHLHLVKL 552
KLG G FG V +G G + AVK L + + +F E +I+ S+ H +L++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 553 RGFCAEGTHRL-LAYEFMANGSL-DKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC 610
G TH L + E GSL D+ +K+ T + A+ A G+ YL
Sbjct: 62 YGVVL--THPLMMVTELAPLGSLLDR--LRKDALGHFLISTLCDYAVQIANGMRYLES-- 115
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT--LRGTRGYLAPEWITN 668
+R IH D+ N+LL + K+ DFGL + + + + H L+ + APE +
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 669 YAISEKSDVYSYGMVLLEI 687
S SDV+ +G+ L E+
Sbjct: 175 RTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 6e-19
Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 34/226 (15%)
Query: 500 LGQGGFGSVYQGVL-PDGTRLAVKKLEG--IGQGKKE---FRAEVSIIGSIHHLHLVKLR 553
+G+G F +V A+K L+ + + KK + + H ++KL
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 554 GFCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
+ + L E+ NG L ++I +K TRF A L YLH +
Sbjct: 69 -YTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKC-TRFYAAE-ILLALEYLH---SK 121
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV-------------------FTT 653
IIH D+KPEN+LLD + H K++DFG AK++ S F +
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181
Query: 654 LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNF-DPNE 698
GT Y++PE + + SD+++ G ++ +++ G+ F NE
Sbjct: 182 FVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 27/230 (11%)
Query: 500 LGQGGFGSVYQ-GVLPDGTRLAVKKL--EGIGQGKKE--FRAEVSIIGSIHHLHLVKLRG 554
LG GGFG V V A+K + I + ++ +E I+ +H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
+ + + E+ G L + + ++ RF IA YLH + I
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGL--FDEYTARFYIA-CVVLAFEYLHN---RGI 114
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGLAK-LMTREQSHVFTTLRGTRGYLAPEWITNYAISE 673
I+ D+KPEN+LLD N + K+ DFG AK L + +++ T GT Y+APE I N
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW---TFCGTPEYVAPEIILNKGYDF 171
Query: 674 KSDVYSYGMVLLEIIGGRKNF-----DPNET-------SDKAHFPSYAFK 711
D +S G++L E++ GR F DP E + K FP+Y K
Sbjct: 172 SVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDK 221
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (218), Expect = 6e-19
Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 30/207 (14%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEF-----RAEVSIIGSIHHLHLVKL 552
KLG+G +G VY+ G +A+KK+ + ++ R E+S++ + H ++VKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIR-LDNEEEGIPSTALR-EISLLKELKHPNIVKL 63
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRF--NIALGTAKGLAYLHEDC 610
L +E+ L K++ K+ +I +GLAY H
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPL----SPNLIKSIMYQLLRGLAYCHS-- 116
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT---REQSHVFTTLRGTRGYLAPEWI- 666
RI+H D+KP+N+L++ + K++DFGLA+ R +H TL Y APE +
Sbjct: 117 -HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTL----WYRAPEILL 171
Query: 667 --TNYAISEKSDVYSYGMVLLEIIGGR 691
+Y+ + D++S G + E+I G+
Sbjct: 172 GSKHYSTA--VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 7e-19
Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 25/200 (12%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558
KLG G FG V+ G T++AVK L+ + F E I+ + H LV+L +E
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 559 GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRF-------NIALGTAKGLAYLHEDCD 611
++ E+M+ GSL +FL D E R ++A A G+AY+
Sbjct: 73 EPIYIVT-EYMSKGSL--------LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER--- 120
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITN 668
IH D++ N+L+ D K++DFGLA+L+ + + +T +G + + APE
Sbjct: 121 MNYIHRDLRSANILVGDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALY 177
Query: 669 YAISEKSDVYSYGMVLLEII 688
+ KSDV+S+G++L E++
Sbjct: 178 GRFTIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 7e-19
Identities = 61/196 (31%), Positives = 103/196 (52%), Gaps = 11/196 (5%)
Query: 496 FSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
VKLGQG FG V+ G T++A+K L+ + F E I+ + H LV L
Sbjct: 10 LDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
+E ++ EFM GSL ++ + + ++ L ++A A G+AY+ I
Sbjct: 70 VSEEPIYIVT-EFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYIER---MNYI 124
Query: 616 HCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNYAIS 672
H D++ N+L+ DN K++DFGLA+L+ + + +T +G + + APE +
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 673 EKSDVYSYGMVLLEII 688
KSDV+S+G++L E++
Sbjct: 182 IKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 8e-19
Identities = 54/202 (26%), Positives = 107/202 (52%), Gaps = 24/202 (11%)
Query: 500 LGQGGFGSVYQGV-LPDGTRL----AVKKLEGIGQGKKEFRA---EVSIIGSIHHLHLVK 551
LG G FG+V++G+ +P+G + A+K ++ G++ F+ + +GS+ H ++V+
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD-RSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 552 LRGFCAEGTHRLLAYEFMANGSLDKWIFKK----NQEFLLDWETRFNIALGTAKGLAYLH 607
L G C G L + GSL + + + + LL+W + AKG+ YL
Sbjct: 74 LLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLE 126
Query: 608 EDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM-TREQSHVFTTLRGTRGYLAPEWI 666
E R++H ++ N+LL + +++DFG+A L+ ++ + ++ + ++A E I
Sbjct: 127 E---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 667 TNYAISEKSDVYSYGMVLLEII 688
+ +SDV+SYG+ + E++
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 60/210 (28%), Positives = 111/210 (52%), Gaps = 25/210 (11%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVKKLE----GIGQGK-------KEFRAEVSIIGSIHHL 547
+G+G +G VY + + G +AVK++E G+ K R+E+ + + HL
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 548 HLVKLRGFCAEGTHRLLAYEFMANGSLDKWI--FKKNQEFLLDWETRFNIALGTAKGLAY 605
++V+ GF + + E++ GS+ + + + +E L+ + T +GLAY
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-----QVLEGLAY 123
Query: 606 LHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF-TTLRGTRGYLAPE 664
LH + I+H D+K +N+L+D + K+SDFG++K + +++G+ ++APE
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 665 WITNY--AISEKSDVYSYGMVLLEIIGGRK 692
I +Y S K D++S G V+LE+ GR+
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 64/224 (28%), Positives = 112/224 (50%), Gaps = 27/224 (12%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVKKLE---GIGQGKKEFRA-------EVSIIGSIHHLH 548
+G G FGSVY G+ G +AVK++E K R+ E++++ + H +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 549 LVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHE 608
+V+ G + H + E++ GS+ + N + N KGL YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLH- 123
Query: 609 DCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRG-------YL 661
++ IIH DIK N+L+D+ K+SDFG++K + E + + T G R ++
Sbjct: 124 --NRGIIHRDIKGANILVDNKGGIKISDFGISKKL--EANSLSTKTNGARPSLQGSVFWM 179
Query: 662 APEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHF 705
APE + + + K+D++S G +++E++ G+ F P+ T +A F
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF-PDCTQLQAIF 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 32/214 (14%)
Query: 499 KLGQGGFGSVY----QGVLP--DGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVK 551
+LG+G FG V+ + P D +AVK L+ +K+F+ E ++ ++ H H+VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 552 LRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQE--FLLDWETR-----------FNIALG 598
G C +G ++ +E+M +G L+K++ + L+D + R +IA
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 599 TAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM-----TREQSHVFTT 653
A G+ YL Q +H D+ N L+ N K+ DFG+++ + R H
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 654 LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEI 687
+R ++ PE I + +SDV+S+G++L EI
Sbjct: 189 IR----WMPPESIMYRKFTTESDVWSFGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 61/201 (30%), Positives = 90/201 (44%), Gaps = 13/201 (6%)
Query: 500 LGQGGFGSVYQGVLPD-GTRLAVKKLEG----IGQGKKEFRAEVSIIGSIHHLHLVKLRG 554
LG+GGFG V + G A KKL+ +G++ E I+ + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
L M G L I+ + + F A GL +LH+ +RI
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA-QIICGLEHLHQ---RRI 116
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLR-GTRGYLAPEWITNYAISE 673
++ D+KPENVLLDD+ + ++SD GLA + + R GT GY+APE +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEVYDF 173
Query: 674 KSDVYSYGMVLLEIIGGRKNF 694
D ++ G L E+I GR F
Sbjct: 174 SVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 500 LGQGGFGSVYQGVL----PDGTRL--AVKKLEGIGQGKKE--FRAEVSIIGSIHHLHLVK 551
LG G FG VY+G+ D L AVK L + E F E I+ +H ++V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 552 LRGFCAEGTHRLLAYEFMANGSLDKWIF----KKNQEFLLDWETRFNIALGTAKGLAYLH 607
L G E R + E MA G L ++ + + L + A AKG YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 608 EDCDQRIIHCDIKPENVLLDD---NYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPE 664
E+ IH DI N LL AK++DFG+A+ + R + +G R L +
Sbjct: 134 EN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY----RKGGRAMLPIK 186
Query: 665 WITNYAISE-----KSDVYSYGMVLLEI 687
W+ A + K+DV+S+G++L EI
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 28/206 (13%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRA--------EVSIIGSI-HHLH 548
+LG G FGSVY G +A+KK+ KK+F + EV + + H +
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKM------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 549 LVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHE 608
+VKL+ E +E+M G+L + + K + +I +GLA++H+
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 609 DCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI-- 666
H D+KPEN+L+ K++DFGLA+ + +T TR Y APE +
Sbjct: 118 ---HGFFHRDLKPENLLVSGPEVVKIADFGLAREI--RSRPPYTDYVSTRWYRAPEILLR 172
Query: 667 -TNYAISEKSDVYSYGMVLLEIIGGR 691
T+Y S D+++ G ++ E+ R
Sbjct: 173 STSY--SSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 4e-18
Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 51/219 (23%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEF-----RAEVSIIGSIHHLHLVKL 552
++G+G +G VY+ G +A+KK+ + K+ F R E+ ++ + H ++V+L
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIR-MENEKEGFPITAIR-EIKLLQKLRHPNIVRL 63
Query: 553 RGF---CAEGTHRLLAYEFMA---NGSLD-----------KWIFKKNQEFLLDWETRFNI 595
+ +G+ + +E+M G LD K K+ LL
Sbjct: 64 KEIVTSKGKGSI-YMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQ----LL-------- 110
Query: 596 ALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLR 655
+GL YLH I+H DIK N+L++++ K++DFGLA+ T+ S +T
Sbjct: 111 -----EGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRV 162
Query: 656 GTRGYLAPEWI---TNYAISEKSDVYSYGMVLLEIIGGR 691
T Y PE + T Y + D++S G +L E+ G+
Sbjct: 163 ITLWYRPPELLLGATRY--GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 25/202 (12%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKK---------LEGIGQGKKEFRAEVSIIGSIHHLH 548
+G+G FG VY+ + +A+K +E I Q E+ + +
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ-------EIQFLSQCRSPY 60
Query: 549 LVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHE 608
+ K G +G+ + E+ GS + + LD I GL YLHE
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLEYLHE 116
Query: 609 DCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN 668
+ IH DIK N+LL + K++DFG++ +T S T + GT ++APE I
Sbjct: 117 ---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQ 172
Query: 669 YAISEKSDVYSYGMVLLEIIGG 690
EK+D++S G+ +E+ G
Sbjct: 173 SGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 8e-18
Identities = 64/197 (32%), Positives = 102/197 (51%), Gaps = 20/197 (10%)
Query: 500 LGQGGFGSVYQG-VLPDGTRLAVK--KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRG-F 555
LG G G+VY+ L LAVK L+ + +K+ +E+ I+ +++ G F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 556 CAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
E +R+ + EFM GSLD +++K E +L IA+ KGL YL +I
Sbjct: 69 FVE--NRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYL---WSLKI 116
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEK 674
+H D+KP N+L++ K+ DFG++ T+ + + T GT Y+APE I+
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVS---TQLVNSIAKTYVGTNAYMAPERISGEQYGIH 173
Query: 675 SDVYSYGMVLLEIIGGR 691
SDV+S G+ +E+ GR
Sbjct: 174 SDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 9e-18
Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 35/225 (15%)
Query: 500 LGQGGFGSVYQG----VLPDGT---RLAVKKLE--GIGQGKKEFRAEVSIIGSIHHLHLV 550
LG G FG VY+G +L G+ R+AVK L Q KKEF E ++ + +H ++V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLDKWIFK----KNQEFLLDWETRFNIALGTAKGLAYL 606
KL G C + + E M G L ++ + LL + +I L AKG YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 607 HEDCDQRIIHCDIKPENVLLDDNYHA-----KVSDFGLAKLMTREQSHVFTTLRGTR--- 658
IH D+ N L+ + + K+ DFGLA+ + + + G
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD---YYRKEGEGLLP 176
Query: 659 -GYLAPEWITNYAISEKSDVYSYGMVLLEII-------GGRKNFD 695
++APE + + + +SDV+S+G+++ EI+ N +
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE 221
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 494 NNFSVKL----GQGGFGSVYQGVL--PDGTRL--AVKKLEGIGQGKKE--FRAEVSIIGS 543
+N S+K+ G G FG + +G L P L A+ L K+ F AE +G
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 544 IHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGL 603
H ++V+L G G ++ E+M+NG+LD F + E L + G A G+
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDS--FLRKHEGQLVAGQLMGMLPGLASGM 120
Query: 604 AYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL-- 661
YL E +H + VL++ + K+S F +L + ++TT+ G L
Sbjct: 121 KYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWA 175
Query: 662 APEWITNYAISEKSDVYSYGMVLLEII--GGRKNFD 695
APE I + S SDV+S+G+V+ E++ G R +D
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 71/221 (32%), Positives = 111/221 (50%), Gaps = 27/221 (12%)
Query: 484 FTYRDLQTATNNFSVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQGK--KEFRAEV-S 539
FT DL+ ++G+G FG+V + + GT +AVK++ K K ++
Sbjct: 1 FTAEDLKDLG-----EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDV 55
Query: 540 IIGSIHHLHLVKLRG--FCAEGTHRLLAYEFMANGSLDKW--IFKKNQEFLLDWETRFNI 595
++ S ++VK G F EG + E M + SLDK+ + + ++ E I
Sbjct: 56 VMRSSDCPYIVKFYGALF-REGDC-WICMELM-DISLDKFYKYVYEVLKSVIPEEILGKI 112
Query: 596 ALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLR 655
A+ T K L YL E+ +IIH D+KP N+LLD N + K+ DFG++ + S T
Sbjct: 113 AVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDA 168
Query: 656 GTRGYLAPEWIT-----NYAISEKSDVYSYGMVLLEIIGGR 691
G R Y+APE I Y + +SDV+S G+ L E+ G+
Sbjct: 169 GCRPYMAPERIDPSARDGYDV--RSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 17/199 (8%)
Query: 500 LGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQGKKEFRAEVS-------IIGSIHHLHLVK 551
LGQG FG VY D G LAVK++ E + EV+ ++ ++ H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVP-FDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 552 LRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCD 611
G + + E+M GS+ + K L + TR +G+ YLH
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTR-KYTRQILEGVEYLH---S 122
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAK-LMT-REQSHVFTTLRGTRGYLAPEWITNY 669
I+H DIK N+L D + K+ DFG +K L T ++ GT +++PE I+
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 670 AISEKSDVYSYGMVLLEII 688
K+DV+S G ++E++
Sbjct: 183 GYGRKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 72/282 (25%), Positives = 122/282 (43%), Gaps = 40/282 (14%)
Query: 500 LGQGGFGSVY--QGVLPDGTRLAVKKLE----GIGQGKKE-------FRAEVSIIG-SIH 545
LG G FG VY + LA+K++ G+ K+E +EV+II +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 546 HLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIF---KKNQEFLLDWETRFNIALGTAKG 602
H ++V+ E + + + L + +K Q F E +NI +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRF--TEERIWNIFVQMVLA 125
Query: 603 LAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLA 662
L YLH++ +RI+H D+ P N++L ++ ++DFGLAK E T++ GT Y
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGTILYSC 181
Query: 663 PEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEG-KLRNI 721
PE + N EK+DV+++G +L ++ P P Y+ M+ K+
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMC----TLQP---------PFYSTNMLSLATKIVEA 228
Query: 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQML 763
+ L S+ V + C+ D RP + +V M+
Sbjct: 229 VYEPLPEGMYSEDVTDVIT---SCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 64/212 (30%), Positives = 112/212 (52%), Gaps = 29/212 (13%)
Query: 500 LGQGGFGSVYQGV-LPDGTRL----AVKKLEGIGQGK--KEFRAEVSIIGSIHHLHLVKL 552
LG G FG+VY+G+ +PDG + A+K L K KE E ++ + ++ +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQ-----EFLLDWETRFNIALGTAKGLAYLH 607
G C T +L+ + M G L ++ ++N+ + LL+W + AKG++YL
Sbjct: 75 LGICLTSTVQLVT-QLMPYGCLLDYV-RENKDRIGSQDLLNW------CVQIAKGMSYLE 126
Query: 608 EDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPE 664
E R++H D+ NVL+ H K++DFGLA+L+ +++ G + ++A E
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD--GGKVPIKWMALE 181
Query: 665 WITNYAISEKSDVYSYGMVLLEIIG-GRKNFD 695
I + + +SDV+SYG+ + E++ G K +D
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 65/209 (31%), Positives = 95/209 (45%), Gaps = 12/209 (5%)
Query: 500 LGQGGFGSVYQ-GVLPDGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRG 554
LG+GGFG V V G A KKL+ G+K E I+ ++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
TH L M G L I+ + L + E + + G+ +LH I
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGL-EMERVIHYSAQITCGILHLHS---MDI 116
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEK 674
++ D+KPENVLLDD + ++SD GLA + ++ T GT GY+APE + S
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSYP 174
Query: 675 SDVYSYGMVLLEIIGGRKNF-DPNETSDK 702
D ++ G + E++ GR F D E K
Sbjct: 175 VDWFAMGCSIYEMVAGRTPFKDHKEKVAK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 30/210 (14%)
Query: 500 LGQGGFGSVYQGVL--PDGT--RLAVK--KLEGIGQGK-KEFRAEVSIIGSIHHLHLVKL 552
LG+G FGSV +G L DG+ ++AVK KL+ + +EF +E + + H +++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 553 RGFCAEGTHR------LLAYEFMANGSLDKWIFK---KNQEFLLDWETRFNIALGTAKGL 603
G C E + ++ FM +G L ++ L +T + A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 604 AYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR----- 658
YL ++ IH D+ N +L ++ V+DFGL+K + + R R
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYY-----RQGRIAKMP 178
Query: 659 -GYLAPEWITNYAISEKSDVYSYGMVLLEI 687
++A E + + + KSDV+++G+ + EI
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 58/200 (29%), Positives = 105/200 (52%), Gaps = 17/200 (8%)
Query: 500 LGQGGFGSVYQGVL--PDGTRL--AVKKLEGIGQGKK--EFRAEVSIIGSIHHLHLVKLR 553
+G+G FG VY G L DG ++ AVK L I ++ +F E I+ H +++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 554 GFC--AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCD 611
G C +EG+ L+ +M +G L +I +++ + L AKG+ YL
Sbjct: 63 GICLPSEGS-PLVVLPYMKHGDLRNFI--RSETHNPTVKDLIGFGLQVAKGMEYLAS--- 116
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITN 668
++ +H D+ N +LD+++ KV+DFGLA+ + ++ + G + ++A E +
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176
Query: 669 YAISEKSDVYSYGMVLLEII 688
+ KSDV+S+G++L E++
Sbjct: 177 QKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 5e-17
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 499 KLGQGGFGSVYQGVLPD------GTRLAVKKLEGIGQGKK--EFRAEVSIIGSIHHLHLV 550
+LGQG FG VY+G D TR+AVK + ++ EF E S++ H+V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLDKWI--FKKNQE-----FLLDWETRFNIALGTAKGL 603
+L G ++G L+ E MA+G L ++ + E + +A A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 604 AYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRG---- 659
AYL+ ++ +H D+ N ++ ++ K+ DFG MTR+ +G +G
Sbjct: 133 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 185
Query: 660 -YLAPEWITNYAISEKSDVYSYGMVLLEI 687
++APE + + + SD++S+G+VL EI
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL----EGIGQGKKEFRAEVSIIGSIHHLHLVKLR 553
K+G+G +G VY+ G +A+KK+ E G K R E+ ++ ++H +++KL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLL 64
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
L +EFM D + K+++ L + +GLA+ H
Sbjct: 65 DVFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HG 118
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN---YA 670
I+H D+KPEN+L++ K++DFGLA+ +T TR Y APE + Y
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVVTRWYRAPELLLGDKGY- 176
Query: 671 ISEKSDVYSYGMVLLEIIGGR 691
S D++S G + E++ R
Sbjct: 177 -STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 6e-17
Identities = 69/225 (30%), Positives = 104/225 (46%), Gaps = 29/225 (12%)
Query: 500 LGQGGFGSVYQGVLPDGTRL-AVKKLEG---IGQGKKE-FRAEVSIIGSIHHLHLVKLRG 554
LG G FG V + A+K L + + E E I+ SI H LV L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRF---NIALGTAKGLAYLHEDCD 611
+ ++ L E++ G L +K+ F RF + L L YLH D
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSH-LRKSGRFPEPV-ARFYAAQVVLA----LEYLH-SLD 121
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAI 671
I++ D+KPEN+LLD + + K++DFG AK R + + TL GT YLAPE I +
Sbjct: 122 --IVYRDLKPENLLLDSDGYIKITDFGFAK---RVKGRTY-TLCGTPEYLAPEIILSKGY 175
Query: 672 SEKSDVYSYGMVLLEIIGGRKNF---DPNET-----SDKAHFPSY 708
+ D ++ G+++ E++ G F +P + K FPS+
Sbjct: 176 GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSF 220
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 7e-17
Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 23/218 (10%)
Query: 496 FSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
F +LG G FG V G +A+K ++ + EF E ++ + H LV+L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEF----LLDWETRFNIALGTAKGLAYLHEDCD 611
C + + E+M+NG L ++ + + F LL+ + +G+AYL
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLE------MCKDVCEGMAYLES--- 118
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITN 668
++ IH D+ N L+DD KVSDFGL++ + ++ +T+ G++ + PE +
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLLY 175
Query: 669 YAISEKSDVYSYGMVLLEIIGGRK----NFDPNETSDK 702
S KSDV+++G+++ E+ K F+ +ET +K
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK 213
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 13/210 (6%)
Query: 499 KLGQGGFGSVYQGV--LPDGTRL--AVK--KLEGIGQGKKEFRAEVSIIGSIHHLHLVKL 552
+G+G FG VYQGV P+ ++ AVK K +++F E I+ H H+VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
G E ++ E G L ++ + N+ L D + + + LAYL +
Sbjct: 73 IGVITENPVWIV-MELAPLGELRSYL-QVNKYSL-DLASLILYSYQLSTALAYLE---SK 126
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAIS 672
R +H DI NVL+ K+ DFGL++ + E + + + ++APE I +
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT 186
Query: 673 EKSDVYSYGMVLLEIIG-GRKNFDPNETSD 701
SDV+ +G+ + EI+ G K F + +D
Sbjct: 187 SASDVWMFGVCMWEILMLGVKPFQGVKNND 216
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 19/199 (9%)
Query: 498 VKLGQGGFGSVYQGVLPDGTR---LAVK--KLEGIGQGKKEFRAEVSIIGSIHHLHLVKL 552
V+LG G FG V +GV + +A+K K E + E E I+ + + ++V++
Sbjct: 1 VELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIAL---GTAKGLAYLHED 609
G C E +L E + G L+K++ K E T N+ + G+ YL
Sbjct: 61 IGVC-EAEALMLVMEMASGGPLNKFLSGKKDEI-----TVSNVVELMHQVSMGMKYLEG- 113
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGT--RGYLAPEWIT 667
+ +H D+ NVLL + ++AK+SDFGL+K + + S+ G + APE I
Sbjct: 114 --KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171
Query: 668 NYAISEKSDVYSYGMVLLE 686
S +SDV+SYG+ + E
Sbjct: 172 FRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 65/230 (28%), Positives = 115/230 (50%), Gaps = 40/230 (17%)
Query: 486 YRDLQTATNNFSVKLGQGGFGSVYQG-VLPDGTRL--AVKKLEGIGQ--GKKEFRAEVSI 540
Y L+ F +G+G FG V + + DG R+ A+K+++ ++F E+ +
Sbjct: 1 YPVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60
Query: 541 IGSI-HHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGT 599
+ + HH +++ L G C + LA E+ +G+L ++ K +L+ + F IA T
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR---VLETDPAFAIANST 117
Query: 600 A----------------KGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643
A +G+ YL + ++ IH D+ N+L+ +NY AK++DFGL
Sbjct: 118 ASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL---- 170
Query: 644 TREQSHVFTTLRGTRGYLAPEWIT----NYAI-SEKSDVYSYGMVLLEII 688
+R Q ++ T G L W+ NY++ + SDV+SYG++L EI+
Sbjct: 171 SRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 73/289 (25%), Positives = 133/289 (46%), Gaps = 48/289 (16%)
Query: 499 KLGQGGFGSVYQGVL-------PDGTRLAVKKLEGIGQGKK--EFRAEVSIIGSIHHLHL 549
+LGQG FG VY+G+ P+ TR+A+K + ++ EF E S++ + H+
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 550 VKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEF-------LLDWETRFNIALGTAKG 602
V+L G ++G L+ E M G L ++ E + +A A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 603 LAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRG--- 659
+AYL+ + + +H D+ N ++ +++ K+ DFG MTR+ +G +G
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLP 184
Query: 660 --YLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGK 717
+++PE + + + SDV+S+G+VL EI + A P M E
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEI------------ATLAEQPYQG--MSNEQV 230
Query: 718 LRNILDSRL--NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764
LR +++ L D D +F +++ C Q + +RPS +++ ++
Sbjct: 231 LRFVMEGGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 59/224 (26%), Positives = 109/224 (48%), Gaps = 43/224 (19%)
Query: 500 LGQGGFGSVYQGV------LPDGTRLAVKKLEGIGQGKKEFRA---EVSIIGSIHHLHLV 550
LG+G FG V + T +AVK L+ E R E +++ ++H H++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE-NASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLDKWI--------------FKKNQEFLLDWETR---- 592
KL G C++ LL E+ GSL ++ +N +L + + R
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 593 ---FNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649
+ A ++G+ YL E +++H D+ NVL+ + K+SDFGL++ + E S+
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 650 VFTTLRGTRG-----YLAPEWITNYAISEKSDVYSYGMVLLEII 688
V + ++G ++A E + ++ + +SDV+S+G++L EI+
Sbjct: 184 V----KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 61/226 (26%), Positives = 108/226 (47%), Gaps = 33/226 (14%)
Query: 488 DLQTATNNFSVKLGQGGFGSVYQG--VLP--DGTRL-AVKKLEGIGQGKK--EFRAEVSI 540
+L + F +LG+ FG +Y+G LP D +L A+K L+ I ++ EF+ E S+
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 541 IGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQ--------------EFL 586
+ +HH ++V L G + + +E++ G L +++ ++ +
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 587 LDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM--- 643
LD +IA+ A G+ YL +H D+ N+L+ + H K+SD GL++ +
Sbjct: 121 LDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 644 --TREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEI 687
R Q +R ++ PE I S SD++S+G+VL EI
Sbjct: 178 DYYRVQPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 40/214 (18%)
Query: 500 LGQGGFGSVYQGVLPDGTRLAVKKLEG-------------IGQGKKE-FRAEVSIIGSIH 545
+ +G +G V+ LA KK G I + + + E I+
Sbjct: 1 ISKGAYGRVF---------LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ 51
Query: 546 HLHLVKLRGFCA-EGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGL 603
++VKL + + +G L L E++ G L + +N L + R IA L
Sbjct: 52 SPYVVKL--YYSFQGKKNLYLVMEYLPGGDLASLL--ENVGSLDEDVARIYIA-EIVLAL 106
Query: 604 AYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL-MTREQSHVF------TTLRG 656
YLH IIH D+KP+N+L+D N H K++DFGL+K+ + R Q ++ + G
Sbjct: 107 EYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163
Query: 657 TRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGG 690
T Y+APE I S+ D +S G +L E + G
Sbjct: 164 TPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 21/218 (9%)
Query: 488 DLQTATNNFSVKLGQGGFGSVYQGV-LPDGTRLAVKKL-EGIGQGKKEFRAEVSIIGSIH 545
+ + N V LG+G +G VY L R+A+K++ E + + E+++ +
Sbjct: 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLK 63
Query: 546 HLHLVKLRGFCAEGTHRLLAYEFMANGSLD-----KWIFKKNQEFLLDWETRFNIALGTA 600
H ++V+ G +E + E + GSL KW K+ E + + T+
Sbjct: 64 HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-----QIL 118
Query: 601 KGLAYLHEDCDQRIIHCDIKPENVLLDDNYHA--KVSDFGLAKLMTREQSHVFTTLRGTR 658
+GL YLH D +I+H DIK +NVL+ + Y K+SDFG +K + T GT
Sbjct: 119 EGLKYLH---DNQIVHRDIKGDNVLV-NTYSGVVKISDFGTSKRLAGINP-CTETFTGTL 173
Query: 659 GYLAPEWITN--YAISEKSDVYSYGMVLLEIIGGRKNF 694
Y+APE I +D++S G ++E+ G+ F
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 69/274 (25%), Positives = 133/274 (48%), Gaps = 31/274 (11%)
Query: 500 LGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFR----AEVSIIGSIHHLHLVKLRGF 555
+G+G FG V+ +L + K + Q K+ R E ++ + H ++++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
E ++ E+ G+L ++I K+ LLD +T + + L ++H + I+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNS-LLDEDTILHFFVQILLALHHVHT---KLIL 123
Query: 616 HCDIKPENVLLDDNYHA-KVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEK 674
H D+K +N+LLD + K+ DFG++K+++ +S +T + GT Y++PE ++K
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVV-GTPCYISPELCEGKPYNQK 181
Query: 675 SDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDR 734
SD+++ G VL E+ ++ F + A+ P+ K+M G I SDR
Sbjct: 182 SDIWALGCVLYELASLKRAF------EAANLPALVLKIM-SGTFAPI----------SDR 224
Query: 735 VFTAVK-VALWCVQEDMSLRPSMTKVVQMLEGIC 767
++ + L + D S RP ++++ M + IC
Sbjct: 225 YSPDLRQLILSMLNLDPSKRPQLSQI--MAQPIC 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 24/220 (10%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKE-------FRAEVSIIGSIHHLHLVK 551
LG G F S YQ + GT +AVK++ + E R E+ ++ ++H H+++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 552 LRGFCAEGTHRLLAYEFMANGSLDKWIFKKN--QEFLLDWETRFNIALGTAKGLAYLHED 609
+ G E +H L E+MA GS+ + K +E ++ N +GL+YLH
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLH-- 120
Query: 610 CDQRIIHCDIKPENVLLDDN-YHAKVSDFGLAKLMTREQS---HVFTTLRGTRGYLAPEW 665
+ +IIH D+K N+L+D +++DFG A + + + L GT ++APE
Sbjct: 121 -ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 666 ITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHF 705
+ DV+S G V++E+ + ++ + S+ H
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN--HL 217
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 15/203 (7%)
Query: 499 KLGQGGFGSVYQGVLPDGTRL-AVKKLEGIGQG---KKEFRAEVSIIGSIHHLHLVKLRG 554
+G+G +G V + + A+KK + KK EV ++ + H ++V L+
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
L +E++ L+ L + + + +AY H I
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELLEASPGG---LPPDAVRSYIWQLLQAIAYCHS---HNI 121
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI---TNYAI 671
IH DIKPEN+L+ ++ K+ DFG A+ + + T TR Y APE + TNY
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGK 181
Query: 672 SEKSDVYSYGMVLLEIIGGRKNF 694
DV++ G ++ E++ G F
Sbjct: 182 P--VDVWAIGCIMAELLDGEPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 68/201 (33%), Positives = 97/201 (48%), Gaps = 13/201 (6%)
Query: 500 LGQGGFGSVYQ-GVLPDGTRLAVKKLEG--IGQGKKEFRA--EVSIIGSIHHLHLVKLRG 554
LG+GGFG V V G A KKLE I + K E A E I+ ++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66
Query: 555 FCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
+ E L L M G L I+ + + F A GL LH+ +R
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-YAAEICCGLEDLHQ---ER 122
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISE 673
I++ D+KPEN+LLDD+ H ++SD GLA + Q+ GT GY+APE + N +
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTF 180
Query: 674 KSDVYSYGMVLLEIIGGRKNF 694
D ++ G +L E+I G+ F
Sbjct: 181 SPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 56/193 (29%), Positives = 105/193 (54%), Gaps = 11/193 (5%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558
KLG G FG V+ T++AVK ++ + F AE +++ ++ H LVKL +
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 559 GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCD 618
++ EFMA GSL ++ K ++ + + A+G+A++ + + IH D
Sbjct: 73 EPIYIIT-EFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRD 127
Query: 619 IKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNYAISEKS 675
++ N+L+ + K++DFGLA+++ + + +T G + + APE I + + KS
Sbjct: 128 LRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 676 DVYSYGMVLLEII 688
DV+S+G++L+EI+
Sbjct: 185 DVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 6e-16
Identities = 79/341 (23%), Positives = 146/341 (42%), Gaps = 23/341 (6%)
Query: 430 PVVVIIVLSTSVVILGLLYVAIRYVRKKRKAPESPQETSEEDNFLENL---SGMPVRFTY 486
P + T L L VA +V + + + ED E S + T
Sbjct: 626 PSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITI 685
Query: 487 RDLQTATNNFSVKLGQGGFGSVYQG-VLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH 545
D+ ++ +V + +G G+ Y+G + +G + VK++ + A+ +G +
Sbjct: 686 NDILSSLKEENV-ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD---MGKLQ 741
Query: 546 HLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAY 605
H ++VKL G C L +E++ +L + + L WE R IA+G AK L +
Sbjct: 742 HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRF 795
Query: 606 LHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEW 665
LH C ++ ++ PE +++D + L L+ + ++ Y+APE
Sbjct: 796 LHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPET 849
Query: 666 ITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS- 724
I+EKSD+Y +G++L+E++ G+ D E +A + L +D
Sbjct: 850 RETKDITEKSDIYGFGLILIELLTGKSPADA-EFGVHGSIVEWARYCYSDCHLDMWIDPS 908
Query: 725 -RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764
R ++ + + + +AL C D + RP V++ LE
Sbjct: 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-15
Identities = 49/172 (28%), Positives = 82/172 (47%), Gaps = 20/172 (11%)
Query: 532 KEFRAEVSIIGSIHHLHLVKL--RGFCAEGTHRLLA-YEFMANGSLDKWIFKKNQEFLLD 588
FR E ++ ++H ++V L G G L A +E++ +L + + L
Sbjct: 23 ARFRRETALCARLYHPNIVALLDSGEAPPG--LLFAVFEYVPGRTLREVL--AADGALPA 78
Query: 589 WETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL---DDNYHAKVSDFGLAKLMTR 645
ET + L LA H +Q I+H D+KP+N+++ HAKV DFG+ L+
Sbjct: 79 GET-GRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPG 134
Query: 646 EQSHVFTTLR------GTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGR 691
+ TL GT Y APE + ++ SD+Y++G++ LE + G+
Sbjct: 135 VRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 68/239 (28%), Positives = 118/239 (49%), Gaps = 21/239 (8%)
Query: 488 DLQTATNNFSVKLGQGGFGSV-YQGVLPDGTRLAVKKLEGIGQGKKEFR-AEVSIIGSIH 545
D +T +NF +K+G+G G V V G +AVKK++ Q ++E EV I+
Sbjct: 17 DPRTYLDNF-IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ 75
Query: 546 HLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAY 605
H ++V++ G + EF+ G+L + ++ E + L K L+
Sbjct: 76 HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKALSV 131
Query: 606 LHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEW 665
LH Q +IH DIK +++LL + K+SDFG +++E +L GT ++APE
Sbjct: 132 LHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR-KSLVGTPYWMAPEL 187
Query: 666 ITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEG---KLRNI 721
I+ + D++S G++++E++ G + NE P A KM+ + KL+N+
Sbjct: 188 ISRLPYGPEVDIWSLGIMVIEMVDGEPPYF-NEP------PLKAMKMIRDNLPPKLKNL 239
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 499 KLGQGGFGSVY----QGVLPDGTRL--AVKKLEGIGQ-GKKEFRAEVSIIGSIHHLHLVK 551
+LG+G FG V+ +LP+ ++ AVK L+ + +++F+ E ++ + H H+V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 552 LRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETR------------FNIALGT 599
G C EG L+ +E+M +G L++++ + + IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 600 AKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF--TTLRGT 657
A G+ YL +H D+ N L+ K+ DFG+++ + + T+
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 658 RGYLAPEWITNYAISEKSDVYSYGMVLLEI 687
R ++ PE I + +SD++S+G+VL EI
Sbjct: 189 R-WMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 57/194 (29%), Positives = 101/194 (52%), Gaps = 10/194 (5%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRA-EVSIIGSIHHLHLVKLRGFC 556
K+GQG G+V+ + + G +A+K++ Q KKE E+ ++ + + ++V
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 557 AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIH 616
G + E++A GSL + E +D + + L +LH + ++IH
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECLQALEFLHAN---QVIH 138
Query: 617 CDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSD 676
DIK +NVLL + K++DFG +T EQS +T+ GT ++APE +T A K D
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 677 VYSYGMVLLEIIGG 690
++S G++ +E++ G
Sbjct: 198 IWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 59/199 (29%), Positives = 100/199 (50%), Gaps = 21/199 (10%)
Query: 499 KLGQGGFGSVYQGVL---PDGTRLAVKKLEGIGQG---KKEFRAEVSIIGSIHHLHLVKL 552
+LG G FG+V +G+ +AVK L+ K E E +++ + + ++V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNI---ALGTAKGLAYLHED 609
G C E +L E G L+K++ +KN+ T NI + G+ YL E
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL-QKNKHV-----TEKNITELVHQVSMGMKYLEE- 113
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGT--RGYLAPEWIT 667
+H D+ NVLL ++AK+SDFGL+K + ++++ G + APE +
Sbjct: 114 --TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171
Query: 668 NYAISEKSDVYSYGMVLLE 686
Y S KSDV+S+G+++ E
Sbjct: 172 YYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 11/205 (5%)
Query: 488 DLQTATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFR-AEVSIIGSIH 545
D + ++F +K+G+G G V G ++AVKK++ Q ++E EV I+ H
Sbjct: 19 DPREYLDSF-IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH 77
Query: 546 HLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAY 605
H ++V + G + EF+ G+L + ++ E + L + L+Y
Sbjct: 78 HENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLRALSY 133
Query: 606 LHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEW 665
LH +Q +IH DIK +++LL + K+SDFG +++E +L GT ++APE
Sbjct: 134 LH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR-KSLVGTPYWMAPEV 189
Query: 666 ITNYAISEKSDVYSYGMVLLEIIGG 690
I+ + D++S G++++E+I G
Sbjct: 190 ISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 58/194 (29%), Positives = 100/194 (51%), Gaps = 10/194 (5%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRA-EVSIIGSIHHLHLVKLRGFC 556
K+GQG G+VY + + G +A+K++ Q KKE E+ ++ H ++V
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 557 AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIH 616
G + E++A GSL + E +D + + L +LH + ++IH
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVIH 138
Query: 617 CDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSD 676
DIK +N+LL + K++DFG +T EQS +T+ GT ++APE +T A K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 677 VYSYGMVLLEIIGG 690
++S G++ +E++ G
Sbjct: 198 IWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 67/213 (31%), Positives = 110/213 (51%), Gaps = 23/213 (10%)
Query: 500 LGQGGFGSVY---QGVLPD-GTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKL 552
LGQG FG V+ + PD G A+K L+ + + + E I+ ++H +VKL
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 553 R-GFCAEGTHRLLAYEFMANGSLDKWIFKK-NQEFLLDWE-TRFNIALGTAKGLAYLHED 609
F EG L+ +F+ G L F + ++E + E +F +A A L +LH
Sbjct: 64 HYAFQTEGKLYLI-LDFLRGGDL----FTRLSKEVMFTEEDVKFYLA-ELALALDHLH-- 115
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNY 669
II+ D+KPEN+LLD+ H K++DFGL+K + + + GT Y+APE +
Sbjct: 116 -SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY-SFCGTVEYMAPEVVNRR 173
Query: 670 AISEKSDVYSYGMVLLEIIGGRKNF---DPNET 699
++ +D +S+G+++ E++ G F D ET
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET 206
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 19/202 (9%)
Query: 495 NFSVKLGQGGFGSVYQG-VLPDGTRLAVKKLEGIGQGKKEFR-AEVSIIGSIHHLHLVKL 552
NF VK+G+G G V G ++AVKK++ Q ++E EV I+ H ++V++
Sbjct: 23 NF-VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
G + EF+ G+L + ++ E + L K L++LH Q
Sbjct: 82 YSSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLAVLKALSFLHA---Q 134
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFG----LAKLMTREQSHVFTTLRGTRGYLAPEWITN 668
+IH DIK +++LL + K+SDFG ++K + R +S V GT ++APE I+
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPYWMAPEVISR 189
Query: 669 YAISEKSDVYSYGMVLLEIIGG 690
+ D++S G++++E++ G
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 500 LGQGGFGSVYQGVL----PDGTRLAVKKLEGIGQGKKEFR---AEVSIIGSIHHLHLVKL 552
LG+G FG L D + + K++ +KE R E+ I+ + H +++
Sbjct: 8 LGKGAFGE---ATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
+ L+ E+ G+L I ++ + L + E ++Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ-LFEEEMVLWYLFQIVSAVSYIHK---A 120
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAIS 672
I+H DIK N+ L K+ DFG++K++ E S T + GT Y++PE +
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYN 179
Query: 673 EKSDVYSYGMVLLEIIGGRKNFD 695
KSD+++ G VL E++ ++ FD
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFD 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 4e-15
Identities = 57/194 (29%), Positives = 100/194 (51%), Gaps = 10/194 (5%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRA-EVSIIGSIHHLHLVKLRGFC 556
K+GQG G+VY + + G +A+K++ Q KKE E+ ++ + ++V
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 557 AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIH 616
G + E++A GSL + E +D + + L +LH + ++IH
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLHSN---QVIH 138
Query: 617 CDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSD 676
DIK +N+LL + K++DFG +T EQS +T+ GT ++APE +T A K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 677 VYSYGMVLLEIIGG 690
++S G++ +E++ G
Sbjct: 198 IWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 28/206 (13%)
Query: 500 LGQGGFGSVYQGVLPDGTRL-AVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFCA 557
+G+G +G VY+ +L A+K ++ I ++E + E +I+ +H ++ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFI 73
Query: 558 EGTHRL------LAYEFMANGS---LDKWIFKKNQEFLLDWETRFNIAL---GTAKGLAY 605
+ L E GS L K + KK + +W IA T +GLAY
Sbjct: 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAYILRETLRGLAY 128
Query: 606 LHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEW 665
LHE+ ++IH DIK +N+LL N K+ DFG++ + T + GT ++APE
Sbjct: 129 LHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAPEV 184
Query: 666 IT-----NYAISEKSDVYSYGMVLLE 686
I + + +SDV+S G+ +E
Sbjct: 185 IACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 7e-15
Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 24/204 (11%)
Query: 500 LGQGGFGSV----YQGVLPDGTR----LAVKKL--EGIGQGKKEFRAEVSIIGSIHHLHL 549
LG+G FG V Y P+G +AVK L E G + + E+ I+ +++H ++
Sbjct: 12 LGEGHFGKVELCRYD---PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 550 VKLRGFCAEGTHR--LLAYEFMANGSLDKWIFK-KNQEFLLDWETRFNIALGTAKGLAYL 606
VK +G C E L EF+ +GSL +++ + KN+ ++ + + A+ KG+ YL
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYL 125
Query: 607 HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH--VFTTLRGTRGYLAPE 664
++ +H D+ NVL++ + K+ DFGL K + ++ + V L + APE
Sbjct: 126 GS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182
Query: 665 WITNYAISEKSDVYSYGMVLLEII 688
+ SDV+S+G+ L E++
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 9e-15
Identities = 72/277 (25%), Positives = 127/277 (45%), Gaps = 27/277 (9%)
Query: 495 NFSV--KLGQGGFGSVYQGV-LPDGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHL 547
NF + K+G+G F VY+ L DG +A+KK++ + + + E+ ++ ++H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 548 HLVKLRGFCAEGTHRLLAYEFMANGSLDKWI--FKKNQEFLLDWETRFNIALGTAKGLAY 605
+++K E + E G L + I FKK Q+ L+ +T + + L +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEH 121
Query: 606 LHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEW 665
+H +R++H DIKP NV + K+ D GL + + + + +L GT Y++PE
Sbjct: 122 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH-SLVGTPYYMSPER 177
Query: 666 ITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725
I + KSD++S G +L E+ + F DK + S K +E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYSLC-KKIEQCDY-----PP 227
Query: 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762
L D S+ + V + C+ D RP +T V +
Sbjct: 228 LPSDHYSEELRQLVNM---CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 59/227 (25%), Positives = 103/227 (45%), Gaps = 30/227 (13%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVK--KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
++G G +G VY+ + G +A+K KLE G + + E+S++ H ++V G
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEP-GDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
+ E+ GSL I++ + L + + + + T KGLAYLHE I
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAY-VCRETLKGLAYLHE---TGKI 123
Query: 616 HCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI---TNYAIS 672
H DIK N+LL ++ K++DFG++ +T + + GT ++APE
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR-KSFIGTPYWMAPEVAAVERKGGYD 182
Query: 673 EKSDVYSYGMVLLEI-----------------IGGRKNFDPNETSDK 702
K D+++ G+ +E+ + + NF P + DK
Sbjct: 183 GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDK 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 69/204 (33%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 500 LGQGGFGSVYQ-GVLPDGTRLAVKKLEG--IGQGKKEFRA--EVSIIGSIHHLHLVKLRG 554
LG+GGFG V V G A KKLE I + K E A E I+ ++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 555 FCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
+ E L L M G L I+ + F A T GL LH +R
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC-GLEDLHR---ER 122
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLR---GTRGYLAPEWITNYA 670
I++ D+KPEN+LLDD H ++SD GLA + + T+R GT GY+APE + N
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-----TIRGRVGTVGYMAPEVVKNER 177
Query: 671 ISEKSDVYSYGMVLLEIIGGRKNF 694
+ D + G ++ E+I G+ F
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 51/195 (26%), Positives = 93/195 (47%), Gaps = 11/195 (5%)
Query: 496 FSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
F +LG G FG V+ G ++A+K + +++F E ++ + H LV+L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
C + + EFM NG L ++ ++ + D ++ +G+ YL + I
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKD--MLLSMCQDVCEGMEYLERN---SFI 122
Query: 616 HCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNYAIS 672
H D+ N L+ KVSDFG+ + + ++ +T+ G + + PE S
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE---YTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 673 EKSDVYSYGMVLLEI 687
KSDV+S+G+++ E+
Sbjct: 180 SKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 65/204 (31%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 500 LGQGGFGSVY------QGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLR 553
LG+GGFG V G L +L K+L+ +G + E I+ +H +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK-RKGYEGAMVEKRILAKVHSRFIVSLA 59
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAK---GLAYLHEDC 610
T L M G L I+ ++E E R TA+ GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPR--ACFYTAQIISGLEHLHQ-- 115
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYA 670
+RII+ D+KPENVLLD++ + ++SD GLA + QS GT G++APE +
Sbjct: 116 -RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT-KGYAGTPGFMAPELLQGEE 173
Query: 671 ISEKSDVYSYGMVLLEIIGGRKNF 694
D ++ G+ L E+I R F
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 496 FSVKLGQGGFGSVYQ----GVLPDGT--RLAVKKLEGIGQG--KKEFRAEVSIIGSI-HH 546
F LG G FG V + G+ ++AVK L+ ++ +E+ I+ + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 547 LHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYL 606
++V L G C G L+ E+ G L ++ ++ +E L E + + AKG+A+L
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKGMAFL 157
Query: 607 -HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRG-TR---GYL 661
++C IH D+ NVLL K+ DFGLA+ + + ++V ++G R ++
Sbjct: 158 ASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNARLPVKWM 210
Query: 662 APEWITNYAISEKSDVYSYGMVLLEI 687
APE I N + +SDV+SYG++L EI
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 58/196 (29%), Positives = 96/196 (48%), Gaps = 13/196 (6%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEF---RAEVSIIGSIHHLHLVKLRGF 555
++G+G FG VY+G+ + K+ + + + E + E++++ ++ + G
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 556 CAEGTHRLLAYEFMANGS-LDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
+GT + E++ GS LD + K L+ I KGL YLH +R
Sbjct: 71 YLKGTKLWIIMEYLGGGSALD--LLKPGP---LEETYIATILREILKGLDYLHS---ERK 122
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEK 674
IH DIK NVLL + K++DFG+A +T Q T GT ++APE I A K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR-NTFVGTPFWMAPEVIKQSAYDFK 181
Query: 675 SDVYSYGMVLLEIIGG 690
+D++S G+ +E+ G
Sbjct: 182 ADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 32/273 (11%)
Query: 499 KLGQGGFGSVYQGVL-PDGTRLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
++G+G FG V+ G L D T +AVK K +F E I+ H ++V+L G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
C + + E + G D F + + L + + A G+ YL I
Sbjct: 62 CTQKQPIYIVMELVQGG--DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 616 HCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR----GYLAPEWITNYAI 671
H D+ N L+ + K+SDFG+++ E+ V+ + G + + APE +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 672 SEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731
S +SDV+S+G++L E N ++ + + +E+G RL E
Sbjct: 174 SSESDVWSFGILLWEAFSLGAVPYANLSNQQTR------EAIEQG-------VRLPCPEL 220
Query: 732 -SDRVFTAVKVALWCVQEDMSLRPSMTKVVQML 763
D V+ ++ C + D RPS + V Q L
Sbjct: 221 CPDAVY---RLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 58/196 (29%), Positives = 97/196 (49%), Gaps = 13/196 (6%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEF---RAEVSIIGSIHHLHLVKLRGF 555
++G+G FG V++G+ ++ K+ + + + E + E++++ ++ K G
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 556 CAEGTHRLLAYEFMANGS-LDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
+GT + E++ GS LD EF + T L KGL YLH ++
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI--ATMLKEIL---KGLDYLHS---EKK 122
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEK 674
IH DIK NVLL + K++DFG+A +T Q T GT ++APE I A K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR-NTFVGTPFWMAPEVIQQSAYDSK 181
Query: 675 SDVYSYGMVLLEIIGG 690
+D++S G+ +E+ G
Sbjct: 182 ADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 3e-14
Identities = 54/182 (29%), Positives = 87/182 (47%), Gaps = 32/182 (17%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL---------EGIGQGKKEFRA--EVSIIGSIHH 546
KLG+G + VY+ G +A+KK+ +GI F A E+ ++ + H
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGI-----NFTALREIKLLQELKH 61
Query: 547 LHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYL 606
+++ L ++ L +EFM L+K + K L + + + L T +GL YL
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFME-TDLEK-VIKDKSIVLTPADIK-SYMLMTLRGLEYL 118
Query: 607 HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM---TREQSH-VFTTLRGTRGYLA 662
H I+H D+KP N+L+ + K++DFGLA+ R+ +H V TR Y A
Sbjct: 119 H---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-----TRWYRA 170
Query: 663 PE 664
PE
Sbjct: 171 PE 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 500 LGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKK--EFRAEVSIIGSIHHLHLVKL-RGFC 556
LG G FG VY+ + A K+ I ++ +F E+ I+ H ++V L +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 557 AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIH 616
E +L EF G+LD I + + L + + R+ + + L +LH ++IH
Sbjct: 73 YENKLWIL-IEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLH---SHKVIH 126
Query: 617 CDIKPENVLLDDNYHAKVSDFGL-AKLMTREQSHVFTTLRGTRGYLAPEWI-----TNYA 670
D+K N+LL + K++DFG+ AK + Q T GT ++APE + +
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFIGTPYWMAPEVVACETFKDNP 184
Query: 671 ISEKSDVYSYGMVLLEIIGGR 691
K+D++S G+ L+E+
Sbjct: 185 YDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 3e-14
Identities = 57/194 (29%), Positives = 100/194 (51%), Gaps = 10/194 (5%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRA-EVSIIGSIHHLHLVKLRGFC 556
K+GQG G+VY + + G +A++++ Q KKE E+ ++ + ++V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 557 AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIH 616
G + E++A GSL + E +D + + L +LH + ++IH
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 617 CDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSD 676
DIK +N+LL + K++DFG +T EQS +T+ GT ++APE +T A K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 677 VYSYGMVLLEIIGG 690
++S G++ +E+I G
Sbjct: 199 IWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 70/205 (34%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 500 LGQGGFGSVYQ-GVLPDGTRLAVKKLEG--IGQGKKEFRA--EVSIIGSIHHLHLVKLRG 554
LG+GGFG V V G A KKLE I + K E A E I+ ++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 555 FCAEGTHRL-LAYEFMANGSLDKWIFK-KNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
+ E L L M G L I+ N F D + A GL L +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF--DEQRAIFYAAELCCGLEDLQR---E 121
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLR---GTRGYLAPEWITNY 669
RI++ D+KPEN+LLDD H ++SD GLA + + T+R GT GY+APE I N
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-----TVRGRVGTVGYMAPEVINNE 176
Query: 670 AISEKSDVYSYGMVLLEIIGGRKNF 694
+ D + G ++ E+I G+ F
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 68/222 (30%), Positives = 101/222 (45%), Gaps = 35/222 (15%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEV------SIIGSIHHLH---- 548
+LG+G +GSVY+ + + G+ KE R E+ II + LH
Sbjct: 8 ELGKGNYGSVYK---------VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS 58
Query: 549 --LVKLRG-FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAY 605
+V G F EG + E+M GSLDK + + I KGL +
Sbjct: 59 PYIVDFYGAFFIEGA-VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 606 LHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEW 665
L E+ IIH D+KP NVL++ N K+ DFG++ + + T G + Y+APE
Sbjct: 118 LKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA---KTNIGCQSYMAPER 172
Query: 666 IT------NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSD 701
I N + +SDV+S G+ +LE+ GR + P ET
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP-ETYA 213
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 499 KLGQGGFGSVYQG-VLPDGTRLAVKKLEGIGQGKKEFRA---EVSIIGSIHHLHLVKLRG 554
K+G+G FG +Y D +K+++ KE A EV ++ + H ++V
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 555 FCAEGTHRLLAYEFMANGSLDKWI-------FKKNQEFLLDWETRFNIALGTAKGLAYLH 607
E + E+ G L K I F ++Q +L W + I+LG L ++H
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ--ILSWFVQ--ISLG----LKHIH 118
Query: 608 EDCDQRIIHCDIKPENVLLDDNYH-AKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI 666
D++I+H DIK +N+ L N AK+ DFG+A+ + +T + GT YL+PE
Sbjct: 119 ---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEIC 174
Query: 667 TNYAISEKSDVYSYGMVLLEIIGGRKNFDPN 697
N + K+D++S G VL E+ + F+ N
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 5e-14
Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 35/212 (16%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQG--KKEFRAEVSIIGSIHHLHLVKLRGF 555
++G G G+VY+ + P G A+K + G + +++ E+ I+ ++H ++VK
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
+ EFM GSL+ Q FL D +A G+AYLH + I+
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIADEQ-FLAD------VARQILSGIAYLHR---RHIV 190
Query: 616 HCDIKPENVLLDDNYHAKVSDFG----LAKLMTREQSHVFTTLRGTRGYLAPEWITN--- 668
H DIKP N+L++ + K++DFG LA+ M S V GT Y++PE I
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-----GTIAYMSPERINTDLN 245
Query: 669 ------YAISEKSDVYSYGMVLLEIIGGRKNF 694
YA D++S G+ +LE GR F
Sbjct: 246 HGAYDGYA----GDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 58/217 (26%), Positives = 109/217 (50%), Gaps = 34/217 (15%)
Query: 496 FSVKLGQGGFGSVYQGVLP-DGTRL--AVKKLEGIG--QGKKEFRAEVSIIGSI-HHLHL 549
F +G+G FG V + ++ DG ++ A+K L+ ++F E+ ++ + HH ++
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 550 VKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAY---- 605
+ L G C + +A E+ G+L ++ K +L+ + F GTA L
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSR---VLETDPAFAKEHGTASTLTSQQLL 122
Query: 606 ---------LHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRG 656
+ +++ IH D+ NVL+ +N +K++DFGL++ E+ +V +
Sbjct: 123 QFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYV----KK 175
Query: 657 TRGYLAPEWIT----NYAI-SEKSDVYSYGMVLLEII 688
T G L W+ NY++ + KSDV+S+G++L EI+
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (180), Expect = 8e-14
Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 29/209 (13%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQ----GKKEFRAEVSIIGSIHHLHLVKLRG 554
+G G +G V V G ++A+KK+ + K+ R E+ ++ + H +++ L
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGLLD 66
Query: 555 -FCAEGTHRL----LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED 609
+ E M L K I K+ + L D ++ +GL YLH
Sbjct: 67 ILRPPSPEDFNDVYIVTELMET-DLHKVI--KSPQPLTDDHIQY-FLYQILRGLKYLHS- 121
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH--VFTTLRGTRGYLAPEWIT 667
+IH D+KP N+L++ N K+ DFGLA+ + ++ T TR Y APE +
Sbjct: 122 --ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLL 179
Query: 668 N-----YAISEKSDVYSYGMVLLEIIGGR 691
+ AI D++S G + E++ +
Sbjct: 180 SSSRYTKAI----DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 8e-14
Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 31/204 (15%)
Query: 499 KLGQGGFGSVYQGVL----PDGTRLAVKKLEGIGQGKK----EFRAEVSIIGSIHHLHLV 550
K+G+G FG + +L DG + +K++ I + E R EV+++ ++ H ++V
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEI-NISKMSPKEREESRKEVAVLSNMKHPNIV 62
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLDKWI-------FKKNQEFLLDWETRFNIALGTAKGL 603
+ + E + + ++ G L K I F ++Q +LDW + +AL
Sbjct: 63 QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQ--ILDWFVQICLAL------ 114
Query: 604 AYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAP 663
++H D++I+H DIK +N+ L + K+ DFG+A+++ T + GT YL+P
Sbjct: 115 KHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSP 170
Query: 664 EWITNYAISEKSDVYSYGMVLLEI 687
E N + KSD+++ G VL E+
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 55/195 (28%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEF---RAEVSIIGSIHHLHLVKLRGF 555
K+G+G FG V++G+ ++ K+ + + + E + E++++ ++ K G
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
+ T + E++ GS + + LD I KGL YLH ++ I
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHS---EKKI 123
Query: 616 HCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKS 675
H DIK NVLL ++ K++DFG+A +T Q T GT ++APE I A K+
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-NTFVGTPFWMAPEVIKQSAYDSKA 182
Query: 676 DVYSYGMVLLEIIGG 690
D++S G+ +E+ G
Sbjct: 183 DIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 61/216 (28%), Positives = 113/216 (52%), Gaps = 40/216 (18%)
Query: 500 LGQGGFGSVYQGVLP-DGTRL--AVKKLEGIG--QGKKEFRAEVSIIGSI-HHLHLVKLR 553
+G+G FG V + + DG R+ A+K+++ ++F E+ ++ + HH +++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTA------------- 600
G C + LA E+ +G+L ++ K +L+ + F IA TA
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSR---VLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 601 ---KGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGT 657
+G+ YL + ++ IH D+ N+L+ +NY AK++DFGL++ ++ +V + T
Sbjct: 120 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV----KKT 169
Query: 658 RGYLAPEWIT----NYAI-SEKSDVYSYGMVLLEII 688
G L W+ NY++ + SDV+SYG++L EI+
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 1e-13
Identities = 67/261 (25%), Positives = 101/261 (38%), Gaps = 65/261 (24%)
Query: 500 LGQGGFGSVYQGVLPDGTRL-AVKKLEGIGQGKKE----------FRAEVSIIGSIHHLH 548
+G+G FG V+ D ++ A+K L +K RAE I+
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVL------RKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 549 LVKLRGFCA-EGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYL 606
+VKL + + + L L E+M G L + +K+ + RF IA L +
Sbjct: 63 IVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDV--FPEETARFYIAELVL-ALDSV 117
Query: 607 HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM-----------------TREQSH 649
H IH DIKP+N+L+D + H K++DFGL K M R+
Sbjct: 118 H---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 650 VFTTLR-----------GTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNF---D 695
V GT Y+APE + + D +S G++L E++ G F
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234
Query: 696 PNETSDKAH-------FPSYA 709
ET +K FP
Sbjct: 235 LQETYNKIINWKESLRFPPDP 255
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 500 LGQGGFGSVYQG-VLPDGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHL-HLVKLRGF 555
+G G G VY+ G +AVK++ G + K ++ ++ H ++VK G+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQ---EFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
+ + E M+ LDK + + E +L + + K L YL E
Sbjct: 83 FITDSDVFICMELMST-CLDKLLKRIQGPIPEDILG-----KMTVAIVKALHYLKEK--H 134
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWIT----- 667
+IH D+KP N+LLD + + K+ DFG++ + ++ T G Y+APE I
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDPPDPN 192
Query: 668 -NYAISEKSDVYSYGMVLLEIIGGRKNFDPNET 699
Y I ++DV+S G+ L+E+ G+ + +T
Sbjct: 193 PKYDI--RADVWSLGISLVELATGQFPYKNCKT 223
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 43/127 (33%), Positives = 72/127 (56%), Gaps = 12/127 (9%)
Query: 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL 626
E M GSLD+ + KK + + +IA+ +GL YL E +I+H D+KP N+L+
Sbjct: 79 EHMDGGSLDQ-VLKKAGRIPENILGKISIAV--LRGLTYLREK--HKIMHRDVKPSNILV 133
Query: 627 DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI--TNYAISEKSDVYSYGMVL 684
+ K+ DFG++ + ++ F GTR Y++PE + T+Y + SD++S G+ L
Sbjct: 134 NSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYTVQ--SDIWSLGLSL 188
Query: 685 LEIIGGR 691
+E+ GR
Sbjct: 189 VEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 30/210 (14%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLA---VKKLEGIGQGKKE--FRAEVSIIGSIHHLHLVKLR 553
++G G FG V G G A VK+L ++ F EV ++H ++++
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLL---DWETRFNIALGTAKGLAYLHEDC 610
G C E LL EF G L ++ + N+ + + +A A GL +LH+
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE------QSHVFTTLRGTRGYLAPE 664
IH D+ N L + K+ D+GLA E H LR +LAPE
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLR----WLAPE 172
Query: 665 WITNYA-------ISEKSDVYSYGMVLLEI 687
+ ++KS+++S G+ + E+
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 42/135 (31%), Positives = 74/135 (54%), Gaps = 8/135 (5%)
Query: 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL 626
E M GSLD+ + K+ + + E +++ +GLAYL E +I+H D+KP N+L+
Sbjct: 83 EHMDGGSLDQ-VLKEAKR--IPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILV 137
Query: 627 DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLE 686
+ K+ DFG++ + ++ F GTR Y++PE + S +SD++S G+ L+E
Sbjct: 138 NSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 194
Query: 687 IIGGRKNFDPNETSD 701
+ GR P + +
Sbjct: 195 LAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 12/203 (5%)
Query: 500 LGQGGFGS--VYQGVLPDGTRLAVK--KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLR-G 554
+G+G FG + Q V D + A+K +L ++ R E ++ + H ++V +
Sbjct: 8 VGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
F A+G H + E+ G L + I K + L +T + G+ ++H ++R+
Sbjct: 67 FEADG-HLYIVMEYCDGGDLMQKI-KLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRV 121
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEK 674
+H DIK +N+ L N K+ DFG A+L+T ++ T + GT Y+ PE N + K
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNNK 180
Query: 675 SDVYSYGMVLLEIIGGRKNFDPN 697
SD++S G +L E+ + F N
Sbjct: 181 SDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 484 FTYRDLQTATNNFSVKLGQGGFGSVYQGVLP------DGTRLAVKKLEGIG--QGKKEFR 535
F +LQ T LG+G FG V+ T + VK L+ + EFR
Sbjct: 2 FPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56
Query: 536 AEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKW--IFKKNQEFL----LDW 589
E+ + + H ++V+L G C E + E+ G L ++ K E L L
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 590 ETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK-LMTREQS 648
+ + + A G+ +L + R +H D+ N L+ KVS L+K + E
Sbjct: 117 KQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173
Query: 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEI 687
+ L R +LAPE + S KSDV+S+G+++ E+
Sbjct: 174 KLRNALIPLR-WLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 41/226 (18%)
Query: 495 NFSVKLGQGGFGSVY----------------QGVLPDGTRL-AVKKL--EGIGQGKKEFR 535
NF KLG+G FG V+ + D L AVK L + +++F
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 536 AEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFK--------KNQEFLL 587
EV I+ + ++ +L G C + E+M NG L++++ K L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 588 DWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE- 646
+ T +A A G+ YL +H D+ N L+ NY K++DFG M+R
Sbjct: 128 SFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFG----MSRNL 180
Query: 647 QSHVFTTLRGTRGYLAPEWITNYAI-----SEKSDVYSYGMVLLEI 687
S + ++G R L W+ ++ + KSDV+++G+ L EI
Sbjct: 181 YSSDYYRVQG-RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 40/103 (38%), Positives = 54/103 (52%), Gaps = 13/103 (12%)
Query: 602 GLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK--LMTREQSHVFTTLRGTRG 659
G+ LH+ IIH DIKPEN+L+D H K++DFGL++ L ++ GT
Sbjct: 109 GVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-------GTPD 158
Query: 660 YLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDK 702
YLAPE I + SD +S G V+ E + G F ET D
Sbjct: 159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA-ETPDA 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-13
Identities = 69/250 (27%), Positives = 114/250 (45%), Gaps = 36/250 (14%)
Query: 457 KRKAPESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSVKLGQGGFGSVYQGVLPDG 516
K+K +S +E ++ + Y D NF LG G FG V +
Sbjct: 11 KKKDSDSTKEPKRKN-----------KMKYEDF-----NFIRTLGTGSFGRVILATYKNE 54
Query: 517 T--RLAVKKLEG---IGQGKKE-FRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570
+A+K+ E I Q + + +E I+ I+H V L G + ++ L EF+
Sbjct: 55 DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVI 114
Query: 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ-RIIHCDIKPENVLLDDN 629
G ++ ++N+ F D + A + + E I++ D+KPEN+LLD +
Sbjct: 115 GGEFFTFL-RRNKRFPND------VGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKD 167
Query: 630 YHAKVSDFGLAKLM-TREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEII 688
K++DFG AK++ TR TL GT Y+APE + N + +D ++ G+ + EI+
Sbjct: 168 GFIKMTDFGFAKVVDTRTY-----TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
Query: 689 GGRKNFDPNE 698
G F NE
Sbjct: 223 VGCPPFYANE 232
|
Length = 340 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-13
Identities = 46/128 (35%), Positives = 67/128 (52%), Gaps = 10/128 (7%)
Query: 605 YLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPE 664
YLH D II+ D+KPEN+LLD+ H KV+DFG AK + +++ TL GT YLAPE
Sbjct: 133 YLHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-DRTF---TLCGTPEYLAPE 185
Query: 665 WITNYAISEKSDVYSYGMVLLEIIGGRKNF---DPNETSDKAHFPSYAFKMMEEGKLRNI 721
I + + D ++ G++L E I G F P +K F +G+ R++
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDL 245
Query: 722 LDSRLNID 729
+ L D
Sbjct: 246 VKGLLQTD 253
|
Length = 329 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 54/202 (26%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 495 NFSV--KLGQGGFGSVYQGV-LPDGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHL 547
NF + K+G+G F VY+ L D +A+KK++ + +++ E+ ++ ++H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 548 HLVKLRGFCAEGTHRLLAYEFMANGSLDKWI--FKKNQEFLLDWETRFNIALGTAKGLAY 605
+++K E + E G L + I FKK Q+ L+ T + + + +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEH 121
Query: 606 LHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEW 665
+H +R++H DIKP NV + K+ D GL + + + + +L GT Y++PE
Sbjct: 122 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH-SLVGTPYYMSPER 177
Query: 666 ITNYAISEKSDVYSYGMVLLEI 687
I + KSD++S G +L E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 21/206 (10%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFCA 557
+G+G +G VY+ DG+ AVK L+ I +E AE +I+ S+ +H ++VK G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89
Query: 558 EGTHRL-----LAYEFMANGS---LDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED 609
+ + L E GS L K + Q LD I G GL +LH
Sbjct: 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR--LDEAMISYILYGALLGLQHLH-- 145
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWIT-- 667
+ RIIH D+K N+LL K+ DFG++ +T + T++ GT ++APE I
Sbjct: 146 -NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACE 203
Query: 668 ---NYAISEKSDVYSYGMVLLEIIGG 690
+Y+ + DV+S G+ +E+ G
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 63/201 (31%), Positives = 90/201 (44%), Gaps = 13/201 (6%)
Query: 500 LGQGGFGSVYQ-GVLPDGTRLAVKKLEG--IGQGKKEFRA--EVSIIGSIHHLHLVKLRG 554
LG+GGFG V V G A K+LE I + K E A E I+ ++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66
Query: 555 FCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
+ E L L M G L I+ + F A GL LH +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF-YAAEILCGLEDLHR---EN 122
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISE 673
++ D+KPEN+LLDD H ++SD GLA + + GT GY+APE + N +
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNNQRYTL 180
Query: 674 KSDVYSYGMVLLEIIGGRKNF 694
D + G ++ E+I G+ F
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 9e-13
Identities = 67/213 (31%), Positives = 96/213 (45%), Gaps = 18/213 (8%)
Query: 500 LGQGGFGSVYQGVLP-DGTRLAVKKL--EGIGQGK--KEFRAEVSI-IGSIHHLHLVKLR 553
+G+G FG V DG AVK L + I + K K AE ++ + ++ H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 554 GFCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
+ + +L +++ G L + + + + RF A A L YLH
Sbjct: 63 -YSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARF-YAAEIASALGYLHS---L 115
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAIS 672
II+ D+KPEN+LLD H ++DFGL K E S +T GT YLAPE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174
Query: 673 EKSDVYSYGMVLLEIIGGRKNF---DPNETSDK 702
D + G VL E++ G F D E D
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDN 207
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 66/222 (29%), Positives = 104/222 (46%), Gaps = 27/222 (12%)
Query: 487 RDLQTATNNFSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGI--GQGKKEFRAEVSI-IG 542
DL+ LG+G +G V + +P GT +AVK++ Q +K ++ I +
Sbjct: 1 DDLEVIEE-----LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMR 55
Query: 543 SIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKW---IFKKNQEFLLDWETRFNIALGT 599
S+ + V G + E M + SLDK+ ++ K D + IA+
Sbjct: 56 SVDCPYTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGK--IAVSI 112
Query: 600 AKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRG 659
K L YLH +IH D+KP NVL++ N K+ DFG++ + S T G +
Sbjct: 113 VKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV--DSVAKTIDAGCKP 168
Query: 660 YLAPEWI------TNYAISEKSDVYSYGMVLLEIIGGRKNFD 695
Y+APE I Y + KSDV+S G+ ++E+ GR +D
Sbjct: 169 YMAPERINPELNQKGYDV--KSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 65/239 (27%), Positives = 112/239 (46%), Gaps = 47/239 (19%)
Query: 500 LGQGGFGSV-YQGVLPDGTRLAVKKLEGIGQGKKEFRA---EVSIIGSIHHLHLVKLR-- 553
+G+G +G V DG + +KKL ++E +A E ++ + H ++V R
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 554 ------------GFCAEGT--HRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGT 599
GFC G H+L + G L +NQ +++W + +AL
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQK----GKL----LPENQ--VVEWFVQIAMAL-- 115
Query: 600 AKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRG 659
YLHE + I+H D+K +NV L KV D G+A+++ Q + +TL GT
Sbjct: 116 ----QYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIGTPY 167
Query: 660 YLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKL 718
Y++PE +N + KSDV++ G + E+ + F+ + + S ++++ EGKL
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRII-EGKL 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 49/230 (21%)
Query: 495 NFSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKE------FRAEVSIIGSIHHL 547
KLG+G FG VY+ + G +A+KK+ + +K+ R E+ I+ + H
Sbjct: 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKI--LMHNEKDGFPITALR-EIKILKKLKHP 67
Query: 548 HLVKLRGFCAE---GTHRLLAYEFMA--------NGSLDKWIFKKNQEFLLDWETRFNIA 596
++V L E + R +M +G L+ N L
Sbjct: 68 NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE------NPSVKLTESQIKCYM 121
Query: 597 LGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT----------RE 646
L +G+ YLHE I+H DIK N+L+D+ K++DFGLA+
Sbjct: 122 LQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 647 QSHVFTTLRGTRGYLAPEWI---TNY--AISEKSDVYSYGMVLLEIIGGR 691
+ +T L TR Y PE + Y A+ D++ G V E+ R
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 41/135 (30%), Positives = 72/135 (53%), Gaps = 8/135 (5%)
Query: 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL 626
E M GSLD+ + K + + + +++ KGL YL E +I+H D+KP N+L+
Sbjct: 83 EHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILV 137
Query: 627 DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLE 686
+ K+ DFG++ + ++ F GTR Y++PE + S +SD++S G+ L+E
Sbjct: 138 NSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 194
Query: 687 IIGGRKNFDPNETSD 701
+ GR P + +
Sbjct: 195 MAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 28/210 (13%)
Query: 500 LGQGGFGSVYQGVLPDGTR------LAVKKLEGIGQGKKEF---RAEVSIIGSIHHLHLV 550
LG+GG+G V+Q G + V K I + +K+ +AE +I+ ++ H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 551 KLRGFCAEGTHRLLAYEFMANGSL-----DKWIFKKNQE-FLLDWETRFNIALGTAKGLA 604
L G L E+++ G L + IF ++ F L + ++AL
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYL---SEISLALE------ 114
Query: 605 YLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPE 664
+LH+ Q II+ D+KPEN+LLD H K++DFGL K E + V T GT Y+APE
Sbjct: 115 HLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPE 170
Query: 665 WITNYAISEKSDVYSYGMVLLEIIGGRKNF 694
+ + D +S G ++ +++ G F
Sbjct: 171 ILMRSGHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 63/238 (26%), Positives = 115/238 (48%), Gaps = 21/238 (8%)
Query: 488 DLQTATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFR-AEVSIIGSIH 545
D ++ N+ +K+G+G G V G ++AVK ++ Q ++E EV I+
Sbjct: 18 DPRSLLENY-IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ 76
Query: 546 HLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAY 605
H ++V++ G + EF+ G+L + + L+ E + + L Y
Sbjct: 77 HQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV----SQTRLNEEQIATVCESVLQALCY 132
Query: 606 LHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEW 665
LH Q +IH DIK +++LL + K+SDFG ++++ +L GT ++APE
Sbjct: 133 LHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR-KSLVGTPYWMAPEV 188
Query: 666 ITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEG---KLRN 720
I+ + D++S G++++E++ G +P SD P A K + + KL+N
Sbjct: 189 ISRTPYGTEVDIWSLGIMVIEMVDG----EPPYFSDS---PVQAMKRLRDSPPPKLKN 239
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 67/300 (22%), Positives = 131/300 (43%), Gaps = 61/300 (20%)
Query: 500 LGQGGFGSVYQGVL------PDGTRLAVKKLEGIGQGK--KEFRAEVSIIGSI-HHLHLV 550
LG+G FG V + + + +AVK L+ K + +E+ ++ I H +++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLDKWIFK---KNQE--FLLDWETRFNI--------AL 597
L G C + + E+ A+G+L ++ + + A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 598 GTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGT 657
A+G+ +L ++ IH D+ NVL+ +++ K++DFGLA R+ H+ + T
Sbjct: 140 QVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLA----RDIHHIDYYRKTT 192
Query: 658 RGYLAPEWITNYAISEK-----SDVYSYGMVLLEII--GGRKNFDPNETSDKAHFPSYA- 709
G L +W+ A+ ++ SDV+S+G++L EI GG + +P
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG------------SPYPGIPV 240
Query: 710 ---FKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
FK+++EG ++ N + ++ + C E S RP+ ++V+ L+ +
Sbjct: 241 EELFKLLKEGYR---MEKPQNC---TQELYH---LMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 23/199 (11%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKE----FRAEVSIIGSIHHLHLVKLR 553
++G G FG+VY + +A+KK+ G+ E EV + + H + ++ +
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
G L E+ + D I + +++ L + E I G +GLAYLH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASD--ILEVHKKPLQEVEIA-AICHGALQGLAYLHSHE--- 135
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISE 673
IH DIK N+LL + K++DFG A L++ S V GT ++APE I A+ E
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVI--LAMDE 188
Query: 674 -----KSDVYSYGMVLLEI 687
K DV+S G+ +E+
Sbjct: 189 GQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRG-FC 556
+G G +G VY+G + G A+K ++ G ++E + E++++ HH ++ G F
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 557 AEGTHRL-----LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCD 611
+ + L EF GS+ I K + L E I +GL++LH+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREILRGLSHLHQ--- 129
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWIT---- 667
++IH DIK +NVLL +N K+ DFG++ + R T GT ++APE I
Sbjct: 130 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR-NTFIGTPYWMAPEVIACDEN 188
Query: 668 -NYAISEKSDVYSYGMVLLEIIGG 690
+ KSD++S G+ +E+ G
Sbjct: 189 PDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 498 VKLGQGGFGSVYQGVLPD-GTRLAVKKL-EGIGQGKKEFR---AEVSIIGSIHHLHLVKL 552
++GQGG+G V+ D G +A+K++ + + E R E I+ + LVKL
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
+ + LA E++ G D N L + RF +A + LHE
Sbjct: 67 LYAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEMFE-AVDALHE---L 120
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAK-LMTREQSHVFTTLRGTRGYLAPEWITNYAI 671
IH D+KPEN L+D + H K++DFGL+K ++T S V G+ Y+APE +
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-----GSPDYMAPEVLRGKGY 175
Query: 672 SEKSDVYSYGMVLLEIIGGRKNFD---PNET 699
D +S G +L E + G F PNET
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNET 206
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 31/205 (15%)
Query: 499 KLGQGGFGSVYQ------GVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKL 552
+LG G FG VY+ G L + K E + +++ E+ I+ + +H ++VKL
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL----EDYMVEIEILATCNHPYIVKL 74
Query: 553 RG-FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCD 611
G F +G ++ EF G++D + + ++ L + + + I + L YLH
Sbjct: 75 LGAFYWDGKLWIMI-EFCPGGAVDAIMLELDRG-LTEPQIQV-ICRQMLEALQYLHS--- 128
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLA----KLMTREQSHVFTTLRGTRGYLAPEWIT 667
+IIH D+K NVLL + K++DFG++ K + R S + GT ++APE +
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVM 183
Query: 668 NYAISE-----KSDVYSYGMVLLEI 687
+ + K+D++S G+ L+E+
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 51/209 (24%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL----EGIGQGKKEFRAEVSIIGSIHHLHLVKLR 553
+G G +G V + G ++A+KK+ + K+ R E+ I+ H +++ +R
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNIIAIR 70
Query: 554 GFC----AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED 609
A+ + + M + L I +Q + F L +GL Y+H
Sbjct: 71 DILRPPGADFKDVYVVMDLMES-DLHH-IIHSDQPLTEEHIRYFLYQL--LRGLKYIHSA 126
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR---EQSHVFTTLRGTRGYLAPEWI 666
+IH D+KP N+L++++ ++ DFG+A+ ++ E + T TR Y APE +
Sbjct: 127 N---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183
Query: 667 -TNYAISEKSDVYSYGMVLLEIIGGRKNF 694
+ + D++S G + E++G R+ F
Sbjct: 184 LSLPEYTTAIDMWSVGCIFAEMLGRRQLF 212
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 6e-12
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 500 LGQGGFGSVYQGVLPD-GTRLAVKKL----EGIGQGKKEFRAEVSIIGSIHHLHLVKLRG 554
+G G +G V G ++A+KKL + K+ +R E+ ++ + H +++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLD 81
Query: 555 FCAEGTHR------LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHE 608
+ L M L+ I K + L D +F + +GL Y+H
Sbjct: 82 VFTPASSLEDFQDVYLVTHLMG-ADLNN-IVK--CQKLSDDHIQF-LVYQILRGLKYIHS 136
Query: 609 DCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN 668
IIH D+KP N+ ++++ K+ DFGLA R T TR Y APE + N
Sbjct: 137 ---AGIIHRDLKPSNIAVNEDCELKILDFGLA----RHTDDEMTGYVATRWYRAPEIMLN 189
Query: 669 YAISEKS-DVYSYGMVLLEIIGGRKNF 694
+ ++ D++S G ++ E++ G+ F
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 34/102 (33%), Positives = 61/102 (59%), Gaps = 7/102 (6%)
Query: 602 GLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL 661
GL ++H ++ +++ D+KP N+LLD++ H ++SD GLA ++++ H GT GY+
Sbjct: 109 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162
Query: 662 APEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDK 702
APE + A +D +S G +L +++ G F ++T DK
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 29/205 (14%)
Query: 499 KLGQGGFGSVYQGVLPD-----GTRLAVKKLEGIGQGKK----EFRAEVSIIGSIHHLHL 549
+LG+G FG+VY ++ D RL V K +G+ + E ++ + H +
Sbjct: 7 RLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64
Query: 550 VKLRGFCAEGTHRLLAYEFMANGSLDKWI--FKKNQEFL-----LDWETRFNIALGTAKG 602
VK E + E+ LD + K + L +W + + G
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------G 118
Query: 603 LAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLA 662
+ Y+H+ +RI+H D+K +N+ L +N K+ DFG+++L+ + TT GT Y++
Sbjct: 119 VHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM-GSCDLATTFTGTPYYMS 173
Query: 663 PEWITNYAISEKSDVYSYGMVLLEI 687
PE + + KSD++S G +L E+
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 35/208 (16%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVK--KLEGIGQGKKEFRAEVSIIGSIHHL---HLVKLR 553
+G+G +G+VY+G +P G +A+K L+ + + EV+++ + ++ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 554 GFCAEGTHRLLAYEFMANGSL----------DKWIFKKNQEFLLDWETRFNIALGTAKGL 603
G +G + E+ GS+ +K+I +E L+ L
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLV--------------AL 114
Query: 604 AYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAP 663
Y+H+ +IH DIK N+L+ + + K+ DFG+A L+ + S +T GT ++AP
Sbjct: 115 KYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR-STFVGTPYWMAP 170
Query: 664 EWITN-YAISEKSDVYSYGMVLLEIIGG 690
E IT K+D++S G+ + E+ G
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 23/206 (11%)
Query: 500 LGQGGFGSVYQGVLPD-GTRLAVKKLE---GIGQGKKEFRA---EVSIIGSIHHLHLVKL 552
LGQG FG VY D G LAVK+++ + KE A E+ ++ ++ H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 553 RGFCAEGTHRLLA--YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC 610
G + R L+ E M GS+ + K+ L + TR +G++YLH +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTR-KYTRQILEGVSYLHSN- 125
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT-----TLRGTRGYLAPEW 665
I+H DIK N+L D + K+ DFG +K R Q+ + ++ GT +++PE
Sbjct: 126 --MIVHRDIKGANILRDSVGNVKLGDFGASK---RLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 666 ITNYAISEKSDVYSYGMVLLEIIGGR 691
I+ K+D++S G ++E++ +
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-11
Identities = 20/82 (24%), Positives = 34/82 (41%), Gaps = 3/82 (3%)
Query: 328 CDHSKGSTELVSAGDGLNYFALGFVPPSSKADLNGCKKACLGNCSCLAMFFQNSSGNCFL 387
C + + D + + L C++ACL NCSC A + N SG C L
Sbjct: 5 CGGDGSTDGFLKLPD-VKLPDNASA--ITAISLEECREACLSNCSCTAYAYNNGSGGCLL 61
Query: 388 FDRIGSLQSSNQGSGFVSYIKI 409
++ + + S G Y+++
Sbjct: 62 WNGLLNNLRSLSSGGGTLYLRL 83
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 15/197 (7%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKK--EFRAEVSIIGSIHHLHLVKL-RGF 555
+LG G FG VY+ + LA K+ ++ ++ E+ I+ S H ++VKL F
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
E +L EF A G++D + + + L + + R + T + L YLHE+ +II
Sbjct: 72 YYENNLWILI-EFCAGGAVDAVMLELERP-LTEPQIRV-VCKQTLEALNYLHEN---KII 125
Query: 616 HCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI-----TNYA 670
H D+K N+L + K++DFG++ TR + GT ++APE + +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR-DSFIGTPYWMAPEVVMCETSKDRP 184
Query: 671 ISEKSDVYSYGMVLLEI 687
K+DV+S G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 37/214 (17%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL----EGIGQGKKEFRAEVSIIGSIHHLHLVKLR 553
K+G+G +G VY+ G +A+KK+ E G R E+S++ ++H ++VKL
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLL 65
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAK--------GLAY 605
L +EF+ + L K+ +D I L K GLA+
Sbjct: 66 DVIHTENKLYLVFEFL-HQDLKKF---------MDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 606 LHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK---LMTREQSHVFTTLRGTRGYLA 662
H R++H D+KP+N+L++ K++DFGLA+ + R +H TL Y A
Sbjct: 116 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL----WYRA 168
Query: 663 PEWI--TNYAISEKSDVYSYGMVLLEIIGGRKNF 694
PE + Y S D++S G + E++ R F
Sbjct: 169 PEILLGCKY-YSTAVDIWSLGCIFAEMVTRRALF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 1e-11
Identities = 37/106 (34%), Positives = 57/106 (53%), Gaps = 12/106 (11%)
Query: 601 KGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK-LMTREQSHVFTTLR---G 656
K L Y+H +IH D+KP N+LL+ + K++DFGLA+ L E++ L
Sbjct: 118 KALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 657 TRGYLAPEWI---TNYAISEKSDVYSYGMVLLEIIGGRKNFDPNET 699
TR Y APE + T Y ++ D++S G +L E++ G+ F T
Sbjct: 175 TRWYRAPEILLGSTRY--TKGVDMWSVGCILGEMLLGKPLFPGTST 218
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 34/102 (33%), Positives = 61/102 (59%), Gaps = 7/102 (6%)
Query: 602 GLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL 661
GL ++H ++ +++ D+KP N+LLD++ H ++SD GLA ++++ H GT GY+
Sbjct: 109 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162
Query: 662 APEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDK 702
APE + A +D +S G +L +++ G F ++T DK
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 51/216 (23%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVKKL------EGIGQGKKEFRAEVSI---IGSIHHLHL 549
+G+G +G+VY+ L G +A+KK+ EGI R E+++ + S H ++
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLST--LR-EIALLKQLESFEHPNI 63
Query: 550 VKLRGFCA-----EGTHRLLAYE--------FMANGS---LDKWIFKKNQEFLLDWETRF 593
V+L C L +E +++ L K LL
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL------ 117
Query: 594 NIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT 653
+G+ +LH RI+H D+KP+N+L+ + K++DFGLA++ + E + T+
Sbjct: 118 -------RGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTS 165
Query: 654 LRGTRGYLAPEWITN--YAISEKSDVYSYGMVLLEI 687
+ T Y APE + YA D++S G + E+
Sbjct: 166 VVVTLWYRAPEVLLQSSYATP--VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 67/258 (25%), Positives = 118/258 (45%), Gaps = 42/258 (16%)
Query: 500 LGQGGFGSVYQGVL---PDG--------TRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLH 548
LGQG F ++Y+GVL D + +K L + F S++ + H H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 549 LVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHE 608
LVKL G C + ++ E++ G LD ++ ++ L W + ++A A L YL
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE- 118
Query: 609 DCDQRIIHCDIKPENVLL---DDNYH----AKVSDFGLAK-LMTREQSHVFTTLRGTRG- 659
D++++H ++ +N+L+ N K+SD G+ +++RE+ R R
Sbjct: 119 --DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE-------RVERIP 169
Query: 660 YLAPEWITNYA--ISEKSDVYSYGMVLLEII-GGRKNFDPNETSDKAHFPSYA----FKM 712
++APE I N ++ +D +S+G LLEI G + +S+K F Y M
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF--YQDQHRLPM 227
Query: 713 MEEGKLRNILDSRLNIDE 730
+ +L N+++ D
Sbjct: 228 PDCAELANLINQCWTYDP 245
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFCA 557
+G G +G VY+G + G A+K ++ ++E + E++++ HH ++ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 558 EGT------HRLLAYEFMANGSLDKWIFK-KNQEFLLDWETRFNIALGTAKGLAYLHEDC 610
+ + L EF GS+ + K DW I +GLA+LH
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHA-- 139
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWIT--- 667
++IH DIK +NVLL +N K+ DFG++ + R T GT ++APE I
Sbjct: 140 -HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR-NTFIGTPYWMAPEVIACDE 197
Query: 668 --NYAISEKSDVYSYGMVLLEIIGG 690
+ +SD++S G+ +E+ G
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 66/203 (32%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 500 LGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKE----FRAEVSII-GSIHHLHLVKLR 553
+G+G FG V DG+ AVK L+ KK+ AE +++ ++ H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 554 -GF-CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCD 611
F AE + +L Y NG + + + + L+ RF A A + YLH
Sbjct: 63 YSFQTAEKLYFVLDY---VNGG-ELFFHLQRERCFLEPRARF-YAAEVASAIGYLHS--- 114
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAI 671
II+ D+KPEN+LLD H ++DFGL K E +T GT YLAPE +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 672 SEKSDVYSYGMVLLEIIGGRKNF 694
D + G VL E++ G F
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 68/244 (27%), Positives = 109/244 (44%), Gaps = 30/244 (12%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKE----FRAEVSIIGSIHHLHLVKLR 553
++G G FG+VY + + +A+KK+ G+ E EV + + H + ++ R
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
G L E+ + D + + +++ L + E + G +GLAYLH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIA-AVTHGALQGLAYLH---SHN 135
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISE 673
+IH D+K N+LL + K+ DFG A +M V GT ++APE I A+ E
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI--LAMDE 188
Query: 674 -----KSDVYSYGMVLLEIIGGRKN--FDPNETSDKAHFPSYAFKMMEEGK----LRNIL 722
K DV+S G+ +E + RK F+ N S H ++ G RN +
Sbjct: 189 GQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247
Query: 723 DSRL 726
DS L
Sbjct: 248 DSCL 251
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 74/302 (24%), Positives = 130/302 (43%), Gaps = 36/302 (11%)
Query: 499 KLGQGGFGSVYQGVLPDGTRL-AVKK-LEGIGQG--KKEFRAEVSIIGSIHHLHLVKLRG 554
+G+G +G V + + ++ A+KK LE KK E+ ++ + H +LV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
L +EF+ + LD + LD +G+ + H I
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCH---SHNI 121
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI---TNYAI 671
IH DIKPEN+L+ + K+ DFG A+ + V+T TR Y APE + T Y
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYTDYVATRWYRAPELLVGDTKYG- 179
Query: 672 SEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731
D+++ G ++ E++ G F + D+ + +++ L N++ I ++
Sbjct: 180 -RAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLY------HIIK--CLGNLIPRHQEIFQK 230
Query: 732 SDRVFTAVKVALWCVQEDMSLR---PSMTKVVQMLEGICPVPQP---PTCSPLGARLYSS 785
+ +F +++ V+E L P ++ +V L C P P+ S L L+
Sbjct: 231 N-PLFAGMRLPE--VKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL---LHHE 284
Query: 786 FF 787
FF
Sbjct: 285 FF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 40/126 (31%), Positives = 64/126 (50%), Gaps = 19/126 (15%)
Query: 600 AKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF-----TTL 654
A GL +LH + II+ D+K +NV+LD H K++DFG+ K ++F T
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK------ENIFGGKTTRTF 161
Query: 655 RGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNE-----TSDKAHFPSYA 709
GT Y+APE I + D +++G++L E++ G+ FD + S H SY
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP 221
Query: 710 FKMMEE 715
+ +E
Sbjct: 222 KSLSKE 227
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 500 LGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSII-GSIHHLHLVKLR 553
+G+G FG V DG AVK L+ + +K AE +++ ++ H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 554 GFCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
+ + T +L +F+ G L + + + + RF A A L YLH
Sbjct: 63 -YSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAA-EIASALGYLHS---I 115
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAIS 672
I++ D+KPEN+LLD H ++DFGL K QS TT GT YLAPE I
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGI-AQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 673 EKSDVYSYGMVLLEIIGGRKNFDPNETSD 701
D + G VL E++ G F + ++
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 500 LGQGGFGSVYQGVLPDGT---RLAVKKLEGIGQGKKE---FRAEVSIIGSIHHLHLVKLR 553
LG+G FGSV +G L ++AVK ++ + E F +E + H ++++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 554 GFCAEGTHR------LLAYEFMANGSLDKWIFKK---NQEFLLDWETRFNIALGTAKGLA 604
G C + ++ FM +G L ++ + L + A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 605 YLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPE 664
YL + IH D+ N +L++N + V+DFGL+K + + +G + +
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY----RQGRIAKMPVK 179
Query: 665 WITNYAISE-----KSDVYSYGMVLLEI 687
WI ++++ KSDV+S+G+ + EI
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 32/212 (15%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL----EGIGQGKKEFRAEVSIIGSIHHLHLVKLR 553
K+G+G +G VY+G G +A+KK+ E G R E+S++ + H ++V L+
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHPNIVCLQ 65
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFL-----LDWETRFNIALGTAKGLAYLHE 608
+ + L +EF+ S+D KK + L +D E + +G+ + H
Sbjct: 66 DVLMQESRLYLIFEFL---SMD---LKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119
Query: 609 DCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK---LMTREQSHVFTTLRGTRGYLAPEW 665
+R++H D+KP+N+L+D+ K++DFGLA+ + R +H TL Y APE
Sbjct: 120 ---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTL----WYRAPEV 172
Query: 666 I---TNYAISEKSDVYSYGMVLLEIIGGRKNF 694
+ Y S D++S G + E+ + F
Sbjct: 173 LLGSPRY--STPVDIWSIGTIFAEMATKKPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 7e-11
Identities = 65/235 (27%), Positives = 110/235 (46%), Gaps = 37/235 (15%)
Query: 482 VRFTYRDLQTATNNFSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQ----GKKEFRA 536
V YRDL+ ++G G +G+V + G ++A+KKL Q K+ +R
Sbjct: 13 VPDRYRDLK--------QVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR- 63
Query: 537 EVSIIGSIHHLHLVKLRG-FCAEGT-----HRLLAYEFMAN--GSLDKWIFKKNQEFLLD 588
E+ ++ + H +++ L F + + L FM G L K E L +
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK------HEKLSE 117
Query: 589 WETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648
+F + KGL Y+H IIH D+KP N+ ++++ K+ DFGLA R+
Sbjct: 118 DRIQF-LVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA----RQTD 169
Query: 649 HVFTTLRGTRGYLAPEWITNYA-ISEKSDVYSYGMVLLEIIGGRKNFDPNETSDK 702
T TR Y APE I N+ ++ D++S G ++ E++ G+ F ++ D+
Sbjct: 170 SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ 224
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 58/222 (26%), Positives = 108/222 (48%), Gaps = 38/222 (17%)
Query: 500 LGQGGFGSVYQ----GVLPDG----TRLAVKKLEGIGQGK--KEFRAEVSIIGSI-HHLH 548
LG+G FG V G+ + T++AVK L+ K + +E+ ++ I H +
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 549 LVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKK-------------NQEFLLDWETRFNI 595
++ L G C + + E+ + G+L +++ + E L ++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 596 ALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLR 655
A A+G+ YL ++ IH D+ NVL+ ++ K++DFGLA R+ H+ +
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RDIHHIDYYKK 198
Query: 656 GTRG-----YLAPEWITNYAISEKSDVYSYGMVLLEI--IGG 690
T G ++APE + + + +SDV+S+G++L EI +GG
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 43/119 (36%), Positives = 68/119 (57%), Gaps = 14/119 (11%)
Query: 602 GLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL-MTREQSHVFTTLRGTRGY 660
GL +LH+ + II+ D+K +NVLLD + H K++DFG+ K M E +T GT Y
Sbjct: 108 GLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA--STFCGTPDY 162
Query: 661 LAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNF---DPNE-----TSDKAHFPSYAFK 711
+APE + +E D +S+G++L E++ G+ F D +E +D+ HFP + K
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISK 221
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 7e-11
Identities = 62/229 (27%), Positives = 94/229 (41%), Gaps = 37/229 (16%)
Query: 499 KLGQGGFGSVYQGVLPD-GTRLAVK---KLEGIGQGK-KEFRAEVSIIGSIHHLHLVKLR 553
LG+G G V+ L G A+K K E I + K K E I+ ++ H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
T+ L ++ G L + + ++ + L + RF A L YLH
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL-ALEYLHL---LG 123
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLR------------------ 655
I++ D+KPEN+LL ++ H +SDF L+K E V LR
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183
Query: 656 ----------GTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNF 694
GT Y+APE I+ D ++ G++L E++ G F
Sbjct: 184 EPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 8e-11
Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 17/200 (8%)
Query: 500 LGQGGFGSVYQGVLPD-GTRLAVKKLE---GIGQGKKEFRA---EVSIIGSIHHLHLVKL 552
LGQG FG VY D G LA K+++ + KE A E+ ++ ++ H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 553 RGFCAEGTHRLLA--YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC 610
G + + L E+M GS+ + K L + TR +G++YLH +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTR-KYTRQILEGMSYLHSN- 125
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAK-LMTREQSHV-FTTLRGTRGYLAPEWITN 668
I+H DIK N+L D + K+ DFG +K L T S ++ GT +++PE I+
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183
Query: 669 YAISEKSDVYSYGMVLLEII 688
K+DV+S G ++E++
Sbjct: 184 EGYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 8e-11
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 494 NNFSVK--LGQGGFGSVYQGVLPDGTR--LAVKKLEGIGQGKKE----FRAEVSIIGSIH 545
+F VK +G+G FG V Q V T A+K ++ +E F E I+ +
Sbjct: 1 KDFDVKSLVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 546 HLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAY 605
+ +L+ + + L E+ G L + + +F D +F +A +
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM-AQFYLAELVL-AIHS 117
Query: 606 LHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLR-GTRGYLAPE 664
+H+ +H DIKPENVL+D H K++DFG A +T + V + L GT Y+APE
Sbjct: 118 VHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYIAPE 173
Query: 665 WITNYAISEKS------DVYSYGMVLLEIIGGRKNF 694
+T K D +S G++ E+I GR F
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 23/203 (11%)
Query: 500 LGQGGFGSVYQGVLPD-GTRLAVKKLE---GIGQGKKEFRA---EVSIIGSIHHLHLVKL 552
LG+G FG VY D G LAVK++ + KE A E+ ++ ++ H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 553 RGFCAEGTHRLLA--YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC 610
G + + L+ E+M GS+ + K L + TR +G++YLH +
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTR-RYTRQILQGVSYLHSN- 125
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT-----TLRGTRGYLAPEW 665
I+H DIK N+L D + K+ DFG +K R Q+ + ++ GT +++PE
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASK---RIQTICMSGTGIKSVTGTPYWMSPEV 180
Query: 666 ITNYAISEKSDVYSYGMVLLEII 688
I+ K+DV+S ++E++
Sbjct: 181 ISGEGYGRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 601 KGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGY 660
+GL Y+H ++H D+KP N+L+++N K+ DFGLA R Q T TR Y
Sbjct: 119 RGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLA----RIQDPQMTGYVSTRYY 171
Query: 661 LAPE-WITNYAISEKSDVYSYGMVLLEIIGGRKNF 694
APE +T + D++S G + E++ G+ F
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 61/242 (25%), Positives = 111/242 (45%), Gaps = 34/242 (14%)
Query: 500 LGQGGFGSVYQ----GVLPD----GTRLAVKKLEGIGQGK--KEFRAEVSIIGSI-HHLH 548
LG+G FG V G+ D +AVK L+ K + +E+ ++ I H +
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 549 LVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQ-------------EFLLDWETRFNI 595
++ L G C + + E+ + G+L +++ + E L ++ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 596 ALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTL- 654
A A+G+ YL Q+ IH D+ NVL+ ++ K++DFGLA+ + + TT
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 655 RGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMME 714
R ++APE + + + +SDV+S+G++L EI F + FK+++
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI------FTLGGSPYPGIPVEELFKLLK 250
Query: 715 EG 716
EG
Sbjct: 251 EG 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 31/209 (14%)
Query: 500 LGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQG----KKEFRAEV---------SIIGSIH 545
+G G FG V+ P DG R+A+KK+ + Q K+ FR E+ +++ ++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSALD 66
Query: 546 HLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAY 605
L + F + E M L K I Q D F + +GL Y
Sbjct: 67 ILQPPHIDPF----EEIYVVTELM-QSDLHKIIVS-PQPLSSDHVKVFLYQI--LRGLKY 118
Query: 606 LHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEW 665
LH I+H DIKP N+L++ N K+ DFGLA++ ++S T T+ Y APE
Sbjct: 119 LHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEI 175
Query: 666 IT---NYAISEKSDVYSYGMVLLEIIGGR 691
+ +Y + D++S G + E++G R
Sbjct: 176 LMGSRHY--TSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 56/218 (25%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 498 VKLGQGGFGSVYQGV-LPDGTRLAVKKL------EGIGQGKKEFRAEVSIIGSIHHLHLV 550
K+G+G +G+V++ +A+K++ EG+ R E+ ++ + H ++V
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LR-EICLLKELKHKNIV 62
Query: 551 KLRGFCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED 609
+L +L L +E+ + L K+ N + +D E + KGLA+ H
Sbjct: 63 RLYDVL-HSDKKLTLVFEY-CDQDLKKYFDSCNGD--IDPEIVKSFMFQLLKGLAFCHS- 117
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK---LMTREQSHVFTTLRGTRGYLAPEWI 666
++H D+KP+N+L++ N K++DFGLA+ + R S TL Y P+ +
Sbjct: 118 --HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTL----WYRPPDVL 171
Query: 667 TNYAISEKS-DVYSYGMVLLEII-GGRKNFDPNETSDK 702
+ S D++S G + E+ GR F N+ D+
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 45/218 (20%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKK--LEGIGQG--KKEFRAEVSIIGSIHHLHLVKLR 553
K+G+G +G VY+ G +A+KK LE +G R E+S++ ++H ++V+L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELNHPNIVRLL 64
Query: 554 GFCAEGTHRLLAYEFM-----------ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKG 602
L +EF+ LD + K LL +G
Sbjct: 65 DVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLL-------------QG 111
Query: 603 LAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK---LMTREQSHVFTTLRGTRG 659
+AY H R++H D+KP+N+L+D K++DFGLA+ + R +H TL
Sbjct: 112 IAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTL----W 164
Query: 660 YLAPEWI---TNYAISEKSDVYSYGMVLLEIIGGRKNF 694
Y APE + Y S D++S G + E++ R F
Sbjct: 165 YRAPEILLGSRQY--STPVDIWSIGCIFAEMVNRRPLF 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 26/208 (12%)
Query: 499 KLGQGGFGSVYQGVLPDG---TRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLR 553
++G G FG V G + G ++ VK+L Q + +F E S+ H +L++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWI--FKKNQEFLLDWETRFNIALGTAKGLAYLHEDCD 611
G C E T LL EF G L ++ +K + D T +A A GL +LH++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-- 119
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV-----FTTLRGTRGYLAPEWI 666
IH D+ N LL + K+ D+GL+ +E +V + LR ++APE +
Sbjct: 120 -NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR----WIAPELV 174
Query: 667 ----TNYAI---SEKSDVYSYGMVLLEI 687
N + +++S+V+S G+ + E+
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 67/250 (26%), Positives = 104/250 (41%), Gaps = 55/250 (22%)
Query: 500 LGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQGKKE----FRAEVSIIGSIHHLHLVKLRG 554
+G+G FG V D G A+KKL +KE RAE I+ + +VKL
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL-- 66
Query: 555 FCA--EGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
+ + + + L E++ G + + KK+ + ETRF IA T + +H+
Sbjct: 67 YYSFQDENYLYLIMEYLPGGDMMTLLMKKDT--FTEEETRFYIA-ETILAIDSIHK---L 120
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAK-----------------LMTREQSHVFTTLR 655
IH DIKP+N+LLD H K+SDFGL L + + +
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 656 --------------------GTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNF- 694
GT Y+APE +++ D +S G+++ E++ G F
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240
Query: 695 --DPNETSDK 702
+P ET K
Sbjct: 241 SDNPQETYRK 250
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 58/214 (27%), Positives = 90/214 (42%), Gaps = 36/214 (16%)
Query: 497 SVKLGQGGFGSVYQGVL---PDGTRLAVKKLEGIGQGKKEFRA-EVSIIGSIHHL----- 547
+KL G FG V VL P K ++ K F A E + H L
Sbjct: 21 KLKLIDGKFGKVS--VLKHKPTQKLFVQKIIK-----AKNFNAIEPMV----HQLMKDNP 69
Query: 548 HLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLH 607
+ +KL +L +++ +G L + K + L + E + I + L LH
Sbjct: 70 NFIKLYYSVTTLKGHVLIMDYIKDGDL--FDLLKKEGKLSEAEVK-KIIRQLVEALNDLH 126
Query: 608 EDCDQRIIHCDIKPENVLLDDN-YHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI 666
+ IIH DIK ENVL D + D+GL K++ + GT Y +PE I
Sbjct: 127 K---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII-----GTPSCYDGTLDYFSPEKI 178
Query: 667 T--NYAISEKSDVYSYGMVLLEIIGGRKNFDPNE 698
NY +S D ++ G++ E++ G+ F +E
Sbjct: 179 KGHNYDVS--FDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 53/183 (28%), Positives = 88/183 (48%), Gaps = 20/183 (10%)
Query: 584 EFLLDWETRFNIALGTAKGLAYL-HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642
E LD E + + AKG+++L ++C IH D+ N+LL K+ DFGLA+
Sbjct: 208 ELALDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARD 263
Query: 643 MTREQSHVFT-TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSD 701
+ + ++V R ++APE I N + +SDV+SYG++L EI + P D
Sbjct: 264 IRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD 323
Query: 702 KAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761
S +KM++EG R+ E + + + W D RP+ ++VQ
Sbjct: 324 -----SKFYKMIKEG-------YRMLSPECAPSEMYDIMKSCW--DADPLKRPTFKQIVQ 369
Query: 762 MLE 764
++E
Sbjct: 370 LIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 8/165 (4%)
Query: 556 CAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
C + T RL L E++ G L + Q L + RF A L +LHE + I
Sbjct: 64 CFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARF-YAAEICIALNFLHE---RGI 117
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEK 674
I+ D+K +NVLLD + H K++D+G+ K +T GT Y+APE +
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTSTFCGTPNYIAPEILRGEEYGFS 176
Query: 675 SDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLR 719
D ++ G+++ E++ GR FD + + Y F+++ E +R
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR 221
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 31/211 (14%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLE---GIGQGKKEFRAEVSIIGSIHHLHLVKLRG 554
KLG+G + +VY+G G +A+K++ G R E+S++ + H ++V+L
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENIVRLHD 65
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
+L +E+M + L K++ LD T + KG+A+ HE+ R+
Sbjct: 66 VIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGLAKL----MTREQSHVFT-------TLRGTRGYLAP 663
+H D+KP+N+L++ K++DFGLA+ + + V T L G+R Y
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY--- 178
Query: 664 EWITNYAISEKSDVYSYGMVLLEIIGGRKNF 694
S D++S G ++ E+I GR F
Sbjct: 179 --------STSIDIWSVGCIMAEMITGRPLF 201
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 57/228 (25%), Positives = 103/228 (45%), Gaps = 17/228 (7%)
Query: 462 ESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSVK-LGQGGFGSVYQGVLPDGTRLA 520
+S E+ ++D+ + L +P + R++ + +K L G G V+ P
Sbjct: 39 DSASESDDDDD--DGL--IPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATKPGQPDPV 94
Query: 521 VKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFK 580
V K IGQ K E ++ +++H +++++ G + + + S D + +
Sbjct: 95 VLK---IGQ-KGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYL 147
Query: 581 KNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLA 640
+ L + I +GL YLH QRIIH D+K EN+ ++D + D G A
Sbjct: 148 TKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAA 204
Query: 641 KLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEII 688
+ + F L GT APE + + K+D++S G+VL E++
Sbjct: 205 QFPVVAPA--FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 70/236 (29%), Positives = 110/236 (46%), Gaps = 37/236 (15%)
Query: 500 LGQGGFGSVYQGVLPDGTRL-AVKKLEGIGQGKKEF--RAEVS-IIGSIHHL-------- 547
+G+G FG VYQ D R+ A+K L KKE + EV+ IG + L
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS-----KKEIVAKKEVAHTIGERNILVRTLLDES 55
Query: 548 -HLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYL 606
+V L+ + L ++M+ G L W +K F D +F IA L +L
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGEL-FWHLQKEGRFSED-RAKFYIA-ELVLALEHL 112
Query: 607 HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK--LMTREQSHVFTTLRGTRGYLAPE 664
H+ I++ D+KPEN+LLD H + DFGL+K L + ++ F GT YLAPE
Sbjct: 113 HK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC---GTTEYLAPE 166
Query: 665 WITNYA-ISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLR 719
+ + ++ D +S G+++ E+ G F +T ++ + GK+R
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-------MYRNIAFGKVR 215
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 51/167 (30%), Positives = 79/167 (47%), Gaps = 28/167 (16%)
Query: 537 EVSIIGSIHHLHLVKLRGFCAEGTHRLL--AYEFMANGSLDKWIFKKNQEFLLDWETRFN 594
E ++ + H +++L F E R L E++ G L + L RF+
Sbjct: 51 EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSY---------LRNSGRFS 99
Query: 595 IALGTAKG------LAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK-LMTREQ 647
+ G L YLH + I++ D+KPEN+LLD H K++DFG AK L R
Sbjct: 100 NSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW 156
Query: 648 SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNF 694
TL GT YLAPE I + ++ D ++ G+++ E++ G F
Sbjct: 157 -----TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 36/113 (31%), Positives = 59/113 (52%), Gaps = 12/113 (10%)
Query: 602 GLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL 661
GL +LHE + II+ D+K +NVLLD H K++DFG+ K +T GT Y+
Sbjct: 108 GLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT-STFCGTPDYI 163
Query: 662 APEWITNYAISEKSDVYSYGMVLLEIIGGRKNFD-PNETS-------DKAHFP 706
APE ++ D ++ G++L E++ G+ F+ +E D+ +P
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP 216
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 48/183 (26%), Positives = 87/183 (47%), Gaps = 23/183 (12%)
Query: 534 FRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRF 593
F S++ + H+HL + G C G+ ++ EF+ +G LD + K+ + W +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 594 NIALGTAKGLAYLHEDCDQRIIHCDIKPENVL-----LDDNYHA--KVSDFGLA-KLMTR 645
+A A L+YL D+ ++H ++ +N+L L + K+SD G++ ++R
Sbjct: 121 TVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR 177
Query: 646 EQSHVFTTLRGTR-GYLAPEWITNY-AISEKSDVYSYGMVLLEI-IGGRKNFDPNETSDK 702
E+ R R ++APE + ++S +D +S+G LLEI G S+K
Sbjct: 178 EE-------RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230
Query: 703 AHF 705
F
Sbjct: 231 ERF 233
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 16/199 (8%)
Query: 499 KLGQGGFGSVYQGVLPD-GTRLAVKKL---EGIGQGKKEFRAEVSIIGSIHHLHLVKLRG 554
K+G+G +G V++ + G +A+KK E KK E+ ++ + H +LV L
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
L +E+ + L++ +KN + + + I T + + + H+
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNE--LEKNPRGVPEHLIK-KIIWQTLQAVNFCHK---HNC 121
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI---TNYAI 671
IH D+KPEN+L+ K+ DFG A+++T +T TR Y APE + T Y
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTG-PGDDYTDYVATRWYRAPELLVGDTQYGP 180
Query: 672 SEKSDVYSYGMVLLEIIGG 690
DV++ G V E++ G
Sbjct: 181 P--VDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 19/199 (9%)
Query: 545 HHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLA 604
+H LV L C + RL NG D + Q L + RF A + L
Sbjct: 54 NHPFLVGLHS-CFQTESRLFFVIEYVNGG-DLMFHMQRQRKLPEEHARFYSA-EISLALN 110
Query: 605 YLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPE 664
YLHE + II+ D+K +NVLLD H K++D+G+ K R +T GT Y+APE
Sbjct: 111 YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPE 166
Query: 665 WITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDK--AHFPSYAFKMMEEGKLR--- 719
+ D ++ G+++ E++ GR FD +SD + Y F+++ E ++R
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 226
Query: 720 -------NILDSRLNIDEQ 731
++L S LN D +
Sbjct: 227 SLSVKAASVLKSFLNKDPK 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 57/222 (25%), Positives = 104/222 (46%), Gaps = 38/222 (17%)
Query: 500 LGQGGFGSVYQ----GVLPD----GTRLAVKKLEGIGQGK--KEFRAEVSIIGSI-HHLH 548
LG+G FG V + G+ +AVK L+ K + +E+ ++ I H +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 549 LVKLRGFCAEGTHRLLAYEFMANGSLDKWI-------------FKKNQEFLLDWETRFNI 595
++ L G C + + E+ A G+L +++ K E L ++ +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 596 ALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLR 655
A A+G+ YL +R IH D+ NVL+ ++ K++DFGLA R + +
Sbjct: 140 AYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLA----RGVHDIDYYKK 192
Query: 656 GTRG-----YLAPEWITNYAISEKSDVYSYGMVLLEI--IGG 690
+ G ++APE + + + +SDV+S+G+++ EI +GG
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGG 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 60/231 (25%), Positives = 96/231 (41%), Gaps = 47/231 (20%)
Query: 485 TYRDLQTATNNFSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRA--EVSII 541
Y++L +G+G +G V P G ++A+KK+ R E+ I+
Sbjct: 6 RYQNLS--------YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKIL 57
Query: 542 GSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAK 601
H +++ + R ++E D +I QE + ET + T
Sbjct: 58 RRFKHENIIGILDI-----IRPPSFESFN----DVYIV---QELM---ETDLYKLIKTQH 102
Query: 602 ---------------GLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646
GL Y+H ++H D+KP N+LL+ N K+ DFGLA++ E
Sbjct: 103 LSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159
Query: 647 QSH--VFTTLRGTRGYLAPEWITNYAISEKS-DVYSYGMVLLEIIGGRKNF 694
H T TR Y APE + N K+ D++S G +L E++ R F
Sbjct: 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 65/231 (28%), Positives = 100/231 (43%), Gaps = 33/231 (14%)
Query: 500 LGQGGFGSVYQGVLPDGTRL-AVKKLEGIGQGKKEF---RAEVS-------IIGSIHHLH 548
LG+G FG V + A+K L KKE + EV+ ++ + H
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKIL------KKEVIIAKDEVAHTLTESRVLQNTRHPF 56
Query: 549 LVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHE 608
L L+ + + RL ANG + + + F D RF A L YLH
Sbjct: 57 LTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARFYGA-EIVSALGYLHS 113
Query: 609 DCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT--TLRGTRGYLAPEWI 666
+++ D+K EN++LD + H K++DFGL K S T T GT YLAPE +
Sbjct: 114 ---CDVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVL 167
Query: 667 TNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGK 717
+ D + G+V+ E++ GR F ++ H + +MEE +
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPF-----YNQDHEKLFELILMEEIR 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 60/223 (26%), Positives = 107/223 (47%), Gaps = 35/223 (15%)
Query: 499 KLGQGGFGSVYQG--VLPDGTRLAVK--KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRG 554
KLG+G + +VY+G L D +A+K +LE EVS++ + H ++V L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNI------ALGTAKGLAYLHE 608
L +E+ LDK + +++L D N+ +GL Y H
Sbjct: 72 IIHTEKSLTLVFEY-----LDKDL----KQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR 122
Query: 609 DCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK---LMTREQSHVFTTLRGTRGYLAPEW 665
++++H D+KP+N+L+++ K++DFGLA+ + T+ S+ TL Y P+
Sbjct: 123 ---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTL----WYRPPDI 175
Query: 666 I---TNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHF 705
+ T+Y S + D++ G + E+ GR F + ++ HF
Sbjct: 176 LLGSTDY--STQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHF 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 68/245 (27%), Positives = 102/245 (41%), Gaps = 48/245 (19%)
Query: 500 LGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQGKKE----FRAEVSIIGSIHHLHLVKLRG 554
+G+G FG V D G A+K L +KE RAE I+ L +VK+
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
+ + L EF+ G + + KK+ L + ET+F IA T + +H+
Sbjct: 69 SFQDKLNLYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIA-ETVLAIDSIHQ---LGF 122
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGL----------------------------------A 640
IH DIKP+N+LLD H K+SDFGL A
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 641 KLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNF---DPN 697
+ R + + + GT Y+APE ++ D +S G+++ E++ G F P
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 698 ETSDK 702
ET K
Sbjct: 243 ETYKK 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 5e-10
Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 28/203 (13%)
Query: 499 KLGQGGFGSVYQG-VLPDGTRLAVKKLEGIGQGKKEFR--------AEVSIIGSI-HHLH 548
K+G+G F V + G A+K + KK F+ E+ + + H +
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCM------KKHFKSLEQVNNLREIQALRRLSPHPN 59
Query: 549 LVKLRGFCAEGTHRLLA--YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYL 606
+++L + LA +E M + +L + I K ++ L + + K L ++
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELM-DMNLYELI--KGRKRPLPEKRVKSYMYQLLKSLDHM 116
Query: 607 HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI 666
H + I H DIKPEN+L+ D+ K++DFG + +T TR Y APE +
Sbjct: 117 HRN---GIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYISTRWYRAPECL 170
Query: 667 -TNYAISEKSDVYSYGMVLLEII 688
T+ K D+++ G V EI+
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 23/199 (11%)
Query: 499 KLGQGGFGSVYQGVLPDGTRL-AVKKLEGIGQGKKE----FRAEVSIIGSIHHLHLVKLR 553
++G G FG+VY + AVKK+ G+ E EV + + H + ++ +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
G + L E+ + D + + +++ L + E I G +GLAYLH
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIA-AITHGALQGLAYLHSHN--- 141
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISE 673
+IH DIK N+LL + K++DFG A + S V GT ++APE I A+ E
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVI--LAMDE 194
Query: 674 -----KSDVYSYGMVLLEI 687
K DV+S G+ +E+
Sbjct: 195 GQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 67/288 (23%), Positives = 122/288 (42%), Gaps = 43/288 (14%)
Query: 500 LGQGGFGSVYQGVLP--DGT--RLAVKKLEG---IGQGKKEFRAEVSIIGSIHHLHLVKL 552
LG+G FGSV + L DG+ ++AVK L+ +EF E + + H +++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 553 RGFC--AEGTHRL----LAYEFMANGSLDKWIFKK---NQEFLLDWETRFNIALGTAKGL 603
G + RL + FM +G L ++ + F L +T + A G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 604 AYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAP 663
YL + IH D+ N +L++N V+DFGL+K + + +G L
Sbjct: 127 EYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYY----RQGCASKLPV 179
Query: 664 EWITNYAISE-----KSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKL 718
+W+ ++++ SDV+++G+ + EI+ T + + +E ++
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIM----------TRGQTPYAG-----VENSEI 224
Query: 719 RNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
N L + + D + ++ C + RPS + LE I
Sbjct: 225 YNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVS-----IIGSIHHLHLVKLR 553
+G+G FG V + AVK L+ KK+ + ++ ++ H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 554 GFCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
F + +L +++ G L + + + L+ RF A A L YLH
Sbjct: 63 -FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARF-YAAEIASALGYLHS---L 115
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAIS 672
I++ D+KPEN+LLD H ++DFGL K E + +T GT YLAPE +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 673 EKSDVYSYGMVLLEIIGGRKNFDPNETSD 701
D + G VL E++ G F T++
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 7e-10
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 500 LGQGGFGSVYQGVLPD-GTRLAVKKL----EGIGQGKKEFRAEVSIIGSIHHLHLVKLRG 554
+G+G +G V + ++A+KK+ + K+ R E+ ++ + H +++ ++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKD 71
Query: 555 FCAEGTHR------LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHE 608
HR + YE M + L + I + +Q D F L +GL Y+H
Sbjct: 72 -IMPPPHREAFNDVYIVYELM-DTDLHQ-IIRSSQTLSDDHCQYFLYQL--LRGLKYIHS 126
Query: 609 DCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN 668
++H D+KP N+LL+ N K+ DFGLA+ T E+ T TR Y APE + N
Sbjct: 127 ---ANVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYRAPELLLN 182
Query: 669 YAISEKS-DVYSYGMVLLEIIGGRKNF 694
+ + DV+S G + E++G + F
Sbjct: 183 CSEYTTAIDVWSVGCIFAELLGRKPLF 209
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 7/97 (7%)
Query: 602 GLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT---REQSHVFTTLRGTR 658
GL Y+H ++H D+KP N+L++ + K+ DFGLA+ + E + T TR
Sbjct: 117 GLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 659 GYLAPEWITNYAISEKS-DVYSYGMVLLEIIGGRKNF 694
Y APE + ++ K+ DV+S G +L E++G + F
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 42/129 (32%), Positives = 65/129 (50%), Gaps = 23/129 (17%)
Query: 600 AKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK------LMTREQSHVFTT 653
+ GL +LH + II+ D+K +NV+LD H K++DFG+ K + TR T
Sbjct: 111 SVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR-------T 160
Query: 654 LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDK------AHFPS 707
GT Y+APE I + D ++YG++L E++ G+ FD E D+ H S
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD-GEDEDELFQSIMEHNVS 219
Query: 708 YAFKMMEEG 716
Y + +E
Sbjct: 220 YPKSLSKEA 228
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 51/223 (22%), Positives = 100/223 (44%), Gaps = 38/223 (17%)
Query: 496 FSVKLGQGGFGSVY----QGVL-------PDGTR----LAVKKL--EGIGQGKKEFRAEV 538
KLG+G FG V+ +G+ P+ +AVK L + + +F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 539 SIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKK---------NQEFLLDW 589
I+ + + ++++L G C + E+M NG L++++ ++ N +
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 590 ETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM-----T 644
+A+ A G+ YL +H D+ N L+ ++Y K++DFG+++ +
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 645 REQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEI 687
R Q +R ++A E I + SDV+++G+ L E+
Sbjct: 186 RIQGRAVLPIR----WMAWESILLGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVKKL----EGIGQGKKEFRAEVSIIGSIHHLHLVKLRG 554
+G G +GSV G R+AVKKL + I K+ +R E+ ++ + H +++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83
Query: 555 FCAEGT-----HRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED 609
+ + + L+ + K Q+ L D +F I +GL Y+H
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQK-LTDDHVQFLI-YQILRGLKYIHS- 138
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNY 669
IIH D+KP N+ ++++ K+ DFGLA+ E T TR Y APE + N+
Sbjct: 139 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNW 192
Query: 670 A-ISEKSDVYSYGMVLLEIIGGRKNF 694
++ D++S G ++ E++ GR F
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 8e-10
Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 33/227 (14%)
Query: 500 LGQGGFGSVYQGV---LPDG-----TRLAVKKLEGIGQGKKE-FRAEVSIIGSIHHLHLV 550
LGQG F +++G+ + D T + +K L+ + E F S++ + H HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAY-LHED 609
G C G ++ E++ GSLD ++ K + W+ L AK LA+ LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK------LEVAKQLAWALHFL 116
Query: 610 CDQRIIHCDIKPENVLL----DDNYHA----KVSDFGLA-KLMTREQSHVFTTLRGTRGY 660
D+ + H ++ +NVLL D K+SD G++ ++ +E L +
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE------ILLERIPW 170
Query: 661 LAPEWITN-YAISEKSDVYSYGMVLLEII-GGRKNFDPNETSDKAHF 705
+ PE I N +S +D +S+G L EI GG K ++ K F
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 58/221 (26%), Positives = 105/221 (47%), Gaps = 36/221 (16%)
Query: 500 LGQGGFGSVYQ----GVLPDGTR----LAVKKLEGIGQGK--KEFRAEVSIIGSI-HHLH 548
LG+G FG V G+ D + +AVK L+ K + +E+ ++ I H +
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 549 LVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIA------------ 596
++ L G C + + E+ + G+L +++ + E ++IA
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRP---PGMEYSYDIARVPDEQMTFKDL 139
Query: 597 ----LGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT 652
A+G+ YL Q+ IH D+ NVL+ +N K++DFGLA+ + + T
Sbjct: 140 VSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 653 TL-RGTRGYLAPEWITNYAISEKSDVYSYGMVLLEI--IGG 690
T R ++APE + + + +SDV+S+G+++ EI +GG
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 69/245 (28%), Positives = 110/245 (44%), Gaps = 30/245 (12%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKE----FRAEVSIIGSIHHLHLVKLR 553
++G G FG+VY + +A+KK+ G+ E EV + I H + ++ +
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
G L E+ + D + + +++ L + E I G +GLAYLH
Sbjct: 92 GCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIA-AITHGALQGLAYLHS---HN 145
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISE 673
+IH DIK N+LL + K++DFG A + + S V GT ++APE I A+ E
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVI--LAMDE 198
Query: 674 -----KSDVYSYGMVLLEIIGGRKN--FDPNETSDKAHFPSYAFKMMEEGK----LRNIL 722
K DV+S G+ +E + RK F+ N S H ++ + RN +
Sbjct: 199 GQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 257
Query: 723 DSRLN 727
DS L
Sbjct: 258 DSCLQ 262
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 67/209 (32%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 500 LGQGGFGSVYQGVLPDGTRL-AVKKLEG---IGQGKKEFRAEVSIIGSIHHLH--LVKLR 553
LG+G FG V L + RL AVK L+ + E I S+ H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 554 GFCAEGTHRLL-AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
C + RL EF+ G L I +K++ F RF A T+ L +LH D+
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEA-RARFYAAEITS-ALMFLH---DK 115
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAIS 672
II+ D+K +NVLLD H K++DFG+ K +T GT Y+APE +
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTFCGTPDYIAPEILQEMLYG 174
Query: 673 EKSDVYSYGMVLLEIIGGRKNFDPNETSD 701
D ++ G++L E++ G F+ E D
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFEA-ENED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 499 KLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRA--EVSIIGSIHHLHLVKLRGF 555
KLG+G + +VY+G +G +A+K + + F A E S++ + H ++V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
L +E++ + L +++ K + F L +GL+Y+H+ + I+
Sbjct: 72 IHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQL--LRGLSYIHQ---RYIL 125
Query: 616 HCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI---TNYAIS 672
H D+KP+N+L+ D K++DFGLA+ + SH ++ T Y P+ + T Y S
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSNEVVTLWYRPPDVLLGSTEY--S 182
Query: 673 EKSDVYSYGMVLLEIIGGRKNF 694
D++ G + +E+I G F
Sbjct: 183 TCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 58/212 (27%), Positives = 105/212 (49%), Gaps = 32/212 (15%)
Query: 499 KLGQGGFGSVYQGV--LPDGTRLAVKKL----EGIGQGKKEFRAEVSIIGSIHHLHLVKL 552
K+G+G +G VY+ + + T +A+KK+ E G R E+S++ + H ++V+L
Sbjct: 9 KIGEGTYGVVYKARDRVTNET-IALKKIRLEQEDEGVPSTAIR-EISLLKEMQHGNIVRL 66
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWI-----FKKNQEFLLDWETRFNIALGTAKGLAYLH 607
+ L +E++ + L K + F KN + + + +G+AY H
Sbjct: 67 QDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQI------LRGIAYCH 119
Query: 608 EDCDQRIIHCDIKPENVLLDDNYHA-KVSDFGLAK---LMTREQSHVFTTLRGTRGYLAP 663
R++H D+KP+N+L+D +A K++DFGLA+ + R +H TL Y AP
Sbjct: 120 S---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTL----WYRAP 172
Query: 664 E-WITNYAISEKSDVYSYGMVLLEIIGGRKNF 694
E + + S D++S G + E++ + F
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQKPLF 204
|
Length = 294 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 53/217 (24%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 499 KLGQGGFGSVYQGV-LPDGTR-LAVKKL------EGIGQGKKEFRAEVSIIGSIHHLHLV 550
++G+G +G V++ L +G R +A+K++ EG+ A + + + H ++V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 551 KLRGFCA-----EGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAY 605
+L C T L +E + + L ++ K E + ET ++ +GL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 606 LHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEW 665
LH R++H D+KP+N+L+ + K++DFGLA++ + + T++ T Y APE
Sbjct: 126 LHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEV 180
Query: 666 ITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDK 702
+ + + D++S G + E+ + F + D+
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 42/132 (31%), Positives = 69/132 (52%), Gaps = 11/132 (8%)
Query: 587 LDWETRFNIALGTAKGLAYL-HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645
LD + + A+G+ +L ++C IH D+ NVLL D AK+ DFGLA+ +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 646 EQSHVFT-TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAH 704
+ ++V R ++APE I + + +SDV+SYG++L EI K+ P +
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN--- 321
Query: 705 FPSYAFKMMEEG 716
S +KM++ G
Sbjct: 322 --SKFYKMVKRG 331
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 46/204 (22%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 502 QGGFGSVYQGVL----PDGTRLAVKKLEGIGQGKKE-----FRAEVSIIGSIHHLHLVKL 552
+G FG ++ G+L P K + E E ++ + H +++ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKT--VKDHASEIQVTLLLQESCLLYGLSHQNILPI 73
Query: 553 RGFCAEGTHR-LLAYEFMANGSLDKWIFK-----KNQEFLLDWETRFNIALGTAKGLAYL 606
C E + Y +M G+L ++ + N L + ++A+ A G++YL
Sbjct: 74 LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL 133
Query: 607 HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF--TTLRGTRGYLAPE 664
H+ + +IH DI N ++D+ K++D L++ + H R + ++A E
Sbjct: 134 HK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK-WMALE 189
Query: 665 WITNYAISEKSDVYSYGMVLLEII 688
+ N S SDV+S+G++L E++
Sbjct: 190 SLVNKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 53/223 (23%), Positives = 101/223 (45%), Gaps = 27/223 (12%)
Query: 488 DLQTATNNFSVKLGQGGFGSVYQGVLPDGT------RLAVKKLEGIGQG--KKEFRAEVS 539
++ +T F +LG+ FG VY+G L +A+K L+ +G ++EF+ E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 540 IIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIF-------------KKNQEFL 586
+ + H ++V L G + + + + ++ L +++ K +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 587 LDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646
L+ +I A G+ +L ++H D+ NVL+ D + K+SD GL + +
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 647 QSHVF--TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEI 687
+ +L R +++PE I S SD++SYG+VL E+
Sbjct: 178 DYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-09
Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 500 LGQGGFGSVYQGVLPDGT-RLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558
+G G FG VY+ + D + ++A+KK+ Q K E+ I+ +++H++++ L+ +
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR---ELLIMKNLNHINIIFLKDYYYT 130
Query: 559 GTHRLLAYEFMANGSLD----------KWIFKKNQEFLLDWETRFNIALGTAKGLAYLHE 608
+ N ++ K + N L ++ L + LAY+H
Sbjct: 131 ECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL--CRALAYIHS 188
Query: 609 DCDQRIIHCDIKPENVLLDDNYHA-KVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI- 666
+ I H D+KP+N+L+D N H K+ DFG AK + Q V + +R Y APE +
Sbjct: 189 ---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV--SYICSRFYRAPELML 243
Query: 667 --TNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDK 702
TNY + D++S G ++ E+I G F + D+
Sbjct: 244 GATNY--TTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ 279
|
Length = 440 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 61/212 (28%), Positives = 87/212 (41%), Gaps = 34/212 (16%)
Query: 500 LGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEF---RAEVS----------IIGSIH 545
LG+G FG V G A+K L KK R EV S
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKAL------KKGDIIARDEVESLMCEKRIFETANSER 60
Query: 546 HLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAY 605
H LV L H E+ A G L I + + + F A GL Y
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI---HTDVFSEPRAVFYAAC-VVLGLQY 116
Query: 606 LHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ---SHVFTTLRGTRGYLA 662
LHE+ +I++ D+K +N+LLD K++DFGL K E +T GT +LA
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTSTFCGTPEFLA 169
Query: 663 PEWITNYAISEKSDVYSYGMVLLEIIGGRKNF 694
PE +T + + D + G+++ E++ G F
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 500 LGQGGFGSVYQGVLPDGTRL----AVKKLEGIGQGKKEFR-AEVSIIGSIHHLHLVKLRG 554
+G+G FG V Q D R+ ++K + + + AE +++ ++ +V L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59
Query: 555 FCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALG---TAKGLAYLHEDC 610
F + +L L F+ G L F Q E RF+++ TA+ L L
Sbjct: 60 FSFQSPEKLYLVLAFINGGEL----FHHLQR-----EGRFDLSRARFYTAELLCALENLH 110
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYA 670
+I+ D+KPEN+LLD H + DFGL KL + T GT YLAPE + +
Sbjct: 111 KFNVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLAPELLLGHG 169
Query: 671 ISEKSDVYSYGMVLLEIIGG 690
++ D ++ G++L E++ G
Sbjct: 170 YTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQ----GKKEFRAEVSIIGSIHHLHLVKLRG 554
+G G +GSV + G ++A+KKL Q K+ +R E++++ + H +++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81
Query: 555 -FCAEGTHR-----LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHE 608
F + + L +M L K + E + + + GL Y+H
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQY-----LVYQMLCGLKYIHS 135
Query: 609 DCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN 668
IIH D+KP N+ ++++ K+ DFGLA+ E T TR Y APE I N
Sbjct: 136 ---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILN 188
Query: 669 YAISEKS-DVYSYGMVLLEIIGGRKNF 694
+ ++ D++S G ++ E++ G+ F
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGKTLF 215
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 6e-09
Identities = 35/103 (33%), Positives = 54/103 (52%), Gaps = 1/103 (0%)
Query: 603 LAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS-HVFTTLRGTRGYL 661
L +H + +IH DIK N+LL N K+ DFG +K+ S V T GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 662 APEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAH 704
APE S+K+D++S G++L E++ ++ FD + H
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH 255
|
Length = 496 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 38/118 (32%), Positives = 63/118 (53%), Gaps = 12/118 (10%)
Query: 602 GLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL 661
GL +LH + II+ D+K +NV+LD + H K++DFG+ K + +T GT Y+
Sbjct: 108 GLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA-STFCGTPDYI 163
Query: 662 APEWITNYAISEKSDVYSYGMVLLEIIGGRKNF---DPNE-----TSDKAHFPSYAFK 711
APE + + D +S+G++L E++ G+ F D +E D H+P + K
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITK 221
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 56/182 (30%), Positives = 91/182 (50%), Gaps = 21/182 (11%)
Query: 546 HLHLVKLRGFCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWE-TRF---NIALGTA 600
H LV L C + RL EF++ G L +F ++ L E RF I+L
Sbjct: 55 HPFLVGLHS-CFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLA-- 108
Query: 601 KGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGY 660
L +LHE + II+ D+K +NVLLD H K++D+G+ K R +T GT Y
Sbjct: 109 --LNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTFCGTPNY 162
Query: 661 LAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFD---PNETSDKAHFPSYAFKMMEEGK 717
+APE + D ++ G+++ E++ GR FD ++ D+ + Y F+++ E +
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ-NTEDYLFQVILEKQ 221
Query: 718 LR 719
+R
Sbjct: 222 IR 223
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 36/114 (31%), Positives = 61/114 (53%), Gaps = 8/114 (7%)
Query: 602 GLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL 661
L YLH + + +++ D+K EN++LD + H K++DFGL K ++ + T GT YL
Sbjct: 107 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTFCGTPEYL 163
Query: 662 APEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEE 715
APE + + D + G+V+ E++ GR F ++ H + +MEE
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----YNQDHEKLFELILMEE 212
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 603 LAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLA 662
L YLH + +++ DIK EN++LD + H K++DFGL K + + T GT YLA
Sbjct: 108 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTPEYLA 163
Query: 663 PEWITNYAISEKSDVYSYGMVLLEIIGGRKNF 694
PE + + D + G+V+ E++ GR F
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 8e-09
Identities = 53/190 (27%), Positives = 89/190 (46%), Gaps = 16/190 (8%)
Query: 537 EVSIIGSIHHLHLVKLRGFCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWE-TRFN 594
E ++ + H L L+ + + RL E++ G L F ++E + + TRF
Sbjct: 45 ESRVLKNTRHPFLTSLK-YSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFY 100
Query: 595 IALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTL 654
A L YLH +I++ D+K EN++LD + H K++DFGL K + + T
Sbjct: 101 GA-EIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKTF 155
Query: 655 RGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMME 714
GT YLAPE + + D + G+V+ E++ GR F ++ H + +ME
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----YNQDHEKLFELILME 210
Query: 715 EGKLRNILDS 724
+ K L +
Sbjct: 211 DIKFPRTLSA 220
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 8e-09
Identities = 34/103 (33%), Positives = 57/103 (55%), Gaps = 8/103 (7%)
Query: 601 KGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGY 660
+GL Y+H IIH D+KP NV ++++ ++ DFGLA R+ T TR Y
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLA----RQADDEMTGYVATRWY 181
Query: 661 LAPEWITNYA-ISEKSDVYSYGMVLLEIIGGRKNFDPNETSDK 702
APE + N+ ++ D++S G ++ E++ G+ F N+ D+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ 224
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 29/210 (13%)
Query: 500 LGQGGFGSVYQGVL--PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH-HLHLVKLRGF- 555
+G+G +G V++ VL +G++ AVK L+ I +E AE +I+ ++ H ++VK G
Sbjct: 26 IGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 556 ----CAEGTHRLLAYEFMANGS---LDKWIFKKNQ---EFLLDWETRFNIALGTAKGLAY 605
G L E GS L K K+ + E ++ + I GL +
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-----ILHEALMGLQH 139
Query: 606 LHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEW 665
LH + + IH D+K N+LL K+ DFG++ +T + T GT ++APE
Sbjct: 140 LHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEV 195
Query: 666 IT-----NYAISEKSDVYSYGMVLLEIIGG 690
I + + DV+S G+ +E+ G
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-08
Identities = 34/93 (36%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 602 GLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL 661
G+ +LH IIH D+KP N+++ + K+ DFGLA+ T S + T TR Y
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 184
Query: 662 APEWITNYAISEKSDVYSYGMVLLEIIGGRKNF 694
APE I E D++S G ++ E+I G F
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 43/170 (25%), Positives = 85/170 (50%), Gaps = 28/170 (16%)
Query: 600 AKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT-TLRGTR 658
A+G+ +L ++ IH D+ N+LL +N K+ DFGLA+ + ++ +V R
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 659 GYLAPEWITNYAISEKSDVYSYGMVLLEI--IGGRKNFDPNETSDKAHFPSYAFKMMEE- 715
++APE I + + +SDV+S+G++L EI +G P ++ EE
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS--------------PYPGVQIDEEF 285
Query: 716 -GKLRNILDSRLNIDEQS-DRVFTAVKVALWCVQEDMSLRPSMTKVVQML 763
+L+ +R+ E + +++ + L C + RP+ +++V++L
Sbjct: 286 CRRLKE--GTRMRAPEYATPEIYSIM---LDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 603 LAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLA 662
L +LH+ II+ DIK EN+LLD H ++DFGL+K E+ + GT Y+A
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 663 PEWIT--NYAISEKSDVYSYGMVLLEIIGGRKNF 694
PE I + + D +S G++ E++ G F
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 9/100 (9%)
Query: 595 IALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTL 654
+ L +GL YLHE+ IIH D+K N+LL D K++DFGLA+ + T
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR-TYGLPAKPMTPK 168
Query: 655 RGTRGYLAPEWI---TNYAISEKSDVYSYGMVLLEIIGGR 691
T Y APE + T Y + D+++ G +L E++ +
Sbjct: 169 VVTLWYRAPELLLGCTTY--TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 32/102 (31%), Positives = 56/102 (54%), Gaps = 5/102 (4%)
Query: 601 KGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGY 660
+GL +LH +C I+H D+KPEN+L+ K++DFGLA++ + + + T + T Y
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWY 173
Query: 661 LAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDK 702
APE + + D++S G + E+ + F N +D+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 55/233 (23%), Positives = 101/233 (43%), Gaps = 47/233 (20%)
Query: 496 FSVKLGQGGFGSVY-------QGV----LPDGTR------LAVKKL--EGIGQGKKEFRA 536
F KLG+G FG V+ Q + P R +AVK L + + +F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 537 EVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWI----------------FK 580
EV I+ + ++++L G C + + E+M NG L++++
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 581 KNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLA 640
+ + + + ++AL A G+ YL +H D+ N L+ +N K++DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 641 KLM-----TREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEII 688
+ + R Q +R ++A E I + SDV+++G+ L EI+
Sbjct: 186 RNLYAGDYYRIQGRAVLPIR----WMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 57/233 (24%), Positives = 104/233 (44%), Gaps = 42/233 (18%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFR------------AEVSIIGSIHH 546
KLG+G + +V++G KL KE R EVS++ ++ H
Sbjct: 12 KLGEGTYATVFKGR---------SKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKH 62
Query: 547 LHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYL 606
++V L L +E++ + D + N L+ +GL+Y
Sbjct: 63 ANIVTLHDIIHTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYC 119
Query: 607 HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK---LMTREQSHVFTTLRGTRGYLAP 663
H+ ++I+H D+KP+N+L+++ K++DFGLA+ + T+ S+ TL Y P
Sbjct: 120 HK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTL----WYRPP 172
Query: 664 EWI---TNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMM 713
+ + T Y S D++ G +L E+ GR F + ++ H F+++
Sbjct: 173 DVLLGSTEY--STPIDMWGVGCILYEMATGRPMFPGSTVKEELHL---IFRLL 220
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 54/217 (24%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 499 KLGQGGFGSVYQG---VLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
KLG+G + +V++G + + L +LE EVS++ + H ++V L
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIAL---GTAKGLAYLHEDCDQ 612
L +E+ LDK + K+ + + + N+ + +GLAY H +
Sbjct: 73 VHTDKSLTLVFEY-----LDKDL-KQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---R 123
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAK---LMTREQSHVFTTLRGTRGYLAPEWITNY 669
+++H D+KP+N+L+++ K++DFGLA+ + T+ S+ TL Y P+ +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTL----WYRPPDVLLGS 179
Query: 670 A-ISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHF 705
+ S + D++ G + E+ GR F + D+ H
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 53/218 (24%), Positives = 100/218 (45%), Gaps = 35/218 (16%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKK----LEGIGQGKKEFRAEVSIIGSIHH-LHLVKL 552
K+G+G +G VY+ G +A+KK ++ G R E+S++ + +++V+L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSESIYIVRL 66
Query: 553 RGFCAEGTHR-------LLAYEFMANGSLDKWI--FKKNQEFLLDWETRFNIALGTAKGL 603
E L +E++ + L K++ + L +T + KG+
Sbjct: 67 --LDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 604 AYLHEDCDQRIIHCDIKPENVLLDDNYHA-KVSDFGLAKLMT---REQSHVFTTLRGTRG 659
A+ H+ ++H D+KP+N+L+D K++D GL + + + +H TL
Sbjct: 124 AHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTL----W 176
Query: 660 YLAPEWI---TNYAISEKSDVYSYGMVLLEIIGGRKNF 694
Y APE + T+Y S D++S G + E+ + F
Sbjct: 177 YRAPEVLLGSTHY--STPVDIWSVGCIFAEMSRKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 3e-08
Identities = 60/237 (25%), Positives = 106/237 (44%), Gaps = 21/237 (8%)
Query: 501 GQGGFGSVYQGVLPDGTRLAVKKL----EGIGQGKKEFRAEVSIIGSIHHLHLVKLRG-F 555
QG + Y VL +A+KKL + K+ +R E+ ++ ++H +++ L F
Sbjct: 29 AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 85
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
+ + ++ +D + + Q LD E + G+ +LH II
Sbjct: 86 TPQKSLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHS---AGII 141
Query: 616 HCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKS 675
H D+KP N+++ + K+ DFGLA+ T S + T TR Y APE I E
Sbjct: 142 HRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 199
Query: 676 DVYSYGMVLLEII------GGRKNFDP-NETSDKAHFPSYAFKMMEEGKLRNILDSR 725
D++S G ++ E++ GR D N+ ++ P F + +RN +++R
Sbjct: 200 DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 54/234 (23%), Positives = 101/234 (43%), Gaps = 43/234 (18%)
Query: 487 RDLQTATNNFSVKLGQGGFGSVY----QGVLP-------------DGTRLAVKKL--EGI 527
R T F KLG+G FG V+ +G+ +AVK L +
Sbjct: 4 RKRLT----FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN 59
Query: 528 GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFK-KNQEFL 586
+ +F E+ I+ + ++++L C + E+M NG L++++ + + QE
Sbjct: 60 KNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA 119
Query: 587 LDWETRF-------NIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGL 639
+ +A A G+ YL +H D+ N L+ NY K++DFG+
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 640 AKLMTREQSHVFTTLRGTRGYLAPEWITNYAI-----SEKSDVYSYGMVLLEII 688
++ + + ++G R L W++ +I + SDV+++G+ L EI+
Sbjct: 177 SRNLYSGD---YYRIQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 45/217 (20%)
Query: 499 KLGQGGFGSVYQGVLP-DGTRLAVKKL-----EGIGQGKKEFRA--EVSIIGSIHHLHLV 550
KLG+G + +VY+G G +A+K++ EG F A E S++ + H ++V
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-----PFTAIREASLLKDLKHANIV 66
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRF----NIALGT---AKGL 603
L L +E++ + L ++ +D N+ L +GL
Sbjct: 67 TLHDIIHTKKTLTLVFEYL-DTDLKQY---------MDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 604 AYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK---LMTREQSHVFTTLRGTRGY 660
AY H +R++H D+KP+N+L+ + K++DFGLA+ + ++ S+ TL Y
Sbjct: 117 AYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTL----WY 169
Query: 661 LAPEWI---TNYAISEKSDVYSYGMVLLEIIGGRKNF 694
P+ + T Y S D++ G + E+ GR F
Sbjct: 170 RPPDVLLGSTEY--STSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 65/245 (26%), Positives = 100/245 (40%), Gaps = 48/245 (19%)
Query: 500 LGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQGKKE----FRAEVSIIGSIHHLHLVKLRG 554
+G+G FG V D G A+K L +KE RAE I+ +VK+
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
+ + L EF+ G + + KK+ L + T+F IA T + +H+
Sbjct: 69 SFQDKRNLYLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIA-ETVLAIDAIHQ---LGF 122
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGL----------------------------------A 640
IH DIKP+N+LLD H K+SDFGL A
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 641 KLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNF---DPN 697
+ + + + + GT Y+APE ++ D +S G+++ E++ G F P
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 698 ETSDK 702
ET K
Sbjct: 243 ETYRK 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 51/212 (24%), Positives = 95/212 (44%), Gaps = 36/212 (16%)
Query: 500 LGQGGFGSVYQGVLPD---------GTRLAVKK-LEGIGQGKKE----FRAEVSIIGSIH 545
LG+G +Y G+L +K L+ + ++ F S++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 546 HLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAY 605
H H+V L G C ++ EF+ G LD ++ +K+ W +F +A A L+Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 606 LHEDCDQRIIHCDIKPENVLL-----DDNY--HAKVSDFGLA-KLMTREQSHVFTTLRGT 657
L D+ ++H ++ +N+LL D K+SD G+ +++R++
Sbjct: 121 LE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQE-------CVE 170
Query: 658 R-GYLAPEWITNYA-ISEKSDVYSYGMVLLEI 687
R ++APE + + +S +D +S+G L EI
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 4/99 (4%)
Query: 601 KGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGY 660
K + + H++ I+H DIKPEN+L+ N K+ DFG A+ ++ + +T TR Y
Sbjct: 111 KAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWY 167
Query: 661 LAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNET 699
+PE + + D++S G +L E+ G+ F P E+
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF-PGES 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 59/231 (25%), Positives = 97/231 (41%), Gaps = 40/231 (17%)
Query: 486 YRDLQTATNNFSVKLGQGGFGSVYQGVLPD-GTRLAVKKLE-GIGQGKKEFRAEVSIIGS 543
Y DL+ LG G G V+ V D R+AVKK+ Q K E+ II
Sbjct: 7 YMDLR--------PLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRR 58
Query: 544 IHHLHLVKLRGFCAEGTHRL--------------LAYEFMANGSLDKWIFKKNQEFLLDW 589
+ H ++VK+ L + E+M L + Q L +
Sbjct: 59 LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL---EQGPLSEE 114
Query: 590 ETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD-DNYHAKVSDFGLAKLMTREQS 648
R +GL Y+H ++H D+KP NV ++ ++ K+ DFGLA+++ S
Sbjct: 115 HARL-FMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYS 170
Query: 649 HVFTTLRG--TRGYLAPEWI---TNYAISEKSDVYSYGMVLLEIIGGRKNF 694
H G T+ Y +P + NY ++ D+++ G + E++ G+ F
Sbjct: 171 HKGYLSEGLVTKWYRSPRLLLSPNNY--TKAIDMWAAGCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 42/268 (15%)
Query: 486 YRDLQTATNNFSV--------KLGQGGFG---SVYQGVLPDGTRLAVKKL----EGIGQG 530
+ +Q A + F+V +G G G + + VL G +AVKKL +
Sbjct: 7 FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHA 64
Query: 531 KKEFRAEVSIIGSIHHLHLVKL------RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQE 584
K+ +R E+ ++ ++H +++ L + E L E M + +L + I +
Sbjct: 65 KRAYR-ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME--- 119
Query: 585 FLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644
LD E + G+ +LH IIH D+KP N+++ + K+ DFGLA+ T
Sbjct: 120 --LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--T 172
Query: 645 REQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAH 704
+ + T TR Y APE I E D++S G ++ E++ G F + D+ +
Sbjct: 173 ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN 232
Query: 705 -------FPSYAFKMMEEGKLRNILDSR 725
PS F + +RN +++R
Sbjct: 233 KVIEQLGTPSAEFMNRLQPTVRNYVENR 260
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 47/227 (20%)
Query: 500 LGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQGKKEFRA----EVSIIGSIHHLHLVKLRG 554
+G+G +G VY+ D G +A+KK+ + K+ F E+ I+ ++H ++V L+
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVR-LDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 555 FCAEGTHRL----------LAYEFMAN---GSLDKWIFKKNQEF-------LLDWETRFN 594
+ L L +E+M + G L+ + +++ LL+
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE------ 127
Query: 595 IALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTL 654
GL Y H + +H DIK N+LL++ K++DFGLA+L E+S +T
Sbjct: 128 -------GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 655 RGTRGYLAPEWI---TNYAISEKSDVYSYGMVLLEIIGGRKNFDPNE 698
T Y PE + Y + DV+S G +L E+ + F N+
Sbjct: 178 VITLWYRPPELLLGEERYGPA--IDVWSCGCILGELFTKKPIFQANQ 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 16/102 (15%)
Query: 600 AKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK------LMTREQSHVFTT 653
A GL +LH + II+ D+K +NV+LD H K++DFG+ K + T+ T
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK-------T 160
Query: 654 LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFD 695
GT Y+APE I + D +++G++L E++ G+ F+
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 7e-08
Identities = 63/238 (26%), Positives = 98/238 (41%), Gaps = 26/238 (10%)
Query: 471 DNFLENLSGMPVRFTYRDLQTATNNFS-VKL-GQGGFGSVYQGVLPDGTR--LAVKKLEG 526
DNFL L+ +F +K+ G+G FG V Q V ++ A+K L
Sbjct: 22 DNFLSRYE--KAAEKITKLRMKAEDFDVIKVIGRGAFGEV-QLVRHKSSKQVYAMKLLSK 78
Query: 527 IGQGKKE----FRAEVSIIGSIHHLHLVKLRGFCA--EGTHRLLAYEFMANGSLDKWIFK 580
K+ F E I+ + +V+L A + + + E+M G L +
Sbjct: 79 FEMIKRSDSAFFWEERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLM-- 134
Query: 581 KNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLA 640
N + W RF A L +H IH D+KP+N+LLD + H K++DFG
Sbjct: 135 SNYDIPEKW-ARFYTA-EVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC 189
Query: 641 KLMTREQSHVFTTLRGTRGYLAPEWITNYAIS----EKSDVYSYGMVLLEIIGGRKNF 694
M T GT Y++PE + + + D +S G+ L E++ G F
Sbjct: 190 MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 31/95 (32%), Positives = 56/95 (58%), Gaps = 8/95 (8%)
Query: 602 GLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK--LMTREQSHVFTTLRGTRG 659
GL +LH + I++ D+K +N+LLD + H K++DFG+ K ++ ++ F GT
Sbjct: 108 GLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC---GTPD 161
Query: 660 YLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNF 694
Y+APE + + D +S+G++L E++ G+ F
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 30/82 (36%), Positives = 46/82 (56%), Gaps = 1/82 (1%)
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISE 673
I++ DIK EN+LLD H ++DFGL+K E+ + GT Y+APE I
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHG 185
Query: 674 KS-DVYSYGMVLLEIIGGRKNF 694
K+ D +S G+++ E++ G F
Sbjct: 186 KAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-07
Identities = 51/220 (23%), Positives = 86/220 (39%), Gaps = 33/220 (15%)
Query: 499 KLGQGGFGSVYQGVLPD-GTRLAVKK----LEGIGQGKKEFRAEVSIIGSIHHLHLVKLR 553
+G+GG G VY P R+A+KK L KK F E I + H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 554 GFCAEGTHRLLAYEFMANGSL--------DKWIFKKNQEFLLDWETRFNIALGTAKGLAY 605
C++G ++ +L K K +I + Y
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 606 LHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ--------------SHVF 651
+H + ++H D+KP+N+LL + D+G A E+
Sbjct: 129 VHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 652 TT---LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEII 688
T + GT Y+APE + SE +D+Y+ G++L +++
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 45/161 (27%), Positives = 80/161 (49%), Gaps = 3/161 (1%)
Query: 535 RAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFN 594
R+E+ + + H +VK LL E+ + G L+K I ++ +E L E +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQE--YE 170
Query: 595 IALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS-HVFTT 653
+ L + + L E ++++H D+K N+ L K+ DFG +K + S V ++
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 654 LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNF 694
GT YLAPE S+K+D++S G++L E++ + F
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 58/237 (24%), Positives = 104/237 (43%), Gaps = 33/237 (13%)
Query: 504 GFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFC--AEGTH 561
G S QG P RL K+++ + + E+ +G ++H +++K+ T+
Sbjct: 181 GVNSTNQGK-PKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTY 239
Query: 562 RLLA------YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
+ Y FM + + D W K++ L +TR I + Y+H D+++I
Sbjct: 240 MITQKYDFDLYSFMYDEAFD-W---KDRPLL--KQTR-AIMKQLLCAVEYIH---DKKLI 289
Query: 616 HCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKS 675
H DIK EN+ L+ + + DFG A +E+ GT +PE + E +
Sbjct: 290 HRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEIT 349
Query: 676 DVYSYGMVLLEIIGGRKNFDP-NETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731
D++S G++LL+++ +F P + K +L I+DS DE+
Sbjct: 350 DIWSCGLILLDMLS--HDFCPIGDGGGKPG-----------KQLLKIIDSLSVCDEE 393
|
Length = 501 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 49/212 (23%), Positives = 90/212 (42%), Gaps = 35/212 (16%)
Query: 499 KLGQGGFGSVYQGVL---PDGTRLAVKKLEGIGQGKK--EFRAEVSIIGSIHHLHLVKLR 553
++G G FG V + R+ VK+L+ K+ EF + + H ++++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 554 GFCAEGTHRLLAYEFMANGSL------DKWIFKKNQEFLLDWETRFNIALGTAKGLAYLH 607
G C E LL +E+ G L ++W + +Q LL +A A G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMACEIAAGVTHMH 116
Query: 608 EDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE-----QSHVFTTLRGTRGYLA 662
+ +H D+ N L + KV D+G+ +E + LR +LA
Sbjct: 117 K---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----WLA 169
Query: 663 PEWITNY-------AISEKSDVYSYGMVLLEI 687
PE + + ++ S+V++ G+ L E+
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 35/101 (34%), Positives = 52/101 (51%), Gaps = 5/101 (4%)
Query: 602 GLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL 661
G+ +LH IIH D+KP N+++ + K+ DFGLA+ T S + T TR Y
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 662 APEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDK 702
APE I E D++S G ++ E+I G F + D+
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 42/199 (21%), Positives = 92/199 (46%), Gaps = 20/199 (10%)
Query: 507 SVYQGVLPDGTRLAVKKLEGIGQGKK----EFRAEVSIIGSIHHLHLVKLRGFCAEGTHR 562
S+Y+G+ + + ++ + +G K E+ + I +++K+ GF +
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 563 L----LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCD 618
L L E+ G L + + K+ L ++T+ ++A+ KGL L++ ++ + +
Sbjct: 94 LPRLSLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKN 148
Query: 619 IKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNY--AISEKSD 676
+ + L+ +NY K+ GL K+++ + Y + + + + + K D
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFM----VYFSYKMLNDIFSEYTIKDD 204
Query: 677 VYSYGMVLLEIIGGRKNFD 695
+YS G+VL EI G+ F+
Sbjct: 205 IYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 31/89 (34%), Positives = 53/89 (59%), Gaps = 4/89 (4%)
Query: 600 AKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT-TLRGTR 658
AKG+ +L ++ IH D+ N+LL +N K+ DFGLA+ + ++ +V R
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 659 GYLAPEWITNYAISEKSDVYSYGMVLLEI 687
++APE I + + +SDV+S+G++L EI
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 43/216 (19%)
Query: 499 KLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRA--EVSIIGSIHHLHLVKLRG- 554
KLG+G + +VY+G+ +G +A+K + + F A E S++ + H ++V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 555 --------FCAEGTHRLLAYEFMAN--GSLDKWIFKKNQEFLLDWETRFNIAL---GTAK 601
F E H LA ++M G L +N+ L +
Sbjct: 72 IHTKETLTFVFEYMHTDLA-QYMIQHPGGLHP----------------YNVRLFMFQLLR 114
Query: 602 GLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL 661
GLAY+H Q I+H D+KP+N+L+ K++DFGLA+ + S +++ T Y
Sbjct: 115 GLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIP-SQTYSSEVVTLWYR 170
Query: 662 APEWI---TNYAISEKSDVYSYGMVLLEIIGGRKNF 694
P+ + T+Y S D++ G + +E++ G+ F
Sbjct: 171 PPDVLLGATDY--SSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 35/106 (33%), Positives = 54/106 (50%), Gaps = 17/106 (16%)
Query: 599 TAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK--LMTRE----QSHVFT 652
T L YLH + I+H D+KP+N+L+ H K++DFGL+K LM+ + H+
Sbjct: 110 TVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166
Query: 653 TLR--------GTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGG 690
R GT Y+APE I + D ++ G++L E + G
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 30/100 (30%), Positives = 53/100 (53%), Gaps = 11/100 (11%)
Query: 601 KGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ-SHVF-TTLRGTR 658
+ L Y+H + H D+KP+N+L + + K+ DFGLA++ + + +F T TR
Sbjct: 114 RALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 659 GYLAPE----WITNYAISEKSDVYSYGMVLLEIIGGRKNF 694
Y APE + + Y + D++S G + E++ G+ F
Sbjct: 171 WYRAPELCGSFFSKY--TPAIDIWSIGCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 30/89 (33%), Positives = 54/89 (60%), Gaps = 4/89 (4%)
Query: 600 AKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT-TLRGTR 658
A+G+ +L ++ IH D+ N+LL +N K+ DFGLA+ + ++ +V + R
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 659 GYLAPEWITNYAISEKSDVYSYGMVLLEI 687
++APE I + + +SDV+S+G++L EI
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 66/238 (27%), Positives = 104/238 (43%), Gaps = 26/238 (10%)
Query: 471 DNFLENLSGMPVRFTYRDLQTATNNFSVK--LGQGGFGSVYQGVLPDGTR--LAVKKLEG 526
DNFL + VR R LQ ++ V +G+G FG V Q V ++ A+K L
Sbjct: 22 DNFLNRYEKI-VR-KIRKLQMKAEDYDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSK 78
Query: 527 IGQGKKE----FRAEVSIIGSIHHLHLVKLRGFCA--EGTHRLLAYEFMANGSLDKWIFK 580
K+ F E I+ + +V+L FCA + + + E+M G L +
Sbjct: 79 FEMIKRSDSAFFWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLM-- 134
Query: 581 KNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLA 640
N + W + TA+ + L +IH D+KP+N+LLD + H K++DFG
Sbjct: 135 SNYDVPEKWAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC 189
Query: 641 KLMTREQSHVFTTLRGTRGYLAPEWITNYA----ISEKSDVYSYGMVLLEIIGGRKNF 694
M T GT Y++PE + + + D +S G+ L E++ G F
Sbjct: 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 39/147 (26%), Positives = 57/147 (38%), Gaps = 52/147 (35%)
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGL----------------------------------- 639
IH DIKP+N+L+D + H K++DFGL
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 640 AKLMTREQSHVFTTLR-------GTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRK 692
+L E+ R GT Y+APE + ++ D +S G++L E++ G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 693 NF---DPNETSDKA-------HFPSYA 709
F P ET K H PS A
Sbjct: 243 PFLADTPAETQLKVINWETTLHIPSQA 269
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 66/236 (27%), Positives = 102/236 (43%), Gaps = 22/236 (9%)
Query: 471 DNFLENLSGMPVRFTYRDLQTATNNFSVK--LGQGGFGSVYQGVLPDGTR--LAVKKLEG 526
DNFL + RDL+ ++ V +G+G FG V Q V TR A+K L
Sbjct: 22 DNFLNRYKDTINKI--RDLRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSK 78
Query: 527 IGQGKKE----FRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKN 582
K+ F E I+ + +V+L + + + E+M G L + N
Sbjct: 79 FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SN 136
Query: 583 QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642
+ W RF TA+ + L IH D+KP+N+LLD + H K++DFG
Sbjct: 137 YDVPEKW-ARFY----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191
Query: 643 MTREQSHVFTTLRGTRGYLAPEWITNYA----ISEKSDVYSYGMVLLEIIGGRKNF 694
M +E T GT Y++PE + + + D +S G+ L E++ G F
Sbjct: 192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 36/127 (28%), Positives = 59/127 (46%), Gaps = 15/127 (11%)
Query: 606 LHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEW 665
+H +H DIKP+NVLLD N H +++DFG M ++ + + GT Y++PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 666 ITNY-----AISEKSDVYSYGMVLLEIIGGRKNFDPN---ET-------SDKAHFPSYAF 710
+ + D +S G+ + E++ G F ET ++ FPS+
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHIT 234
Query: 711 KMMEEGK 717
+ EE K
Sbjct: 235 DVSEEAK 241
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 485 TYRDLQTATNNFSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEF-----RAEV 538
Y L K+GQG FG V++ +A+KK+ + K+ F R E+
Sbjct: 13 KYEKLA--------KIGQGTFGEVFKARHKKTKQIVALKKVL-MENEKEGFPITALR-EI 62
Query: 539 SIIGSIHHLHLVKLRGFC---AEGTHR-----LLAYEFMANGSLDKWIFKKNQEFLLDWE 590
I+ + H ++V L C A +R L +EF + L + KN +F L
Sbjct: 63 KILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEI 121
Query: 591 TRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK---LMTREQ 647
+ L GL Y+H + +I+H D+K N+L+ + K++DFGLA+ L +
Sbjct: 122 KKVMKMLLN--GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176
Query: 648 SHVFTTLRGTRGYLAPE 664
+ +T T Y PE
Sbjct: 177 PNRYTNRVVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 4/99 (4%)
Query: 603 LAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLA 662
L +LH +I+ D+K +N+LLD H K++DFG+ K TT GT Y+A
Sbjct: 109 LMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTTTFCGTPDYIA 164
Query: 663 PEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSD 701
PE + D ++ G+++ E++ G+ F+ + D
Sbjct: 165 PEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 34/116 (29%), Positives = 60/116 (51%), Gaps = 14/116 (12%)
Query: 582 NQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK 641
N+ L + + A G+ +L + +H D+ NVL+ + K+ DFGLA+
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR 287
Query: 642 LMTREQSHV-----FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEI--IGG 690
+ R+ +++ F L+ ++APE I N + SDV+S+G++L EI +GG
Sbjct: 288 DIMRDSNYISKGSTFLPLK----WMAPESIFNNLYTTLSDVWSFGILLWEIFTLGG 339
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 56/233 (24%), Positives = 92/233 (39%), Gaps = 53/233 (22%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVKKLE--GIGQGKKEFRA-------------EVSIIGS 543
LG+G +G V + G +A+KK++ I + R E+ I+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 544 IHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFN------IAL 597
I H +++ L EG L + MA L K ++D + R I L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKK---------VVDRKIRLTESQVKCILL 126
Query: 598 GTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLA-------------KLMT 644
GL LH+ +H D+ P N+ ++ K++DFGLA K T
Sbjct: 127 QILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183
Query: 645 REQSHVFTTLRGTRGYLAPEWI---TNYAISEKSDVYSYGMVLLEIIGGRKNF 694
++ T+ T Y APE + Y + D++S G + E++ G+ F
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFA--VDMWSVGCIFAELLTGKPLF 234
|
Length = 335 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 29/94 (30%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWIT--NYAI 671
II+ DIK EN+LLD N H ++DFGL+K ++ + GT Y+AP+ + +
Sbjct: 126 IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGH 185
Query: 672 SEKSDVYSYGMVLLEIIGGRKNF----DPNETSD 701
+ D +S G+++ E++ G F + N ++
Sbjct: 186 DKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAE 219
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 38/169 (22%), Positives = 70/169 (41%), Gaps = 31/169 (18%)
Query: 495 NFSVKLGQGGFGSVYQGVL---PDGTRLAVKKLEGIGQGKKEFRA----EVSIIGSIHHL 547
+G+G +G VY+ DG A+KK +G + E++++ + H
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHE 62
Query: 548 HLVKLRGFCAEGTHRL--LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAK---- 601
++V L E + L +++ + I K +++ R +I K
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDYAEHDLW--QIIKFHRQ-----AKRVSIPPSMVKSLLW 115
Query: 602 ----GLAYLHEDCDQRIIHCDIKPENVLL--DDNYHA--KVSDFGLAKL 642
G+ YLH ++H D+KP N+L+ + K+ D GLA+L
Sbjct: 116 QILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 62/235 (26%), Positives = 100/235 (42%), Gaps = 37/235 (15%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVK--KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
++G G +G VY+ L G AVK KLE G + E+ ++ H ++V G
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKN---QEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
+ E+ GSL I+ E + + R T +GLAYLH
Sbjct: 75 YLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCR-----ETLQGLAYLHSKGK- 127
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWIT---NY 669
+H DIK N+LL DN K++DFG+A +T + + GT ++APE N
Sbjct: 128 --MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR-KSFIGTPYWMAPEVAAVEKNG 184
Query: 670 AISEKSDVYSYGMVLLEI-----------------IGGRKNFDPNETSDKAHFPS 707
++ D+++ G+ +E+ + + NF P + DK + S
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSS 239
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 34/205 (16%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLA---VKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
++G G +G VY+ + LA V KLE G+ + E+ ++ H ++V G
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKN---QEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
+ EF GSL I+ E + + +R T +GL YLH +
Sbjct: 75 YLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSR-----ETLQGLYYLH---SK 125
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT----REQSHVFTTLRGTRGYLAPEWITN 668
+H DIK N+LL DN H K++DFG++ +T + +S + GT ++APE
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-----GTPYWMAPEVA-- 178
Query: 669 YAISEKS------DVYSYGMVLLEI 687
A+ K D+++ G+ +E+
Sbjct: 179 -AVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 5e-06
Identities = 65/251 (25%), Positives = 112/251 (44%), Gaps = 44/251 (17%)
Query: 480 MPVRFTYRDLQTATNNFSV--KLGQGGFGSVYQGVLPDGTR----LAVKKLEGIG---QG 530
MP + Y D ++ N + V K+G G FG V+ L R K + G +
Sbjct: 1 MPGK--YDDGESRLNEYEVIKKIGNGRFGEVF---LVKHKRTQEFFCWKAISYRGLKERE 55
Query: 531 KKEFRAEVSIIGSIHHLHLVK-LRGFCAEGTHRL-LAYEFMANGSLDKWIFKKNQEF-LL 587
K + EV+++ + H ++V+ + F + +L + EF G L + I K + F +
Sbjct: 56 KSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKI 115
Query: 588 DWETRFNIALGTAKGLAYLHEDCD----QRIIHCDIKPENVLLDDNYH------------ 631
+ +I LAY H D +R++H D+KP+N+ L
Sbjct: 116 EEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175
Query: 632 -----AKVSDFGLAKLMTREQ-SHVFTTLRGTRGYLAPEWITNYAIS--EKSDVYSYGMV 683
AK+ DFGL+K + E +H + GT Y +PE + + S +KSD+++ G +
Sbjct: 176 NGRPIAKIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCI 232
Query: 684 LLEIIGGRKNF 694
+ E+ G+ F
Sbjct: 233 IYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 34/99 (34%), Positives = 49/99 (49%), Gaps = 4/99 (4%)
Query: 590 ETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLA-KLMTREQS 648
E I + LAYLH + IIH D+K EN+ LD+ +A + DFG A KL +
Sbjct: 185 EQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241
Query: 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEI 687
GT +PE + K+D++S G+VL E+
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 30/108 (27%), Positives = 43/108 (39%), Gaps = 18/108 (16%)
Query: 595 IALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTL 654
+ L L LH Q K N+LL + K+ G T EQS
Sbjct: 22 VCLQCLGALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQS------ 64
Query: 655 RGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGR-KNFDPNETSD 701
R ++APE I + +EK+D+YS G+ L E + + E S
Sbjct: 65 RPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA 112
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 32/95 (33%), Positives = 54/95 (56%), Gaps = 8/95 (8%)
Query: 600 AKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF--TTLRGT 657
A+G+ +L + +H D+ NVLL K+ DFGLA+ + + ++V +T
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303
Query: 658 RGYLAPEWITNYAISEKSDVYSYGMVLLEI--IGG 690
+ ++APE I + + SDV+SYG++L EI +GG
Sbjct: 304 K-WMAPESIFDNLYTTLSDVWSYGILLWEIFSLGG 337
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 38/137 (27%), Positives = 57/137 (41%), Gaps = 49/137 (35%)
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGLA---------------------------------- 640
IH DIKP+N+L+D + H K++DFGL
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 641 -----KLMTREQ----SH---VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEII 688
+L T EQ H + +L GT Y+APE + ++ D +S G++L E++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 689 GGRKNF---DPNETSDK 702
G+ F P ET K
Sbjct: 243 VGQPPFLAPTPTETQLK 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 63/277 (22%), Positives = 97/277 (35%), Gaps = 86/277 (31%)
Query: 494 NNFS-VK-LGQGGFGSV--YQGVLPDGTRLAVKKLEGIGQGKKE----FRAEVSIIGSIH 545
+F VK +G+G FG V Q G A+K L KK+ +AE ++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQK-KDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD 59
Query: 546 HLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWE------TRFNIA--- 596
+V L + + L EF+ G L L+ ++ TRF +A
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDL--------MTMLIKYDTFSEDVTRFYMAECV 111
Query: 597 --LGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK-LMTREQSHVFTT 653
+ L + IH DIKP+N+L+D H K+SDFGL+ + S +
Sbjct: 112 LAIEAVHKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQK 162
Query: 654 LR---------------------------------------------GTRGYLAPEWITN 668
L GT Y+APE
Sbjct: 163 LLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ 222
Query: 669 YAISEKSDVYSYGMVLLEIIGGRKNF---DPNETSDK 702
++ D +S G ++ E + G F + +ET K
Sbjct: 223 QGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRK 259
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-05
Identities = 63/288 (21%), Positives = 113/288 (39%), Gaps = 66/288 (22%)
Query: 455 RKKRKAPESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSV--KLGQGGFGSVYQGV 512
+KK+ P ++ EE +F L D+ +T F + LG+G FG V +
Sbjct: 98 KKKKVTYALPNQSREEGHFYVVLG--------EDIDVSTQRFKILSLLGEGTFGKVVEAW 149
Query: 513 LPDGTR---LAVKKLEGIGQGKKEFRAEVSIIGSIHH------LHLVKL-RGFCAEGTHR 562
D R AVK + + + ++ + E+ + + L+K+ R F E H
Sbjct: 150 --DRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207
Query: 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETR---FN------IALGTAKGLAYLHEDCDQR 613
+ + K LLDW + F+ I T L Y H +
Sbjct: 208 CI-------------VMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL--H 252
Query: 614 IIHCDIKPENVLLD----------------DNYHAKVSDFGLAKLMTREQSHVFTTLRGT 657
++H D+KPEN+L++ D ++ D G ++ H T + T
Sbjct: 253 LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG----GCCDERHSRTAIVST 308
Query: 658 RGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHF 705
R Y +PE + +D++S G ++ E+ G+ +D ++ + H
Sbjct: 309 RHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356
|
Length = 467 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 4e-05
Identities = 22/48 (45%), Positives = 32/48 (66%), Gaps = 4/48 (8%)
Query: 600 AKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL-MTRE 646
A L YLH IIH D+KP+N+L+ + H K++DFGL+K+ + RE
Sbjct: 114 ALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 8e-05
Identities = 33/93 (35%), Positives = 47/93 (50%), Gaps = 15/93 (16%)
Query: 602 GLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV---FTTLRGTR 658
G+A+LH D I+H D+K N+LL++ K+ DFGLA RE +T L T
Sbjct: 118 GVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLA----REYGSPLKPYTQLVVTL 170
Query: 659 GYLAPEW---ITNYAISEKSDVYSYGMVLLEII 688
Y APE Y S D++S G + E++
Sbjct: 171 WYRAPELLLGAKEY--STAIDMWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-05
Identities = 31/108 (28%), Positives = 49/108 (45%), Gaps = 9/108 (8%)
Query: 601 KGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGY 660
+ + YLHE+ RIIH DIK EN+ ++ + DFG A ++ + GT
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249
Query: 661 LAPEWITNYAISEKSDVYSYGMVLLEIIGG------RKNFDPNETSDK 702
APE + D++S G+VL E+ + D + SD+
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDR 297
|
Length = 391 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 51/228 (22%), Positives = 98/228 (42%), Gaps = 27/228 (11%)
Query: 499 KLGQGGFGSVYQGVLPDG---TRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRG- 554
K+G+G +G VY+ DG A+K++EG G R E++++ + H +++ L+
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR-EIALLRELKHPNVISLQKV 66
Query: 555 FCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAK--------GLAY 605
F + ++ L +++ + D W K + + G K G+ Y
Sbjct: 67 FLSHADRKVWLLFDYAEH---DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 606 LHEDCDQRIIHCDIKPENVLL----DDNYHAKVSDFGLAKLMTREQSHV--FTTLRGTRG 659
LH + ++H D+KP N+L+ + K++D G A+L + + T
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 660 YLAPEWITNYAISEKS-DVYSYGMVLLEIIGGRKNFDPNETSDKAHFP 706
Y APE + K+ D+++ G + E++ F + K P
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 228
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 20/52 (38%), Positives = 30/52 (57%)
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPE 664
+H DIKP+NVLLD N H +++DFG + + + GT Y++PE
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 51/215 (23%), Positives = 83/215 (38%), Gaps = 37/215 (17%)
Query: 500 LGQGGFGSVYQ---GVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH----------- 545
+G GGFG VY+ AV K+E + + E + +I+
Sbjct: 20 IGCGGFGCVYETQCASDHCINNQAVAKIENLEN--ETIVMETLVYNNIYDIDKIALWKNI 77
Query: 546 ----HLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEF--LLDWETRF--NIAL 597
HL + K G C + Y F+ L+K + + F + + NI
Sbjct: 78 HNIDHLGIPKYYG-CGSFKRCRMYYRFIL---LEKLVENTKEIFKRIKCKNKKLIKNIMK 133
Query: 598 GTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTL--- 654
L Y+HE I H DIKPEN+++D N + D+G+A H+ +
Sbjct: 134 DMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQK 190
Query: 655 ---RGTRGYLAPEWITNYAISEKSDVYSYGMVLLE 686
RGT Y + ++ + D+ S G +L+
Sbjct: 191 DLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 24/85 (28%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISE- 673
+H DIKP+N+L+D N H +++DFG + + + + GT Y++PE + +
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183
Query: 674 ----KSDVYSYGMVLLEIIGGRKNF 694
+ D +S G+ + E++ G F
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 39/151 (25%), Positives = 58/151 (38%), Gaps = 56/151 (37%)
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGLAKLM--------------TREQSHVFT-------- 652
IH DIKP+N+L+D + H K++DFGL R+ S F+
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 653 ------------------------TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEII 688
+L GT Y+APE + ++ D +S G++L E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 689 GGRKNF---DPNETSDKA-------HFPSYA 709
G+ F P ET K H P A
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQA 273
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 51/237 (21%), Positives = 95/237 (40%), Gaps = 45/237 (18%)
Query: 499 KLGQGGFGSVYQGVLPDG---TRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
K+G+G +G VY+ DG A+K++EG G R E++++ + H +++ L+
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR-EIALLRELKHPNVIALQKV 66
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAK-------------- 601
F+++ W+ E L +F+ A K
Sbjct: 67 ------------FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLL 114
Query: 602 -----GLAYLHEDCDQRIIHCDIKPENVLL----DDNYHAKVSDFGLAKLMTREQSHV-- 650
G+ YLH + ++H D+KP N+L+ + K++D G A+L +
Sbjct: 115 YQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171
Query: 651 FTTLRGTRGYLAPEWITNYAISEKS-DVYSYGMVLLEIIGGRKNFDPNETSDKAHFP 706
+ T Y APE + K+ D+++ G + E++ F + K P
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 228
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|214742 smart00605, CW, CW domain | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 6e-04
Identities = 12/56 (21%), Positives = 28/56 (50%), Gaps = 3/56 (5%)
Query: 359 DLNGCKKACLGNCSCLAMFFQNSSGNCFLF--DRIGSLQSSNQGSGFVSYIKILSN 412
+ C + C + +C+ + + NSS C+LF + +++ + SG K+ ++
Sbjct: 23 SWDECIQKCYEDSNCV-LAYGNSSETCYLFSYGTVLTVKKLSSSSGKKVAFKVSTD 77
|
Length = 94 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.001
Identities = 60/302 (19%), Positives = 107/302 (35%), Gaps = 57/302 (18%)
Query: 500 LGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFR---AEVSIIGSIHHLHLVKLRGFC 556
+ + P T +AVKK+ K++ + E+ + H +++
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 557 AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFN-------IAL---GTAKGLAYL 606
+ + MA GS E LL T F IA L Y+
Sbjct: 69 IVDSELYVVSPLMAYGSC---------EDLLK--THFPEGLPELAIAFILKDVLNALDYI 117
Query: 607 HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT----REQSHVFTTLRGTR--GY 660
H + IH +K ++LL + +S + M R++ + +
Sbjct: 118 HS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174
Query: 661 LAPEW----ITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETS---------------D 701
L+PE + Y +EKSD+YS G+ E+ G F + D
Sbjct: 175 LSPEVLQQNLQGY--NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLD 232
Query: 702 KAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAV--KVALWCVQEDMSLRPSMTKV 759
K+ +P Y M + ++R ++D R F+ + C+Q D RPS +++
Sbjct: 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQL 292
Query: 760 VQ 761
+
Sbjct: 293 LN 294
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 817 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.66 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.63 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.54 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.5 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.35 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.3 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.22 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.17 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.17 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.17 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.07 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.07 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.0 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.98 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 98.94 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.93 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.84 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.83 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.77 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.73 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.68 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.59 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 98.55 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.43 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.42 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.4 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.3 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.24 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.14 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.09 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.01 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.92 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.87 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.86 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 97.86 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 97.85 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.85 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.83 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.81 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 97.73 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.71 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.66 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.48 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.48 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.46 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.43 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.32 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.18 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.09 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.08 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.02 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.98 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.83 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.82 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.47 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.44 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.42 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.04 | |
| PLN02236 | 344 | choline kinase | 95.95 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.79 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.45 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.38 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.28 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.22 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.09 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-55 Score=471.28 Aligned_cols=287 Identities=50% Similarity=0.824 Sum_probs=256.8
Q ss_pred CCcccCHHHHHHHhhccc--cccCCCcceeEEEEEcCCCcEEEEEEeccCCcC-HHHHHHHHHHhhccCcceeeeeeeEe
Q 036583 480 MPVRFTYRDLQTATNNFS--VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQG-KKEFRAEVSIIGSIHHLHLVKLRGFC 556 (817)
Q Consensus 480 ~~~~~~~~~l~~~~~~~~--~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~-~~~~~~Ev~~l~~l~h~niv~l~~~~ 556 (817)
....|+|.+|..||++|+ +.||+|+||.||+|.+++|+.||||++...... .++|.+|++++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 456799999999999998 799999999999999999999999999776544 77899999999999999999999999
Q ss_pred ecCC-eeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEe
Q 036583 557 AEGT-HRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVS 635 (817)
Q Consensus 557 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~ 635 (817)
.+.+ +++||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+.+.+.|+||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9998 599999999999999999876654 78999999999999999999999988899999999999999999999999
Q ss_pred ecCCccccCCCCceeeeec-cCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhh
Q 036583 636 DFGLAKLMTREQSHVFTTL-RGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMME 714 (817)
Q Consensus 636 Dfgla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 714 (817)
|||+|+....... ..... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+.........+..|++..+.
T Consensus 220 DFGLa~~~~~~~~-~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 220 DFGLAKLGPEGDT-SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred CccCcccCCcccc-ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999976554111 11222 899999999999999999999999999999999999999987665555568999999999
Q ss_pred hcchhhhcccccC-CcccH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 715 EGKLRNILDSRLN-IDEQS-DRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 715 ~~~~~~~~d~~~~-~~~~~-~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
++.+.+++|+++. ..... +++.++..++.+|++.+|++||+|.||+++|+.+..
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 9999999999987 44443 688889999999999999999999999999976543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=401.36 Aligned_cols=260 Identities=27% Similarity=0.443 Sum_probs=225.5
Q ss_pred HHHHHhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 488 DLQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 488 ~l~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
++......+.++||+|.||+||.|.++....||+|.++......++|.+|+++|++|+|+|||+++|+|..++.++||||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 34445556778999999999999999888899999998877778899999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
||+.|+|.++|+... +..+...+.+.++.|||+||+||++ +++|||||.++||||+++..+||+|||||+....+.
T Consensus 282 ~m~~GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred ecccCcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 999999999998733 3378889999999999999999999 999999999999999999999999999999666555
Q ss_pred ceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
........-+..|.|||.+....++.|||||||||+||||+| |+.|+...... ++.+.++...
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~----------------ev~~~le~Gy 421 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE----------------EVLELLERGY 421 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH----------------HHHHHHhccC
Confidence 554445566779999999999999999999999999999999 88888644322 2334445555
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
+.+.+..++..+.+++..||+.+|++|||++.+...|+.+.
T Consensus 422 Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 422 RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 55666667888999999999999999999999999998763
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=410.69 Aligned_cols=308 Identities=26% Similarity=0.451 Sum_probs=256.2
Q ss_pred cccCHHHHHHHhhccc-----------cccCCCcceeEEEEEcCC----CcEEEEEEeccC--CcCHHHHHHHHHHhhcc
Q 036583 482 VRFTYRDLQTATNNFS-----------VKLGQGGFGSVYQGVLPD----GTRLAVKKLEGI--GQGKKEFRAEVSIIGSI 544 (817)
Q Consensus 482 ~~~~~~~l~~~~~~~~-----------~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~--~~~~~~~~~Ev~~l~~l 544 (817)
.+++|+|--.|-.+|. +.||.|.||+|++|+++- ...||||.|+.. .+.+.+|+.|..||.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 3677877655555553 568999999999999753 346999999865 34578999999999999
Q ss_pred CcceeeeeeeEeecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 036583 545 HHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENV 624 (817)
Q Consensus 545 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NI 624 (817)
+||||++|.|+.......++|+|||++|+|+.||+.+.. .+++.+...++++||.||.||.+ .++|||||.++||
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNI 762 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNI 762 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhhe
Confidence 999999999999999999999999999999999987664 58999999999999999999998 9999999999999
Q ss_pred EecCCCcEEEeecCCccccCCCCceeeeeccC--CCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCC
Q 036583 625 LLDDNYHAKVSDFGLAKLMTREQSHVFTTLRG--TRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSD 701 (817)
Q Consensus 625 ll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~ 701 (817)
|++.+..+|++||||++.+..+.....++..| +.+|.|||.+..+.++.++||||||||+||.++ |.+||-+..
T Consensus 763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS--- 839 (996)
T KOG0196|consen 763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--- 839 (996)
T ss_pred eeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc---
Confidence 99999999999999999887666444444444 569999999999999999999999999999998 999985443
Q ss_pred CCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCCCC-CCCCCCCcc
Q 036583 702 KAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQ-PPTCSPLGA 780 (817)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~-~~~~~~~~~ 780 (817)
+.++.+-++..++.+++++++..+.+|++.|||+|-.+||.+.||+.+|++++.-|. .....+...
T Consensus 840 -------------NQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~~ 906 (996)
T KOG0196|consen 840 -------------NQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPESP 906 (996)
T ss_pred -------------hHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCCC
Confidence 334555666777888899999999999999999999999999999999998744332 111111111
Q ss_pred cccccceecccCCCCCCCCCCCCccccccccccc
Q 036583 781 RLYSSFFRSISEEGTSSGPSDCNSDAYLSAVRLS 814 (817)
Q Consensus 781 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (817)
..-..+.+.+.+..+...+.++||++|||.
T Consensus 907 ----r~s~~lld~~~~~~~~f~sv~~WL~aIkm~ 936 (996)
T KOG0196|consen 907 ----RPSQPLLDRSGSDFTPFRSVGDWLEAIKMG 936 (996)
T ss_pred ----CCcccccCCCCCCCcccCCHHHHHHHhhhh
Confidence 122334566777888888999999999985
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=394.92 Aligned_cols=250 Identities=32% Similarity=0.505 Sum_probs=207.4
Q ss_pred ccccCCCcceeEEEEEcCCCcEEEEEEeccCCcC---HHHHHHHHHHhhccCcceeeeeeeEeecCC-eeeEEEeeccCC
Q 036583 497 SVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQG---KKEFRAEVSIIGSIHHLHLVKLRGFCAEGT-HRLLAYEFMANG 572 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~---~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~g 572 (817)
.+.||+|+||+||+|.++....||||++...... .++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 3459999999999999955555999999765332 568999999999999999999999999988 799999999999
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCc-eeecCCCCCCeEecCCC-cEEEeecCCccccCCCCcee
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR-IIHCDIKPENVLLDDNY-HAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~-ivH~Dlk~~NIll~~~~-~~ki~Dfgla~~~~~~~~~~ 650 (817)
+|.++|+.. ....+++..+++++.|||+||.|||+ .+ ||||||||+|||++.++ ++||+|||+++...... ..
T Consensus 126 sL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~ 200 (362)
T KOG0192|consen 126 SLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TS 200 (362)
T ss_pred cHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-cc
Confidence 999999885 23379999999999999999999999 66 99999999999999997 99999999998765432 22
Q ss_pred eeeccCCCCccCccccc--cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 651 FTTLRGTRGYLAPEWIT--NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~--~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
.+...||+.|||||++. ...|+.|+|||||||+||||+||+.||..... ...+......+. +.
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~---------Rp 265 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGL---------RP 265 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCC---------CC
Confidence 23478999999999999 66999999999999999999999999975443 111222222221 11
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
+.+......+..++.+||+.||..||++.|++.+|+.+
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 11222455788999999999999999999999999876
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=365.88 Aligned_cols=256 Identities=29% Similarity=0.398 Sum_probs=210.1
Q ss_pred ccCHHHHHHHhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecC
Q 036583 483 RFTYRDLQTATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG 559 (817)
Q Consensus 483 ~~~~~~l~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~ 559 (817)
.++..||+. .+.||+|..|+|||++++ +++.+|+|.+... ....+++.+|++++++.+||+||.++|.|...
T Consensus 75 ~i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 75 GISLSDLER-----LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred ccCHHHhhh-----hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 355555543 467999999999999976 5778999999433 33468899999999999999999999999988
Q ss_pred C-eeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecC
Q 036583 560 T-HRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFG 638 (817)
Q Consensus 560 ~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg 638 (817)
. ...++||||++|+|++++...+ .+++...-+|+.+|++||.|||++ ++||||||||+|||++..|++||+|||
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecccc
Confidence 8 5999999999999999997653 588999999999999999999963 999999999999999999999999999
Q ss_pred CccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcch
Q 036583 639 LAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKL 718 (817)
Q Consensus 639 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 718 (817)
.+..+... ...+..||..|||||.+++..|+.++||||||+.++|+++|+.||....... ....+. +
T Consensus 225 VS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-~~~~~L---------l 291 (364)
T KOG0581|consen 225 VSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-LDIFEL---------L 291 (364)
T ss_pred ccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-CCHHHH---------H
Confidence 99987654 3456899999999999999999999999999999999999999997652211 111111 1
Q ss_pred hhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 719 RNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 719 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..+.+......+......++..++..|+++||.+||+++|+++
T Consensus 292 ~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 292 CAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2222211111111135667899999999999999999999987
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=367.28 Aligned_cols=252 Identities=26% Similarity=0.377 Sum_probs=206.4
Q ss_pred HHHhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC--c------CHHHHHHHHHHhhccCcceeeeeeeEeecCC
Q 036583 490 QTATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG--Q------GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT 560 (817)
Q Consensus 490 ~~~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~--~------~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~ 560 (817)
.+..+-++++||+|+||.|-+|.- .+|+.||||++.+.. . ......+|+++|++|+|||||+++++|.+.+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 455667789999999999999984 579999999996531 1 1234579999999999999999999999999
Q ss_pred eeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCC---CcEEEeec
Q 036583 561 HRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDN---YHAKVSDF 637 (817)
Q Consensus 561 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~ki~Df 637 (817)
..|||||||+||+|.+++-.+. .+.+....-++.|++.|+.|||+ .+|+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999997765 57778888999999999999999 999999999999999755 88999999
Q ss_pred CCccccCCCCceeeeeccCCCCccCccccccCc--cC-ccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhh
Q 036583 638 GLAKLMTREQSHVFTTLRGTRGYLAPEWITNYA--IS-EKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMME 714 (817)
Q Consensus 638 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~-~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 714 (817)
|+|+..+. ...+.+.+||+.|.|||++.+.. +. .++|+||+|||||-+++|.+||....... -+.+.+.
T Consensus 324 GlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~------sl~eQI~ 395 (475)
T KOG0615|consen 324 GLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP------SLKEQIL 395 (475)
T ss_pred chhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc------cHHHHHh
Confidence 99998763 34457799999999999998653 33 48899999999999999999997544322 1223333
Q ss_pred hcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 715 EGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 715 ~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.|+..-. .+...+..++..+++.+||..||++|||+.|+++
T Consensus 396 ~G~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 KGRYAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cCccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 3332111 1122345677899999999999999999999987
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=397.46 Aligned_cols=263 Identities=25% Similarity=0.439 Sum_probs=221.0
Q ss_pred HHHHHHhhccccccCCCcceeEEEEEcC------CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeec
Q 036583 487 RDLQTATNNFSVKLGQGGFGSVYQGVLP------DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558 (817)
Q Consensus 487 ~~l~~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~ 558 (817)
.++......+.++||+|+||+||+|+.. +.+.||||.++... +..++|++|++++..++|||||+|+|.|.+
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 3445555566789999999999999843 34579999998764 357899999999999999999999999999
Q ss_pred CCeeeEEEeeccCCChhhhhhhccc-----------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec
Q 036583 559 GTHRLLAYEFMANGSLDKWIFKKNQ-----------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD 627 (817)
Q Consensus 559 ~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~ 627 (817)
++..+||+|||..|||.+||..... ..+|+..+.+.||.|||.||+||-+ +.+|||||..+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceec
Confidence 9999999999999999999985321 1238889999999999999999998 9999999999999999
Q ss_pred CCCcEEEeecCCccccCCCCceeee-eccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcc
Q 036583 628 DNYHAKVSDFGLAKLMTREQSHVFT-TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHF 705 (817)
Q Consensus 628 ~~~~~ki~Dfgla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~ 705 (817)
++..|||+||||++..-..+..... ...-+.+|||||.+..+.|+.+||||||||+|||+++ |+.|+..-..
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn------ 711 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN------ 711 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch------
Confidence 9999999999999987665554433 2345679999999999999999999999999999999 8889865433
Q ss_pred hHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 706 PSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 706 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
+.+...+.++.+. +.+..++.++.+|+..||+.+|++||+++||-..|+....
T Consensus 712 -~EVIe~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 712 -QEVIECIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred -HHHHHHHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 3355666666542 3334566789999999999999999999999999987643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=359.51 Aligned_cols=197 Identities=29% Similarity=0.502 Sum_probs=176.7
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
+.+.++||.|.|++||+|++. ++.+||||.+.... +..+.+..|+.+|+.++|||||++++++..++..+||||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 445677999999999999975 57899999997652 23456789999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCC------CcEEEeecCCcccc
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDN------YHAKVSDFGLAKLM 643 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~------~~~ki~Dfgla~~~ 643 (817)
.+|+|.+||++.+ .+++...+.++.|||.||++||+ ++||||||||+||||+.. -.+||+|||+|+.+
T Consensus 92 ~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 92 NGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred CCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999998876 59999999999999999999999 999999999999999764 56899999999988
Q ss_pred CCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCC
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNE 698 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~ 698 (817)
.... ...+.+|++-|||||+++...|+.|+|+||+|+||||+++|+.||+...
T Consensus 166 ~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 166 QPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred Cchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 7543 3356899999999999999999999999999999999999999997443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=374.70 Aligned_cols=245 Identities=25% Similarity=0.390 Sum_probs=208.8
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
+|...+.||+|+|..+|.++. ..|+.||+|++.+. ...++...+||+|.+.|+|||||+++++|++.++.|||.|
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE 98 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE 98 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence 455567799999999999996 78999999999763 3456789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
+|++++|.+++.+.. .+++.+++.++.||+.||.|||+ ++|+|||||-.|+||+++.++||+|||||..+..+.
T Consensus 99 LC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 99 LCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred ecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999999987433 79999999999999999999999 999999999999999999999999999999887553
Q ss_pred ceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
. ...+.+|||.|+|||++....++..+||||+|||+|-|+.|++||+...-. ..+..++.. ...
T Consensus 173 E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk-------ety~~Ik~~--------~Y~ 236 (592)
T KOG0575|consen 173 E-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK-------ETYNKIKLN--------EYS 236 (592)
T ss_pred c-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH-------HHHHHHHhc--------Ccc
Confidence 3 335789999999999999999999999999999999999999999754311 112222211 111
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.+. .....+.+|+..+|+.||.+|||+++|+.
T Consensus 237 ~P~--~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 237 MPS--HLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ccc--ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111 33446789999999999999999999996
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=339.92 Aligned_cols=258 Identities=26% Similarity=0.401 Sum_probs=211.6
Q ss_pred HhhccccccCCCcceeEEEEE-cCCCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeee-EeecCCe-eeEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRG-FCAEGTH-RLLA 565 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~-~~~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~-~~~~~~~-~~lv 565 (817)
+.+.+.++||.|.||+|||+. +.+|..+|.|.+.-. .+.++++.+|+.+|++|+|||||++++ .+.++.+ .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 445567889999999999998 678999999998632 234578999999999999999999999 5666555 8999
Q ss_pred EeeccCCChhhhhhh-cccccchhhhHHHHHHHHHHHHHHHHHhcCCC-ceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 566 YEFMANGSLDKWIFK-KNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ-RIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~-~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
|||+..|+|...++. +..+..++++..++++.|+++||.++|...++ -|+||||||.||+|+++|.+||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999875 23345799999999999999999999974323 4899999999999999999999999999998
Q ss_pred CCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
...... ....+|||.||+||.+.+.+|+.|+||||+||++|||..-+.||.... + ....+.+.+++...+.+
T Consensus 179 ~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~-~~L~~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 179 SSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------L-LSLCKKIEQGDYPPLPD 250 (375)
T ss_pred cchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------H-HHHHHHHHcCCCCCCcH
Confidence 765443 345799999999999999999999999999999999999999997652 1 12344555554333322
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
.-....+..++..|+..||+.||+...+++.+..
T Consensus 251 --------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 251 --------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 3455678889999999999999996666665543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=386.64 Aligned_cols=263 Identities=27% Similarity=0.449 Sum_probs=214.7
Q ss_pred HHHHhhccccccCCCcceeEEEEEcCC--Cc----EEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecCC
Q 036583 489 LQTATNNFSVKLGQGGFGSVYQGVLPD--GT----RLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT 560 (817)
Q Consensus 489 l~~~~~~~~~~lG~G~fG~Vy~g~~~~--g~----~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~ 560 (817)
+......+.+.||+|+||.||.|...+ |. .||||.+... .+...+|++|..+|++++|||||+++|.|.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 444555566789999999999999643 33 4899999765 345679999999999999999999999999999
Q ss_pred eeeEEEeeccCCChhhhhhhccc----ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEee
Q 036583 561 HRLLAYEFMANGSLDKWIFKKNQ----EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSD 636 (817)
Q Consensus 561 ~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D 636 (817)
..++++|||++|+|..||++.+. ...|...+.+.++.|||+|+.|||+ +++|||||.++|+||++...+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcc
Confidence 99999999999999999987621 3368999999999999999999999 9999999999999999999999999
Q ss_pred cCCccccCCCCceeeeec-cCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHH-Hh
Q 036583 637 FGLAKLMTREQSHVFTTL-RGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFK-MM 713 (817)
Q Consensus 637 fgla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~-~~ 713 (817)
||||+.+........... .-+.+|||||.+..+.++.|+|||||||+|||++| |..||......+ +.. ..
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-------v~~~~~ 918 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-------VLLDVL 918 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-------HHHHHH
Confidence 999996654443332222 33468999999999999999999999999999999 888996544322 122 22
Q ss_pred hhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCCCC
Q 036583 714 EEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQ 771 (817)
Q Consensus 714 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 771 (817)
+.+ +.+.+..++..+.+++..||+.+|++||++..+++.++.+.+...
T Consensus 919 ~gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 919 EGG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred hCC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 222 222333455678899999999999999999999999988754433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=336.23 Aligned_cols=243 Identities=26% Similarity=0.364 Sum_probs=200.1
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
.+.+.||+|+||+|++++.. .++.+|+|.+++.. ...+...+|..+|.+++||+||+++-.|++.+++|||+||+
T Consensus 28 ~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~ 107 (357)
T KOG0598|consen 28 EILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYL 107 (357)
T ss_pred eeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEecc
Confidence 34588999999999999854 58899999997642 24567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
.||.|..+|.+.+ .+++..+.-++..|+.||.|||+ .+||||||||+|||||++|.++|+||||++.......
T Consensus 108 ~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~- 180 (357)
T KOG0598|consen 108 NGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD- 180 (357)
T ss_pred CCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC-
Confidence 9999999998766 58889899999999999999999 9999999999999999999999999999996543322
Q ss_pred eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
...+.+||+.|||||++.+..|+..+|.||+|+++|||++|.+||...... ...+.+..+++ ..
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-------~~~~~I~~~k~--------~~- 244 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-------KMYDKILKGKL--------PL- 244 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-------HHHHHHhcCcC--------CC-
Confidence 234589999999999999999999999999999999999999999654321 12223333321 11
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCC----CHHHHH
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRP----SMTKVV 760 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RP----t~~evl 760 (817)
.+.-...+..+++...++.||++|- ++.+|-
T Consensus 245 ~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 245 PPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred CCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhh
Confidence 1111223577889999999999994 455544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=322.86 Aligned_cols=258 Identities=22% Similarity=0.298 Sum_probs=202.7
Q ss_pred ccccCCCcceeEEEEEcCC-CcEEEEEEeccCCcC---HHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 497 SVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQG---KKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~---~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
.-++|+|+||+|||.+.++ |+.||||++..++++ .+-.++|+++|++++|+|+|.|+.+|......+||+||++.-
T Consensus 7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhT 86 (396)
T KOG0593|consen 7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHT 86 (396)
T ss_pred hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchH
Confidence 3469999999999999765 899999999766443 345689999999999999999999999999999999999985
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeee
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT 652 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 652 (817)
-|.+ |.+... .++.....+++.|+++|+.|+|+ +++|||||||+||||+.++.+||||||.|+.+.. ....++
T Consensus 87 vL~e-Le~~p~--G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~YT 159 (396)
T KOG0593|consen 87 VLHE-LERYPN--GVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNYT 159 (396)
T ss_pred HHHH-HHhccC--CCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchhh
Confidence 5544 444333 48889999999999999999999 8999999999999999999999999999998864 334456
Q ss_pred eccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchH--------HHHHHh-hhcchhhhc
Q 036583 653 TLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPS--------YAFKMM-EEGKLRNIL 722 (817)
Q Consensus 653 ~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~--------~~~~~~-~~~~~~~~~ 722 (817)
..+.|..|+|||.+.+ .+|.+.+||||+||++.||++|.+.|-+..+.+..+... ...... .++....+.
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~ 239 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR 239 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence 6788999999999987 789999999999999999999999997665544322111 111111 111122221
Q ss_pred ccccCCcccH-----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 723 DSRLNIDEQS-----DRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 723 d~~~~~~~~~-----~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
-|......+. ....-+++++..|++.||.+|++-+|+++
T Consensus 240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1221111111 22346789999999999999999999885
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=345.91 Aligned_cols=268 Identities=21% Similarity=0.347 Sum_probs=215.4
Q ss_pred HHHHHHHhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeee
Q 036583 486 YRDLQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 486 ~~~l~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 563 (817)
.+|.......|.++||+|-||.|.+.....+..||||+++... ..+.+|.+|+++|.+++||||++|+|+|..++..+
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 3444555556678999999999999999888999999998764 34689999999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+|+|||++|+|..||.++... .+.-...++|+.||+.||+||.+ .+++||||.++|+|+|.++++||+|||+++.+
T Consensus 612 mI~EYmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCccccccc
Confidence 999999999999999887533 24566778899999999999999 99999999999999999999999999999977
Q ss_pred CCCCceeee-eccCCCCccCccccccCccCccccccchhhhHHHhhh--CCCCCCCCCCCCCCcchHHHHHHhhhcchhh
Q 036583 644 TREQSHVFT-TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG--GRKNFDPNETSDKAHFPSYAFKMMEEGKLRN 720 (817)
Q Consensus 644 ~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (817)
-........ ..+-+.+|||||.+.-+.++.++|||+||+.+||+++ ..+||.....+. ..+........+....
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQV 764 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCcce
Confidence 655544433 3556789999999999999999999999999999865 778886433221 1111111111111111
Q ss_pred hcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 721 ILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 721 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
. ...+.-++..+.+++.+||..|-++||+++++...|...
T Consensus 765 ~------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 V------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred e------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1 112223456788999999999999999999999988753
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=342.34 Aligned_cols=257 Identities=24% Similarity=0.323 Sum_probs=205.4
Q ss_pred cccccCCCcceeEEEEE-cCCCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecC--CeeeEEEeec
Q 036583 496 FSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG--THRLLAYEFM 569 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~-~~~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~ 569 (817)
-.++||+|.||.|||++ ..+|+.||+|++.-.. .......+||.||++|.||||++|.+...+. ...|||+|||
T Consensus 121 ki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYM 200 (560)
T KOG0600|consen 121 KIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYM 200 (560)
T ss_pred HHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecc
Confidence 34679999999999999 5679999999996543 2245678999999999999999999998776 6899999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++ +|.-++....- .++..++..++.||+.||+|+|. ++|+|||||.+|||||++|.+||+|||||+++......
T Consensus 201 dh-DL~GLl~~p~v--kft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~ 274 (560)
T KOG0600|consen 201 DH-DLSGLLSSPGV--KFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA 274 (560)
T ss_pred cc-hhhhhhcCCCc--ccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence 98 88888876544 48889999999999999999999 99999999999999999999999999999998887777
Q ss_pred eeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhh--------cchh-
Q 036583 650 VFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEE--------GKLR- 719 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~- 719 (817)
.++..+-|..|.|||.+.+. .|+.++|+||.||||.||+.|++.|+.....+..+.. ++.... .++.
T Consensus 275 ~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kI---fklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 275 PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKI---FKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHH---HHHhCCCChhccccccCCc
Confidence 77888899999999999864 7999999999999999999999999877654332111 111110 0010
Q ss_pred -hhcccccCCcc-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 720 -NILDSRLNIDE-----QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 720 -~~~d~~~~~~~-----~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..+.+...... -.......++|+..+|..||.+|.|+.++++
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 01111000000 0112345678999999999999999999987
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=350.86 Aligned_cols=263 Identities=27% Similarity=0.438 Sum_probs=208.2
Q ss_pred HHHHHHHhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCCee
Q 036583 486 YRDLQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHR 562 (817)
Q Consensus 486 ~~~l~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~ 562 (817)
+.||......+..+||+|.||+||+|++.+ .||||+++-.. +..+.|++||..+++-+|.||+-+.|+|.....
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 344444444456889999999999999844 59999997542 345789999999999999999999999999887
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
.+|+.+|++-+|+.+|+-... .++..+.+.|+.||++||.|||. ++|||||||..||+|.+++.|||+||||+..
T Consensus 463 AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceee
Confidence 999999999999999987654 58889999999999999999999 9999999999999999999999999999976
Q ss_pred cCCC-CceeeeeccCCCCccCccccc---cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcch
Q 036583 643 MTRE-QSHVFTTLRGTRGYLAPEWIT---NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKL 718 (817)
Q Consensus 643 ~~~~-~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 718 (817)
...- .........|..-|||||+++ ..+|++.+||||||+|+|||++|..||..... +... -++..|.+
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-dqIi------fmVGrG~l 610 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-DQII------FMVGRGYL 610 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-hheE------EEeccccc
Confidence 5432 111223355677899999996 45899999999999999999999999983322 2111 01122211
Q ss_pred hhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 719 RNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 719 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
. .|. .........++.+|+..||..++++||.+.+|+..|+.+.+
T Consensus 611 ~--pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 611 M--PDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred C--ccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1 110 01122345578899999999999999999999999988744
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=357.06 Aligned_cols=262 Identities=27% Similarity=0.410 Sum_probs=210.1
Q ss_pred HHHHhhccccccCCCcceeEEEEEcCC--C--cE-EEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecC
Q 036583 489 LQTATNNFSVKLGQGGFGSVYQGVLPD--G--TR-LAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG 559 (817)
Q Consensus 489 l~~~~~~~~~~lG~G~fG~Vy~g~~~~--g--~~-vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~ 559 (817)
|......+.++||+|+||.||+|++.. + .. ||||..+.. ....++|++|.+++++++|||||+++|++...
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE 233 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 333444455889999999999999643 2 23 899998742 34567999999999999999999999999999
Q ss_pred CeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCC
Q 036583 560 THRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGL 639 (817)
Q Consensus 560 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl 639 (817)
...++|||+|.||+|.+||.+... .++..++++++.+.|+||+|||+ .+++||||.++|+|++.++.+||+||||
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCcccc
Confidence 999999999999999999988664 58999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeee-eccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcc
Q 036583 640 AKLMTREQSHVFT-TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGK 717 (817)
Q Consensus 640 a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 717 (817)
++.... ..... ...-+.+|+|||.+....|+.++|||||||++||+++ |..||.+.... .+...+.
T Consensus 309 s~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-------~v~~kI~--- 376 (474)
T KOG0194|consen 309 SRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-------EVKAKIV--- 376 (474)
T ss_pred ccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-------HHHHHHH---
Confidence 886431 11111 1235679999999999999999999999999999999 78898654321 1111221
Q ss_pred hhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCCCCC
Q 036583 718 LRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQP 772 (817)
Q Consensus 718 ~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 772 (817)
....+.+.+...+..+..++..||..+|++||+|.++.+.|+.+.....+
T Consensus 377 -----~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 377 -----KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred -----hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 11122222224455677888899999999999999999999987555444
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=341.94 Aligned_cols=260 Identities=26% Similarity=0.348 Sum_probs=206.6
Q ss_pred HhhccccccCCCcceeEEEEE-cCCCcEEEEEEeccCCcCHHHH--HHHHHHhhccC-cceeeeeeeEeecCC-eeeEEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEF--RAEVSIIGSIH-HLHLVKLRGFCAEGT-HRLLAY 566 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~-~~~g~~vavK~l~~~~~~~~~~--~~Ev~~l~~l~-h~niv~l~~~~~~~~-~~~lv~ 566 (817)
.+|...++||.|.||.||+|+ ...|..||||++++.-..-++. ++|++.|++|. ||||++|.+.+.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 456677899999999999999 4568899999998654444443 68999999998 999999999999888 999999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
|||+. +|.+++...+ ..++...++.|+.||++||+|+|+ +|+.|||+||+|||+.....+||+|||||+.....
T Consensus 90 E~Md~-NLYqLmK~R~--r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 90 EFMDC-NLYQLMKDRN--RLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred Hhhhh-hHHHHHhhcC--CcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccccC
Confidence 99987 8999987663 489999999999999999999999 99999999999999999999999999999987654
Q ss_pred CceeeeeccCCCCccCccccc-cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhc---------
Q 036583 647 QSHVFTTLRGTRGYLAPEWIT-NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEG--------- 716 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--------- 716 (817)
. .++..+.|..|+|||++. ...|+.+.||||+|||++|+.+-++.|-+..+.+.... +...+...
T Consensus 164 p--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~K---Ic~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 164 P--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYK---ICEVLGTPDKDSWPEGY 238 (538)
T ss_pred C--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHH---HHHHhCCCccccchhHH
Confidence 3 346678999999999885 67889999999999999999999999966544332110 01111110
Q ss_pred chhhhcccccCC-------cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 717 KLRNILDSRLNI-------DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 717 ~~~~~~d~~~~~-------~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.+...+.-++.. ..-.....++++++.+|+.+||.+|||++|++++
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111111111110 0001245678899999999999999999999983
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=349.03 Aligned_cols=263 Identities=27% Similarity=0.403 Sum_probs=224.8
Q ss_pred cCHHHHHHHhhccccccCCCcceeEEEEEcCC-CcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCee
Q 036583 484 FTYRDLQTATNNFSVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHR 562 (817)
Q Consensus 484 ~~~~~l~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~ 562 (817)
.+-.|+++......++||-|-||.||.|.++. .-.||||.|+......++|++|..+|+.++|||+|+|+|+|......
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 34556666666777999999999999999865 56799999998888889999999999999999999999999999999
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
|||+|||.+|+|.+||++.+.. .++-...+.++.||+.||+||.. +++|||||.++|+|+.++..+||+||||+++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999887643 56777889999999999999999 9999999999999999999999999999999
Q ss_pred cCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhh
Q 036583 643 MTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721 (817)
Q Consensus 643 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (817)
+..+.........-+..|.|||.+....++.|+|||+|||+||||.| |..||-..+ ...++. +
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-------lSqVY~---------L 478 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYG---------L 478 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-------HHHHHH---------H
Confidence 98765544333455678999999999999999999999999999999 777874332 122333 3
Q ss_pred cccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 722 ~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
++...+.+.+..++..+.+|+..||+++|.+||+++|+.+.+|..
T Consensus 479 LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 479 LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 444444455556777899999999999999999999999988865
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=352.55 Aligned_cols=258 Identities=26% Similarity=0.430 Sum_probs=202.1
Q ss_pred HhhccccccCCCcceeEEEEEc------CCCcEEEEEEeccCC--cCHHHHHHHHHHhhcc-CcceeeeeeeEeecCC-e
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL------PDGTRLAVKKLEGIG--QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGT-H 561 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~------~~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~-~ 561 (817)
..+.+.++||+|+||.||+|.. ..++.||||++.... ...+.+.+|+.++.++ +||||++++++|.... .
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 4566778899999999999973 235679999997542 2346789999999999 8999999999987644 5
Q ss_pred eeEEEeeccCCChhhhhhhccc----------------------------------------------------------
Q 036583 562 RLLAYEFMANGSLDKWIFKKNQ---------------------------------------------------------- 583 (817)
Q Consensus 562 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 583 (817)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 7899999999999999875321
Q ss_pred -ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee-eeeccCCCCcc
Q 036583 584 -EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV-FTTLRGTRGYL 661 (817)
Q Consensus 584 -~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~ 661 (817)
...+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++......... .....++..|+
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 1247788899999999999999999 899999999999999999999999999998654332211 12245667899
Q ss_pred CccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHH
Q 036583 662 APEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVK 740 (817)
Q Consensus 662 aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 740 (817)
|||.+.+..++.++|||||||++|||++ |..||...... ......+..+.... ........+.+
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~------~~~~~~~~~~~~~~---------~~~~~~~~l~~ 308 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN------EEFCQRLKDGTRMR---------APENATPEIYR 308 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc------HHHHHHHhcCCCCC---------CCCCCCHHHHH
Confidence 9999999899999999999999999997 99999643221 11122222221110 11122346889
Q ss_pred HHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 741 VALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 741 l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
++.+||+.||++|||+.|++++|+.+.
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=344.17 Aligned_cols=239 Identities=26% Similarity=0.425 Sum_probs=201.9
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCChhhh
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKW 577 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 577 (817)
+=||.|+-|-||+|++ .++.||||+++.. -..+|+-|++|+|+||+.+.|+|....-.|||||||+.|.|.+.
T Consensus 130 eWlGSGaQGAVF~Grl-~netVAVKKV~el------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRL-HNETVAVKKVREL------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhhccCcccceeeeec-cCceehhHHHhhh------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 3499999999999999 6678999998642 14578889999999999999999999999999999999999999
Q ss_pred hhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeeeccCC
Q 036583 578 IFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGT 657 (817)
Q Consensus 578 l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt 657 (817)
|+..+ .+.......+..+||.||.|||. +.|||||||.-||||..+..+||+|||-++..... .....+.||
T Consensus 203 Lka~~---~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGT 274 (904)
T KOG4721|consen 203 LKAGR---PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGT 274 (904)
T ss_pred HhccC---ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhh
Confidence 98766 57888899999999999999999 99999999999999999999999999999876543 223458999
Q ss_pred CCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHH
Q 036583 658 RGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFT 737 (817)
Q Consensus 658 ~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 737 (817)
..|||||++++.+.++|+||||||||||||+||..||...+.... +-.+-...+..+.+..++.-
T Consensus 275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---------------IwGVGsNsL~LpvPstcP~G 339 (904)
T KOG4721|consen 275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---------------IWGVGSNSLHLPVPSTCPDG 339 (904)
T ss_pred HhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---------------EEeccCCcccccCcccCchH
Confidence 999999999999999999999999999999999999964332110 00011112333444456667
Q ss_pred HHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 738 AVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 738 ~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
+.-|+++||+..|..||++++++..|+=.
T Consensus 340 fklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 340 FKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred HHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 88899999999999999999999999743
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=328.68 Aligned_cols=259 Identities=24% Similarity=0.357 Sum_probs=206.2
Q ss_pred HhhccccccCCCcceeEEEEE-cCCCcEEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~-~~~g~~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
..|++.++||.|.-++||+|+ .+.++.||||++.-. ....+++.+|+..+..++||||++++..|..+..+++||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 345667889999999999999 567899999999543 34468899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
|.+|++.+++...-.. .+++..+..|+.++++||.|||. ++.||||||+.||||+.+|.+||+|||.+-.+.....
T Consensus 106 Ma~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 9999999999865433 48889999999999999999999 9999999999999999999999999998766543221
Q ss_pred ---eeeeeccCCCCccCcccccc--CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 649 ---HVFTTLRGTRGYLAPEWITN--YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 649 ---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
..+.+..||+.|||||++.. ..|+.|+||||||+...||.+|..||....+.. .....+ ++.......
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------vLl~tL-qn~pp~~~t 254 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------VLLLTL-QNDPPTLLT 254 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------HHHHHh-cCCCCCccc
Confidence 12245789999999999653 478999999999999999999999996433211 111111 111111111
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..+..+........+.+++..|++.||++|||++++++
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11222222334457889999999999999999999986
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=310.42 Aligned_cols=258 Identities=25% Similarity=0.348 Sum_probs=204.5
Q ss_pred hccccccCCCcceeEEEEE-cCCCcEEEEEEeccCC--cC-HHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGIG--QG-KKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~-~~~g~~vavK~l~~~~--~~-~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
|.-.++||+|.||.||+|+ ...|+.||||+++... ++ .....+|++.|+.++|+||+.|++.|.+.+...||+|||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 3344679999999999999 4579999999997543 22 456789999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
+. +|...++.... .+...+...++.++++|++|||+ +.|+||||||.|+|++++|.+||+|||+|+.+......
T Consensus 84 ~t-dLe~vIkd~~i--~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 84 PT-DLEVVIKDKNI--ILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred cc-cHHHHhccccc--ccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 87 89999976654 78999999999999999999999 99999999999999999999999999999998765432
Q ss_pred eeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcch------hhh-
Q 036583 650 VFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKL------RNI- 721 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~~- 721 (817)
....+.|..|+|||.+.+ +.|+..+||||.|||+.||+-|.+-|.+..+.+.. ....+.+..... ..+
T Consensus 158 -~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL---~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 158 -QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQL---SKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred -cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHH---HHHHHHcCCCCcccCccccccc
Confidence 233478899999999986 57899999999999999999998888665443321 111111111111 111
Q ss_pred --------cccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 722 --------LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 722 --------~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
..+.+.. .-......+.+++..|+..||.+|+|++|++++
T Consensus 234 dY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111111 111234566899999999999999999999985
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=332.68 Aligned_cols=263 Identities=27% Similarity=0.408 Sum_probs=202.2
Q ss_pred ccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhc--cCcceeeeeeeEeecCC----eeeEEEee
Q 036583 495 NFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGS--IHHLHLVKLRGFCAEGT----HRLLAYEF 568 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~--l~h~niv~l~~~~~~~~----~~~lv~e~ 568 (817)
.+.+.||+|+||.||||++ +++.||||++.. +..+.|.+|-+|... ++|+||+++++.-..+. +.+||+||
T Consensus 213 ~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~--~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE--QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hhHHHhhcCccceeehhhc-cCceeEEEecCH--HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 3456799999999999999 558999999973 456778888877655 48999999999987666 88999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcC------CCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC------DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~------~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
.+.|+|.+||..+ .++|....+|+..+++||+|||++. ++.|+|||||++||||.++++..|+|||||..
T Consensus 290 h~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 290 HPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred ccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 9999999999765 5999999999999999999999864 45799999999999999999999999999998
Q ss_pred cCCCCce-eeeeccCCCCccCccccccC-ccC-----ccccccchhhhHHHhhhCCCCCCCCC-CCCCCcch--------
Q 036583 643 MTREQSH-VFTTLRGTRGYLAPEWITNY-AIS-----EKSDVYSYGMVLLEIIGGRKNFDPNE-TSDKAHFP-------- 706 (817)
Q Consensus 643 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~-----~~~DvwS~Gvvl~elltg~~pf~~~~-~~~~~~~~-------- 706 (817)
+...... .....+||.+|||||++.+. .+. .+.||||+|.|||||+++-..+++.. +.....+.
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 8754332 22348999999999999864 222 47899999999999999876664311 11111111
Q ss_pred -HHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 707 -SYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 707 -~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
+.++..+...+.+..+...... ...+..+++.+..||+.||+.|-|+.=|-+++..+.
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 2222222222222222111111 134567889999999999999999999998887653
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=332.11 Aligned_cols=250 Identities=29% Similarity=0.418 Sum_probs=199.1
Q ss_pred cccccCCCcceeEEEEEcCC-CcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCC--eeeEEEeeccC
Q 036583 496 FSVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT--HRLLAYEFMAN 571 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~~~ 571 (817)
..+.||+|.||+||++...+ |+..|||.+.... ...+.+.+|+.+|.+++|||||+.+|...... ..++.|||+++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~ 100 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG 100 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence 44679999999999999654 8999999986542 12567899999999999999999999855444 68999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC-CCcEEEeecCCccccCC--CCc
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD-NYHAKVSDFGLAKLMTR--EQS 648 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~Dfgla~~~~~--~~~ 648 (817)
|+|.+++.+.+. .++...++++..||++||+|||+ ++|+||||||+|||++. ++.+||+|||+++.... ...
T Consensus 101 GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 101 GSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred CcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 999999987654 58999999999999999999998 99999999999999999 79999999999997763 222
Q ss_pred eeeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 649 HVFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
.......||+.|||||++..+ ....++|||||||++.||+||++||... .....+......+.....+
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~i------ 244 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPEI------ 244 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCCC------
Confidence 223347899999999999953 3345999999999999999999999642 1111222222222211111
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
+........+++..|++.||++||||+|+++.--
T Consensus 245 ---p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 245 ---PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ---CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 1123446789999999999999999999998553
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=341.01 Aligned_cols=242 Identities=26% Similarity=0.405 Sum_probs=206.1
Q ss_pred cccCCCcceeEEEEE-cCCCcEEEEEEeccCCcCHH-HHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCChh
Q 036583 498 VKLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKK-EFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLD 575 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~-~~~g~~vavK~l~~~~~~~~-~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 575 (817)
++||+|+.|.||.++ ...++.||||++....+..+ -+.+|+.+|+..+|+|||++++.+..++++++|||||++|+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 579999999999998 55788999999987766654 5689999999999999999999999999999999999999999
Q ss_pred hhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeeecc
Q 036583 576 KWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLR 655 (817)
Q Consensus 576 ~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~ 655 (817)
+.+... .+++.++..|++++++||+|||. ++|+|||||.+|||++.++.+||+|||++..+..... ...+.+
T Consensus 359 DvVt~~----~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~TmV 430 (550)
T KOG0578|consen 359 DVVTKT----RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTMV 430 (550)
T ss_pred hhhhcc----cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cccccc
Confidence 998654 48899999999999999999999 9999999999999999999999999999988766554 345689
Q ss_pred CCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHH
Q 036583 656 GTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRV 735 (817)
Q Consensus 656 gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 735 (817)
||+-|||||+.....|.+|+||||||++++||+.|.+||-...+.. -++....+|. ..........
T Consensus 431 GTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr------AlyLIa~ng~--------P~lk~~~klS 496 (550)
T KOG0578|consen 431 GTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIATNGT--------PKLKNPEKLS 496 (550)
T ss_pred CCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH------HHHHHhhcCC--------CCcCCccccC
Confidence 9999999999999999999999999999999999999996433221 1111112221 1122233445
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 736 FTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 736 ~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..+.+++.+||+.|+++||++.|+|+
T Consensus 497 ~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 497 PELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 67889999999999999999999998
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=386.90 Aligned_cols=269 Identities=25% Similarity=0.460 Sum_probs=215.4
Q ss_pred ccCHHHHHHHhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCe
Q 036583 483 RFTYRDLQTATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTH 561 (817)
Q Consensus 483 ~~~~~~l~~~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~ 561 (817)
.++++++..+ ....+.||+|+||.||+|+. .+++.||||++...... ..+|++++++++||||++++++|.+.+.
T Consensus 682 ~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 682 SITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKG 757 (968)
T ss_pred hhhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence 3556665543 23446799999999999996 57899999998754322 2356889999999999999999999999
Q ss_pred eeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcc
Q 036583 562 RLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK 641 (817)
Q Consensus 562 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 641 (817)
.++||||+++|+|.++++ .++|..+.+++.||++||+|||..+..+|+||||||+||+++.++.+++. |+.+.
T Consensus 758 ~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~ 830 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830 (968)
T ss_pred CEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence 999999999999999995 37899999999999999999997666899999999999999999988886 66654
Q ss_pred ccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhh
Q 036583 642 LMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721 (817)
Q Consensus 642 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (817)
..... ....+++.|+|||++.+..++.++|||||||++|||++|+.||+..... ......|+...........+
T Consensus 831 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 904 (968)
T PLN00113 831 LLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMW 904 (968)
T ss_pred ccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhhe
Confidence 33221 1236788999999999999999999999999999999999999643322 23344555444444455556
Q ss_pred cccccCC--cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 722 LDSRLNI--DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 722 ~d~~~~~--~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
+++.+.. ....++..++.+++.+||+.||++||||+||+++|+++..
T Consensus 905 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred eCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 6665532 3344667788999999999999999999999999998743
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=337.27 Aligned_cols=246 Identities=25% Similarity=0.340 Sum_probs=205.7
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccC----CcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEe
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI----GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 567 (817)
..|.+.||+|.|++|++++. ..++++|||++.+. ....+-...|-.+|.+| .||.|++|+-.|.+...+|+|+|
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe 154 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE 154 (604)
T ss_pred cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence 34668899999999999994 46899999999764 23345677888999999 89999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+++|+|.++|.+.+ .+++...+.++.+|+.||+|||+ ++||||||||+|||||.++++||+|||.|+.+.+..
T Consensus 155 ~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 155 YAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred ecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 999999999998876 68999999999999999999999 999999999999999999999999999999886532
Q ss_pred ce----------ee--eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhh
Q 036583 648 SH----------VF--TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEE 715 (817)
Q Consensus 648 ~~----------~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 715 (817)
.. .. ...+||..|.+||++.....++.+|+|+|||+||+|+.|++||....+- ..
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-------li------ 295 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-------LI------ 295 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-------HH------
Confidence 22 11 3478999999999999999999999999999999999999999644321 01
Q ss_pred cchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 716 GKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 716 ~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.+++++-... +.....+.+.+|+...|..||.+|+|.+||.++
T Consensus 296 --FqkI~~l~y~--fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 296 --FQKIQALDYE--FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred --HHHHHHhccc--CCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1223322222 222233567899999999999999999999874
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=342.28 Aligned_cols=248 Identities=26% Similarity=0.419 Sum_probs=204.8
Q ss_pred HHhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccC-----C-cCHHHHHHHHHHhhccC-cceeeeeeeEeecCCee
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI-----G-QGKKEFRAEVSIIGSIH-HLHLVKLRGFCAEGTHR 562 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~-----~-~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~ 562 (817)
...+.+.+.||+|.||+|++|.. ..++.||+|.+... . ...+.+.+|+.++++++ ||||++++.++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 34566778899999999999974 46899999976543 1 22456678999999998 99999999999999999
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCC-CcEEEeecCCcc
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDN-YHAKVSDFGLAK 641 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~Dfgla~ 641 (817)
++||||+.+|+|.+++.+.. .+.+..+.+++.|++.|++|||+ ++|+||||||+|||+|.+ +++||+|||++.
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999998743 58889999999999999999999 999999999999999999 999999999999
Q ss_pred ccCCCCceeeeeccCCCCccCccccccCc-cC-ccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchh
Q 036583 642 LMTREQSHVFTTLRGTRGYLAPEWITNYA-IS-EKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLR 719 (817)
Q Consensus 642 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (817)
... .......+.+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..... .....+..+
T Consensus 170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~-------~l~~ki~~~--- 238 (370)
T KOG0583|consen 170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP-------NLYRKIRKG--- 238 (370)
T ss_pred ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH-------HHHHHHhcC---
Confidence 874 2233456789999999999999877 86 7899999999999999999999763211 112222222
Q ss_pred hhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 720 NILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 720 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
....+.... ...+..++.+|++.||.+|+|+.|+++
T Consensus 239 -----~~~~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 239 -----EFKIPSYLL-SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred -----CccCCCCcC-CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 222222211 457889999999999999999999994
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.64 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=209.1
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+++.+.||+|+-|.|-+|++ ..|+.+|||++.+. ......+.+|+.||+.+.|||++++++.+.+..++|||.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 44567899999999999995 56999999999654 22346789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++|.|.++|.+++ .++..++.+++.||+.|+.|+|. .+|+||||||+|+|||.++++||+|||||.+-.++
T Consensus 94 v~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-- 165 (786)
T KOG0588|consen 94 VPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-- 165 (786)
T ss_pred cCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCC--
Confidence 99999999998876 69999999999999999999999 99999999999999999999999999999875443
Q ss_pred eeeeeccCCCCccCccccccCccC-ccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAIS-EKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
....+.+|.+.|.|||++++.+|. .++||||.|||||.|++|+.||++... .....++..|..
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-------r~LLlKV~~G~f--------- 229 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-------RVLLLKVQRGVF--------- 229 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH-------HHHHHHHHcCcc---------
Confidence 345678999999999999999986 689999999999999999999974321 122333333321
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcC
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM--LEGI 766 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~--L~~~ 766 (817)
+.+.....++.+|+.+|+..||++|.|++||+++ |.+.
T Consensus 230 -~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 230 -EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred -cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 1112334568899999999999999999999984 4444
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=333.70 Aligned_cols=256 Identities=24% Similarity=0.387 Sum_probs=204.6
Q ss_pred HHHhhccccccCCCcceeEEEEEcC----CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeee
Q 036583 490 QTATNNFSVKLGQGGFGSVYQGVLP----DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 490 ~~~~~~~~~~lG~G~fG~Vy~g~~~----~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 563 (817)
....+.+.+.||+|+||.||+|.+. .+..||+|.++... ...+.|.+|+.++.+++||||+++++++..++..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 3455677789999999999999753 35689999987543 23457899999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+||||+++|+|.+++..... .+++..++.++.||+.||+|||+ .+++||||||+||+++.++.+|++|||.+...
T Consensus 83 lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999999976432 58899999999999999999998 89999999999999999999999999987654
Q ss_pred CCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
............++..|+|||.+.+..++.++|||||||++||+++ |+.||...... .....+.++.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-------~~~~~~~~~~----- 225 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-------DVIKAVEDGF----- 225 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHHCCC-----
Confidence 3222111112345678999999999999999999999999999775 99999644221 1112222221
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
..+.....+..+.+++..||+.+|++||+++|+++.|+++
T Consensus 226 ----~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 ----RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1111222345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=334.66 Aligned_cols=244 Identities=20% Similarity=0.323 Sum_probs=198.4
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccCCcC----HHHHHHHHHHhhccCcceeeeeeeEeec----CCeeeEEEeec
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQG----KKEFRAEVSIIGSIHHLHLVKLRGFCAE----GTHRLLAYEFM 569 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~----~~~~~~Ev~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 569 (817)
..||+|++|.||+|.. +|+.||||+++..... .+.|.+|+.++.+++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 4589999999999998 7889999999765333 3677899999999999999999999976 34678999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++|+|.+++.... .+++...++++.|++.||.|||+. .+++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 9999999997643 588999999999999999999972 478899999999999999999999999998654322
Q ss_pred eeeeccCCCCccCcccccc--CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 650 VFTTLRGTRGYLAPEWITN--YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+..+. ..
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-------~~~~~i~~~~--------~~ 240 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-------EIYDLIINKN--------NS 240 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcC--------CC
Confidence 23467889999999976 68899999999999999999999999743211 1111111111 01
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
...+......+.+++.+||+.||++|||++|+++.|+..
T Consensus 241 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 241 LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 111112345688999999999999999999999999875
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=328.24 Aligned_cols=257 Identities=28% Similarity=0.418 Sum_probs=209.0
Q ss_pred HHHHhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 489 LQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 489 l~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+......+.++||+|+||.||+|...+++.||+|.++......+++.+|+.++++++|+||+++++++...+..+++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 33455677789999999999999987788999999976655678899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++++|.+++.... ...+++..+..++.|++.|+.|||+ .+|+|+||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999997643 2358899999999999999999998 8999999999999999999999999999987653322
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
........+..|+|||.+.+..++.++||||||++++||++ |+.||..... ......+... ..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~---------~~ 222 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-------AEVLQQVDQG---------YR 222 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcC---------CC
Confidence 11111223457999999998899999999999999999999 9999964321 1111112111 11
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
.+........+.+++.+|++.+|++||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11112234568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=328.27 Aligned_cols=253 Identities=25% Similarity=0.399 Sum_probs=206.5
Q ss_pred hhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
.+.+.++||+|+||.||+|...+++.||+|.+.......+.+.+|+.++++++|+||+++++.+.+.+..+++|||++++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (261)
T cd05072 7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKG 86 (261)
T ss_pred HeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCC
Confidence 44566889999999999999888889999998765555778999999999999999999999999999999999999999
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeee
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT 652 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 652 (817)
+|.+++..... ..+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++............
T Consensus 87 ~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05072 87 SLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE 162 (261)
T ss_pred cHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCceeccC
Confidence 99999975432 257888999999999999999998 89999999999999999999999999999876543322222
Q ss_pred eccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 653 TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 653 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
...++..|+|||.+....++.++|||||||++|||++ |+.||...... .....+.++. ..+..
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~~~~~---------~~~~~ 226 (261)
T cd05072 163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-------DVMSALQRGY---------RMPRM 226 (261)
T ss_pred CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-------HHHHHHHcCC---------CCCCC
Confidence 3345678999999998889999999999999999998 99999533211 1111111111 01111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
......+.+++.+|++.+|++||++++++++|+.
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1233467899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=334.07 Aligned_cols=242 Identities=28% Similarity=0.438 Sum_probs=204.3
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcC---HHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQG---KKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~---~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.+.+.||+|.||.||||+.+ +.+.||+|.+.+.... .+.+.+|++|+++++||||+.++++|+...+.++|.||+.
T Consensus 5 hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~ 84 (808)
T KOG0597|consen 5 HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAV 84 (808)
T ss_pred hHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhh
Confidence 34567999999999999965 4788999999776444 3567899999999999999999999999999999999998
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+ +|..+|.... .++++.+..|+.+++.||.|||+ .+|.|||+||+|||++..+.+|++|||+|+.+... ...
T Consensus 85 g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~v 156 (808)
T KOG0597|consen 85 G-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSV 156 (808)
T ss_pred h-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC-cee
Confidence 8 9999998765 58999999999999999999999 99999999999999999999999999999987653 345
Q ss_pred eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 651 FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
.+.+.|||-|||||...+.+|+..+|+||+|||+||+++|++||-... +...+ +.+..... ..
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s----------i~~Lv-----~~I~~d~v--~~ 219 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS----------ITQLV-----KSILKDPV--KP 219 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH----------HHHHH-----HHHhcCCC--CC
Confidence 567899999999999999999999999999999999999999995321 11111 11111111 11
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+......+..++...++.||.+|.|..+++.
T Consensus 220 p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 220 PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 2244567889999999999999999999886
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=346.50 Aligned_cols=257 Identities=28% Similarity=0.456 Sum_probs=202.5
Q ss_pred HhhccccccCCCcceeEEEEEc------CCCcEEEEEEeccCC--cCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL------PDGTRLAVKKLEGIG--QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHR 562 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~------~~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~ 562 (817)
..+.+.++||+|+||.||+++. ..+..||||+++... ...+.+.+|+.++..+ +||||++++++|.++...
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 3456678999999999999963 235689999997542 2346789999999999 899999999999999999
Q ss_pred eEEEeeccCCChhhhhhhccc-----------------------------------------------------------
Q 036583 563 LLAYEFMANGSLDKWIFKKNQ----------------------------------------------------------- 583 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------- 583 (817)
++||||+++|+|.+++.....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999999999999865321
Q ss_pred -------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 584 -------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 584 -------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
...+++..+++++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 1247888999999999999999999 899999999999999999999999999998764432211
Q ss_pred -eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 651 -FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 651 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||...... ......+.++.. .
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~------~~~~~~~~~~~~---------~ 336 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD------SKFYKMIKEGYR---------M 336 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch------HHHHHHHHhCcc---------C
Confidence 112345668999999999999999999999999999998 88888543211 111222222210 0
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
........++.+++.+||+.||++||+|.||+++|++.
T Consensus 337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 00111234688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.96 Aligned_cols=250 Identities=24% Similarity=0.416 Sum_probs=203.6
Q ss_pred hccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCC
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGS 573 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 573 (817)
..+.++||+|+||.||++...++..+|+|.+.......+++.+|++++++++||||+++++++.+....++||||+++|+
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC 85 (256)
T ss_pred cEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCc
Confidence 45567899999999999999888899999987655567789999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeee
Q 036583 574 LDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT 653 (817)
Q Consensus 574 L~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 653 (817)
|.+++..... .+++..++.++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||+++............
T Consensus 86 L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 86 LLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred HHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 9999875432 58899999999999999999998 899999999999999999999999999998654332222122
Q ss_pred ccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccH
Q 036583 654 LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQS 732 (817)
Q Consensus 654 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 732 (817)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+.++.. ...+ .
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-------~~~~~i~~~~~--~~~~-------~ 224 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-------EVVEMISRGFR--LYRP-------K 224 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCC--CCCC-------C
Confidence 345568999999998889999999999999999999 89999643211 11112222110 0001 1
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 733 DRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 733 ~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
.....+.+++.+||+.+|++||+|+|+++.|.
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 12346789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=330.35 Aligned_cols=245 Identities=23% Similarity=0.315 Sum_probs=203.4
Q ss_pred ccccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 497 SVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
...||+|+||.||+++-+ .|..+|+|++++.. ...+..+.|-.+|....+|.||+|+-.|.+.+.+||||||++|
T Consensus 146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG 225 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG 225 (550)
T ss_pred heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence 367999999999999954 58999999998753 3457889999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC------
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR------ 645 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~------ 645 (817)
|++..+|.+.. .|+...+..++.+++-|+.-||+ .++|||||||+|+|||..|.+||+||||+.-+..
T Consensus 226 GD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~ 299 (550)
T KOG0605|consen 226 GDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIES 299 (550)
T ss_pred ccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhhhhhh
Confidence 99999998876 79999999999999999999999 9999999999999999999999999999854311
Q ss_pred -----------------CCce----e-------------------eeeccCCCCccCccccccCccCccccccchhhhHH
Q 036583 646 -----------------EQSH----V-------------------FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLL 685 (817)
Q Consensus 646 -----------------~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ 685 (817)
+... . ....+|||.|||||++.+..|+..+|.||||||+|
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Imy 379 (550)
T KOG0605|consen 300 YRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMY 379 (550)
T ss_pred hcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHH
Confidence 0000 0 01246999999999999999999999999999999
Q ss_pred HhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCC---CHHHHHH
Q 036583 686 EIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRP---SMTKVVQ 761 (817)
Q Consensus 686 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RP---t~~evl~ 761 (817)
|||.|.+||..+.+ ...++.+.+.+. .+..+...+...++.+||.+|+. ||++|- .++||.+
T Consensus 380 EmLvGyPPF~s~tp-------~~T~rkI~nwr~------~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 380 EMLVGYPPFCSETP-------QETYRKIVNWRE------TLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHhCCCCCCCCCH-------HHHHHHHHHHhh------hccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 99999999975543 334555544331 23333334444678899999999 999997 4677765
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=306.04 Aligned_cols=231 Identities=29% Similarity=0.386 Sum_probs=196.6
Q ss_pred cccccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 496 FSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
+.+.||.|+||.|.+.+.+ +|..+|+|++.+.. ...+...+|..+|+.+.||+++++.+.|.+....+|||||.+
T Consensus 48 ~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~ 127 (355)
T KOG0616|consen 48 RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVP 127 (355)
T ss_pred heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccC
Confidence 4567999999999999964 58889999997642 234677899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
||.|.++|++.+ .++...++-++.||+.||+|||+ ..|++|||||+|||||.+|.+||+|||.|+.....
T Consensus 128 GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r---- 197 (355)
T KOG0616|consen 128 GGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR---- 197 (355)
T ss_pred CccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc----
Confidence 999999998876 58999999999999999999999 99999999999999999999999999999976543
Q ss_pred eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 651 FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
.-+.+|||.|+|||+++...+..++|.|||||++|||+.|.+||..... ...+..+.+++ +..+.
T Consensus 198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------~~iY~KI~~~~--------v~fP~ 262 (355)
T KOG0616|consen 198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------IQIYEKILEGK--------VKFPS 262 (355)
T ss_pred EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------HHHHHHHHhCc--------ccCCc
Confidence 3568999999999999999999999999999999999999999975543 12333333333 22221
Q ss_pred cHHHHHHHHHHHHhccccCCCCC
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLR 753 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~R 753 (817)
-....+.+|+...++.|-.+|
T Consensus 263 --~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 263 --YFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --ccCHHHHHHHHHHHhhhhHhh
Confidence 122356788888888888888
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.73 Aligned_cols=255 Identities=28% Similarity=0.429 Sum_probs=206.9
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
....+.++||+|+||.||+|... .++.+|+|++.......+++.+|++++.+++|+||+++++++......+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 33556688999999999999965 47889999987665556789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+++|.+++..... ..+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||++..........
T Consensus 86 ~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 86 YGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 9999999865432 258899999999999999999998 899999999999999999999999999998765432221
Q ss_pred eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 651 FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ...+..+..+ ...+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-------~~~~~~~~~~---------~~~~ 225 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYELLEKG---------YRME 225 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCC---------CCCC
Confidence 122334568999999998899999999999999999998 8999864321 1112222221 1111
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
........+.+++.+|++.+|++||++.|++++|+.+
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1122345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=333.82 Aligned_cols=262 Identities=22% Similarity=0.346 Sum_probs=199.8
Q ss_pred HhhccccccCCCcceeEEEEEcCC-----------------CcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPD-----------------GTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKL 552 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~-----------------g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l 552 (817)
..+.+.++||+|+||.||++..++ +..||+|.+.... ....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 445667889999999999997532 3369999987542 234679999999999999999999
Q ss_pred eeEeecCCeeeEEEeeccCCChhhhhhhccc----------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceee
Q 036583 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQ----------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIH 616 (817)
Q Consensus 553 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH 616 (817)
++++.+.+..++||||+++|+|.+++..... ...+++...++++.||+.||+|||+ .+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 9999999999999999999999999864321 1246788899999999999999999 89999
Q ss_pred cCCCCCCeEecCCCcEEEeecCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh--CCCC
Q 036583 617 CDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG--GRKN 693 (817)
Q Consensus 617 ~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt--g~~p 693 (817)
|||||+|||+++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 9999999999999999999999998664432221 122455788999999998889999999999999999987 4566
Q ss_pred CCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 694 FDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 694 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
|....... ....+.......... .. .......+..+.+++.+||+.||++||||+||++.|++
T Consensus 242 ~~~~~~~~---~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQ---VIENAGEFFRDQGRQ-VY-----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHH---HHHHHHHHhhhcccc-cc-----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 75332111 111111111111000 00 00111233468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=343.36 Aligned_cols=258 Identities=27% Similarity=0.455 Sum_probs=202.2
Q ss_pred HHhhccccccCCCcceeEEEEEc------CCCcEEEEEEeccCC--cCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCe
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVL------PDGTRLAVKKLEGIG--QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTH 561 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~------~~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~ 561 (817)
...+.+.++||+|+||.||+++. .++..||||++.... ...+.+.+|+++++.+ +|+||++++++|.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 34556678999999999999873 234579999997542 2345688999999999 89999999999999999
Q ss_pred eeEEEeeccCCChhhhhhhccc----------------------------------------------------------
Q 036583 562 RLLAYEFMANGSLDKWIFKKNQ---------------------------------------------------------- 583 (817)
Q Consensus 562 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 583 (817)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999864321
Q ss_pred ---------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee-eee
Q 036583 584 ---------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV-FTT 653 (817)
Q Consensus 584 ---------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~-~~~ 653 (817)
...+++...++++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++......... ...
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1247788899999999999999999 899999999999999999999999999998654332211 122
Q ss_pred ccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccH
Q 036583 654 LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQS 732 (817)
Q Consensus 654 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 732 (817)
..++..|+|||++.+..++.++|||||||++|||++ |+.||....... ........+. ......
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~~~~~~---------~~~~~~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKMVKRGY---------QMSRPD 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHHHHccc---------CccCCC
Confidence 345678999999998899999999999999999997 999996432211 1111111110 000011
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 733 DRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 733 ~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.....+.+++.+||+.||++|||+.+|+++|+++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=317.33 Aligned_cols=248 Identities=22% Similarity=0.396 Sum_probs=210.4
Q ss_pred HHhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEE
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv 565 (817)
+-+++|.++||+|.||.|-++.- ..|+.||||.+++.. ++.-.+.+|++||..|+||||+.++.+|+..+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 34567778899999999999985 679999999997653 2334678999999999999999999999999999999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|||..+|.|.+|+.+.+ .|+...++.++.||..|+.|+|+ ++++|||||.+|||||.++++||+||||+.++..
T Consensus 132 MEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999998766 59999999999999999999999 9999999999999999999999999999988755
Q ss_pred CCceeeeeccCCCCccCccccccCccC-ccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccc
Q 036583 646 EQSHVFTTLRGTRGYLAPEWITNYAIS-EKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 724 (817)
.. ...+.+|++-|.+||++.+.+|. +.+|-|||||+||-|+.|..||++.+.. .+.+.+..|.
T Consensus 206 ~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-------~lvrQIs~Ga------- 269 (668)
T KOG0611|consen 206 KK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-------RLVRQISRGA------- 269 (668)
T ss_pred cc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-------HHHHHhhccc-------
Confidence 43 34678999999999999999985 7899999999999999999999865321 1222233332
Q ss_pred ccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 725 RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 725 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
+..+. .+..+.-||.||+..+|++|.|+.+|.....
T Consensus 270 -YrEP~---~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 270 -YREPE---TPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred -ccCCC---CCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 22221 2235678999999999999999999998763
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=322.52 Aligned_cols=256 Identities=26% Similarity=0.421 Sum_probs=208.7
Q ss_pred HHHHhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 489 LQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 489 l~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+...++.+.++||+|+||.||++...+++.+|+|.+.......+++.+|+.++++++|+||+++++++. .+..+++|||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 455677888999999999999999989999999999876666788999999999999999999999874 4578999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++++|.+++..... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 82 MENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 999999999875432 368889999999999999999998 8999999999999999999999999999987653322
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
.......++..|+|||.+....++.++||||||++++||++ |+.||...... .....+..+. .
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~---------~ 221 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-------EVIQNLERGY---------R 221 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-------HHHHHHHcCC---------C
Confidence 22223445678999999998889999999999999999999 99999643211 1111111111 1
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
.+........+.+++.+|++.+|++||++++++++|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11111223468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=328.95 Aligned_cols=248 Identities=32% Similarity=0.535 Sum_probs=193.2
Q ss_pred cccccCCCcceeEEEEEcC-----CCcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 496 FSVKLGQGGFGSVYQGVLP-----DGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~-----~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.||.|.||.||+|.+. .+..|+||.+..... ..++|.+|++.+.+++||||++++|++.+.+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999975 256899999965322 357899999999999999999999999988889999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++|+|.++|..... ..+++..+..|+.||++||+|||+ .+++|++|+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNK-EPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTCT-TTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccc-cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 999999999987622 268999999999999999999999 8999999999999999999999999999987733222
Q ss_pred e-eeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 649 H-VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 649 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
. ..........|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+.++....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-------~~~~~~~~~~~~~~------ 225 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-------EEIIEKLKQGQRLP------ 225 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-------HHHHHHHHTTEETT------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccccccccccce------
Confidence 1 1222456778999999999899999999999999999999 6788753311 11222222222111
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQML 763 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L 763 (817)
........+.+++..||+.||++||||+++++.|
T Consensus 226 ---~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ---IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112334678999999999999999999999976
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=322.81 Aligned_cols=251 Identities=24% Similarity=0.393 Sum_probs=204.3
Q ss_pred hhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
.+.+.++||+|+||+||+|...++..+|+|.+.......++|.+|+.++.+++||||+++++++.+....++||||+++|
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG 84 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence 34567889999999999999877778999998765555678999999999999999999999999999999999999999
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeee
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT 652 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 652 (817)
+|.+++..... .+++..++.++.||+.||+|||+ .+++|+||||+||++++++.+||+|||+++...........
T Consensus 85 ~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 85 CLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred cHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 99999976433 58899999999999999999998 89999999999999999999999999998866443322212
Q ss_pred eccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 653 TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 653 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ........+... ...
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~---------~~~ 223 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-------ETVEKVSQGLRL---------YRP 223 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHhcCCCC---------CCC
Confidence 2345678999999998889999999999999999998 99998543211 111122221110 011
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
......+.+++.+||+.+|.+||++.++++.|+
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=321.95 Aligned_cols=255 Identities=26% Similarity=0.392 Sum_probs=205.7
Q ss_pred HHhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
...+.+.++||+|+||.||+|+..+...||+|++.......+++.+|++++.+++|+||+++++.+.+ ...++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 34567788999999999999998777789999998655566789999999999999999999998754 56799999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+|+|.+++.+... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++.........
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 84 KGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 9999999975432 257899999999999999999999 899999999999999999999999999998664433222
Q ss_pred eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 651 FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ........+. ..+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-------~~~~~~~~~~---------~~~ 223 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERGY---------RMP 223 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-------HHHHHHhcCC---------CCC
Confidence 223446678999999988889999999999999999999 88888543211 1111111110 111
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
...+....+.+++.+|++.+|++||++.+++++|+..
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 1223445688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=320.92 Aligned_cols=253 Identities=26% Similarity=0.417 Sum_probs=204.6
Q ss_pred HhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
..+.+.++||+|+||.||++...++..+|+|.+.......+.+.+|+.++++++|+|++++++++. ....+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence 345677889999999999999888889999999876556778999999999999999999999885 4568999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
++|.+++..... ..+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++...........
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 85 GSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 999999975432 257899999999999999999999 8999999999999999999999999999987644322221
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+..+ ...+.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-------~~~~~~~~~---------~~~~~ 224 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-------EVLEQVERG---------YRMPC 224 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcC---------CCCCC
Confidence 22345668999999988889999999999999999999 88898643211 111111111 11111
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
.......+.+++.+|++.+|++|||+.++++.|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 22234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=321.21 Aligned_cols=250 Identities=24% Similarity=0.404 Sum_probs=202.6
Q ss_pred hccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCC
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGS 573 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 573 (817)
..+.++||+|+||.||++...++..+|+|.+........++.+|++++++++|+||+++++++......++||||+++++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGC 85 (256)
T ss_pred cchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCC
Confidence 44567899999999999998777789999987655556789999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeee
Q 036583 574 LDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT 653 (817)
Q Consensus 574 L~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 653 (817)
|.+++..... .+++..++.++.||+.||+|||+ .+++||||||+||++++++.+||+|||+++............
T Consensus 86 L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 86 LLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred HHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 9999976433 58899999999999999999999 899999999999999999999999999998654322211112
Q ss_pred ccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccH
Q 036583 654 LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQS 732 (817)
Q Consensus 654 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 732 (817)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+. ......
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~---------~~~~~~ 224 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-------VVESVSAGY---------RLYRPK 224 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-------HHHHHHcCC---------cCCCCC
Confidence 234457999999998899999999999999999999 888986432211 111111110 011111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 733 DRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 733 ~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
.....+.+++.+||+.+|++||||.|++++|.
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 23447889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=343.30 Aligned_cols=248 Identities=27% Similarity=0.470 Sum_probs=207.6
Q ss_pred ccccCCCcceeEEEEEc-CCCc----EEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 497 SVKLGQGGFGSVYQGVL-PDGT----RLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~-~~g~----~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
.++||+|+||+||||.+ ++|+ +||+|++... .+..+++++|+.+|.+++||||+||+|+|.... ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 46799999999999984 4444 6899998655 345789999999999999999999999998766 88999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
+.|+|.+|++.++. .+-.+..+.+..|||+||.|||+ ++++||||.++||||..-..+||.|||+++.+..+..+
T Consensus 780 P~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred ccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999988665 57778899999999999999998 99999999999999999999999999999998876554
Q ss_pred eeee-ccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 650 VFTT-LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 650 ~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
.... ..-.+.|||-|.++...|+.++|||||||.+||++| |..|++.....+ +.+++....+
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e----------------I~dlle~geR 918 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE----------------IPDLLEKGER 918 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH----------------hhHHHhcccc
Confidence 3332 344668999999999999999999999999999999 999997654322 2222222222
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.+-+.-...++..++..||..|+..||+++++...+.+.
T Consensus 919 LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 919 LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 333344566889999999999999999999999877654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=325.73 Aligned_cols=248 Identities=27% Similarity=0.331 Sum_probs=198.5
Q ss_pred ccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 495 NFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
...++||+|+||+||++.. .+++.||+|.+.... .....+.+|+.++.+++|+||+++++.+.+++..++||||+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence 3457899999999999985 568999999986432 23346789999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++.......
T Consensus 83 ~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 83 NGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred CCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 99999988865332 258889999999999999999999 999999999999999999999999999998754322
Q ss_pred eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........ .......... .. ..
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~--------~~--~~ 223 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKE--------DQ--EE 223 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhc--------cc--cc
Confidence 12345789999999999999999999999999999999999999975432110 0111111111 00 11
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPS-----MTKVVQ 761 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt-----~~evl~ 761 (817)
........+.+++..||+.||++||+ ++|+++
T Consensus 224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 11123346789999999999999997 788887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=329.97 Aligned_cols=256 Identities=25% Similarity=0.414 Sum_probs=216.2
Q ss_pred HHHHhhccccccCCCcceeEEEEEcC---CCc--EEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCe
Q 036583 489 LQTATNNFSVKLGQGGFGSVYQGVLP---DGT--RLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTH 561 (817)
Q Consensus 489 l~~~~~~~~~~lG~G~fG~Vy~g~~~---~g~--~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~ 561 (817)
|.++.....++||+|-||.||+|.+- .|+ .||||..+.. .+..+.|+.|..+|+.++||||++|+|.|.+ ..
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 44444555678999999999999842 333 4888988764 3457889999999999999999999999986 56
Q ss_pred eeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcc
Q 036583 562 RLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK 641 (817)
Q Consensus 562 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 641 (817)
.++|||.++.|.|..||+.... .|+......++.||..||+|||+ .+.+||||.++|||+...-.+||+||||++
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred eeEEEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhh
Confidence 8999999999999999987654 68889999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhh
Q 036583 642 LMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRN 720 (817)
Q Consensus 642 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (817)
.+..+.........-+..|||||.+.-+.++.++|||-|||.+||++. |.+||+.-...+ +..
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------VI~ 603 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------VIG 603 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------eEE
Confidence 998777666555666779999999999999999999999999999988 999998654433 222
Q ss_pred hcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 721 ILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 721 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.++..-+.+.+..++..+..++.+||..+|.+||.+.|+...|+.+
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 2333334445556677889999999999999999999999887655
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=324.42 Aligned_cols=241 Identities=25% Similarity=0.382 Sum_probs=204.0
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCCh
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSL 574 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 574 (817)
++||+|.||.||||... .++.||+|++.-. ....+++.+|+.++..++++||.++++.+..+..++++||||.+|++
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 57999999999999954 5788999998643 44567899999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeeec
Q 036583 575 DKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTL 654 (817)
Q Consensus 575 ~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~ 654 (817)
.+.|.... .+++....-|+.+++.|+.|||. .+.+|||||+.|||+..+|.+|++|||++-.+....... .+.
T Consensus 99 ~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tf 171 (467)
T KOG0201|consen 99 LDLLKSGN---ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTF 171 (467)
T ss_pred hhhhccCC---CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhcc-ccc
Confidence 99997655 45777788899999999999999 899999999999999999999999999998876654443 668
Q ss_pred cCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHH
Q 036583 655 RGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDR 734 (817)
Q Consensus 655 ~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 734 (817)
+||+-|||||++....|+.|+||||||++.+||++|.+|+....+.....+ +.+-..|.+.. ..
T Consensus 172 vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl------------Ipk~~PP~L~~----~~ 235 (467)
T KOG0201|consen 172 VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL------------IPKSAPPRLDG----DF 235 (467)
T ss_pred cccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe------------ccCCCCCcccc----cc
Confidence 999999999999998999999999999999999999999976554321111 11111222222 33
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 735 VFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 735 ~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
...+.+++..|++.||+.||++.++++
T Consensus 236 S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 236 SPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 446889999999999999999999986
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=325.81 Aligned_cols=254 Identities=26% Similarity=0.460 Sum_probs=203.5
Q ss_pred hhccccccCCCcceeEEEEEcCC------CcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPD------GTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLL 564 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 564 (817)
...+.++||+|+||.||+|.... ...||+|.+..... ...+|.+|+.++.+++||||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 34566889999999999998533 25799999865432 34678999999999999999999999999999999
Q ss_pred EEeeccCCChhhhhhhccc-------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCc
Q 036583 565 AYEFMANGSLDKWIFKKNQ-------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYH 631 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 631 (817)
+|||+++++|.+++..... ...+++...+.++.|++.||+|||+ .+++|+||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence 9999999999999975421 1357888999999999999999999 89999999999999999999
Q ss_pred EEEeecCCccccCCCCce-eeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHH
Q 036583 632 AKVSDFGLAKLMTREQSH-VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYA 709 (817)
Q Consensus 632 ~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~ 709 (817)
+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... ..
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-------~~ 235 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------EV 235 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HH
Confidence 999999999865433221 1223456788999999998899999999999999999998 99999643221 12
Q ss_pred HHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 710 FKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 710 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
...+.++... ......+..+.+++.+||+.||.+||+++||+++|+.
T Consensus 236 ~~~i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 IEMIRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 2222222211 1122344678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.85 Aligned_cols=239 Identities=22% Similarity=0.301 Sum_probs=195.0
Q ss_pred ccCCCcceeEEEEEc-CCCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCC
Q 036583 499 KLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGS 573 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 573 (817)
.||+|+||.||+++. .+|+.+|+|++.... .....+.+|+.++.+++||||+++++++..++..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 599999999999985 468899999997531 233567889999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeee
Q 036583 574 LDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT 653 (817)
Q Consensus 574 L~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 653 (817)
|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 82 L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~ 154 (323)
T cd05571 82 LFFHLSRER---VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT 154 (323)
T ss_pred HHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cccc
Confidence 999987644 58899999999999999999999 8999999999999999999999999999875422211 1234
Q ss_pred ccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHH
Q 036583 654 LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSD 733 (817)
Q Consensus 654 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 733 (817)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+..+. .. ....
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~~~~~~~~~~--------~~--~p~~ 217 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILMEE--------IR--FPRT 217 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-------HHHHHHHcCC--------CC--CCCC
Confidence 57999999999999999999999999999999999999999643211 1111111111 11 1112
Q ss_pred HHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 036583 734 RVFTAVKVALWCVQEDMSLRP-----SMTKVVQ 761 (817)
Q Consensus 734 ~~~~~~~l~~~cl~~dp~~RP-----t~~evl~ 761 (817)
....+.+++.+||+.||++|| ++.|+++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 234678999999999999999 7999886
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=320.58 Aligned_cols=253 Identities=28% Similarity=0.456 Sum_probs=207.1
Q ss_pred hhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCc-CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQ-GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~-~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
.+.+.++||+|+||.||+|...+++.+++|.+..... ...++.+|+.+++.++|+||+++++++.+....++||||+++
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEK 86 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeeccc
Confidence 3556688999999999999988899999999976543 467899999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
++|.+++..... ..+++..++.++.||+.||+|||+ .+|+|+||||+||++++++.+||+|||++......... .
T Consensus 87 ~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-~ 161 (261)
T cd05148 87 GSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-S 161 (261)
T ss_pred CCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc-c
Confidence 999999976432 368899999999999999999998 89999999999999999999999999999876433221 1
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
....++..|+|||.+....++.++||||||++++||++ |+.||...... ........+ ...+.
T Consensus 162 ~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-------~~~~~~~~~---------~~~~~ 225 (261)
T cd05148 162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-------EVYDQITAG---------YRMPC 225 (261)
T ss_pred cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-------HHHHHHHhC---------CcCCC
Confidence 23445678999999998889999999999999999998 89999643211 111111111 11111
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.......+.+++.+|++.||++|||++++++.|+.+
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 223345688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.78 Aligned_cols=253 Identities=27% Similarity=0.459 Sum_probs=203.7
Q ss_pred hhccccccCCCcceeEEEEEcCC----CcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPD----GTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
.+.+.++||+|+||.||+|.+.. ...||||.+..... ...+|.+|+.++.+++||||+++++++.+....+++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 84 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT 84 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence 35567889999999999998642 45799999865432 3467899999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
||+++++|.+++..... .+++..+++++.|++.|++|||+ .+|+|+||||+||++++++.+||+|||+++.....
T Consensus 85 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 85 EYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999976443 58899999999999999999998 99999999999999999999999999999987522
Q ss_pred Ccee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccc
Q 036583 647 QSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724 (817)
Q Consensus 647 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 724 (817)
.... .....++..|+|||.+.+..++.++||||||++++||++ |..||..... ......+.++.
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~~------- 225 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-------QDVIKAVEDGY------- 225 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-------HHHHHHHHcCC-------
Confidence 2211 112345678999999998899999999999999999998 9999853221 11112221111
Q ss_pred ccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 725 RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 725 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
..+........+.+++.+|++.+|++||+++||+++|+++
T Consensus 226 --~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 --RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111122345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=318.02 Aligned_cols=253 Identities=27% Similarity=0.404 Sum_probs=203.6
Q ss_pred HhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
..+.+.++||+|+||.||++....+..+|+|++.......+.+.+|+.++++++|+|++++++++. ....+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 446677889999999999999877778999998765556678999999999999999999999875 4567899999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
++|.+++..... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++...........
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 85 GSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 999999976432 257899999999999999999998 8999999999999999999999999999986643322222
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ........+. ..+.
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~---------~~~~ 224 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-------EVLEQVERGY---------RMPC 224 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCC---------CCCC
Confidence 22345678999999998889999999999999999999 89998643211 1111111110 0111
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
.......+.+++.+||+.||++||++++|+++|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 12234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.05 Aligned_cols=257 Identities=24% Similarity=0.383 Sum_probs=201.9
Q ss_pred hhccccccCCCcceeEEEEEcC------CCcEEEEEEeccCC--cCHHHHHHHHHHhhccC-cceeeeeeeEeecCCeee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP------DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIH-HLHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~ 563 (817)
.+.+.++||+|+||.||+|+.. .+..||||++.... ...+.+.+|++++.++. ||||++++++|.+....+
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY 117 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence 3445678999999999999842 23479999996542 23467999999999996 999999999999999999
Q ss_pred EEEeeccCCChhhhhhhccc------------------------------------------------------------
Q 036583 564 LAYEFMANGSLDKWIFKKNQ------------------------------------------------------------ 583 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~------------------------------------------------------------ 583 (817)
|||||+++|+|.++|.....
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (400)
T cd05105 118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA 197 (400)
T ss_pred EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence 99999999999998865321
Q ss_pred ---------------------------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC
Q 036583 584 ---------------------------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY 630 (817)
Q Consensus 584 ---------------------------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~ 630 (817)
...+++..+..++.||++||+|||+ .+|+||||||+|||+++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCCC
Confidence 1247788889999999999999999 8999999999999999999
Q ss_pred cEEEeecCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHH
Q 036583 631 HAKVSDFGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSY 708 (817)
Q Consensus 631 ~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~ 708 (817)
.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....... .
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~------~ 348 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS------T 348 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH------H
Confidence 99999999998654332211 122456778999999998899999999999999999997 889986432111 1
Q ss_pred HHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 709 AFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 709 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
....+..+. ...........+.+++.+||+.||++||++.+|+++|+.+.
T Consensus 349 ~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 FYNKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 111122111 11111223456889999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=322.88 Aligned_cols=256 Identities=25% Similarity=0.427 Sum_probs=205.3
Q ss_pred HHhhccccccCCCcceeEEEEEcCC------CcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCee
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLPD------GTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHR 562 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~ 562 (817)
..++.+.+.||+|+||.||+|...+ ++.||||.+..... ..+.+.+|++++.+++|+||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3456677889999999999998633 47899999976533 357899999999999999999999999999999
Q ss_pred eEEEeeccCCChhhhhhhccc-----------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCc
Q 036583 563 LLAYEFMANGSLDKWIFKKNQ-----------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYH 631 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 631 (817)
++||||+++++|.+++..... ...+++.....++.|++.|++|||+ .+++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 999999999999999975421 2357889999999999999999998 89999999999999999999
Q ss_pred EEEeecCCccccCCCCce-eeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHH
Q 036583 632 AKVSDFGLAKLMTREQSH-VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYA 709 (817)
Q Consensus 632 ~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~ 709 (817)
+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-------~~ 233 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-------EV 233 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HH
Confidence 999999999865332211 1122345678999999999999999999999999999998 99998543221 11
Q ss_pred HHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 710 FKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 710 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
......+.... ........+.+++.+||+.||++||++.||++.|++
T Consensus 234 ~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 234 IECITQGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 12222222111 111234568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=330.13 Aligned_cols=243 Identities=27% Similarity=0.330 Sum_probs=199.3
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
.+.+.+.||+|+||.||+++.. +++.||+|.+... ....+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 98 (329)
T PTZ00263 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE 98 (329)
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence 3556788999999999999965 5889999998643 2334678999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 99 FVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred CCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 999999999997654 57888889999999999999999 999999999999999999999999999998664332
Q ss_pred ceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+.++. +.
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~~i~~~~--------~~ 233 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-------FRIYEKILAGR--------LK 233 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-------HHHHHHHhcCC--------cC
Confidence 235789999999999999999999999999999999999999964321 11122222221 11
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPS-----MTKVVQM 762 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt-----~~evl~~ 762 (817)
.+ ......+.+++.+||+.||.+||+ ++++++.
T Consensus 234 ~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 234 FP--NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CC--CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11 112235779999999999999997 6887753
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=330.85 Aligned_cols=256 Identities=26% Similarity=0.445 Sum_probs=200.9
Q ss_pred HHhhccccccCCCcceeEEEEEcC-CCc----EEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeee
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLP-DGT----RLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~----~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 563 (817)
...+...++||+|+||.||+|++. +++ .||+|+++... ...+++.+|+.+++.++||||++++++|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 344555678999999999999853 333 48999986542 3356899999999999999999999999864 567
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+++||+++|+|.+++..... .+++...++++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999999976543 57888999999999999999999 89999999999999999999999999999976
Q ss_pred CCCCceee-eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhh
Q 036583 644 TREQSHVF-TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721 (817)
Q Consensus 644 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (817)
........ ....++..|+|||.+.+..++.++|||||||++|||++ |+.||+..... ........+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~---- 228 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------EISSILEKGE---- 228 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHhCCC----
Confidence 54332211 12334668999999999999999999999999999998 99999643211 1111111111
Q ss_pred cccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 722 ~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
..+........+.+++..||+.+|.+||++.++++.|..+..
T Consensus 229 -----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 229 -----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred -----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 111111223467899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=322.31 Aligned_cols=255 Identities=26% Similarity=0.429 Sum_probs=202.3
Q ss_pred HhhccccccCCCcceeEEEEEc-----CCCcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-----PDGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLL 564 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-----~~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 564 (817)
....+.++||+|+||.||+|.. ..+..+++|.+..... ..+++.+|++++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3455678899999999999983 3467899999975432 33678999999999999999999999999999999
Q ss_pred EEeeccCCChhhhhhhccc--------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC
Q 036583 565 AYEFMANGSLDKWIFKKNQ--------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY 630 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~ 630 (817)
||||+++++|.+++..... ...+++...+.++.|++.||+|||+ .+++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 9999999999999853221 2257888999999999999999999 8999999999999999999
Q ss_pred cEEEeecCCccccCCCCce-eeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHH
Q 036583 631 HAKVSDFGLAKLMTREQSH-VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSY 708 (817)
Q Consensus 631 ~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~ 708 (817)
.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |..||..... ..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-------~~ 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------QE 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------HH
Confidence 9999999999866433221 1223445678999999988889999999999999999998 9889854321 11
Q ss_pred HHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 709 AFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 709 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
....+...... +........+.+++.+|++.||++||++.+|+++|..
T Consensus 235 ~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 22222222111 1111223467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=330.57 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=201.3
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.++||+|+||.||+|+.. +++.||||++... ....+.+.+|++++..++||||+++++++.+++..++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 445678999999999999965 5889999999653 12346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++|+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 83 VPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 99999999997544 58889999999999999999999 9999999999999999999999999999986543
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
......|++.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.... ..+......
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~--~~~~~~~~~ 223 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-------TWENLKYWK--ETLQRPVYD 223 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-------HHHHHHhcc--ccccCCCCC
Confidence 1234578999999999999899999999999999999999999996433211 111111110 001100001
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.........+.+++.+|++.+|++||+++|+++.
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1111234567899999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=316.73 Aligned_cols=252 Identities=23% Similarity=0.302 Sum_probs=201.8
Q ss_pred HhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc---------------CHHHHHHHHHHhhccCcceeeeeeeE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ---------------GKKEFRAEVSIIGSIHHLHLVKLRGF 555 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~---------------~~~~~~~Ev~~l~~l~h~niv~l~~~ 555 (817)
..+.+.++||+|.||.|-+|+. -+++.||||++.+... ..+...+||.+|++++|||||+|+.+
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 3455667899999999999994 4689999999864311 12578899999999999999999999
Q ss_pred eec--CCeeeEEEeeccCCChhhhhhhcccccc-hhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcE
Q 036583 556 CAE--GTHRLLAYEFMANGSLDKWIFKKNQEFL-LDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHA 632 (817)
Q Consensus 556 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 632 (817)
..+ .+..|||+|||..|.+...= ...+ ++..++++++.+++.||+|||. ++||||||||+|+||+++|++
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcE
Confidence 976 45789999999998765422 2224 8999999999999999999999 999999999999999999999
Q ss_pred EEeecCCccccCCCC----ceeeeeccCCCCccCccccccCc----cCccccccchhhhHHHhhhCCCCCCCCCCCCCCc
Q 036583 633 KVSDFGLAKLMTREQ----SHVFTTLRGTRGYLAPEWITNYA----ISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAH 704 (817)
Q Consensus 633 ki~Dfgla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~ 704 (817)
||+|||.+....... ........|||.|+|||.+.+.. .+.+.||||+||.||-|+.|+.||-.+...
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~---- 325 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL---- 325 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH----
Confidence 999999998763221 11223478999999999998632 246889999999999999999999543211
Q ss_pred chHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 705 FPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
.-..+++...+..+...+..+++.+|++++|++||+.|.+..+|....--
T Consensus 326 -----------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 326 -----------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred -----------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 11234455555556555667788999999999999999999999887643
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=320.97 Aligned_cols=262 Identities=19% Similarity=0.268 Sum_probs=198.8
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
+.+.+.||+|+||+||+++.. +++.+|+|++.... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 456678999999999999975 57889999986542 23567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
+++.+..+..... .+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 83 EKNMLELLEEMPN---GVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 9987765543322 58888999999999999999998 89999999999999999999999999999876543332
Q ss_pred eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCC--------cchHHHHHH-hhhcchhh
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA--------HFPSYAFKM-MEEGKLRN 720 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~--------~~~~~~~~~-~~~~~~~~ 720 (817)
......|++.|+|||++.+..++.++|||||||++|||++|+.||......+.. .++...... ........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 233457899999999999888999999999999999999999999754321100 000000000 00000000
Q ss_pred hcccccCCccc------HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 721 ILDSRLNIDEQ------SDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 721 ~~d~~~~~~~~------~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
...+....... ......+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 012346889999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=332.41 Aligned_cols=257 Identities=19% Similarity=0.238 Sum_probs=195.5
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
.+.+.++||+|+||.||++.. ..++.||+|+.. .+.+.+|++++++++||||+++++++......++|+|++.
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~- 166 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK- 166 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-
Confidence 456678899999999999985 468899999754 3457899999999999999999999999999999999986
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
++|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..........
T Consensus 167 ~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~ 240 (391)
T PHA03212 167 TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240 (391)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccc
Confidence 68888886543 57889999999999999999999 8999999999999999999999999999975433222223
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcc-hHHHHHHhhh-c------------c
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHF-PSYAFKMMEE-G------------K 717 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~-~~~~~~~~~~-~------------~ 717 (817)
....||+.|+|||++.+..++.++|||||||++|||++|+.||-.......... .......+.. + .
T Consensus 241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~ 320 (391)
T PHA03212 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320 (391)
T ss_pred ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence 346799999999999998999999999999999999999988754322111100 0000000000 0 0
Q ss_pred hhhhc---------cc--ccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 718 LRNIL---------DS--RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 718 ~~~~~---------d~--~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+.... .+ +............+.+++.+||+.||++|||++|+++
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 00 0000001123456889999999999999999999996
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=325.93 Aligned_cols=242 Identities=24% Similarity=0.301 Sum_probs=198.6
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.++||+|+||.||++... +++.+|+|++.... ...+.+.+|++++++++||||+++++++.++...++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 345678999999999999965 58899999986431 2345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++|+|.+++.... .+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~- 155 (291)
T cd05612 83 VPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT- 155 (291)
T ss_pred CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence 99999999997654 58889999999999999999999 999999999999999999999999999998664321
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+..+. ...
T Consensus 156 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~--------~~~ 217 (291)
T cd05612 156 ---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-------FGIYEKILAGK--------LEF 217 (291)
T ss_pred ---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC--------cCC
Confidence 235689999999999998899999999999999999999999964321 11122222221 111
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPS-----MTKVVQM 762 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt-----~~evl~~ 762 (817)
+ ......+.+++.+|++.||.+||+ ++|+++.
T Consensus 218 ~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 218 P--RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred C--ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1 112346789999999999999995 8888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=330.80 Aligned_cols=259 Identities=26% Similarity=0.424 Sum_probs=202.1
Q ss_pred HhhccccccCCCcceeEEEEEcC------CCcEEEEEEeccCC--cCHHHHHHHHHHhhcc-CcceeeeeeeEeec-CCe
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP------DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAE-GTH 561 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~-~~~ 561 (817)
..+.+.+.||+|+||.||+|... .++.||+|++.... ...+.+..|+.++.++ +|+||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 45667789999999999999642 24789999987532 2245678899999999 89999999998865 456
Q ss_pred eeEEEeeccCCChhhhhhhccc----------------------------------------------------------
Q 036583 562 RLLAYEFMANGSLDKWIFKKNQ---------------------------------------------------------- 583 (817)
Q Consensus 562 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 583 (817)
.++++||+++++|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 7899999999999999864321
Q ss_pred ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee-eeeccCCCCccC
Q 036583 584 EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV-FTTLRGTRGYLA 662 (817)
Q Consensus 584 ~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~a 662 (817)
...+++..+.+++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.+....... .....++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 1257899999999999999999998 899999999999999999999999999998764332211 122456678999
Q ss_pred ccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHH
Q 036583 663 PEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKV 741 (817)
Q Consensus 663 PE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l 741 (817)
||++.+..++.++|||||||+++||++ |..||......+ .....+.++... .........+.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTRM---------RAPEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCCC---------CCCccCCHHHHHH
Confidence 999999999999999999999999998 999996432211 111122221110 0111223468899
Q ss_pred HHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 742 ALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 742 ~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
+.+||+.+|++||++.|++++|+.+.+
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998644
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=316.62 Aligned_cols=255 Identities=27% Similarity=0.430 Sum_probs=207.5
Q ss_pred HHhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
...+.+.++||+|+||.||++..++++.+|||.+.......+++.+|+.++++++|+||+++++++......++||||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 34455678899999999999998888899999998766667889999999999999999999999999899999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+++|.+++..... ..+++..+..++.|++.|++|||+ .+++|+||||+||++++++.+||+|||++..........
T Consensus 85 ~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 85 KGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 9999999976432 258899999999999999999998 899999999999999999999999999998765322211
Q ss_pred eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 651 FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
......+..|+|||.+.+..++.++||||||++++|+++ |+.||...... .....+..+ ...+
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-------~~~~~~~~~---------~~~~ 224 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-------EVLEQVERG---------YRMP 224 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcC---------CCCC
Confidence 122334568999999998889999999999999999998 99999543211 111111111 0111
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
........+.+++.+|++.+|++||+++|+++.|+.
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111224468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=326.59 Aligned_cols=238 Identities=23% Similarity=0.311 Sum_probs=192.8
Q ss_pred cCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCCh
Q 036583 500 LGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSL 574 (817)
Q Consensus 500 lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 574 (817)
||+|+||.||+++.. +++.||+|++... ......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999964 5789999998643 23346788999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeeec
Q 036583 575 DKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTL 654 (817)
Q Consensus 575 ~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~ 654 (817)
.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 153 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTF 153 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccc
Confidence 99997644 58889999999999999999999 9999999999999999999999999999986433221 22345
Q ss_pred cCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHH
Q 036583 655 RGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDR 734 (817)
Q Consensus 655 ~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 734 (817)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||..... . ........+ .... ....
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~-~~~~~~~~~--------~~~~--~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------N-EMYRKILQE--------PLRF--PDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------H-HHHHHHHcC--------CCCC--CCcC
Confidence 789999999999999999999999999999999999999964321 1 111111111 1111 1122
Q ss_pred HHHHHHHHHhccccCCCCCCC---HHHHHH
Q 036583 735 VFTAVKVALWCVQEDMSLRPS---MTKVVQ 761 (817)
Q Consensus 735 ~~~~~~l~~~cl~~dp~~RPt---~~evl~ 761 (817)
...+.+++..||+.||++||+ +.|+++
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 346789999999999999985 555554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.16 Aligned_cols=256 Identities=23% Similarity=0.420 Sum_probs=201.2
Q ss_pred HHhhccccccCCCcceeEEEEEcC------CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCee
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLP------DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHR 562 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~ 562 (817)
...+.+.++||+|+||.||+|... .+..||+|++.... ....++.+|+.+++.++||||+++++++.++...
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 344666789999999999998742 24679999986432 2345789999999999999999999999999999
Q ss_pred eEEEeeccCCChhhhhhhccc-------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEe
Q 036583 563 LLAYEFMANGSLDKWIFKKNQ-------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVS 635 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~ 635 (817)
++||||+++++|.+++.+... ...+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEEC
Confidence 999999999999999875321 1246788899999999999999999 899999999999999999999999
Q ss_pred ecCCccccCCCCceee-eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHh
Q 036583 636 DFGLAKLMTREQSHVF-TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMM 713 (817)
Q Consensus 636 Dfgla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 713 (817)
|||+++.......... ....++..|+|||.+.+..++.++|||||||++|||++ |..||..... .......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-------~~~~~~~ 234 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-------EQVLRFV 234 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHH
Confidence 9999886543322111 12345678999999998889999999999999999999 7888854321 1111222
Q ss_pred hhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 714 EEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 714 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
.++..... .......+.+++.+|++.+|++|||+.|++++|++
T Consensus 235 ~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 MEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 22211111 11223468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=316.38 Aligned_cols=256 Identities=24% Similarity=0.409 Sum_probs=206.4
Q ss_pred HHHHhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 489 LQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 489 l~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+..+.+.+.++||+|+||.||++...++..+|+|.+.......+.+.+|++++++++|+||+++++++.+ ...+++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 3445667788999999999999998788889999987655556789999999999999999999999887 778999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++++|.+++.+... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 82 MAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 999999999976432 257888999999999999999998 8999999999999999999999999999986643322
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
.......++..|+|||.+....++.++||||||++++|+++ |+.||...... .....+..+. .
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~~~~~---------~ 221 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-------EVIRALERGY---------R 221 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHhCCC---------C
Confidence 22222345678999999998889999999999999999999 89999643211 1111111111 1
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
.+........+.+++.+|++.+|++||++.+++++|+.
T Consensus 222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11112233468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=294.99 Aligned_cols=261 Identities=23% Similarity=0.297 Sum_probs=209.5
Q ss_pred HhhccccccCCCcceeEEEEE-cCCCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCC-----eeeE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT-----HRLL 564 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~-~~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~-----~~~l 564 (817)
.++.+.++||+|||.-||+++ +.+++.+|+|++.... ++.+..++|++..++++||||+++++++..+. ..||
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 456677899999999999999 6788899999997654 56788999999999999999999999986544 4899
Q ss_pred EEeeccCCChhhhhhhccc-ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 565 AYEFMANGSLDKWIFKKNQ-EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+++|...|+|.+.+..... +..+++.+.++|+.+|.+||++||+. ..+++||||||.|||+.+.+.++|.|||.+...
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 9999999999999876433 33799999999999999999999982 234999999999999999999999999998865
Q ss_pred CCCCc---ee-----eeeccCCCCccCccccc---cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHH
Q 036583 644 TREQS---HV-----FTTLRGTRGYLAPEWIT---NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKM 712 (817)
Q Consensus 644 ~~~~~---~~-----~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 712 (817)
.-.-. .. -.....|..|+|||.+. +...++++|||||||+||+|+.|..||+......+.
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS--------- 250 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS--------- 250 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe---------
Confidence 32110 00 01245688999999986 456789999999999999999999999643321110
Q ss_pred hhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 713 MEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 713 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
-...+....+..+......+.+.+++.+|++.||.+||++.|++..++.+
T Consensus 251 ----laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 251 ----LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ----EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 01122333344444455777899999999999999999999999998865
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=314.11 Aligned_cols=244 Identities=26% Similarity=0.423 Sum_probs=195.9
Q ss_pred ccCCCcceeEEEEEc---CCCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 499 KLGQGGFGSVYQGVL---PDGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~---~~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
+||+|+||.||+|.+ .+++.+|+|+++.... ..+++.+|+.++.+++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 699999999999964 3578899999865432 2467899999999999999999999885 45678999999999
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee-
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF- 651 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~- 651 (817)
+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999996543 58889999999999999999998 8999999999999999999999999999987654432211
Q ss_pred -eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 652 -TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 652 -~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
....++..|+|||.+....++.++||||||+++|||++ |+.||...... .....+.++.. .+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~i~~~~~---------~~ 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-------EVTQMIESGER---------ME 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHCCCC---------CC
Confidence 12334578999999988888999999999999999998 99999643211 11222222211 11
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
........+.+++.+||+.||++||++++|+++|++
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 111233468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=319.78 Aligned_cols=254 Identities=24% Similarity=0.422 Sum_probs=198.3
Q ss_pred ccccccCCCcceeEEEEEcC-CCc----EEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGT----RLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~----~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
.+.+.||+|+||+||+|... +++ .+++|.+.... ....++..|+.++.+++||||+++++++. +...++++|
T Consensus 10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e 88 (279)
T cd05111 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQ 88 (279)
T ss_pred eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEE
Confidence 44578999999999999853 444 47777775432 22357888999999999999999999886 455788999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+++|+|.+++..... .+++..+..++.||+.||+|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 89 ~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 89 LSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred eCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 9999999999976443 58899999999999999999998 899999999999999999999999999998764332
Q ss_pred ce-eeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccc
Q 036583 648 SH-VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725 (817)
Q Consensus 648 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 725 (817)
.. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+.++....
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~~----- 231 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-------HEVPDLLEKGERLA----- 231 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCCcCC-----
Confidence 21 1223456778999999998899999999999999999998 9999964321 11112222221111
Q ss_pred cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCCC
Q 036583 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVP 770 (817)
Q Consensus 726 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 770 (817)
........+.+++.+||+.||++|||+.|+++.|+.+...|
T Consensus 232 ----~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 232 ----QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 01112235678899999999999999999999998865433
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=324.50 Aligned_cols=240 Identities=23% Similarity=0.311 Sum_probs=194.6
Q ss_pred cccCCCcceeEEEEEc-CCCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 498 VKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
+.||+|+||.||+++. .+|+.||+|++... ......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3589999999999985 46899999999653 123456788999999999999999999999999999999999999
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeee
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT 652 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 652 (817)
+|..++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~ 153 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 153 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccc
Confidence 9998886544 58899999999999999999999 899999999999999999999999999987543221 1123
Q ss_pred eccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccH
Q 036583 653 TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQS 732 (817)
Q Consensus 653 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 732 (817)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+... .... +.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~~~~~--------~~~~--p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILME--------EIRF--PR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcC--------CCCC--CC
Confidence 457899999999999989999999999999999999999999643211 111111111 1111 11
Q ss_pred HHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 036583 733 DRVFTAVKVALWCVQEDMSLRP-----SMTKVVQ 761 (817)
Q Consensus 733 ~~~~~~~~l~~~cl~~dp~~RP-----t~~evl~ 761 (817)
.....+.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 2234678999999999999998 8888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=332.20 Aligned_cols=249 Identities=22% Similarity=0.293 Sum_probs=192.8
Q ss_pred ccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 495 NFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
.+.++||+|+||+||+|+. .+++.+|||++.... ...+.+.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~ 83 (381)
T cd05626 4 VKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (381)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecC
Confidence 4457899999999999985 457899999996532 23457889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc-
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS- 648 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~- 648 (817)
++|+|.+++.+.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 84 ~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 84 PGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 9999999997654 57888889999999999999999 9999999999999999999999999999764321000
Q ss_pred ---------------------------------------------eeeeeccCCCCccCccccccCccCccccccchhhh
Q 036583 649 ---------------------------------------------HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMV 683 (817)
Q Consensus 649 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvv 683 (817)
.......||+.|+|||.+.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00112469999999999998899999999999999
Q ss_pred HHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHh--ccccCCCCCCCHHHHHH
Q 036583 684 LLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALW--CVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 684 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~--cl~~dp~~RPt~~evl~ 761 (817)
+|||++|+.||....... ....+... ...+..+........+.+++.+ |+..+|..||+++|+++
T Consensus 238 l~elltG~~Pf~~~~~~~-------~~~~i~~~------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTE-------TQLKVINW------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHHhCCCCCcCCCHHH-------HHHHHHcc------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 999999999996533211 01111100 0011111111122355666766 55667777999999997
Q ss_pred H
Q 036583 762 M 762 (817)
Q Consensus 762 ~ 762 (817)
.
T Consensus 305 h 305 (381)
T cd05626 305 H 305 (381)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=315.13 Aligned_cols=246 Identities=24% Similarity=0.365 Sum_probs=196.1
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCCh
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSL 574 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 574 (817)
++||+|+||.||+|+.. +++.+|+|.+.... .....+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999864 68899999886432 2346799999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee-ee
Q 036583 575 DKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF-TT 653 (817)
Q Consensus 575 ~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~-~~ 653 (817)
.+++..... .+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++........... ..
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTEGP--RLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999965432 57899999999999999999998 8999999999999999999999999999886543211110 11
Q ss_pred ccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccH
Q 036583 654 LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQS 732 (817)
Q Consensus 654 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 732 (817)
...+..|+|||.+.+..++.++||||||+++|||++ |..||...... ........ ........
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-------~~~~~~~~---------~~~~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-------QTREAIEQ---------GVRLPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-------HHHHHHHc---------CCCCCCcc
Confidence 223457999999998889999999999999999998 88888532211 11111111 11111112
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 733 DRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 733 ~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
.....+.+++.+|++.+|++|||+.|++++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 23457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=321.56 Aligned_cols=256 Identities=24% Similarity=0.421 Sum_probs=204.3
Q ss_pred hccccccCCCcceeEEEEEc------CCCcEEEEEEeccCCc-CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVL------PDGTRLAVKKLEGIGQ-GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~------~~g~~vavK~l~~~~~-~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
+.+.++||+|+||.||+++. .++..+++|.+..... ..+.+.+|++++.+++|+||+++++++......++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVF 86 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEE
Confidence 44567899999999999974 2355689999865432 3467999999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccc-------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEE
Q 036583 567 EFMANGSLDKWIFKKNQ-------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAK 633 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 633 (817)
||+++++|.+++..... ...+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 99999999999975421 1247899999999999999999998 9999999999999999999999
Q ss_pred EeecCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHH
Q 036583 634 VSDFGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFK 711 (817)
Q Consensus 634 i~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 711 (817)
|+|||++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ....
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------~~~~ 236 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-------EVIE 236 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHH
Confidence 99999998654432211 122456788999999999899999999999999999999 99998543211 1122
Q ss_pred HhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 712 MMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 712 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
....+..... ....+..+.+++.+||+.+|++||++++|+++|+.+..
T Consensus 237 ~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 CITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 2222221111 11223468899999999999999999999999998733
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=326.37 Aligned_cols=260 Identities=21% Similarity=0.288 Sum_probs=199.8
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
.+.+.++||+|+||.||+++.. .+..+|+|.+.... ...+.+.+|++++.+++||||+++++++..++..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (331)
T cd06649 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85 (331)
T ss_pred cceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecC
Confidence 3455678999999999999965 57889999886532 23467999999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++++|.+++.... .+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 158 (331)
T cd06649 86 DGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (331)
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc--
Confidence 9999999997644 57888999999999999999997 2469999999999999999999999999998654322
Q ss_pred eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhh--------------
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEE-------------- 715 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-------------- 715 (817)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||....... +..........
T Consensus 159 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred -cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcccc
Confidence 223568999999999999899999999999999999999999996432110 00000000000
Q ss_pred --------------------cchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 036583 716 --------------------GKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQML 763 (817)
Q Consensus 716 --------------------~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L 763 (817)
.....+................+.+++.+||+.||++|||++|+++.-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000000000000000112345688999999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=319.93 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=202.2
Q ss_pred HhhccccccCCCcceeEEEEEcC------CCcEEEEEEeccCCcC--HHHHHHHHHHhhccCcceeeeeeeEeecCCeee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP------DGTRLAVKKLEGIGQG--KKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~~~--~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 563 (817)
..+.+.++||+|+||.||+|... +++.||+|++...... .+.+.+|+.++.+++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34556788999999999999853 2468999999754322 457889999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhhhcc-------------cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC
Q 036583 564 LAYEFMANGSLDKWIFKKN-------------QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY 630 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~ 630 (817)
+++||+++++|.+++.... ....+++..+.+++.|++.||+|||+ .+|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCC
Confidence 9999999999999985321 12247888899999999999999998 8999999999999999999
Q ss_pred cEEEeecCCccccCCCCce-eeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHH
Q 036583 631 HAKVSDFGLAKLMTREQSH-VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSY 708 (817)
Q Consensus 631 ~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~ 708 (817)
.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||..... ..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~ 234 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------QD 234 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-------HH
Confidence 9999999998866433221 1223456778999999988889999999999999999998 8888864321 11
Q ss_pred HHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 709 AFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 709 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
....+.++... +........+.+++..|++.+|++||+++||++.|+.
T Consensus 235 ~~~~i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 22222222211 1112234568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=326.20 Aligned_cols=249 Identities=21% Similarity=0.250 Sum_probs=199.1
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.++||+|+||+||+++.. +++.+|+|+++... ...+.+.+|+.++..++|+||+++++++.+....++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 445678999999999999854 68899999997532 2346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++|+|.+++.+... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 83 QPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999976532 58889999999999999999999 9999999999999999999999999999987654433
Q ss_pred eeeeeccCCCCccCccccc------cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 649 HVFTTLRGTRGYLAPEWIT------NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...... . ....+.+..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~-~~~~i~~~~----- 225 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------K-TYNNIMNFQ----- 225 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------H-HHHHHHcCC-----
Confidence 3333457899999999986 456778999999999999999999999643221 1 111111110
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..+..+........+.+++..|++ +|++||+++++++
T Consensus 226 -~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 226 -RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 001111111233467788899998 9999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=312.63 Aligned_cols=245 Identities=28% Similarity=0.387 Sum_probs=198.3
Q ss_pred ccCCCcceeEEEEEcCCCcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCChhh
Q 036583 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDK 576 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 576 (817)
.||+|+||.||+|...+++.+|+|.+..... ....+.+|++++.+++||||+++++++......++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 5899999999999988899999999875432 24578999999999999999999999999999999999999999999
Q ss_pred hhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeeeccC
Q 036583 577 WIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRG 656 (817)
Q Consensus 577 ~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g 656 (817)
++..... .+++..++.++.|++.+|.|||+ .+++|+||||+||++++++.+||+|||++...............+
T Consensus 82 ~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 82 FLRKKKD--ELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9865432 57899999999999999999998 899999999999999999999999999987543322211122344
Q ss_pred CCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHH
Q 036583 657 TRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRV 735 (817)
Q Consensus 657 t~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 735 (817)
+..|+|||++.+..++.++||||||+++||+++ |..||...... ........+. .........
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~ 220 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------QAREQVEKGY---------RMSCPQKCP 220 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHHcCC---------CCCCCCCCC
Confidence 568999999998889999999999999999998 99999643211 1111121111 011111234
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 736 FTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 736 ~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
..+.+++.+|++.+|++||++.|+++.|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 57889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=331.78 Aligned_cols=249 Identities=25% Similarity=0.329 Sum_probs=201.6
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.++||+|+||+||+++.. +++.||||++... ....+.+.+|++++..++||||+++++++.+++..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 455678999999999999965 6899999999653 13456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC-
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ- 647 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~- 647 (817)
+++++|.+++.+.. .++...+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 83 MPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 99999999997653 58889999999999999999999 999999999999999999999999999998765432
Q ss_pred ---------------------------ceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCC
Q 036583 648 ---------------------------SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETS 700 (817)
Q Consensus 648 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~ 700 (817)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 11123356899999999999999999999999999999999999999654311
Q ss_pred CCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 036583 701 DKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPS-MTKVVQM 762 (817)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt-~~evl~~ 762 (817)
.....+.... .....+........+.+++..|++ ||.+||+ ++|+++.
T Consensus 237 -------~~~~~i~~~~------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 -------ETYNKIINWK------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred -------HHHHHHhccC------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1111111100 111111111134567889999997 9999999 9999984
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=312.82 Aligned_cols=250 Identities=26% Similarity=0.464 Sum_probs=203.0
Q ss_pred hccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCC
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGS 573 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 573 (817)
..+.++||+|+||.||++...+++.+|+|++........+|.+|++++++++|||++++++++......++|+||+++++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC 85 (256)
T ss_pred eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCc
Confidence 45667899999999999998778899999987665566789999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeee
Q 036583 574 LDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT 653 (817)
Q Consensus 574 L~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 653 (817)
|.+++..... .++++.+..++.|++.|++|||+ .+++|+||||+||+++.++.+||+|||++.............
T Consensus 86 L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 86 LSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred HHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence 9999875432 57889999999999999999998 899999999999999999999999999988654332211122
Q ss_pred ccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccH
Q 036583 654 LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQS 732 (817)
Q Consensus 654 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 732 (817)
..++.+|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+.++. ....+.
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~--~~~~~~------- 224 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-------EVVETINAGF--RLYKPR------- 224 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-------HHHHHHhCCC--CCCCCC-------
Confidence 335578999999998889999999999999999998 99999643211 1111111110 111111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 733 DRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 733 ~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
.....+.+++.+||+.+|++|||+.|++++|.
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 12346889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=327.43 Aligned_cols=277 Identities=20% Similarity=0.360 Sum_probs=201.1
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecC-----CeeeE
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG-----THRLL 564 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~-----~~~~l 564 (817)
+.+.++||+|+||.||+|+. .+++.||||++... ......+.+|++++++++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 45567899999999999995 46899999998643 22345788999999999999999999988543 24799
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
||||++ ++|.+++.... .+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 82 v~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 82 VFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 999996 58988886543 58899999999999999999999 899999999999999999999999999998653
Q ss_pred CCCce--eeeeccCCCCccCcccccc--CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCc--------chHHHHHH
Q 036583 645 REQSH--VFTTLRGTRGYLAPEWITN--YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAH--------FPSYAFKM 712 (817)
Q Consensus 645 ~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~--------~~~~~~~~ 712 (817)
..... ......|++.|+|||++.+ ..++.++|||||||++|||++|+.||.......... .+......
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 32211 1123578999999999875 678899999999999999999999996543211000 00000111
Q ss_pred hhhcchhhhcc---cccCCccc---HHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcCCCCCCCCCCCC
Q 036583 713 MEEGKLRNILD---SRLNIDEQ---SDRVFTAVKVALWCVQEDMSLRPSMTKVVQM--LEGICPVPQPPTCSP 777 (817)
Q Consensus 713 ~~~~~~~~~~d---~~~~~~~~---~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~--L~~~~~~~~~~~~~~ 777 (817)
+......+.+. ........ ......+.+++.+||+.||++|||++|+++. +++.......+...|
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~ 307 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQP 307 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCc
Confidence 11111111111 00000000 0112456799999999999999999999973 555444444344333
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=319.67 Aligned_cols=247 Identities=23% Similarity=0.302 Sum_probs=196.4
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+.||+|+||.||+++.. +++.+|+|+++... ...+.+.+|+.++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999964 57899999997532 2345688999999888 699999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
|+|..++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TT 153 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ce
Confidence 99999886544 58999999999999999999999 8999999999999999999999999999875322211 22
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....................... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~~~p-- 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--------IRIP-- 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--------CCCC--
Confidence 346789999999999999999999999999999999999999975433322222233333322221 1111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSM------TKVVQ 761 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~------~evl~ 761 (817)
......+.+++.+|++.||++||++ +++++
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 259 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKS 259 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence 1122357799999999999999984 56655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=325.55 Aligned_cols=240 Identities=23% Similarity=0.307 Sum_probs=195.2
Q ss_pred ccCCCcceeEEEEEc-CCCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCC
Q 036583 499 KLGQGGFGSVYQGVL-PDGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGS 573 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 573 (817)
.||+|+||.||+++. .+++.+|+|++... ......+.+|+.+++.++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 589999999999985 46899999999653 2234678899999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeee
Q 036583 574 LDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT 653 (817)
Q Consensus 574 L~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 653 (817)
|..++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 82 L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 154 (328)
T cd05593 82 LFFHLSRER---VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKT 154 (328)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccc
Confidence 998886543 58899999999999999999999 899999999999999999999999999987543221 12234
Q ss_pred ccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHH
Q 036583 654 LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSD 733 (817)
Q Consensus 654 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 733 (817)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+..+. .. .+..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-------~~~~~~~~~~--------~~--~p~~ 217 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILMED--------IK--FPRT 217 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-------HHHHHhccCC--------cc--CCCC
Confidence 57899999999999889999999999999999999999999643211 0111111110 01 1112
Q ss_pred HHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 036583 734 RVFTAVKVALWCVQEDMSLRP-----SMTKVVQM 762 (817)
Q Consensus 734 ~~~~~~~l~~~cl~~dp~~RP-----t~~evl~~ 762 (817)
....+.+++.+|++.||++|| ++.|+++.
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 234678999999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=325.25 Aligned_cols=237 Identities=25% Similarity=0.349 Sum_probs=195.5
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEee
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
.|...||+|.||+|+++.++ +++.+|||.+++. .++.+..+.|.+|+... +||.|++|+.+|...++.+.||||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey 450 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY 450 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence 45578999999999999975 4778999999875 34567788899998877 599999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
..||++..+.+.. .++...+.-++..|+.||.|||+ ++||+||||-+|||||.+|.+||+||||++......
T Consensus 451 ~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g- 522 (694)
T KOG0694|consen 451 VAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG- 522 (694)
T ss_pred cCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCCCC-
Confidence 9999944333222 58899999999999999999999 999999999999999999999999999999654222
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
....+.+||+.|||||++.+..|+.++|.|||||+||||+.|..||..++.++ +...+.. ...
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-------~FdsI~~--------d~~-- 585 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-------VFDSIVN--------DEV-- 585 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHhc--------CCC--
Confidence 24467999999999999999999999999999999999999999997554322 1222211 111
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSM 756 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~ 756 (817)
.++.-...+.+.++.+++..+|++|--+
T Consensus 586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1222344578899999999999999866
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=315.23 Aligned_cols=253 Identities=27% Similarity=0.503 Sum_probs=201.9
Q ss_pred hhccccccCCCcceeEEEEEcCC-C---cEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPD-G---TRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~-g---~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
.+...+.||+|+||.||+|+... + ..+|+|.+.... ...+++.+|++++.+++|+|++++++++.+.+..++||
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT 85 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence 34456789999999999999642 3 368999886542 23567899999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
||+++++|.+++..... .+++..+..++.|++.|++|||+ .+++|+||||+||++++++.+||+|||++......
T Consensus 86 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 86 EYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999976432 58899999999999999999998 89999999999999999999999999999866443
Q ss_pred Cceeeee--ccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 647 QSHVFTT--LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 647 ~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
....... ...+..|+|||.+.+..++.++|||||||++|||++ |+.||..... ......+..+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-------~~~~~~i~~~------- 226 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-------HEVMKAINDG------- 226 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-------HHHHHHHhcC-------
Confidence 2222121 223457999999998889999999999999999997 9999954321 1111222211
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
...+........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 --~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 --FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111222345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=290.33 Aligned_cols=244 Identities=27% Similarity=0.362 Sum_probs=203.7
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
++.+.||+|-||.||.|+.+ .+-.||+|++.+.. +-..++.+|++|-..|+||||++++++|.+....||++||.
T Consensus 25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya 104 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA 104 (281)
T ss_pred cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence 34578999999999999965 46789999997642 34578999999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
+.|+|...|...... .++......++.|+|.|+.|+|. ++++||||||+|+|++.++..||+|||-+..-. ..
T Consensus 105 ~~gel~k~L~~~~~~-~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~~ 177 (281)
T KOG0580|consen 105 PRGELYKDLQEGRMK-RFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SN 177 (281)
T ss_pred CCchHHHHHHhcccc-cccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC---CC
Confidence 999999999854332 58888899999999999999999 999999999999999999999999999987543 22
Q ss_pred eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
...+.+||..|++||...+..++..+|+|++|++.||++.|.+||..... +..++.+.+ -++..+
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-------~etYkrI~k--------~~~~~p 242 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-------SETYKRIRK--------VDLKFP 242 (281)
T ss_pred CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-------HHHHHHHHH--------ccccCC
Confidence 34568999999999999999999999999999999999999999964431 112222222 122222
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
......+.+++.+|+..+|.+|.+..|++..
T Consensus 243 --~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 --STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred --cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 2233467899999999999999999999874
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=319.60 Aligned_cols=247 Identities=24% Similarity=0.337 Sum_probs=194.5
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+.||+|+||.||+++.. +++.+|+|+++... ...+.+..|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 35999999999999964 57899999997531 2345678899888777 899999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
|+|..++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TT 153 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cc
Confidence 99998886544 58899999999999999999999 8999999999999999999999999999875432211 12
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCC--CcchHHHHHHhhhcchhhhcccccCCc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDK--AHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+....+.... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--------~~~p 225 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--------IRIP 225 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--------CCCC
Confidence 345789999999999999999999999999999999999999964322211 111222222222221 1111
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCC------HHHHHH
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPS------MTKVVQ 761 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt------~~evl~ 761 (817)
......+.+++.+||+.||++||+ +.++++
T Consensus 226 --~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 226 --RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred --CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 122346779999999999999998 467654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=309.18 Aligned_cols=266 Identities=23% Similarity=0.348 Sum_probs=203.2
Q ss_pred HHhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhc--cCcceeeeeeeEeecCC----eeeE
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGS--IHHLHLVKLRGFCAEGT----HRLL 564 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~--l~h~niv~l~~~~~~~~----~~~l 564 (817)
..+..+.+.||+|+||+||+|.+ .|+.||||++.. .+++.+.+|.+|... |+|+||+.+++.=..+. +++|
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s--rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS--RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEecc--cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 34455668899999999999999 788899999974 345667777777654 59999999999865443 6799
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhc-----CCCceeecCCCCCCeEecCCCcEEEeecCC
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED-----CDQRIIHCDIKPENVLLDDNYHAKVSDFGL 639 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~-----~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl 639 (817)
|++|.++|||.+||.+. .++.+..++++..+|.||+|||.+ ..+.|.|||||++|||+..++.+.|+|+||
T Consensus 287 vTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred eeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 99999999999999763 689999999999999999999964 367899999999999999999999999999
Q ss_pred ccccCCCCce---eeeeccCCCCccCccccccC----cc--CccccccchhhhHHHhhhC----------CCCCCCCCCC
Q 036583 640 AKLMTREQSH---VFTTLRGTRGYLAPEWITNY----AI--SEKSDVYSYGMVLLEIIGG----------RKNFDPNETS 700 (817)
Q Consensus 640 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~----~~--~~~~DvwS~Gvvl~elltg----------~~pf~~~~~~ 700 (817)
|......... .....+||.+|||||++... .+ -..+||||||+|+||+.-+ +.||.+..+.
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 9877654322 22347899999999999753 12 2469999999999999653 3566543332
Q ss_pred CCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 701 DKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
+. . .+.+.+.+-..+++..+..+.. ..+.+..+.+++..||..+|..|-|+-.+.+.|.++..
T Consensus 443 DP-s-~eeMrkVVCv~~~RP~ipnrW~---s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 443 DP-S-FEEMRKVVCVQKLRPNIPNRWK---SDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CC-C-HHHHhcceeecccCCCCCcccc---cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 21 1 1112222222333333333332 33566778899999999999999999999998887653
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=321.32 Aligned_cols=240 Identities=27% Similarity=0.380 Sum_probs=194.0
Q ss_pred cccCCCcceeEEEEEc----CCCcEEEEEEeccC-----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 498 VKLGQGGFGSVYQGVL----PDGTRLAVKKLEGI-----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~----~~g~~vavK~l~~~-----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
++||+|+||.||+++. ..++.||||.+... ......+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4699999999999984 35789999998643 12335678999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++++|.+++.... .+.+..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999987654 57778888899999999999999 9999999999999999999999999999875432221
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+..+ ....
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-------~~~~~~~~~--------~~~~ 219 (323)
T cd05584 156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-------KTIDKILKG--------KLNL 219 (323)
T ss_pred -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcC--------CCCC
Confidence 123357899999999999888999999999999999999999999643211 111111111 1111
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRP-----SMTKVVQ 761 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~evl~ 761 (817)
+ ......+.+++.+|++.||++|| +++++++
T Consensus 220 ~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 P--PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred C--CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1 11234678999999999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=320.99 Aligned_cols=261 Identities=20% Similarity=0.317 Sum_probs=196.1
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
+.+.++||+|+||+||+|... +++.||+|++... ......+.+|+.++++++||||+++++++.+....++||||++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 556678999999999999864 5889999998643 2334578899999999999999999999999999999999998
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+ +|.+++..... .+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++....... .
T Consensus 87 ~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~ 159 (288)
T cd07871 87 S-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-T 159 (288)
T ss_pred c-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-c
Confidence 5 89998865432 57888999999999999999999 9999999999999999999999999999976543221 1
Q ss_pred eeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcc--------hHHHHHHhh-hcchhh
Q 036583 651 FTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHF--------PSYAFKMME-EGKLRN 720 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~--------~~~~~~~~~-~~~~~~ 720 (817)
.....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||........... ....+.... ......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 233567899999999875 5688999999999999999999999965432110000 000000000 000011
Q ss_pred hcccccCCcc----cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 721 ILDSRLNIDE----QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 721 ~~d~~~~~~~----~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
...+...... .......+.+++.+|++.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111110000 0012345789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=319.24 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=202.8
Q ss_pred hhccccccCCCcceeEEEEEcC------CCcEEEEEEeccCC--cCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP------DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~ 563 (817)
.+.+.+.||+|+||.||++... ....+|+|++.... +...++.+|+.++.++ +|+||+++++++..+...+
T Consensus 13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (293)
T cd05053 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLY 92 (293)
T ss_pred HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeE
Confidence 3455678999999999999853 23579999987542 2345688999999999 8999999999999999999
Q ss_pred EEEeeccCCChhhhhhhc-------------ccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC
Q 036583 564 LAYEFMANGSLDKWIFKK-------------NQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY 630 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~ 630 (817)
++|||+++|+|.+++... .....+++..++.++.|++.||+|||+ .+|+||||||+||++++++
T Consensus 93 li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~~~ 169 (293)
T cd05053 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDH 169 (293)
T ss_pred EEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcCCC
Confidence 999999999999998642 123368899999999999999999998 8999999999999999999
Q ss_pred cEEEeecCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHH
Q 036583 631 HAKVSDFGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSY 708 (817)
Q Consensus 631 ~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~ 708 (817)
.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..
T Consensus 170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~ 242 (293)
T cd05053 170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-------EE 242 (293)
T ss_pred eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH-------HH
Confidence 99999999998765432211 122345678999999998899999999999999999998 8888853321 11
Q ss_pred HHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 709 AFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 709 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
.......+. ...........+.+++.+|++.||++||||.|+++.|+.+.
T Consensus 243 ~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LFKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 122222211 11111223446889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=319.31 Aligned_cols=240 Identities=25% Similarity=0.318 Sum_probs=190.0
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+.||+|+||.||+|+.. +++.||+|.++.. ....+.+..|..++..+ +||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 5788999998653 22344566677777654 899999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
|+|.+++.... .++......++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 99999987644 57888899999999999999999 999999999999999999999999999998643322 222
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+... ... .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~--------~~~--~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-------DELFDSILND--------RPH--FP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcC--------CCC--CC
Confidence 346789999999999998999999999999999999999999964321 1111111111 000 11
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMT-KVVQ 761 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~-evl~ 761 (817)
......+.+++.+||+.||++||++. ++++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 11233577899999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=311.38 Aligned_cols=246 Identities=26% Similarity=0.421 Sum_probs=195.3
Q ss_pred ccCCCcceeEEEEEcC---CCcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCC
Q 036583 499 KLGQGGFGSVYQGVLP---DGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGS 573 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~---~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 573 (817)
+||+|+||.||+|.+. .+..||+|++..... ..+++.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999753 355799999865432 3467999999999999999999999885 457899999999999
Q ss_pred hhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee--
Q 036583 574 LDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF-- 651 (817)
Q Consensus 574 L~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~-- 651 (817)
|.+++..... .+++..+++++.||+.||+|||+ .+++||||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGKKD--EITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9999875432 58899999999999999999998 8999999999999999999999999999986544322211
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
....++..|+|||.+.+..++.++||||||+++||+++ |+.||...... .....+..+.. .+.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~---------~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-------EVMSFIEQGKR---------LDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHHCCCC---------CCC
Confidence 11233578999999988889999999999999999996 99999643211 11222222211 111
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
+......+.+++..||+.+|++||++.+|.+.|+.+
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 122345778999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=321.77 Aligned_cols=248 Identities=24% Similarity=0.366 Sum_probs=208.6
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCCe-eeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTH-RLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~ 568 (817)
|...+.+|+|+||.++..+.+ +++.+++|++.-.. ..++...+|+.++++++|||||.+.+.+.+++. .+|||+|
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y 85 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY 85 (426)
T ss_pred hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence 445678999999999998864 57789999986542 345578999999999999999999999998888 8999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
++||+|.+.+.+.. +..++.+...+++.|++.|+.|||+ .+|+|||||+.||+++.+..+||.|||+|+.+..+..
T Consensus 86 ~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 86 CEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred cCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 99999999998765 3478899999999999999999998 9999999999999999999999999999999887652
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
...+..||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+.. ..+.+.. . ....
T Consensus 162 -~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~------~Li~ki~-----~-----~~~~ 224 (426)
T KOG0589|consen 162 -LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS------ELILKIN-----R-----GLYS 224 (426)
T ss_pred -hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH------HHHHHHh-----h-----ccCC
Confidence 235679999999999999999999999999999999999999999754322 1111111 1 1122
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
+.+.....++..++..|++.+|+.||++.+++.+
T Consensus 225 Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 3334456678899999999999999999999974
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=317.32 Aligned_cols=257 Identities=23% Similarity=0.375 Sum_probs=204.4
Q ss_pred HHhhccccccCCCcceeEEEEEcCC-----CcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeec-CCee
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLPD-----GTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAE-GTHR 562 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~~-----g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~-~~~~ 562 (817)
...+.+.+.||+|+||.||+|...+ +..|++|++.... ...+.+.+|+.++.+++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 3455667889999999999999755 6789999987542 234678899999999999999999998876 5678
Q ss_pred eEEEeeccCCChhhhhhhcccc-----cchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeec
Q 036583 563 LLAYEFMANGSLDKWIFKKNQE-----FLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDF 637 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df 637 (817)
++++||+++++|.+++...... ..+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998764321 368899999999999999999998 89999999999999999999999999
Q ss_pred CCccccCCCCceee-eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhh
Q 036583 638 GLAKLMTREQSHVF-TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEE 715 (817)
Q Consensus 638 gla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 715 (817)
|+++.+........ ....++..|+|||.+.+..++.++||||||+++||+++ |+.||...... . ....+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~-~~~~~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF------E-MAAYLKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH------H-HHHHHHc
Confidence 99987654332221 22345678999999998889999999999999999999 99999643211 1 1111111
Q ss_pred cchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 716 GKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 716 ~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
+. ...........+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 235 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 235 GY---------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred CC---------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 10 1111112234688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=320.22 Aligned_cols=246 Identities=24% Similarity=0.346 Sum_probs=196.0
Q ss_pred ccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 499 KLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
.||+|+||.||+++.. +++.||+|+++.. ....+.+..|..++.++ +||||+++++++.+....++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 5899999999999864 5889999999753 12345688899999988 7999999999999999999999999999
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeee
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT 652 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 652 (817)
+|.+++.+.. .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 82 ~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (329)
T cd05588 82 DLMFHMQRQR---KLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTS 154 (329)
T ss_pred CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccc
Confidence 9999886553 58999999999999999999999 999999999999999999999999999987532211 1223
Q ss_pred eccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCC--CCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 653 TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSD--KAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 653 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
...||+.|+|||++.+..++.++|||||||++|||++|+.||+...... ......+....+.... ...+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~p- 225 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------IRIP- 225 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------CCCC-
Confidence 4678999999999999999999999999999999999999996433222 1112222222222221 1111
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCC------HHHHHH
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRPS------MTKVVQ 761 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RPt------~~evl~ 761 (817)
......+.+++.+|++.||.+||+ ++++++
T Consensus 226 -~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 226 -RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 112346789999999999999997 677765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=323.18 Aligned_cols=199 Identities=26% Similarity=0.384 Sum_probs=172.3
Q ss_pred HHhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
...+.+.++||+|+||.||++... ++..+|+|.+.... ...+.+.+|++++.+++|+||++++++|.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 345667789999999999999965 57889999886542 234678999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+++++|.+++.... .+++.....++.|++.||.|||+ ..+|+|+||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 999999999997643 57888899999999999999997 2479999999999999999999999999987653321
Q ss_pred ceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCC
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPN 697 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~ 697 (817)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 12356889999999999888999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=326.34 Aligned_cols=244 Identities=25% Similarity=0.351 Sum_probs=199.7
Q ss_pred HhhccccccCCCcceeEEEEEcCC--CcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPD--GTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~--g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv 565 (817)
..+.+.++||+|+||.||+|...+ +..||+|++... ....+.+.+|+.++..++||||+++++++.++...++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 446677899999999999998543 368999998643 23356788999999999999999999999999999999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|||+++|+|.+++.+.. .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999997654 58889999999999999999999 9999999999999999999999999999987643
Q ss_pred CCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccc
Q 036583 646 EQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 725 (817)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+..
T Consensus 184 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~~~~~i~~~~~------- 245 (340)
T PTZ00426 184 RT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-------LLIYQKILEGII------- 245 (340)
T ss_pred Cc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-------HHHHHHHhcCCC-------
Confidence 21 245789999999999988899999999999999999999999964321 112222222211
Q ss_pred cCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 036583 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRP-----SMTKVVQM 762 (817)
Q Consensus 726 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~evl~~ 762 (817)
..+ ......+.+++.+|++.||++|+ +++|+++.
T Consensus 246 -~~p--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 -YFP--KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -CCC--CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 111 11223567899999999999995 89998874
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=317.80 Aligned_cols=268 Identities=26% Similarity=0.381 Sum_probs=198.4
Q ss_pred hccccccCCCcceeEEEEEc-----CCCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeec--CCeeeEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-----PDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAE--GTHRLLA 565 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-----~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~--~~~~~lv 565 (817)
+.+.+.||+|+||.||++.. .+++.||+|++.... ...+.+.+|++++.+++||||+++++++.. ....++|
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 85 (284)
T cd05081 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV 85 (284)
T ss_pred ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEE
Confidence 44567899999999999974 257889999987543 335688999999999999999999998754 3467899
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
+||+++++|.+++.+... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++.....
T Consensus 86 ~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 86 MEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999999975432 58899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCceeee--eccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 646 EQSHVFT--TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 646 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
....... ...++..|+|||.+.+..++.++|||||||+++||++|..++......-................+.+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 3221111 12234469999999988899999999999999999998776532211000000000000000000011111
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.....+........+.+++.+||+.+|++||||.||++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1111111222345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=327.60 Aligned_cols=197 Identities=28% Similarity=0.386 Sum_probs=170.9
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
.+.++||+|+||+||++... .++.+|+|++.... .....+.+|+.++.+++|+||+++++.+.+....++||||+
T Consensus 4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (363)
T cd05628 4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFL 83 (363)
T ss_pred eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCC
Confidence 44578999999999999854 58899999996532 23456888999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc-
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS- 648 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~- 648 (817)
++|+|.+++.+.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 84 PGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 9999999997654 58899999999999999999999 9999999999999999999999999999876532110
Q ss_pred ---------------------------------eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCC
Q 036583 649 ---------------------------------HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFD 695 (817)
Q Consensus 649 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~ 695 (817)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 00123579999999999999999999999999999999999999996
Q ss_pred CC
Q 036583 696 PN 697 (817)
Q Consensus 696 ~~ 697 (817)
..
T Consensus 238 ~~ 239 (363)
T cd05628 238 SE 239 (363)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.91 Aligned_cols=264 Identities=25% Similarity=0.366 Sum_probs=200.4
Q ss_pred ccccccCCCcceeEEEEEc-----CCCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecC--CeeeEE
Q 036583 495 NFSVKLGQGGFGSVYQGVL-----PDGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG--THRLLA 565 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~-----~~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~~lv 565 (817)
.+.+.||+|+||+||++.. .+++.||+|.+.... ...+.+.+|++++++++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 5567899999999988652 357789999987542 2456889999999999999999999998653 357899
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|||+++++|.+++... .+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 87 ~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999998653 48999999999999999999999 8999999999999999999999999999987644
Q ss_pred CCcee--eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 646 EQSHV--FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 646 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
..... .....++..|+|||.+.+..++.++||||||++++||++|..|+......-.. .............+.+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh-hhcccccccchhhhhhhhh
Confidence 32211 11234566799999999888999999999999999999999998643211000 0000000000011111122
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.....+........+.+++..||+.+|++|||+++++++|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 1111111223345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=326.66 Aligned_cols=243 Identities=25% Similarity=0.391 Sum_probs=189.9
Q ss_pred cccccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 496 FSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
+.++||+|+||+||+++.. +++.||||++.... ...+.+.+|++++++++|+||+++++++.+.+..++||||++++
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 4578999999999999854 68999999986542 23467899999999999999999999999999999999999999
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeee
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT 652 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 652 (817)
+|.... ...+.....++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++....... ...
T Consensus 158 ~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 226 (353)
T PLN00034 158 SLEGTH-------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCN 226 (353)
T ss_pred cccccc-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-ccc
Confidence 986543 34566778899999999999999 8999999999999999999999999999987643221 123
Q ss_pred eccCCCCccCcccccc-----CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 653 TLRGTRGYLAPEWITN-----YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 653 ~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
...|+..|+|||.+.. ...+.++|||||||++|||++|+.||......+ +...... ..... .
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~-~~~~~---------~ 293 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCA-ICMSQ---------P 293 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHH-HhccC---------C
Confidence 4578999999998753 233568999999999999999999997332211 1111100 00000 0
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
..........+.+++.+||+.||++|||+.|+++.
T Consensus 294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111233468899999999999999999999984
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=334.96 Aligned_cols=254 Identities=23% Similarity=0.286 Sum_probs=210.0
Q ss_pred ccccccCCCcceeEEEEEcCCC-cEEEEEEeccC-CcCHHHHHHHHHHhhccC-cceeeeeeeE-eec------CCeeeE
Q 036583 495 NFSVKLGQGGFGSVYQGVLPDG-TRLAVKKLEGI-GQGKKEFRAEVSIIGSIH-HLHLVKLRGF-CAE------GTHRLL 564 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~~g-~~vavK~l~~~-~~~~~~~~~Ev~~l~~l~-h~niv~l~~~-~~~------~~~~~l 564 (817)
.+.+.|.+|||+.||.+....+ .++|+|++-.. ..+.+.+.+||++|++|+ |+|||.+++. ... .-+.+|
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll 119 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL 119 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence 3456799999999999997666 99999998543 455678999999999997 9999999993 321 236789
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
+||||++|.|-+++...... .|++.++++|+.|+++|+++||. +..+|||||||-+||||+.++..||||||.|.-.-
T Consensus 120 LmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~ 197 (738)
T KOG1989|consen 120 LMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKI 197 (738)
T ss_pred ehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence 99999999999999865444 49999999999999999999997 56789999999999999999999999999987543
Q ss_pred CCCcee--------eeeccCCCCccCccccc---cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHh
Q 036583 645 REQSHV--------FTTLRGTRGYLAPEWIT---NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMM 713 (817)
Q Consensus 645 ~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 713 (817)
...... .....-|+.|+|||.+. +.++++|+|||+|||+||-|+....||+...
T Consensus 198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg--------------- 262 (738)
T KOG1989|consen 198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG--------------- 262 (738)
T ss_pred CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc---------------
Confidence 221110 01134588999999884 7789999999999999999999999996432
Q ss_pred hhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCC
Q 036583 714 EEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPV 769 (817)
Q Consensus 714 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 769 (817)
...|++.....+........+..||..||+.||.+||++-+|++.+-++...
T Consensus 263 ----~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 263 ----KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ----ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 2346667777777778889999999999999999999999999988776433
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=321.80 Aligned_cols=250 Identities=22% Similarity=0.283 Sum_probs=197.1
Q ss_pred hccccccCCCcceeEEEEEc----CCCcEEEEEEeccC-----CcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeee
Q 036583 494 NNFSVKLGQGGFGSVYQGVL----PDGTRLAVKKLEGI-----GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~----~~g~~vavK~l~~~-----~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~ 563 (817)
+.+.++||+|+||.||+++. ..++.+|+|++... ....+.+..|+.++.++ +|+||+++++++......+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 34567899999999999874 35789999998643 12245678899999999 5999999999999999999
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 82 lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999987644 58889999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCceeeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
............||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ .......+...
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~~~~~~~~~------ 226 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT---QSEVSRRILKC------ 226 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC---HHHHHHHHhcC------
Confidence 44333333346799999999999865 478899999999999999999999964432211 11111111110
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRP-----SMTKVVQM 762 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~evl~~ 762 (817)
++.. .......+.+++.+||+.||++|| +++++++.
T Consensus 227 ~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 DPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1111 111234577899999999999999 77788763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=317.83 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=202.9
Q ss_pred hccccccCCCcceeEEEEEc------CCCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVL------PDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~------~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
+.+.+.||+|+||.||++.. .++..+|+|.+.... ...+.+.+|++++.+++||||+++++++......++||
T Consensus 7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (288)
T cd05093 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 86 (288)
T ss_pred eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 44567899999999999984 234568999887543 33567999999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhcc----------cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEee
Q 036583 567 EFMANGSLDKWIFKKN----------QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSD 636 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D 636 (817)
||+++++|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 87 EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEecc
Confidence 9999999999987432 11248999999999999999999998 8999999999999999999999999
Q ss_pred cCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhh
Q 036583 637 FGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMME 714 (817)
Q Consensus 637 fgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 714 (817)
||+++......... .....++..|+|||.+.+..++.++|||||||+++||++ |+.||..... ......+.
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-------~~~~~~i~ 236 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-------NEVIECIT 236 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHH
Confidence 99998654332211 122345678999999998889999999999999999998 8999854321 11122222
Q ss_pred hcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 715 EGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 715 ~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
.+..... .......+.+++.+|++.||.+|||+.|+++.|+.+.
T Consensus 237 ~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 237 QGRVLQR---------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred cCCcCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 2221111 0112346889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=329.99 Aligned_cols=260 Identities=23% Similarity=0.419 Sum_probs=202.7
Q ss_pred HHHHhhccccccCCCcceeEEEEEcC------CCcEEEEEEeccCC--cCHHHHHHHHHHhhccC-cceeeeeeeEeecC
Q 036583 489 LQTATNNFSVKLGQGGFGSVYQGVLP------DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIH-HLHLVKLRGFCAEG 559 (817)
Q Consensus 489 l~~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~ 559 (817)
+......+.++||+|+||.||+|++. .++.||||+++... ...+.+.+|++++.++. ||||++++++|...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 33444556688999999999999853 34679999997542 22457899999999997 99999999999999
Q ss_pred CeeeEEEeeccCCChhhhhhhccc--------------------------------------------------------
Q 036583 560 THRLLAYEFMANGSLDKWIFKKNQ-------------------------------------------------------- 583 (817)
Q Consensus 560 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 583 (817)
...++|+||+++|+|.+++++...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 999999999999999999975321
Q ss_pred ---------------------------------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 036583 584 ---------------------------------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENV 624 (817)
Q Consensus 584 ---------------------------------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NI 624 (817)
...+++...+.++.||+.||+|||+ .+++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceE
Confidence 1236777889999999999999998 8999999999999
Q ss_pred EecCCCcEEEeecCCccccCCCCce-eeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCC
Q 036583 625 LLDDNYHAKVSDFGLAKLMTREQSH-VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDK 702 (817)
Q Consensus 625 ll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~ 702 (817)
|+++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~-- 348 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN-- 348 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch--
Confidence 9999999999999999865332211 1122456788999999998889999999999999999998 88898543211
Q ss_pred CcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 703 AHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
......+..+. ...........+.+++..||+.+|.+||+++||++.|+.+
T Consensus 349 ----~~~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 349 ----EQFYNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred ----HHHHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11111111111 0111112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=323.10 Aligned_cols=237 Identities=25% Similarity=0.343 Sum_probs=192.2
Q ss_pred cccCCCcceeEEEEEc----CCCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 498 VKLGQGGFGSVYQGVL----PDGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~----~~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
++||+|+||.||+++. ..|+.+|+|++.... .....+..|++++.+++||||+++++++.++...++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999874 357899999997532 234567889999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+|+|.+++.+.. .+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++....... .
T Consensus 82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~ 154 (318)
T cd05582 82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-K 154 (318)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-c
Confidence 999999986543 58899999999999999999999 8999999999999999999999999999986543321 2
Q ss_pred eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 651 FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+... ....+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-------~~~~~i~~~--------~~~~p- 218 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-------ETMTMILKA--------KLGMP- 218 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-------HHHHHHHcC--------CCCCC-
Confidence 23467899999999999888999999999999999999999999643211 111111111 11111
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCCHHH
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRPSMTK 758 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RPt~~e 758 (817)
......+.+++.+||+.||++||++.+
T Consensus 219 -~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 -QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 112345778999999999999999555
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.61 Aligned_cols=236 Identities=27% Similarity=0.357 Sum_probs=187.9
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHH-HhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVS-IIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+.||+|+||+||+++.. +|+.||+|++.... ...+++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 35999999999999964 68999999996431 22345555555 56789999999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTT 153 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccc
Confidence 99999987644 57888899999999999999999 899999999999999999999999999987542221 122
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+..+. ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~--------~~~~-- 216 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-------AEMYDNILNKP--------LRLK-- 216 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-------HHHHHHHHcCC--------CCCC--
Confidence 345789999999999999999999999999999999999999964321 11111111111 1111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHH
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMT 757 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~ 757 (817)
......+.+++.+|++.||++||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11234678999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=329.46 Aligned_cols=251 Identities=20% Similarity=0.255 Sum_probs=199.1
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
..+.+.++||+|+||.||+++.. +++.+|+|++... ....+.+.+|+.+++.++||||+++++++.++...++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 44566688999999999999864 5889999999643 123456789999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
||+++|+|.+++... .++...+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 123 Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 123 EYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred cCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999988653 36777888899999999999999 89999999999999999999999999999876543
Q ss_pred CceeeeeccCCCCccCccccccC----ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 647 QSHVFTTLRGTRGYLAPEWITNY----AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
.........||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... .....+....
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~----- 263 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMDHK----- 263 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-------HHHHHHHcCC-----
Confidence 32222346799999999998653 4788999999999999999999999643311 1111221111
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSL--RPSMTKVVQM 762 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~--RPt~~evl~~ 762 (817)
..+..+........+.+++..|++.+|.+ ||+++|+++.
T Consensus 264 -~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 264 -NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 01111111223456789999999999988 9999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.02 Aligned_cols=252 Identities=24% Similarity=0.383 Sum_probs=196.6
Q ss_pred cccccCCCcceeEEEEEcCCC-c--EEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecC------Ceee
Q 036583 496 FSVKLGQGGFGSVYQGVLPDG-T--RLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG------THRL 563 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~~g-~--~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~------~~~~ 563 (817)
+.++||+|+||.||+|+..+. + .+|+|.++... ...+.+.+|++++.+++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 457899999999999997543 2 58999886542 2346788999999999999999999987532 2468
Q ss_pred EEEeeccCCChhhhhhhcc---cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCc
Q 036583 564 LAYEFMANGSLDKWIFKKN---QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLA 640 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 640 (817)
+++||+++|+|.+++.... ....+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcc
Confidence 9999999999999875321 22358899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCceee-eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcch
Q 036583 641 KLMTREQSHVF-TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKL 718 (817)
Q Consensus 641 ~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 718 (817)
+.......... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+.++..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~~~ 232 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-------SEIYDYLRQGNR 232 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHcCCC
Confidence 87654322111 12345678999999999899999999999999999999 7888864321 112222222221
Q ss_pred hhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 719 RNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 719 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.. ........+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 233 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 LK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 1112234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=323.60 Aligned_cols=263 Identities=25% Similarity=0.412 Sum_probs=205.5
Q ss_pred HHHHHhhccccccCCCcceeEEEEEcC--------CCcEEEEEEeccCC--cCHHHHHHHHHHhhcc-CcceeeeeeeEe
Q 036583 488 DLQTATNNFSVKLGQGGFGSVYQGVLP--------DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSI-HHLHLVKLRGFC 556 (817)
Q Consensus 488 ~l~~~~~~~~~~lG~G~fG~Vy~g~~~--------~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l-~h~niv~l~~~~ 556 (817)
++...++.+.++||+|+||.||+++.. .+..||+|.+.... ...+++.+|++++.++ +||||++++++|
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 344456778889999999999999732 12368999887532 2346899999999999 799999999999
Q ss_pred ecCCeeeEEEeeccCCChhhhhhhcc-------------cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCC
Q 036583 557 AEGTHRLLAYEFMANGSLDKWIFKKN-------------QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPEN 623 (817)
Q Consensus 557 ~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~N 623 (817)
.++...++++||+++|+|.+++.+.. ....+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccce
Confidence 99999999999999999999997532 12357889999999999999999999 999999999999
Q ss_pred eEecCCCcEEEeecCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCC
Q 036583 624 VLLDDNYHAKVSDFGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSD 701 (817)
Q Consensus 624 Ill~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~ 701 (817)
|+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 242 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-- 242 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 999999999999999998654322111 112334567999999999899999999999999999998 8888854321
Q ss_pred CCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCC
Q 036583 702 KAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPV 769 (817)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 769 (817)
......+..+.. .+........+.+++.+|++.+|.+||+|.|+++.|+.+...
T Consensus 243 -----~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 243 -----EELFKLLKEGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred -----HHHHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 111122221111 111112234688999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=339.56 Aligned_cols=249 Identities=20% Similarity=0.242 Sum_probs=198.7
Q ss_pred hccccccCCCcceeEEEEEcC-C-CcEEEEEEeccCCc-CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-D-GTRLAVKKLEGIGQ-GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~-g~~vavK~l~~~~~-~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
+.+.++||+|+||.||++... + ++.||+|.+..... ....+.+|+.+++.++||||+++++++..++..+|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 566788999999999999843 3 57788887654332 34567889999999999999999999999999999999999
Q ss_pred CCChhhhhhhcc-cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc-
Q 036583 571 NGSLDKWIFKKN-QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS- 648 (817)
Q Consensus 571 ~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~- 648 (817)
+|+|.++|.... ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 999999886432 23357888999999999999999999 8999999999999999999999999999987644322
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+....
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-------~~~~~~~~~~~~~~-------- 290 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-------REIMQQVLYGKYDP-------- 290 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCC--------
Confidence 122345799999999999999999999999999999999999999964321 11111111111110
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
........+.+++.+||+.||++||+++++++
T Consensus 291 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11122346889999999999999999999874
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=317.87 Aligned_cols=239 Identities=25% Similarity=0.328 Sum_probs=191.0
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
++||+|+||.||+++.. +|+.||+|.++.. ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999965 5889999999753 23345677788888754 899999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
|+|..++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRA 153 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cce
Confidence 99999987643 57888999999999999999999 999999999999999999999999999987532211 122
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+. +.. +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-------~~~~~~~~~~~------~~~--~-- 216 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-------DELFESIRVDT------PHY--P-- 216 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC------CCC--C--
Confidence 346789999999999999999999999999999999999999964321 11111111110 111 1
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMT-KVV 760 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~-evl 760 (817)
......+.+++..|++.||++||++. +++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11233577899999999999999985 565
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=326.06 Aligned_cols=247 Identities=23% Similarity=0.317 Sum_probs=195.4
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
.+.++||+|+||+||+++.. +++.||||++... ......+.+|+.++..++||||+++++++.++...++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (364)
T cd05599 4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL 83 (364)
T ss_pred eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCC
Confidence 45578999999999999964 5889999999653 223456788999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+......
T Consensus 84 ~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 84 PGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 9999999997654 58899999999999999999999 89999999999999999999999999998764321100
Q ss_pred -------------------------------------eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCC
Q 036583 650 -------------------------------------VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRK 692 (817)
Q Consensus 650 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~ 692 (817)
......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0012468999999999999899999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCC---HHHHHH
Q 036583 693 NFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPS---MTKVVQ 761 (817)
Q Consensus 693 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt---~~evl~ 761 (817)
||...... .....+.... ..+..+........+.+++.+|+. +|.+|++ ++|+++
T Consensus 238 Pf~~~~~~-------~~~~~i~~~~------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 238 PFCSDNPQ-------ETYRKIINWK------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCHH-------HHHHHHHcCC------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99643211 1111111110 011111111223456788888886 9999998 888887
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.79 Aligned_cols=251 Identities=22% Similarity=0.271 Sum_probs=197.1
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
..+.+.++||+|+||.||+++.. +++.+|+|.+.+. ....+.+.+|+.++..++||||+++++++.++...++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 34556688999999999999965 5788999998642 223456889999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
||+++|+|.+++... .++...+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||++......
T Consensus 123 Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 123 EYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred cCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 999999999998643 36788889999999999999999 99999999999999999999999999999876543
Q ss_pred CceeeeeccCCCCccCccccccC----ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 647 QSHVFTTLRGTRGYLAPEWITNY----AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
.........||+.|+|||++.+. .++.++|||||||++|||++|+.||...... . ....+....
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~-~~~~i~~~~----- 263 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------G-TYSKIMDHK----- 263 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCC-----
Confidence 33233456799999999999754 3778999999999999999999999643211 1 111111110
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSL--RPSMTKVVQM 762 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~--RPt~~evl~~ 762 (817)
..+..+........+.+++..|++.++.+ ||++.|+++.
T Consensus 264 -~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 264 -NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 01111222223445778888899865544 8999999985
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.18 Aligned_cols=259 Identities=24% Similarity=0.321 Sum_probs=199.6
Q ss_pred cccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcce-eeeeeeEeecCC------eeeE
Q 036583 496 FSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLH-LVKLRGFCAEGT------HRLL 564 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~n-iv~l~~~~~~~~------~~~l 564 (817)
..++||+|+||+||+|+. .+|+.||+|++.-..+ ......+|+.++++++|+| |++|++++...+ ..++
T Consensus 15 ~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~l 94 (323)
T KOG0594|consen 15 KVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYL 94 (323)
T ss_pred HHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEE
Confidence 346799999999999994 4688999999975533 2356789999999999999 999999998877 7889
Q ss_pred EEeeccCCChhhhhhhcccc-cchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 565 AYEFMANGSLDKWIFKKNQE-FLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
|+||++. +|..++...... ..++......++.||++||+|||+ ++|+||||||+||||+++|.+||+|||+|+..
T Consensus 95 vfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 95 VFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred EEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchHHHh
Confidence 9999977 999999765521 246668899999999999999999 99999999999999999999999999999966
Q ss_pred CCCCceeeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcc-----
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGK----- 717 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----- 717 (817)
.-.. ...+...+|..|.|||++.+. .|+...||||+|||+.||++++..|.+....+. .....+.+....
T Consensus 171 ~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q---l~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 171 SIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ---LFRIFRLLGTPNEKDWP 246 (323)
T ss_pred cCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH---HHHHHHHcCCCCccCCC
Confidence 5322 224567889999999999876 789999999999999999999999976544221 111122221111
Q ss_pred -hhhhcccccCC-----ccc--H---HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 718 -LRNILDSRLNI-----DEQ--S---DRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 718 -~~~~~d~~~~~-----~~~--~---~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
+..+.+-.... +.. . .......+++.+|++.+|.+|.|++.++++
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 01111111000 000 0 111367899999999999999999999985
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=309.81 Aligned_cols=249 Identities=30% Similarity=0.472 Sum_probs=203.7
Q ss_pred hhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
.+.+.+.||+|+||.||++.. .|+.||+|.+.......+++.+|+.++++++|+||+++++++.+....++||||++++
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 85 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKG 85 (256)
T ss_pred hccceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCC
Confidence 445668899999999999987 4789999999766555678999999999999999999999999999999999999999
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeee
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT 652 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 652 (817)
+|.+++..... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++.......
T Consensus 86 ~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---- 157 (256)
T cd05039 86 SLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---- 157 (256)
T ss_pred cHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc----
Confidence 99999976442 258999999999999999999999 9999999999999999999999999999987633221
Q ss_pred eccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 653 TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 653 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
....+..|+|||.+....++.++||||||++++|+++ |+.||..... .........+. .....
T Consensus 158 ~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~---------~~~~~ 221 (256)
T cd05039 158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KDVVPHVEKGY---------RMEAP 221 (256)
T ss_pred cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHhcCC---------CCCCc
Confidence 2334567999999988889999999999999999997 9999853321 11111111110 01111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
...+..+.+++.+|++.+|++||++.|++++|+.+
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 12245688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=309.39 Aligned_cols=246 Identities=30% Similarity=0.448 Sum_probs=197.0
Q ss_pred cccCCCcceeEEEEEcCC----CcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 498 VKLGQGGFGSVYQGVLPD----GTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
++||+|+||.||+|+... +..+|+|.+..... ..+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997432 26899999876543 4568999999999999999999999876 5568999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999997654 58899999999999999999998 8999999999999999999999999999987654332211
Q ss_pred e--eccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 652 T--TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 652 ~--~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
. ...++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+..+.. .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-------~~~~~~~~~~~---------~ 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-------EVIAMLESGER---------L 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHHcCCc---------C
Confidence 1 1223467999999998899999999999999999998 99999643211 11122222110 0
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
+........+.+++.+|++.+|++||++.++++.|+++
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11112234678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=323.94 Aligned_cols=247 Identities=23% Similarity=0.367 Sum_probs=206.9
Q ss_pred hccccccCCCcceeEEEEEcC--CCc--EEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP--DGT--RLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~--~g~--~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
....++||+|.||.|++|.+. .|+ .||||.++.... ...+|++|+.+|.+|+|+|+++|+|...+ ....||+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 334578999999999999974 344 589999987643 46899999999999999999999999988 78899999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
.++.|+|.+.|++. ....+-......++.|||.||.||.. +++|||||.++|+||-..-.+||+||||.+.+....
T Consensus 191 LaplGSLldrLrka-~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKA-KKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhhc-cccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999999883 33367778889999999999999999 999999999999999999999999999999887654
Q ss_pred ceee-ee-ccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccc
Q 036583 648 SHVF-TT-LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724 (817)
Q Consensus 648 ~~~~-~~-~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 724 (817)
.... .. ..-...|.|||.+..+.++.++|||+|||.+|||++ |..|+-+.... .+.+.+|.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------------qIL~~iD~ 330 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------------QILKNIDA 330 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------------HHHHhccc
Confidence 4332 22 445678999999999999999999999999999999 77788543211 13344455
Q ss_pred ccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 725 RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 725 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+-..+....+.++++++++.||..+|++|||+..|.+
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 5555566677889999999999999999999999974
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=315.19 Aligned_cols=250 Identities=26% Similarity=0.330 Sum_probs=198.9
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+...++||+|+||+||++.. .+++.||+|++.... .....+.+|+.++++++||||+++++.+..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 44567899999999999985 468899999996532 2235678899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++|+|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 82 MNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 999999998865432 258899999999999999999999 8999999999999999999999999999986543221
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
.....|+..|+|||.+.+..++.++||||+||++|||++|+.||....... ........+... ..
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~----------~~ 222 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKED----------QE 222 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhc----------cc
Confidence 123568999999999998889999999999999999999999997533211 000011111110 01
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRP-----SMTKVVQM 762 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~evl~~ 762 (817)
.........+.+++..||+.||++|| +++++++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11122344678999999999999999 88888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=298.13 Aligned_cols=255 Identities=20% Similarity=0.243 Sum_probs=197.4
Q ss_pred ccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc--C-HHHHHHHHHHhhccCcceeeeeeeEee--cCCeeeEEEeecc
Q 036583 497 SVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ--G-KKEFRAEVSIIGSIHHLHLVKLRGFCA--EGTHRLLAYEFMA 570 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--~-~~~~~~Ev~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~ 570 (817)
.++|++|.||.||+|+.. +++.||+|+++-..+ + .-.-++||.+|.+++|||||.+..+.. +-+..|||||||+
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 468999999999999964 578999999975432 2 134589999999999999999998875 4457999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+ +|..++..-.+ ++...+..-+..|+++|++|||. ..|+|||||++|+|+.+.|.+||+|||||+.++... ..
T Consensus 161 h-DLksl~d~m~q--~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~-k~ 233 (419)
T KOG0663|consen 161 H-DLKSLMETMKQ--PFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL-KP 233 (419)
T ss_pred h-hHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc-cc
Confidence 8 89999977654 57778888999999999999999 999999999999999999999999999999887653 34
Q ss_pred eeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhc-----------ch
Q 036583 651 FTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEG-----------KL 718 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-----------~~ 718 (817)
++..+-|..|+|||.+.+ ..|+.+.|+||+|||+.||+++++.|.+....+..+ .++..+... ..
T Consensus 234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~---~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD---KIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH---HHHHHhCCCccccCCCccccch
Confidence 566788999999999986 478999999999999999999999997765443211 111111110 00
Q ss_pred h------hhcccccCCcccHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 719 R------NILDSRLNIDEQSD-RVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 719 ~------~~~d~~~~~~~~~~-~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
. +..-..++..+... ..+.-.+++..++..||.+|.|++|.++
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0 00000001111111 2345678888999999999999999887
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=312.06 Aligned_cols=254 Identities=28% Similarity=0.498 Sum_probs=202.5
Q ss_pred HhhccccccCCCcceeEEEEEcC----CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP----DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~----~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv 565 (817)
..+.+.+.||+|+||.||+|... .+..+|+|.++... ...+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 34556788999999999999853 23479999886542 2346889999999999999999999999999999999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|||+++++|.+++..... .+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999976542 57889999999999999999999 9999999999999999999999999999987654
Q ss_pred CCceeeee--ccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 646 EQSHVFTT--LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 646 ~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
........ ..++..|+|||.+.+..++.++||||||++++|+++ |+.||......+ ....+.++.
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~----- 226 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-------VIKAIEEGY----- 226 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-------HHHHHhCCC-----
Confidence 33222222 223568999999998889999999999999999886 999986432211 111121110
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
..+.....+..+.+++.+|++.+|.+||+|.++++.|+++
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ----RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1111122344678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=317.03 Aligned_cols=253 Identities=26% Similarity=0.439 Sum_probs=200.2
Q ss_pred cccccCCCcceeEEEEEcC------CCcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 496 FSVKLGQGGFGSVYQGVLP------DGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
+.+.||+|+||.||+|... ....+++|.+..... ..+++.+|+.++..++||||+++++.+...+..++++|
T Consensus 4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence 4567999999999999842 235788888865432 24678999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcc---------------------cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEe
Q 036583 568 FMANGSLDKWIFKKN---------------------QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL 626 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll 626 (817)
|+++++|.+++.... ....+++..++.++.|++.||+|||+ .+|+||||||+||++
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nill 160 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLV 160 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEEE
Confidence 999999999986421 11257889999999999999999998 999999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCc
Q 036583 627 DDNYHAKVSDFGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAH 704 (817)
Q Consensus 627 ~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~ 704 (817)
++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++ |+.||.....
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----- 235 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP----- 235 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-----
Confidence 999999999999998654332211 122345678999999988889999999999999999998 9999854321
Q ss_pred chHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 705 FPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
...+.....+ ...+........+.+++.+|++.+|++||++.|+++.|+++.
T Consensus 236 --~~~~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 236 --ERLFNLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred --HHHHHHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 1122222211 111111223346889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=292.75 Aligned_cols=248 Identities=22% Similarity=0.351 Sum_probs=200.8
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
.+.+.++||+|.|+.||+... +.|++.|+|++... ..+.+++.+|++|.+.|+||||++|.+...+....+||+|+
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~ 91 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 91 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence 345567899999999999874 56888888887432 34678999999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec---CCCcEEEeecCCccccCC
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD---DNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~ki~Dfgla~~~~~ 645 (817)
|.|++|..-+-+. ...++..+-..+.||+.+|.|+|. ++|+|||+||.|+++- ..--+||+|||+|..+..
T Consensus 92 m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 92 VTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred ccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 9999997655443 367888899999999999999999 9999999999999994 345699999999998872
Q ss_pred CCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccc
Q 036583 646 EQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 725 (817)
........|||+|||||+++..+|+..+|||+.|||||-|+.|.+||.+.... ..++.+..+... +
T Consensus 166 --g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-------rlye~I~~g~yd-~---- 231 (355)
T KOG0033|consen 166 --GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYEQIKAGAYD-Y---- 231 (355)
T ss_pred --ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-------HHHHHHhccccC-C----
Confidence 23335578999999999999999999999999999999999999999754322 123333333211 0
Q ss_pred cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 726 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..+.-....+...+++.+|+..||.+|.|+.|.++
T Consensus 232 -~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 232 -PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred -CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11111223346789999999999999999998875
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=310.80 Aligned_cols=252 Identities=25% Similarity=0.420 Sum_probs=198.5
Q ss_pred cccccCCCcceeEEEEEcCC----CcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecCCe------e
Q 036583 496 FSVKLGQGGFGSVYQGVLPD----GTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTH------R 562 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~------~ 562 (817)
+.+.||+|+||.||+|.... +..||+|+++.... ....+.+|+++++.++||||+++++++..... .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 45779999999999998642 36799999875422 24578999999999999999999999876554 7
Q ss_pred eEEEeeccCCChhhhhhhcc---cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCC
Q 036583 563 LLAYEFMANGSLDKWIFKKN---QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGL 639 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl 639 (817)
++++||+++|+|..++.... ....+++.....++.|++.||+|||+ .+++||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCccc
Confidence 99999999999999986532 22358889999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCceee-eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcc
Q 036583 640 AKLMTREQSHVF-TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGK 717 (817)
Q Consensus 640 a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 717 (817)
++.......... ....++..|+|||.+.+..++.++||||||+++|||++ |..||...... ........+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~ 232 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-------EIYDYLRHGN 232 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCC
Confidence 987654322211 11335678999999998899999999999999999999 88888543211 1111222211
Q ss_pred hhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 718 LRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 718 ~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.. .........+.+++.+|++.||++||++.|+++.|+.+
T Consensus 233 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 RL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 11112344788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=320.60 Aligned_cols=237 Identities=27% Similarity=0.341 Sum_probs=188.4
Q ss_pred cccCCCcceeEEEEEc-CCCcEEEEEEeccC----CcCHHHHHHHHH-HhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 498 VKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI----GQGKKEFRAEVS-IIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~----~~~~~~~~~Ev~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+.||+|+||+||+++. .+|+.+|+|++... ....+++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3599999999999985 46899999998643 122345666655 46778999999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
|+|..++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TT 153 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Cc
Confidence 99998886544 58889999999999999999999 9999999999999999999999999999875422211 12
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+..+. +....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~~~~~~--------~~~~~- 217 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-------EMYDNILHKP--------LVLRP- 217 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-------HHHHHHHcCC--------ccCCC-
Confidence 3457899999999999999999999999999999999999999643211 1112222211 11111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHH
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMTK 758 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~e 758 (817)
.....+.+++..|++.+|.+||++.+
T Consensus 218 -~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 218 -GASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred -CCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 12345778999999999999998864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.18 Aligned_cols=256 Identities=26% Similarity=0.452 Sum_probs=200.6
Q ss_pred hhccccccCCCcceeEEEEEc-CCCc----EEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGT----RLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~----~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv 565 (817)
...+.++||+|+||+||+|+. .+++ .||+|++.... ...+++.+|+.++..++|+||+++++++.. ...+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~ 86 (279)
T cd05109 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLV 86 (279)
T ss_pred heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEE
Confidence 344567899999999999984 3444 48999986542 235678999999999999999999999975 457899
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
+||+++|+|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 87 ~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 87 TQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999976432 58889999999999999999999 8999999999999999999999999999987654
Q ss_pred CCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 646 EQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 646 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
..... .....++..|+|||.+.+..++.++|||||||++|||++ |..||+..... .....+..+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~------ 228 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-------EIPDLLEKGE------ 228 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCC------
Confidence 32221 112344678999999998899999999999999999998 89998643211 1111111111
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCCC
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVP 770 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 770 (817)
..+........+.+++..||+.||++||++.|+++.|+.+...+
T Consensus 229 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 229 ---RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ---cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 11111123346789999999999999999999999998875444
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=328.28 Aligned_cols=249 Identities=20% Similarity=0.280 Sum_probs=193.2
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.++||+|+||+||+++.. .++.+|||++... ....+.+.+|++++.+++|+||+++++.+.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 445678999999999999854 5889999998643 22346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++|+|.+++.+.. .++......++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 83 ~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 83 IPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999997654 57888888999999999999999 9999999999999999999999999999753311000
Q ss_pred ------------------------------------------eeeeeccCCCCccCccccccCccCccccccchhhhHHH
Q 036583 649 ------------------------------------------HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLE 686 (817)
Q Consensus 649 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~e 686 (817)
.......||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 00112468999999999999999999999999999999
Q ss_pred hhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCC---CHHHHHHH
Q 036583 687 IIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRP---SMTKVVQM 762 (817)
Q Consensus 687 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RP---t~~evl~~ 762 (817)
|++|+.||....... ....+.... ..+..+........+.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 237 ll~G~~Pf~~~~~~~-------~~~~i~~~~------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAE-------TQLKVINWE------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHH-------HHHHHhccC------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999996543211 111111100 01111111112334566777765 5999999 88999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=314.25 Aligned_cols=255 Identities=24% Similarity=0.411 Sum_probs=202.5
Q ss_pred HhhccccccCCCcceeEEEEEcCC------CcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPD------GTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 563 (817)
..+.+.++||+|+||.||+|...+ +..+|+|.+.... ....++.+|+.++..++|+||+++++++..+...+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 345566889999999999998642 4689999986543 23457899999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhhhccc-------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEee
Q 036583 564 LAYEFMANGSLDKWIFKKNQ-------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSD 636 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D 636 (817)
+||||+++++|.+++..... ...+++..++.++.||+.||.|||+ .+++||||||+||+++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECC
Confidence 99999999999999975322 1246888999999999999999998 9999999999999999999999999
Q ss_pred cCCccccCCCCce-eeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhh
Q 036583 637 FGLAKLMTREQSH-VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMME 714 (817)
Q Consensus 637 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 714 (817)
||+++........ ......++..|+|||.+.+..++.++|||||||++||+++ |+.||...... .......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~ 235 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE-------EVLKFVI 235 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH-------HHHHHHh
Confidence 9999865443221 1123456778999999988889999999999999999998 89898543211 1122222
Q ss_pred hcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 715 EGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 715 ~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
.+..... +......+.+++..||+.+|++|||+.|+++.|+.
T Consensus 236 ~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 DGGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred cCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 2111111 11124578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=313.94 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=197.5
Q ss_pred hccccccCCCcceeEEEEEcCC------CcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPD------GTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv 565 (817)
+.+.+.||+|+||.||+|...+ +..||+|.+..... ....|.+|+.++++++|+||+++++++.+....++|
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFIL 87 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEE
Confidence 4455789999999999998753 56788998864432 345789999999999999999999999999999999
Q ss_pred EeeccCCChhhhhhhccc----ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC---cEEEeecC
Q 036583 566 YEFMANGSLDKWIFKKNQ----EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY---HAKVSDFG 638 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ki~Dfg 638 (817)
|||+++++|.+++..... ...+++..+++++.||+.||+|||+ .+++|+||||+||+++.++ .+||+|||
T Consensus 88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccCc
Confidence 999999999999976432 1258899999999999999999999 8999999999999998654 69999999
Q ss_pred CccccCCCCceee-eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhc
Q 036583 639 LAKLMTREQSHVF-TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEG 716 (817)
Q Consensus 639 la~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 716 (817)
+++.......... .....+..|+|||++.+..++.++|||||||++|||++ |+.||...... . ....+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~------~-~~~~~~~~ 237 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ------E-VMEFVTGG 237 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------H-HHHHHHcC
Confidence 9987643221111 11233568999999998899999999999999999997 99999643221 1 11111111
Q ss_pred chhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 717 KLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 717 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
............+.+++.+|++.+|++||++.+|++.|+
T Consensus 238 ---------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 ---------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ---------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111111223346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=312.83 Aligned_cols=254 Identities=28% Similarity=0.484 Sum_probs=201.2
Q ss_pred HhhccccccCCCcceeEEEEEcCC-C---cEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPD-G---TRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~-g---~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv 565 (817)
+.+.+.+.||+|+||.||+|.... + ..||||.+.... ...++|..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 345677899999999999999643 3 369999987542 2356899999999999999999999999999999999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|||+++++|.+++..... .+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999999976433 57889999999999999999998 8999999999999999999999999999886543
Q ss_pred CCcee-eee-cc--CCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhh
Q 036583 646 EQSHV-FTT-LR--GTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRN 720 (817)
Q Consensus 646 ~~~~~-~~~-~~--gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (817)
..... ... .. .+..|+|||.+.+..++.++|||||||++||+++ |..||...... .....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-------~~~~~i~~~---- 227 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-------DVINAIEQD---- 227 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-------HHHHHHHcC----
Confidence 22211 111 11 2357999999998899999999999999999886 99999643211 111111111
Q ss_pred hcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 721 ILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 721 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
...+...+.+..+.+++.+||+.+|++||++++|+++|+.+
T Consensus 228 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 -----YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111122344678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=303.05 Aligned_cols=258 Identities=22% Similarity=0.338 Sum_probs=201.0
Q ss_pred cccCCCcceeEEEEEc-CCCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeec-----CCeeeEEEee
Q 036583 498 VKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE-----GTHRLLAYEF 568 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~-----~~~~~lv~e~ 568 (817)
+.||+|+||.|..+.. .+|+.||||++... ....++-.+|+++|+.++|+||+.+.+.+.. -...|+|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 5699999999999985 46899999999743 2345778899999999999999999999865 3578999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC-C
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE-Q 647 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~-~ 647 (817)
|+. +|...++... .|+.....-++.||++||.|+|+ .+|+||||||+|+|++.+...||+|||||+..... .
T Consensus 108 Met-DL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 108 MET-DLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE 180 (359)
T ss_pred Hhh-HHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeeccccCc
Confidence 954 8998887654 48889999999999999999999 99999999999999999999999999999987543 1
Q ss_pred ceeeeeccCCCCccCccccc-cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcc--------hHHHHHHhhhcch
Q 036583 648 SHVFTTLRGTRGYLAPEWIT-NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHF--------PSYAFKMMEEGKL 718 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~--------~~~~~~~~~~~~~ 718 (817)
....+..+.|..|.|||++. ...|+.+.||||.|||+.||++|++.|.+.+......+ .......+.....
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a 260 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA 260 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence 22235577899999999986 46899999999999999999999999977654332211 1222233333333
Q ss_pred hhhcccccCC---ccc---HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 719 RNILDSRLNI---DEQ---SDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 719 ~~~~d~~~~~---~~~---~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
...+...... +.. ......+++++.+|+..||.+|+|++|+++.
T Consensus 261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 3222211111 100 0223467899999999999999999999973
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.75 Aligned_cols=259 Identities=25% Similarity=0.401 Sum_probs=203.6
Q ss_pred HHHhhccccccCCCcceeEEEEEcC--------CCcEEEEEEeccCC--cCHHHHHHHHHHhhcc-CcceeeeeeeEeec
Q 036583 490 QTATNNFSVKLGQGGFGSVYQGVLP--------DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAE 558 (817)
Q Consensus 490 ~~~~~~~~~~lG~G~fG~Vy~g~~~--------~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~ 558 (817)
....+.+.++||+|+||.||+++.. +...+|+|.+.... ....++.+|++++.++ +||||+++++++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3456677889999999999999742 23569999997542 2345788999999999 79999999999999
Q ss_pred CCeeeEEEeeccCCChhhhhhhccc-------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeE
Q 036583 559 GTHRLLAYEFMANGSLDKWIFKKNQ-------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVL 625 (817)
Q Consensus 559 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIl 625 (817)
....++||||+++|+|.+++..... ...+++..+++++.|++.||+|||+ .+++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheE
Confidence 9999999999999999999976421 1258899999999999999999998 89999999999999
Q ss_pred ecCCCcEEEeecCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCC
Q 036583 626 LDDNYHAKVSDFGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKA 703 (817)
Q Consensus 626 l~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~ 703 (817)
++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---- 248 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 248 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH----
Confidence 9999999999999988654322111 111234568999999998889999999999999999998 8888853221
Q ss_pred cchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 704 HFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
......+..+.. .+........+.+++.+|++.+|++||+|.||++.|+.+.
T Consensus 249 ---~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 249 ---EELFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred ---HHHHHHHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 111222222111 1111123346788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=318.42 Aligned_cols=242 Identities=25% Similarity=0.329 Sum_probs=191.9
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHh---hccCcceeeeeeeEeecCCeeeEEE
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSII---GSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l---~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
.+.+.||+|+||.||++... +++.||||+++.. ....+.+..|++++ ..++||||+++++++.++...++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 35678999999999999854 5889999999643 12345667776655 5678999999999999999999999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
||+++++|..++... .+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 82 E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 82 EYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred cCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999888543 58999999999999999999999 99999999999999999999999999998754322
Q ss_pred CceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 647 QSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
.. ......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+..+. .
T Consensus 155 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-------~~~~~i~~~~--------~ 218 (324)
T cd05589 155 GD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-------EVFDSIVNDE--------V 218 (324)
T ss_pred CC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC--------C
Confidence 21 123467899999999999989999999999999999999999999643211 1111111111 1
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRP-----SMTKVVQ 761 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~evl~ 761 (817)
..+ ......+.+++.+||+.||.+|| ++.++++
T Consensus 219 ~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 RYP--RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCC--CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 111 11234578899999999999999 5677666
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.21 Aligned_cols=245 Identities=23% Similarity=0.354 Sum_probs=212.9
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
.|++.+.||+|.|..|-++++ -.|..||||++.+..- ....+..|++.|+.++|||||+|+.+......+|||.|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 355667899999999999984 4799999999987643 356789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEe-cCCCcEEEeecCCccccCCCC
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL-DDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll-~~~~~~ki~Dfgla~~~~~~~ 647 (817)
=++|+|.+||.++.. .+.+..+.+++.||+.|+.|+|+ ..+|||||||+||.+ ..-|-+||.|||++..+.+..
T Consensus 99 GD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred cCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999998776 58999999999999999999999 999999999999865 677899999999998776543
Q ss_pred ceeeeeccCCCCccCccccccCccC-ccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAIS-EKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
..++.+|...|-|||++.+..|+ +++||||||||||-|++|+.||+...+.+ .+..++|..+
T Consensus 174 --kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE---------------TLTmImDCKY 236 (864)
T KOG4717|consen 174 --KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE---------------TLTMIMDCKY 236 (864)
T ss_pred --hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh---------------hhhhhhcccc
Confidence 45678999999999999999887 67899999999999999999998654432 3566777766
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..+. ....++.+||..|++.||++|.+.+||+.
T Consensus 237 tvPs--hvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 TVPS--HVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cCch--hhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 5443 35567899999999999999999999986
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=313.99 Aligned_cols=253 Identities=23% Similarity=0.419 Sum_probs=199.6
Q ss_pred hccccccCCCcceeEEEEEcC------CCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP------DGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
..+.++||+|+||.||++... ++..+|+|.+.... ...+.+.+|++++.+++|+||+++++++.++...+++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (280)
T cd05092 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVF 86 (280)
T ss_pred ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEE
Confidence 345678999999999999632 35678999886543 33568999999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccc------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEE
Q 036583 567 EFMANGSLDKWIFKKNQ------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKV 634 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki 634 (817)
||+++++|.+++..... ...+++..++.++.||+.|++|||+ .+++|+||||+||++++++.+||
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 87 EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred ecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEEE
Confidence 99999999999975431 1247889999999999999999998 99999999999999999999999
Q ss_pred eecCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHH
Q 036583 635 SDFGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKM 712 (817)
Q Consensus 635 ~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 712 (817)
+|||++.......... .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+ ....
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~ 236 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-------AIEC 236 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-------HHHH
Confidence 9999997654332211 122345678999999998899999999999999999998 899985332111 1111
Q ss_pred hhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 713 MEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 713 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
...+.. ..........+.+++.+||+.||.+||++.||++.|++
T Consensus 237 ~~~~~~---------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 237 ITQGRE---------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHcCcc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111110 01111223467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=319.30 Aligned_cols=236 Identities=25% Similarity=0.354 Sum_probs=186.8
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHH-HhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVS-IIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+.||+|+||.||+++.. +++.+|+|++.... ....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 35999999999999964 58899999986431 22345556654 57889999999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
++|..++.... .++...+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT 153 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence 99998886543 57788888999999999999998 899999999999999999999999999987542221 112
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+..+ ....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~--------~~~~~-- 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-------SQMYDNILHK--------PLQLP-- 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-------HHHHHHHhcC--------CCCCC--
Confidence 345789999999999998999999999999999999999999964321 1111111111 11111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHH
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMT 757 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~ 757 (817)
......+.+++.+|++.||.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 12234678999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=308.11 Aligned_cols=252 Identities=25% Similarity=0.355 Sum_probs=191.5
Q ss_pred cccCCCcceeEEEEEcCC---CcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 498 VKLGQGGFGSVYQGVLPD---GTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~---g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
++||+|+||.||+|...+ +..+|+|+++.... ....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998543 45799999875432 3357889999999999999999999999999999999999999
Q ss_pred Chhhhhhhccc--ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 573 SLDKWIFKKNQ--EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 573 sL~~~l~~~~~--~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+|.+++..... ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975321 2245677888999999999999999 899999999999999999999999999997654332211
Q ss_pred e-eeccCCCCccCccccccC-------ccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhh
Q 036583 651 F-TTLRGTRGYLAPEWITNY-------AISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721 (817)
Q Consensus 651 ~-~~~~gt~~y~aPE~~~~~-------~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (817)
. ....++..|+|||++.+. .++.++||||||+++|||++ |+.||....... .......+....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ-------VLTYTVREQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH-------HHHHHhhcccCCC
Confidence 1 224567889999998642 35789999999999999996 999995432111 1111111111122
Q ss_pred cccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 722 ~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
.++.+.. .....+.+++..|+ .+|++|||++||++.|+
T Consensus 231 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222211 12235677888898 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=318.77 Aligned_cols=262 Identities=24% Similarity=0.401 Sum_probs=205.6
Q ss_pred HHHHhhccccccCCCcceeEEEEEc--------CCCcEEEEEEeccC--CcCHHHHHHHHHHhhcc-CcceeeeeeeEee
Q 036583 489 LQTATNNFSVKLGQGGFGSVYQGVL--------PDGTRLAVKKLEGI--GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCA 557 (817)
Q Consensus 489 l~~~~~~~~~~lG~G~fG~Vy~g~~--------~~g~~vavK~l~~~--~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~ 557 (817)
+....+.+.+.||+|+||.||+++. .++..||+|.+... ....+++.+|+.++..+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 3345556678899999999999973 12457999988653 23356789999999999 8999999999999
Q ss_pred cCCeeeEEEeeccCCChhhhhhhccc-------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 036583 558 EGTHRLLAYEFMANGSLDKWIFKKNQ-------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENV 624 (817)
Q Consensus 558 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NI 624 (817)
.....++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+ .+++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceE
Confidence 99999999999999999999976421 1257888999999999999999999 8999999999999
Q ss_pred EecCCCcEEEeecCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCC
Q 036583 625 LLDDNYHAKVSDFGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDK 702 (817)
Q Consensus 625 ll~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~ 702 (817)
++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--- 245 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 245 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---
Confidence 99999999999999998764432221 122445678999999998889999999999999999998 7788853221
Q ss_pred CcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCC
Q 036583 703 AHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPV 769 (817)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 769 (817)
......+..+.. ..........+.+++.+||+.+|++||+|.|+++.|+++...
T Consensus 246 ----~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 ----EELFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred ----HHHHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 112222222111 011112345688899999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=316.13 Aligned_cols=256 Identities=28% Similarity=0.455 Sum_probs=202.5
Q ss_pred HhhccccccCCCcceeEEEEEc------CCCcEEEEEEeccCCc--CHHHHHHHHHHhhcc-CcceeeeeeeEeecCCee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL------PDGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHR 562 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~------~~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~ 562 (817)
....+.++||+|+||.||++.. ..+..+|||+++.... ..+.+.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 3455668899999999999973 1345799999875432 245789999999999 799999999999999999
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
++||||+++|+|.+++..... ..+++.++..++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||+++.
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999999975432 248999999999999999999999 8999999999999999999999999999986
Q ss_pred cCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhh
Q 036583 643 MTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRN 720 (817)
Q Consensus 643 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (817)
........ .....++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .........+
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~------~~~~~~~~~~---- 260 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD------SKFYKLIKEG---- 260 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch------HHHHHHHHcC----
Confidence 64432211 122345678999999998889999999999999999998 99998643221 1111111111
Q ss_pred hcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 721 ILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 721 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
............+.+++.+|++.+|++|||+.|+++.|+..
T Consensus 261 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 -----YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -----CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11111111234688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=308.03 Aligned_cols=252 Identities=25% Similarity=0.325 Sum_probs=190.4
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCC-----eeeEEEeeccC
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT-----HRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~ 571 (817)
+.+|.|.||.||+|++. .++.||||+...... .-.+|+.+|+++.|||||+|+-+|.... ...+|||||+.
T Consensus 30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~ 106 (364)
T KOG0658|consen 30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE 106 (364)
T ss_pred EEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH
Confidence 57999999999999965 468999999865432 2357999999999999999999985422 23589999998
Q ss_pred CChhhhhhhc-ccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCC-CcEEEeecCCccccCCCCce
Q 036583 572 GSLDKWIFKK-NQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDN-YHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 572 gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~Dfgla~~~~~~~~~ 649 (817)
+|.++++.- ..+..++...+.-+..||.+||+|||+ .+|+||||||+|+|+|.+ |.+||||||.|+.+......
T Consensus 107 -tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn 182 (364)
T KOG0658|consen 107 -TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN 182 (364)
T ss_pred -HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc
Confidence 898888742 112256777778899999999999999 999999999999999965 99999999999988665433
Q ss_pred eeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhc---chh------
Q 036583 650 VFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEG---KLR------ 719 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~------ 719 (817)
.....+.-|+|||.+.+ ..|+.+.||||.|||+.||+-|++.|.+.+..+.. ....+.+.-. .+.
T Consensus 183 --iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL---~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 183 --ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQL---VEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred --eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHH---HHHHHHhCCCCHHHHhhcCccc
Confidence 33456778999999986 47899999999999999999999999775433221 1111111111 110
Q ss_pred -hhcccccCCc-----ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 720 -NILDSRLNID-----EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 720 -~~~d~~~~~~-----~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+...+.+... .......+.++++.++++.+|.+|.++.|++.
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1111111111 12234457889999999999999999999986
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=309.13 Aligned_cols=256 Identities=22% Similarity=0.351 Sum_probs=203.6
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.++||+|+||.||+|+.. +++.||||.+.... .....+.+|+++++.++||||+++++++.+.+..++++||
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 455678999999999999954 68899999885422 2235688999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcc-cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 569 MANGSLDKWIFKKN-QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 569 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
+++++|.+++.... ....++......++.||+.||+|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 99999999886422 12357888999999999999999998 899999999999999999999999999988764332
Q ss_pred ceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
. ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ... ....+..... +
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~-~~~~~~~~~~-----~--- 226 (267)
T cd08228 161 T-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFS-LCQKIEQCDY-----P--- 226 (267)
T ss_pred H-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHH-HHHHHhcCCC-----C---
Confidence 1 112346788999999999888999999999999999999999998543221 111 1111111110 0
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
..........+.+++.+||+.+|++||++.||++.|+++
T Consensus 227 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 011122345688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=314.79 Aligned_cols=258 Identities=22% Similarity=0.338 Sum_probs=191.3
Q ss_pred hccccccCCCcceeEEEEEc--CCCcEEEEEEeccCC---cCHHHHHHHHHHhhcc---CcceeeeeeeEee-----cCC
Q 036583 494 NNFSVKLGQGGFGSVYQGVL--PDGTRLAVKKLEGIG---QGKKEFRAEVSIIGSI---HHLHLVKLRGFCA-----EGT 560 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~--~~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l---~h~niv~l~~~~~-----~~~ 560 (817)
+.+.++||+|+||.||+++. .+++.||+|++.... .....+.+|+.++..+ +||||++++++|. ...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 45667899999999999985 246789999986432 2234667788777666 6999999999985 245
Q ss_pred eeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCc
Q 036583 561 HRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLA 640 (817)
Q Consensus 561 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 640 (817)
..++||||++ ++|.+++...... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 6899999997 5899988654322 57889999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhh---cc
Q 036583 641 KLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEE---GK 717 (817)
Q Consensus 641 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~ 717 (817)
+..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+. .......... ..
T Consensus 158 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~---~~~i~~~~~~~~~~~ 232 (290)
T cd07862 158 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPGEED 232 (290)
T ss_pred EeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHHhCCCChhh
Confidence 865433 122345689999999999988999999999999999999999999975432110 0000000000 00
Q ss_pred h-------hhhcccccCCcc---cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 718 L-------RNILDSRLNIDE---QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 718 ~-------~~~~d~~~~~~~---~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
. ............ .......+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 000000000000 0012345679999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=314.45 Aligned_cols=257 Identities=24% Similarity=0.414 Sum_probs=200.7
Q ss_pred HHhhccccccCCCcceeEEEEEcC------CCcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCee
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLP------DGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHR 562 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~ 562 (817)
...+.+.++||+|+||.||+|... .+..||+|.+..... ...++.+|+.++++++||||+++++++.++...
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 345667789999999999999743 245799998865432 234688999999999999999999999999999
Q ss_pred eEEEeeccCCChhhhhhhccc-------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEe
Q 036583 563 LLAYEFMANGSLDKWIFKKNQ-------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVS 635 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~ 635 (817)
++||||+++|+|.+++..... ...+++.....++.|++.||.|||+ ++|+||||||+||++++++.+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEEC
Confidence 999999999999999975321 1235667888999999999999999 999999999999999999999999
Q ss_pred ecCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHh
Q 036583 636 DFGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMM 713 (817)
Q Consensus 636 Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 713 (817)
|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... + ....+
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~-~~~~~ 234 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------Q-VLKFV 234 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHH
Confidence 999998654322211 112345678999999998899999999999999999998 78888543211 1 11111
Q ss_pred hhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 714 EEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 714 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
..+... .........+.+++.+|++.||++|||+.++++.|+..
T Consensus 235 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 235 MDGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111111 01112235788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=312.13 Aligned_cols=246 Identities=26% Similarity=0.331 Sum_probs=195.3
Q ss_pred cCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCCh
Q 036583 500 LGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSL 574 (817)
Q Consensus 500 lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 574 (817)
||+|+||+||++... +++.+|+|++.... ...+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999854 68899999986432 2235678899999999999999999999999999999999999999
Q ss_pred hhhhhhcc-cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeee
Q 036583 575 DKWIFKKN-QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT 653 (817)
Q Consensus 575 ~~~l~~~~-~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 653 (817)
..++.... ....+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 98875422 22368899999999999999999999 8999999999999999999999999999986644322 1233
Q ss_pred ccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHH
Q 036583 654 LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSD 733 (817)
Q Consensus 654 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 733 (817)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||........ ...... .+..... .....
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~---~~~~~~--------~~~~~~~--~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKELKQ--------RILNDSV--TYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh---HHHHHH--------hhcccCC--CCccc
Confidence 5789999999999999999999999999999999999999965432110 000000 1111111 11122
Q ss_pred HHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 036583 734 RVFTAVKVALWCVQEDMSLRP-----SMTKVVQM 762 (817)
Q Consensus 734 ~~~~~~~l~~~cl~~dp~~RP-----t~~evl~~ 762 (817)
....+.+++..|++.||++|| +++|+++.
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 345678999999999999999 77888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=315.90 Aligned_cols=263 Identities=20% Similarity=0.330 Sum_probs=198.8
Q ss_pred HHhhccccccCCCcceeEEEEEcCC---------------CcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeee
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLPD---------------GTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLR 553 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~~---------------g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~ 553 (817)
...+.+.++||+|+||.||++...+ ...||+|++.... .....|.+|++++.+++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3456677889999999999987532 2248999987542 2345799999999999999999999
Q ss_pred eEeecCCeeeEEEeeccCCChhhhhhhccc---------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 036583 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQ---------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENV 624 (817)
Q Consensus 554 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NI 624 (817)
+++......++||||+++++|.+++..... ...+++..++.++.|++.||+|||+ .+++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhE
Confidence 999999999999999999999999865321 1136788999999999999999998 8999999999999
Q ss_pred EecCCCcEEEeecCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh--CCCCCCCCCCCC
Q 036583 625 LLDDNYHAKVSDFGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG--GRKNFDPNETSD 701 (817)
Q Consensus 625 ll~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt--g~~pf~~~~~~~ 701 (817)
++++++.+||+|||++.......... .....++..|+|||.+.+..++.++|||||||+++||++ +..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999998654332211 122345678999999998889999999999999999998 556775332111
Q ss_pred CCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 702 KAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
.............. ..........+..+.+++.+|++.||++||+|.+|++.|+.
T Consensus 241 ---~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 ---VIENTGEFFRNQGR------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ---HHHHHHHhhhhccc------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 00000000110000 00000111123478999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=316.11 Aligned_cols=260 Identities=23% Similarity=0.298 Sum_probs=194.4
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
.+.+.++||+|+||.||+|+.. +++.+|||++.... .....+.+|+.+++.++||||+++++++.++...++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 3556688999999999999965 68899999986542 23456789999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
+ ++|.+++..... .++...+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++...... .
T Consensus 86 ~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 158 (303)
T cd07869 86 H-TDLCQYMDKHPG--GLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H 158 (303)
T ss_pred C-cCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence 6 578887765432 57888899999999999999999 899999999999999999999999999987543222 1
Q ss_pred eeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcc---------hh
Q 036583 650 VFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGK---------LR 719 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---------~~ 719 (817)
......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||....... .........+.... ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchhhcc
Confidence 1233567899999999865 457889999999999999999999997532210 00000000000000 00
Q ss_pred hhcccccC--CcccH-------HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 720 NILDSRLN--IDEQS-------DRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 720 ~~~d~~~~--~~~~~-------~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
........ .+... .....+.+++..|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000000 00000 01235778999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=319.57 Aligned_cols=241 Identities=23% Similarity=0.294 Sum_probs=194.1
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
++||+|+||.||+|+.. .++.+|+|++... ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 35999999999999865 4789999998653 23345678899998866 799999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
|+|..++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TT 153 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cc
Confidence 99999887654 58889999999999999999999 8999999999999999999999999999875432221 12
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+. ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-------~~~~~i~~~~--------~~~p-- 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-------DLFESILHDD--------VLYP-- 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCC--------CCCC--
Confidence 3457899999999999989999999999999999999999999644311 1111111111 1111
Q ss_pred HHHHHHHHHHHHhccccCCCCCC-------CHHHHHHH
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRP-------SMTKVVQM 762 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RP-------t~~evl~~ 762 (817)
......+.+++..|++.||++|| +++++++.
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11234678999999999999999 88888753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=319.58 Aligned_cols=240 Identities=25% Similarity=0.334 Sum_probs=193.4
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+.||+|+||+||+++.. +++.||||++... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 35999999999999964 5789999998643 23346678888888876 699999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TT 153 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cc
Confidence 99999887654 58889999999999999999999 9999999999999999999999999999875432211 22
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+..+.. .. .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~~~~~i~~~~~--------~~--~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-------DLFEAILNDEV--------VY--P 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------HHHHHHhcCCC--------CC--C
Confidence 3457899999999999989999999999999999999999999643211 11122222111 11 1
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSM------TKVVQ 761 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~------~evl~ 761 (817)
......+.+++.+|++.||++||++ +++++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~ 252 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR 252 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence 1123467899999999999999998 66654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.99 Aligned_cols=241 Identities=22% Similarity=0.316 Sum_probs=194.3
Q ss_pred ccCCCcceeEEEEEc-CCCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCC
Q 036583 499 KLGQGGFGSVYQGVL-PDGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGS 573 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 573 (817)
.||+|+||.||++.. .+++.+|+|++... ......+..|++++..++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 589999999999985 46889999999753 1234567889999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeee
Q 036583 574 LDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT 653 (817)
Q Consensus 574 L~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 653 (817)
|..++.... .+++..+..++.||+.||+|||+. .+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 82 L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (325)
T cd05594 82 LFFHLSRER---VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKT 155 (325)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cccc
Confidence 999886544 588999999999999999999962 6999999999999999999999999999875432221 1234
Q ss_pred ccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHH
Q 036583 654 LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSD 733 (817)
Q Consensus 654 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 733 (817)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.... ... +..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-------~~~~~i~~~~--------~~~--p~~ 218 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILMEE--------IRF--PRT 218 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-------HHHHHHhcCC--------CCC--CCC
Confidence 57899999999999989999999999999999999999999643211 1111111111 111 111
Q ss_pred HHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 036583 734 RVFTAVKVALWCVQEDMSLRP-----SMTKVVQM 762 (817)
Q Consensus 734 ~~~~~~~l~~~cl~~dp~~RP-----t~~evl~~ 762 (817)
....+.+++.+|++.||++|+ ++.++++.
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 234678999999999999996 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=317.80 Aligned_cols=253 Identities=25% Similarity=0.449 Sum_probs=197.6
Q ss_pred hhccccccCCCcceeEEEEEcC-CCc--EEEEEEeccCC--cCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGT--RLAVKKLEGIG--QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~--~vavK~l~~~~--~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 566 (817)
.+.+.+.||+|+||.||+|..+ ++. .+++|++.... ...+.+.+|++++.++ +|+||+++++++.+++..++||
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 87 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 87 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence 3456688999999999999864 344 46777776432 2346788999999999 8999999999999999999999
Q ss_pred eeccCCChhhhhhhccc-------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEE
Q 036583 567 EFMANGSLDKWIFKKNQ-------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAK 633 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 633 (817)
||+++++|.+++..... ...+++..++.++.||+.||+|||+ .+++||||||+|||+++++.+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcEE
Confidence 99999999999975421 2257889999999999999999998 9999999999999999999999
Q ss_pred EeecCCccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHH
Q 036583 634 VSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKM 712 (817)
Q Consensus 634 i~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 712 (817)
|+|||++........ ......+..|+|||.+.+..++.++|||||||+++||++ |..||......+ ....
T Consensus 165 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~ 235 (303)
T cd05088 165 IADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEK 235 (303)
T ss_pred eCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-------HHHH
Confidence 999999864321110 111234567999999988889999999999999999998 999995432111 1111
Q ss_pred hhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 713 MEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 713 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
...+ ............+.+++.+|++.+|++||++++++++|+.+
T Consensus 236 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 236 LPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111 01111111234678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=310.56 Aligned_cols=244 Identities=26% Similarity=0.367 Sum_probs=192.9
Q ss_pred cCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCCh
Q 036583 500 LGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSL 574 (817)
Q Consensus 500 lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 574 (817)
||+|+||.||+++.. +|+.+|+|.+.... ...+.+..|++++.+++||||+++++.+.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 58999999986431 2234567799999999999999999999999999999999999999
Q ss_pred hhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeeec
Q 036583 575 DKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTL 654 (817)
Q Consensus 575 ~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~ 654 (817)
.+++..... ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++....... .....
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR 154 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence 988865432 258889999999999999999999 999999999999999999999999999998664332 22345
Q ss_pred cCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHH
Q 036583 655 RGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDR 734 (817)
Q Consensus 655 ~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 734 (817)
.|+..|+|||++.+..++.++|||||||++|||++|+.||........ ........ ........ ....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~---~~~~~~~~--------~~~~~~~~-~~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA---KEELKRRT--------LEDEVKFE-HQNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh---HHHHHHHh--------hccccccc-cccC
Confidence 689999999999988899999999999999999999999964322110 00011111 11111100 0122
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 735 VFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 735 ~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
...+.+++..||+.||++||+++|+++
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchh
Confidence 346789999999999999999977664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=310.19 Aligned_cols=247 Identities=25% Similarity=0.447 Sum_probs=193.9
Q ss_pred ccCCCcceeEEEEEcCC-Cc--EEEEEEeccCC--cCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 499 KLGQGGFGSVYQGVLPD-GT--RLAVKKLEGIG--QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~~-g~--~vavK~l~~~~--~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
.||+|+||.||+|+..+ +. .+++|.+.... ...+.+.+|++++.++ +||||+++++++......++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 58999999999999754 43 46888887432 3346789999999999 8999999999999999999999999999
Q ss_pred Chhhhhhhcc-------------cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCC
Q 036583 573 SLDKWIFKKN-------------QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGL 639 (817)
Q Consensus 573 sL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl 639 (817)
+|.+++.... ....+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999987532 11247889999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcch
Q 036583 640 AKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKL 718 (817)
Q Consensus 640 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 718 (817)
+....... .......+..|+|||++....++.++||||||++++||++ |..||...... . .......+
T Consensus 159 ~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~-~~~~~~~~-- 227 (270)
T cd05047 159 SRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------E-LYEKLPQG-- 227 (270)
T ss_pred ccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------H-HHHHHhCC--
Confidence 86322111 0111233567999999988889999999999999999997 99999543211 1 11111111
Q ss_pred hhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 719 RNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 719 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
...+........+.+++.+|++.+|.+|||+.|+++.|+++
T Consensus 228 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 -------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred -------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 01111112234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=306.29 Aligned_cols=247 Identities=25% Similarity=0.383 Sum_probs=201.5
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.+.+.||+|+||.||++... +++.+++|.+... ....+++.+|++++++++|||++++++++.+....++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 45578999999999999864 6889999998643 2345688999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+++|.+++.... ...+++..++.++.|++.||.|||+ .+++|+||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~- 157 (256)
T cd08529 83 NGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF- 157 (256)
T ss_pred CCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch-
Confidence 999999997642 2368889999999999999999998 89999999999999999999999999998876543221
Q ss_pred eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 651 FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
.....+++.|+|||++.+..++.++||||||++++||++|+.||..... .........+... +.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~---------~~ 221 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-------GALILKIIRGVFP---------PV 221 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCC---------CC
Confidence 2335678899999999998899999999999999999999999964331 1111111111111 11
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11234568899999999999999999999873
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=308.59 Aligned_cols=256 Identities=23% Similarity=0.355 Sum_probs=204.1
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.+.||+|+||.||++.. .+++.+|||.+.... ...+++.+|+.+++.++|+||+++++++.+++..+++|||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 44567899999999999995 578999999886432 2345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhc-ccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 569 MANGSLDKWIFKK-NQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 569 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
+++++|.+++... .....+++..++.++.||+.||+|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 9999999988642 222368899999999999999999998 999999999999999999999999999988664332
Q ss_pred ceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
. ......++..|+|||.+.+..++.++||||||+++|||++|..||....... .......... ..+
T Consensus 161 ~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~-----~~~--- 226 (267)
T cd08229 161 T-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YSLCKKIEQC-----DYP--- 226 (267)
T ss_pred c-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-----HHHhhhhhcC-----CCC---
Confidence 1 1223568889999999998889999999999999999999999996432210 0011111111 011
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
..........+.+++.+|++.||++||||.+|++++++.
T Consensus 227 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 111112345688999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=336.98 Aligned_cols=251 Identities=25% Similarity=0.307 Sum_probs=199.0
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCC--------
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT-------- 560 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~-------- 560 (817)
.+.+.++||+|+||+||+++. .+++.||||++.... .....+.+|+.++..++|+|+++++..+....
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 456678899999999999984 568999999986542 23456889999999999999999988775432
Q ss_pred eeeEEEeeccCCChhhhhhhcc-cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCC
Q 036583 561 HRLLAYEFMANGSLDKWIFKKN-QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGL 639 (817)
Q Consensus 561 ~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl 639 (817)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 3679999999999999986532 22368889999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCce-eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcch
Q 036583 640 AKLMTREQSH-VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKL 718 (817)
Q Consensus 640 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 718 (817)
++........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .........+..
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------~~~~~~~~~~~~ 262 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-------EEVMHKTLAGRY 262 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhcCCC
Confidence 9876433221 22346799999999999999999999999999999999999999964321 111111111111
Q ss_pred hhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 719 RNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 719 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.. ........+.+++..||+.||.+||++.+++++
T Consensus 263 ~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 263 DP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11 111233468899999999999999999999864
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=288.71 Aligned_cols=246 Identities=28% Similarity=0.426 Sum_probs=201.5
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccC-----CcCH----HHHHHHHHHhhcc-CcceeeeeeeEeecCCeee
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI-----GQGK----KEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~-----~~~~----~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~ 563 (817)
.-.+.||.|..++|-+...+ .|++.|+|++... .+.. ++-..|+.||+++ .||+|+.+.++++.+...+
T Consensus 20 ~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~F 99 (411)
T KOG0599|consen 20 EPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVF 99 (411)
T ss_pred ChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhh
Confidence 33467999999999988764 5789999998532 1112 3456799999999 6999999999999999999
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+|+|.|+.|.|.++|...- .++++...+|+.|+..|++|||. ++|+||||||+|||+|++.++||+|||.+..+
T Consensus 100 lVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 100 LVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred hhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeecc
Confidence 9999999999999998766 69999999999999999999999 99999999999999999999999999999988
Q ss_pred CCCCceeeeeccCCCCccCcccccc------CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcc
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITN------YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGK 717 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 717 (817)
.+.. .....+|||+|+|||.+.. ..|+..+|+|+.||++|-|+.|.+||--.. ...+.+++.+|.
T Consensus 174 ~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------QmlMLR~ImeGk 244 (411)
T KOG0599|consen 174 EPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QMLMLRMIMEGK 244 (411)
T ss_pred CCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HHHHHHHHHhcc
Confidence 6643 3456899999999999864 357788999999999999999999994211 112233333433
Q ss_pred hhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 718 LRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 718 ~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.. ...+.-.+......+++.+|++.||.+|.|++|+++
T Consensus 245 yq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 245 YQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred cc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 21 112333355667889999999999999999999986
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=324.52 Aligned_cols=248 Identities=21% Similarity=0.289 Sum_probs=192.6
Q ss_pred ccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 495 NFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
.+.++||+|+||+||++.. .+++.||||++.... ...+.+.+|++++.+++||||+++++++.+....++||||+
T Consensus 4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 83 (377)
T cd05629 4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFL 83 (377)
T ss_pred eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCC
Confidence 4557899999999999985 468899999986431 23457889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 84 ~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 84 PGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 9999999997543 57888888999999999999999 99999999999999999999999999999643211000
Q ss_pred ----------------------------------------------eeeeccCCCCccCccccccCccCccccccchhhh
Q 036583 650 ----------------------------------------------VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMV 683 (817)
Q Consensus 650 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvv 683 (817)
......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0002468999999999999899999999999999
Q ss_pred HHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCC---CCHHHHH
Q 036583 684 LLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLR---PSMTKVV 760 (817)
Q Consensus 684 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~R---Pt~~evl 760 (817)
+|||++|+.||...... .....+.... ..+..+........+.+++..|++ +|.+| +++.|++
T Consensus 238 l~elltG~~Pf~~~~~~-------~~~~~i~~~~------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 238 MFECLIGWPPFCSENSH-------ETYRKIINWR------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred hhhhhcCCCCCCCCCHH-------HHHHHHHccC------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 99999999999643321 1111111100 011111111123457788889997 66665 6999988
Q ss_pred HH
Q 036583 761 QM 762 (817)
Q Consensus 761 ~~ 762 (817)
+.
T Consensus 304 ~h 305 (377)
T cd05629 304 SH 305 (377)
T ss_pred cC
Confidence 74
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=306.40 Aligned_cols=248 Identities=29% Similarity=0.441 Sum_probs=198.3
Q ss_pred hhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEee-cCCeeeEEEeeccC
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCA-EGTHRLLAYEFMAN 571 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~~ 571 (817)
.+.+.+.||+|+||.||++.. .|+.+|+|.++.. ...+.+.+|+.++++++|+|++++++++. ++...++++||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred hCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC-chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 455668899999999999987 4778999998643 33567999999999999999999999764 55678999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
++|.+++.+... ..+++..++.++.||+.||+|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---- 156 (256)
T cd05082 85 GSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 156 (256)
T ss_pred CcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC----
Confidence 999999876432 258889999999999999999998 899999999999999999999999999988653322
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||..... .. ....+..+.. ...
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~-~~~~~~~~~~---------~~~ 220 (256)
T cd05082 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KD-VVPRVEKGYK---------MDA 220 (256)
T ss_pred CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HH-HHHHHhcCCC---------CCC
Confidence 12334568999999998889999999999999999998 9999853221 11 1111111110 111
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.......+.+++.+|++.+|++|||++++++.|+.+
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 112334678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=322.19 Aligned_cols=259 Identities=26% Similarity=0.404 Sum_probs=199.8
Q ss_pred HHhhccccccCCCcceeEEEEEc------CCCcEEEEEEeccCC--cCHHHHHHHHHHhhcc-CcceeeeeeeEeecC-C
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVL------PDGTRLAVKKLEGIG--QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEG-T 560 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~------~~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~-~ 560 (817)
...+.+.++||+|+||.||+|.. ..++.||||+++... ...+.+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 34567788999999999999973 357789999997542 2345788999999999 789999999988654 4
Q ss_pred eeeEEEeeccCCChhhhhhhccc---------------------------------------------------------
Q 036583 561 HRLLAYEFMANGSLDKWIFKKNQ--------------------------------------------------------- 583 (817)
Q Consensus 561 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 583 (817)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999864321
Q ss_pred -------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce-eeeecc
Q 036583 584 -------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH-VFTTLR 655 (817)
Q Consensus 584 -------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~ 655 (817)
...+++..+..++.||++||+|||+ .+|+||||||+||++++++.+||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 1246788889999999999999999 99999999999999999999999999999865332211 112234
Q ss_pred CCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHH
Q 036583 656 GTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDR 734 (817)
Q Consensus 656 gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 734 (817)
++..|+|||.+.+..++.++||||||+++|||++ |..||...... ......+.++..... + ...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~~~~~-------~--~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRRLKEGTRMRA-------P--DYT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc------HHHHHHHhccCCCCC-------C--CCC
Confidence 5678999999998899999999999999999997 88898543211 111111222211100 0 011
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 735 VFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 735 ~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
...+.+++..||+.||++|||+.||++.|+.+.
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 235789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=316.66 Aligned_cols=243 Identities=28% Similarity=0.411 Sum_probs=198.5
Q ss_pred ccCCCcceeEEEEEcCC-CcEEEEEEeccC-CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCChhh
Q 036583 499 KLGQGGFGSVYQGVLPD-GTRLAVKKLEGI-GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDK 576 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 576 (817)
.||+|.||+||.|+..+ ...+|||.+... .+..+.+.+|+.+.++++|.|||+++|.|.+++..-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 59999999999999644 567999998654 4556788999999999999999999999999999999999999999999
Q ss_pred hhhhcccccch--hhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec-CCCcEEEeecCCccccCCCCceeeee
Q 036583 577 WIFKKNQEFLL--DWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD-DNYHAKVSDFGLAKLMTREQSHVFTT 653 (817)
Q Consensus 577 ~l~~~~~~~~l--~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~ki~Dfgla~~~~~~~~~~~~~ 653 (817)
+|..+=. ++ .+.+.--+..||++||.|||+ ..|||||||-+||||+ -.|.+||+|||-++.+..-. ....+
T Consensus 662 LLrskWG--PlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TET 735 (1226)
T KOG4279|consen 662 LLRSKWG--PLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTET 735 (1226)
T ss_pred HHHhccC--CCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCC-ccccc
Confidence 9986432 44 556667788999999999999 9999999999999997 57899999999998775432 23456
Q ss_pred ccCCCCccCccccccC--ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 654 LRGTRGYLAPEWITNY--AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 654 ~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
..||..|||||++..+ .|.+++|||||||.+.||.||++||-...... +.+..-|.. ....+.+
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--------AAMFkVGmy------KvHP~iP 801 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--------AAMFKVGMY------KVHPPIP 801 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--------Hhhhhhcce------ecCCCCc
Confidence 8899999999999854 68899999999999999999999995432221 111111111 1122344
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.+...++..++++|+.+||.+||+++++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 556678899999999999999999999987
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=315.43 Aligned_cols=256 Identities=23% Similarity=0.405 Sum_probs=198.8
Q ss_pred hccccccCCCcceeEEEEEcCC-Cc--EEEEEEeccCC--cCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEe
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPD-GT--RLAVKKLEGIG--QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~-g~--~vavK~l~~~~--~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 567 (817)
+.+.+.||+|+||.||+|...+ +. .+++|.++... ...+.+.+|++++.++ +||||+++++++.+....++++|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 3456789999999999998654 33 47888886432 2346789999999999 79999999999999999999999
Q ss_pred eccCCChhhhhhhcc-------------cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEE
Q 036583 568 FMANGSLDKWIFKKN-------------QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKV 634 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki 634 (817)
|+++++|.+++.... ....+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEEE
Confidence 999999999996532 11247889999999999999999998 89999999999999999999999
Q ss_pred eecCCccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHh
Q 036583 635 SDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMM 713 (817)
Q Consensus 635 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 713 (817)
+|||++....... .......+..|+|||.+.+..++.++|||||||++|||++ |..||...... ......
T Consensus 161 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-------~~~~~~ 231 (297)
T cd05089 161 ADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-------ELYEKL 231 (297)
T ss_pred CCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHH
Confidence 9999986432111 1111223557999999998889999999999999999997 99999643211 111111
Q ss_pred hhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCCC
Q 036583 714 EEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVP 770 (817)
Q Consensus 714 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 770 (817)
..+ ............+.+++.+|++.+|.+||+++++++.|+.+....
T Consensus 232 ~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 232 PQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred hcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111 111111123346789999999999999999999999998775433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.57 Aligned_cols=240 Identities=23% Similarity=0.313 Sum_probs=191.5
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
++||+|+||+||+|+.. +++.||||+++.. ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999965 4789999999753 23345667788888764 899999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT 153 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence 99999987543 57888999999999999999999 8999999999999999999999999999875322211 22
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... +.. +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-------~~~~~~i~~~~------~~~----~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-------EELFQSIRMDN------PCY----P 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC------CCC----C
Confidence 345789999999999998999999999999999999999999964321 11111111111 111 1
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMT-KVVQ 761 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~-evl~ 761 (817)
......+.+++.+|++.||++||++. ++.+
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11233577899999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=315.51 Aligned_cols=243 Identities=23% Similarity=0.313 Sum_probs=193.8
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEee
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
.+.++||+|+||.||+++.. +++.+|+|.+.... ...+.+..|..++..+ +|++|+++++++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY 82 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence 45678999999999999865 57799999987532 2334567788888777 689999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 83 VNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 99999999887654 58889999999999999999999 8999999999999999999999999999975432221
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.+. ....
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-------~~~~~i~~~--------~~~~ 220 (323)
T cd05616 157 -TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQSIMEH--------NVAY 220 (323)
T ss_pred -ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhC--------CCCC
Confidence 123467899999999999999999999999999999999999999643211 111111111 1111
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSM-----TKVVQ 761 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~-----~evl~ 761 (817)
+......+.+++.+|++.||++|++. .++++
T Consensus 221 --p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 221 --PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred --CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 11233467899999999999999984 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=310.93 Aligned_cols=268 Identities=24% Similarity=0.414 Sum_probs=204.8
Q ss_pred hhccccccCCCcceeEEEEEcC-----CCcEEEEEEeccCCcC--HHHHHHHHHHhhccCcceeeeeeeEeec--CCeee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-----DGTRLAVKKLEGIGQG--KKEFRAEVSIIGSIHHLHLVKLRGFCAE--GTHRL 563 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-----~g~~vavK~l~~~~~~--~~~~~~Ev~~l~~l~h~niv~l~~~~~~--~~~~~ 563 (817)
...+.+.||+|+||.||++++. .+..+|||.+...... .++|.+|++++++++|+||+++++++.. +...+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 3445678999999999999853 3678999999765543 6789999999999999999999999977 56789
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
++|||+++++|.+++..... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++...
T Consensus 85 lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999976543 58999999999999999999998 89999999999999999999999999999877
Q ss_pred CCCCceee--eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhh
Q 036583 644 TREQSHVF--TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721 (817)
Q Consensus 644 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (817)
........ ....++..|+|||.+.+..++.++||||||++++||++|+.|+............. .........+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRLLEL 238 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHHHHH
Confidence 53322111 12344567999999988889999999999999999999999985432211000000 0000000001111
Q ss_pred cccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 722 ~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
+......+........+.+++.+|++.+|++||||.||+++|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111111222335788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=311.22 Aligned_cols=260 Identities=24% Similarity=0.397 Sum_probs=201.0
Q ss_pred hhccccccCCCcceeEEEEEc-----CCCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecC--Ceee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-----PDGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG--THRL 563 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-----~~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~~ 563 (817)
++.+.++||+|+||.||+++. ..+..||+|.+.... ...+.+.+|++++++++|||++++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 445567899999999999973 357789999986542 2346799999999999999999999999775 5678
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+||||+++++|.+++.+... .+++..+..++.||+.||+|||+ .+++||||||+||++++++.+||+|||+++..
T Consensus 85 lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999865432 58899999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCce--eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCC--------CCCcchHHHHHHh
Q 036583 644 TREQSH--VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETS--------DKAHFPSYAFKMM 713 (817)
Q Consensus 644 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~--------~~~~~~~~~~~~~ 713 (817)
...... ......++..|+|||.+.+..++.++||||||++++||++++.|....... .............
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 543221 112345677899999999888999999999999999999987765321110 0000011111111
Q ss_pred hhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 714 EEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 714 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
..+. ..+........+.+++.+|++.+|++||+++++++.|+.+
T Consensus 240 ~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111 1111112345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=314.30 Aligned_cols=253 Identities=27% Similarity=0.449 Sum_probs=199.8
Q ss_pred hccccccCCCcceeEEEEEcC------CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP------DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv 565 (817)
+.+.++||+|+||.||++... ++..+|+|++.... ...+++.+|+.++.+++||||+++++++.++...+++
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (288)
T cd05050 7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL 86 (288)
T ss_pred ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence 445578999999999999853 46789999987542 2346799999999999999999999999999999999
Q ss_pred EeeccCCChhhhhhhcc-------------------cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEe
Q 036583 566 YEFMANGSLDKWIFKKN-------------------QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL 626 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll 626 (817)
+||+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+||++
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil~ 163 (288)
T cd05050 87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLV 163 (288)
T ss_pred EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheEe
Confidence 99999999999997431 11247788899999999999999998 899999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCce-eeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCc
Q 036583 627 DDNYHAKVSDFGLAKLMTREQSH-VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAH 704 (817)
Q Consensus 627 ~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~ 704 (817)
++++.+||+|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~----- 238 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH----- 238 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence 99999999999998765332211 1112334667999999998899999999999999999998 8888853321
Q ss_pred chHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 705 FPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
......+..+.... ........+.+++.+|++.+|++|||+.|+++.|++
T Consensus 239 --~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 --EEVIYYVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HHHHHHHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11122222222111 111223568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=312.01 Aligned_cols=262 Identities=23% Similarity=0.338 Sum_probs=201.0
Q ss_pred HhhccccccCCCcceeEEEEEcCC-----------------CcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPD-----------------GTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKL 552 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~-----------------g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l 552 (817)
..+.+.++||+|+||.||++...+ +..||+|++.... ...+++.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 345567889999999999988542 2458999987543 235688999999999999999999
Q ss_pred eeEeecCCeeeEEEeeccCCChhhhhhhccc--------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 036583 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQ--------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENV 624 (817)
Q Consensus 553 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NI 624 (817)
++++..+...++++||+++++|.+++..... ...+++..++.++.|++.||+|||+ .+|+|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhce
Confidence 9999999999999999999999999976431 1257899999999999999999998 8999999999999
Q ss_pred EecCCCcEEEeecCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh--CCCCCCCCCCCC
Q 036583 625 LLDDNYHAKVSDFGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG--GRKNFDPNETSD 701 (817)
Q Consensus 625 ll~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt--g~~pf~~~~~~~ 701 (817)
++++++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ +..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-- 239 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh--
Confidence 99999999999999998654332211 223456778999999998889999999999999999998 6667743221
Q ss_pred CCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 702 KAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
.......... ..........+.....+.++.+++.+|++.||++|||+.||++.|+.
T Consensus 240 -----~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 -----QQVIENAGHF--FRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred -----HHHHHHHHhc--cccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1111111110 00000000011111223578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.22 Aligned_cols=244 Identities=24% Similarity=0.311 Sum_probs=194.1
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCc-ceeeeeeeEeecCCeeeEEEe
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHH-LHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 567 (817)
+.+.+.||+|+||.||+|+.. .++.||||++... ....+.+..|++++..++| ++|+++++++.+.+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 345678999999999999865 4778999999653 2345678889999999965 568899999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 82 YVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999999987654 57889999999999999999999 899999999999999999999999999987532221
Q ss_pred ceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.+. ...
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~~~~~i~~~--------~~~ 219 (324)
T cd05587 156 K-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-------ELFQSIMEH--------NVS 219 (324)
T ss_pred C-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcC--------CCC
Confidence 1 223467899999999999999999999999999999999999999643211 111111111 111
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSM-----TKVVQ 761 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~-----~evl~ 761 (817)
. .......+.+++.+|++.||.+|++. +++++
T Consensus 220 ~--~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 220 Y--PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred C--CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1 11123467899999999999999976 56654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=321.15 Aligned_cols=252 Identities=21% Similarity=0.269 Sum_probs=196.5
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
..+.+.+.||+|+||.||+++.. +++.+|+|.+... ....+.+.+|+.++..++||||+++++.+.++...++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 45566788999999999999965 5788999998642 123456789999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
||+++|+|.+++... .++...+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 123 Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 123 EYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred cCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 999999999998643 36778888999999999999999 99999999999999999999999999999876543
Q ss_pred CceeeeeccCCCCccCccccccC----ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 647 QSHVFTTLRGTRGYLAPEWITNY----AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
.........||+.|+|||++.+. .++.++|||||||++|||++|+.||...... . ....+....
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~-~~~~i~~~~----- 263 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------G-TYSKIMNHK----- 263 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------H-HHHHHHcCC-----
Confidence 33233346799999999999754 3788999999999999999999999643211 1 111111110
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSL--RPSMTKVVQML 763 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~--RPt~~evl~~L 763 (817)
..+..+........+.+++..|++.++.+ ||+++|+++..
T Consensus 264 -~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 264 -NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 00111111223446778899999844443 78999998853
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=326.65 Aligned_cols=247 Identities=20% Similarity=0.278 Sum_probs=190.6
Q ss_pred ccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 495 NFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
.+.++||+|+||+||+++. .+++.+|+|++.... ...+.+.+|++++++++|+||+++++.+.+++..++||||+
T Consensus 4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (382)
T cd05625 4 VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI 83 (382)
T ss_pred EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCC
Confidence 4557899999999999985 467899999986532 23457889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc-
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS- 648 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~- 648 (817)
++|+|.+++.+.. .++......++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 84 ~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 84 PGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 9999999987653 57888889999999999999999 8999999999999999999999999999753311000
Q ss_pred ---------------------------------------------eeeeeccCCCCccCccccccCccCccccccchhhh
Q 036583 649 ---------------------------------------------HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMV 683 (817)
Q Consensus 649 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvv 683 (817)
.......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 00112468999999999999999999999999999
Q ss_pred HHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCC---HHHHH
Q 036583 684 LLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPS---MTKVV 760 (817)
Q Consensus 684 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt---~~evl 760 (817)
+|||++|+.||....... ....+... ...+..+........+.+++.+|+ .+|.+|++ ++|++
T Consensus 238 l~elltG~~Pf~~~~~~~-------~~~~i~~~------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLE-------TQMKVINW------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK 303 (382)
T ss_pred HHHHHhCCCCCCCCCHHH-------HHHHHHcc------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence 999999999996432210 11111110 011111111122334566666665 49999997 88877
Q ss_pred H
Q 036583 761 Q 761 (817)
Q Consensus 761 ~ 761 (817)
+
T Consensus 304 ~ 304 (382)
T cd05625 304 A 304 (382)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=315.67 Aligned_cols=257 Identities=25% Similarity=0.406 Sum_probs=201.5
Q ss_pred HhhccccccCCCcceeEEEEEcC--------CCcEEEEEEeccCC--cCHHHHHHHHHHhhcc-CcceeeeeeeEeecCC
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP--------DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGT 560 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~--------~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~ 560 (817)
..+.+.++||+|+||.||+++.. ....+|+|++.... ....++.+|+.++.++ +||||+++++++.+..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 44556789999999999999731 24568999887542 2345788999999999 6999999999999999
Q ss_pred eeeEEEeeccCCChhhhhhhccc-------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec
Q 036583 561 HRLLAYEFMANGSLDKWIFKKNQ-------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD 627 (817)
Q Consensus 561 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~ 627 (817)
..+++|||+++|+|.+++..... ...+++..+.+++.||+.||.|||+ .+++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence 99999999999999999975321 2358899999999999999999998 9999999999999999
Q ss_pred CCCcEEEeecCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcc
Q 036583 628 DNYHAKVSDFGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHF 705 (817)
Q Consensus 628 ~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~ 705 (817)
+++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~------ 242 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV------ 242 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH------
Confidence 99999999999998664322111 112234567999999998889999999999999999999 8888853321
Q ss_pred hHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 706 PSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 706 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
.........+... .........+.+++.+|++.+|++|||+.|+++.|+++.
T Consensus 243 -~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 243 -EELFKLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred -HHHHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1122222222111 111122346779999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.11 Aligned_cols=239 Identities=23% Similarity=0.395 Sum_probs=188.0
Q ss_pred cccCCCcceeEEEEEcCC-------------CcEEEEEEeccCCc-CHHHHHHHHHHhhccCcceeeeeeeEeecCCeee
Q 036583 498 VKLGQGGFGSVYQGVLPD-------------GTRLAVKKLEGIGQ-GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~-------------g~~vavK~l~~~~~-~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 563 (817)
+.||+|+||.||+|+... ...|++|.+..... ....|.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 22588888765432 3457889999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCc-------EEEee
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYH-------AKVSD 636 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~-------~ki~D 636 (817)
+||||+++++|..++..... .+++..+++++.||++||+|||+ .+|+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999998865433 58889999999999999999998 99999999999999987654 89999
Q ss_pred cCCccccCCCCceeeeeccCCCCccCccccc-cCccCccccccchhhhHHHhh-hCCCCCCCCCCCCCCcchHHHHHHhh
Q 036583 637 FGLAKLMTREQSHVFTTLRGTRGYLAPEWIT-NYAISEKSDVYSYGMVLLEII-GGRKNFDPNETSDKAHFPSYAFKMME 714 (817)
Q Consensus 637 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~ 714 (817)
||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.||....... . ....
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~-~~~~ 222 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------K-ERFY 222 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------H-HHHH
Confidence 9998765332 2245778899999987 567889999999999999998 5888875432111 0 0011
Q ss_pred hcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 715 EGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 715 ~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
.+. ... .......+.+++.+||+.||.+||++.++++.|+
T Consensus 223 ~~~--------~~~--~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQ--------CML--VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcC--------ccC--CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 111 000 0111246789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.01 Aligned_cols=247 Identities=28% Similarity=0.419 Sum_probs=198.8
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCChh
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLD 575 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 575 (817)
++||+|+||.||++...+++.||+|++..... ..+.+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36999999999999987799999999875432 3568999999999999999999999999999999999999999999
Q ss_pred hhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee-eec
Q 036583 576 KWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF-TTL 654 (817)
Q Consensus 576 ~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~-~~~ 654 (817)
+++..... .+++.....++.+++.||+|||+ .+++||||||+||+++.++.+||+|||++........... ...
T Consensus 81 ~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKKN--RLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99976433 57888999999999999999998 8999999999999999999999999999986543221111 112
Q ss_pred cCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHH
Q 036583 655 RGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSD 733 (817)
Q Consensus 655 ~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 733 (817)
..+..|+|||.+.+..++.++||||||++++||++ |..||...... .....+..+ ........
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-------~~~~~~~~~---------~~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-------QTRERIESG---------YRMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-------HHHHHHhcC---------CCCCCCcc
Confidence 33567999999998889999999999999999999 88888543211 011111111 11111122
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 734 RVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 734 ~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
....+.+++.+|++.+|++|||+.|+++.|+.
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 34478899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=304.86 Aligned_cols=248 Identities=29% Similarity=0.474 Sum_probs=202.9
Q ss_pred cccCCCcceeEEEEEcCC----CcEEEEEEeccCCcC--HHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 498 VKLGQGGFGSVYQGVLPD----GTRLAVKKLEGIGQG--KKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~~~~--~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+.||+|+||.||++.... +..+++|.+...... .+.+.+|++++..++|+|++++++++.++...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 369999999999999654 788999999765433 67899999999999999999999999999999999999999
Q ss_pred CChhhhhhhccc------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 572 GSLDKWIFKKNQ------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 572 gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
++|.+++..... ...+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999987521 2368999999999999999999998 9999999999999999999999999999987755
Q ss_pred CCc-eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 646 EQS-HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 646 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
... .......++..|+|||.+....++.++||||+|++++||++ |+.||..... ......+..+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~----- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-------EEVLEYLRKGYR----- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCC-----
Confidence 332 11223567889999999998889999999999999999999 6999965421 112222222110
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
..........+.+++.+|++.+|++|||+.|++++|+
T Consensus 226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111122457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=303.94 Aligned_cols=256 Identities=24% Similarity=0.390 Sum_probs=205.5
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.++||+|+||.||+|... +|+.+|+|.++.. ....+.+.+|++++++++|+|++++++++.+.+..++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 456688999999999999976 7899999988642 12356789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcc-cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 569 MANGSLDKWIFKKN-QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 569 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
+++++|.+++.... ....+++..++.++.|++.||+|||+ .+|+|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 99999999986532 22357889999999999999999999 999999999999999999999999999988654332
Q ss_pred ceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
.. .....++..|+|||.+.+..++.++|||||||++|||++|+.||...... ... .......+.....
T Consensus 161 ~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~~~~~~~~------ 228 (267)
T cd08224 161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYS-LCKKIEKCDYPPL------ 228 (267)
T ss_pred cc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHH-HHhhhhcCCCCCC------
Confidence 21 12346788999999999888999999999999999999999999543211 111 1111111111111
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
........+.+++.+|++.+|++|||+.+|+++|+.+
T Consensus 229 --~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 229 --PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred --ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1112344678999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.21 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=188.3
Q ss_pred cccCCCcceeEEEEEcCC---CcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 498 VKLGQGGFGSVYQGVLPD---GTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~---g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
++||+|+||.||+|...+ ...+++|.+.... .....+.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 3468888775432 23457889999999999999999999999999999999999999
Q ss_pred Chhhhhhhccc--ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 573 SLDKWIFKKNQ--EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 573 sL~~~l~~~~~--~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+|.+++..... ....++.....++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 1235677888999999999999999 899999999999999999999999999987543322111
Q ss_pred -eeeccCCCCccCcccccc-------CccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhh
Q 036583 651 -FTTLRGTRGYLAPEWITN-------YAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721 (817)
Q Consensus 651 -~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (817)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||...... .........+ ...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~-~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------QVLKQVVREQ-DIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhhcc-CccC
Confidence 122345678999999753 356789999999999999999 77888543211 1111111111 1112
Q ss_pred cccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 722 ~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
..+... ......+.+++..|+ .||++|||++||+++|.
T Consensus 231 ~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222111 122334566777788 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.32 Aligned_cols=248 Identities=25% Similarity=0.325 Sum_probs=197.7
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc------CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ------GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~------~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
+...+.||+|++|.||++.. .+++.+|+|.+..... ..+.+.+|++++.+++||||+++++++.+.+..++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 34457899999999999985 4688999998864321 2356889999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
||+++++|.+++.... .++...+..++.|++.||+|||+ .+|+|+||+|+||++++++.+||+|||+++.....
T Consensus 84 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 84 EYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 9999999999987654 57888899999999999999999 89999999999999999999999999999765432
Q ss_pred Cceee--eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccc
Q 036583 647 QSHVF--TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724 (817)
Q Consensus 647 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 724 (817)
..... ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ........ .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~---------~ 222 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIAT---------Q 222 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhc---------c
Confidence 21111 2345778999999999988999999999999999999999999643211 00111110 0
Q ss_pred ccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 725 RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 725 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.............+.+++.+||+.+|.+|||+.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 01111112233467899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=312.81 Aligned_cols=249 Identities=26% Similarity=0.382 Sum_probs=210.0
Q ss_pred HhhccccccCCCcceeEEEEEcCC-CcEEEEEEeccCC----cCHHHHHHHHHHhhccC-cceeeeeeeEeecCCeeeEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGIG----QGKKEFRAEVSIIGSIH-HLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lv 565 (817)
..+.+.++||+|.||.||+++.+. |+.+|+|.+.+.. ...+.+.+|+.+|+++. |||||.+.+.+++....++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 456677899999999999999765 9999999997653 23468999999999998 99999999999999999999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC----CCcEEEeecCCcc
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD----NYHAKVSDFGLAK 641 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~ki~Dfgla~ 641 (817)
||++.+|.|.+.+.+. .++...+..++.||+.++.|||+ .+|+||||||+|+|+.. ++.+|++|||++.
T Consensus 115 mEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 9999999999999776 28889999999999999999999 99999999999999963 3579999999999
Q ss_pred ccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhh
Q 036583 642 LMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721 (817)
Q Consensus 642 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (817)
.... .......+||+.|+|||++....|+..+||||+||++|.|++|..||....... ....+..+..
T Consensus 188 ~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~-------~~~~i~~~~~--- 255 (382)
T KOG0032|consen 188 FIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE-------IFLAILRGDF--- 255 (382)
T ss_pred EccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH-------HHHHHHcCCC---
Confidence 8876 445567899999999999999999999999999999999999999997654322 1112222222
Q ss_pred cccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 722 ~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
....+.-......+.+++..|+..||.+|+|+.++++.
T Consensus 256 ---~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ---DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ---CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11122223445678899999999999999999999994
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=315.00 Aligned_cols=251 Identities=19% Similarity=0.245 Sum_probs=194.4
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.++||+|+||+||+++.. +++.+|+|.+... ....+.+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 445678999999999999964 5788999998642 12345688899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++|+|.+++.+... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 83 YVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999976432 57888899999999999999999 9999999999999999999999999999987654433
Q ss_pred eeeeeccCCCCccCcccccc-----CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 649 HVFTTLRGTRGYLAPEWITN-----YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
.......|++.|+|||++.+ ..++.++|||||||++|||++|+.||...... . ....+....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~-~~~~i~~~~------ 224 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------E-TYGKIMNHE------ 224 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------H-HHHHHHcCC------
Confidence 22334579999999999875 46788999999999999999999999643211 1 111111110
Q ss_pred cccCCcc-cHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 036583 724 SRLNIDE-QSDRVFTAVKVALWCVQEDMSL--RPSMTKVVQM 762 (817)
Q Consensus 724 ~~~~~~~-~~~~~~~~~~l~~~cl~~dp~~--RPt~~evl~~ 762 (817)
.+...+. .......+.+++.+|+..++++ |++++++++.
T Consensus 225 ~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 225 ERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0011110 0112346778888888865544 5688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=307.25 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=198.7
Q ss_pred HhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
..+.+.++||+|+||.||+|+. .+++.+|+|++.... ...+.+.+|+.++.+++||||+++++.+..+...++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 3456678899999999999995 568899999987543 34567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 89 GGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 9999999986543 57889999999999999999998 8999999999999999999999999999986643221
Q ss_pred eeeeccCCCCccCccccc---cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 650 VFTTLRGTRGYLAPEWIT---NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
......++..|+|||.+. ...++.++|||||||+++||++|+.||.......... .+... ....+..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~---~~~~~~~ 231 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKS---NFQPPKL 231 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecC---CCCCCCC
Confidence 112346788999999884 3457789999999999999999999985432211100 00000 0000111
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQML 763 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L 763 (817)
. ........+.+++.+||+.+|++||+++++++.|
T Consensus 232 ~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 K--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred c--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 1112234688999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.09 Aligned_cols=261 Identities=21% Similarity=0.335 Sum_probs=198.7
Q ss_pred hhccccccCCCcceeEEEEEcC-----------------CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-----------------DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLR 553 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-----------------~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~ 553 (817)
.+.+.++||+|+||.||++... ++..+|+|++.... ....++.+|++++.+++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 4566788999999999998532 23468999987542 2346899999999999999999999
Q ss_pred eEeecCCeeeEEEeeccCCChhhhhhhccc--------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeE
Q 036583 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQ--------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVL 625 (817)
Q Consensus 554 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIl 625 (817)
+++..++..++||||+++++|.+++..... ...+++..+..++.|++.||+|||+ .+++|+||||+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Nil 162 (296)
T cd05095 86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheEE
Confidence 999999999999999999999999876321 1247788899999999999999999 89999999999999
Q ss_pred ecCCCcEEEeecCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh--CCCCCCCCCCCCC
Q 036583 626 LDDNYHAKVSDFGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG--GRKNFDPNETSDK 702 (817)
Q Consensus 626 l~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt--g~~pf~~~~~~~~ 702 (817)
++.++.+||+|||+++.+....... .....++..|+|||...+..++.++|||||||++|||++ |..||.......
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~- 241 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ- 241 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH-
Confidence 9999999999999998654332211 112334678999999888889999999999999999998 667875332211
Q ss_pred CcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 703 AHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
.............. .. ..+........+.+++.+||+.||++||++.||++.|+.
T Consensus 242 --~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 --VIENTGEFFRDQGR-QV-----YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred --HHHHHHHHHhhccc-cc-----cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00000000101000 00 011111233578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=316.07 Aligned_cols=240 Identities=24% Similarity=0.318 Sum_probs=194.2
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+.||+|+||+||++... +++.+|||++... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999865 4789999999753 23345678899998888 799999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
|+|..++.+.. .+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TT 153 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cc
Confidence 99999887654 58899999999999999999998 9999999999999999999999999999875322211 12
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... ... +
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-------~~~~~~i~~~~--------~~~--~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-------DELFQSILEDE--------VRY--P 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-------HHHHHHHHcCC--------CCC--C
Confidence 335689999999999999999999999999999999999999964321 11111111111 111 1
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSM-----TKVVQ 761 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~-----~evl~ 761 (817)
......+.+++.+||+.||.+||++ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1223467899999999999999999 88876
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.74 Aligned_cols=248 Identities=26% Similarity=0.392 Sum_probs=195.7
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhcc-CcceeeeeeeEeecC------CeeeEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEG------THRLLA 565 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~------~~~~lv 565 (817)
+.+.++||+|+||.||+|... .++.+|+|++........++..|+.++.++ +|+||+++++++... ...+++
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 87 (272)
T cd06637 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 87 (272)
T ss_pred hhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence 445578999999999999864 578899999976666677899999999998 799999999998753 457899
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|||+++++|.+++..... ..+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 88 MEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 999999999999876432 258899999999999999999999 8999999999999999999999999999986543
Q ss_pred CCceeeeeccCCCCccCccccc-----cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhh
Q 036583 646 EQSHVFTTLRGTRGYLAPEWIT-----NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRN 720 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (817)
... ......|+..|+|||++. +..++.++|||||||++|||++|+.||....... .........
T Consensus 164 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-------~~~~~~~~~--- 232 (272)
T cd06637 164 TVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-------ALFLIPRNP--- 232 (272)
T ss_pred ccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-------HHHHHhcCC---
Confidence 221 223456888999999986 3457889999999999999999999996432111 000111100
Q ss_pred hcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 721 ILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 721 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.... ........+.+++.+||+.+|.+|||+.|+++
T Consensus 233 --~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 --APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred --CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000 11122346789999999999999999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=312.06 Aligned_cols=251 Identities=19% Similarity=0.248 Sum_probs=193.2
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.++||+|+||+||+++.. .++.+|+|++.+. ......+.+|+.++..++|+||+++++.+.+....++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 345678999999999999965 4778999998642 12334588999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++|+|.+++.+... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 83 YVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred cCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999976432 57888899999999999999999 9999999999999999999999999999976544333
Q ss_pred eeeeeccCCCCccCccccc-----cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 649 HVFTTLRGTRGYLAPEWIT-----NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...... . ....+.....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~-~~~~i~~~~~----- 225 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------E-TYGKIMNHKE----- 225 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------H-HHHHHhCCCc-----
Confidence 2233457999999999986 346788999999999999999999999643211 1 1111111110
Q ss_pred cccCCcc-cHHHHHHHHHHHHhccccCCC--CCCCHHHHHHH
Q 036583 724 SRLNIDE-QSDRVFTAVKVALWCVQEDMS--LRPSMTKVVQM 762 (817)
Q Consensus 724 ~~~~~~~-~~~~~~~~~~l~~~cl~~dp~--~RPt~~evl~~ 762 (817)
+...+. .......+.+++.+|+..++. .|++++|+++.
T Consensus 226 -~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 -RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000000 011234567788887755444 47899999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=308.35 Aligned_cols=238 Identities=24% Similarity=0.401 Sum_probs=185.9
Q ss_pred ccCCCcceeEEEEEcCC-------------------------CcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeee
Q 036583 499 KLGQGGFGSVYQGVLPD-------------------------GTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKL 552 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~~-------------------------g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l 552 (817)
+||+|+||.||+|.+.. ...|++|++.... ....+|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 1358889886542 234678899999999999999999
Q ss_pred eeEeecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC--
Q 036583 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY-- 630 (817)
Q Consensus 553 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-- 630 (817)
+++|.+....++||||+++|+|..++.+... .+++..++.++.||++||+|||+ .+|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999999865433 57888899999999999999998 8999999999999997643
Q ss_pred -----cEEEeecCCccccCCCCceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhh-hCCCCCCCCCCCCCC
Q 036583 631 -----HAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEII-GGRKNFDPNETSDKA 703 (817)
Q Consensus 631 -----~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~ell-tg~~pf~~~~~~~~~ 703 (817)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.......
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-- 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-- 229 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--
Confidence 4899999988644322 12356788999998875 56889999999999999994 6899986432211
Q ss_pred cchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 704 HFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
...... .....+. .....+.+++.+||+.+|++||||.+|++.|.
T Consensus 230 -----~~~~~~---------~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 -----KERFYE---------KKHRLPE--PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -----HHHHHH---------hccCCCC--CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 001111 0111110 11235789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=308.27 Aligned_cols=255 Identities=27% Similarity=0.382 Sum_probs=201.5
Q ss_pred HHhhccccccCCCcceeEEEEEcCC----CcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeE
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLPD----GTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLL 564 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 564 (817)
...+.+.++||+|+||.||+|...+ ...|++|...... ...+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3445667889999999999998543 2468999886543 235689999999999999999999999875 45789
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
||||+++++|.+++..... .+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999976432 58899999999999999999998 899999999999999999999999999998765
Q ss_pred CCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 645 REQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 645 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
...........++..|+|||.+....++.++||||||++++|+++ |+.||....... ....+..+...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~~~~---- 227 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-------VIGRIENGERL---- 227 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHcCCcC----
Confidence 443222222334568999999988889999999999999999986 999996443211 11112221100
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
.........+.+++.+|+..+|++|||+.++++.|+.+.
T Consensus 228 -----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 228 -----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111123346889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=303.82 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=197.7
Q ss_pred cccCCCcceeEEEEEcCC--C--cEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 498 VKLGQGGFGSVYQGVLPD--G--TRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~--g--~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
++||+|++|.||+|.+.. + ..+|+|.+..... ..+++.+|+.++++++||||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998643 3 3689999976533 45789999999999999999999999988 889999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee-
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV- 650 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~- 650 (817)
++|.+++..... ..+++...+.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999976542 368999999999999999999999 899999999999999999999999999998765432211
Q ss_pred -eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 651 -FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 651 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
.....++..|+|||.+.+..++.++||||||++++||++ |+.||...... + ....... .....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~-~~~~~~~--------~~~~~ 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS------Q-ILKKIDK--------EGERL 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHh--------cCCcC
Confidence 112456778999999998899999999999999999999 99998533211 1 1111111 00001
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
......+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 111123456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=323.34 Aligned_cols=258 Identities=19% Similarity=0.233 Sum_probs=195.0
Q ss_pred hccccccCCCcceeEEEEEcCC-CcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
+.+.++||+|+||.||++.... ++.||||... ...+.+|++++++++|+||+++++++..+...++|||++. +
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~ 244 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-S 244 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-C
Confidence 4556789999999999999754 7889999643 2346789999999999999999999999999999999995 6
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee-e
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV-F 651 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~-~ 651 (817)
+|.+++..... .+++..++.++.||++||.|||+ .+|+||||||+||||+.++.+||+|||+++......... .
T Consensus 245 ~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 245 DLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 88888865432 58999999999999999999999 899999999999999999999999999998764332211 1
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCC-CCCCCCCCcchHHHHHHhhhcchh--hhc------
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFD-PNETSDKAHFPSYAFKMMEEGKLR--NIL------ 722 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~--~~~------ 722 (817)
....||..|+|||++.+..++.++|||||||+||||++|..|+- .................+...... ++.
T Consensus 320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~ 399 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR 399 (461)
T ss_pred cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence 23579999999999999999999999999999999999886553 222211122222222222221110 000
Q ss_pred -------------ccccCCccc---HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 723 -------------DSRLNIDEQ---SDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 723 -------------d~~~~~~~~---~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.+....... ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000000 0112357789999999999999999999974
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=307.24 Aligned_cols=248 Identities=27% Similarity=0.459 Sum_probs=196.2
Q ss_pred ccCCCcceeEEEEEcCC-------CcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 499 KLGQGGFGSVYQGVLPD-------GTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~~-------g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
.||+|+||.||+|+..+ ++.+|+|.+.... ....++.+|+.+++.++||||+++++++......++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998643 2578999886543 34678999999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccc----ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC-----cEEEeecCCc
Q 036583 570 ANGSLDKWIFKKNQ----EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY-----HAKVSDFGLA 640 (817)
Q Consensus 570 ~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-----~~ki~Dfgla 640 (817)
++++|.+++.+... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.+. .+||+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999975321 2247889999999999999999998 8999999999999999877 8999999999
Q ss_pred cccCCCCce-eeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcch
Q 036583 641 KLMTREQSH-VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKL 718 (817)
Q Consensus 641 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 718 (817)
+........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... . ....+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~------~-~~~~~~~~~- 230 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ------E-VLQHVTAGG- 230 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH------H-HHHHHhcCC-
Confidence 765432211 1112345678999999999899999999999999999998 99998533211 1 111111111
Q ss_pred hhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 719 RNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 719 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
........+..+.+++.+||+.+|++||++.++++.|++
T Consensus 231 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 --------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111112234567899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.92 Aligned_cols=260 Identities=27% Similarity=0.330 Sum_probs=202.7
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
..+.+.++||+|+||+||++... +++.+|+|++... ....+.+.+|++++..++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 44556688999999999999854 5889999987643 23457899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++++|.+++.+.. .+++.....++.+++.+|.|||+ ..+++|+||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 99999999886643 58899999999999999999996 2589999999999999999999999999987543221
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCC-cchHHHHHHhhhcchhhhcccccC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA-HFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||......... ......... ...++.....
T Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~ 231 (284)
T cd06620 159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-----LQQIVQEPPP 231 (284)
T ss_pred --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH-----HHHHhhccCC
Confidence 12356889999999998888999999999999999999999999754432110 000000010 1111111111
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
..........+.+++.+|++.||++|||+.|++++..
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 232 RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 1111123446889999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=323.75 Aligned_cols=257 Identities=25% Similarity=0.328 Sum_probs=194.9
Q ss_pred cccccCCCcceeEEEEEc-CCCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCC-----eeeEEE
Q 036583 496 FSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT-----HRLLAY 566 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~-----~~~lv~ 566 (817)
+.++||+|+||.||++.. .+++.||||++.... ...+.+.+|+++++.++|+||+++++++.... ..++|+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 346799999999999995 468999999986532 23467889999999999999999999998776 789999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
||+. ++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 84 ELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred eccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9997 47888775543 58899999999999999999999 89999999999999999999999999999865443
Q ss_pred CceeeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhh-----------
Q 036583 647 QSHVFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMME----------- 714 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~----------- 714 (817)
.........+++.|+|||.+.+. .++.++|||||||+++||++|+.||........ .........
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ---LDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCCCHHHHHHhh
Confidence 33223345678899999998864 578999999999999999999999975432210 000000000
Q ss_pred hcchhhhcccccCC-------cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 715 EGKLRNILDSRLNI-------DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 715 ~~~~~~~~d~~~~~-------~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.+....+....... .........+.+++.+|++.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000000000 0011123467899999999999999999999974
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=310.17 Aligned_cols=252 Identities=20% Similarity=0.232 Sum_probs=192.9
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.++||+|+||+||+++.. +++.+|+|++... ....+.+.+|+.++..++|+||+++++++.++...++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 456688999999999999964 5889999999642 22345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++|+|.+++.+... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 83 YVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred CCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999975332 57888999999999999999999 9999999999999999999999999999876544332
Q ss_pred eeeeeccCCCCccCcccccc-----CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 649 HVFTTLRGTRGYLAPEWITN-----YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ...............+..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~~~~ 231 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHFQFPP 231 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCcccCCC
Confidence 22233568999999999863 4578899999999999999999999964321 111111111111111110
Q ss_pred cccCCcccHHHHHHHHHHHHhcccc--CCCCCCCHHHHHHH
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQE--DMSLRPSMTKVVQM 762 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~--dp~~RPt~~evl~~ 762 (817)
........+.+++.+|+.. ++..||+++++++.
T Consensus 232 ------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 232 ------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0011233566777776654 44448899999885
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=313.47 Aligned_cols=239 Identities=25% Similarity=0.327 Sum_probs=191.5
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccC-cceeeeeeeEeecCCeeeEEEe
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIH-HLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 567 (817)
.++.+.||+|+||+||+++.. +++.||+|++... ....+.+..|..++..+. |++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 356688999999999999854 6889999998653 223456788999988885 6788899999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+++|+|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 82 y~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 82 YVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999999987654 58899999999999999999999 899999999999999999999999999987543222
Q ss_pred ceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... ..
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-------~~~~~~i~~~~--------~~ 219 (323)
T cd05615 156 V-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-------DELFQSIMEHN--------VS 219 (323)
T ss_pred c-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC--------CC
Confidence 1 12335689999999999998999999999999999999999999964321 11111111111 11
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCH
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSM 756 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~ 756 (817)
.+ ......+.+++.+|++.+|.+|++.
T Consensus 220 ~p--~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 YP--KSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CC--ccCCHHHHHHHHHHcccCHhhCCCC
Confidence 11 1123467889999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=308.63 Aligned_cols=248 Identities=24% Similarity=0.367 Sum_probs=199.6
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
++.+.++||+|+||.||+|+. .+++.+++|.+.... ...+.+.+|+.+++.++|+||+++++.+..+.+.++||||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 455567899999999999985 468899999987543 345678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+++|.+++... .+++.++..++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++.........
T Consensus 101 ~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~- 172 (296)
T cd06654 101 GGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (296)
T ss_pred CCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc-
Confidence 99999998543 47888999999999999999998 89999999999999999999999999998865433211
Q ss_pred eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 651 FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
.....+++.|+|||.+.+..++.++|||||||++|||++|+.||........ .......+ ......
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~------~~~~~~~~--------~~~~~~ 238 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNG--------TPELQN 238 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh------HHHHhcCC--------CCCCCC
Confidence 1234688899999999988889999999999999999999999964432110 00001000 000111
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.......+.+++.+||+.+|++||++.|+++.
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 12233467889999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=319.52 Aligned_cols=248 Identities=24% Similarity=0.309 Sum_probs=192.9
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
.+.+.||+|+||.||++... .++.+|+|++... ....+.+.+|+.++..++|+||+++++.+.+++..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (360)
T cd05627 4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFL 83 (360)
T ss_pred eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 34578999999999999864 5889999999643 223467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++|+|.+++.+.. .++...+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 84 ~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 84 PGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred CCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 9999999997654 58889999999999999999999 99999999999999999999999999998754321100
Q ss_pred ----------------------------------eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCC
Q 036583 650 ----------------------------------VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFD 695 (817)
Q Consensus 650 ----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~ 695 (817)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 0113468999999999999999999999999999999999999996
Q ss_pred CCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 036583 696 PNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPS---MTKVVQM 762 (817)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt---~~evl~~ 762 (817)
..... .....+.... ..+..+........+.+++.+++ .||.+|++ ++|+++.
T Consensus 238 ~~~~~-------~~~~~i~~~~------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 238 SETPQ-------ETYRKVMNWK------ETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCHH-------HHHHHHHcCC------CceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 44321 1111111110 01111111112335667777766 49999985 6676653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=301.89 Aligned_cols=238 Identities=25% Similarity=0.431 Sum_probs=190.4
Q ss_pred cccCCCcceeEEEEEcCCCc-----------EEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 498 VKLGQGGFGSVYQGVLPDGT-----------RLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~-----------~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
+.||+|+||.||+|...+.. .+++|.+.........|.+|+.++++++||||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 36999999999999975432 57888776544337889999999999999999999999988 7789999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC-------cEEEeecCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY-------HAKVSDFGL 639 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-------~~ki~Dfgl 639 (817)
||+++|+|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+||+++.++ .+||+|||+
T Consensus 80 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 80 EYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999976543 57888999999999999999998 9999999999999999887 799999999
Q ss_pred ccccCCCCceeeeeccCCCCccCccccccC--ccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhc
Q 036583 640 AKLMTREQSHVFTTLRGTRGYLAPEWITNY--AISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEG 716 (817)
Q Consensus 640 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 716 (817)
+...... ....++..|+|||.+.+. .++.++||||||+++|||++ |..||....... ........
T Consensus 155 a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-------~~~~~~~~ 222 (259)
T cd05037 155 PITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-------KERFYQDQ 222 (259)
T ss_pred ccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-------HHHHHhcC
Confidence 9865431 224566789999999876 78899999999999999999 566775432111 00001100
Q ss_pred chhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 717 KLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 717 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
. ....+ ....+.+++.+||+.+|.+|||+.|+++.|+
T Consensus 223 ~-------~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 H-------RLPMP----DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C-------CCCCC----CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00011 1157889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=336.79 Aligned_cols=257 Identities=22% Similarity=0.321 Sum_probs=199.6
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.++||+|+||.||+|... .++.||+|++.... ...++|.+|++++.+++||||+++++++.+++..++||||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 456688999999999999864 58899999996532 1245789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccc--------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCc
Q 036583 569 MANGSLDKWIFKKNQ--------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLA 640 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 640 (817)
+++|+|.+++..... ...+++..+++++.||++||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCcc
Confidence 999999999864211 1245667889999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCc-----------------eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCC
Q 036583 641 KLMTREQS-----------------HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA 703 (817)
Q Consensus 641 ~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~ 703 (817)
+....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki- 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI- 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh-
Confidence 87621110 001124689999999999999999999999999999999999999965322110
Q ss_pred cchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcCC
Q 036583 704 HFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRP-SMTKVVQMLEGIC 767 (817)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-t~~evl~~L~~~~ 767 (817)
... .. +.++. ......+.+..+.+++.+|++.||++|| +++++++.|+...
T Consensus 240 -----~~~----~~---i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 240 -----SYR----DV---ILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred -----hhh----hh---ccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 000 00 00000 0001112234577899999999999996 6777888777653
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=304.29 Aligned_cols=247 Identities=25% Similarity=0.352 Sum_probs=194.9
Q ss_pred ccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 495 NFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
.+.+.||+|+||.||++.. .+++.+|+|.+.... ...+++.+|++++.+++||||+++++++...+..++||||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 3457799999999999985 468899999986542 2346789999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
++|..+. .+++.....++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++....... .
T Consensus 84 ~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~ 150 (279)
T cd06619 84 GSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---A 150 (279)
T ss_pred CChHHhh-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---c
Confidence 9997653 35677888999999999999999 999999999999999999999999999998654321 1
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
....++..|+|||.+.+..++.++||||||+++|||++|+.||....................... .+.+ ..
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~---~~ 222 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL---PV 222 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC---CC
Confidence 235788999999999988899999999999999999999999965332221111111111111110 0111 11
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
......+.+++.+|++.+|++||+++|+++.
T Consensus 223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1123467899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=304.43 Aligned_cols=248 Identities=26% Similarity=0.430 Sum_probs=191.0
Q ss_pred cccCCCcceeEEEEEcC----CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEee-cCCeeeEEEeecc
Q 036583 498 VKLGQGGFGSVYQGVLP----DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCA-EGTHRLLAYEFMA 570 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~----~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~ 570 (817)
+.||+|+||.||+|... ++..+|+|++.... ...+.+.+|+.+++.++||||+++++++. .+...++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999853 24579999986432 23567889999999999999999999876 4556789999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+++|.+++..... .+++..+..++.||+.||+|||+ .+++||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999975432 35677788999999999999998 899999999999999999999999999998654322111
Q ss_pred ---eeeccCCCCccCccccccCccCccccccchhhhHHHhhhC-CCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 651 ---FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGG-RKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 651 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
.....++..|+|||.+.+..++.++||||||+++|||++| ..||..... .. ....+..+.. .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~-~~~~~~~~~~-------~ 221 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FD-ITVYLLQGRR-------L 221 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------HH-HHHHHhcCCC-------C
Confidence 1123456789999999888899999999999999999995 555643211 01 1111111110 0
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
......+..+.+++..||+.+|++||++.|+++.|+.+
T Consensus 222 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 222 --LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred --CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00111234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.49 Aligned_cols=198 Identities=27% Similarity=0.411 Sum_probs=173.4
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhccC-c-----ceeeeeeeEeecCCeeeEE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH-H-----LHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~-h-----~niv~l~~~~~~~~~~~lv 565 (817)
+|.+.+.||+|.||.|-|+.. ..++.||||++++...-..+-..|+.+|..|+ | -|+|+++++|...+|.|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 677788999999999999985 45899999999987666677788999999997 4 3899999999999999999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC--CCcEEEeecCCcccc
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD--NYHAKVSDFGLAKLM 643 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~ki~Dfgla~~~ 643 (817)
+|.+.. +|.++|....-. .++....+.++.||+.||.+||+ .+|||+||||+||||.+ ...+||+|||.+...
T Consensus 267 fELL~~-NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred ehhhhh-hHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 999976 999999865543 68899999999999999999999 99999999999999974 347999999999875
Q ss_pred CCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCC
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNET 699 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~ 699 (817)
...- .+...+.-|+|||++.+.+|+.+.||||||||+.||++|.+.|.+...
T Consensus 342 ~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 342 SQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred CCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 4332 145667889999999999999999999999999999999988866543
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=305.85 Aligned_cols=251 Identities=24% Similarity=0.371 Sum_probs=199.4
Q ss_pred cccccCCCcceeEEEEEcC------CCcEEEEEEeccCCcC--HHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 496 FSVKLGQGGFGSVYQGVLP------DGTRLAVKKLEGIGQG--KKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~~~--~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
...+||+|+||.||+++.. +.+.+++|.+...... .+++.+|++++++++|+||+++++++.+....++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (275)
T cd05046 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE 88 (275)
T ss_pred eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence 4467999999999999853 3457999988654332 4689999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccc------cchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcc
Q 036583 568 FMANGSLDKWIFKKNQE------FLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK 641 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 641 (817)
|+++|+|.+++...... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~~~ 165 (275)
T cd05046 89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSK 165 (275)
T ss_pred ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccccccc
Confidence 99999999999765422 158999999999999999999998 899999999999999999999999999987
Q ss_pred ccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhh
Q 036583 642 LMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRN 720 (817)
Q Consensus 642 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (817)
..............++..|+|||.+.+..++.++||||||++++||++ |..||...... ........+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-------~~~~~~~~~~~~- 237 (275)
T cd05046 166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-------EVLNRLQAGKLE- 237 (275)
T ss_pred ccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-------HHHHHHHcCCcC-
Confidence 554332222233456678999999988888999999999999999999 78888532211 111112211111
Q ss_pred hcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 721 ILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 721 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
..........+.+++.+|++.+|++||++.|++++|+
T Consensus 238 -------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 238 -------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111123346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=314.34 Aligned_cols=239 Identities=23% Similarity=0.297 Sum_probs=186.5
Q ss_pred cCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhcc---CcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 500 LGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSI---HHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 500 lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
||+|+||+||+++.. +++.||||++.... .....+..|..++... +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999864 58899999986431 1223455677776655 699999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~ 153 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TT 153 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Cc
Confidence 99999887544 58889999999999999999999 8999999999999999999999999999875432221 12
Q ss_pred eeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 652 TTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
....||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... ......+..+.. ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-------~~~~~~i~~~~~--------~~~- 217 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-------QQMYRNIAFGKV--------RFP- 217 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-------HHHHHHHHcCCC--------CCC-
Confidence 346789999999998754 578999999999999999999999964321 111222222211 111
Q ss_pred cHHHHHHHHHHHHhccccCCCCCC----CHHHHHH
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRP----SMTKVVQ 761 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RP----t~~evl~ 761 (817)
.......+.+++.+||+.||.+|| ++.|+++
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 011234577899999999999998 5666665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=311.69 Aligned_cols=196 Identities=22% Similarity=0.395 Sum_probs=161.1
Q ss_pred cccCCCcceeEEEEEcC---CCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeec--CCeeeEEEeeccCC
Q 036583 498 VKLGQGGFGSVYQGVLP---DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE--GTHRLLAYEFMANG 572 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~---~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g 572 (817)
.+||+|+||+||+|+.. .++.+|+|.+.... ....+.+|++++++++||||+++++++.. +...+++|||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-
Confidence 57999999999999854 46789999987542 34567899999999999999999999854 4567899999865
Q ss_pred Chhhhhhhcc------cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEe----cCCCcEEEeecCCccc
Q 036583 573 SLDKWIFKKN------QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL----DDNYHAKVSDFGLAKL 642 (817)
Q Consensus 573 sL~~~l~~~~------~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~ki~Dfgla~~ 642 (817)
+|.+++.... ....+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 7887775321 12247888899999999999999999 899999999999999 4668999999999987
Q ss_pred cCCCCce--eeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCC
Q 036583 643 MTREQSH--VFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNE 698 (817)
Q Consensus 643 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~ 698 (817)
....... ......+|+.|+|||++.+ ..++.++||||+||+++||++|+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 6433221 1234678999999999976 458899999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=302.09 Aligned_cols=250 Identities=29% Similarity=0.497 Sum_probs=197.7
Q ss_pred ccccccCCCcceeEEEEEcCC-CcEEEEEEeccCCcCHH---HHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 495 NFSVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQGKK---EFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~---~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.+.++||+|+||+||+++... ++.+|+|.+........ ...+|+.++++++||||+++++++.+....++||||++
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 456789999999999999654 66899999987643322 34569999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+++|.+++.... .+++..+..++.||++||++||+ .+|+|+||||+||++++++.++|+|||++.... .....
T Consensus 82 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~ 154 (260)
T PF00069_consen 82 GGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNEN 154 (260)
T ss_dssp TEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSE
T ss_pred cccccccccccc---ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-ccccc
Confidence 999999998333 58999999999999999999999 899999999999999999999999999998642 12223
Q ss_pred eeeccCCCCccCccccc-cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 651 FTTLRGTRGYLAPEWIT-NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
.....++..|+|||++. +..++.++||||+|+++++|++|..||......+ .................. .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~-~- 225 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD-------QLEIIEKILKRPLPSSSQ-Q- 225 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH-------HHHHHHHHHHTHHHHHTT-S-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchh-------hhhhhhhccccccccccc-c-
Confidence 34467889999999998 8889999999999999999999999997541100 011111111101111100 0
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.......+.+++..|++.||++||++.++++
T Consensus 226 -~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 -SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011257889999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=301.50 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=199.3
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
.+.++||+|+||.||+++.. +++.+|+|.++.. ....+.+.+|+.++++++|+||+++++.+.++...+++|||+++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG 82 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence 45678999999999999854 6889999988543 23456788999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
++|.+++..... ..++....+.++.||+.||.|||+ .+|+|+||||+||++++++.++|+|||++........ ..
T Consensus 83 ~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (255)
T cd08219 83 GDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YA 157 (255)
T ss_pred CcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-cc
Confidence 999998865322 257888999999999999999998 8999999999999999999999999999986643222 12
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
....+++.|+|||++.+..++.++||||||+++|+|++|+.||...... . ....+..+....+ .
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~~~---------~ 221 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------N-LILKVCQGSYKPL---------P 221 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------H-HHHHHhcCCCCCC---------C
Confidence 3356888999999999888999999999999999999999999643211 1 1111112211111 1
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
......+.+++.+||+.||++||++.|++..
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1223457899999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.30 Aligned_cols=255 Identities=27% Similarity=0.448 Sum_probs=201.6
Q ss_pred HhhccccccCCCcceeEEEEEcCC-Cc----EEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPD-GT----RLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLL 564 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~----~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 564 (817)
..+.+.+.||+|+||.||+|...+ |+ .+|+|.+..... ...++.+|+.++.+++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 345566889999999999998643 32 589998865432 34678999999999999999999999987 78899
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
|+||+++|+|.+++..... .+++..+..++.||+.||+|||+ .+++|+||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999976543 48899999999999999999999 999999999999999999999999999998765
Q ss_pred CCCceee-eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 645 REQSHVF-TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 645 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
....... ....++..|+|||.+....++.++||||||++++|+++ |+.||..... ......+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~---- 229 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-------VEIPDLLEKGER---- 229 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-------HHHHHHHhCCCC----
Confidence 4332211 11233568999999988889999999999999999998 9999964321 111122222110
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
.+.+......+.+++..||..+|.+||++.++++.|+.+..
T Consensus 230 -----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 -----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11111123467889999999999999999999999988633
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=301.61 Aligned_cols=251 Identities=19% Similarity=0.319 Sum_probs=188.2
Q ss_pred ccCCCcceeEEEEEcCCC---cEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCC
Q 036583 499 KLGQGGFGSVYQGVLPDG---TRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGS 573 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~~g---~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 573 (817)
+||+|+||.||+|...++ ..+++|.+.... ...+.+.+|+.+++.++||||+++++.|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999975433 346677765432 345689999999999999999999999999999999999999999
Q ss_pred hhhhhhhccc-ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC-ceee
Q 036583 574 LDKWIFKKNQ-EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ-SHVF 651 (817)
Q Consensus 574 L~~~l~~~~~-~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~-~~~~ 651 (817)
|.+++.+... ....+......++.||++||+|||+ .+++||||||+|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999976422 2245667778999999999999998 899999999999999999999999999986432211 1111
Q ss_pred eeccCCCCccCcccccc-------CccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 652 TTLRGTRGYLAPEWITN-------YAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
....++..|+|||++.. ..++.++||||||+++|||++ |..||..... .. .......+....+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~-~~~~~~~~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------RE-VLNHVIKDQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HH-HHHHHHhhcccccCC
Confidence 23567889999999853 245779999999999999997 5667753221 11 112222222223333
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
+.+... ....+.+++..|| .+|++||+++||++.|.
T Consensus 232 ~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 333222 2235667888899 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=303.45 Aligned_cols=253 Identities=25% Similarity=0.336 Sum_probs=195.5
Q ss_pred HHhhcc--ccccCCCcceeEEEEEcC-CCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 491 TATNNF--SVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 491 ~~~~~~--~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
.++.++ ...||+|+||.||+|+.. +++.|++|.+.... ...+.+.+|++++++++|+||+++++++..++..++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 344444 357999999999999954 57789999887543 34568999999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC-CCcEEEeecCCccccCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD-NYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~Dfgla~~~~~ 645 (817)
||+++++|.+++.........++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 999999999999764322112778888999999999999998 89999999999999986 67999999999876543
Q ss_pred CCceeeeeccCCCCccCccccccC--ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 646 EQSHVFTTLRGTRGYLAPEWITNY--AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
... ......+++.|+|||++.+. .++.++||||||+++|||++|+.||........ ..+......
T Consensus 162 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-----~~~~~~~~~------- 228 (268)
T cd06624 162 INP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-----AMFKVGMFK------- 228 (268)
T ss_pred CCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-----hHhhhhhhc-------
Confidence 221 12234578899999998754 378899999999999999999999964321110 000000000
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.....+......+.+++.+||+.+|++|||+.|+++
T Consensus 229 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 --IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred --cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 000111123346789999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.87 Aligned_cols=248 Identities=27% Similarity=0.348 Sum_probs=196.3
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
...+.||+|+||+||++... +++.+|+|.+.... ...+.+.+|+.++.+++|+|++++++.+.+.+..++||||+
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEec
Confidence 34567999999999999864 68899999986532 12345788999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++++|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++........
T Consensus 83 ~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 83 NGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred CCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 99999998865432 258889999999999999999998 9999999999999999999999999999876543221
Q ss_pred eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||........ .......... .. ..
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~---~~~~~~~~~~-----~~-~~---- 223 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK---REEVERLVKE-----VQ-EE---- 223 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch---HHHHHhhhhh-----hh-hh----
Confidence 1234689999999999998999999999999999999999999975432110 0000000000 00 00
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPS-----MTKVVQ 761 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt-----~~evl~ 761 (817)
........+.+++..||+.||++||| ++|+++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 224 YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 11112335779999999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=306.36 Aligned_cols=248 Identities=25% Similarity=0.309 Sum_probs=195.7
Q ss_pred ccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 495 NFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
...+.||+|+||+||++.. .+++.+|+|.+.... ...+.+.+|++++.+++|+|++++.+.+..++..++||||+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEec
Confidence 3456799999999999986 468899999986532 22345788999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++++|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++........
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 83 NGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred cCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 99999988865432 258999999999999999999998 8999999999999999999999999999876543221
Q ss_pred eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ............. . .
T Consensus 158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~---~~~~~~~~~~~~~--------~--~ 223 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV---KREEVDRRVLETE--------E--V 223 (285)
T ss_pred -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhhhccc--------c--c
Confidence 233568999999999998899999999999999999999999996432111 0000111111110 0 0
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPS-----MTKVVQ 761 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt-----~~evl~ 761 (817)
........+.+++..|++.||++||+ +.++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 224 YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 11122335678999999999999999 667766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=300.47 Aligned_cols=247 Identities=27% Similarity=0.398 Sum_probs=200.9
Q ss_pred hccccccCCCcceeEEEEEcCC-CcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
+.+.++||+|+||.||+++..+ ++.+++|.+..... .+++.+|++++++++|+||+++++++.+....++++||++++
T Consensus 5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 83 (256)
T cd06612 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAG 83 (256)
T ss_pred chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCC
Confidence 4456789999999999999765 78999999875433 678999999999999999999999999999999999999999
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeee
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT 652 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 652 (817)
+|.+++..... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++........ ...
T Consensus 84 ~L~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (256)
T cd06612 84 SVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRN 157 (256)
T ss_pred cHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccc
Confidence 99999865432 68999999999999999999998 8999999999999999999999999999987654321 122
Q ss_pred eccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccH
Q 036583 653 TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQS 732 (817)
Q Consensus 653 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 732 (817)
...++..|+|||.+.+..++.++||||||+++|||++|+.||........ ...... ...+. .....
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-------~~~~~~-----~~~~~--~~~~~ 223 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-------IFMIPN-----KPPPT--LSDPE 223 (256)
T ss_pred cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-------hhhhcc-----CCCCC--CCchh
Confidence 34578899999999988999999999999999999999999964322110 000000 00011 11111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 733 DRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 733 ~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.....+.+++.+|++.||++|||+.|+++
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 23346889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=315.53 Aligned_cols=239 Identities=25% Similarity=0.325 Sum_probs=187.9
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHH-HhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVS-IIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+.||+|+||+||+++.. +++.+|+|++.... ....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 35999999999999965 57789999986431 22344555544 56788999999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
|+|.+++.... .+.......++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~ 153 (325)
T cd05602 81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TT 153 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cc
Confidence 99999987644 46777888899999999999999 9999999999999999999999999999975432221 22
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.... ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~i~~~~--------~~~~-- 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------EMYDNILNKP--------LQLK-- 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-------HHHHHHHhCC--------cCCC--
Confidence 3457899999999999999999999999999999999999999643211 1111111111 1111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMTKVV 760 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~evl 760 (817)
......+.+++..|++.||.+||++.+.+
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 11234678999999999999999887443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=313.36 Aligned_cols=261 Identities=19% Similarity=0.322 Sum_probs=195.1
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
+.+.++||+|+||+||+|+.. +++.||+|.++... .....+.+|++++++++||||+++++++..++..++||||++
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 455678999999999999864 57889999986442 234568899999999999999999999999999999999998
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+ +|.+++..... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 88 ~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 160 (309)
T cd07872 88 K-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-T 160 (309)
T ss_pred C-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-c
Confidence 6 88888765432 57888899999999999999999 8999999999999999999999999999976533221 1
Q ss_pred eeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcch--------HHHHHHhhhc-chhh
Q 036583 651 FTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFP--------SYAFKMMEEG-KLRN 720 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~--------~~~~~~~~~~-~~~~ 720 (817)
.....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+..... ...+..+... ....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 223467889999999865 46789999999999999999999999654322110000 0000000000 0000
Q ss_pred hcccccCC----cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 721 ILDSRLNI----DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 721 ~~d~~~~~----~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.-.+.... .........+.+++.+|++.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000 000112345779999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=321.15 Aligned_cols=264 Identities=21% Similarity=0.257 Sum_probs=199.0
Q ss_pred HHHHHhhccccccCCCcceeEEEEEcC---CCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeE
Q 036583 488 DLQTATNNFSVKLGQGGFGSVYQGVLP---DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLL 564 (817)
Q Consensus 488 ~l~~~~~~~~~~lG~G~fG~Vy~g~~~---~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 564 (817)
.+....+.+.++||+|+||.||++... .++.||+|.+... +...+|++++++++||||+++++++......++
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 344456777889999999999999743 3567999988643 345689999999999999999999999999999
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
|||++. ++|.+++.... .+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 164 v~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRSG---PLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred EehhcC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 999996 58888884433 68999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCce-eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcch-----
Q 036583 645 REQSH-VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKL----- 718 (817)
Q Consensus 645 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----- 718 (817)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.+.+.....
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 43222 122357899999999999999999999999999999999999999654432211111111111100000
Q ss_pred ---------hhh---cccccCCcc---cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 719 ---------RNI---LDSRLNIDE---QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 719 ---------~~~---~d~~~~~~~---~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
... ..+....+. .......+.+++.+|++.||++|||+.|++++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 000000000 00123457789999999999999999999984
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=304.93 Aligned_cols=245 Identities=24% Similarity=0.357 Sum_probs=197.4
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
+...++||+|+||.||+|... +++.||+|.+.... ...+.+.+|++++++++||||+++++++..+...++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 344567999999999999854 57889999886432 234678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+++|.+++... .+++..+..++.|++.|+.|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 86 ~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06642 86 GGSALDLLKPG----PLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK- 157 (277)
T ss_pred CCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcchh-
Confidence 99999988542 57889999999999999999998 89999999999999999999999999999866433211
Q ss_pred eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 651 FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
.....++..|+|||.+.+..++.++||||||++++||++|+.|+....... ....+..+. ....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------~~~~~~~~~---------~~~~ 221 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-------VLFLIPKNS---------PPTL 221 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-------HHhhhhcCC---------CCCC
Confidence 122457889999999998889999999999999999999999986432111 000011110 0111
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.......+.+++.+||+.+|++||+|.|++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11234567899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=300.57 Aligned_cols=246 Identities=27% Similarity=0.453 Sum_probs=197.7
Q ss_pred hhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
.+.+.+.||+|+||.||++.. .++.+|+|.+... ...+.+.+|+.++.+++|||++++++++... ..+++|||++++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~ 83 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD-VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG 83 (254)
T ss_pred HceeeeeeccCCCCceEeccc-CCCceEEEeecCc-chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence 456678899999999999986 6788999998643 2356789999999999999999999998764 479999999999
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeee
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT 652 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 652 (817)
+|.+++..... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....... .
T Consensus 84 ~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~ 155 (254)
T cd05083 84 NLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----D 155 (254)
T ss_pred CHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC----C
Confidence 99999976432 257888999999999999999998 999999999999999999999999999987643221 1
Q ss_pred eccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 653 TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 653 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
....+..|+|||.+.+..++.++||||||+++|||++ |+.||...... ........+ ...+..
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~---------~~~~~~ 219 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-------EVKECVEKG---------YRMEPP 219 (254)
T ss_pred CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-------HHHHHHhCC---------CCCCCC
Confidence 2334568999999998889999999999999999998 99998643211 111111111 111111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 2234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=304.66 Aligned_cols=248 Identities=23% Similarity=0.358 Sum_probs=200.2
Q ss_pred HhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
..+.+.++||+|+||.||++.. .+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 4455668899999999999995 578999999996543 34567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++++|.+++.+. .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred CCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 999999998643 47888999999999999999999 89999999999999999999999999998865443221
Q ss_pred eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
.....+++.|+|||.+.+..++.++|||||||++|++++|+.||........... .... ......
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~--------~~~~~~ 236 (297)
T cd06656 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATN--------GTPELQ 236 (297)
T ss_pred -cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccC--------CCCCCC
Confidence 1234678899999999988899999999999999999999999965432211000 0000 000011
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
........+.+++.+||+.+|++||+++++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11223345778999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=309.49 Aligned_cols=261 Identities=21% Similarity=0.286 Sum_probs=197.0
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
+.+.++||+|+||.||++... ++..+|+|.+..... ...++.+|++++.+++||||+++++++.+++..++||||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 345678999999999999864 577888888864322 23568899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+++|.+++.+.. .+++..+..++.||++||.|||+ ..+++|+||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 83 GGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 999999997653 57888999999999999999997 2589999999999999999999999999987653321
Q ss_pred eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhh---------------
Q 036583 651 FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEE--------------- 715 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--------------- 715 (817)
.....++..|+|||.+.+..++.++||||||++++||++|+.||.....................
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 12356889999999998888999999999999999999999998543211100000000000000
Q ss_pred ------cchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 716 ------GKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 716 ------~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.....+................+.+++.+|++.+|++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000000001123458899999999999999999999985
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=293.73 Aligned_cols=252 Identities=25% Similarity=0.345 Sum_probs=210.1
Q ss_pred cccccCCCcceeEEEEEcCC-CcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 496 FSVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
+.++||.|.-|+||++.+++ +...|+|++.+.. ....+...|-+||..++||.++.|++.|+.+...|||||||+
T Consensus 81 llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCp 160 (459)
T KOG0610|consen 81 LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCP 160 (459)
T ss_pred HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCC
Confidence 45689999999999999865 4789999997652 233567789999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC-----
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR----- 645 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~----- 645 (817)
||+|..++++...+ .++...++-++..|+-||+|||. .+||.|||||+||||-++|.+-|+||.|+.....
T Consensus 161 GGdL~~LrqkQp~~-~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~ 236 (459)
T KOG0610|consen 161 GGDLHSLRQKQPGK-RFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV 236 (459)
T ss_pred CccHHHHHhhCCCC-ccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence 99999988766543 78999999999999999999999 9999999999999999999999999998754310
Q ss_pred ----------------------------C-Cc---------------------eeeeeccCCCCccCccccccCccCccc
Q 036583 646 ----------------------------E-QS---------------------HVFTTLRGTRGYLAPEWITNYAISEKS 675 (817)
Q Consensus 646 ----------------------------~-~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~ 675 (817)
. .. ......+||-.|+|||++.+...+.++
T Consensus 237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAV 316 (459)
T KOG0610|consen 237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAV 316 (459)
T ss_pred ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchh
Confidence 0 00 011225689999999999999999999
Q ss_pred cccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCC
Q 036583 676 DVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPS 755 (817)
Q Consensus 676 DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt 755 (817)
|.|+|||+||||+.|..||.+..... .+.+++...+..+........+.+||...|.+||++|--
T Consensus 317 DWWtfGIflYEmLyG~TPFKG~~~~~---------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg 381 (459)
T KOG0610|consen 317 DWWTFGIFLYEMLYGTTPFKGSNNKE---------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLG 381 (459)
T ss_pred hHHHHHHHHHHHHhCCCCcCCCCchh---------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhc
Confidence 99999999999999999997654322 345566666666655566778899999999999999998
Q ss_pred ----HHHHHH--HHhcC
Q 036583 756 ----MTKVVQ--MLEGI 766 (817)
Q Consensus 756 ----~~evl~--~L~~~ 766 (817)
+.||-+ +++++
T Consensus 382 ~~rGA~eIK~HpFF~gV 398 (459)
T KOG0610|consen 382 SKRGAAEIKRHPFFEGV 398 (459)
T ss_pred cccchHHhhcCccccCC
Confidence 888876 34554
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=313.03 Aligned_cols=190 Identities=24% Similarity=0.368 Sum_probs=162.1
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
..+.+.++||+|+||.||+|+.. .++.||+|..... ....|+.++.+++|+||+++++++.++...++|+||+.
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 34666789999999999999965 4678999975432 23569999999999999999999999999999999995
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
++|.+++..... .+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 141 -~~l~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~ 212 (357)
T PHA03209 141 -SDLYTYLTKRSR--PLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--A 212 (357)
T ss_pred -CcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc--c
Confidence 588888865433 68999999999999999999999 899999999999999999999999999997543221 1
Q ss_pred eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCC
Q 036583 651 FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNF 694 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf 694 (817)
.....||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 23456899999999999989999999999999999999865544
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=303.68 Aligned_cols=239 Identities=24% Similarity=0.427 Sum_probs=188.0
Q ss_pred cccCCCcceeEEEEEcCC--------CcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 498 VKLGQGGFGSVYQGVLPD--------GTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~--------g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.||+|+||.||+|.... ..++++|.+.... ...+++.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998532 2348888876443 3346789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCc--------EEEeecCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYH--------AKVSDFGLA 640 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~--------~ki~Dfgla 640 (817)
+++|+|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+||+++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999976543 57889999999999999999999 99999999999999987765 699999998
Q ss_pred cccCCCCceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCC-CCCCCCCCCCCCcchHHHHHHhhhcch
Q 036583 641 KLMTREQSHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGR-KNFDPNETSDKAHFPSYAFKMMEEGKL 718 (817)
Q Consensus 641 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~ 718 (817)
...... ....++..|+|||++.+ ..++.++||||||+++|||++|. .|+....... .....
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-------~~~~~----- 218 (258)
T cd05078 156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-------KLQFY----- 218 (258)
T ss_pred cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-------HHHHH-----
Confidence 755332 22457789999999986 45789999999999999999985 5554221110 00000
Q ss_pred hhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 719 RNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 719 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
..+...+ ......+.+++..||+.||++|||++++++.|+
T Consensus 219 ----~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 219 ----EDRHQLP--APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----HccccCC--CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0111111 112246789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=301.47 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=197.6
Q ss_pred ccccccCCCcceeEEEEEcCC--CcEEEEEEeccC-----------CcCHHHHHHHHHHhhc-cCcceeeeeeeEeecCC
Q 036583 495 NFSVKLGQGGFGSVYQGVLPD--GTRLAVKKLEGI-----------GQGKKEFRAEVSIIGS-IHHLHLVKLRGFCAEGT 560 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~~--g~~vavK~l~~~-----------~~~~~~~~~Ev~~l~~-l~h~niv~l~~~~~~~~ 560 (817)
.+.++||+|+||.||+|.... ++.+|+|.+... .....++..|+.++.+ ++||||+++++++.+++
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 82 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND 82 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence 345679999999999999765 678999987532 1123457788888865 79999999999999999
Q ss_pred eeeEEEeeccCCChhhhhhhc-ccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCC
Q 036583 561 HRLLAYEFMANGSLDKWIFKK-NQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGL 639 (817)
Q Consensus 561 ~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl 639 (817)
..+++|||+++++|.+++... .....+++..+++++.|++.||.|||+ ..+++|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecccc
Confidence 999999999999999988542 122358889999999999999999995 26899999999999999999999999999
Q ss_pred ccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchh
Q 036583 640 AKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLR 719 (817)
Q Consensus 640 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (817)
+....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... . ......++...
T Consensus 161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~ 231 (269)
T cd08528 161 AKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------S-LATKIVEAVYE 231 (269)
T ss_pred eeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------H-HHHHHhhccCC
Confidence 98765432 223456888999999999888999999999999999999999999533211 1 11111111111
Q ss_pred hhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 720 NILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 720 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
.. ........+.+++.+|++.||++||++.|+.++++
T Consensus 232 ~~--------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 232 PL--------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cC--------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 10 11122346889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=310.37 Aligned_cols=255 Identities=19% Similarity=0.249 Sum_probs=191.7
Q ss_pred cccccCCC--cceeEEEEEc-CCCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 496 FSVKLGQG--GFGSVYQGVL-PDGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 496 ~~~~lG~G--~fG~Vy~g~~-~~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
+.++||+| +|++||++.. .+|+.||+|++.... ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 34679999 7899999986 468999999996542 22356778999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++|+|.+++...... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFMD-GMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999999654322 47889999999999999999998 89999999999999999999999999865543211110
Q ss_pred e------eeeccCCCCccCcccccc--CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhh
Q 036583 650 V------FTTLRGTRGYLAPEWITN--YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721 (817)
Q Consensus 650 ~------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (817)
. .....++..|+|||++.+ ..++.++|||||||+++||++|+.||....... ..... ..+.+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~~-~~~~~~~~ 230 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ------MLLEK-LNGTVPCL 230 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH------HHHHH-hcCCcccc
Confidence 0 012346678999999976 468899999999999999999999996432111 00000 00000000
Q ss_pred cc-------------------cc-----------------cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 722 LD-------------------SR-----------------LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 722 ~d-------------------~~-----------------~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
++ .. ...+........+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 00 000111122346889999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=298.60 Aligned_cols=248 Identities=29% Similarity=0.489 Sum_probs=200.2
Q ss_pred cccccCCCcceeEEEEEcCC-----CcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 496 FSVKLGQGGFGSVYQGVLPD-----GTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~~-----g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.||.|+||.||+++..+ +..||+|.+..... ..+.+..|++++..++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 45679999999999999654 37899999976543 467899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++++|.+++...... .+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 83 MEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred cCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999764421 28999999999999999999999 8999999999999999999999999999987654422
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
.......++..|+|||.+.+..++.++||||+|++++||++ |+.||..... .........+...
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~-------- 223 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-------EEVLEYLKKGYRL-------- 223 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHhcCCCC--------
Confidence 22212346789999999988889999999999999999998 7888864211 1111222221111
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQML 763 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L 763 (817)
.........+.+++.+|++.+|++|||+.|+++.|
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 -PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11111345688899999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=309.66 Aligned_cols=250 Identities=28% Similarity=0.477 Sum_probs=195.6
Q ss_pred cccccCCCcceeEEEEEcC-CCc----EEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 496 FSVKLGQGGFGSVYQGVLP-DGT----RLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~-~g~----~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
..+.||+|+||.||+|... +++ .+|+|.+..... ...++.+|+.++.+++||||++++++|... ..++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence 4467999999999999853 343 478888865432 234789999999999999999999998754 46799999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++|+|.+++..... .+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||+++.......
T Consensus 90 ~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 90 MPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred cCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCccc
Confidence 999999999876533 47888999999999999999998 8999999999999999999999999999987643322
Q ss_pred ee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 649 HV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 649 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
.. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..+..
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~-------- 229 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-------REIPDLLEKGER-------- 229 (303)
T ss_pred ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHCCCC--------
Confidence 11 112345678999999998899999999999999999997 8899854321 111111211110
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
.+........+.+++..||..+|++||+++++++.|+.+.
T Consensus 230 -~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 230 -LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111112346789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=307.91 Aligned_cols=196 Identities=22% Similarity=0.399 Sum_probs=160.4
Q ss_pred cccCCCcceeEEEEEcC---CCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeec--CCeeeEEEeeccCC
Q 036583 498 VKLGQGGFGSVYQGVLP---DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE--GTHRLLAYEFMANG 572 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~---~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g 572 (817)
.+||+|+||+||+|+.. .+..+|+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 57999999999999964 35689999987543 34567899999999999999999999854 5577899999876
Q ss_pred Chhhhhhhcc------cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEe----cCCCcEEEeecCCccc
Q 036583 573 SLDKWIFKKN------QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL----DDNYHAKVSDFGLAKL 642 (817)
Q Consensus 573 sL~~~l~~~~------~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~ki~Dfgla~~ 642 (817)
+|.+++.... ....+++..+..++.||+.||.|||+ .+|+||||||+|||+ ++++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 7777764321 12257888899999999999999999 899999999999999 5678999999999987
Q ss_pred cCCCCce--eeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCC
Q 036583 643 MTREQSH--VFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNE 698 (817)
Q Consensus 643 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~ 698 (817)
....... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 6543221 1233568899999999876 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=297.31 Aligned_cols=249 Identities=22% Similarity=0.329 Sum_probs=201.5
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
+.+.+.||+|+||.||.++. .+++.+++|++... ....+++.+|++++++++|+||+++++++.+....+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 44567899999999999884 46889999998643 234567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++++|.+++.+.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 82 NGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred CCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999997643 2257889999999999999999998 8999999999999999999999999999987644332
Q ss_pred eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
......+++.|+|||.+.+..++.++||||||++++||++|+.||...... . ....+..+....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~-~~~~~~~~~~~~--------- 220 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------N-LVVKIVQGNYTP--------- 220 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------H-HHHHHHcCCCCC---------
Confidence 223456889999999999888899999999999999999999999643211 1 111111121111
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQML 763 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L 763 (817)
........+.+++.+|++.+|++||++.|+++.+
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1122334678999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=299.83 Aligned_cols=246 Identities=27% Similarity=0.428 Sum_probs=196.4
Q ss_pred cccccCCCcceeEEEEEcCCCcEEEEEEeccCCc-------CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 496 FSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQ-------GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~-------~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
..+.||+|+||+||+|...+++.+|+|.+..... ..+.+.+|++++++++|+||+++++++.+....++++||
T Consensus 4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF 83 (265)
T ss_pred ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence 4567999999999999988899999999864321 124688999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC-
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ- 647 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~- 647 (817)
+++++|.+++.+.. .+++..+..++.|++.||+|||+ .+|+|+||+|+||++++++.+||+|||++.......
T Consensus 84 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 84 VPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999997644 47889999999999999999998 899999999999999999999999999987653211
Q ss_pred ----ceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 648 ----SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 648 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
........++..|+|||.+.+..++.++||||||++++||++|+.||....... .. ...... .. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~--~~~~~~--~~-~~ 227 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----AM--FYIGAH--RG-LM 227 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----HH--HHhhhc--cC-CC
Confidence 111223568889999999998889999999999999999999999996432111 00 000000 00 00
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+.. .......+.+++.+||+.+|++||++.|+++
T Consensus 228 ~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 PRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111 1123346789999999999999999999886
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=303.72 Aligned_cols=262 Identities=22% Similarity=0.299 Sum_probs=194.9
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.+.++||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.++.+++||||+++++++.++...++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS 82 (285)
T ss_pred eEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence 45578999999999999964 68899999986432 234678899999999999999999999999999999999998
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
++|.+++........+++..+..++.||+.||+|||+ .+|+|+||||+||++++++.+||+|||++........ .
T Consensus 83 -~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 157 (285)
T cd07861 83 -MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-V 157 (285)
T ss_pred -CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-c
Confidence 5898888654433468999999999999999999998 8999999999999999999999999999976543221 1
Q ss_pred eeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCc--------chHHHHHHhhh-cchhh
Q 036583 651 FTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAH--------FPSYAFKMMEE-GKLRN 720 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~--------~~~~~~~~~~~-~~~~~ 720 (817)
.....+++.|+|||.+.+. .++.++||||||++++||++|+.||.......... .....+..... .....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 2234568899999988754 57889999999999999999999997543211000 00000000000 00000
Q ss_pred hcccccC---CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 721 ILDSRLN---IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 721 ~~d~~~~---~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
....... .........++.+++.+||+.||++|||+.+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 0000012346679999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=324.09 Aligned_cols=257 Identities=21% Similarity=0.300 Sum_probs=187.6
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecC--------Ceee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG--------THRL 563 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--------~~~~ 563 (817)
.+.+.++||+|+||.||+|... .++.||||++.... ....+|+.+++.++||||+++++++... ...+
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 3556788999999999999864 58899999886432 3345799999999999999999886432 2357
Q ss_pred EEEeeccCCChhhhhhhc-ccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC-cEEEeecCCcc
Q 036583 564 LAYEFMANGSLDKWIFKK-NQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY-HAKVSDFGLAK 641 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Dfgla~ 641 (817)
+||||+++ +|.+++... .....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++
T Consensus 144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 89999986 677666432 222368889999999999999999999 9999999999999999654 79999999998
Q ss_pred ccCCCCceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcc---
Q 036583 642 LMTREQSHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGK--- 717 (817)
Q Consensus 642 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 717 (817)
.+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|++||......+. +.. ....+....
T Consensus 220 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~-i~~~~~~p~~~~ 294 (440)
T PTZ00036 220 NLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVR-IIQVLGTPTEDQ 294 (440)
T ss_pred hccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHHhCCCCHHH
Confidence 7643322 123567899999999875 4689999999999999999999999965432110 000 000000000
Q ss_pred -------hhhhcccc-----cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 718 -------LRNILDSR-----LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 718 -------~~~~~d~~-----~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
...+.-+. +....+.....++.+++.+||+.||.+|||+.|+++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00000000 000001112356889999999999999999999996
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=299.20 Aligned_cols=245 Identities=24% Similarity=0.344 Sum_probs=199.1
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
+...++||+|+||.||+|... .++.||+|.+.... ...+.+.+|+.++++++|+||+++++++.++...++||||++
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCC
Confidence 334567999999999999864 57899999886432 335678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+++|.+++... .+++.....++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 86 ~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06640 86 GGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-c
Confidence 99999998643 47888899999999999999998 8999999999999999999999999999987644322 1
Q ss_pred eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 651 FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||....... .......+ .....
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------~~~~~~~~---------~~~~~ 221 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-------VLFLIPKN---------NPPTL 221 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-------HhhhhhcC---------CCCCC
Confidence 223467888999999998889999999999999999999999996443211 00001000 01112
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.......+.+++..||+.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 22345578899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=297.38 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=198.0
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeec-CCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAE-GTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 568 (817)
+.+.+.||+|++|.||+++.. +++.+|+|++.... ...+.+.+|++++++++|+|++++++.+.. ....+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 456688999999999999954 57889999986432 234678999999999999999999998764 4467899999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++++|.+++..... ..+++.+++.++.|++.|++|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 82 CEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred cCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 999999999976322 258899999999999999999998 8999999999999999999999999999987643222
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
......+++.|+|||.+.+..++.++||||||++++||++|+.||..... ..... .+..+.+.
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~-~~~~~~~~--------- 220 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVY-RIIEGKLP--------- 220 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHH-HHHhcCCC---------
Confidence 22335688899999999998999999999999999999999999964321 11111 11111111
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.........+.+++.+|++.+|++||++.|+++.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1112234568899999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.36 Aligned_cols=238 Identities=25% Similarity=0.351 Sum_probs=195.6
Q ss_pred cccCCCcceeEEEEEc-CCCcEEEEEEeccCCc-C---HHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 498 VKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ-G---KKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~-~---~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
++||.|.||-||.++. .+.+.||||++.-+.. . -.++.+||..|.+++|||.+.+-|++......+||||||-|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG- 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG- 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-
Confidence 5699999999999995 4677899999975532 2 25789999999999999999999999999999999999966
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeee
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT 652 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 652 (817)
+-.++|.-+.+ ++....+..|..+.+.||+|||+ ++.||||||+.|||+++.|.|||+|||.|....+. .
T Consensus 111 SAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-----n 180 (948)
T KOG0577|consen 111 SASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-----N 180 (948)
T ss_pred cHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch-----h
Confidence 66777654433 68889999999999999999999 89999999999999999999999999999877554 3
Q ss_pred eccCCCCccCccccc---cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 653 TLRGTRGYLAPEWIT---NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 653 ~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
.++|||-|||||++. .+.|+-|+||||||+...||...++|+-...... + +..+.......-
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-------A--------LYHIAQNesPtL 245 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------A--------LYHIAQNESPTL 245 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-------H--------HHHHHhcCCCCC
Confidence 578999999999985 5789999999999999999999999985443221 1 111111111111
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
...+-...++.++..|++.-|.+|||.+++++
T Consensus 246 qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 246 QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 23345667889999999999999999999887
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=324.16 Aligned_cols=260 Identities=20% Similarity=0.299 Sum_probs=189.4
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhccCc------ceeeeeeeEeecC-Ceee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHH------LHLVKLRGFCAEG-THRL 563 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h------~niv~l~~~~~~~-~~~~ 563 (817)
..+.+.++||+|+||+||++... .++.||||+++......+++..|+.++.+++| .+++++++++... .+.+
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~ 208 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC 208 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence 34556689999999999999864 57889999997544445566778877777754 4589999988764 5788
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC-------------
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY------------- 630 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~------------- 630 (817)
+|||++ +++|.+++.+.. .+++..+..|+.||+.||+|||+. .+|+||||||+|||++.++
T Consensus 209 iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred EEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 999988 668888887654 588999999999999999999961 5999999999999998765
Q ss_pred ---cEEEeecCCccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCc---
Q 036583 631 ---HAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAH--- 704 (817)
Q Consensus 631 ---~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~--- 704 (817)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+...
T Consensus 283 ~~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 358 (467)
T PTZ00284 283 DPCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME 358 (467)
T ss_pred CCceEEECCCCccccCccc----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 4999999988643221 234678999999999999999999999999999999999999997543211100
Q ss_pred -----chHHHHHHhhhcchhhhccc------ccC-----------CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 705 -----FPSYAFKMMEEGKLRNILDS------RLN-----------IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 705 -----~~~~~~~~~~~~~~~~~~d~------~~~-----------~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
++.............++.+. ... ..........+++|+.+||+.||++|||++|+++
T Consensus 359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 00000000000000000000 000 0000011345779999999999999999999997
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.42 Aligned_cols=249 Identities=24% Similarity=0.330 Sum_probs=195.5
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+.+.++||+|+||.||++... .+..+++|.+.... ...+.+.+|+++++.++|||++++++++..+...++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 344577999999999999965 46788899886543 3456789999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
++|..++.+... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........ ..
T Consensus 87 ~~l~~~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~ 160 (282)
T cd06643 87 GAVDAVMLELER--PLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR 160 (282)
T ss_pred CcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc-cc
Confidence 999998865332 68999999999999999999999 8999999999999999999999999999876533211 12
Q ss_pred eeccCCCCccCccccc-----cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 652 TTLRGTRGYLAPEWIT-----NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
....++..|+|||++. +..++.++|||||||++|||++|+.||...... ... ......... ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~-~~~~~~~~~-----~~ 228 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVL-LKIAKSEPP-----TL 228 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHH-HHHhhcCCC-----CC
Confidence 3356889999999984 345778999999999999999999999643211 001 111111100 00
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
..+......+.+++.+||+.||.+||++.++++.
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111223467899999999999999999998863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=299.76 Aligned_cols=245 Identities=24% Similarity=0.345 Sum_probs=199.1
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
+.+.++||.|+||.||+|+.. +++.+|+|.+.... .....+.+|+.+++.++|+|++++++++.++...++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 345577999999999999964 58899999986542 334678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+++|.+++... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||+++....... .
T Consensus 83 ~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 154 (274)
T cd06609 83 GGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-K 154 (274)
T ss_pred CCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-c
Confidence 99999998754 58899999999999999999998 8999999999999999999999999999987654321 1
Q ss_pred eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 651 FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||....... ....+..... +.+...
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-------~~~~~~~~~~-----~~~~~~- 221 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-------VLFLIPKNNP-----PSLEGN- 221 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-------HHHHhhhcCC-----CCCccc-
Confidence 233567889999999998889999999999999999999999996433111 1111111111 111100
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.....+.+++.+|++.+|++|||++++++
T Consensus 222 --~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 --KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred --ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 13346788999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.55 Aligned_cols=245 Identities=25% Similarity=0.391 Sum_probs=196.0
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcC----------HHHHHHHHHHhhccCcceeeeeeeEeecCCeee
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQG----------KKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~----------~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 563 (817)
.+...||+|+||.||+|... +++.+|+|.+...... .+.+.+|+.++.+++||||+++++++.+....+
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence 35567999999999999854 5789999988643211 246889999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+++||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||+++..
T Consensus 83 lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 83 IFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred EEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 9999999999999997653 57888999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCce-----eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcch
Q 036583 644 TREQSH-----VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKL 718 (817)
Q Consensus 644 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 718 (817)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~-~~~~~--- 226 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAI-FKIGE--- 226 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHH-HHHhc---
Confidence 532111 111245788999999999888999999999999999999999999643211 000 00111
Q ss_pred hhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 719 RNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 719 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
...+. ........+.+++.+||+.||.+||++.|+++
T Consensus 227 --~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 --NASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --cCCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11111 11123456789999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=303.76 Aligned_cols=246 Identities=24% Similarity=0.371 Sum_probs=199.0
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+.+.++||.|+||.||+|.. .+++.|++|.+.... ...+.+.+|+++++.++|||++++++++..+...++|+||+++
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence 44567899999999999984 568999999986543 3456789999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
++|.+++... .+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++......... .
T Consensus 101 ~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~ 172 (296)
T cd06655 101 GSLTDVVTET----CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-R 172 (296)
T ss_pred CcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-C
Confidence 9999988643 47899999999999999999999 89999999999999999999999999998865443221 1
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
....++..|+|||.+.+..++.++|||||||++|||++|+.||....... .. ........ +.+ ...
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~~-~~~~~~~~-----~~~--~~~ 238 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------AL-YLIATNGT-----PEL--QNP 238 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhcCC-----ccc--CCc
Confidence 23467889999999998889999999999999999999999996543211 00 00111000 001 011
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
......+.+++.+||+.||++||++.++++
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 122345778999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=302.99 Aligned_cols=258 Identities=24% Similarity=0.331 Sum_probs=190.7
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhcc---CcceeeeeeeEeec-----CCe
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSI---HHLHLVKLRGFCAE-----GTH 561 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l---~h~niv~l~~~~~~-----~~~ 561 (817)
+.+.++||+|+||+||++... +++.||+|.+.... .....+.+|+.++.++ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 445678999999999999864 58899999986532 2234567788777666 69999999998864 345
Q ss_pred eeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcc
Q 036583 562 RLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK 641 (817)
Q Consensus 562 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 641 (817)
.+++|||+++ +|.+++..... ..+++..+..++.||+.||.|||+ .+|+||||||+||++++++.+||+|||+++
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred EEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 7999999985 88888865432 248899999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhh-
Q 036583 642 LMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRN- 720 (817)
Q Consensus 642 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 720 (817)
....... .....++..|+|||++.+..++.++|||||||++|||++|++||........ + ..............
T Consensus 157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~-~~~~~~~~~~~~~~~ 231 (288)
T cd07863 157 IYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--L-GKIFDLIGLPPEDDW 231 (288)
T ss_pred cccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--H-HHHHHHhCCCChhhC
Confidence 7643221 2235678899999999988999999999999999999999999964432110 0 00000000000000
Q ss_pred ---------hcccccCC---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 721 ---------ILDSRLNI---DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 721 ---------~~d~~~~~---~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
...+.... .........+.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 000122345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=331.77 Aligned_cols=257 Identities=23% Similarity=0.331 Sum_probs=196.6
Q ss_pred HHHHHHhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeec--CC
Q 036583 487 RDLQTATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAE--GT 560 (817)
Q Consensus 487 ~~l~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~--~~ 560 (817)
.++....+.+.++||+|+||+||+++.. .+..+|+|.+.... .....|..|+.++.+++||||++++++|.+ ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 4444456777889999999999999964 46788999886432 234678999999999999999999998854 45
Q ss_pred eeeEEEeeccCCChhhhhhhccc-ccchhhhHHHHHHHHHHHHHHHHHhcC----CCceeecCCCCCCeEecC-------
Q 036583 561 HRLLAYEFMANGSLDKWIFKKNQ-EFLLDWETRFNIALGTAKGLAYLHEDC----DQRIIHCDIKPENVLLDD------- 628 (817)
Q Consensus 561 ~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~l~~LH~~~----~~~ivH~Dlk~~NIll~~------- 628 (817)
..+|||||+++|+|.++|..... ...+++..++.|+.||+.||+|||+.. ..+|+||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 68999999999999999975321 236899999999999999999999732 145999999999999964
Q ss_pred ----------CCcEEEeecCCccccCCCCceeeeeccCCCCccCcccccc--CccCccccccchhhhHHHhhhCCCCCCC
Q 036583 629 ----------NYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN--YAISEKSDVYSYGMVLLEIIGGRKNFDP 696 (817)
Q Consensus 629 ----------~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~pf~~ 696 (817)
...+||+|||++........ .....||+.|+|||++.+ ..++.++||||||||||||++|+.||..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 34589999999987643321 233578999999999864 4588999999999999999999999964
Q ss_pred CCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 697 NETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
... +. .....+..+. .+.. ......+.+|+..||+.+|.+||++.|+++
T Consensus 246 ~~~-----~~-qli~~lk~~p-------~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 ANN-----FS-QLISELKRGP-------DLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCc-----HH-HHHHHHhcCC-------CCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 321 11 1111111111 0100 112346889999999999999999999994
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=310.71 Aligned_cols=258 Identities=24% Similarity=0.307 Sum_probs=192.4
Q ss_pred HhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecCC------e
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT------H 561 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~------~ 561 (817)
..+.+.+.||+|+||.||++.. ..|+.||||++... ......+.+|+.++..++||||+++++++.... .
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 4456678899999999999985 45889999999643 223567889999999999999999999986543 5
Q ss_pred eeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcc
Q 036583 562 RLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK 641 (817)
Q Consensus 562 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 641 (817)
.++||||+++ +|...+.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 101 ~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 101 VYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred eEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 7999999976 56665532 36778888999999999999999 899999999999999999999999999997
Q ss_pred ccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCC---------cchHHHHHH
Q 036583 642 LMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA---------HFPSYAFKM 712 (817)
Q Consensus 642 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~---------~~~~~~~~~ 712 (817)
...... ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||......+.. ....+. ..
T Consensus 172 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~ 248 (359)
T cd07876 172 TACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM-NR 248 (359)
T ss_pred ccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH-HH
Confidence 643321 123357889999999999999999999999999999999999999754321100 000000 00
Q ss_pred hhhcchhhhcccccC--------------C----cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 713 MEEGKLRNILDSRLN--------------I----DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 713 ~~~~~~~~~~d~~~~--------------~----~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.. ..+......... . .........+.+++.+|++.||++|||+.|+++.
T Consensus 249 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 249 LQ-PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HH-HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 000000000000 0 0001123457899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=296.47 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=196.5
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.+.+.++||+|+||.||+++. .+++.+|+|.++... .....+.+|+.+++.++||||+++++.+...+..++|+||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 445567899999999999985 458899999986543 334568899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+++|.+++.... .+++.....++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........ .
T Consensus 90 ~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06645 90 GGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-K 162 (267)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-c
Confidence 999999986544 58899999999999999999999 8999999999999999999999999999876543221 1
Q ss_pred eeeccCCCCccCccccc---cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 651 FTTLRGTRGYLAPEWIT---NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
.....|+..|+|||.+. ...++.++|||||||++|||++|+.||........ ... ...... ..+...
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~-~~~~~~---~~~~~~ 232 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFL-MTKSNF---QPPKLK 232 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHh-hhccCC---CCCccc
Confidence 23356889999999984 45678899999999999999999999854322110 000 011110 000010
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
. .......+.+++.+|++.+|++||+++++++
T Consensus 233 ~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 D--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred c--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0 0112235779999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=299.89 Aligned_cols=252 Identities=25% Similarity=0.406 Sum_probs=195.4
Q ss_pred cccccCCCcceeEEEEEcC----CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCC------ee
Q 036583 496 FSVKLGQGGFGSVYQGVLP----DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT------HR 562 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~----~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~------~~ 562 (817)
+.+.||+|+||.||+|... .++.+|||++.... ...+++.+|++++++++||||+++++++.... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 4567999999999999853 36789999987542 23457889999999999999999999886543 23
Q ss_pred eEEEeeccCCChhhhhhhcc---cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCC
Q 036583 563 LLAYEFMANGSLDKWIFKKN---QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGL 639 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl 639 (817)
++++||+++|+|.+++.... ....+++.....++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcccc
Confidence 78899999999998875322 12257888999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcc
Q 036583 640 AKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGK 717 (817)
Q Consensus 640 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 717 (817)
++......... .....+++.|++||.+....++.++||||||+++|||++ |+.||...... ........+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~ 232 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-------EIYNYLIKGN 232 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-------HHHHHHHcCC
Confidence 98764332211 122345678999999998889999999999999999999 88888633211 1111111111
Q ss_pred hhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 718 LRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 718 ~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
. +. ........+.+++.+|++.+|++||++.|+++.|+++
T Consensus 233 ~-------~~--~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 R-------LK--QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred c-------CC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00 1112334788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=306.20 Aligned_cols=262 Identities=19% Similarity=0.311 Sum_probs=195.0
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
.+.+.++||+|+||.||+|+.. +++.||+|.+... ......+.+|+.++.+++||||+++++++..+...++||||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 3455678999999999999864 5789999998643 233457889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
+ ++|.+++..... .+++..+..++.||++||+|||+ .+|+|+||||+||++++++.+||+|||++........
T Consensus 87 ~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 87 D-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred c-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 7 589888865433 57888999999999999999999 9999999999999999999999999999976533221
Q ss_pred eeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcc--------hHHHHHHh-hhcchh
Q 036583 650 VFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHF--------PSYAFKMM-EEGKLR 719 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~--------~~~~~~~~-~~~~~~ 719 (817)
......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||........... ....+... ......
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 1123456889999999875 3578899999999999999999999965432110000 00000000 000000
Q ss_pred hhcccccCCc----ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 720 NILDSRLNID----EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 720 ~~~d~~~~~~----~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..-.+....+ ........+.+++.+|++.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000000 00112345789999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=295.91 Aligned_cols=247 Identities=22% Similarity=0.364 Sum_probs=199.0
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
+.+.++||+|+||.||++.. .+++.+|+|++... ....+++.+|+.++++++||||+++++++......++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 45568899999999999985 46889999998643 223468899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++++|.+++..... ..+++..+++++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 82 EGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 99999998875432 247888999999999999999998 89999999999999999999999999999866442211
Q ss_pred eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
.....+++.|+|||.+.+..++.++|||||||+++||++|+.||..... ..... ....+... +
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~-~~~~~~~~---------~ 220 (256)
T cd08218 158 -ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVL-KIIRGSYP---------P 220 (256)
T ss_pred -hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHH-HHhcCCCC---------C
Confidence 1224578899999999988899999999999999999999999964321 11111 11111110 1
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
........+.+++.+|++.+|++||+|.||++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11223446889999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=304.18 Aligned_cols=249 Identities=25% Similarity=0.311 Sum_probs=198.6
Q ss_pred hccccccCCCcceeEEEEEcCC-CcEEEEEEeccCCc----CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQ----GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~----~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.++||+|+||+||++...+ ++.+|+|.+..... ..+.+.+|++++..++|+||+++++.+.++...++||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 3455789999999999999654 88999999965422 345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+.+++|.+++.... ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 83 CPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred cCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999987542 2368889999999999999999998 8999999999999999999999999999875532111
Q ss_pred e----------------------------eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCC
Q 036583 649 H----------------------------VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETS 700 (817)
Q Consensus 649 ~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~ 700 (817)
. ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 011235788999999999888999999999999999999999999644321
Q ss_pred CCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCC----HHHHHH
Q 036583 701 DKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPS----MTKVVQ 761 (817)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt----~~evl~ 761 (817)
. . ..++.......+........+.+++.+|++.||++||+ ++|+++
T Consensus 239 ~-------~--------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 E-------T--------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred H-------H--------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1 0 11111222222222224557899999999999999999 677666
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=300.33 Aligned_cols=249 Identities=23% Similarity=0.325 Sum_probs=196.6
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.+.+.++||+|+||.||+|+.. +++.+++|.+.... ...+.+.+|+.++++++|+||+++++.+..+...++||||++
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP 92 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence 4556678999999999999965 47899999987543 335678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+++|..++.+... .+++..+..++.|++.+|+|||+ .+++||||||+||+++.++.+||+|||++........ .
T Consensus 93 ~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 166 (292)
T cd06644 93 GGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ-R 166 (292)
T ss_pred CCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc-c
Confidence 9999988765433 58899999999999999999998 8999999999999999999999999999875433211 1
Q ss_pred eeeccCCCCccCccccc-----cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccc
Q 036583 651 FTTLRGTRGYLAPEWIT-----NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 725 (817)
.....++..|+|||.+. ...++.++|||||||++|||++|+.||...... .......... .+.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~-----~~~ 234 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKSE-----PPT 234 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-------HHHHHHhcCC-----Ccc
Confidence 22356788999999985 345678999999999999999999999643211 0111111111 000
Q ss_pred cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 726 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
. .........+.+++.+||+.+|++||+++|+++
T Consensus 235 ~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 235 L--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred C--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 111122346788999999999999999999987
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.52 Aligned_cols=243 Identities=28% Similarity=0.426 Sum_probs=196.6
Q ss_pred cccccCCCcceeEEEEEcC-CCcEEEEEEeccCC------cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 496 FSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG------QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~------~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.||+|+||.||+|... +++.|++|.+.... +..+.+.+|+.++++++|+||+++++++.++...++++||
T Consensus 4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL 83 (258)
T ss_pred ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence 4467999999999999976 78999999886432 2346789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++++|.+++.+.. .+++..+..++.||+.||+|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 84 VPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 99999999997643 47889999999999999999999 899999999999999999999999999988754432
Q ss_pred eeeeeccCCCCccCccccccCc-cCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYA-ISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
......++..|+|||.+.... ++.++|+||||+++|||++|+.||...... ..............
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~------- 222 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRSKELPP------- 222 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhcccCCC-------
Confidence 123456888999999988766 889999999999999999999999643211 11111111011100
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
........+.+++.+||+.+|++||++.++++
T Consensus 223 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 --IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11122346788999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=299.82 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=194.3
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhcc-CcceeeeeeeEeec------CCeeeE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAE------GTHRLL 564 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~------~~~~~l 564 (817)
.+.+.++||+|+||.||+|+. ..++.+|+|.+........++..|+.++.++ +|+||+++++++.. ....++
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 96 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWL 96 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEE
Confidence 345557899999999999996 4578999999876555567789999999998 79999999999853 457899
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
+|||+++|+|.+++..... ..+++..+..++.||+.||+|||+ .+|+|+||||+||++++++.+||+|||++....
T Consensus 97 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 97 VMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 9999999999999875432 257788889999999999999999 899999999999999999999999999987653
Q ss_pred CCCceeeeeccCCCCccCccccc-----cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchh
Q 036583 645 REQSHVFTTLRGTRGYLAPEWIT-----NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLR 719 (817)
Q Consensus 645 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (817)
.... ......|+..|+|||.+. ...++.++|||||||++|||++|+.||........ .. ....
T Consensus 173 ~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~------~~-~~~~---- 240 (282)
T cd06636 173 RTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA------LF-LIPR---- 240 (282)
T ss_pred cccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh------hh-hHhh----
Confidence 3211 112356888999999986 34678899999999999999999999964322110 00 0000
Q ss_pred hhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 720 NILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 720 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..... .........+.+++.+||+.||.+||++.|+++
T Consensus 241 -~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 241 -NPPPK---LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -CCCCC---CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00000 011123346889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=299.92 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=197.1
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
+++.+.||+|+||.||++... .++.+|+|.+.... ...+.+.+|+.++.+++|+||+++++.+......++||||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 445678999999999999975 68899999886432 224678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+++|..++........+++..+..++.|++.||.|||+. .+|+|+||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 157 (286)
T cd06622 83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--- 157 (286)
T ss_pred CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc---
Confidence 999999987643233689999999999999999999962 589999999999999999999999999987653321
Q ss_pred eeeccCCCCccCccccccC------ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccc
Q 036583 651 FTTLRGTRGYLAPEWITNY------AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 724 (817)
.....+++.|+|||.+.+. .++.++|||||||++|||++|+.||....... ....+ ..+.+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-------~~~~~-----~~~~~~ 225 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-------IFAQL-----SAIVDG 225 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-------HHHHH-----HHHhhc
Confidence 1234578899999998654 34789999999999999999999996432111 01111 111111
Q ss_pred ccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 725 RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 725 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.. ..........+.+++.+|++.+|++||+++++++
T Consensus 226 ~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 226 DP-PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CC-CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 00 0111124456789999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=294.33 Aligned_cols=250 Identities=23% Similarity=0.322 Sum_probs=200.3
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+.+.++||+|+||.||++... +++.+++|.+.... ...+.+.+|++++++++||||+++++++.++...+++|||+++
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~ 84 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG 84 (262)
T ss_pred eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCC
Confidence 455678999999999999864 57889999987543 3467899999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
++|.+++..... .++...+..++.|++.||+|||+ .+|+|+||+|+||++++++.+||+|||++........ ..
T Consensus 85 ~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 158 (262)
T cd06613 85 GSLQDIYQVTRG--PLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KR 158 (262)
T ss_pred CcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh-cc
Confidence 999999876522 58889999999999999999998 8999999999999999999999999999886543221 12
Q ss_pred eeccCCCCccCccccccC---ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 652 TTLRGTRGYLAPEWITNY---AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~---~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
....++..|+|||.+.+. .++.++||||||+++|||++|+.||....... ......... +.... .
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-------~~~~~~~~~---~~~~~--~ 226 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-------ALFLISKSN---FPPPK--L 226 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhcc---CCCcc--c
Confidence 335678899999999876 78899999999999999999999996432111 000111110 01111 1
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.........+.+++.+||+.+|.+|||+++|+.
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 112234456889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=287.40 Aligned_cols=245 Identities=25% Similarity=0.358 Sum_probs=206.7
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCC
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGS 573 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 573 (817)
++..+||+|.||.|||+.++ .|+.+|+|++.. ..+.+++.+|+.++.+.+.|++|+++|.+.....+++|||||..|+
T Consensus 36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 34578999999999999975 489999999864 3457899999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeee
Q 036583 574 LDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT 653 (817)
Q Consensus 574 L~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 653 (817)
..+.++..++ +|....+..++..-++||+|||. ..-+|||||+.|||++.+|.+||+|||.|-.+... .....+
T Consensus 115 iSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAKRNT 188 (502)
T KOG0574|consen 115 ISDIMRARRK--PLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAKRNT 188 (502)
T ss_pred HHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhh-HHhhCc
Confidence 9999987654 79999999999999999999998 88899999999999999999999999999876542 223356
Q ss_pred ccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc-cccCCcccH
Q 036583 654 LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD-SRLNIDEQS 732 (817)
Q Consensus 654 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-~~~~~~~~~ 732 (817)
..||+-|||||++..-.|..++||||||+...||..|++||....+..... -+.. +......+.
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---------------MIPT~PPPTF~KPE 253 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---------------MIPTKPPPTFKKPE 253 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE---------------eccCCCCCCCCChH
Confidence 789999999999999999999999999999999999999997654432111 0111 111122333
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 733 DRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 733 ~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.-..++-+++..|+-..|++|.|+.++++
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 44667889999999999999999998887
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=297.52 Aligned_cols=261 Identities=22% Similarity=0.312 Sum_probs=197.0
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
+.+..+||+|+||.||+++.. +++.||+|++.... ...+.+.+|+.++++++|+|++++++++..+...++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 445678999999999999975 58899999986432 23467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
+++.|..++.... .+++..+..++.||+.||+|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 83 DHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred CccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 9998888765433 48899999999999999999999 9999999999999999999999999999987654321
Q ss_pred eeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchH--------HHHHHhhhcc-hh
Q 036583 650 VFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPS--------YAFKMMEEGK-LR 719 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~--------~~~~~~~~~~-~~ 719 (817)
......++..|+|||.+.+ ..++.++||||||++++||++|+.||......+...... .......... ..
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 1223457789999999876 567899999999999999999999996543221100000 0000000000 00
Q ss_pred hhcccccCCccc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 720 NILDSRLNIDEQ-----SDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 720 ~~~d~~~~~~~~-----~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
....+....... ......+.+++.+||+.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000011000000 112356789999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=300.75 Aligned_cols=258 Identities=28% Similarity=0.377 Sum_probs=197.9
Q ss_pred HHHHHHhhc--cccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhcc-CcceeeeeeeEeecC---
Q 036583 487 RDLQTATNN--FSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEG--- 559 (817)
Q Consensus 487 ~~l~~~~~~--~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~--- 559 (817)
.++..++.+ +.++||+|+||.||++.. .+++.+|+|.+........++.+|+.++.++ +|||++++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 344334443 457899999999999986 4688999999876544567788999999999 899999999998753
Q ss_pred --CeeeEEEeeccCCChhhhhhhcc-cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEee
Q 036583 560 --THRLLAYEFMANGSLDKWIFKKN-QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSD 636 (817)
Q Consensus 560 --~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D 636 (817)
...++|+||+++++|.+++.... ....+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~d 171 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVD 171 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEee
Confidence 35799999999999999886421 22358899999999999999999998 8999999999999999999999999
Q ss_pred cCCccccCCCCceeeeeccCCCCccCccccccC-----ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHH
Q 036583 637 FGLAKLMTREQSHVFTTLRGTRGYLAPEWITNY-----AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFK 711 (817)
Q Consensus 637 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 711 (817)
||++......... .....++..|+|||.+... .++.++|||||||++|||++|+.||....... ....
T Consensus 172 fg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~------~~~~ 244 (291)
T cd06639 172 FGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK------TLFK 244 (291)
T ss_pred cccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH------HHHH
Confidence 9998865432211 1234678899999998643 36789999999999999999999996432111 0111
Q ss_pred HhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 712 MMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 712 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
+.......+. ...+....+.+++.+|++.+|++||++.|+++.
T Consensus 245 -~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 -IPRNPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -HhcCCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111111111 111223468899999999999999999999873
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=299.07 Aligned_cols=251 Identities=24% Similarity=0.316 Sum_probs=194.2
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhcc-CcceeeeeeeEee-----cCCeeeEEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFCA-----EGTHRLLAY 566 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~-----~~~~~~lv~ 566 (817)
+.+.+.||+|+||.||++... .++.+|+|.+........++.+|+.++.++ +||||+++++++. .+...++||
T Consensus 20 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 99 (286)
T cd06638 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVL 99 (286)
T ss_pred eeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEE
Confidence 445578999999999999864 578999999876544457788999999999 6999999999884 345689999
Q ss_pred eeccCCChhhhhhhcc-cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 567 EFMANGSLDKWIFKKN-QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
||+++++|.+++.... ....+++..+..++.|+++||.|||+ .+++||||||+||++++++.+||+|||++.....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 176 (286)
T cd06638 100 ELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176 (286)
T ss_pred eecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceeeccc
Confidence 9999999999876421 22357888899999999999999998 8999999999999999999999999999886643
Q ss_pred CCceeeeeccCCCCccCcccccc-----CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhh
Q 036583 646 EQSHVFTTLRGTRGYLAPEWITN-----YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRN 720 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (817)
... ......|++.|+|||.+.. ..++.++|||||||++|||++|+.||........ . .......
T Consensus 177 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~------~-~~~~~~~--- 245 (286)
T cd06638 177 TRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA------L-FKIPRNP--- 245 (286)
T ss_pred CCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH------H-hhccccC---
Confidence 221 1223568899999999853 4578899999999999999999999964322110 0 0000000
Q ss_pred hcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 721 ILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 721 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.+.... .......+.+++.+||+.||++|||+.|+++.
T Consensus 246 --~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 246 --PPTLHQ--PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred --CCcccC--CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 001100 01122357899999999999999999999975
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=294.87 Aligned_cols=249 Identities=29% Similarity=0.435 Sum_probs=199.0
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
+...++||+|+||.||+|... +++.+++|.+..... ..+.+.+|+.++++++|+||+++++.+...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 345578999999999999854 688999999875533 4578899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++++|.+++.... .+++..+..++.|+++||+|||+ .+|+|+||+|+||++++++.+||+|||++.........
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 82 SGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999997643 47888999999999999999999 89999999999999999999999999999876543322
Q ss_pred ee---eeccCCCCccCccccccCc---cCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 650 VF---TTLRGTRGYLAPEWITNYA---ISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 650 ~~---~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
.. ....++..|+|||.+.+.. ++.++||||||++++|+++|+.||....... ..... ...+
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~~-~~~~------- 222 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFH-VGAG------- 222 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHHH-HhcC-------
Confidence 11 1346788999999998766 7899999999999999999999996432110 00110 1111
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.....+........+.+++.+|++.+|++||++.|++.
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111111122446779999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=310.60 Aligned_cols=258 Identities=24% Similarity=0.300 Sum_probs=193.1
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecC------Ce
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG------TH 561 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~------~~ 561 (817)
..+.+.++||+|+||.||++... .++.||||++.... ...+.+.+|+.+++.++||||+++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 34566688999999999999854 58889999997532 2346788999999999999999999987543 35
Q ss_pred eeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcc
Q 036583 562 RLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK 641 (817)
Q Consensus 562 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 641 (817)
.++||||+++ +|.+++.. .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred EEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 7999999976 67776643 36778889999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCC---------cchHHHHHH
Q 036583 642 LMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA---------HFPSYAFKM 712 (817)
Q Consensus 642 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~---------~~~~~~~~~ 712 (817)
...... ......++..|+|||++.+..++.++|||||||++|||++|+.||......... ..+.. ...
T Consensus 175 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~ 251 (364)
T cd07875 175 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF-MKK 251 (364)
T ss_pred ccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH-HHh
Confidence 654322 123357899999999999999999999999999999999999999654321100 00000 000
Q ss_pred hhhcchhhhcccc--------------cC----CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 713 MEEGKLRNILDSR--------------LN----IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 713 ~~~~~~~~~~d~~--------------~~----~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
+.. .+......+ .. ..........+.+++.+|++.||.+|||+.|+++.
T Consensus 252 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhH-HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 000000000 00 00011123467899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=295.20 Aligned_cols=244 Identities=24% Similarity=0.352 Sum_probs=188.4
Q ss_pred cccccCCCcceeEEEEEcC-CCcEEEEEEeccCC------cCHHHHHHHHHHhhccCcceeeeeeeEeec--CCeeeEEE
Q 036583 496 FSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG------QGKKEFRAEVSIIGSIHHLHLVKLRGFCAE--GTHRLLAY 566 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~------~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 566 (817)
..+.||+|+||.||++... .++.+++|++.... +..+.+.+|+.++++++||||+++++++.+ ....++++
T Consensus 6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence 3467999999999999864 58899999886432 123468889999999999999999999875 35678999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
||+++++|.+++.... .+++.....++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||+++.....
T Consensus 86 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 86 EYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred eCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 9999999999997543 47888899999999999999998 89999999999999999999999999999865432
Q ss_pred Cc--eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccc
Q 036583 647 QS--HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724 (817)
Q Consensus 647 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 724 (817)
.. .......++..|+|||.+.+..++.++|||||||++|||++|+.||...... .......... ..+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~~-----~~~ 228 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQP-----TNP 228 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcCC-----CCC
Confidence 11 1112345788999999999888999999999999999999999999643211 0010000000 001
Q ss_pred ccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 725 RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 725 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..+......+..++ +||..+|++||+|+||++
T Consensus 229 ----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 229 ----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11111223344555 788899999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.45 Aligned_cols=243 Identities=25% Similarity=0.395 Sum_probs=195.3
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCChh
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLD 575 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 575 (817)
.+||+|+||.||++... ++..||||++.... ...+.+.+|+.++.+++|+||+++++.+..++..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 56999999999999864 58899999986543 33567899999999999999999999999999999999999999999
Q ss_pred hhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeeecc
Q 036583 576 KWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLR 655 (817)
Q Consensus 576 ~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~ 655 (817)
+++... .+++.....++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++........ ......
T Consensus 108 ~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~ 179 (292)
T cd06658 108 DIVTHT----RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLV 179 (292)
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceee
Confidence 988543 47889999999999999999999 8999999999999999999999999999876543222 122356
Q ss_pred CCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHH
Q 036583 656 GTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRV 735 (817)
Q Consensus 656 gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 735 (817)
++..|+|||.+.+..++.++||||||++++||++|+.||....... ....+. ....+.... .....
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-------~~~~~~-----~~~~~~~~~--~~~~~ 245 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-------AMRRIR-----DNLPPRVKD--SHKVS 245 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHH-----hcCCCcccc--ccccC
Confidence 8889999999988889999999999999999999999996432110 111111 111111111 11223
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 736 FTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 736 ~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
..+.+++..|++.||.+|||++|+++.
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 357788999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=293.20 Aligned_cols=253 Identities=23% Similarity=0.351 Sum_probs=201.6
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
+.+.+.||.|+||+||+|... ++..+++|++... ....+.+.+|+++++.++|+|++++++.+..++..++|+|+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 455678999999999999954 6788999998643 2345789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce-
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH- 649 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~- 649 (817)
+++|.+++........+++.....++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999999765332358899999999999999999998 99999999999999999999999999998876543322
Q ss_pred --eeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 650 --VFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 650 --~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
......++..|+|||.+... .++.++||||||++++||++|+.||....... ...+.... ..+.+
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~------~~~~~ 227 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQN------DPPSL 227 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcC------CCCCc
Confidence 11234688899999999876 78899999999999999999999996443211 01111111 01111
Q ss_pred CCcc-cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 727 NIDE-QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 727 ~~~~-~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.... .......+.+++..|++.||++||+++|+++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111 1123456789999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=292.46 Aligned_cols=246 Identities=22% Similarity=0.367 Sum_probs=197.6
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
+.+.+.||+|+||.||++.. .+++.+|+|.+.... ...+.+.+|++++++++||||+++++.+..++..++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 34567899999999999985 468899999986532 33567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCC-CcEEEeecCCccccCCCCc
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDN-YHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~Dfgla~~~~~~~~ 648 (817)
++++|.+++..... ..+++..+..++.|++.+|+|||+ .+++|+||+|+||+++++ ..+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 82 PGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999976432 257889999999999999999999 899999999999999854 5689999999987644321
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
.....++..|+|||.+.+..++.++||||||+++++|++|+.||...... ... .....+....+
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~-~~~~~~~~~~~------- 221 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALV-LKIMSGTFAPI------- 221 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHH-HHHHhcCCCCC-------
Confidence 12346788999999999888899999999999999999999999643321 111 11111111111
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.......+.+++.+||+.+|++|||++|+++
T Consensus 222 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 --SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred --CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1123346789999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=297.57 Aligned_cols=249 Identities=22% Similarity=0.316 Sum_probs=197.8
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+.+.++||+|+||.||++... +++.+|+|.+.... ...+.+.+|++++++++|+||+++++.+..+...++||||+++
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG 86 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence 455678999999999999964 58899999986543 2346789999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
++|.+++.+... .+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++........ ..
T Consensus 87 ~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~ 160 (280)
T cd06611 87 GALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KR 160 (280)
T ss_pred CcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc-cc
Confidence 999999876433 58899999999999999999999 8999999999999999999999999999876543222 12
Q ss_pred eeccCCCCccCccccc-----cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 652 TTLRGTRGYLAPEWIT-----NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
....+++.|+|||.+. ...++.++||||||+++|||++|+.||....... ....+..+.. +.+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~-----~~~ 228 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-------VLLKILKSEP-----PTL 228 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-------HHHHHhcCCC-----CCc
Confidence 2356888999999985 3456789999999999999999999996432111 1111111110 011
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.........+.+++..||+.+|++||++.++++.
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 --DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1111223467789999999999999999999873
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.80 Aligned_cols=262 Identities=22% Similarity=0.319 Sum_probs=198.5
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
+.+.++||+|+||.||++... +++.||+|+++.. ....+.+.+|++++++++|+||+++++++..++..++||||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 456688999999999999975 5789999998653 233578899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
+++.+..++.+.. .+++..+..++.||+.||+|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 83 ~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 83 ERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 9877766554432 47889999999999999999999 89999999999999999999999999999877554332
Q ss_pred eeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCc--------chHHHHHHh-hhcchh
Q 036583 650 VFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAH--------FPSYAFKMM-EEGKLR 719 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~--------~~~~~~~~~-~~~~~~ 719 (817)
......++..|+|||++.+. .++.++||||||+++|||++|+.||......+... +........ .+....
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 23345678899999999887 88899999999999999999999996432211000 000000000 000000
Q ss_pred --hhcccccC----CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 720 --NILDSRLN----IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 720 --~~~d~~~~----~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+..+.... ..........+.+++.+||+.+|++||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000000 0001112467889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=327.43 Aligned_cols=261 Identities=24% Similarity=0.378 Sum_probs=210.5
Q ss_pred HHHHHhhccccccCCCcceeEEEEEcC--------CCcEEEEEEeccCC--cCHHHHHHHHHHhhcc-CcceeeeeeeEe
Q 036583 488 DLQTATNNFSVKLGQGGFGSVYQGVLP--------DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSI-HHLHLVKLRGFC 556 (817)
Q Consensus 488 ~l~~~~~~~~~~lG~G~fG~Vy~g~~~--------~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l-~h~niv~l~~~~ 556 (817)
|+......+.+.||+|.||.|++|... ....||||.++... .+.+.+..|+++|..+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 333444456678999999999999842 14579999997653 3467899999999999 699999999999
Q ss_pred ecCCeeeEEEeeccCCChhhhhhhcc-c----c--------cchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCC
Q 036583 557 AEGTHRLLAYEFMANGSLDKWIFKKN-Q----E--------FLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPEN 623 (817)
Q Consensus 557 ~~~~~~~lv~e~~~~gsL~~~l~~~~-~----~--------~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~N 623 (817)
.+....++|+||+..|+|.++|++.+ . . ..+...+.+.++.|||.||+||++ .+++||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhh
Confidence 99999999999999999999998766 0 0 138889999999999999999999 899999999999
Q ss_pred eEecCCCcEEEeecCCccccCCCCceeeeecc--CCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCC
Q 036583 624 VLLDDNYHAKVSDFGLAKLMTREQSHVFTTLR--GTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETS 700 (817)
Q Consensus 624 Ill~~~~~~ki~Dfgla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~ 700 (817)
||+.++..+||+|||+|+.............. -+..|||||.+....|+.|+|||||||+||||++ |..||....
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-- 526 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-- 526 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC--
Confidence 99999999999999999976655444323223 3457999999999999999999999999999999 788885311
Q ss_pred CCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 701 DKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
....+.+.+++|.. .+.+..+..++.++++.||+.+|++||++.|+++.++..
T Consensus 527 ----~~~~l~~~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 ----PTEELLEFLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ----cHHHHHHHHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 11122444444432 222233355788999999999999999999999999874
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=295.07 Aligned_cols=245 Identities=24% Similarity=0.354 Sum_probs=197.8
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
+.+.++||+|+||.||+|.. .+++.+|+|.+.... ...+.+.+|+.++.+++||||+++++++.++...++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 44567899999999999985 468899999886432 234678899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+++|.+++... .+++.....++.|++.++.|||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 86 ~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06641 86 GGSALDLLEPG----PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh-h
Confidence 99999998643 47899999999999999999998 9999999999999999999999999999876543221 1
Q ss_pred eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 651 FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
.....++..|+|||.+.+..++.++|||||||+++||++|..||...... .....+..+.. ...
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~---------~~~ 221 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-------KVLFLIPKNNP---------PTL 221 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-------HHHHHHhcCCC---------CCC
Confidence 22346788999999998888899999999999999999999999532211 01111111110 011
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.......+.+++.+|++.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11233467899999999999999999999994
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=309.30 Aligned_cols=257 Identities=24% Similarity=0.298 Sum_probs=192.2
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecC------Cee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG------THR 562 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~------~~~ 562 (817)
.+.+.+.||+|+||.||++... .++.+|||++.... ...+.+.+|+.+++.++||||+++++++... ...
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 97 (355)
T cd07874 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV 97 (355)
T ss_pred ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence 4555688999999999999854 58899999997542 2345778899999999999999999988643 356
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 98 ~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 98 YLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred EEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 999999976 66666643 37788889999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCC---------cchHHHHHHh
Q 036583 643 MTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA---------HFPSYAFKMM 713 (817)
Q Consensus 643 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~---------~~~~~~~~~~ 713 (817)
..... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+.. ...+
T Consensus 169 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 245 (355)
T cd07874 169 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF-MKKL 245 (355)
T ss_pred CCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH-HHhh
Confidence 54321 123357899999999999989999999999999999999999999654321100 00000 0000
Q ss_pred hhcchhhhcccc----------------cC--CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 714 EEGKLRNILDSR----------------LN--IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 714 ~~~~~~~~~d~~----------------~~--~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
. ..+...++.. .. ..........+.+++.+|++.||++|||+.|+++.
T Consensus 246 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 246 Q-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred c-HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0 0000000000 00 00011123467899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=299.07 Aligned_cols=261 Identities=24% Similarity=0.335 Sum_probs=196.4
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
+.+.++||+|+||.||++... .++.+|+|++.... ...+.+.+|++++..++||||+++++++..+...++|+||+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 445688999999999999975 48899999886432 23467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++++|.++..... .+++..+..++.||+.||+|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 83 DHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred CccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence 9999988765433 48899999999999999999999 8999999999999999999999999999987644321
Q ss_pred eeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCC--------cchHHHHHHhhhcch-h
Q 036583 650 VFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA--------HFPSYAFKMMEEGKL-R 719 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~--------~~~~~~~~~~~~~~~-~ 719 (817)
......++..|+|||++.+ ..++.++||||||++++||++|++||......+.. .+............. .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 2233457889999999875 45678999999999999999999999643321100 000000000000000 0
Q ss_pred hhcccccCCcc-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 720 NILDSRLNIDE-----QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 720 ~~~d~~~~~~~-----~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
....+...... .......+.+++.+||+.+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000000 0122456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=278.80 Aligned_cols=267 Identities=22% Similarity=0.339 Sum_probs=204.0
Q ss_pred HHHHHHHhhccccccCCCcceeEEEEE-cCCCcEEEEEEeccC-CcCHHHHHHHHHHhhccC-cceeeeeeeEeecCCee
Q 036583 486 YRDLQTATNNFSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGI-GQGKKEFRAEVSIIGSIH-HLHLVKLRGFCAEGTHR 562 (817)
Q Consensus 486 ~~~l~~~~~~~~~~lG~G~fG~Vy~g~-~~~g~~vavK~l~~~-~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~ 562 (817)
++|+-+-|. +.||+|+|+.|--++ +..|.++|||++.+. ...+....+|++++.+.+ |+||+.|+++|+++...
T Consensus 75 F~d~YkLt~---e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 75 FEDMYKLTS---ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHHHHHhHH---HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence 455544443 459999999999887 678999999999776 345778999999999995 99999999999999999
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC---cEEEeecCC
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY---HAKVSDFGL 639 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ki~Dfgl 639 (817)
|||||-|.||+|..+|++.. .+++.++.++..+|+.||.|||. ++|.||||||+|||..+.. -+||+||.|
T Consensus 152 YLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeecccc
Confidence 99999999999999998765 68899999999999999999999 9999999999999986543 489999998
Q ss_pred ccccCCC------CceeeeeccCCCCccCccccc-----cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHH
Q 036583 640 AKLMTRE------QSHVFTTLRGTRGYLAPEWIT-----NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSY 708 (817)
Q Consensus 640 a~~~~~~------~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~ 708 (817)
+.-.... ......+.+|+..|||||+.. ...|+.+.|.||||||||-|++|.+||.++-..+...-...
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 8754321 122234578889999999874 34678999999999999999999999987765443211111
Q ss_pred HHHHhhhcchhhhcccccCCcc--cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 709 AFKMMEEGKLRNILDSRLNIDE--QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 709 ~~~~~~~~~~~~~~d~~~~~~~--~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+.+.-.+.-.+.+-+.....+. -.....+..+++...+..|+..|-++.++++
T Consensus 306 ~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 306 VCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1111111111122222222211 1233456678888888899999999999987
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=293.75 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=199.2
Q ss_pred ccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeec--CCeeeEEEee
Q 036583 495 NFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAE--GTHRLLAYEF 568 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~ 568 (817)
.+.+.||.|+||.||++.. .+++.+|+|.+.... ...+.+.+|++++++++|+||+++++++.. +...+++|||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~ 82 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY 82 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence 4557899999999999985 467899999986432 234578899999999999999999998754 4567899999
Q ss_pred ccCCChhhhhhhcc-cccchhhhHHHHHHHHHHHHHHHHHhcC--CCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 569 MANGSLDKWIFKKN-QEFLLDWETRFNIALGTAKGLAYLHEDC--DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 569 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~l~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
+++++|.+++.... ....+++..++.++.||+.||+|||..+ ..+++|+||||+||++++++.+||+|||++.....
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~ 162 (265)
T cd08217 83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162 (265)
T ss_pred ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence 99999999997532 2236899999999999999999999221 28999999999999999999999999999987754
Q ss_pred CCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccc
Q 036583 646 EQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 725 (817)
.... .....+++.|+|||.+.+..++.++||||||+++++|++|+.||..... .........+...
T Consensus 163 ~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~------ 228 (265)
T cd08217 163 DSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-------LQLASKIKEGKFR------ 228 (265)
T ss_pred Cccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-------HHHHHHHhcCCCC------
Confidence 3321 2335688999999999988899999999999999999999999964331 1112222222111
Q ss_pred cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 726 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.........+.+++.+|++.+|++||++.||+++
T Consensus 229 ---~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 ---RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1112234578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=292.93 Aligned_cols=248 Identities=27% Similarity=0.423 Sum_probs=196.4
Q ss_pred cccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc-------CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 496 FSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ-------GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~-------~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
..+.||+|+||.||++.. .+++.+|+|.+..... ..+.+.+|++++++++|+||+++++++.+++..++|+|
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 83 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE 83 (268)
T ss_pred ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence 346799999999999984 5688999999864321 23678999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC-cEEEeecCCccccCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY-HAKVSDFGLAKLMTRE 646 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Dfgla~~~~~~ 646 (817)
|+++++|.+++.+.. .+++.....++.||+.||+|||+ .+++|+||+|+||+++.++ .+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 84 WMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred ccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 999999999997543 57889999999999999999999 8999999999999998775 6999999998876543
Q ss_pred Cce---eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 647 QSH---VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 647 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
... ......++..|+|||.+.+..++.++||||+|++++||++|+.||........ ...... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~---------~~~ 225 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFK---------IAS 225 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHH---------Hhc
Confidence 111 11234678899999999888899999999999999999999999964322110 011100 000
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.......+......+.+++.+|++.+|++||++.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00111122233456889999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=292.66 Aligned_cols=245 Identities=22% Similarity=0.307 Sum_probs=190.5
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC------cCHHHHHHHHHHhhccCcceeeeeeeEeecC--CeeeEE
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG------QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG--THRLLA 565 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~------~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~~lv 565 (817)
.+.+.||+|+||.||++... +++.||+|.+.... ...+.+.+|+.++.+++||||+++++++.+. ...+++
T Consensus 5 ~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (265)
T cd06652 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF 84 (265)
T ss_pred eEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEE
Confidence 34578999999999999864 58899999885321 1235788899999999999999999998764 457899
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|||+++++|.+++.+.. .+++....+++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 85 MEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 99999999999987543 47788889999999999999998 8999999999999999999999999999986543
Q ss_pred CCc--eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 646 EQS--HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 646 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
... .......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ... .....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~-~~~~~-------- 223 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------AAI-FKIAT-------- 223 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------HHH-HHHhc--------
Confidence 211 1122346888999999998888999999999999999999999999632110 000 00000
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.......+......+.+++..|+. +|++||+++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 224 QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 000111122334467788888885 9999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=297.46 Aligned_cols=247 Identities=25% Similarity=0.377 Sum_probs=200.5
Q ss_pred hccccccCCCcceeEEEEEcCCCcEEEEEEeccC---CcCHHHHHHHHHHhhccC-cceeeeeeeEeecCCeeeEEEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIH-HLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
|.+.++||.||.+.||++...+.+.+|+|++... .+...-|.+|+.+|.+|+ |.+|++|++|-..++.+||||||=
T Consensus 363 Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G 442 (677)
T KOG0596|consen 363 YEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG 442 (677)
T ss_pred hhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc
Confidence 4455789999999999999988899999987543 234567999999999995 999999999999999999999975
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
+. +|..+|.+.... ...| .++.+..|++.++.++|+ .+|||.||||.|+|+-. |.+||+|||+|..+..+...
T Consensus 443 d~-DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 443 DI-DLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred cc-cHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCccccc
Confidence 44 999999876542 3444 678899999999999999 99999999999998864 68999999999998877665
Q ss_pred eee-eccCCCCccCccccccCc-----------cCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcc
Q 036583 650 VFT-TLRGTRGYLAPEWITNYA-----------ISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGK 717 (817)
Q Consensus 650 ~~~-~~~gt~~y~aPE~~~~~~-----------~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 717 (817)
... ..+||+.||+||.+.... .+.++||||+|||||+|+.|+.||+.- .. .-.+
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--------~n------~~aK 581 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--------IN------QIAK 581 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--------HH------HHHH
Confidence 544 489999999999985432 457899999999999999999999521 11 1124
Q ss_pred hhhhcccccCCcccH-HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 718 LRNILDSRLNIDEQS-DRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 718 ~~~~~d~~~~~~~~~-~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+..+.++....+++. ....+++++++.||+.||.+||+..|+|+
T Consensus 582 l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 582 LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 566677755443322 22223899999999999999999999998
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=294.31 Aligned_cols=250 Identities=26% Similarity=0.417 Sum_probs=194.7
Q ss_pred cccccCCCcceeEEEEEc-CCCcEEEEEEeccCC----c-------CHHHHHHHHHHhhccCcceeeeeeeEeecCCeee
Q 036583 496 FSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG----Q-------GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~----~-------~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 563 (817)
..+.||+|+||.||+|.. .+++.+|+|.++... . ..+.+.+|+.++.+++|+|++++++++...+..+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 346799999999999985 468899999875321 1 1246788999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+||||+++++|.+++.+.. .+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.+||+|||+++..
T Consensus 85 lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred EEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 9999999999999997653 58888999999999999999998 89999999999999999999999999999865
Q ss_pred CCCCce-eeeeccCCCCccCccccccCc--cCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhh
Q 036583 644 TREQSH-VFTTLRGTRGYLAPEWITNYA--ISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRN 720 (817)
Q Consensus 644 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (817)
...... ......++..|+|||.+.... ++.++||||||++++|+++|+.||...... ...... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~-~~~~~~~ 231 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKL-GNKRSAP 231 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHh-hccccCC
Confidence 432211 122356788999999987654 789999999999999999999999532211 001110 0111111
Q ss_pred hcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 721 ILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 721 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.+.. .........+.+++..|++.+|++||++.+|++.
T Consensus 232 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 232 PIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111 1111234578889999999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=298.23 Aligned_cols=259 Identities=22% Similarity=0.290 Sum_probs=196.3
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc------CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ------GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~------~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
+.+.++||+|+||.||+|... +++.||||++..... ....+..|++++++++|+||+++++++.+....++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 345577999999999999964 688999999965422 2356788999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
||+ +++|.+++.... ..+++..++.++.||++||+|||+ .+|+|+||+|+||+++.++.+||+|||+++.....
T Consensus 82 e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 82 EFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred ccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 999 889999997644 258999999999999999999999 89999999999999999999999999999876543
Q ss_pred CceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhc---------
Q 036583 647 QSHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEG--------- 716 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--------- 716 (817)
.. ......++..|+|||.+.+ ..++.++|||||||+++||++|.+||......+. ...........
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ---LGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred Cc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH---HHHHHHHcCCCchhhhhhcc
Confidence 21 1123456778999998864 4678899999999999999999887764332110 00000000000
Q ss_pred chhhhcccccCCccc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 717 KLRNILDSRLNIDEQ-----SDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 717 ~~~~~~d~~~~~~~~-----~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.+............. ......+.+++.+||+.+|++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000000 1224568899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=306.15 Aligned_cols=258 Identities=23% Similarity=0.308 Sum_probs=190.3
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecC------Cee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG------THR 562 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~------~~~ 562 (817)
.+.+.+.||+|+||+||++.. .+++.||||++.... ...+.+.+|+.++++++||||+++++++... ...
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV 95 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence 344557899999999999985 467899999986532 2345678999999999999999999988543 356
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
++++|++ +++|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++.
T Consensus 96 ~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 96 YLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred EEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCcccee
Confidence 8999988 67898877532 48889999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCC--------cchHHHHHHh
Q 036583 643 MTREQSHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA--------HFPSYAFKMM 713 (817)
Q Consensus 643 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~--------~~~~~~~~~~ 713 (817)
..... ....|++.|+|||++.+ ..++.++|||||||++|||++|+.||......... .........+
T Consensus 168 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 168 ADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred cCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 54321 23568999999999876 56889999999999999999999999654321100 0000000000
Q ss_pred hhcchhhhcccccCCcc-c-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 714 EEGKLRNILDSRLNIDE-Q-----SDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 714 ~~~~~~~~~d~~~~~~~-~-----~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
........+......+. . ......+.+++.+|++.||.+|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000000 0 0012246799999999999999999999973
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=291.85 Aligned_cols=256 Identities=28% Similarity=0.328 Sum_probs=197.6
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecC--CeeeEEEeec
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG--THRLLAYEFM 569 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~ 569 (817)
.+.++||.|++|.||++... .++.+|+|.+.... ...+++.+|++++++++||||+++++++.+. ...++||||+
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 83 (287)
T cd06621 4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC 83 (287)
T ss_pred EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEec
Confidence 34578999999999999974 57889999987543 2356789999999999999999999998653 4689999999
Q ss_pred cCCChhhhhhhcc-cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 570 ANGSLDKWIFKKN-QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 570 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
++++|.+++.... ....++......++.||+.||+|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 84 EGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred CCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 9999999876422 22357888999999999999999999 9999999999999999999999999999876543221
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
....++..|+|||.+.+..++.++||||||+++|||++|+.||......... ..+ ....+.......+.+. .
T Consensus 161 ---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~---~ 232 (287)
T cd06621 161 ---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG-PIE-LLSYIVNMPNPELKDE---P 232 (287)
T ss_pred ---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC-hHH-HHHHHhcCCchhhccC---C
Confidence 2345778999999999889999999999999999999999999755321111 011 1111111111111110 0
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.........+.+++.+||+.+|++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 111123456889999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=297.31 Aligned_cols=243 Identities=23% Similarity=0.361 Sum_probs=195.7
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccC-CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCChh
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI-GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLD 575 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 575 (817)
.+||+|+||.||++... +++.||+|.+... ....+.+.+|+.++..++||||+++++++..++..++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 46999999999999864 6889999998643 334567889999999999999999999999999999999999999999
Q ss_pred hhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeeecc
Q 036583 576 KWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLR 655 (817)
Q Consensus 576 ~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~ 655 (817)
+++... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++........ ......
T Consensus 107 ~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~ 178 (297)
T cd06659 107 DIVSQT----RLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLV 178 (297)
T ss_pred HHHhhc----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccccee
Confidence 987542 47889999999999999999998 8999999999999999999999999999876543321 122356
Q ss_pred CCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHH
Q 036583 656 GTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRV 735 (817)
Q Consensus 656 gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 735 (817)
++..|+|||.+.+..++.++|||||||+++||++|+.||....... ....+.... ...... .....
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~-----~~~~~~--~~~~~ 244 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-------AMKRLRDSP-----PPKLKN--AHKIS 244 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhccC-----CCCccc--cCCCC
Confidence 8899999999998889999999999999999999999996432111 111111111 000000 11123
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 736 FTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 736 ~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
..+.+++..|++.+|++||+++|+++.
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 457889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.92 Aligned_cols=243 Identities=23% Similarity=0.407 Sum_probs=198.9
Q ss_pred cccccCCCcceeEEEEEcC-CCcEEEEEEe-----ccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCe--eeEEEe
Q 036583 496 FSVKLGQGGFGSVYQGVLP-DGTRLAVKKL-----EGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTH--RLLAYE 567 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l-----~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~--~~lv~e 567 (817)
|..+||+|+|-+||||... +|.+||--.+ .+.....+.|..|+.+|+.|+||||++++.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 4567999999999999964 4667763322 2233445789999999999999999999999987665 678899
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec-CCCcEEEeecCCccccCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD-DNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~ki~Dfgla~~~~~~ 646 (817)
.|..|+|..|+.+.+ .++.+....+++||++||.|||++ .++|||||||-+||+|+ ..|.|||+|+|||..+...
T Consensus 124 L~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999998877 478889999999999999999984 67999999999999998 5689999999999988655
Q ss_pred CceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 647 QSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
.. ....|||.|||||... ..|.+.+||||||+.++||+|+..||..-.. +..+++.+..|....-+..-
T Consensus 200 ~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n------~AQIYKKV~SGiKP~sl~kV- 268 (632)
T KOG0584|consen 200 HA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN------PAQIYKKVTSGIKPAALSKV- 268 (632)
T ss_pred cc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC------HHHHHHHHHcCCCHHHhhcc-
Confidence 33 3378999999999988 6899999999999999999999999964322 33456666666543333221
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
. ..++.++|..|+.. .++|||+.|+|+
T Consensus 269 --~-----dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 269 --K-----DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred --C-----CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1 12578999999999 999999999997
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=295.34 Aligned_cols=241 Identities=28% Similarity=0.361 Sum_probs=197.2
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.+.||+|+||.||++... +++.+|+|.+.... ...+.+.+|++++++++||||+++++++.++...++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 345678999999999999964 58899999986532 2346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++++|.+++.... .++...+..++.||+.||.|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 83 ~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 83 VPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 99999999997653 58889999999999999999999 99999999999999999999999999999876443
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
.....+++.|+|||.+.+...+.++||||||++++||++|+.||..... .........+. ...
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~--------~~~ 217 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-------IQIYEKILEGK--------VRF 217 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCC--------ccC
Confidence 1235688999999999888889999999999999999999999964331 11111111111 111
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRP-----SMTKVVQ 761 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~evl~ 761 (817)
+ ......+.+++.+||+.||.+|| +++|+++
T Consensus 218 ~--~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 218 P--SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred C--ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1 11234678999999999999999 6677664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=296.30 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=200.2
Q ss_pred HhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccC-CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI-GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
.++.+.++||+|+||.||++.. .+++.+|+|.+... ....+.+.+|+.++++++|||++++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 3455668899999999999985 46789999998643 334567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++++|.+++.+. .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 999999998653 36788899999999999999998 89999999999999999999999999998765443221
Q ss_pred eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
.....+++.|+|||.+....++.++||||||+++||+++|+.||........... ... .......
T Consensus 172 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~--------~~~~~~~ 236 (293)
T cd06647 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IAT--------NGTPELQ 236 (293)
T ss_pred -cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhc--------CCCCCCC
Confidence 1234678899999999888899999999999999999999999965433211000 000 0011111
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
........+.+++.+||+.+|++||++.+++++
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111223467789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=297.58 Aligned_cols=259 Identities=20% Similarity=0.282 Sum_probs=193.7
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
+.+.++||+|+||.||+++.. +|+.+|+|++.... .....+.+|++++++++||||+++++++.+....++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 445678999999999999964 68899999986432 22457888999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++ +|.+++..... .+++..++.++.||++||.|||+ .+|+|+||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 82 DQ-DLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred CC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 75 78887765432 58999999999999999999999 8999999999999999999999999999986543221
Q ss_pred eeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhc------chhhhc
Q 036583 650 VFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEG------KLRNIL 722 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~~~ 722 (817)
......++..|+|||.+.+. .++.++|||||||++|||++|+.|+........ ............ .+....
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChHHhHHhhhcc
Confidence 12234578899999998764 468999999999999999999988743322110 000000000000 000000
Q ss_pred ccc----cCC-----cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 723 DSR----LNI-----DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 723 d~~----~~~-----~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+.. ... .........+.+++.+|++.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 000 000112356789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=299.52 Aligned_cols=252 Identities=20% Similarity=0.242 Sum_probs=197.9
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.+.||+|+||.||++... .++.|++|.+.... ...+.+.+|+++++.++||||+++++.+..+.+.++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 345678999999999999964 47889999986542 2345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 83 VEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 99999999996643 58889999999999999999998 8999999999999999999999999999874211100
Q ss_pred --------------eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhh
Q 036583 649 --------------HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMME 714 (817)
Q Consensus 649 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 714 (817)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-------~~~~~~~~ 229 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-------EELFGQVI 229 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHH
Confidence 001124577899999999888899999999999999999999999964321 11111111
Q ss_pred hcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 715 EGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 715 ~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
.+. ...+.. .......+.+++.+||+.||++||++.++.++|+.
T Consensus 230 ~~~---~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 SDD---IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred hcc---cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111 001110 01233467899999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=295.60 Aligned_cols=260 Identities=22% Similarity=0.307 Sum_probs=199.1
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
+.+.++||+|+||.||+|... +|+.||+|++.... ...+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 456678999999999999964 68899999986543 23468999999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
+++|.+++.... ..+++..++.++.||++||+|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 82 -~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 82 -PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred -CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 999999987644 268999999999999999999998 89999999999999999999999999999876544322
Q ss_pred eeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcc-----------
Q 036583 650 VFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGK----------- 717 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----------- 717 (817)
......++..|+|||.+.+. .++.++||||+|++++||++|++||....... .............
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCcc
Confidence 23345788899999998654 46889999999999999999988885433211 0000000000000
Q ss_pred -hhhhcccccCC----cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 718 -LRNILDSRLNI----DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 718 -~~~~~d~~~~~----~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
...+..+.... ....+....+.+++.+|++.+|++||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 0001123678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=297.44 Aligned_cols=244 Identities=24% Similarity=0.320 Sum_probs=193.3
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.++||+|+||+||+|+.. +++.||+|.+.... ...+++.+|+++++.++||||++++++|.+++..++|+||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 555678999999999999864 58899999986432 2235788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
++ |+|.+++..... .+++..+..++.|++.||.|||+ .+|+|+||+|+||++++++.+||+|||++......
T Consensus 97 ~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 97 CL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred hC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 97 577777754332 58999999999999999999998 89999999999999999999999999998765432
Q ss_pred eeeeeccCCCCccCccccc---cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccc
Q 036583 649 HVFTTLRGTRGYLAPEWIT---NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 725 (817)
....++..|+|||.+. ...++.++||||||+++|||++|+.||....... ... .......
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~-~~~~~~~------- 231 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALY-HIAQNDS------- 231 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHH-HHhcCCC-------
Confidence 2345788999999874 4568889999999999999999999996432111 000 0111000
Q ss_pred cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 036583 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQML 763 (817)
Q Consensus 726 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L 763 (817)
...........+.+++.+||+.+|++||++.+++++.
T Consensus 232 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 232 -PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred -CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0001112345688999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.18 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=200.7
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
+.+.+.||+|+||.||++..+ +++.+++|.+.......+.+.+|++++.+++|+|++++++.+......++++||++++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 100 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence 334467999999999999976 5889999999765445678999999999999999999999999999999999999999
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeee
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT 652 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 652 (817)
+|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++........ ...
T Consensus 101 ~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~ 174 (286)
T cd06614 101 SLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRN 174 (286)
T ss_pred cHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhc
Confidence 9999998754 258999999999999999999998 9999999999999999999999999999876543221 112
Q ss_pred eccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccH
Q 036583 653 TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQS 732 (817)
Q Consensus 653 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 732 (817)
...++..|+|||.+.+..++.++||||||+++|||++|+.||....... .. .......... .....
T Consensus 175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~------~~-~~~~~~~~~~-------~~~~~ 240 (286)
T cd06614 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------AL-FLITTKGIPP-------LKNPE 240 (286)
T ss_pred cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhcCCCC-------Ccchh
Confidence 3457789999999998889999999999999999999999986432110 00 1111111110 11111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 733 DRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 733 ~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.....+.+++.+|++.+|.+||++.++++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 13346889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=296.64 Aligned_cols=259 Identities=21% Similarity=0.327 Sum_probs=193.0
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
+.+.++||+|+||.||+|+.. +++.||+|.+.... .....+.+|++++++++|+||+++++++.+++..++||||++
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence 445678999999999999965 68899999986532 223567889999999999999999999999999999999998
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+ +|.+++..... .+++.....++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 87 ~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~ 159 (291)
T cd07844 87 T-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-T 159 (291)
T ss_pred C-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-c
Confidence 5 99998875443 57889999999999999999998 8999999999999999999999999999875432211 1
Q ss_pred eeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhc---chhh------
Q 036583 651 FTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEG---KLRN------ 720 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~------ 720 (817)
.....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||........ .....+..+... ....
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhhhccc
Confidence 122346788999999875 4578999999999999999999999964431100 000000000000 0000
Q ss_pred hcccccCC---------cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 721 ILDSRLNI---------DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 721 ~~d~~~~~---------~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
........ .........+.+++.+|++.+|++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000 000111246779999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.47 Aligned_cols=244 Identities=23% Similarity=0.369 Sum_probs=196.2
Q ss_pred ccccccCCCcceeEEEEEc-CCCcEEEEEEeccC--CcCHHHHHHHHHHhhccC---cceeeeeeeEeecCCeeeEEEee
Q 036583 495 NFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI--GQGKKEFRAEVSIIGSIH---HLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~--~~~~~~~~~Ev~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
.+.++||+|+||.||+|.. .+++.+|+|.+... ....+++.+|+.++++++ |||++++++++.++...++||||
T Consensus 4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06917 4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY 83 (277)
T ss_pred hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEec
Confidence 3456799999999999995 56889999998653 234567889999999997 99999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++++|.+++... .+++...+.++.|++.||.|||+ .+|+|+||+|+||++++++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 84 AEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred CCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 9999999998643 58899999999999999999998 8999999999999999999999999999987654332
Q ss_pred eeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 649 HVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
. .....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||........ . ..... ...+.+.
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~-~~~~~-----~~~~~~~ 223 (277)
T cd06917 157 K-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------M-MLIPK-----SKPPRLE 223 (277)
T ss_pred c-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------h-hcccc-----CCCCCCC
Confidence 1 233568889999999875 4568899999999999999999999965432110 0 00000 0011111
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.. .....+.+++.+|++.||++||++.|+++
T Consensus 224 ~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 224 DN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred cc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11 13346789999999999999999999987
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=297.03 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=197.3
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+...++||+|+||.||+++. .+++.+|+|++.... ...+++.+|++++++++|||++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 34456799999999999995 468899999986432 1235788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++ +|.+++..... .+++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.+||+|||++......
T Consensus 107 ~~g-~l~~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 107 CLG-SASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CCC-CHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 975 78777754432 58999999999999999999998 89999999999999999999999999998754332
Q ss_pred eeeeeccCCCCccCccccc---cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccc
Q 036583 649 HVFTTLRGTRGYLAPEWIT---NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 725 (817)
....++..|+|||.+. ...++.++|||||||++|||++|+.||....... ....+..+.
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-------~~~~~~~~~-------- 240 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNE-------- 240 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-------HHHHHHhcc--------
Confidence 2346788999999974 4568899999999999999999999986432110 011111111
Q ss_pred cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCCCC
Q 036583 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQ 771 (817)
Q Consensus 726 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 771 (817)
............+.+++.+|++.+|.+||++.++++.+......+.
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 241 SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 0011111233467899999999999999999999997765544443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=289.92 Aligned_cols=241 Identities=26% Similarity=0.329 Sum_probs=194.5
Q ss_pred cCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCCh
Q 036583 500 LGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSL 574 (817)
Q Consensus 500 lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 574 (817)
||.|+||.||+++.. .++.+|+|.+.... ...+.+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 48899999986532 2346789999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeeec
Q 036583 575 DKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTL 654 (817)
Q Consensus 575 ~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~ 654 (817)
.+++.+.. .+++..+..++.||+.||+|||+ .+++|+||+|+||+++.++.+||+|||++....... .....
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 99997653 47889999999999999999998 999999999999999999999999999998765432 11234
Q ss_pred cCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHH
Q 036583 655 RGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDR 734 (817)
Q Consensus 655 ~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 734 (817)
.++..|+|||.+.+..++.++|+||||+++|||++|+.||....... .. .... +.........+...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~-~~~~--------~~~~~~~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----ME-IYND--------ILKGNGKLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HH-HHHH--------HhccCCCCCCCccc
Confidence 67889999999988889999999999999999999999997543211 11 1111 11101111111122
Q ss_pred HHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 036583 735 VFTAVKVALWCVQEDMSLRPS-----MTKVVQ 761 (817)
Q Consensus 735 ~~~~~~l~~~cl~~dp~~RPt-----~~evl~ 761 (817)
...+.+++..||+.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 457889999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=293.76 Aligned_cols=247 Identities=27% Similarity=0.395 Sum_probs=189.8
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHH-hhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSI-IGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.+.++||+|+||.||+++.. +|+.||+|+++... ....++..|+.+ ++.++||||+++++++..+...+++|||++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD 83 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence 45578999999999999965 58999999987543 234456667665 566789999999999999999999999997
Q ss_pred CCChhhhhhhc-ccccchhhhHHHHHHHHHHHHHHHHHhcCCC-ceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 571 NGSLDKWIFKK-NQEFLLDWETRFNIALGTAKGLAYLHEDCDQ-RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 571 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~-~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
|+|.+++... .....+++..+..++.||+.||+|||+ . +++||||||+||+++.++.+||+|||++........
T Consensus 84 -~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (283)
T cd06617 84 -TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA 159 (283)
T ss_pred -ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 5888887642 222368999999999999999999998 5 899999999999999999999999999986543211
Q ss_pred eeeeeccCCCCccCcccccc----CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccc
Q 036583 649 HVFTTLRGTRGYLAPEWITN----YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 724 (817)
.....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...... . ...... ..+....+.
T Consensus 160 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~-~~~~~~-~~~~~~~~~-- 229 (283)
T cd06617 160 --KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----F-QQLKQV-VEEPSPQLP-- 229 (283)
T ss_pred --cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----H-HHHHHH-HhcCCCCCC--
Confidence 122467889999998865 45688999999999999999999999532111 0 111111 111111110
Q ss_pred ccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 725 RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 725 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.......+.+++.+||+.+|++||++.++++
T Consensus 230 ------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 230 ------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112346889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=320.40 Aligned_cols=268 Identities=16% Similarity=0.225 Sum_probs=185.8
Q ss_pred HHHhhccccccCCCcceeEEEEEcCC--CcEEEEE------------------EeccCCcCHHHHHHHHHHhhccCccee
Q 036583 490 QTATNNFSVKLGQGGFGSVYQGVLPD--GTRLAVK------------------KLEGIGQGKKEFRAEVSIIGSIHHLHL 549 (817)
Q Consensus 490 ~~~~~~~~~~lG~G~fG~Vy~g~~~~--g~~vavK------------------~l~~~~~~~~~~~~Ev~~l~~l~h~ni 549 (817)
....+.+.++||+|+||+||++..+. +...++| ++.........+.+|+.++.+++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 34567777899999999999987532 1112222 222222234568899999999999999
Q ss_pred eeeeeEeecCCeeeEEEeeccCCChhhhhhhccc--ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec
Q 036583 550 VKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQ--EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD 627 (817)
Q Consensus 550 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~ 627 (817)
+++++++.+.+..++|+|++.. +|.+++..... ...........++.||+.||+|||+ .+|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEC
Confidence 9999999999999999999864 77777654321 1122345677899999999999999 8999999999999999
Q ss_pred CCCcEEEeecCCccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCC-CCCCCCCCCCcch
Q 036583 628 DNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKN-FDPNETSDKAHFP 706 (817)
Q Consensus 628 ~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p-f~~~~~~~~~~~~ 706 (817)
.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..+ +..........+.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 999999999999987754433323346799999999999999999999999999999999998754 4322211100000
Q ss_pred H-----------------HHHHHhhhcchhhhcccccCC-cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 707 S-----------------YAFKMMEEGKLRNILDSRLNI-DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 707 ~-----------------~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
. ..+..+.......... .+.. -........+.+++.+|++.||.+|||+.|++++
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGH-SVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCcc-chhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 0000000000000000 0000 0000112346678899999999999999999873
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=306.14 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=199.1
Q ss_pred ccccCCCcceeEEEEEc-CCCcEEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecCC------eeeEEEe
Q 036583 497 SVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT------HRLLAYE 567 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~------~~~lv~e 567 (817)
.+.||+|+||.||+|+. ..|+.||||.+... ....+...+|++++++++|+|||++++.-.+.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 46799999999999995 56999999999765 345678899999999999999999999875543 5689999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec--C--CCcEEEeecCCcccc
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD--D--NYHAKVSDFGLAKLM 643 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~--~--~~~~ki~Dfgla~~~ 643 (817)
||.+|||+..|.+..+...|+....+.++.++..||.|||+ ++|+||||||.||++- + .-..||+|||.|+.+
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 99999999999998888889999999999999999999998 9999999999999983 2 335899999999987
Q ss_pred CCCCceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcc--hhh
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGK--LRN 720 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~ 720 (817)
..+. ......||..|++||.... +.|+..+|.|||||++||++||..||.+........ ..++....+.. +.-
T Consensus 175 ~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~--~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 175 DDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNK--EIMWHIITKKPSGVAI 250 (732)
T ss_pred CCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccc--hhhhhhhccCCCceeE
Confidence 6544 5677899999999999984 889999999999999999999999998765543211 11222221111 100
Q ss_pred hccccc------------CCcccHHHHHHHHHHHHhccccCCCCCC
Q 036583 721 ILDSRL------------NIDEQSDRVFTAVKVALWCVQEDMSLRP 754 (817)
Q Consensus 721 ~~d~~~------------~~~~~~~~~~~~~~l~~~cl~~dp~~RP 754 (817)
...+.. ..........++-++...++..+|++|-
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 111111 1122234456677888889999999997
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=284.88 Aligned_cols=250 Identities=21% Similarity=0.296 Sum_probs=206.5
Q ss_pred ccccCCCcceeEEEEEcC------CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeec-CCeeeEEEe
Q 036583 497 SVKLGQGGFGSVYQGVLP------DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAE-GTHRLLAYE 567 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 567 (817)
+..+-+|.||.||.|.+. +.+.|-||.++... .....++.|..++..+.|||+..+.+.+.+ ....+++|.
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 456899999999999654 34567788876543 235678999999999999999999999865 556799999
Q ss_pred eccCCChhhhhh-----hcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 568 FMANGSLDKWIF-----KKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 568 ~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
++.-|+|..+|. +......++..+...++.|++.|++|||. +++||.||.++|.+||+..++||+|-.|++.
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkltDsaLSRD 445 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLTDSALSRD 445 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEeccchhccc
Confidence 999999999998 44444578888899999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCceeeee-ccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhh
Q 036583 643 MTREQSHVFTT-LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRN 720 (817)
Q Consensus 643 ~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (817)
+.+.+.+.... ...+..||+||.+.+..|+.++|||||||+||||+| |+.|+...++ ..+...+.+|
T Consensus 446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP-------fEm~~ylkdG---- 514 (563)
T KOG1024|consen 446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP-------FEMEHYLKDG---- 514 (563)
T ss_pred cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH-------HHHHHHHhcc----
Confidence 87766655443 456779999999999999999999999999999999 8999864432 2233333333
Q ss_pred hcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 721 ILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 721 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
.+...+..++.++..++.-||..+|++||+++|+++-|.+
T Consensus 515 -----yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 515 -----YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred -----ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 2333344567789999999999999999999999998865
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=291.79 Aligned_cols=250 Identities=26% Similarity=0.369 Sum_probs=199.1
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
.+.+.||+|+||.||++... +++.+|+|++.... ...+++.+|++++++++||||+++++.+..+...++++||+++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG 83 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence 34567999999999999975 58899999987542 3456789999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
++|.+++.... ..++......++.|++.||+|||+ ..+++|+||||+||++++++.+||+|||.+.........
T Consensus 84 ~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-- 157 (265)
T cd06605 84 GSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-- 157 (265)
T ss_pred CcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh--
Confidence 99999997653 267888899999999999999997 379999999999999999999999999998765432221
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
...++..|+|||.+.+..++.++||||||+++++|++|+.||........ ...... .....+. ......
T Consensus 158 -~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~-~~~~~~~--------~~~~~~ 226 (265)
T cd06605 158 -TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELL-QYIVNEP--------PPRLPS 226 (265)
T ss_pred -cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHH-HHHhcCC--------CCCCCh
Confidence 15678899999999988999999999999999999999999965432111 111111 1111110 000011
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
......+.+++..|+..+|++|||+.|+++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 227 GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 113446889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=291.57 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=197.1
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCC------eeeE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGT------HRLL 564 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~------~~~l 564 (817)
.+.+.+.||+|+||.||+|... +++.+++|.+.......+++.+|+.+++++ +|+||+++++++.+.. ..++
T Consensus 7 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~l 86 (275)
T cd06608 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWL 86 (275)
T ss_pred heeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEE
Confidence 3455688999999999999974 578899999877655667899999999999 7999999999997644 4899
Q ss_pred EEeeccCCChhhhhhhcc-cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 565 AYEFMANGSLDKWIFKKN-QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
||||+++++|.+++.... ....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 87 VMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred EEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence 999999999999986532 12368899999999999999999998 89999999999999999999999999998765
Q ss_pred CCCCceeeeeccCCCCccCcccccc-----CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcch
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITN-----YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKL 718 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 718 (817)
..... ......++..|+|||.+.. ..++.++||||||++++||++|+.||....... ....+..+..
T Consensus 164 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~ 235 (275)
T cd06608 164 DSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-------ALFKIPRNPP 235 (275)
T ss_pred ccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-------HHHHhhccCC
Confidence 43221 1223568889999998853 346789999999999999999999996432110 0011111110
Q ss_pred hhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 719 RNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 719 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+ ...........+.+++.+|+..||++|||+.|+++
T Consensus 236 -----~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 236 -----P--TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -----C--CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 11111223457889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=290.90 Aligned_cols=244 Identities=25% Similarity=0.345 Sum_probs=196.8
Q ss_pred cCCCcceeEEEEEcCC-CcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCCh
Q 036583 500 LGQGGFGSVYQGVLPD-GTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSL 574 (817)
Q Consensus 500 lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 574 (817)
||+|+||.||+++... |+.+++|.+.... ...+.+.+|++++.+++||||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 8999999986542 2456789999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc------
Q 036583 575 DKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS------ 648 (817)
Q Consensus 575 ~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~------ 648 (817)
.+++.+.. .+++..+..++.||+.||+|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99997654 58899999999999999999998 8999999999999999999999999999886543211
Q ss_pred -eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 649 -HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 649 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
.......++..|+|||.+.....+.++||||||++++||++|+.||...... ........+. ..
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~~~~--------~~ 219 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-------EIFQNILNGK--------IE 219 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCC--------cC
Confidence 1122356788999999998888899999999999999999999999643311 1111111111 11
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
.+........+.+++.+|++.+|++|||+.++.+.|+
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 1111112456789999999999999999977776665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=290.01 Aligned_cols=247 Identities=24% Similarity=0.381 Sum_probs=197.6
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.+.+.||+|+||.||++... +|..+|+|.+... ....+.+.+|+.++++++|+||+++++.+.+....++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD 82 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence 45678999999999999965 5788999998643 2345678899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC-cEEEeecCCccccCCCCce
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY-HAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Dfgla~~~~~~~~~ 649 (817)
+++|.+++..... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++ .+||+|||.+........
T Consensus 83 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (257)
T cd08225 83 GGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME- 157 (257)
T ss_pred CCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-
Confidence 9999999875432 257899999999999999999998 8999999999999999875 569999999987654322
Q ss_pred eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
......|++.|+|||.+.+..++.++||||||++++||++|+.||..... ...... ...+....
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~-~~~~~~~~--------- 221 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLK-ICQGYFAP--------- 221 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHH-HhcccCCC---------
Confidence 12234688899999999888899999999999999999999999964321 111111 11111111
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
........+.+++.+|++.+|++|||+.|+++.
T Consensus 222 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 011223468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=290.59 Aligned_cols=245 Identities=23% Similarity=0.293 Sum_probs=199.0
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.++||+|+||.||++... .++.+|+|.+.... ...+.+.+|++++++++||||+++++.+.++...++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 345678999999999999975 58899999996532 3457899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++++|.+++.... .+++..+..++.||++||.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 82 LLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999997652 58889999999999999999998 899999999999999999999999999988765432
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... .......... .. .
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~--------~~--~ 219 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET--------AD--V 219 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc--------cc--c
Confidence 1233567889999999998889999999999999999999999997544321 1111111110 00 1
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCH--HHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSM--TKVV 760 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~--~evl 760 (817)
.........+.+++.+||+.||.+||++ +|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1111223578899999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=295.55 Aligned_cols=258 Identities=21% Similarity=0.276 Sum_probs=196.1
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecC--CeeeEEEee
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG--THRLLAYEF 568 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~ 568 (817)
.+.++||+|+||.||+|+.. +++.+|+|++.... ...+.+.+|++++++++|+|++++++++.+. ...++|+||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 35578999999999999965 48899999997652 2346788999999999999999999999888 889999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++ +|.+++.... ..+++..++.++.||+.||+|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 82 MDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 985 8988886543 258899999999999999999998 8999999999999999999999999999987755432
Q ss_pred eeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhc---c---hhh-
Q 036583 649 HVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEG---K---LRN- 720 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~---~~~- 720 (817)
.......++..|+|||.+.+ ..++.++||||||++++||++|+.||........ ........... . ...
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhccccccc
Confidence 22233456788999998765 4678999999999999999999999965432110 00000000000 0 000
Q ss_pred ----hcccccC------CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 721 ----ILDSRLN------IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 721 ----~~d~~~~------~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
...+... ..........+.+++.+|++.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000 0000012457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=291.86 Aligned_cols=242 Identities=24% Similarity=0.386 Sum_probs=196.2
Q ss_pred cccCCCcceeEEEEEc-CCCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCChh
Q 036583 498 VKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLD 575 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 575 (817)
++||+|++|.||++.. .+++.+++|++.... ...+.+.+|+.+++.++||||+++++++..++..++++||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 5799999999999985 468899999986443 33567889999999999999999999999999999999999999999
Q ss_pred hhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeeecc
Q 036583 576 KWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLR 655 (817)
Q Consensus 576 ~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~ 655 (817)
+++... .+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.+||+|||++........ ......
T Consensus 105 ~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~ 176 (285)
T cd06648 105 DIVTHT----RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLV 176 (285)
T ss_pred HHHHhC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cccccc
Confidence 998762 47889999999999999999999 8999999999999999999999999998876543322 112356
Q ss_pred CCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHH
Q 036583 656 GTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRV 735 (817)
Q Consensus 656 gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 735 (817)
|+..|+|||.+.+..++.++||||||++++||++|+.||...... .......... .+... ......
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-------~~~~~~~~~~-----~~~~~--~~~~~~ 242 (285)
T cd06648 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-------QAMKRIRDNL-----PPKLK--NLHKVS 242 (285)
T ss_pred CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-------HHHHHHHhcC-----CCCCc--ccccCC
Confidence 888999999999888999999999999999999999999643211 1111111111 01111 111133
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 736 FTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 736 ~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..+.+++.+||+.+|++||++.++++
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHcc
Confidence 46889999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=284.59 Aligned_cols=246 Identities=25% Similarity=0.386 Sum_probs=200.6
Q ss_pred cccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc-CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCC
Q 036583 496 FSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ-GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGS 573 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~-~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 573 (817)
..+.||+|++|.||++... +++.+++|++..... ..+.+.+|++++++++|+|++++++++......++++||+++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 83 (253)
T cd05122 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS 83 (253)
T ss_pred eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence 4567999999999999975 688999999976543 56789999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeee
Q 036583 574 LDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT 653 (817)
Q Consensus 574 L~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 653 (817)
|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||.+........ ...
T Consensus 84 L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~ 156 (253)
T cd05122 84 LKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNT 156 (253)
T ss_pred HHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccc
Confidence 999987653 258999999999999999999998 9999999999999999999999999999987655432 234
Q ss_pred ccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHH
Q 036583 654 LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSD 733 (817)
Q Consensus 654 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 733 (817)
..++..|+|||.+.+..++.++||||||++++||++|+.||....... .. ........... .....
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~-~~~~~~~~~~~-------~~~~~ 222 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK------AL-FKIATNGPPGL-------RNPEK 222 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH------HH-HHHHhcCCCCc-------Ccccc
Confidence 567889999999998888999999999999999999999996432110 00 01111111111 11111
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 734 RVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 734 ~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
....+.+++.+|++.||++|||+.|+++.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 13468899999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=291.03 Aligned_cols=241 Identities=25% Similarity=0.351 Sum_probs=187.1
Q ss_pred ccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhh---ccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 499 KLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIG---SIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.||+|+||.||++... +++.+|+|.+.... .....+.+|..++. ..+|||++.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999964 58899999886532 12234455554443 3479999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+++|.+++.... .+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 999999987554 58999999999999999999999 8999999999999999999999999999875533221
Q ss_pred eeeccCCCCccCccccc-cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 651 FTTLRGTRGYLAPEWIT-NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
....|+..|+|||.+. +..++.++|||||||+++||++|+.||........ ....... . .....
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~----~------~~~~~ 217 (279)
T cd05633 153 -HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMT----L------TVNVE 217 (279)
T ss_pred -cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH----HHHHHHh----h------cCCcC
Confidence 2346899999999986 45688999999999999999999999965432211 0010000 0 00111
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRP-----SMTKVVQM 762 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~evl~~ 762 (817)
........+.+++..|++.||++|| +++|++++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1122345678999999999999999 69999884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=297.77 Aligned_cols=245 Identities=22% Similarity=0.366 Sum_probs=205.2
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
..+.+..+||+|.|++|.+++.. .+.+||+|.+.+..- ..+.+.+|+++|..++|||||+++.+......+|+|||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 44556788999999999999954 589999999987632 33568899999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|..+|.+.+||.+++. .....+..++.|+.+|++|||+ +.|+|||||++||||+.+.++||+|||++..+...
T Consensus 136 ya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~- 208 (596)
T KOG0586|consen 136 YASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG- 208 (596)
T ss_pred eccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccc-
Confidence 9999999999988774 5558889999999999999999 99999999999999999999999999999987643
Q ss_pred ceeeeeccCCCCccCccccccCcc-CccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAI-SEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
....+.+|++.|.|||++.+..| .+.+|+||+|++||-|++|..||++.....-. .+.+-..+
T Consensus 209 -~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr---------------~rvl~gk~ 272 (596)
T KOG0586|consen 209 -LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR---------------PRVLRGKY 272 (596)
T ss_pred -ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc---------------chheeeee
Confidence 34567899999999999998877 47999999999999999999999865432210 11122223
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+.++.+ ..++.++++.++-.+|.+|++++++.+
T Consensus 273 rIp~~m--s~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 273 RIPFYM--SCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ccccee--echhHHHHHHhhccCccccCCHHHhhh
Confidence 333332 235678999999999999999999987
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=292.73 Aligned_cols=261 Identities=24% Similarity=0.331 Sum_probs=196.7
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
+.+.++||+|++|.||+|+.. +|+.||||.+.... ...+.+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 345678999999999999975 58899999987542 235678899999999999999999999999999999999998
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+ +|.+++........+++..+..++.||+.||+|||+ .+++|+||||+||++++++.+||+|||++........ .
T Consensus 82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (284)
T cd07836 82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T 156 (284)
T ss_pred c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence 5 898888765444468999999999999999999998 8999999999999999999999999999976543211 1
Q ss_pred eeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcc--------hHHHHHHhhhcchhhh
Q 036583 651 FTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHF--------PSYAFKMMEEGKLRNI 721 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 721 (817)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||........... ....+..+.. ....
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 234 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ--LPEY 234 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc--Cchh
Confidence 1234568899999988654 568899999999999999999999965432110000 0000000000 0000
Q ss_pred cccccC------CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 722 LDSRLN------IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 722 ~d~~~~------~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
...... ..........+.+++.+|++.||.+||+++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 0000122356789999999999999999999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=291.77 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=192.6
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
...+.||+|+||.||+|+.. +++.+|||++.... ...+.+.+|++++++++||||+++++++.+++..++||||+.
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 82 (284)
T ss_pred eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence 34567999999999999864 68899999986432 234678999999999999999999999999999999999996
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
++|.+++..... ..+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++........ .
T Consensus 83 -~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 156 (284)
T cd07860 83 -QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-T 156 (284)
T ss_pred -cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-c
Confidence 589888865432 258899999999999999999998 8999999999999999999999999999876543221 1
Q ss_pred eeeccCCCCccCccccccCc-cCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhc-c--------hhh
Q 036583 651 FTTLRGTRGYLAPEWITNYA-ISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEG-K--------LRN 720 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~--------~~~ 720 (817)
.....++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... ...+..... . ...
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID------QLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHHHhCCCChhhhhhhhH
Confidence 22345678899999887644 5889999999999999999999996443211 011100000 0 000
Q ss_pred hcc-----cccCCc----ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 721 ILD-----SRLNID----EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 721 ~~d-----~~~~~~----~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+.. +..... ........+.+++.+|++.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000 000000 00011235678999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=289.53 Aligned_cols=243 Identities=27% Similarity=0.358 Sum_probs=192.2
Q ss_pred cCCCcceeEEEEEc-CCCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCCh
Q 036583 500 LGQGGFGSVYQGVL-PDGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSL 574 (817)
Q Consensus 500 lG~G~fG~Vy~g~~-~~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 574 (817)
||+|+||+||++.. .+|+.+|+|.+... ....+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999985 46889999998643 22345678899999999999999999999999999999999999999
Q ss_pred hhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeeec
Q 036583 575 DKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTL 654 (817)
Q Consensus 575 ~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~ 654 (817)
.+++.+... ..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++....... .....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGR 154 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccc
Confidence 999976543 258889999999999999999999 899999999999999999999999999987654321 12234
Q ss_pred cCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHH
Q 036583 655 RGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDR 734 (817)
Q Consensus 655 ~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 734 (817)
.++..|+|||.+.+..++.++||||||++++||++|+.||........ ...+..... ... .......
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~----~~~--~~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-------KEELKRRTL----EMA--VEYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-------HHHHHhccc----ccc--ccCCccC
Confidence 677899999999888899999999999999999999999965433110 001111100 000 0111122
Q ss_pred HHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 036583 735 VFTAVKVALWCVQEDMSLRP-----SMTKVVQ 761 (817)
Q Consensus 735 ~~~~~~l~~~cl~~dp~~RP-----t~~evl~ 761 (817)
...+.+++.+||+.+|++|| ++.++++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 44678999999999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=294.67 Aligned_cols=264 Identities=19% Similarity=0.280 Sum_probs=194.5
Q ss_pred hccccccCCCcceeEEEEEcC---CCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecC--CeeeE
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP---DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG--THRLL 564 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~---~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~~l 564 (817)
+.+.++||+|+||.||+|... .++.+|+|.+.... ...+.+.+|+.++.+++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 345678999999999999964 47899999997632 2346788999999999999999999999888 78999
Q ss_pred EEeeccCCChhhhhhhccc--ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC----CCcEEEeecC
Q 036583 565 AYEFMANGSLDKWIFKKNQ--EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD----NYHAKVSDFG 638 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~ki~Dfg 638 (817)
||||+++ +|.+++..... ...++......++.||+.||.|||+ .+|+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999986 67666653321 1257888999999999999999998 89999999999999999 9999999999
Q ss_pred CccccCCCCce--eeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchH---HH---
Q 036583 639 LAKLMTREQSH--VFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPS---YA--- 709 (817)
Q Consensus 639 la~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~---~~--- 709 (817)
++......... ......++..|+|||.+.+ ..++.++||||||++++||++|+.||...........+. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 99876443221 1123467889999998876 457899999999999999999999997654432111100 00
Q ss_pred HHHhhh------------cchhhhccccc--CCc--ccH-------HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 710 FKMMEE------------GKLRNILDSRL--NID--EQS-------DRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 710 ~~~~~~------------~~~~~~~d~~~--~~~--~~~-------~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
...+.. .......+... ... ... .....+.+++.+|++.||++|||+.|+++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 00000000000 000 000 12346789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=293.40 Aligned_cols=259 Identities=20% Similarity=0.268 Sum_probs=191.0
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
+.+.++||+|+||.||+|.. .+++.+|+|++.... .....+.+|+.++..++|+||+++++++..+...++|+||+.
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 44567899999999999985 468899999986542 234577899999999999999999999999999999999996
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
++|.+++..... .+.+..+..++.||+.||+|||+ .+|+|+||||+||+++.++++||+|||+++........
T Consensus 87 -~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~- 159 (291)
T cd07870 87 -TDLAQYMIQHPG--GLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT- 159 (291)
T ss_pred -CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-
Confidence 677777654332 46778888999999999999998 89999999999999999999999999999764332211
Q ss_pred eeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHH-----------hhh--c
Q 036583 651 FTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKM-----------MEE--G 716 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~-----------~~~--~ 716 (817)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||+....... . ....+.. +.. .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-Q-LEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-H-HHHHHHHcCCCChhhhhhhhhccc
Confidence 1234568899999998754 578899999999999999999999974432100 0 0000000 000 0
Q ss_pred chhhhccc----ccCC-cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 717 KLRNILDS----RLNI-DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 717 ~~~~~~d~----~~~~-~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
........ .+.. .........+.+++.+|++.||++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000 0000 000011346778999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=285.96 Aligned_cols=249 Identities=29% Similarity=0.387 Sum_probs=202.2
Q ss_pred ccccccCCCcceeEEEEEcCC-CcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 495 NFSVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
.+.+.||+|++|.||+++..+ ++.++||++.... ...+++.+|+.++.+++|+|++++++++..+...++|+||+++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG 83 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence 445789999999999999764 8999999987653 3467899999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
++|.+++.... .++...+..++.|+++|++|||+. .+++|+||+|+||+++.++.++|+|||++......... .
T Consensus 84 ~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~ 157 (264)
T cd06623 84 GSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-C 157 (264)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-c
Confidence 99999997653 688999999999999999999962 79999999999999999999999999999876543322 1
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
....++..|+|||.+.+..++.++||||||+++|||++|+.||....... .... ...+..... ....
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~-~~~~~~~~~---------~~~~ 224 (264)
T cd06623 158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---FFEL-MQAICDGPP---------PSLP 224 (264)
T ss_pred cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC---HHHH-HHHHhcCCC---------CCCC
Confidence 23467889999999998889999999999999999999999996543211 1111 111111111 1111
Q ss_pred HH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 732 SD-RVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 732 ~~-~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.. ....+.+++.+|++.+|++||++.|+++.
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11 34578899999999999999999999973
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=291.75 Aligned_cols=261 Identities=20% Similarity=0.232 Sum_probs=194.4
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecC--CeeeEEEe
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG--THRLLAYE 567 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 567 (817)
+.+.++||+|+||.||+|... +++.+|+|.++... .....+.+|+.++.+++||||+++++++... ...++|||
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e 86 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME 86 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence 445678999999999999975 58899999986442 2234678899999999999999999999877 88999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+++ +|.+++..... .+++..+..++.||+.||+|||+ .+++|+||||+||++++++.+||+|||++.......
T Consensus 87 ~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 87 YVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred hcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9985 99998876443 58999999999999999999998 899999999999999999999999999998765432
Q ss_pred ceeeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCc--------chHHHHHHhhh---
Q 036583 648 SHVFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAH--------FPSYAFKMMEE--- 715 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~--------~~~~~~~~~~~--- 715 (817)
. ......+++.|+|||.+.+. .++.++||||||++++||++|+.||.......... .....+.....
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 K-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred c-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 1 12234567899999998754 46889999999999999999999996443211000 00000000000
Q ss_pred ---cchhhhcccccCCcccHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 716 ---GKLRNILDSRLNIDEQSD-RVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 716 ---~~~~~~~d~~~~~~~~~~-~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..........+....... ....+.+++..|++.+|++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000000011111 2445789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=291.82 Aligned_cols=249 Identities=28% Similarity=0.407 Sum_probs=190.1
Q ss_pred ccccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHHhhccC-cceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 497 SVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIH-HLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
.++||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++. |+||+++++++..+...+++|||+..
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~- 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI- 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence 467999999999999854 58899999986542 33567899999999996 99999999999999999999999875
Q ss_pred Chhhhh---hhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 573 SLDKWI---FKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 573 sL~~~l---~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
+|.++. .... ...+++.....++.|++.||+|||+. .+++||||||+||+++.++.+||+|||++.........
T Consensus 88 ~l~~l~~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 164 (288)
T cd06616 88 SLDKFYKYVYEVL-KSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK 164 (288)
T ss_pred CHHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc
Confidence 554433 2221 23688899999999999999999972 58999999999999999999999999999765432211
Q ss_pred eeeeccCCCCccCccccccC---ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 650 VFTTLRGTRGYLAPEWITNY---AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
....++..|+|||.+.+. .++.++|||||||++|||++|+.||..... ...... ....+. .+.+
T Consensus 165 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~-~~~~~~-----~~~~ 231 (288)
T cd06616 165 --TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLT-QVVKGD-----PPIL 231 (288)
T ss_pred --ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHh-hhcCCC-----CCcC
Confidence 234678899999999865 688999999999999999999999963320 000000 000110 1111
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
...........+.+++.+|++.+|++|||++||++.
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111112344578899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=289.81 Aligned_cols=245 Identities=27% Similarity=0.327 Sum_probs=200.8
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
+.||+|+||.||-.+.+ .|+.+|.|++.+. .++....++|-.||.+++.+.||.+--.|...+.+|+|+..|.||
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 67999999999999865 5889999988543 345667789999999999999999999999999999999999999
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeee
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT 652 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 652 (817)
+|.-||...+.. .++...++-++.+|+.||++||. .+||.|||||+|||||++|+++|+|+|||..+...+.. .
T Consensus 271 DLkfHiyn~g~~-gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~--~ 344 (591)
T KOG0986|consen 271 DLKFHIYNHGNP-GFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI--R 344 (591)
T ss_pred ceeEEeeccCCC-CCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCCcc--c
Confidence 999999887653 68999999999999999999999 99999999999999999999999999999988665443 3
Q ss_pred eccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccH
Q 036583 653 TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQS 732 (817)
Q Consensus 653 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 732 (817)
..+||.+|||||++.+..|+...|.||+||+||||+.|+.||....... ...++.+.+-. ....++.
T Consensus 345 ~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv------------k~eEvdrr~~~-~~~ey~~ 411 (591)
T KOG0986|consen 345 GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV------------KREEVDRRTLE-DPEEYSD 411 (591)
T ss_pred cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh------------hHHHHHHHHhc-chhhccc
Confidence 3589999999999999999999999999999999999999996432211 11111111110 1122334
Q ss_pred HHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 036583 733 DRVFTAVKVALWCVQEDMSLRP-----SMTKVVQ 761 (817)
Q Consensus 733 ~~~~~~~~l~~~cl~~dp~~RP-----t~~evl~ 761 (817)
...+++.++....++.||++|- .++||.+
T Consensus 412 kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 412 KFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE 445 (591)
T ss_pred ccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence 4455677788888999999986 4556654
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=283.15 Aligned_cols=246 Identities=27% Similarity=0.372 Sum_probs=201.2
Q ss_pred cccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecC--CeeeEEEeec
Q 036583 496 FSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG--THRLLAYEFM 569 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~ 569 (817)
..+.||+|++|.||+|... +++.+++|++.... ...+.+.+|+.++++++|+||+++++.+.+. ...++++||+
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 83 (260)
T cd06606 4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83 (260)
T ss_pred eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence 3467999999999999976 68899999987654 3467899999999999999999999999988 8899999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++++|.+++.... .+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.+||+|||.+.........
T Consensus 84 ~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 84 SGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999999997654 68999999999999999999999 89999999999999999999999999999877554321
Q ss_pred -eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 650 -VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 650 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
......++..|+|||.+.+...+.++||||||+++++|++|+.||..... .......... .....
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~---------~~~~~ 223 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGS---------SGEPP 223 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccc---------cCCCc
Confidence 12335678899999999988899999999999999999999999975441 1111111110 00111
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.........+.+++.+|++.+|++||++.|+++
T Consensus 224 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111122457889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=293.96 Aligned_cols=261 Identities=22% Similarity=0.285 Sum_probs=193.7
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCC-------
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT------- 560 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~------- 560 (817)
..+.+.++||+|+||.||+|... +++.||+|+++... .....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~ 86 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence 44556788999999999999975 58899999996432 23457788999999999999999999987655
Q ss_pred ---eeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeec
Q 036583 561 ---HRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDF 637 (817)
Q Consensus 561 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df 637 (817)
..++|+||+++ +|..++.... ..+++..++.++.||+.||+|||+ .+|+|+||||+||++++++.+||+||
T Consensus 87 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 87 DKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred cCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCcc
Confidence 78999999987 6777665442 258899999999999999999999 89999999999999999999999999
Q ss_pred CCccccCCCCceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhc
Q 036583 638 GLAKLMTREQSHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEG 716 (817)
Q Consensus 638 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 716 (817)
|++...............++..|+|||.+.+ ..++.++|||||||+++||++|+.||........ ...........
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~---~~~~~~~~~~~ 237 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ---LELISRLCGSP 237 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCC
Confidence 9998765433222223346778999998864 4578899999999999999999999974432110 00000000000
Q ss_pred ch---hhh--------cccccCC-----cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 717 KL---RNI--------LDSRLNI-----DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 717 ~~---~~~--------~d~~~~~-----~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.. ..+ .+..... .........+.+++..||+.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 000 0000000 000012346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=315.32 Aligned_cols=244 Identities=27% Similarity=0.424 Sum_probs=183.0
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecC---------------
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG--------------- 559 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--------------- 559 (817)
+.||+||||.|||++.+ ||+.+|||++.-.. .....+.+|++++++|+|||||+++..+.+.
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 46999999999999954 89999999996542 3346788999999999999999997651000
Q ss_pred --------------------------------------------------------------------------------
Q 036583 560 -------------------------------------------------------------------------------- 559 (817)
Q Consensus 560 -------------------------------------------------------------------------------- 559 (817)
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence
Q ss_pred ------------------------CeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCcee
Q 036583 560 ------------------------THRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615 (817)
Q Consensus 560 ------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~iv 615 (817)
..+||-||||+.-.|++++.+..-. -.....++++.+|+.||+|+|+ .+||
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH~---~giI 719 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIHD---QGII 719 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHHh---Ccee
Confidence 1236778999887777777654421 1456789999999999999999 8999
Q ss_pred ecCCCCCCeEecCCCcEEEeecCCccccC-----------------CCCceeeeeccCCCCccCccccccC---ccCccc
Q 036583 616 HCDIKPENVLLDDNYHAKVSDFGLAKLMT-----------------REQSHVFTTLRGTRGYLAPEWITNY---AISEKS 675 (817)
Q Consensus 616 H~Dlk~~NIll~~~~~~ki~Dfgla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~ 675 (817)
||||||.||++|++..|||+|||+|.... .......+...||.-|+|||++.+. .|+.|+
T Consensus 720 HRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~Ki 799 (1351)
T KOG1035|consen 720 HRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKI 799 (1351)
T ss_pred eccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchh
Confidence 99999999999999999999999998732 0111133457899999999999865 499999
Q ss_pred cccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCC
Q 036583 676 DVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPS 755 (817)
Q Consensus 676 DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt 755 (817)
|+||+||||+||+. ||..... ...+...++++.+..- .....+....-.+++.||++.||.+|||
T Consensus 800 DmYSLGIVlFEM~y---PF~TsME------Ra~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPt 864 (1351)
T KOG1035|consen 800 DMYSLGIVLFEMLY---PFGTSME------RASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPT 864 (1351)
T ss_pred hhHHHHHHHHHHhc---cCCchHH------HHHHHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccCCC
Confidence 99999999999983 4643211 0111222222222111 1112234445679999999999999999
Q ss_pred HHHHHH
Q 036583 756 MTKVVQ 761 (817)
Q Consensus 756 ~~evl~ 761 (817)
+.|+++
T Consensus 865 A~eLL~ 870 (1351)
T KOG1035|consen 865 ATELLN 870 (1351)
T ss_pred HHHHhh
Confidence 999987
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=290.49 Aligned_cols=257 Identities=19% Similarity=0.246 Sum_probs=180.8
Q ss_pred HhhccccccCCCcceeEEEEEcCCC----cEEEEEEeccCCcC--H----------HHHHHHHHHhhccCcceeeeeeeE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPDG----TRLAVKKLEGIGQG--K----------KEFRAEVSIIGSIHHLHLVKLRGF 555 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~g----~~vavK~l~~~~~~--~----------~~~~~Ev~~l~~l~h~niv~l~~~ 555 (817)
..+.+.++||+|+||+||+|...+. ..+|+|+....... . .....+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4566778899999999999996543 45566643221111 0 112233445667789999999997
Q ss_pred eecCC----eeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCc
Q 036583 556 CAEGT----HRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYH 631 (817)
Q Consensus 556 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 631 (817)
+.... ..++++|++.. ++.+.+.... ..++..+..++.|++.||+|||+ .+|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCc
Confidence 75543 34677776643 5655554322 34677788999999999999998 89999999999999999999
Q ss_pred EEEeecCCccccCCCCce------eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcc
Q 036583 632 AKVSDFGLAKLMTREQSH------VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHF 705 (817)
Q Consensus 632 ~ki~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~ 705 (817)
+||+|||+++.+...... ......||+.|+|||.+.+..++.++|||||||+++||++|+.||........ +
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~--~ 242 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN--L 242 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH--H
Confidence 999999999876432111 11224699999999999999999999999999999999999999975432211 0
Q ss_pred hHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 706 PSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 706 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
......+-+..+.......+. ....+.+++..|++.+|++||++.++++.|+
T Consensus 243 ----~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 ----IHAAKCDFIKRLHEGKIKIKN---ANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred ----HHHhHHHHHHHhhhhhhccCC---CCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 000001111111111111111 1346789999999999999999999999874
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=286.53 Aligned_cols=257 Identities=21% Similarity=0.236 Sum_probs=190.9
Q ss_pred ccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC--cCHHHHHHHHHHhhccC-cceeeeeeeEeecC--CeeeEEEee
Q 036583 495 NFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIH-HLHLVKLRGFCAEG--THRLLAYEF 568 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~ 568 (817)
.+.++||+|+||.||++.. .+++.+|+|+++... .......+|+.++.++. |+|++++++++.++ +..++|+||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 4567899999999999985 468899999987542 22344567899999885 99999999999887 889999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
++ ++|.+++..... .+++..+..++.|++.||+|||+ .+++||||+|+||+++. +.+||+|||+++.......
T Consensus 82 ~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 82 MD-MNLYELIKGRKR--PLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred CC-ccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 97 488888765332 68999999999999999999999 89999999999999999 9999999999987643322
Q ss_pred eeeeeccCCCCccCccccc-cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCC---------cchHHHHHHhhhcch
Q 036583 649 HVFTTLRGTRGYLAPEWIT-NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA---------HFPSYAFKMMEEGKL 718 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~---------~~~~~~~~~~~~~~~ 718 (817)
.....++..|+|||.+. +..++.++|||||||++|||++|+.||......+.. ....+ .........
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (282)
T cd07831 155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKFRKSRH 231 (282)
T ss_pred --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhhccccc
Confidence 12345788999999765 456788999999999999999999999654321100 00000 000000000
Q ss_pred hhhcccccCC----cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 719 RNILDSRLNI----DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 719 ~~~~d~~~~~----~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.....+.... .........+.+++.+|++.+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000000 000123467899999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=293.41 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=191.1
Q ss_pred cccCCC--cceeEEEEEc-CCCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 498 VKLGQG--GFGSVYQGVL-PDGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G--~fG~Vy~g~~-~~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
++||+| +||+||+++. ..|+.||+|++..... ..+.+.+|+.+++.++||||++++++|..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 357777 8999999986 4789999999865432 236788999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee-
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV- 650 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~- 650 (817)
++|.+++...... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 9999998764322 47888889999999999999998 899999999999999999999999997654322111100
Q ss_pred --e---eeccCCCCccCccccccC--ccCccccccchhhhHHHhhhCCCCCCCCCCCCCC---------------cchHH
Q 036583 651 --F---TTLRGTRGYLAPEWITNY--AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA---------------HFPSY 708 (817)
Q Consensus 651 --~---~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~---------------~~~~~ 708 (817)
. ....++..|+|||++.+. .++.++|||||||+++||++|+.||......... ..+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 238 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC- 238 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch-
Confidence 0 112345679999999763 4789999999999999999999999643211000 0000
Q ss_pred HHHHh-------h----h-----cchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 709 AFKMM-------E----E-----GKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 709 ~~~~~-------~----~-----~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..... . + +....+.+..+..+........+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000 0 0 0000111111222223345567899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=284.83 Aligned_cols=247 Identities=26% Similarity=0.368 Sum_probs=200.6
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
+.+.++||+|+||.||+++. .+++.+++|.+.... ....++.+|++++++++|+||+++++++.+....++|+||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 34567899999999999975 467899999986532 23457889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcc-cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 570 ANGSLDKWIFKKN-QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 570 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
++++|.+++.+.. ....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~- 157 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM- 157 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence 9999999986622 12368889999999999999999998 899999999999999999999999999998765441
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
.....++..|+|||.+.+..++.++|+||||++++||++|+.||...... ........+...
T Consensus 158 --~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~--------- 219 (256)
T cd08530 158 --AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-------DLRYKVQRGKYP--------- 219 (256)
T ss_pred --cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCCC---------
Confidence 22356788999999999989999999999999999999999999644321 111111111111
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.........+.+++.+|++.+|++||++.|+++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1112344578999999999999999999999873
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=287.61 Aligned_cols=254 Identities=24% Similarity=0.330 Sum_probs=193.4
Q ss_pred cccccCCCcceeEEEEEc-CCCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 496 FSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+.++||.|++|.||+|.. .+|+.||+|++.... ...+.+.+|++++++++|||++++++++.++...+++|||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence 457899999999999985 468999999986442 234678899999999999999999999999999999999995
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
++|.+++..... ..+++..++.++.|+++||+|||+ .+++|+||+|+||+++.++.+||+|||++........ ..
T Consensus 82 ~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~ 156 (283)
T cd07835 82 LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TY 156 (283)
T ss_pred cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-cc
Confidence 689998865432 258899999999999999999998 8999999999999999999999999999976543221 11
Q ss_pred eeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhh-cc--------hhhh
Q 036583 652 TTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEE-GK--------LRNI 721 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~--------~~~~ 721 (817)
....++..|+|||++.+. .++.++||||||+++|||++|+.||........ ....... +. ...+
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ------LFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHHHhCCCChHHhhhhhhc
Confidence 223567899999988654 578899999999999999999999964432110 0000000 00 0000
Q ss_pred ccc-----ccC----CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 722 LDS-----RLN----IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 722 ~d~-----~~~----~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.+. ... ..........+.+++.+|++.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 000 0001112246789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=292.26 Aligned_cols=260 Identities=21% Similarity=0.258 Sum_probs=191.3
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCe-----ee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTH-----RL 563 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~-----~~ 563 (817)
+.+.++||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +||||+++++++...+. .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 345678999999999999964 68899999886432 2346788999999999 46999999999977665 79
Q ss_pred EEEeeccCCChhhhhhhccc--ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC-CCcEEEeecCCc
Q 036583 564 LAYEFMANGSLDKWIFKKNQ--EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD-NYHAKVSDFGLA 640 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~Dfgla 640 (817)
+||||+++ +|.+++..... ...+++..++.++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999986 89888865332 2368999999999999999999998 89999999999999998 899999999998
Q ss_pred cccCCCCceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchh
Q 036583 641 KLMTREQSHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLR 719 (817)
Q Consensus 641 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (817)
+....... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||........ + ......+......
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~-~~~~~~~~~~~~~ 234 (295)
T cd07837 159 RAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--L-LHIFKLLGTPTEQ 234 (295)
T ss_pred eecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--H-HHHHHHhCCCChh
Confidence 86533211 1122356788999998865 4578999999999999999999999964322110 0 0000000000000
Q ss_pred h------hcc----cccCC----cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 720 N------ILD----SRLNI----DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 720 ~------~~d----~~~~~----~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
. ..+ +.... .........+.+++.+||+.||.+||+++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 000 00000 000123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=272.13 Aligned_cols=243 Identities=24% Similarity=0.328 Sum_probs=195.9
Q ss_pred ccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 495 NFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
+|.+.||+|.||.|.+.+- ..++.+|+|++++.. .....-+.|-++|...+||.+..|--.|...+++|.||||.
T Consensus 171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya 250 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA 250 (516)
T ss_pred hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence 3567899999999999985 468899999998652 22345578999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
.||.|.-+|.+.. .++....+-+-..|+.||.|||+ ++||.||||.+|.|+|.+|.+||+||||.+.--. ...
T Consensus 251 nGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-~g~ 323 (516)
T KOG0690|consen 251 NGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-YGD 323 (516)
T ss_pred cCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccc-ccc
Confidence 9999999997755 68888888899999999999999 9999999999999999999999999999985322 222
Q ss_pred eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
...+.+|||.|+|||++....|..++|.|.+|||+|||++|+.||...+... .+..+ +...++.
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k-------LFeLI--------l~ed~kF- 387 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK-------LFELI--------LMEDLKF- 387 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH-------HHHHH--------HhhhccC-
Confidence 3466899999999999999999999999999999999999999996543221 11111 1111111
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRP-----SMTKVVQ 761 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~evl~ 761 (817)
+.....++..++...+..||.+|- .+.||.+
T Consensus 388 -Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 388 -PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred -CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 112233566788888999999995 4566554
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=287.93 Aligned_cols=252 Identities=22% Similarity=0.280 Sum_probs=197.6
Q ss_pred ccccccCCCcceeEEEEEc----CCCcEEEEEEeccCC-----cCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeE
Q 036583 495 NFSVKLGQGGFGSVYQGVL----PDGTRLAVKKLEGIG-----QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLL 564 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~----~~g~~vavK~l~~~~-----~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~l 564 (817)
.+.+.||+|+||.||+++. .+++.+|||.+.... ...+.+.+|+.++.++ +||||+++++.+..+...++
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 4567899999999999874 357889999986431 2345788999999999 59999999999999999999
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
||||+++++|.+++.... .+++.....++.|++++|.|||+ .+++|+||+|+||+++.++.++|+|||+++...
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 83 ILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 999999999999987543 57888899999999999999998 899999999999999999999999999988765
Q ss_pred CCCceeeeeccCCCCccCccccccCc--cCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 645 REQSHVFTTLRGTRGYLAPEWITNYA--ISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 645 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
...........++..|+|||.+.+.. .+.++||||||++++||++|+.||....... ...... ... .
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~-~~~--------~ 225 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEIS-RRI--------L 225 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHH-HHH--------H
Confidence 43322222356788999999987654 7889999999999999999999996432111 011111 111 0
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
.... +........+.+++.+||+.||++|||+.++.+.|+.
T Consensus 226 ~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 226 KSKP--PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ccCC--CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0000 1111123457789999999999999999999888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=299.95 Aligned_cols=263 Identities=23% Similarity=0.339 Sum_probs=194.3
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecC-----CeeeEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG-----THRLLA 565 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~-----~~~~lv 565 (817)
+.+.++||+|+||.||+|+. .+|+.||+|++... ......+.+|+.++.+++|+||+++++++... ...++|
T Consensus 7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 86 (336)
T cd07849 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86 (336)
T ss_pred eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence 45568899999999999985 46889999998643 23346788999999999999999999987654 357999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
+||+++ +|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 87 ~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 87 QELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred ehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 999975 787777432 58889999999999999999999 8999999999999999999999999999986543
Q ss_pred CCce--eeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhh---cchh
Q 036583 646 EQSH--VFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEE---GKLR 719 (817)
Q Consensus 646 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~ 719 (817)
.... ......++..|+|||.+.+ ..++.++|||||||+++||++|+.||....... ........+.. ....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQEDLN 235 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHHHH
Confidence 2211 1123467889999998754 568899999999999999999999996432111 00000000000 0000
Q ss_pred hhcccc-----------cCCcc---cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcCC
Q 036583 720 NILDSR-----------LNIDE---QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM--LEGIC 767 (817)
Q Consensus 720 ~~~d~~-----------~~~~~---~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~--L~~~~ 767 (817)
.+.+.. ...+. .......+.+++.+||+.+|++|||+.|+++. ++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 000000 00000 01123467899999999999999999999986 55543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=283.53 Aligned_cols=243 Identities=25% Similarity=0.285 Sum_probs=189.6
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccCCc----CHHHHHHHHHHh-hccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ----GKKEFRAEVSII-GSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~----~~~~~~~Ev~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+.||+|+||.||+|... +++.||+|.+..... ....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 45899999999999864 588999999865321 123345555444 455899999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
++|.+++.... .+++..+..++.||+.||.|||+ .+++|+||+|+||++++++.+||+|||+++.....
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----- 150 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----- 150 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceecccc-----
Confidence 99999997644 57889999999999999999999 89999999999999999999999999998764331
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
....++..|+|||.+.+..++.++||||||++++||++|..||..... ......+..+... ......
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~------~~~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-------DAVFDNILSRRIN------WPEEVK 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcccC------CCCccc
Confidence 234678899999999888889999999999999999999999964321 1111112111110 000111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
......+.+++.+|++.+|++||++.++.+.|.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 123456889999999999999998876666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=298.82 Aligned_cols=265 Identities=22% Similarity=0.325 Sum_probs=195.7
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecC-----CeeeE
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG-----THRLL 564 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~-----~~~~l 564 (817)
+.+.+.||+|+||+||+++. .+++.||||.+... ......+.+|+.++..++|+||+++++++... ...++
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 44557899999999999985 46889999998653 23345778899999999999999999988654 35799
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
|+||+. ++|.+++.... .+++.....++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++...
T Consensus 87 v~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 87 VYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 999996 68988886543 58899999999999999999998 899999999999999999999999999998764
Q ss_pred CCCceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcc--------hHHHHHHhhh
Q 036583 645 REQSHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHF--------PSYAFKMMEE 715 (817)
Q Consensus 645 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~--------~~~~~~~~~~ 715 (817)
... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||........... ..........
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 160 EKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred CCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 332 11223467889999998864 4688999999999999999999999964421100000 0000000000
Q ss_pred cchhhhccccc---CC---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcC
Q 036583 716 GKLRNILDSRL---NI---DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM--LEGI 766 (817)
Q Consensus 716 ~~~~~~~d~~~---~~---~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~--L~~~ 766 (817)
....+.+.... .. .........+.+++.+|++.+|++|||++|+++. ++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 11111000000 00 0001234567899999999999999999999986 6554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=289.26 Aligned_cols=242 Identities=25% Similarity=0.396 Sum_probs=194.3
Q ss_pred cccCCCcceeEEEEEc-CCCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCChh
Q 036583 498 VKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLD 575 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 575 (817)
.+||+|+||.||++.. .+++.||+|++.... ...+.+.+|+.+++.++|+|++++++.+..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5699999999999986 468899999986433 34567899999999999999999999999999999999999999999
Q ss_pred hhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeeecc
Q 036583 576 KWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLR 655 (817)
Q Consensus 576 ~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~ 655 (817)
+++... .+++.....++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++........ ......
T Consensus 106 ~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 177 (292)
T cd06657 106 DIVTHT----RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV 177 (292)
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccc
Confidence 987543 47888999999999999999999 8999999999999999999999999999876543321 123356
Q ss_pred CCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHH
Q 036583 656 GTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRV 735 (817)
Q Consensus 656 gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 735 (817)
++..|+|||.+.+..++.++||||||++++||++|+.||....... ........ ....+.. .....
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~-------~~~~~~~~-----~~~~~~~--~~~~~ 243 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDN-----LPPKLKN--LHKVS 243 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhh-----CCcccCC--cccCC
Confidence 7889999999988888999999999999999999999996432110 11111111 1111111 11123
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 736 FTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 736 ~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..+.+++.+|++.+|.+||++.++++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 35778999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=296.00 Aligned_cols=260 Identities=23% Similarity=0.276 Sum_probs=193.2
Q ss_pred HhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecC------Ce
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG------TH 561 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~------~~ 561 (817)
..+...+.||+|+||.||+++. .+++.||+|++... ....+++.+|+.++++++|+||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 4455668899999999999995 46889999998643 22345678899999999999999999988643 35
Q ss_pred eeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcc
Q 036583 562 RLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK 641 (817)
Q Consensus 562 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 641 (817)
.++||||+.+ +|.+.+.. .++...+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 96 VYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred EEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 7999999965 88877753 26788889999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCC---------CcchHHH---
Q 036583 642 LMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDK---------AHFPSYA--- 709 (817)
Q Consensus 642 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~---------~~~~~~~--- 709 (817)
....... .....++..|+|||.+.+..++.++|||||||++++|++|+.||........ .....+.
T Consensus 167 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 167 TAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred eCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 6543221 2234578899999999999999999999999999999999999964432110 0000000
Q ss_pred ----HHHhhhc------chhhhccccc----CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 710 ----FKMMEEG------KLRNILDSRL----NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 710 ----~~~~~~~------~~~~~~d~~~----~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
....... ...++..... ...........+.+++.+|++.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 0000000000 000011234567899999999999999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=289.01 Aligned_cols=252 Identities=18% Similarity=0.209 Sum_probs=190.5
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCCh
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSL 574 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 574 (817)
+.+|.|+++.||++.. +++.+|||++... ....+.+.+|+++++.++|+||+++++++.+.+..+++|||+++++|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3456666666676666 7899999998654 23456899999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce-----
Q 036583 575 DKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH----- 649 (817)
Q Consensus 575 ~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~----- 649 (817)
.+++...... .+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.+.........
T Consensus 87 ~~~l~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 87 EDLLKTHFPE-GLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 9999764322 57888889999999999999999 89999999999999999999999999988755322110
Q ss_pred -eeeeccCCCCccCcccccc--CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc----
Q 036583 650 -VFTTLRGTRGYLAPEWITN--YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL---- 722 (817)
Q Consensus 650 -~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 722 (817)
......++..|+|||.+.. ..++.++|||||||++|||++|+.||....... ....... +.....+
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~------~~~~~~~-~~~~~~~~~~~ 235 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ------MLLEKVR-GTVPCLLDKST 235 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-ccCccccccCc
Confidence 1122456778999999876 357889999999999999999999996432111 0000000 0000000
Q ss_pred ----------------ccc----cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 723 ----------------DSR----LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 723 ----------------d~~----~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
++. ............+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000 001111223456889999999999999999999997
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=289.61 Aligned_cols=256 Identities=23% Similarity=0.286 Sum_probs=196.8
Q ss_pred cccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 496 FSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+.+.||+|++|.||++... +++.+++|++..... ....+.+|++++++++|+||+++++++..+...++|+||+++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT 82 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence 4567999999999999864 688999999865432 356788999999999999999999999999999999999986
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
+|.+++.... ..+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.+||+|||.+....... ...
T Consensus 83 -~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~ 155 (283)
T cd05118 83 -DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY 155 (283)
T ss_pred -CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence 8888887643 268899999999999999999999 899999999999999999999999999998765543 112
Q ss_pred eeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhc---chhh-------
Q 036583 652 TTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEG---KLRN------- 720 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~------- 720 (817)
....++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+. .......+... ....
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhhhhh
Confidence 234577889999999876 788999999999999999999999965432110 00000000000 0000
Q ss_pred ----hcccccC--CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 721 ----ILDSRLN--IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 721 ----~~d~~~~--~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
....... ..........+.+++..||+.||.+||+++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000000 0001123467889999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=290.51 Aligned_cols=245 Identities=23% Similarity=0.312 Sum_probs=192.4
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+...++||+|+||.||+|+.. +++.+|+|.+.... ...+++.+|+++++.++|+|++++++++......++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 444567999999999999964 57889999986421 2235688999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+. |+|.+++..... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 97 ~~-~~l~~~~~~~~~--~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 97 CL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred cC-CCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 97 588777754332 57889999999999999999998 89999999999999999999999999998765432
Q ss_pred eeeeeccCCCCccCccccc---cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccc
Q 036583 649 HVFTTLRGTRGYLAPEWIT---NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 725 (817)
....++..|+|||.+. ...++.++|||||||++|||++|+.||....... .......+.. +
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~-----~- 232 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNES-----P- 232 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-------HHHHHhhcCC-----C-
Confidence 2345788999999975 3467889999999999999999999985432110 0011111111 0
Q ss_pred cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 726 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
..........+.+++.+||+.+|++||+++++++...
T Consensus 233 --~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 233 --ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred --CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 0011123346789999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=282.08 Aligned_cols=246 Identities=21% Similarity=0.293 Sum_probs=191.8
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccC------CcCHHHHHHHHHHhhccCcceeeeeeeEeecC--CeeeE
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI------GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG--THRLL 564 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~------~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~~l 564 (817)
+.+.+.||+|+||.||++... +++.+|+|.+... .+..+.+.+|++++++++|+||+++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 345678999999999999854 5889999987432 12235788999999999999999999998764 45789
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
++||+++++|.+++.... .+++....+++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||+++...
T Consensus 84 v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 84 FVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 999999999999987543 47888899999999999999998 899999999999999999999999999998654
Q ss_pred CCCc--eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 645 REQS--HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 645 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
.... .......++..|+|||.+.+..++.++|||||||+++||++|+.||...... . .. .+..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~----~~-----~~~~ 222 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------A----AI-----FKIA 222 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------H----HH-----HHHH
Confidence 3111 1112346888999999999888899999999999999999999999643211 0 00 0111
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
........+......+.+++.+|++ +|.+||++.+++.
T Consensus 223 ~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 223 TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111111122233568899999999 5799999998876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=292.03 Aligned_cols=260 Identities=20% Similarity=0.251 Sum_probs=190.1
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCC--------
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT-------- 560 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~-------- 560 (817)
.+.+.++||+|+||.||++... +++.||||++.... .....+.+|++++++++||||+++++++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 3566788999999999999964 58899999885432 22345678999999999999999999987654
Q ss_pred eeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCc
Q 036583 561 HRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLA 640 (817)
Q Consensus 561 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 640 (817)
..++||||+.+ +|.+++..... .+++.....++.||+.||+|||+ .+++|+||||+||+++.++.+||+|||++
T Consensus 93 ~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 93 SFYLVFEFCEH-DLAGLLSNKNV--KFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred eEEEEEcCCCc-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 34999999975 78887765432 57899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCce---eeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHH------
Q 036583 641 KLMTREQSH---VFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAF------ 710 (817)
Q Consensus 641 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~------ 710 (817)
......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||................
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 866432211 11234567889999988764 46889999999999999999999996543211000000000
Q ss_pred --HHhhhcc----------hhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 711 --KMMEEGK----------LRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 711 --~~~~~~~----------~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
....... .......++.. ......+.+++.+|++.||.+|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~---~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKP---YVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhccc---ccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000000 00000000000 001235678999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=289.39 Aligned_cols=249 Identities=23% Similarity=0.379 Sum_probs=191.3
Q ss_pred hccccccCCCcceeEEEEEcCC-CcEEEEEEeccCC--cCHHHHHHHHHHhhccC-cceeeeeeeEeecCCeeeEEEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGIG--QGKKEFRAEVSIIGSIH-HLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
+.+.++||+|+||.||++...+ ++.+|||++.... ....++..|+.++.+.+ |+||+++++++.++...+++|||+
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 96 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM 96 (296)
T ss_pred heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence 4556889999999999999765 8899999997543 23456777887777775 999999999999999999999998
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++ +|.+++..... .+++..+..++.||+.||+|||+ ..+|+||||+|+||++++++.+||+|||++..+......
T Consensus 97 ~~-~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~ 171 (296)
T cd06618 97 ST-CLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK 171 (296)
T ss_pred Cc-CHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc
Confidence 64 77776655332 68899999999999999999996 258999999999999999999999999998765432221
Q ss_pred eeeeccCCCCccCccccccCc----cCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccc
Q 036583 650 VFTTLRGTRGYLAPEWITNYA----ISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 725 (817)
....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... .... .....+....
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~-~~~~~~~~~~----- 238 (296)
T cd06618 172 --TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVL-TKILQEEPPS----- 238 (296)
T ss_pred --cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHH-HHHhcCCCCC-----
Confidence 2245778999999987553 788999999999999999999999642211 0011 1111111000
Q ss_pred cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 726 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.+........+.+++.+||+.||++||++.+++++
T Consensus 239 --~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 --LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111233468899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=294.56 Aligned_cols=262 Identities=20% Similarity=0.318 Sum_probs=195.1
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeec----CCeeeEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAE----GTHRLLA 565 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~----~~~~~lv 565 (817)
+.+.+.||+|+||.||++... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 86 (334)
T cd07855 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV 86 (334)
T ss_pred eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEE
Confidence 445578999999999999854 58999999986532 335678889999999999999999998853 3568999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|||+. ++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++.....
T Consensus 87 ~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 87 MDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred Eehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 99996 58988886543 48899999999999999999999 8999999999999999999999999999976543
Q ss_pred CCce---eeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCC--------cchHHHHHHh
Q 036583 646 EQSH---VFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA--------HFPSYAFKMM 713 (817)
Q Consensus 646 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~--------~~~~~~~~~~ 713 (817)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ..+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 2211 1123568889999999865 46789999999999999999999999654321100 0000001111
Q ss_pred hhcchhhhccccc-CCccc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 714 EEGKLRNILDSRL-NIDEQ-----SDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 714 ~~~~~~~~~d~~~-~~~~~-----~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
....+.+..+... ..... ......+.+++.+|++.+|++||+++++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1111111111000 00000 1234578899999999999999999999883
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=283.74 Aligned_cols=240 Identities=24% Similarity=0.325 Sum_probs=186.6
Q ss_pred ccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHH---hhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 499 KLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSI---IGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~---l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.||+|+||.||++... .++.||+|.+.... .....+..|..+ +...+||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999864 58899999986532 122234455443 444579999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+++|.+++.... .+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||++........
T Consensus 81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-- 152 (278)
T cd05606 81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (278)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence 999999886543 68999999999999999999999 8999999999999999999999999999876543221
Q ss_pred eeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 651 FTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
....|+..|+|||.+.+. .++.++||||+|++++||++|+.||......... ........ ....
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~------~~~~---- 217 (278)
T cd05606 153 -HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLT------MAVE---- 217 (278)
T ss_pred -cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH----HHHHHhhc------cCCC----
Confidence 234688999999999754 6889999999999999999999999754322110 00000000 0111
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRP-----SMTKVVQ 761 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~evl~ 761 (817)
........+.+++..|++.+|.+|| ++.|+++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1111234688999999999999999 9999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-33 Score=320.26 Aligned_cols=243 Identities=28% Similarity=0.414 Sum_probs=195.9
Q ss_pred cccCCCcceeEEEEE-cCCCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCC
Q 036583 498 VKLGQGGFGSVYQGV-LPDGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGS 573 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~-~~~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 573 (817)
.+||.|.||.||-+. .++|...|||.+.-. ....+...+|+.++..++|||+|+++|+-.+.+..+|.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 679999999999998 556888999987543 2345678899999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce---e
Q 036583 574 LDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH---V 650 (817)
Q Consensus 574 L~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~---~ 650 (817)
|.+.+...+ .+++.....+..|++.|++|||+ .+||||||||.||+|+.+|.+|++|||.|..+...... .
T Consensus 1321 La~ll~~gr---i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1321 LASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred HHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 999997665 46677777889999999999999 99999999999999999999999999999987654211 1
Q ss_pred eeeccCCCCccCccccccC---ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHH-HHHhhhcchhhhccccc
Q 036583 651 FTTLRGTRGYLAPEWITNY---AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYA-FKMMEEGKLRNILDSRL 726 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~---~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~d~~~ 726 (817)
.....||+.|||||++.+. ....++||||+|||++||+||++|+...+.. |+ .-++.-|...++
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V~~gh~Pq~----- 1462 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHVAAGHKPQI----- 1462 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHHhccCCCCC-----
Confidence 2346799999999999754 3456899999999999999999999643221 11 111222222111
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
+.....+-.+++.+|++.||++|-++.|+++.
T Consensus 1463 ----P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1463 ----PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ----chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 22244566799999999999999998877764
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=280.26 Aligned_cols=245 Identities=26% Similarity=0.387 Sum_probs=199.4
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
+.+.++||+|++|.||+++.. +++.+++|.+..... ..+.+.+|++++.+++|+|++++++++.++...+++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 345678999999999999864 578999999976542 4567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++++|.+++.... .+++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.+||+|||++.........
T Consensus 82 ~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 82 ENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999987653 68999999999999999999998 89999999999999999999999999999876543321
Q ss_pred eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
.....++..|+|||...+..++.++||||+|++++||++|+.||...... ...+.. ..... + .
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~~~~~~-~~~~~-----~----~ 218 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM------AALFRI-VQDDH-----P----P 218 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHH-hccCC-----C----C
Confidence 22356788999999998888889999999999999999999999643210 001111 11110 0 1
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
........+.+++.+|++.+|++||++.|++.
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11122346789999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=287.98 Aligned_cols=258 Identities=22% Similarity=0.312 Sum_probs=191.3
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
+.+.++||+|++|+||+|... +++.+|+|++.... ...+.+.+|++++++++||||+++++++.++...++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 445678999999999999965 68899999986432 23467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC-CCcEEEeecCCccccCCCCc
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD-NYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~Dfgla~~~~~~~~ 648 (817)
++ +|.+++..... ..+++.....++.||+.||+|||+ .+++|+||+|+||+++. ++.+||+|||++........
T Consensus 84 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 84 DL-DLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred cc-cHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 64 78887754332 235778888999999999999998 89999999999999985 56799999999976543211
Q ss_pred eeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc-----
Q 036583 649 HVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL----- 722 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 722 (817)
......+++.|+|||++.+ ..++.++||||||+++|||++|+.||......+. + .......... .....
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~-~~~~~~~~~~-~~~~~~~~~~ 233 (294)
T PLN00009 159 -TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--L-FKIFRILGTP-NEETWPGVTS 233 (294)
T ss_pred -ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHHhCCC-Chhhcccccc
Confidence 1123456789999999876 4578899999999999999999999965432110 0 0000000000 00000
Q ss_pred --c-----cccCCc----ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 723 --D-----SRLNID----EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 723 --d-----~~~~~~----~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+ +..... ........+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000000 00112345789999999999999999999997
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=292.51 Aligned_cols=260 Identities=20% Similarity=0.253 Sum_probs=192.1
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecC--CeeeEEE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG--THRLLAY 566 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 566 (817)
.+.+.++||+|+||.||+|... +|+.||+|++.... .....+.+|+.++.+++|+||+++++++... +..++||
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 3455678999999999999964 58999999986432 1234567899999999999999999998754 4689999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
||+.+ +|.+++.... ..+++..+..++.||+.||+|||+ .+++||||||+||++++++.+||+|||++......
T Consensus 88 e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 88 EYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred ecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 99975 8888886543 258899999999999999999999 89999999999999999999999999999876543
Q ss_pred CceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHH-----------hh
Q 036583 647 QSHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKM-----------ME 714 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~-----------~~ 714 (817)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ....... ..
T Consensus 162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 162 AK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCChhhchhhh
Confidence 21 1122345778999999875 4678999999999999999999999964432110 0000000 00
Q ss_pred hcch-h--hhcccccCCc--ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 715 EGKL-R--NILDSRLNID--EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 715 ~~~~-~--~~~d~~~~~~--~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.... . .+........ ........+.+++.+|++.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 0 0000000000 000123456789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=295.42 Aligned_cols=263 Identities=22% Similarity=0.321 Sum_probs=193.8
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC---CcCHHHHHHHHHHhhcc-CcceeeeeeeEeecC--CeeeE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI---GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEG--THRLL 564 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~--~~~~l 564 (817)
..+.+.+.||+|+||.||+|... +++.+|+|++... ......+.+|+.++.++ +||||+++++++... ...++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 34556678999999999999965 5789999988542 23345678899999999 999999999998653 46899
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
||||++ ++|.+++... .+++..+..++.||+.||+|||+ .+|+|+||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 87 VFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred Eecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 999997 4898888653 57888999999999999999998 899999999999999999999999999998764
Q ss_pred CCCce----eeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCC--------cchHHHHH
Q 036583 645 REQSH----VFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA--------HFPSYAFK 711 (817)
Q Consensus 645 ~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~--------~~~~~~~~ 711 (817)
..... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 43221 2223567889999998865 46788999999999999999999999643221100 00000000
Q ss_pred Hhhhcchhhhcc----cccC--CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 712 MMEEGKLRNILD----SRLN--IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 712 ~~~~~~~~~~~d----~~~~--~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.+.......+++ .... ..........+.+++.+||+.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000011111 0000 00000124568899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=279.84 Aligned_cols=247 Identities=26% Similarity=0.395 Sum_probs=201.1
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.+.+.||.|+||.||++... +++.+++|++.... ...+++.+|+++++.++|+|++++++.+..+...++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~ 82 (258)
T cd08215 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD 82 (258)
T ss_pred eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence 44577999999999999965 58899999987543 345678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcc-cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 571 NGSLDKWIFKKN-QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 571 ~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
+++|.+++.... ....+++..+..++.+++.||+|||+ .+++|+||+|+||++++++.++|+|||++....... .
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~ 158 (258)
T cd08215 83 GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-D 158 (258)
T ss_pred CCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc-c
Confidence 999999997642 12368999999999999999999999 899999999999999999999999999998765443 1
Q ss_pred eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
......+++.|+|||.+.+..++.++||||+|+++++|++|+.||..... .. ............+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~-~~~~~~~~~~~~~-------- 223 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LE-LALKILKGQYPPI-------- 223 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HH-HHHHHhcCCCCCC--------
Confidence 22335678899999999988899999999999999999999999964321 11 1111111111111
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.......+.+++.+|++.+|++|||+.|+++
T Consensus 224 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 -PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1123346789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=285.63 Aligned_cols=261 Identities=24% Similarity=0.313 Sum_probs=194.7
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc--CHHHHHHHHHHhhccC-cceeeeeeeEeecCCeeeEEEeecc
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIH-HLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.+.++||+|+||+||+|+.. .++.|++|++..... ......+|+..+.+++ |+|++++++++.+++..++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 35678999999999999975 478899999865433 2334567999999999 999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+|+|.+++.... ...+++..+..++.|++.+|.|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 789999887654 2258999999999999999999998 8999999999999999999999999999986643221
Q ss_pred eeeccCCCCccCccccc-cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCC----------cchHHHHHHhhhcchh
Q 036583 651 FTTLRGTRGYLAPEWIT-NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA----------HFPSYAFKMMEEGKLR 719 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~----------~~~~~~~~~~~~~~~~ 719 (817)
.....++..|+|||.+. ...++.++||||||++++||++|+.||......+.. .-..|...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 12345788999999885 456789999999999999999999999654321100 0000000000000000
Q ss_pred hhcccccCCcc---cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 720 NILDSRLNIDE---QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 720 ~~~d~~~~~~~---~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
..+........ .......+.+++.+|++.+|++|||++|++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000000 00113568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=286.21 Aligned_cols=248 Identities=21% Similarity=0.280 Sum_probs=193.1
Q ss_pred ccccccCCCcceeEEEEEc----CCCcEEEEEEeccCC-----cCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeE
Q 036583 495 NFSVKLGQGGFGSVYQGVL----PDGTRLAVKKLEGIG-----QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLL 564 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~----~~g~~vavK~l~~~~-----~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~l 564 (817)
.+.++||+|+||.||+++. .+|+.+|+|++.... ...+.+.+|++++.++ +|+||+++++.+..+...++
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 4557899999999999985 468899999986431 2346788999999999 59999999999999999999
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
||||+++++|.+++.... .+++.....++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++....
T Consensus 83 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 83 ILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 999999999999997653 57888889999999999999998 999999999999999999999999999998764
Q ss_pred CCCceeeeeccCCCCccCccccccC--ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 645 REQSHVFTTLRGTRGYLAPEWITNY--AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 645 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
...........|+..|+|||.+.+. .++.++||||||+++|||++|+.||....... ..... .......
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~-~~~~~~~------ 227 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEI-SRRILKS------ 227 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHH-HHHhhcc------
Confidence 4332222335688899999998753 46789999999999999999999996432211 11111 1111000
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRP-----SMTKVVQ 761 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~evl~ 761 (817)
.. +.+......+.+++..|++.||++|| ++.+++.
T Consensus 228 --~~--~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 --EP--PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --CC--CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 00 11112234677999999999999997 5666655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=265.03 Aligned_cols=245 Identities=23% Similarity=0.369 Sum_probs=193.3
Q ss_pred ccccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHHhhccC-cceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 497 SVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIH-HLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
...||.|..|.|++.+.+ .|..+|||.+.... +..+.++..+.++.+-+ .|+||+.+|+|..+....+.||.|..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 456999999999999965 58899999997653 34567888888877775 99999999999999999999999965
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeee
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT 652 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 652 (817)
.++.+|.+... ++++..+-++...+++||.||.+ .++|+|||+||+|||+|+.|++|++|||++-.+-.... .+
T Consensus 176 C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA--ht 249 (391)
T KOG0983|consen 176 CAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA--HT 249 (391)
T ss_pred HHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccc--cc
Confidence 45555544332 68888888999999999999998 58999999999999999999999999999987654332 24
Q ss_pred eccCCCCccCcccccc---CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 653 TLRGTRGYLAPEWITN---YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 653 ~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
...|-+.|||||.+.- ..|+.++||||||+.|+||.||+.||.....+= .+...+.+.. .+.+.
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF------e~ltkvln~e-----PP~L~-- 316 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF------EVLTKVLNEE-----PPLLP-- 316 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH------HHHHHHHhcC-----CCCCC--
Confidence 4678899999999963 468889999999999999999999997643321 1122222211 12222
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
........+.+++..|++.|+.+||...++++
T Consensus 317 ~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 317 GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred cccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 12224557889999999999999999999887
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=270.60 Aligned_cols=202 Identities=24% Similarity=0.377 Sum_probs=169.1
Q ss_pred hccccccCCCcceeEEEEEcC---C--CcEEEEEEeccCCcC---HHHHHHHHHHhhccCcceeeeeeeEeec-CCeeeE
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP---D--GTRLAVKKLEGIGQG---KKEFRAEVSIIGSIHHLHLVKLRGFCAE-GTHRLL 564 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~---~--g~~vavK~l~~~~~~---~~~~~~Ev~~l~~l~h~niv~l~~~~~~-~~~~~l 564 (817)
++...+||+|.||.|||+.-. + ...+|+|+++...++ .....+|+.+++.++||||+.|..++.. +...+|
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l 105 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL 105 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence 455678999999999999632 2 237899999765332 3567889999999999999999999977 778899
Q ss_pred EEeeccCCChhhhhhhcc--cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCC----CcEEEeecC
Q 036583 565 AYEFMANGSLDKWIFKKN--QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDN----YHAKVSDFG 638 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~ki~Dfg 638 (817)
++||.+. +|..+++.++ ....++......|+.||+.|+.|||+ .-|+||||||.|||+..+ |.+||+|||
T Consensus 106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999988 8888886432 23478889999999999999999999 899999999999999866 999999999
Q ss_pred CccccCCCCcee--eeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCC
Q 036583 639 LAKLMTREQSHV--FTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNET 699 (817)
Q Consensus 639 la~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~ 699 (817)
+++.+...-... ....+.|..|.|||.+.+. .|+++.||||.|||+.||++-++.|...+.
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~ 245 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE 245 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence 999886543322 2336778999999999864 789999999999999999999999976553
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=279.07 Aligned_cols=234 Identities=21% Similarity=0.286 Sum_probs=182.2
Q ss_pred cCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEeeccCCChhhh
Q 036583 500 LGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKW 577 (817)
Q Consensus 500 lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 577 (817)
||+|+||.||++.. .+++.+|+|.+....... .|+.....+ +|||++++++.+...+..++||||+++++|.++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~ 99 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL 99 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence 59999999999985 457889999886532111 122222222 799999999999999999999999999999999
Q ss_pred hhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC-cEEEeecCCccccCCCCceeeeeccC
Q 036583 578 IFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY-HAKVSDFGLAKLMTREQSHVFTTLRG 656 (817)
Q Consensus 578 l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Dfgla~~~~~~~~~~~~~~~g 656 (817)
+.... .+++..+..++.||++||.|||+ .+++||||||+||+++.++ .++|+|||++....... ...+
T Consensus 100 l~~~~---~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-----~~~~ 168 (267)
T PHA03390 100 LKKEG---KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-----CYDG 168 (267)
T ss_pred HHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-----cCCC
Confidence 97654 68999999999999999999999 8999999999999999988 99999999987654322 2467
Q ss_pred CCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHH
Q 036583 657 TRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVF 736 (817)
Q Consensus 657 t~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 736 (817)
+..|+|||++.+..++.++||||||++++||++|+.||....... .....+. . ...... ........
T Consensus 169 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~-----~-----~~~~~~--~~~~~~~~ 235 (267)
T PHA03390 169 TLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLL-----K-----RQQKKL--PFIKNVSK 235 (267)
T ss_pred CCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHH-----H-----hhcccC--CcccccCH
Confidence 889999999998899999999999999999999999997432211 0111110 0 001111 11112344
Q ss_pred HHHHHHHhccccCCCCCCC-HHHHHH
Q 036583 737 TAVKVALWCVQEDMSLRPS-MTKVVQ 761 (817)
Q Consensus 737 ~~~~l~~~cl~~dp~~RPt-~~evl~ 761 (817)
.+.+++..|++.+|.+||+ ++|+++
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 236 NANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHHHhccChhhCCchHHHHhc
Confidence 6889999999999999996 688875
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=293.44 Aligned_cols=249 Identities=21% Similarity=0.315 Sum_probs=197.5
Q ss_pred hhccccccCCCcceeEEEEEcCCCc-EEEEEEeccC-CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPDGT-RLAVKKLEGI-GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~g~-~vavK~l~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
..++.-+||.|+||.|||+..++.. ..|.|.+... ....++|+-|++||....||+||+|++.|...+.++++.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 3455667999999999999976533 4566777543 3456889999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
||-.+.++..-.. .|...++.-+++|++.||.|||+ .+|||||||+.|||++-+|.++|+|||.+-..... ...
T Consensus 113 GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qk 186 (1187)
T KOG0579|consen 113 GGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQK 186 (1187)
T ss_pred CchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhH-Hhh
Confidence 9999988866543 69999999999999999999999 99999999999999999999999999987643322 122
Q ss_pred eeeccCCCCccCccccc-----cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccc
Q 036583 651 FTTLRGTRGYLAPEWIT-----NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 725 (817)
.....|||.|||||+.. ..+|+.++||||||+.|.||..+.+|...-.+ ..+...+..... |.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-------MRVllKiaKSeP-----PT 254 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEP-----PT 254 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-------HHHHHHHhhcCC-----Cc
Confidence 34578999999999875 46899999999999999999999988743221 111112211111 11
Q ss_pred cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 726 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+..+ ..-...+.+++.+|+..||..||+++++++
T Consensus 255 LlqP--S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 255 LLQP--SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ccCc--chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1111 123446779999999999999999999987
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=281.96 Aligned_cols=257 Identities=23% Similarity=0.325 Sum_probs=192.3
Q ss_pred ccccccCCCcceeEEEEEcCC-CcEEEEEEeccCCc---CHHHHHHHHHHhhcc---CcceeeeeeeEeecCCe-----e
Q 036583 495 NFSVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQ---GKKEFRAEVSIIGSI---HHLHLVKLRGFCAEGTH-----R 562 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l---~h~niv~l~~~~~~~~~-----~ 562 (817)
.+.++||+|+||.||+|+... ++.+|+|++..... ....+.+|+.++.++ +|+|++++++++...+. .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 355789999999999999764 89999999964322 234677788877666 59999999999988776 8
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
+++|||+.+ +|.+++..... ..+++..++.++.|+++||+|||+ .+++|+||+|+||+++.++.+||+|||++..
T Consensus 82 ~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 82 TLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred EEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 999999975 89888865432 258899999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhh-cch---
Q 036583 643 MTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEE-GKL--- 718 (817)
Q Consensus 643 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~--- 718 (817)
...... .....++..|+|||.+.+..++.++||||||++++||++|+.||......+ .+.. ....... +..
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~ 231 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDK-IFDVIGLPSEEEWP 231 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHH-HHHHcCCCChHhcC
Confidence 643321 123457889999999998889999999999999999999999997543211 0000 0000000 000
Q ss_pred ------hhhcccccCCcc---cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 719 ------RNILDSRLNIDE---QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 719 ------~~~~d~~~~~~~---~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
............ .......+.+++.+||+.||++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000000 1122356789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=286.35 Aligned_cols=240 Identities=24% Similarity=0.372 Sum_probs=189.4
Q ss_pred ccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc----CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 497 SVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ----GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~----~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
.++||+|+||+||+|+.. +++.+++|++..... ..+.+.+|++++++++|||++++++++.+....++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 367999999999999854 588999999864321 23568899999999999999999999999999999999996
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
|+|.+++..... .+++..+..++.||+.||+|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 105 ~~l~~~l~~~~~--~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~----- 174 (313)
T cd06633 105 GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----- 174 (313)
T ss_pred CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC-----
Confidence 577777755432 58899999999999999999998 89999999999999999999999999998653221
Q ss_pred eeccCCCCccCccccc---cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 652 TTLRGTRGYLAPEWIT---NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
....++..|+|||.+. ...++.++|||||||++|||++|+.||....... ..... ........
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~~~-~~~~~~~~------- 240 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHI-AQNDSPTL------- 240 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHH-HhcCCCCC-------
Confidence 2356788999999984 4567889999999999999999999986432211 11111 11111111
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
........+.+++.+|++.+|.+||++.++++.
T Consensus 241 -~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 -QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122357889999999999999999999973
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=284.68 Aligned_cols=245 Identities=25% Similarity=0.381 Sum_probs=198.4
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccC-cceeeeeeeEeecCCeeeEEEe
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIH-HLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 567 (817)
+.+.+.||+|+||.||++... +++.+|+|.+... ....+.+.+|++++.+++ |+||+++++++..++..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 345678999999999999965 6899999998653 223467889999999998 9999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+++++|.+++.+.. .+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 83 YAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 999999999997654 58999999999999999999998 899999999999999999999999999998765432
Q ss_pred c-------------------eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHH
Q 036583 648 S-------------------HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSY 708 (817)
Q Consensus 648 ~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~ 708 (817)
. .......++..|+|||.+....++.++||||||++++|+++|+.||...... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~ 229 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-------L 229 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-------H
Confidence 1 1122345788999999998888999999999999999999999999644310 0
Q ss_pred HHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCH----HHHHH
Q 036583 709 AFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSM----TKVVQ 761 (817)
Q Consensus 709 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~----~evl~ 761 (817)
..... ..... .........+.+++.+||+.+|++||++ +++++
T Consensus 230 ~~~~~--------~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 TFQKI--------LKLEY--SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHH--------HhcCC--CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 01111 11111 1111224468899999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=288.85 Aligned_cols=258 Identities=23% Similarity=0.345 Sum_probs=189.8
Q ss_pred cccccCCCcceeEEEEEc-CCCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecCC------eeeEE
Q 036583 496 FSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT------HRLLA 565 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~------~~~lv 565 (817)
+.+.||+|+||.||+|+. .+++.||||++... ......+.+|+.++++++||||+++++++.... +.++|
T Consensus 19 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 98 (342)
T cd07879 19 SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98 (342)
T ss_pred EEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEE
Confidence 347899999999999995 46899999998643 223456889999999999999999999986543 46899
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
+||+.. +|..++. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++....
T Consensus 99 ~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 99 MPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred eccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 999975 6766542 147888999999999999999999 8999999999999999999999999999886533
Q ss_pred CCceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHH----------HHHHhh
Q 036583 646 EQSHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSY----------AFKMME 714 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~----------~~~~~~ 714 (817)
.. ....++..|+|||.+.+ ..++.++|||||||+++||++|+.||........ +... ......
T Consensus 170 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 170 EM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHHHHHhc
Confidence 21 22456788999999876 4688999999999999999999999975432110 0000 000000
Q ss_pred hcchhhhcccccCCc-cc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcCCC
Q 036583 715 EGKLRNILDSRLNID-EQ-----SDRVFTAVKVALWCVQEDMSLRPSMTKVVQM--LEGICP 768 (817)
Q Consensus 715 ~~~~~~~~d~~~~~~-~~-----~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~--L~~~~~ 768 (817)
............... .. ......+.+++.+|++.||++||+++|+++. ++...+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000000000000000 00 0123457899999999999999999999964 666644
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=280.67 Aligned_cols=247 Identities=23% Similarity=0.334 Sum_probs=191.9
Q ss_pred hccccccCCCcceeEEEEEcCC-CcEEEEEEeccC------CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGI------GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~------~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
+.+.++||+|+||.||+++... +..+++|.++.. .....++..|+.++++++||||+++++++.+....++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 4566889999999999998643 444566655432 123346778999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhc-ccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 567 EFMANGSLDKWIFKK-NQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 567 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
||+++++|.+++... .....+++..++.++.|++.||.|||+ .+++|+||+|+||++++ +.+||+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999999988652 122368999999999999999999998 99999999999999986 5699999999887643
Q ss_pred CCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccc
Q 036583 646 EQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 725 (817)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... .... .....+. .
T Consensus 158 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~-~~~~~~~-----~-- 222 (260)
T cd08222 158 SCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVV-LRIVEGP-----T-- 222 (260)
T ss_pred Ccc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHH-HHHHcCC-----C--
Confidence 322 12235678899999999888889999999999999999999999953221 1111 1111111 0
Q ss_pred cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 726 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..........+.+++.+|++.+|++||++.|+++
T Consensus 223 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 --PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1112233457889999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=292.69 Aligned_cols=256 Identities=23% Similarity=0.270 Sum_probs=191.4
Q ss_pred ccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcC---------------HHHHHHHHHHhhccCcceeeeeeeEeecCC
Q 036583 497 SVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQG---------------KKEFRAEVSIIGSIHHLHLVKLRGFCAEGT 560 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~---------------~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~ 560 (817)
.+.||+|+||+||++... .++.||||++...... ...+.+|++++.+++|+||+++++++..++
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 356999999999999954 6889999998643211 125789999999999999999999999999
Q ss_pred eeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCc
Q 036583 561 HRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLA 640 (817)
Q Consensus 561 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 640 (817)
..++||||++ ++|.+++.... .+++.....++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccce
Confidence 9999999997 58999886543 58889999999999999999998 89999999999999999999999999999
Q ss_pred cccCCCC-------------ceeeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcch
Q 036583 641 KLMTREQ-------------SHVFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFP 706 (817)
Q Consensus 641 ~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~ 706 (817)
....... ........++..|+|||.+.+. .++.++||||||++++||++|+.||......+ ..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~---~~ 243 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID---QL 243 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HH
Confidence 8664111 1111223467789999998764 46889999999999999999999996543211 00
Q ss_pred HHHHHHhhhcchhhhcc--------cc-cCCcc-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 707 SYAFKMMEEGKLRNILD--------SR-LNIDE-----QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 707 ~~~~~~~~~~~~~~~~d--------~~-~~~~~-----~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
..............+.+ +. ...+. .......+.+++..|++.+|++||+++|++..
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 11111111000000000 00 00000 00123467899999999999999999999973
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=294.24 Aligned_cols=267 Identities=23% Similarity=0.332 Sum_probs=200.7
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCC-----eeeE
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT-----HRLL 564 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~-----~~~l 564 (817)
+.+.++||+|+||.||+++.. .++.+|+|++.... ...+.+.+|+++++.++|+||+++++++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 445678999999999999965 48899999987542 34568999999999999999999999998775 7899
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
+|||+++ +|.+++.... .+++..+..++.||+.||+|||+ .+|+|+||||+||+++.++.++|+|||++....
T Consensus 82 v~e~~~~-~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 82 VTELMET-DLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred Eecchhh-hHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999985 8888886543 68899999999999999999999 899999999999999999999999999998765
Q ss_pred CCCc--eeeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCc--------chHHHHHHh
Q 036583 645 REQS--HVFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAH--------FPSYAFKMM 713 (817)
Q Consensus 645 ~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~--------~~~~~~~~~ 713 (817)
.... .......++..|+|||.+.+. .++.++||||||+++++|++|+.||.......... .....+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 4321 112334678899999999887 78999999999999999999999996543211000 000000000
Q ss_pred hhcchhhhccc-ccCCcc-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcCC
Q 036583 714 EEGKLRNILDS-RLNIDE-----QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM--LEGIC 767 (817)
Q Consensus 714 ~~~~~~~~~d~-~~~~~~-----~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~--L~~~~ 767 (817)
......+.+.. ...... .......+.+++.+||+.+|++||+++++++. +++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 00000000000 000000 01124567899999999999999999999984 55543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=280.89 Aligned_cols=242 Identities=26% Similarity=0.427 Sum_probs=195.2
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCC
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGS 573 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 573 (817)
+.||+|-||+||-|+++ .|+.||||++.+. ..+...+++|+.||..++||.||.+...|+..+..++|||-+.| +
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-D 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-D 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-h
Confidence 67999999999999964 6999999999764 35567899999999999999999999999999999999999955 6
Q ss_pred hhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC---CCcEEEeecCCccccCCCCcee
Q 036583 574 LDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD---NYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 574 L~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+.+.+.....+ .|+.....-++.||+.||.|||. ++|+|+||||+|||+.. --++||+|||.|+.++.....
T Consensus 649 MLEMILSsEkg-RL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR- 723 (888)
T KOG4236|consen 649 MLEMILSSEKG-RLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR- 723 (888)
T ss_pred HHHHHHHhhcc-cchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhhh-
Confidence 65655443332 68888888899999999999999 99999999999999964 357999999999998765432
Q ss_pred eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 651 FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
...+||+.|+|||+++...|...-|+||.|||+|--++|..||...++..+ .+.+. .++ ....+
T Consensus 724 -rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd---------QIQNA---aFM---yPp~P 787 (888)
T KOG4236|consen 724 -RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND---------QIQNA---AFM---YPPNP 787 (888)
T ss_pred -hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH---------Hhhcc---ccc---cCCCc
Confidence 457899999999999999999999999999999999999999965443211 00010 011 11112
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
-.+....++++|...+|..-++|.|..+.+.
T Consensus 788 W~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 788 WSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred hhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 2234456788888999999999998876653
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=286.92 Aligned_cols=262 Identities=24% Similarity=0.319 Sum_probs=193.0
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCC------ee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT------HR 562 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~------~~ 562 (817)
++.+.+.||+|+||.||++.. .+++.||||++.... ...+.+.+|++++++++||||+++++++.... ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF 95 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence 345567899999999999984 468999999986432 22456889999999999999999999987553 45
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
++||||+ +++|.+++... .+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||++..
T Consensus 96 ~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 96 YLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred EEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 8999998 67898887542 48889999999999999999998 8999999999999999999999999999986
Q ss_pred cCCCCceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCC--------CcchHHHHHHh
Q 036583 643 MTREQSHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDK--------AHFPSYAFKMM 713 (817)
Q Consensus 643 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~--------~~~~~~~~~~~ 713 (817)
..... ....+++.|+|||.+.+ ..++.++||||||+++++|++|+.||........ ...+......+
T Consensus 168 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 168 TDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred cccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 54321 23457889999999876 4578899999999999999999999974432100 00000000111
Q ss_pred hhcchhhhccc--ccCCc----ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcC
Q 036583 714 EEGKLRNILDS--RLNID----EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ--MLEGI 766 (817)
Q Consensus 714 ~~~~~~~~~d~--~~~~~----~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~--~L~~~ 766 (817)
........... ..... ........+.+++.+|++.||++|||+.++++ .++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 11101111000 00000 00112335789999999999999999999994 44444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=279.95 Aligned_cols=259 Identities=24% Similarity=0.293 Sum_probs=195.5
Q ss_pred cccccCCCcceeEEEEEcC-CCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 496 FSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+.++||+|+||.||+|+.. +++.+|+|.+... ....+.+..|+.++++++|+|++++++++.+....++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 3467999999999999975 4899999999764 2234678899999999999999999999999999999999998
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
++|.+++.+... .+++..+..++.|++.||+|||+ .+|+|+||+|+||++++++.+||+|||++........ ..
T Consensus 82 ~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (282)
T cd07829 82 MDLKKYLDKRPG--PLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY 155 (282)
T ss_pred cCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence 489999976532 58899999999999999999999 8999999999999999999999999999987644322 12
Q ss_pred eeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCc--------chHHHHHHhhhcc-hhhh
Q 036583 652 TTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAH--------FPSYAFKMMEEGK-LRNI 721 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~--------~~~~~~~~~~~~~-~~~~ 721 (817)
....++..|+|||.+.+. .++.++||||||++++||++|+.||.......... .....+.....-. ....
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 234456789999998766 78899999999999999999999996543211000 0000000000000 0000
Q ss_pred cccccCCcc---cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 722 LDSRLNIDE---QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 722 ~d~~~~~~~---~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
......... .......+.+++..|++.+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000 0011346899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=274.70 Aligned_cols=235 Identities=29% Similarity=0.343 Sum_probs=191.9
Q ss_pred cCCCcceeEEEEEcC-CCcEEEEEEeccCCc----CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCCh
Q 036583 500 LGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ----GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSL 574 (817)
Q Consensus 500 lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~----~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 574 (817)
||+|+||.||++... +++.+|+|.+..... ..+.+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 488999999865422 345889999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeeec
Q 036583 575 DKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTL 654 (817)
Q Consensus 575 ~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~ 654 (817)
.+++.... .+++.....++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTF 153 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCC
Confidence 99997654 58899999999999999999999 9999999999999999999999999999987644321 12335
Q ss_pred cCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHH
Q 036583 655 RGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDR 734 (817)
Q Consensus 655 ~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 734 (817)
.++..|+|||...+...+.++|+||||+++||+++|+.||..... ......... .... .+...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~--------~~~~--~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KEIYEKILK--------DPLR--FPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhc--------CCCC--CCCCC
Confidence 678899999999888889999999999999999999999954321 011111111 1111 11112
Q ss_pred HHHHHHHHHhccccCCCCCCCHHH
Q 036583 735 VFTAVKVALWCVQEDMSLRPSMTK 758 (817)
Q Consensus 735 ~~~~~~l~~~cl~~dp~~RPt~~e 758 (817)
...+.+++.+|++.||++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 446789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=285.39 Aligned_cols=260 Identities=23% Similarity=0.278 Sum_probs=189.4
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCC--------
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT-------- 560 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~-------- 560 (817)
.+.+.++||+|+||.||+|... +++.+|+|++.... .....+.+|++++++++||||+++++++.+..
T Consensus 9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 88 (311)
T cd07866 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG 88 (311)
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence 3455678999999999999964 58899999986432 22356789999999999999999999875433
Q ss_pred eeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCc
Q 036583 561 HRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLA 640 (817)
Q Consensus 561 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 640 (817)
..++|+||+.+ +|...+..... .+++..+..++.||++||+|||+ .+|+|+||||+||++++++.+||+|||++
T Consensus 89 ~~~lv~~~~~~-~l~~~~~~~~~--~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 89 SVYMVTPYMDH-DLSGLLENPSV--KLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred eEEEEEecCCc-CHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 46999999976 67776654332 58999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCce----------eeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHH
Q 036583 641 KLMTREQSH----------VFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYA 709 (817)
Q Consensus 641 ~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~ 709 (817)
+........ ......+++.|+|||.+.+ ..++.++||||||++++||++|+.||........ ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~---~~~~ 239 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ---LHLI 239 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH
Confidence 865432211 1122456788999998865 4578999999999999999999999964432110 0000
Q ss_pred HHHhhh---------cchhhhc----ccccCCcc---cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 710 FKMMEE---------GKLRNIL----DSRLNIDE---QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 710 ~~~~~~---------~~~~~~~----d~~~~~~~---~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
...... ..+.... ........ .......+.+++.+|++.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000 0000000 00000000 0011246789999999999999999999876
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-32 Score=274.30 Aligned_cols=273 Identities=22% Similarity=0.333 Sum_probs=212.9
Q ss_pred CCcccCHHHHHHHhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhccC-c-c----eeeee
Q 036583 480 MPVRFTYRDLQTATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH-H-L----HLVKL 552 (817)
Q Consensus 480 ~~~~~~~~~l~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~-h-~----niv~l 552 (817)
+...+...|....++.+..++|+|.||.|-+.... .+..||||+++......+..+-|++++.++. + | -+|.+
T Consensus 77 GH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 77 GHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred ceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 33456667777788888899999999999999854 3789999999987777888899999999993 2 2 48889
Q ss_pred eeEeecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC----
Q 036583 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD---- 628 (817)
Q Consensus 553 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~---- 628 (817)
.++|.-.++.|+|+|.|. -|+.++|...+. .+++......|+.|++++++|||+ .+++|.||||+|||+.+
T Consensus 157 ~~wFdyrghiCivfellG-~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 157 RDWFDYRGHICIVFELLG-LSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred ehhhhccCceEEEEeccC-hhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceE
Confidence 999999999999999983 389999976543 378889999999999999999999 99999999999999831
Q ss_pred ----------------CCcEEEeecCCccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCC
Q 036583 629 ----------------NYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRK 692 (817)
Q Consensus 629 ----------------~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~ 692 (817)
+..+||+|||.|....... ...+.|..|.|||++.+..++.++||||+||||+|+.+|..
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~ 307 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET 307 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence 3458999999998754443 45678999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCC--------cchHHHHHHh------hhcch-----------hhhcccccC----CcccHHHHHHHHHHHH
Q 036583 693 NFDPNETSDKA--------HFPSYAFKMM------EEGKL-----------RNILDSRLN----IDEQSDRVFTAVKVAL 743 (817)
Q Consensus 693 pf~~~~~~~~~--------~~~~~~~~~~------~~~~~-----------~~~~d~~~~----~~~~~~~~~~~~~l~~ 743 (817)
.|+..+..+.. .++..+.... ..+++ ....++... ......+..++.+|+.
T Consensus 308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 99877643311 2222222222 11111 111111100 0112245677999999
Q ss_pred hccccCCCCCCCHHHHHH
Q 036583 744 WCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 744 ~cl~~dp~~RPt~~evl~ 761 (817)
.|+..||.+|+|+.|+++
T Consensus 388 ~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALS 405 (415)
T ss_pred HHHccCccccccHHHHhc
Confidence 999999999999999986
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=262.81 Aligned_cols=256 Identities=25% Similarity=0.285 Sum_probs=201.7
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhcc-CcceeeeeeeEeec----CCeeeEEEeeccC
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAE----GTHRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~----~~~~~lv~e~~~~ 571 (817)
++||-|-.|.|-....+ .+++.|+|+|... ...++|+++.-.. .|||||.+++++.+ ..-+++|||.|+|
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meG 143 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEG 143 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccc
Confidence 57999999999998864 5888999998754 4457788887666 69999999999864 3356799999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec---CCCcEEEeecCCccccCCCCc
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD---DNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~ki~Dfgla~~~~~~~~ 648 (817)
|.|...++..+.. .++++++-.|+.||..|+.|||+ .+|.||||||+|+|.. .+-.+||+|||+|+.... .
T Consensus 144 GeLfsriq~~g~~-afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~--~ 217 (400)
T KOG0604|consen 144 GELFSRIQDRGDQ-AFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE--P 217 (400)
T ss_pred hHHHHHHHHcccc-cchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCC--C
Confidence 9999999876643 78999999999999999999999 9999999999999996 456799999999997543 2
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
....+.+-|+-|.|||++....|+...|+||+||++|-|++|.+||..+... .+.--+...+..| ....
T Consensus 218 ~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~g--------qy~F 286 (400)
T KOG0604|consen 218 GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRTG--------QYEF 286 (400)
T ss_pred ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhcc--------CccC
Confidence 3456678899999999999999999999999999999999999999755432 1111122222222 2222
Q ss_pred c--ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcCCCCCCCCC
Q 036583 729 D--EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ--MLEGICPVPQPPT 774 (817)
Q Consensus 729 ~--~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~--~L~~~~~~~~~~~ 774 (817)
+ .-....+...+++..++..+|.+|.|++|++. .+.+...+|..|.
T Consensus 287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl 336 (400)
T KOG0604|consen 287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPL 336 (400)
T ss_pred CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCc
Confidence 2 22234566789999999999999999999987 3445455555443
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=281.23 Aligned_cols=257 Identities=20% Similarity=0.279 Sum_probs=190.4
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeec-CCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE-GTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 568 (817)
+.+.+.||+|+||.||++.. .+++.+|+|++... ....+.+..|++++.+++||||+++++++.. ....++++||
T Consensus 12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~ 91 (328)
T cd07856 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91 (328)
T ss_pred eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence 44457899999999999984 47899999988542 2235678899999999999999999999865 5678999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+. ++|.+++... .+++.....++.|++.||+|||+ .+|+|+||+|+||++++++.+||+|||++.......
T Consensus 92 ~~-~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~- 162 (328)
T cd07856 92 LG-TDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM- 162 (328)
T ss_pred hc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCCc-
Confidence 84 5888887542 46778888899999999999999 899999999999999999999999999987543221
Q ss_pred eeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCC--------cchHHHHHHhhhcchh
Q 036583 649 HVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA--------HFPSYAFKMMEEGKLR 719 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~--------~~~~~~~~~~~~~~~~ 719 (817)
....++..|+|||.+.+ ..++.++||||||++++||++|+.||......... ..+.........+...
T Consensus 163 ---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 163 ---TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred ---CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 23456788999998865 56889999999999999999999999643321000 0000000000001001
Q ss_pred hhccc-ccCCcccH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 720 NILDS-RLNIDEQS-----DRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 720 ~~~d~-~~~~~~~~-----~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
+++.. ........ .....+.+++.+|++.+|++||+++|++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11000 00001010 123578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=283.72 Aligned_cols=261 Identities=20% Similarity=0.237 Sum_probs=188.4
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecC-----------
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG----------- 559 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~----------- 559 (817)
++.+.+.||.|+||.||+|.. .+++.||+|++.... ...+.+.+|++++++++||||+++++++...
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 455668899999999999986 458899999986543 4457789999999999999999999876543
Q ss_pred ---CeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec-CCCcEEEe
Q 036583 560 ---THRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD-DNYHAKVS 635 (817)
Q Consensus 560 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~ki~ 635 (817)
...++|+||++ ++|.+++... .+++.....++.||+.||.|||+ .+|+||||||+||+++ +++.+||+
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 4888877532 47889999999999999999998 8999999999999997 56679999
Q ss_pred ecCCccccCCCCcee--eeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCc--------
Q 036583 636 DFGLAKLMTREQSHV--FTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAH-------- 704 (817)
Q Consensus 636 Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~-------- 704 (817)
|||+++......... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||..........
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999998654321111 122357888999998754 567889999999999999999999996443211000
Q ss_pred chHHHHHHhhhcchhhhcccccCCcc-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 705 FPSYAFKMMEEGKLRNILDSRLNIDE-----QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~d~~~~~~~-----~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.......................... .......+.+++..|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000000000000000000000000 0012346789999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=284.85 Aligned_cols=266 Identities=23% Similarity=0.315 Sum_probs=192.7
Q ss_pred CHHHHHHHhhcc--ccccCCCcceeEEEEEc-CCCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeec
Q 036583 485 TYRDLQTATNNF--SVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558 (817)
Q Consensus 485 ~~~~l~~~~~~~--~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~ 558 (817)
..+++...+.+| .+.||+|+||.||++.. .+++.||+|++.... ...+.+.+|+.++.+++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 334455444444 47899999999999985 568899999986532 234568889999999999999999998864
Q ss_pred C------CeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcE
Q 036583 559 G------THRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHA 632 (817)
Q Consensus 559 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 632 (817)
. ...+++++++ +++|.+++... .+++..+..++.||++||+|||+ .+|+||||||+||++++++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCE
Confidence 3 3467888876 67998877543 47889999999999999999999 899999999999999999999
Q ss_pred EEeecCCccccCCCCceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCC--------
Q 036583 633 KVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA-------- 703 (817)
Q Consensus 633 ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~-------- 703 (817)
||+|||++...... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||.........
T Consensus 160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999998865332 123467889999999876 56788999999999999999999999543221100
Q ss_pred cchHHHHHHhhhcchhhhc---ccccCCcc---cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 704 HFPSYAFKMMEEGKLRNIL---DSRLNIDE---QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~---d~~~~~~~---~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.........+........+ ........ .......+.+++.+|++.||.+||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000000000000000 00000000 00123457899999999999999999999873
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=240.52 Aligned_cols=257 Identities=22% Similarity=0.307 Sum_probs=192.0
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cC-HHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCC
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QG-KKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGS 573 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~-~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 573 (817)
++||+|.||+|+||+.. .++.||+|+++-.. ++ .....+|+-+++.++|.|||++++....+....+|+|||.. +
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-d 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-H
Confidence 57999999999999965 47889999986543 22 46789999999999999999999999999999999999976 8
Q ss_pred hhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeee
Q 036583 574 LDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT 653 (817)
Q Consensus 574 L~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 653 (817)
|..+...-+. .++.+....++.|+++||.|+|+ +++.|||+||+|.||+.+|+.|++|||+++.++-.- .....
T Consensus 87 lkkyfdslng--~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipv-rcysa 160 (292)
T KOG0662|consen 87 LKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCYSA 160 (292)
T ss_pred HHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCce-Eeeec
Confidence 8888876554 58889999999999999999999 999999999999999999999999999999876432 23345
Q ss_pred ccCCCCccCccccccC-ccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhc---chhhhcccccCC
Q 036583 654 LRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEG---KLRNILDSRLNI 728 (817)
Q Consensus 654 ~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d~~~~~ 728 (817)
.+.|..|.+|+++.+. -|+...|+||.||++.|+.. |++.|.+++..+.....-+......+. .+.++.|-..-.
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp 240 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP 240 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence 6778999999999875 57889999999999999987 555564443322111111111111111 122233322111
Q ss_pred cccH---------HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 729 DEQS---------DRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 729 ~~~~---------~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.++. .....=.++....+.-+|..|.++++.++
T Consensus 241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1110 11112246677777889999999988776
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=280.40 Aligned_cols=261 Identities=22% Similarity=0.274 Sum_probs=189.0
Q ss_pred hccccccCCCcceeEEEEEcC-C--CcEEEEEEeccCC---cCHHHHHHHHHHhhcc-CcceeeeeeeEeecC----Cee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-D--GTRLAVKKLEGIG---QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEG----THR 562 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~--g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~----~~~ 562 (817)
+.+.+.||+|+||.||+++.. . +..+|+|++.... ...+.+.+|++++.++ +||||+++++.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 345678999999999999964 3 6789999986432 2346788999999999 599999999976432 456
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
++++||+. ++|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++.
T Consensus 82 ~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 82 YLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 88888886 58988886543 58899999999999999999998 8999999999999999999999999999986
Q ss_pred cCCCCce---eeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCC--------cchHHHH
Q 036583 643 MTREQSH---VFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA--------HFPSYAF 710 (817)
Q Consensus 643 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~--------~~~~~~~ 710 (817)
....... ......|+..|+|||.+.+ ..++.++|||||||++++|++|+.||......... .......
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 5432211 1123468899999998765 46889999999999999999999999654311000 0000000
Q ss_pred HHhhhcchhhhcc---cccCCc---ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 711 KMMEEGKLRNILD---SRLNID---EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 711 ~~~~~~~~~~~~d---~~~~~~---~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..+.......... ...... ........+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000 000000 00011346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=269.66 Aligned_cols=242 Identities=24% Similarity=0.335 Sum_probs=196.3
Q ss_pred HHHHhhccccccCCCcceeEEEEEcCC-CcEEEEEEeccCC----cCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCee
Q 036583 489 LQTATNNFSVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGIG----QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHR 562 (817)
Q Consensus 489 l~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~ 562 (817)
+..+..+|...||+|.||.|.++..+. .+.+|||++++.. .+.+--+.|-++|... +-|.++.++.+|..-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 344557888999999999999998754 4568999998752 2344457788888777 577999999999999999
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
|.||||+.+|+|-.++++-+ .+.+..+.-+|..||-||-+||+ ++|+.||||..|||||.+|.+||+|||+.+.
T Consensus 426 yFVMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eeEEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccc
Confidence 99999999999999998765 46778889999999999999999 9999999999999999999999999999985
Q ss_pred cCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 643 MTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 643 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
--.+. ....+.+|||.|+|||++...+|+..+|.|||||+||||+.|++||+..+.++ +.+. +.
T Consensus 500 ni~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-------lF~a--------I~ 563 (683)
T KOG0696|consen 500 NIFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-------LFQA--------IM 563 (683)
T ss_pred cccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHH--------HH
Confidence 32222 23356899999999999999999999999999999999999999998665322 2222 22
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCC
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRP 754 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RP 754 (817)
+... .++.....+++.+....+..+|.+|-
T Consensus 564 ehnv--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 564 EHNV--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HccC--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 2222 22333445677888888899999984
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=284.89 Aligned_cols=237 Identities=25% Similarity=0.327 Sum_probs=193.6
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEeecc
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.+.+..++|.|+|+.|-.+.. ..++..+||++.+. ..+-.+|+.++... +||||+++.+.+.++.+.++|||.+.
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 355667799999999999885 46788999999765 23445677676666 79999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEe-cCCCcEEEeecCCccccCCCCce
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL-DDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll-~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++-|.+.+..... .. ..+..|+.+|+.|+.|||+ ++++||||||+|||+ ++.++++|+|||.++.....
T Consensus 400 g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 400 GGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred ccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 9988877765542 22 6777899999999999999 999999999999999 59999999999999987665
Q ss_pred eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
..+.+-|..|.|||++....|++++|+||||++||+|++|+.||...... ......+..+.
T Consensus 470 -~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~------------ 530 (612)
T KOG0603|consen 470 -CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPK------------ 530 (612)
T ss_pred -hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCc------------
Confidence 33456688999999999999999999999999999999999999754332 11222222221
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+.......+.+|+.+|++.||.+||+|.++..
T Consensus 531 ~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 531 FSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred cccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 22334557889999999999999999999987
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=284.23 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=190.9
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCe------ee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTH------RL 563 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~------~~ 563 (817)
+.+.+.||+|+||.||+|+.. +++.+|+|++... ....+.+.+|+.++++++|+|++++++++...+. .+
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence 345578999999999999965 5789999998643 2234567889999999999999999998876554 89
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+|+||+ +++|.+++... .+++..+..++.|+++||+|||+ .+|+|+||||+||++++++.+||+|||++...
T Consensus 97 lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 97 LVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred EEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 999998 56999988652 58899999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCC--------cchHHHHHHhh
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA--------HFPSYAFKMME 714 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~--------~~~~~~~~~~~ 714 (817)
... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... .........+.
T Consensus 169 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 169 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 432 223467888999999865 46788999999999999999999999643321100 00000000000
Q ss_pred hcchhhhcccccC---Ccc---cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 715 EGKLRNILDSRLN---IDE---QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 715 ~~~~~~~~d~~~~---~~~---~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
......++..... ... .......+.+++.+|++.||++|||+.||++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000001000000 000 0012457889999999999999999999987
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=266.54 Aligned_cols=220 Identities=21% Similarity=0.155 Sum_probs=176.2
Q ss_pred CcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCChhhhhhhc
Q 036583 503 GGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKK 581 (817)
Q Consensus 503 G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~ 581 (817)
|.||.||+++. .+++.+|+|++.... .+..|...+....|||++++++++.+.+..++||||+++|+|.+++.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 88999999995 468899999997542 3344555566667999999999999999999999999999999998765
Q ss_pred ccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeeeccCCCCcc
Q 036583 582 NQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL 661 (817)
Q Consensus 582 ~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~ 661 (817)
. .+++.....++.|++.||+|||+ .+|+||||||+||+++.++.++++|||++....... ....++..|+
T Consensus 80 ~---~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~ 149 (237)
T cd05576 80 L---NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYC 149 (237)
T ss_pred c---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcccc
Confidence 3 48899999999999999999998 899999999999999999999999999876554321 2234567899
Q ss_pred CccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHH
Q 036583 662 APEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKV 741 (817)
Q Consensus 662 aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l 741 (817)
|||.+.+..++.++||||+|++++||++|+.|+........ .. . .+.. +......+.++
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~~--~-----~~~~--~~~~~~~~~~l 208 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------TH--T-----TLNI--PEWVSEEARSL 208 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------cc--c-----ccCC--cccCCHHHHHH
Confidence 99999888889999999999999999999988753211100 00 0 0000 11123467889
Q ss_pred HHhccccCCCCCCCHH
Q 036583 742 ALWCVQEDMSLRPSMT 757 (817)
Q Consensus 742 ~~~cl~~dp~~RPt~~ 757 (817)
+.+|++.||++||++.
T Consensus 209 i~~~l~~dp~~R~~~~ 224 (237)
T cd05576 209 LQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHccCCHHHhcCCC
Confidence 9999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=303.63 Aligned_cols=142 Identities=27% Similarity=0.395 Sum_probs=127.0
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc----CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ----GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~----~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.++||+|+||+||+|... .++.||||++..... ....+..|+.++..++|+||+++++.+......+|||||
T Consensus 6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy 85 (669)
T cd05610 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY 85 (669)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence 445688999999999999965 688999999965321 236788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK 641 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 641 (817)
+++++|.+++.... .+++..++.|+.||+.||.|||. .+|+||||||+||||+.++.+||+|||+++
T Consensus 86 ~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 86 LIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999997543 57888899999999999999998 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=260.95 Aligned_cols=249 Identities=27% Similarity=0.363 Sum_probs=189.2
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEeeccCCC
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFMANGS 573 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gs 573 (817)
.+||.|.||+|+|-.++ .|+..|||+++... ...++++.|.+...+- +.||||+++|.+-.+...++.||.|+- +
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-S 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-h
Confidence 35999999999998864 58999999997653 4567888999876555 799999999999999999999999975 6
Q ss_pred hhhhhhh--cccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 574 LDKWIFK--KNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 574 L~~~l~~--~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
|+.+-.. ..+...+++...-.|....+.||.||.+. ..|||||+||+|||||..|.+||+|||+.-.+...- +.
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si--Ak 224 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI--AK 224 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHH--Hh
Confidence 6554321 11122577788888888999999999984 899999999999999999999999999987664332 12
Q ss_pred eeccCCCCccCcccccc--CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 652 TTLRGTRGYLAPEWITN--YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
+.-.|-..|||||.+.. ..|+.++||||||+.|+|+.||+.|+..-.. ..+ ....+..|....+.. ..
T Consensus 225 T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfe-ql~~Vv~gdpp~l~~----~~ 294 (361)
T KOG1006|consen 225 TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFE-QLCQVVIGDPPILLF----DK 294 (361)
T ss_pred hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHH-HHHHHHcCCCCeecC----cc
Confidence 33567788999999963 3588999999999999999999999963221 000 111122222111111 11
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
...+....++.++-.|+..|.+.||...++++
T Consensus 295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 22345567889999999999999999999886
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=266.24 Aligned_cols=257 Identities=25% Similarity=0.362 Sum_probs=197.6
Q ss_pred HHHhhccccccCCCcceeEEEEE-cCCCcEEEEEEeccCCc--------CHHHHHHHHHHhhccCcceeeeeeeEee-cC
Q 036583 490 QTATNNFSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQ--------GKKEFRAEVSIIGSIHHLHLVKLRGFCA-EG 559 (817)
Q Consensus 490 ~~~~~~~~~~lG~G~fG~Vy~g~-~~~g~~vavK~l~~~~~--------~~~~~~~Ev~~l~~l~h~niv~l~~~~~-~~ 559 (817)
...+|-+.+.||+|+|+.|||+. +...+.||||+-.-... ..+...+|..|.+.|.||.||++++++. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 33444455789999999999998 45678899998632211 2345678999999999999999999995 55
Q ss_pred CeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec---CCCcEEEee
Q 036583 560 THRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD---DNYHAKVSD 636 (817)
Q Consensus 560 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~ki~D 636 (817)
+..|-|.||++|.+|+-||..+. .++...++.|+.||+.||.||.+ ...+|||-||||.||||. .-|.+||.|
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeee
Confidence 67899999999999999998765 68999999999999999999997 468999999999999995 458899999
Q ss_pred cCCccccCCCCce------eeeeccCCCCccCcccccc----CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcch
Q 036583 637 FGLAKLMTREQSH------VFTTLRGTRGYLAPEWITN----YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFP 706 (817)
Q Consensus 637 fgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~ 706 (817)
|||++.+..+... ......||..|++||.+-- -.++.|+||||.|||+|.++.|++||+.+....
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ----- 691 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ----- 691 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-----
Confidence 9999998754332 2233689999999999853 256789999999999999999999997553221
Q ss_pred HHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 707 SYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 707 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..+.+..+.... ....+.......++..+|.+|++..-++|....++..
T Consensus 692 ----dILqeNTIlkAt--EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 692 ----DILQENTILKAT--EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ----HHHhhhchhcce--eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 112222211111 1222333334456788999999999999987666543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=283.88 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=207.8
Q ss_pred HhhccccccCCCcceeEEEEE-cCCCcEEEEEEeccCCcCHHHHHHHHHHhhcc-CcceeeeeeeEeec-----CCeeeE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAE-----GTHRLL 564 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~-~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~-----~~~~~l 564 (817)
.+..|.+.||+|.+|.||+++ .++++.+|||++.......++...|.++++.. +|||++.++|++.. +++++|
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 345567889999999999999 45789999999998888889999999999988 69999999999853 568999
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
|||||.+|+.-+++.... +..+.|..+.-|++.+++|+.+||. ..++|||||-.|||++.++.+|+.|||++..+.
T Consensus 99 VMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred EeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 999999999999987655 4479999999999999999999998 899999999999999999999999999998775
Q ss_pred CCCceeeeeccCCCCccCcccccc-----CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchh
Q 036583 645 REQSHVFTTLRGTRGYLAPEWITN-----YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLR 719 (817)
Q Consensus 645 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (817)
.... ...+..||+-|||||++.. ..|+.++|+||||++..||..|.+|+....+.... +..
T Consensus 175 sT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL------F~I------- 240 (953)
T KOG0587|consen 175 STVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL------FLI------- 240 (953)
T ss_pred cccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh------ccC-------
Confidence 4332 2345789999999999974 35677999999999999999999999765443211 000
Q ss_pred hhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 720 NILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 720 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
...|......+..-..++.+++..|+..|..+||++.++++
T Consensus 241 -pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 241 -PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11122222233455678899999999999999999998876
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=295.06 Aligned_cols=248 Identities=23% Similarity=0.268 Sum_probs=201.9
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.+.||+|+||.|...+++ .++.+|+|++.+- ......|..|-.+|..-..+=|+.++-.|.+..++|+||||
T Consensus 77 feilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY 156 (1317)
T KOG0612|consen 77 FEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDY 156 (1317)
T ss_pred hHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEec
Confidence 344578999999999999975 4778999999762 33457899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
|+||+|-.++.+.. .++...++-++..|+-||.-||+ .|+|||||||+|||||..|.+||+|||....+..+..
T Consensus 157 ~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 157 MPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred ccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence 99999999997665 58889999999999999999999 9999999999999999999999999999988887777
Q ss_pred eeeeeccCCCCccCccccc----c-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 649 HVFTTLRGTRGYLAPEWIT----N-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
......+|||.|++||++. + +.|++.+|.||+||++|||+.|..||.... +..-..+.+....
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KIm~hk~------ 298 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKIMNHKE------ 298 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHHhchhh------
Confidence 6677789999999999996 3 578899999999999999999999995322 1111111121111
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCC---HHHHHH
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPS---MTKVVQ 761 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt---~~evl~ 761 (817)
.+..+...+....+.+||+..+. +|+.|-. ++++-.
T Consensus 299 -~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 299 -SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred -hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 22333233455567777777664 6777776 888876
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=262.56 Aligned_cols=285 Identities=24% Similarity=0.312 Sum_probs=213.7
Q ss_pred ccccccccccCCCcccCHHHHHH-HhhccccccCCCcceeEEEEE-cCCCcEEEEEEeccCCcCHHHHHHHHHHhhccC-
Q 036583 469 EEDNFLENLSGMPVRFTYRDLQT-ATNNFSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH- 545 (817)
Q Consensus 469 ~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~lG~G~fG~Vy~g~-~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~- 545 (817)
++++..++..+++++....|+.+ ++|-+.+|||.|.|++||++. .++.+.||+|+.+......+..+.||++|.+++
T Consensus 54 eqE~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~ 133 (590)
T KOG1290|consen 54 EQEDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVRE 133 (590)
T ss_pred cccChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHh
Confidence 34455667788899999999998 889999999999999999998 457889999999877777788899999999984
Q ss_pred ----c---ceeeeeeeEeec----CCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCce
Q 036583 546 ----H---LHLVKLRGFCAE----GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614 (817)
Q Consensus 546 ----h---~niv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~i 614 (817)
| .+||+|+++|.. +.|.|||+|++.. +|..+|....- +.++.....+|+.||+.||.|||.. .+|
T Consensus 134 ~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGd-nLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~e--cgI 209 (590)
T KOG1290|consen 134 GDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGD-NLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHRE--CGI 209 (590)
T ss_pred cCCCCCCCceeeeeeccceecCCCCcEEEEEehhhhh-HHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHh--cCc
Confidence 2 379999999964 6689999999954 78888876543 3688999999999999999999996 699
Q ss_pred eecCCCCCCeEecCC-----------C-----------------------------------------------------
Q 036583 615 IHCDIKPENVLLDDN-----------Y----------------------------------------------------- 630 (817)
Q Consensus 615 vH~Dlk~~NIll~~~-----------~----------------------------------------------------- 630 (817)
||.||||+|||+..+ +
T Consensus 210 IHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~ 289 (590)
T KOG1290|consen 210 IHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLA 289 (590)
T ss_pred cccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhc
Confidence 999999999998211 0
Q ss_pred --------------------------------------------------------------------------------
Q 036583 631 -------------------------------------------------------------------------------- 630 (817)
Q Consensus 631 -------------------------------------------------------------------------------- 630 (817)
T Consensus 290 ~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~ 369 (590)
T KOG1290|consen 290 GLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPS 369 (590)
T ss_pred ccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcC
Confidence
Q ss_pred ----------------------cEEEeecCCccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhh
Q 036583 631 ----------------------HAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEII 688 (817)
Q Consensus 631 ----------------------~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ell 688 (817)
++||+|||-|..... .++.-..|..|+|||++.+..|+..+||||++|++|||+
T Consensus 370 s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~k----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELa 445 (590)
T KOG1290|consen 370 SPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHK----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELA 445 (590)
T ss_pred CccccccccccCCCCCCCccceeEEEeeccchhhhhh----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhh
Confidence 012333333322111 112233567899999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCC----cchHHH-------HHHhhhcc-hhhhcccc--------c-----------CCcccHHHHHH
Q 036583 689 GGRKNFDPNETSDKA----HFPSYA-------FKMMEEGK-LRNILDSR--------L-----------NIDEQSDRVFT 737 (817)
Q Consensus 689 tg~~pf~~~~~~~~~----~~~~~~-------~~~~~~~~-~~~~~d~~--------~-----------~~~~~~~~~~~ 737 (817)
||...|++.....-. ++...+ +.....|+ -+++++.+ + ......++..+
T Consensus 446 TGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~ 525 (590)
T KOG1290|consen 446 TGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQ 525 (590)
T ss_pred cCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHH
Confidence 999999877644321 211111 11111121 11222221 1 12344577888
Q ss_pred HHHHHHhccccCCCCCCCHHHHHH
Q 036583 738 AVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 738 ~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+.+++.-||+.+|++|||+.+.++
T Consensus 526 fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 526 FSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHHHHHHHHhcCccccccHHHHhc
Confidence 999999999999999999999986
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=260.20 Aligned_cols=236 Identities=28% Similarity=0.398 Sum_probs=192.5
Q ss_pred cceeEEEEEcCC-CcEEEEEEeccCCc-C-HHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCChhhhhhh
Q 036583 504 GFGSVYQGVLPD-GTRLAVKKLEGIGQ-G-KKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFK 580 (817)
Q Consensus 504 ~fG~Vy~g~~~~-g~~vavK~l~~~~~-~-~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 580 (817)
+||.||+++..+ ++.+++|++..... . .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999764 89999999975432 2 68899999999999999999999999999999999999999999999876
Q ss_pred cccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeeeccCCCCc
Q 036583 581 KNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGY 660 (817)
Q Consensus 581 ~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y 660 (817)
.. .+++..+..++.++++++.|||+ .+++|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 44 27889999999999999999999 899999999999999999999999999998765432 22345678899
Q ss_pred cCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHH-HHHHHH
Q 036583 661 LAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSD-RVFTAV 739 (817)
Q Consensus 661 ~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~-~~~~~~ 739 (817)
++||.+.+..++.++||||||++++||++|..||...... .........+... ...... ....+.
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~------~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 218 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL------LELFKKIGKPKPP--------FPPPEWKISPEAK 218 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHhccCCC--------CccccccCCHHHH
Confidence 9999999888899999999999999999999999642111 1111111111111 000000 334788
Q ss_pred HHHHhccccCCCCCCCHHHHHH
Q 036583 740 KVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 740 ~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=283.68 Aligned_cols=241 Identities=27% Similarity=0.400 Sum_probs=186.6
Q ss_pred cccCCCccee-EEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEeeccCCChh
Q 036583 498 VKLGQGGFGS-VYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFMANGSLD 575 (817)
Q Consensus 498 ~~lG~G~fG~-Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 575 (817)
+.+|.|+-|+ ||+|.. +|+.||||++-.. -.+...+|+..|..- +|||||++++.-.+....|++.|.|.. +|.
T Consensus 515 eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e--~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~ 590 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY-EGREVAVKRLLEE--FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQ 590 (903)
T ss_pred HHcccCCCCcEEEEEee-CCceehHHHHhhH--hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHH
Confidence 4589999986 799999 8889999998532 233457899999888 699999999999999999999999976 999
Q ss_pred hhhhhccccc-chhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC-----CCcEEEeecCCccccCCCCce
Q 036583 576 KWIFKKNQEF-LLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD-----NYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 576 ~~l~~~~~~~-~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~ki~Dfgla~~~~~~~~~ 649 (817)
+++....... ...-...+.+..|++.||++||+ .+||||||||+||||+. ..+++|+|||+++.+..+...
T Consensus 591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred HHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 9998742111 11114557889999999999999 99999999999999975 368999999999998765543
Q ss_pred e--eeeccCCCCccCccccccCccCccccccchhhhHHHhhhC-CCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 650 V--FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGG-RKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 650 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
. .....||-+|+|||.+....-+.++||||+|||+|+.++| ..||+..-..+. .+..+... + .
T Consensus 668 ~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~---------NIl~~~~~-L----~ 733 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA---------NILTGNYT-L----V 733 (903)
T ss_pred hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh---------hhhcCccc-e----e
Confidence 3 3347799999999999988888899999999999999995 899975422110 01111100 0 0
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
......++ ++.+||.+|++.+|..||++.+|+.
T Consensus 734 ~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 01111111 6789999999999999999999985
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-31 Score=253.75 Aligned_cols=260 Identities=22% Similarity=0.335 Sum_probs=192.6
Q ss_pred ccccCCCcceeEEEEEcCC-CcEEEEEEec--cCCcC-HHHHHHHHHHhhccCcceeeeeeeEeecC--------CeeeE
Q 036583 497 SVKLGQGGFGSVYQGVLPD-GTRLAVKKLE--GIGQG-KKEFRAEVSIIGSIHHLHLVKLRGFCAEG--------THRLL 564 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~--~~~~~-~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--------~~~~l 564 (817)
..+||+|.||.||+++..+ |+.||+|++- ....+ ...-.+|+++|..++|+|++.++..|... ...+|
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 3579999999999999754 6778988752 22233 35668999999999999999999998532 24699
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
|+.+|+. +|.-+|..... .++...+.+++.++..||.|+|. ..|+|||+||.|+||+.++.+||+|||+++.+.
T Consensus 102 Vf~~ceh-DLaGlLsn~~v--r~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSNRKV--RFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred eHHHhhh-hHHHHhcCccc--cccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 9999988 88888865433 47778899999999999999998 899999999999999999999999999998764
Q ss_pred CCC---ceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchH--------HHHHH
Q 036583 645 REQ---SHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPS--------YAFKM 712 (817)
Q Consensus 645 ~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~--------~~~~~ 712 (817)
... ...++..+.|..|++||.+.+ +.|+++.|||..|||+.||.++.+-++.+......++.. .+|..
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 322 122344667899999999875 578999999999999999999999998775443222211 11222
Q ss_pred hhhcchhhhcccc-c-CCcc--cHHH------HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 713 MEEGKLRNILDSR-L-NIDE--QSDR------VFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 713 ~~~~~~~~~~d~~-~-~~~~--~~~~------~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
+.+-.+.+-+... + .... -.+. -...++++..++..||.+|+++++++..
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 2221111111000 0 0000 0000 1256788899999999999999999874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=279.18 Aligned_cols=258 Identities=19% Similarity=0.212 Sum_probs=176.5
Q ss_pred hccccccCCCcceeEEEEEc-----------------CCCcEEEEEEeccCCcC-HHH--------------HHHHHHHh
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-----------------PDGTRLAVKKLEGIGQG-KKE--------------FRAEVSII 541 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-----------------~~g~~vavK~l~~~~~~-~~~--------------~~~Ev~~l 541 (817)
+.+.++||+|+||+||+|.. .+++.||||++....+. .++ +..|+.++
T Consensus 147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l 226 (507)
T PLN03224 147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC 226 (507)
T ss_pred ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence 44558899999999999963 24568999998654321 223 34477777
Q ss_pred hccCccee-----eeeeeEeec--------CCeeeEEEeeccCCChhhhhhhccc---------------------ccch
Q 036583 542 GSIHHLHL-----VKLRGFCAE--------GTHRLLAYEFMANGSLDKWIFKKNQ---------------------EFLL 587 (817)
Q Consensus 542 ~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l 587 (817)
.+++|.++ ++++++|.. ....+|||||+++++|.++|+.... ...+
T Consensus 227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~ 306 (507)
T PLN03224 227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR 306 (507)
T ss_pred HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence 77776654 677888753 3568999999999999999874321 1124
Q ss_pred hhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeeeccCCCCccCccccc
Q 036583 588 DWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWIT 667 (817)
Q Consensus 588 ~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 667 (817)
++..+..++.|++.+|.|||+ .+|+||||||+|||++.++.+||+|||++...............+++.|+|||.+.
T Consensus 307 ~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 307 DINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred CHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 677888999999999999998 89999999999999999999999999999765433221111234578999999875
Q ss_pred cCc--------------------c--CccccccchhhhHHHhhhCCC-CCCCCCCCCCC----cchHHHHHHhhhcchhh
Q 036583 668 NYA--------------------I--SEKSDVYSYGMVLLEIIGGRK-NFDPNETSDKA----HFPSYAFKMMEEGKLRN 720 (817)
Q Consensus 668 ~~~--------------------~--~~~~DvwS~Gvvl~elltg~~-pf~~~~~~~~~----~~~~~~~~~~~~~~~~~ 720 (817)
... + ..+.||||+||+++||+++.. ||......... ......|+.....
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~---- 459 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ---- 459 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc----
Confidence 322 1 134799999999999999875 66422110000 0000011111111
Q ss_pred hcccccCCcccHHHHHHHHHHHHhccccCC---CCCCCHHHHHHH
Q 036583 721 ILDSRLNIDEQSDRVFTAVKVALWCVQEDM---SLRPSMTKVVQM 762 (817)
Q Consensus 721 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp---~~RPt~~evl~~ 762 (817)
....+..........+++..++..+| .+|+|++|++++
T Consensus 460 ----~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 ----KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ----CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11111111233467788999998765 689999999873
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=285.88 Aligned_cols=256 Identities=18% Similarity=0.205 Sum_probs=165.6
Q ss_pred hhccccccCCCcceeEEEEEcC-C----CcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeE------eecCCe
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-D----GTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGF------CAEGTH 561 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~----g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~------~~~~~~ 561 (817)
.+.+.++||+|+||.||+|++. + +..||||++..... .+.+..| .+....+.++..++.. +..+..
T Consensus 133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCc
Confidence 3455689999999999999964 4 68999999864322 1112222 1112222222222221 245678
Q ss_pred eeEEEeeccCCChhhhhhhccccc-----------------chhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 036583 562 RLLAYEFMANGSLDKWIFKKNQEF-----------------LLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENV 624 (817)
Q Consensus 562 ~~lv~e~~~~gsL~~~l~~~~~~~-----------------~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NI 624 (817)
.++||||+++++|.+++....... ......+..++.||+.||+|||+ ++|+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHHE
Confidence 899999999999999986542110 11223456799999999999999 8999999999999
Q ss_pred EecC-CCcEEEeecCCccccCCCCceeeeeccCCCCccCccccccC----------------------ccCccccccchh
Q 036583 625 LLDD-NYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNY----------------------AISEKSDVYSYG 681 (817)
Q Consensus 625 ll~~-~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DvwS~G 681 (817)
|+++ ++.+||+|||+++.+............+++.|+|||.+... .++.++||||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 9985 68999999999987654433333446789999999965321 234567999999
Q ss_pred hhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhc-----chhhhcccccCCc------ccHHHHHHHHHHHHhccccCC
Q 036583 682 MVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEG-----KLRNILDSRLNID------EQSDRVFTAVKVALWCVQEDM 750 (817)
Q Consensus 682 vvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~d~~~~~~------~~~~~~~~~~~l~~~cl~~dp 750 (817)
|+||||+++..+++... ... ...+... .......+....+ ..........+|+.+|++.||
T Consensus 367 viL~el~~~~~~~~~~~-------~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 367 LIFLQMAFPNLRSDSNL-------IQF-NRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred HHHHHHHhCcCCCchHH-------HHH-HHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 99999998776553210 000 0000000 0001111110000 000011234589999999999
Q ss_pred CCCCCHHHHHHH
Q 036583 751 SLRPSMTKVVQM 762 (817)
Q Consensus 751 ~~RPt~~evl~~ 762 (817)
++|||++|+++.
T Consensus 439 ~kR~ta~e~L~H 450 (566)
T PLN03225 439 RQRISAKAALAH 450 (566)
T ss_pred ccCCCHHHHhCC
Confidence 999999999983
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=267.71 Aligned_cols=242 Identities=24% Similarity=0.309 Sum_probs=198.8
Q ss_pred cccCCCcceeEEEEEcCCCc-EEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 498 VKLGQGGFGSVYQGVLPDGT-RLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~-~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
..||-|+||.|=+.+..... ..|+|.+++. ....+....|-.||...+.|.||+++-.|.+....|++||-|-||
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 46999999999999874433 3788888653 234567889999999999999999999999999999999999999
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeee
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT 652 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 652 (817)
.|...|...+ .++.....-++..+++|++|||. ++||.|||||+|.+||.+|.+||.|||.|+.+..... .-
T Consensus 506 ElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K--Tw 577 (732)
T KOG0614|consen 506 ELWTILRDRG---SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK--TW 577 (732)
T ss_pred hhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCCc--ee
Confidence 9999998766 58888999999999999999999 9999999999999999999999999999998876543 35
Q ss_pred eccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccH
Q 036583 653 TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQS 732 (817)
Q Consensus 653 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 732 (817)
+.+|||.|.|||++.+..++.++|.||||++++||++|.+||...++.. .+..+.+|. .. ...+.
T Consensus 578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk-------tYn~ILkGi-d~-------i~~Pr 642 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK-------TYNLILKGI-DK-------IEFPR 642 (732)
T ss_pred eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH-------HHHHHHhhh-hh-------hhccc
Confidence 6899999999999999999999999999999999999999997654322 222222221 10 11122
Q ss_pred HHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 036583 733 DRVFTAVKVALWCVQEDMSLRPS-----MTKVVQM 762 (817)
Q Consensus 733 ~~~~~~~~l~~~cl~~dp~~RPt-----~~evl~~ 762 (817)
.......+++++....+|.+|-- +.+|-++
T Consensus 643 ~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 643 RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 23345678888888999999975 6666653
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=251.21 Aligned_cols=260 Identities=25% Similarity=0.347 Sum_probs=199.7
Q ss_pred cccCCCcceeEEEEEc-CCCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecC-----CeeeEEEee
Q 036583 498 VKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEG-----THRLLAYEF 568 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~ 568 (817)
+-||.|+||.||..+. ++|+.||+|++...-+ ..+.+.+|+++|..++|.|++..++...-. .+.|+++|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 3499999999999986 4699999999865432 357788999999999999999999887543 256888898
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
|.. +|..++-... .++.+...-+.+||++||.|||+ .+|.||||||.|.|++.+...||+|||+++....++.
T Consensus 139 mQS-DLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 139 MQS-DLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHh-hhhheeccCC---CCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 865 7887776654 68888888899999999999999 9999999999999999999999999999998877766
Q ss_pred eeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcc--------hHHHHHHhhhcchh
Q 036583 649 HVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHF--------PSYAFKMMEEGKLR 719 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~--------~~~~~~~~~~~~~~ 719 (817)
..++..+.|.-|.|||++.+ +.|+.+.||||.|||+.||+..+..|+...+.....+ .....+..-+|.-.
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 66666778899999999986 5789999999999999999999999975543322111 11122222223222
Q ss_pred hhcccccCC---------cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 720 NILDSRLNI---------DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 720 ~~~d~~~~~---------~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
.++....+. ........+.+.+.+.++..||++|.+.++.+..+.
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 222222111 111122334567788899999999999999988663
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=229.44 Aligned_cols=194 Identities=28% Similarity=0.413 Sum_probs=161.8
Q ss_pred ccccCCCcceeEEEEEc-CCCcEEEEEEeccC--CcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 497 SVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI--GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~--~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
..+||+|++|.|-+-++ .+|+..|+|++... .+..+..+.|+.+..+- .+|.+|.++|...+....++.||.|+.
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t- 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT- 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-
Confidence 36799999999988874 57999999999765 34567788899886655 799999999999999999999999976
Q ss_pred Chhhhhhhc-ccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 573 SLDKWIFKK-NQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 573 sL~~~l~~~-~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
||+.+-.+- ..+..+++...-+|+..+++||.|||+. ..++|||+||+||||+.+|++||||||++-.+...-. .
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA--k 205 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA--K 205 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhH--H
Confidence 777654431 1233688888999999999999999994 8999999999999999999999999999887654321 1
Q ss_pred eeccCCCCccCcccccc----CccCccccccchhhhHHHhhhCCCCCC
Q 036583 652 TTLRGTRGYLAPEWITN----YAISEKSDVYSYGMVLLEIIGGRKNFD 695 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~----~~~~~~~DvwS~Gvvl~elltg~~pf~ 695 (817)
+...|-..|||||.+.. ..|+.|+||||||+.+.||.+++.||+
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 22457788999999863 378899999999999999999999995
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=254.25 Aligned_cols=210 Identities=23% Similarity=0.372 Sum_probs=175.3
Q ss_pred HHHHHHHhhccc-----cccCCCcceeEEEEEc-CCCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeE
Q 036583 486 YRDLQTATNNFS-----VKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGF 555 (817)
Q Consensus 486 ~~~l~~~~~~~~-----~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~ 555 (817)
|-.|.++.-+-+ +.||-|+||+|-+++- +....+|+|.|++.. ......++|-.||.....+=||+|+-.
T Consensus 618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 444555443322 5699999999999984 445678999997642 334577899999999999999999999
Q ss_pred eecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEe
Q 036583 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVS 635 (817)
Q Consensus 556 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~ 635 (817)
|.+.+.+|+||+|++||++-.+|.+.+ .+.+..++-++..+..|+++.|. .++|||||||+|||||.+|.+||.
T Consensus 698 FQDkdnLYFVMdYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLT 771 (1034)
T KOG0608|consen 698 FQDKDNLYFVMDYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLT 771 (1034)
T ss_pred eccCCceEEEEeccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeee
Confidence 999999999999999999999998766 68888899999999999999999 999999999999999999999999
Q ss_pred ecCCccccCC---------CC------------------------------ce--eeeeccCCCCccCccccccCccCcc
Q 036583 636 DFGLAKLMTR---------EQ------------------------------SH--VFTTLRGTRGYLAPEWITNYAISEK 674 (817)
Q Consensus 636 Dfgla~~~~~---------~~------------------------------~~--~~~~~~gt~~y~aPE~~~~~~~~~~ 674 (817)
||||..-++- .. .. .....+||+.|+|||++....++..
T Consensus 772 DFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~ 851 (1034)
T KOG0608|consen 772 DFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL 851 (1034)
T ss_pred eccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc
Confidence 9999764420 00 00 0112569999999999999999999
Q ss_pred ccccchhhhHHHhhhCCCCCCCCCCCC
Q 036583 675 SDVYSYGMVLLEIIGGRKNFDPNETSD 701 (817)
Q Consensus 675 ~DvwS~Gvvl~elltg~~pf~~~~~~~ 701 (817)
+|.||.|||||||+.|+.||-.....+
T Consensus 852 cdwws~gvil~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 852 CDWWSVGVILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred chhhHhhHHHHHHhhCCCCccCCCCCc
Confidence 999999999999999999997665544
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=236.16 Aligned_cols=242 Identities=23% Similarity=0.313 Sum_probs=193.5
Q ss_pred cccccCCCcceeEEEEEcCC-CcEEEEEEeccC----CcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEeec
Q 036583 496 FSVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGI----GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
+...||+|.|..|.++++.. .+.+|+|++++. .++.+-...|-.+.... +||.+|.|+.+|.....++.|.||+
T Consensus 254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv 333 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV 333 (593)
T ss_pred eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence 34679999999999999754 677899988653 23334456677777666 6999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++|+|--++++.+ .|+.+.++-+...|.-||.|||+ ++||.||||..|||+|..|.+|+.|+|+.+.--... .
T Consensus 334 ~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~g-d 406 (593)
T KOG0695|consen 334 NGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG-D 406 (593)
T ss_pred cCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCCC-c
Confidence 9999988887665 58999999999999999999999 999999999999999999999999999998643222 2
Q ss_pred eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCC-CCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETS-DKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
...+.+|||.|+|||++++..|...+|.|++||+++||+.|+.||+.-... .+.+..++.++.+.+.. ++.
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq--------iri 478 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ--------IRI 478 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc--------ccc
Confidence 345689999999999999999999999999999999999999999754322 22234445555444432 222
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCC
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRP 754 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RP 754 (817)
+.. ...++..+++..++.||.+|-
T Consensus 479 prs--lsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 479 PRS--LSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cce--eehhhHHHHHHhhcCCcHHhc
Confidence 222 223455778888999999884
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=232.11 Aligned_cols=209 Identities=36% Similarity=0.576 Sum_probs=183.6
Q ss_pred cCCCcceeEEEEEcCC-CcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCChhh
Q 036583 500 LGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDK 576 (817)
Q Consensus 500 lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 576 (817)
||+|.+|.||++...+ ++.+++|++..... ..+.+.+|+..+..++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 88999999976543 25789999999999999999999999999999999999999999999
Q ss_pred hhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC-CCcEEEeecCCccccCCCCceeeeecc
Q 036583 577 WIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD-NYHAKVSDFGLAKLMTREQSHVFTTLR 655 (817)
Q Consensus 577 ~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~Dfgla~~~~~~~~~~~~~~~ 655 (817)
++.... ..+++..+..++.++++++++||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 987653 257889999999999999999999 89999999999999999 89999999999987654321 122345
Q ss_pred CCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHH
Q 036583 656 GTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDR 734 (817)
Q Consensus 656 gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 734 (817)
+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 77889999999877 788999999999999999
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 735 VFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 735 ~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
..+.+++..|++.+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 367789999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-28 Score=253.06 Aligned_cols=276 Identities=22% Similarity=0.263 Sum_probs=216.5
Q ss_pred CCCcccCHHHHHHHhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhccC------cceeee
Q 036583 479 GMPVRFTYRDLQTATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH------HLHLVK 551 (817)
Q Consensus 479 ~~~~~~~~~~l~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~------h~niv~ 551 (817)
.++..+.+.|+....|.+.-..|+|-|++|..|... .|+.||||++.......+.=+.|++||++|+ .-|+++
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 456678899999999999889999999999999954 4889999999887666777789999999996 348999
Q ss_pred eeeEeecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCC-C
Q 036583 552 LRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDN-Y 630 (817)
Q Consensus 552 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~ 630 (817)
|+-.|...+|+|||+|-+.- +|.++|.+-+....|.......++.|+.-||..|.. .+|+|.||||.|||+++. .
T Consensus 499 l~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcc
Confidence 99999999999999997754 899999987777789999999999999999999998 899999999999999864 5
Q ss_pred cEEEeecCCccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchH---
Q 036583 631 HAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPS--- 707 (817)
Q Consensus 631 ~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~--- 707 (817)
.+||||||.|........ +....+.-|.|||++.+.+|+...|+||.||.||||.||+..|.+........+..
T Consensus 575 iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred eeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 689999999987654432 23344567999999999999999999999999999999999996554322110000
Q ss_pred --HHHHHhhhcchh-hhcccc--------------------------------c-----CCcccHHHHHHHHHHHHhccc
Q 036583 708 --YAFKMMEEGKLR-NILDSR--------------------------------L-----NIDEQSDRVFTAVKVALWCVQ 747 (817)
Q Consensus 708 --~~~~~~~~~~~~-~~~d~~--------------------------------~-----~~~~~~~~~~~~~~l~~~cl~ 747 (817)
+..++++.+... +-+|.. + ....+......+.+|+..|+.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 001111111100 000000 0 012233556778899999999
Q ss_pred cCCCCCCCHHHHHH
Q 036583 748 EDMSLRPSMTKVVQ 761 (817)
Q Consensus 748 ~dp~~RPt~~evl~ 761 (817)
.||++|.|..++|+
T Consensus 732 LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 732 LDPEKRITVNQALK 745 (752)
T ss_pred cChhhcCCHHHHhc
Confidence 99999999998876
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=223.39 Aligned_cols=250 Identities=18% Similarity=0.280 Sum_probs=186.1
Q ss_pred hhccccccCCCcceeEEEEEcCC-CcEEEEEEeccCCcCHHHHHHHHHHhhcc-CcceeeeeeeE-eecCCeeeEEEeec
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGF-CAEGTHRLLAYEFM 569 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~-~~~~~~~~lv~e~~ 569 (817)
.+++.+.||+|.||.+.++.++. .+.+++|.+.......++|.+|...--.| .|.||+.-++. |...+..+.++||+
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a 104 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA 104 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence 35667789999999999999764 67899999987767788999998776666 59999988775 56667788999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec--CCCcEEEeecCCccccCCCC
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD--DNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~ki~Dfgla~~~~~~~ 647 (817)
+.|+|.+-+... .+-+....+++.|++.||.|+|+ .++||||||.+||||- +..++|++|||+.+..+..
T Consensus 105 P~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t- 176 (378)
T KOG1345|consen 105 PRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT- 176 (378)
T ss_pred ccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCce-
Confidence 999999988654 36777888999999999999999 9999999999999993 4458999999998754321
Q ss_pred ceeeeeccCCCCccCccccccC-----ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 648 SHVFTTLRGTRGYLAPEWITNY-----AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
.....-+..|.|||..... ...+.+|||.||++++.++||+.|++.....+..+ |-+..+..+......
T Consensus 177 ---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y---~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 177 ---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY---WEWEQWLKRKNPALP 250 (378)
T ss_pred ---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH---HHHHHHhcccCccCc
Confidence 1223345679999987532 34678999999999999999999998544433322 223333333322221
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
+ .-.. ....+.++.++-+..+|++|=-..++.++
T Consensus 251 ~--~F~~----fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 251 K--KFNP----FSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred h--hhcc----cCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 1 1111 22356677777888999999555555443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=247.81 Aligned_cols=190 Identities=26% Similarity=0.354 Sum_probs=164.7
Q ss_pred ccccCCCcceeEEEEEcCC-CcEEEEEEeccCCcC---------HHHHHHHHHHhhccC---cceeeeeeeEeecCCeee
Q 036583 497 SVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQG---------KKEFRAEVSIIGSIH---HLHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~---------~~~~~~Ev~~l~~l~---h~niv~l~~~~~~~~~~~ 563 (817)
..+||+|+||.|+.+.++. ..+|+||.+.+...- ....-.|+.||..++ |+||++++++|++++..|
T Consensus 566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy 645 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY 645 (772)
T ss_pred eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence 3679999999999999765 567899988654211 123567999999997 999999999999999999
Q ss_pred EEEeecc-CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 564 LAYEFMA-NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 564 lv~e~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
|+||-.. +-+|.+++..+. .+++..+.-|+.||+.|+++||+ .+|+|||||-+||.++.+|-+||+|||.+..
T Consensus 646 l~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 646 LETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred EEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccchhh
Confidence 9999764 558999998766 58999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCceeeeeccCCCCccCccccccCccC-ccccccchhhhHHHhhhCCCCCC
Q 036583 643 MTREQSHVFTTLRGTRGYLAPEWITNYAIS-EKSDVYSYGMVLLEIIGGRKNFD 695 (817)
Q Consensus 643 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~Gvvl~elltg~~pf~ 695 (817)
..... +...+||..|.|||++.+..|- ..-|||++|++||-++....||.
T Consensus 720 ~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 720 TKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 76543 3567899999999999998874 56799999999999999888874
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-26 Score=217.58 Aligned_cols=255 Identities=19% Similarity=0.305 Sum_probs=189.3
Q ss_pred hhccccccCCCcceeEEEEE-cCCCcEEEEEEeccCCcCHHHHHHHHHHhhccC-cceeeeeeeEeecCC--eeeEEEee
Q 036583 493 TNNFSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH-HLHLVKLRGFCAEGT--HRLLAYEF 568 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~-~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~--~~~lv~e~ 568 (817)
.+.+.+++|.|-+++|+.|. ..+.++++||+++.. ..+.+.+|++||..|. ||||++|++...+.. ...||+||
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 45566789999999999998 457888999999853 4578999999999997 999999999998755 45799999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC-CCcEEEeecCCccccCCCC
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD-NYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~Dfgla~~~~~~~ 647 (817)
..+.+...+.. .++...+.-++.++++||.|+|+ .+|+|||+||.|++||. .-..+|+|+|||....+..
T Consensus 117 v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 117 VNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 99988776553 46777888999999999999999 99999999999999995 5679999999999876654
Q ss_pred ceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcch--------HHHHHHhhhc--
Q 036583 648 SHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFP--------SYAFKMMEEG-- 716 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~--------~~~~~~~~~~-- 716 (817)
.. ...+.+.-|--||.+-. ..|+..-|+|||||+|.+|+..+.||--.....+ .+. +.....+.+-
T Consensus 188 eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 188 EY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred ee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHHHHHHHhChHHHHHHHHHHcc
Confidence 43 23345566788999865 4677889999999999999999999953322211 110 0111111111
Q ss_pred ----chhhhcccccC--------CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 717 ----KLRNILDSRLN--------IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 717 ----~~~~~~d~~~~--------~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
....++....+ .+...-...++++++...+..|.++|||++|.+.
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 11111111100 0000111256788999999999999999999875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=226.40 Aligned_cols=196 Identities=34% Similarity=0.526 Sum_probs=170.4
Q ss_pred cccccCCCcceeEEEEEcCC-CcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 496 FSVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
+.+.||+|++|.||++...+ ++.+++|.+..... ..+.+.+|++.+.+++|+|++++++++......++++||++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 45679999999999999865 88999999976533 4678999999999999999999999999999999999999999
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeee
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT 652 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 652 (817)
+|.+++..... .+++.....++.+++.++.+||+ .+++|+||+|.||+++.++.++|+|||++............
T Consensus 83 ~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 83 DLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 99999876542 17889999999999999999999 89999999999999999999999999999877554211222
Q ss_pred eccCCCCccCcccc-ccCccCccccccchhhhHHHhhhCCCCCCC
Q 036583 653 TLRGTRGYLAPEWI-TNYAISEKSDVYSYGMVLLEIIGGRKNFDP 696 (817)
Q Consensus 653 ~~~gt~~y~aPE~~-~~~~~~~~~DvwS~Gvvl~elltg~~pf~~ 696 (817)
...++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 34677889999998 667788899999999999999999999953
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=223.36 Aligned_cols=251 Identities=25% Similarity=0.306 Sum_probs=183.4
Q ss_pred cCCCcceeEEEEE-cCCCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecC------CeeeEEEeec
Q 036583 500 LGQGGFGSVYQGV-LPDGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG------THRLLAYEFM 569 (817)
Q Consensus 500 lG~G~fG~Vy~g~-~~~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~------~~~~lv~e~~ 569 (817)
+|.|.- .|-.+. .-.++.||+|++... ....+...+|..++..++|+|+++++.++.-. .+.|+|||+|
T Consensus 25 ~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m 103 (369)
T KOG0665|consen 25 IGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM 103 (369)
T ss_pred cCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh
Confidence 566665 444443 225788999988543 23346678899999999999999999999643 3569999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
.. +|...+.- .++-++...|+.|++.|+.|||+ .+|+||||||+||++..+..+||.|||+|+.-... .
T Consensus 104 ~~-nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~ 172 (369)
T KOG0665|consen 104 DA-NLCQVILM-----ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--F 172 (369)
T ss_pred hh-HHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCcc--c
Confidence 76 88888763 36678889999999999999999 99999999999999999999999999999854333 2
Q ss_pred eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCC------------Cc----chHHHHHHh
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDK------------AH----FPSYAFKMM 713 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~------------~~----~~~~~~~~~ 713 (817)
..+..+.+.-|.|||++-+..+.+.+||||.||++.||++|+..|.+....+. .. +...+....
T Consensus 173 ~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv 252 (369)
T KOG0665|consen 173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYV 252 (369)
T ss_pred ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHh
Confidence 34557888999999999988899999999999999999999998864432111 00 001111111
Q ss_pred hhcc------h-hhhcccccCC--cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 714 EEGK------L-RNILDSRLNI--DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 714 ~~~~------~-~~~~d~~~~~--~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
+... . +.+.|..... +.+......+.+++.+|+-.||++|.+++++|+.
T Consensus 253 ~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 253 ENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 1000 0 0111111111 1111234457789999999999999999999984
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-25 Score=241.05 Aligned_cols=247 Identities=22% Similarity=0.299 Sum_probs=194.0
Q ss_pred cccccCCCcceeEEEEEc-CCCcEEEEEEeccC-CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCC
Q 036583 496 FSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI-GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGS 573 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 573 (817)
...++|.|.||.|||++. ..++..|||.++-. ....+-...|+-+++..+||||+.++|.+...+..+++|||+.+|+
T Consensus 19 llqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggs 98 (829)
T KOG0576|consen 19 LLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS 98 (829)
T ss_pred heeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence 345799999999999995 45888999998755 3455677889999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeee
Q 036583 574 LDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT 653 (817)
Q Consensus 574 L~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 653 (817)
|.+.-+-.. +++..+.....+..++|++|||. .+-+|||||-.||++++.+.+|++|||.+-.+...- .....
T Consensus 99 lQdiy~~Tg---plselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~Krks 171 (829)
T KOG0576|consen 99 LQDIYHVTG---PLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AKRKS 171 (829)
T ss_pred ccceeeecc---cchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh-hhhhc
Confidence 999876554 78888888999999999999998 898999999999999999999999999987664321 12345
Q ss_pred ccCCCCccCccccc---cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 654 LRGTRGYLAPEWIT---NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 654 ~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
..||+.|||||+.. .+.|..++|||+.|+...|+-.-++|.-...+ ..+...+.+... -.+.+ ..
T Consensus 172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-------mr~l~LmTkS~~---qpp~l--kD 239 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-------MRALFLMTKSGF---QPPTL--KD 239 (829)
T ss_pred ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-------HHHHHHhhccCC---CCCcc--cC
Confidence 78999999999874 56789999999999999999877766532211 111111111110 01111 12
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
...-...+-++++.++-.+|++||+++.+++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 2233446778999999999999999987664
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-25 Score=267.08 Aligned_cols=195 Identities=18% Similarity=0.227 Sum_probs=139.1
Q ss_pred ccCc-ceeeeeeeEe-------ecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCce
Q 036583 543 SIHH-LHLVKLRGFC-------AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614 (817)
Q Consensus 543 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~i 614 (817)
.++| +||++++++| .+.+..++++||+ +++|.++|.... ..+++..++.++.||++||+|||+ ++|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHS---QGI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 4556 6888899988 2334567778987 559999997543 258999999999999999999998 999
Q ss_pred eecCCCCCCeEecC-------------------CCcEEEeecCCccccCCCCc---------------eeeeeccCCCCc
Q 036583 615 IHCDIKPENVLLDD-------------------NYHAKVSDFGLAKLMTREQS---------------HVFTTLRGTRGY 660 (817)
Q Consensus 615 vH~Dlk~~NIll~~-------------------~~~~ki~Dfgla~~~~~~~~---------------~~~~~~~gt~~y 660 (817)
+||||||+||||+. ++.+||+|||+++....... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999965 44556666666653211000 000113578889
Q ss_pred cCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHH
Q 036583 661 LAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVK 740 (817)
Q Consensus 661 ~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 740 (817)
||||++.+..++.++|||||||+||||++|..|+.... .....+... .+.+. ..........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---------~~~~~~~~~----~~~~~-----~~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---------RTMSSLRHR----VLPPQ-----ILLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---------HHHHHHHHh----hcChh-----hhhcCHHHHH
Confidence 99999999999999999999999999999888764211 001111111 11111 0112234567
Q ss_pred HHHhccccCCCCCCCHHHHHH
Q 036583 741 VALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 741 l~~~cl~~dp~~RPt~~evl~ 761 (817)
++.+||+.+|.+||+|.|+++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 888999999999999999986
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-24 Score=191.73 Aligned_cols=110 Identities=35% Similarity=0.613 Sum_probs=96.3
Q ss_pred CCCCEEEeCCCeeEEeeecCCCCCceEEEEEEecCCceEEEEcCCCCCCCCCCCcEEecCceEEE-ecCCeEEEEeCCCC
Q 036583 48 KNGLFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVSL-QKGGSVVWSVNPSG 126 (817)
Q Consensus 48 ~~~~~lvs~~g~f~~gf~~~~~~~~~y~~i~~~~~~~t~vWvAnr~~Pi~~~~~~~~~~~g~l~l-~~~~~~vWstn~~~ 126 (817)
..|++|+|++|.|++|||++..+...|.+|||...++++||.|||+.|......+.|..||+|+| +.+|.+||++++.+
T Consensus 5 ~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~~ 84 (116)
T cd00028 5 SSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTTR 84 (116)
T ss_pred CCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEecccC
Confidence 34899999999999999999766547899999876689999999999966666788999999998 56889999999875
Q ss_pred -CceeEEEEecCCCEEEEccCCccccccccCC
Q 036583 127 -ASVSAMELRDSGNLVLLGNDNKVLWQSFSHP 157 (817)
Q Consensus 127 -~~~~~a~LldsGNLVL~~~~~~~lWQSFd~P 157 (817)
.....++|+|+|||||++.++.+||||||||
T Consensus 85 ~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P 116 (116)
T cd00028 85 VNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116 (116)
T ss_pred CCCceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence 4556789999999999999999999999998
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=221.88 Aligned_cols=191 Identities=24% Similarity=0.340 Sum_probs=159.1
Q ss_pred ccccCCCcceeEEEEEcC----CCcEEEEEEeccCCcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 497 SVKLGQGGFGSVYQGVLP----DGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~~----~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
.++||+|.|++||++.+. ..+.||+|.+.... ....+.+|+++|..+ .+.||+++.+++..+++.++|+||+++
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H 119 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEH 119 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCc
Confidence 478999999999999854 35789999986532 345689999999999 599999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC-CCcEEEeecCCccccCCCC---
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD-NYHAKVSDFGLAKLMTREQ--- 647 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~Dfgla~~~~~~~--- 647 (817)
....++... ++...+..+++.+.+||+++|. .+||||||||+|+|.+. .+.-.|.|||||.......
T Consensus 120 ~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~ 190 (418)
T KOG1167|consen 120 DRFRDLYRS------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTE 190 (418)
T ss_pred cCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhhhhhh
Confidence 999888853 5678889999999999999999 99999999999999984 5678999999998211000
Q ss_pred ------------------------------c----------eeeeeccCCCCccCcccccc-CccCccccccchhhhHHH
Q 036583 648 ------------------------------S----------HVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLE 686 (817)
Q Consensus 648 ------------------------------~----------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~e 686 (817)
. .......||++|.|||++.. ...+.++||||.|||++-
T Consensus 191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls 270 (418)
T KOG1167|consen 191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS 270 (418)
T ss_pred hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence 0 00112469999999999975 456889999999999999
Q ss_pred hhhCCCCCCCC
Q 036583 687 IIGGRKNFDPN 697 (817)
Q Consensus 687 lltg~~pf~~~ 697 (817)
+++++.||-..
T Consensus 271 lls~~~PFf~a 281 (418)
T KOG1167|consen 271 LLSRRYPFFKA 281 (418)
T ss_pred hhccccccccC
Confidence 99999999543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.8e-25 Score=213.06 Aligned_cols=249 Identities=20% Similarity=0.328 Sum_probs=189.8
Q ss_pred hccccccCCCcceeEEEEEcCCCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.++..+|.+...|+.|+|+++. ..+++|++... ..-.++|..|.-.|+.+.||||+.++|.|....+..++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 3455689999999999999954 45667777432 3345789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
.|+|...|+.... ...+-.++.+++.+||+|++|||+. .+-|..--|.++.++||++.+++|+= +-+++....
T Consensus 271 ~gslynvlhe~t~-vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsfqe---- 343 (448)
T KOG0195|consen 271 FGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQE---- 343 (448)
T ss_pred chHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeeeec----
Confidence 9999999986543 4688899999999999999999983 33455557899999999999988852 111111111
Q ss_pred eeeccCCCCccCccccccCccC---ccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 651 FTTLRGTRGYLAPEWITNYAIS---EKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~~~~---~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
....-.+.||+||.++..+-+ .++|+|||.++||||.|...||..-.+.+... ++.-+.++
T Consensus 344 -~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm---------------kialeglr 407 (448)
T KOG0195|consen 344 -VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM---------------KIALEGLR 407 (448)
T ss_pred -cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---------------hhhhcccc
Confidence 112335789999999876554 47899999999999999999997544332111 11112222
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
...+......+.+++.-|+.+||.+||.+..|+-.||+.
T Consensus 408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 333333445678888999999999999999999999975
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.1e-25 Score=196.04 Aligned_cols=101 Identities=43% Similarity=0.737 Sum_probs=68.7
Q ss_pred CceEEEEcCCCCCCCC---CCCcEEecCceEEE-ecCCeEEEEe-CCCCC--ceeEEEEecCCCEEEEccCCcccccccc
Q 036583 83 SSTIIWTANRGSPVAN---SDNFVFKKDGEVSL-QKGGSVVWSV-NPSGA--SVSAMELRDSGNLVLLGNDNKVLWQSFS 155 (817)
Q Consensus 83 ~~t~vWvAnr~~Pi~~---~~~~~~~~~g~l~l-~~~~~~vWst-n~~~~--~~~~a~LldsGNLVL~~~~~~~lWQSFd 155 (817)
++|+||+|||++|+.. ...|.|+.||+|+| +.+++++|++ ++.+. ....|+|+|+|||||+|.++++||||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~ 80 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFD 80 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTT
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecC
Confidence 3699999999999953 25678999999998 5677899999 44433 4678999999999999999999999999
Q ss_pred CCCcccccCCccCCCc------eeecCCCCCCcc
Q 036583 156 HPTDTLISNQDFTQGM------KLVSAPSTNNLS 183 (817)
Q Consensus 156 ~PtDTlLP~~~l~~~~------kl~s~~s~g~~s 183 (817)
|||||+||+|+|+.+. ++++|.+..|+|
T Consensus 81 ~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 81 YPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp SSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred CCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 9999999999988632 356666665553
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=205.25 Aligned_cols=167 Identities=20% Similarity=0.223 Sum_probs=125.2
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
|+|.+++..... .+++..++.++.||++||.|||+ .+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRGR--PLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc----
Confidence 689999975432 69999999999999999999998 44 999999999999999 99988654422
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
..|++.|||||++.+..++.++|||||||++|||++|+.||....... ... ..+........... ....
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-----~~~-~~~~~~~~~~~~~~---~~~~ 132 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-----AIL-EILLNGMPADDPRD---RSNL 132 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-----HHH-HHHHHHhccCCccc---cccH
Confidence 258899999999999999999999999999999999999996432211 111 11111110000000 0111
Q ss_pred HHHH--HHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 732 SDRV--FTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 732 ~~~~--~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.... ..+.+++.+|++.+|.+||++.|+++.+...
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 1122 2588999999999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=182.71 Aligned_cols=108 Identities=37% Similarity=0.644 Sum_probs=94.4
Q ss_pred CCCCEEEeCCCeeEEeeecCCCCCceEEEEEEecCCceEEEEcCCCCCCCCCCCcEEecCceEEE-ecCCeEEEEeCCC-
Q 036583 48 KNGLFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVSL-QKGGSVVWSVNPS- 125 (817)
Q Consensus 48 ~~~~~lvs~~g~f~~gf~~~~~~~~~y~~i~~~~~~~t~vWvAnr~~Pi~~~~~~~~~~~g~l~l-~~~~~~vWstn~~- 125 (817)
.+|++|+|+++.|++|||.+..+ ..+.+|||+..++++||+|||+.|+.++..+.+..||+|+| +.+|.+||++++.
T Consensus 5 ~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t~~ 83 (114)
T smart00108 5 SSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNTTG 83 (114)
T ss_pred CCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEecccC
Confidence 35899999999999999998765 56899999876588999999999988777788999999998 6678999999986
Q ss_pred CCceeEEEEecCCCEEEEccCCccccccccC
Q 036583 126 GASVSAMELRDSGNLVLLGNDNKVLWQSFSH 156 (817)
Q Consensus 126 ~~~~~~a~LldsGNLVL~~~~~~~lWQSFd~ 156 (817)
+.....++|+|+|||||++..+++|||||||
T Consensus 84 ~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~ 114 (114)
T smart00108 84 ANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114 (114)
T ss_pred CCCceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence 4455678999999999999999999999997
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.5e-22 Score=211.68 Aligned_cols=171 Identities=21% Similarity=0.183 Sum_probs=129.8
Q ss_pred HhhccccccCCCcceeEEEEEcC--CCcEEEEEEeccCC------cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP--DGTRLAVKKLEGIG------QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~--~g~~vavK~l~~~~------~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 563 (817)
..+.+.+.||+|+||+||+|... +++.+|||++.... ...+.|.+|++++.+++|+|++..+.. ....+
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~ 94 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDG 94 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcE
Confidence 44666788999999999999864 57778999875321 124568999999999999999853322 24579
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCC-CCCCeEecCCCcEEEeecCCccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDI-KPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~ki~Dfgla~~ 642 (817)
+||||+++++|... . .. ....++.|++++|.|||+ .+|+|||| ||+|||++.++.+||+|||+++.
T Consensus 95 LVmE~~~G~~L~~~-~-~~--------~~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 95 LVRGWTEGVPLHLA-R-PH--------GDPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred EEEEccCCCCHHHh-C-cc--------chHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 99999999999632 1 11 014678899999999999 99999999 99999999999999999999997
Q ss_pred cCCCCce-------eeeeccCCCCccCccccccCc------cCcccccc
Q 036583 643 MTREQSH-------VFTTLRGTRGYLAPEWITNYA------ISEKSDVY 678 (817)
Q Consensus 643 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~------~~~~~Dvw 678 (817)
+...... ......+++.|+|||.+.... .+..+|-|
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 7543211 113466888999999996432 23346666
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-19 Score=196.76 Aligned_cols=258 Identities=21% Similarity=0.276 Sum_probs=188.1
Q ss_pred hhccccccCCCcceeEEEEEcCCC--cEEEEEEeccCC-cCHHHHHHHHHHhhccCc----ceeeeeeeEe-ecCCeeeE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPDG--TRLAVKKLEGIG-QGKKEFRAEVSIIGSIHH----LHLVKLRGFC-AEGTHRLL 564 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~g--~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h----~niv~l~~~~-~~~~~~~l 564 (817)
.+.+.++||+|+||.||++..... ..+|+|.-.... .....+..|+.++..+.+ +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 456678999999999999996543 477888765542 222378889999988873 5888999888 47778899
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCC-----CcEEEeecCC
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDN-----YHAKVSDFGL 639 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-----~~~ki~Dfgl 639 (817)
||+.. |.+|.++..... ...++..+.++|+.|++.+|.+||+ .+++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99877 559999775544 3468999999999999999999999 999999999999999754 4699999999
Q ss_pred ccccC--CCCce----e---eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHH
Q 036583 640 AKLMT--REQSH----V---FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAF 710 (817)
Q Consensus 640 a~~~~--~~~~~----~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~ 710 (817)
++... ..... . .....||.+|.++....+...+.+.|+||++.++.|++.|..|+........ .
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-------~ 246 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-------K 246 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-------H
Confidence 99322 21110 1 1235699999999999999999999999999999999999999854433221 0
Q ss_pred HHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 711 KMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 711 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
.............. ........+.++...+-..+...+|....+...|+...
T Consensus 247 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 247 SKFEKDPRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred HHHHHHhhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 11111111111110 01111223444444455589999999999999987653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.9e-19 Score=191.00 Aligned_cols=259 Identities=31% Similarity=0.395 Sum_probs=194.8
Q ss_pred ccccccCCCcceeEEEEEcCCCcEEEEEEeccCCc----CHHHHHHHHHHhhccCcc-eeeeeeeEeecCCeeeEEEeec
Q 036583 495 NFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQ----GKKEFRAEVSIIGSIHHL-HLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~----~~~~~~~Ev~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~~ 569 (817)
.+...||.|.||.||++... ..+++|.+..... ....+.+|+.++..+.|+ +++++.+.+......+++++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 34567999999999999986 7889999865422 367899999999999988 7999999997777789999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC-cEEEeecCCccccCCCCc
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY-HAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Dfgla~~~~~~~~ 648 (817)
.+++|.+++........+.......++.|++.++.|+|+ .+++|||+||+||+++... .++++|||+++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 999999766543211147788899999999999999999 8899999999999999988 799999999986654332
Q ss_pred e-----eeeeccCCCCccCcccccc---CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhh
Q 036583 649 H-----VFTTLRGTRGYLAPEWITN---YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRN 720 (817)
Q Consensus 649 ~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (817)
. ......|+..|+|||.+.+ ..+....|+||+|++++++++|..||...... .........+......
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~- 233 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP- 233 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc-
Confidence 2 2355789999999999987 57888999999999999999999997544321 0011122222211111
Q ss_pred hcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 721 ILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 721 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.................+.+++..++..+|..|.++.+....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223467788899999999999999887763
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.5e-21 Score=218.76 Aligned_cols=250 Identities=23% Similarity=0.258 Sum_probs=184.9
Q ss_pred ccccCCCcceeEEEEEcC-CCcEEEEEEec----cCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 497 SVKLGQGGFGSVYQGVLP-DGTRLAVKKLE----GIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~----~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
.+.+|.|++|.|+..... .....+.|... .... ....+..|+-+-..++|+|++..+..+.+.....-.|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 356999999977777632 23333333322 2111 112366788888899999999988888877776666999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++ +|..++.+.. .+....+..++.|++.|+.|||+ .+|.|||+|++|++++.++.+||+|||.+..+.-...
T Consensus 403 ~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 403 CPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred ccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 999 9999987653 47778888999999999999999 9999999999999999999999999999988754433
Q ss_pred ---eeeeeccCCCCccCccccccCccCc-cccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccc
Q 036583 649 ---HVFTTLRGTRGYLAPEWITNYAISE-KSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724 (817)
Q Consensus 649 ---~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 724 (817)
.......|...|+|||++.+..|.+ ..||||.|+++..|++|+.||......+.... ......-..+..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~------~~~~~~~~~~~~- 548 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK------TNNYSDQRNIFE- 548 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh------hhcccccccccc-
Confidence 2334578999999999999999986 58999999999999999999965544432210 000000000000
Q ss_pred ccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 725 RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 725 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
-........+.+...++.+|++.||.+|.|+++|++
T Consensus 549 -~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 549 -GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 001111233456778999999999999999999987
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=173.27 Aligned_cols=203 Identities=22% Similarity=0.336 Sum_probs=168.2
Q ss_pred HHhhccccccCCCcceeEEEEE-cCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCc-ceeeeeeeEeecCCeeeEEEee
Q 036583 491 TATNNFSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHH-LHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~-~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~ 568 (817)
...+.+.++||.|+||.+|.|. +.+|.+||||.=+. ......+.-|.++.+.++| ..|..+..+..+...-.|||+.
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~-~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS-KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecc-cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 3456777999999999999998 66899999997653 3345577889999999974 5788888888999999999998
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec---CCCcEEEeecCCccccCC
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD---DNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~ki~Dfgla~~~~~ 645 (817)
. +.+|.+++.-... .++..+.+.++.|++.-++|+|. ++++||||||+|+|.. ....+.++|||||+....
T Consensus 93 L-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 93 L-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred c-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 8 5589888865544 47888999999999999999999 9999999999999986 345799999999997754
Q ss_pred CCce------eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCC
Q 036583 646 EQSH------VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETS 700 (817)
Q Consensus 646 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~ 700 (817)
.... ......||.+|.+-....+...+.+.|+=|+|.+|..+.-|..||++....
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 3221 112367999999988887878888999999999999999999999876544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-19 Score=176.90 Aligned_cols=137 Identities=15% Similarity=0.163 Sum_probs=107.3
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccCCc---C-------HHHH-----------------HHHHHHhhccCcceee
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQ---G-------KKEF-----------------RAEVSIIGSIHHLHLV 550 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~---~-------~~~~-----------------~~Ev~~l~~l~h~niv 550 (817)
..||+|+||.||+|...+|+.||||+++.... . ...| ..|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 46999999999999988899999999965321 1 1122 3499999999887764
Q ss_pred eeeeEeecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHH-HhcCCCceeecCCCCCCeEecCC
Q 036583 551 KLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYL-HEDCDQRIIHCDIKPENVLLDDN 629 (817)
Q Consensus 551 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~L-H~~~~~~ivH~Dlk~~NIll~~~ 629 (817)
....+.. ...+|||||+++++|...+.... .++......++.|++.+|.|| |+ .+|+||||||+|||++ +
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~---~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~ 153 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKDA---PLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-C
Confidence 4333222 23389999999987765433222 578889999999999999999 67 8999999999999998 4
Q ss_pred CcEEEeecCCcccc
Q 036583 630 YHAKVSDFGLAKLM 643 (817)
Q Consensus 630 ~~~ki~Dfgla~~~ 643 (817)
+.++|+|||++...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.7e-19 Score=195.70 Aligned_cols=217 Identities=24% Similarity=0.406 Sum_probs=163.9
Q ss_pred hhccCcceeeeeeeEeecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCce-eecCC
Q 036583 541 IGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI-IHCDI 619 (817)
Q Consensus 541 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~i-vH~Dl 619 (817)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+..... .++|.-...++.+|+.||+|||. ..| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~--~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI--KLDYFFILSFIRDISKGLAYLHN---SPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc--CccHHHHHHHHHHHHHHHHHHhc---Ccceeeeee
Confidence 4578999999999999999999999999999999999987443 68999999999999999999998 444 99999
Q ss_pred CCCCeEecCCCcEEEeecCCccccCCCC-ceeeeeccCCCCccCccccccC-------ccCccccccchhhhHHHhhhCC
Q 036583 620 KPENVLLDDNYHAKVSDFGLAKLMTREQ-SHVFTTLRGTRGYLAPEWITNY-------AISEKSDVYSYGMVLLEIIGGR 691 (817)
Q Consensus 620 k~~NIll~~~~~~ki~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwS~Gvvl~elltg~ 691 (817)
+++|.++|....+||+|||+........ ........-..-|.|||.++.. ..+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999988764311 1111112234479999999763 1467899999999999999999
Q ss_pred CCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 692 KNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 692 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
.||+........ ......++++. ...+.|.+ ....+....+..++..||..+|.+||++++|-..++.+..
T Consensus 156 ~~~~~~~~~~~~---~eii~~~~~~~-~~~~rP~i--~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 156 GPFDLRNLVEDP---DEIILRVKKGG-SNPFRPSI--ELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred CccccccccCCh---HHHHHHHHhcC-CCCcCcch--hhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 999765433322 22222233311 11111111 1111333368899999999999999999999998887633
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.1e-19 Score=175.68 Aligned_cols=200 Identities=23% Similarity=0.328 Sum_probs=168.1
Q ss_pred hccccccCCCcceeEEEEE-cCCCcEEEEEEeccCCcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 494 NNFSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~-~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+.+.++||+|.||.++.|+ +-+++.||||.=. ......++..|.+..+.| ..+.|...+-|-.++.+-.||+|.+ |
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP-rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP-RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred ceeccccccCcceeeecccccccCceEEEEecc-ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence 4567899999999999998 5589999999643 333456788898888888 5788999888888999999999988 5
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec-----CCCcEEEeecCCccccCCC
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD-----DNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~-----~~~~~ki~Dfgla~~~~~~ 646 (817)
-+|.+++.-... .++.++...+|.|++.-++|+|+ +.+|.|||||+|+||. +...+.|+|||||+.....
T Consensus 108 PSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 108 PSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred cCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 589888866554 58889999999999999999999 9999999999999996 3456999999999987654
Q ss_pred Ccee------eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCC
Q 036583 647 QSHV------FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETS 700 (817)
Q Consensus 647 ~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~ 700 (817)
.... .....||.+||+-....++..+.+.|+=|+|-|+++.+-|..||++-...
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 3221 23467999999999999999999999999999999999999999865443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.8e-19 Score=177.93 Aligned_cols=173 Identities=11% Similarity=0.083 Sum_probs=133.8
Q ss_pred HHHHHHhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHH----------HHHHHHHHhhccCcceeeeeeeEe
Q 036583 487 RDLQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKK----------EFRAEVSIIGSIHHLHLVKLRGFC 556 (817)
Q Consensus 487 ~~l~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~----------~~~~Ev~~l~~l~h~niv~l~~~~ 556 (817)
+++....+...+.||.|+||.||+... ++..+|||.+.......+ .+.+|+..+.+++|++|..+..++
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 344556677778999999999999766 577899999975432222 168999999999999999999986
Q ss_pred ecC--------CeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC
Q 036583 557 AEG--------THRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD 628 (817)
Q Consensus 557 ~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~ 628 (817)
... ...+|+|||++|.+|.++.. ++. ....+++.++..+|+ .+++|||+||+||++++
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSK 170 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeC
Confidence 543 35789999999999987632 221 245699999999999 99999999999999999
Q ss_pred CCcEEEeecCCccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhh
Q 036583 629 NYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEII 688 (817)
Q Consensus 629 ~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ell 688 (817)
++ ++|+|||.......+... ..+...+.+..++|+|+||+.+..+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 88 999999988765322211 11334455677999999999987764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-19 Score=205.95 Aligned_cols=244 Identities=22% Similarity=0.287 Sum_probs=179.5
Q ss_pred ccccccCCCcceeEEEEEcCCCcEEEEEEeccCC--cCHHHHHHHHHH--hhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 495 NFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIG--QGKKEFRAEVSI--IGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~--~~~~~~~~Ev~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.+.+.||.++|=.|.+++.++|. |+||++-+.. ...+.|.++++- ...++|||.+++.-.-......|||-+|..
T Consensus 26 ~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvk 104 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVK 104 (1431)
T ss_pred eeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHh
Confidence 34567999999999999998887 9999985442 234555444333 455689999999888777778889999987
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc--CCCCc
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM--TREQS 648 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~--~~~~~ 648 (817)
+ +|.+.|.... .+...+...|+.|++.||.-+|+ .+|+|+|||.+||||+.-.-+.|+||..-+.. ..+..
T Consensus 105 h-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 105 H-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred h-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 7 8888885443 68888889999999999999999 99999999999999999999999999865532 22322
Q ss_pred eeee----eccCCCCccCcccccc----------Cc-cCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHH
Q 036583 649 HVFT----TLRGTRGYLAPEWITN----------YA-ISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKM 712 (817)
Q Consensus 649 ~~~~----~~~gt~~y~aPE~~~~----------~~-~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 712 (817)
..+. +...-.-|+|||.+-. .. .+++-||||+||++.||++ |++||...... +++.
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~--------aYr~ 249 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLL--------AYRS 249 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHH--------hHhc
Confidence 2222 2233346999998743 12 5678899999999999988 78888532100 0111
Q ss_pred hhhc----chhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 713 MEEG----KLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 713 ~~~~----~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.... -+.++-|. .+.+++..|++.||++|-++++.++.-.++
T Consensus 250 ~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 250 GNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred cCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 1011 11112121 467899999999999999999999975554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.5e-18 Score=170.03 Aligned_cols=140 Identities=16% Similarity=0.141 Sum_probs=110.0
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccCCcC---------------------------HHHHHHHHHHhhccCcceee
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQG---------------------------KKEFRAEVSIIGSIHHLHLV 550 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~---------------------------~~~~~~Ev~~l~~l~h~niv 550 (817)
..||+|+||.||+|...+|+.||||+++..... ...+..|.+.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 469999999999999878999999998754210 11235789999999999875
Q ss_pred eeeeEeecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC
Q 036583 551 KLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY 630 (817)
Q Consensus 551 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~ 630 (817)
....+... ..+|||||++++++........ .++.....+++.|++.++.+||+. .+|+||||||+||+++ ++
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~---~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKDV---PLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhhc---cCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE-CC
Confidence 54444332 3489999999886544322222 467788899999999999999973 7999999999999999 78
Q ss_pred cEEEeecCCccccCC
Q 036583 631 HAKVSDFGLAKLMTR 645 (817)
Q Consensus 631 ~~ki~Dfgla~~~~~ 645 (817)
.++|+|||++.....
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999987644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-18 Score=155.41 Aligned_cols=108 Identities=22% Similarity=0.374 Sum_probs=91.9
Q ss_pred cccCccccccccCCCcceeeeccCCCeeeeecCCcceEEEEEEecCCCcceEEEEEECCCceEEEEEccCCCCCceeecc
Q 036583 206 WSMGREERKTINKGGGEVTSASLSANSWRFYDNNKIFLWQFIFSDNTDGNATWIAVLANDGFISFYNLQDGEPSTASNTK 285 (817)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~g~l~~~~~~~~~~~w~~~~~ 285 (817)
|++|+|++.+|. |.+.+.......+.|+.++++.+++|.+.+.+ .++|++|+.+|+++++.|.+....|...|.
T Consensus 1 wrsG~WnG~~f~---g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s---~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~ 74 (110)
T PF00954_consen 1 WRSGPWNGQRFS---GIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSS---VLSRLVLDSDGQLQRYIWNESTQSWSVFWS 74 (110)
T ss_pred CCccccCCeEEC---CcccccccceeEEEEEECCCeEEEEEecCCCc---eEEEEEEeeeeEEEEEEEecCCCcEEEEEE
Confidence 789999888875 34444444556788999999999999877543 677899999999999999999999999999
Q ss_pred ccCCCCCCCCCCCCCccCCC--CCcccCCCCcCCCC
Q 036583 286 IPNSPCSTPEPCDAYYICSG--INKCQCPSVISSQN 319 (817)
Q Consensus 286 ~p~~~C~~~~~Cg~yg~C~~--~~~C~C~~gf~~~~ 319 (817)
+|.+.|++|+.||+||+|+. .+.|.|++||.+++
T Consensus 75 ~p~d~Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 75 APKDQCDVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred ecccCCCCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 99999999999999999976 46799999998653
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.4e-18 Score=165.81 Aligned_cols=181 Identities=15% Similarity=0.097 Sum_probs=137.6
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHH-----HHHHHHHHhhccC-cceeeeeeeEeecCCeeeEEEeeccC
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKK-----EFRAEVSIIGSIH-HLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~-----~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
..|++|+||+||.+.- ++.+++.+.+.......+ .+.+|+++|.+++ |+++.+++++ ...+++|||+.+
T Consensus 8 ~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G 82 (218)
T PRK12274 8 EPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG 82 (218)
T ss_pred eeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence 5699999999997776 777888888876544222 5789999999995 5889999886 446999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCC-CCCCeEecCCCcEEEeecCCccccCCCCce-
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDI-KPENVLLDDNYHAKVSDFGLAKLMTREQSH- 649 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~ki~Dfgla~~~~~~~~~- 649 (817)
.+|...+.. ....++.|++++|.++|+ .+|+|||| ||.|||++.++.++|+|||++.........
T Consensus 83 ~~L~~~~~~----------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 83 AAMYQRPPR----------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ccHHhhhhh----------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 998654321 113477899999999999 99999999 799999999999999999999865433210
Q ss_pred ------ee----e-eccCCCCccCccccccC-ccC-ccccccchhhhHHHhhhCCCCCCC
Q 036583 650 ------VF----T-TLRGTRGYLAPEWITNY-AIS-EKSDVYSYGMVLLEIIGGRKNFDP 696 (817)
Q Consensus 650 ------~~----~-~~~gt~~y~aPE~~~~~-~~~-~~~DvwS~Gvvl~elltg~~pf~~ 696 (817)
.. . ....++.|++|+...-. ..+ ...+.++-|.-+|.++|++.++-.
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 00 0 12356677777754321 223 567999999999999999887643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-18 Score=190.50 Aligned_cols=223 Identities=27% Similarity=0.325 Sum_probs=176.3
Q ss_pred cCCCcceeEEEEE----cCCCcEEEEEEeccCC---cCHHHHHHHHHHhhccC-cceeeeeeeEeecCCeeeEEEeeccC
Q 036583 500 LGQGGFGSVYQGV----LPDGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIH-HLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 500 lG~G~fG~Vy~g~----~~~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+|+|.||.|++.+ .+.|..+|+|.+.+.. ........|..++..++ ||.++++.-.+..+...+++.+|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999999865 3456778888876542 11225567888888897 99999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
|.|...+.+.. ..+......+...++-+++++|+ .+|+|||+|++||+++.+|.+|+.|||+++..-....
T Consensus 82 g~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 82 GDLFTRLSKEV---MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred chhhhccccCC---chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 99988886655 46666777788889999999999 9999999999999999999999999999987644332
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
.+||..|||||++. .....+|.||||++++||++|..||... .+..++... ...+
T Consensus 153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~-------------------~~~~Il~~~--~~~p 207 (612)
T KOG0603|consen 153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD-------------------TMKRILKAE--LEMP 207 (612)
T ss_pred --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH-------------------HHHHHhhhc--cCCc
Confidence 28999999999998 5678999999999999999999999741 111122111 2223
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCH
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSM 756 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~ 756 (817)
......+.+++..+...+|.+|--.
T Consensus 208 ~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 208 RELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 3444556677777888888888644
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=171.47 Aligned_cols=228 Identities=20% Similarity=0.267 Sum_probs=146.9
Q ss_pred ccccCCCcceeEEEEEcCC-CcEEEEEEeccC----CcCHHHHHHHHHHhhccCc----------ceeeeeeeEe-----
Q 036583 497 SVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHH----------LHLVKLRGFC----- 556 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h----------~niv~l~~~~----- 556 (817)
...||.|+|+.||.++..+ +++.|||..... ....+++++|.-.+..+.+ -.++..++..
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 4569999999999999754 899999988432 2234677777766655432 2222222222
Q ss_pred ----ecCC--------eeeEEEeeccCCChhhhhhh---cc-cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCC
Q 036583 557 ----AEGT--------HRLLAYEFMANGSLDKWIFK---KN-QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIK 620 (817)
Q Consensus 557 ----~~~~--------~~~lv~e~~~~gsL~~~l~~---~~-~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk 620 (817)
.... +.+++|+-+ .++|.+++.. .. ....+....++.+..|+++.+++||. .+++|+||+
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEecccc
Confidence 1111 235677776 4488777542 21 12346667778888999999999999 999999999
Q ss_pred CCCeEecCCCcEEEeecCCccccCCCCceeeeeccCCCCccCcccccc--------CccCccccccchhhhHHHhhhCCC
Q 036583 621 PENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN--------YAISEKSDVYSYGMVLLEIIGGRK 692 (817)
Q Consensus 621 ~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwS~Gvvl~elltg~~ 692 (817)
|+|++++.+|.++|+||+.....+.. ......+..|.+||.... ..++.+.|.|++|+++|.|.+++.
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999999999999877644321 111345578999997754 256889999999999999999999
Q ss_pred CCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCC
Q 036583 693 NFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLR 753 (817)
Q Consensus 693 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~R 753 (817)
||+.......... ......+.++.+..++..+++.||.+|
T Consensus 249 Pf~~~~~~~~~~~---------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW---------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG---------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc---------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9976543321110 111111455678899999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=158.65 Aligned_cols=132 Identities=20% Similarity=0.243 Sum_probs=102.6
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccC-CcCHHHHHHHHHHhhcc-----CcceeeeeeeEeecCC---ee-eEEEe
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGI-GQGKKEFRAEVSIIGSI-----HHLHLVKLRGFCAEGT---HR-LLAYE 567 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~-~~~~~~~~~Ev~~l~~l-----~h~niv~l~~~~~~~~---~~-~lv~e 567 (817)
..||+|+||.||. .-.++.. +||++... ....+.+.+|+.++..+ .||||++++|++.++. .. .+|+|
T Consensus 8 ~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 4699999999996 3234444 78887653 33467899999999999 5799999999998764 33 37899
Q ss_pred e--ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHH-HHHHhcCCCceeecCCCCCCeEecC----CCcEEEeecCCc
Q 036583 568 F--MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGL-AYLHEDCDQRIIHCDIKPENVLLDD----NYHAKVSDFGLA 640 (817)
Q Consensus 568 ~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l-~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~ki~Dfgla 640 (817)
| +++++|.+++.+.. ++.. ..++.|++.++ +|||+ .+|+||||||+|||++. +.+++|+||+.+
T Consensus 86 ~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 86 FDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 9 55899999996532 4433 35677888777 99999 99999999999999973 348999995443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=3e-16 Score=160.94 Aligned_cols=140 Identities=16% Similarity=0.157 Sum_probs=108.5
Q ss_pred hccccccCCCcceeEEEEE--cCCCcEEEEEEeccCCc---C----------------------HHHHHHHHHHhhccCc
Q 036583 494 NNFSVKLGQGGFGSVYQGV--LPDGTRLAVKKLEGIGQ---G----------------------KKEFRAEVSIIGSIHH 546 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~--~~~g~~vavK~l~~~~~---~----------------------~~~~~~Ev~~l~~l~h 546 (817)
+.+.+.||+|+||.||+|. ..+|+.||+|++..... . ...+..|+.++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 3456789999999999998 56899999999864321 0 1235689999999975
Q ss_pred c--eeeeeeeEeecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCc-eeecCCCCCC
Q 036583 547 L--HLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR-IIHCDIKPEN 623 (817)
Q Consensus 547 ~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~-ivH~Dlk~~N 623 (817)
. .+.+++++ ...++||||+++++|........ .+.......++.||+.++.+||+ .+ |+||||||+|
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~N 179 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYN 179 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhh
Confidence 3 33444443 23589999999988876543222 34555678899999999999999 88 9999999999
Q ss_pred eEecCCCcEEEeecCCccccC
Q 036583 624 VLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 624 Ill~~~~~~ki~Dfgla~~~~ 644 (817)
|+++ ++.++|+|||++....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999987543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.2e-16 Score=159.95 Aligned_cols=197 Identities=22% Similarity=0.281 Sum_probs=136.9
Q ss_pred CcceeeeeeeEeec---------------------------CCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHH
Q 036583 545 HHLHLVKLRGFCAE---------------------------GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIAL 597 (817)
Q Consensus 545 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 597 (817)
+|||||++.++|.+ +...|+||.-.+. +|.++|.... .+...+.-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence 68888888887643 2356888887766 8999987543 56677788999
Q ss_pred HHHHHHHHHHhcCCCceeecCCCCCCeEe--cCCC--cEEEeecCCccccCCC-----CceeeeeccCCCCccCcccccc
Q 036583 598 GTAKGLAYLHEDCDQRIIHCDIKPENVLL--DDNY--HAKVSDFGLAKLMTRE-----QSHVFTTLRGTRGYLAPEWITN 668 (817)
Q Consensus 598 qia~~l~~LH~~~~~~ivH~Dlk~~NIll--~~~~--~~ki~Dfgla~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~ 668 (817)
|+++|+.|||+ ++|.|||+|++|||| |++. ...|+|||.+.--... -........|....||||+...
T Consensus 349 QlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 99999999999 999999999999998 3443 5788999976532221 0111123567788999999864
Q ss_pred Ccc------CccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHH
Q 036583 669 YAI------SEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVA 742 (817)
Q Consensus 669 ~~~------~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~ 742 (817)
.+- -.|+|.|+.|-+.||+++...||....... +. .....+..+..+. ...+..+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~---L~---~r~Yqe~qLPalp---------~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML---LD---TRTYQESQLPALP---------SRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe---ec---hhhhhhhhCCCCc---------ccCChHHHHHH
Confidence 321 358999999999999999999996522110 00 0011222222221 12333567888
Q ss_pred HhccccCCCCCCCHHHHHHHHh
Q 036583 743 LWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 743 ~~cl~~dp~~RPt~~evl~~L~ 764 (817)
...++.||++|++..-....|.
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 8999999999998766555543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.4e-16 Score=156.89 Aligned_cols=133 Identities=18% Similarity=0.277 Sum_probs=113.6
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccCCc---------CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQ---------GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~---------~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.||+|++|.||+|.. .|..+++|+...... ....+.+|++++..++|+++.....++.+....+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999988 777899998653221 123578899999999999998888888778888999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
+++++|.+++.... + .+..++.+++.+|.+||+ .+++|+|++|.||+++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999885432 1 778899999999999999 8999999999999999 78999999999874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.2e-16 Score=154.72 Aligned_cols=136 Identities=17% Similarity=0.194 Sum_probs=108.2
Q ss_pred hccccccCCCcceeEEEEEcCCCcEEEEEEeccCCc-----------------------CHHHHHHHHHHhhccCcce--
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQ-----------------------GKKEFRAEVSIIGSIHHLH-- 548 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~-----------------------~~~~~~~Ev~~l~~l~h~n-- 548 (817)
+.+.+.||+|+||.||++..++|+.||||++..... ....+..|..++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 455678999999999999998899999998754221 0123577889999998874
Q ss_pred eeeeeeEeecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC
Q 036583 549 LVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD 628 (817)
Q Consensus 549 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~ 628 (817)
+...++. ...++||||+++++|..+... .....++.+++.++.++|+ .+|+|+||||+||++++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDD 160 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcC
Confidence 4444432 345899999999998765421 2345788999999999999 99999999999999999
Q ss_pred CCcEEEeecCCccccCC
Q 036583 629 NYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 629 ~~~~ki~Dfgla~~~~~ 645 (817)
++.++|+|||++.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 99999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.9e-16 Score=183.51 Aligned_cols=197 Identities=20% Similarity=0.244 Sum_probs=156.0
Q ss_pred HHHHHhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccC---cceeeeeeeEeecCCeeeE
Q 036583 488 DLQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH---HLHLVKLRGFCAEGTHRLL 564 (817)
Q Consensus 488 ~l~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~---h~niv~l~~~~~~~~~~~l 564 (817)
++....+.+.++||+|+||+||+|...+|+.||+|.-+.... -+|.--.+++.+|+ -+-|..+.....-.+.-+|
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~--WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP--WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc--eeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 344445566789999999999999988899999998765422 23333334444444 2334444444555677789
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec-------CCCcEEEeec
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD-------DNYHAKVSDF 637 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~-------~~~~~ki~Df 637 (817)
|+||.+.|+|.+++... +.++|...+.++.|+++-+++||. .+|||+||||+|+||. +...++|+||
T Consensus 772 v~ey~~~Gtlld~~N~~---~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINTN---KVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeccccccHHHhhccC---CCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEec
Confidence 99999999999999733 379999999999999999999999 9999999999999994 3456999999
Q ss_pred CCccccCC-CCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCC
Q 036583 638 GLAKLMTR-EQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRK 692 (817)
Q Consensus 638 gla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~ 692 (817)
|-+..+.- .....+....+|-.+-.+|...+++.+..+|.|.+.-+++-|+.|+.
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99876643 22235566788899999999999999999999999999999998874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.5e-16 Score=154.09 Aligned_cols=129 Identities=17% Similarity=0.288 Sum_probs=107.3
Q ss_pred ccCCCcceeEEEEEcCCCcEEEEEEeccCC--c-------CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIG--Q-------GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~--~-------~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
.||+|+||.||+|.. ++..+++|...... . ..+.+.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999996 67889999864321 1 1255778999999999887766666666777789999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
++++|.+++.... . .++.+++++|.+||+ .+++|+|++|.||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875421 1 789999999999999 9999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.7e-15 Score=175.05 Aligned_cols=131 Identities=16% Similarity=0.247 Sum_probs=108.5
Q ss_pred ccccCCCcceeEEEEEcCCCcEEEEEE-eccC-Cc-------CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 497 SVKLGQGGFGSVYQGVLPDGTRLAVKK-LEGI-GQ-------GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~~~g~~vavK~-l~~~-~~-------~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
.++||+|+||+||+|.+.+.. +++|+ +.+. .. ..+.+.+|++++.+++|++++....++......++|||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred cceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 578999999999999975544 44443 3221 11 12468899999999999999988888888788899999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
|+++++|.+++. ....++.+++++|.+||+ .+++||||||+||++ +++.++|+|||+++..
T Consensus 417 ~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 417 YIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred ecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999998874 346789999999999999 999999999999999 6779999999999753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.9e-16 Score=169.79 Aligned_cols=174 Identities=22% Similarity=0.366 Sum_probs=130.7
Q ss_pred eeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCc
Q 036583 561 HRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLA 640 (817)
Q Consensus 561 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 640 (817)
..++.|+++...+|.++|.+.......++.....++.|++.|+.| ++.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 568999999999999999866555567888899999999999999 57899999999999999999999999998
Q ss_pred cccCCCC-----ceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhh
Q 036583 641 KLMTREQ-----SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMME 714 (817)
Q Consensus 641 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 714 (817)
....... ....+...||..||+||.+.+..|+.|+||||||++|+|++. =..+++.. -....++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------~t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------ATLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------Hhhhhhh
Confidence 8765443 223345789999999999999999999999999999999986 22222110 0111122
Q ss_pred hcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 036583 715 EGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKV 759 (817)
Q Consensus 715 ~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev 759 (817)
++.+. +....+. ..-..|+.+++...|.+||++.++
T Consensus 474 ~g~ip----~~~~~d~-----p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 474 DGIIP----PEFLQDY-----PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred cCCCC----hHHhhcC-----cHHHHHHHHhcCCCcccCchHHHH
Confidence 22221 1111111 133578889999999999944443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=2e-14 Score=142.85 Aligned_cols=137 Identities=19% Similarity=0.215 Sum_probs=97.8
Q ss_pred ccccCCCcceeEEEEEcCCCcEEEEEEeccCCcC---HHHH----------------------HHHHHHhhccCcce--e
Q 036583 497 SVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQG---KKEF----------------------RAEVSIIGSIHHLH--L 549 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~---~~~~----------------------~~Ev~~l~~l~h~n--i 549 (817)
.+.||+|+||.||++...+++.||||++...... ...+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 3569999999999999888999999988653211 1111 34555555554332 3
Q ss_pred eeeeeEeecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCC
Q 036583 550 VKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDN 629 (817)
Q Consensus 550 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~ 629 (817)
.+.++. ...++||||++++.+......... .. .....++.+++.++.++|.+ .+|+|+||||+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-C
Confidence 344432 245899999999654322111110 11 56778999999999999973 7899999999999999 8
Q ss_pred CcEEEeecCCccccC
Q 036583 630 YHAKVSDFGLAKLMT 644 (817)
Q Consensus 630 ~~~ki~Dfgla~~~~ 644 (817)
+.++|+|||++....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 999999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.5e-14 Score=134.01 Aligned_cols=133 Identities=24% Similarity=0.208 Sum_probs=113.4
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCc--ceeeeeeeEeecCCeeeEEEeeccCCChh
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHH--LHLVKLRGFCAEGTHRLLAYEFMANGSLD 575 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 575 (817)
++||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++.+++.+....+..++++||++++.+.
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 569999999999999854 7899999865433 5689999999999977 58999999988888899999999998776
Q ss_pred hhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 576 KWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 576 ~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
.+ +......++.++++++++||.....+++|+|++|.||++++.+.+++.|||.+..
T Consensus 82 ~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 82 EV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 43 3455677899999999999985445799999999999999999999999998874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.50 E-value=7.7e-15 Score=168.01 Aligned_cols=201 Identities=22% Similarity=0.291 Sum_probs=134.9
Q ss_pred cccCCCcceeEEEEEcCC-CcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCChhh
Q 036583 498 VKLGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDK 576 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 576 (817)
+.|..|+||.||..+++. .+..|+|+-++.- +.+- ++.....|.+| |+-..
T Consensus 89 klisngAygavylvrh~~trqrfa~kiNkq~l-----ilRn--ilt~a~npfvv---------------------gDc~t 140 (1205)
T KOG0606|consen 89 KLISNGAYGAVYLVRHKETRQRFAMKINKQNL-----ILRN--ILTFAGNPFVV---------------------GDCAT 140 (1205)
T ss_pred EeeccCCCCceeeeeccccccchhhcccccch-----hhhc--cccccCCccee---------------------chhhh
Confidence 568999999999998764 5567774433210 1110 23333344433 34344
Q ss_pred hhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC---------
Q 036583 577 WIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ--------- 647 (817)
Q Consensus 577 ~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~--------- 647 (817)
.+.... .++.. ++.+++|||+ .+|+|||+||+|.+|+.-|.+|+.|||+.+......
T Consensus 141 llk~~g---~lPvd--------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I 206 (1205)
T KOG0606|consen 141 LLKNIG---PLPVD--------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHI 206 (1205)
T ss_pred hcccCC---CCcch--------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcch
Confidence 443322 22222 2789999999 999999999999999999999999999987642110
Q ss_pred ---ce--eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 648 ---SH--VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 648 ---~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
.+ .-...+||+.|+|||++....|.+.+|.|++|+|+||.+.|..||..+.++. .+..+.... ....
T Consensus 207 ~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee-------lfg~visd~-i~wp 278 (1205)
T KOG0606|consen 207 EKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-------LFGQVISDD-IEWP 278 (1205)
T ss_pred HHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH-------HHhhhhhhh-cccc
Confidence 00 1123589999999999999999999999999999999999999998664432 111111111 1111
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCC
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRP 754 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RP 754 (817)
+. +.....++.+++.+.++.+|..|-
T Consensus 279 E~------dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 279 EE------DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred cc------CcCCCHHHHHHHHHHHHhChHhhc
Confidence 11 222334567888888999999995
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.9e-13 Score=140.65 Aligned_cols=134 Identities=18% Similarity=0.198 Sum_probs=104.5
Q ss_pred cccC-CCcceeEEEEEcCCCcEEEEEEeccCC--------------cCHHHHHHHHHHhhccCccee--eeeeeEeecCC
Q 036583 498 VKLG-QGGFGSVYQGVLPDGTRLAVKKLEGIG--------------QGKKEFRAEVSIIGSIHHLHL--VKLRGFCAEGT 560 (817)
Q Consensus 498 ~~lG-~G~fG~Vy~g~~~~g~~vavK~l~~~~--------------~~~~~~~~Ev~~l~~l~h~ni--v~l~~~~~~~~ 560 (817)
..|| .|+.|+||+.... +..++||++.... .....+.+|++++.+++|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4587 8999999999884 6789999874310 123567889999999998874 77777654322
Q ss_pred ----eeeEEEeeccC-CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEe
Q 036583 561 ----HRLLAYEFMAN-GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVS 635 (817)
Q Consensus 561 ----~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~ 635 (817)
..++|+|++++ .+|.+++... .++.. .+.+|+.+|.+||+ .+|+|+||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 6898887542 23322 36789999999999 999999999999999998899999
Q ss_pred ecCCcccc
Q 036583 636 DFGLAKLM 643 (817)
Q Consensus 636 Dfgla~~~ 643 (817)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99988753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=9.3e-15 Score=168.17 Aligned_cols=249 Identities=23% Similarity=0.247 Sum_probs=185.1
Q ss_pred hccccccCCCcceeEEEEEcCC--CcEEEEEEeccCCcC---HHHHHHHHHHhhccC-cceeeeeeeEeecCCeeeEEEe
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPD--GTRLAVKKLEGIGQG---KKEFRAEVSIIGSIH-HLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~--g~~vavK~l~~~~~~---~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 567 (817)
+.+.+.||+|.|+.|-...... ...+|+|.+...... .+....|..+-..+. |+|++++++...+.+..+++.|
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 3445569999999999887643 345666766544322 334455777777776 9999999999999999999999
Q ss_pred eccCCChhhhhh-hcccccchhhhHHHHHHHHHHHHHHHHH-hcCCCceeecCCCCCCeEecCCC-cEEEeecCCccccC
Q 036583 568 FMANGSLDKWIF-KKNQEFLLDWETRFNIALGTAKGLAYLH-EDCDQRIIHCDIKPENVLLDDNY-HAKVSDFGLAKLMT 644 (817)
Q Consensus 568 ~~~~gsL~~~l~-~~~~~~~l~~~~~~~i~~qia~~l~~LH-~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Dfgla~~~~ 644 (817)
|..++++.+.+. .... ..+....-.++.|+..++.|+| + .++.|+||||+|.+++..+ ..|++|||+|..+.
T Consensus 102 ~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cccccccccccccCCcc--CCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 999999988883 3221 3556677789999999999999 7 8999999999999999999 99999999999876
Q ss_pred C--CCceeeeeccC-CCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhh
Q 036583 645 R--EQSHVFTTLRG-TRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRN 720 (817)
Q Consensus 645 ~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (817)
. ..........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++.......... .
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~-~------------- 242 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS-S------------- 242 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce-e-------------
Confidence 6 33333444678 9999999999885 446789999999999999999999975544332211 1
Q ss_pred hccccc--CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 721 ILDSRL--NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 721 ~~d~~~--~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
...... .............++...++..+|.+|.+.+++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 243 WKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 111100 01111122234567777788899999998887654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.7e-12 Score=141.61 Aligned_cols=140 Identities=20% Similarity=0.233 Sum_probs=98.9
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccCCcC---------------------------H--------------HHHHH
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQG---------------------------K--------------KEFRA 536 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~---------------------------~--------------~~~~~ 536 (817)
+.||.|++|.||+|++.+|+.||||+.+..... . -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 459999999999999999999999998643100 0 02344
Q ss_pred HHHHhhccC----cceeeeeeeEe-ecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHH-HHHHHHhcC
Q 036583 537 EVSIIGSIH----HLHLVKLRGFC-AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAK-GLAYLHEDC 610 (817)
Q Consensus 537 Ev~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-~l~~LH~~~ 610 (817)
|...+.+++ |.+-+.+-..+ ......+|||||++|++|.++....... . .+.+++.+++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~-- 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLR-- 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHh--
Confidence 554444442 22223322233 2344679999999999998876532211 1 34456776666 4677887
Q ss_pred CCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 611 ~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
.+++|+|+||.||++++++++++.|||++..+..
T Consensus 276 -~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 -DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred -CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8999999999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.2e-12 Score=128.10 Aligned_cols=203 Identities=19% Similarity=0.276 Sum_probs=137.7
Q ss_pred HHHhhccCcceeeeeeeEeecCC-----eeeEEEeeccCCChhhhhhhccc-ccchhhhHHHHHHHHHHHHHHHHHhcCC
Q 036583 538 VSIIGSIHHLHLVKLRGFCAEGT-----HRLLAYEFMANGSLDKWIFKKNQ-EFLLDWETRFNIALGTAKGLAYLHEDCD 611 (817)
Q Consensus 538 v~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~l~~LH~~~~ 611 (817)
..-|-.+.|.|||+++.|+.+.. ...++.|||..|+|..+|++... ...+......+++.||..||.|||+ |+
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 34455667999999999986543 46789999999999999986432 3356777778899999999999998 78
Q ss_pred CceeecCCCCCCeEecCCCcEEEeecCCccccCCC----CceeeeeccCCCCccCccccccCccCccccccchhhhHHHh
Q 036583 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE----QSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEI 687 (817)
Q Consensus 612 ~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el 687 (817)
+.|+|+++..+.|++..++-+||.--. ....... .........+-++|.|||+-.....+.++|||+||+..+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 999999999999999999999985321 1111100 00011123467899999987777778899999999999999
Q ss_pred hhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 688 IGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 688 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.-+..--....... ..+ ..+...+- .+... .-..++..|++..|..||+|++++.
T Consensus 276 ailEiq~tnseS~~---~~e--------e~ia~~i~-~len~-------lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 276 AILEIQSTNSESKV---EVE--------ENIANVII-GLENG-------LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHheeccCCCccee---ehh--------hhhhhhee-eccCc-------cccCcCcccccCCCCCCcchhhhhc
Confidence 87654211111100 000 00000000 00000 1124566799999999999988764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.3e-12 Score=138.12 Aligned_cols=252 Identities=21% Similarity=0.230 Sum_probs=184.3
Q ss_pred HHHHHHhhccccccCC--CcceeEEEEEc---CCCcEEEEEEeccC---CcCHHHHHHHHHHhhcc-CcceeeeeeeEee
Q 036583 487 RDLQTATNNFSVKLGQ--GGFGSVYQGVL---PDGTRLAVKKLEGI---GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCA 557 (817)
Q Consensus 487 ~~l~~~~~~~~~~lG~--G~fG~Vy~g~~---~~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~ 557 (817)
.+....+..+...+|. |.+|.||++.. .++..+|+|+-+.. ......=.+|+...+++ .|+|.++....+.
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence 3444555566778999 99999999987 35778899885332 22333446777777788 4999999888999
Q ss_pred cCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHH----HHHHHHhcCCCceeecCCCCCCeEecCC-CcE
Q 036583 558 EGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAK----GLAYLHEDCDQRIIHCDIKPENVLLDDN-YHA 632 (817)
Q Consensus 558 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~ 632 (817)
.++..++-+|++. .+|..+...... .++....+.+..+..+ |+.++|. ..++|-|+||.||++..+ ...
T Consensus 189 ~~~~lfiqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 189 GSGILFIQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred cCCcceeeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheeccccccee
Confidence 9999999999886 588887765443 4666777888888888 9999999 999999999999999988 899
Q ss_pred EEeecCCccccCCCCcee----eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHH
Q 036583 633 KVSDFGLAKLMTREQSHV----FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSY 708 (817)
Q Consensus 633 ki~Dfgla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~ 708 (817)
++.|||+...+....... .....|...|++||...+ .++.+.|+|++|.+..|..++..+....-...
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------- 334 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS------- 334 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC-------
Confidence 999999999886644221 122367788999998865 67889999999999999999887664331111
Q ss_pred HHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 709 AFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 709 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
|...+.+. +..++......++...+..|++.+|..|++.+.+..
T Consensus 335 -W~~~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 335 -WSQLRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -cccccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11111111 111111112234445888899999999998887765
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.22 E-value=4.8e-11 Score=116.43 Aligned_cols=130 Identities=21% Similarity=0.082 Sum_probs=96.5
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceee-eeeeEeecCCeeeEEEeeccCCChhh
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLV-KLRGFCAEGTHRLLAYEFMANGSLDK 576 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL~~ 576 (817)
+.|+.|.++.||+.... ++.+++|...........+..|++++..+.+.+++ +++.+. ....++||||+++.++..
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 45889999999999874 77899998765433344578899999998765544 444443 334589999999988764
Q ss_pred hhhhcccccchhhhHHHHHHHHHHHHHHHHHhcC--CCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 577 WIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC--DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 577 ~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
.- .....++.+++++|+.||+.. ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 81 ~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 ED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 30 111345678999999999821 12369999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.5e-11 Score=97.20 Aligned_cols=50 Identities=40% Similarity=0.774 Sum_probs=43.7
Q ss_pred CCCceeeecccCCCC------CccChhhHHHHhhccCceeeEeecc--CCCceEEEec
Q 036583 341 GDGLNYFALGFVPPS------SKADLNGCKKACLGNCSCLAMFFQN--SSGNCFLFDR 390 (817)
Q Consensus 341 ~~~~~~~~~~~~p~~------~~~~~~~C~~~Cl~nCsC~Ay~~~~--~~g~C~~~~~ 390 (817)
+|+|..+.++++|++ ...++++|++.||+||||+||+|.+ ++++|++|..
T Consensus 4 ~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~ 61 (66)
T PF08276_consen 4 GDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYG 61 (66)
T ss_pred CCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcC
Confidence 588999999999987 3468999999999999999999986 6689999953
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.7e-11 Score=99.23 Aligned_cols=67 Identities=16% Similarity=0.279 Sum_probs=54.7
Q ss_pred CCCceeeecccCCCCCccChhhHHHHhhc---cCceeeEeeccCCCceEEEeccc--ccccCCCCCCceeEEE
Q 036583 341 GDGLNYFALGFVPPSSKADLNGCKKACLG---NCSCLAMFFQNSSGNCFLFDRIG--SLQSSNQGSGFVSYIK 408 (817)
Q Consensus 341 ~~~~~~~~~~~~p~~~~~~~~~C~~~Cl~---nCsC~Ay~~~~~~g~C~~~~~~~--~l~~~~~~~g~~~ylr 408 (817)
+++|.++..+++|++...+++||+++|++ ||||+||+|.+.+++|++|.+.+ +++.. ...|.++|+|
T Consensus 8 ~g~fl~~~~~klpd~~~~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~-~~~g~~Ly~r 79 (80)
T cd00129 8 AGTTLIKIALKIKTTKANTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKE-FSHGFDLYEN 79 (80)
T ss_pred CCeEEEeecccCCcccccCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhc-cCCCceeEeE
Confidence 46788788899999999999999999999 99999999987556899995544 55553 3347889987
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.2e-11 Score=135.32 Aligned_cols=138 Identities=15% Similarity=0.147 Sum_probs=89.6
Q ss_pred cccCCCcceeEEEEEcCC-CcEEEEEEeccCCc---------------------------C--------HH------HHH
Q 036583 498 VKLGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQ---------------------------G--------KK------EFR 535 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~---------------------------~--------~~------~~~ 535 (817)
+.||+|++|.||+|++++ |++||||++++... . .+ +|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 469999999999999987 99999999864310 0 01 123
Q ss_pred HHHHHhhccC----cceeeeeeeEeec-CCeeeEEEeeccCCChhhhh--hhcc-cccchhhhHHHHHHHHHHHHHHHHH
Q 036583 536 AEVSIIGSIH----HLHLVKLRGFCAE-GTHRLLAYEFMANGSLDKWI--FKKN-QEFLLDWETRFNIALGTAKGLAYLH 607 (817)
Q Consensus 536 ~Ev~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~-~~~~l~~~~~~~i~~qia~~l~~LH 607 (817)
+|+..+.+++ +.+.+.+-..+.+ ....+|||||++|+.+.++- ...+ ....+.......++.|+.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------- 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------- 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 3443333332 3333333333322 44668999999999998742 2221 111232223333333333
Q ss_pred hcCCCceeecCCCCCCeEecCCC----cEEEeecCCccccCC
Q 036583 608 EDCDQRIIHCDIKPENVLLDDNY----HAKVSDFGLAKLMTR 645 (817)
Q Consensus 608 ~~~~~~ivH~Dlk~~NIll~~~~----~~ki~Dfgla~~~~~ 645 (817)
. .+++|+|+||.||+++.++ ++++.|||+...+..
T Consensus 278 ~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3 7999999999999999888 999999999987754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.1e-09 Score=119.42 Aligned_cols=165 Identities=15% Similarity=0.174 Sum_probs=122.5
Q ss_pred cCCCcEEEEEEeccCCc-CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCChhhhhhhcccccchhhhH
Q 036583 513 LPDGTRLAVKKLEGIGQ-GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWET 591 (817)
Q Consensus 513 ~~~g~~vavK~l~~~~~-~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~ 591 (817)
..++.+|.|...+.... ......+-++.++.++||||++++.........|||+|-+. .|..++.+.. ...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~------~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG------KEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH------HHH
Confidence 44688888888865543 23456778899999999999999999999999999999873 4666665432 344
Q ss_pred HHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeeeccCCCCccCccccccCcc
Q 036583 592 RFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAI 671 (817)
Q Consensus 592 ~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 671 (817)
..-.+.||+.||.|||+ +.+++|++|.-..|++++.|..||++|.+......-.. ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 45578999999999997 38999999999999999999999999988764322111 001111122456666544322
Q ss_pred CccccccchhhhHHHhhhC
Q 036583 672 SEKSDVYSYGMVLLEIIGG 690 (817)
Q Consensus 672 ~~~~DvwS~Gvvl~elltg 690 (817)
-..|.|-||++++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.7e-09 Score=106.27 Aligned_cols=134 Identities=16% Similarity=0.144 Sum_probs=97.2
Q ss_pred ccCCCcceeEEEEEcCC-------CcEEEEEEeccCC----------c-C------------HHHHH----HHHHHhhcc
Q 036583 499 KLGQGGFGSVYQGVLPD-------GTRLAVKKLEGIG----------Q-G------------KKEFR----AEVSIIGSI 544 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~~-------g~~vavK~l~~~~----------~-~------------~~~~~----~Ev~~l~~l 544 (817)
.||.|--+.||.|.-.+ +..+|||+.+... . + .+.+. +|.+.|.++
T Consensus 4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl 83 (197)
T cd05146 4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM 83 (197)
T ss_pred ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 58999999999998653 4789999764210 0 0 11223 799999888
Q ss_pred Cc--ceeeeeeeEeecCCeeeEEEeeccCCChhh-hhhhcccccchhhhHHHHHHHHHHHHHHHH-HhcCCCceeecCCC
Q 036583 545 HH--LHLVKLRGFCAEGTHRLLAYEFMANGSLDK-WIFKKNQEFLLDWETRFNIALGTAKGLAYL-HEDCDQRIIHCDIK 620 (817)
Q Consensus 545 ~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qia~~l~~L-H~~~~~~ivH~Dlk 620 (817)
.. -++.+++++ ...+|||||+.+..+.. .|... .++..+...+..+++.+|..| |+ .+|+|+||+
T Consensus 84 ~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs 152 (197)
T cd05146 84 QKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLS 152 (197)
T ss_pred HHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence 53 456666654 46689999998754422 22211 234455667889999999999 77 899999999
Q ss_pred CCCeEecCCCcEEEeecCCccccC
Q 036583 621 PENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 621 ~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
+.||++++ +.+.|+|||.+....
T Consensus 153 ~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEEC-CcEEEEECCCceeCC
Confidence 99999974 689999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.8e-09 Score=108.83 Aligned_cols=141 Identities=21% Similarity=0.262 Sum_probs=109.6
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccCCc--CHHHHHHHHHHhhccCc--ceeeeeeeEeecCC---eeeEEEeecc
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHH--LHLVKLRGFCAEGT---HRLLAYEFMA 570 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~ 570 (817)
+.|+.|..+.||++...+|+.+++|....... ....+..|++++..+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 34899999999999987778899999765432 45678999999999975 44677777776543 5689999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED----------------------------------------- 609 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~----------------------------------------- 609 (817)
+.++.+.+.. ..++...+..++.+++++|..||+.
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988776532 1356667778888888888888842
Q ss_pred ------------CCCceeecCCCCCCeEecC--CCcEEEeecCCccc
Q 036583 610 ------------CDQRIIHCDIKPENVLLDD--NYHAKVSDFGLAKL 642 (817)
Q Consensus 610 ------------~~~~ivH~Dlk~~NIll~~--~~~~ki~Dfgla~~ 642 (817)
....++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1246799999999999998 66789999988764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.2e-10 Score=123.91 Aligned_cols=242 Identities=20% Similarity=0.247 Sum_probs=171.9
Q ss_pred ccccccCCCcceeEEEEEcC--CCcEEEEEEeccCCc---CHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEee
Q 036583 495 NFSVKLGQGGFGSVYQGVLP--DGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~--~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
.+..+||.|.|+.|++...+ ++..+++|.+.+... ++..-..|+.+...+ .|.++++....+...++.++--||
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~ 347 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF 347 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence 34468999999999998743 577899998865422 122235567666666 588999988888888888899999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCC-CcEEEeecCCccccCCCC
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDN-YHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~Dfgla~~~~~~~ 647 (817)
++++++...+.-. ..++...++++..|++.++.++|+ +.++|+|+||+||++..+ +.-++.|||.+..+....
T Consensus 348 ~~~~s~~l~~~~~---~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~ 421 (524)
T KOG0601|consen 348 CEGGSSSLRSVTS---QMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS 421 (524)
T ss_pred hcCcchhhhhHHH---HhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccccceec
Confidence 9999887766322 257888899999999999999998 999999999999999886 889999999987532211
Q ss_pred ceeeeeccCCCCcc--CccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccc
Q 036583 648 SHVFTTLRGTRGYL--APEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725 (817)
Q Consensus 648 ~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 725 (817)
......-+++ +++......+-.+.|++|||.-+.|.+++...-..... +..+..+... .
T Consensus 422 ----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----------~~~i~~~~~p-----~ 482 (524)
T KOG0601|consen 422 ----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----------SLTIRSGDTP-----N 482 (524)
T ss_pred ----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc----------ceeeeccccc-----C
Confidence 1112223344 56666677888999999999999999988753321110 0111111111 1
Q ss_pred cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 726 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
+ .. ....+..++.-++..++..||.+.++..+.+.+
T Consensus 483 ~---~~--~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 483 L---PG--LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred C---Cc--hHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 1 11 113455667778999999999999888766543
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.3e-09 Score=92.58 Aligned_cols=67 Identities=31% Similarity=0.655 Sum_probs=49.7
Q ss_pred CceeeecccCCCC----CccChhhHHHHhhccCceeeEeeccCCCceEEEeccc-ccccCCCCCCceeEEEee
Q 036583 343 GLNYFALGFVPPS----SKADLNGCKKACLGNCSCLAMFFQNSSGNCFLFDRIG-SLQSSNQGSGFVSYIKIL 410 (817)
Q Consensus 343 ~~~~~~~~~~p~~----~~~~~~~C~~~Cl~nCsC~Ay~~~~~~g~C~~~~~~~-~l~~~~~~~g~~~ylrl~ 410 (817)
+|..+.+++.|+. ...++++|++.||+||+|+||+|.+++|+|++|...+ +.+. ....+...|||++
T Consensus 13 ~f~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~-~~~~~~~~yiKv~ 84 (84)
T cd01098 13 GFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRS-LSSGGGTLYLRLA 84 (84)
T ss_pred EEEEeCCeeCCCchhhhccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEe-ecCCCcEEEEEeC
Confidence 4555556666654 4568999999999999999999998888999997655 3333 2233578899873
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.3e-08 Score=96.42 Aligned_cols=130 Identities=18% Similarity=0.253 Sum_probs=100.9
Q ss_pred ccCCCcceeEEEEEcCCCcEEEEEEe-ccCCc--------CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 499 KLGQGGFGSVYQGVLPDGTRLAVKKL-EGIGQ--------GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~~g~~vavK~l-~~~~~--------~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
.+.+|+-..+|.+.+. |..+++|.- .+... ..+.-.+|..++.+++--.|.-..-+..+.....|+|||.
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 4789999999999773 434555543 32211 1235678999999997666666666777888899999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
++..|.+++... +..++..+-+-+.-||. .+|+|+||.++||.+..+. +.++||||+...
T Consensus 82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999888654 24567777788888999 9999999999999998775 999999999743
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.2e-08 Score=93.10 Aligned_cols=141 Identities=20% Similarity=0.281 Sum_probs=106.0
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEE-eccCC--------cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKK-LEGIG--------QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~-l~~~~--------~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
..|-||+-+.|+++.. .|+...||. +.+.. -..+...+|++++.+++--.|.-..-++.+...-.|+|||
T Consensus 13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 4578999999999998 555555553 33211 1235678899999999866666666677788888999999
Q ss_pred ccC-CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC---cEEEeecCCcccc
Q 036583 569 MAN-GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY---HAKVSDFGLAKLM 643 (817)
Q Consensus 569 ~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ki~Dfgla~~~ 643 (817)
.++ .++.+++...... .........++..|-+.+.-||. ..|+|+||..+||+|..++ .+.++|||++...
T Consensus 92 ~~g~~~vk~~i~~~~~~-~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMED-ESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred ccchhHHHHHHHHHccC-cccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 987 4788888765432 22223336788999999999998 9999999999999996544 4589999998643
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.9e-08 Score=105.91 Aligned_cols=168 Identities=16% Similarity=0.284 Sum_probs=130.0
Q ss_pred ceeEEEEEc-CCCcEEEEEEeccCCc-CHHHHHHHHHHhhccCcceeeeeeeEee----cCCeeeEEEeeccC-CChhhh
Q 036583 505 FGSVYQGVL-PDGTRLAVKKLEGIGQ-GKKEFRAEVSIIGSIHHLHLVKLRGFCA----EGTHRLLAYEFMAN-GSLDKW 577 (817)
Q Consensus 505 fG~Vy~g~~-~~g~~vavK~l~~~~~-~~~~~~~Ev~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~~~ 577 (817)
-.+.||+.. .||..+++|+++.... .......-+++++++.|+|+|++..++. .+...++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357888874 4899999999954422 2224456688999999999999999886 34467999999986 577776
Q ss_pred hhhcc------------cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 578 IFKKN------------QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 578 l~~~~------------~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
-+... ....+++...+.++.|+..||.++|+ .|+.-+-|.+++|+++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 55322 12246778899999999999999999 8999999999999999999999999998877655
Q ss_pred CCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCC
Q 036583 646 EQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKN 693 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p 693 (817)
+... -+ .-..+-|.=.||.+++.|.||...
T Consensus 446 d~~~---------------~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPTE---------------PL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCc---------------ch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 4311 11 113467888999999999999653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.5e-09 Score=122.40 Aligned_cols=239 Identities=19% Similarity=0.221 Sum_probs=160.7
Q ss_pred ccCCCcceeEEEEEcCC-CcEEEEEEecc---C-CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCC
Q 036583 499 KLGQGGFGSVYQGVLPD-GTRLAVKKLEG---I-GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGS 573 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~~-g~~vavK~l~~---~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 573 (817)
-+-.|.++.+..+.-.. |...+.|.... . ....+....+-.++...+||-+++..--+.-.....|+++|..+++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~ 890 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD 890 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence 46778888888766321 22222222211 1 1223344455555555667777776666667778899999999999
Q ss_pred hhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC--------
Q 036583 574 LDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR-------- 645 (817)
Q Consensus 574 L~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~-------- 645 (817)
|...|+... ..+.+-....+..+..+++|||. ..+.|+|++|.|+++..++..+++||+......-
T Consensus 891 ~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~s 964 (1205)
T KOG0606|consen 891 LPSKLHNSG---CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLS 964 (1205)
T ss_pred chhhhhcCC---CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcCCcc
Confidence 999988765 45556666777888999999998 6699999999999999999999999984332110
Q ss_pred -----------------CCc-----eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCC
Q 036583 646 -----------------EQS-----HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA 703 (817)
Q Consensus 646 -----------------~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~ 703 (817)
... .......+|+.|.+||.+.+......+|.|+.|++++|.++|..||.......
T Consensus 965 g~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~-- 1042 (1205)
T KOG0606|consen 965 GPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ-- 1042 (1205)
T ss_pred cccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh--
Confidence 000 00123568999999999999999999999999999999999999997554332
Q ss_pred cchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHH
Q 036583 704 HFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMT 757 (817)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ 757 (817)
..+.+.++.+ +.... .......+.+++...+..+|.+|-.|.
T Consensus 1043 -----~f~ni~~~~~-----~~p~g--~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1043 -----IFENILNRDI-----PWPEG--PEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred -----hhhccccCCC-----CCCCC--ccccChhhhhhhhhhhccCchhccCcc
Confidence 1111111111 11111 112223455666667788888887665
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=1e-07 Score=93.51 Aligned_cols=125 Identities=21% Similarity=0.269 Sum_probs=84.3
Q ss_pred eEEEEEcCCCcEEEEEEeccC--------------Cc---------C----HHHHHHHHHHhhccCcc--eeeeeeeEee
Q 036583 507 SVYQGVLPDGTRLAVKKLEGI--------------GQ---------G----KKEFRAEVSIIGSIHHL--HLVKLRGFCA 557 (817)
Q Consensus 507 ~Vy~g~~~~g~~vavK~l~~~--------------~~---------~----~~~~~~Ev~~l~~l~h~--niv~l~~~~~ 557 (817)
.||.|...+|..+|||..+.. .. . .....+|.+.|.++..- ++.+++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389999989999999976321 00 0 12456799999999755 566666552
Q ss_pred cCCeeeEEEeecc--CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHH-HhcCCCceeecCCCCCCeEecCCCcEEE
Q 036583 558 EGTHRLLAYEFMA--NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYL-HEDCDQRIIHCDIKPENVLLDDNYHAKV 634 (817)
Q Consensus 558 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~L-H~~~~~~ivH~Dlk~~NIll~~~~~~ki 634 (817)
..+|||||++ +..+..+.... ++......++.+++..+..+ |. .+|+|+||.+.||+++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEE
Confidence 4589999999 55554433221 22455677888888866664 66 899999999999999988 9999
Q ss_pred eecCCccccC
Q 036583 635 SDFGLAKLMT 644 (817)
Q Consensus 635 ~Dfgla~~~~ 644 (817)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.9e-07 Score=97.13 Aligned_cols=132 Identities=18% Similarity=0.095 Sum_probs=96.3
Q ss_pred eeEEEEEcCCCcEEEEEEeccCCc------------CHHHHHHHHHHhhccCcc--eeeeeeeEeec-----CCeeeEEE
Q 036583 506 GSVYQGVLPDGTRLAVKKLEGIGQ------------GKKEFRAEVSIIGSIHHL--HLVKLRGFCAE-----GTHRLLAY 566 (817)
Q Consensus 506 G~Vy~g~~~~g~~vavK~l~~~~~------------~~~~~~~Ev~~l~~l~h~--niv~l~~~~~~-----~~~~~lv~ 566 (817)
..|.+..+ +|+.+.||+...... ....+.+|...+.+++.. ....++++... ...-+||+
T Consensus 36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 34667666 677899997743321 112478899999888533 33445556543 23468999
Q ss_pred eeccCC-ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC-------CCcEEEeecC
Q 036583 567 EFMANG-SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD-------NYHAKVSDFG 638 (817)
Q Consensus 567 e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-------~~~~ki~Dfg 638 (817)
|++++- +|.+++..... ...+...+..++.+++..+.-||+ .+|+|+|++++|||++. +..+.++||+
T Consensus 115 e~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 115 EDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred eeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 999986 89988853211 134456677899999999999999 99999999999999975 5789999999
Q ss_pred Cccc
Q 036583 639 LAKL 642 (817)
Q Consensus 639 la~~ 642 (817)
.+..
T Consensus 191 r~~~ 194 (268)
T PRK15123 191 RAQI 194 (268)
T ss_pred cccc
Confidence 8753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.6e-07 Score=92.82 Aligned_cols=135 Identities=19% Similarity=0.200 Sum_probs=96.9
Q ss_pred hccccccCCCcceeEEEEEcCCCcEEEEEEeccC-----------------------CcCHHHHHHHHHHhhccCcc--e
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGI-----------------------GQGKKEFRAEVSIIGSIHHL--H 548 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~-----------------------~~~~~~~~~Ev~~l~~l~h~--n 548 (817)
+.+.++||.|--+.||.|..+.|.++|||.-+.. ...+....+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 3456789999999999999999999999953210 00123457799999998654 6
Q ss_pred eeeeeeEeecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC
Q 036583 549 LVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD 628 (817)
Q Consensus 549 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~ 628 (817)
+.+.+++ +...+|||+.++-.|...- ++.+..-.++..|+.-+..+-. .+|+|+|+++-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEec
Confidence 6666655 4558999999997665432 1233334445555554444444 89999999999999999
Q ss_pred CCcEEEeecCCcccc
Q 036583 629 NYHAKVSDFGLAKLM 643 (817)
Q Consensus 629 ~~~~ki~Dfgla~~~ 643 (817)
+|.+.++||--+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999766543
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.2e-07 Score=84.81 Aligned_cols=96 Identities=21% Similarity=0.326 Sum_probs=71.1
Q ss_pred CCCeeeeecCCcce---EEEEEEecCCCcceEEEEEECCCceEEEEEcc-CCCCC---ceeeccccCCCCCCC-CCCCCC
Q 036583 229 SANSWRFYDNNKIF---LWQFIFSDNTDGNATWIAVLANDGFISFYNLQ-DGEPS---TASNTKIPNSPCSTP-EPCDAY 300 (817)
Q Consensus 229 ~~~~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~~g~l~~~~~~-~~~~~---w~~~~~~p~~~C~~~-~~Cg~y 300 (817)
+|++..|.+.+++. .+.|.|+++.++.++++.+.+.+ .+.+++.+ ++..+ |......|...+..| +.|+.|
T Consensus 5 ~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s-~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~Cd~y 83 (110)
T PF00954_consen 5 PWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSS-VLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQCDVY 83 (110)
T ss_pred ccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCc-eEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCCCCc
Confidence 78899998888763 47777888888888775544444 44444444 44433 777777787788888 689999
Q ss_pred ccCCCCCcccCCCCcCCCCcccCCcC
Q 036583 301 YICSGINKCQCPSVISSQNCKTGIAS 326 (817)
Q Consensus 301 g~C~~~~~C~C~~gf~~~~C~~~~~~ 326 (817)
+.||+++.|+-.. .+.|.|++||..
T Consensus 84 ~~CG~~g~C~~~~-~~~C~Cl~GF~P 108 (110)
T PF00954_consen 84 GFCGPNGICNSNN-SPKCSCLPGFEP 108 (110)
T ss_pred cccCCccEeCCCC-CCceECCCCcCC
Confidence 9999999997544 478999999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.7e-06 Score=82.90 Aligned_cols=137 Identities=19% Similarity=0.192 Sum_probs=103.1
Q ss_pred cCCCcceeEEEEEcCCCcEEEEEEeccC-------CcCHHHHHHHHHHhhccCc--ceeeeeeeEeecC-----CeeeEE
Q 036583 500 LGQGGFGSVYQGVLPDGTRLAVKKLEGI-------GQGKKEFRAEVSIIGSIHH--LHLVKLRGFCAEG-----THRLLA 565 (817)
Q Consensus 500 lG~G~fG~Vy~g~~~~g~~vavK~l~~~-------~~~~~~~~~Ev~~l~~l~h--~niv~l~~~~~~~-----~~~~lv 565 (817)
-|.||.+.|+.-.+ +|+.+-+|+-+.. .-+...|.+|...|.++.. -.+.+++ ++... -.-+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 46689999999887 4457889987521 3367899999999999853 2355555 33211 235799
Q ss_pred EeeccC-CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCc--EEEeecCCccc
Q 036583 566 YEFMAN-GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYH--AKVSDFGLAKL 642 (817)
Q Consensus 566 ~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~ki~Dfgla~~ 642 (817)
+|-+++ -+|.+++...... ..+...+..++.++++.++-||+ .++.|+|+.+.||+++.++. ++++||.-.+.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~-~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVS-PYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcC-CcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997764 5888888654321 45667778999999999999999 99999999999999986666 99999976653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.5e-06 Score=91.48 Aligned_cols=258 Identities=15% Similarity=0.152 Sum_probs=150.9
Q ss_pred ccccCCCcceeEEEEEcCCCcEEEEEEeccCCcC-HHHHHHHHHHhhcc-CcceeeeeeeEe------ecCCe-eeEEEe
Q 036583 497 SVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQG-KKEFRAEVSIIGSI-HHLHLVKLRGFC------AEGTH-RLLAYE 567 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~-~~~~~~Ev~~l~~l-~h~niv~l~~~~------~~~~~-~~lv~e 567 (817)
++.||+|+.+.+|-.--- +.. +.|+....... ..+. ++.|.+. .||-+..-+.+= -+... .-++|.
T Consensus 16 gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchh-hch-hheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 456999999999964321 112 34666543221 2222 2223333 465433312111 11112 345566
Q ss_pred eccCC-Chhhhhh---hcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 568 FMANG-SLDKWIF---KKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 568 ~~~~g-sL~~~l~---~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
.+++. -...++. +...-...+|.-.++.+..+|.+.+-||+ .+.+-+|++++|+|+.+++.+.|.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec
Confidence 55543 2222221 11222357899999999999999999999 89999999999999999999999985433322
Q ss_pred CCCCceeeeeccCCCCccCccccc-----cCccCccccccchhhhHHHhhhC-CCCCCCCCCCCCCcchHHHHHHhhhcc
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWIT-----NYAISEKSDVYSYGMVLLEIIGG-RKNFDPNETSDKAHFPSYAFKMMEEGK 717 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~ 717 (817)
.........+|...|.+||.-. +..-+...|-|.+||++++++.| +.||.+........-+- ...+..+.
T Consensus 168 --~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~--E~~Ia~g~ 243 (637)
T COG4248 168 --ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL--ETDIAHGR 243 (637)
T ss_pred --cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc--hhhhhcce
Confidence 1222234467889999999764 33456789999999999999886 89997653221111000 00111121
Q ss_pred hhhhccccc------CCcccHHHHHHHHHHHHhcccc--CCCCCCCHHHHHHHHhcC
Q 036583 718 LRNILDSRL------NIDEQSDRVFTAVKVALWCVQE--DMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 718 ~~~~~d~~~------~~~~~~~~~~~~~~l~~~cl~~--dp~~RPt~~evl~~L~~~ 766 (817)
...-.+.+. ...+-.-....+..+..+|+.. ++.-|||++-.+..|..+
T Consensus 244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 111111111 0111111223455666677765 477899999999888655
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.5e-07 Score=105.44 Aligned_cols=152 Identities=21% Similarity=0.319 Sum_probs=101.3
Q ss_pred HHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee--------eeccCCCCccCcccc
Q 036583 595 IALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF--------TTLRGTRGYLAPEWI 666 (817)
Q Consensus 595 i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~--------~~~~gt~~y~aPE~~ 666 (817)
-+.+++.|+.|+|. ..++||+.|.|++|.++..+..||+.|+.+........... .-......|.|||++
T Consensus 104 nl~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 104 NLGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 34556699999998 48999999999999999999999999998765443111110 012234579999999
Q ss_pred ccCccCccccccchhhhHHHhh-hCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhc
Q 036583 667 TNYAISEKSDVYSYGMVLLEII-GGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWC 745 (817)
Q Consensus 667 ~~~~~~~~~DvwS~Gvvl~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~c 745 (817)
.+...+.++|+||+|++++-+. .|+.-+......... . .....+..-......+.+.++.+=+..+
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-----~--------~~~~~~~~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-----S--------FSRNLLNAGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhccCCcchh-----h--------hhhcccccccccccccCcHHHHHHHHHH
Confidence 9988899999999999999999 455555433211100 0 0000000001111123334566667778
Q ss_pred cccCCCCCCCHHHHHH
Q 036583 746 VQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 746 l~~dp~~RPt~~evl~ 761 (817)
+..++..||++.++..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 8899999998777654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.30 E-value=4.1e-06 Score=84.30 Aligned_cols=107 Identities=19% Similarity=0.247 Sum_probs=84.3
Q ss_pred HHHHHHHHHHhhccC--cceeeeeeeEeecCC----eeeEEEeeccCC-ChhhhhhhcccccchhhhHHHHHHHHHHHHH
Q 036583 531 KKEFRAEVSIIGSIH--HLHLVKLRGFCAEGT----HRLLAYEFMANG-SLDKWIFKKNQEFLLDWETRFNIALGTAKGL 603 (817)
Q Consensus 531 ~~~~~~Ev~~l~~l~--h~niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l 603 (817)
.....+|...+..++ .-...+.+++..... .-++|+|++++- +|.+++..... ++......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 456788888888775 334566666665422 348999999884 89998876332 45566788999999999
Q ss_pred HHHHhcCCCceeecCCCCCCeEecCCC---cEEEeecCCcccc
Q 036583 604 AYLHEDCDQRIIHCDIKPENVLLDDNY---HAKVSDFGLAKLM 643 (817)
Q Consensus 604 ~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ki~Dfgla~~~ 643 (817)
+-||+ .+|+|+|+++.|||++.+. .+.++||+-++..
T Consensus 132 ~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 9999999999999999887 8999999887653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=3.4e-06 Score=95.15 Aligned_cols=140 Identities=19% Similarity=0.241 Sum_probs=89.8
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccCCcC---------------------------H----H----------HHHH
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQG---------------------------K----K----------EFRA 536 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~---------------------------~----~----------~~~~ 536 (817)
+-|+.++-|.||+|++++|+.||||+.++.-.. . + ++..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 458899999999999999999999986542110 0 1 1223
Q ss_pred HHHHhhccC-----cceeeeeeeEeecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHH-HHHHhcC
Q 036583 537 EVSIIGSIH-----HLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGL-AYLHEDC 610 (817)
Q Consensus 537 Ev~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l-~~LH~~~ 610 (817)
|..-+.+++ .+++.=..=+..-.....|+|||++|-.+.+....+.. ..+ +..++..++++. ..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d---~k~ia~~~~~~f~~q~~~-- 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GID---RKELAELLVRAFLRQLLR-- 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCC---HHHHHHHHHHHHHHHHHh--
Confidence 333333332 22222222222335677999999999988887432221 233 233444444332 11212
Q ss_pred CCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 611 ~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
.+++|.|.+|.||+++.++++.+.|||+...+..
T Consensus 284 -dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 -DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 6899999999999999999999999999887654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.7e-05 Score=79.41 Aligned_cols=139 Identities=16% Similarity=0.178 Sum_probs=85.0
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcce--eeeeeeEeecCCeeeEEEeeccCCC-h
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLH--LVKLRGFCAEGTHRLLAYEFMANGS-L 574 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs-L 574 (817)
..||+|..+.||+. .+...++|..... .......+|.+++..+..-. +.+.+++....+...+|||+++|.. +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~-~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG-FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC-CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 35899999999984 2445677877642 23456789999998886433 4677888777777889999999963 2
Q ss_pred hhhhh---------------------hcc-cccchhhhHHHHHHH----------HHHH-HHHHHHhc-CCCceeecCCC
Q 036583 575 DKWIF---------------------KKN-QEFLLDWETRFNIAL----------GTAK-GLAYLHED-CDQRIIHCDIK 620 (817)
Q Consensus 575 ~~~l~---------------------~~~-~~~~l~~~~~~~i~~----------qia~-~l~~LH~~-~~~~ivH~Dlk 620 (817)
...+. .-. ....+... ..++.. .+.. ...+|... ....++|+|+.
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 000 00001000 000000 0011 11222211 13457899999
Q ss_pred CCCeEecCCCcEEEeecCCccc
Q 036583 621 PENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 621 ~~NIll~~~~~~ki~Dfgla~~ 642 (817)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999988753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.09 E-value=3e-05 Score=77.55 Aligned_cols=135 Identities=17% Similarity=0.194 Sum_probs=90.9
Q ss_pred ccCCCcceeEEEEEcCCCcEEEEEEeccCCcC----------HHH---------------HHHHHHHhhccC--cceeee
Q 036583 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQG----------KKE---------------FRAEVSIIGSIH--HLHLVK 551 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~----------~~~---------------~~~Ev~~l~~l~--h~niv~ 551 (817)
.|.+|--..||+|.-.++..+|||+....... ... ..+|..-|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 47788889999999888999999988543211 111 134555555552 334444
Q ss_pred eeeEeecCCeeeEEEeeccCCC-hhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC
Q 036583 552 LRGFCAEGTHRLLAYEFMANGS-LDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY 630 (817)
Q Consensus 552 l~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~ 630 (817)
.+++. +..|||||+.... -.-.|..- .+.......+..++++.+.-|-. ..++||+||+.-|||+. ++
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~LkDv----~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLKDV----PLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DG 203 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcccC----CcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CC
Confidence 44443 3489999997641 11122111 22333566777888888887764 27999999999999999 88
Q ss_pred cEEEeecCCccccC
Q 036583 631 HAKVSDFGLAKLMT 644 (817)
Q Consensus 631 ~~ki~Dfgla~~~~ 644 (817)
.+.|+|++-|....
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 99999999887654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.01 E-value=2.4e-06 Score=94.68 Aligned_cols=181 Identities=18% Similarity=0.133 Sum_probs=132.0
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcce-eeeeeeEeecCCeeeEEEeeccCC-Chh
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLH-LVKLRGFCAEGTHRLLAYEFMANG-SLD 575 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g-sL~ 575 (817)
+..++|+++.++|.+-...+...++.+... ....-++++|.+++||| .++.++-+..+....++++++..+ +-.
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 557899999999988544444445555432 45567899999999999 788888888888889999999887 221
Q ss_pred hhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeeecc
Q 036583 576 KWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLR 655 (817)
Q Consensus 576 ~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~ 655 (817)
.-... ....+...+...+...-++++++||+ ..-+|+| ||+..+ +..|..||+.+..+.+.. ......
T Consensus 324 ~~~~~--se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~ 391 (829)
T KOG0576|consen 324 LEMTV--SEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAI 391 (829)
T ss_pred ccCCh--hhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc--ccccCC
Confidence 11111 11123334445556667788999997 4457888 777665 689999999988775543 224567
Q ss_pred CCCCccCccccccCccCccccccchhhhHHHhhhCCCCC
Q 036583 656 GTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNF 694 (817)
Q Consensus 656 gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf 694 (817)
+++.++|||+.....+..+.|+|++|+-..++.-|-+|-
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 899999999999999999999999999877777776665
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.92 E-value=3.1e-05 Score=76.30 Aligned_cols=105 Identities=24% Similarity=0.280 Sum_probs=82.9
Q ss_pred HHHHHHhhccCc-ceeeeeeeEeecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCc
Q 036583 535 RAEVSIIGSIHH-LHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613 (817)
Q Consensus 535 ~~Ev~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ 613 (817)
.+|.-++..+++ +++.+++|+|-+ ++|.||.+.+++...-..-..-...+|..|.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888888876 699999999954 789999998765421000001114689999999999999999999866667
Q ss_pred eeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 614 ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+...|++++|+-+++++++|+.|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 899999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00015 Score=72.03 Aligned_cols=133 Identities=14% Similarity=0.154 Sum_probs=82.4
Q ss_pred hccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcC-HHH---------HHHHHHHhhccCc---ceeeeeeeEee---
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQG-KKE---------FRAEVSIIGSIHH---LHLVKLRGFCA--- 557 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~-~~~---------~~~Ev~~l~~l~h---~niv~l~~~~~--- 557 (817)
+...+.+-......|.+-.. +|+...+|..+..... .+. ..+++..+.+++. ...+.++.+..
T Consensus 33 ~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~ 111 (229)
T PF06176_consen 33 YKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKI 111 (229)
T ss_pred ceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeee
Confidence 33334455555556666666 5677888876543211 111 2334444444432 22233222222
Q ss_pred --cCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEe
Q 036583 558 --EGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVS 635 (817)
Q Consensus 558 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~ 635 (817)
-....+|+|||++|..|.++.. ++. .++..++.++.-||+ .++.|+|++|.|++++++ .+++.
T Consensus 112 ~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~i~iI 176 (229)
T PF06176_consen 112 FRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-GIRII 176 (229)
T ss_pred ccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-cEEEE
Confidence 2234578999999988876542 221 245667788999999 999999999999999865 49999
Q ss_pred ecCCccc
Q 036583 636 DFGLAKL 642 (817)
Q Consensus 636 Dfgla~~ 642 (817)
||+..+.
T Consensus 177 D~~~k~~ 183 (229)
T PF06176_consen 177 DTQGKRM 183 (229)
T ss_pred ECccccc
Confidence 9987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.86 E-value=8.8e-05 Score=83.49 Aligned_cols=140 Identities=16% Similarity=0.169 Sum_probs=88.4
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccCCcC--------------------------------------HHHHHHHHH
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQG--------------------------------------KKEFRAEVS 539 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~--------------------------------------~~~~~~Ev~ 539 (817)
+.||.-..|.||+|++++|+.||||+-++.-+. +-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 458999999999999999999999976442110 012334443
Q ss_pred Hhhcc----Ccce------eeeeeeEeecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhc
Q 036583 540 IIGSI----HHLH------LVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED 609 (817)
Q Consensus 540 ~l~~l----~h~n------iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~ 609 (817)
-..++ .|-+ |.+++-. -...+.|+||||+|..+.+.-.-... .++.. .++..+.++...+ -
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~---~i~~~l~~~~~~q--I 317 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKR--GISPH---DILNKLVEAYLEQ--I 317 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHc--CCCHH---HHHHHHHHHHHHH--H
Confidence 33333 3444 2222222 23578999999999877765332211 13333 3333333332221 1
Q ss_pred CCCceeecCCCCCCeEecC----CCcEEEeecCCccccCCC
Q 036583 610 CDQRIIHCDIKPENVLLDD----NYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 610 ~~~~ivH~Dlk~~NIll~~----~~~~ki~Dfgla~~~~~~ 646 (817)
...+++|+|-+|.||++.. ++++.+-|||+...+...
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 1268999999999999983 678999999998866543
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.86 E-value=1.9e-05 Score=71.36 Aligned_cols=51 Identities=31% Similarity=0.573 Sum_probs=40.6
Q ss_pred Eec-CceEEEec-C-CeEEEEeCCCC--CceeEEEEecCCCEEEEccCCccccccc
Q 036583 104 FKK-DGEVSLQK-G-GSVVWSVNPSG--ASVSAMELRDSGNLVLLGNDNKVLWQSF 154 (817)
Q Consensus 104 ~~~-~g~l~l~~-~-~~~vWstn~~~--~~~~~a~LldsGNLVL~~~~~~~lWQSF 154 (817)
+.. ||++++-. . +++||++|+.. .....+.|.++|||||++.++.++|||-
T Consensus 26 ~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~ 81 (116)
T cd00028 26 MQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSN 81 (116)
T ss_pred CCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEec
Confidence 444 89998843 2 58999999864 3445678899999999999999999984
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.85 E-value=2.1e-05 Score=70.92 Aligned_cols=50 Identities=34% Similarity=0.650 Sum_probs=40.1
Q ss_pred EecCceEEEecC--CeEEEEeCCCCC--ceeEEEEecCCCEEEEccCCcccccc
Q 036583 104 FKKDGEVSLQKG--GSVVWSVNPSGA--SVSAMELRDSGNLVLLGNDNKVLWQS 153 (817)
Q Consensus 104 ~~~~g~l~l~~~--~~~vWstn~~~~--~~~~a~LldsGNLVL~~~~~~~lWQS 153 (817)
+..||++|+-.. +++||++|+... ....+.|.++|||||++.++.++|+|
T Consensus 26 ~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 26 MQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred CCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEe
Confidence 457899998433 589999997632 22567889999999999989999998
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.85 E-value=9.4e-05 Score=75.90 Aligned_cols=142 Identities=18% Similarity=0.182 Sum_probs=84.4
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcc--eeeeeeeEeec---CCeeeEEEeeccCC
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHL--HLVKLRGFCAE---GTHRLLAYEFMANG 572 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~~~g 572 (817)
+.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++.+... ....+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 358889999999999877 68999997654 4456788999998888533 35666665433 33468999999998
Q ss_pred Chhh----------------hhh---hc-ccccchhh-h--------HHHHH------------HHHHHH-HHHHHHh--
Q 036583 573 SLDK----------------WIF---KK-NQEFLLDW-E--------TRFNI------------ALGTAK-GLAYLHE-- 608 (817)
Q Consensus 573 sL~~----------------~l~---~~-~~~~~l~~-~--------~~~~i------------~~qia~-~l~~LH~-- 608 (817)
.+.. .+. .. .......+ . ..... ...+.+ .+..+++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 7776 111 11 00000000 0 00000 111222 2333332
Q ss_pred --cCCCceeecCCCCCCeEec-CCCcEEEeecCCcc
Q 036583 609 --DCDQRIIHCDIKPENVLLD-DNYHAKVSDFGLAK 641 (817)
Q Consensus 609 --~~~~~ivH~Dlk~~NIll~-~~~~~ki~Dfgla~ 641 (817)
.....++|+|+.+.||+++ +++.+-|.||+.+.
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1346799999999999999 66677899998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.0002 Score=74.28 Aligned_cols=138 Identities=15% Similarity=0.105 Sum_probs=84.0
Q ss_pred CCCcc-eeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccC-cceeeeeeeEeecCCeeeEEEeeccCCChhhhh
Q 036583 501 GQGGF-GSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH-HLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWI 578 (817)
Q Consensus 501 G~G~f-G~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l 578 (817)
-.|.. ..||+...+ +..+.||+..... ..++.+|++++..+. +--+.+++++...++..++|||+++|.+|....
T Consensus 7 ~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~ 83 (244)
T cd05150 7 TEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALW 83 (244)
T ss_pred CCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhh
Confidence 33444 789999874 4678888876432 345778999988884 445667777777666789999999998776432
Q ss_pred h-------------------hccc-ccchh--hhHHHHHHH--------------------HHHHHHHHHHh----cCCC
Q 036583 579 F-------------------KKNQ-EFLLD--WETRFNIAL--------------------GTAKGLAYLHE----DCDQ 612 (817)
Q Consensus 579 ~-------------------~~~~-~~~l~--~~~~~~i~~--------------------qia~~l~~LH~----~~~~ 612 (817)
. .... ..... ......... .+...+..|-+ ....
T Consensus 84 ~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 163 (244)
T cd05150 84 EELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDL 163 (244)
T ss_pred cccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCce
Confidence 1 0000 00000 000000000 01111112211 0125
Q ss_pred ceeecCCCCCCeEecCCCcEEEeecCCcc
Q 036583 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAK 641 (817)
Q Consensus 613 ~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 641 (817)
.++|+|+.|.||+++++..+.|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 68999999999999998788999998765
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.0002 Score=64.35 Aligned_cols=99 Identities=21% Similarity=0.426 Sum_probs=63.9
Q ss_pred CEEEeCCCeeEEeeecCCCCCceEEEEEEecCCceEEEEc-CCCCCCCCCCCcEEecCceEEE-ecCCeEEEEeCCCCCc
Q 036583 51 LFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTA-NRGSPVANSDNFVFKKDGEVSL-QKGGSVVWSVNPSGAS 128 (817)
Q Consensus 51 ~~lvs~~g~f~~gf~~~~~~~~~y~~i~~~~~~~t~vWvA-nr~~Pi~~~~~~~~~~~g~l~l-~~~~~~vWstn~~~~~ 128 (817)
+.+.+.+|.+.|-|...|+ |.+.. ...+++|.. +....-.....+.|..|||||| +..+.++|++. ....
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl~~--~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf-~~pt 83 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVLYD--SNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSF-DYPT 83 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEEEE--TTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEEST-TSSS
T ss_pred cccccccccccceECCCCe-----EEEEc--CCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeec-CCCc
Confidence 4455655889999988776 44332 335679999 4333332345577999999998 67899999994 3344
Q ss_pred eeEEEEec--CCCEEEEccCCccccccccCCC
Q 036583 129 VSAMELRD--SGNLVLLGNDNKVLWQSFSHPT 158 (817)
Q Consensus 129 ~~~a~Lld--sGNLVL~~~~~~~lWQSFd~Pt 158 (817)
...+...+ .||++ ..+...+.|.|-+.|+
T Consensus 84 dt~L~~q~l~~~~~~-~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 84 DTLLPGQKLGDGNVT-GKNDSLTSWSSNTDPS 114 (114)
T ss_dssp -EEEEEET--TSEEE-EESTSSEEEESS----
T ss_pred cEEEeccCcccCCCc-cccceEEeECCCCCCC
Confidence 45555555 78888 6666788999977663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=97.73 E-value=8.8e-05 Score=61.62 Aligned_cols=33 Identities=36% Similarity=0.926 Sum_probs=30.0
Q ss_pred ccChhhHHHHhhc-cCceeeEeeccCCCceEEEe
Q 036583 357 KADLNGCKKACLG-NCSCLAMFFQNSSGNCFLFD 389 (817)
Q Consensus 357 ~~~~~~C~~~Cl~-nCsC~Ay~~~~~~g~C~~~~ 389 (817)
..++++|++.|++ +|+|.||.|.++++.|++|.
T Consensus 24 ~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~ 57 (78)
T smart00473 24 VASLEECASKCLNSNCSCRSFTYNNGTKGCLLWS 57 (78)
T ss_pred CCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEee
Confidence 4589999999999 99999999987678999997
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00032 Score=66.46 Aligned_cols=128 Identities=18% Similarity=0.237 Sum_probs=85.4
Q ss_pred ccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeee-eeeEeecCCeeeEEEeeccCCChh
Q 036583 497 SVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVK-LRGFCAEGTHRLLAYEFMANGSLD 575 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~gsL~ 575 (817)
...|++|++|.||+|.+ .|..+|+|+-.. +..+..+..|++++..+.-.++.+ ++.+-. ..+.|||..|..|.
T Consensus 27 ~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L~ 100 (201)
T COG2112 27 EKELAKGTTSVVYLGEW-RGGEVALKVRRR-DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhcccccEEEEeec-cCceEEEEEecC-CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcchh
Confidence 35699999999999999 455788887654 345678999999999997655543 333322 23459999998887
Q ss_pred hhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCC-CCCeEecCCCcEEEeecCCcccc
Q 036583 576 KWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIK-PENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 576 ~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk-~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+.-... +-+ -...++..---|.. .+|-|+.|. |..++|-.+..+.|+||..|+.-
T Consensus 101 ~~~~~~------~rk----~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 101 KLEIGG------DRK----HLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhcc------cHH----HHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 654321 112 22334444222333 788888886 44455555559999999998743
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00038 Score=85.01 Aligned_cols=77 Identities=14% Similarity=0.304 Sum_probs=57.1
Q ss_pred cccCCCcceeEEEEEcCCC---cEEEEEEeccCC--cCHHHHHHHHHHhhccC-ccee--eeeeeEeecC---CeeeEEE
Q 036583 498 VKLGQGGFGSVYQGVLPDG---TRLAVKKLEGIG--QGKKEFRAEVSIIGSIH-HLHL--VKLRGFCAEG---THRLLAY 566 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g---~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv~ 566 (817)
+.++.|.+..+|+....++ ..+++|+..... .....+.+|.++++.+. |.++ .+++.+|.+. ...++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 4588999999999887554 367777764322 23457889999999995 6654 8888888764 3578999
Q ss_pred eeccCCCh
Q 036583 567 EFMANGSL 574 (817)
Q Consensus 567 e~~~~gsL 574 (817)
||+++..+
T Consensus 124 E~v~G~~~ 131 (822)
T PLN02876 124 EYLEGRIF 131 (822)
T ss_pred EecCCccc
Confidence 99998643
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0013 Score=70.05 Aligned_cols=75 Identities=8% Similarity=0.036 Sum_probs=56.4
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCc---ceeeeeeeEeecC---CeeeEEEeeccC
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHH---LHLVKLRGFCAEG---THRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h---~niv~l~~~~~~~---~~~~lv~e~~~~ 571 (817)
+.||+|..+.||+....+++ +.+|..+. ......+..|.+.++.+.. ..+.++++.|..+ +..+||||++++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~-~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGN-PMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCC-EEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 45999999999999876664 56666432 2234688999999988853 4688888887543 568999999998
Q ss_pred CCh
Q 036583 572 GSL 574 (817)
Q Consensus 572 gsL 574 (817)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 765
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0022 Score=63.55 Aligned_cols=126 Identities=20% Similarity=0.295 Sum_probs=88.9
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccCC-----------------cCHHHHHHHHHHhhccC------cceeeeeee
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIG-----------------QGKKEFRAEVSIIGSIH------HLHLVKLRG 554 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~-----------------~~~~~~~~Ev~~l~~l~------h~niv~l~~ 554 (817)
..||+|+.-.||. +++.....||+..... ...++..+|+.....+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 3589999999995 4555566788775433 23467778887776666 889999999
Q ss_pred EeecCCeeeEEEeeccC------CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC
Q 036583 555 FCAEGTHRLLAYEFMAN------GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD 628 (817)
Q Consensus 555 ~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~ 628 (817)
+.+.+...-+|+|.+.+ -+|.+++.+.. ++. ...+. +-+-..||-+ ..|+.+|++|.||++..
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~~~---L~~f~~~l~~---~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-ELRQA---LDEFKRYLLD---HHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHHHH---HHHHHHHHHH---cCCeecCCCcccEEEEe
Confidence 99999888999988643 26778885443 333 33333 3334456666 78999999999999953
Q ss_pred C---C-cEEEee
Q 036583 629 N---Y-HAKVSD 636 (817)
Q Consensus 629 ~---~-~~ki~D 636 (817)
. . .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 2 2 567766
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0012 Score=68.05 Aligned_cols=72 Identities=15% Similarity=0.098 Sum_probs=47.5
Q ss_pred ccCCCcceeEEEEEcCC--CcEEEEEEeccCCcCHHHHHHHHHHhhccCcce-eeeeeeEeecCCeeeEEEeeccCCCh
Q 036583 499 KLGQGGFGSVYQGVLPD--GTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLH-LVKLRGFCAEGTHRLLAYEFMANGSL 574 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~~--g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~gsL 574 (817)
.|..|-...+|+....+ ++.+++|+........-+..+|+.++..+.... ..++++.+. ..++|||+++.++
T Consensus 5 ~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 5 RFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 47778888999998764 678888877543222223357888888885333 344444332 2479999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.001 Score=68.59 Aligned_cols=72 Identities=13% Similarity=0.196 Sum_probs=45.0
Q ss_pred ccCCCcce-eEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcc---eeeeeeeEeecC---CeeeEEEeeccC
Q 036583 499 KLGQGGFG-SVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHL---HLVKLRGFCAEG---THRLLAYEFMAN 571 (817)
Q Consensus 499 ~lG~G~fG-~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~~~ 571 (817)
.|+.|+.. .||+. +..+++|.... ......+.+|.+++..+... -+.++++..... ...+++||+++|
T Consensus 4 ~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G 78 (235)
T cd05155 4 PVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEG 78 (235)
T ss_pred eccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecC
Confidence 46766666 58875 23466776543 33456789999999887532 344444443332 234889999999
Q ss_pred CChh
Q 036583 572 GSLD 575 (817)
Q Consensus 572 gsL~ 575 (817)
.++.
T Consensus 79 ~~l~ 82 (235)
T cd05155 79 ETAT 82 (235)
T ss_pred CCCC
Confidence 7764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0017 Score=63.73 Aligned_cols=124 Identities=24% Similarity=0.346 Sum_probs=89.8
Q ss_pred HhhccccccCCCcc-eeEEEEEcCCCcEEEEEEecc---C---------C----------cCHHHHHHHHHHhhccC---
Q 036583 492 ATNNFSVKLGQGGF-GSVYQGVLPDGTRLAVKKLEG---I---------G----------QGKKEFRAEVSIIGSIH--- 545 (817)
Q Consensus 492 ~~~~~~~~lG~G~f-G~Vy~g~~~~g~~vavK~l~~---~---------~----------~~~~~~~~Ev~~l~~l~--- 545 (817)
+..+|.+.||.|.- |.|||.++ +|+.+|+|.+.. . . .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 56677789999999 99999999 778999999321 0 0 01135788999988885
Q ss_pred ccee--eeeeeEeecC------------------CeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHH
Q 036583 546 HLHL--VKLRGFCAEG------------------THRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAY 605 (817)
Q Consensus 546 h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~ 605 (817)
+.++ |+.+||..-. ..+.||.||.+... ....+-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccchhHHHHHHHHHHH
Confidence 4455 8999987322 12356777765532 1123345677888889
Q ss_pred HHhcCCCceeecCCCCCCeEecCCCcEEEeecCCc
Q 036583 606 LHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLA 640 (817)
Q Consensus 606 LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 640 (817)
+|. .+|+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 998 99999999999986 5689999864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.002 Score=67.28 Aligned_cols=137 Identities=14% Similarity=0.105 Sum_probs=77.7
Q ss_pred cCCCcceeEEEEEcCCCcEEEEEEeccCCcCH-HHHHHHHHHhhccCccee-eeeeeEeecCCeeeEEEeeccCCChhhh
Q 036583 500 LGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGK-KEFRAEVSIIGSIHHLHL-VKLRGFCAEGTHRLLAYEFMANGSLDKW 577 (817)
Q Consensus 500 lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~-~~~~~Ev~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~~ 577 (817)
+..|-...+|+... +++.+++|......... -+..+|.++++.+....+ .+++.... ..+||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 56688889998874 56678888765432221 245788888888864333 33443332 3689999998765421
Q ss_pred --------------h---hhcc-cccchhhhHH-HHHHHH---------HHHHHHHHHhc-----CCCceeecCCCCCCe
Q 036583 578 --------------I---FKKN-QEFLLDWETR-FNIALG---------TAKGLAYLHED-----CDQRIIHCDIKPENV 624 (817)
Q Consensus 578 --------------l---~~~~-~~~~l~~~~~-~~i~~q---------ia~~l~~LH~~-----~~~~ivH~Dlk~~NI 624 (817)
| +... ....++.... ..+..+ +.+.+..+... ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 1 1110 0111111111 111111 11112222111 124689999999999
Q ss_pred EecCCCcEEEeecCCccc
Q 036583 625 LLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 625 ll~~~~~~ki~Dfgla~~ 642 (817)
++++++ +.|+||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999987753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0063 Score=66.94 Aligned_cols=73 Identities=14% Similarity=0.141 Sum_probs=53.0
Q ss_pred cccCCCcceeEEEEEcCCC-cEEEEEEeccC--------CcCHHHHHHHHHHhhccC---cceeeeeeeEeecCCeeeEE
Q 036583 498 VKLGQGGFGSVYQGVLPDG-TRLAVKKLEGI--------GQGKKEFRAEVSIIGSIH---HLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g-~~vavK~l~~~--------~~~~~~~~~Ev~~l~~l~---h~niv~l~~~~~~~~~~~lv 565 (817)
+.||.|.+..||+....+| +.++||.-... ....+.+..|.+.|..+. -.++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 4699999999999998877 48999974321 123456777888887763 2356677766 44567899
Q ss_pred EeeccCC
Q 036583 566 YEFMANG 572 (817)
Q Consensus 566 ~e~~~~g 572 (817)
|||+++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0012 Score=78.87 Aligned_cols=196 Identities=18% Similarity=0.173 Sum_probs=135.8
Q ss_pred HHHHHHHhhccCcceeeeeeeEeecCCee----eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhc
Q 036583 534 FRAEVSIIGSIHHLHLVKLRGFCAEGTHR----LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED 609 (817)
Q Consensus 534 ~~~Ev~~l~~l~h~niv~l~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~ 609 (817)
..-|.+.+.++.|+|+++++.+-.+.... .+..|++..-++...+.... .++....+.+..++..|++|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~h~- 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYLHS- 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHHHH-
Confidence 34577788899999999999997654433 34458888888888887655 57888889999999999999998
Q ss_pred CCCceeecCCCCC---CeEecCCCcEEEe--ecCCccccCCCCceeeeeccCCCCccCccccccCccCc--cccccchhh
Q 036583 610 CDQRIIHCDIKPE---NVLLDDNYHAKVS--DFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISE--KSDVYSYGM 682 (817)
Q Consensus 610 ~~~~ivH~Dlk~~---NIll~~~~~~ki~--Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DvwS~Gv 682 (817)
....|.-+..+ +-..+..+.+.++ ||+..+.+...... ....-+..+.|||......+.. ..|+|.+|.
T Consensus 305 --~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 305 --LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred --hccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 55555555554 5555677778877 88888766443221 1223445678888877665554 479999999
Q ss_pred hHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 683 VLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 683 vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.+..+..|..+-..... ...+++... . .........|...++++|+++.+++.+
T Consensus 381 l~~~~~~~~~i~~~~~~------------------~~~~l~~~~----~----~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSAV------------------PVSLLDVLS----T----SELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HHhhhhhcCcccccccc------------------hhhhhcccc----c----hhhhhhhhhhcchhhhhccchhhhhhc
Confidence 99999987654321110 011111100 0 034566778999999999999999985
Q ss_pred H
Q 036583 763 L 763 (817)
Q Consensus 763 L 763 (817)
.
T Consensus 435 ~ 435 (1351)
T KOG1035|consen 435 P 435 (1351)
T ss_pred h
Confidence 5
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0039 Score=66.88 Aligned_cols=139 Identities=20% Similarity=0.199 Sum_probs=82.4
Q ss_pred ccCCCcceeEEEEEcCC-------CcEEEEEEeccCCcCHHHHHHHHHHhhccCcce-eeeeeeEeecCCeeeEEEeecc
Q 036583 499 KLGQGGFGSVYQGVLPD-------GTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLH-LVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~~-------g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.|..|--..+|+....+ ++.+++|+.........+..+|.+++..+.... ..++++++.. .+|+||++
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~ 80 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIP 80 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeC
Confidence 35566677899988755 578889987654333345678888888875333 3345555432 35899998
Q ss_pred CCChhhh-----------------hhhcccc--------cchhhhHHHH--------------------------HHHHH
Q 036583 571 NGSLDKW-----------------IFKKNQE--------FLLDWETRFN--------------------------IALGT 599 (817)
Q Consensus 571 ~gsL~~~-----------------l~~~~~~--------~~l~~~~~~~--------------------------i~~qi 599 (817)
|..+... |++.... ...-|..... +...+
T Consensus 81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (302)
T cd05156 81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE 160 (302)
T ss_pred CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence 8765431 1110000 0011111100 11122
Q ss_pred HHHHHHHHh------cCCCceeecCCCCCCeEecCC----CcEEEeecCCcc
Q 036583 600 AKGLAYLHE------DCDQRIIHCDIKPENVLLDDN----YHAKVSDFGLAK 641 (817)
Q Consensus 600 a~~l~~LH~------~~~~~ivH~Dlk~~NIll~~~----~~~ki~Dfgla~ 641 (817)
.+-+..|.. .....++|+|+.+.||+++++ +.++++||..+.
T Consensus 161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 222334431 235678999999999999984 889999998875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0037 Score=66.86 Aligned_cols=141 Identities=20% Similarity=0.198 Sum_probs=85.6
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcce--eeeeeeE------eecCCeeeEEEeec
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLH--LVKLRGF------CAEGTHRLLAYEFM 569 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e~~ 569 (817)
+.|..|....+|+....++ .+++|+... ........|++++..+++.. +.+++.. ...++..++|++|+
T Consensus 20 ~~i~~G~~n~~y~v~~~~~-~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 20 EGISAGIENTNYFVTTDSG-RYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred ecccCccccceEEEEeCCC-cEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 3477787889999887444 688888764 34556778888888885332 4444432 12334568999999
Q ss_pred cCCChhh----h----------hhhcccc--------cchhhhHHH----------HHHHHHHHHHHHHHh----cCCCc
Q 036583 570 ANGSLDK----W----------IFKKNQE--------FLLDWETRF----------NIALGTAKGLAYLHE----DCDQR 613 (817)
Q Consensus 570 ~~gsL~~----~----------l~~~~~~--------~~l~~~~~~----------~i~~qia~~l~~LH~----~~~~~ 613 (817)
+|..+.. . |+..... ....|.... .....+..++.++.+ .....
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 9876532 0 1110000 011222111 011123334444443 22457
Q ss_pred eeecCCCCCCeEecCCCcEEEeecCCcc
Q 036583 614 IIHCDIKPENVLLDDNYHAKVSDFGLAK 641 (817)
Q Consensus 614 ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 641 (817)
++|+|+.|.||+++++..+.|.||+.+.
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhc
Confidence 9999999999999998778999998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0012 Score=68.33 Aligned_cols=132 Identities=16% Similarity=0.155 Sum_probs=88.1
Q ss_pred hccccccCCCcceeEEEEEcCCCcEEEEEEecc-----------------CCc------CHHHHHHHHHHhhccCc-c-e
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEG-----------------IGQ------GKKEFRAEVSIIGSIHH-L-H 548 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~-----------------~~~------~~~~~~~Ev~~l~~l~h-~-n 548 (817)
+.+.++||-|--+.||.+...+|++.++|.-+- ... .+-...+|...|+.|.. . -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 445689999999999999999999999884210 000 11234678888888853 2 3
Q ss_pred eeeeeeEeecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC
Q 036583 549 LVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD 628 (817)
Q Consensus 549 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~ 628 (817)
+.+.+++ ...++|||++.+-.|...-+- .+..+... .+..-+--|.. +++||+|..-=||++++
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~---~lm~~Iv~la~---~GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDPPTLYD---DLMGLIVRLAN---HGLIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeeec------CChHHHHH---HHHHHHHHHHH---cCceecccchheeEEec
Confidence 4444444 445899999988777654321 12222222 22222233334 89999999999999999
Q ss_pred CCcEEEeecCCcc
Q 036583 629 NYHAKVSDFGLAK 641 (817)
Q Consensus 629 ~~~~ki~Dfgla~ 641 (817)
+..++++||--..
T Consensus 238 d~~i~vIDFPQmv 250 (465)
T KOG2268|consen 238 DDKIVVIDFPQMV 250 (465)
T ss_pred CCCEEEeechHhh
Confidence 9999999996443
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0012 Score=54.01 Aligned_cols=35 Identities=29% Similarity=0.643 Sum_probs=31.2
Q ss_pred ccChhhHHHHhhccCceeeEeeccCCCceEEEecc
Q 036583 357 KADLNGCKKACLGNCSCLAMFFQNSSGNCFLFDRI 391 (817)
Q Consensus 357 ~~~~~~C~~~Cl~nCsC~Ay~~~~~~g~C~~~~~~ 391 (817)
..+.++|++.|+.||+|.||.|..+.+.|+++...
T Consensus 24 ~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~~ 58 (73)
T cd01100 24 ASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSSE 58 (73)
T ss_pred cCCHHHHHHHcCCCCCceEEEEECCCCeEEcccCC
Confidence 45889999999999999999999888899999654
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.034 Score=59.78 Aligned_cols=141 Identities=22% Similarity=0.244 Sum_probs=82.4
Q ss_pred ccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcc--eeeeeeeEe------ecCCeeeEEEeecc
Q 036583 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHL--HLVKLRGFC------AEGTHRLLAYEFMA 570 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~--niv~l~~~~------~~~~~~~lv~e~~~ 570 (817)
.++.|.-..+|+....+| .+++|+.... ...++...|++++..|... .+.+++... ...+..++++||++
T Consensus 29 ~~~~G~~n~~y~v~t~~~-~~vLK~~~~~-~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~ 106 (307)
T TIGR00938 29 GIAEGVENSNYLLTTDVG-RYILTLYEKR-VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFLQ 106 (307)
T ss_pred ccCCccccceEEEEeCCC-cEEEEEecCC-CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeCC
Confidence 466777789999887555 5677876542 2245566777777777422 234444321 22455689999998
Q ss_pred CCChhh-----------h---hhhccccc---------chhhhHHH------------HHHHHHHHHHHHHHh----cCC
Q 036583 571 NGSLDK-----------W---IFKKNQEF---------LLDWETRF------------NIALGTAKGLAYLHE----DCD 611 (817)
Q Consensus 571 ~gsL~~-----------~---l~~~~~~~---------~l~~~~~~------------~i~~qia~~l~~LH~----~~~ 611 (817)
|..+.. . ++...... .-.|.... .....+.+.++++.. ...
T Consensus 107 G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~ 186 (307)
T TIGR00938 107 GLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDLP 186 (307)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 854321 1 11111100 11221110 011123334555532 235
Q ss_pred CceeecCCCCCCeEecCCCcEEEeecCCcc
Q 036583 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAK 641 (817)
Q Consensus 612 ~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 641 (817)
.+++|+|+++.||++++++...|.||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 789999999999999988777899998765
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.034 Score=60.09 Aligned_cols=140 Identities=14% Similarity=0.156 Sum_probs=77.7
Q ss_pred ccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcc--eeeeeee------EeecCCeeeEEEeecc
Q 036583 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHL--HLVKLRG------FCAEGTHRLLAYEFMA 570 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~--niv~l~~------~~~~~~~~~lv~e~~~ 570 (817)
.|..|....+|+....+| .+++|+.+ ....+....|+.++..|... .+.+.+. +....+..++++||++
T Consensus 29 ~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l~ 105 (319)
T PRK05231 29 GIAEGIENSNFFLTTTQG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFLE 105 (319)
T ss_pred hhccccccceEEEEeCCC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEecC
Confidence 467788789999887665 68889876 22334445566666555321 1333332 1123456789999999
Q ss_pred CCChhh-----------hh---hhcccc--------cchhh-hHHHH------------HHHH-HHHHHHHHHhc----C
Q 036583 571 NGSLDK-----------WI---FKKNQE--------FLLDW-ETRFN------------IALG-TAKGLAYLHED----C 610 (817)
Q Consensus 571 ~gsL~~-----------~l---~~~~~~--------~~l~~-~~~~~------------i~~q-ia~~l~~LH~~----~ 610 (817)
|..+.. .| +..... ..+.| ..... ...+ +...++.+.+. .
T Consensus 106 G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l 185 (319)
T PRK05231 106 GKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPAL 185 (319)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccccC
Confidence 875421 11 111000 01112 11111 1111 11122232211 3
Q ss_pred CCceeecCCCCCCeEecCCCcEEEeecCCcc
Q 036583 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAK 641 (817)
Q Consensus 611 ~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 641 (817)
..+++|+|+++.||+++.+...-|.||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 4689999999999999977666899998875
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.00053 Score=83.32 Aligned_cols=159 Identities=16% Similarity=0.096 Sum_probs=113.2
Q ss_pred HHHHHHHhhccCcceeeeeeeEee--cCCeeeEEEeeccCCChhhhhhhccccc-chhhhHHHHHHHHH-HHHHHHHHhc
Q 036583 534 FRAEVSIIGSIHHLHLVKLRGFCA--EGTHRLLAYEFMANGSLDKWIFKKNQEF-LLDWETRFNIALGT-AKGLAYLHED 609 (817)
Q Consensus 534 ~~~Ev~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~-~l~~~~~~~i~~qi-a~~l~~LH~~ 609 (817)
...|...++...|+++.....-.. +..+.+.+++|+..|.+.+.|.+...+. .++..-. ...+++ ..+..-+|..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v-~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPV-HLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchH-HHHHHHHHhccchhhhc
Confidence 344555566678988776655543 3445688999999999999987654432 2322222 223333 5555555543
Q ss_pred C--CCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHh
Q 036583 610 C--DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEI 687 (817)
Q Consensus 610 ~--~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el 687 (817)
. ..-.+|+++|+-|.+|+.+.++|+.++|+.+...+ .........+++-|++|+....-.++.++|+|..|+.+|+.
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 2 23468999999999999999999999999994332 22233456778889999998888899999999999999999
Q ss_pred hhCCCCC
Q 036583 688 IGGRKNF 694 (817)
Q Consensus 688 ltg~~pf 694 (817)
--|..+|
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8887766
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.027 Score=59.46 Aligned_cols=72 Identities=19% Similarity=0.303 Sum_probs=48.2
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccC---cceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH---HLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
+.|+.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+.+++++....+..+||+||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 458889999999988 477889999887 333457888888888773 446788888887777789999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.051 Score=59.27 Aligned_cols=138 Identities=17% Similarity=0.205 Sum_probs=78.2
Q ss_pred cCCCcceeEEEEEcCC-----CcEEEEEEeccCCcCHHHHHHHHHHhhccCccee-eeeeeEeecCCeeeEEEeeccCCC
Q 036583 500 LGQGGFGSVYQGVLPD-----GTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHL-VKLRGFCAEGTHRLLAYEFMANGS 573 (817)
Q Consensus 500 lG~G~fG~Vy~g~~~~-----g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs 573 (817)
|-.|-.-.+|+....+ ++.+++|+........-+-.+|..++..+...++ .++++.+..+ .|+||+++.+
T Consensus 44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~ 119 (344)
T PLN02236 44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHART 119 (344)
T ss_pred cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCC
Confidence 4446677888887532 3578888775443222233678888888854433 3555655433 5799998766
Q ss_pred hhhh-----------------hhhcc---cccchhhhHHHHHHHH-----------------HHHHHHHHH----h-cCC
Q 036583 574 LDKW-----------------IFKKN---QEFLLDWETRFNIALG-----------------TAKGLAYLH----E-DCD 611 (817)
Q Consensus 574 L~~~-----------------l~~~~---~~~~l~~~~~~~i~~q-----------------ia~~l~~LH----~-~~~ 611 (817)
|... +++.. ......|.+..++..+ +...+..|. . ...
T Consensus 120 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~ 199 (344)
T PLN02236 120 LSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQE 199 (344)
T ss_pred CCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCC
Confidence 6421 11100 0001122222222211 111122222 1 123
Q ss_pred CceeecCCCCCCeEecC-CCcEEEeecCCcc
Q 036583 612 QRIIHCDIKPENVLLDD-NYHAKVSDFGLAK 641 (817)
Q Consensus 612 ~~ivH~Dlk~~NIll~~-~~~~ki~Dfgla~ 641 (817)
..++|+|+++.||++++ ++.+.++||..+.
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 57899999999999986 4789999998775
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.061 Score=56.67 Aligned_cols=31 Identities=26% Similarity=0.573 Sum_probs=25.8
Q ss_pred CceeecCCCCCCeEecCCCc-EEEeecCCccc
Q 036583 612 QRIIHCDIKPENVLLDDNYH-AKVSDFGLAKL 642 (817)
Q Consensus 612 ~~ivH~Dlk~~NIll~~~~~-~ki~Dfgla~~ 642 (817)
..++|+|+++.||+++++++ .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 56999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.13 Score=54.73 Aligned_cols=135 Identities=16% Similarity=0.282 Sum_probs=76.5
Q ss_pred EEEEEcCCCcEEEEEEeccC---CcCHHHHHHHHHHhhccCc--ceeeeeeeEeecCC--eeeEEEeeccCCChhhhhhh
Q 036583 508 VYQGVLPDGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHH--LHLVKLRGFCAEGT--HRLLAYEFMANGSLDKWIFK 580 (817)
Q Consensus 508 Vy~g~~~~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~~~gsL~~~l~~ 580 (817)
+|.... .+++.+|. .... ........+|.++|+.+.- .-+.+.++.|.++. ..+.||+|.+|..+.+.+..
T Consensus 41 t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~ 118 (321)
T COG3173 41 TFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP 118 (321)
T ss_pred eEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc
Confidence 444433 26667777 3211 2233455677777777742 34566677787766 66999999998543332221
Q ss_pred ccc-----------------------------------ccchhhhHHHHH--------HHHHHHHHHHHHhc-----CCC
Q 036583 581 KNQ-----------------------------------EFLLDWETRFNI--------ALGTAKGLAYLHED-----CDQ 612 (817)
Q Consensus 581 ~~~-----------------------------------~~~l~~~~~~~i--------~~qia~~l~~LH~~-----~~~ 612 (817)
... ...-.|....+. .-...+-..+|++. ...
T Consensus 119 ~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~ 198 (321)
T COG3173 119 ESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPP 198 (321)
T ss_pred ccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCc
Confidence 100 000111111100 00111223334332 134
Q ss_pred ceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 613 ~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
.++|+|+++.||+++.+.-+-|.||+++..-.
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 68999999999999998889999999987643
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.16 Score=54.82 Aligned_cols=71 Identities=15% Similarity=0.134 Sum_probs=46.2
Q ss_pred ccCCCcceeEEEEEcCCC-cEEEEEEeccC--------CcCHHHHHHHHHHhhccC--cc-eeeeeeeEeecCCeeeEEE
Q 036583 499 KLGQGGFGSVYQGVLPDG-TRLAVKKLEGI--------GQGKKEFRAEVSIIGSIH--HL-HLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~~g-~~vavK~l~~~--------~~~~~~~~~Ev~~l~~l~--h~-niv~l~~~~~~~~~~~lv~ 566 (817)
+||.|-...||++..++| +.|+||.-... .-..++..-|.+.|.... -| .+.+++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 689999999999998765 57999964211 222344556677776553 34 34444433 455667999
Q ss_pred eeccC
Q 036583 567 EFMAN 571 (817)
Q Consensus 567 e~~~~ 571 (817)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.07 Score=53.79 Aligned_cols=122 Identities=18% Similarity=0.184 Sum_probs=61.3
Q ss_pred CcEEEEEEeccCCcCHHHHHHHHHHhhccCccee-eeeeeEeecCCeeeEEEeeccCCChhh-------hhh--------
Q 036583 516 GTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHL-VKLRGFCAEGTHRLLAYEFMANGSLDK-------WIF-------- 579 (817)
Q Consensus 516 g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~-------~l~-------- 579 (817)
++.|+||+........-.-..|..+++.+....+ .++++++.++ +|+||+++..|.. .+.
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~ 77 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLAK 77 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHHH
Confidence 4578888887665556677889999988865444 4555555432 5778887655422 110
Q ss_pred --h--c--ccccchhhhHHHHH----------------------HHHHHHHHHHHHh-----cCCCceeecCCCCCCeEe
Q 036583 580 --K--K--NQEFLLDWETRFNI----------------------ALGTAKGLAYLHE-----DCDQRIIHCDIKPENVLL 626 (817)
Q Consensus 580 --~--~--~~~~~l~~~~~~~i----------------------~~qia~~l~~LH~-----~~~~~ivH~Dlk~~NIll 626 (817)
. . .....--|.....+ ...+..-+..+.+ .....++|+|+.+.||++
T Consensus 78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~ 157 (211)
T PF01633_consen 78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI 157 (211)
T ss_dssp HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence 0 0 00001111211111 1111222222221 012467999999999999
Q ss_pred -cCCCcEEEeecCCcc
Q 036583 627 -DDNYHAKVSDFGLAK 641 (817)
Q Consensus 627 -~~~~~~ki~Dfgla~ 641 (817)
+.++.++++||..+.
T Consensus 158 ~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 158 NNKDGEVKLIDFEYAG 173 (211)
T ss_dssp TSSSSCEEE--GTT-E
T ss_pred ccCCCeEEEecHHHHh
Confidence 889999999998775
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.22 E-value=0.29 Score=52.99 Aligned_cols=71 Identities=15% Similarity=0.069 Sum_probs=47.1
Q ss_pred CcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcc--eeeeee---e--EeecCCeeeEEEeeccCCC
Q 036583 503 GGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHL--HLVKLR---G--FCAEGTHRLLAYEFMANGS 573 (817)
Q Consensus 503 G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~--niv~l~---~--~~~~~~~~~lv~e~~~~gs 573 (817)
+.-..||+....+++.+++|..+.......+...|++.+..+... .++... | ....++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 455789999988888899998764444567788888888777321 122221 2 1223456788999998764
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.23 Score=54.71 Aligned_cols=71 Identities=17% Similarity=0.204 Sum_probs=47.9
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccC-----C---cCHHHHHHHHHHhhccC---cceeeeeeeEeecCCeeeEEE
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGI-----G---QGKKEFRAEVSIIGSIH---HLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~-----~---~~~~~~~~Ev~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 566 (817)
+.||.|....||+.... ++.++||+-... . .....-..|.+.|..+. ..++.+++.++. +..+++|
T Consensus 38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM 114 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM 114 (418)
T ss_pred EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence 56899999999998874 556889875411 1 12233344566665553 347888888877 4467889
Q ss_pred eeccC
Q 036583 567 EFMAN 571 (817)
Q Consensus 567 e~~~~ 571 (817)
|++++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99976
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 817 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-64 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-62 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-43 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-42 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-37 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-37 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-34 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-22 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-21 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-20 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-20 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-19 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-18 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-18 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-18 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-18 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-18 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-18 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-18 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-18 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 6e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-08 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-08 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 6e-08 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 6e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-08 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 7e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-07 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 465 bits (1200), Expect = e-159
Identities = 136/305 (44%), Positives = 195/305 (63%), Gaps = 9/305 (2%)
Query: 468 SEEDNFLENLSGMPVRFTYRDLQTATNNFSV--KLGQGGFGSVYQGVLPDGTRLAVKKL- 524
+EED E G RF+ R+LQ A++NFS LG+GGFG VY+G L DGT +AVK+L
Sbjct: 6 AEEDP--EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLK 63
Query: 525 EGIGQG-KKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIF-KKN 582
E QG + +F+ EV +I H +L++LRGFC T RLL Y +MANGS+ + +
Sbjct: 64 EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE 123
Query: 583 QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642
+ LDW R IALG+A+GLAYLH+ CD +IIH D+K N+LLD+ + A V DFGLAKL
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183
Query: 643 MTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETS-- 700
M + +HV T +RGT G++APE+++ SEK+DV+ YG++LLE+I G++ FD +
Sbjct: 184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
Query: 701 DKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVV 760
D + +++E KL ++D L + + + V ++VAL C Q RP M++VV
Sbjct: 244 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 761 QMLEG 765
+MLEG
Sbjct: 304 RMLEG 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 396 bits (1019), Expect = e-132
Identities = 108/312 (34%), Positives = 165/312 (52%), Gaps = 23/312 (7%)
Query: 470 EDNFLENLSGMPVRFTYRDLQTATNNFS--------VKLGQGGFGSVYQGVLPDGTRLAV 521
E+ LE F++ +L+ TNNF K+G+GGFG VY+G + + T +AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 522 KKLE-----GIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDK 576
KKL + K++F E+ ++ H +LV+L GF ++G L Y +M NGSL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 577 WIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSD 636
+ + L W R IA G A G+ +LHE+ IH DIK N+LLD+ + AK+SD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 637 FGLAKLM-TREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFD 695
FGLA+ Q+ + + + GT Y+APE + I+ KSD+YS+G+VLLEII G D
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 696 PNETSDKAHFPSYAFKMM-EEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRP 754
+ + ++ EE + + +D ++N D S V VA C+ E + RP
Sbjct: 236 EHR--EPQLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 755 SMTKVVQMLEGI 766
+ KV Q+L+ +
Sbjct: 293 DIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 386 bits (995), Expect = e-129
Identities = 112/321 (34%), Positives = 167/321 (52%), Gaps = 19/321 (5%)
Query: 455 RKKRKAPESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSVK--LGQGGFGSVYQGV 512
K KA S + + S R DL+ ATNNF K +G G FG VY+GV
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESY---RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGV 59
Query: 513 LPDGTRLAVKKL-EGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571
L DG ++A+K+ QG +EF E+ + H HLV L GFC E +L Y++M N
Sbjct: 60 LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN 119
Query: 572 GSLDKWIFKKNQEFL-LDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY 630
G+L + ++ + + + WE R I +G A+GL YLH IIH D+K N+LLD+N+
Sbjct: 120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENF 176
Query: 631 HAKVSDFGLAKLMTR-EQSHVFTTLRGTRGYLAPEWITNYAIS----EKSDVYSYGMVLL 685
K++DFG++K T +Q+H+ T ++GT GY+ PE Y I EKSDVYS+G+VL
Sbjct: 177 VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPE----YFIKGRLTEKSDVYSFGVVLF 232
Query: 686 EIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWC 745
E++ R + + + +A + G+L I+D L + + + A+ C
Sbjct: 233 EVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKC 292
Query: 746 VQEDMSLRPSMTKVVQMLEGI 766
+ RPSM V+ LE
Sbjct: 293 LALSSEDRPSMGDVLWKLEYA 313
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 2e-73
Identities = 74/313 (23%), Positives = 117/313 (37%), Gaps = 36/313 (11%)
Query: 482 VRFTYRDLQTATNNFSV--KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVS 539
V +L + + +G FG V++ +AVK + + EV
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQNEYEVY 70
Query: 540 IIGSIHHLHLVKLRGFCAEG----THRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNI 595
+ + H ++++ G G L F GSL ++ ++ W +I
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHI 126
Query: 596 ALGTAKGLAYLHED-------CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648
A A+GLAYLHED I H DIK +NVLL +N A ++DFGLA +S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 649 HVFTTLR-GTRGYLAPEWI-----TNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDK 702
T + GTR Y+APE + + D+Y+ G+VL E+ D
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 703 AHF-----PSYAFKMMEE----GKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLR 753
F + + M+E K R +L + + C D R
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAML---CETIEECWDHDAEAR 303
Query: 754 PSMTKVVQMLEGI 766
S V + + +
Sbjct: 304 LSAGCVGERITQM 316
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 2e-63
Identities = 70/269 (26%), Positives = 118/269 (43%), Gaps = 23/269 (8%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558
+G+G FG V + +A+K++E +K F E+ + ++H ++VKL G C
Sbjct: 15 VVGRGAFGVVCKAKW-RAKDVAIKQIES-ESERKAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 559 GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCD 618
L E+ GSL + + L ++G+AYLH + +IH D
Sbjct: 73 --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 619 IKPENVLLDDNY-HAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDV 677
+KP N+LL K+ DFG A + T +G+ ++APE SEK DV
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDV 186
Query: 678 YSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFT 737
+S+G++L E+I RK FD + + G R + + +
Sbjct: 187 FSWGIILWEVITRRKPFD-----EIGGPAFRIMWAVHNGT-------RPPLIKNLPKPI- 233
Query: 738 AVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
+ C +D S RPSM ++V+++ +
Sbjct: 234 -ESLMTRCWSKDPSQRPSMEEIVKIMTHL 261
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 2e-63
Identities = 82/325 (25%), Positives = 141/325 (43%), Gaps = 32/325 (9%)
Query: 455 RKKRKAPESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSVKLGQGGFGSVYQGVLP 514
+ T+E F + G + + DL K+G G FG+V++
Sbjct: 5 HHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLN-----IKEKIGAGSFGTVHRAEW- 58
Query: 515 DGTRLAVKKL---EGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571
G+ +AVK L + + EF EV+I+ + H ++V G + + + E+++
Sbjct: 59 HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118
Query: 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYH 631
GSL + + K LD R ++A AKG+ YLH + I+H ++K N+L+D Y
Sbjct: 119 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYT 177
Query: 632 AKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGR 691
KV DFGL++L + GT ++APE + + +EKSDVYS+G++L E+ +
Sbjct: 178 VKVCDFGLSRLKASTFLSS-KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236
Query: 692 ---KNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQE 748
N +P + + + K RL I + + C
Sbjct: 237 QPWGNLNPAQV---------VAAVGFKCK-------RLEIPRNLNPQV--AAIIEGCWTN 278
Query: 749 DMSLRPSMTKVVQMLEGICPVPQPP 773
+ RPS ++ +L + PP
Sbjct: 279 EPWKRPSFATIMDLLRPLIKSAVPP 303
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 5e-63
Identities = 69/337 (20%), Positives = 129/337 (38%), Gaps = 50/337 (14%)
Query: 482 VRFTYRDLQTATNNFSV--KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVS 539
+ + +N + +G+G +G+VY+G L D +AVK ++ F E +
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSF--ANRQNFINEKN 57
Query: 540 I--IGSIHHLHLVKLRGFCAEG-----THRLLAYEFMANGSLDKWIFKKNQEFLLDWETR 592
I + + H ++ + LL E+ NGSL K++ DW +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSS 113
Query: 593 FNIALGTAKGLAYLHEDCDQR------IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR- 645
+A +GLAYLH + + I H D+ NVL+ ++ +SDFGL+ +T
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 646 ------EQSHVFTTLRGTRGYLAPEWITN-------YAISEKSDVYSYGMVLLEIIGGRK 692
E+ + + GT Y+APE + + ++ D+Y+ G++ EI
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 693 NFDPNETSDKAHFPSYA-------FKMMEE----GKLRNILDSRLNIDEQSDRVFTAVKV 741
+ P E+ + F+ M+ K R + + R +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL--KET 291
Query: 742 ALWCVQEDMSLRPSMTKVVQMLEGIC-PVPQPPTCSP 777
C +D R + + + + + + SP
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSP 328
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 7e-58
Identities = 83/313 (26%), Positives = 130/313 (41%), Gaps = 39/313 (12%)
Query: 499 KLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ-GKKEFRAEVSIIGSIHHLHLVKLRGFC 556
LG+G FG + G + +K+L + ++ F EV ++ + H +++K G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 557 AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIH 616
+ E++ G+L I K+ + W R + A A G+AYLH IIH
Sbjct: 77 YKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 617 CDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH-------------VFTTLRGTRGYLAP 663
D+ N L+ +N + V+DFGLA+LM E++ T+ G ++AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 664 EWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723
E I + EK DV+S+G+VL EII GR N DP+ F + G L
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDYLPRTM-----DFGLNVRGFL----- 240
Query: 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC-----PVPQPPTCSPL 778
F + + C D RPS K+ LE + +P P L
Sbjct: 241 -DRYCPPNCPPSF--FPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQL 297
Query: 779 GARLYSSFFRSIS 791
+ ++ R S
Sbjct: 298 DRGFWETYRRGES 310
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 1e-57
Identities = 72/287 (25%), Positives = 126/287 (43%), Gaps = 44/287 (15%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL--------EGIGQGKKEFRAEVSIIGSIHHLHL 549
++G+GGFG V++G + D + +A+K L + + +EF+ EV I+ +++H ++
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 550 VKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED 609
VKL G + EF+ G L + K + W + + L A G+ Y+ +
Sbjct: 86 VKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALGIEYMQ-N 140
Query: 610 CDQRIIHCDIKPENVLLD-----DNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPE 664
+ I+H D++ N+ L AKV+DFGL+ ++ H + L G ++APE
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS----QQSVHSVSGLLGNFQWMAPE 196
Query: 665 WIT--NYAISEKSDVYSYGMVLLEIIGGR---KNFDPNETSDKAHFPSYAFKMMEEGKLR 719
I + +EK+D YS+ M+L I+ G + + + + EEG
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-------IKFINMIREEGL-- 247
Query: 720 NILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
R I E V C D RP + +V+ L +
Sbjct: 248 -----RPTIPEDCPPRL--RNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 4e-57
Identities = 78/284 (27%), Positives = 120/284 (42%), Gaps = 42/284 (14%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKL-----EGIGQGKKEFRAEVSIIGSIHHLHLVKLR 553
+G GGFG VY+ G +AVK E I Q + R E + + H +++ LR
Sbjct: 14 IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
G C + + L EF G L++ + K + + N A+ A+G+ YLH++
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 614 IIHCDIKPENVLLD--------DNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEW 665
IIH D+K N+L+ N K++DFGLA+ R + G ++APE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAPEV 185
Query: 666 ITNYAISEKSDVYSYGMVLLEIIGGR---KNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722
I S+ SDV+SYG++L E++ G + D A+ +
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV---------AYGVAMNKL----- 231
Query: 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
L I F K+ C D RPS T ++ L I
Sbjct: 232 --ALPIPSTCPEPF--AKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 4e-55
Identities = 55/283 (19%), Positives = 106/283 (37%), Gaps = 38/283 (13%)
Query: 495 NFSVKLGQGGFGSVYQGVLPDGTRLAVKKL---EGIGQGKKEFRAEVSIIGSIHHLHLVK 551
NF KL + G +++G G + VK L + + ++F E + H +++
Sbjct: 13 NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 552 LRGFCAEGTHRLLAY--EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED 609
+ G C +M GSL + + F++D AL A+G+A+LH
Sbjct: 72 VLGACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMARGMAFLH-T 129
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN- 668
+ I + +V++D++ A++S + ++APE +
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEALQKK 183
Query: 669 --YAISEKSDVYSYGMVLLEIIGGR---KNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723
+D++S+ ++L E++ + E K+ EG
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI---------GMKVALEGL------ 228
Query: 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
R I K+ C+ ED + RP +V +LE +
Sbjct: 229 -RPTIPPGISPHV--SKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 2e-53
Identities = 73/279 (26%), Positives = 131/279 (46%), Gaps = 34/279 (12%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
++G G FG+VY+G G +AVK L Q + F+ EV ++ H++++ G+
Sbjct: 31 RIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
+ ++ SL + E + + +IA TA+G+ YLH + II
Sbjct: 89 STAP-QLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHA---KSII 142
Query: 616 HCDIKPENVLLDDNYHAKVSDFGLAKLMTR-EQSHVFTTLRGTRGYLAPEWITNYAI--- 671
H D+K N+ L ++ K+ DFGLA +R SH F L G+ ++APE I
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 672 SEKSDVYSYGMVLLEIIGGR---KNFDPNETSDKAHFPSYAFKMMEEGKLR-NILDSRLN 727
S +SDVY++G+VL E++ G+ N + + +M+ G L ++ R N
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---------IIEMVGRGSLSPDLSKVRSN 253
Query: 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
++ ++ C+++ RPS +++ +E +
Sbjct: 254 CPKR------MKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 4e-51
Identities = 65/284 (22%), Positives = 111/284 (39%), Gaps = 39/284 (13%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKL---EGIGQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
+G+G FG VY G G +A++ + K F+ EV H ++V G
Sbjct: 40 LIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
C H + +L + ++ + +LD IA KG+ YLH + I+
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGIL 152
Query: 616 HCDIKPENVLLDDNYHAKVSDFGLAKLMTR----EQSHVFTTLRGTRGYLAPEWITNYAI 671
H D+K +NV D+ ++DFGL + + G +LAPE I +
Sbjct: 153 HKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 672 ---------SEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722
S+ SDV++ G + E+ F M G N+
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-------AEAIIWQMGTGMKPNL- 263
Query: 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
S++ + ++ + L+C + RP+ TK++ MLE +
Sbjct: 264 -SQIGMGKE------ISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 1e-49
Identities = 64/311 (20%), Positives = 122/311 (39%), Gaps = 41/311 (13%)
Query: 483 RFTYRDLQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSI-- 540
R RD+ +G+G +G V++G G +AVK + +K + E +
Sbjct: 4 RTVARDIT-----LLECVGKGRYGEVWRGSW-QGENVAVKIFSS--RDEKSWFRETELYN 55
Query: 541 IGSIHHLHLVKLRGFCAEGTHRLLAY----EFMANGSLDKWIFKKNQEFLLDWETRFNIA 596
+ H +++ H + GSL ++ LD + I
Sbjct: 56 TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIV 111
Query: 597 LGTAKGLAYLHEDCDQR-----IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV- 650
L A GLA+LH + I H D+K +N+L+ N ++D GLA + ++ + +
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD 171
Query: 651 --FTTLRGTRGYLAPE------WITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDK 702
GT+ Y+APE + + ++ D++++G+VL E+ + E
Sbjct: 172 VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231
Query: 703 AHF----PSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVAL---WCVQEDMSLRPS 755
+ +F+ M + + R NI + T +A C ++ S R +
Sbjct: 232 PFYDVVPNDPSFEDMRKVVCVD--QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289
Query: 756 MTKVVQMLEGI 766
++ + L I
Sbjct: 290 ALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-49
Identities = 64/333 (19%), Positives = 129/333 (38%), Gaps = 40/333 (12%)
Query: 462 ESPQETSEEDNFLENLSGMPV---RFTYRDLQTATNNFSVKLGQGGFGSVYQGVLPDGTR 518
ES ++ E+ + SG+P+ R + +Q ++G+G +G V+ G G +
Sbjct: 9 ESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQ-----MVKQIGKGRYGEVWMGKW-RGEK 62
Query: 519 LAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY----EFMANGSL 574
+AVK + E+ + H +++ +GT ++ NGSL
Sbjct: 63 VAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSL 122
Query: 575 DKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR-----IIHCDIKPENVLLDDN 629
++ LD ++ +A + GL +LH + I H D+K +N+L+ N
Sbjct: 123 YDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178
Query: 630 YHAKVSDFGLAKLMTREQSHVF---TTLRGTRGYLAPE------WITNYAISEKSDVYSY 680
++D GLA + + V T GT+ Y+ PE ++ +D+YS+
Sbjct: 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSF 238
Query: 681 GMVLLEIIGGRKNFDPNETSDKAHF----PSYAFKMMEEGKLRNILDSRLNIDEQSDRVF 736
G++L E+ + E + +++ M E R + +
Sbjct: 239 GLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIK--KLRPSFPNRWSSDE 296
Query: 737 TAVKVAL---WCVQEDMSLRPSMTKVVQMLEGI 766
++ C + + R + +V + L +
Sbjct: 297 CLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-47
Identities = 71/347 (20%), Positives = 135/347 (38%), Gaps = 56/347 (16%)
Query: 461 PESPQETSEEDNFLENL----------SGMPV---RFTYRDLQTATNNFSVKLGQGGFGS 507
P + E L++L SG+P+ R R + +G+G FG
Sbjct: 3 PSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIV-----LQESIGKGRFGE 57
Query: 508 VYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSI--IGSIHHLHLVKLRGFC----AEGTH 561
V++G G +AVK + ++ + E I + H +++ T
Sbjct: 58 VWRGKW-RGEEVAVKIFSS--REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114
Query: 562 RLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR-----IIH 616
L ++ +GSL ++ + + E +AL TA GLA+LH + I H
Sbjct: 115 LWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 170
Query: 617 CDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF---TTLRGTRGYLAPE------WIT 667
D+K +N+L+ N ++D GLA + GT+ Y+APE +
Sbjct: 171 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 230
Query: 668 NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHF----PSYAFKMMEEG----KLR 719
++ +++D+Y+ G+V EI +E ++ + + M + KLR
Sbjct: 231 HFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR 290
Query: 720 NILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
+ +R E + K+ C + + R + ++ + L +
Sbjct: 291 PNIPNRWQSCEALRVM---AKIMRECWYANGAARLTALRIKKTLSQL 334
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-40
Identities = 69/289 (23%), Positives = 113/289 (39%), Gaps = 48/289 (16%)
Query: 499 KLGQGGFGSVYQGVL-PDGTRLAVKKL-EGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGF 555
++G+G FG V+ G L D T +AVK E + K +F E I+ H ++V+L G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
C + + E + G F + + L +T + A G+ YL + I
Sbjct: 181 CTQKQPIYIVMELVQGGDFLT--FLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCI 235
Query: 616 HCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL-----APEWITNYA 670
H D+ N L+ + K+SDFG+++ G + APE +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGV----YAASGGLRQVPVKWTAPEALNYGR 291
Query: 671 ISEKSDVYSYGMVLLEII-------GGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723
S +SDV+S+G++L E N + +E+G
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------------TREFVEKGG------ 332
Query: 724 SRLNIDEQ-SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQ 771
RL E D VF ++ C + RPS + + Q L+ I +
Sbjct: 333 -RLPCPELCPDAVF---RLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-39
Identities = 69/290 (23%), Positives = 126/290 (43%), Gaps = 37/290 (12%)
Query: 499 KLGQGGFGSVYQGVLP-----DGTRLAVKKL--EGIGQGKKEFRAEVSIIGSIHHLHLVK 551
LG+G FG V G ++AVK L E G + + E+ I+ +++H ++VK
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 552 LRGFCAEGTHR--LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED 609
+G C E L EF+ +GSL + + + ++ + + A+ KG+ YL
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKE--YLPKNKNKINLKQQLKYAVQICKGMDYLGS- 144
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWI 666
++ +H D+ NVL++ + K+ DFGL K + ++ + +T + APE +
Sbjct: 145 --RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY-YTVKDDRDSPVFWYAPECL 201
Query: 667 TNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSY-------AFKMMEEGKL 718
SDV+S+G+ L E++ + P K P++ ++EGK
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK- 260
Query: 719 RNILDSRLNIDEQ-SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767
RL D V+ ++ C + S R S +++ E +
Sbjct: 261 ------RLPCPPNCPDEVY---QLMRKCWEFQPSNRTSFQNLIEGFEALL 301
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 70/297 (23%), Positives = 127/297 (42%), Gaps = 42/297 (14%)
Query: 499 KLGQGGFGSVYQGVLP-----DGTRLAVKKL-EGIGQGKKEFRAEVSIIGSIHHLHLVKL 552
+LG+G FGSV G +AVK+L +++F+ E+ I+ ++H +VK
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 553 RGFCAEGTHR--LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC 610
RG + L E++ +G L F + LD + KG+ YL
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQICKGMEYLGS-- 145
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRG---YLAPEWIT 667
+R +H D+ N+L++ H K++DFGLAKL+ ++ + + + + APE ++
Sbjct: 146 -RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY-YVVREPGQSPIFWYAPESLS 203
Query: 668 NYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSY-------AFKMMEEGKLR 719
+ S +SDV+S+G+VL E+ K+ P+ + +++EEG+
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ-- 261
Query: 720 NILDSRLNIDEQ----SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQP 772
RL V ++ C RPS + + L+ + +
Sbjct: 262 -----RL---PAPPACPAEVH---ELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-38
Identities = 70/279 (25%), Positives = 122/279 (43%), Gaps = 30/279 (10%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558
KLGQG FG V+ G TR+A+K L+ + F E ++ + H LV+L +E
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 559 GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCD 618
+ E+M+ GSL + K L ++A A G+AY+ +H D
Sbjct: 251 -EPIYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 305
Query: 619 IKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNYAISEKS 675
++ N+L+ +N KV+DFGLA+L+ + +T +G + + APE + KS
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 676 DVYSYGMVLLEII-GGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ-SD 733
DV+S+G++L E+ GR + + +E G R+ + +
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGY-------RMPCPPECPE 408
Query: 734 RVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQP 772
+ + C +++ RP+ + LE +P
Sbjct: 409 SLH---DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-38
Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 499 KLGQGGFGSVYQGV---LPDGTRL--AVKKL-EGIGQGKKEFRAEVSIIGSIHHLHLVKL 552
+LG+G FGSV L D T AVKKL + ++F E+ I+ S+ H ++VK
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 553 RGFCAEGTHR--LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC 610
+G C R L E++ GSL + + + +D KG+ YL
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYLGT-- 132
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRG---YLAPEWIT 667
+R IH D+ N+L+++ K+ DFGL K++ +++ F + APE +T
Sbjct: 133 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF-FKVKEPGESPIFWYAPESLT 190
Query: 668 NYAISEKSDVYSYGMVLLEII 688
S SDV+S+G+VL E+
Sbjct: 191 ESKFSVASDVWSFGVVLYELF 211
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 59/283 (20%), Positives = 120/283 (42%), Gaps = 49/283 (17%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCA 557
+G GGFG V++ DG +K+ + ++ EV + + H+++V G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNNEKAEREVKALAKLDHVNIVHYNGCWD 74
Query: 558 EGTHRLLAY----------------EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAK 601
+ EF G+L++WI +K + LD + K
Sbjct: 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALELFEQITK 133
Query: 602 GLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL 661
G+ Y+H +++I+ D+KP N+ L D K+ DFGL + + T +GT Y+
Sbjct: 134 GVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSKGTLRYM 188
Query: 662 APEWITNYAISEKSDVYSYGMVLLEII-GGRKNFDPNETSDKAHFPSYAFKMMEEGKLRN 720
+PE I++ ++ D+Y+ G++L E++ F+ ++ F + +G + +
Sbjct: 189 SPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF----------FTDLRDGIISD 238
Query: 721 ILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQML 763
I D + + + + RP+ +++++ L
Sbjct: 239 IFDKKEK------------TLLQKLLSKKPEDRPNTSEILRTL 269
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 59/193 (30%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558
++G G FG V+ G + ++A+K + +++F E ++ + H LV+L G C E
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 559 GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCD 618
L EFM +G L + + Q L ET + L +G+AYL E +IH D
Sbjct: 75 QAPICLVTEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRD 129
Query: 619 IKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNYAISEKS 675
+ N L+ +N KVSDFG+ + + +Q +T+ GT+ + +PE + S KS
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 676 DVYSYGMVLLEII 688
DV+S+G+++ E+
Sbjct: 187 DVWSFGVLMWEVF 199
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 499 KLGQGGFGSVYQGV---LPDGTRL--AVKKL-EGIGQGKKEFRAEVSIIGSIHHLHLVKL 552
+LG+G FGSV L D T AVKKL + ++F E+ I+ S+ H ++VK
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 553 RGFCAEGTHR--LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC 610
+G C R L E++ GSL + + + +D KG+ YL
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYLGT-- 163
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRG---YLAPEWIT 667
+R IH D+ N+L+++ K+ DFGL K++ +++ + + + APE +T
Sbjct: 164 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY-YKVKEPGESPIFWYAPESLT 221
Query: 668 NYAISEKSDVYSYGMVLLEII 688
S SDV+S+G+VL E+
Sbjct: 222 ESKFSVASDVWSFGVVLYELF 242
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-37
Identities = 70/279 (25%), Positives = 122/279 (43%), Gaps = 30/279 (10%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558
KLGQG FG V+ G TR+A+K L+ + F E ++ + H LV+L +E
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 559 GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCD 618
+ E+M+ GSL + K L ++A A G+AY+ +H D
Sbjct: 334 -EPIYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 388
Query: 619 IKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNYAISEKS 675
++ N+L+ +N KV+DFGLA+L+ + +T +G + + APE + KS
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 676 DVYSYGMVLLEII-GGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ-SD 733
DV+S+G++L E+ GR + + +E G R+ + +
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGY-------RMPCPPECPE 491
Query: 734 RVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQP 772
+ + C +++ RP+ + LE +P
Sbjct: 492 SLH---DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-36
Identities = 71/274 (25%), Positives = 128/274 (46%), Gaps = 30/274 (10%)
Query: 499 KLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCA 557
KLG G +G VY+GV +AVK L+ +EF E +++ I H +LV+L G C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 558 EGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHC 617
+ EFM G+L ++ ++ + +A + + YL + + IH
Sbjct: 287 REPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHR 342
Query: 618 DIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNYAISEK 674
++ N L+ +N+ KV+DFGL++LM +T G + + APE + S K
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 675 SDVYSYGMVLLEII-GGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI-DEQS 732
SDV+++G++L EI G + + S ++++E+ R+ +
Sbjct: 400 SDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDY-------RMERPEGCP 445
Query: 733 DRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
++V+ ++ C Q + S RPS ++ Q E +
Sbjct: 446 EKVY---ELMRACWQWNPSDRPSFAEIHQAFETM 476
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 52/193 (26%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558
+LG G FG V G +AVK ++ + EF E + + H LVK G C++
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 559 GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCD 618
+ E+++NG L + ++ L+ + +G+A+L + IH D
Sbjct: 75 EYPIYIVTEYISNGCLLN--YLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRD 129
Query: 619 IKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNYAISEKS 675
+ N L+D + KVSDFG+ + + +Q + + GT+ + APE + S KS
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 676 DVYSYGMVLLEII 688
DV+++G+++ E+
Sbjct: 187 DVWAFGILMWEVF 199
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 63/271 (23%), Positives = 106/271 (39%), Gaps = 36/271 (13%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKE---FRAEVSIIGSI-HHLHLVKLR 553
+LG G +G V++ DG AVK+ +G K+ AEV + H V+L
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETR-FNIALGTAKGLAYLHEDCDQ 612
EG L E SL + E + + T LA+LH Q
Sbjct: 124 QAWEEGGILYLQTEL-CGPSLQQHCEAWGASLP---EAQVWGYLRDTLLALAHLH---SQ 176
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN-YAI 671
++H D+KP N+ L K+ DFGL + + G Y+APE + Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EVQEGDPRYMAPELLQGSY-- 232
Query: 672 SEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731
+DV+S G+ +LE+ + E ++ + +G L + L+ + +
Sbjct: 233 GTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYLPPEFTAGLSSELR 282
Query: 732 SDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762
S V + ++ D LR + ++ +
Sbjct: 283 S--------VLVMMLEPDPKLRATAEALLAL 305
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 49/216 (22%), Positives = 89/216 (41%), Gaps = 29/216 (13%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKK--LEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
LG+GGFG V++ D A+K+ L +++ EV + + H +V+
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 556 CAEGTHRLLAY------------EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGL 603
E + +L W+ + + +I L A+ +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 604 AYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS-----------HVFT 652
+LH + ++H D+KP N+ + KV DFGL M +++ T
Sbjct: 132 EFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 653 TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEII 688
GT+ Y++PE I + S K D++S G++L E++
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 71/294 (24%), Positives = 124/294 (42%), Gaps = 49/294 (16%)
Query: 499 KLGQGGFGSVYQGVL---PDGTRL--AVKKL--EGIGQGKKEFRAEVSIIGSIHHLHLVK 551
LG+G FG V DGT AVK L + Q + ++ E+ I+ +++H H++K
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 552 LRGFCAEGTHR--LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED 609
+G C + L E++ GSL ++ ++ + A +G+AYLH
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHS---IGLAQLLLFAQQICEGMAYLHA- 152
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL-----APE 664
Q IH D+ NVLLD++ K+ DFGLAK + + G APE
Sbjct: 153 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR---EDGDSPVFWYAPE 207
Query: 665 WITNYAISEKSDVYSYGMVLLEII-GGRKNFDPNETSDKAHFPSY-------AFKMMEEG 716
+ Y SDV+S+G+ L E++ + P + + +++E G
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267
Query: 717 KLRNILDSRLNIDEQ----SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
+ RL + V+ + C + + S RP+ ++ +L+ +
Sbjct: 268 E-------RL---PRPDKCPAEVY---HLMKNCWETEASFRPTFENLIPILKTV 308
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 498 VKLGQGGFGSVYQGVLPDG---TRLAVKKL--EGIGQGKKEFRAEVSIIGSIHHLHLVKL 552
++LG G FGSV QGV +A+K L +E E I+ + + ++V+L
Sbjct: 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
G C L+ E G L K F + + + + G+ YL E +
Sbjct: 76 IGVCQAEALMLVM-EMAGGGPLHK--FLVGKREEIPVSNVAELLHQVSMGMKYLEE---K 129
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRG------TRGYLAPEWI 666
+H D+ NVLL + ++AK+SDFGL+K + + S+ G APE I
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECI 185
Query: 667 TNYAISEKSDVYSYGMVLLEII 688
S +SDV+SYG+ + E +
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEAL 207
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 62/204 (30%), Positives = 106/204 (51%), Gaps = 26/204 (12%)
Query: 499 KLGQGGFGSVYQGVL-PDGTRL----AVKKL-EGIGQG-KKEFRAEVSIIGSIHHLHLVK 551
LG G FG+VY+G+ P+G ++ A+K+L E KE E ++ S+ + H+ +
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 552 LRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEF----LLDWETRFNIALGTAKGLAYLH 607
L G C T +L+ + M G L ++ + LL+W + AKG+ YL
Sbjct: 82 LLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 134
Query: 608 EDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPE 664
+ +R++H D+ NVL+ H K++DFGLAKL+ E+ G + ++A E
Sbjct: 135 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKWMALE 189
Query: 665 WITNYAISEKSDVYSYGMVLLEII 688
I + + +SDV+SYG+ + E++
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELM 213
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-36
Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 11/193 (5%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558
+LG G FG V G +A+K ++ + EF E ++ ++ H LV+L G C +
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 559 GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCD 618
+ E+MANG L + + + + + + YL ++ +H D
Sbjct: 91 QRPIFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRD 145
Query: 619 IKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNYAISEKS 675
+ N L++D KVSDFGL++ + ++ +T+ G++ + PE + S KS
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 676 DVYSYGMVLLEII 688
D++++G+++ EI
Sbjct: 203 DIWAFGVLMWEIY 215
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-35
Identities = 56/193 (29%), Positives = 104/193 (53%), Gaps = 11/193 (5%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558
KLG G FG V+ T++AVK ++ + F AE +++ ++ H LVKL +
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 559 GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCD 618
+ EFMA GSL ++ K ++ + + A+G+A++ + + IH D
Sbjct: 255 -EPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRD 309
Query: 619 IKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRG---YLAPEWITNYAISEKS 675
++ N+L+ + K++DFGLA+++ + + +T G + + APE I + + KS
Sbjct: 310 LRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366
Query: 676 DVYSYGMVLLEII 688
DV+S+G++L+EI+
Sbjct: 367 DVWSFGILLMEIV 379
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 499 KLGQGGFGSVYQGVLPDG----TRLAVKKL--EGIGQGKKEFRAEVSIIGSIHHLHLVKL 552
+G G G V G L +A+K L + +++F +E SI+G H ++++L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
G G ++ E+M NGSLD F + + + G G+ YL +
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---L 170
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRG------TRGYLAPEWI 666
+H D+ NVL+D N KVSDFGL++++ + +TT G T APE I
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APEAI 226
Query: 667 TNYAISEKSDVYSYGMVLLEII 688
S SDV+S+G+V+ E++
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVL 248
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 15/195 (7%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558
+LG G FG V+ G T++AVK L+ F AE +++ + H LV+L +
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 559 GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCD 618
+ E+M NGSL ++ K L ++A A+G+A++ E + IH D
Sbjct: 80 -EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 134
Query: 619 IKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL-----APEWITNYAISE 673
++ N+L+ D K++DFGLA+L+ + +T G + APE I +
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAK--FPIKWTAPEAINYGTFTI 189
Query: 674 KSDVYSYGMVLLEII 688
KSDV+S+G++L EI+
Sbjct: 190 KSDVWSFGILLTEIV 204
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 22/203 (10%)
Query: 499 KLGQGGFGSVYQGVL--PDGTRL---AVKKL-EG-IGQGKKEFRAEVSIIGSIHHLHLVK 551
+G G FG VY+G+L G + A+K L G + + +F E I+G H ++++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 552 LRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCD 611
L G ++ ++ E+M NG+LDK F + ++ + G A G+ YL
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGMKYLAN--- 165
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRG------TRGYLAPEW 665
+H D+ N+L++ N KVSDFGL++++ + +TT G T APE
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APEA 221
Query: 666 ITNYAISEKSDVYSYGMVLLEII 688
I+ + SDV+S+G+V+ E++
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVM 244
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 71/312 (22%), Positives = 129/312 (41%), Gaps = 42/312 (13%)
Query: 458 RKAPESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSVKLGQGGFGSVYQGV-LPDG 516
+ P+ N L N +R + K+G+G F VY+ L DG
Sbjct: 15 QFQPQKALRPDMGYNTLAN---------FRIEK--------KIGRGQFSEVYRAACLLDG 57
Query: 517 TRLAVKKLEGIGQGKKEFRA----EVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANG 572
+A+KK++ + RA E+ ++ ++H +++K E + E G
Sbjct: 58 VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG 117
Query: 573 SLDKWI--FKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY 630
L + I FKK + L+ T + + L ++H +R++H DIKP NV +
Sbjct: 118 DLSRMIKHFKKQKR-LIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATG 173
Query: 631 HAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGG 690
K+ D GL + + + + +L GT Y++PE I + KSD++S G +L E+
Sbjct: 174 VVKLGDLGLGRFFSSKTTAA-HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 232
Query: 691 RKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDM 750
+ F ++ + + K +E+ + S+ + V C+ D
Sbjct: 233 QSPFYGDKMNLYS-----LCKKIEQCDYPPLPSDHY-----SEELRQLVN---MCINPDP 279
Query: 751 SLRPSMTKVVQM 762
RP +T V +
Sbjct: 280 EKRPDVTYVYDV 291
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-35
Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 26/204 (12%)
Query: 499 KLGQGGFGSVYQGVLPDG-----TRLAVKKL-EGIG-QGKKEFRAEVSIIGSIHHLHLVK 551
LG G FG+V++GV + +K + + G Q + + IGS+ H H+V+
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 552 LRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEF----LLDWETRFNIALGTAKGLAYLH 607
L G C + +L+ +++ GSL + + LL+W + AKG+ YL
Sbjct: 80 LLGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYYLE 132
Query: 608 EDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPE 664
E ++H ++ NVLL +V+DFG+A L+ + + + + ++A E
Sbjct: 133 E---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--EAKTPIKWMALE 187
Query: 665 WITNYAISEKSDVYSYGMVLLEII 688
I + +SDV+SYG+ + E++
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELM 211
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 26/205 (12%)
Query: 499 KLGQGGFGSVYQGVL--PDGTRL--AVKKL-EGI---GQGKKEFRAEVSIIGSIHHLHLV 550
KLG G FG V +G P G + AVK L + + +F EV+ + S+ H +L+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEF----LLDWETRFNIALGTAKGLAYL 606
+L G +++ E GSL + K F L + A+ A+G+ YL
Sbjct: 85 RLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQVAEGMGYL 137
Query: 607 HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAP 663
+R IH D+ N+LL K+ DFGL + + + H + + + AP
Sbjct: 138 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH-YVMQEHRKVPFAWCAP 193
Query: 664 EWITNYAISEKSDVYSYGMVLLEII 688
E + S SD + +G+ L E+
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMF 218
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 499 KLGQGGFGSVYQGVLPDGTRL---AVKKL-EGI--GQGKKEFRAEVSIIGSIHHLHLVKL 552
+LG G FG+V +G + AVK L K E AE +++ + + ++V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
G C + L+ E G L+K++ ++N+ + + + G+ YL E
Sbjct: 84 IGICEAESWMLVM-EMAELGPLNKYL-QQNRHVKD--KNIIELVHQVSMGMKYLEE---S 136
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNY 669
+H D+ NVLL ++AK+SDFGL+K + ++++ + + + APE I Y
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YKAQTHGKWPVKWYAPECINYY 195
Query: 670 AISEKSDVYSYGMVLLEII 688
S KSDV+S+G+++ E
Sbjct: 196 KFSSKSDVWSFGVLMWEAF 214
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-35
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 499 KLGQGGFGSVYQGVLPDGTRL----AVKKL--EGIGQGKKEFRAEVSIIGSIHHLHLVKL 552
+G G FG V G L ++ A+K L + +++F E SI+G H ++++L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
G + ++ E+M NGSLD F + + + G A G+ YL +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYLSD---M 166
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRG------TRGYLAPEWI 666
+H D+ N+L++ N KVSDFGL +++ + +TT G T +PE I
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SPEAI 222
Query: 667 TNYAISEKSDVYSYGMVLLEII 688
+ SDV+SYG+VL E++
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVM 244
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-34
Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 21/196 (10%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558
+G+G FG V G G ++AVK ++ + F AE S++ + H +LV+L G E
Sbjct: 200 TIGKGEFGDVMLGDY-RGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 559 GTHRLLAY---EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
L Y E+MA GSL ++ + +L + +L + + YL +
Sbjct: 258 EKGGL--YIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFV 311
Query: 616 HCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNYAIS 672
H D+ NVL+ ++ AKVSDFGL K +T + + APE + S
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 364
Query: 673 EKSDVYSYGMVLLEII 688
KSDV+S+G++L EI
Sbjct: 365 TKSDVWSFGILLWEIY 380
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 79/332 (23%), Positives = 142/332 (42%), Gaps = 61/332 (18%)
Query: 499 KLGQGGFGSVYQGVL-PDGTRL----AVKKL-EGIGQG-KKEFRAEVSIIGSIHHLHLVK 551
LG G FG+VY+G+ P+G ++ A+K+L E KE E ++ S+ + H+ +
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 552 LRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCD 611
L G C T L + M G L + + + + + N + AKG+ YL +
Sbjct: 82 LLGICLTST-VQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYLED--- 135
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITN 668
+R++H D+ NVL+ H K++DFGLAKL+ E+ G + ++A E I +
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKWMALESILH 193
Query: 669 YAISEKSDVYSYGMVLLEII-------GGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721
+ +SDV+SYG+ + E++ G + ++E+G+
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------------ISSILEKGE---- 236
Query: 722 LDSRLNIDEQ----SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVP------Q 771
RL Q + V+ + + C D RP +++ + P Q
Sbjct: 237 ---RL---PQPPICTIDVY---MIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 287
Query: 772 PPTCSPLGARLYSSFFRSISEEGTSSGPSDCN 803
L + S+F+R++ +E D +
Sbjct: 288 GDERMHLPSPTDSNFYRALMDEEDMDDVVDAD 319
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 50/201 (24%), Positives = 93/201 (46%), Gaps = 9/201 (4%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRA---EVSIIGSIHHLHLVKLRG 554
K+G+G FG DG + +K++ KE EV+++ ++ H ++V+ R
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
E + ++ G L K I + L + + + L ++H D++I
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH---DRKI 146
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEK 674
+H DIK +N+ L + ++ DFG+A+++ GT YL+PE N + K
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA-RACIGTPYYLSPEICENKPYNNK 205
Query: 675 SDVYSYGMVLLEIIGGRKNFD 695
SD+++ G VL E+ + F+
Sbjct: 206 SDIWALGCVLYELCTLKHAFE 226
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 56/272 (20%), Positives = 108/272 (39%), Gaps = 37/272 (13%)
Query: 496 FSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKE---FRAEVSIIGSIHHLHLVK 551
F +++G+G F +VY+G+ +A +L+ K E F+ E ++ + H ++V+
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 552 LRGFC---AEGTHRLLAY-EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLH 607
+G ++ E M +G+L ++ K+ + + + KGL +LH
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVM--KIKVLRSWCRQILKGLQFLH 146
Query: 608 EDCDQRIIHCDIKPENVLLDDNY-HAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI 666
IIH D+K +N+ + K+ D GLA L + + GT ++APE
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMY 202
Query: 667 TNYAISEKSDVYSYGMVLLEIIGGR---KNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723
E DVY++GM +LE+ + ++ + G D
Sbjct: 203 EEKY-DESVDVYAFGMCMLEMATSEYPYSECQN---------AAQIYRRVTSGVKPASFD 252
Query: 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPS 755
+ + C++++ R S
Sbjct: 253 KVAIPEVKE---II-----EGCIRQNKDERYS 276
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-34
Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 498 VKLGQGGFGSVYQGVLPDG---TRLAVKKL--EGIGQGKKEFRAEVSIIGSIHHLHLVKL 552
++LG G FGSV QGV +A+K L +E E I+ + + ++V+L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
G C L+ E G L K++ K +E + + + G+ YL E +
Sbjct: 402 IGVCQAEALMLVM-EMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEE---K 455
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNY 669
+H ++ NVLL + ++AK+SDFGL+K + + S+ +T + + APE I
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY-YTARSAGKWPLKWYAPECINFR 514
Query: 670 AISEKSDVYSYGMVLLEII 688
S +SDV+SYG+ + E +
Sbjct: 515 KFSSRSDVWSYGVTMWEAL 533
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 69/299 (23%), Positives = 115/299 (38%), Gaps = 44/299 (14%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFC 556
KLG+GGF V L DG A+K++ Q ++E + E + +H ++++L +C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 557 AE---GTHRL-LAYEFMANGSLDKWI--FKKNQEFLLDWETRFNIALGTAKGLAYLHEDC 610
H L F G+L I K FL + + + LG +GL +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL-WLLLGICRGLEAIH--- 151
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM--------TREQSHVFTTLRGTRGYLA 662
+ H D+KP N+LL D + D G + R T Y A
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 663 PEWITNY---AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLR 719
PE + I E++DV+S G VL ++ G +D + +
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF--------------QKGDSVA 257
Query: 720 NILDSRLNI---DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI-CPVPQPPT 774
+ ++L+I S ++ + + D RP + ++ LE + P P T
Sbjct: 258 LAVQNQLSIPQSPRHSSALWQLLN---SMMTVDPHQRPHIPLLLSQLEALQPPAPGQHT 313
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 499 KLGQGGFGSVYQGVLPDG-TRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCA 557
KLG G +G VY+GV +AVK L+ +EF E +++ I H +LV+L G C
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 558 EGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHC 617
+ EFM G+L ++ ++ + +A + + YL + + IH
Sbjct: 80 REPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHR 135
Query: 618 DIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNYAISEK 674
D+ N L+ +N+ KV+DFGL++LM +T G + + APE + S K
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 675 SDVYSYGMVLLEII 688
SDV+++G++L EI
Sbjct: 193 SDVWAFGVLLWEIA 206
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 53/217 (24%), Positives = 88/217 (40%), Gaps = 37/217 (17%)
Query: 499 KLGQGGFGSVYQGVL--------PDGTRLAVKKL-EGIGQGKKEFRAEVSIIGSIHHLHL 549
LGQG F +++GV T + +K L + + F S++ + H HL
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 550 VKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED 609
V G C G +L EF+ GSLD + K + ++ + +A A + +L E
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDT--YLKKNKNCINILWKLEVAKQLAAAMHFLEE- 131
Query: 610 CDQRIIHCDIKPENVLLD--------DNYHAKVSDFGLAKLMTREQSHVF----TTLRGT 657
+IH ++ +N+LL + K+SD G++ + +
Sbjct: 132 --NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV----- 184
Query: 658 RGYLAPEWITNYAI-SEKSDVYSYGMVLLEII-GGRK 692
PE I N + +D +S+G L EI GG K
Sbjct: 185 ----PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-34
Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 499 KLGQGGFGSVYQGVLPDG----TRLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKL 552
+G+G FG VY G D + A+K L I Q + F E ++ ++H +++ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 553 RGFCAEGT-HRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCD 611
G + +M +G L + F ++ + + + L A+G+ YL E
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQ--FIRSPQRNPTVKDLISFGLQVARGMEYLAE--- 142
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL-----APEWI 666
Q+ +H D+ N +LD+++ KV+DFGLA+ + ++ + L A E +
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDI--LDREYYSVQQHRHARLPVKWTALESL 200
Query: 667 TNYAISEKSDVYSYGMVLLEII 688
Y + KSDV+S+G++L E++
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELL 222
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 72/288 (25%), Positives = 117/288 (40%), Gaps = 50/288 (17%)
Query: 499 KLGQGGFGSVYQGVLPDG----TRLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKL 552
+G+G FG VY G L D AVK L I +F E I+ H +++ L
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 553 RGFCAEGTH-RLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCD 611
G C L+ +M +G L +I + + + L AKG+ YL
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLAS--- 146
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL-----APEWI 666
++ +H D+ N +LD+ + KV+DFGLA+ M ++ T L A E +
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 667 TNYAISEKSDVYSYGMVLLEII-------GGRKNFDPNETSDKAHFPSYAFKMMEEGKLR 719
+ KSDV+S+G++L E++ FD + +G+
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------------ITVYLLQGR-- 249
Query: 720 NILDSRLNIDEQ-SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
RL E D ++ +V L C +RPS +++V + I
Sbjct: 250 -----RLLQPEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAI 289
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 66/303 (21%), Positives = 118/303 (38%), Gaps = 58/303 (19%)
Query: 493 TNNFSV--KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHL 549
++F LGQG FG V + D A+KK+ + +EV ++ S++H ++
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 550 VKLRGFCAEGTHRLLAY-------------EFMANGSLDKWIFKKNQEFLLDWETRFNIA 596
V+ E + + E+ NG+L I +N + + +
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLF 122
Query: 597 LGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE---------- 646
+ L+Y+H Q IIH D+KP N+ +D++ + K+ DFGLAK + R
Sbjct: 123 RQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 647 ---QSHVFTTLRGTRGYLAPEWITN---YAISEKSDVYSYGMVLLEIIGGRKNFDPNETS 700
S T+ GT Y+A E + Y +EK D+YS G++ E+
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHY--NEKIDMYSLGIIFFEM------------- 224
Query: 701 DKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVF--TAVKVALWCVQEDMSLRPSMTK 758
+ S + + L+ + + D K+ + D + RP
Sbjct: 225 --IYPFSTGMERVNI--LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGART 280
Query: 759 VVQ 761
++
Sbjct: 281 LLN 283
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 18/199 (9%)
Query: 499 KLGQGGFGSVYQGVLPDG----TRLAVK--KLEGIGQGKKEFRAEVSIIGSIHHLHLVKL 552
+G+G FG V+QG+ +A+K K +++F E + H H+VKL
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
G E + E G L F + +++ LD + A + LAYL +
Sbjct: 82 IGVITENPV-WIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLES---K 135
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNY 669
R +H DI NVL+ N K+ DFGL++ M + + ++APE I
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST---YYKASKGKLPIKWMAPESINFR 192
Query: 670 AISEKSDVYSYGMVLLEII 688
+ SDV+ +G+ + EI+
Sbjct: 193 RFTSASDVWMFGVCMWEIL 211
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 50/288 (17%)
Query: 499 KLGQGGFGSVYQGVLPDG----TRLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKL 552
+G+G FG VY G L D AVK L I +F E I+ H +++ L
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 553 RGFCAEGTH-RLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCD 611
G C L+ +M +G L +I + + + L AKG+ +L
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLAS--- 210
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL-----APEWI 666
++ +H D+ N +LD+ + KV+DFGLA+ M ++ + T L A E +
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD--SVHNKTGAKLPVKWMALESL 268
Query: 667 TNYAISEKSDVYSYGMVLLEII-------GGRKNFDPNETSDKAHFPSYAFKMMEEGKLR 719
+ KSDV+S+G++L E++ FD + +G+
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------------ITVYLLQGR-- 313
Query: 720 NILDSRLNIDEQ-SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
RL E D ++ +V L C +RPS +++V + I
Sbjct: 314 -----RLLQPEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAI 353
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 18/199 (9%)
Query: 499 KLGQGGFGSVYQGVL----PDGTRLAVK--KLEGIGQGKKEFRAEVSIIGSIHHLHLVKL 552
LG+G FG VY+GV + +AVK K + K++F +E I+ ++ H H+VKL
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
G E + E G L + + + L T +L K +AYL
Sbjct: 79 IGIIEEEP-TWIIMELYPYGELGH--YLERNKNSLKVLTLVLYSLQICKAMAYLES---I 132
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR---GYLAPEWITNY 669
+H DI N+L+ K+ DFGL++ + E + TR +++PE I
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED---YYKASVTRLPIKWMSPESINFR 189
Query: 670 AISEKSDVYSYGMVLLEII 688
+ SDV+ + + + EI+
Sbjct: 190 RFTTASDVWMFAVCMWEIL 208
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 60/196 (30%), Positives = 95/196 (48%), Gaps = 21/196 (10%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558
+G+G FG V G G ++AVK ++ + F AE S++ + H +LV+L G E
Sbjct: 28 TIGKGEFGDVMLGDY-RGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 559 GTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHC 617
L + E+MA GSL ++ + +L + +L + + YL +H
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHR 141
Query: 618 DIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL-----APEWITNYAIS 672
D+ NVL+ ++ AKVSDFGL +E +T + L APE + S
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLT----KE---ASSTQDTGK--LPVKWTAPEALREKKFS 192
Query: 673 EKSDVYSYGMVLLEII 688
KSDV+S+G++L EI
Sbjct: 193 TKSDVWSFGILLWEIY 208
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-33
Identities = 53/289 (18%), Positives = 96/289 (33%), Gaps = 29/289 (10%)
Query: 468 SEEDNFLENLSGMPVRFTYRDLQTATNNFSVK--LGQGGFGSVYQGVLPDGTRLAVKKLE 525
S N E +P + Q + V LG+G F VY+ D K+
Sbjct: 39 SSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKF 98
Query: 526 GIGQGKK----EF---RAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWI 578
+ K EF + + +K +L E + G+L I
Sbjct: 99 VLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAI 158
Query: 579 --FKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL---------- 626
+K E ++ + A+ + +H+ IIH DIKP+N +L
Sbjct: 159 NLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDE 215
Query: 627 -DDNYHAKVSDFGLAKLMTR-EQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVL 684
D + + D G + M + +FT T G+ E ++N + + D + +
Sbjct: 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATV 275
Query: 685 LEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKL-RNILDSRLNIDEQS 732
++ G + + P F+ + + LNI +
Sbjct: 276 YCMLFGT--YMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCH 322
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 66/296 (22%), Positives = 121/296 (40%), Gaps = 58/296 (19%)
Query: 499 KLGQGGFGSVYQGVLPDG----TRLAVK--KLEGIGQG-KKEFRAEVSIIGSIHHLHLVK 551
LG+G FGSV +G L ++AVK KL+ Q +EF +E + + H ++++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 552 LRGFCAEGTHRLLAY-----EFMANGSLDKWIFK---KNQEFLLDWETRFNIALGTAKGL 603
L G C E + + + FM G L ++ + + +T + A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 604 AYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL-- 661
YL + +H D+ N +L D+ V+DFGL+K + + +G +
Sbjct: 161 EYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR----QGRIAKMPV 213
Query: 662 ---APEWITNYAISEKSDVYSYGMVLLEII-------GGRKNFDPNETSDKAHFPSYAFK 711
A E + + + KSDV+++G+ + EI G +N + +
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-------------MYD 260
Query: 712 MMEEGKLRNILDSRLNIDEQ-SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
+ G RL E D ++ ++ C + D RP+ + + LE +
Sbjct: 261 YLLHGH-------RLKQPEDCLDELY---EIMYSCWRTDPLDRPTFSVLRLQLEKL 306
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 66/306 (21%), Positives = 113/306 (36%), Gaps = 62/306 (20%)
Query: 499 KLGQGGFGSVYQGVLPDG------TRLAVKKL-EGIGQGKKEFRAEVSIIGSIHHLHLVK 551
+LG+G FG V+ + +AVK L E +++F+ E ++ + H H+V+
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 552 LRGFCAEGTHRLLAYEFMANGSLDKW------------IFKKNQEFLLDWETRFNIALGT 599
G C EG L+ +E+M +G L+++ + L +A
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 600 AKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRG 659
A G+ YL +H D+ N L+ K+ DFG+++ + G R
Sbjct: 168 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----YYRVGGRT 220
Query: 660 YL-----APEWITNYAISEKSDVYSYGMVLLEII-------GGRKNFDPNETSDKAHFPS 707
L PE I + +SDV+S+G+VL EI N +
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE------------ 268
Query: 708 YAFKMMEEGKLRNILDSRLNIDEQ-SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
A + +G+ L V+ + C Q + R S+ V L+ +
Sbjct: 269 -AIDCITQGR-------ELERPRACPPEVY---AIMRGCWQREPQQRHSIKDVHARLQAL 317
Query: 767 CPVPQP 772
P
Sbjct: 318 AQAPPV 323
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 73/251 (29%), Positives = 114/251 (45%), Gaps = 33/251 (13%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVK-----KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLR 553
LG+G FG+VY LA+K +LE G + R EV I + H ++++L
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILRLY 75
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
G+ + T L E+ G++ + + +K +F + T I A L+Y H +R
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYREL-QKLSKFD-EQRTATYITE-LANALSYCHS---KR 129
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISE 673
+IH DIKPEN+LL K++DFG + S T L GT YL PE I E
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTDLCGTLDYLPPEMIEGRMHDE 186
Query: 674 KSDVYSYGMVLLEIIGGRKNFD---PNETSDK-----AHFPSYAFKMMEEGK--LRNILD 723
K D++S G++ E + G+ F+ ET + FP + + E + + +L
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF---VTEGARDLISRLLK 243
Query: 724 ----SRLNIDE 730
R + E
Sbjct: 244 HNPSQRPMLRE 254
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 65/280 (23%), Positives = 110/280 (39%), Gaps = 39/280 (13%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVK--KLEGI-GQGKKEFRAEVSIIGSI--HHLHLVKLR 553
++G GG V+Q + A+K LE Q +R E++ + + H +++L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
+ + + E N L+ W+ KK +D R + + + +H
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIH---QHG 128
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF-TTLRGTRGYLAPEWITN---- 668
I+H D+KP N L+ D K+ DFG+A M + + V + GT Y+ PE I +
Sbjct: 129 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 669 -------YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721
IS KSDV+S G +L + G+ F KL I
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------------KLHAI 233
Query: 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761
+D I+ V C++ D R S+ +++
Sbjct: 234 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 64/280 (22%), Positives = 111/280 (39%), Gaps = 39/280 (13%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVK--KLEGI-GQGKKEFRAEVSIIGSI--HHLHLVKLR 553
++G GG V+Q + A+K LE Q +R E++ + + H +++L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
+ + + E N L+ W+ K ++ + WE + + + +H
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKS-YWKNMLEAVHTIH---QHG 147
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF-TTLRGTRGYLAPEWITN---- 668
I+H D+KP N L+ D K+ DFG+A M + + V + GT Y+ PE I +
Sbjct: 148 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 669 -------YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721
IS KSDV+S G +L + G+ F KL I
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------------KLHAI 252
Query: 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761
+D I+ V C++ D R S+ +++
Sbjct: 253 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 60/242 (24%), Positives = 100/242 (41%), Gaps = 21/242 (8%)
Query: 458 RKAPESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSVKLGQGGFGSVYQGV-LPDG 516
K ET + + L PV + YR+ + ++G+G FG V++ G
Sbjct: 25 AKLQRLGPETEDNEGVLLTEKLKPVDYEYRE-EVHWMTHQPRVGRGSFGEVHRMKDKQTG 83
Query: 517 TRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDK 576
+ AVKK+ + + E E+ + +V L G EG + E + GSL +
Sbjct: 84 FQCAVKKVR-LEVFRVE---ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139
Query: 577 WI--FKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDN-YHAK 633
I E + +GL YLH +RI+H D+K +NVLL + A
Sbjct: 140 LIKQMGCLPEDRALYYLG-----QALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAA 191
Query: 634 VSDFGLAKLMTREQSHVFT----TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG 689
+ DFG A + + + GT ++APE + K D++S ++L ++
Sbjct: 192 LCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN 251
Query: 690 GR 691
G
Sbjct: 252 GC 253
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 65/301 (21%), Positives = 119/301 (39%), Gaps = 63/301 (20%)
Query: 499 KLGQGGFGSVYQGVLPDG------TRLAVKKL-EGIGQGKKEFRAEVSIIGSIHHLHLVK 551
+LG+G FG V+ + +AVK L + +K+F+ E ++ ++ H H+VK
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 552 LRGFCAEGTHRLLAYEFMANGSLDKW-------------IFKKNQEFLLDWETRFNIALG 598
G C +G ++ +E+M +G L+K+ + + L +IA
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 599 TAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR 658
A G+ YL Q +H D+ N L+ N K+ DFG+++ + G
Sbjct: 142 IASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD----YYRVGGH 194
Query: 659 GYL-----APEWITNYAISEKSDVYSYGMVLLEII-------GGRKNFDPNETSDKAHFP 706
L PE I + +SDV+S+G++L EI N +
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE----------- 243
Query: 707 SYAFKMMEEGKLRNILDSRLNIDEQ-SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765
+ + +G+ L V+ V L C Q + R ++ ++ ++L
Sbjct: 244 --VIECITQGR-------VLERPRVCPKEVY---DVMLGCWQREPQQRLNIKEIYKILHA 291
Query: 766 I 766
+
Sbjct: 292 L 292
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 22/221 (9%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLE--GIGQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
LGQG +V++G G A+K + E ++ ++H ++VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 556 CAEGTHRL--LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
E T R L EF GSL + + + + L + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132
Query: 614 IIHCDIKPENVLL----DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNY 669
I+H +IKP N++ D K++DFG A+ + E F +L GT YL P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSLYGTEEYLHPDMYERA 190
Query: 670 AI--------SEKSDVYSYGMVLLEIIGGRKNFDPNETSDK 702
+ D++S G+ G F P E +
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 64/251 (25%), Positives = 112/251 (44%), Gaps = 30/251 (11%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVK-----KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLR 553
LG+G F VY+ + G +A+K + G ++ + EV I + H +++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILELY 77
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
+ + + L E NG +++++ + + F + E R + G+ YLH
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS-ENEARHFMH-QIITGMLYLHS---HG 132
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISE 673
I+H D+ N+LL N + K++DFGLA + TL GT Y++PE T A
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP-HEKHYTLCGTPNYISPEIATRSAHGL 191
Query: 674 KSDVYSYGMVLLEIIGGRKNFDPNETSD--------KAHFPSYAFKMMEEGK--LRNILD 723
+SDV+S G + ++ GR FD + + PS+ + E K + +L
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSF---LSIEAKDLIHQLLR 248
Query: 724 ----SRLNIDE 730
RL++
Sbjct: 249 RNPADRLSLSS 259
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-32
Identities = 68/307 (22%), Positives = 113/307 (36%), Gaps = 59/307 (19%)
Query: 499 KLGQGGFGSVYQGVLPDG----TRLAVKKL-EGIG--QGKKEFRAEVSIIGSIHHLHLVK 551
LG+G FGSV + L ++AVK L I +EF E + + H H+ K
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 552 LRGFCAEGTHRLLAY------EFMANGSLDKWIFK---KNQEFLLDWETRFNIALGTAKG 602
L G + FM +G L ++ F L +T + A G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 603 LAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL- 661
+ YL + IH D+ N +L ++ V+DFGL++ + + +G L
Sbjct: 150 MEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR----QGCASKLP 202
Query: 662 ----APEWITNYAISEKSDVYSYGMVLLEII-------GGRKNFDPNETSDKAHFPSYAF 710
A E + + + SDV+++G+ + EI+ G +N + +
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-------------IY 249
Query: 711 KMMEEGKLRNILDSRLNIDEQ-SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPV 769
+ G RL + + V+ + C D RPS T + LE I
Sbjct: 250 NYLIGGN-------RLKQPPECMEEVY---DLMYQCWSADPKQRPSFTCLRMELENILGH 299
Query: 770 PQPPTCS 776
+ S
Sbjct: 300 LSVLSTS 306
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 73/314 (23%), Positives = 117/314 (37%), Gaps = 64/314 (20%)
Query: 499 KLGQGGFGSVYQGVL------PDGTRLAVKKL-EGIG-QGKKEFRAEVSIIGSIHHLHLV 550
LG G FG VY+G + P ++AVK L E Q + +F E II +H ++V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLDKWI----FKKNQEFLLDWETRFNIALGTAKGLAYL 606
+ G + R + E MA G L ++ + +Q L ++A A G YL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 607 HEDCDQRIIHCDIKPENVLLD---DNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL-- 661
E IH DI N LL AK+ DFG+A+ + R +G L
Sbjct: 157 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----YYRKGGCAMLPV 209
Query: 662 ---APEWITNYAISEKSDVYSYGMVLLEII-------GGRKNFDPNETSDKAHFPSYAFK 711
PE + K+D +S+G++L EI + N + +
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------------VLE 256
Query: 712 MMEEGKLRNILDSRLNIDEQ-SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC--- 767
+ G R++ + V+ ++ C Q RP+ +++ +E
Sbjct: 257 FVTSGG-------RMDPPKNCPGPVY---RIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306
Query: 768 ---PVPQPPTCSPL 778
P PL
Sbjct: 307 DVINTALPIEYGPL 320
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 61/246 (24%), Positives = 103/246 (41%), Gaps = 18/246 (7%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKE---FRAEVSIIGSIHHLHLVKLRG 554
+G G +G + DG L K+L+ + E +EV+++ + H ++V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 555 -FCAEGTHRLLAY-EFMANGSLDKWIFK-KNQEFLLDWETRFNIALGTAKGLAYLHE--D 609
L E+ G L I K + LD E + L H D
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNY 669
++H D+KP NV LD + K+ DFGLA+++ + S T GT Y++PE +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA-KTFVGTPYYMSPEQMNRM 191
Query: 670 AISEKSDVYSYGMVLLEIIGGRKNFDPNETSD------KAHFPSYAFKMMEEGKLRNILD 723
+ +EKSD++S G +L E+ F + + F ++ +E L I+
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE--LNEIIT 249
Query: 724 SRLNID 729
LN+
Sbjct: 250 RMLNLK 255
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 67/251 (26%), Positives = 110/251 (43%), Gaps = 33/251 (13%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVK-----KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLR 553
LG+G FG+VY + +A+K +LE G + R E+ I + H +++++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHPNILRMY 80
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
+ + L EF G L K + +K+ F + + + A L Y HE ++
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFD-EQRSATFMEE-LADALHYCHE---RK 134
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISE 673
+IH DIKPEN+L+ K++DFG + S T+ GT YL PE I E
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHA---PSLRRRTMCGTLDYLPPEMIEGKTHDE 191
Query: 674 KSDVYSYGMVLLEIIGGRKNFD---PNETSDK-----AHFPSYAFKMMEEGK--LRNILD 723
K D++ G++ E + G FD ET + FP + + + K + +L
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPF---LSDGSKDLISKLLR 248
Query: 724 ----SRLNIDE 730
RL +
Sbjct: 249 YHPPQRLPLKG 259
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-31
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 22/201 (10%)
Query: 499 KLGQGGFGSVYQGVLPDG----TRLAVK--KLEGIGQGKKEFRAEVSIIGSIHHLHLVKL 552
+G+G FG V+QG+ +A+K K +++F E + H H+VKL
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
G E + E G L F + ++F LD + A + LAYL +
Sbjct: 457 IGVITENP-VWIIMELCTLGELRS--FLQVRKFSLDLASLILYAYQLSTALAYLES---K 510
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL-----APEWIT 667
R +H DI NVL+ N K+ DFGL++ M T + ++G L APE I
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGKLPIKWMAPESIN 565
Query: 668 NYAISEKSDVYSYGMVLLEII 688
+ SDV+ +G+ + EI+
Sbjct: 566 FRRFTSASDVWMFGVCMWEIL 586
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 61/251 (24%), Positives = 105/251 (41%), Gaps = 31/251 (12%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVK-----KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLR 553
LG+GGF ++ A K L Q +K E+SI S+ H H+V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 81
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
GF + + E SL + ++ L + E R+ G YLH R
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARY-YLRQIVLGCQYLHR---NR 135
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISE 673
+IH D+K N+ L+++ K+ DFGLA + + L GT Y+APE ++ S
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSKKGHSF 194
Query: 674 KSDVYSYGMVLLEIIGGRKNFDPNETSD--------KAHFPSYAFKMMEEGK--LRNILD 723
+ DV+S G ++ ++ G+ F+ + + + P + + ++ +L
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH---INPVAASLIQKMLQ 251
Query: 724 S----RLNIDE 730
+ R I+E
Sbjct: 252 TDPTARPTINE 262
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 63/234 (26%), Positives = 106/234 (45%), Gaps = 17/234 (7%)
Query: 463 SPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSVKLGQGGFGSVYQGV-LPDGTRLAV 521
S + T E D + L D + N V LG+G +G VY G L + R+A+
Sbjct: 1 SMRSTEEGDCESDLLEY--------DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAI 52
Query: 522 KKLEGIGQGK-KEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFK 580
K++ + E+++ + H ++V+ G +E + E + GSL +
Sbjct: 53 KEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRS 112
Query: 581 KNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD-DNYHAKVSDFGL 639
K + +T +GL YLH D +I+H DIK +NVL++ + K+SDFG
Sbjct: 113 KWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGT 169
Query: 640 AKLMTREQSHVFTTLRGTRGYLAPEWITNYAI--SEKSDVYSYGMVLLEIIGGR 691
+K + T GT Y+APE I + +D++S G ++E+ G+
Sbjct: 170 SKRLAGINPCT-ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-31
Identities = 65/295 (22%), Positives = 113/295 (38%), Gaps = 42/295 (14%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVK--KLEGIGQGKKE-FRAEVSIIGSIHH--LHLVKLR 553
++G GG V+Q + A+K LE + +R E++ + + +++L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
+ + + E N L+ W+ KK +D R + + + +H+
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---HG 175
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF-TTLRGTRGYLAPEWITN---- 668
I+H D+KP N L+ D K+ DFG+A M + + V + G Y+ PE I +
Sbjct: 176 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 669 -------YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721
IS KSDV+S G +L + G+ F KL I
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------------KLHAI 280
Query: 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ---MLEGICPVPQPP 773
+D I+ V C++ D R S+ +++ + PV Q
Sbjct: 281 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMA 335
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 73/331 (22%), Positives = 130/331 (39%), Gaps = 70/331 (21%)
Query: 499 KLGQGGFGSVYQGVLPDG------TRLAVKKL--EGIGQGKKEFRAEVSIIGSIHHLHLV 550
+LGQG FG VY+GV TR+A+K + + + EF E S++ + H+V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLDKW-------IFKKNQEFLLDWETRFNIALGTAKGL 603
+L G ++G L+ E M G L + + +A A G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 604 AYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL-- 661
AYL+ + +H D+ N ++ +++ K+ DFG+ + + +G +G L
Sbjct: 152 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGLLPV 204
Query: 662 ---APEWITNYAISEKSDVYSYGMVLLEII-------GGRKNFDPNETSDKAHFPSYAFK 711
+PE + + + SDV+S+G+VL EI G N +
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------------VLR 251
Query: 712 MMEEGKLRNILDSRLNIDEQ-SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVP 770
+ EG L+ + D +F ++ C Q + +RPS +++ ++
Sbjct: 252 FVMEGG-------LLDKPDNCPDMLF---ELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301
Query: 771 QPPTCSPLGARLYSSFFRSISEEGTSSGPSD 801
SF+ SEE P +
Sbjct: 302 FR----------EVSFY--YSEENKLPEPEE 320
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 62/251 (24%), Positives = 106/251 (42%), Gaps = 31/251 (12%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVK-----KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLR 553
LG+GGF ++ A K L Q +K E+SI S+ H H+V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 107
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
GF + + E SL + K ++ L + E R+ G YLH R
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARY-YLRQIVLGCQYLHR---NR 161
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISE 673
+IH D+K N+ L+++ K+ DFGLA + + L GT Y+APE ++ S
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSKKGHSF 220
Query: 674 KSDVYSYGMVLLEIIGGRKNFDPNETSD--------KAHFPSYAFKMMEEGK--LRNILD 723
+ DV+S G ++ ++ G+ F+ + + + P + + ++ +L
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH---INPVAASLIQKMLQ 277
Query: 724 S----RLNIDE 730
+ R I+E
Sbjct: 278 TDPTARPTINE 288
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-31
Identities = 71/316 (22%), Positives = 116/316 (36%), Gaps = 68/316 (21%)
Query: 499 KLGQGGFGSVYQGVLPDG------TRLAVKKL-EGIG-QGKKEFRAEVSIIGSIHHLHLV 550
LG G FG VY+G + ++AVK L E Q + +F E II +H ++V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLDKWI----FKKNQEFLLDWETRFNIALGTAKGLAYL 606
+ G + R + E MA G L ++ + +Q L ++A A G YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 607 HEDCDQRIIHCDIKPENVLLD---DNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL-- 661
E IH DI N LL AK+ DFG+A+ + R +G L
Sbjct: 198 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----YYRKGGCAMLPV 250
Query: 662 ---APEWITNYAISEKSDVYSYGMVLLEII-------GGRKNFDPNETSDKAHFPSYAFK 711
PE + K+D +S+G++L EI + N + +
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------------VLE 297
Query: 712 MMEEGKLRNILDSRLNIDEQ-SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC--- 767
+ G R++ + V+ ++ C Q RP+ +++ +E
Sbjct: 298 FVTSGG-------RMDPPKNCPGPVY---RIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347
Query: 768 -------PVPQPPTCS 776
P+ P
Sbjct: 348 DVINTALPIEYGPLVE 363
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-31
Identities = 54/220 (24%), Positives = 86/220 (39%), Gaps = 22/220 (10%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLE--GIGQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
LGQG +V++G G A+K + E ++ ++H ++VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 556 CAEGTHRL--LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
E T R L EF GSL + + + + L + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132
Query: 614 IIHCDIKPENVLL----DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNY 669
I+H +IKP N++ D K++DFG A+ + E F +L GT YL P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSLYGTEEYLHPDMYERA 190
Query: 670 AI--------SEKSDVYSYGMVLLEIIGGRKNFDPNETSD 701
+ D++S G+ G F P E
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-31
Identities = 60/279 (21%), Positives = 108/279 (38%), Gaps = 42/279 (15%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEF----RAEVSI-IGSIHHLHLVKLR 553
LG G G++ + D +AVK++ E EV + S H ++++
Sbjct: 31 VLGHGAEGTIVYRGMFDNRDVAVKRI------LPECFSFADREVQLLRESDEHPNVIRYF 84
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
+ + +A E A +L +++ +K+ L E + T GLA+LH
Sbjct: 85 CTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHL-GLEPI-TLLQQTTSGLAHLHS---LN 138
Query: 614 IIHCDIKPENVLL-----DDNYHAKVSDFGLAKLMTREQS--HVFTTLRGTRGYLAPEWI 666
I+H D+KP N+L+ A +SDFGL K + + + + GT G++APE +
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 667 ---TNYAISEKSDVYSYGMVLLEII-GGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722
+ D++S G V +I G F + A ++ L +
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS-------LQRQANILLGACSLDCLH 251
Query: 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761
+ + + + D RPS V++
Sbjct: 252 PEKHEDVIARELI-------EKMIAMDPQKRPSAKHVLK 283
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 499 KLGQGGFGSVYQGVLPD------GTRLAVKKL-EGIGQG-KKEFRAEVSIIGSI-HHLHL 549
LG G FG V + ++AVK L K+ +E+ I+ + H ++
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 550 VKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETR-----------FNIALG 598
V L G C G L+ E+ G L ++ +K++ D + +
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 599 TAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR 658
A+G+A+L + IH D+ NVLL + + AK+ DFGLA+ + + +++
Sbjct: 173 VAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI----VKGN 225
Query: 659 GYL-----APEWITNYAISEKSDVYSYGMVLLEII 688
L APE I + + +SDV+SYG++L EI
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 52/219 (23%), Positives = 86/219 (39%), Gaps = 34/219 (15%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRA---EVSIIGSI-HHLHLVKLR 553
K+G G FGSV++ V DG A+K+ + G + + EV + H H+V+
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETR-FNIALGTAKGLAYLHEDCDQ 612
AE H L+ E+ GSL I + + E ++ L +GL Y+H
Sbjct: 78 SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SM 134
Query: 613 RIIHCDIKPENVLLDDN-------------------YHAKVSDFGLAKLMTREQSHVFTT 653
++H DIKP N+ + K+ D G ++ Q
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ-----V 189
Query: 654 LRGTRGYLAPE-WITNYAISEKSDVYSYGMVLLEIIGGR 691
G +LA E NY K+D+++ + ++ G
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 52/216 (24%), Positives = 92/216 (42%), Gaps = 33/216 (15%)
Query: 499 KLGQGGFGSVYQGVLPDG------TRLAVKKL-EGI-GQGKKEFRAEVSIIGSIHHLHLV 550
+LG+ FG VY+G L +A+K L + G ++EFR E + + H ++V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLDKW-------------IFKKNQEFLLDWETRFNIAL 597
L G + + + + ++G L ++ + + L+ ++
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 598 GTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGT 657
A G+ YL ++H D+ NVL+ D + K+SD GL + + + +
Sbjct: 136 QIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREV--YAADYYKL--LG 188
Query: 658 RGYL-----APEWITNYAISEKSDVYSYGMVLLEII 688
L APE I S SD++SYG+VL E+
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 34/214 (15%)
Query: 499 KLGQGGFGSVYQGVLPDG---TRLAVKKL-EGIGQG-KKEFRAEVSIIGSI-HHLHLVKL 552
+G+G FG V + + A+K++ E + ++F E+ ++ + HH +++ L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFN-------------IALGT 599
G C + LA E+ +G+L ++ K N A
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 600 AKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRG 659
A+G+ YL + ++ IH D+ N+L+ +NY AK++DFGL+ R Q ++ T G
Sbjct: 152 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS----RGQE---VYVKKTMG 201
Query: 660 YL-----APEWITNYAISEKSDVYSYGMVLLEII 688
L A E + + SDV+SYG++L EI+
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 36/219 (16%)
Query: 499 KLGQGGFGSVYQGVLPD------GTRLAVKKL-EGIGQG-KKEFRAEVSIIGSI-HHLHL 549
LG G FG V + +AVK L ++ +E+ ++ + +H+++
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 550 VKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFN--------------- 594
V L G C G L+ E+ G L ++ +K F+ +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 595 IALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTL 654
+ AKG+A+L + IH D+ N+LL K+ DFGLA+ + + ++V
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV---- 202
Query: 655 RGTRGYL-----APEWITNYAISEKSDVYSYGMVLLEII 688
L APE I N + +SDV+SYG+ L E+
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-30
Identities = 65/302 (21%), Positives = 127/302 (42%), Gaps = 61/302 (20%)
Query: 499 KLGQGGFGSVYQGVL--------PDGTRLAVKKL-EGIGQG-KKEFRAEVSIIGSI-HHL 547
LG+G FG V + +AVK L + + + +E+ ++ I H
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 548 HLVKLRGFCAEGTHRLLAYEFMANGSL-------------DKWIFKKNQEFLLDWETRFN 594
+++ L G C + + E+ + G+L + + E + ++ +
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 595 IALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTL 654
A+G+ YL Q+ IH D+ NVL+ +N K++DFGLA+ + +
Sbjct: 208 CTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK---- 260
Query: 655 RGTRGYL-----APEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYA 709
+ T G L APE + + + +SDV+S+G+++ EI T + +P
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF----------TLGGSPYPGIP 310
Query: 710 ----FKMMEEGKLRNILDSRLNIDEQ-SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764
FK+++EG R++ ++ ++ + C S RP+ ++V+ L+
Sbjct: 311 VEELFKLLKEGH-------RMDKPANCTNELY---MMMRDCWHAVPSQRPTFKQLVEDLD 360
Query: 765 GI 766
I
Sbjct: 361 RI 362
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 41/224 (18%)
Query: 499 KLGQGGFGSVYQGVLPDG------TRLAVKKL-EGIGQG-KKEFRAEVSIIGSIHHLHLV 550
LG+G FG V + T +AVK L E ++ +E +++ ++H H++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 551 KLRGFCAEGTHRLLAYEFMANGSL---------------------DKWIFKKNQEFLLDW 589
KL G C++ LL E+ GSL + E L
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 590 ETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649
+ A ++G+ YL E +++H D+ N+L+ + K+SDFGL++ + E S+
Sbjct: 150 GDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 650 VFTTLRGTRGYL-----APEWITNYAISEKSDVYSYGMVLLEII 688
V + ++G + A E + ++ + +SDV+S+G++L EI+
Sbjct: 207 V----KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 5e-30
Identities = 73/328 (22%), Positives = 128/328 (39%), Gaps = 52/328 (15%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSI-HHLHLVKLRGF 555
L +GGF VY+ + G A+K+L + + EV + + H ++V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 556 CAEGTHRLLA--YEFM-----ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHE 608
+ G EF+ G L +++ K L +T I T + + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 609 DCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT-----------TLRGT 657
IIH D+K EN+LL + K+ DFG A ++ + ++ T T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 658 RGYLAPEWI---TNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMME 714
Y PE I +N+ I EK D+++ G +L + + F+ +
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE------------------D 255
Query: 715 EGKLRNILDSRLNI---DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQ 771
KLR I++ + +I D Q + ++ +Q + R S+ +VV L+ I
Sbjct: 256 GAKLR-IVNGKYSIPPHDTQYTVFHSLIR---AMLQVNPEERLSIAEVVHQLQEIAAARN 311
Query: 772 PPTCSPLGARLYSSFFRSISEEGTSSGP 799
SP+ L + S GP
Sbjct: 312 VNPKSPITELLEQN--GGYGSATLSRGP 337
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 51/219 (23%), Positives = 95/219 (43%), Gaps = 36/219 (16%)
Query: 499 KLGQGGFGSVYQGVLPD--------GTRLAVKKL-EGIGQG-KKEFRAEVSIIGSI-HHL 547
LG+G FG V +AVK L + + + +E+ ++ I H
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 548 HLVKLRGFCAEGTHRLLAYEFMANGSL-------------DKWIFKKNQEFLLDWETRFN 594
+++ L G C + + E+ + G+L + + E + ++ +
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 595 IALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTL 654
A+G+ YL Q+ IH D+ NVL+ +N K++DFGLA+ + +
Sbjct: 162 CTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK---- 214
Query: 655 RGTRGYL-----APEWITNYAISEKSDVYSYGMVLLEII 688
+ T G L APE + + + +SDV+S+G+++ EI
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 69/316 (21%), Positives = 120/316 (37%), Gaps = 72/316 (22%)
Query: 499 KLGQGGFGSVYQGVLPDG------TRLAVKKL-EGI-GQGKKEFRAEVSIIGSIHHLHLV 550
+G+G FG V+Q P T +AVK L E + +F+ E +++ + ++V
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 551 KLRGFCAEGTHRLLAYEFMANGSL---------------------DKWIFKKNQEFLLDW 589
KL G CA G L +E+MA G L + L
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 590 ETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649
+ IA A G+AYL E ++ +H D+ N L+ +N K++DFGL++ + +
Sbjct: 174 AEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 650 VFTTLRGTRGYL-----APEWITNYAISEKSDVYSYGMVLLEII-------GGRKNFDPN 697
+ PE I + +SDV++YG+VL EI G + +
Sbjct: 231 K----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE-- 284
Query: 698 ETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ-SDRVFTAVKVALWCVQEDMSLRPSM 756
+ +G L E ++ + C + + RPS
Sbjct: 285 -----------VIYYVRDGN-------ILACPENCPLELY---NLMRLCWSKLPADRPSF 323
Query: 757 TKVVQMLEGICPVPQP 772
+ ++L+ +C +
Sbjct: 324 CSIHRILQRMCERAEG 339
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 499 KLGQGGFGSVYQGVLPDGTRL----AVKKLEGIGQGKKE----FRAEVSIIGSIHHLHLV 550
KLG GG +VY D T L A+K + + K+E F EV + H ++V
Sbjct: 18 KLGGGGMSTVYLAE--D-TILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC 610
+ E L E++ +L ++I L +T N G+ + H+
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAHD-- 129
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYA 670
RI+H DIKP+N+L+D N K+ DFG+AK ++ + GT Y +PE A
Sbjct: 130 -MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 671 ISEKSDVYSYGMVLLEIIGGRKNFD 695
E +D+YS G+VL E++ G F+
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFN 213
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 124 bits (311), Expect = 2e-29
Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 19/206 (9%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVK--KLEGIGQGKKEFRAEVSIIGSIHHLHLVKL--- 552
+LG GGFG V + + G ++A+K + E + ++ + E+ I+ ++H ++V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 553 ---RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALG-TAKGLAYLHE 608
A LLA E+ G L K++ + L E L + L YLHE
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK-EGPIRTLLSDISSALRYLHE 139
Query: 609 DCDQRIIHCDIKPENVLLDDNYHA---KVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEW 665
RIIH D+KPEN++L K+ D G AK + +Q + T GT YLAPE
Sbjct: 140 ---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLAPEL 194
Query: 666 ITNYAISEKSDVYSYGMVLLEIIGGR 691
+ + D +S+G + E I G
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-29
Identities = 43/209 (20%), Positives = 78/209 (37%), Gaps = 30/209 (14%)
Query: 499 KLGQGGFGSVYQGVLPDGTRL-----AVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVK 551
+ GG G +Y + D + +K L G + + AE + + H +V+
Sbjct: 87 CIAHGGLGWIYLAL--D-RNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 552 LRGFCAEGTH--RLLAY---EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYL 606
+ F + Y E++ SL + +K L L L+YL
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYL 198
Query: 607 HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI 666
H +++ D+KPEN++L + K+ D G + GT G+ APE +
Sbjct: 199 HS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLY-----GTPGFQAPEIV 249
Query: 667 TNYAISEKSDVYSYGMVLLEIIGGRKNFD 695
+ +D+Y+ G L + +
Sbjct: 250 RTGP-TVATDIYTVGRTLAALTLDLPTRN 277
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 35/218 (16%)
Query: 499 KLGQGGFGSVYQGVL------PDGTRLAVKKL-EGIGQG-KKEFRAEVSIIGSI-HHLHL 549
LG+G FG V + +AVK L EG + +E+ I+ I HHL++
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 550 VKLRGFC-AEGTHRLLAYEFMANGSL-------------DKWIFKKNQEFLLDWETRFNI 595
V L G C G ++ EF G+L K + + L E
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 596 ALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLR 655
+ AKG+ +L ++ IH D+ N+LL + K+ DFGLA+ + ++ +V R
Sbjct: 154 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV----R 206
Query: 656 GTRGYL-----APEWITNYAISEKSDVYSYGMVLLEII 688
L APE I + + +SDV+S+G++L EI
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 62/279 (22%), Positives = 103/279 (36%), Gaps = 54/279 (19%)
Query: 452 RYVRKKRKAPESPQETSEEDNFLENLSGMPVRFTYRD--------LQTATNNFSVKLGQG 503
+Y ++ R + + E + Y L+ F LG G
Sbjct: 2 KYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLE-----FGKVLGSG 56
Query: 504 GFGSVYQGVLPDG------TRLAVKKL-EGIGQG-KKEFRAEVSIIGSI-HHLHLVKLRG 554
FG V ++AVK L E ++ +E+ ++ + H ++V L G
Sbjct: 57 AFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG 116
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFN-------------------- 594
C L +E+ G L ++ K ++F D N
Sbjct: 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLC 176
Query: 595 IALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTL 654
A AKG+ +L + +H D+ NVL+ K+ DFGLA+ + + ++V
Sbjct: 177 FAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV---- 229
Query: 655 RGTRGYL-----APEWITNYAISEKSDVYSYGMVLLEII 688
L APE + + KSDV+SYG++L EI
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-29
Identities = 57/261 (21%), Positives = 102/261 (39%), Gaps = 46/261 (17%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEF----RAEVSI-IGSIHHLHLVKLR 553
LG G G+V G +AVK++ +F E+ + S H ++++
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRM------LIDFCDIALMEIKLLTESDDHPNVIRYY 75
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWI-----FKKNQEFLLDWETRFNIALGTAKGLAYLHE 608
+A E N +L + +N + ++ ++ A G+A+LH
Sbjct: 76 CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAHLHS 133
Query: 609 DCDQRIIHCDIKPENVLLD-------------DNYHAKVSDFGLAKLMTREQSHVFTTLR 655
+IIH D+KP+N+L+ +N +SDFGL K + QS T L
Sbjct: 134 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 656 ---GTRGYLAPEWITNYAI-------SEKSDVYSYGMVLLEII-GGRKNFDPNETSDKAH 704
GT G+ APE + + D++S G V I+ G+ F + +
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 705 FP-SYAFKMMEEGKLRNILDS 724
++ M+ R+++
Sbjct: 251 IRGIFSLDEMKCLHDRSLIAE 271
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 36/219 (16%)
Query: 499 KLGQGGFGSVYQGVLPD--------GTRLAVKKL-EGIGQG-KKEFRAEVSIIGSI-HHL 547
LG+G FG V T++AVK L + + +E+ ++ I H
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 548 HLVKLRGFCAEGTHRLLAYEFMANGSL-------------DKWIFKKNQEFLLDWETRFN 594
+++ L G C + + E+ + G+L + N E L + +
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 595 IALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTL 654
A A+G+ YL ++ IH D+ NVL+ ++ K++DFGLA+ + +
Sbjct: 196 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK---- 248
Query: 655 RGTRGYL-----APEWITNYAISEKSDVYSYGMVLLEII 688
+ T G L APE + + + +SDV+S+G++L EI
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 11/238 (4%)
Query: 499 KLGQGGFGSVYQGVL-PDGTRLAVKK--LEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
+LG G G V++ P G +A K LE + + E+ ++ + ++V G
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
+ E M GSLD+ + KK + +++ KGL YL E +I+
Sbjct: 100 FYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGK--VSIAVIKGLTYLREK--HKIM 154
Query: 616 HCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKS 675
H D+KP N+L++ K+ DFG++ + ++ F GTR Y++PE + S +S
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQS 211
Query: 676 DVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSD 733
D++S G+ L+E+ GR P + + + +++
Sbjct: 212 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 54/224 (24%), Positives = 86/224 (38%), Gaps = 35/224 (15%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLE------------------GIGQGKKEFRAEVSI 540
L QG F + D A+KK E I +F+ E+ I
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 541 IGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQ------EFLLDWETRFN 594
I I + + + G + YE+M N S+ K+ F+ +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC- 155
Query: 595 IALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTL 654
I +Y+H + + I H D+KP N+L+D N K+SDFG ++ M
Sbjct: 156 IIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIKGS 210
Query: 655 RGTRGYLAPEWITN---YAISEKSDVYSYGMVLLEIIGGRKNFD 695
RGT ++ PE+ +N Y K D++S G+ L + F
Sbjct: 211 RGTYEFMPPEFFSNESSYN-GAKVDIWSLGICLYVMFYNVVPFS 253
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 25/291 (8%), Positives = 59/291 (20%), Gaps = 51/291 (17%)
Query: 458 RKAPESPQETSEEDNFLENL---SGMPVRFTYRDLQTATNNFSV--KLGQGGFGSVYQGV 512
E+ +E + + L + L G V+
Sbjct: 24 YCREEALKEPAAMVEAVTATVWPQNAETTVDS-LLSQGERKLKLVEPLRVGDRSVVFLVR 82
Query: 513 -LPDGTRLAVK----KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFC----------- 556
+ A+K E + + + R
Sbjct: 83 DVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142
Query: 557 ---------------AEGTHRLLAYEFMANGSLDKWI----FKKNQEFLLDWETRFNIAL 597
+ LL + L+ F +
Sbjct: 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTA 201
Query: 598 GTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGT 657
+ A L + ++H P+N+ + + + D +
Sbjct: 202 QLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSAL----WKVGTRGPASSVP 254
Query: 658 RGYLAPEWIT--NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFP 706
Y E++ + + + G+ + + F K +
Sbjct: 255 VTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWK 305
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 37/218 (16%)
Query: 499 KLGQGGFGSVYQGVLPDGTRL----AVKKLEGIGQGKKE----------FRAEVSIIGSI 544
LG GG V+ D R AVK L + + FR E ++
Sbjct: 19 ILGFGGMSEVHLAR--D-LRDHRDVAVKVL------RADLARDPSFYLRFRREAQNAAAL 69
Query: 545 HHLHLVKL--RGFCAEGTHRLLAY---EFMANGSLDKWIFKKNQEFLLDWETRFNIALGT 599
+H +V + G AE L Y E++ +L + + E + + +
Sbjct: 70 NHPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADA 125
Query: 600 AKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT--LRGT 657
+ L + H+ IIH D+KP N+++ KV DFG+A+ + + V T + GT
Sbjct: 126 CQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 658 RGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFD 695
YL+PE ++ +SDVYS G VL E++ G F
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 4e-28
Identities = 35/238 (14%), Positives = 67/238 (28%), Gaps = 54/238 (22%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVK--------KLEGIGQGKKE----------------- 533
LGQ + + G V I Q K+E
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 534 ----FRAEVSIIGSIHHLHLVKLRGFCAEGT--HRLLAYEFMA--NGSLDKWIFKKNQE- 584
F ++ ++++R + R Y M + + + +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 585 FLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644
L R + L + LA LH ++H ++P +++LD ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 645 REQSHVFTTLRGTRGYLAPEWITNYAI-----------SEKSDVYSYGMVLLEIIGGR 691
+RG+ PE A + D ++ G+V+ I
Sbjct: 258 A-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 47/207 (22%), Positives = 76/207 (36%), Gaps = 21/207 (10%)
Query: 499 KLGQGGFGSVYQGVLPDGTRL----AVKKLEGIGQGKKEFRA----EVSIIGSIHHLHLV 550
+G+GG G VY+ D T A+K + FR E G + H+V
Sbjct: 41 LVGRGGMGDVYEAE--D-TVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC 610
+ F + + L + ++ L I L H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHA-- 152
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT--LRGTRGYLAPEWITN 668
H D+KPEN+L+ + A + DFG+A T + GT Y+APE +
Sbjct: 153 -AGATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSE 209
Query: 669 YAISEKSDVYSYGMVLLEIIGGRKNFD 695
+ ++D+Y+ VL E + G +
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPPYQ 236
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 39/208 (18%), Positives = 81/208 (38%), Gaps = 34/208 (16%)
Query: 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL 626
+ +L W+ ++ + +I + A+ + +LH + ++H D+KP N+
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFF 197
Query: 627 DDNYHAKVSDFGLAKLMTREQS-----------HVFTTLRGTRGYLAPEWITNYAISEKS 675
+ KV DFGL M +++ T GT+ Y++PE I S K
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 676 DVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFK-MMEEGKLRNILDSRLNIDEQSDR 734
D++S G++L E++ Y+F ME ++ + + + +
Sbjct: 258 DIFSLGLILFELL-------------------YSFSTQMERVRIITDVRNLKFPLLFTQK 298
Query: 735 VFTAVKVALWCVQEDMSLRPSMTKVVQM 762
+ + + RP T +++
Sbjct: 299 YPQEHMMVQDMLSPSPTERPEATDIIEN 326
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 30/206 (14%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVK----------KLEGIGQGKKEFRAEVSIIGSI-HH 546
LG+G V + + P AVK E + + ++ EV I+ + H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 547 LHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYL 606
++++L+ T L ++ M G L ++ +K L + ETR I + + L
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETR-KIMRALLEVICAL 140
Query: 607 HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPE-- 664
H I+H D+KPEN+LLDD+ + K++DFG + + + + GT YLAPE
Sbjct: 141 H---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAPEII 195
Query: 665 ------WITNYAISEKSDVYSYGMVL 684
Y ++ D++S G+++
Sbjct: 196 ECSMNDNHPGY--GKEVDMWSTGVIM 219
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 53/200 (26%), Positives = 97/200 (48%), Gaps = 22/200 (11%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKE-FRAEVSIIGSIHHLHLVKLRGFC 556
K+G+G G V G ++AVK ++ Q ++E EV I+ H ++V++
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 557 AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFN------IALGTAKGLAYLHEDC 610
G + EF+ G+L + + R N + + LAYLH
Sbjct: 112 LVGEELWVLMEFLQGGALTDIV----------SQVRLNEEQIATVCEAVLQALAYLHA-- 159
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYA 670
Q +IH DIK +++LL + K+SDFG ++++ +L GT ++APE I+
Sbjct: 160 -QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR-KSLVGTPYWMAPEVISRSL 217
Query: 671 ISEKSDVYSYGMVLLEIIGG 690
+ + D++S G++++E++ G
Sbjct: 218 YATEVDIWSLGIMVIEMVDG 237
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 22/200 (11%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKE-FRAEVSIIGSIHHLHLVKLRGFC 556
K+GQG G+VY + + G +A++++ Q KKE E+ ++ + ++V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 557 AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFN------IALGTAKGLAYLHEDC 610
G + E++A GSL + ET + + + L +LH
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQIAAVCRECLQALEFLHS-- 134
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYA 670
++IH DIK +N+LL + K++DFG +T EQS +T+ GT ++APE +T A
Sbjct: 135 -NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKA 192
Query: 671 ISEKSDVYSYGMVLLEIIGG 690
K D++S G++ +E+I G
Sbjct: 193 YGPKVDIWSLGIMAIEMIEG 212
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-26
Identities = 53/240 (22%), Positives = 97/240 (40%), Gaps = 22/240 (9%)
Query: 454 VRKKRKAPESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSV--KLGQGGFGSVYQG 511
VR K P+ ++ + PV + + + + +LG G FG V++
Sbjct: 14 VRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSV---YDYYDILEELGSGAFGVVHRC 70
Query: 512 V-LPDGTRLAVKKLEGIGQGKKE-FRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569
V G K + K + E+SI+ +HH L+ L + +L EF+
Sbjct: 71 VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130
Query: 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGT---AKGLAYLHEDCDQRIIHCDIKPENVLL 626
+ G L I ++ + + + +GL ++HE I+H DIKPEN++
Sbjct: 131 SGGELFDRIAAEDYKM-----SEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMC 182
Query: 627 --DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVL 684
K+ DFGLA + + T + APE + + +D+++ G++
Sbjct: 183 ETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 56/242 (23%), Positives = 103/242 (42%), Gaps = 20/242 (8%)
Query: 456 KKRKAPESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFS--------VKLGQGGFGS 507
P ++ ++ P F +R + + LG G FG
Sbjct: 45 NADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQ 104
Query: 508 VYQGV-LPDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLA 565
V++ G +LA K ++ G + K+E + E+S++ + H +L++L +L
Sbjct: 105 VHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164
Query: 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVL 625
E++ G L I ++ + +T +G+ ++H+ I+H D+KPEN+L
Sbjct: 165 MEYVDGGELFDRIIDESYNL-TELDTI-LFMKQICEGIRHMHQ---MYILHLDLKPENIL 219
Query: 626 L--DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMV 683
D K+ DFGLA+ + GT +LAPE + +S +D++S G V
Sbjct: 220 CVNRDAKQIKIIDFGLARRY--KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVG-V 276
Query: 684 LL 685
+
Sbjct: 277 IA 278
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 50/193 (25%), Positives = 88/193 (45%), Gaps = 15/193 (7%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVK---KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRG 554
+LG+G F V + V G A K + + ++ E I + H ++V+L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
E + L ++ + G L + I + EF + + + + +AY H I
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADAS-HCIQQILESIAYCH---SNGI 126
Query: 615 IHCDIKPENVLL---DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAI 671
+H ++KPEN+LL K++DFGLA + S + GT GYL+PE +
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 672 SEKSDVYSYGMVL 684
S+ D+++ G++L
Sbjct: 185 SKPVDIWACGVIL 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 7e-26
Identities = 50/200 (25%), Positives = 85/200 (42%), Gaps = 16/200 (8%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVK-----KLEGI-GQGKKEFRAEVSIIGSIHHLHLVK 551
+G+G F V + + G + AVK K G ++ + E SI + H H+V+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 552 LRGFCAEGTHRLLAYEFMANGSL-DKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC 610
L + + +EFM L + + + + F+ + + L Y H+
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-- 148
Query: 611 DQRIIHCDIKPENVLL---DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWIT 667
IIH D+KP VLL +++ K+ FG+A + V GT ++APE +
Sbjct: 149 -NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL-VAGGRVGTPHFMAPEVVK 206
Query: 668 NYAISEKSDVYSYGMVLLEI 687
+ DV+ G V+L I
Sbjct: 207 REPYGKPVDVWGCG-VILFI 225
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-26
Identities = 49/202 (24%), Positives = 88/202 (43%), Gaps = 25/202 (12%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVK-----KLEGIGQGKKE----FRAEVSIIGSIHHLH 548
LG G G V ++A++ K + + E+ I+ ++H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 549 LVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHE 608
++K++ F + + E M G L + L + + + YLH
Sbjct: 202 IIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNK--RLKEATCK-LYFYQMLLAVQYLH- 256
Query: 609 DCDQRIIHCDIKPENVLL---DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEW 665
+ IIH D+KPENVLL +++ K++DFG +K++ ++ + TL GT YLAPE
Sbjct: 257 --ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPEV 312
Query: 666 ITNYAI---SEKSDVYSYGMVL 684
+ + + D +S G++L
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVIL 334
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-26
Identities = 66/287 (22%), Positives = 104/287 (36%), Gaps = 47/287 (16%)
Query: 461 PESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSV--KLGQGGFGSVYQGV-LPDGT 517
E F +L P F + + KLG G +G V
Sbjct: 4 HHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63
Query: 518 RLAVK---KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSL 574
A+K K + EV+++ + H +++KL F + + L E G L
Sbjct: 64 ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL 123
Query: 575 DKWIFKKNQEFLLDWETRFN------IALGTAKGLAYLHEDCDQRIIHCDIKPENVLL-- 626
I + +FN I G+ YLH+ I+H D+KPEN+LL
Sbjct: 124 FDEIIHRM---------KFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLES 171
Query: 627 -DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWIT-NYAISEKSDVYSYGMVL 684
+ + K+ DFGL+ + E GT Y+APE + Y EK DV+S G++L
Sbjct: 172 KEKDALIKIVDFGLSAVF--ENQKKMKERLGTAYYIAPEVLRKKY--DEKCDVWSIGVIL 227
Query: 685 LEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731
++ G F ++ LR + + D
Sbjct: 228 FILLAGYPPF---------------GGQTDQEILRKVEKGKYTFDSP 259
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 18/204 (8%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKK--LEGIGQGKKEFRAEVSII-GSIHHLHLVKLRG 554
+LG+G +G V + +P G +AVK+ Q +K ++ I ++ V G
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 555 FCAEGTHRLLAYEFMANGSLD---KWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCD 611
+ E M + SLD K + K Q D + IA+ K L +LH
Sbjct: 74 ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALEHLHSK-- 128
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAI 671
+IH D+KP NVL++ K+ DFG++ + G + Y+APE I
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD--DVAKDIDAGCKPYMAPERINPELN 186
Query: 672 ----SEKSDVYSYGMVLLEIIGGR 691
S KSD++S G+ ++E+ R
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILR 210
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 50/191 (26%), Positives = 89/191 (46%), Gaps = 14/191 (7%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKE-FRAEVSIIGSIHHLHLVKLRGFC 556
LG G F V+ G A+K ++ + E++++ I H ++V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 557 AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIH 616
TH L + ++ G L I ++ + + + + YLH + I+H
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILER--GVYTEKDAS-LVIQQVLSAVKYLH---ENGIVH 129
Query: 617 CDIKPENVLL---DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISE 673
D+KPEN+L ++N ++DFGL+K+ EQ+ + +T GT GY+APE + S+
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGTPGYVAPEVLAQKPYSK 186
Query: 674 KSDVYSYGMVL 684
D +S G++
Sbjct: 187 AVDCWSIGVIT 197
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 30/232 (12%), Positives = 60/232 (25%), Gaps = 43/232 (18%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGK----KEFRAEVSIIGSIHHLH------ 548
LGQ + + G V + K+ + EV + + +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 549 ----------LVKLRGFCAEG-----------THRLLAYEFMA--NGSLDKWIFKKNQEF 585
LVK R Y M + + + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 586 -LLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644
L R + L + LA LH ++H ++P +++LD ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 645 REQSHVFTTLRGTRGYLAPEWIT-----NYAISEKSDVYSYGMVLLEIIGGR 691
A + ++ D ++ G+ + I
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 16/202 (7%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKK--LEGIGQGKKEFRAEVSII-GSIHHLHLVKLRG 554
++G G G V++ G +AVK+ G + K ++ ++ S ++V+ G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
T +A E M +K + + + + K L YL E +
Sbjct: 92 TFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGK--MTVAIVKALYYLKEK--HGV 146
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISE- 673
IH D+KP N+LLD+ K+ DFG++ + G Y+APE I ++
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVD--DKAKDRSAGCAAYMAPERIDPPDPTKP 204
Query: 674 ----KSDVYSYGMVLLEIIGGR 691
++DV+S G+ L+E+ G+
Sbjct: 205 DYDIRADVWSLGISLVELATGQ 226
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 44/195 (22%), Positives = 85/195 (43%), Gaps = 15/195 (7%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVK---KLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLR 553
+LG+G F V Q + G A K K + E E++++ ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
+ +L E+ A G + + E + + + + +G+ YLH+
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI-RLIKQILEGVYYLHQ---NN 151
Query: 614 IIHCDIKPENVLL---DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYA 670
I+H D+KP+N+LL K+ DFG+++ + + + GT YLAPE +
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREIMGTPEYLAPEILNYDP 209
Query: 671 ISEKSDVYSYGMVLL 685
I+ +D+++ G ++
Sbjct: 210 ITTATDMWNIG-IIA 223
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 55/200 (27%), Positives = 85/200 (42%), Gaps = 30/200 (15%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVK---KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRG 554
LG+G FG V + AVK K + EV ++ + H +++KL
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFN------IALGTAKGLAYLHE 608
+ + + E G L I K+ RF+ I G+ Y+H
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGITYMH- 138
Query: 609 DCDQRIIHCDIKPENVLL---DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEW 665
I+H D+KPEN+LL + + K+ DFGL+ +Q+ GT Y+APE
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYYIAPEV 194
Query: 666 IT-NYAISEKSDVYSYGMVL 684
+ Y EK DV+S G++L
Sbjct: 195 LRGTY--DEKCDVWSAGVIL 212
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-25
Identities = 58/250 (23%), Positives = 106/250 (42%), Gaps = 43/250 (17%)
Query: 462 ESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSV--KLGQGGFGSVYQGV-LPDGTR 518
+ E+ + + ++ P + + ++ KLG G +G V +
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63
Query: 519 LAVKKL--------------EGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLL 564
A+K + + I + +E E+S++ S+ H +++KL + + L
Sbjct: 64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL 123
Query: 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFN------IALGTAKGLAYLHEDCDQRIIHCD 618
EF G L + I ++ +F+ I G+ YLH+ I+H D
Sbjct: 124 VTEFYEGGELFEQIINRH---------KFDECDAANIMKQILSGICYLHK---HNIVHRD 171
Query: 619 IKPENVLL---DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWIT-NYAISEK 674
IKPEN+LL + + K+ DFGL+ + + GT Y+APE + Y +EK
Sbjct: 172 IKPENILLENKNSLLNIKIVDFGLSSFF--SKDYKLRDRLGTAYYIAPEVLKKKY--NEK 227
Query: 675 SDVYSYGMVL 684
DV+S G+++
Sbjct: 228 CDVWSCGVIM 237
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 31/251 (12%)
Query: 455 RKKRKAPESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSVK--LGQGGFGSVYQGV 512
+ K Q E+ + +++ + + + K +G+G V + V
Sbjct: 55 LAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCV 114
Query: 513 -LPDGTRLAVK---------KLEGIGQGKKEFRAEVSIIGSIH-HLHLVKLRGFCAEGTH 561
G AVK E + + ++ R E I+ + H H++ L +
Sbjct: 115 HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174
Query: 562 RLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKP 621
L ++ M G L ++ +K L + ETR +I + +++LH I+H D+KP
Sbjct: 175 MFLVFDLMRKGELFDYLTEK--VALSEKETR-SIMRSLLEAVSFLH---ANNIVHRDLKP 228
Query: 622 ENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPE--------WITNYAISE 673
EN+LLDDN ++SDFG + + E L GT GYLAPE Y +
Sbjct: 229 ENILLDDNMQIRLSDFGFSCHL--EPGEKLRELCGTPGYLAPEILKCSMDETHPGY--GK 284
Query: 674 KSDVYSYGMVL 684
+ D+++ G++L
Sbjct: 285 EVDLWACGVIL 295
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKK--LEGIGQGKKEFRAEVSII-GSIHHLHLVKLRG 554
++G+G +GSV + V P G +AVK+ + +K+ ++ ++ S ++V+ G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFN------IALGTAKGLAYLHE 608
+ E M+ S DK +K L + I L T K L +L E
Sbjct: 89 ALFREGDCWICMELMS-TSFDK-FYKYVYSVL---DDVIPEEILGKITLATVKALNHLKE 143
Query: 609 DCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI-- 666
+ +IIH DIKP N+LLD + + K+ DFG++ + + G R Y+APE I
Sbjct: 144 N--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPERIDP 199
Query: 667 ----TNYAISEKSDVYSYGMVLLEIIGGR 691
Y +SDV+S G+ L E+ GR
Sbjct: 200 SASRQGY--DVRSDVWSLGITLYELATGR 226
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVK--KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
K+G+G FG V++G+ +A+K LE ++ + E++++ ++ K G
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
+ T + E++ GS + + LD I KGL YLH ++ I
Sbjct: 89 YLKDTKLWIIMEYLGGGSALD-LLEPG---PLDETQIATILREILKGLDYLHS---EKKI 141
Query: 616 HCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKS 675
H DIK NVLL ++ K++DFG+A +T Q T GT ++APE I A K+
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-NTFVGTPFWMAPEVIKQSAYDSKA 200
Query: 676 DVYSYGMVLLEIIGG 690
D++S G+ +E+ G
Sbjct: 201 DIWSLGITAIELARG 215
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 63/193 (32%), Positives = 100/193 (51%), Gaps = 8/193 (4%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCA 557
KLG+G +GSVY+ + G +A+K++ + +E E+SI+ H+VK G
Sbjct: 36 KLGEGSYGSVYKAIHKETGQIVAIKQVP-VESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 558 EGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHC 617
+ T + E+ GS+ I + + L + E I T KGL YLH R IH
Sbjct: 95 KNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIAT-ILQSTLKGLEYLHF---MRKIHR 149
Query: 618 DIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDV 677
DIK N+LL+ HAK++DFG+A +T + T+ GT ++APE I + +D+
Sbjct: 150 DIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR-NTVIGTPFWMAPEVIQEIGYNCVADI 208
Query: 678 YSYGMVLLEIIGG 690
+S G+ +E+ G
Sbjct: 209 WSLGITAIEMAEG 221
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 20/198 (10%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVK-------KLEGIGQGKKEFRAEVSIIGSIHHLHLV 550
+LG G F V + G A K + G ++E EVSI+ + H +++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC 610
L T +L E ++ G L ++ +K E L + E + G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEAT-SFIKQILDGVNYLHT-- 133
Query: 611 DQRIIHCDIKPENVLL----DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI 666
++I H D+KPEN++L H K+ DFGLA + E F + GT ++APE +
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIV 190
Query: 667 TNYAISEKSDVYSYGMVL 684
+ ++D++S G++
Sbjct: 191 NYEPLGLEADMWSIGVIT 208
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-25
Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 500 LGQGGFGSVYQGVLPDGTRL-AVKKL--EGIGQGKKEF--RAEVSIIGSIHHLHLVKLRG 554
LG+GGFG V + ++ A KKL + I + K E E I+ ++ +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 250
Query: 555 FCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
+ E L L M G L I+ Q + F A GL LH +R
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA-EICCGLEDLHR---ER 306
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISE 673
I++ D+KPEN+LLDD+ H ++SD GLA + Q+ GT GY+APE + N +
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTF 364
Query: 674 KSDVYSYGMVLLEIIGGRKNFDPNETSDKAH 704
D ++ G +L E+I G+ F + K
Sbjct: 365 SPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 395
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 44/195 (22%), Positives = 81/195 (41%), Gaps = 17/195 (8%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCA 557
LG+G FG V++ V K ++ G + + E+SI+ H +++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 558 EGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGT---AKGLAYLHEDCDQRI 614
++ +EF++ + + I E I + L +LH I
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFEL-----NEREIVSYVHQVCEALQFLHS---HNI 123
Query: 615 IHCDIKPENVLL--DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAIS 672
H DI+PEN++ + K+ +FG A+ + + F L Y APE + +S
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDVVS 181
Query: 673 EKSDVYSYGMVLLEI 687
+D++S G L+ +
Sbjct: 182 TATDMWSLG-TLVYV 195
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKE-FRAEVSIIGSIHHLHLVKLRGFC 556
+LG G FG VY+ G A K +E + + E + E+ I+ + H ++VKL G
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 557 AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIH 616
+ EF G++D I + L + + + + + L +LH +RIIH
Sbjct: 86 YHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLEALNFLHS---KRIIH 140
Query: 617 CDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISE--- 673
D+K NVL+ +++DFG++ + + GT ++APE + + +
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR-DSFIGTPYWMAPEVVMCETMKDTPY 199
Query: 674 --KSDVYSYGMVLLEIIGG 690
K+D++S G+ L+E+
Sbjct: 200 DYKADIWSLGITLIEMAQI 218
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 25/202 (12%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVK-----KLEGIGQGKKE----FRAEVSIIGSIHHLH 548
LG G G V ++A+K K + + E+ I+ ++H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 549 LVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHE 608
++K++ F + + E M G L + + L + + + YLH
Sbjct: 77 IIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN--KRLKEATCK-LYFYQMLLAVQYLH- 131
Query: 609 DCDQRIIHCDIKPENVLL---DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEW 665
+ IIH D+KPENVLL +++ K++DFG +K++ ++ + TL GT YLAPE
Sbjct: 132 --ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPEV 187
Query: 666 ITNYAI---SEKSDVYSYGMVL 684
+ + + D +S G++L
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVIL 209
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 24/225 (10%)
Query: 500 LGQGGFGSVYQGVLPDGTRL-AVKKL--EGIGQGKKE--FRAEVSIIGSIHHLHLVKLRG 554
LG+G F +V +R A+K L I + K E ++ + H VKL
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 555 FCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIA-LGTAKGLAYLHEDCDQ 612
F + +L + NG L K+I +K F TRF A + +A L YLH +
Sbjct: 97 FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDET-CTRFYTAEIVSA--LEYLHG---K 149
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT-TLRGTRGYLAPEWITNYAI 671
IIH D+KPEN+LL+++ H +++DFG AK+++ E + GT Y++PE +T +
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 209
Query: 672 SEKSDVYSYGMVLLEIIGGR---KNFDPNET-----SDKAHFPSY 708
+ SD+++ G ++ +++ G + + + FP
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 254
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 21/201 (10%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVK-------KLEGIGQGKKEFRAEVSIIGSIHHLHLV 550
+LG G F V + G A K + G ++E EVSI+ + H +++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC 610
L T +L E ++ G L ++ +K E L + E + G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEAT-SFIKQILDGVNYLHT-- 133
Query: 611 DQRIIHCDIKPENVLL----DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI 666
++I H D+KPEN++L H K+ DFGLA + E F + GT ++APE +
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIV 190
Query: 667 TNYAISEKSDVYSYGMVLLEI 687
+ ++D++S G V+ I
Sbjct: 191 NYEPLGLEADMWSIG-VITYI 210
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 50/193 (25%), Positives = 88/193 (45%), Gaps = 15/193 (7%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVK---KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRG 554
+LG+G F V + V G A K + + ++ E I + H ++V+L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
E + L ++ + G L + I + EF + + + + +AY H I
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADAS-HCIQQILESIAYCHS---NGI 149
Query: 615 IHCDIKPENVLL---DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAI 671
+H ++KPEN+LL K++DFGLA + S + GT GYL+PE +
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 672 SEKSDVYSYGMVL 684
S+ D+++ G++L
Sbjct: 208 SKPVDIWACGVIL 220
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 51/209 (24%), Positives = 85/209 (40%), Gaps = 22/209 (10%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVK--KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
+G G V P ++A+K LE E E+ + HH ++V
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFN---IAL---GTAKGLAYLHED 609
L + ++ GS+ I K + IA +GL YLH+
Sbjct: 82 FVVKDELWLVMKLLSGGSVLD-IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK- 139
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFG----LAKLMTREQSHVFTTLRGTRGYLAPEW 665
IH D+K N+LL ++ +++DFG LA ++ V T GT ++APE
Sbjct: 140 --NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 666 ITN---YAISEKSDVYSYGMVLLEIIGGR 691
+ Y K+D++S+G+ +E+ G
Sbjct: 198 MEQVRGY--DFKADIWSFGITAIELATGA 224
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 32/215 (14%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVK-----KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLR 553
LG+G +G V + + R AVK KL I G+ + E+ ++ + H ++++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 554 G--FCAEGTHRLLAYEFMANGS---LDKWIFKKNQEFLLDWETR--FN--IALGTAKGLA 604
+ E + E+ G LD K+ + F I GL
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPV----CQAHGYFCQLID-----GLE 123
Query: 605 YLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE-QSHVFTTLRGTRGYLAP 663
YLH Q I+H DIKP N+LL K+S G+A+ + T +G+ + P
Sbjct: 124 YLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 664 EWITN---YAISEKSDVYSYGMVLLEIIGGRKNFD 695
E ++ K D++S G+ L I G F+
Sbjct: 181 EIANGLDTFS-GFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVK-----KLEGIGQG--KKEFRAEVSIIGSIHHLHLV 550
+LG G F V + G A K +L +G ++E EV+I+ I H +++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC 610
L T +L E ++ G L ++ +K E L + E G+ YLH
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEK--ESLTEDEAT-QFLKQILDGVHYLHS-- 126
Query: 611 DQRIIHCDIKPENVLL----DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI 666
+RI H D+KPEN++L N K+ DFG+A + E + F + GT ++APE +
Sbjct: 127 -KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIFGTPEFVAPEIV 183
Query: 667 TNYAISEKSDVYSYGMVLLEI 687
+ ++D++S G V+ I
Sbjct: 184 NYEPLGLEADMWSIG-VITYI 203
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 30/200 (15%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVK---KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRG 554
LG+G FG V + AVK K + EV ++ + H +++KL
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFN------IALGTAKGLAYLHE 608
+ + + E G L I K+ RF+ I G+ Y+H+
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGITYMHK 139
Query: 609 DCDQRIIHCDIKPENVLL---DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEW 665
I+H D+KPEN+LL + + K+ DFGL+ +Q+ GT Y+APE
Sbjct: 140 ---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYYIAPEV 194
Query: 666 IT-NYAISEKSDVYSYGMVL 684
+ Y EK DV+S G++L
Sbjct: 195 LRGTY--DEKCDVWSAGVIL 212
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 68/257 (26%), Positives = 115/257 (44%), Gaps = 39/257 (15%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVK---KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
LG+G +G V V +AVK + + + E+ I ++H ++VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVKFYGH 73
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETR--FN--IALGTAKGLAYLHEDCD 611
EG + L E+ + G L I + + + + F+ +A G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA-----GVVYLHG--- 123
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT-REQSHVFTTLRGTRGYLAPEWITN-- 668
I H DIKPEN+LLD+ + K+SDFGLA + + + + GT Y+APE +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 669 YAISEKSDVYSYGMVLLEIIGGRKNF-DPNET--------SDKAHFPSYAFKMMEEGK-- 717
+ +E DV+S G+VL ++ G + P+++ K + + K+
Sbjct: 184 FH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW-KKIDSAPLAL 241
Query: 718 LRNILD----SRLNIDE 730
L IL +R+ I +
Sbjct: 242 LHKILVENPSARITIPD 258
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 57/202 (28%), Positives = 89/202 (44%), Gaps = 33/202 (16%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVK-----KLEGIGQGKKEFRAEVSIIGSIHHLHLVKL 552
LG+G FG V G AVK +++ K+ EV ++ + H +++KL
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-KTDKESLLREVQLLKQLDHPNIMKL 91
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFN------IALGTAKGLAYL 606
F + + L E G L I + RF+ I G+ Y+
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGELFDEIISRK---------RFSEVDAARIIRQVLSGITYM 142
Query: 607 HEDCDQRIIHCDIKPENVLL---DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAP 663
H+ +I+H D+KPEN+LL + + ++ DFGL+ E S GT Y+AP
Sbjct: 143 HK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAP 197
Query: 664 EWIT-NYAISEKSDVYSYGMVL 684
E + Y EK DV+S G++L
Sbjct: 198 EVLHGTY--DEKCDVWSTGVIL 217
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 53/237 (22%), Positives = 84/237 (35%), Gaps = 54/237 (22%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVK-----KLEGIGQGKKE-FRAEVSIIGSIHHLHLVK 551
+GQG +G V + A+K K+ I E + EV ++ +HH ++ +
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 552 LRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAK---------- 601
L + + L E G L + +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 602 ---------------------------GLAYLHEDCDQRIIHCDIKPENVLL--DDNYHA 632
L YLH Q I H DIKPEN L + ++
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEI 209
Query: 633 KVSDFGLAKLMTR---EQSHVFTTLRGTRGYLAPEWI--TNYAISEKSDVYSYGMVL 684
K+ DFGL+K + + + TT GT ++APE + TN + K D +S G++L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVK----- 551
+G G +G VY+G + G A+K ++ G ++E + E++++ HH ++
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 552 LRGFCAEGTHRL-LAYEFMANGSL-DKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED 609
++ +L L EF GS+ D + K + L E I +GL++LH+
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTLKEEWIAYICREILRGLSHLHQ- 147
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNY 669
++IH DIK +NVLL +N K+ DFG++ + R T GT ++APE I
Sbjct: 148 --HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR-RNTFIGTPYWMAPEVIACD 204
Query: 670 AISE-----KSDVYSYGMVLLEIIGG 690
+ KSD++S G+ +E+ G
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKE----FRAEVSIIGSIHHLHLVKLR 553
++G G FG+VY + + +A+KK+ G+ E EV + + H + ++ R
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
G L E+ + D + + +++ L + E + G +GLAYLH
Sbjct: 121 GCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGALQGLAYLHS---HN 174
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISE 673
+IH D+K N+LL + K+ DFG A +M S V GT ++APE I +
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQ 229
Query: 674 ---KSDVYSYGMVLLEIIGG 690
K DV+S G+ +E+
Sbjct: 230 YDGKVDVWSLGITCIELAER 249
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-24
Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 22/221 (9%)
Query: 494 NNFSVK--LGQGGFGSVYQGVLPDGTRL-AVKKLE--GIGQGKKEF--RAEVSI---IGS 543
N+FSV +G+GGFG VY D ++ A+K L+ I + E E + + +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 544 IHHLHLVKLRGFCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKG 602
+V + + +L + M G L + ++ F + RF A G
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEA-DMRFYAA-EIILG 304
Query: 603 LAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLA 662
L ++H + +++ D+KP N+LLD++ H ++SD GLA ++++ H GT GY+A
Sbjct: 305 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMA 358
Query: 663 PEWITNYAISEKS-DVYSYGMVLLEIIGGRKNFDPNETSDK 702
PE + + S D +S G +L +++ G F ++T DK
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-24
Identities = 50/245 (20%), Positives = 96/245 (39%), Gaps = 24/245 (9%)
Query: 456 KKRKAPESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSV------KLGQGGFGSVY 509
+ + + N+ + + ++ + ++ ++ +LG G FG V+
Sbjct: 115 VDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVH 174
Query: 510 QGV-LPDGTRLAVKKLE-GIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567
+ G A K + K+ R E+ + + H LV L + ++ YE
Sbjct: 175 RVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234
Query: 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGT---AKGLAYLHEDCDQRIIHCDIKPENV 624
FM+ G L + + ++ + + KGL ++HE +H D+KPEN+
Sbjct: 235 FMSGGELFEKVADEHNKM-----SEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENI 286
Query: 625 LL--DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGM 682
+ + K+ DFGL + + GT + APE + +D++S G
Sbjct: 287 MFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVG- 343
Query: 683 VLLEI 687
VL I
Sbjct: 344 VLSYI 348
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-24
Identities = 59/277 (21%), Positives = 109/277 (39%), Gaps = 45/277 (16%)
Query: 471 DNFLENLSGMPVRFTYRDLQTATNNFSVK--LGQGGFGSVYQGVLPDGTRL-AVKKLEGI 527
+LE P + ++ +F + +G+G FG V L + ++ A+K L
Sbjct: 53 LEYLEWAK--PFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKIL--- 107
Query: 528 GQGKKE----------FRAEVSIIGSIHHLHLVKLRGFCAEGTHRL-LAYEFMANGSLDK 576
K FR E ++ + + L + + + L L ++ G L
Sbjct: 108 ---NKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLT 163
Query: 577 WIFKKNQEFLLDWETRFNIA-LGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVS 635
+ K + RF +A + A + +H+ +H DIKP+N+L+D N H +++
Sbjct: 164 LLSKFEDRLPEEM-ARFYLAEMVIA--IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLA 217
Query: 636 DFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKS-----DVYSYGMVLLEIIGG 690
DFG + + + + GT Y++PE + + D +S G+ + E++ G
Sbjct: 218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
Query: 691 RKNF---DPNETSDK-------AHFPSYAFKMMEEGK 717
F ET K FP+ + E K
Sbjct: 278 ETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAK 314
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 48/202 (23%), Positives = 79/202 (39%), Gaps = 36/202 (17%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVK-----KLEGIGQGKKEFRAEVSIIGSIHHLHLVKL 552
+G+G +G V V R A K +E F+ E+ I+ S+ H ++++L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED----VDRFKQEIEIMKSLDHPNIIRL 71
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFN------IALGTAKGLAYL 606
+ T L E G L + + K F I +AY
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKR---------VFRESDAARIMKDVLSAVAYC 122
Query: 607 HEDCDQRIIHCDIKPENVLL---DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAP 663
H + H D+KPEN L + K+ DFGLA + + T GT Y++P
Sbjct: 123 H---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTKVGTPYYVSP 177
Query: 664 EWIT-NYAISEKSDVYSYGMVL 684
+ + Y + D +S G+++
Sbjct: 178 QVLEGLY--GPECDEWSAGVMM 197
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 7e-24
Identities = 55/278 (19%), Positives = 105/278 (37%), Gaps = 45/278 (16%)
Query: 471 DNFLENLSGMPVRFTYRDLQTATNNFSVK--LGQGGFGSVYQGVLPDGTRL-AVKKLEGI 527
+FL+ P+ ++++ ++F + +G+G F V + ++ A+K +
Sbjct: 40 ADFLQWAE--PIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM--- 94
Query: 528 GQGKKE----------FRAEVSIIGSIHHLHLVKLRGFCAEGTHRL-LAYEFMANGSLDK 576
K FR E ++ + + +L F + + L L E+ G L
Sbjct: 95 ---NKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLT 150
Query: 577 WIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSD 636
+ K + + RF +A + +H +H DIKP+N+LLD H +++D
Sbjct: 151 LLSKFGERIPAEM-ARFYLA-EIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLAD 205
Query: 637 FGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVY-------SYGMVLLEIIG 689
FG + + + GT YL+PE + + Y + G+ E+
Sbjct: 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265
Query: 690 GRKNF---DPNET-------SDKAHFPSYAFKMMEEGK 717
G+ F ET + P + EE +
Sbjct: 266 GQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEAR 303
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-24
Identities = 46/193 (23%), Positives = 89/193 (46%), Gaps = 14/193 (7%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVK---KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRG 554
+LG+G F V + V + G A + + ++ E I + H ++V+L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
+E H L ++ + G L + I + E+ + + + + + + H+ +
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADAS-HCIQQILEAVLHCHQ---MGV 131
Query: 615 IHCDIKPENVLL---DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAI 671
+H ++KPEN+LL K++DFGLA + EQ + GT GYL+PE +
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTPGYLSPEVLRKDPY 190
Query: 672 SEKSDVYSYGMVL 684
+ D+++ G++L
Sbjct: 191 GKPVDLWACGVIL 203
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 28/211 (13%)
Query: 500 LGQGGFGSVYQGVLPDGTRL-AVKKLEGIGQGKKEF----------RAEVSIIGSIHHLH 548
LG+GGFG V+ + +L A KKL K+ E I+ +H
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKL------NKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 549 LVKLRGFCAEGTHRL-LAYEFMANGSLDKWIFKKNQE---FLLDWETRFNIALGTAKGLA 604
+V L + E L L M G + I+ +++ F F A GL
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP-RAIFYTA-QIVSGLE 303
Query: 605 YLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPE 664
+LH+ + II+ D+KPENVLLDD+ + ++SD GLA + Q+ GT G++APE
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT-KGYAGTPGFMAPE 359
Query: 665 WITNYAISEKSDVYSYGMVLLEIIGGRKNFD 695
+ D ++ G+ L E+I R F
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 68/257 (26%), Positives = 113/257 (43%), Gaps = 39/257 (15%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVK---KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
LG+G +G V V +AVK + + + E+ I ++H ++VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVKFYGH 73
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETR--FN--IALGTAKGLAYLHEDCD 611
EG + L E+ + G L I + + + + F+ +A G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA-----GVVYLHG--- 123
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT-REQSHVFTTLRGTRGYLAPEWITN-- 668
I H DIKPEN+LLD+ + K+SDFGLA + + + + GT Y+APE +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 669 YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA---------HFPSYAFKMMEEGK-- 717
+ +E DV+S G+VL ++ G +D S + + + K+
Sbjct: 184 FH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW-KKIDSAPLAL 241
Query: 718 LRNILD----SRLNIDE 730
L IL +R+ I +
Sbjct: 242 LHKILVENPSARITIPD 258
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 50/198 (25%), Positives = 84/198 (42%), Gaps = 23/198 (11%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLE--GIGQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
KLG G FG V+ G +K + ++ AE+ ++ S+ H +++K+
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFN--IALGTAK----GLAYLHED 609
+ + + E G L + I + K LAY H
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQAR-----GKALSEGYVAELMKQMMNALAYFHS- 142
Query: 610 CDQRIIHCDIKPENVLL---DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI 666
Q ++H D+KPEN+L + K+ DFGLA+L + T GT Y+APE +
Sbjct: 143 --QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF--KSDEHSTNAAGTALYMAPE-V 197
Query: 667 TNYAISEKSDVYSYGMVL 684
++ K D++S G+V+
Sbjct: 198 FKRDVTFKCDIWSAGVVM 215
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 61/231 (26%), Positives = 110/231 (47%), Gaps = 33/231 (14%)
Query: 500 LGQGGFGSVYQGVLPDGTRL-AVKKL--EGIGQGKKEFR---AEVSIIGSIHHLHLVKLR 553
+G+G FG V D ++ A+K + + + + E R E+ I+ + H LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE-RNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 554 GFCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIA-LGTAKGLAYLHEDCD 611
+ + + + + + G L ++ ++N F + + I L A L YL
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFKEE-TVKLFICELVMA--LDYLQN--- 133
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAI 671
QRIIH D+KP+N+LLD++ H ++DF +A ++ RE TT+ GT+ Y+APE ++
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--TTMAGTKPYMAPEMFSSRKG 191
Query: 672 SE--KS-DVYSYGMVLLEIIGGRKNF------DPNET-----SDKAHFPSY 708
+ + D +S G+ E++ GR+ + E + +PS
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSA 242
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 54/196 (27%), Positives = 90/196 (45%), Gaps = 25/196 (12%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCA 557
+LG+G VY+ A+K L+ KK R E+ ++ + H +++KL+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLK-KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 558 EGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRF------NIALGTAKGLAYLHEDCD 611
T L E + G L I +K + + + +AYLHE
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEK---------GYYSERDAADAVKQILEAVAYLHE--- 166
Query: 612 QRIIHCDIKPENVLL---DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN 668
I+H D+KPEN+L + K++DFGL+K++ E + T+ GT GY APE +
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVCGTPGYCAPEILRG 224
Query: 669 YAISEKSDVYSYGMVL 684
A + D++S G++
Sbjct: 225 CAYGPEVDMWSVGIIT 240
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 21/201 (10%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVK-------KLEGIGQGKKEFRAEVSIIGSIHHLHLV 550
+LG G F V + G + A K K G +++ EVSI+ I H +++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC 610
L T +L E +A G L ++ +K E L + E G+ YLH
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT-EFLKQILNGVYYLHS-- 132
Query: 611 DQRIIHCDIKPENVLL----DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI 666
+I H D+KPEN++L K+ DFGLA + + + F + GT ++APE +
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEIV 189
Query: 667 TNYAISEKSDVYSYGMVLLEI 687
+ ++D++S G V+ I
Sbjct: 190 NYEPLGLEADMWSIG-VITYI 209
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 45/192 (23%), Positives = 83/192 (43%), Gaps = 16/192 (8%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIG-SIHHLHLVKLRGFC 556
+G G + + + AVK I + K++ E+ I+ H +++ L+
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKI---IDKSKRDPTEEIEILLRYGQHPNIITLKDVY 85
Query: 557 AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIH 616
+G + + E M G L I ++ +F + E + K + YLH Q ++H
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILRQ--KFFSEREAS-AVLFTITKTVEYLH---AQGVVH 139
Query: 617 CDIKPENVLL----DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAIS 672
D+KP N+L + ++ DFG AK + E + T T ++APE +
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLLMTPCYTANFVAPEVLERQGYD 198
Query: 673 EKSDVYSYGMVL 684
D++S G++L
Sbjct: 199 AACDIWSLGVLL 210
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 63/253 (24%), Positives = 108/253 (42%), Gaps = 35/253 (13%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVK-----KLEGIGQGKKEFRA--EVSIIGSIHHL--HL 549
LG GGFGSVY G+ + D +A+K ++ G+ R EV ++ + +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 550 VKLRGFCAEGTHRLLAYEFMAN-GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHE 608
++L + +L E L +I ++ L + R + + + + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELAR-SFFWQVLEAVRHCH- 166
Query: 609 DCDQRIIHCDIKPENVLLDDNY-HAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWIT 667
+ ++H DIK EN+L+D N K+ DFG L+ V+T GTR Y PEWI
Sbjct: 167 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 221
Query: 668 N--YAISEKSDVYSYGMVLLEIIGGRKNFDPNE--TSDKAHFPSYAFKMMEEGK--LRNI 721
Y + V+S G++L +++ G F+ +E + F + E + +R
Sbjct: 222 YHRYH-GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR---VSSECQHLIRWC 277
Query: 722 LD----SRLNIDE 730
L R +E
Sbjct: 278 LALRPSDRPTFEE 290
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 62/257 (24%), Positives = 110/257 (42%), Gaps = 41/257 (15%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVK--------KLEGIGQGKKEFRAEVSII----GSIHH 546
LG+GGFG+V+ G L D ++A+K + EV+++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGGH 97
Query: 547 LHLVKLRGFCAEGTHRLLAYEFMANGS--LDKWIFKKNQEFLLDWETRFNIALGTAKGLA 604
+++L + +L E D K L + +R +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSR-CFFGQVVAAIQ 153
Query: 605 YLHEDCDQRIIHCDIKPENVLLD-DNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAP 663
+ H + ++H DIK EN+L+D AK+ DFG L+ E +T GTR Y P
Sbjct: 154 HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE---PYTDFDGTRVYSPP 207
Query: 664 EWITN--YAISEKSDVYSYGMVLLEIIGGRKNFDPNE--TSDKAHFPSYAFKMMEEGK-- 717
EWI+ Y + + V+S G++L +++ G F+ ++ + HFP++ + +
Sbjct: 208 EWISRHQYH-ALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAH---VSPDCCAL 263
Query: 718 LRNILD----SRLNIDE 730
+R L SR +++E
Sbjct: 264 IRRCLAPKPSSRPSLEE 280
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 67/276 (24%), Positives = 112/276 (40%), Gaps = 48/276 (17%)
Query: 462 ESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSVK-------LGQGGFGSVYQGVLP 514
+ ++ SE+++ E L+ F + + N + LG G FG V
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK 63
Query: 515 DGTRL-AVKKLEGIGQGKKEF----------RAEVSIIGSIHHLHLVKLRGFCAEGTHRL 563
+ A+K L K+ E I+ +++ LVKL + ++
Sbjct: 64 ESGNHYAMKIL------DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117
Query: 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRF---NIALGTAKGLAYLHEDCDQRIIHCDIK 620
+ E++A G + ++ F RF I L YLH +I+ D+K
Sbjct: 118 MVMEYVAGGEM-FSHLRRIGRFSEPH-ARFYAAQIVLT----FEYLHS---LDLIYRDLK 168
Query: 621 PENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSY 680
PEN+L+D + +V+DFG AK TL GT LAPE I + ++ D ++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWAL 224
Query: 681 GMVLLEIIGGRKNF---DPNET-----SDKAHFPSY 708
G+++ E+ G F P + S K FPS+
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 48/226 (21%), Positives = 82/226 (36%), Gaps = 29/226 (12%)
Query: 476 NLSGMPVRFTYRDLQTATNNFSVK-------LGQGGFGSVYQGV-LPDGTRLAVKKLEGI 527
+ + ++ + + LG G G V + G + A+K L
Sbjct: 6 HHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD- 64
Query: 528 GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAY----EFMANGSL-DKWIFKK 581
+ R EV H+V + H E M G L + I ++
Sbjct: 65 ---SPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSR-IQER 120
Query: 582 NQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL---DDNYHAKVSDFG 638
+ + E I + +LH I H D+KPEN+L + + K++DFG
Sbjct: 121 GDQAFTEREAA-EIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176
Query: 639 LAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVL 684
AK T+ T T Y+APE + + D++S G+++
Sbjct: 177 FAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 52/193 (26%), Positives = 85/193 (44%), Gaps = 18/193 (9%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKE-FRAEVSIIGSI-HHLHLVKLRGF 555
LG+G F + V AVK I + + + E++ + H ++VKL
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKI---ISKRMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 556 CAEGTHRLLAYEFMANGSL-DKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
+ H L E + G L ++ I KK + + E I ++++H D +
Sbjct: 75 FHDQLHTFLVMELLNGGELFER-IKKK--KHFSETEAS-YIMRKLVSAVSHMH---DVGV 127
Query: 615 IHCDIKPENVLL---DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAI 671
+H D+KPEN+L +DN K+ DFG A+L + T T Y APE +
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLK-PPDNQPLKTPCFTLHYAAPELLNQNGY 186
Query: 672 SEKSDVYSYGMVL 684
E D++S G++L
Sbjct: 187 DESCDLWSLGVIL 199
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 3e-22
Identities = 38/208 (18%), Positives = 71/208 (34%), Gaps = 20/208 (9%)
Query: 499 KLGQG--GFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEF---RAEVSIIGSIHHLHLVKL 552
+G+G +V P G + V+++ + + E+ + +H ++V
Sbjct: 32 VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 553 RGFCAEGTHRLLAYEFMANGSL-DKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCD 611
R + FMA GS D + + ++ I G K L Y+H
Sbjct: 92 RATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMNELAIAYILQGVLKALDYIHH--- 146
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLR------GTRGYLAPEW 665
+H +K ++L+ + +S M +L+PE
Sbjct: 147 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206
Query: 666 ITNYAI--SEKSDVYSYGMVLLEIIGGR 691
+ KSD+YS G+ E+ G
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVK-----KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLR 553
LG G FG V G G ++AVK K+ + K R E+ + H H++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHIIKLY 77
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETR--FN--IALGTAKGLAYLHED 609
+ T + E+++ G L +I K + + + E R F ++ + Y H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILS-----AVDYCHR- 129
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN- 668
++H D+KPENVLLD + +AK++DFGL+ +M+ T G+ Y APE I+
Sbjct: 130 --HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSCGSPNYAAPEVISGR 185
Query: 669 -YAISEKSDVYSYGMVLLEIIGGRKNFD 695
YA + D++S G++L ++ G FD
Sbjct: 186 LYA-GPEVDIWSCGVILYALLCGTLPFD 212
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 55/253 (21%), Positives = 97/253 (38%), Gaps = 35/253 (13%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVK-----KLEGIGQGKKEFRA----EVSIIGSIHHLHL 549
LG G FG V+ V + VK K+ + E++I+ + H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 550 VKLRGFCAEGTHRLLAYEFMANGS--LDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLH 607
+K+ L E +G L + I + YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLAS-YIFRQLVSAVGYLR 147
Query: 608 EDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWIT 667
+ IIH DIK EN+++ +++ K+ DFG A + E+ +F T GT Y APE +
Sbjct: 148 L---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYTFCGTIEYCAPEVLM 202
Query: 668 N--YAISEKSDVYSYGMVLLEIIGGRKNFD-PNETSD-KAHFPSYAFKMMEEGK--LRNI 721
Y + +++S G+ L ++ F ET + H P + +E + +
Sbjct: 203 GNPYR-GPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYL---VSKELMSLVSGL 258
Query: 722 LD----SRLNIDE 730
L R +++
Sbjct: 259 LQPVPERRTTLEK 271
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 72/317 (22%), Positives = 120/317 (37%), Gaps = 43/317 (13%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558
+G G FG +AVK +E + + E+ S+ H ++V+ +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 559 GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFN----IALGTAKGLAYLHEDCDQRI 614
TH + E+ + G L + I + + E RF ++ G++Y H +I
Sbjct: 88 PTHLAIIMEYASGGELYERICNAGR--FSEDEARFFFQQLLS-----GVSYCHS---MQI 137
Query: 615 IHCDIKPENVLLDDNYHA--KVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN--YA 670
H D+K EN LLD + K+ DFG +K + GT Y+APE + Y
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--LHSQPKSTVGTPAYIAPEVLLRQEYD 195
Query: 671 ISEKSDVYSYGMVLLEIIGGRKNF-DPNETSD-----------KAHFPSYAFKMMEEGK- 717
+ +DV+S G+ L ++ G F DP E D K P + E
Sbjct: 196 -GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR-ISPECCH 253
Query: 718 -LRNILD----SRLNIDE-QSDRVFTA-VKVALWCVQEDMSLRPSMTKVVQMLEGICPVP 770
+ I +R++I E ++ F + L S + +Q L+ I +
Sbjct: 254 LISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQII 313
Query: 771 QPPTCSPLGARLYSSFF 787
T + R F
Sbjct: 314 SEATIPAVRNRCLDDFM 330
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 27/208 (12%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVK-----KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLR 553
LG+G FG V ++A+K L+ + R E+S + + H H++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER-EISYLKLLRHPHIIKLY 75
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETR--FN--IALGTAKGLAYLHED 609
T ++ E+ A G L +I +K + + + E R F I + Y H
Sbjct: 76 DVITTPTDIVMVIEY-AGGELFDYIVEKKR--MTEDEGRRFFQQIIC-----AIEYCHR- 126
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN- 668
+I+H D+KPEN+LLDDN + K++DFGL+ +MT + T G+ Y APE I
Sbjct: 127 --HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKTSCGSPNYAAPEVINGK 182
Query: 669 -YAISEKSDVYSYGMVLLEIIGGRKNFD 695
YA + DV+S G+VL ++ GR FD
Sbjct: 183 LYA-GPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-21
Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 32/229 (13%)
Query: 475 ENLSGMPVRFTYRDLQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEF 534
+ +G Y + + +G G FG V+Q L + +A+KK + Q K+
Sbjct: 31 DGKTGEQREIAYTNCK--------VIGNGSFGVVFQAKLVESDEVAIKK---VLQDKRFK 79
Query: 535 RAEVSIIGSIHHLHLVKLRGFCAEGTHRL------LAYEFMANGSLDKWI--FKKNQEFL 586
E+ I+ + H ++V L+ F + L E++ ++ + + K ++ +
Sbjct: 80 NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTM 138
Query: 587 LDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHA-KVSDFGLAKLMTR 645
+ + LAY+H I H DIKP+N+LLD K+ DFG AK++
Sbjct: 139 PMLLIKL-YMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194
Query: 646 EQSHVFTTLRGTRGYLAPEWI---TNYAISEKSDVYSYGMVLLEIIGGR 691
+ + +R Y APE I TNY + D++S G V+ E++ G+
Sbjct: 195 GEP--NVSYICSRYYRAPELIFGATNY--TTNIDIWSTGCVMAELMQGQ 239
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 8e-21
Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 26/208 (12%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVK-----KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLR 553
LG G FG V G G ++AVK K+ + K R E+ + H H++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR-EIQNLKLFRHPHIIKLY 82
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETR--FN--IALGTAKGLAYLHED 609
+ + + E+++ G L +I K + L + E+R F ++ G+ Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILS-----GVDYCHR- 134
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN- 668
++H D+KPENVLLD + +AK++DFGL+ +M+ T G+ Y APE I+
Sbjct: 135 --HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSCGSPNYAAPEVISGR 190
Query: 669 -YAISEKSDVYSYGMVLLEIIGGRKNFD 695
YA E D++S G++L ++ G FD
Sbjct: 191 LYAGPE-VDIWSSGVILYALLCGTLPFD 217
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 9e-21
Identities = 63/278 (22%), Positives = 108/278 (38%), Gaps = 56/278 (20%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVK-----KLEGIGQGKKEFRA----------------- 536
+G+G +G V D T A+K KL +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 537 -----EVSIIGSIHHLHLVKLRG--FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDW 589
E++I+ + H ++VKL H + +E + G + + L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLSE 136
Query: 590 ETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649
+ KG+ YLH Q+IIH DIKP N+L+ ++ H K++DFG++ +
Sbjct: 137 DQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 650 VFTTLRGTRGYLAPEWITNYAIS---EKSDVYSYGMVLLEIIGGRKNF-DPNET------ 699
+ T GT ++APE ++ + DV++ G+ L + G+ F D
Sbjct: 194 LSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKI 252
Query: 700 -SDKAHFPSYAFKMMEEGK--LRNILD----SRLNIDE 730
S FP + E+ K + +LD SR+ + E
Sbjct: 253 KSQALEFPDQ-PDIAEDLKDLITRMLDKNPESRIVVPE 289
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-20
Identities = 66/228 (28%), Positives = 110/228 (48%), Gaps = 41/228 (17%)
Query: 481 PVRFTYRDLQTATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKK-EFRAEV 538
P +Y D + +G G FG VYQ L G +A+KK + Q K+ + R E+
Sbjct: 51 PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKK---VLQDKRFKNR-EL 98
Query: 539 SIIGSIHHLHLVKLRG-FCAEGTHRL-----LAYEFMANGSLDKWI--FKKNQEFLLDWE 590
I+ + H ++V+LR F + G + L +++ ++ + + + ++ L
Sbjct: 99 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIY 157
Query: 591 TRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHA-KVSDFGLAKLMTREQ-- 647
+ + LAY+H I H DIKP+N+LLD + K+ DFG AK + R +
Sbjct: 158 VKL-YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213
Query: 648 -SHVFTTLRGTRGYLAPEWI---TNYAISEKSDVYSYGMVLLEIIGGR 691
S++ +R Y APE I T+Y + DV+S G VL E++ G+
Sbjct: 214 VSYIC-----SRYYRAPELIFGATDY--TSSIDVWSAGCVLAELLLGQ 254
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 47/234 (20%)
Query: 500 LGQGGFGSVYQGVLPDGTRL-AVKKLEGIGQGKKEF----------RAEVSIIGSIHHLH 548
LG G FG V+ R A+K L KKE E ++ + H
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVL------KKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 549 LVKLRGFCAEGTHRLLAYEFMANGSLDKWIF---KKNQEFLLDWETRF---NIALGTAKG 602
++++ G + + +++ G L F +K+Q F +F + L
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGEL----FSLLRKSQRFPNP-VAKFYAAEVCLA---- 118
Query: 603 LAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLA 662
L YLH + II+ D+KPEN+LLD N H K++DFG AK V TL GT Y+A
Sbjct: 119 LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK----YVPDVTYTLCGTPDYIA 171
Query: 663 PEWITNYAISEKSDVYSYGMVLLEIIGGRKNF---DPNET-----SDKAHFPSY 708
PE ++ ++ D +S+G+++ E++ G F + +T + + FP +
Sbjct: 172 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF 225
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 4e-20
Identities = 66/261 (25%), Positives = 103/261 (39%), Gaps = 35/261 (13%)
Query: 462 ESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSVK--LGQGGFGSVYQGVLPDGTRL 519
+ ++ DNFL RDL+ ++ V +G+G FG V ++
Sbjct: 39 PALRKNKNIDNFLSRYK--DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKV 96
Query: 520 -AVKKLEGIGQGKKE---------FRAEVSIIGSIHHLHLVKLRGFCAEGTHRL-LAYEF 568
A+K L K E F E I+ + +V+L + + L + E+
Sbjct: 97 YAMKLLS-----KFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEY 150
Query: 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD 628
M G L + N + W RF A L +H IH D+KP+N+LLD
Sbjct: 151 MPGGDLVNLM--SNYDVPEKW-ARFYTAEVVL-ALDAIHS---MGFIHRDVKPDNMLLDK 203
Query: 629 NYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEK----SDVYSYGMVL 684
+ H K++DFG M +E T GT Y++PE + + D +S G+ L
Sbjct: 204 SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 263
Query: 685 LEIIGGRKNF---DPNETSDK 702
E++ G F T K
Sbjct: 264 YEMLVGDTPFYADSLVGTYSK 284
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 52/204 (25%), Positives = 89/204 (43%), Gaps = 19/204 (9%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVK-----KLEGIGQGKKEFRAEVSIIGSIHHLHLVKLR 553
+G+G F V + G +A+K +L K EV I+ ++H ++VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK--LFREVRIMKILNHPNIVKLF 80
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
L E+ + G + ++ + + + E R + + Y H+ +R
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEAR-SKFRQIVSAVQYCHQ---KR 134
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN--YAI 671
I+H D+K EN+LLD + + K++DFG + T G Y APE Y
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLDAFCGAPPYAAPELFQGKKYD- 191
Query: 672 SEKSDVYSYGMVLLEIIGGRKNFD 695
+ DV+S G++L ++ G FD
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFD 215
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 6e-20
Identities = 53/200 (26%), Positives = 79/200 (39%), Gaps = 24/200 (12%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKE-FRAEVSIIGSI-HHLHLVKLRGF 555
LG G G V Q + A+K L+ R EV + H+V++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 123
Query: 556 C----AEGTHRLLAYEFMANGSL-DKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC 610
A L+ E + G L + I + + + E I + + YLH
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSR-IQDRGDQAFTEREAS-EIMKSIGEAIQYLH--- 178
Query: 611 DQRIIHCDIKPENVLL---DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWIT 667
I H D+KPEN+L N K++DFG AK T TT T Y+APE +
Sbjct: 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLG 236
Query: 668 NYAISEKSDVYSYGMVLLEI 687
+ D++S G V++ I
Sbjct: 237 PEKYDKSCDMWSLG-VIMYI 255
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 7e-20
Identities = 68/268 (25%), Positives = 111/268 (41%), Gaps = 38/268 (14%)
Query: 461 PESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSVKLGQGGFGSVYQGVLPDGTRL- 519
SP + S + +L+ R T + + LG+G FG V R
Sbjct: 122 SGSPSDNSGAEEMEVSLAKPKHRVTMNEF-----EYLKLLGKGTFGKVILVKEKATGRYY 176
Query: 520 AVKKLEGIGQGKKEF----------RAEVSIIGSIHHLHLVKLRGFCAEGTHRL-LAYEF 568
A+K L KKE E ++ + H L L+ + + RL E+
Sbjct: 177 AMKIL------KKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEY 229
Query: 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD 628
G L + + + F D RF A L YLH + + +++ D+K EN++LD
Sbjct: 230 ANGGELFFHL-SRERVFSED-RARFYGA-EIVSALDYLHSEKN--VVYRDLKLENLMLDK 284
Query: 629 NYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEII 688
+ H K++DFGL K ++ + + T GT YLAPE + + D + G+V+ E++
Sbjct: 285 DGHIKITDFGLCKEGIKDGATM-KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 343
Query: 689 GGRKNF---DPNET-----SDKAHFPSY 708
GR F D + ++ FP
Sbjct: 344 CGRLPFYNQDHEKLFELILMEEIRFPRT 371
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 60/250 (24%), Positives = 93/250 (37%), Gaps = 43/250 (17%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVKKLE-GIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFC 556
LG+G V + L AVK +E G + EV ++ H ++++L F
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 557 AEGTHRLLAYEFMANGSL-DKWIFKKNQEFLLDWETRFN------IALGTAKGLAYLHED 609
E L +E M GS+ I K+ FN + A L +LH
Sbjct: 81 EEEDRFYLVFEKMRGGSILSH-IHKRR---------HFNELEASVVVQDVASALDFLH-- 128
Query: 610 CDQRIIHCDIKPENVLL---DDNYHAKVSDFGLAKLMTREQSH------VFTTLRGTRGY 660
++ I H D+KPEN+L + K+ DF L + T G+ Y
Sbjct: 129 -NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 661 LAPE-------WITNYAISEKSDVYSYGMVLLEII-GGRKNFDPNETSDKAHFPSYAFKM 712
+APE + Y ++ D++S G V+L I+ G F SD A
Sbjct: 188 MAPEVVEAFSEEASIY--DKRCDLWSLG-VILYILLSGYPPFVGRCGSDCGWDRGEACPA 244
Query: 713 MEEGKLRNIL 722
+ +I
Sbjct: 245 CQNMLFESIQ 254
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 2e-19
Identities = 69/235 (29%), Positives = 108/235 (45%), Gaps = 44/235 (18%)
Query: 500 LGQGGFGSVYQ---GVLPDGTRL-AVKKLEGIGQGKKEF---------RAEVSIIGSIHH 546
LGQG FG V+ D +L A+K L KK + E I+ ++H
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVL------KKATLKVRDRVRTKMERDILVEVNH 85
Query: 547 LHLVKLRGFCAEGTHRL-LAYEFMANGSLDKWIF---KKNQEFLLDWETRFNIA-LGTAK 601
+VKL + + +L L +F+ G L F K F + +F +A L A
Sbjct: 86 PFIVKLH-YAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEED-VKFYLAELALA- 138
Query: 602 GLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL 661
L +LH II+ D+KPEN+LLD+ H K++DFGL+K + + GT Y+
Sbjct: 139 -LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA-YSFCGTVEYM 193
Query: 662 APEWITNYAISEKSDVYSYGMVLLEIIGGRKNF---DPNET-----SDKAHFPSY 708
APE + ++ +D +S+G+++ E++ G F D ET K P +
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF 248
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 62/228 (27%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 500 LGQGGFGSVYQ---GVLPDGTRL-AVKKL--EGIGQGKKEF---RAEVSIIGSIHHLHLV 550
LG+GG+G V+Q + ++ A+K L I + K+ +AE +I+ + H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 551 KLRGFCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIA-LGTAKGLAYLHE 608
L + + +L L E+++ G L + ++ F+ D F +A + A L +LH+
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGELFMQL-EREGIFMED-TACFYLAEISMA--LGHLHQ 139
Query: 609 DCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN 668
+ II+ D+KPEN++L+ H K++DFGL K + + T GT Y+APE +
Sbjct: 140 ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT-HTFCGTIEYMAPEILMR 195
Query: 669 YAISEKSDVYSYGMVLLEIIGGRKNF---DPNET-----SDKAHFPSY 708
+ D +S G ++ +++ G F + +T K + P Y
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY 243
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 58/238 (24%), Positives = 99/238 (41%), Gaps = 40/238 (16%)
Query: 500 LGQGGFGSVYQ---GVLPDGTRL-AVKKL--EGIGQGKKEF---RAEVSIIGSI-HHLHL 549
LG G +G V+ D +L A+K L I Q K R E ++ I L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 550 VKLRGFCAEGTHRL-LAYEFMANGSLDKWIF---KKNQEFLLDWETRFNIA-LGTAKGLA 604
V L + + +L L +++ G L F + + F + + + A L
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGEL----FTHLSQRERFTEHE-VQIYVGEIVLA--LE 173
Query: 605 YLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPE 664
+LH+ II+ DIK EN+LLD N H ++DFGL+K +++ GT Y+AP+
Sbjct: 174 HLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230
Query: 665 WIT--NYAISEKSDVYSYGMVLLEIIGGRKNFDPNET------------SDKAHFPSY 708
+ + + D +S G+++ E++ G F + + +P
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 288
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-19
Identities = 63/250 (25%), Positives = 109/250 (43%), Gaps = 53/250 (21%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRA----EVSIIGSIHHL------ 547
KLG G F +V+ + + T +A+K I +G K + E+ ++ ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMK----IVRGDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 548 -----HLVKL------RGFCAEGTHRLLAYEFMANGSLDKWIFK-KNQEFLLDWETRFNI 595
H++KL +G G H ++ +E + +L I K +++ L + + +
Sbjct: 82 SMGANHILKLLDHFNHKG--PNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISK 138
Query: 596 ALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD------NYHAKVSDFGLAKLMTREQSH 649
L GL Y+H C IIH DIKPENVL++ K++D G A H
Sbjct: 139 QL--LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEH 191
Query: 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNE----TSDKAHF 705
+++ TR Y +PE + +D++S ++ E+I G F+P+E T D H
Sbjct: 192 YTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH- 249
Query: 706 PSYAFKMMEE 715
+ E
Sbjct: 250 ----IAQIIE 255
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 61/229 (26%), Positives = 94/229 (41%), Gaps = 34/229 (14%)
Query: 500 LGQGGFGSVYQGVLPDGTRL-AVKKLEGIGQGKKEF----------RAEVSIIGSIHHLH 548
LG+G FG V R A+K L +KE E ++ + H
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKIL------RKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 549 LVKLRGFCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLH 607
L L+ + + RL E+ G L + + + F + RF A L YLH
Sbjct: 67 LTALK-YAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEE-RARFYGA-EIVSALEYLH 122
Query: 608 EDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWIT 667
+ +++ DIK EN++LD + H K++DFGL K + T GT YLAPE +
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLE 178
Query: 668 NYAISEKSDVYSYGMVLLEIIGGRKNF---DPNET-----SDKAHFPSY 708
+ D + G+V+ E++ GR F D ++ FP
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT 227
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 6e-18
Identities = 60/234 (25%), Positives = 94/234 (40%), Gaps = 43/234 (18%)
Query: 500 LGQGGFGSVYQGVLPDGTRL-AVKKLEGIGQGKKEF----------RAEVSIIG-SIHHL 547
+G+G FG V AVK L +K+ +E +++ ++ H
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVL------QKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 548 HLVKLRGFCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRF---NIALGTAKGL 603
LV L F + +L +++ G L + ++ + FL RF IA L
Sbjct: 100 FLVGLH-FSFQTADKLYFVLDYINGGELFYHL-QRERCFLEPR-ARFYAAEIASA----L 152
Query: 604 AYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL-MTREQSHVFTTLRGTRGYLA 662
YLH I++ D+KPEN+LLD H ++DFGL K + + +T GT YLA
Sbjct: 153 GYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--STFCGTPEYLA 207
Query: 663 PEWITNYAISEKSDVYSYGMVLLEIIGGRKNF---DPNET-----SDKAHFPSY 708
PE + D + G VL E++ G F + E +
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN 261
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 48/241 (19%), Positives = 90/241 (37%), Gaps = 38/241 (15%)
Query: 479 GMPVRFTYRDLQTATNNFSV--------KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQG 530
GM + ++ + G +G+V GV +G +A+K++
Sbjct: 1 GMQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSD 60
Query: 531 KKEFRA------------EVSIIGSIHHLHLVKLRG-FCAEGTHRL----LAYEFMANGS 573
+ E+ ++ HH +++ LR F + L E M
Sbjct: 61 GRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-D 119
Query: 574 LDKWIFKKNQEFLLDWETRFNI--ALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYH 631
L + + + + ++ + L GL LH + ++H D+ P N+LL DN
Sbjct: 120 LAQ-VIHDQRIVISPQHIQYFMYHIL---LGLHVLH---EAGVVHRDLHPGNILLADNND 172
Query: 632 AKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAI-SEKSDVYSYGMVLLEIIGG 690
+ DF LA+ T R Y APE + + ++ D++S G V+ E+
Sbjct: 173 ITICDFNLAR--EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
Query: 691 R 691
+
Sbjct: 231 K 231
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL------EGIGQGKKEFRA--EVSIIGSIHHLHL 549
K+G+G +G V++ G +A+KK I + A E+ ++ + H +L
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVI-----KKIALREIRMLKQLKHPNL 64
Query: 550 VKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED 609
V L L +E+ + ++ + + + + +I T + + + H+
Sbjct: 65 VNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEH-LVK-SITWQTLQAVNFCHK- 120
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI--- 666
IH D+KPEN+L+ + K+ DFG A+L+T S + TR Y +PE +
Sbjct: 121 --HNCIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEVATRWYRSPELLVGD 177
Query: 667 TNY--AISEKSDVYSYGMVLLEIIGGR 691
T Y + DV++ G V E++ G
Sbjct: 178 TQYGPPV----DVWAIGCVFAELLSGV 200
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 59/231 (25%), Positives = 97/231 (41%), Gaps = 37/231 (16%)
Query: 500 LGQGGFGSVYQGVLPDGTRL-AVKKLEGIGQGKKEF----------RAEVSIIG-SIHHL 547
LG+G FG V+ + A+K L KK+ E ++ + H
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKAL------KKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 548 HLVKLRGFCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYL 606
L + + L E++ G L I + +F L F A GL +L
Sbjct: 79 FLTHMF-CTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLS-RATFYAA-EIILGLQFL 134
Query: 607 HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL-MTREQSHVFTTLRGTRGYLAPEW 665
H + I++ D+K +N+LLD + H K++DFG+ K M + T GT Y+APE
Sbjct: 135 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEI 189
Query: 666 ITNYAISEKSDVYSYGMVLLEIIGGRKNF---DPNET-----SDKAHFPSY 708
+ + D +S+G++L E++ G+ F D E D +P +
Sbjct: 190 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW 240
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 61/231 (26%), Positives = 94/231 (40%), Gaps = 37/231 (16%)
Query: 500 LGQGGFGSVYQGVLPDGTRL-AVKKLEGIGQGKKEF----------RAEVSIIGSI-HHL 547
LG+G FG V L AVK L KK+ E ++
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKIL------KKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 548 HLVKLRGFCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYL 606
L +L C + RL E++ G L I ++ F F A A GL +L
Sbjct: 82 FLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPH-AVFYAA-EIAIGLFFL 137
Query: 607 HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL-MTREQSHVFTTLRGTRGYLAPEW 665
+ II+ D+K +NV+LD H K++DFG+ K + + T GT Y+APE
Sbjct: 138 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KTFCGTPDYIAPEI 192
Query: 666 ITNYAISEKSDVYSYGMVLLEIIGGRKNF---DPNET-----SDKAHFPSY 708
I + D +++G++L E++ G+ F D +E +P
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS 243
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKK--LEGIGQGKKEFRA----EVSIIGSIHHLHLVK 551
LG+G F +VY+ +A+KK L + K E+ ++ + H +++
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 552 LRGFCAEGTHRLLAYEFMANGSLD-KWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC 610
L ++ L ++FM D + I K N L + L T +GL YLH
Sbjct: 77 LLDAFGHKSNISLVFDFM---ETDLEVIIKDNSLVLTPSHIK-AYMLMTLQGLEYLH--- 129
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI---T 667
I+H D+KP N+LLD+N K++DFGLAK + +T TR Y APE +
Sbjct: 130 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRAYTHQVVTRWYRAPELLFGAR 188
Query: 668 NYAISEKSDVYSYGMVLLEIIGGR 691
Y D+++ G +L E++
Sbjct: 189 MY--GVGVDMWAVGCILAELLLRV 210
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 64/231 (27%), Positives = 103/231 (44%), Gaps = 37/231 (16%)
Query: 500 LGQGGFGSVYQGVLPDGTRL-AVKKLEGIGQGKKEF----------RAEVSIIGSI-HHL 547
LG+G FG V + + L AVK L KK+ E I+ +H
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVL------KKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 548 HLVKLRGFCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYL 606
L +L C + RL EF+ G L I +K++ F RF A L +L
Sbjct: 85 FLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEAR-ARFYAA-EIISALMFL 140
Query: 607 HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL-MTREQSHVFTTLRGTRGYLAPEW 665
H+ + II+ D+K +NVLLD H K++DFG+ K + + T GT Y+APE
Sbjct: 141 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--ATFCGTPDYIAPEI 195
Query: 666 ITNYAISEKSDVYSYGMVLLEIIGGRKNF---DPNET-----SDKAHFPSY 708
+ D ++ G++L E++ G F + ++ +D+ +P++
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW 246
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 82.4 bits (203), Expect = 3e-16
Identities = 61/230 (26%), Positives = 93/230 (40%), Gaps = 35/230 (15%)
Query: 500 LGQGGFGSVYQGVLPDGTRL-AVKKLEGIGQGKKEF----------RAEVSIIGSI-HHL 547
LG+G FG V L AVK L KK+ E ++
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKIL------KKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 548 HLVKLRGFCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYL 606
L +L C + RL E++ G L I ++ F F A A GL +L
Sbjct: 403 FLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEP-HAVFYAA-EIAIGLFFL 458
Query: 607 HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI 666
+ II+ D+K +NV+LD H K++DFG+ K + T GT Y+APE I
Sbjct: 459 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT-KTFCGTPDYIAPEII 514
Query: 667 TNYAISEKSDVYSYGMVLLEIIGGRKNF---DPNET-----SDKAHFPSY 708
+ D +++G++L E++ G+ F D +E +P
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS 564
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 23/208 (11%)
Query: 499 KLGQGGFGSVYQGVL-PDGTRLAVKK-LEGIGQGKKEFRAEVSIIGSIHHLHLVKLR-GF 555
GQG FG+V G G +A+KK ++ +E + + + +HH ++V+L+ F
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQLQSYF 88
Query: 556 CAEGTHRL------LAYEFMANGSLDKWI--FKKNQEFLLDWETRFNIALGTAKGLAYLH 607
G + E++ +L + + + Q + + + LH
Sbjct: 89 YTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKV-FLFQLIRSIGCLH 146
Query: 608 EDCDQRIIHCDIKPENVLLD-DNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI 666
+ H DIKP NVL++ + K+ DFG AK ++ + +V +R Y APE I
Sbjct: 147 LPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC--SRYYRAPELI 203
Query: 667 ---TNYAISEKSDVYSYGMVLLEIIGGR 691
+Y + D++S G + E++ G
Sbjct: 204 FGNQHY--TTAVDIWSVGCIFAEMMLGE 229
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 30/247 (12%), Positives = 64/247 (25%), Gaps = 60/247 (24%)
Query: 460 APESPQETSEEDNFLENLSGMPV---RFTYRDLQTATNNFSVKLGQGGFGSVYQGVLPDG 516
E +E+S + ++ + G + R YR L G +Q + D
Sbjct: 6 LREPDRESSAPPDDVQLVPGARIANGR--YRLLI--------FHGGVPPLQFWQAL--D- 52
Query: 517 TRL----AVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568
T L A+ ++ G +E + + I + ++ L+ E+
Sbjct: 53 TALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEW 112
Query: 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD 628
+ GSL + + A H + P V +
Sbjct: 113 IRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSI 164
Query: 629 NYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEII 688
+ ++ + + + D+ G L ++
Sbjct: 165 DGDVVLAYP---------------------ATMPDA-------NPQDDIRGIGASLYALL 196
Query: 689 GGRKNFD 695
R
Sbjct: 197 VNRWPLP 203
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 65/245 (26%), Positives = 109/245 (44%), Gaps = 39/245 (15%)
Query: 500 LGQGGFGSVYQGVLPDGTRL-AVKKLEGIGQGKKEF----------RAEVSIIGSI-HHL 547
+G+G + V L R+ A+K + KKE + E + +H
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVV------KKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 548 HLVKLRGFCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRF---NIALGTAKGL 603
LV L C + RL E++ G L + ++ ++ + RF I+L L
Sbjct: 71 FLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEH-ARFYSAEISLA----L 123
Query: 604 AYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAP 663
YLHE + II+ D+K +NVLLD H K++D+G+ K R +T GT Y+AP
Sbjct: 124 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTPNYIAP 179
Query: 664 EWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723
E + D ++ G+++ E++ GR FD +SD + E+ + IL+
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT------EDYLFQVILE 233
Query: 724 SRLNI 728
++ I
Sbjct: 234 KQIRI 238
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 4e-16
Identities = 62/285 (21%), Positives = 98/285 (34%), Gaps = 83/285 (29%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH--------HLHL 549
KLG G F +V+ + +A+K ++ + E+ ++ S+ +
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 550 VKL------RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGL 603
V+L G GTH + +E + + L KWI K+ L I +GL
Sbjct: 104 VQLLDDFKISG--VNGTHICMVFEVLGH-HLLKWI-IKSNYQGLPLPCVKKIIQQVLQGL 159
Query: 604 AYLHEDCDQRIIHCDIKPENVLL------------------------------------- 626
YLH C RIIH DIKPEN+LL
Sbjct: 160 DYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 627 ------------DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEK 674
+ K++D G A FT TR Y + E + +
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNA----CWVHKHFTEDIQTRQYRSLEVLIGSGYNTP 273
Query: 675 SDVYSYGMVLLEIIGGRKNFDP----NETSDKAHFPSYAFKMMEE 715
+D++S + E+ G F+P T D+ H ++ E
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIA-----LIIE 313
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 4e-16
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKL------EGIGQGKKEFRA--EVSIIGSIHHLHLV 550
K+G+G +G VY+ G +A+K++ EGI A E+S++ +HH ++V
Sbjct: 28 KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGI-----PSTAIREISLLKELHHPNIV 82
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLD-KWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED 609
L L +EFM D K + +N+ L D + + +G+A+ H
Sbjct: 83 SLIDVIHSERCLTLVFEFM---EKDLKKVLDENKTGLQDSQIK-IYLYQLLRGVAHCH-- 136
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI--- 666
RI+H D+KP+N+L++ + K++DFGLA+ +T T Y AP+ +
Sbjct: 137 -QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP-VRSYTHEVVTLWYRAPDVLMGS 194
Query: 667 TNYAISEKSDVYSYGMVLLEIIGGR 691
Y S D++S G + E+I G+
Sbjct: 195 KKY--STSVDIWSIGCIFAEMITGK 217
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 49/207 (23%), Positives = 87/207 (42%), Gaps = 30/207 (14%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL------EGIGQGKKEFRA--EVSIIGSIHHLHL 549
+G+G +G V + G +A+KK + + + A E+ ++ + H +L
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV-----KKIAMREIKLLKQLRHENL 86
Query: 550 VKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED 609
V L C + L +EF+ + ++ + + G+ + H
Sbjct: 87 VNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQ-VVQ-KYLFQIINGIGFCH-- 141
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI--- 666
IIH DIKPEN+L+ + K+ DFG A+ + V+ TR Y APE +
Sbjct: 142 -SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEVATRWYRAPELLVGD 199
Query: 667 TNY--AISEKSDVYSYGMVLLEIIGGR 691
Y A+ DV++ G ++ E+ G
Sbjct: 200 VKYGKAV----DVWAIGCLVTEMFMGE 222
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 6e-16
Identities = 50/236 (21%), Positives = 89/236 (37%), Gaps = 53/236 (22%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCA 557
LG G FG V + + G R A+KK+ + + + R E+ I+ + H++++KL +
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKV--LQDPRYKNR-ELDIMKVLDHVNIIKLVDYFY 70
Query: 558 EGTHRLLAYEFMANGSLDKWIFKKN---------------------QEFL-------LDW 589
+ E++ L
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130
Query: 590 ETRFNIALG----------TAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHA-KVSDFG 638
R ++ + + ++H I H DIKP+N+L++ + K+ DFG
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 639 LAKLMTREQSHVFTTLRGTRGYLAPEWI---TNYAISEKSDVYSYGMVLLEIIGGR 691
AK + + V +R Y APE + T Y + D++S G V E+I G+
Sbjct: 188 SAKKLIPSEPSVAYIC--SRFYRAPELMLGATEY--TPSIDLWSIGCVFGELILGK 239
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 7e-16
Identities = 52/274 (18%), Positives = 98/274 (35%), Gaps = 63/274 (22%)
Query: 448 YVAIRYVRKKRKAPESPQETSEEDNFLEN-----LSGMPVRFTYRDLQTATNNFSVKLGQ 502
+ + E D+ +N +G Y +G+
Sbjct: 15 TENLYFQSMSSHKKERKVYNDGYDD--DNYDYIVKNGEKWMDRYEIDSL--------IGK 64
Query: 503 GGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRA----EVSIIGSIHHL------HLVK 551
G FG V + + +A+K I + KK F EV ++ ++ ++V
Sbjct: 65 GSFGQVVKAYDRVEQEWVAIK----IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVH 120
Query: 552 LRG-FCAEGTHR--------LLA---YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGT 599
L+ F R +L+ Y+ + + + A
Sbjct: 121 LKRHF----MFRNHLCLVFEMLSYNLYDLL----------RNTNFRGVSLNLTRKFAQQM 166
Query: 600 AKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHA--KVSDFGLAKLMTREQSHVFTTLRGT 657
L +L + IIHCD+KPEN+LL + + K+ DFG + + ++ ++ +
Sbjct: 167 CTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRIYQYIQ-S 221
Query: 658 RGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGR 691
R Y +PE + D++S G +L+E+ G
Sbjct: 222 RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 7e-16
Identities = 61/308 (19%), Positives = 117/308 (37%), Gaps = 49/308 (15%)
Query: 461 PESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSVKLGQGGFGSVYQGV-LPDGTRL 519
+ E+ + + + + V Y +G+G +G VY +
Sbjct: 3 HHHHHSSGRENLYFQGIKNVHVPDNYIIKH--------LIGRGSYGYVYLAYDKNTEKNV 54
Query: 520 AVKKLEGIGQ----GKKEFRAEVSIIGSIHHLHLVKLRG-FCAEGTHRL----LAYEFMA 570
A+KK+ + + K+ R E++I+ + ++++L + + + E
Sbjct: 55 AIKKVNRMFEDLIDCKRILR-EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD 113
Query: 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY 630
+ L K +FK L + + I G ++HE IIH D+KP N LL+ +
Sbjct: 114 S-DLKK-LFKTPIF-LTEEHIKT-ILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDC 166
Query: 631 HAKVSDFGLAKLMTREQSHVFTTLRG---------------------TRGYLAPEWITNY 669
KV DFGLA+ + E+ TR Y APE I
Sbjct: 167 SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ 226
Query: 670 AI-SEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728
++ D++S G + E++ ++ + T+ FP + + + + + N
Sbjct: 227 ENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNR 286
Query: 729 DEQSDRVF 736
D Q + +F
Sbjct: 287 D-QLNIIF 293
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 46/207 (22%), Positives = 89/207 (42%), Gaps = 28/207 (13%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL------EGIGQGKKEFRA--EVSIIGSIHHLHL 549
K+G+G +G+V++ +A+K++ EG+ A E+ ++ + H ++
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV-----PSSALREICLLKELKHKNI 63
Query: 550 VKLRGFCAEGTHRLLAYEFMANGSLD-KWIFKKNQEFLLDWETRFNIALGTAKGLAYLHE 608
V+L L +EF D K F L + + KGL + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVK-SFLFQLLKGLGFCH- 118
Query: 609 DCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI-- 666
+ ++H D+KP+N+L++ N K+++FGLA+ ++ T Y P+ +
Sbjct: 119 --SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFG 175
Query: 667 -TNYAISEKSDVYSYGMVLLEIIGGRK 692
Y S D++S G + E+ +
Sbjct: 176 AKLY--STSIDMWSAGCIFAELANAGR 200
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 33/219 (15%)
Query: 500 LGQGGFGSVYQGVLPDGTRL-AVKKLEGIGQGKKEF----------RAEVSIIGSI-HHL 547
+G+G + V L R+ A++ + KKE + E + +H
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVV------KKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 548 HLVKLRGFCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRF---NIALGTAKGL 603
LV L C + RL E++ G L + ++ ++ + RF I+L L
Sbjct: 114 FLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEH-ARFYSAEISLA----L 166
Query: 604 AYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAP 663
YLHE + II+ D+K +NVLLD H K++D+G+ K R +T GT Y+AP
Sbjct: 167 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTPNYIAP 222
Query: 664 EWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDK 702
E + D ++ G+++ E++ GR FD +SD
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 261
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 23/206 (11%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQ----GKKEFRAEVSIIGSIHHLHLVKLRG 554
+G G G V +A+KKL Q K+ +R E+ ++ ++H +++ L
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLN 91
Query: 555 -FCAEGTHRL-----LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHE 608
F + + + E M + +L + I + L + + G+ +LH
Sbjct: 92 VFTPQKSLEEFQDVYIVMELM-DANLCQVIQME----LDHERMSY-LLYQMLCGIKHLH- 144
Query: 609 DCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN 668
IIH D+KP N+++ + K+ DFGLA+ T S + T TR Y APE I
Sbjct: 145 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 200
Query: 669 YAISEKSDVYSYGMVLLEIIGGRKNF 694
E D++S G ++ E+I G F
Sbjct: 201 MGYKENVDIWSVGCIMGEMIKGGVLF 226
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 66/221 (29%), Positives = 107/221 (48%), Gaps = 33/221 (14%)
Query: 486 YRDLQTATNNFSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQ----GKKEFRAEVSI 540
YRDLQ +G G +G+V V G ++A+KKL Q K+ +R E+ +
Sbjct: 27 YRDLQP--------VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRL 77
Query: 541 IGSIHHLHLVKLRG-FCAEGTHRL-----LAYEFMANGSLDKWIFKKNQEFLLDWETRFN 594
+ + H +++ L F + T L FM L K + K+++ L + +F
Sbjct: 78 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM--KHEK-LGEDRIQF- 132
Query: 595 IALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTL 654
+ KGL Y+H IIH D+KP N+ ++++ K+ DFGLA R+ T
Sbjct: 133 LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA----RQADSEMTGY 185
Query: 655 RGTRGYLAPEWITNYAI-SEKSDVYSYGMVLLEIIGGRKNF 694
TR Y APE I N+ ++ D++S G ++ E+I G+ F
Sbjct: 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKL------EGIGQGKKEFRA--EVSIIGSIHHLHLV 550
K+G+G +G VY+ G A+KK+ EGI E+SI+ + H ++V
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI-----PSTTIREISILKELKHSNIV 63
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLD-KWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED 609
KL +L +E + D K + + L + + L G+AY H
Sbjct: 64 KLYDVIHTKKRLVLVFEHL---DQDLKKLLDVCEGGLESVTAK-SFLLQLLNGIAYCH-- 117
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI--- 666
D+R++H D+KP+N+L++ K++DFGLA+ +T T Y AP+ +
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEIVTLWYRAPDVLMGS 175
Query: 667 TNYAISEKSDVYSYGMVLLEIIGGR 691
Y S D++S G + E++ G
Sbjct: 176 KKY--STTIDIWSVGCIFAEMVNGT 198
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 56/216 (25%), Positives = 88/216 (40%), Gaps = 48/216 (22%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRA----EVSIIGSIHHL------H 548
+G+G FG V + +A+K + + +K F E+ I+ + +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALK----MVRNEKRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 549 LVKLRGFCAEGTHR--------LLA---YEFMANGSLDKWIFKKNQEFLLDWETRFNIAL 597
++ + T R LL+ YE + KKN+ A
Sbjct: 161 VIHMLEN---FTFRNHICMTFELLSMNLYELI----------KKNKFQGFSLPLVRKFAH 207
Query: 598 GTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHA--KVSDFGLAKLMTREQSHVFTTLR 655
+ L LH RIIHCD+KPEN+LL + KV DFG + E V+T ++
Sbjct: 208 SILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTYIQ 261
Query: 656 GTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGR 691
+R Y APE I D++S G +L E++ G
Sbjct: 262 -SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 3e-15
Identities = 33/107 (30%), Positives = 54/107 (50%), Gaps = 12/107 (11%)
Query: 587 LDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646
L E + AKG+ +L ++ IH D+ N+LL + K+ DFGLA+ + ++
Sbjct: 190 LTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 647 QSHVFTTLRGTRGYL-----APEWITNYAISEKSDVYSYGMVLLEII 688
+V R L APE I + + +SDV+S+G++L EI
Sbjct: 247 PDYV----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 38/163 (23%), Positives = 61/163 (37%), Gaps = 20/163 (12%)
Query: 499 KLGQGGFGSVYQGVL------PDGTRLAVKKL-EGIGQG-KKEFRAEVSIIGSI-HHLHL 549
LG+G FG V + +AVK L EG + +E+ I+ I HHL++
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 550 VKLRGFC-AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHE 608
V L G C G ++ EF G+L ++ K EF+ KG +
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKT----------KGARFRQG 138
Query: 609 DCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651
I D+K + + + S F K ++ +
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 34/221 (15%)
Query: 486 YRDLQTATNNFSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQ----GKKEFRAEVSI 540
Y +G G +GSV + G ++A+KKL Q K+ +R E+ +
Sbjct: 26 YVSPT--------HVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLL 76
Query: 541 IGSIHHLHLVKLRG-FCAEGTHRL-----LAYEFMANGSLDKWIFKKNQEFLLDWETRFN 594
+ + H +++ L F + R L FM L K + K + + ++
Sbjct: 77 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK----FSEEKIQY- 130
Query: 595 IALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTL 654
+ KGL Y+H ++H D+KP N+ ++++ K+ DFGLA R T
Sbjct: 131 LVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA----RHADAEMTGY 183
Query: 655 RGTRGYLAPEWITNYAI-SEKSDVYSYGMVLLEIIGGRKNF 694
TR Y APE I ++ ++ D++S G ++ E++ G+ F
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 50/204 (24%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 499 KLGQGGFGSVYQGVLPD-GTRLAVKKL-----EGIGQGKKEFRA--EVSIIGSIHHLHLV 550
KLG+G + +VY+G +A+K++ EG A EVS++ + H ++V
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIV 63
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC 610
L L +E++ + L +++ + +++ +GLAY H
Sbjct: 64 TLHDIIHTEKSLTLVFEYL-DKDLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYCHR-- 118
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI---T 667
Q+++H D+KP+N+L+++ K++DFGLA+ + + + T Y P+ + T
Sbjct: 119 -QKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKTYDNEVVTLWYRPPDILLGST 176
Query: 668 NYAISEKSDVYSYGMVLLEIIGGR 691
+Y S + D++ G + E+ GR
Sbjct: 177 DY--STQIDMWGVGCIFYEMATGR 198
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 3e-15
Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQ----GKKEFRAEVSIIGSIHHLHLVKLRG 554
+G G G V +A+KKL Q K+ +R E+ ++ ++H +++ L
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 128
Query: 555 -FCAEGTHRL-----LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHE 608
F + T L E M + +L + I + L + + G+ +LH
Sbjct: 129 VFTPQKTLEEFQDVYLVMELM-DANLCQVIQME----LDHERMSY-LLYQMLCGIKHLH- 181
Query: 609 DCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN 668
IIH D+KP N+++ + K+ DFGLA+ T S + T TR Y APE I
Sbjct: 182 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 237
Query: 669 YAISEKSDVYSYGMVLLEIIGGR 691
E D++S G ++ E++ +
Sbjct: 238 MGYKENVDIWSVGCIMGEMVRHK 260
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 42/158 (26%), Positives = 62/158 (39%), Gaps = 19/158 (12%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFC 556
LG G G V Q + A+K L+ + R EV + H+V++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVY 80
Query: 557 ----AEGTHRLLAYEFMANGSL-DKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCD 611
A L+ E + G L + I + + + E I + + YLH
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSR-IQDRGDQAFTEREAS-EIMKSIGEAIQYLH---S 135
Query: 612 QRIIHCDIKPENVLL---DDNYHAKVSDFGLAKLMTRE 646
I H D+KPEN+L N K++DFG AK T E
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-15
Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 33/221 (14%)
Query: 486 YRDLQTATNNFSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQ----GKKEFRAEVSI 540
Y++L +G G +GSV G R+AVKKL Q K+ +R E+ +
Sbjct: 31 YQNLS--------PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRL 81
Query: 541 IGSIHHLHLVKLRG-FCAEGTHRL-----LAYEFMANGSLDKWIFKKNQEFLLDWETRFN 594
+ + H +++ L F + L M L+ + K Q+ L D +F
Sbjct: 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQK-LTDDHVQF- 136
Query: 595 IALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTL 654
+ +GL Y+H IIH D+KP N+ ++++ K+ DFGLA R + T
Sbjct: 137 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTADEMTGY 189
Query: 655 RGTRGYLAPEWITNYAI-SEKSDVYSYGMVLLEIIGGRKNF 694
TR Y APE + N+ ++ D++S G ++ E++ GR F
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 54/226 (23%), Positives = 106/226 (46%), Gaps = 33/226 (14%)
Query: 486 YRDLQTATNNFSV--------KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRA 536
Y D ++ + KLG+G + V++ + + + ++ VK L+ + + KK R
Sbjct: 22 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKR- 79
Query: 537 EVSIIGSI-HHLHLVKLRGFCAEGTHRLLAY--EFMANGSLDKWIFKKNQEFLLDWETRF 593
E+ I+ ++ +++ L + R A E + N + L D++ RF
Sbjct: 80 EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRF 134
Query: 594 NI--ALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD-DNYHAKVSDFGLAKLMTREQSHV 650
+ L K L Y H I+H D+KP NV++D ++ ++ D+GLA+ Q +
Sbjct: 135 YMYEIL---KALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY- 187
Query: 651 FTTLR-GTRGYLAPEWITNYAISEKS-DVYSYGMVLLEIIGGRKNF 694
+R +R + PE + +Y + + S D++S G +L +I ++ F
Sbjct: 188 --NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 9e-15
Identities = 60/337 (17%), Positives = 116/337 (34%), Gaps = 61/337 (18%)
Query: 450 AIRYVRKKRKAPESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSV--------KLG 501
+ ++ + S + + +++ + +G
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIG 62
Query: 502 QGGFGSVYQGV-LPDGTRLAVKKL----EGIGQGKKEFRAEVSIIGSIHHLHLVKLRG-F 555
G +G V + + +A+KK+ E + K+ R E++I+ ++H H+VK+
Sbjct: 63 TGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVLDIV 121
Query: 556 CAEGTHRL----LAYEFMANGSLD-KWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC 610
+ + + E D K +F+ L + + + G+ Y+H
Sbjct: 122 IPKDVEKFDELYVVLEIA---DSDFKKLFRTPVY-LTELHIKT-LLYNLLVGVKYVHS-- 174
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRG-------------- 656
I+H D+KP N L++ + KV DFGLA+ + ++
Sbjct: 175 -AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233
Query: 657 ------------TRGYLAPEWI---TNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSD 701
TR Y APE I NY +E DV+S G + E++ K
Sbjct: 234 KNLKRQLTGHVVTRWYRAPELILLQENY--TEAIDVWSIGCIFAELLNMIKENVAYHADR 291
Query: 702 KAHFP--SYAFKMMEEGKLRNILDSRLNIDEQSDRVF 736
FP S ++ + +Q + +F
Sbjct: 292 GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIF 328
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 9e-15
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL-----EGIGQGKKEFRA--EVSIIGSIHHLHLV 550
KLG G + +VY+G+ G +A+K++ EG A E+S++ + H ++V
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT-----PSTAIREISLMKELKHENIV 66
Query: 551 KLRGFCAEGTHRLLAYEFMAN---GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLH 607
+L L +EFM N +D L + +GLA+ H
Sbjct: 67 RLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK-YFQWQLLQGLAFCH 125
Query: 608 EDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI- 666
+ +I+H D+KP+N+L++ K+ DFGLA+ + F++ T Y AP+ +
Sbjct: 126 ---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP-VNTFSSEVVTLWYRAPDVLM 181
Query: 667 --TNYAISEKSDVYSYGMVLLEIIGGR 691
Y S D++S G +L E+I G+
Sbjct: 182 GSRTY--STSIDIWSCGCILAEMITGK 206
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 36/216 (16%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL------EGIGQGKKEFRA--EVSIIGSIHHLHL 549
K+GQG FG V++ G ++A+KK+ EG A E+ I+ + H ++
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF-----PITALREIKILQLLKHENV 78
Query: 550 VKLRGFCAEGTHRL--------LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAK 601
V L C L ++F + L + +F L E + +
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS-EIK-RVMQMLLN 135
Query: 602 GLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM---TREQSHVFTTLRGTR 658
GL Y+H +I+H D+K NVL+ + K++DFGLA+ Q + +T T
Sbjct: 136 GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 192
Query: 659 GYLAPEWI---TNYAISEKSDVYSYGMVLLEIIGGR 691
Y PE + +Y D++ G ++ E+
Sbjct: 193 WYRPPELLLGERDY--GPPIDLWGAGCIMAEMWTRS 226
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 55/253 (21%), Positives = 101/253 (39%), Gaps = 48/253 (18%)
Query: 466 ETSEEDNFLENLSGMPVRFTYRDLQTATN--NFSV--KLGQGGFGSVYQGV-LPDGTRLA 520
LE + P + +AT+ + KLG+G +G VY+ + +A
Sbjct: 4 HHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVA 63
Query: 521 VKKL------EGIGQGKKEFRA--EVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANG 572
+K++ EG+ A EVS++ + H ++++L+ L +E+
Sbjct: 64 IKRIRLEHEEEGV-----PGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA--- 115
Query: 573 SLDKWIFKKNQEFLLDWETRFNIALG------TAKGLAYLHEDCDQRIIHCDIKPENVLL 626
D KK +D ++ + G+ + H +R +H D+KP+N+LL
Sbjct: 116 END---LKK----YMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLL 165
Query: 627 DDNYHA-----KVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI---TNYAISEKSDVY 678
+ + K+ DFGLA+ FT T Y PE + +Y S D++
Sbjct: 166 SVSDASETPVLKIGDFGLARAFGIP-IRQFTHEIITLWYRPPEILLGSRHY--STSVDIW 222
Query: 679 SYGMVLLEIIGGR 691
S + E++
Sbjct: 223 SIACIWAEMLMKT 235
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 50/222 (22%), Positives = 91/222 (40%), Gaps = 45/222 (20%)
Query: 499 KLGQGGFGSVYQGV---LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRG- 554
K+G+G +G VY+ D A+K++EG G R E++++ + H +++ L+
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-EIALLRELKHPNVISLQKV 86
Query: 555 FCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAK--------GLAY 605
F + ++ L +++ D W K + + G K G+ Y
Sbjct: 87 FLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 606 LHEDCDQRIIHCDIKPENVLLDDNYHA----KVSDFGLA-------KLMTREQSHVFTTL 654
LH ++H D+KP N+L+ K++D G A K + V
Sbjct: 144 LH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV--- 197
Query: 655 RGTRGYLAPEWI---TNY--AISEKSDVYSYGMVLLEIIGGR 691
T Y APE + +Y AI D+++ G + E++
Sbjct: 198 --TFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSE 233
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVKKL---EGIGQGKKEFRAEVSIIGSIHHLHLVKLRG- 554
+G+G +G V + R+A+KK+ E ++ R E+ I+ H +++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 555 FCAEGTHRL----LAYEFMANGSLDKWIFKKNQEFLLDWETRFNI--ALGTAKGLAYLHE 608
A ++ + + M L K + K Q L + + + L +GL Y+H
Sbjct: 94 IRAPTIEQMKDVYIVQDLM-ETDLYKLL--KTQH-LSNDHICYFLYQIL---RGLKYIH- 145
Query: 609 DCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF--TTLRGTRGYLAPEWI 666
++H D+KP N+LL+ K+ DFGLA++ + H T TR Y APE +
Sbjct: 146 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 667 TNYAI-SEKSDVYSYGMVLLEIIGGR 691
N ++ D++S G +L E++ R
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 6e-14
Identities = 62/262 (23%), Positives = 109/262 (41%), Gaps = 49/262 (18%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKK--LEGIGQGKKEF-----RAEVSI---IGSIHHL 547
++G G +G+VY+ G +A+K + G G R EV++ + + H
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVALLRRLEAFEHP 74
Query: 548 HLVKLRGFCAEGTHRL-----LAYEFMANGSLD-KWIFKKNQEFLLDWETRFNIALGTAK 601
++V+L CA L +E + D + K L ET ++ +
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 602 GLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYL 661
GL +LH I+H D+KPEN+L+ K++DFGLA++ + + + T + T Y
Sbjct: 132 GLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPVVVTLWYR 186
Query: 662 APEWI--TNYAISEKSDVYSYGMVLLEIIGGR-------------KNFD----PNETS-- 700
APE + + Y + D++S G + E+ + K FD P E
Sbjct: 187 APEVLLQSTY--ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244
Query: 701 DKAHFPSYAFKMMEEGKLRNIL 722
P AF +++++
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVV 266
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 6e-14
Identities = 56/217 (25%), Positives = 89/217 (41%), Gaps = 32/217 (14%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL---EGIGQGKKEFRAEVSIIGSIHHLHLVKLRG 554
LG+G +G V P G +A+KK+ + + R E+ I+ H +++ +
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENIITIFN 76
Query: 555 -FCAEGTHRL----LAYEFMANGSLDKWIFKKNQEFLLDWETRFNI--ALGTAKGLAYLH 607
+ + E M L + I Q L D ++ I L + + LH
Sbjct: 77 IQRPDSFENFNEVYIIQELMQT-DLHRVI--STQM-LSDDHIQYFIYQTL---RAVKVLH 129
Query: 608 EDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRG---------TR 658
+IH D+KP N+L++ N KV DFGLA+++ + TR
Sbjct: 130 ---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 659 GYLAPEWITNYAI-SEKSDVYSYGMVLLEIIGGRKNF 694
Y APE + A S DV+S G +L E+ R F
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 59/262 (22%), Positives = 97/262 (37%), Gaps = 79/262 (30%)
Query: 499 KLGQGGFGSVYQGV--LPDGTRLAVKKLEGIGQGKKEFRA----EVSIIGSIHHL----- 547
LG+G FG V + + +++A+K I + ++R E++++ I
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALK----IIRNVGKYREAARLEINVLKKIKEKDKENK 81
Query: 548 -HLVKLRG-FCAEGTHR--------LLA---YEFMANGSLDKWIFKKNQE--FLLDWETR 592
V + F LL +EF+ K+N + L
Sbjct: 82 FLCVLMSDWF----NFHGHMCIAFELLGKNTFEFL----------KENNFQPYPLPHVRH 127
Query: 593 FNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHA-------------------K 633
L A L +LH + ++ H D+KPEN+L ++ +
Sbjct: 128 MAYQLCHA--LRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182
Query: 634 VSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKN 693
V+DFG A T + H T + TR Y PE I ++ DV+S G +L E G
Sbjct: 183 VADFGSA---TFDHEHHTTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTL 238
Query: 694 FDPNETSDKAHFPSYAFKMMEE 715
F ++ H MME+
Sbjct: 239 F-QTH-ENREH-----LVMMEK 253
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL--EGIGQGKKEFRAEVSIIGSIHHLHLVKLRG- 554
LG GG G V+ V R+A+KK+ K R E+ II + H ++VK+
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFEI 76
Query: 555 FCAEGTHRL-------------LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAK 601
G+ + E+M L + ++ LL+ R +
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLAN-VLEQGP--LLEEHARL-FMYQLLR 131
Query: 602 GLAYLHEDCDQRIIHCDIKPENVLLD-DNYHAKVSDFGLAKLMTREQSH--VFTTLRGTR 658
GL Y+H ++H D+KP N+ ++ ++ K+ DFGLA++M SH + T+
Sbjct: 132 GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 659 GYLAPEWITNYAI-SEKSDVYSYGMVLLEIIGGR 691
Y +P + + ++ D+++ G + E++ G+
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 58/237 (24%), Positives = 89/237 (37%), Gaps = 76/237 (32%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRA----EVSIIGSI-----HHLH 548
K+G G FG V + + AVK + + K++ E I+ I ++ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVK----VVRNIKKYTRSAKIEADILKKIQNDDINNNN 97
Query: 549 LVKLRG-FCAEGTHR--------LLA---YEFMANGSLDKWIFKKNQE--FLLDWETRFN 594
+VK G F + L YE + +N F ++ + +
Sbjct: 98 IVKYHGKF----MYYDHMCLIFEPLGPSLYEII----------TRNNYNGFHIE-DIK-L 141
Query: 595 IALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHA---------------------- 632
+ K L YL + H D+KPEN+LLDD Y
Sbjct: 142 YCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
Query: 633 ---KVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLE 686
K+ DFG A T + + + + TR Y APE I N SD++S+G VL E
Sbjct: 199 TGIKLIDFGCA---TFKSDYHGSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 50/214 (23%), Positives = 103/214 (48%), Gaps = 36/214 (16%)
Query: 499 KLGQGGFGSVYQG--VLPDGTRLAVKKL------EGIGQGKKEFRA--EVSI---IGSIH 545
++G+G +G V++ + G +A+K++ EG+ EV++ + +
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-----PLSTIREVAVLRHLETFE 72
Query: 546 HLHLVKLR----GFCAEGTHRL-LAYEFMANGSLD-KWIFKKNQEFLLDWETRFNIALGT 599
H ++V+L + +L L +E + D K E + ET ++
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHV---DQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 600 AKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRG 659
+GL +LH R++H D+KP+N+L+ + K++DFGLA++ + + + T++ T
Sbjct: 130 LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLW 184
Query: 660 YLAPEWI--TNYAISEKSDVYSYGMVLLEIIGGR 691
Y APE + ++Y + D++S G + E+ +
Sbjct: 185 YRAPEVLLQSSY--ATPVDLWSVGCIFAEMFRRK 216
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 56/233 (24%), Positives = 89/233 (38%), Gaps = 72/233 (30%)
Query: 499 KLGQGGFGSVYQGV--LPDGTRLAVKKLEGIGQGKKEFRA----EVSIIGSIHHL----- 547
LG+G FG V + + G +AVK I + + E+ ++ ++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVK----IVKNVDRYCEAARSEIQVLEHLNTTDPNST 76
Query: 548 -HLVKLRG-FCAEGTHR--------LLA---YEFMANGSLDKWIFKKNQE--FLLDWETR 592
V++ F H LL Y+F+ K+N F LD +
Sbjct: 77 FRCVQMLEWF----EHHGHICIVFELLGLSTYDFI----------KENGFLPFRLDHIRK 122
Query: 593 FNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHA-------------------K 633
+ + + +LH ++ H D+KPEN+L + + K
Sbjct: 123 MAYQICKS--VNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177
Query: 634 VSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLE 686
V DFG A T + H T + TR Y APE I S+ DV+S G +L+E
Sbjct: 178 VVDFGSA---TYDDEHHSTLVS-TRHYRAPEVILALGWSQPCDVWSIGCILIE 226
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 30/192 (15%), Positives = 60/192 (31%), Gaps = 36/192 (18%)
Query: 499 KLGQGGFGSVYQGV---------LPDGTRLAVKKLEGIGQGKKEFR-----AEVSIIGSI 544
+ G +Y+ P + ++K G+ E A+ +
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 545 HHLHLVKLRGF-------CAEGTHRLLAYEFMANG-SLDKWIFKKNQEFLLDWETRFNIA 596
L+ L + +R L + G SL + + +L + +A
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSPKHVLSERSVLQVA 165
Query: 597 LGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKV--SDFGLAKLMTREQSHV---- 650
L +LHE +H ++ EN+ +D ++V + +G A HV
Sbjct: 166 CRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222
Query: 651 --FTTLRGTRGY 660
+ G +
Sbjct: 223 GSRSPHEGDLEF 234
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 20/205 (9%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHH-LHLVKLRGFC 556
K+G G FG +Y G + G +A+K E + + E I + + + +R
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 557 AEGTHRLLAYEFMANG-SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
AEG + ++ E + G SL+ +++F L +T +A + Y+H + I
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLFNFCSRKFSL--KTVLLLADQMISRIEYIHS---KNFI 127
Query: 616 HCDIKPENVLLDDNYHAK---VSDFGLAKLMTREQSHV------FTTLRGTRGYLAPEWI 666
H D+KP+N L+ + DFGLAK ++H L GT Y +
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 187
Query: 667 TNYAISEKSDVYSYGMVLLEIIGGR 691
S + D+ S G VL+ G
Sbjct: 188 LGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 46/214 (21%), Positives = 89/214 (41%), Gaps = 24/214 (11%)
Query: 494 NNFSV--KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHH-LHL 549
++ V ++G+G FG +++G L + ++A+K E + R E + +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGI 68
Query: 550 VKLRGFCAEGTHRLLAYEFMANG-SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHE 608
+ F EG H +L + + G SL+ + ++F + +T A + +HE
Sbjct: 69 PNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSV--KTVAMAAKQMLARVQSIHE 124
Query: 609 DCDQRIIHCDIKPENVLLDDNYHAK-----VSDFGLAK--LMTREQSHV----FTTLRGT 657
+ +++ DIKP+N L+ V DFG+ K + H+ L GT
Sbjct: 125 ---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181
Query: 658 RGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGR 691
Y++ S + D+ + G V + + G
Sbjct: 182 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 6e-11
Identities = 40/221 (18%), Positives = 65/221 (29%), Gaps = 52/221 (23%)
Query: 481 PVRFTYRDLQTATNNFS--VKLGQGGFGSVYQGVLPDGTRLAVKKL---------EGIGQ 529
PV F++ T K+G+G FG V+Q + D T +A+K + +
Sbjct: 10 PVPFSHCL---PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQK 65
Query: 530 GKKEFRAEVSIIGSIHHLHLVKL---------------RGFCAEGTHRLLAYEFMANGSL 574
+E E+ I + L +G + + GS
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 575 DK--WIFKKNQEFL------------------LDWETRFNIALGTAKGLAYLHEDCDQRI 614
+ FK +Q F+ T +I LA R
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RF 183
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLR 655
H D+ NVLL K+ K T + ++
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 50/225 (22%), Positives = 80/225 (35%), Gaps = 43/225 (19%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVK--KLE--GIGQGKKEFR-----AEVSIIGSIHHLH 548
K+G GGFG +Y + A K+E G E + A+ I
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 549 LVKLRGF----------CAEGTHRLLAYEFMANG-SLDKWIFKKNQEFLLDWETRFNIAL 597
+ G ++R + E + G L K I +N F T + +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKK--STVLQLGI 158
Query: 598 GTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKV--SDFGLAKLMTREQSHV----- 650
L Y+HE +H DIK N+LL +V +D+GL+ +H
Sbjct: 159 RMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215
Query: 651 -FTTLRGTRGYLAPEWITN---YAISEKSDVYSYGMVLLEIIGGR 691
GT + + + A+S +SDV G +L + G+
Sbjct: 216 PRKGHNGTIEFTS---LDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 42/224 (18%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQ----GKKEFRAEVSIIGSIH-HLHLVKL 552
KLG+G +G V++ + G +AVKK+ Q ++ FR E+ I+ + H ++V L
Sbjct: 16 KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNL 74
Query: 553 RG-FCAEGTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC 610
A+ + L +++M L I + L ++ + K + YLH
Sbjct: 75 LNVLRADNDRDVYLVFDYMET-DLHAVI--RANI-LEPVHKQY-VVYQLIKVIKYLH--- 126
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRG-------------- 656
++H D+KP N+LL+ H KV+DFGL++ +
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 657 ------TRGYLAPEWI---TNYAISEKSDVYSYGMVLLEIIGGR 691
TR Y APE + T Y ++ D++S G +L EI+ G+
Sbjct: 187 LTDYVATRWYRAPEILLGSTKY--TKGIDMWSLGCILGEILCGK 228
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 45/224 (20%), Positives = 76/224 (33%), Gaps = 38/224 (16%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGI-------GQGKKEFR-----AEVSIIGSIHH 546
+GQGGFG +Y + + + G E + A+ I
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 547 LHLVKLRGFC----------AEGTHRLLAYEFMANG-SLDKWIFKKNQEFLLDWETRFNI 595
+K G ++R + + G L K + F +T +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSR--KTVLQL 157
Query: 596 ALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKV--SDFGLAKLMTREQSHV--- 650
+L L Y+HE +H DIK N+LL+ +V D+GLA E H
Sbjct: 158 SLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA 214
Query: 651 ---FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGR 691
GT + + + A S + D+ G +++ + G
Sbjct: 215 ADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 40/158 (25%), Positives = 66/158 (41%), Gaps = 18/158 (11%)
Query: 494 NNFSV--KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHH-LHL 549
NF V K+G G FG + G L +A+K LE + + E + +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGI 67
Query: 550 VKLRGFCAEGTHRLLAYEFMANG-SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHE 608
++ F G + + E + G SL+ ++ F L +T IA+ + Y+H
Sbjct: 68 PQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSL--KTVLMIAIQLISRMEYVHS 123
Query: 609 DCDQRIIHCDIKPENVLLDDNYHAKVS-----DFGLAK 641
+ +I+ D+KPEN L+ + DF LAK
Sbjct: 124 ---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 51/211 (24%), Positives = 86/211 (40%), Gaps = 20/211 (9%)
Query: 494 NNFSV--KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH-HLHL 549
N F + K+G G FG +Y G + +A+K E + + E I + +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGI 65
Query: 550 VKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED 609
+R F EG + +L + + SL+ +++ L +T +A + ++H
Sbjct: 66 PNVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHS- 121
Query: 610 CDQRIIHCDIKPENVLLDDNYHAK---VSDFGLAKLMTREQSHV------FTTLRGTRGY 660
+ +H DIKP+N L+ A + DFGLAK +H L GT Y
Sbjct: 122 --KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
Query: 661 LAPEWITNYAISEKSDVYSYGMVLLEIIGGR 691
+ S + D+ S G VL+ + G
Sbjct: 180 ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 59.3 bits (142), Expect = 1e-09
Identities = 49/252 (19%), Positives = 82/252 (32%), Gaps = 37/252 (14%)
Query: 50 GLFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGE 109
G +LLS N F + N LVI + +W AN P +++ KK
Sbjct: 26 GQYLLSPNQRFKLLLQGDGN------LVIQD--NGATVWVANEQQPFSSTIPLRNKKAPL 77
Query: 110 VSLQKGGSVVWSVN--------------PSGASVSAMELRDSGNLVLLGNDNKVLWQSFS 155
+ G+ + + + + + L+D GN+VL+ +
Sbjct: 78 AFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVDSLALWNGTPAI 137
Query: 156 HPTDTLISNQDFTQGMKLVSAPSTNNLSYVLEIKSGDVVLSAGFPTPQPYWSMGREERKT 215
I + G +LV + L + D L A P W+
Sbjct: 138 PLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQG-DGNLVAYGPNGAATWN-------A 189
Query: 216 INKGGGEVTSASLSANSWRFYDNNKIFLWQFIFSDNTDGNATWIAVLANDGFISFYNLQD 275
+G G V + + Y LW +T G+A+ + L +G I+ D
Sbjct: 190 GTQGKGAVRAVFQGDGNLVVYGAGNAVLWHS----HTGGHASAVLRLQANGSIAIL---D 242
Query: 276 GEPSTASNTKIP 287
+P A P
Sbjct: 243 EKPVWARFGFQP 254
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 56.1 bits (134), Expect = 9e-09
Identities = 37/210 (17%), Positives = 59/210 (28%), Gaps = 17/210 (8%)
Query: 88 WTANRGSPVANSDN-FVFKKDGEVSLQKGGSVVWSVNPSGASVSAMELRDSGNLVLLGND 146
T + + S F + D + L VW+ N +GA+ L+ G LV+L
Sbjct: 15 QTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVLQSDGLLVILTAQ 74
Query: 147 NKVLWQSFSHPTDTLISNQDFTQGMKLVSAPSTNNLSYVLEIKSGDVVLSAGFPTPQPYW 206
N + W S + + LV P Y +
Sbjct: 75 NTIRWSSGTKGSI---------GNYVLVLQPDRTVTIYGPGLWDSGTSNKGSVVVANNGN 125
Query: 207 SMGREERKTINKGGGEVTSASLSANSWRFYDNNKIFL-----WQFIFSDNTDG-NATWIA 260
S+ + N + SL + +R L ++S NT G A
Sbjct: 126 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRA 185
Query: 261 VLANDGFISFYNLQDGEPSTASNTKIPNSP 290
VL +G + S
Sbjct: 186 VLQPNGRMDVLT-NQNIAVWTSGNSRSAGR 214
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 1e-08
Identities = 16/102 (15%), Positives = 40/102 (39%), Gaps = 10/102 (9%)
Query: 56 NNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVSLQKG 115
+ F + N LV+ ++ +W + + + DG + + G
Sbjct: 17 AEGGYLFIIQNDCN------LVLYD--NNRAVWASGTNGKASGC-VLKMQNDGNLVIYSG 67
Query: 116 GSVVWSVNPSGASVS-AMELRDSGNLVLLGNDNKVLWQSFSH 156
+W+ N + + + + L+ N+V+ N N +W + ++
Sbjct: 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTN 109
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 2e-08
Identities = 16/89 (17%), Positives = 33/89 (37%), Gaps = 5/89 (5%)
Query: 83 SSTIIWTANRGSPVANSDNF--VFKKDGEVSLQKGGSVVWSVNPSGASVSA-MELRDSGN 139
I+ + + + + + D + L + +W+ N G L+ G
Sbjct: 13 HPQILHATESLEILFGTHVYRFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGV 72
Query: 140 LVLLGNDNKVLWQS--FSHPTDTLISNQD 166
LV++ N+N +WQS ++ Q
Sbjct: 73 LVVITNENVTVWQSPVAGKAGHYVLVLQP 101
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 39.9 bits (93), Expect = 4e-04
Identities = 24/107 (22%), Positives = 39/107 (36%), Gaps = 14/107 (13%)
Query: 49 NGLFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDG 108
L +L + F +T N LV+ + IW N G V + DG
Sbjct: 21 ESLEILFGTHVYRFIMQTDCN------LVLYDN--NNPIWATNTGGLGNGC-RAVLQPDG 71
Query: 109 E-VSLQKGGSVVWSVNPSGASVS-AMELRDSGNLVLLGNDNKVLWQS 153
V + VW +G + + L+ N+V+ G+ LW +
Sbjct: 72 VLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGD---ALWAT 115
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.7 bits (128), Expect = 2e-07
Identities = 107/722 (14%), Positives = 195/722 (27%), Gaps = 227/722 (31%)
Query: 25 MASIQ-SIGKILPGFQGAQMTFIDKNGLFLLSNNSDFAFG-FRTTENDVTLFLLVIMHKA 82
Q IL F+ A F+D F + D E D +++
Sbjct: 11 TGEHQYQYKDILSVFEDA---FVDN---FDCKDVQDMPKSILSKEEID---HIIMSKDAV 61
Query: 83 SST--IIWT-ANRGSPVANSDNFVFKKDGEVSLQKGGSVVWS------VNPSGASVSAME 133
S T + WT ++ + FV E L+ + S PS + +E
Sbjct: 62 SGTLRLFWTLLSKQEEMV--QKFV-----EEVLRINYKFLMSPIKTEQRQPSMMTRMYIE 114
Query: 134 LRDSGNLVLLGNDNKVLWQSFSHPTDTLISNQDFTQGMKLVSAPSTNNLSYVLEIKSGDV 193
RD L NDN+V + Q + KL A +LE++
Sbjct: 115 QRDR-----LYNDNQVF------AKYNVSRLQPYL---KLRQA--------LLELRPAKN 152
Query: 194 VLSAGFPTPQPYWSMGREERKTINKGGGEVTSASLSANSWRFYD--NNKIFLWQFIFSDN 251
VL G + G G+ A S++ + KIF W + + N
Sbjct: 153 VLIDG---------VL---------GSGKTWVALDVCLSYKVQCKMDFKIF-WLNLKNCN 193
Query: 252 TDGNATWIAVLANDGFISFYNLQDGEPSTASNTKIPNSPCSTPEPCDA------YYICS- 304
+ + +L D P+ S + + + + S
Sbjct: 194 SPETV--LEMLQK-----LLYQID--PNWTSR---SDHSSNIKLRIHSIQAELRRLLKSK 241
Query: 305 GINKC-------QCPSVISSQN--CKTGIASPCDHSKGSTELVSAGDG----LNYFALGF 351
C Q ++ N CK + + K T+ +SA L++ ++
Sbjct: 242 PYENCLLVLLNVQNAKAWNAFNLSCKILLTT---RFKQVTDFLSAATTTHISLDHHSMTL 298
Query: 352 VPPSSK---ADLNGCKKACLGNCSCLAMFFQNSSGNCFLFDRIGSLQSSNQGSGFVSYIK 408
P K C+ L + N I
Sbjct: 299 TPDEVKSLLLKYLDCRPQDLPREVL--------TTNPRRLSIIAES-------------- 336
Query: 409 ILSNGGSDTNNGGSGSNKKHFPVVVIIVLSTSVVILGLLYVAIRYVRKKRKAPESPQETS 468
+ +G + +N ++V + T+
Sbjct: 337 -IRDGLATWDN-------------------------------WKHVNCDKL-------TT 357
Query: 469 EEDNFLENLSGMPVRFTYRDLQTATNNF--SVKLGQGGFGSVYQGVLPDGTRLAVKKLEG 526
++ L L R + L F S + ++ V+ + V KL
Sbjct: 358 IIESSLNVLEPAEYRKMFDRLSV----FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413
Query: 527 ---IGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT--HRLL--AYEFMANGSLDKWIF 579
+ + KE SI ++L +L+ HR + Y D
Sbjct: 414 YSLVEKQPKESTI------SIPSIYL-ELKVKLENEYALHRSIVDHYNIPKT--FDSDDL 464
Query: 580 KKNQEFLLD--WETRFNIALGTAKGLAYLH-EDCDQRIIHCDIKPENVLLDDNY-HAKVS 635
LD + ++ + + H ++ + V LD + K+
Sbjct: 465 IPPY---LDQYF---YSH-------IGH-HLKNIEH--PERMTLFRMVFLDFRFLEQKIR 508
Query: 636 DFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFD 695
A + + L+ + Y I + Y ++ +F
Sbjct: 509 HDSTAWNASGSILNTLQQLKFYKPY----------ICDNDPKYE------RLVNAILDFL 552
Query: 696 PN 697
P
Sbjct: 553 PK 554
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 3e-06
Identities = 59/381 (15%), Positives = 114/381 (29%), Gaps = 115/381 (30%)
Query: 445 GLLYVAIRYVRKKRKAPESPQET-SEEDNFLEN----LSGMPV-RF-TYRDLQTATNNFS 497
L I+ +++ P E+ + L N + V R Y L+ A
Sbjct: 92 KFLMSPIKT---EQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELR 148
Query: 498 ----VKL-GQGGFG-SVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVK 551
V + G G G + +A+ ++ + + I L+L
Sbjct: 149 PAKNVLIDGVLGSGKTW----------VALDVC-------LSYKVQCKMDFKIFWLNL-- 189
Query: 552 LRGFCAEGTHRL-----LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYL 606
C L L Y+ N + + + + R +
Sbjct: 190 --KNCNSPETVLEMLQKLLYQIDPN-------WTSRSDHSSNIKLRIHSI---------- 230
Query: 607 HEDCDQRIIHCDIKPENVL-LDDNYHAKVSD-FGL-AKLM--TREQS-----------HV 650
+ +R++ +L L + +AK + F L K++ TR + H+
Sbjct: 231 -QAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHI 289
Query: 651 FT-------TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA 703
T + L +++ +V + L II T D
Sbjct: 290 SLDHHSMTLTPDEVKSLLL-KYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLA-TWDN- 346
Query: 704 HFPSYAFKMMEEGKLRNILDSRLNI---DEQSDR-----VF-------TAVKVALWC--- 745
+K + KL I++S LN+ E VF T + +W
Sbjct: 347 ------WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVI 400
Query: 746 VQEDMSLRPSMTKVVQ--MLE 764
+ M + + K+ + ++E
Sbjct: 401 KSDVMVV---VNKLHKYSLVE 418
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-07
Identities = 18/60 (30%), Positives = 27/60 (45%), Gaps = 1/60 (1%)
Query: 95 PVANSDNFVFKKDGEVSLQKGGSVVWSVNPSGASVSAME-LRDSGNLVLLGNDNKVLWQS 153
V S + + D L G VW+ N G L ++GNLV+ N+V+WQ+
Sbjct: 17 EVGPSYRLIMQGDCNFVLYDSGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQT 76
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-05
Identities = 19/107 (17%), Positives = 35/107 (32%), Gaps = 14/107 (13%)
Query: 54 LSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGE-VSL 112
L + + N V+ +W +N G + +G V
Sbjct: 16 LEVGPSYRLIMQGDCN------FVLYDS--GKPVWASNTGGLGSGC-RLTLHNNGNLVIY 66
Query: 113 QKGGSVVWSVNPSGASVS-AMELRDSGNLVLLGNDNKVLWQSFSHPT 158
+ V+W +G + L+ N+V+ G V+W + S P
Sbjct: 67 DQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYG---PVVWATGSGPA 110
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 4e-07
Identities = 16/66 (24%), Positives = 27/66 (40%), Gaps = 2/66 (3%)
Query: 93 GSPVANSDNFVFKKDGEVSLQKGGSVVWSVN--PSGASVSAMELRDSGNLVLLGNDNKVL 150
S +F+ ++D + L + VW+ N G L+ GN V+ + + L
Sbjct: 14 QSLDVEPYHFIMQEDCNLVLYDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSL 73
Query: 151 WQSFSH 156
W S S
Sbjct: 74 WASHSV 79
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 9e-07
Identities = 22/103 (21%), Positives = 43/103 (41%), Gaps = 13/103 (12%)
Query: 56 NNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVSLQ-K 114
+ + F + N LV+ ST +W +N G V + DG +
Sbjct: 17 DVEPYHFIMQEDCN------LVLYDH--STSVWASNTGILGKKGCKAVLQSDGNFVVYDA 68
Query: 115 GGSVVWSVN-PSGASVSAMELRDSGNLVLLGNDNKVLWQSFSH 156
G +W+ + G + L++ GN+V+ G+D +W + ++
Sbjct: 69 EGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD---IWSTGTY 108
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-05
Identities = 15/68 (22%), Positives = 29/68 (42%), Gaps = 2/68 (2%)
Query: 91 NRGSPVANSDN-FVFKKDGEVSLQKGGSVVWSVNPSGASVSA-MELRDSGNLVLLGNDNK 148
+ G + N F+ ++D + L +W+ N G + ++ GNLV+ N
Sbjct: 11 SPGEFLNNGRYVFIMQEDCNLVLYDVDKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNN 70
Query: 149 VLWQSFSH 156
+W S +
Sbjct: 71 PIWASNTG 78
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-05
Identities = 13/65 (20%), Positives = 24/65 (36%), Gaps = 1/65 (1%)
Query: 93 GSPVANSDNFVFKKDGEVSLQKGGSVVWSVNPSGASVSA-MELRDSGNLVLLGNDNKVLW 151
S A + + + + G +W+ N + L GNLV+ ++N +W
Sbjct: 15 HSLQAGAYTLTIQNKCNLVKYQNGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVW 74
Query: 152 QSFSH 156
S
Sbjct: 75 GSACW 79
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 3e-05
Identities = 16/68 (23%), Positives = 26/68 (38%), Gaps = 3/68 (4%)
Query: 91 NRGSPVANSDN-FVFKKDGEVSLQKGGSVVWSVNPSGASVSA-MELRDSGNLVLLGNDNK 148
+ ++ V + D + L GG W N G + L G L++ +D K
Sbjct: 16 YGDGRLTAKNHQLVMQGDCNLVLY-GGKYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFK 74
Query: 149 VLWQSFSH 156
+W S S
Sbjct: 75 TIWSSRSS 82
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 40.2 bits (94), Expect = 2e-04
Identities = 14/59 (23%), Positives = 22/59 (37%), Gaps = 4/59 (6%)
Query: 102 FVFKKDGEVSLQKGGSVVWSVNPSGASVSA-MELRDSGNLVLLGNDNKVLWQSFSHPTD 159
V + D + L G W N + + L D G LV+ D +W+S +
Sbjct: 25 LVMQDDCNLVLYNGN---WQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVK 80
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 40.2 bits (94), Expect = 3e-04
Identities = 13/64 (20%), Positives = 22/64 (34%), Gaps = 3/64 (4%)
Query: 93 GSPVANSDNFVFKKDGEVSL--QKGGSVVWSVNPSGASVSA-MELRDSGNLVLLGNDNKV 149
+ V + D + L ++VW SG M L SG L + +
Sbjct: 19 AQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNT 78
Query: 150 LWQS 153
++ S
Sbjct: 79 VFVS 82
|
| >4a5v_A MIC4, micronemal protein 4; adhesion; NMR {Toxoplasma gondii} Length = 161 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 3e-04
Identities = 20/119 (16%), Positives = 29/119 (24%), Gaps = 11/119 (9%)
Query: 291 CSTPEPCDAYYICSGINKCQC----PSVISSQNCKTGIASPCDHSKGSTELVSAGDGLNY 346
C + C + C P + KT + CD S + G
Sbjct: 40 CKAVDGCTHFTYNDDSKMCHVKEGKPDLYDLTGGKTA-SRSCDRSCFEQHVSYEGAPDVM 98
Query: 347 FALGFVPPSSKADLNGCKKACLGNCSCLAMFFQNSSGNCFLFDRIGSLQSSNQGSGFVS 405
+ C+ AC + SC + C R S G S
Sbjct: 99 T------AMVTSQSADCQAACAADPSCEIFTYNEHDQKCTFKGRGFSAFKERGVLGVTS 151
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* Length = 339 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 5e-04
Identities = 29/233 (12%), Positives = 59/233 (25%), Gaps = 32/233 (13%)
Query: 452 RYVRKKRKAPESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSVKLGQGGFGSVY-- 509
Y K + S + L ++ + T +L Y
Sbjct: 48 SYFIKLKYGYHDEINLS----IIRLLHDSGIKEIIFPIHTLEAKLFQQLK-HFKIIAYPF 102
Query: 510 -QGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHL-------HLVKLRGFCAEGTH 561
L K+ + +G+ ++ IH ++ + +
Sbjct: 103 IHAPNGFTQNLTGKQWKQLGK----------VLRQIHETSVPISIQQQLRKEIYSPKWRE 152
Query: 562 RLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR-----IIH 616
+ + F D K F + L + + H
Sbjct: 153 IVRS--FYNQIEFDNSDDKLTAAFKSFFNQNSAAIHRLVDTSEKLSKKIQPDLDKYVLCH 210
Query: 617 CDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNY 669
DI NVL+ + + D+ L +E+ +F + P I +
Sbjct: 211 SDIHAGNVLVGNEESIYIIDWDEPMLAPKERDLMFIGGGVGNVWNKPHEIQYF 263
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 817 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.71 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.7 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.66 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.6 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.58 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.44 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.42 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.32 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.3 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.24 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.24 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.23 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.14 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.1 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.99 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 98.9 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.86 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 98.74 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.65 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.62 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.59 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 98.58 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.43 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.32 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.28 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.21 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.16 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.09 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.04 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.96 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.87 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.73 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.67 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.47 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.19 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.15 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.99 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.95 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.85 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.81 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.63 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.63 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.6 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.36 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.32 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.01 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.43 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.25 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 92.31 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.35 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=451.79 Aligned_cols=265 Identities=23% Similarity=0.360 Sum_probs=217.1
Q ss_pred cCHHHHHHHhhccccccCCCcceeEEEEEcC------CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeE
Q 036583 484 FTYRDLQTATNNFSVKLGQGGFGSVYQGVLP------DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGF 555 (817)
Q Consensus 484 ~~~~~l~~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~ 555 (817)
..+.|+..++..|.++||+|+||+||+|++. +++.||||+++... ...++|.+|+.++++++|||||+++|+
T Consensus 18 ~~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 97 (308)
T 4gt4_A 18 AKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGV 97 (308)
T ss_dssp -CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence 3344555667788999999999999999863 46789999997542 346889999999999999999999999
Q ss_pred eecCCeeeEEEeeccCCChhhhhhhccc-------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCC
Q 036583 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQ-------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPE 622 (817)
Q Consensus 556 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~ 622 (817)
|.+++..+||||||++|+|.++|..... ...++|..+++|+.|||+||+|||+ ++|+||||||+
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~ 174 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATR 174 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCcccc
Confidence 9999999999999999999999965321 2368999999999999999999999 89999999999
Q ss_pred CeEecCCCcEEEeecCCccccCCCCce-eeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCC
Q 036583 623 NVLLDDNYHAKVSDFGLAKLMTREQSH-VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETS 700 (817)
Q Consensus 623 NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~ 700 (817)
||||++++.+||+|||+++........ ......||+.|||||++.+..++.++|||||||+||||+| |+.||.....
T Consensus 175 NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~- 253 (308)
T 4gt4_A 175 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN- 253 (308)
T ss_dssp GEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-
T ss_pred ceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-
Confidence 999999999999999999876543322 2334679999999999999999999999999999999998 8999964321
Q ss_pred CCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 701 DKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
..+...+.++... +.+...+..+.+++.+||+.||++||||+||++.|+...
T Consensus 254 ------~~~~~~i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 254 ------QDVVEMIRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp ------HHHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ------HHHHHHHHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 1223333333221 112233456889999999999999999999999998753
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=447.87 Aligned_cols=256 Identities=24% Similarity=0.421 Sum_probs=204.6
Q ss_pred ccccccCCCcceeEEEEEcC------CCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 495 NFSVKLGQGGFGSVYQGVLP------DGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
.+.++||+|+||+||+|++. +++.||||+++... ...++|.+|++++++++|||||+++|+|.+++..+||||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 45688999999999999853 47889999997653 345789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccc------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEe
Q 036583 568 FMANGSLDKWIFKKNQ------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVS 635 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~ 635 (817)
||++|+|.++|+.... ...++|.++++|+.|||+||+|||+ ++|+||||||+||||++++.+||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEEc
Confidence 9999999999976432 2368999999999999999999999 899999999999999999999999
Q ss_pred ecCCccccCCCCce-eeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHh
Q 036583 636 DFGLAKLMTREQSH-VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMM 713 (817)
Q Consensus 636 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 713 (817)
|||+++........ ......||+.|||||++.+..++.++|||||||+||||+| |+.||..... ..+...+
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-------~~~~~~i 273 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-------TEAIDCI 273 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-------HHHHHHH
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-------HHHHHHH
Confidence 99999976544322 2234679999999999999999999999999999999999 8999964321 1223333
Q ss_pred hhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCC
Q 036583 714 EEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPV 769 (817)
Q Consensus 714 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 769 (817)
.++.. + +.+...+..+.+++.+||+.||++||||+||+++|+.+.+.
T Consensus 274 ~~g~~-------~--~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 TQGRE-------L--ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHTCC-------C--CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HcCCC-------C--CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 33321 1 11122345688999999999999999999999999987553
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=443.98 Aligned_cols=256 Identities=25% Similarity=0.445 Sum_probs=210.4
Q ss_pred hhccccccCCCcceeEEEEEcC------CCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP------DGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv 565 (817)
.+.+.++||+|+||+||+|++. +++.||||+++... ...++|.+|++++++++|||||+++|+|.+++..+||
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 93 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 93 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 3456789999999999999853 47789999997653 3457899999999999999999999999999999999
Q ss_pred EeeccCCChhhhhhhcc----------cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEe
Q 036583 566 YEFMANGSLDKWIFKKN----------QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVS 635 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~ 635 (817)
||||++|+|.++|.+.. ....++|.++++|+.||++||+|||+ ++|+||||||+||||++++.+||+
T Consensus 94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEEC
Confidence 99999999999997643 12368999999999999999999999 899999999999999999999999
Q ss_pred ecCCccccCCCCceee-eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHh
Q 036583 636 DFGLAKLMTREQSHVF-TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMM 713 (817)
Q Consensus 636 Dfgla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 713 (817)
|||+|+.......... ....||+.|||||++.+..++.++|||||||+||||+| |+.||..... ..+...+
T Consensus 171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-------~~~~~~i 243 (299)
T 4asz_A 171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-------NEVIECI 243 (299)
T ss_dssp CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHHHH
T ss_pred CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHH
Confidence 9999987654433322 23568999999999999999999999999999999999 8999964321 2233333
Q ss_pred hhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 714 EEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 714 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
.++.... .+...+..+.+++.+||+.||++||||+||++.|+.+.
T Consensus 244 ~~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 244 TQGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 3332211 11223456889999999999999999999999998763
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=428.30 Aligned_cols=256 Identities=27% Similarity=0.441 Sum_probs=201.5
Q ss_pred hhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
...+.++||+|+||+||+|++.+ .||||+++.... ..++|.+|++++++++|||||+++|+|.+ +..+||||||
T Consensus 37 ~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~ 113 (307)
T 3omv_A 37 EVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWC 113 (307)
T ss_dssp SCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcC
Confidence 34567899999999999999754 599999875432 34679999999999999999999999865 5689999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC-c
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ-S 648 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~-~ 648 (817)
++|+|.++|..... .++|.++++|+.|||+||+|||+ ++|+||||||+||||++++.+||+|||+|+...... .
T Consensus 114 ~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 114 EGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp SSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999976543 59999999999999999999999 899999999999999999999999999998765432 2
Q ss_pred eeeeeccCCCCccCcccccc---CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccc
Q 036583 649 HVFTTLRGTRGYLAPEWITN---YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 725 (817)
.......||+.|||||++.+ ..|+.++|||||||+||||+||+.||..... .......+..+.. .+.
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~------~~~~~~~~~~~~~----~p~ 258 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN------RDQIIFMVGRGYA----SPD 258 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC------HHHHHHHHHTTCC----CCC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh------HHHHHHHHhcCCC----CCC
Confidence 23345789999999999964 4689999999999999999999999964322 1122222222211 111
Q ss_pred cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 726 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
+. ......+..+.+++.+||+.||++||||+||+++|+.+.
T Consensus 259 ~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 259 LS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp ST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred cc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 11 111223456889999999999999999999999998763
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=424.35 Aligned_cols=265 Identities=22% Similarity=0.288 Sum_probs=202.3
Q ss_pred hccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCC----eeeEEEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT----HRLLAYEFM 569 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~ 569 (817)
+.+.++||+|+||+||+|++ +|+.||||++.........+..|+..+.+++|||||+++++|.+++ ..+||||||
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~ 83 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence 44568899999999999998 6899999999754333334455677778899999999999998654 579999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcC-----CCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC-----DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~-----~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
++|+|.++|... .++|..+++++.|+++||+|||+.+ ..+|+||||||+||||++++++||+|||+++...
T Consensus 84 ~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 84 EHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp TTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 999999999754 4899999999999999999999731 2499999999999999999999999999998765
Q ss_pred CCCcee---eeeccCCCCccCccccccC------ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCc--------chH
Q 036583 645 REQSHV---FTTLRGTRGYLAPEWITNY------AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAH--------FPS 707 (817)
Q Consensus 645 ~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~--------~~~ 707 (817)
...... .....||+.|||||++.+. .++.++|||||||+||||+||+.||.......... ...
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 443221 2236799999999999754 46789999999999999999998886443222111 111
Q ss_pred HHHHHhhhcchhhhcccccCC-cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 708 YAFKMMEEGKLRNILDSRLNI-DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 708 ~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
.....+..+. .++.+.. ....+....+.+++.+||+.||++||||+||+++|+.+.
T Consensus 240 ~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 240 EMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1222222221 2222211 122345667889999999999999999999999998763
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=430.59 Aligned_cols=262 Identities=26% Similarity=0.405 Sum_probs=212.4
Q ss_pred HHHHHhhccccccCCCcceeEEEEEcC------CCcEEEEEEeccCC--cCHHHHHHHHHHhhccC-cceeeeeeeEeec
Q 036583 488 DLQTATNNFSVKLGQGGFGSVYQGVLP------DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIH-HLHLVKLRGFCAE 558 (817)
Q Consensus 488 ~l~~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~ 558 (817)
|+....+.+.++||+|+||+||+|++. .++.||||++.... ...++|.+|+++|.+++ |||||+++|+|.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 444556677789999999999999853 24689999997643 23567999999999995 5999999999976
Q ss_pred -CCeeeEEEeeccCCChhhhhhhccc-------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 036583 559 -GTHRLLAYEFMANGSLDKWIFKKNQ-------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENV 624 (817)
Q Consensus 559 -~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NI 624 (817)
+...+||||||++|+|.++|++... ...+++..++.++.|||+||+|||+ ++|+||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccce
Confidence 4568999999999999999976432 2358999999999999999999999 9999999999999
Q ss_pred EecCCCcEEEeecCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCC
Q 036583 625 LLDDNYHAKVSDFGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDK 702 (817)
Q Consensus 625 ll~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~ 702 (817)
|+++++.+||+|||+|+.+....... .....||+.|||||++.+..|+.++|||||||+||||+| |+.||......
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~-- 294 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-- 294 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH--
Confidence 99999999999999999775544332 334679999999999999999999999999999999998 89999654321
Q ss_pred CcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 703 AHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
..+...+.++.... .+.....++.+++.+||+.||++||||+||+++|+.+.
T Consensus 295 ----~~~~~~i~~g~~~~---------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 295 ----EEFCRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp ----HHHHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHHHHcCCCCC---------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 22333343332111 11122346889999999999999999999999998763
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=418.84 Aligned_cols=246 Identities=24% Similarity=0.372 Sum_probs=205.5
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccC-CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI-GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+.+.++||+|+||+||+|+.. +|+.||||++... ....+.+.+|+++|++++|||||++++++.+++..|||||||++
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 555688999999999999964 6999999999654 34456789999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
|+|.+++.+. .+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+.+..... ..
T Consensus 156 g~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~ 227 (346)
T 4fih_A 156 GALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR 227 (346)
T ss_dssp EEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CB
T ss_pred CcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cc
Confidence 9999999653 48999999999999999999999 9999999999999999999999999999997754332 23
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ......+.++. .+.+ ...
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~~i~~~~-----~~~~--~~~ 293 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-------LKAMKMIRDNL-----PPRL--KNL 293 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSS-----CCCC--SCG
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHcCC-----CCCC--Ccc
Confidence 457899999999999999999999999999999999999999964321 11222222211 1111 111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
......+.+|+.+||+.||++|||++|+++
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 223456889999999999999999999987
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=424.12 Aligned_cols=248 Identities=21% Similarity=0.353 Sum_probs=199.5
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
.|.+.++||+|+||+||+++. .+|+.||||++..... ..+.+.+|++++++++|||||++++++.+++..||||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 356678999999999999985 4699999999975432 346789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
|++|+|.++|..... ..+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+.......
T Consensus 105 ~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 105 CEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp CTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred CCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 999999999975432 257888999999999999999999 9999999999999999999999999999997643221
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||..... .. ....+.++....
T Consensus 181 -~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~-~~~~i~~~~~~~-------- 244 (350)
T 4b9d_A 181 -LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KN-LVLKIISGSFPP-------- 244 (350)
T ss_dssp -HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HH-HHHHHHHTCCCC--------
T ss_pred -cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HH-HHHHHHcCCCCC--------
Confidence 12346799999999999999999999999999999999999999964321 11 222222222111
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
........+.+|+.+||+.||++|||++|+++
T Consensus 245 -~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 -VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122346889999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=408.95 Aligned_cols=243 Identities=21% Similarity=0.420 Sum_probs=196.8
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeec----CCeeeEEE
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAE----GTHRLLAY 566 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 566 (817)
.|.++||+|+||+||+|... .++.||+|++.... ...+.|.+|++++++++|||||+++++|.+ ....+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999854 58899999996542 234679999999999999999999999865 34579999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCc--eeecCCCCCCeEec-CCCcEEEeecCCcccc
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR--IIHCDIKPENVLLD-DNYHAKVSDFGLAKLM 643 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~--ivH~Dlk~~NIll~-~~~~~ki~Dfgla~~~ 643 (817)
|||++|+|.++|.+.. .+++..+..++.||+.||+|||+ ++ |+||||||+||||+ .++.+||+|||+|+..
T Consensus 109 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 9999999999997654 68999999999999999999998 66 99999999999998 4799999999999865
Q ss_pred CCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
... ......||+.|||||++.+ .|+.++|||||||+||||+||+.||..... ...+...+..+.....+
T Consensus 183 ~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~------~~~~~~~i~~~~~~~~~- 251 (290)
T 3fpq_A 183 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVKPASF- 251 (290)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHHHHTTTCCCGGG-
T ss_pred CCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc------HHHHHHHHHcCCCCCCC-
Confidence 433 2345789999999999875 699999999999999999999999964321 12222333322211111
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+.....++.+++.+||+.||++|||++|+++
T Consensus 252 -------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 -------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112235789999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=414.60 Aligned_cols=249 Identities=22% Similarity=0.257 Sum_probs=201.2
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
+.+.++||+|+||+||+|+. .+|+.||||+++.... ..+|+.++++++|||||++++++.+++..+||||||++|
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 34457899999999999995 4689999999975432 246999999999999999999999999999999999999
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC-cEEEeecCCccccCCCCcee-
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY-HAKVSDFGLAKLMTREQSHV- 650 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Dfgla~~~~~~~~~~- 650 (817)
+|.++|.+.. .+++..+..++.||+.||+|||+ ++|+||||||+||||+.++ .+||+|||+|+.+.......
T Consensus 136 ~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 136 SLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp BHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 9999997654 68999999999999999999999 9999999999999999987 69999999999875432211
Q ss_pred ---eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 651 ---FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 651 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||....... + ...+..+... . .
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~----~~~i~~~~~~-~--~--- 276 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---L----CLKIASEPPP-I--R--- 276 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---C----HHHHHHSCCG-G--G---
T ss_pred eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---H----HHHHHcCCCC-c--h---
Confidence 123579999999999999999999999999999999999999997543322 1 1111111110 0 0
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.........+.+++.+||+.||++|||+.|+++.|...
T Consensus 277 -~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 277 -EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp -GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 01112234678999999999999999999999988654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=409.50 Aligned_cols=244 Identities=24% Similarity=0.357 Sum_probs=206.3
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.++||+|+||+||+++. .+|+.||||++.+. ....+.+.+|++++++++|||||++++++.+++..||||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 66778999999999999995 56899999999643 34567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++|+|.++|.+.. .+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 114 ~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 114 AKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999997654 58999999999999999999999 9999999999999999999999999999998754332
Q ss_pred -eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 649 -HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 649 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
....+.+||+.|||||++.+..|+.++||||+||+||||++|+.||..... ......+.++.. .
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~~i~~~~~--------~ 252 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------GLIFAKIIKLEY--------D 252 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCC--------C
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCC--------C
Confidence 233457899999999999999999999999999999999999999964321 112222322221 1
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVV 760 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl 760 (817)
.+ .....++.+|+.+||+.||++|||++|++
T Consensus 253 ~p--~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 FP--EKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CC--TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CC--cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11 11234678999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=419.73 Aligned_cols=246 Identities=24% Similarity=0.369 Sum_probs=205.4
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+.+.++||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+.+|++++|||||++++++.+++..|||||||++
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 55668999999999999996 468999999997543 4456789999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
|+|.+++... .+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+.+..... ..
T Consensus 233 G~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~ 304 (423)
T 4fie_A 233 GALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR 304 (423)
T ss_dssp EEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CB
T ss_pred CcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-cc
Confidence 9999998643 48899999999999999999999 9999999999999999999999999999997754432 23
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ..+...+..+. .+.+.. .
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~~i~~~~-----~~~~~~--~ 370 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-------LKAMKMIRDNL-----PPRLKN--L 370 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSC-----CCCCSC--T
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHcCC-----CCCCcc--c
Confidence 457899999999999999999999999999999999999999964321 11222222221 111111 1
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
......+.+|+.+||+.||++|||++|+++
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 122346789999999999999999999987
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=396.63 Aligned_cols=243 Identities=24% Similarity=0.396 Sum_probs=190.7
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
.+.+.++||+|+||+||+++. .+|+.||||++.+. ....+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 467778999999999999995 46899999999653 2335679999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+ +|+|.+++.+.. .+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 94 y~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 94 YA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp CC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred CC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 99 679999997654 58999999999999999999999 999999999999999999999999999998764432
Q ss_pred ceeeeeccCCCCccCccccccCcc-CccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAI-SEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
......||+.|||||++.+..+ +.++||||+||++|||++|+.||..... ......+.++..
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-------~~~~~~i~~~~~-------- 229 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-------PVLFKNISNGVY-------- 229 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCC--------
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCCC--------
Confidence 2345789999999999998876 5799999999999999999999964321 122233333221
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..+ ......+.+++.+||+.||++|||++|+++
T Consensus 230 ~~p--~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 TLP--KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCC--TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCC--CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111 112346789999999999999999999997
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=403.17 Aligned_cols=245 Identities=24% Similarity=0.325 Sum_probs=195.0
Q ss_pred hhccccccCCCcceeEEEEEc----CCCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL----PDGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~----~~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv 565 (817)
.+.+.++||+|+||+||+++. ..++.||||+++... .....+.+|++++++++|||||++++++.+++..+||
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 366778999999999999984 247899999996532 2345788999999999999999999999999999999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|||+++|+|.++|.+.. .+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+....
T Consensus 105 mEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp ECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999997654 68999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccc
Q 036583 646 EQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 725 (817)
... ......||+.|||||++.+..|+.++|||||||+||||++|+.||..... ......+.++.
T Consensus 179 ~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~~i~~~~-------- 242 (304)
T 3ubd_A 179 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-------KETMTMILKAK-------- 242 (304)
T ss_dssp --C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC--------
T ss_pred CCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-------HHHHHHHHcCC--------
Confidence 322 23457899999999999999999999999999999999999999964321 11222222221
Q ss_pred cCCcccHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 036583 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRPSM-----TKVVQ 761 (817)
Q Consensus 726 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~-----~evl~ 761 (817)
...+ .....++.+++.+||+.||++|||+ +|+++
T Consensus 243 ~~~p--~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 243 LGMP--QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCCC--TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCC--CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1111 1223467899999999999999984 67765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=393.50 Aligned_cols=247 Identities=21% Similarity=0.335 Sum_probs=186.0
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCC----------
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT---------- 560 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~---------- 560 (817)
+.+.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|++++++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 55668999999999999985 468999999996543 23467899999999999999999999987544
Q ss_pred --eeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecC
Q 036583 561 --HRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFG 638 (817)
Q Consensus 561 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg 638 (817)
..++||||+++|+|.+++.........++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccCc
Confidence 368999999999999999876543345566788999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCce-----------eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchH
Q 036583 639 LAKLMTREQSH-----------VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPS 707 (817)
Q Consensus 639 la~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~ 707 (817)
+|+.+...... .....+||+.|||||++.+..|+.++|||||||++|||++ ||.... . ..
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~-~~ 234 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----E-RV 234 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----H-HH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----H-HH
Confidence 99977543221 1223579999999999999999999999999999999996 774210 0 00
Q ss_pred HHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 708 YAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 708 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.....+.+.... +........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~p---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 RTLTDVRNLKFP---------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHTTCCC---------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHhcCCCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011111111110 111122345678999999999999999999987
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=377.61 Aligned_cols=288 Identities=45% Similarity=0.762 Sum_probs=242.1
Q ss_pred CCcccCHHHHHHHhhccc--cccCCCcceeEEEEEcCCCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeE
Q 036583 480 MPVRFTYRDLQTATNNFS--VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGF 555 (817)
Q Consensus 480 ~~~~~~~~~l~~~~~~~~--~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~ 555 (817)
....+++.++...+.+|. +.||+|+||+||+|+..+++.||||++.... .....+.+|++++.+++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 345788899988887775 7899999999999998889999999997542 234479999999999999999999999
Q ss_pred eecCCeeeEEEeeccCCChhhhhhhccc-ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEE
Q 036583 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQ-EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKV 634 (817)
Q Consensus 556 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki 634 (817)
+.+....++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.+..+|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 9999999999999999999999976432 335899999999999999999999933339999999999999999999999
Q ss_pred eecCCccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCC--CCCCCcchHHHHHH
Q 036583 635 SDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNE--TSDKAHFPSYAFKM 712 (817)
Q Consensus 635 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~--~~~~~~~~~~~~~~ 712 (817)
+|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||+... .........+....
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999999876555544555679999999999999899999999999999999999999996322 11222344455455
Q ss_pred hhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 713 MEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 713 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
.....+..+.+..+......+....+.+++.+||+.||.+|||++||+++|++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 5556667777777777777788889999999999999999999999999999753
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=386.86 Aligned_cols=259 Identities=20% Similarity=0.306 Sum_probs=197.2
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeec------CCee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAE------GTHR 562 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~------~~~~ 562 (817)
.+.+.++||+|+||+||+|+. .+|+.||||++..... ..+.+.+|+++|++++|||||++++++.. ....
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 356678999999999999995 4699999999976533 24578899999999999999999998753 3678
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
|||||||+ |+|.+++.+.. .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.
T Consensus 135 ~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 99999996 68999997654 68999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCC---ceeeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhc--
Q 036583 643 MTREQ---SHVFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEG-- 716 (817)
Q Consensus 643 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-- 716 (817)
+.... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||......+ ....+.......
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~---~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH---QLQLIMMVLGTPSP 284 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHHHCCCCG
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhcCCCCh
Confidence 64322 1223457899999999998875 56899999999999999999999997543211 000000000000
Q ss_pred ---------chhhhccccc-CCcccH-----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 717 ---------KLRNILDSRL-NIDEQS-----DRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 717 ---------~~~~~~d~~~-~~~~~~-----~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.....+.... ..+... .....+.+|+.+||+.||++|||++|+++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000000 000000 11346789999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=372.20 Aligned_cols=269 Identities=35% Similarity=0.641 Sum_probs=231.0
Q ss_pred cccccCCCcceeEEEEEcCCCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCCh
Q 036583 496 FSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSL 574 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 574 (817)
+.+.||+|+||+||+|+..+++.||||++.... ...+.+.+|++++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 43 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 122 (321)
T 2qkw_B 43 HKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122 (321)
T ss_dssp CCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBT
T ss_pred ccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcH
Confidence 347899999999999998889999999987653 3457899999999999999999999999999999999999999999
Q ss_pred hhhhhhccc-ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc-eeee
Q 036583 575 DKWIFKKNQ-EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS-HVFT 652 (817)
Q Consensus 575 ~~~l~~~~~-~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~-~~~~ 652 (817)
.+++..... ...+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 123 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 199 (321)
T 2qkw_B 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199 (321)
T ss_dssp GGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBC
T ss_pred HHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeeccccccccccccccccc
Confidence 999975432 2358999999999999999999999 8999999999999999999999999999986543222 2223
Q ss_pred eccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccH
Q 036583 653 TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQS 732 (817)
Q Consensus 653 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 732 (817)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||.............+.......+.+..++++.+......
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (321)
T 2qkw_B 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRP 279 (321)
T ss_dssp CCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCH
T ss_pred ccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCH
Confidence 35689999999999988999999999999999999999999987665555555555555666667777777776666667
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 733 DRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 733 ~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
+....+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 280 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 280 ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp HHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 78889999999999999999999999999999764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=373.84 Aligned_cols=195 Identities=24% Similarity=0.360 Sum_probs=167.1
Q ss_pred hhccccccCCCcceeEEEEEc----CCCcEEEEEEeccCCcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEe
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL----PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~----~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 567 (817)
.+.+.++||+|+||+||+|+. ..++.||||++... .....+.+|++++..+ +||||+++++++.+.++.++|||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE 100 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP 100 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence 466778999999999999974 24678999998654 3456788999999998 69999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCC-CcEEEeecCCccccCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDN-YHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~Dfgla~~~~~~ 646 (817)
|+++|+|.+++. .+++..+..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 101 ~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 101 YLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp CCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred CCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 999999999983 37888999999999999999999 999999999999999876 79999999999865432
Q ss_pred Cc---------------------------eeeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCC
Q 036583 647 QS---------------------------HVFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPN 697 (817)
Q Consensus 647 ~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~ 697 (817)
.. ......+||+.|||||++.+. .++.++||||+||++|||++|+.||...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 11 112345799999999999875 5899999999999999999999999644
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=389.78 Aligned_cols=245 Identities=23% Similarity=0.315 Sum_probs=197.7
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHH---HHHhhccCcceeeeeeeEeecCCeeeEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAE---VSIIGSIHHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~E---v~~l~~l~h~niv~l~~~~~~~~~~~lv 565 (817)
+.+.+.||+|+||+||+++.. +|+.||||++.+. ......+.+| +.++..++|||||++++++.+.+..|||
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 455688999999999999964 6899999999643 2333444444 6677788999999999999999999999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|||++||+|.++|.+.. .+++..+..++.||+.||+|||+ ++|+||||||+||||+.+|.+||+|||+|+.+..
T Consensus 271 mEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp ECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999997654 58999999999999999999999 9999999999999999999999999999987754
Q ss_pred CCceeeeeccCCCCccCccccc-cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccc
Q 036583 646 EQSHVFTTLRGTRGYLAPEWIT-NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 724 (817)
.. ..+.+||+.|||||++. +..|+.++|||||||+||||++|+.||....... . ..........
T Consensus 345 ~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---~-~~i~~~i~~~-------- 409 (689)
T 3v5w_A 345 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---K-HEIDRMTLTM-------- 409 (689)
T ss_dssp CC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---H-HHHHHHHHHC--------
T ss_pred CC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---H-HHHHHhhcCC--------
Confidence 43 23578999999999996 4579999999999999999999999996433221 0 1111111111
Q ss_pred ccCCcccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 036583 725 RLNIDEQSDRVFTAVKVALWCVQEDMSLRPS-----MTKVVQ 761 (817)
Q Consensus 725 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt-----~~evl~ 761 (817)
....+ ......+.+|+.+||+.||.+|++ ++||++
T Consensus 410 ~~~~p--~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 410 AVELP--DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CCCCC--TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCCCC--ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11111 122346789999999999999998 688875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=393.78 Aligned_cols=249 Identities=21% Similarity=0.335 Sum_probs=205.7
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.+.+.++||+|+||+||+++. .+|+.||+|++.... ...+.+.+|+++|+.++|||||++++++.+....+||||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 456778999999999999995 468999999997643 335678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCC--CcEEEeecCCccccCCCCc
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDN--YHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~--~~~ki~Dfgla~~~~~~~~ 648 (817)
+|+|.++|..... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 238 gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 238 GGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp CCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred CCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 9999999965433 58999999999999999999999 999999999999999854 899999999999876543
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ......+...... ...
T Consensus 312 -~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-------~~~~~~i~~~~~~------~~~ 377 (573)
T 3uto_A 312 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-------DETLRNVKSCDWN------MDD 377 (573)
T ss_dssp -EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHTTCCC------CCS
T ss_pred -ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHhCCCC------CCc
Confidence 23456899999999999999999999999999999999999999964321 1122222222110 111
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.........+.+|+.+||+.||.+|||++|+++
T Consensus 378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122346789999999999999999999988
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=355.80 Aligned_cols=256 Identities=23% Similarity=0.382 Sum_probs=214.6
Q ss_pred HhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
..+.+.++||+|+||+||+++..++..||||++.......+++.+|++++.+++||||+++++++.+....++||||+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISN 87 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCC
Confidence 45667789999999999999998888999999987777788999999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
++|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...........
T Consensus 88 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 162 (268)
T 3sxs_A 88 GCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162 (268)
T ss_dssp CBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred CcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence 999999976543 58999999999999999999999 8999999999999999999999999999987765544333
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
....+++.|+|||.+.+..++.++||||||++++||++ |+.||...... .....+..+.. ...
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~---------~~~ 226 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-------EVVLKVSQGHR---------LYR 226 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHHHHTTCC---------CCC
T ss_pred cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-------HHHHHHHcCCC---------CCC
Confidence 34566778999999999899999999999999999999 99999643211 11111111110 011
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
+......+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 11123468899999999999999999999999998754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=353.14 Aligned_cols=280 Identities=38% Similarity=0.627 Sum_probs=228.1
Q ss_pred CCcccCHHHHHHHhhccc--------cccCCCcceeEEEEEcCCCcEEEEEEeccCC-----cCHHHHHHHHHHhhccCc
Q 036583 480 MPVRFTYRDLQTATNNFS--------VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIG-----QGKKEFRAEVSIIGSIHH 546 (817)
Q Consensus 480 ~~~~~~~~~l~~~~~~~~--------~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~-----~~~~~~~~Ev~~l~~l~h 546 (817)
....|++.++..++.+|. ++||+|+||.||+|.. +++.||||++.... ...+.+.+|+.++.+++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 346799999999999986 4599999999999998 68899999986532 225679999999999999
Q ss_pred ceeeeeeeEeecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEe
Q 036583 547 LHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL 626 (817)
Q Consensus 547 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll 626 (817)
|||+++++++.+.+..++||||+++++|.+++........+++..++.++.||+.||+|||+ .+|+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEE
Confidence 99999999999999999999999999999999765544578999999999999999999999 899999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcc
Q 036583 627 DDNYHAKVSDFGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHF 705 (817)
Q Consensus 627 ~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~ 705 (817)
+.++.+||+|||+++......... .....|++.|+|||.+.+ .++.++||||||+++|||++|+.||....... .+
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~ 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LL 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--BT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--HH
Confidence 999999999999998765433222 233578999999998875 57899999999999999999999997654322 11
Q ss_pred hHHHHHHh-hhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 706 PSYAFKMM-EEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 706 ~~~~~~~~-~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
..+..... ....+...+++.+. .........+.+++.+||+.||.+|||++||+++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11111111 11223444444332 334456778999999999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=362.47 Aligned_cols=262 Identities=27% Similarity=0.442 Sum_probs=201.3
Q ss_pred HhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcC---HHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQG---KKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~---~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
..+.+.++||+|+||+||+++. +|+.||||++...... .+++.+|++++.+++||||+++++++.+....++||||
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred hHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 4456678999999999999987 6889999999765322 35789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCc--eeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR--IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
+++|+|.+++........+++..++.++.||+.||+|||+ .+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 9999999999876544458999999999999999999998 78 999999999999999999999999999865432
Q ss_pred CceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 647 QSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... . ........ ...
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~------~-~~~~~~~~------~~~- 257 (309)
T 3p86_A 193 F-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA------Q-VVAAVGFK------CKR- 257 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH------H-HHHHHHHS------CCC-
T ss_pred c-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhc------CCC-
Confidence 2 1223467899999999999999999999999999999999999999643211 1 11111100 001
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCCCCCC
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQPP 773 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~ 773 (817)
..........+.+++.+||+.||.+|||++|+++.|+.+.....||
T Consensus 258 -~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 258 -LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred -CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 1111122346889999999999999999999999999875544333
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=366.05 Aligned_cols=262 Identities=26% Similarity=0.319 Sum_probs=206.9
Q ss_pred hhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCC----eeeEEEee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT----HRLLAYEF 568 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~ 568 (817)
.+.+.++||+|+||+||+|+.. ++.||||++.........+..|+.++.+++||||+++++++.+.. ..++||||
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~ 103 (322)
T 3soc_A 25 PLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF 103 (322)
T ss_dssp EEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred hchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEec
Confidence 4556688999999999999974 789999999765555566778999999999999999999998754 46999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCC----------ceeecCCCCCCeEecCCCcEEEeecC
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ----------RIIHCDIKPENVLLDDNYHAKVSDFG 638 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~----------~ivH~Dlk~~NIll~~~~~~ki~Dfg 638 (817)
+++|+|.+++... .+++..++.++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||
T Consensus 104 ~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 104 HEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp CTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 9999999999653 48999999999999999999998 7 99999999999999999999999999
Q ss_pred CccccCCCCce-eeeeccCCCCccCcccccc-----CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHH----
Q 036583 639 LAKLMTREQSH-VFTTLRGTRGYLAPEWITN-----YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSY---- 708 (817)
Q Consensus 639 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~---- 708 (817)
+++........ ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..........+...
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 99876543322 1223578999999999986 3566789999999999999999999976544332222111
Q ss_pred -----HHHHhhhcchhhhcccccCC-cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 709 -----AFKMMEEGKLRNILDSRLNI-DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 709 -----~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.......... .+.+.. .........+.+++.+||+.||++|||++||++.|+.+
T Consensus 257 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 257 PSLEDMQEVVVHKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CCHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CchhhhhhhhhcccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111111111 111111 11224556789999999999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=379.45 Aligned_cols=256 Identities=27% Similarity=0.479 Sum_probs=196.6
Q ss_pred HhhccccccCCCcceeEEEEEcC----CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP----DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~----~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv 565 (817)
..+.+.+.||+|+||.||+|+.. ++..||||+++... ...++|.+|+.++.+++||||+++++++.+....++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 45566788999999999999864 56789999997542 2356799999999999999999999999999999999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|||+++|+|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 125 ~e~~~~~sL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999976543 58899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCceeee--eccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 646 EQSHVFT--TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 646 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
....... ...++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..+
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-------~~~~~~i~~~------ 266 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-------QDVIKAVDEG------ 266 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-------HHHHHHHHTT------
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcC------
Confidence 3322212 2345678999999999999999999999999999998 9999964321 1111222221
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
...+........+.+++.+||+.||++||+++||+++|+.+..
T Consensus 267 ---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 267 ---YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp ---EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 1111222334568899999999999999999999999988743
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=355.49 Aligned_cols=253 Identities=26% Similarity=0.450 Sum_probs=211.7
Q ss_pred hhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
.+.+.++||+|+||+||+++..+++.||+|++.......+++.+|++++.+++||||+++++++.+....++||||++++
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (269)
T 4hcu_A 11 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 90 (269)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred hceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCC
Confidence 45567889999999999999888999999999877777889999999999999999999999999999999999999999
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeee
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT 652 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 652 (817)
+|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...........
T Consensus 91 ~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 91 CLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp BHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred cHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 99999976443 58899999999999999999999 89999999999999999999999999999876543332233
Q ss_pred eccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 653 TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 653 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
...+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..+. .....
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-------~~~~~~~~~~~---------~~~~~ 229 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVVEDISTGF---------RLYKP 229 (269)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTC---------CCCCC
T ss_pred CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-------HHHHHHHhcCc---------cCCCC
Confidence 4566778999999999999999999999999999999 9999964321 11122222211 11111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
......+.+++..||+.||++|||++|++++|+++
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 11234688999999999999999999999999876
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=385.36 Aligned_cols=260 Identities=27% Similarity=0.415 Sum_probs=215.8
Q ss_pred HHHHhhccccccCCCcceeEEEEEcCC-CcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 489 LQTATNNFSVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 489 l~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
+....+.+.++||+|+||.||+|+... ++.||||++.......++|.+|+.++++++||||++++++|.+....++|||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 344556677899999999999999764 8899999998776678899999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+++|+|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 9999999999976432 258899999999999999999999 899999999999999999999999999999775443
Q ss_pred ceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
........++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+...+..+ .
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~---------~ 436 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELLEKD---------Y 436 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-------GHHHHHHTT---------C
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcC---------C
Confidence 322233456778999999999999999999999999999999 99999654321 122222221 1
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
...........+.+++.+||+.||++||||.||+++|+.+..
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 112222334568899999999999999999999999998743
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=367.02 Aligned_cols=258 Identities=26% Similarity=0.464 Sum_probs=207.1
Q ss_pred HHHhhccccccCCCcceeEEEEEcC----CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeee
Q 036583 490 QTATNNFSVKLGQGGFGSVYQGVLP----DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 490 ~~~~~~~~~~lG~G~fG~Vy~g~~~----~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 563 (817)
....+.+.++||+|+||+||+|... .+..||||++.... ...+.+.+|+.++.+++||||+++++++.++...+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3345566688999999999999964 34569999997542 23567999999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+||||+++|+|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 127 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999965533 58899999999999999999999 89999999999999999999999999999977
Q ss_pred CCCCceee--eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhh
Q 036583 644 TREQSHVF--TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRN 720 (817)
Q Consensus 644 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (817)
........ ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..+
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-------~~~~~~~~~~---- 270 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-------RDVISSVEEG---- 270 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------HHHHHHHHTT----
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHHcC----
Confidence 54432222 22456778999999999999999999999999999999 9999964321 1112222221
Q ss_pred hcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 721 ILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 721 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
...+........+.+++.+||+.||++|||++||+++|+.+..
T Consensus 271 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 271 -----YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1111222334568899999999999999999999999998744
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=382.86 Aligned_cols=259 Identities=24% Similarity=0.402 Sum_probs=212.7
Q ss_pred HHHHhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 489 LQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 489 l~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+....+.+.++||+|+||+||+|...+++.||||+++......++|.+|+.++++++||||+++++++. .+..++||||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 334456667899999999999999988899999999877677889999999999999999999999987 5678999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++|+|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 264 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 999999999975432 257888999999999999999999 8999999999999999999999999999987654322
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
.......++..|+|||.+....++.++|||||||++|||++ |+.||..... ......+..+. .
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-------~~~~~~i~~~~---------~ 403 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-------PEVIRALERGY---------R 403 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHHHTC---------C
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCC---------C
Confidence 22223456778999999998899999999999999999999 9999964321 11222222221 1
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
.+.+......+.+++.+||+.||++|||+++|+++|+.+..
T Consensus 404 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 11122234578899999999999999999999999998743
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=353.18 Aligned_cols=254 Identities=22% Similarity=0.376 Sum_probs=209.1
Q ss_pred HhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
..+.+.++||+|+||+||++...++..||||++.......+++.+|++++.+++||||+++++++.+....++||||+++
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 103 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTT
T ss_pred HHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCC
Confidence 45566789999999999999998888999999987777788999999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
++|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++..........
T Consensus 104 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 104 GCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp CBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred CcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 999999976433 58999999999999999999999 8999999999999999999999999999987654332222
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..+. ....
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-------~~~~~~~~~~~---------~~~~ 242 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-------SETAEHIAQGL---------RLYR 242 (283)
T ss_dssp TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHHHHHTTC---------CCCC
T ss_pred cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-------hHHHHHHhccc---------CCCC
Confidence 33556788999999998899999999999999999998 9999964321 11112222211 1111
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.......+.+++.+||+.||++|||++|+++.|+.+
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 243 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 111234688999999999999999999999999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=366.58 Aligned_cols=257 Identities=25% Similarity=0.406 Sum_probs=207.8
Q ss_pred HhhccccccCCCcceeEEEEEc--------CCCcEEEEEEeccCCc--CHHHHHHHHHHhhcc-CcceeeeeeeEeecCC
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL--------PDGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGT 560 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~--------~~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~ 560 (817)
..+.+.+.||+|+||.||+|+. .++..||||++..... ..+++.+|++++.++ +||||++++++|.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 3455678899999999999984 2456799999975432 346799999999999 8999999999999999
Q ss_pred eeeEEEeeccCCChhhhhhhccc-------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec
Q 036583 561 HRLLAYEFMANGSLDKWIFKKNQ-------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD 627 (817)
Q Consensus 561 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~ 627 (817)
..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEEC
Confidence 99999999999999999976431 1247889999999999999999999 8999999999999999
Q ss_pred CCCcEEEeecCCccccCCCCce-eeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcc
Q 036583 628 DNYHAKVSDFGLAKLMTREQSH-VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHF 705 (817)
Q Consensus 628 ~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~ 705 (817)
.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~----- 312 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----- 312 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH-----
Confidence 9999999999999876543221 1123457789999999999999999999999999999999 99999653221
Q ss_pred hHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 706 PSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 706 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
.....+..+.. ..........+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 313 --~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 313 --ELFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp --GHHHHHHTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 12222222211 1111223346889999999999999999999999998763
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=379.26 Aligned_cols=258 Identities=26% Similarity=0.389 Sum_probs=206.8
Q ss_pred HHhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
...+.+.++||+|+||.||+|...++..||||+++......++|.+|++++++++||||+++++++.+ +..++||||++
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 34456678999999999999999888889999998766667899999999999999999999999976 67899999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+|+|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.........
T Consensus 262 ~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 262 KGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp TCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 9999999975432 258899999999999999999999 899999999999999999999999999998765433222
Q ss_pred eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 651 FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ......+..+. ..+
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-------~~~~~~i~~~~---------~~~ 401 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGY---------RMP 401 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTC---------CCC
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCC---------CCC
Confidence 233557789999999999999999999999999999999 9999964321 11222222221 111
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCC
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPV 769 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 769 (817)
.+......+.+++.+||+.||++|||++++++.|+.+...
T Consensus 402 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 1223345688999999999999999999999999987543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=355.89 Aligned_cols=256 Identities=28% Similarity=0.424 Sum_probs=206.6
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.+.+.++||+|+||+||++... +++.||+|++.... ...+.+.+|++++.+++||||+++++++.++...++||||++
T Consensus 11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (310)
T 3s95_A 11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK 90 (310)
T ss_dssp GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecC
Confidence 4456688999999999999964 58899999986543 345789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+|+|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 91 ~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 91 GGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp TCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999999976433 58999999999999999999999 899999999999999999999999999998764432211
Q ss_pred -------------eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcc
Q 036583 651 -------------FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGK 717 (817)
Q Consensus 651 -------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 717 (817)
.....||+.|+|||.+.+..++.++||||||+++|||++|..|+.............
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~---------- 235 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN---------- 235 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC----------
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh----------
Confidence 114579999999999999999999999999999999999999986543322111000
Q ss_pred hhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 718 LRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 718 ~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
.....+.... ......+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 236 ~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 236 VRGFLDRYCP----PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp HHHHHHHTCC----TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhccccccCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0011111110 111235778999999999999999999999998773
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=369.96 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=206.0
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
..+.+.++||+|+||.||+|+.. +++.||||.+..... ..++|.+|++++++++||||+++++++.+.+..++||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 34556789999999999999975 689999999875422 235688999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++|+|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 194 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 194 VQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred CCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 999999999976543 58899999999999999999999 8999999999999999999999999999986543321
Q ss_pred eee-eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 649 HVF-TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 649 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
... ....++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ......+..+.
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-------~~~~~~~~~~~--------- 332 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-------QQTREFVEKGG--------- 332 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-------HHHHHHHHTTC---------
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCC---------
Confidence 111 11235678999999998899999999999999999998 9999964321 11222222221
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
..+.+...+..+.+++.+||+.||++|||++|+++.|+.+
T Consensus 333 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 1111122334688999999999999999999999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=347.55 Aligned_cols=247 Identities=24% Similarity=0.373 Sum_probs=204.0
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccC-CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI-GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.+.+.++||+|+||+||++.. .+++.||||++... ....+.+.+|+.++++++||||+++++++..++..++||||++
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 455668899999999999985 56899999999654 3456788999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+|+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 101 ~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 172 (297)
T 3fxz_A 101 GGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (297)
T ss_dssp TCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred CCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-
Confidence 99999999654 48889999999999999999999 89999999999999999999999999999876544322
Q ss_pred eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 651 FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .........+. + ....
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~------~--~~~~ 238 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGT------P--ELQN 238 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCS------C--CCSC
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC------C--CCCC
Confidence 23467999999999999999999999999999999999999999643211 11111111111 0 1111
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.......+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 2223446789999999999999999999987
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=350.40 Aligned_cols=259 Identities=23% Similarity=0.340 Sum_probs=211.7
Q ss_pred cccCHHHHHHHhhc------------cccccCCCcceeEEEEEcC-CCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcc
Q 036583 482 VRFTYRDLQTATNN------------FSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHL 547 (817)
Q Consensus 482 ~~~~~~~l~~~~~~------------~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~ 547 (817)
..++++++..++.. +.++||+|+||.||+|+.. +|+.||||++.... ...+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 46888888887754 2357999999999999965 69999999997553 4567899999999999999
Q ss_pred eeeeeeeEeecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec
Q 036583 548 HLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD 627 (817)
Q Consensus 548 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~ 627 (817)
||+++++++...+..++||||+++++|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+||+++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEC
Confidence 9999999999999999999999999999998643 48999999999999999999999 8999999999999999
Q ss_pred CCCcEEEeecCCccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchH
Q 036583 628 DNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPS 707 (817)
Q Consensus 628 ~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~ 707 (817)
.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-------~ 247 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-------V 247 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------H
T ss_pred CCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------H
Confidence 999999999999987654322 12346799999999999999999999999999999999999999964321 1
Q ss_pred HHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 708 YAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 708 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.....+.... .+.+. ........+.+++.+||+.||++|||++|+++.
T Consensus 248 ~~~~~~~~~~-----~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 248 QAMKRLRDSP-----PPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHHHSS-----CCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhcCC-----CCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112222111 11111 111223467899999999999999999999983
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=351.36 Aligned_cols=258 Identities=27% Similarity=0.426 Sum_probs=214.7
Q ss_pred HHHHhhccccccCCCcceeEEEEEcCC-CcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 489 LQTATNNFSVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 489 l~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
+....+.+.++||+|+||+||+|.... ++.||+|++.......+.+.+|++++++++||||+++++++.+....++|||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 334556677899999999999999754 7889999998766667889999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+++++|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 9999999999976433 268899999999999999999999 899999999999999999999999999999876554
Q ss_pred ceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
........+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+... .
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-------~~~~~~~~---------~ 229 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKD---------Y 229 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHHHHTT---------C
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcc---------C
Confidence 444444667889999999999999999999999999999999 999996543211 11111111 1
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
...........+.+++.+|++.||.+|||++|++++|+.+
T Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 1111122335688999999999999999999999999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=345.21 Aligned_cols=261 Identities=26% Similarity=0.381 Sum_probs=204.9
Q ss_pred HhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc----CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ----GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~----~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
..+.+.++||+|+||.||+++. ..++.||+|++..... ..+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 3456678999999999999985 4688999999854322 2367899999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
||+++++|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 91 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999999997654 58999999999999999999999 89999999999999999999999999999877554
Q ss_pred CceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 647 QSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
.........||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ........... ......
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~-~~~~~~--- 234 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDS-VPNVTT--- 234 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSSC-CCCHHH---
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhcc-CCCcch---
Confidence 33333446799999999999999999999999999999999999999964321 11111111111 111100
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcCCCCC
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRP-SMTKVVQMLEGICPVP 770 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RP-t~~evl~~L~~~~~~~ 770 (817)
......+..+.+++.+|++.||++|| +++++.+.|+.+....
T Consensus 235 --~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 235 --DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp --HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred --hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 00111234688999999999999998 9999999999875443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=369.39 Aligned_cols=249 Identities=29% Similarity=0.450 Sum_probs=204.5
Q ss_pred HhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCC-eeeEEEeecc
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT-HRLLAYEFMA 570 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~ 570 (817)
..+.+.++||+|+||.||+|.. .++.||||+++... ..+.|.+|++++++++||||+++++++.+.. ..++||||++
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~ 270 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 270 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCT
T ss_pred HHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecC
Confidence 3445568899999999999998 47899999997643 5678999999999999999999999987665 7899999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+|+|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 271 ~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 343 (450)
T 1k9a_A 271 KGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 343 (450)
T ss_dssp TCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc---
Confidence 9999999986542 247889999999999999999999 899999999999999999999999999998543321
Q ss_pred eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 651 FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
....++..|+|||.+.+..++.++|||||||++|||++ |+.||....... +...+..+. ..+
T Consensus 344 -~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~---------~~~ 406 (450)
T 1k9a_A 344 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGY---------KMD 406 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-------HHHHHHTTC---------CCC
T ss_pred -cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC---------CCC
Confidence 22467889999999999999999999999999999998 999997543221 122222221 111
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.+......+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1222345788999999999999999999999999876
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=358.48 Aligned_cols=266 Identities=25% Similarity=0.399 Sum_probs=202.9
Q ss_pred HHhhccccccCCCcceeEEEEEc-----CCCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecC--Cee
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVL-----PDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG--THR 562 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~-----~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~ 562 (817)
...+.+.++||+|+||+||++++ .+++.||||++.... ...+.+.+|++++.+++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 34566778999999999999983 368899999997543 2346799999999999999999999998653 458
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
++||||+++|+|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 999999999999999976543 58899999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCce--eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCC-----CCCcchHHHHHHhhh
Q 036583 643 MTREQSH--VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETS-----DKAHFPSYAFKMMEE 715 (817)
Q Consensus 643 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~-----~~~~~~~~~~~~~~~ 715 (817)
....... ......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~----- 238 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV----- 238 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH-----
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH-----
Confidence 6543221 122345677899999999999999999999999999999999988532100 0000000000
Q ss_pred cchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 716 GKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 716 ~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
..+.+.+......+........+.+++.+||+.||++|||++|+++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 001111111111222223345788999999999999999999999999876
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=345.14 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=210.5
Q ss_pred hhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
.+.+.++||+|+||.||++...+++.||+|++.......+++.+|++++.+++||||+++++++.+.+..++||||++++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHG 88 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTC
T ss_pred heeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCC
Confidence 45566889999999999999888899999999877667789999999999999999999999999999999999999999
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeee
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT 652 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 652 (817)
+|.+++..... .+++..++.++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++............
T Consensus 89 ~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (267)
T 3t9t_A 89 CLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163 (267)
T ss_dssp BHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred cHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence 99999976533 58899999999999999999999 89999999999999999999999999999876443222223
Q ss_pred eccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 653 TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 653 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..+.. ...+
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~i~~~~~---------~~~~ 227 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVVEDISTGFR---------LYKP 227 (267)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCC---------CCCC
T ss_pred cccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-------HHHHHHHhcCCc---------CCCC
Confidence 3456778999999998899999999999999999999 8999964321 111222222110 0111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
......+.+++.+||+.||++|||++|++++|+.+
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11234678999999999999999999999999876
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=382.07 Aligned_cols=259 Identities=25% Similarity=0.387 Sum_probs=212.4
Q ss_pred HHHhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 490 QTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 490 ~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
....+.+.++||+|+||.||+|.+.++..||||+++......++|.+|++++++++||||+++++++.+ +..++||||+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 334556678999999999999999888899999998766667899999999999999999999999976 6789999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++|+|.++|..... ..+++..++.++.||+.||+|||+ ++|+||||||+||||++++.+||+|||+++........
T Consensus 344 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 344 SKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp TTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred cCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 99999999975422 258899999999999999999999 89999999999999999999999999999876543222
Q ss_pred eeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
......++..|+|||.+.+..++.++|||||||+||||++ |+.||..... ......+..+. ..
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-------~~~~~~i~~~~---------~~ 483 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGY---------RM 483 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-------HHHHHHHHTTC---------CC
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCC---------CC
Confidence 2223456788999999999899999999999999999999 9999964321 11222222221 11
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCC
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPV 769 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 769 (817)
+........+.+++.+||+.||++|||+++|+++|+.+...
T Consensus 484 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 11122344688999999999999999999999999987543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=347.07 Aligned_cols=254 Identities=27% Similarity=0.431 Sum_probs=209.7
Q ss_pred HhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
..+.+.++||+|+||.||+|...+++.||||++.......+.+.+|++++.+++||||+++++++.+ +..++||||+++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 91 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCC
Confidence 4566778999999999999998888899999998766678899999999999999999999999874 568999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
++|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++...........
T Consensus 92 ~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T 1qpc_A 92 GSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (279)
T ss_dssp CBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence 999999975432 258899999999999999999999 8999999999999999999999999999987765433333
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
....++..|+|||.+.+..++.++||||||++++||++ |+.||..... ......+..+. ....
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~~---------~~~~ 231 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PEVIQNLERGY---------RMVR 231 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTC---------CCCC
T ss_pred cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-------HHHHHHHhccc---------CCCC
Confidence 33556789999999998899999999999999999999 8999964321 11122222211 1111
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.......+.+++.+|++.||++|||++++++.|+.+
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 112234688999999999999999999999999876
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=349.21 Aligned_cols=259 Identities=23% Similarity=0.344 Sum_probs=200.5
Q ss_pred HhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhc--cCcceeeeeeeEeec----CCeeeEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGS--IHHLHLVKLRGFCAE----GTHRLLA 565 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~--l~h~niv~l~~~~~~----~~~~~lv 565 (817)
..+.+.++||+|+||+||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++.+ ....++|
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv 84 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI 84 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence 3456678999999999999998 7899999999643 34556667776665 799999999999754 3457999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHH--------hcCCCceeecCCCCCCeEecCCCcEEEeec
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLH--------EDCDQRIIHCDIKPENVLLDDNYHAKVSDF 637 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH--------~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df 637 (817)
|||+++|+|.+++... .+++..++.++.||+.||+||| + .+|+||||||+|||++.++.+||+||
T Consensus 85 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 85 THYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp ECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECCC
T ss_pred hhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEeeC
Confidence 9999999999999543 5899999999999999999999 6 89999999999999999999999999
Q ss_pred CCccccCCCCcee---eeeccCCCCccCccccccC------ccCccccccchhhhHHHhhhC----------CCCCCCCC
Q 036583 638 GLAKLMTREQSHV---FTTLRGTRGYLAPEWITNY------AISEKSDVYSYGMVLLEIIGG----------RKNFDPNE 698 (817)
Q Consensus 638 gla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~Gvvl~elltg----------~~pf~~~~ 698 (817)
|+++......... .....||+.|+|||.+.+. .++.++|||||||++|||++| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9998765443322 1234799999999999876 556799999999999999999 77775433
Q ss_pred CCCCCcchHHHHHHhhhcchhhhcccccC-CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 699 TSDKAHFPSYAFKMMEEGKLRNILDSRLN-IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.... .. ........... ..+... ..........+.+++.+||+.||++|||++||++.|+++
T Consensus 238 ~~~~-~~-~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PNDP-SF-EDMRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSSC-CH-HHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCc-ch-hhhhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2221 11 11111111111 011111 112234667899999999999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=350.98 Aligned_cols=245 Identities=21% Similarity=0.320 Sum_probs=203.0
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
.+.+.++||+|+||.||+|+. .+|+.||||++..... ..+.+.+|+++++.++||||+++++++......++||||
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 95 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence 355668899999999999996 5799999999975432 345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 96 ~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 169 (328)
T 3fe3_A 96 ASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169 (328)
T ss_dssp CTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc
Confidence 99999999997654 58899999999999999999999 8999999999999999999999999999987654322
Q ss_pred eeeeeccCCCCccCccccccCccC-ccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAIS-EKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
.....||+.|+|||.+.+..+. .++|||||||++|||++|+.||..... ......+..+. ..
T Consensus 170 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~--------~~ 232 (328)
T 3fe3_A 170 --LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-------KELRERVLRGK--------YR 232 (328)
T ss_dssp --GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC--------CC
T ss_pred --cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC--------CC
Confidence 2446799999999999987765 799999999999999999999964321 11222222221 11
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.+ ......+.+++.+||+.||.+|||++|+++.
T Consensus 233 ~p--~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 233 IP--FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CC--TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CC--CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11 1123467899999999999999999999873
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=356.23 Aligned_cols=254 Identities=26% Similarity=0.457 Sum_probs=200.0
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCc----EEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGT----RLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLL 564 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~----~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 564 (817)
..+.+.++||+|+||+||+|+.. +++ +||+|.+... ....+++.+|+.++.+++||||++++++|.++. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 44566789999999999999953 444 3688887543 345678999999999999999999999998754 789
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
|+||+++|+|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999999976543 58899999999999999999999 899999999999999999999999999998765
Q ss_pred CCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 645 REQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 645 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
...... .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... ....+..+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~----- 236 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGE----- 236 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTC-----
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-------HHHHHHcCC-----
Confidence 443222 223566889999999999999999999999999999999 999996543211 112222211
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
..+........+.+++.+||+.||++||+++|+++.|+.+.
T Consensus 237 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 237 ----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ----CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11112223446889999999999999999999999998763
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=362.60 Aligned_cols=259 Identities=25% Similarity=0.403 Sum_probs=207.0
Q ss_pred HHHhhccccccCCCcceeEEEEEc------CCCcEEEEEEeccCCc--CHHHHHHHHHHhhcc-CcceeeeeeeEeecCC
Q 036583 490 QTATNNFSVKLGQGGFGSVYQGVL------PDGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGT 560 (817)
Q Consensus 490 ~~~~~~~~~~lG~G~fG~Vy~g~~------~~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~ 560 (817)
....+.+.++||+|+||.||+|+. .+++.||||++..... ..+.+.+|++++.++ +||||+++++++.+.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 345566678999999999999972 3567899999975432 346799999999999 8999999999998755
Q ss_pred -eeeEEEeeccCCChhhhhhhccc--------------------------------------------------------
Q 036583 561 -HRLLAYEFMANGSLDKWIFKKNQ-------------------------------------------------------- 583 (817)
Q Consensus 561 -~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 583 (817)
..++||||+++|+|.+++.....
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 48999999999999999976532
Q ss_pred -------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc-eeeeecc
Q 036583 584 -------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS-HVFTTLR 655 (817)
Q Consensus 584 -------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~-~~~~~~~ 655 (817)
...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .......
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 1128899999999999999999999 8999999999999999999999999999987644332 2233467
Q ss_pred CCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHH
Q 036583 656 GTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDR 734 (817)
Q Consensus 656 gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 734 (817)
||+.|+|||++.+..++.++||||||+++|||++ |+.||...... ......+..+.... .....
T Consensus 257 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~~~~~~~~~~---------~~~~~ 321 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRRLKEGTRMR---------APDYT 321 (359)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS------HHHHHHHHHTCCCC---------CCTTC
T ss_pred CCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh------HHHHHHHHcCCCCC---------CCCCC
Confidence 8899999999999999999999999999999998 99999654322 12222222221111 11112
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 735 VFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 735 ~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
...+.+++..||+.||++|||++|++++|+.+
T Consensus 322 ~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 322 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 34688999999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=353.59 Aligned_cols=253 Identities=25% Similarity=0.431 Sum_probs=200.5
Q ss_pred hhccccccCCCcceeEEEEEcC-CCc----EEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGT----RLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~----~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv 565 (817)
.+.+.++||+|+||+||+|+.. +++ +||+|.+... ....+.+.+|+.++.+++||||+++++++. +...++|
T Consensus 14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 92 (325)
T 3kex_A 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLV 92 (325)
T ss_dssp TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEE
T ss_pred HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEE
Confidence 3455678999999999999853 444 3788887543 233467889999999999999999999986 4668999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|||+++|+|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRG--ALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EECCTTCBSHHHHHSSGG--GSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEeCCCCCHHHHHHHccc--cCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999976533 68999999999999999999999 8999999999999999999999999999998755
Q ss_pred CCce-eeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 646 EQSH-VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 646 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+..+....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~--- 237 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-------VPDLLEKGERLA--- 237 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-------HHHHHHTTCBCC---
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCCCCC---
Confidence 4322 2234667889999999999999999999999999999999 999997543221 122222221110
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
........+.+++.+||+.||.+|||++|+++.|+.+.
T Consensus 238 ------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 238 ------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp ------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11112224678999999999999999999999998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=363.66 Aligned_cols=259 Identities=19% Similarity=0.243 Sum_probs=204.5
Q ss_pred HHHHHHHhhc--cccccCCCcceeEEEEEcCC-CcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeec
Q 036583 486 YRDLQTATNN--FSVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558 (817)
Q Consensus 486 ~~~l~~~~~~--~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~ 558 (817)
+.++...+.+ +.++||+|+||+||+++... ++.||||++.+. ....+.+.+|+.++..++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3344333334 45889999999999999754 788999999652 2233458999999999999999999999999
Q ss_pred CCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecC
Q 036583 559 GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFG 638 (817)
Q Consensus 559 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg 638 (817)
.+..++||||+++|+|.+++.+... .+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~--~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999976432 58999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeeeccCCCCccCccccc-----cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHh
Q 036583 639 LAKLMTREQSHVFTTLRGTRGYLAPEWIT-----NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMM 713 (817)
Q Consensus 639 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 713 (817)
+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||...... .....+
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-------~~~~~i 293 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKI 293 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHH
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-------HHHHhh
Confidence 99877655444444578999999999997 467899999999999999999999999643211 111222
Q ss_pred hhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCC--CCCHHHHHH
Q 036583 714 EEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSL--RPSMTKVVQ 761 (817)
Q Consensus 714 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~--RPt~~evl~ 761 (817)
...... +.-+.. .......+.+++.+|++.+|++ ||+++|+++
T Consensus 294 ~~~~~~-~~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 294 MNHKER-FQFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HTHHHH-CCCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hhcccc-ccCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 111100 000100 0112346788999999888888 999999997
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=347.11 Aligned_cols=245 Identities=23% Similarity=0.309 Sum_probs=203.0
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
.+.+.+.||+|+||+||+++.. +|+.||+|++++. ....+.+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence 3456688999999999999964 6899999999653 3456788999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+++|+|.+++.+.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 86 YANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp CCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 999999999997654 58899999999999999999999 899999999999999999999999999998643322
Q ss_pred ceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+. ..
T Consensus 160 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~--------~~ 223 (337)
T 1o6l_A 160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELILMEE--------IR 223 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC--------CC
T ss_pred C-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-------HHHHHHHHcCC--------CC
Confidence 1 23446799999999999999999999999999999999999999964321 11222222211 11
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRP-----SMTKVVQ 761 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~evl~ 761 (817)
.+ ......+.+++.+||+.||++|| +++|+++
T Consensus 224 ~p--~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 224 FP--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CC--TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CC--CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 11 12234678999999999999999 8999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=342.68 Aligned_cols=266 Identities=23% Similarity=0.309 Sum_probs=212.1
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecCC--eeeEEEe
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT--HRLLAYE 567 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~--~~~lv~e 567 (817)
.+.+.++||+|+||+||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.... ..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (319)
T 4euu_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (319)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence 3556788999999999999965 4899999999754 345678899999999999999999999998755 7799999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEe----cCCCcEEEeecCCcccc
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL----DDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~ki~Dfgla~~~ 643 (817)
|+++++|.+++........+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp CCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred CCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 99999999999876554458999999999999999999999 899999999999999 88889999999999876
Q ss_pred CCCCceeeeeccCCCCccCccccc--------cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhh
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWIT--------NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEE 715 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 715 (817)
..... .....||+.|+|||++. +..++.++|||||||++|||++|+.||........ ...........
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~ 242 (319)
T 4euu_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIITG 242 (319)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHHHHHHHH
T ss_pred CCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHHHhcC
Confidence 54432 23457899999999986 46789999999999999999999999975433221 12222222221
Q ss_pred cchhhhcc---------------cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 716 GKLRNILD---------------SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 716 ~~~~~~~d---------------~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.....+. ..............+.+++.+||+.||++|||++|+++.....
T Consensus 243 -~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 243 -KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp -CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred -CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 1111000 0011123345667788999999999999999999999998765
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=358.39 Aligned_cols=249 Identities=21% Similarity=0.260 Sum_probs=202.3
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.++||+|+||+||+++.. +++.||+|++.+. ....+.+.+|+.++..++||||+++++++.+....++||||
T Consensus 71 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 150 (410)
T 3v8s_A 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 150 (410)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 444588999999999999965 5889999999652 23445688999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 151 ~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 151 MPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp CTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred CCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 9999999998653 47889999999999999999999 8999999999999999999999999999987765544
Q ss_pred eeeeeccCCCCccCccccccCc----cCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccc
Q 036583 649 HVFTTLRGTRGYLAPEWITNYA----ISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 724 (817)
.......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ......+..+...
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~----- 291 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------VGTYSKIMNHKNS----- 291 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTHHHH-----
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-------hhHHHHHHhcccc-----
Confidence 4444678999999999998655 78999999999999999999999964321 1112222221100
Q ss_pred ccCCcccHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 036583 725 RLNIDEQSDRVFTAVKVALWCVQEDMSL--RPSMTKVVQM 762 (817)
Q Consensus 725 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~--RPt~~evl~~ 762 (817)
+..+........+.+++.+|++.+|.+ ||+++||+++
T Consensus 292 -~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 292 -LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp -CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred -ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 111111122346789999999999988 9999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=348.05 Aligned_cols=247 Identities=20% Similarity=0.297 Sum_probs=204.8
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
.+.+.++||+|+||+||++... +++.+|+|.+.........+.+|+.++..++||||+++++++.+.+..++||||+++
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g 85 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCC
Confidence 3556788999999999999964 588999999976555567789999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC--CCcEEEeecCCccccCCCCce
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD--NYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~ki~Dfgla~~~~~~~~~ 649 (817)
|+|.+++..... .+++..+..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 86 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-- 158 (321)
T 1tki_A 86 LDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-- 158 (321)
T ss_dssp CBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--
T ss_pred CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--
Confidence 999999975432 58899999999999999999999 89999999999999987 7899999999998775443
Q ss_pred eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+. ...+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~--------~~~~ 223 (321)
T 1tki_A 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------QQIIENIMNAE--------YTFD 223 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTC--------CCCC
T ss_pred ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-------HHHHHHHHcCC--------CCCC
Confidence 23456789999999999998899999999999999999999999964321 11112222211 1111
Q ss_pred c--cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 730 E--QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 730 ~--~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
. .......+.+++.+|++.||.+|||+.|+++
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0122346889999999999999999999998
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=364.73 Aligned_cols=260 Identities=25% Similarity=0.374 Sum_probs=207.3
Q ss_pred HHHHhhccccccCCCcceeEEEEEcC------CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCC
Q 036583 489 LQTATNNFSVKLGQGGFGSVYQGVLP------DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT 560 (817)
Q Consensus 489 l~~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~ 560 (817)
+....+.+.++||+|+||+||+|+.. .++.||||++.... ....++.+|+.++.+++||||+++++++.+..
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 33455667789999999999999843 46689999996542 33457899999999999999999999999999
Q ss_pred eeeEEEeeccCCChhhhhhhccc----ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC---cEE
Q 036583 561 HRLLAYEFMANGSLDKWIFKKNQ----EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY---HAK 633 (817)
Q Consensus 561 ~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~k 633 (817)
..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999999976431 2358899999999999999999999 8999999999999999554 599
Q ss_pred EeecCCccccCCCCc-eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHH
Q 036583 634 VSDFGLAKLMTREQS-HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFK 711 (817)
Q Consensus 634 i~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 711 (817)
|+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||..... .....
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-------~~~~~ 297 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------QEVLE 297 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHH
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHH
Confidence 999999986532211 11233567899999999999999999999999999999998 9999964321 11222
Q ss_pred HhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 712 MMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 712 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
.+..+.. ..........+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 298 ~i~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 298 FVTSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHcCCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 2222211 1111222346889999999999999999999999998763
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=348.98 Aligned_cols=256 Identities=25% Similarity=0.428 Sum_probs=208.1
Q ss_pred HhhccccccCCCcceeEEEEEc------CCCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL------PDGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~------~~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 563 (817)
..+.+.++||+|+||.||++.. .+++.||||++.... ...+.+.+|++++.+++||||+++++++.+....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 102 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL 102 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence 3455668899999999999984 345789999997543 23467899999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhhhccc---------------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCC
Q 036583 564 LAYEFMANGSLDKWIFKKNQ---------------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPE 622 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~ 622 (817)
+||||+++++|.+++..... ...+++..++.++.||+.||+|||+ .+|+||||||+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~ 179 (314)
T 2ivs_A 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAAR 179 (314)
T ss_dssp EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGG
T ss_pred EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccchh
Confidence 99999999999999976432 1248899999999999999999999 89999999999
Q ss_pred CeEecCCCcEEEeecCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCC
Q 036583 623 NVLLDDNYHAKVSDFGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETS 700 (817)
Q Consensus 623 NIll~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~ 700 (817)
||++++++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 259 (314)
T 2ivs_A 180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259 (314)
T ss_dssp GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999998765433222 223467788999999999899999999999999999999 99999654321
Q ss_pred CCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 701 DKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.....+..+.. ..........+.+++.+||+.||++|||++|+++.|+++
T Consensus 260 -------~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 260 -------RLFNLLKTGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp -------GHHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------HHHHHhhcCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 12222222211 111122334688999999999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=349.52 Aligned_cols=250 Identities=26% Similarity=0.363 Sum_probs=200.5
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
.+.+.++||+|+||+||+++.. +++.||||++.... ...+.+.+|+.+++.++||||+++++++.++...++||||+
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 87 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence 3556688999999999999865 68999999986442 23467899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 88 ~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 88 SGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp TTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999999996543 58899999999999999999999 99999999999999999999999999999876433222
Q ss_pred -eeeeccCCCCccCccccccCcc-CccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 650 -VFTTLRGTRGYLAPEWITNYAI-SEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 650 -~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ........ ...
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~~~~~~--------~~~ 227 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWKEK--------KTY 227 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH------HHHHHHTT--------CTT
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH------HHHHHhcc--------ccc
Confidence 2234679999999999987765 7789999999999999999999975433210 11111111 111
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
..........+.+++.+||+.||++|||++|+++.
T Consensus 228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11112233467799999999999999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=362.73 Aligned_cols=261 Identities=26% Similarity=0.398 Sum_probs=210.9
Q ss_pred HHHHhhccccccCCCcceeEEEEEc--------CCCcEEEEEEeccCCc--CHHHHHHHHHHhhcc-CcceeeeeeeEee
Q 036583 489 LQTATNNFSVKLGQGGFGSVYQGVL--------PDGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSI-HHLHLVKLRGFCA 557 (817)
Q Consensus 489 l~~~~~~~~~~lG~G~fG~Vy~g~~--------~~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l-~h~niv~l~~~~~ 557 (817)
+....+.+.++||+|+||+||+|+. ..++.||||++..... ..+.+.+|++++.++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 3345666778999999999999984 2346799999976432 346789999999999 9999999999999
Q ss_pred cCCeeeEEEeeccCCChhhhhhhccc-------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 036583 558 EGTHRLLAYEFMANGSLDKWIFKKNQ-------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENV 624 (817)
Q Consensus 558 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NI 624 (817)
+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+ .+|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceE
Confidence 99999999999999999999976431 1258999999999999999999999 8999999999999
Q ss_pred EecCCCcEEEeecCCccccCCCCc-eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCC
Q 036583 625 LLDDNYHAKVSDFGLAKLMTREQS-HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDK 702 (817)
Q Consensus 625 ll~~~~~~ki~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~ 702 (817)
|++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||+++||++ |+.||.....
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--- 299 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 299 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 999999999999999987654322 12233567889999999999999999999999999999999 9999964321
Q ss_pred CcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 703 AHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
......+..+... .........+.+++.+||+.||++|||++||++.|+.+..
T Consensus 300 ----~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 300 ----EELFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp ----HHHHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHcCCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1122222222111 1111223468899999999999999999999999998744
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=346.37 Aligned_cols=253 Identities=26% Similarity=0.367 Sum_probs=193.5
Q ss_pred HhhccccccCCCcceeEEEEEcCC----CcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPD----GTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv 565 (817)
..+.+.++||+|+||.||+|.... +..||+|++.... ...+.+.+|+.++.+++||||+++++++. .+..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence 456677899999999999998643 4579999987543 23467899999999999999999999985 4678999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|||+++++|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999999976432 58899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccc
Q 036583 646 EQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 724 (817)
..........+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+..+...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-------~~~~i~~~~~~----- 236 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERL----- 236 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTCCC-----
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-------HHHHHHcCCCC-----
Confidence 43333334567789999999998899999999999999999996 999997543211 11222222111
Q ss_pred ccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 725 RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 725 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
+........+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 237 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 237 ----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11112334688999999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=354.58 Aligned_cols=261 Identities=25% Similarity=0.390 Sum_probs=208.8
Q ss_pred HHHhhccccccCCCcceeEEEEEc------CCCcEEEEEEeccC--CcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCC
Q 036583 490 QTATNNFSVKLGQGGFGSVYQGVL------PDGTRLAVKKLEGI--GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGT 560 (817)
Q Consensus 490 ~~~~~~~~~~lG~G~fG~Vy~g~~------~~g~~vavK~l~~~--~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~ 560 (817)
....+.+.+.||+|+||.||+|+. ..++.||||++... ....+.+.+|+.++.++ +||||+++++++.+.+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 344566678999999999999985 24568999999754 23457899999999999 8999999999999999
Q ss_pred eeeEEEeeccCCChhhhhhhcccc--------------------cchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCC
Q 036583 561 HRLLAYEFMANGSLDKWIFKKNQE--------------------FLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIK 620 (817)
Q Consensus 561 ~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk 620 (817)
..++||||+++|+|.+++...... ..+++..++.++.||+.||+|||+ .+|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCC
Confidence 999999999999999999765321 247899999999999999999999 899999999
Q ss_pred CCCeEecCCCcEEEeecCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCC
Q 036583 621 PENVLLDDNYHAKVSDFGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNE 698 (817)
Q Consensus 621 ~~NIll~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~ 698 (817)
|+||+++.++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999999999999999999998765443322 233567889999999999999999999999999999998 999996543
Q ss_pred CCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 699 TSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
.. ......+..+. ..+........+.+++.+||+.||.+|||+.|+++.|+.+..
T Consensus 280 ~~------~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 280 VD------ANFYKLIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CS------HHHHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cH------HHHHHHHhcCC---------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 22 11222222221 111111223468899999999999999999999999998744
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=348.87 Aligned_cols=248 Identities=23% Similarity=0.348 Sum_probs=202.9
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc-------CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ-------GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLL 564 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~-------~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 564 (817)
.+.+.++||+|+||+||+++.. +|+.||+|.+..... ..+.+.+|+.++.+++||||+++++++.+....++
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 4566789999999999999964 689999999965421 35789999999999999999999999999999999
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC----cEEEeecCCc
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY----HAKVSDFGLA 640 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~ki~Dfgla 640 (817)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||++
T Consensus 93 v~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 93 ILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 999999999999997644 58999999999999999999999 8999999999999998877 7999999999
Q ss_pred cccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhh
Q 036583 641 KLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRN 720 (817)
Q Consensus 641 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (817)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+...
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-------~~~~~~i~~~~~~- 236 (361)
T 2yab_A 167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANITAVSYD- 236 (361)
T ss_dssp EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHTTCCC-
T ss_pred eEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcCCC-
Confidence 8765432 22346799999999999998999999999999999999999999964321 1111222221110
Q ss_pred hcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 721 ILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 721 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
............+.+++..||+.||++|||++|+++
T Consensus 237 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 -----FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -----CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000112346789999999999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=351.79 Aligned_cols=251 Identities=23% Similarity=0.297 Sum_probs=195.0
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
.+.+.++||+|+||+||+++.. +++.||||++.......+.+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 100 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG 100 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCC
Confidence 4667789999999999999965 689999999987666678899999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCc--EEEeecCCccccCCCCce
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYH--AKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~ki~Dfgla~~~~~~~~~ 649 (817)
|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||+++......
T Consensus 101 ~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~-- 172 (361)
T 3uc3_A 101 GELYERICNAG---RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 172 (361)
T ss_dssp CBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--
Confidence 99999997654 58899999999999999999999 99999999999999987765 9999999998543221
Q ss_pred eeeeccCCCCccCccccccCccCcc-ccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEK-SDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
......||+.|+|||++.+..++.+ +|||||||++|||++|+.||........ +.... . .+.......
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~-~--------~~~~~~~~~ 241 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTI-Q--------RILSVKYSI 241 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHH-H--------HHHTTCCCC
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHH-H--------HHhcCCCCC
Confidence 1234579999999999988877655 8999999999999999999975433221 11111 1 111111111
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
+........+.+++.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 242 PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 1111223467899999999999999999999974
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=346.59 Aligned_cols=249 Identities=20% Similarity=0.315 Sum_probs=197.1
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCC--------
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT-------- 560 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~-------- 560 (817)
..+.+.++||+|+||.||+|+.. +|+.||||++.... ...+.+.+|++++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 34566789999999999999975 78999999997542 34578999999999999999999999986543
Q ss_pred -------------------------------------------------eeeEEEeeccCCChhhhhhhcccccchhhhH
Q 036583 561 -------------------------------------------------HRLLAYEFMANGSLDKWIFKKNQEFLLDWET 591 (817)
Q Consensus 561 -------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~ 591 (817)
..++||||+++++|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 2799999999999999998765544566777
Q ss_pred HHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce-----------eeeeccCCCCc
Q 036583 592 RFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH-----------VFTTLRGTRGY 660 (817)
Q Consensus 592 ~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-----------~~~~~~gt~~y 660 (817)
++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........ ......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 89999999999999999 89999999999999999999999999999877553211 11235699999
Q ss_pred cCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHH
Q 036583 661 LAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVK 740 (817)
Q Consensus 661 ~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 740 (817)
+|||.+.+..++.++||||||+++|||++|..|+... ............ ..........+.+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~---------~~~~~~~~~~~~---------~~~~~~~~~~~~~ 304 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER---------VRIITDVRNLKF---------PLLFTQKYPQEHM 304 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH---------HHHHHHHHTTCC---------CHHHHHHCHHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH---------HHHHHHhhccCC---------CcccccCChhHHH
Confidence 9999999999999999999999999999987665210 001111111110 1111233456789
Q ss_pred HHHhccccCCCCCCCHHHHHH
Q 036583 741 VALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 741 l~~~cl~~dp~~RPt~~evl~ 761 (817)
++.+||+.||++|||++|+++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHccCCCCcCCCHHHHhh
Confidence 999999999999999999987
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=351.32 Aligned_cols=256 Identities=26% Similarity=0.442 Sum_probs=198.8
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCc----EEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGT----RLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLL 564 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~----~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 564 (817)
..+.+.++||+|+||+||+|... +++ +||+|.+... ....+++.+|+.++.+++||||+++++++..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 34556688999999999999853 444 3578877543 345788999999999999999999999998765 789
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
|+||+++|+|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 9999999999999976543 58899999999999999999999 899999999999999999999999999998765
Q ss_pred CCCce-eeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 645 REQSH-VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 645 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+..+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~~~----- 236 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGE----- 236 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTC-----
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCC-----
Confidence 43222 1223456788999999999999999999999999999999 999997543221 112222211
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCC
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPV 769 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 769 (817)
..+........+.+++.+||+.||.+|||++|+++.|+.+...
T Consensus 237 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 237 ----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1111222334688999999999999999999999999987543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=353.84 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=208.4
Q ss_pred HhhccccccCCCcceeEEEEEcC------CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP------DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 563 (817)
..+.+.++||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++.+++||||+++++++.+++..+
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 126 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 126 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence 34556688999999999999964 34789999997543 23467999999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhhhccc---------------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCC
Q 036583 564 LAYEFMANGSLDKWIFKKNQ---------------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPE 622 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~ 622 (817)
+||||+++|+|.+++..... ...+++..++.++.||+.||.|||+ .+|+||||||+
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~ 203 (343)
T 1luf_A 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATR 203 (343)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcc
Confidence 99999999999999976421 1368999999999999999999999 89999999999
Q ss_pred CeEecCCCcEEEeecCCccccCCCCc-eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCC
Q 036583 623 NVLLDDNYHAKVSDFGLAKLMTREQS-HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETS 700 (817)
Q Consensus 623 NIll~~~~~~ki~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~ 700 (817)
||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~- 282 (343)
T 1luf_A 204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH- 282 (343)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-
T ss_pred eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh-
Confidence 99999999999999999987643322 12234567889999999999899999999999999999999 9999964321
Q ss_pred CCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 701 DKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
......+..+..... .......+.+++.+||+.||++|||+.|++++|+++..
T Consensus 283 ------~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 283 ------EEVIYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp ------HHHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ------HHHHHHHhCCCcCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 112222222222111 11223468899999999999999999999999998754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=340.68 Aligned_cols=248 Identities=30% Similarity=0.455 Sum_probs=191.9
Q ss_pred hhccccccCCCcceeEEEEEcCCCcEEEEEEeccCC-----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIG-----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~-----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
.+.+.++||+|+||+||+|.. .++.||||++.... ...+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred heeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 455668899999999999997 48899999986532 234789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCc---eeecCCCCCCeEecC--------CCcEEEee
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR---IIHCDIKPENVLLDD--------NYHAKVSD 636 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~---ivH~Dlk~~NIll~~--------~~~~ki~D 636 (817)
|+++++|.+++... .+++..++.++.|++.||+|||+ .+ |+||||||+||+++. ++.+||+|
T Consensus 87 ~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 87 FARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred cCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999998533 58899999999999999999999 66 999999999999986 77899999
Q ss_pred cCCccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhc
Q 036583 637 FGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEG 716 (817)
Q Consensus 637 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 716 (817)
||++........ ....|++.|+|||.+.+..++.++||||||++++||++|+.||...... . ........
T Consensus 160 fg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~ 229 (271)
T 3dtc_A 160 FGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------A-VAYGVAMN 229 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------H-HHHHHHTS
T ss_pred CCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHhhhcC
Confidence 999986544322 2357899999999999999999999999999999999999999643211 1 11111111
Q ss_pred chhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 717 KLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 717 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
....+........+.+++.+||+.||++|||++|++++|+.+
T Consensus 230 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 --------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111111222334688999999999999999999999999863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=353.19 Aligned_cols=258 Identities=25% Similarity=0.417 Sum_probs=206.5
Q ss_pred HHhhccccccCCCcceeEEEEEcCC------CcEEEEEEeccCC--cCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCe
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLPD------GTRLAVKKLEGIG--QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTH 561 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~ 561 (817)
...+.+.+.||+|+||.||+|.... ...||+|.+.... ...+.+.+|+.++.++ +||||+++++++.+++.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 3445667899999999999998532 3479999997643 2356789999999999 89999999999999999
Q ss_pred eeEEEeeccCCChhhhhhhccc-----------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC
Q 036583 562 RLLAYEFMANGSLDKWIFKKNQ-----------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY 630 (817)
Q Consensus 562 ~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~ 630 (817)
.++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCC
Confidence 9999999999999999976431 2247889999999999999999999 8999999999999999999
Q ss_pred cEEEeecCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHH
Q 036583 631 HAKVSDFGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSY 708 (817)
Q Consensus 631 ~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~ 708 (817)
.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... ..
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------~~ 275 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN------SK 275 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS------HH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh------HH
Confidence 99999999998764433222 223567789999999999899999999999999999998 99999654321 11
Q ss_pred HHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 709 AFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 709 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.......+. ...........+.+++.+||+.||.+|||++|++++|+.+
T Consensus 276 ~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 276 FYKLVKDGY---------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhcCC---------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 122222211 1111111234688999999999999999999999999865
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=342.18 Aligned_cols=249 Identities=24% Similarity=0.344 Sum_probs=203.4
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC-------cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG-------QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-------~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 563 (817)
..+.+.++||+|+||.||+++.. +|+.||+|.+.... ...+.+.+|+.++.+++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45677889999999999999964 58999999986532 13578999999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC----cEEEeecCC
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY----HAKVSDFGL 639 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~ki~Dfgl 639 (817)
+||||+++++|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999997543 58999999999999999999999 9999999999999999887 899999999
Q ss_pred ccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchh
Q 036583 640 AKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLR 719 (817)
Q Consensus 640 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (817)
++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.....
T Consensus 165 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~~~~~~~- 234 (326)
T 2y0a_A 165 AHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANVSAVNY- 234 (326)
T ss_dssp CEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHHTCC-
T ss_pred CeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-------HHHHHHHHhcCC-
Confidence 987654322 2346799999999999998999999999999999999999999964321 111111111110
Q ss_pred hhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 720 NILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 720 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.............+.+++.+||+.||++|||++|+++
T Consensus 235 -----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 -----EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -----CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000112346789999999999999999999998
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=347.11 Aligned_cols=257 Identities=28% Similarity=0.465 Sum_probs=209.3
Q ss_pred HhhccccccCCCcceeEEEEEc------CCCcEEEEEEeccCCc--CHHHHHHHHHHhhcc-CcceeeeeeeEeecCCee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL------PDGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHR 562 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~------~~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~ 562 (817)
..+.+.+.||+|+||.||+|+. .+++.||||++..... ..+.+.+|+.++.++ +||||+++++++.+++..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 4566778999999999999973 3567899999975432 346799999999999 999999999999999999
Q ss_pred eEEEeeccCCChhhhhhhccc---------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec
Q 036583 563 LLAYEFMANGSLDKWIFKKNQ---------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD 627 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~ 627 (817)
++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+ .+|+||||||+||+++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEc
Confidence 999999999999999976542 1248899999999999999999999 8999999999999999
Q ss_pred CCCcEEEeecCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcc
Q 036583 628 DNYHAKVSDFGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHF 705 (817)
Q Consensus 628 ~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~ 705 (817)
.++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----- 254 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD----- 254 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-----
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch-----
Confidence 99999999999998776543322 223567889999999999999999999999999999999 99999654322
Q ss_pred hHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 706 PSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 706 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
......+..+. ...........+.+++.+||+.||.+|||++|++++|+.+
T Consensus 255 -~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 255 -SKFYKMIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp -HHHHHHHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -hHHHHHhccCC---------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 11122222111 1111112234688999999999999999999999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=349.20 Aligned_cols=260 Identities=24% Similarity=0.384 Sum_probs=194.2
Q ss_pred HhhccccccCCCcceeEEEEEcCCCc----EEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCee--
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPDGT----RLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHR-- 562 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~g~----~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~-- 562 (817)
..+.+.+.||+|+||+||+|+..... .||||++... ....+.+.+|++++++++||||+++++++......
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 45666789999999999999975432 7999999754 23357899999999999999999999999877655
Q ss_pred ----eEEEeeccCCChhhhhhhccc---ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEe
Q 036583 563 ----LLAYEFMANGSLDKWIFKKNQ---EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVS 635 (817)
Q Consensus 563 ----~lv~e~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~ 635 (817)
++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+ .+|+||||||+|||+++++.+||+
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEEC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEEe
Confidence 999999999999999975432 1258899999999999999999999 899999999999999999999999
Q ss_pred ecCCccccCCCCce-eeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHh
Q 036583 636 DFGLAKLMTREQSH-VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMM 713 (817)
Q Consensus 636 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 713 (817)
|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~ 252 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-------IYNYL 252 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHH
T ss_pred eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-------HHHHH
Confidence 99999876443322 1223556788999999999999999999999999999999 999997543221 11112
Q ss_pred hhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCCC
Q 036583 714 EEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVP 770 (817)
Q Consensus 714 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 770 (817)
..+.. ..........+.+++.+||+.||++|||+.|+++.|+++..-+
T Consensus 253 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 253 IGGNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hcCCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11111 1111223346889999999999999999999999999875433
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.04 Aligned_cols=252 Identities=23% Similarity=0.275 Sum_probs=199.0
Q ss_pred ccCHHHHHHHhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcC---HHHHHHHHHHhhcc-CcceeeeeeeEee
Q 036583 483 RFTYRDLQTATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQG---KKEFRAEVSIIGSI-HHLHLVKLRGFCA 557 (817)
Q Consensus 483 ~~~~~~l~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~---~~~~~~Ev~~l~~l-~h~niv~l~~~~~ 557 (817)
+....++....+.+.++||+|+||+||+|+.. +++.||||++...... ...+..|+..+.++ +||||++++++|.
T Consensus 48 p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~ 127 (311)
T 3p1a_A 48 PSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE 127 (311)
T ss_dssp TTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence 34455666777888899999999999999965 7899999998654332 33455666666555 8999999999999
Q ss_pred cCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeec
Q 036583 558 EGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDF 637 (817)
Q Consensus 558 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df 637 (817)
++...++||||+ +++|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 128 ~~~~~~lv~e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DF 201 (311)
T 3p1a_A 128 EGGILYLQTELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDF 201 (311)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCC
T ss_pred eCCEEEEEEecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccc
Confidence 999999999999 6699998876543 58999999999999999999999 89999999999999999999999999
Q ss_pred CCccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcc
Q 036583 638 GLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGK 717 (817)
Q Consensus 638 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 717 (817)
|++....... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+... ..+..+..+.
T Consensus 202 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~~~~~~~ 268 (311)
T 3p1a_A 202 GLLVELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQQLRQGY 268 (311)
T ss_dssp TTCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHHHHTTTC
T ss_pred eeeeecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHHHHhccC
Confidence 9998764432 2234579999999999886 7899999999999999999997766321 1122222221
Q ss_pred hhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 718 LRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 718 ~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.... ........+.+++.+||+.||++|||++|+++
T Consensus 269 ~~~~--------~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 269 LPPE--------FTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CCHH--------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcc--------cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1111 11122356889999999999999999999987
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=342.38 Aligned_cols=259 Identities=22% Similarity=0.293 Sum_probs=199.3
Q ss_pred hhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
.+.+.++||+|+||+||+++..+++.||||++..... ..+.+.+|++++++++||||+++++++.++...++||||+
T Consensus 22 ~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 101 (311)
T 3niz_A 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM 101 (311)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECC
T ss_pred hhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCC
Confidence 4556688999999999999988899999999965422 2467899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++ +|.+++..... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 102 ~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 174 (311)
T 3niz_A 102 EK-DLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR- 174 (311)
T ss_dssp SE-EHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred CC-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence 85 88888865443 58899999999999999999999 8999999999999999999999999999987643322
Q ss_pred eeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhh-------
Q 036583 650 VFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI------- 721 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 721 (817)
......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+. ................
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGGGTTSH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhhhhccc
Confidence 2234578999999999876 5689999999999999999999999975443321 1111111111100000
Q ss_pred --cccccC--Ccc-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 722 --LDSRLN--IDE-----QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 722 --~d~~~~--~~~-----~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
...... ... ......++.+++.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000 000 0012346789999999999999999999997
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=348.39 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=201.3
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 566 (817)
.+.+.++||+|+||+||+++.. +++.+|||++++.. ...+.+.+|..++.++ +||||+++++++.+....++||
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~ 132 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence 3556689999999999999965 57889999997542 2235688999999887 8999999999999999999999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
||+++|+|..++.+.. .+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++.....
T Consensus 133 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 133 EYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 9999999999997654 58999999999999999999999 89999999999999999999999999999863322
Q ss_pred CceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCC--CcchHHHHHHhhhcchhhhccc
Q 036583 647 QSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDK--AHFPSYAFKMMEEGKLRNILDS 724 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~ 724 (817)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..........+..+.
T Consensus 207 ~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------- 278 (396)
T 4dc2_A 207 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------- 278 (396)
T ss_dssp T-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-------
T ss_pred C-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-------
Confidence 2 123457899999999999999999999999999999999999999965432221 111222223222221
Q ss_pred ccCCcccHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 036583 725 RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSM------TKVVQ 761 (817)
Q Consensus 725 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~------~evl~ 761 (817)
+..+ ......+.+++.+||+.||.+||++ +|+++
T Consensus 279 -~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 279 -IRIP--RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp -CCCC--TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred -cCCC--CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 1111 1123467899999999999999985 67765
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=339.21 Aligned_cols=260 Identities=18% Similarity=0.249 Sum_probs=207.3
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEeecc
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.+.+.+.||+|+||.||+|+. .+++.||||++... ...+.+.+|+.++.++ +|+|++++++++.++...++||||+
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 88 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 88 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC-CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-
Confidence 455678899999999999994 57899999998643 2345688999999999 8999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCc-----EEEeecCCccccCC
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYH-----AKVSDFGLAKLMTR 645 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~-----~ki~Dfgla~~~~~ 645 (817)
+++|.+++..... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++. +||+|||+++....
T Consensus 89 ~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 89 GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 9999999976543 58999999999999999999998 89999999999999987776 99999999987654
Q ss_pred CCce------eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchh
Q 036583 646 EQSH------VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLR 719 (817)
Q Consensus 646 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (817)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ......+......
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~ 239 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN----KQKYERIGEKKQS 239 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH----HHHHHHHHHHHHH
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc----HHHHHHHHhhccC
Confidence 3221 12346799999999999999999999999999999999999999976443221 1111111111110
Q ss_pred hhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 720 NILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 720 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
.... ... ......+.+++.+||+.||++||++++|++.|+.+..
T Consensus 240 ~~~~-~~~----~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 240 TPLR-ELC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp SCHH-HHT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccHH-HHH----hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 0000 000 0123468899999999999999999999999988743
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=346.32 Aligned_cols=254 Identities=27% Similarity=0.409 Sum_probs=197.6
Q ss_pred hhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
.+.+.+.||+|+||+||+++. .++.||||++... ...+.|.+|++++.+++||||+++++++.+ ..++||||+++|
T Consensus 9 ~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~ 84 (307)
T 2eva_A 9 EIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGG 84 (307)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTC
T ss_pred HeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCC
Confidence 455668899999999999998 4788999998643 345789999999999999999999999874 479999999999
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCc-EEEeecCCccccCCCCceee
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYH-AKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~-~ki~Dfgla~~~~~~~~~~~ 651 (817)
+|.+++........+++..++.++.||++||+|||+....+|+||||||+||+++.++. +||+|||++...... .
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~ 160 (307)
T 2eva_A 85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----M 160 (307)
T ss_dssp BHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred CHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----c
Confidence 99999986554335788899999999999999999854468999999999999998876 799999999765432 1
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .... .....+... +..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~-~~~~~~~~~---------~~~ 226 (307)
T 2eva_A 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIM-WAVHNGTRP---------PLI 226 (307)
T ss_dssp ----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHH-HHHHTTCCC---------CCB
T ss_pred ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHH-HHHhcCCCC---------Ccc
Confidence 23468999999999999999999999999999999999999996432211 1111 111111111 111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
......+.+++.+||+.||++|||++|++++|+.+.+
T Consensus 227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1223467899999999999999999999999987643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=344.80 Aligned_cols=256 Identities=17% Similarity=0.235 Sum_probs=204.6
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+.+.++||+|+||+||+|+. .+++.||||++.... ..+.+.+|++++.++ +||||+++++++.++...++||||+ +
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (330)
T 2izr_A 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-G 88 (330)
T ss_dssp EEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-C
T ss_pred eEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-C
Confidence 45668899999999999994 578999999986542 234688999999999 9999999999999999999999999 9
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCc-----EEEeecCCccccCCC
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYH-----AKVSDFGLAKLMTRE 646 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~-----~ki~Dfgla~~~~~~ 646 (817)
++|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||+++.....
T Consensus 89 ~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 89 PSLEDLFDLCDR--TFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp CBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred CCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 999999976432 68999999999999999999999 89999999999999998887 999999999876443
Q ss_pred Cce------eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhh
Q 036583 647 QSH------VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRN 720 (817)
Q Consensus 647 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (817)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... . ......+.......
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~---~-~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT---L-KERYQKIGDTKRAT 239 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS---H-HHHHHHHHHHHHHS
T ss_pred CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc---H-HHHHHHHHhhhccC
Confidence 221 1234679999999999999999999999999999999999999997653322 1 11111111111100
Q ss_pred hcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 721 ILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 721 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.. ..+. ...+ .+.+++..|++.||.+||++++|++.|+.+
T Consensus 240 ~~-~~~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 240 PI-EVLC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp CH-HHHT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CH-HHHh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 00 0000 0112 788999999999999999999999999765
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=336.28 Aligned_cols=251 Identities=29% Similarity=0.481 Sum_probs=200.3
Q ss_pred HhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc--C------HHHHHHHHHHhhccCcceeeeeeeEeecCCee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ--G------KKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHR 562 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~--~------~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~ 562 (817)
..+.+.++||+|+||+||+++. .+++.||||++..... . .+.+.+|+.++.+++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 3456678899999999999996 4789999999864321 1 167899999999999999999999997655
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCc--eeecCCCCCCeEecCCCc-----EEEe
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR--IIHCDIKPENVLLDDNYH-----AKVS 635 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~--ivH~Dlk~~NIll~~~~~-----~ki~ 635 (817)
++||||+++|+|.+++..... .+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++. +||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred eEEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 699999999999998876543 68999999999999999999998 78 999999999999988776 9999
Q ss_pred ecCCccccCCCCceeeeeccCCCCccCccccc--cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHh
Q 036583 636 DFGLAKLMTREQSHVFTTLRGTRGYLAPEWIT--NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMM 713 (817)
Q Consensus 636 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 713 (817)
|||+++..... .....||+.|+|||.+. ...++.++||||||+++|||++|+.||....... .. .....
T Consensus 172 Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~-~~~~~ 242 (287)
T 4f0f_A 172 DFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IK-FINMI 242 (287)
T ss_dssp CCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HH-HHHHH
T ss_pred CCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HH-HHHHH
Confidence 99999854332 34467899999999984 5567899999999999999999999996543221 00 11111
Q ss_pred hhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 714 EEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 714 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.... ............+.+++..||+.||++|||++|+++.|+++
T Consensus 243 ~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 REEG--------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHSC--------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred hccC--------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111 11111122334688999999999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=346.15 Aligned_cols=246 Identities=24% Similarity=0.309 Sum_probs=199.3
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv 565 (817)
..+.+.++||+|+||+||+++.. +++.||||++.+. ....+.+.+|..++..+ +||||+++++++.+.+..++|
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 44566789999999999999964 5899999999753 23456788999999988 799999999999999999999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|||+++|+|.+++.+.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 99999999999997654 58999999999999999999999 8999999999999999999999999999986433
Q ss_pred CCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccc
Q 036583 646 EQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 725 (817)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+.
T Consensus 177 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~~-------- 240 (353)
T 3txo_A 177 NG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-------DDLFEAILNDE-------- 240 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC--------
T ss_pred CC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCC--------
Confidence 22 223446899999999999999999999999999999999999999964321 11222222221
Q ss_pred cCCcccHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 036583 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRPSM------TKVVQ 761 (817)
Q Consensus 726 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~------~evl~ 761 (817)
...+ ......+.+++.+|++.||.+||++ +|+++
T Consensus 241 ~~~p--~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 VVYP--TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCCC--TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCC--CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1111 1123467899999999999999998 77775
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=345.26 Aligned_cols=270 Identities=22% Similarity=0.325 Sum_probs=203.5
Q ss_pred ccCHHHHHHHhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhcc--CcceeeeeeeEeecC-
Q 036583 483 RFTYRDLQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSI--HHLHLVKLRGFCAEG- 559 (817)
Q Consensus 483 ~~~~~~l~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l--~h~niv~l~~~~~~~- 559 (817)
+....+.....+.+.++||+|+||.||+|+.. ++.||||++.... ...+..|.+++..+ +||||+++++++.+.
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 34445556677888899999999999999984 8999999996432 34455555555554 899999999999877
Q ss_pred ---CeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCC--------ceeecCCCCCCeEecC
Q 036583 560 ---THRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ--------RIIHCDIKPENVLLDD 628 (817)
Q Consensus 560 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~--------~ivH~Dlk~~NIll~~ 628 (817)
...++||||+++|+|.+++... .+++..++.++.|++.||+|||+ . +|+||||||+|||++.
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~~ 177 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVKK 177 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEECT
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEECC
Confidence 6889999999999999999654 48899999999999999999998 6 9999999999999999
Q ss_pred CCcEEEeecCCccccCCCCcee---eeeccCCCCccCccccccCccCcc------ccccchhhhHHHhhhC---------
Q 036583 629 NYHAKVSDFGLAKLMTREQSHV---FTTLRGTRGYLAPEWITNYAISEK------SDVYSYGMVLLEIIGG--------- 690 (817)
Q Consensus 629 ~~~~ki~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~DvwS~Gvvl~elltg--------- 690 (817)
++.+||+|||+++......... .....||+.|+|||.+.+.....+ +|||||||++|||++|
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 9999999999998764433221 123579999999999987766654 9999999999999999
Q ss_pred -CCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC-cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 691 -RKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI-DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 691 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
+.||........ ............. ..+.... .........+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 258 ~~~p~~~~~~~~~--~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 258 YQLPYHDLVPSDP--SYEDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp CCCTTTTTSCSSC--CHHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccHhhhcCCCC--chhhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 445533222111 1111111111111 1111111 1123566789999999999999999999999999998743
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=340.93 Aligned_cols=267 Identities=23% Similarity=0.353 Sum_probs=206.4
Q ss_pred HHHhhccccccCCCcceeEEEEE-----cCCCcEEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecC--C
Q 036583 490 QTATNNFSVKLGQGGFGSVYQGV-----LPDGTRLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG--T 560 (817)
Q Consensus 490 ~~~~~~~~~~lG~G~fG~Vy~g~-----~~~g~~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~ 560 (817)
....+.+.++||+|+||.||+++ ..+++.||||++... ....+.+.+|++++.+++||||+++++++.+. .
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 33456677899999999999998 346889999999754 34467899999999999999999999999876 6
Q ss_pred eeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCc
Q 036583 561 HRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLA 640 (817)
Q Consensus 561 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 640 (817)
..++||||+++++|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccccc
Confidence 68999999999999999965443 58899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCce--eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCC----CCcchHHHHHHhh
Q 036583 641 KLMTREQSH--VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSD----KAHFPSYAFKMME 714 (817)
Q Consensus 641 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~----~~~~~~~~~~~~~ 714 (817)
......... ......+|..|+|||.+.+..++.++||||||+++|||++|+.|+....... .........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---- 249 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV---- 249 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH----
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH----
Confidence 877654332 1233567888999999999999999999999999999999998864221000 000000000
Q ss_pred hcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 715 EGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 715 ~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
..+...+......+........+.+++.+||+.||.+|||++|++++|+.+
T Consensus 250 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 250 -TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp -HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 001111111111122223345788999999999999999999999999875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=339.56 Aligned_cols=246 Identities=22% Similarity=0.337 Sum_probs=193.9
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc---------------------------CHHHHHHHHHHhhcc
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ---------------------------GKKEFRAEVSIIGSI 544 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~---------------------------~~~~~~~Ev~~l~~l 544 (817)
.+.+.++||+|+||.||+|+. .+++.||||++..... ..+.+.+|+++++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 455678899999999999985 4688999999865321 125689999999999
Q ss_pred CcceeeeeeeEeec--CCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCC
Q 036583 545 HHLHLVKLRGFCAE--GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPE 622 (817)
Q Consensus 545 ~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~ 622 (817)
+||||+++++++.+ ....++||||+++++|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~ 166 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPS 166 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHH
Confidence 99999999999986 56889999999999998876432 58999999999999999999999 89999999999
Q ss_pred CeEecCCCcEEEeecCCccccCCCCceeeeeccCCCCccCccccccCc---cCccccccchhhhHHHhhhCCCCCCCCCC
Q 036583 623 NVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYA---ISEKSDVYSYGMVLLEIIGGRKNFDPNET 699 (817)
Q Consensus 623 NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~elltg~~pf~~~~~ 699 (817)
|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||.....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999999999999999987654332 234467999999999998654 47889999999999999999999964321
Q ss_pred CCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 700 SDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
......+.... ...+........+.+++.+||+.||++|||++|+++
T Consensus 246 -------~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 -------MCLHSKIKSQA--------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp -------HHHHHHHHHCC--------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -------HHHHHHHhccc--------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 11111121111 111111122346889999999999999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=353.86 Aligned_cols=251 Identities=21% Similarity=0.321 Sum_probs=203.6
Q ss_pred HHhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
...+.+.++||+|+||+||++.. .+|+.+|+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 34567778999999999999985 568999999997543 23457899999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec---CCCcEEEeecCCcccc
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD---DNYHAKVSDFGLAKLM 643 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~ki~Dfgla~~~ 643 (817)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++ +++.+||+|||++...
T Consensus 90 E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 90 DLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp CCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999999999997654 58899999999999999999999 8999999999999998 5688999999999876
Q ss_pred CCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+... ...
T Consensus 164 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~-~~~ 234 (444)
T 3soa_A 164 EGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-------HRLYQQIKAGAYD-FPS 234 (444)
T ss_dssp CTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTCCC-CCT
T ss_pred cCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHhCCCC-CCc
Confidence 54332 22346799999999999999999999999999999999999999964321 1122223222211 111
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+ ........+.+++..||+.||++|||+.|+++
T Consensus 235 ~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 235 P-----EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp T-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred c-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1 11122346789999999999999999999998
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.71 Aligned_cols=242 Identities=24% Similarity=0.351 Sum_probs=202.3
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
.+.+.++||+|+||.||+++.. +|+.||+|++... ....+.+.+|+.++..++||||+++++++.+....++|||
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence 3556688999999999999964 6899999999653 2456788999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 87 YIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp CCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 999999999997654 58889999999999999999998 89999999999999999999999999999875432
Q ss_pred ceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+. ..
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~--------~~ 221 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MKTYEKILNAE--------LR 221 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHCC--------CC
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC--------CC
Confidence 2346799999999999999999999999999999999999999964321 11122222221 11
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRP-----SMTKVVQ 761 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~evl~ 761 (817)
.+ ......+.+++.+|++.||++|| +++|+++
T Consensus 222 ~p--~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 222 FP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CC--TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CC--CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11 11234678999999999999999 8999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=344.63 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=203.9
Q ss_pred HHhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccC------CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeee
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI------GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~------~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 563 (817)
...+.+.++||+|+||+||++.. .+++.||||++... ....+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45677889999999999999985 46899999998532 224678999999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhhhcc-cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCc---EEEeecCC
Q 036583 564 LAYEFMANGSLDKWIFKKN-QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYH---AKVSDFGL 639 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~ki~Dfgl 639 (817)
+||||+++++|.+++.... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998886543 22357889999999999999999999 89999999999999986654 99999999
Q ss_pred ccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchh
Q 036583 640 AKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLR 719 (817)
Q Consensus 640 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (817)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......+..+...
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~i~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--------ERLFEGIIKGKYK 250 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--------HHHHHHHHHTCCC
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--------HHHHHHHHcCCCC
Confidence 987654322 2234679999999999999999999999999999999999999996421 1122222222111
Q ss_pred hhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 720 NILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 720 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.. + .........+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~--~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 MN--P----RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CC--H----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC--c----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0 000112346789999999999999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=344.08 Aligned_cols=243 Identities=25% Similarity=0.364 Sum_probs=200.3
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
.+.+.++||+|+||.||+|.. .+++.||||++... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 456678899999999999995 57899999998643 2345689999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+ +|+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||+++++.+||+|||++.......
T Consensus 90 ~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 90 YA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp CC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred CC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 99 679999887654 58999999999999999999999 899999999999999999999999999998765432
Q ss_pred ceeeeeccCCCCccCccccccCcc-CccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAI-SEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
. .....||+.|+|||.+.+..+ ++++|||||||++|||++|+.||......... ..+.....
T Consensus 163 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------------~~i~~~~~ 225 (336)
T 3h4j_B 163 F--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------------KKVNSCVY 225 (336)
T ss_dssp T--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------------CCCCSSCC
T ss_pred c--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------------HHHHcCCC
Confidence 2 234679999999999998776 68999999999999999999999754322110 00111011
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
. .+......+.+++.+||+.||.+|||++|+++
T Consensus 226 ~--~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 226 V--MPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp C--CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred C--CcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1 11112346789999999999999999999987
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=337.12 Aligned_cols=262 Identities=26% Similarity=0.480 Sum_probs=197.7
Q ss_pred HHHHHHhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcC---HHHHHHHHHHhhccCcceeeeeeeEeecCCeee
Q 036583 487 RDLQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQG---KKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 487 ~~l~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~---~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 563 (817)
.|+....+.+.++||+|+||+||+|+..+ .+|||++...... .+.+.+|++++++++||||+++++++ .....+
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 34555667778899999999999998743 5999999754332 46789999999999999999999965 456789
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+||||+++++|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 96 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEEecCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccc
Confidence 99999999999999965543 58899999999999999999999 89999999999999999999999999999865
Q ss_pred CCCC-ceeeeeccCCCCccCccccc---cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchh
Q 036583 644 TREQ-SHVFTTLRGTRGYLAPEWIT---NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLR 719 (817)
Q Consensus 644 ~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (817)
.... ........||+.|+|||.+. +..++.++||||||+++|||++|+.||...... .........+...
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~ 244 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIEMVGRGSLS 244 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH------HHHHHHHHHTSCC
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH------HHHHHHhcccccC
Confidence 4322 22233467899999999986 567888999999999999999999999643321 2222233332221
Q ss_pred hhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 720 NILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 720 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
..+.. ........+.+++.+||+.||.+|||++|++++|+.+.
T Consensus 245 ~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 245 PDLSK-----VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCTTS-----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cchhh-----ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 11110 11123356889999999999999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=372.97 Aligned_cols=246 Identities=27% Similarity=0.406 Sum_probs=199.0
Q ss_pred ccCCCcceeEEEEEcC---CCcEEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCC
Q 036583 499 KLGQGGFGSVYQGVLP---DGTRLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGS 573 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~---~g~~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 573 (817)
+||+|+||.||+|.+. ++..||||+++.. ....++|.+|++++++++||||++++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999863 4567999999764 3456889999999999999999999999976 56899999999999
Q ss_pred hhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee--e
Q 036583 574 LDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV--F 651 (817)
Q Consensus 574 L~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~--~ 651 (817)
|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+||||++++.+||+|||+++......... .
T Consensus 422 L~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 9999976433 58999999999999999999999 899999999999999999999999999998765433221 1
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .+...+..+.. ...
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~~~~i~~~~~---------~~~ 560 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQGKR---------MEC 560 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-------HHHHHHHTTCC---------CCC
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHcCCC---------CCC
Confidence 22445689999999999999999999999999999998 99999754321 12223333221 111
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.......+.+++..||+.||++||++.+|++.|+.+
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 222345788999999999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=338.27 Aligned_cols=251 Identities=27% Similarity=0.397 Sum_probs=203.8
Q ss_pred hcccc-ccCCCcceeEEEEEcC---CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 494 NNFSV-KLGQGGFGSVYQGVLP---DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 494 ~~~~~-~lG~G~fG~Vy~g~~~---~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
+.+.+ +||+|+||.||+|... +++.||||++.... ...+.+.+|++++.+++||||+++++++ +.+..++|||
T Consensus 11 ~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 89 (287)
T 1u59_A 11 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVME 89 (287)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEE
Confidence 33444 8999999999999853 57789999997643 2356799999999999999999999999 5567899999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+++++|.+++..... .+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 90 MAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp CCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred eCCCCCHHHHHHhCCc--cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 9999999999975433 58899999999999999999999 899999999999999999999999999998775443
Q ss_pred ceee--eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccc
Q 036583 648 SHVF--TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724 (817)
Q Consensus 648 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 724 (817)
.... ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+..+..
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~i~~~~~------ 231 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQGKR------ 231 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------HHHHHHHTTCC------
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHhcCCc------
Confidence 3221 22456889999999998899999999999999999998 99999654321 12222222211
Q ss_pred ccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 725 RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 725 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
..........+.+++..||+.||++||++.|+++.|+.+
T Consensus 232 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 232 ---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp ---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111122344788999999999999999999999999876
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=343.60 Aligned_cols=249 Identities=23% Similarity=0.325 Sum_probs=181.7
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhccC-cceeeeeeeEeecCCeeeEEEeeccCCChh
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH-HLHLVKLRGFCAEGTHRLLAYEFMANGSLD 575 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 575 (817)
++||+|+||+||++... +++.||||++... ....+.+|+.++.+++ ||||+++++++.++...++||||+++|+|.
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence 57999999999999964 5899999999643 4567889999999997 999999999999999999999999999999
Q ss_pred hhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC---cEEEeecCCccccCCCCceeee
Q 036583 576 KWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY---HAKVSDFGLAKLMTREQSHVFT 652 (817)
Q Consensus 576 ~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ki~Dfgla~~~~~~~~~~~~ 652 (817)
+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++....... ...
T Consensus 95 ~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~ 167 (325)
T 3kn6_A 95 ERIKKKK---HFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLK 167 (325)
T ss_dssp HHHHHCS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-ccc
Confidence 9997654 68999999999999999999999 8999999999999997665 899999999986644322 234
Q ss_pred eccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccH
Q 036583 653 TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQS 732 (817)
Q Consensus 653 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 732 (817)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||..................+..+... ...+...
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~~~~ 241 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGEAWK 241 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSHHHH
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCccccc
Confidence 4678999999999999999999999999999999999999997654322212222222223222211 0011111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 733 DRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 733 ~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.....+.+++.+||+.||++|||++|+++
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 23456889999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=350.28 Aligned_cols=264 Identities=19% Similarity=0.229 Sum_probs=202.6
Q ss_pred HhhccccccCCCcceeEEEEEcCC------CcEEEEEEeccCCc------------CHHHHHHHHHHhhccCcceeeeee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPD------GTRLAVKKLEGIGQ------------GKKEFRAEVSIIGSIHHLHLVKLR 553 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~------------~~~~~~~Ev~~l~~l~h~niv~l~ 553 (817)
..+.+.++||+|+||+||+|.... ++.||||++..... ....+..|+..+..++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 456677899999999999998754 47899999865421 112344566677788899999999
Q ss_pred eEeecC----CeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec--
Q 036583 554 GFCAEG----THRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD-- 627 (817)
Q Consensus 554 ~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~-- 627 (817)
+++... ...+|||||+ +++|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+|||++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--RFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESS
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecC
Confidence 999764 4579999999 9999999976433 68999999999999999999999 8999999999999999
Q ss_pred CCCcEEEeecCCccccCCCCcee------eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCC
Q 036583 628 DNYHAKVSDFGLAKLMTREQSHV------FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSD 701 (817)
Q Consensus 628 ~~~~~ki~Dfgla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~ 701 (817)
.++.+||+|||+++.+....... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 89999999999998765432211 123459999999999999999999999999999999999999997432211
Q ss_pred CCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 702 KAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
..... ........+..++++.+... ..+..+.+++..||+.||.+||++++++++|+.+.
T Consensus 269 --~~~~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 269 --KYVRD-SKIRYRENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp --HHHHH-HHHHHHHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred --HHHHH-HHHHhhhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 11111 11111223344444433211 12346789999999999999999999999998764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=344.88 Aligned_cols=248 Identities=25% Similarity=0.352 Sum_probs=194.5
Q ss_pred hhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcC---HHHHHHHHHHhhccCc--ceeeeeeeEeecCCeeeEEEe
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQG---KKEFRAEVSIIGSIHH--LHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~---~~~~~~Ev~~l~~l~h--~niv~l~~~~~~~~~~~lv~e 567 (817)
.+.+.++||+|+||.||++...+++.||||++...... .+.+.+|+.++.+++| |||+++++++.++...++|||
T Consensus 10 ~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e 89 (343)
T 3dbq_A 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 89 (343)
T ss_dssp EEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe
Confidence 35567889999999999999988999999999754332 3678999999999976 999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
+.+++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+++......
T Consensus 90 -~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 90 -CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp -CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred -CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 56789999997654 58899999999999999999999 8999999999999997 5789999999998775443
Q ss_pred ce-eeeeccCCCCccCcccccc-----------CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhh
Q 036583 648 SH-VFTTLRGTRGYLAPEWITN-----------YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEE 715 (817)
Q Consensus 648 ~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 715 (817)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~-------- 228 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----IS-------- 228 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HH--------
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HH--------
Confidence 22 2234679999999999865 67889999999999999999999999642210 00
Q ss_pred cchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 716 GKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 716 ~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.+..++++......+......+.+++.+||+.||.+|||+.|+++.
T Consensus 229 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 229 -KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1112222222222222223467899999999999999999999974
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.93 Aligned_cols=259 Identities=24% Similarity=0.403 Sum_probs=208.0
Q ss_pred HHhhccccccCCCcceeEEEEEc--------CCCcEEEEEEeccCC--cCHHHHHHHHHHhhcc-CcceeeeeeeEeecC
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVL--------PDGTRLAVKKLEGIG--QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEG 559 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~--------~~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~ 559 (817)
...+.+.+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|++++.++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 35566778999999999999985 346789999997543 2346789999999999 899999999999999
Q ss_pred CeeeEEEeeccCCChhhhhhhccc-------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEe
Q 036583 560 THRLLAYEFMANGSLDKWIFKKNQ-------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL 626 (817)
Q Consensus 560 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll 626 (817)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+ .+|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence 999999999999999999976432 1248899999999999999999999 899999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCc
Q 036583 627 DDNYHAKVSDFGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAH 704 (817)
Q Consensus 627 ~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~ 704 (817)
+.++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----- 265 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 265 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-----
Confidence 999999999999998765433222 223467788999999998899999999999999999999 9999964321
Q ss_pred chHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 705 FPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
......+..+... .........+.+++.+||+.||.+|||++|+++.|+.+..
T Consensus 266 --~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 266 --EELFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp --HHHHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHHhcCCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1122222222111 1111223468899999999999999999999999998744
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=348.31 Aligned_cols=245 Identities=24% Similarity=0.359 Sum_probs=195.3
Q ss_pred ccccCCCcceeEEEEEc-CCCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCCh
Q 036583 497 SVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSL 574 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 574 (817)
.+.||+|+||.||+|.. .+|+.||+|++.... ...+++.+|++++.+++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 35799999999999985 468999999997653 3457899999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEe--cCCCcEEEeecCCccccCCCCceeee
Q 036583 575 DKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL--DDNYHAKVSDFGLAKLMTREQSHVFT 652 (817)
Q Consensus 575 ~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll--~~~~~~ki~Dfgla~~~~~~~~~~~~ 652 (817)
.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++....... ..
T Consensus 174 ~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~ 246 (373)
T 2x4f_A 174 FDRIIDESY--NLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LK 246 (373)
T ss_dssp HHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CC
T ss_pred HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cc
Confidence 998875432 58899999999999999999999 899999999999999 6778999999999987654332 23
Q ss_pred eccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccH
Q 036583 653 TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQS 732 (817)
Q Consensus 653 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 732 (817)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ....+...... .......
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~-~~~~i~~~~~~------~~~~~~~ 313 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------E-TLNNILACRWD------LEDEEFQ 313 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHHTCCC------SCSGGGT
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhccCC------CChhhhc
Confidence 457999999999999989999999999999999999999999643211 1 11111111100 0001111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 733 DRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 733 ~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.....+.+++.+||+.||.+|||++|+++
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 22346889999999999999999999997
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=351.95 Aligned_cols=253 Identities=27% Similarity=0.445 Sum_probs=191.9
Q ss_pred hccccccCCCcceeEEEEEcC--CC--cEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeec-CCeeeEEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP--DG--TRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAE-GTHRLLAY 566 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~--~g--~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 566 (817)
+.+.++||+|+||+||+|+.. ++ ..||||.+.... ...++|.+|+.++++++||||+++++++.+ .+..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 345678999999999999853 22 368999986543 235789999999999999999999998754 55789999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
||+++|+|.+++..... .+++..++.++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 171 e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp ECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred ECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999976443 57889999999999999999999 89999999999999999999999999999876433
Q ss_pred Cce---eeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 647 QSH---VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 647 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
... ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||....... ....+..+...
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-------~~~~~~~~~~~--- 315 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGRRL--- 315 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-------HHHHHHTTCCC---
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-------HHHHHHcCCCC---
Confidence 221 1123457788999999999999999999999999999999 677775443221 11112222110
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
..+......+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 316 ------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 316 ------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011122346889999999999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=332.49 Aligned_cols=249 Identities=22% Similarity=0.353 Sum_probs=201.6
Q ss_pred hhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecC--CeeeEEEe
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEG--THRLLAYE 567 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 567 (817)
.+.+.++||+|+||+||+|+. +++.||||++..... ..+.+.+|+.++.+++||||+++++++.+. ...++|||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 11 QLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 456678899999999999998 588999999976432 346799999999999999999999999887 77899999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCc--eeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR--IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|+++|+|.+++..... ..+++..++.++.||+.||+|||+ .+ |+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp CCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999976442 258999999999999999999998 77 99999999999999999999999998765332
Q ss_pred CCceeeeeccCCCCccCccccccCccCc---cccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 646 EQSHVFTTLRGTRGYLAPEWITNYAISE---KSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
. ...||+.|+|||.+.+..++. ++||||||+++|||++|+.||..... ..........+.
T Consensus 166 ~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~----- 228 (271)
T 3kmu_A 166 P------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKVALEGL----- 228 (271)
T ss_dssp T------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHHHHSCC-----
T ss_pred c------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHHHhcCC-----
Confidence 2 246789999999998765544 79999999999999999999964321 111111111111
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
...........+.+++..||+.||++|||++|+++.|+.+.
T Consensus 229 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 229 ----RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11111123346889999999999999999999999998764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=342.42 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=200.7
Q ss_pred HHhhccccccCCCcceeEEEEEcCC-C-------cEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCe
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLPD-G-------TRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTH 561 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g-------~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~ 561 (817)
...+.+.++||+|+||+||+|+... + ..||+|++.... ...+.+.+|++++.+++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3456677899999999999998543 3 479999996543 446789999999999999999999999999999
Q ss_pred eeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCc--------EE
Q 036583 562 RLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYH--------AK 633 (817)
Q Consensus 562 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~--------~k 633 (817)
.++||||+++|+|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999976543 48889999999999999999999 89999999999999998877 99
Q ss_pred EeecCCccccCCCCceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHH
Q 036583 634 VSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKM 712 (817)
Q Consensus 634 i~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 712 (817)
|+|||++...... ....+++.|+|||.+.+ ..++.++||||||+++|||++|..|+...... ......
T Consensus 162 l~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~------~~~~~~ 230 (289)
T 4fvq_A 162 LSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS------QRKLQF 230 (289)
T ss_dssp ECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHH
T ss_pred eccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch------HHHHHH
Confidence 9999999765332 23457889999999987 77899999999999999999965544322110 001111
Q ss_pred hhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 713 MEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 713 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
.... . ..... ....+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 231 ~~~~--~-----~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 231 YEDR--H-----QLPAP----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHTT--C-----CCCCC----SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hhcc--C-----CCCCC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1110 0 00001 12257789999999999999999999999998854
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=341.09 Aligned_cols=270 Identities=23% Similarity=0.334 Sum_probs=212.2
Q ss_pred cccCHHHHHHHhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhc--cCcceeeeeeeEeecC
Q 036583 482 VRFTYRDLQTATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGS--IHHLHLVKLRGFCAEG 559 (817)
Q Consensus 482 ~~~~~~~l~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~--l~h~niv~l~~~~~~~ 559 (817)
.++...+.....+.+.++||+|+||.||+|+. +++.||||++... ..+.+.+|++++.. ++||||+++++++...
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 34555666777888889999999999999998 6899999999643 35678888888877 7899999999999887
Q ss_pred C----eeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHH--------hcCCCceeecCCCCCCeEec
Q 036583 560 T----HRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLH--------EDCDQRIIHCDIKPENVLLD 627 (817)
Q Consensus 560 ~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH--------~~~~~~ivH~Dlk~~NIll~ 627 (817)
. ..++||||+++|+|.+++.+. .+++..++.++.||+.||+||| + .+|+||||||+|||++
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVK 181 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEEC
T ss_pred CCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEEC
Confidence 6 789999999999999999653 4889999999999999999999 6 8999999999999999
Q ss_pred CCCcEEEeecCCccccCCCCcee---eeeccCCCCccCccccccC------ccCccccccchhhhHHHhhhC--------
Q 036583 628 DNYHAKVSDFGLAKLMTREQSHV---FTTLRGTRGYLAPEWITNY------AISEKSDVYSYGMVLLEIIGG-------- 690 (817)
Q Consensus 628 ~~~~~ki~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~Gvvl~elltg-------- 690 (817)
.++.+||+|||++.......... .....||+.|+|||.+.+. .++.++||||||+++|||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 99999999999998765443221 2335789999999999765 344789999999999999999
Q ss_pred --CCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc-ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 691 --RKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID-EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 691 --~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
+.||........ ........+..... .+.+... ...+....+.+++.+||+.||++|||++||+++|+.+.
T Consensus 262 ~~~~p~~~~~~~~~--~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 262 DYQLPYYDLVPSDP--SVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp CCCCTTTTTSCSSC--CHHHHHHHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccCccccCcCcc--cHHHHHHHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 667754332211 11111222212111 1111111 12356678899999999999999999999999998763
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=348.24 Aligned_cols=254 Identities=25% Similarity=0.460 Sum_probs=198.3
Q ss_pred hhccccccCCCcceeEEEEEcCC-----CcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPD-----GTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~-----g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv 565 (817)
.+.+.+.||+|+||+||+|.... +..||||++.... .....+.+|+.++.+++||||+++++++.+....++|
T Consensus 45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 124 (333)
T 1mqb_A 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 124 (333)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEE
Confidence 34455789999999999998542 2369999997543 2345789999999999999999999999999999999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|||+++++|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 125 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 125 TEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999976433 58899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCcee--eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 646 EQSHV--FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 646 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
..... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..+.
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~~~~~~~~~~----- 267 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAINDGF----- 267 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTC-----
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHHCCC-----
Confidence 32221 122456778999999999899999999999999999999 9999964321 11222222211
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
..+........+.+++.+||+.||++||++.|++++|+.+.
T Consensus 268 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 268 ----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp ----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111223346889999999999999999999999998764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=344.26 Aligned_cols=251 Identities=21% Similarity=0.340 Sum_probs=204.3
Q ss_pred HHhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
...+.+.++||+|+||.||++... +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+....++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456777889999999999999864 689999999975432 2357889999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCC---CcEEEeecCCcccc
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDN---YHAKVSDFGLAKLM 643 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~ki~Dfgla~~~ 643 (817)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||++...
T Consensus 108 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999999987654 58899999999999999999999 899999999999999865 45999999999876
Q ss_pred CCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+... .
T Consensus 182 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-------~~~~~~i~~~~~~-~-- 249 (362)
T 2bdw_A 182 NDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYAQIKAGAYD-Y-- 249 (362)
T ss_dssp TTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCC-C--
T ss_pred cCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCCCC-C--
Confidence 5432 22346799999999999998999999999999999999999999964321 1122222222211 0
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
..+........+.+++.+||+.||++|||+.|+++.
T Consensus 250 ---~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 ---PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ---CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ---CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011111223467899999999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.47 Aligned_cols=252 Identities=27% Similarity=0.389 Sum_probs=199.7
Q ss_pred hhccccccCCCcceeEEEEEcCC----CcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPD----GTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
.+.+.+.||+|+||+||+|+..+ +..||||.+.... ...+.+.+|+.++++++||||+++++++.+ +..++||
T Consensus 13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 91 (281)
T 3cc6_A 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIM 91 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEE
T ss_pred ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEE
Confidence 45566889999999999998532 3469999987642 235689999999999999999999999875 4568999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
||+++++|.+++..... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 92 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 92 ELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp ECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred ecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 99999999999976443 58899999999999999999999 99999999999999999999999999999876554
Q ss_pred CceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccc
Q 036583 647 QSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 725 (817)
.........+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+..+..
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-------~~~~~~~~~~------- 232 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-------VIGVLEKGDR------- 232 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-------HHHHHHHTCC-------
T ss_pred cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-------HHHHHhcCCC-------
Confidence 3333344567889999999998899999999999999999998 999996433211 1112222111
Q ss_pred cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 726 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.+........+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 233 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 233 --LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 111111234688999999999999999999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=337.66 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=194.6
Q ss_pred cccCCCcceeEEEEEc-CCCcEEEEEEeccCC-cCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEeeccCCCh
Q 036583 498 VKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFMANGSL 574 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 574 (817)
+.||+|+||+||+++. .+++.||||++.... ...+.+.+|++++.++ +||||+++++++.+++..++||||+++++|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 5699999999999995 468999999997653 4567899999999885 799999999999999999999999999999
Q ss_pred hhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCc---EEEeecCCccccCCCCc---
Q 036583 575 DKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYH---AKVSDFGLAKLMTREQS--- 648 (817)
Q Consensus 575 ~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~ki~Dfgla~~~~~~~~--- 648 (817)
.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||++........
T Consensus 99 ~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 172 (316)
T 2ac3_A 99 LSHIHKRR---HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172 (316)
T ss_dssp HHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----------
T ss_pred HHHHhccC---CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccc
Confidence 99997654 58899999999999999999999 89999999999999998776 99999999986543211
Q ss_pred ---eeeeeccCCCCccCcccccc-----CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcc--------hHHHHHH
Q 036583 649 ---HVFTTLRGTRGYLAPEWITN-----YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHF--------PSYAFKM 712 (817)
Q Consensus 649 ---~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~--------~~~~~~~ 712 (817)
.......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.... .......
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
T 2ac3_A 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES 252 (316)
T ss_dssp ---------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHH
T ss_pred ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHH
Confidence 11223568999999999975 5688999999999999999999999976543321110 0111111
Q ss_pred hhhcchhhhcccccCCccc--HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 713 MEEGKLRNILDSRLNIDEQ--SDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 713 ~~~~~~~~~~d~~~~~~~~--~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+..+. ...+.. ......+.+++.+||+.||++|||++|+++
T Consensus 253 i~~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 253 IQEGK--------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHCC--------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhccC--------cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 21111 111110 112346889999999999999999999998
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=348.58 Aligned_cols=265 Identities=26% Similarity=0.408 Sum_probs=205.7
Q ss_pred ccccccCCCcceeEEEEEc-----CCCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeec--CCeeeEE
Q 036583 495 NFSVKLGQGGFGSVYQGVL-----PDGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAE--GTHRLLA 565 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~-----~~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~--~~~~~lv 565 (817)
.+.++||+|+||+||++.+ .+++.||||++.... ...+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 5678999999999998864 257889999997643 234678999999999999999999999987 4578999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|||+++|+|.+++... .+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 114 ~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp ECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 9999999999999654 38899999999999999999999 8999999999999999999999999999987755
Q ss_pred CCce--eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 646 EQSH--VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 646 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
.... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........ ....+.........+.+.+.
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHHHh
Confidence 4322 12335678889999999998999999999999999999999999853211000 00000000011111222222
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
.....+........+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 22222233334457889999999999999999999999998763
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=346.91 Aligned_cols=259 Identities=24% Similarity=0.406 Sum_probs=207.8
Q ss_pred HHhhccccccCCCcceeEEEEEcC------CCcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCee
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLP------DGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHR 562 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~ 562 (817)
...+.+.++||+|+||.||+|+.. .++.||||++..... ....+.+|++++++++||||+++++++.++...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 345667789999999999999854 367899999975432 345789999999999999999999999999999
Q ss_pred eEEEeeccCCChhhhhhhcccc-------cchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEe
Q 036583 563 LLAYEFMANGSLDKWIFKKNQE-------FLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVS 635 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~-------~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~ 635 (817)
++||||+++|+|.+++...... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEEC
Confidence 9999999999999999764321 246889999999999999999999 899999999999999999999999
Q ss_pred ecCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHh
Q 036583 636 DFGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMM 713 (817)
Q Consensus 636 Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 713 (817)
|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~ 253 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------EQVLRFV 253 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-------HHHHHHH
T ss_pred cCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-------HHHHHHH
Confidence 999998664432211 122456889999999999899999999999999999999 8899864321 1122222
Q ss_pred hhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 714 EEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 714 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
..+.... ........+.+++.+||+.||.+|||+.|+++.|+....
T Consensus 254 ~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 254 MEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 2221111 111223468899999999999999999999999998743
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=338.93 Aligned_cols=242 Identities=24% Similarity=0.292 Sum_probs=203.1
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
.+.+.+.||+|+||.||+++.. +|+.||||++... ....+.+.+|+.++..++||||+++++++.+....++|||
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 121 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 3455688999999999999964 6899999999643 2456788999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+++|+|.+++.+.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 122 ~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~ 195 (350)
T 1rdq_E 122 YVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp CCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCCc
Confidence 999999999997654 58899999999999999999999 999999999999999999999999999998765432
Q ss_pred ceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+.. .
T Consensus 196 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~~--------~ 256 (350)
T 1rdq_E 196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIYEKIVSGKV--------R 256 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCC--------C
T ss_pred ----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-------HHHHHHHHcCCC--------C
Confidence 345789999999999999999999999999999999999999964321 112222222221 1
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPS-----MTKVVQ 761 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt-----~~evl~ 761 (817)
.+ ......+.+++.+||+.||.+||+ ++|+++
T Consensus 257 ~p--~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 FP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CC--TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CC--CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11 112346889999999999999998 888886
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=350.43 Aligned_cols=250 Identities=18% Similarity=0.202 Sum_probs=199.5
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.++||+|+||+||+++.. +|+.||||++.+.. ...+.+.+|..++..++||||+++++++.+.+..++||||
T Consensus 63 f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~ 142 (412)
T 2vd5_A 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEY 142 (412)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcC
Confidence 344578999999999999964 68999999996531 2234588999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++|+|.+++.+... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 143 ~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 143 YVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp CCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 999999999976532 58899999999999999999999 9999999999999999999999999999987765443
Q ss_pred eeeeeccCCCCccCccccc-------cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhh
Q 036583 649 HVFTTLRGTRGYLAPEWIT-------NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (817)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+..... ..
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~i~~~~~-~~ 289 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST-------AETYGKIVHYKE-HL 289 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTHHH-HC
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhccc-Cc
Confidence 3334468999999999997 35789999999999999999999999964321 111112211110 00
Q ss_pred cccccCCcccHHHHHHHHHHHHhccccCCCCC---CCHHHHHH
Q 036583 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLR---PSMTKVVQ 761 (817)
Q Consensus 722 ~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~R---Pt~~evl~ 761 (817)
..+.. .......+.+++.+||+ +|.+| |+++|+++
T Consensus 290 ~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 290 SLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp CCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 00100 11123468899999999 99998 69999987
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=341.98 Aligned_cols=271 Identities=24% Similarity=0.369 Sum_probs=208.0
Q ss_pred HhhccccccCCCcceeEEEEEc-----CCCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEee--cCCeee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-----PDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCA--EGTHRL 563 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-----~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~--~~~~~~ 563 (817)
..+.+.++||+|+||.||++++ ..++.||||++.... ...+.+.+|++++.+++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4456678999999999999983 468899999997653 33467999999999999999999999986 456689
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+||||+++++|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999976443 58999999999999999999999 99999999999999999999999999999877
Q ss_pred CCCCceee--eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhh
Q 036583 644 TREQSHVF--TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721 (817)
Q Consensus 644 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (817)
........ ....+|+.|+|||.+.+..++.++||||||+++|||++|+.||............ ..........+.+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG-CERDVPALSRLLEL 256 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc-cccccccHHHHHHH
Confidence 54433221 2356788899999999999999999999999999999999998532210000000 00000000011111
Q ss_pred cccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 722 ~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
+......+........+.+++.+||+.||++|||++|++++|+.+..
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11122222223344578899999999999999999999999998743
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=335.17 Aligned_cols=258 Identities=22% Similarity=0.310 Sum_probs=196.4
Q ss_pred hccccccCCCcceeEEEEEcCCCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
+.+.++||+|+||+||+++...++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 45668899999999999998789999999996542 234788999999999999999999999999999999999998
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+ +|.+++..... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 84 ~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (288)
T 1ob3_A 84 Q-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (288)
T ss_dssp E-EHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred C-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-c
Confidence 6 89998876433 58889999999999999999999 8999999999999999999999999999987643221 2
Q ss_pred eeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcch------hh--h
Q 036583 651 FTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKL------RN--I 721 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~--~ 721 (817)
.....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... .............. .+ .
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHHCCCChhhchhhhcccc
Confidence 234578999999999976 458999999999999999999999996432111 00011111100000 00 0
Q ss_pred cccccCC-------cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 722 LDSRLNI-------DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 722 ~d~~~~~-------~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.++.... .........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 000112346789999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=345.99 Aligned_cols=268 Identities=19% Similarity=0.213 Sum_probs=199.9
Q ss_pred HHHHHHhhccccccCCCcceeEEEEEcC----CCcEEEEEEeccCCc------------CHHHHHHHHHHhhccCcceee
Q 036583 487 RDLQTATNNFSVKLGQGGFGSVYQGVLP----DGTRLAVKKLEGIGQ------------GKKEFRAEVSIIGSIHHLHLV 550 (817)
Q Consensus 487 ~~l~~~~~~~~~~lG~G~fG~Vy~g~~~----~g~~vavK~l~~~~~------------~~~~~~~Ev~~l~~l~h~niv 550 (817)
.++....+.+.++||+|+||.||+|... .+..+|||++..... ..+.+.+|+.++..++||||+
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~ 111 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence 3344455677789999999999999975 567899999865421 223567888999999999999
Q ss_pred eeeeEeec----CCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEe
Q 036583 551 KLRGFCAE----GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL 626 (817)
Q Consensus 551 ~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll 626 (817)
++++++.+ ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+|||+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 184 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLL 184 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred eeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEE
Confidence 99999987 77889999999 999999997654 68999999999999999999999 899999999999999
Q ss_pred cCCC--cEEEeecCCccccCCCCce------eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCC
Q 036583 627 DDNY--HAKVSDFGLAKLMTREQSH------VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNE 698 (817)
Q Consensus 627 ~~~~--~~ki~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~ 698 (817)
+.++ .+||+|||+++.+...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 264 (345)
T 2v62_A 185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL 264 (345)
T ss_dssp ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9887 9999999999876432211 1133578999999999999999999999999999999999999995322
Q ss_pred CCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 699 TSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
... ........... ..+...+..... .......+.+++..||+.||++|||+++|++.|+...
T Consensus 265 ~~~--~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 265 KDP--VAVQTAKTNLL-DELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp TCH--HHHHHHHHHHH-HTTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred ccc--HHHHHHHHhhc-ccccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 111 00000011111 111111111000 0022346889999999999999999999999998763
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=335.85 Aligned_cols=251 Identities=27% Similarity=0.413 Sum_probs=201.2
Q ss_pred hhcccc-ccCCCcceeEEEEEc---CCCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEE
Q 036583 493 TNNFSV-KLGQGGFGSVYQGVL---PDGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 493 ~~~~~~-~lG~G~fG~Vy~g~~---~~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv 565 (817)
.+.+.+ +||+|+||+||+|.. ..++.||||++..... ..+++.+|++++..++||||+++++++ +.+..++|
T Consensus 17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv 95 (291)
T 1xbb_A 17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV 95 (291)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence 344555 899999999999953 3467899999975432 256899999999999999999999999 56778999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|||+++++|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 99999999999997654 58899999999999999999999 8999999999999999999999999999987755
Q ss_pred CCceee--eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 646 EQSHVF--TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 646 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
...... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..+..
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~---- 238 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SEVTAMLEKGER---- 238 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCC----
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCC----
Confidence 433221 22456788999999998889999999999999999999 9999964321 112222222211
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
..........+.+++.+||+.||++||++.|+++.|+.+
T Consensus 239 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 239 -----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111122334688999999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=330.83 Aligned_cols=253 Identities=23% Similarity=0.371 Sum_probs=205.8
Q ss_pred HHHHHHhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeec-------
Q 036583 487 RDLQTATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE------- 558 (817)
Q Consensus 487 ~~l~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~------- 558 (817)
.......+.+.+.||+|+||.||+++.. +++.||+|++.... +.+.+|++++.+++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 3445566777889999999999999975 78999999997543 467899999999999999999998854
Q ss_pred ---------CCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCC
Q 036583 559 ---------GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDN 629 (817)
Q Consensus 559 ---------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~ 629 (817)
....++||||+++++|.+++..... ..+++..++.++.||+.||.|||+ .+|+|+||||+||+++++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEET
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCC
Confidence 4457999999999999999976432 268899999999999999999999 899999999999999999
Q ss_pred CcEEEeecCCccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHH
Q 036583 630 YHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYA 709 (817)
Q Consensus 630 ~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~ 709 (817)
+.+||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|..|+... ...
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~ 227 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKF 227 (284)
T ss_dssp TEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHH
T ss_pred CCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHH
Confidence 9999999999987654322 23456899999999999999999999999999999999999887311 111
Q ss_pred HHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCC
Q 036583 710 FKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPV 769 (817)
Q Consensus 710 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 769 (817)
...+..+.+ ... ....+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 228 ~~~~~~~~~--------~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 228 FTDLRDGII--------SDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHHHTTCC--------CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred HHHhhcccc--------ccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 111111111 111 123577899999999999999999999999987543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=343.30 Aligned_cols=263 Identities=25% Similarity=0.371 Sum_probs=195.2
Q ss_pred hhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHH--hhccCcceeeeeeeEeec-----CCeeeEE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSI--IGSIHHLHLVKLRGFCAE-----GTHRLLA 565 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~--l~~l~h~niv~l~~~~~~-----~~~~~lv 565 (817)
.+.+.++||+|+||+||+|+. +++.||||++.... ...+..|.++ +..++||||+++++.+.. ....++|
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 90 (336)
T 3g2f_A 14 NLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90 (336)
T ss_dssp SEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred HhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence 455668899999999999987 78999999997433 3444444444 556899999999986532 3356899
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCC---------ceeecCCCCCCeEecCCCcEEEee
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ---------RIIHCDIKPENVLLDDNYHAKVSD 636 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~---------~ivH~Dlk~~NIll~~~~~~ki~D 636 (817)
|||+++|+|.+++.... .++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|
T Consensus 91 ~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp ECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEEee
Confidence 99999999999996543 5788899999999999999998 6 999999999999999999999999
Q ss_pred cCCccccCCCCc-------eeeeeccCCCCccCcccccc-------CccCccccccchhhhHHHhhhCCCCCCCCCCCCC
Q 036583 637 FGLAKLMTREQS-------HVFTTLRGTRGYLAPEWITN-------YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDK 702 (817)
Q Consensus 637 fgla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~ 702 (817)
||+++....... .......||+.|+|||.+.+ ..++.++|||||||++|||++|..||........
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 999987654221 11223579999999999986 4667899999999999999999887754433221
Q ss_pred Ccc-----------hHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 703 AHF-----------PSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 703 ~~~-----------~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
... ................+.. ...........+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 100 0000111111111111100 01122345567999999999999999999999999998863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=347.81 Aligned_cols=247 Identities=24% Similarity=0.349 Sum_probs=194.9
Q ss_pred hccccccCCCcceeEEEEEcCCCcEEEEEEeccCCc---CHHHHHHHHHHhhccC--cceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIH--HLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.++||+|+||.||++...+++.||||++..... ..+.+.+|+.++.+++ ||||+++++++...+..++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 566789999999999999988899999999965432 3467899999999996 5999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+.+++|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++ ++.+||+|||+++.......
T Consensus 137 ~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 137 CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 67889999997654 57888999999999999999999 8999999999999996 57999999999987754332
Q ss_pred e-eeeeccCCCCccCcccccc-----------CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhc
Q 036583 649 H-VFTTLRGTRGYLAPEWITN-----------YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEG 716 (817)
Q Consensus 649 ~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 716 (817)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~--------- 275 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----IS--------- 275 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HH---------
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HH---------
Confidence 2 2234679999999999875 36889999999999999999999999643211 01
Q ss_pred chhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 717 KLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 717 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.+..++++......+......+.+++.+||+.||.+|||+.|+++.
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 276 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1112222222111111123467899999999999999999999974
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=346.90 Aligned_cols=264 Identities=18% Similarity=0.230 Sum_probs=202.5
Q ss_pred HhhccccccCCC--cceeEEEEEcC-CCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEE
Q 036583 492 ATNNFSVKLGQG--GFGSVYQGVLP-DGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 492 ~~~~~~~~lG~G--~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv 565 (817)
..+.+.++||+| +||+||+++.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 346677899999 99999999965 689999999975432 235788899999999999999999999999999999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|||+++|+|.+++...... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 105 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFMD-GMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EECCTTCBHHHHHHHTCTT-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEccCCCCHHHHHhhhccc-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 9999999999999765322 58899999999999999999999 8999999999999999999999999999875432
Q ss_pred CCce------eeeeccCCCCccCcccccc--CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcc
Q 036583 646 EQSH------VFTTLRGTRGYLAPEWITN--YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGK 717 (817)
Q Consensus 646 ~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 717 (817)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ + .....+.
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~-----~~~~~~~ 253 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--L-----LEKLNGT 253 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--H-----HHC----
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--H-----HHHhcCC
Confidence 2111 1112468889999999987 6789999999999999999999999975433221 0 0000000
Q ss_pred hhhhccc------------------------------c------cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 718 LRNILDS------------------------------R------LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 718 ~~~~~d~------------------------------~------~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
...+.+. + ...+........+.+++.+||+.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0000000 0 000011122356889999999999999999999997
Q ss_pred H--HhcC
Q 036583 762 M--LEGI 766 (817)
Q Consensus 762 ~--L~~~ 766 (817)
. ++++
T Consensus 334 hp~f~~~ 340 (389)
T 3gni_B 334 HSFFKQI 340 (389)
T ss_dssp SGGGGGC
T ss_pred CHHHHHH
Confidence 4 4544
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=373.50 Aligned_cols=246 Identities=27% Similarity=0.421 Sum_probs=197.9
Q ss_pred cccCCCcceeEEEEEc---CCCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 498 VKLGQGGFGSVYQGVL---PDGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~---~~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
++||+|+||+||+|.+ ..++.||||+++... ...+++.+|++++.+++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999964 246789999997542 235789999999999999999999999964 568899999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce--
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH-- 649 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-- 649 (817)
|+|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++........
T Consensus 454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999997543 58899999999999999999999 89999999999999999999999999999877543321
Q ss_pred eeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+...+..+.. .
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-------~~~~~~i~~~~~---------~ 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SEVTAMLEKGER---------M 591 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCC---------C
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCC---------C
Confidence 1223456789999999999999999999999999999998 9999964432 112222333221 1
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.........+.+++..||+.||++||++++|++.|+.+
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11222345788999999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=347.51 Aligned_cols=268 Identities=22% Similarity=0.303 Sum_probs=212.7
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecCC--eeeEEEe
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT--HRLLAYE 567 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~--~~~lv~e 567 (817)
.+.+.++||+|+||+||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+.. ..++|||
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 89 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence 4556788999999999999965 4899999999754 245678899999999999999999999998755 6799999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEe----cCCCcEEEeecCCcccc
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL----DDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~ki~Dfgla~~~ 643 (817)
|+++|+|.+++........+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp CCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred cCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 99999999999876554458999999999999999999999 899999999999999 78888999999999876
Q ss_pred CCCCceeeeeccCCCCccCcccccc--------CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhh
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITN--------YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEE 715 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 715 (817)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...........
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~--~~~~~~~~~~~ 242 (396)
T 4eut_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIITG 242 (396)
T ss_dssp CCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT--CHHHHHHHHHS
T ss_pred cCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc--hHHHHHHHhcC
Confidence 54322 234679999999999875 5678899999999999999999999975443221 12222222222
Q ss_pred cchhhhcc---------------cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 716 GKLRNILD---------------SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 716 ~~~~~~~d---------------~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
.....+. ..............+.+++.+||+.||++||+++|+++.++.+..
T Consensus 243 -~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 243 -KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp -CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred -CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 1111100 001112234566778899999999999999999999999887643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=337.04 Aligned_cols=253 Identities=27% Similarity=0.445 Sum_probs=198.5
Q ss_pred hccccccCCCcceeEEEEEcCC----CcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEee-cCCeeeEEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPD----GTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCA-EGTHRLLAY 566 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~-~~~~~~lv~ 566 (817)
+.+.++||+|+||+||+|+..+ ...+|+|.+..... ..+.+.+|+.++++++||||+++++++. .+...++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 4556889999999999998543 23589999875432 3467899999999999999999999864 456789999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
||+++|+|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 107 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 107 PYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp ECCTTCBHHHHHHCTTC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eCCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999999976433 57889999999999999999999 89999999999999999999999999999876543
Q ss_pred Cce---eeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 647 QSH---VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 647 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
... ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||....... .......+..
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-------~~~~~~~~~~---- 250 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGRR---- 250 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-------HHHHHHTTCC----
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhcCCC----
Confidence 221 1233567789999999999999999999999999999999 555664432221 1111111110
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
..........+.+++.+||+.||++|||++|++++|+.+.
T Consensus 251 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 251 -----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0001112346889999999999999999999999998864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=339.13 Aligned_cols=263 Identities=24% Similarity=0.332 Sum_probs=202.3
Q ss_pred HhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEee----cCCeeeEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCA----EGTHRLLA 565 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~----~~~~~~lv 565 (817)
..+.+.++||+|+||.||+++. .+++.||||++.... ...+.+.+|++++.+++||||+++++++. .....++|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 3466678999999999999995 578999999986543 34567899999999999999999999997 34478999
Q ss_pred EeeccCCChhhhhhhcc-cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 566 YEFMANGSLDKWIFKKN-QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
|||+++|+|.+++.... ....+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 99999999999997631 12368999999999999999999999 899999999999999999999999999987653
Q ss_pred CCCce--------eeeeccCCCCccCccccccCc---cCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHh
Q 036583 645 REQSH--------VFTTLRGTRGYLAPEWITNYA---ISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMM 713 (817)
Q Consensus 645 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 713 (817)
..... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----------- 254 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD----------- 254 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-----------
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-----------
Confidence 21110 011245799999999987543 68899999999999999999999952111000
Q ss_pred hhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCCCC
Q 036583 714 EEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQ 771 (817)
Q Consensus 714 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 771 (817)
.+..........+........+.+++.+||+.||.+|||++|+++.|+.+.+.++
T Consensus 255 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 255 ---SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp ---CHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred ---hhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 0000011111111112233468899999999999999999999999998854433
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=342.03 Aligned_cols=248 Identities=24% Similarity=0.342 Sum_probs=202.2
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
..+.+.+.||+|+||.||+++.. +++.||+|++... ....+.+.+|+.++..++||||+++++++.+....++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 34566789999999999999854 5889999998643 345678999999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999997654 58899999999999999999999 89999999999999999999999999999876543
Q ss_pred CceeeeeccCCCCccCcccccc---CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 647 QSHVFTTLRGTRGYLAPEWITN---YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||....... .......+....
T Consensus 169 ~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~----~~~~~~~~~~~~------ 236 (384)
T 4fr4_A 169 T--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS----SKEIVHTFETTV------ 236 (384)
T ss_dssp C--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC----HHHHHHHHHHCC------
T ss_pred C--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc----HHHHHHHHhhcc------
Confidence 2 2345789999999999974 458999999999999999999999997543322 111111111111
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPS-MTKVVQ 761 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt-~~evl~ 761 (817)
. ..+......+.+++.+||+.||.+||+ ++++++
T Consensus 237 --~--~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 --V--TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --C--CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --c--CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1 111122346889999999999999998 777765
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=338.92 Aligned_cols=252 Identities=24% Similarity=0.324 Sum_probs=201.1
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc----CHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ----GKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~----~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 566 (817)
.+.+.+.||+|+||.||+++.. +++.||+|++..... ..+.+.+|+.++.++ +||||+++++++.+....++||
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 89 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence 3556688999999999999965 588999999975421 235678999999988 8999999999999999999999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
||+++|+|.+++.+.. .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 90 EYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred eCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 9999999999997654 58899999999999999999999 89999999999999999999999999999864322
Q ss_pred CceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCC--cchHHHHHHhhhcchhhhccc
Q 036583 647 QSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA--HFPSYAFKMMEEGKLRNILDS 724 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~ 724 (817)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .........+..+.
T Consensus 164 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------- 235 (345)
T 3a8x_A 164 GD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------- 235 (345)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-------
T ss_pred CC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-------
Confidence 21 234568999999999999999999999999999999999999999653322111 11122222222221
Q ss_pred ccCCcccHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 036583 725 RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSM------TKVVQ 761 (817)
Q Consensus 725 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~------~evl~ 761 (817)
...+ ......+.+++.+||+.||++||++ +|+++
T Consensus 236 -~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 236 -IRIP--RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp -CCCC--TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred -CCCC--CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 1111 1223467899999999999999995 67765
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=344.84 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=203.3
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.+.+.++||+|+||.||+|... +++.+|+|++.... .....+.+|++++.+++||||+++++++.+....++||||++
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 4667789999999999999864 68899999997543 235678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC--CCcEEEeecCCccccCCCCc
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD--NYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~ki~Dfgla~~~~~~~~ 648 (817)
+|+|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 132 gg~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 132 GGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 9999999975432 58899999999999999999999 89999999999999974 57899999999987754432
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+...... ...
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~~~~~i~~~~~~------~~~ 271 (387)
T 1kob_A 207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ETLQNVKRCDWE------FDE 271 (387)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHHCCCC------CCS
T ss_pred --eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCC------CCc
Confidence 23457999999999999999999999999999999999999999643211 111111111110 001
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.........+.+++.+||+.||++|||+.|+++.
T Consensus 272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1111223468899999999999999999999984
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.06 Aligned_cols=258 Identities=26% Similarity=0.407 Sum_probs=207.0
Q ss_pred HHhhccccccCCCcceeEEEEEc------CCCcEEEEEEeccCCc--CHHHHHHHHHHhhcc-CcceeeeeeeEeecCC-
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVL------PDGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGT- 560 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~------~~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~- 560 (817)
...+.+.+.||+|+||+||+++. .+++.||||++..... ..+.+.+|++++.++ +||||+++++++...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 34566678999999999999973 3568899999976432 345789999999999 7999999999987654
Q ss_pred eeeEEEeeccCCChhhhhhhcccc-------------cchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec
Q 036583 561 HRLLAYEFMANGSLDKWIFKKNQE-------------FLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD 627 (817)
Q Consensus 561 ~~~lv~e~~~~gsL~~~l~~~~~~-------------~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~ 627 (817)
..++||||+++++|.+++...... ..+++..++.++.||+.||.|||+ .+|+||||||+||+++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 182 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEEC
Confidence 589999999999999999765431 128899999999999999999999 8999999999999999
Q ss_pred CCCcEEEeecCCccccCCCCce-eeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcc
Q 036583 628 DNYHAKVSDFGLAKLMTREQSH-VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHF 705 (817)
Q Consensus 628 ~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~ 705 (817)
.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----- 257 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----- 257 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-----
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh-----
Confidence 9999999999999876544332 2233567889999999999999999999999999999998 99999654321
Q ss_pred hHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 706 PSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 706 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
......+..+.... ........+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 258 -~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 258 -EEFCRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp -HHHHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHhccCccCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11222222221111 1111234688999999999999999999999999876
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=343.61 Aligned_cols=245 Identities=22% Similarity=0.288 Sum_probs=201.5
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 566 (817)
.+.+.+.||+|+||.||+++.. +++.||||+++.. ....+.+..|..++..+ +||||+++++++.+.+..++||
T Consensus 18 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~ 97 (345)
T 1xjd_A 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 97 (345)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEE
Confidence 4556688999999999999964 5889999999753 34567788999999887 9999999999999999999999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 98 EYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred eCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 9999999999997654 58899999999999999999999 89999999999999999999999999999864332
Q ss_pred CceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 647 QSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+. .
T Consensus 172 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~--------~ 235 (345)
T 1xjd_A 172 DA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------EELFHSIRMDN--------P 235 (345)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC--------C
T ss_pred CC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHhCC--------C
Confidence 21 23456899999999999999999999999999999999999999964321 11222222221 1
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMT-KVVQ 761 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~-evl~ 761 (817)
.. +......+.+++.+||+.||++||++. |+++
T Consensus 236 ~~--p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 236 FY--PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp CC--CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CC--CcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 11 111234678999999999999999997 7653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=343.05 Aligned_cols=248 Identities=24% Similarity=0.359 Sum_probs=187.1
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
.+.+.++||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++.+++||||+++++++.+....++||||+++
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 132 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence 3556688999999999999975 57899999997542 456788999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC---CCcEEEeecCCccccCCCCc
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD---NYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~Dfgla~~~~~~~~ 648 (817)
++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 133 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~- 205 (349)
T 2w4o_A 133 GELFDRIVEKG---YYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV- 205 (349)
T ss_dssp CBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc-
Confidence 99999997654 58899999999999999999999 89999999999999975 8899999999998764322
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+.+.... .. .
T Consensus 206 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~i~~~~~~-~~-----~ 272 (349)
T 2w4o_A 206 -LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD------QFMFRRILNCEYY-FI-----S 272 (349)
T ss_dssp --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH------HHHHHHHHTTCCC-CC-----T
T ss_pred -ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc------HHHHHHHHhCCCc-cC-----C
Confidence 223467899999999999999999999999999999999999999643321 1122222222111 00 0
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+........+.+++.+||+.||++|||+.|+++
T Consensus 273 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111123346889999999999999999999988
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=338.85 Aligned_cols=255 Identities=22% Similarity=0.320 Sum_probs=193.2
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc-C---HHHHHHHHHHhhccCcceeeeeeeEeecCCe----ee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ-G---KKEFRAEVSIIGSIHHLHLVKLRGFCAEGTH----RL 563 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~-~---~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~----~~ 563 (817)
.+.+.++||+|+||.||+++. .+++.||||++..... . .+.+.+|+.++.+++||||+++++++..... .+
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 456678899999999999995 5789999999976422 2 3578899999999999999999999876554 39
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+||||+++++|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 93 lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred EEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 9999999999999997654 58999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCce--eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhh
Q 036583 644 TREQSH--VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721 (817)
Q Consensus 644 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (817)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ................
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~~~ 240 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIPPS 240 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCCHH
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCCCcc
Confidence 543222 12235689999999999999999999999999999999999999964321 1111222221111000
Q ss_pred cccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHH-HHHhcC
Q 036583 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVV-QMLEGI 766 (817)
Q Consensus 722 ~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl-~~L~~~ 766 (817)
.........+.+++.+||+.||++||++.+++ +.|...
T Consensus 241 -------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 241 -------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp -------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 00011234678999999999999999665554 555554
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=326.76 Aligned_cols=246 Identities=22% Similarity=0.334 Sum_probs=202.7
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC-CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI-GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
..+.+.++||+|+||+||+|... ++..+|+|++... ....+.+.+|++++++++||||+++++++.++...++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 45667789999999999999964 4778999999764 455788999999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEe---cCCCcEEEeecCCccccCCC
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL---DDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~Dfgla~~~~~~ 646 (817)
++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||++......
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 89 TGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999999987654 58899999999999999999999 899999999999999 78899999999999876543
Q ss_pred CceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 647 QSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
.. .....||+.|+|||.+.+. ++.++||||||++++||++|+.||..... ......+.++..
T Consensus 163 ~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~-------- 224 (277)
T 3f3z_A 163 KM--MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD-------SEVMLKIREGTF-------- 224 (277)
T ss_dssp SC--BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCC--------
T ss_pred cc--hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCCC--------
Confidence 32 2346789999999998764 89999999999999999999999964321 112222222211
Q ss_pred CCccc--HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 727 NIDEQ--SDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 727 ~~~~~--~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..+.. ......+.+++.+|++.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11100 012346889999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=341.47 Aligned_cols=254 Identities=23% Similarity=0.278 Sum_probs=197.9
Q ss_pred HhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccC------CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI------GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLL 564 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~------~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 564 (817)
..+.+.++||+|+||+||++.. .+++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 5577779999999999999986 46889999998542 2345789999999999999999999999999999999
Q ss_pred EEeeccCCChhhhhhhc-------------------------------------ccccchhhhHHHHHHHHHHHHHHHHH
Q 036583 565 AYEFMANGSLDKWIFKK-------------------------------------NQEFLLDWETRFNIALGTAKGLAYLH 607 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~-------------------------------------~~~~~l~~~~~~~i~~qia~~l~~LH 607 (817)
||||+++|+|.+++... .....+++..+..++.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999998521 01224577888999999999999999
Q ss_pred hcCCCceeecCCCCCCeEecCCC--cEEEeecCCccccCCCCc---eeeeeccCCCCccCcccccc--CccCccccccch
Q 036583 608 EDCDQRIIHCDIKPENVLLDDNY--HAKVSDFGLAKLMTREQS---HVFTTLRGTRGYLAPEWITN--YAISEKSDVYSY 680 (817)
Q Consensus 608 ~~~~~~ivH~Dlk~~NIll~~~~--~~ki~Dfgla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~ 680 (817)
+ .+|+||||||+||+++.++ .+||+|||+++....... .......||+.|+|||.+.+ ..++.++|||||
T Consensus 186 ~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 186 N---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp H---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred H---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 9 8999999999999998776 899999999986543221 12344679999999999975 678899999999
Q ss_pred hhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 036583 681 GMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVV 760 (817)
Q Consensus 681 Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl 760 (817)
|+++|||++|+.||...... ... ..+..+... ...+........+.+++.+||+.||.+|||+.|++
T Consensus 263 G~il~el~~g~~pf~~~~~~------~~~-~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 329 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDA------DTI-SQVLNKKLC------FENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHH------HHH-HHHHHCCCC------TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred HHHHHHHHHCCCCCCCCChH------HHH-HHHHhcccc------cCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 99999999999999643211 111 111111110 01111112234688999999999999999999998
Q ss_pred H
Q 036583 761 Q 761 (817)
Q Consensus 761 ~ 761 (817)
+
T Consensus 330 ~ 330 (345)
T 3hko_A 330 Q 330 (345)
T ss_dssp H
T ss_pred c
Confidence 7
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=333.42 Aligned_cols=249 Identities=30% Similarity=0.455 Sum_probs=196.4
Q ss_pred HhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecC-CeeeEEEeecc
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG-THRLLAYEFMA 570 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~ 570 (817)
..+.+.+.||+|+||+||++.. .|+.||||++... ...+.+.+|++++.+++||||+++++++.+. ...++||||++
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred hhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch-hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence 3456678899999999999988 5889999999753 3567899999999999999999999997654 47899999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+++|.+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--- 171 (278)
T 1byg_A 99 KGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 171 (278)
T ss_dssp TEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc---
Confidence 9999999976432 247889999999999999999999 899999999999999999999999999998654322
Q ss_pred eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 651 FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+..+. ...
T Consensus 172 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~~~~~~---------~~~ 234 (278)
T 1byg_A 172 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGY---------KMD 234 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-------HHHHHTTTC---------CCC
T ss_pred -cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcCC---------CCC
Confidence 23467889999999999899999999999999999998 999996432211 112222211 111
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
........+.+++..||+.||++|||+.|+++.|+.+
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 1122334688999999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=329.93 Aligned_cols=260 Identities=20% Similarity=0.268 Sum_probs=203.9
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEe-ecCCeeeEEEeecc
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFC-AEGTHRLLAYEFMA 570 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~~ 570 (817)
.+.+.+.||+|+||.||+|+. .+++.||||++.... ..+++.+|+.++..++|++++..+.++ .++...++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence 355668899999999999995 578999999986543 345689999999999988876666665 5677889999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEe---cCCCcEEEeecCCccccCCCC
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL---DDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~Dfgla~~~~~~~ 647 (817)
+++|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++......
T Consensus 88 ~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 88 GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 8999999975433 58999999999999999999999 899999999999999 488999999999998765433
Q ss_pred ce------eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhh
Q 036583 648 SH------VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721 (817)
Q Consensus 648 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (817)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........................+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH
Confidence 21 123467999999999999999999999999999999999999999765433322211111111111110000
Q ss_pred cccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 722 ~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
. ......+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 243 -----~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 243 -----C----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp -----T----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred -----H----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 0 1122468899999999999999999999999988643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=350.02 Aligned_cols=200 Identities=31% Similarity=0.393 Sum_probs=175.7
Q ss_pred HHHHhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhccC-----cceeeeeeeEeecCCee
Q 036583 489 LQTATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH-----HLHLVKLRGFCAEGTHR 562 (817)
Q Consensus 489 l~~~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~-----h~niv~l~~~~~~~~~~ 562 (817)
+....+.+.++||+|+||+||+++. .+++.||||++.......+.+..|+.++.+++ ||||+++++++...+..
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 3445666778999999999999996 46889999999865555677888999999996 99999999999999999
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC--------------
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD-------------- 628 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-------------- 628 (817)
++||||+ +++|.+++...... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 112 ~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRNNYN-GFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp EEEECCC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred EEEEcCC-CCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhccc
Confidence 9999999 88999999765432 58889999999999999999999 99999999999999975
Q ss_pred -----------CCcEEEeecCCccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCC
Q 036583 629 -----------NYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPN 697 (817)
Q Consensus 629 -----------~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~ 697 (817)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 7899999999998654322 3457899999999999999999999999999999999999999754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=331.10 Aligned_cols=260 Identities=20% Similarity=0.269 Sum_probs=202.5
Q ss_pred HhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEe-ecCCeeeEEEeec
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFC-AEGTHRLLAYEFM 569 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~ 569 (817)
..+.+.++||+|+||+||+|+. .+++.||||++.... ..+.+.+|++++..++|++++..+..+ .++...++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence 4466778999999999999995 578899999875432 234588999999999988877776666 6677889999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEe---cCCCcEEEeecCCccccCCC
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL---DDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~Dfgla~~~~~~ 646 (817)
+++|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+|||+ ++++.+||+|||+++.....
T Consensus 88 -~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 88 -GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp -CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred -CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 9999999975433 58999999999999999999999 899999999999999 78999999999999876543
Q ss_pred Cce------eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhh
Q 036583 647 QSH------VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRN 720 (817)
Q Consensus 647 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (817)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........................
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence 321 12346789999999999999999999999999999999999999976544332222111111111111000
Q ss_pred hcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 721 ILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 721 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
.. ......+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 242 ~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 242 LC---------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HT---------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hh---------ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 00 011346889999999999999999999999998864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=337.03 Aligned_cols=252 Identities=24% Similarity=0.375 Sum_probs=199.4
Q ss_pred cccccCCCcceeEEEEEcC-C---CcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCee-eEEEee
Q 036583 496 FSVKLGQGGFGSVYQGVLP-D---GTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHR-LLAYEF 568 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~-~---g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~-~lv~e~ 568 (817)
..++||+|+||+||+|... + +..+|+|++..... ..+.+.+|+.++++++||||+++++++.+.+.. ++||||
T Consensus 25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence 3478999999999999843 2 23799999975432 346789999999999999999999999876665 999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+.+|+|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 105 ~~~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 105 MCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp CTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred ccCCCHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 999999999976433 58889999999999999999999 8999999999999999999999999999986644321
Q ss_pred ---eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccc
Q 036583 649 ---HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725 (817)
Q Consensus 649 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 725 (817)
.......+++.|+|||.+.+..++.++||||||+++|||++|..|+....... .....+..+.
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~------~~~~~~~~~~-------- 245 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF------DLTHFLAQGR-------- 245 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG------GHHHHHHTTC--------
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH------HHHHHhhcCC--------
Confidence 11223567889999999999999999999999999999999666553222111 1111122211
Q ss_pred cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 726 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
...........+.+++.+||+.||.+|||++|+++.|+.+.
T Consensus 246 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 246 -RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111122346889999999999999999999999998763
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=337.57 Aligned_cols=246 Identities=24% Similarity=0.340 Sum_probs=192.6
Q ss_pred HhhccccccCCCcceeEEEEEc----CCCcEEEEEEeccCC-----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL----PDGTRLAVKKLEGIG-----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHR 562 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~----~~g~~vavK~l~~~~-----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~ 562 (817)
..+.+.++||+|+||.||+++. .+++.||+|++.... .....+.+|+.++++++||||+++++++.+++..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 4466778999999999999986 478999999997542 2345688999999999999999999999999999
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
++||||+++++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999997654 57889999999999999999999 8999999999999999999999999999986
Q ss_pred cCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 643 MTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 643 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+...
T Consensus 171 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~------ 236 (327)
T 3a62_A 171 SIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-------KKTIDKILKC------ 236 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHT------
T ss_pred cccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhC------
Confidence 433221 22346799999999999998999999999999999999999999964321 1111112111
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRP-----SMTKVVQ 761 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~evl~ 761 (817)
....+ ......+.+++.+||+.||++|| ++.|+++
T Consensus 237 --~~~~p--~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 237 --KLNLP--PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp --CCCCC--TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred --CCCCC--CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11111 11234678999999999999999 7888876
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=333.53 Aligned_cols=256 Identities=24% Similarity=0.359 Sum_probs=189.2
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
+.+.++||+|+||+||+|... +|+.||||++.... ...+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (317)
T 2pmi_A 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD 86 (317)
T ss_dssp ------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC
T ss_pred eeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC
Confidence 455678999999999999864 58999999996542 345788999999999999999999999999999999999998
Q ss_pred CCChhhhhhhccc---ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 571 NGSLDKWIFKKNQ---EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 571 ~gsL~~~l~~~~~---~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+|.+++..... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 87 -~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 87 -NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp -CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred -CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 599999875421 1258889999999999999999999 899999999999999999999999999998764332
Q ss_pred ceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcc---------
Q 036583 648 SHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGK--------- 717 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--------- 717 (817)
. ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... .............
T Consensus 163 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 163 N-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp C-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCGGGGG
T ss_pred c-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhhhhhh
Confidence 1 2234578999999999976 468999999999999999999999996543211 0001111100000
Q ss_pred ---------------hhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 718 ---------------LRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 718 ---------------~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+.+.+.+... ......+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTK----EPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCS----SCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhHHHhhccccc----ccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000000000 012346889999999999999999999987
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=331.99 Aligned_cols=260 Identities=18% Similarity=0.240 Sum_probs=197.3
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc----CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ----GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~----~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
..+.+.++||+|+||.||++... +++.||+|++..... ..+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 34566789999999999999964 688999999975422 2367899999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
||+++++|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 114 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 114 RLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp ECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9999999999997654 58899999999999999999999 89999999999999999999999999999876554
Q ss_pred CceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 647 QSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
.........|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+.... .. +.
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~-~~---~~- 255 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHINQAI-PR---PS- 255 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHHSCC-CC---GG-
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhccCC-CC---cc-
Confidence 33333456789999999999998999999999999999999999999964321 11111111110 00 00
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcCCCCCC
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRP-SMTKVVQMLEGICPVPQ 771 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RP-t~~evl~~L~~~~~~~~ 771 (817)
.........+.+++.+||+.||++|| +++++++.|+.......
T Consensus 256 --~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 256 --TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp --GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred --ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 00111233678999999999999999 99999999998755443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=340.67 Aligned_cols=246 Identities=23% Similarity=0.305 Sum_probs=202.1
Q ss_pred HhhccccccCCCcceeEEEEEcCC-CcEEEEEEeccC----CcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGI----GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv 565 (817)
..+.+.+.||+|+||.||+++... ++.||||++... ....+.+..|..++..+ +||||+++++++.+.+..++|
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 345667899999999999999754 788999999653 34567789999999988 899999999999999999999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999997654 58899999999999999999999 8999999999999999999999999999986432
Q ss_pred CCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccc
Q 036583 646 EQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 725 (817)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+.
T Consensus 174 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~~-------- 237 (353)
T 2i0e_A 174 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELFQSIMEHN-------- 237 (353)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC--------
T ss_pred CCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhCC--------
Confidence 221 22456899999999999999999999999999999999999999964321 11222222221
Q ss_pred cCCcccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 036583 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRPS-----MTKVVQ 761 (817)
Q Consensus 726 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt-----~~evl~ 761 (817)
...+ ......+.+++.+||+.||.+||+ ++|+++
T Consensus 238 ~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 238 VAYP--KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp CCCC--TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCC--CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1111 122346889999999999999995 577775
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.32 Aligned_cols=264 Identities=22% Similarity=0.303 Sum_probs=198.2
Q ss_pred HHHHHhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC------cCHHHHHHHHHHhhccC---cceeeeeeeEee
Q 036583 488 DLQTATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG------QGKKEFRAEVSIIGSIH---HLHLVKLRGFCA 557 (817)
Q Consensus 488 ~l~~~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~------~~~~~~~~Ev~~l~~l~---h~niv~l~~~~~ 557 (817)
++....+.+.++||+|+||+||+++. .+++.||||++.... .....+.+|++++++++ ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 34455677789999999999999995 568999999986322 22457788888887775 999999999997
Q ss_pred cCC-----eeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcE
Q 036583 558 EGT-----HRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHA 632 (817)
Q Consensus 558 ~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 632 (817)
... ..++||||+. ++|.+++...... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPP-GLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTT-CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCE
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCE
Confidence 755 5799999998 5999999765432 48999999999999999999999 899999999999999999999
Q ss_pred EEeecCCccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHH
Q 036583 633 KVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKM 712 (817)
Q Consensus 633 ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 712 (817)
||+|||+++....... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ........
T Consensus 160 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~ 234 (308)
T 3g33_A 160 KLADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDL 234 (308)
T ss_dssp EECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHH
T ss_pred EEeeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHH
Confidence 9999999987643322 234678999999999999999999999999999999999999996543211 00011111
Q ss_pred hhhcchhhhc------ccccC--Ccc-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 713 MEEGKLRNIL------DSRLN--IDE-----QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 713 ~~~~~~~~~~------d~~~~--~~~-----~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.......... ..... ... ..+....+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1000000000 00000 000 0112356789999999999999999999987
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=332.75 Aligned_cols=250 Identities=23% Similarity=0.357 Sum_probs=203.9
Q ss_pred HHhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc-------CHHHHHHHHHHhhccCcceeeeeeeEeecCCee
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ-------GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHR 562 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~-------~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~ 562 (817)
...+.+.++||+|+||.||+++.. +|+.||||.+..... ..+++.+|+.++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 355777899999999999999964 689999999865321 357899999999999999999999999999999
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC----cEEEeecC
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY----HAKVSDFG 638 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~ki~Dfg 638 (817)
++||||+++++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999997643 58899999999999999999999 8999999999999999887 79999999
Q ss_pred CccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcch
Q 036583 639 LAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKL 718 (817)
Q Consensus 639 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 718 (817)
++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+.....
T Consensus 165 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~~ 235 (321)
T 2a2a_A 165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANITSVSY 235 (321)
T ss_dssp TCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHTTCC
T ss_pred cceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhccc
Confidence 9987654322 2345789999999999999999999999999999999999999964321 111111111110
Q ss_pred hhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 719 RNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 719 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
. .++ .........+.+++.+||+.||++|||++|+++
T Consensus 236 ~--~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 D--FDE----EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp C--CCH----HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred c--cCh----hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 000 000112346789999999999999999999997
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=331.09 Aligned_cols=259 Identities=20% Similarity=0.285 Sum_probs=196.4
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
+.+.++||+|+||+||+++.. +++.||||++..... ..+.+.+|+.++.+++||||+++++++.++...++||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 456688999999999999964 588999999975432 2467899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++ +|.+++..... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~-~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 84 DQ-DLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp SE-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred CC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence 86 56665554332 58999999999999999999999 8999999999999999999999999999987643322
Q ss_pred eeeeccCCCCccCccccccCc-cCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcch------hhhc
Q 036583 650 VFTTLRGTRGYLAPEWITNYA-ISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKL------RNIL 722 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 722 (817)
......||+.|+|||.+.+.. ++.++|||||||++|||++|..||....... ............... ....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhhcccc
Confidence 223467899999999998765 7999999999999999999888864322111 000111111100000 0000
Q ss_pred ccc---------cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 723 DSR---------LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 723 d~~---------~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+.. ............+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000 000011123356789999999999999999999987
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=341.41 Aligned_cols=246 Identities=24% Similarity=0.333 Sum_probs=198.2
Q ss_pred HhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcC----HHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQG----KKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~----~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
..+...++||+|+||+||+|+. .+++.||||++...... .+++.+|++++.+++||||+++++++.++...++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3455668899999999999985 57899999999754322 357899999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
||+. |+|.+++..... .+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9998 588888765432 68999999999999999999999 89999999999999999999999999999876432
Q ss_pred CceeeeeccCCCCccCccccc---cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 647 QSHVFTTLRGTRGYLAPEWIT---NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ...... +..+...
T Consensus 208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~-~~~~~~~---- 271 (348)
T 1u5q_A 208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYH-IAQNESP---- 271 (348)
T ss_dssp -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHH-HHHSCCC----
T ss_pred -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHH-HHhcCCC----
Confidence 2357899999999984 56789999999999999999999999964321 111111 1111111
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQML 763 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L 763 (817)
.. ........+.+++.+||+.||++|||++|+++..
T Consensus 272 -~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 272 -AL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp -CC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred -CC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 11 0111234578999999999999999999999743
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=338.18 Aligned_cols=257 Identities=23% Similarity=0.383 Sum_probs=193.6
Q ss_pred HHhhccccccCCCcceeEEEEEcC----CCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecCCe--
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLP----DGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTH-- 561 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~----~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~-- 561 (817)
...+.+.+.||+|+||.||+|... .++.||||++..... ..+.+.+|+.++.+++||||+++++++.+...
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 345566688999999999999853 345899999875432 23678999999999999999999999987553
Q ss_pred ---eeEEEeeccCCChhhhhhhcc---cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEe
Q 036583 562 ---RLLAYEFMANGSLDKWIFKKN---QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVS 635 (817)
Q Consensus 562 ---~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~ 635 (817)
.++||||+++++|.+++.... ....+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEe
Confidence 499999999999999985421 22368999999999999999999998 899999999999999999999999
Q ss_pred ecCCccccCCCCce-eeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHh
Q 036583 636 DFGLAKLMTREQSH-VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMM 713 (817)
Q Consensus 636 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 713 (817)
|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~ 262 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-------MYDYL 262 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHHH
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-------HHHHH
Confidence 99999876543221 1223567889999999999999999999999999999999 888996443211 11122
Q ss_pred hhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 714 EEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 714 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
..+.. ..........+.+++.+||+.||.+|||++|+++.|+.+
T Consensus 263 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 263 LHGHR---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp HTTCC---------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCCC---------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 22111 111122334688999999999999999999999999876
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=339.36 Aligned_cols=240 Identities=23% Similarity=0.292 Sum_probs=199.6
Q ss_pred HhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc---------CHHHHHHHHHHhhccCcceeeeeeeEeecCCe
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ---------GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTH 561 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~---------~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~ 561 (817)
..+.+.++||+|+||+||+++. .+++.||||++..... ..+.+.+|+.++.+++||||+++++++.+...
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 4566678999999999999984 5688999999975421 23467889999999999999999999999999
Q ss_pred eeEEEeeccCC-ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCc
Q 036583 562 RLLAYEFMANG-SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLA 640 (817)
Q Consensus 562 ~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 640 (817)
.++||||+..| +|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 99999999777 9999997654 58999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCceeeeeccCCCCccCccccccCcc-CccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchh
Q 036583 641 KLMTREQSHVFTTLRGTRGYLAPEWITNYAI-SEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLR 719 (817)
Q Consensus 641 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (817)
+....... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.....
T Consensus 178 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------------- 235 (335)
T 3dls_A 178 AYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------------- 235 (335)
T ss_dssp EECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------------------
T ss_pred eECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------------------
Confidence 87654432 234679999999999988776 7899999999999999999999953211
Q ss_pred hhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 720 NILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 720 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
........+ ......+.+++.+||+.||++|||++|+++.
T Consensus 236 -~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 -TVEAAIHPP--YLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -GTTTCCCCS--SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -HHhhccCCC--cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111111 1123367899999999999999999999984
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=351.26 Aligned_cols=244 Identities=27% Similarity=0.429 Sum_probs=202.8
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
.+.+.+.||+|+||.||+|+.. +|+.||||++... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4556788999999999999964 6899999999643 2345689999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+++|+|.+++.+.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 97 ~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 97 YVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp CCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 999999999997643 58999999999999999999999 899999999999999999999999999998765432
Q ss_pred ceeeeeccCCCCccCccccccCcc-CccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAI-SEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... . .....+..+. .
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------~-~~~~~i~~~~--------~ 233 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV------P-TLFKKICDGI--------F 233 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS------H-HHHHHHHTTC--------C
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH------H-HHHHHHhcCC--------c
Confidence 2244679999999999998765 6899999999999999999999974321 1 1222222221 1
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..+ ......+.+++.+||+.||.+|||++|+++
T Consensus 234 ~~p--~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 YTP--QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CCC--TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCC--ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 111 112236789999999999999999999997
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=327.18 Aligned_cols=250 Identities=26% Similarity=0.368 Sum_probs=202.3
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
..+.+.++||+|+||.||+++.. +++.||||++.... ...+.+.+|+.+++.++||||+++++++.++...++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 45667789999999999999964 68999999996442 3357899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++++|.+++.... .+++..+..++.||+.||+|||+ .+|+|+||||+||+++.++.+||+|||++........
T Consensus 87 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 87 CSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999986543 58899999999999999999999 8999999999999999999999999999987643322
Q ss_pred -eeeeeccCCCCccCccccccCcc-CccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 649 -HVFTTLRGTRGYLAPEWITNYAI-SEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 649 -~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
.......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....+.... .
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~--------~ 226 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWKEKK--------T 226 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH------HHHHHHTTC--------T
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH------HHHHhhhcc--------c
Confidence 12234678999999999987665 7799999999999999999999975432210 111111111 0
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
...........+.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 01111122346789999999999999999999987
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=351.17 Aligned_cols=246 Identities=22% Similarity=0.304 Sum_probs=192.4
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
.+.+.++||+|+||.||+++. .+|+.||||++... ......+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 228 (446)
T 4ejn_A 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 228 (446)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence 355668899999999999985 46899999999643 2334678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. .+|+||||||+||||+.++.+||+|||+++......
T Consensus 229 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 229 YANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp CCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred eCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 999999999997654 589999999999999999999962 789999999999999999999999999998643322
Q ss_pred ceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... ..
T Consensus 304 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~--------~~ 367 (446)
T 4ejn_A 304 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEE--------IR 367 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC--------CC
T ss_pred -cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHHhCC--------CC
Confidence 223457899999999999999999999999999999999999999964321 11111221111 11
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRP-----SMTKVVQ 761 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~evl~ 761 (817)
.+ ......+.+++.+||+.||.+|| +++|+++
T Consensus 368 ~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 FP--RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CC--TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CC--ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11 11234678999999999999999 9999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=344.06 Aligned_cols=265 Identities=25% Similarity=0.391 Sum_probs=205.0
Q ss_pred HhhccccccCCCcceeEEEEEc-----CCCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCC--eee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-----PDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT--HRL 563 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-----~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~--~~~ 563 (817)
..+.+.++||+|+||.||+++. .+++.||||++.... ...+.+.+|++++.+++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 3456678999999999999983 468899999997643 33568999999999999999999999987644 679
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+||||+++++|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 121 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 99999999999999976543 58899999999999999999999 89999999999999999999999999999877
Q ss_pred CCCCceee--eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCC-----CCCcchHHHHHHhhhc
Q 036583 644 TREQSHVF--TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETS-----DKAHFPSYAFKMMEEG 716 (817)
Q Consensus 644 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~-----~~~~~~~~~~~~~~~~ 716 (817)
........ ....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... .......... .
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~-----~ 270 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV-----F 270 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHH-----H
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhH-----H
Confidence 55433211 2245677899999999888999999999999999999999988532100 0000000000 0
Q ss_pred chhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 717 KLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 717 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.+.+.+......+........+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01111111111112223345788999999999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=338.32 Aligned_cols=256 Identities=25% Similarity=0.435 Sum_probs=202.5
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcE--EEEEEeccC--CcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTR--LAVKKLEGI--GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~--vavK~l~~~--~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv 565 (817)
..+.+.+.||+|+||.||+++.. ++.. +|+|++... ....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 45667789999999999999964 4554 499988753 23456799999999999 899999999999999999999
Q ss_pred EeeccCCChhhhhhhcc-------------cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcE
Q 036583 566 YEFMANGSLDKWIFKKN-------------QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHA 632 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 632 (817)
|||+++++|.+++.... ....+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999997643 12358899999999999999999999 999999999999999999999
Q ss_pred EEeecCCccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHH
Q 036583 633 KVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFK 711 (817)
Q Consensus 633 ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 711 (817)
||+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .....
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~~~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AELYE 252 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHH
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-------HHHHH
Confidence 999999997433211 1123456889999999998889999999999999999998 9999964321 11122
Q ss_pred HhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 712 MMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 712 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
.+..+. ...........+.+++.+||+.||.+|||++|+++.|+.+..
T Consensus 253 ~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 253 KLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp HGGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhhcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 222211 111111223468899999999999999999999999987643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=326.71 Aligned_cols=245 Identities=24% Similarity=0.385 Sum_probs=180.9
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.+.||+|+||.||+++. .+++.||||++... ....+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence 45568899999999999985 57899999999643 23357899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++++|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 93 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 93 CHNGEMNRYLKNRVK--PFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp CTTEEHHHHHHTCSS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred CCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 999999999976432 58899999999999999999999 8999999999999999999999999999987653322
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||........ +..+......
T Consensus 168 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------------~~~~~~~~~~- 230 (278)
T 3cok_A 168 K-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---------------LNKVVLADYE- 230 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSCCC-
T ss_pred c-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---------------HHHHhhcccC-
Confidence 1 2235789999999999988899999999999999999999999975432211 0001111111
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.+......+.+++.+||+.||++|||++|+++
T Consensus 231 -~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 231 -MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 11112346789999999999999999999987
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=336.54 Aligned_cols=261 Identities=23% Similarity=0.374 Sum_probs=197.2
Q ss_pred HhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
..+.+.++||+|+||.||++.. .+|+.||||++.... ...+++.+|+.++.+++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 3466778999999999999985 578999999997532 23467899999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhcc-cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 567 EFMANGSLDKWIFKKN-QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
||+++++|.+++.... ....+++..++.++.||+.||.|||+ .+|+|+||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999999987522 22368899999999999999999999 8999999999999999999999999999987644
Q ss_pred CCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccc
Q 036583 646 EQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 725 (817)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... . ......+........
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~-~~~~~~~~~~~~~~~---- 258 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----L-YSLCKKIEQCDYPPL---- 258 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----H-HHHHHHHHTTCSCCC----
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----H-HHHHHHhhcccCCCC----
Confidence 322 123356899999999999999999999999999999999999999643211 1 111122222211111
Q ss_pred cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCC
Q 036583 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPV 769 (817)
Q Consensus 726 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 769 (817)
........+.+++.+||+.||++|||++||++.|+.+.+.
T Consensus 259 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 259 ----PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp ----CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 0112234688999999999999999999999999987443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=327.17 Aligned_cols=250 Identities=24% Similarity=0.331 Sum_probs=196.2
Q ss_pred HhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
..+.+.++||+|+||+||++.. .+++.+|+|++... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 4567778999999999999985 46889999999654 33568899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcc-cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEe---cCCCcEEEeecCCccccC
Q 036583 569 MANGSLDKWIFKKN-QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL---DDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 569 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~Dfgla~~~~ 644 (817)
+++|+|.+++.... ....+++..+..++.||+.||+|||+ .+|+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999999986532 22368999999999999999999999 899999999999999 456889999999998765
Q ss_pred CCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccc
Q 036583 645 REQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724 (817)
Q Consensus 645 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 724 (817)
.... .....|++.|+|||.+. ..++.++||||||+++|||++|+.||..... ............
T Consensus 179 ~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~-------~~~~~~~~~~~~------ 242 (285)
T 3is5_A 179 SDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-------EEVQQKATYKEP------ 242 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCC------
T ss_pred Cccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH-------HHHHhhhccCCc------
Confidence 4322 23467899999999986 4688999999999999999999999964321 111111111110
Q ss_pred ccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 725 RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 725 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.... ........+.+++.+||+.||++|||++|+++
T Consensus 243 ~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 243 NYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00012346779999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=342.33 Aligned_cols=253 Identities=25% Similarity=0.343 Sum_probs=185.5
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC-cCHHHHHHHHHHhhccC-cceeeeeeeEee--------cCCe
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIH-HLHLVKLRGFCA--------EGTH 561 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~--------~~~~ 561 (817)
.+.+.++||+|+||.||+++. .+++.||||++.... ...+.+.+|+.++.++. ||||+++++++. ....
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 456678999999999999995 468999999986543 33567899999999996 999999999994 3445
Q ss_pred eeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCc--eeecCCCCCCeEecCCCcEEEeecCC
Q 036583 562 RLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR--IIHCDIKPENVLLDDNYHAKVSDFGL 639 (817)
Q Consensus 562 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~ki~Dfgl 639 (817)
.++||||+. |+|.+++........+++..++.++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred EEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 789999996 6999998764444469999999999999999999998 77 99999999999999999999999999
Q ss_pred ccccCCCCcee-----------eeeccCCCCccCcccc---ccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcc
Q 036583 640 AKLMTREQSHV-----------FTTLRGTRGYLAPEWI---TNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHF 705 (817)
Q Consensus 640 a~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~ 705 (817)
++......... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---- 260 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---- 260 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----
Confidence 98765432211 1134589999999998 56678899999999999999999999996432211
Q ss_pred hHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 706 PSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 706 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
+.......+........+.+++.+||+.||.+|||++|+++.|+.+..
T Consensus 261 ---------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 261 ---------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp --------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 000111111111112246789999999999999999999999988743
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=334.26 Aligned_cols=262 Identities=19% Similarity=0.298 Sum_probs=205.9
Q ss_pred cccCHHHHHHHhhccc-cccCCCcceeEEEEEcC-CCcEEEEEEeccC---CcCHHHHHHHHHHhhcc-CcceeeeeeeE
Q 036583 482 VRFTYRDLQTATNNFS-VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI---GQGKKEFRAEVSIIGSI-HHLHLVKLRGF 555 (817)
Q Consensus 482 ~~~~~~~l~~~~~~~~-~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l-~h~niv~l~~~ 555 (817)
..|...+.....+.+. ++||+|+||+||++... +++.||||++... .....++.+|+.++.++ +||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3455556666666666 78999999999999864 6899999999754 23467899999999999 56999999999
Q ss_pred eecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC---CCcE
Q 036583 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD---NYHA 632 (817)
Q Consensus 556 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ 632 (817)
+.+....++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++. ++.+
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELA-EMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcE
Confidence 9999999999999999999999865422 268999999999999999999999 89999999999999997 7899
Q ss_pred EEeecCCccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHH
Q 036583 633 KVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKM 712 (817)
Q Consensus 633 ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 712 (817)
||+|||+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .....
T Consensus 174 kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~ 244 (327)
T 3lm5_A 174 KIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ-------ETYLN 244 (327)
T ss_dssp EECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHH
T ss_pred EEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------HHHHH
Confidence 9999999987654322 23467999999999999999999999999999999999999999643211 11111
Q ss_pred hhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 713 MEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 713 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
+..... ....+........+.+++.+||+.||++|||++|+++.
T Consensus 245 i~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 245 ISQVNV------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHTCC------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHhccc------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 111110 01111111233467899999999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=342.81 Aligned_cols=260 Identities=25% Similarity=0.386 Sum_probs=203.7
Q ss_pred HHHHhhccccccCCCcceeEEEEEc------CCCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCC
Q 036583 489 LQTATNNFSVKLGQGGFGSVYQGVL------PDGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT 560 (817)
Q Consensus 489 l~~~~~~~~~~lG~G~fG~Vy~g~~------~~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~ 560 (817)
+....+.+.++||+|+||.||+|+. .+++.||||++.... ....++.+|+.++.+++||||+++++++.+..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 3445677788999999999999984 246789999996442 33567899999999999999999999999999
Q ss_pred eeeEEEeeccCCChhhhhhhccc----ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC---CCcEE
Q 036583 561 HRLLAYEFMANGSLDKWIFKKNQ----EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD---NYHAK 633 (817)
Q Consensus 561 ~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~k 633 (817)
..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+ .+|+||||||+|||++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999999986532 1358889999999999999999999 89999999999999984 45699
Q ss_pred EeecCCccccCCCCce-eeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHH
Q 036583 634 VSDFGLAKLMTREQSH-VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFK 711 (817)
Q Consensus 634 i~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 711 (817)
|+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .....
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~~~~ 256 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------QEVLE 256 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-------HHHHH
Confidence 9999999865433221 1233567889999999998899999999999999999998 9999964321 11122
Q ss_pred HhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 712 MMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 712 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
.+..+.. ..........+.+++.+||+.||.+||++.|+++.|+.+.
T Consensus 257 ~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 257 FVTSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcCCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 2222211 1111122346889999999999999999999999998763
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=344.50 Aligned_cols=260 Identities=15% Similarity=0.158 Sum_probs=202.3
Q ss_pred HhhccccccCCCcceeEEEEEcCC---------CcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeee-----------
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPD---------GTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVK----------- 551 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~---------g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~----------- 551 (817)
..+.+.++||+|+||.||+|+... ++.||||++... +.+.+|++++.+++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 345667899999999999999653 789999998753 46889999999999999998
Q ss_pred ----eeeEeec-CCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEe
Q 036583 552 ----LRGFCAE-GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL 626 (817)
Q Consensus 552 ----l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll 626 (817)
+++++.. +...++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+ .+|+||||||+|||+
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFV 192 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEE
Confidence 5677765 67889999999 999999998652 2368999999999999999999999 899999999999999
Q ss_pred cCCC--cEEEeecCCccccCCCCce------eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCC
Q 036583 627 DDNY--HAKVSDFGLAKLMTREQSH------VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNE 698 (817)
Q Consensus 627 ~~~~--~~ki~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~ 698 (817)
+.++ .+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 9999999999876543211 1123578999999999999999999999999999999999999996543
Q ss_pred CCCCCcchHHHHHHhh--hcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 699 TSDKAHFPSYAFKMME--EGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 699 ~~~~~~~~~~~~~~~~--~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
... ........ ......+.+.... .......+.+++.+||+.||++|||++|++++|+.+..
T Consensus 273 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 273 PNT-----EDIMKQKQKFVDKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp TCH-----HHHHHHHHHHHHSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cCH-----HHHHHHHHhccCChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 211 11111111 1111111111110 01123468899999999999999999999999988743
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=343.92 Aligned_cols=246 Identities=23% Similarity=0.262 Sum_probs=189.4
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhh-ccCcceeeeeeeEeec----CCeeeEEEeeccC
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIG-SIHHLHLVKLRGFCAE----GTHRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~-~l~h~niv~l~~~~~~----~~~~~lv~e~~~~ 571 (817)
+.||+|+||+||++... +++.||||++.. ...+.+|++++. ..+||||+++++++.. ....++||||+++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g 143 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence 57999999999999864 688999999964 356788998874 4589999999999875 5678999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC---CCcEEEeecCCccccCCCCc
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD---NYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~Dfgla~~~~~~~~ 648 (817)
|+|.+++..... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 144 g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~- 218 (400)
T 1nxk_A 144 GELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN- 218 (400)
T ss_dssp EEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred CcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCCCC-
Confidence 999999976432 258999999999999999999999 89999999999999997 7899999999998664322
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .....+..+... +. .
T Consensus 219 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~~~~~i~~~~~~-~~-----~ 288 (400)
T 1nxk_A 219 -SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQYE-FP-----N 288 (400)
T ss_dssp ---------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC---SHHHHHHHTCCC-CC-----T
T ss_pred -ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH---HHHHHHHcCccc-CC-----C
Confidence 2245678999999999999999999999999999999999999997654322111 011122222110 00 0
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
+........+.+++.+||+.||++|||+.|+++.
T Consensus 289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0011223468899999999999999999999984
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=325.78 Aligned_cols=250 Identities=22% Similarity=0.358 Sum_probs=200.8
Q ss_pred HHhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC-------cCHHHHHHHHHHhhccCcceeeeeeeEeecCCee
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG-------QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHR 562 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-------~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~ 562 (817)
...+.+.++||+|+||.||+++.. +++.||+|.+.... ...+.+.+|+.++.+++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 345677889999999999999965 68999999986532 1367899999999999999999999999999999
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC----cEEEeecC
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY----HAKVSDFG 638 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~ki~Dfg 638 (817)
++||||+++++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999997643 58999999999999999999999 8999999999999999877 89999999
Q ss_pred CccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcch
Q 036583 639 LAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKL 718 (817)
Q Consensus 639 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 718 (817)
++........ .....+++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+.....
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~ 228 (283)
T 3bhy_A 158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-------QETLTNISAVNY 228 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTCC
T ss_pred cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-------HHHHHHhHhccc
Confidence 9987644321 2345689999999999998999999999999999999999999964321 111111111110
Q ss_pred hhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 719 RNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 719 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.............+.+++.+|++.||++|||+.|+++
T Consensus 229 ------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 ------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp ------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0000000112346789999999999999999999997
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=339.64 Aligned_cols=250 Identities=18% Similarity=0.188 Sum_probs=201.8
Q ss_pred HhhccccccCCCcceeEEEEE------cCCCcEEEEEEeccCCcCHHHHHHHHHHhhccC---cceeeeeeeEeecCCee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGV------LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH---HLHLVKLRGFCAEGTHR 562 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~------~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~---h~niv~l~~~~~~~~~~ 562 (817)
..+.+.++||+|+||+||+|. ...++.||||++.. ....++..|++++.+++ |+||+++++++...+..
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~ 142 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS--CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC--CChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence 345556889999999999994 45688999999974 34678888888888887 99999999999999999
Q ss_pred eEEEeeccCCChhhhhhhcc--cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC-----------C
Q 036583 563 LLAYEFMANGSLDKWIFKKN--QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD-----------N 629 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-----------~ 629 (817)
++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+ .+|+||||||+||||+. +
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------C
T ss_pred EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccccccc
Confidence 99999999999999997532 22369999999999999999999999 89999999999999998 8
Q ss_pred CcEEEeecCCccccCC-CCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHH
Q 036583 630 YHAKVSDFGLAKLMTR-EQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSY 708 (817)
Q Consensus 630 ~~~ki~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~ 708 (817)
+.+||+|||+++.+.. ..........||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------ 293 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------ 293 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE------
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce------
Confidence 9999999999976542 222334557899999999999999999999999999999999999999953322110
Q ss_pred HHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCC-CCHHHHHHHHhcCC
Q 036583 709 AFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLR-PSMTKVVQMLEGIC 767 (817)
Q Consensus 709 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~R-Pt~~evl~~L~~~~ 767 (817)
. +........ ....+.+++..|++.+|.+| |+++++.+.|+...
T Consensus 294 --------~----~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 294 --------K----PEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp --------E----ECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred --------e----echhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 0 011111111 12356678888999999998 68889988888763
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=335.53 Aligned_cols=250 Identities=21% Similarity=0.341 Sum_probs=200.1
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEeec
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
..+.+.++||+|+||.||++... +++.||||++..... ...+|++++.++ +||||+++++++.++...++||||+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 98 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM 98 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence 45667789999999999999964 588999999976432 245788888888 7999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCC----CcEEEeecCCccccCC
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDN----YHAKVSDFGLAKLMTR 645 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~ki~Dfgla~~~~~ 645 (817)
++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||+.++ +.+||+|||+++....
T Consensus 99 ~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 99 KGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 9999999997654 58999999999999999999999 899999999999998533 3599999999987654
Q ss_pred CCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccc
Q 036583 646 EQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 725 (817)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+..+...
T Consensus 173 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~~~~i~~~~~~------ 241 (342)
T 2qr7_A 173 ENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD----TPEEILARIGSGKFS------ 241 (342)
T ss_dssp TTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS----CHHHHHHHHHHCCCC------
T ss_pred CCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC----CHHHHHHHHccCCcc------
Confidence 332 223467899999999999888999999999999999999999999743221 122223333333211
Q ss_pred cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 726 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
............+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 001111122346789999999999999999999987
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=335.11 Aligned_cols=262 Identities=21% Similarity=0.301 Sum_probs=195.2
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcC---HHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQG---KKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~---~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
+.+.++||+|+||+||+++.. +|+.||||++...... .+.+.+|++++.+++||||+++++++.+....++||||+
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC 84 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence 456688999999999999964 5899999998655332 456889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 157 (311)
T 4agu_A 85 DHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD- 157 (311)
T ss_dssp SEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence 9999999886543 58899999999999999999999 8999999999999999999999999999987653322
Q ss_pred eeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcc--------hHHHHHHhhhcc-hh
Q 036583 650 VFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHF--------PSYAFKMMEEGK-LR 719 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~--------~~~~~~~~~~~~-~~ 719 (817)
......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.... ............ ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 2234578999999999976 6789999999999999999999999965432110000 000000000000 00
Q ss_pred --hhcccccCCcc---cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 720 --NILDSRLNIDE---QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 720 --~~~d~~~~~~~---~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.+.++...... .......+.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000000000 01223457899999999999999999999973
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=346.18 Aligned_cols=274 Identities=24% Similarity=0.308 Sum_probs=208.9
Q ss_pred CCCcccCHHHHHHHhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhccC--------ccee
Q 036583 479 GMPVRFTYRDLQTATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH--------HLHL 549 (817)
Q Consensus 479 ~~~~~~~~~~l~~~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~--------h~ni 549 (817)
+....+...++....+.+.++||+|+||+||+++. .+++.||||++.......+.+.+|++++++++ |+||
T Consensus 24 ~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~i 103 (397)
T 1wak_A 24 GGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103 (397)
T ss_dssp --CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGB
T ss_pred CCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCccee
Confidence 33445556666667788889999999999999984 56889999999765455678899999999996 8889
Q ss_pred eeeeeEee----cCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCC-ceeecCCCCCCe
Q 036583 550 VKLRGFCA----EGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ-RIIHCDIKPENV 624 (817)
Q Consensus 550 v~l~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~-~ivH~Dlk~~NI 624 (817)
+++++++. ++...++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+ + +|+||||||+||
T Consensus 104 v~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NI 178 (397)
T 1wak_A 104 VQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENI 178 (397)
T ss_dssp CCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGE
T ss_pred eeeecceeecCCCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHe
Confidence 99999997 566889999999 5566666654432 258899999999999999999999 7 999999999999
Q ss_pred EecCCC-------------------------------------------------cEEEeecCCccccCCCCceeeeecc
Q 036583 625 LLDDNY-------------------------------------------------HAKVSDFGLAKLMTREQSHVFTTLR 655 (817)
Q Consensus 625 ll~~~~-------------------------------------------------~~ki~Dfgla~~~~~~~~~~~~~~~ 655 (817)
|++.++ .+||+|||++...... .....
T Consensus 179 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~ 254 (397)
T 1wak_A 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDI 254 (397)
T ss_dssp EECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCC
T ss_pred eEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCC
Confidence 999775 7999999999876543 23357
Q ss_pred CCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhh-hcch-----------hhhcc
Q 036583 656 GTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMME-EGKL-----------RNILD 723 (817)
Q Consensus 656 gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~-----------~~~~d 723 (817)
||+.|+|||++.+..++.++|||||||++|||++|+.||.................... .+.. .....
T Consensus 255 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 334 (397)
T 1wak_A 255 QTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFT 334 (397)
T ss_dssp SCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBC
T ss_pred CCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccC
Confidence 89999999999999999999999999999999999999976554332111111111100 0000 00000
Q ss_pred cc-------------------cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 724 SR-------------------LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 724 ~~-------------------~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.. ............+.+++.+||+.||++|||++|+++
T Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 335 KKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp TTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 001223455678899999999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=327.77 Aligned_cols=243 Identities=28% Similarity=0.390 Sum_probs=197.6
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.++||+|+||+||++... +++.||||++... ....+.+.+|+.++.+++||||+++++++.+....++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (279)
T 3fdn_A 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 90 (279)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence 455688999999999999854 5779999998543 23456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~- 163 (279)
T 3fdn_A 91 APLGTVYRELQKLS---KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 163 (279)
T ss_dssp CTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCccc-
Confidence 99999999997654 58899999999999999999998 899999999999999999999999999986544322
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+.... .
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~--------~-- 224 (279)
T 3fdn_A 164 --RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QETYKRISRVE--------F-- 224 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTC--------C--
T ss_pred --ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-------HHHHHHHHhCC--------C--
Confidence 2345789999999999999999999999999999999999999964321 11111111111 0
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
..+......+.+++.+||+.||++|||++|+++.
T Consensus 225 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1111123467899999999999999999999973
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.44 Aligned_cols=256 Identities=25% Similarity=0.354 Sum_probs=195.5
Q ss_pred HhhccccccCCCcceeEEEEEcC--CCc--EEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP--DGT--RLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~--~g~--~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 563 (817)
..+.+.++||+|+||+||+|+.. +++ .||||++.... ...+.+.+|++++.+++||||+++++++.+.. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 45666789999999999999852 333 68999986532 23568899999999999999999999998765 88
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+|+||+++++|.+++..... .+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.+||+|||++...
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhccC--CcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 99999999999999976533 58899999999999999999999 89999999999999999999999999999877
Q ss_pred CCCCcee--eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhh
Q 036583 644 TREQSHV--FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRN 720 (817)
Q Consensus 644 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (817)
....... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... . ....+...
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~-~~~~~~~~---- 240 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------Q-ILHKIDKE---- 240 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H-HHHHHHTS----
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------H-HHHHHHcc----
Confidence 5443322 123567788999999998889999999999999999999 99999643211 1 11111111
Q ss_pred hcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 721 ILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 721 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
....+........+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 241 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 241 ----GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ----CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ----CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 11111112234568899999999999999999999999998743
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=354.27 Aligned_cols=249 Identities=27% Similarity=0.322 Sum_probs=204.5
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.+.||+|+||.||+++.. +|+.||||++... ......+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy 265 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 265 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence 445578999999999999964 6899999999643 34567789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++|+|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++.......
T Consensus 266 ~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~ 341 (576)
T 2acx_A 266 MNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341 (576)
T ss_dssp CCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred CCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence 999999999976542 258899999999999999999999 8999999999999999999999999999987654332
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........+.... .
T Consensus 342 --~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~---~~~~i~~~i~~~~----------~ 406 (576)
T 2acx_A 342 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI---KREEVERLVKEVP----------E 406 (576)
T ss_dssp --EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC---CHHHHHHHHHHCC----------C
T ss_pred --ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch---hHHHHHHHhhccc----------c
Confidence 234689999999999999999999999999999999999999997543221 1111222222111 0
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRP-----SMTKVVQ 761 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~evl~ 761 (817)
.........+.+++.+||+.||.+|| +++||++
T Consensus 407 ~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 11112234688999999999999999 7899886
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=344.46 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=191.4
Q ss_pred HHHHhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC---------cCHHHHHHHHHHhhccCcceeeeeeeEeec
Q 036583 489 LQTATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG---------QGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558 (817)
Q Consensus 489 l~~~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~---------~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~ 558 (817)
.....+.+.++||+|+||+||+|.. .+++.||||++.... .....+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3445677789999999999999985 458899999986431 112358899999999999999999999854
Q ss_pred CCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCC---CcEEEe
Q 036583 559 GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDN---YHAKVS 635 (817)
Q Consensus 559 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~ki~ 635 (817)
+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.+ ..+||+
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred -CceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEe
Confidence 55799999999999999987554 58999999999999999999999 899999999999999754 459999
Q ss_pred ecCCccccCCCCceeeeeccCCCCccCcccccc---CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHH
Q 036583 636 DFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN---YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKM 712 (817)
Q Consensus 636 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 712 (817)
|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ....
T Consensus 285 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~------~~~~ 356 (419)
T 3i6u_A 285 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------LKDQ 356 (419)
T ss_dssp CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC------HHHH
T ss_pred ecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH------HHHH
Confidence 999998765432 2344679999999999863 5778899999999999999999999975432211 1112
Q ss_pred hhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 713 MEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 713 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+..+....... ........+.+++.+||+.||++|||++|+++
T Consensus 357 i~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 ITSGKYNFIPE------VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHTTCCCCCHH------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCCCCCch------hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 22221110000 00112346889999999999999999999987
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=323.87 Aligned_cols=248 Identities=21% Similarity=0.345 Sum_probs=201.2
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
.+.+.++||+|+||.||++... +++.||+|++..... ..+.+.+|+.++.+++||||+++++++.++...++||||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 86 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence 3556688999999999999854 588999999965432 235788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCc---EEEeecCCccccCC
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYH---AKVSDFGLAKLMTR 645 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~ki~Dfgla~~~~~ 645 (817)
+++++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++. +||+|||++.....
T Consensus 87 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 87 VTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 99999999887654 58899999999999999999999 89999999999999986655 99999999987654
Q ss_pred CCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccc
Q 036583 646 EQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 725 (817)
... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+..+... ...
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~-~~~-- 228 (284)
T 3kk8_A 161 SEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYAQIKAGAYD-YPS-- 228 (284)
T ss_dssp SCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCC-CCT--
T ss_pred Ccc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-------hHHHHHHHhcccc-CCc--
Confidence 322 2346789999999999999999999999999999999999999964321 1112222222111 000
Q ss_pred cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 726 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+........+.+++.+|++.||++|||++|+++
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 229 ---PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ---TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111122346789999999999999999999998
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=340.22 Aligned_cols=241 Identities=25% Similarity=0.328 Sum_probs=189.1
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHH-hhccCcceeeeeeeEeecCCeeeEEE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSI-IGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~-l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
.+.+.+.||+|+||.||+++.. +++.+|||++.+.. ...+.+.+|..+ ++.++||||+++++++.+.+..++||
T Consensus 39 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~ 118 (373)
T 2r5t_A 39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118 (373)
T ss_dssp GEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEE
Confidence 4566789999999999999965 57899999996542 234566777777 57789999999999999999999999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
||+++|+|.+++.+.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 119 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 119 DYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999999997654 57888999999999999999999 99999999999999999999999999999864322
Q ss_pred CceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 647 QSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+. +
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~~--------~ 256 (373)
T 2r5t_A 193 N-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-------AEMYDNILNKP--------L 256 (373)
T ss_dssp C-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-------HHHHHHHHHSC--------C
T ss_pred C-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhcc--------c
Confidence 2 123456899999999999999999999999999999999999999964321 11222222221 1
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHH
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMT 757 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ 757 (817)
..+. .....+.+++.+||+.||.+||++.
T Consensus 257 ~~~~--~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 257 QLKP--NITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp CCCS--SSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred CCCC--CCCHHHHHHHHHHcccCHHhCCCCC
Confidence 1111 1234678999999999999999985
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=325.94 Aligned_cols=244 Identities=21% Similarity=0.400 Sum_probs=195.3
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeec----CCeeeEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAE----GTHRLLA 565 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~----~~~~~lv 565 (817)
+.+.++||+|+||+||+|.. .++..||+|++..... ..+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 34557899999999999985 4578999999875432 34678999999999999999999999865 4568999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCc--eeecCCCCCCeEec-CCCcEEEeecCCccc
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR--IIHCDIKPENVLLD-DNYHAKVSDFGLAKL 642 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~--ivH~Dlk~~NIll~-~~~~~ki~Dfgla~~ 642 (817)
|||+++++|.+++.... .+++..++.++.||+.||+|||+ .+ |+||||||+||+++ +++.+||+|||++..
T Consensus 108 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999997643 58899999999999999999998 77 99999999999998 889999999999976
Q ss_pred cCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 643 MTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 643 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
..... .....|++.|+|||.+.+ .++.++||||||+++|||++|+.||...... ......+..+.....
T Consensus 182 ~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~- 250 (290)
T 1t4h_A 182 KRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPAS- 250 (290)
T ss_dssp CCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGG-
T ss_pred ccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------HHHHHHHhccCCccc-
Confidence 54432 234578999999998874 5899999999999999999999999643221 112222222211111
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
........+.+++..||+.||.+|||++|+++
T Consensus 251 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 251 -------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11112236889999999999999999999987
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=343.28 Aligned_cols=238 Identities=16% Similarity=0.137 Sum_probs=186.3
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccC----CcCHHHHHHHH---HHhhccCcceeeeee-------eEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI----GQGKKEFRAEV---SIIGSIHHLHLVKLR-------GFCAE 558 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~----~~~~~~~~~Ev---~~l~~l~h~niv~l~-------~~~~~ 558 (817)
+.+.++||+|+||+||+|+. .+|+.||||++... ....+.+.+|+ +++++++||||++++ +++.+
T Consensus 75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~ 154 (377)
T 3byv_A 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 154 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEEC
T ss_pred EEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhc
Confidence 44567899999999999996 56899999999643 22357889999 555666899999998 55554
Q ss_pred CC-----------------eeeEEEeeccCCChhhhhhhccc----ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeec
Q 036583 559 GT-----------------HRLLAYEFMANGSLDKWIFKKNQ----EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHC 617 (817)
Q Consensus 559 ~~-----------------~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~ 617 (817)
.+ ..++||||+ +|+|.+++..... ...+++..++.++.||+.||+|||+ .+|+||
T Consensus 155 ~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHr 230 (377)
T 3byv_A 155 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHT 230 (377)
T ss_dssp TTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEECS
T ss_pred cCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 43 278999999 5799999976421 1245678889999999999999999 899999
Q ss_pred CCCCCCeEecCCCcEEEeecCCccccCCCCceeeeeccCCCCccCccccccC-----------ccCccccccchhhhHHH
Q 036583 618 DIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNY-----------AISEKSDVYSYGMVLLE 686 (817)
Q Consensus 618 Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwS~Gvvl~e 686 (817)
||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||++||
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 9999999999999999999999986432 2344567 999999999887 89999999999999999
Q ss_pred hhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 687 IIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 687 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
|++|+.||........ ...+.... ......+.+++.+||+.||++|||+.|+++
T Consensus 306 lltg~~Pf~~~~~~~~---------------~~~~~~~~------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 306 IWCADLPITKDAALGG---------------SEWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHSSCCC------CC---------------SGGGGSSC------CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHCCCCCcccccccc---------------hhhhhhhc------cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999965432221 11111110 011246789999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=340.24 Aligned_cols=252 Identities=21% Similarity=0.275 Sum_probs=201.5
Q ss_pred hhccccccCCCcceeEEEEEc----CCCcEEEEEEeccC-----CcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL----PDGTRLAVKKLEGI-----GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHR 562 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~----~~g~~vavK~l~~~-----~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~ 562 (817)
.+.+.++||+|+||.||+++. .+++.||||+++.. ....+.+.+|++++.++ +||||+++++++.+....
T Consensus 55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 134 (355)
T 1vzo_A 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 134 (355)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence 456678999999999999986 46899999998643 23456788899999999 699999999999999999
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 135 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 135 HLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999997654 58899999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCceeeeeccCCCCccCcccccc--CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhh
Q 036583 643 MTREQSHVFTTLRGTRGYLAPEWITN--YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRN 720 (817)
Q Consensus 643 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (817)
.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...........
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~---- 281 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS---QAEISRRILKS---- 281 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC---HHHHHHHHHHC----
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch---HHHHHHHHhcc----
Confidence 65443333344679999999999985 3578899999999999999999999975432221 11111111111
Q ss_pred hcccccCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 036583 721 ILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRP-----SMTKVVQML 763 (817)
Q Consensus 721 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~evl~~L 763 (817)
.. +........+.+++.+||+.||.+|| +++|+++..
T Consensus 282 ----~~--~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 ----EP--PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----CC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----CC--CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 11 11112234678999999999999999 999998754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=360.15 Aligned_cols=246 Identities=23% Similarity=0.305 Sum_probs=203.5
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv 565 (817)
..+.+.++||+|+||.||+++.. +++.||||++++. ....+.+..|..++..+ +||||+++++++.+.+..+||
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV 420 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 420 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence 34556689999999999999964 5788999999753 34567788999999988 799999999999999999999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++....
T Consensus 421 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 99999999999998654 58999999999999999999999 8999999999999999999999999999986433
Q ss_pred CCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccc
Q 036583 646 EQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 725 (817)
... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..... ......+.++ .
T Consensus 495 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-------~~~~~~i~~~--------~ 558 (674)
T 3pfq_A 495 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELFQSIMEH--------N 558 (674)
T ss_dssp TTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHSS--------C
T ss_pred CCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhC--------C
Confidence 222 23457899999999999999999999999999999999999999965321 1122222222 1
Q ss_pred cCCcccHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 036583 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRPSM-----TKVVQ 761 (817)
Q Consensus 726 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~-----~evl~ 761 (817)
+..+ ......+.+++..||+.||++||++ +||++
T Consensus 559 ~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 VAYP--KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp CCCC--TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CCCC--ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1111 1233468899999999999999998 77775
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=343.99 Aligned_cols=250 Identities=10% Similarity=0.028 Sum_probs=180.3
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc----CHHHHHHHHHHhhcc--Ccceeeeee-------eEeecC
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ----GKKEFRAEVSIIGSI--HHLHLVKLR-------GFCAEG 559 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~----~~~~~~~Ev~~l~~l--~h~niv~l~-------~~~~~~ 559 (817)
+.+.++||+|+||+||+|+. .+++.||||++..... ..+.+.+|+.++..+ +||||++++ +++...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 45568899999999999995 4789999999986532 245677885555444 699988755 344322
Q ss_pred -----------------CeeeEEEeeccCCChhhhhhhcccccchhhhHH------HHHHHHHHHHHHHHHhcCCCceee
Q 036583 560 -----------------THRLLAYEFMANGSLDKWIFKKNQEFLLDWETR------FNIALGTAKGLAYLHEDCDQRIIH 616 (817)
Q Consensus 560 -----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qia~~l~~LH~~~~~~ivH 616 (817)
...++||||++ |+|.+++..... .+.+..+ ..++.||+.||+|||+ .+|+|
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivH 217 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQS---KGLVH 217 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCcc
Confidence 34799999999 899999986533 3455666 7888999999999999 89999
Q ss_pred cCCCCCCeEecCCCcEEEeecCCccccCCCCceeeeeccCCCCccCcccccc--CccCccccccchhhhHHHhhhCCCCC
Q 036583 617 CDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN--YAISEKSDVYSYGMVLLEIIGGRKNF 694 (817)
Q Consensus 617 ~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~pf 694 (817)
|||||+|||++.++.+||+|||+++..... .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999866432 124567799999999987 78999999999999999999999999
Q ss_pred CCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 695 DPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..........+. ..............+........+.+++.+||+.||++|||+.|+++
T Consensus 294 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 294 GLVTPGIKGSWK--------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TBCCTTCTTCCC--------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCcCcccccchh--------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 765432211100 00000011111111111123457889999999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.62 Aligned_cols=248 Identities=24% Similarity=0.328 Sum_probs=203.4
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
.+.+.+.||+|+||.||+++.. +++.||||++... ....+.+.+|++++.+++||||+++++++.+....++|||
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 94 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence 4556688999999999999965 5788999998543 2345789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+++++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 95 FAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred eCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 999999999997654 58899999999999999999998 899999999999999999999999999997654322
Q ss_pred ceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+... ...
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~--------~~~ 230 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-------ETHRRIVNV--------DLK 230 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTT--------CCC
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-------HHHHHHhcc--------ccC
Confidence 13457899999999999999999999999999999999999999643211 111111111 111
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcC
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ--MLEGI 766 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~--~L~~~ 766 (817)
. +......+.+++.+|++.||.+|||++|+++ .+...
T Consensus 231 ~--~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 231 F--PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp C--CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred C--CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 1 1112346789999999999999999999997 44443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=328.80 Aligned_cols=245 Identities=24% Similarity=0.366 Sum_probs=202.2
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
+.+.++||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++.+++||||+++++++.+....++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 45568899999999999985 46889999999654 3456889999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+++|.+++... .+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.+||+|||++........ .
T Consensus 104 ~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 175 (303)
T 3a7i_A 104 GGSALDLLEPG----PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K 175 (303)
T ss_dssp TEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-C
T ss_pred CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcccc-c
Confidence 99999998643 58899999999999999999999 8999999999999999999999999999987654322 1
Q ss_pred eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 651 FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+..+.. +...
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~-----~~~~--- 240 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-------MKVLFLIPKNNP-----PTLE--- 240 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCC-----CCCC---
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-------HHHHHHhhcCCC-----CCCc---
Confidence 2345789999999999999999999999999999999999999964321 111111111111 1111
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
......+.+++..||+.||++|||+.|+++.
T Consensus 241 -~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 241 -GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp -SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred -cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1123467899999999999999999999974
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=337.34 Aligned_cols=199 Identities=28% Similarity=0.440 Sum_probs=159.7
Q ss_pred HHhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc---CHHHHHHHHHHhhccC-cceeeeeeeEeecCC--eee
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIH-HLHLVKLRGFCAEGT--HRL 563 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~--~~~ 563 (817)
...+.+.++||+|+||.||+|.. .+|+.||||++..... ..+.+.+|+.++.++. ||||+++++++...+ ..+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 34566778999999999999985 4689999999965422 3456789999999997 999999999997544 689
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+|||||+ ++|..++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 88 lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 9999998 5899988653 58889999999999999999999 89999999999999999999999999999865
Q ss_pred CCC--------------------CceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCC
Q 036583 644 TRE--------------------QSHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPN 697 (817)
Q Consensus 644 ~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~ 697 (817)
... .........||+.|+|||++.+ ..++.++|||||||+++||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 321 1112234679999999999986 67899999999999999999999999654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=327.25 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=203.6
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
..+.+.+.||+|+||.||+++.. +|+.||+|++.... ...+.+.+|+.++.+++||||+++++++.+....++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 45667789999999999999964 68999999997653 34567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEe---cCCCcEEEeecCCccccCCC
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL---DDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~Dfgla~~~~~~ 646 (817)
++++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||++ ++++.+||+|||++......
T Consensus 89 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 89 SGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 9999999987654 58899999999999999999999 899999999999999 78899999999999765432
Q ss_pred CceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 647 QSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+.++... .
T Consensus 163 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~~~-~----- 226 (304)
T 2jam_A 163 I---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-------SKLFEKIKEGYYE-F----- 226 (304)
T ss_dssp T---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHCCCC-C-----
T ss_pred c---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCCCC-C-----
Confidence 1 1235689999999999999999999999999999999999999964321 1122222222110 0
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcC
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ--MLEGI 766 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~--~L~~~ 766 (817)
..+........+.+++.+|++.||++|||++|+++ .+++.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 227 ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 01111122346889999999999999999999997 45543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.35 Aligned_cols=253 Identities=25% Similarity=0.338 Sum_probs=201.0
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEee--cCCeeeEEE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCA--EGTHRLLAY 566 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~--~~~~~~lv~ 566 (817)
.+.+.++||+|+||.||+++.. +++.||+|++..... ..+.+.+|++++.+++||||+++++++. .....++||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 86 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence 3456688999999999999964 689999999975432 3467899999999999999999999885 356789999
Q ss_pred eeccCCChhhhhhhccc-ccchhhhHHHHHHHHHHHHHHHHHhcCCCc-----eeecCCCCCCeEecCCCcEEEeecCCc
Q 036583 567 EFMANGSLDKWIFKKNQ-EFLLDWETRFNIALGTAKGLAYLHEDCDQR-----IIHCDIKPENVLLDDNYHAKVSDFGLA 640 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~l~~LH~~~~~~-----ivH~Dlk~~NIll~~~~~~ki~Dfgla 640 (817)
||+++++|.+++..... ...+++..++.++.||+.||+|||+ .+ |+||||||+||+++.++.+||+|||++
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 99999999999976432 2358999999999999999999999 66 999999999999999999999999999
Q ss_pred cccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhh
Q 036583 641 KLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRN 720 (817)
Q Consensus 641 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (817)
+........ .....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+..+....
T Consensus 164 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~i~~~~~~~ 235 (279)
T 2w5a_A 164 RILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAGKIREGKFRR 235 (279)
T ss_dssp HHC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCC
T ss_pred eeecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-------HHHHHHHhhccccc
Confidence 876543211 1235689999999999998999999999999999999999999964321 11222233332211
Q ss_pred hcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 721 ILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 721 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
+ .......+.+++.+||+.||++|||++|+++.+..
T Consensus 236 ~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 236 I---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp C---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred C---------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1 11223468899999999999999999999997654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=348.34 Aligned_cols=256 Identities=23% Similarity=0.275 Sum_probs=190.5
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecC------Cee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG------THR 562 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~------~~~ 562 (817)
.+.+.++||+|+||+||++.. .+++.||||++.... ...+.+.+|+.+++.++||||+++++++... .+.
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 455668899999999999985 468899999997542 2346788999999999999999999999654 457
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
++||||++++ |.+.+.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 143 ~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 143 YLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred EEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 9999999874 6665532 37888999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhh-------
Q 036583 643 MTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEE------- 715 (817)
Q Consensus 643 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~------- 715 (817)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+...+..
T Consensus 214 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~---~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 214 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ---WNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp ---CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCSCCHHHHT
T ss_pred cCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHHHHH
Confidence 64432 23446899999999999999999999999999999999999999975432110 0000000000
Q ss_pred ---cchhhhcccc---------------c-CC--cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 716 ---GKLRNILDSR---------------L-NI--DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 716 ---~~~~~~~d~~---------------~-~~--~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
......+... . .. .........+.+|+.+||+.||++|||++|+++.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 0 00 0111225578899999999999999999999983
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=332.42 Aligned_cols=249 Identities=26% Similarity=0.411 Sum_probs=200.6
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcC---------HHHHHHHHHHhhcc-CcceeeeeeeEeecCC
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQG---------KKEFRAEVSIIGSI-HHLHLVKLRGFCAEGT 560 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~---------~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~ 560 (817)
..+.+.+.||+|+||.||+++.. +|+.||||++...... .+.+.+|+.++.++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 44566689999999999999975 6999999998654311 35678999999999 7999999999999999
Q ss_pred eeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCc
Q 036583 561 HRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLA 640 (817)
Q Consensus 561 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 640 (817)
..++||||+++++|.+++.... .+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.+||+|||++
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFS 247 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCcc
Confidence 9999999999999999997543 58999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCceeeeeccCCCCccCcccccc------CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhh
Q 036583 641 KLMTREQSHVFTTLRGTRGYLAPEWITN------YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMME 714 (817)
Q Consensus 641 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 714 (817)
..+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+.
T Consensus 248 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-------~~~~~~i~ 318 (365)
T 2y7j_A 248 CHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-------ILMLRMIM 318 (365)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHH
T ss_pred cccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHH
Confidence 87654322 234679999999999864 3578899999999999999999999964321 11112222
Q ss_pred hcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 715 EGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 715 ~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.+.... ..+. .......+.+++.+||+.||++|||++|+++
T Consensus 319 ~~~~~~-~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 319 EGQYQF-SSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HTCCCC-CHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hCCCCC-CCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 221110 0000 0112346889999999999999999999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=325.20 Aligned_cols=246 Identities=25% Similarity=0.359 Sum_probs=194.9
Q ss_pred cccCCCcceeEEEEEc-CCCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCChh
Q 036583 498 VKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLD 575 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 575 (817)
..||+|+||.||+|.. .+++.||||.+.... ...+.+.+|+.++..++||||+++++++.+.+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 4799999999999995 568899999997653 34678999999999999999999999999999999999999999999
Q ss_pred hhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC-CCcEEEeecCCccccCCCCceeeeec
Q 036583 576 KWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD-NYHAKVSDFGLAKLMTREQSHVFTTL 654 (817)
Q Consensus 576 ~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~Dfgla~~~~~~~~~~~~~~ 654 (817)
+++........+++..+..++.||+.||+|||+ .+|+|+||||+||+++. ++.+||+|||++........ .....
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 183 (295)
T 2clq_A 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTETF 183 (295)
T ss_dssp HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCC
T ss_pred HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-ccccc
Confidence 999876444456788889999999999999999 89999999999999987 89999999999987643221 12345
Q ss_pred cCCCCccCccccccCc--cCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccH
Q 036583 655 RGTRGYLAPEWITNYA--ISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQS 732 (817)
Q Consensus 655 ~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 732 (817)
.|++.|+|||.+.+.. ++.++||||||+++|||++|+.||....... .......... ..+. ...
T Consensus 184 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~-----~~~~----~~~ 249 (295)
T 2clq_A 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-----AAMFKVGMFK-----VHPE----IPE 249 (295)
T ss_dssp CCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-----HHHHHHHHHC-----CCCC----CCT
T ss_pred CCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-----HHHHhhcccc-----cccc----ccc
Confidence 7899999999997643 7899999999999999999999995322110 0001100000 0111 111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 733 DRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 733 ~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.....+.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 250 SMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22346789999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=325.35 Aligned_cols=243 Identities=23% Similarity=0.338 Sum_probs=197.4
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---cCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 566 (817)
..+.+.++||+|+||+||+++.. +++.||||++.... ....++.+|+..+.++ +||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 45667789999999999999965 68999999997542 2356788999999999 9999999999999999999999
Q ss_pred eeccCCChhhhhhhccc-ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC-----------------
Q 036583 567 EFMANGSLDKWIFKKNQ-EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD----------------- 628 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~----------------- 628 (817)
||+++++|.+++..... ...+++..++.++.||+.||+|||+ .+|+||||||+||+++.
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999999999976432 1358899999999999999999999 89999999999999984
Q ss_pred --CCcEEEeecCCccccCCCCceeeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcc
Q 036583 629 --NYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHF 705 (817)
Q Consensus 629 --~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~ 705 (817)
...+||+|||++....... ...||+.|+|||.+.+. .++.++||||||++++||++|.+++....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------- 235 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------- 235 (289)
T ss_dssp --CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-------
T ss_pred CCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-------
Confidence 4479999999998765432 24589999999999865 66689999999999999999998764211
Q ss_pred hHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 706 PSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 706 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
....+..+....+ . ......+.+++.+||+.||++|||+.|+++
T Consensus 236 ---~~~~~~~~~~~~~-----~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 ---QWHEIRQGRLPRI-----P----QVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ---HHHHHHTTCCCCC-----S----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHHHHcCCCCCC-----C----cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1222222222111 1 112346789999999999999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=346.43 Aligned_cols=250 Identities=25% Similarity=0.366 Sum_probs=203.4
Q ss_pred HHhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
...+.+.++||+|+||+||+++.. +++.||||++... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 356778899999999999999964 6899999998543 345678999999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec---CCCcEEEeecCCcccc
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD---DNYHAKVSDFGLAKLM 643 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~ki~Dfgla~~~ 643 (817)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||+++..
T Consensus 101 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999999887654 58899999999999999999999 8999999999999995 5567999999999876
Q ss_pred CCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ......+..+....
T Consensus 175 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~~--- 241 (486)
T 3mwu_A 175 QQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------YDILKRVETGKYAF--- 241 (486)
T ss_dssp CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCS---
T ss_pred CCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCC---
Confidence 5432 2334679999999999976 589999999999999999999999964321 11222222222110
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
..+........+.+++.+||+.||.+|||+.|+++.
T Consensus 242 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 ---DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ---CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ---CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111111233468899999999999999999999984
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=340.55 Aligned_cols=262 Identities=21% Similarity=0.312 Sum_probs=200.5
Q ss_pred HHhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
...+.+.++||+|+||+||++... +++.||+|++.... ...+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 345566788999999999999965 68899999997542 234678999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCC-ceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ-RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~-~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
|+++++|.+++.... .+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999997654 58899999999999999999998 5 8999999999999999999999999999765322
Q ss_pred CceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCc----------------------
Q 036583 647 QSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAH---------------------- 704 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~---------------------- 704 (817)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 1234578999999999999999999999999999999999999996543211000
Q ss_pred -chHHHHHHhhhcc----hhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 705 -FPSYAFKMMEEGK----LRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 705 -~~~~~~~~~~~~~----~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+..+......... +..+................+.+++.+||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000000000 00000011111111112346889999999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.88 Aligned_cols=262 Identities=23% Similarity=0.363 Sum_probs=196.3
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcC---HHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQG---KKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~---~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
.+.+.++||+|+||.||+++.. +++.||||++...... .+.+.+|+.++.+++||||+++++++.+....++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 105 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF 105 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence 4556688999999999999965 4899999998654332 35678999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 106 ~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 106 VDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp CSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred CCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999988875543 58899999999999999999999 8999999999999999999999999999986644322
Q ss_pred eeeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCc--------chHHHHHHhhhc-ch
Q 036583 649 HVFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAH--------FPSYAFKMMEEG-KL 718 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~--------~~~~~~~~~~~~-~~ 718 (817)
......|++.|+|||.+.+. .++.++||||||+++|||++|+.||.......... ............ ..
T Consensus 180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 22346789999999999875 78999999999999999999999996543211000 000000000000 00
Q ss_pred hhhcccccCCccc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 719 RNILDSRLNIDEQ-----SDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 719 ~~~~d~~~~~~~~-----~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.....+....... ......+.+++.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1111111111111 122456889999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=345.51 Aligned_cols=249 Identities=25% Similarity=0.358 Sum_probs=199.0
Q ss_pred HHhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
...+.+.++||+|+||+||+++.. +++.||+|++... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 345777889999999999999964 6889999999754 234678999999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC---CCcEEEeecCCcccc
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD---NYHAKVSDFGLAKLM 643 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~Dfgla~~~ 643 (817)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||++...
T Consensus 116 e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999999887654 58899999999999999999999 89999999999999976 455999999999876
Q ss_pred CCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
.... ......||+.|+|||++. ..++.++|||||||++|||++|+.||..... ......+..+... ...
T Consensus 190 ~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~-~~~ 258 (494)
T 3lij_A 190 ENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-------QEILRKVEKGKYT-FDS 258 (494)
T ss_dssp BTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCC-CCS
T ss_pred CCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCC-CCc
Confidence 5432 223467999999999986 4689999999999999999999999964321 1222223222211 000
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+........+.+++.+||+.||.+|||+.|+++
T Consensus 259 -----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 259 -----PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -----GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----hhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 111122346789999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=347.28 Aligned_cols=250 Identities=25% Similarity=0.309 Sum_probs=202.6
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
.+.+.||+|+||.||+++.. +|+.||+|++... ....+.+.+|+.++.+++||||+++++++.+....++||||+
T Consensus 188 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~ 267 (543)
T 3c4z_A 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIM 267 (543)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEec
Confidence 34477999999999999964 6899999999643 245678999999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccc-ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 570 ANGSLDKWIFKKNQ-EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 570 ~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
++|+|.+++..... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 268 ~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~ 344 (543)
T 3c4z_A 268 NGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT 344 (543)
T ss_dssp TTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred cCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence 99999999976432 2358899999999999999999999 8999999999999999999999999999987654332
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........+.... ...
T Consensus 345 ~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~---~~~~~~~~i~~~~--------~~~ 412 (543)
T 3c4z_A 345 K-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV---ENKELKQRVLEQA--------VTY 412 (543)
T ss_dssp C-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC---CHHHHHHHHHHCC--------CCC
T ss_pred c-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch---hHHHHHHHHhhcc--------cCC
Confidence 1 233589999999999999999999999999999999999999997543221 1111222221111 111
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSM-----TKVVQ 761 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~-----~evl~ 761 (817)
+......+.+++.+||+.||++||++ +|+++
T Consensus 413 --p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 413 --PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp --CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred --CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 11223467899999999999999975 66764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=342.68 Aligned_cols=258 Identities=20% Similarity=0.310 Sum_probs=202.8
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhccCc-ceeeeeeeEeecCCeeeEEEeecc
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHH-LHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.+.+.++||+|+||.||+|+. .+++.||||++.... ..+++..|++++..++| +++..+..++.+.+..+|||||+
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~- 85 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence 355668899999999999995 568999999886532 23458899999999976 56666667778888899999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEe---cCCCcEEEeecCCccccCCCC
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL---DDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~Dfgla~~~~~~~ 647 (817)
+++|.+++..... .+++..++.|+.||+.||+|||+ .+|+||||||+|||| +.++.+||+|||+++......
T Consensus 86 g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 86 GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 9999999975433 58999999999999999999999 899999999999999 688999999999998765433
Q ss_pred ce------eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhh
Q 036583 648 SH------VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721 (817)
Q Consensus 648 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (817)
.. ......||+.|+|||.+.+..++.++|||||||+||||++|+.||......... .....+....+...
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~----~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK----QKYEKISEKKVATS 236 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH----HHHHHHHHHHHHSC
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH----HHHHHHhhcccccc
Confidence 21 122467999999999999999999999999999999999999999765432211 11111111111111
Q ss_pred cccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 722 ~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
+.... ......+.+++..||+.||++||++++|+++|+.+
T Consensus 237 ~~~l~-----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 237 IEALC-----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHHH-----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHh-----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11100 11234688999999999999999999999998765
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=330.30 Aligned_cols=260 Identities=20% Similarity=0.314 Sum_probs=183.2
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
..+.+.+.||+|+||.||++... +++.||||++... ....+++.+|+.++.+++||||+++++++...+..++||||
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 94 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence 34556788999999999999864 6889999998643 23456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhc-----ccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 569 MANGSLDKWIFKK-----NQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 569 ~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+++++|.+++... .....+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 9999999998742 112358899999999999999999999 89999999999999999999999999999866
Q ss_pred CCCCc----eeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcch
Q 036583 644 TREQS----HVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKL 718 (817)
Q Consensus 644 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 718 (817)
..... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... ........ ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~-~~ 244 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK------VLMLTLQN-DP 244 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHTS-SC
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh------HHHHHhcc-CC
Confidence 43211 11233578999999999976 568999999999999999999999996543211 11111111 11
Q ss_pred hhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 719 RNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 719 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
...................+.+++.+||+.||.+|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1000000000001112346789999999999999999999987
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=346.69 Aligned_cols=248 Identities=26% Similarity=0.383 Sum_probs=199.4
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC--------------cCHHHHHHHHHHhhccCcceeeeeeeEe
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--------------QGKKEFRAEVSIIGSIHHLHLVKLRGFC 556 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--------------~~~~~~~~Ev~~l~~l~h~niv~l~~~~ 556 (817)
..+.+.++||+|+||+||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34666789999999999999964 57899999986532 2356789999999999999999999999
Q ss_pred ecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC---cEE
Q 036583 557 AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY---HAK 633 (817)
Q Consensus 557 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~k 633 (817)
.+....++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+|
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEE
Confidence 99999999999999999999987654 58999999999999999999999 8999999999999998775 699
Q ss_pred EeecCCccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHh
Q 036583 634 VSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMM 713 (817)
Q Consensus 634 i~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 713 (817)
|+|||++....... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||..... ......+
T Consensus 190 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i 259 (504)
T 3q5i_A 190 IVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND-------QDIIKKV 259 (504)
T ss_dssp ECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHH
T ss_pred EEECCCCEEcCCCC--ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHH
Confidence 99999998765432 2234679999999999874 689999999999999999999999964321 1122223
Q ss_pred hhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 714 EEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 714 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..+....-. +........+.+++.+||+.||.+|||++|+++
T Consensus 260 ~~~~~~~~~------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 260 EKGKYYFDF------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHCCCCCCH------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HcCCCCCCc------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 222211000 000112346889999999999999999999987
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=335.44 Aligned_cols=263 Identities=20% Similarity=0.325 Sum_probs=193.5
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
+.+.++||+|+||+||+|+.. +++.||||++..... ....+.+|++++.+++||||+++++++.+....++||||++
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 456688999999999999965 688999999965422 12245689999999999999999999999999999999998
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+ +|.+++..... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 84 ~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~ 156 (324)
T 3mtl_A 84 K-DLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T 156 (324)
T ss_dssp E-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred c-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-c
Confidence 5 89998876543 58889999999999999999999 8999999999999999999999999999986543221 2
Q ss_pred eeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcc---hhhhc----
Q 036583 651 FTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGK---LRNIL---- 722 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~---- 722 (817)
.....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ....+........ .....
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhcchh
Confidence 234578999999999876 568999999999999999999999996543211 0011111110000 00000
Q ss_pred -----ccccCCc----ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcC
Q 036583 723 -----DSRLNID----EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ--MLEGI 766 (817)
Q Consensus 723 -----d~~~~~~----~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~--~L~~~ 766 (817)
.+..... ........+.+++.+||+.||++|||++|+++ .+..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 0000000 00112346789999999999999999999998 34444
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=334.89 Aligned_cols=255 Identities=21% Similarity=0.289 Sum_probs=189.4
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
.+.+.++||+|+||+||+++. .+++.||||++..... ..+.+.+|++++++++||||+++++++.++...++||||
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence 456678999999999999984 4688999999965422 245678999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEe-----cCCCcEEEeecCCcccc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL-----DDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll-----~~~~~~ki~Dfgla~~~ 643 (817)
+++ +|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 115 ~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 115 AEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp CSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred CCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 985 9999997654 48899999999999999999999 899999999999999 45566999999999876
Q ss_pred CCCCceeeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhh-c--ch-
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEE-G--KL- 718 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~--~~- 718 (817)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ......... + ..
T Consensus 188 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 188 GIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI------DQLFKIFEVLGLPDDT 260 (329)
T ss_dssp C------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCCCCTT
T ss_pred CCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH------HHHHHHHHHhCCCchh
Confidence 43322 22345789999999999874 5899999999999999999999999654321 111111110 0 00
Q ss_pred -----hhhc---c--cccCCc-----ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 719 -----RNIL---D--SRLNID-----EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 719 -----~~~~---d--~~~~~~-----~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.... . +..... ........+.+++.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000 0 000000 00012356789999999999999999999987
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=363.89 Aligned_cols=255 Identities=26% Similarity=0.363 Sum_probs=201.7
Q ss_pred HHHhhccccccCCCcceeEEEEEcCC----CcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCeee
Q 036583 490 QTATNNFSVKLGQGGFGSVYQGVLPD----GTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 490 ~~~~~~~~~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 563 (817)
....+.+.+.||+|+||.||+|.... +..||||++..... ..+.+.+|+.++.+++||||+++++++.+ +..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence 34556677899999999999998632 45799999875432 24679999999999999999999999854 5689
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+||||+++|+|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTT--TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 99999999999999975432 58899999999999999999999 89999999999999999999999999999877
Q ss_pred CCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
............+++.|+|||.+.+..++.++|||||||++|||++ |..||..... ......+..+...
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-------~~~~~~i~~~~~~--- 611 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVIGRIENGERL--- 611 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHHTCCC---
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHcCCCC---
Confidence 5543333334567789999999998899999999999999999997 9999964321 1122222222111
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
+........+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 612 ------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 612 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11112334688999999999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=324.28 Aligned_cols=250 Identities=27% Similarity=0.377 Sum_probs=198.8
Q ss_pred HHhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
...+.+.++||+|+||.||+|... +|+.||||++... ...+++.+|+.++.+++||||+++++++.+....++||||+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT-SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch-HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 345666789999999999999865 5899999999753 34578999999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++++|.+++..... .+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.+||+|||++........
T Consensus 107 ~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (314)
T 3com_A 107 GAGSVSDIIRLRNK--TLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA- 180 (314)
T ss_dssp TTEEHHHHHHHHTC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred CCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence 99999999974332 58899999999999999999999 8999999999999999999999999999987654322
Q ss_pred eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ....... .+.. .
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~-~~~~~~~-----~~~~--~ 246 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAI-FMIPTNP-----PPTF--R 246 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHH-HHHHHSC-----CCCC--S
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHH-HHHhcCC-----Cccc--C
Confidence 123457899999999999989999999999999999999999999643211 111 1111111 0111 1
Q ss_pred ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 730 EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 730 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
........+.+++.+||+.||.+|||+.|+++
T Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 247 KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11122346889999999999999999999987
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=335.02 Aligned_cols=262 Identities=20% Similarity=0.248 Sum_probs=197.0
Q ss_pred HhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeec--------C
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAE--------G 559 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~--------~ 559 (817)
..+.+.++||+|+||+||+++. .+|+.||||++.... .....+.+|++++.+++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 3566778999999999999996 578999999985442 235678899999999999999999999977 4
Q ss_pred CeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCC
Q 036583 560 THRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGL 639 (817)
Q Consensus 560 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl 639 (817)
...++||||+++ +|.+.+..... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999986 77777765433 58899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCC---ceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhh
Q 036583 640 AKLMTREQ---SHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEE 715 (817)
Q Consensus 640 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 715 (817)
++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ...........
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~ 247 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCGS 247 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCC
Confidence 98764321 122234678999999999876 467999999999999999999999997543211 00000000000
Q ss_pred cc-----------hhhhcccccCCccc-HH------HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 716 GK-----------LRNILDSRLNIDEQ-SD------RVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 716 ~~-----------~~~~~d~~~~~~~~-~~------~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.. ....+......... .+ ....+.+++.+||+.||++|||++|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00 00000000000000 01 12357899999999999999999999983
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=341.16 Aligned_cols=196 Identities=26% Similarity=0.374 Sum_probs=164.4
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecC-----Ceee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEG-----THRL 563 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~-----~~~~ 563 (817)
.+.+.+.||+|+||.||+|+. .+++.||||++..... ..+.+.+|++++++++||||+++++++... ...+
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 456678899999999999985 4588999999976432 246789999999999999999999999776 5789
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+||||+++ +|.+++.... .+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 107 lv~e~~~~-~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 107 IVLEIADS-DLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEECCSE-EHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEecCCc-CHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 99999874 9999997643 58999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCc---------------------eeeeeccCCCCccCcccc-ccCccCccccccchhhhHHHhhhCCCCCC
Q 036583 644 TREQS---------------------HVFTTLRGTRGYLAPEWI-TNYAISEKSDVYSYGMVLLEIIGGRKNFD 695 (817)
Q Consensus 644 ~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwS~Gvvl~elltg~~pf~ 695 (817)
..... .......||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 54321 123457899999999986 56679999999999999999998666554
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=348.10 Aligned_cols=250 Identities=25% Similarity=0.346 Sum_probs=205.4
Q ss_pred HHHhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeE
Q 036583 490 QTATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLL 564 (817)
Q Consensus 490 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 564 (817)
....+.+.++||+|+||+||+++.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3456778889999999999999965 6899999999643 3356789999999999999999999999999999999
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEe---cCCCcEEEeecCCcc
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL---DDNYHAKVSDFGLAK 641 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~Dfgla~ 641 (817)
||||+.+|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 104 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999987654 58999999999999999999999 899999999999999 567899999999998
Q ss_pred ccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhh
Q 036583 642 LMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721 (817)
Q Consensus 642 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (817)
....... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ......+..+....
T Consensus 178 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~~- 246 (484)
T 3nyv_A 178 HFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-------YDILKKVEKGKYTF- 246 (484)
T ss_dssp HBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCC-
T ss_pred Ecccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCCCCC-
Confidence 7654322 234679999999999876 689999999999999999999999964321 11222233322110
Q ss_pred cccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 722 ~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..+........+.+++.+||+.||++|||+.|+++
T Consensus 247 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 -----ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -----CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 11111223456889999999999999999999997
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=343.70 Aligned_cols=191 Identities=25% Similarity=0.362 Sum_probs=151.2
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeec-----CCeee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAE-----GTHRL 563 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~-----~~~~~ 563 (817)
.+.+.++||+|+||+||+++.. +++.||||++..... ..+.+.+|++++.+++||||+++++++.. ....+
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 4566789999999999999854 689999999975432 24678999999999999999999999943 35689
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+||||+. ++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++..
T Consensus 134 lv~e~~~-~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 134 VVLEIAD-SDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEECCCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEeccc-cchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 9999985 68999887543 58999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCc--------------------------eeeeeccCCCCccCcccc-ccCccCccccccchhhhHHHhhhC
Q 036583 644 TREQS--------------------------HVFTTLRGTRGYLAPEWI-TNYAISEKSDVYSYGMVLLEIIGG 690 (817)
Q Consensus 644 ~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwS~Gvvl~elltg 690 (817)
..... .......||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 43211 122346789999999986 466799999999999999999994
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=320.13 Aligned_cols=245 Identities=26% Similarity=0.401 Sum_probs=193.8
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
.+.+.++||+|+||.||+|+.. +++.||||++... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4556688999999999999965 6899999998643 2346789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+++++|.+++.... .+++..+..++.||+.||+|||+ .+|+|+||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 92 YVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp CCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred ccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 999999999997654 58889999999999999999999 899999999999999999999999999998765432
Q ss_pred ceeeeeccCCCCccCccccccCcc-CccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAI-SEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
. .....+++.|+|||.+.+..+ +.++||||||++++||++|+.||..... ......+..+..
T Consensus 166 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~-------- 228 (276)
T 2h6d_A 166 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-------PTLFKKIRGGVF-------- 228 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCC--------
T ss_pred c--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------HHHHHHhhcCcc--------
Confidence 1 234578999999999987765 6899999999999999999999964321 112222222110
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.. +......+.+++.+|++.||++|||++|+++.
T Consensus 229 ~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 YI--PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cC--chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 11122457899999999999999999999983
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=330.17 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=193.5
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhcc-CcceeeeeeeEeec------CCeeeEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAE------GTHRLLA 565 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~------~~~~~lv 565 (817)
+.+.+.||+|+||.||+|+. .+++.||||++.......+.+.+|+.++.++ +||||+++++++.. ....++|
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv 105 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 105 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEE
T ss_pred EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEE
Confidence 45568899999999999996 4789999999987666778999999999999 89999999999976 4678999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|||+++++|.+++..... ..+++..+..++.||+.||+|||+ .+|+|+||||+||+++.++.+||+|||++.....
T Consensus 106 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 106 MEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181 (326)
T ss_dssp EECCTTEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred EEcCCCCcHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence 999999999999976432 268889999999999999999999 8999999999999999999999999999987643
Q ss_pred CCceeeeeccCCCCccCccccc-----cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhh
Q 036583 646 EQSHVFTTLRGTRGYLAPEWIT-----NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRN 720 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (817)
... ......|++.|+|||.+. +..++.++||||||+++|||++|+.||...... ... ..+......
T Consensus 182 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~- 252 (326)
T 2x7f_A 182 TVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RAL-FLIPRNPAP- 252 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHH-HHHHHSCCC-
T ss_pred Ccc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHH-HHhhcCccc-
Confidence 221 123457899999999987 567889999999999999999999999643211 111 111111111
Q ss_pred hcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 721 ILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 721 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
... .......+.+++.+||+.||.+|||++|+++
T Consensus 253 ----~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 253 ----RLK---SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp ----CCS---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ----cCC---ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 110 1112346789999999999999999999998
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=341.68 Aligned_cols=196 Identities=24% Similarity=0.340 Sum_probs=170.7
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhcc------CcceeeeeeeEeecCCeeeEE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSI------HHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l------~h~niv~l~~~~~~~~~~~lv 565 (817)
.+.+.++||+|+||+||+|... +++.||||++.......+.+.+|++++..+ +|+||+++++++......++|
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 177 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT 177 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEE
Confidence 4566789999999999999854 588999999986544456788899888877 577999999999999999999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCc--EEEeecCCcccc
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYH--AKVSDFGLAKLM 643 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~ki~Dfgla~~~ 643 (817)
|||+. ++|.+++...... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||+++..
T Consensus 178 ~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 178 FELLS-MNLYELIKKNKFQ-GFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp ECCCC-CBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EeccC-CCHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 99996 5999998765422 58899999999999999999999 89999999999999999887 999999999765
Q ss_pred CCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCC
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPN 697 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~ 697 (817)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 253 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 253 HQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp TCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 432 23457899999999999999999999999999999999999999654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=325.04 Aligned_cols=246 Identities=23% Similarity=0.344 Sum_probs=201.5
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
.+.+.+.||+|+||.||++... +++.+|+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (294)
T 2rku_A 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 95 (294)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEe
Confidence 3456688999999999999965 57889999986542 234678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+++++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 96 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 96 LCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp CCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 999999999887644 58899999999999999999999 899999999999999999999999999998765332
Q ss_pred ceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... . ....+..+. ..
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~--------~~ 233 (294)
T 2rku_A 170 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------E-TYLRIKKNE--------YS 233 (294)
T ss_dssp C-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHTTC--------CC
T ss_pred c-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHhhcc--------CC
Confidence 2 123457899999999999988999999999999999999999999643211 1 111111111 11
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
. .......+.+++.+||+.||++|||++|+++.
T Consensus 234 ~--~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 234 I--PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp C--CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred C--ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1 11122467889999999999999999999973
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=330.96 Aligned_cols=245 Identities=23% Similarity=0.349 Sum_probs=201.3
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC----cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
.+.+.+.||+|+||.||++... +++.+|+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 42 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 121 (335)
T 2owb_A 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 121 (335)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEe
Confidence 4556688999999999999965 47899999986542 234678999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+++++|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 122 ~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 122 LCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp CCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 999999999887643 58899999999999999999999 899999999999999999999999999998765332
Q ss_pred ceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .. ....+..+. ..
T Consensus 196 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~-~~~~~~~~~--------~~ 259 (335)
T 2owb_A 196 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KE-TYLRIKKNE--------YS 259 (335)
T ss_dssp C-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HH-HHHHHHHTC--------CC
T ss_pred c-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------HH-HHHHHhcCC--------CC
Confidence 2 12346789999999999998999999999999999999999999964321 11 111111111 11
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
. .......+.+++.+||+.||++|||++|+++
T Consensus 260 ~--~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 260 I--PKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp C--CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred C--CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 1112235778999999999999999999997
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=326.00 Aligned_cols=255 Identities=20% Similarity=0.302 Sum_probs=197.8
Q ss_pred HhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhccC-cceeeeeeeEeec--CCeeeEEEe
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH-HLHLVKLRGFCAE--GTHRLLAYE 567 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~--~~~~~lv~e 567 (817)
..+.+.++||+|+||+||+++. .+++.||||++.. ...+.+.+|++++.+++ ||||+++++++.+ ....++|||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 3456678999999999999984 5789999999974 34678999999999997 9999999999987 667899999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC-cEEEeecCCccccCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY-HAKVSDFGLAKLMTRE 646 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Dfgla~~~~~~ 646 (817)
|+++++|.+++. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++.....
T Consensus 114 ~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 114 HVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp CCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 999999999884 37788899999999999999999 8999999999999999776 8999999999876543
Q ss_pred CceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccc-
Q 036583 647 QSHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS- 724 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~- 724 (817)
.. .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||........ .+ ...........+.+.++.
T Consensus 185 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l-~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 185 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QL-VRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HH-HHHHHHHCHHHHHHHHHHT
T ss_pred Cc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HH-HHHHHhcCCchhhhHHHHh
Confidence 32 234578999999999987 6789999999999999999999999954322110 00 000011111111111000
Q ss_pred ----------------------ccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 725 ----------------------RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 725 ----------------------~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.............+.+++.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0001111113457889999999999999999999997
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=327.72 Aligned_cols=250 Identities=24% Similarity=0.322 Sum_probs=183.7
Q ss_pred HhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcC---HHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQG---KKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~---~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
..+.+.++||+|+||+||+++. .+++.||||++...... .+.+.++...++.++||||+++++++.+++..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 3456678999999999999995 57899999999754221 2334555566888899999999999999999999999
Q ss_pred eccCCChhhhhhhc-ccccchhhhHHHHHHHHHHHHHHHHHhcCCC-ceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 568 FMANGSLDKWIFKK-NQEFLLDWETRFNIALGTAKGLAYLHEDCDQ-RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 568 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~-~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|+++ +|.+++... .....+++..+..++.||+.||+|||+ . +|+||||||+||+++.++.+||+|||+++....
T Consensus 87 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 87 LMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred hhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9985 888877642 122368999999999999999999998 6 999999999999999999999999999987654
Q ss_pred CCceeeeeccCCCCccCcccc----ccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhh
Q 036583 646 EQSHVFTTLRGTRGYLAPEWI----TNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (817)
... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||...... ...........
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~----- 230 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEEP----- 230 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHSC-----
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhccC-----
Confidence 322 2335789999999996 4667889999999999999999999999643211 11111111111
Q ss_pred cccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 722 ~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
............+.+++.+|++.||++|||++|+++
T Consensus 231 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 ----SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ----CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111111122346889999999999999999999987
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=321.22 Aligned_cols=252 Identities=22% Similarity=0.291 Sum_probs=197.5
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC-----CcCHHHHHHHHHHhhccCcceeeeeeeEee--cCCeeeE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI-----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCA--EGTHRLL 564 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~-----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~--~~~~~~l 564 (817)
.+.+.+.||+|+||.||++... +++.||+|++... ....+.+.+|++++.+++||||+++++++. +....++
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 4556788999999999999964 6889999999643 234578999999999999999999999984 4567899
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
||||++++ |.+++..... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 99999987 7777765332 268899999999999999999999 899999999999999999999999999998765
Q ss_pred CCC-ceeeeeccCCCCccCccccccCc--cCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhh
Q 036583 645 REQ-SHVFTTLRGTRGYLAPEWITNYA--ISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721 (817)
Q Consensus 645 ~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (817)
... ........|++.|+|||.+.+.. ++.++||||||+++|||++|+.||..... ......+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~i~~~~~--- 230 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-------YKLFENIGKGSY--- 230 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHCCC---
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-------HHHHHHHhcCCC---
Confidence 322 22234467899999999997643 47899999999999999999999964321 112222222211
Q ss_pred cccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcC
Q 036583 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM--LEGI 766 (817)
Q Consensus 722 ~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~--L~~~ 766 (817)
.. .......+.+++.+||+.||.+|||++|+++. +...
T Consensus 231 -----~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 231 -----AI--PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp -----CC--CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred -----CC--CCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 11 11123467899999999999999999999973 4444
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=325.35 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=196.1
Q ss_pred HHHhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC---------cCHHHHHHHHHHhhccCcceeeeeeeEeecC
Q 036583 490 QTATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG---------QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG 559 (817)
Q Consensus 490 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---------~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~ 559 (817)
....+.+.++||+|+||.||+++.. +++.||||++.... .....+.+|++++.+++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3456778899999999999999864 57899999986431 1234588999999999999999999998765
Q ss_pred CeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCc---EEEee
Q 036583 560 THRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYH---AKVSD 636 (817)
Q Consensus 560 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~ki~D 636 (817)
. .++||||+++++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 5 899999999999999987543 58899999999999999999999 89999999999999987654 99999
Q ss_pred cCCccccCCCCceeeeeccCCCCccCccccc---cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHh
Q 036583 637 FGLAKLMTREQSHVFTTLRGTRGYLAPEWIT---NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMM 713 (817)
Q Consensus 637 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 713 (817)
||+++....... .....||+.|+|||.+. ...++.++|||||||++|||++|+.||........ ....+
T Consensus 161 fg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~ 232 (322)
T 2ycf_A 161 FGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------LKDQI 232 (322)
T ss_dssp CTTCEECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC------HHHHH
T ss_pred Cccceecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH------HHHHH
Confidence 999987644321 22356899999999974 46788999999999999999999999975433211 11112
Q ss_pred hhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 714 EEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 714 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..+...... .........+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 TSGKYNFIP------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHTCCCCCH------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhCccccCc------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 222111000 000112346889999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=330.45 Aligned_cols=262 Identities=24% Similarity=0.340 Sum_probs=192.7
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcC---HHHHHHHHHHhhccCcceeeeeeeEeecCC------ee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQG---KKEFRAEVSIIGSIHHLHLVKLRGFCAEGT------HR 562 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~---~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~------~~ 562 (817)
.+.+.+.||+|+||.||+|.. .+|+.||||++...... .+.+.+|++++++++||||+++++++.... ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 355668899999999999996 46899999999654322 457889999999999999999999997653 45
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
++||||+ +++|.+++... .+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp EEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 9999999 78999998653 48889999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCc--------chHHHHHHh
Q 036583 643 MTREQSHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAH--------FPSYAFKMM 713 (817)
Q Consensus 643 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~--------~~~~~~~~~ 713 (817)
.... .....+|+.|+|||++.+ ..++.++||||+||+++||++|+.||.......... .+......+
T Consensus 178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 6432 234578999999999987 688999999999999999999999997543211000 000000000
Q ss_pred hhcchhhhccc---ccCC---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcC
Q 036583 714 EEGKLRNILDS---RLNI---DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ--MLEGI 766 (817)
Q Consensus 714 ~~~~~~~~~d~---~~~~---~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~--~L~~~ 766 (817)
........+.. .... .........+.+++.+|++.||++|||++|+++ .++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 00000000000 0000 000122346889999999999999999999998 35544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=332.99 Aligned_cols=262 Identities=23% Similarity=0.331 Sum_probs=202.3
Q ss_pred HHhhccccccCCCcceeEEEEEc--CCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcce------eeeeeeEeecCCee
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVL--PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLH------LVKLRGFCAEGTHR 562 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~--~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~n------iv~l~~~~~~~~~~ 562 (817)
...+.+.++||+|+||+||++.. .+++.||||++.......+.+.+|++++..++|++ ++++++++.+.+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 34667788999999999999985 36889999999765555678899999999998775 99999999999999
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC--------------
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD-------------- 628 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-------------- 628 (817)
++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 9999999 8899999976542 257889999999999999999999 89999999999999987
Q ss_pred -----CCcEEEeecCCccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCC
Q 036583 629 -----NYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA 703 (817)
Q Consensus 629 -----~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~ 703 (817)
++.+||+|||+++...... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.........
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 6789999999998654322 3457899999999999999999999999999999999999999654321100
Q ss_pred --------cchHHHHHHhhhcch------------------hhhcccc-cCCcccHHHHHHHHHHHHhccccCCCCCCCH
Q 036583 704 --------HFPSYAFKMMEEGKL------------------RNILDSR-LNIDEQSDRVFTAVKVALWCVQEDMSLRPSM 756 (817)
Q Consensus 704 --------~~~~~~~~~~~~~~~------------------~~~~d~~-~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~ 756 (817)
.++............ .....+. ............+.+++.+||+.||++|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 000000000000000 0000000 0011122445678999999999999999999
Q ss_pred HHHHH
Q 036583 757 TKVVQ 761 (817)
Q Consensus 757 ~evl~ 761 (817)
+|+++
T Consensus 324 ~ell~ 328 (339)
T 1z57_A 324 REALK 328 (339)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=340.29 Aligned_cols=261 Identities=18% Similarity=0.265 Sum_probs=181.2
Q ss_pred ccccCCCcceeEEEEEcC---CCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEee--cCCeeeEEEeeccC
Q 036583 497 SVKLGQGGFGSVYQGVLP---DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCA--EGTHRLLAYEFMAN 571 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~~---~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~~ 571 (817)
.++||+|+||+||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+++++++. .....++||||+++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~ 104 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 104 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC
Confidence 357999999999999964 57889999997543 3457889999999999999999999995 46788999999975
Q ss_pred CChhhhhhhccc------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEe----cCCCcEEEeecCCcc
Q 036583 572 GSLDKWIFKKNQ------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL----DDNYHAKVSDFGLAK 641 (817)
Q Consensus 572 gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~ki~Dfgla~ 641 (817)
+|.+++..... ...+++..++.++.||+.||+|||+ .+|+||||||+|||| +.++.+||+|||+++
T Consensus 105 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 180 (405)
T 3rgf_A 105 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180 (405)
T ss_dssp -EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred -CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence 78887764321 1248899999999999999999999 899999999999999 778999999999998
Q ss_pred ccCCCCc--eeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCC---CcchHHHHHHhh-
Q 036583 642 LMTREQS--HVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDK---AHFPSYAFKMME- 714 (817)
Q Consensus 642 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~---~~~~~~~~~~~~- 714 (817)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ............
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~ 260 (405)
T 3rgf_A 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 260 (405)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHH
T ss_pred ecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHh
Confidence 7654321 22234678999999999987 4589999999999999999999999975543211 011111111100
Q ss_pred --hcch---hh-------------hcccccCCccc--------HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 715 --EGKL---RN-------------ILDSRLNIDEQ--------SDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 715 --~~~~---~~-------------~~d~~~~~~~~--------~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.... .. +.......... ......+.+|+.+||+.||.+|||++|+++.
T Consensus 261 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 261 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 00 00000000000 0013467899999999999999999999983
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=329.94 Aligned_cols=261 Identities=23% Similarity=0.264 Sum_probs=196.5
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc------CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ------GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLL 564 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~------~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 564 (817)
..+.+.+.||+|+||.||+++.. +|+.||||++..... ..+.+.+|++++.+++||||+++++++.+....++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 34566788999999999999975 589999999864321 12468899999999999999999999999999999
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
||||+++ +|.+++..... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 90 v~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp EEECCSE-EHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred EEEcCCC-CHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 9999987 88888865432 58889999999999999999999 899999999999999999999999999998764
Q ss_pred CCCceeeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 645 REQSHVFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 645 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
.... ......||+.|+|||.+.+. .++.++|||||||++|||++|..||....... ..................+
T Consensus 164 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~---~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 164 SPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp SCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSS
T ss_pred CCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHcCCCChhhhhh
Confidence 3322 22346789999999999754 58899999999999999999999996543111 0000111110000000000
Q ss_pred ------c---ccCCccc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 724 ------S---RLNIDEQ-----SDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 724 ------~---~~~~~~~-----~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
. ....... ......+.+++.+|++.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 0000000 1123578899999999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=320.28 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=190.9
Q ss_pred HhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeec------------
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE------------ 558 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~------------ 558 (817)
..+.+.+.||+|+||.||+|+. .+++.||||++.......+.+.+|+.++.+++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 3456678999999999999995 478999999997654556789999999999999999999998865
Q ss_pred -CCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeec
Q 036583 559 -GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDF 637 (817)
Q Consensus 559 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df 637 (817)
....++||||+++++|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSENL--NQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSCG--GGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cCCceEEEEecCCCCCHHHhhhcccc--ccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEeeC
Confidence 4567999999999999999976442 57788999999999999999999 89999999999999999999999999
Q ss_pred CCccccCCCC-------------ceeeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCC
Q 036583 638 GLAKLMTREQ-------------SHVFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA 703 (817)
Q Consensus 638 gla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~ 703 (817)
|++....... ........|++.|+|||.+.+. .++.++||||||+++|||++ ||....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~----- 232 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM----- 232 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-----
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-----
Confidence 9998764321 1122345689999999999864 68999999999999999998 443110
Q ss_pred cchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 704 HFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
-.......+.... ..............+.+++.+||+.||.+|||++|+++
T Consensus 233 -~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 -ERVNILKKLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -HHHHHHHHHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hHHHHHHhccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 0001111111110 01111122233446789999999999999999999997
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=324.40 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=192.9
Q ss_pred HhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCc---CHHHHHHHHHHhhccC--cceeeeeeeEeecCCeeeEEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIH--HLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 566 (817)
..+.+.++||+|+||.||++...+++.||||++..... ..+.+.+|++++.+++ |+||+++++++.+....++||
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 107 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 107 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence 34556688999999999999998899999999965432 3467899999999997 599999999999999999999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
| +.+++|.+++.... .+++..++.++.||+.||.|||+ .+|+||||||+||++++ +.+||+|||+++.....
T Consensus 108 e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 108 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp C-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred e-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence 9 67889999997654 58889999999999999999999 89999999999999975 89999999999876543
Q ss_pred Cce-eeeeccCCCCccCcccccc-----------CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhh
Q 036583 647 QSH-VFTTLRGTRGYLAPEWITN-----------YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMME 714 (817)
Q Consensus 647 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 714 (817)
... ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ...
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~------ 248 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISK------ 248 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHH------
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HHH------
Confidence 322 1234578999999999875 46788999999999999999999999643211 011
Q ss_pred hcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 715 EGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 715 ~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
+..+.++.............+.+++.+||+.||++||+++|+++.
T Consensus 249 ---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 249 ---LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ---HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111122211111111123467899999999999999999999973
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=323.84 Aligned_cols=250 Identities=21% Similarity=0.308 Sum_probs=195.9
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC-CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI-GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
..+.+.++||+|+||.||+|+.. +++.||+|++... ....+.+.+|++++.+++||||+++++++.+....++||||+
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 34566788999999999999975 5889999998754 345688999999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++++|.+++..... .+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++....... .
T Consensus 99 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 172 (302)
T 2j7t_A 99 PGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-Q 172 (302)
T ss_dssp TTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-H
T ss_pred CCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-c
Confidence 99999999876433 58899999999999999999999 899999999999999999999999999876432111 1
Q ss_pred eeeeccCCCCccCccccc-----cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccc
Q 036583 650 VFTTLRGTRGYLAPEWIT-----NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 724 (817)
......|++.|+|||.+. +..++.++||||||+++|||++|+.||..... .... ..........
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~-~~~~~~~~~~---- 241 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVL-LKIAKSDPPT---- 241 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHH-HHHHHSCCCC----
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHH-HHHhccCCcc----
Confidence 122356899999999984 56788999999999999999999999964321 1111 1111111100
Q ss_pred ccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 725 RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 725 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..........+.+++.+||+.||++|||++|+++
T Consensus 242 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 ---LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ---CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ---cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1111222346889999999999999999999886
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=330.24 Aligned_cols=255 Identities=22% Similarity=0.308 Sum_probs=202.0
Q ss_pred hhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCc--C--H--------------HHHHHHHHHhhccCcceeeeeee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQ--G--K--------------KEFRAEVSIIGSIHHLHLVKLRG 554 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~--~--~--------------~~~~~Ev~~l~~l~h~niv~l~~ 554 (817)
.+.+.++||+|+||.||++.. +++.||||++..... . . +.+.+|+.++.+++||||+++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 110 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred ceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 455678899999999999999 999999999864311 1 1 88999999999999999999999
Q ss_pred EeecCCeeeEEEeeccCCChhhh------hhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC
Q 036583 555 FCAEGTHRLLAYEFMANGSLDKW------IFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD 628 (817)
Q Consensus 555 ~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~ 628 (817)
++.+.+..++||||+++++|.++ +.... ...+++..++.++.||+.||+|||+ ..+|+||||||+||+++.
T Consensus 111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDK 187 (348)
T ss_dssp EEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEECT
T ss_pred EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEcC
Confidence 99999999999999999999998 54421 2368999999999999999999996 379999999999999999
Q ss_pred CCcEEEeecCCccccCCCCceeeeeccCCCCccCccccccC-ccCc-cccccchhhhHHHhhhCCCCCCCCCCCCCCcch
Q 036583 629 NYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNY-AISE-KSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFP 706 (817)
Q Consensus 629 ~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~ 706 (817)
++.+||+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||......
T Consensus 188 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------ 258 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL------ 258 (348)
T ss_dssp TSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS------
T ss_pred CCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH------
Confidence 999999999999876443 23446789999999999877 6666 999999999999999999999754321
Q ss_pred HHHHHHhhhcchhhhccccc-------C---CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 707 SYAFKMMEEGKLRNILDSRL-------N---IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 707 ~~~~~~~~~~~~~~~~d~~~-------~---~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
......+..+... ...... . ..........+.+++.+||+.||.+|||++|+++
T Consensus 259 ~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 VELFNNIRTKNIE-YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHHHTSCCCC-CCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhccCcC-CccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1122222222111 000000 0 0000122356889999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=329.94 Aligned_cols=254 Identities=26% Similarity=0.366 Sum_probs=196.1
Q ss_pred hhccccccCCCcceeEEEEEcCCCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
.+.+.+.||+|+||.||+|+..+ .+|+|++... ....+.+.+|+.++.+++||||+++++++.+....++||||+
T Consensus 34 ~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~ 111 (319)
T 2y4i_B 34 QLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLC 111 (319)
T ss_dssp CEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCC
T ss_pred HeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecc
Confidence 45566889999999999998744 4999998643 233467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc-
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS- 648 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~- 648 (817)
++++|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+||+++ ++.+||+|||+++.......
T Consensus 112 ~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 112 KGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp CSEEHHHHTTSSCC--CCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred cCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 99999999976432 58899999999999999999999 8999999999999998 67999999999876532111
Q ss_pred ---eeeeeccCCCCccCcccccc---------CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhc
Q 036583 649 ---HVFTTLRGTRGYLAPEWITN---------YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEG 716 (817)
Q Consensus 649 ---~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 716 (817)
.......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+..+
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~ 258 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-------EAIIWQMGTG 258 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH-------HHHHHHHHTT
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHhccC
Confidence 11223568899999999874 3578899999999999999999999964321 1112222222
Q ss_pred chhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCC
Q 036583 717 KLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPV 769 (817)
Q Consensus 717 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 769 (817)
....... ......+.+++..||+.||++|||++|++++|+.+...
T Consensus 259 ~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 259 MKPNLSQ--------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp CCCCCCC--------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred CCCCCCc--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 1111111 01123578999999999999999999999999987543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.42 Aligned_cols=263 Identities=22% Similarity=0.273 Sum_probs=193.3
Q ss_pred hhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCC------eeeEEE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT------HRLLAY 566 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~------~~~lv~ 566 (817)
.+.+.++||+|+||+||+++...+..+|+|++..... ...+|+++++.++||||+++++++.... ..++||
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 4566788999999999999987777899999864322 2246999999999999999999995433 378999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec-CCCcEEEeecCCccccCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD-DNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~ki~Dfgla~~~~~ 645 (817)
||++++.+............+++..+..++.||++||+|||+ .+|+||||||+|||++ .++.+||+|||+++....
T Consensus 118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 999986544433322223368899999999999999999999 8999999999999999 799999999999987644
Q ss_pred CCceeeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchh-----
Q 036583 646 EQSHVFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLR----- 719 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----- 719 (817)
... .....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||......+. .......+......
T Consensus 195 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 195 GEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ---LVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp TCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHHHH
T ss_pred CCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHHhh
Confidence 322 2345789999999998764 589999999999999999999999975432110 00011100000000
Q ss_pred --hhccc---ccCC-c----ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcC
Q 036583 720 --NILDS---RLNI-D----EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM--LEGI 766 (817)
Q Consensus 720 --~~~d~---~~~~-~----~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~--L~~~ 766 (817)
..... .... + ........+.+++.+||+.||.+|||+.|+++. ++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 00000 0000 0 001123478899999999999999999999974 4444
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=318.55 Aligned_cols=248 Identities=23% Similarity=0.355 Sum_probs=200.1
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC----------cCHHHHHHHHHHhhccC-cceeeeeeeEeecCC
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----------QGKKEFRAEVSIIGSIH-HLHLVKLRGFCAEGT 560 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----------~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~ 560 (817)
.+.+.++||+|+||.||++... +++.||||++.... ...+.+.+|++++.+++ ||||+++++++.+..
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (298)
T 1phk_A 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97 (298)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence 4556688999999999999964 68899999996542 11356789999999995 999999999999999
Q ss_pred eeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCc
Q 036583 561 HRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLA 640 (817)
Q Consensus 561 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 640 (817)
..++||||+++++|.+++.... .+++..+..++.||+.||+|||+ .+|+|+||||+||+++.++.+||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 98 FFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccch
Confidence 9999999999999999997643 58899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCceeeeeccCCCCccCccccc------cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhh
Q 036583 641 KLMTREQSHVFTTLRGTRGYLAPEWIT------NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMME 714 (817)
Q Consensus 641 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 714 (817)
........ .....+++.|+|||.+. ...++.++||||||++++||++|+.||..... ......+.
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~ 242 (298)
T 1phk_A 172 CQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-------MLMLRMIM 242 (298)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHH
T ss_pred hhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-------HHHHHHHh
Confidence 87654322 23457899999999985 44678899999999999999999999964321 11122222
Q ss_pred hcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 715 EGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 715 ~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.+... ...+........+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 243 SGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cCCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 22111 011111223456889999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=328.71 Aligned_cols=258 Identities=24% Similarity=0.292 Sum_probs=187.9
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecCC------ee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT------HR 562 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~------~~ 562 (817)
.+.+.++||+|+||.||++.. .+++.||||++..... ..+.+.+|+.+++.++||||+++++++.... ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 105 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence 455668899999999999985 4688999999975432 2457889999999999999999999997654 78
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
++||||+++ +|.+++.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 106 YIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred EEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 999999985 78887742 47888999999999999999999 8999999999999999999999999999986
Q ss_pred cCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCC---------CcchHH-----
Q 036583 643 MTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDK---------AHFPSY----- 708 (817)
Q Consensus 643 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~---------~~~~~~----- 708 (817)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+..
T Consensus 177 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 177 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred ccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 54322 22346789999999999999999999999999999999999999975432100 000000
Q ss_pred --HHHHhhhc------chhhhccccc-C--CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 709 --AFKMMEEG------KLRNILDSRL-N--IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 709 --~~~~~~~~------~~~~~~d~~~-~--~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
........ .......... . ..........+.+++.+||+.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00000000 0000000000 0 0011223567899999999999999999999998
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=316.76 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=204.0
Q ss_pred HHHHHHhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCee
Q 036583 487 RDLQTATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHR 562 (817)
Q Consensus 487 ~~l~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~ 562 (817)
+......+.+.++||+|+||.||+++.. +++.||||++... ....+.+.+|++++++++||||+++++++.+....
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 4445567888899999999999999965 6889999998643 34567899999999999999999999999999999
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCC---CcEEEeecCC
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDN---YHAKVSDFGL 639 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~ki~Dfgl 639 (817)
++|+||+++++|.+++.... .+++..++.++.||+.||+|||+ .+|+|+||||+||+++.+ +.+||+|||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 99999999999999887654 58899999999999999999999 899999999999999754 4799999999
Q ss_pred ccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchh
Q 036583 640 AKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLR 719 (817)
Q Consensus 640 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (817)
+........ .....+++.|+|||.+.+ .++.++||||||+++|||++|+.||..... ......+..+...
T Consensus 171 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~ 240 (287)
T 2wei_A 171 STCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------YDILKRVETGKYA 240 (287)
T ss_dssp GGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCC
T ss_pred ceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCC
Confidence 987644321 123457889999999876 488999999999999999999999964321 1122222222211
Q ss_pred hhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 720 NILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 720 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
. ..+........+.+++.+|++.||++|||+.|+++
T Consensus 241 ~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 F------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp C------CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C------CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 00111122346889999999999999999999997
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=329.02 Aligned_cols=260 Identities=24% Similarity=0.320 Sum_probs=199.3
Q ss_pred HHhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhccC-----------cceeeeeeeEeec
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH-----------HLHLVKLRGFCAE 558 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~-----------h~niv~l~~~~~~ 558 (817)
...+.+.++||+|+||+||+++. .+++.||||++.......+.+.+|++++.+++ ||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 34567778999999999999995 57899999999765445677899999999886 8999999999976
Q ss_pred CC----eeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCC-ceeecCCCCCCeEec------
Q 036583 559 GT----HRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ-RIIHCDIKPENVLLD------ 627 (817)
Q Consensus 559 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~-~ivH~Dlk~~NIll~------ 627 (817)
.. ..++||||+ +++|.+++...... .+++..+..++.||+.||+|||+ . +|+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHR-GIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhcc-CCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCc
Confidence 54 789999999 88999999764322 58889999999999999999999 7 999999999999994
Q ss_pred CCCcEEEeecCCccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchH
Q 036583 628 DNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPS 707 (817)
Q Consensus 628 ~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~ 707 (817)
..+.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.............
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 4558999999999876433 233578999999999999999999999999999999999999997554322111111
Q ss_pred HHHHHhh-hcch--------------------------------hhhcccccCCcccHHHHHHHHHHHHhccccCCCCCC
Q 036583 708 YAFKMME-EGKL--------------------------------RNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRP 754 (817)
Q Consensus 708 ~~~~~~~-~~~~--------------------------------~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RP 754 (817)
....... .+.+ ...... ...........+.+++.+||+.||++||
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhccCccccC
Confidence 1111100 0000 000000 1122345667889999999999999999
Q ss_pred CHHHHHH
Q 036583 755 SMTKVVQ 761 (817)
Q Consensus 755 t~~evl~ 761 (817)
|++|+++
T Consensus 327 t~~ell~ 333 (373)
T 1q8y_A 327 DAGGLVN 333 (373)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999998
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=330.01 Aligned_cols=262 Identities=19% Similarity=0.213 Sum_probs=185.4
Q ss_pred HhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCe-------ee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTH-------RL 563 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~-------~~ 563 (817)
..+.+.++||+|+||+||+|+. .+++.||||++.........+.+|++.+..++||||+++++++..... .+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 102 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLN 102 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEE
Confidence 3455668999999999999996 468999999997665556677889999999999999999999965433 78
Q ss_pred EEEeeccCCChhhhhhh-cccccchhhhHHHHHHHHHHHHHHHHH--hcCCCceeecCCCCCCeEecC-CCcEEEeecCC
Q 036583 564 LAYEFMANGSLDKWIFK-KNQEFLLDWETRFNIALGTAKGLAYLH--EDCDQRIIHCDIKPENVLLDD-NYHAKVSDFGL 639 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~l~~LH--~~~~~~ivH~Dlk~~NIll~~-~~~~ki~Dfgl 639 (817)
+||||+++ +|...+.. ......+++..+..++.||+.||.||| + .+|+||||||+|||++. ++.+||+|||+
T Consensus 103 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 103 VVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred EEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 99999987 45444432 222336888899999999999999999 7 89999999999999996 89999999999
Q ss_pred ccccCCCCceeeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcc-
Q 036583 640 AKLMTREQSHVFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGK- 717 (817)
Q Consensus 640 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~- 717 (817)
++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .............
T Consensus 179 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 253 (360)
T 3e3p_A 179 AKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG---QLHEIVRVLGCPSR 253 (360)
T ss_dssp CBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCH
T ss_pred ceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH---HHHHHHHHcCCCCH
Confidence 987654332 2345789999999998754 48999999999999999999999997543211 0000000000000
Q ss_pred -hhhhcccc----------------cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 718 -LRNILDSR----------------LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 718 -~~~~~d~~----------------~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
....+++. ............+.+++.+||+.||.+|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000 0001111234578899999999999999999999973
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=326.25 Aligned_cols=265 Identities=22% Similarity=0.288 Sum_probs=191.6
Q ss_pred HHHHHHHh--hccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcC------------HHHHHHHHHHhhccCcceeee
Q 036583 486 YRDLQTAT--NNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQG------------KKEFRAEVSIIGSIHHLHLVK 551 (817)
Q Consensus 486 ~~~l~~~~--~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~------------~~~~~~Ev~~l~~l~h~niv~ 551 (817)
..++.... +.+.++||+|+||.||+|...+|+.||||++...... .+.+.+|++++.+++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 34444433 4445899999999999999888999999998543211 278999999999999999999
Q ss_pred eeeEeec-----CCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEe
Q 036583 552 LRGFCAE-----GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL 626 (817)
Q Consensus 552 l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll 626 (817)
+++++.. ....++||||++ |+|.+++..... .+++..+..++.||+.||.|||+ .+|+||||||+||++
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI--VISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEE
Confidence 9999843 336799999998 588888875432 58999999999999999999999 899999999999999
Q ss_pred cCCCcEEEeecCCccccCCCCceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcc
Q 036583 627 DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHF 705 (817)
Q Consensus 627 ~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~ 705 (817)
+.++.+||+|||+++...... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... .
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~ 242 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN---Q 242 (362)
T ss_dssp CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H
T ss_pred cCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH---H
Confidence 999999999999998544332 2234578899999999886 678999999999999999999999996543111 0
Q ss_pred hHHHHHHhhhcc-----------hhhhcccccCC-------cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 706 PSYAFKMMEEGK-----------LRNILDSRLNI-------DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 706 ~~~~~~~~~~~~-----------~~~~~d~~~~~-------~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
............ ....+...... .........+.+++.+||+.||++|||++|+++
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 000000000000 00000000000 000112346789999999999999999999997
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.03 Aligned_cols=258 Identities=21% Similarity=0.312 Sum_probs=196.4
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecC-----CeeeE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEG-----THRLL 564 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~-----~~~~l 564 (817)
.+.+.++||+|+||.||++.. .+++.||||++..... ..+.+.+|++++.+++||||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 456678899999999999985 4688999999975432 236789999999999999999999999654 36899
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
||||+++ +|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 108 v~e~~~~-~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 108 VQDLMET-DLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEECCSE-EHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEcccCc-CHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 9999985 899988653 48899999999999999999999 899999999999999999999999999998765
Q ss_pred CCCcee--eeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcch---
Q 036583 645 REQSHV--FTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKL--- 718 (817)
Q Consensus 645 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 718 (817)
...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .............
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQEDL 256 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHHHHHCSCCHHHH
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHHHhCCCCHHHH
Confidence 432211 234579999999998764 4589999999999999999999999975432221 1111110000000
Q ss_pred --------hhhccccc-CCccc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 719 --------RNILDSRL-NIDEQ-----SDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 719 --------~~~~d~~~-~~~~~-----~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
........ ..... ......+.+++.+||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 00000 112346789999999999999999999997
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=339.06 Aligned_cols=256 Identities=24% Similarity=0.288 Sum_probs=189.0
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecC------CeeeEEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG------THRLLAY 566 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 566 (817)
+.+.++||+|+||.||+|+.. +|+.||||++.... +.+.+|++++++++||||+++++++... ...++||
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 455678999999999999974 58999999986532 2235799999999999999999998532 2367999
Q ss_pred eeccCCChhhhhhhc-ccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCC-CcEEEeecCCccccC
Q 036583 567 EFMANGSLDKWIFKK-NQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDN-YHAKVSDFGLAKLMT 644 (817)
Q Consensus 567 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~Dfgla~~~~ 644 (817)
||+++ +|.+.+... .....+++..+..++.||++||+|||+ .+|+||||||+||||+.+ +.+||+|||+++...
T Consensus 133 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp ECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred hcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99987 566655431 122368899999999999999999998 999999999999999954 678999999998764
Q ss_pred CCCceeeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcc---h--
Q 036583 645 REQSHVFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGK---L-- 718 (817)
Q Consensus 645 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---~-- 718 (817)
.... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+. .....+.... +
T Consensus 209 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~-~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 209 RGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLV-EIIKVLGTPTREQIRE 283 (420)
T ss_dssp TTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH-HHHHHHCSCCHHHHHH
T ss_pred cCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHH-HHHHHhCCCCHHHHHh
Confidence 4322 2345789999999999764 78999999999999999999999997543211 000 0111100000 0
Q ss_pred -----hhhcccccCCc-----ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 719 -----RNILDSRLNID-----EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 719 -----~~~~d~~~~~~-----~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.+...+..... ........+.+|+.+||+.||.+|||+.|+++
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00000110000 01112357889999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=331.53 Aligned_cols=257 Identities=21% Similarity=0.267 Sum_probs=191.1
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeec-------------
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE------------- 558 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~------------- 558 (817)
.+.+.++||+|+||+||+++. .+|+.||||++..... ...+|+++++.++||||+++++++..
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~ 84 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence 455678999999999999985 5789999999865422 23479999999999999999999843
Q ss_pred -------------------------CCeeeEEEeeccCCChhhhhhhc-ccccchhhhHHHHHHHHHHHHHHHHHhcCCC
Q 036583 559 -------------------------GTHRLLAYEFMANGSLDKWIFKK-NQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612 (817)
Q Consensus 559 -------------------------~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~ 612 (817)
....++||||+++ +|.+.+... .....+++..+..++.||++||+|||+ .
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~ 160 (383)
T 3eb0_A 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---L 160 (383)
T ss_dssp -------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---C
Confidence 3347899999985 888777642 122368999999999999999999998 9
Q ss_pred ceeecCCCCCCeEec-CCCcEEEeecCCccccCCCCceeeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhC
Q 036583 613 RIIHCDIKPENVLLD-DNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGG 690 (817)
Q Consensus 613 ~ivH~Dlk~~NIll~-~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg 690 (817)
+|+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++||||+||++|||++|
T Consensus 161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 238 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238 (383)
T ss_dssp TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhC
Confidence 999999999999998 689999999999987644332 2345789999999998865 589999999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHHHHHhhhcchhh----------hcccccCCc-----ccHHHHHHHHHHHHhccccCCCCCCC
Q 036583 691 RKNFDPNETSDKAHFPSYAFKMMEEGKLRN----------ILDSRLNID-----EQSDRVFTAVKVALWCVQEDMSLRPS 755 (817)
Q Consensus 691 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~d~~~~~~-----~~~~~~~~~~~l~~~cl~~dp~~RPt 755 (817)
+.||......+. ............... ..-+..... ........+.+++.+||+.||++|||
T Consensus 239 ~~pf~~~~~~~~---~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (383)
T 3eb0_A 239 KPLFSGETSIDQ---LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN 315 (383)
T ss_dssp SCSSCCSSHHHH---HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred CCCCCCCChHHH---HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence 999975432110 000111000000000 000000000 11112346889999999999999999
Q ss_pred HHHHHH
Q 036583 756 MTKVVQ 761 (817)
Q Consensus 756 ~~evl~ 761 (817)
+.|+++
T Consensus 316 ~~e~l~ 321 (383)
T 3eb0_A 316 PYEAMA 321 (383)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=329.22 Aligned_cols=264 Identities=22% Similarity=0.341 Sum_probs=200.4
Q ss_pred HHHHhhccccccCCCcceeEEEEEcC-CC-cEEEEEEeccCCcCHHHHHHHHHHhhccCcce------eeeeeeEeecCC
Q 036583 489 LQTATNNFSVKLGQGGFGSVYQGVLP-DG-TRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLH------LVKLRGFCAEGT 560 (817)
Q Consensus 489 l~~~~~~~~~~lG~G~fG~Vy~g~~~-~g-~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~n------iv~l~~~~~~~~ 560 (817)
.....+.+.++||+|+||+||++... ++ +.||||++.......+.+.+|+.++.+++|++ ++.+++++....
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 33456777889999999999999853 34 68999999765555678899999999998877 999999999999
Q ss_pred eeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEe--------------
Q 036583 561 HRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLL-------------- 626 (817)
Q Consensus 561 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll-------------- 626 (817)
..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eEEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccc
Confidence 999999999 5677777765432 258899999999999999999998 899999999999999
Q ss_pred -----cCCCcEEEeecCCccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCC
Q 036583 627 -----DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSD 701 (817)
Q Consensus 627 -----~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~ 701 (817)
+.++.+||+|||+++...... ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 668899999999998654322 34578999999999999999999999999999999999999997543211
Q ss_pred CC--------cchHHHHHHhhhcch------------------hhhccc-ccCCcccHHHHHHHHHHHHhccccCCCCCC
Q 036583 702 KA--------HFPSYAFKMMEEGKL------------------RNILDS-RLNIDEQSDRVFTAVKVALWCVQEDMSLRP 754 (817)
Q Consensus 702 ~~--------~~~~~~~~~~~~~~~------------------~~~~d~-~~~~~~~~~~~~~~~~l~~~cl~~dp~~RP 754 (817)
.. ..+............ .....+ .............+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 00 000000000000000 000000 000011223455788999999999999999
Q ss_pred CHHHHHH
Q 036583 755 SMTKVVQ 761 (817)
Q Consensus 755 t~~evl~ 761 (817)
|++|+++
T Consensus 327 t~~e~l~ 333 (355)
T 2eu9_A 327 TLAEALL 333 (355)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=326.10 Aligned_cols=255 Identities=24% Similarity=0.335 Sum_probs=178.7
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecC------Cee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEG------THR 562 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~------~~~ 562 (817)
.+.+.+.||+|+||.||+|.. .+|+.||||++..... ..+.+.+|+++++.++||||+++++++... ...
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 109 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109 (367)
T ss_dssp TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence 455668899999999999984 5689999999965432 346788999999999999999999998654 567
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
++|+|++ +++|.+++... .+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 110 ~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 110 YLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp EEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred EEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 9999999 67999988652 58899999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhh------
Q 036583 643 MTREQSHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEE------ 715 (817)
Q Consensus 643 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~------ 715 (817)
.... .....||+.|+|||++.+ ..++.++|||||||+++||++|+.||....... ........+..
T Consensus 182 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 182 TADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPGAELL 254 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHH
T ss_pred cccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHH
Confidence 5432 234678999999999987 678999999999999999999999996543211 00001110000
Q ss_pred -----cchhhhcccccCC-cccH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 716 -----GKLRNILDSRLNI-DEQS-----DRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 716 -----~~~~~~~d~~~~~-~~~~-----~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
......+...... .... .....+.+|+.+||+.||++|||++|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000010000000 0000 113467899999999999999999999973
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=329.50 Aligned_cols=199 Identities=23% Similarity=0.346 Sum_probs=169.4
Q ss_pred HhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhccC-cc-----eeeeeeeEeecCCeeeE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH-HL-----HLVKLRGFCAEGTHRLL 564 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~-h~-----niv~l~~~~~~~~~~~l 564 (817)
..+.+.++||+|+||+||+|+.. +++.||||++.......+++..|+.++..++ |+ +|+++++++...+..++
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 133 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 133 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence 45666789999999999999854 6889999999765444567888999988885 44 49999999999999999
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec--CCCcEEEeecCCccc
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD--DNYHAKVSDFGLAKL 642 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~ki~Dfgla~~ 642 (817)
||||+++ +|.+++...... .+++..+..++.||+.||.|||.+ ..+|+||||||+|||++ .++.+||+|||+++.
T Consensus 134 v~e~~~~-~L~~~l~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 134 VFEMLSY-NLYDLLRNTNFR-GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEECCCC-BHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEecCCC-CHHHHHhhcCcC-CCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 9999965 999999765422 588999999999999999999941 27899999999999994 578899999999987
Q ss_pred cCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCC
Q 036583 643 MTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPN 697 (817)
Q Consensus 643 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~ 697 (817)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 211 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 211 LGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 6432 23467899999999999999999999999999999999999999754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.04 Aligned_cols=255 Identities=22% Similarity=0.274 Sum_probs=187.8
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEee-------------
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCA------------- 557 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~------------- 557 (817)
.+.+.++||+|+||.||+|... +++.||||++.... ...+++.+|++++++++||||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 3455688999999999999975 48899999987543 33567899999999999999999999873
Q ss_pred -cCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec-CCCcEEEe
Q 036583 558 -EGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD-DNYHAKVS 635 (817)
Q Consensus 558 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~ki~ 635 (817)
+....++||||++ |+|.+++... .+++..++.++.||+.||+|||+ .+|+||||||+||+++ +++.+||+
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEc
Confidence 4467899999998 5999998643 47889999999999999999999 8999999999999997 57799999
Q ss_pred ecCCccccCCCCce--eeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHH
Q 036583 636 DFGLAKLMTREQSH--VFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKM 712 (817)
Q Consensus 636 Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 712 (817)
|||+++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------~~~~~ 237 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE------QMQLI 237 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH------HHHHH
Confidence 99999876432211 1233567899999998865 678999999999999999999999997543211 11111
Q ss_pred hhhcc-------------hhhhcccccCCc-c-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 713 MEEGK-------------LRNILDSRLNID-E-----QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 713 ~~~~~-------------~~~~~d~~~~~~-~-----~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..... +...+....... . .......+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 10000 000000000000 0 0112456889999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=333.24 Aligned_cols=247 Identities=23% Similarity=0.307 Sum_probs=184.9
Q ss_pred ccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEeeccCCChh
Q 036583 497 SVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFMANGSLD 575 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 575 (817)
.+.||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +||||+++++++.++...++||||+. |+|.
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~ 96 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ 96 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence 4679999999998766668999999998643 345678999999876 89999999999999999999999996 5999
Q ss_pred hhhhhccccc----chhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCC-------------CcEEEeecC
Q 036583 576 KWIFKKNQEF----LLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDN-------------YHAKVSDFG 638 (817)
Q Consensus 576 ~~l~~~~~~~----~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-------------~~~ki~Dfg 638 (817)
+++....... ...+..++.++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG 173 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence 9997643210 12344567899999999999999 899999999999999754 489999999
Q ss_pred CccccCCCCce---eeeeccCCCCccCcccccc-------CccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchH
Q 036583 639 LAKLMTREQSH---VFTTLRGTRGYLAPEWITN-------YAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPS 707 (817)
Q Consensus 639 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~ 707 (817)
+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~------ 247 (434)
T 2rio_A 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE------ 247 (434)
T ss_dssp TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH------
T ss_pred cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH------
Confidence 99987553322 1234679999999999975 578899999999999999999 999996432110
Q ss_pred HHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 708 YAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 708 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..+..+... .+.............+.+++.+||+.||.+|||+.||++
T Consensus 248 ---~~i~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 ---SNIIRGIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---HHHHHTCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHhcCCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 011111100 011111123345567899999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=323.85 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=191.7
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcC---HHHHHHHHHHhhccCcceeeeeeeEeecCCee------
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQG---KKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHR------ 562 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~---~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~------ 562 (817)
.+.+.++||+|+||+||+|.. .+|+.||||++...... .+.+.+|+.+++.++||||+++++++......
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 445567899999999999985 46899999999764332 46788999999999999999999999877655
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
++||||+. ++|.+++.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 123 ~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp EEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred EEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999998 588887732 48889999999999999999999 8999999999999999999999999999986
Q ss_pred cCCCCceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhh-c----
Q 036583 643 MTREQSHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEE-G---- 716 (817)
Q Consensus 643 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~---- 716 (817)
.... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ......... +
T Consensus 194 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 194 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL------DQLTQILKVTGVPGT 263 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHCCCCH
T ss_pred cccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHHHhCCCcH
Confidence 5432 234678999999999987 68899999999999999999999999754311 111111100 0
Q ss_pred ---------chhhhccc---ccCCcc---cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 717 ---------KLRNILDS---RLNIDE---QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 717 ---------~~~~~~d~---~~~~~~---~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
........ ...... .......+.+++.+||+.||++|||++|+++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000 000000 01123568899999999999999999999873
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.47 Aligned_cols=259 Identities=21% Similarity=0.320 Sum_probs=196.1
Q ss_pred hhccccccCCCcceeEEEEEc--CCCcEEEEEEeccCC---cCHHHHHHHHHHhhcc---CcceeeeeeeEee-----cC
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL--PDGTRLAVKKLEGIG---QGKKEFRAEVSIIGSI---HHLHLVKLRGFCA-----EG 559 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~--~~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l---~h~niv~l~~~~~-----~~ 559 (817)
.+.+.++||+|+||.||+++. .+++.||||++.... .....+.+|+.+++.+ +||||+++++++. ..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 91 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 91 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence 355668899999999999996 468899999986432 2234677888887776 8999999999997 56
Q ss_pred CeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCC
Q 036583 560 THRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGL 639 (817)
Q Consensus 560 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl 639 (817)
...++||||++ |+|.+++...... .+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 92 TKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp EEEEEEEECCS-CBHHHHHHHSCTT-CSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred ceEEEEEecCC-CCHHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 67899999998 5999999765432 48899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchh
Q 036583 640 AKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLR 719 (817)
Q Consensus 640 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (817)
++...... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ...............
T Consensus 167 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 167 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEE 241 (326)
T ss_dssp CCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCGG
T ss_pred cccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCCCcc
Confidence 98764332 1234678999999999999899999999999999999999999997543211 000011100000000
Q ss_pred hh----------cccccC---CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 720 NI----------LDSRLN---IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 720 ~~----------~d~~~~---~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.. ...... ..........+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 000000 0001122346789999999999999999999996
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=319.30 Aligned_cols=263 Identities=22% Similarity=0.299 Sum_probs=195.8
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecC-----CeeeE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEG-----THRLL 564 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~-----~~~~l 564 (817)
.+.+.+.||+|+||.||+|+.. +|+.||||++..... ....+.+|++++.+++||||+++++++... ...++
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 91 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence 3456688999999999999964 688999999965432 245788999999999999999999998754 67899
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
||||+. ++|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 92 IQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 999998 5899988653 58899999999999999999999 899999999999999999999999999998765
Q ss_pred CCCce---------eeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhh
Q 036583 645 REQSH---------VFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMME 714 (817)
Q Consensus 645 ~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 714 (817)
..... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~ 240 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFGIIG 240 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhC
Confidence 32211 1123468999999998764 678999999999999999999999997543110 0000000000
Q ss_pred h------------cchhhhcccccCCc-c-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcC
Q 036583 715 E------------GKLRNILDSRLNID-E-----QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ--MLEGI 766 (817)
Q Consensus 715 ~------------~~~~~~~d~~~~~~-~-----~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~--~L~~~ 766 (817)
. ....+.+....... . .......+.+++.+||+.||++|||++|+++ .++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 0 00000000000000 0 0122346789999999999999999999998 34443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=320.55 Aligned_cols=255 Identities=22% Similarity=0.246 Sum_probs=172.4
Q ss_pred hhccc-cccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeec----CCeeeEEE
Q 036583 493 TNNFS-VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE----GTHRLLAY 566 (817)
Q Consensus 493 ~~~~~-~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 566 (817)
.+.+. +.||+|+||+||+++.. +++.||||++.... +...+....+..++||||+++++++.. +...++||
T Consensus 29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 105 (336)
T 3fhr_A 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence 34453 45999999999999965 68999999996532 222223334566799999999999976 44589999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC---CCcEEEeecCCcccc
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD---NYHAKVSDFGLAKLM 643 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~Dfgla~~~ 643 (817)
||+++|+|.+++..... ..+++..++.++.||+.||.|||+ .+|+||||||+||+++. ++.+||+|||+++..
T Consensus 106 e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 106 ECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp ECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred eccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 99999999999976542 268999999999999999999999 89999999999999986 455999999999865
Q ss_pred CCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
.... .....+|+.|+|||.+.+..++.++||||||+++|||++|+.||......... .........+.
T Consensus 182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~------ 249 (336)
T 3fhr_A 182 TQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS---PGMKRRIRLGQ------ 249 (336)
T ss_dssp -------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------------
T ss_pred cccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh---hhHHHhhhccc------
Confidence 4322 23457899999999999889999999999999999999999999654322110 00000000000
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcC
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ--MLEGI 766 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~--~L~~~ 766 (817)
.....+........+.+++.+||+.||.+|||++|+++ .+.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 250 YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp -CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 00011111123446889999999999999999999998 44443
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=321.79 Aligned_cols=238 Identities=25% Similarity=0.416 Sum_probs=195.7
Q ss_pred HhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc-------CHHHHHHHHHHhhccC--cceeeeeeeEeecCCe
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ-------GKKEFRAEVSIIGSIH--HLHLVKLRGFCAEGTH 561 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~-------~~~~~~~Ev~~l~~l~--h~niv~l~~~~~~~~~ 561 (817)
..+.+.++||+|+||.||+|+. .+++.||||++..... ..+.+.+|+.++.+++ |+||+++++++.+.+.
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~ 122 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence 4466678999999999999984 5688999999965421 2356788999999996 5999999999999999
Q ss_pred eeEEEeeccC-CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec-CCCcEEEeecCC
Q 036583 562 RLLAYEFMAN-GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD-DNYHAKVSDFGL 639 (817)
Q Consensus 562 ~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~ki~Dfgl 639 (817)
.++|+|++.+ ++|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+|||++ +++.+||+|||+
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 9999999986 89999997644 58899999999999999999999 8999999999999999 789999999999
Q ss_pred ccccCCCCceeeeeccCCCCccCccccccCcc-CccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcch
Q 036583 640 AKLMTREQSHVFTTLRGTRGYLAPEWITNYAI-SEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKL 718 (817)
Q Consensus 640 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 718 (817)
++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... ....+.
T Consensus 197 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------------~~~~~~- 259 (320)
T 3a99_A 197 GALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIRGQ- 259 (320)
T ss_dssp CEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHHCC-
T ss_pred cccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------------hhhccc-
Confidence 98765432 234578999999999987666 678999999999999999999995321 011110
Q ss_pred hhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 719 RNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 719 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
... .......+.+++.+||+.||++|||++|+++
T Consensus 260 -------~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 260 -------VFF--RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -------CCC--SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------ccc--cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 0112246789999999999999999999988
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.26 Aligned_cols=242 Identities=25% Similarity=0.395 Sum_probs=190.3
Q ss_pred HHHHHhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc-------CHHHHHHHHHHhhcc----CcceeeeeeeE
Q 036583 488 DLQTATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ-------GKKEFRAEVSIIGSI----HHLHLVKLRGF 555 (817)
Q Consensus 488 ~l~~~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~-------~~~~~~~Ev~~l~~l----~h~niv~l~~~ 555 (817)
+.....+.+.++||+|+||.||+|+. .+++.||||++..... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34456677889999999999999985 4688999999965421 223456799999988 89999999999
Q ss_pred eecCCeeeEEEee-ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec-CCCcEE
Q 036583 556 CAEGTHRLLAYEF-MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD-DNYHAK 633 (817)
Q Consensus 556 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~k 633 (817)
+.+.+..++|+|| +.+++|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+||+++ +++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 78999999997654 58999999999999999999999 8999999999999999 899999
Q ss_pred EeecCCccccCCCCceeeeeccCCCCccCccccccCccC-ccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHH
Q 036583 634 VSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAIS-EKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKM 712 (817)
Q Consensus 634 i~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 712 (817)
|+|||++....... .....|+..|+|||++.+..+. .++||||||+++|||++|+.||.... .
T Consensus 181 l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------------~ 244 (312)
T 2iwi_A 181 LIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------------E 244 (312)
T ss_dssp ECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------H
T ss_pred EEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------------H
Confidence 99999998765432 2345789999999999876664 58999999999999999999995321 0
Q ss_pred hhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 713 MEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 713 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
... ..... .......+.+++.+||+.||++|||++|+++
T Consensus 245 ~~~--------~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 ILE--------AELHF--PAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHH--------TCCCC--CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred Hhh--------hccCC--cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011 11111 1112346789999999999999999999998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=320.43 Aligned_cols=251 Identities=27% Similarity=0.379 Sum_probs=174.3
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc--CHHHHHHHHH-HhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ--GKKEFRAEVS-IIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~Ev~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
+.+.++||+|+||.||++... +|+.||||++..... ...++..|+. +++.++||||+++++++.+.+..++||||+
T Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~ 103 (327)
T 3aln_A 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM 103 (327)
T ss_dssp EEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeec
Confidence 445578999999999999964 688999999975432 2345666665 778889999999999999999999999999
Q ss_pred cCCChhhhhhhc--ccccchhhhHHHHHHHHHHHHHHHHHhcCCC-ceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 570 ANGSLDKWIFKK--NQEFLLDWETRFNIALGTAKGLAYLHEDCDQ-RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 570 ~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~-~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
++ +|.+++... .....+++..+..++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||+++.....
T Consensus 104 ~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 179 (327)
T 3aln_A 104 ST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179 (327)
T ss_dssp SE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred CC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence 86 888777531 112368899999999999999999999 7 9999999999999999999999999999876443
Q ss_pred CceeeeeccCCCCccCcccc----ccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 647 QSHVFTTLRGTRGYLAPEWI----TNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
.. .....|++.|+|||.+ .+..++.++||||||+++|||++|+.||.......... .....+..
T Consensus 180 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~~~~---- 247 (327)
T 3aln_A 180 IA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL------TQVVKGDP---- 247 (327)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCC----
T ss_pred cc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH------HHHhcCCC----
Confidence 21 2234789999999998 45678999999999999999999999996532211000 00000000
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+.+...........+.+++.+||+.||++|||+.|+++
T Consensus 248 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 -PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 01111111122346889999999999999999999976
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=328.97 Aligned_cols=246 Identities=23% Similarity=0.302 Sum_probs=184.1
Q ss_pred hccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEeeccCC
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFMANG 572 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 572 (817)
+.+.+.||+|+||+||.....+++.||||++.... ...+.+|++++.++ +||||+++++++.+....++||||++ |
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g 102 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A 102 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence 34457899999999665555589999999996432 23467899999999 79999999999999999999999997 5
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC-----CCcEEEeecCCccccCCCC
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD-----NYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~ki~Dfgla~~~~~~~ 647 (817)
+|.+++..... .+.+..++.++.||+.||+|||+ .+|+||||||+|||++. ...+||+|||+++......
T Consensus 103 ~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 103 TLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp EHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred CHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 99999976543 34556678899999999999999 89999999999999953 3468899999998765432
Q ss_pred c--eeeeeccCCCCccCccccc---cCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhh
Q 036583 648 S--HVFTTLRGTRGYLAPEWIT---NYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721 (817)
Q Consensus 648 ~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (817)
. .......||+.|+|||++. ...++.++|||||||++|||++ |+.||...... ........... .
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~~~~~~~~~~~-~- 248 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------QANILLGACSL-D- 248 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------HHHHHTTCCCC-T-
T ss_pred cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------HHHHHhccCCc-c-
Confidence 2 1223467999999999997 4567889999999999999999 99999533211 11111111000 0
Q ss_pred cccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 722 ~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
...........+.+++.+||+.||.+|||++||++
T Consensus 249 -----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 -----CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -----TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 01112233445789999999999999999999994
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=321.27 Aligned_cols=250 Identities=23% Similarity=0.337 Sum_probs=191.0
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcC---HHHHHHHHHHhhccCcceeeeeeeEeecCCe------e
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQG---KKEFRAEVSIIGSIHHLHLVKLRGFCAEGTH------R 562 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~---~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~------~ 562 (817)
.+.+.+.||+|+||.||+|.. .+|+.||||++...... .+.+.+|+.++++++||||+++++++..... .
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 355567899999999999986 46899999999754332 4578899999999999999999999987654 4
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
++||||++ ++|.+++.. .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 105 ~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp EEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 99999998 588887743 37889999999999999999999 8999999999999999999999999999986
Q ss_pred cCCCCceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhh-c----
Q 036583 643 MTREQSHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEE-G---- 716 (817)
Q Consensus 643 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~---- 716 (817)
.... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ......... +
T Consensus 176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL------DQLTQILKVTGVPGT 245 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH------HHHHHHHHHHCBCCH
T ss_pred CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCCCH
Confidence 5432 234578999999999886 67899999999999999999999999654321 111111000 0
Q ss_pred ---------chhhhcc---cccC---CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 717 ---------KLRNILD---SRLN---IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 717 ---------~~~~~~d---~~~~---~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.....+. .... ..........+.+++.+|++.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 0000 0011123457889999999999999999999987
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=303.78 Aligned_cols=222 Identities=18% Similarity=0.303 Sum_probs=156.1
Q ss_pred ccccCCccccceeeecCCCCEEEeCCCeeEEeeecCCCCCceEEEEEEecCCceEEEEcCCCCCCCC-----CCCcEEec
Q 036583 32 GKILPGFQGAQMTFIDKNGLFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVAN-----SDNFVFKK 106 (817)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~~~~lvs~~g~f~~gf~~~~~~~~~y~~i~~~~~~~t~vWvAnr~~Pi~~-----~~~~~~~~ 106 (817)
+.|.+|.+++ .|++|||++|+|+||||.++ ++|+ |+ +.+ +|||||||+|+.+ ++.+.|+.
T Consensus 15 ~~l~~g~~l~-------~~~~l~S~~g~F~lgf~~~~---~~~l---y~-~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~ 79 (276)
T 3m7h_A 15 SVLPAYQTLS-------AGQYLLSPNQRFKLLLQGDG---NLVI---QD-NGA-TVWVANEQQPFSSTIPLRNKKAPLAF 79 (276)
T ss_dssp SEECTTEEBC-------TTCEEECTTSSEEEEECTTS---CEEE---EE-TTE-EEEECSTTSTTEEEEECCCTTCCSEE
T ss_pred CEecCCCEec-------CCCEEEcCCCcEEEEEECCC---CeEE---EC-CCC-eEEECCCCCCcCCcccccceEEEEeC
Confidence 5555554433 38999999999999999543 5677 65 557 9999999999987 45678999
Q ss_pred CceEEE---ecCCeEEEEeCCCC------CceeEEEEecCCCEEEEccCCccccccccCCCcccccCCc----cCCCcee
Q 036583 107 DGEVSL---QKGGSVVWSVNPSG------ASVSAMELRDSGNLVLLGNDNKVLWQSFSHPTDTLISNQD----FTQGMKL 173 (817)
Q Consensus 107 ~g~l~l---~~~~~~vWstn~~~------~~~~~a~LldsGNLVL~~~~~~~lWQSFd~PtDTlLP~~~----l~~~~kl 173 (817)
||+|+| +++|++||+||.+. ..++.|+|+|+|||||+| +.+|||| |||||+||+|+ +..|++|
T Consensus 80 ~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg~~~~~~l~~g~~L 155 (276)
T 3m7h_A 80 YVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPGAIDSLLLAPGSEL 155 (276)
T ss_dssp EESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCSCTTCEEECSSEEE
T ss_pred CCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--ccccccccccccccccccCccc
Confidence 999876 45788999999764 245689999999999998 7899999 99999999999 7889988
Q ss_pred ec--CCCCCCccEEEEEecCceEEecCCCCCCcccccCccccccccCCCcceeeeccCCCeeeeecCCcceEEEEEEecC
Q 036583 174 VS--APSTNNLSYVLEIKSGDVVLSAGFPTPQPYWSMGREERKTINKGGGEVTSASLSANSWRFYDNNKIFLWQFIFSDN 251 (817)
Q Consensus 174 ~s--~~s~g~~s~~~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~ 251 (817)
.+ +|++|+|++.++. +++.+++.. ...+||+++.+... ....... ....+.+.+..+...+ ++....
T Consensus 156 ~S~~dps~G~fsl~l~~-dGnlvLy~~--~~~~yW~Sgt~~~~-----~~~l~l~--~dGnLvl~d~~~~~vW-sS~t~~ 224 (276)
T 3m7h_A 156 VQGVVYGAGASKLVFQG-DGNLVAYGP--NGAATWNAGTQGKG-----AVRAVFQ--GDGNLVVYGAGNAVLW-HSHTGG 224 (276)
T ss_dssp CTTCEEEETTEEEEECT-TSCEEEECT--TSSEEEECCCTTTT-----CCEEEEC--TTSCEEEECTTSCEEE-ECSCTT
T ss_pred ccCCCCCCceEEEeecC-CceEEEEeC--CCeEEEECCCCCCc-----cEEEEEc--CCCeEEEEeCCCcEEE-EecCCC
Confidence 55 5666776666642 345556532 25789998876421 1111111 1112334444332222 112211
Q ss_pred CCcceEEEEEECCCceEEEEEccCCCCCceeeccccCC
Q 036583 252 TDGNATWIAVLANDGFISFYNLQDGEPSTASNTKIPNS 289 (817)
Q Consensus 252 ~~~~~~~~~~l~~~g~l~~~~~~~~~~~w~~~~~~p~~ 289 (817)
. . .++++|+.||++++|.| ...|..++.+|+.
T Consensus 225 -~-~-~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~~ 256 (276)
T 3m7h_A 225 -H-A-SAVLRLQANGSIAILDE---KPVWARFGFQPTY 256 (276)
T ss_dssp -C-T-TCEEEECTTSCEEEEEE---EEEEESSSCCTTS
T ss_pred -C-C-CEEEEEcCCccEEEEcC---CCeEEccCccCCc
Confidence 1 1 25699999999999998 3468888877754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=314.60 Aligned_cols=248 Identities=22% Similarity=0.307 Sum_probs=175.5
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcC---HHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQG---KKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~---~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
.+.+.++||+|+||.||+++.. +|+.||||++...... .+.+.++..++..++||||+++++++.+.+..++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 105 (318)
T 2dyl_A 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105 (318)
T ss_dssp GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Confidence 3455678999999999999964 6899999999754322 23344555678888999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCC-ceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ-RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~-~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
+ ++.+..+..... ..+++..+..++.||+.||.|||+ . +|+|+||||+||+++.++.+||+|||++.......
T Consensus 106 ~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 106 M-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp C-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred c-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 9 445555444322 258899999999999999999998 5 89999999999999999999999999997664432
Q ss_pred ceeeeeccCCCCccCccccc-----cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 648 SHVFTTLRGTRGYLAPEWIT-----NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
. .....+++.|+|||.+. ...++.++||||||+++|||++|+.||...... .........+....
T Consensus 180 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~-- 249 (318)
T 2dyl_A 180 A--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD------FEVLTKVLQEEPPL-- 249 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHHHHHSCCCC--
T ss_pred c--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc------HHHHHHHhccCCCC--
Confidence 1 23457899999999994 456788999999999999999999999643211 11111111111110
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.+........+.+++.+||+.||.+||+++|+++
T Consensus 250 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 250 -----LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -----CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -----CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0111112346789999999999999999999987
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=342.05 Aligned_cols=262 Identities=24% Similarity=0.314 Sum_probs=196.3
Q ss_pred HhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeec------CCee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAE------GTHR 562 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~------~~~~ 562 (817)
..+.+.++||+|+||+||++.. .+|+.||||++.... ...+.+.+|++++.+++||||+++++++.. +...
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 4577788999999999999996 458899999987542 235678999999999999999999999765 6778
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCc---EEEeecCC
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYH---AKVSDFGL 639 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~ki~Dfgl 639 (817)
++||||+++|+|.+++........+++..++.++.||+.||+|||+ .+|+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 9999999999999999876544468999999999999999999999 89999999999999997664 99999999
Q ss_pred ccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCC--cchHHHHHH-hhhc
Q 036583 640 AKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA--HFPSYAFKM-MEEG 716 (817)
Q Consensus 640 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~--~~~~~~~~~-~~~~ 716 (817)
+........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ......... ....
T Consensus 171 a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 171 AKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred ccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 987654332 23467899999999999999999999999999999999999999653210000 000000000 0000
Q ss_pred chhhh--ccccc--CCcccHHHHHHHHHHHHhccccCCCCCCCHHH
Q 036583 717 KLRNI--LDSRL--NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTK 758 (817)
Q Consensus 717 ~~~~~--~d~~~--~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~e 758 (817)
..... ....+ ...........+.+++.+|++.||++|||++|
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 00000 00000 11122235567899999999999999999977
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=301.35 Aligned_cols=231 Identities=13% Similarity=0.067 Sum_probs=181.9
Q ss_pred HHHHhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcC----HHHHHHHHHHhhccCcceeeeeeeEeecCCeee
Q 036583 489 LQTATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQG----KKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 489 l~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~----~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 563 (817)
+....+.+.++||+|+||.||+|+.. .++.||||++...... .+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 33455777789999999999999965 4899999999765332 367999999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+||||+++++|.+++... ....++.+++.||+.||+|||+ .+|+||||||+|||++.++.+||++++
T Consensus 108 lv~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 999999999999999542 2344678899999999999999 899999999999999999999997433
Q ss_pred CCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
|++| ++.++|||||||++|||++|+.||........... ....+.
T Consensus 175 ----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~------------~~~~~~ 219 (286)
T 3uqc_A 175 ----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP------------AERDTA 219 (286)
T ss_dssp ----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE------------CCBCTT
T ss_pred ----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH------------HHHHhc
Confidence 4443 68899999999999999999999976543221100 000000
Q ss_pred cccCC--cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 724 SRLNI--DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 724 ~~~~~--~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
..... .........+.+++.+||+.||++| |+.|+++.|+.+..
T Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 00000 0001123468899999999999999 99999999988643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=340.41 Aligned_cols=237 Identities=20% Similarity=0.283 Sum_probs=190.6
Q ss_pred HhhccccccCCCcceeEEEEEcC--CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCe-----e
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP--DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTH-----R 562 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~--~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~-----~ 562 (817)
..+.+.++||+|+||+||++... +++.||||++.... ...+.+.+|+.++.+++||||+++++++.+.+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 45667789999999999999964 58899999986542 234578999999999999999999999987665 6
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
+|||||+++++|.+++.. .+++..++.++.||+.||.|||+ .+|+||||||+|||++.+ .+||+|||+++.
T Consensus 160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 999999999999987754 48899999999999999999999 899999999999999986 999999999987
Q ss_pred cCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 643 MTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 643 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
.... ....||+.|+|||.+.+.. +.++|||||||+++||++|..||........ .
T Consensus 231 ~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-------------------~ 285 (681)
T 2pzi_A 231 INSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-------------------P 285 (681)
T ss_dssp TTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-------------------C
T ss_pred cccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-------------------c
Confidence 6543 3457999999999987654 8899999999999999999988864221110 0
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcC
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRP-SMTKVVQMLEGI 766 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-t~~evl~~L~~~ 766 (817)
...........+.+++.+||+.||++|| +++++.+.|.++
T Consensus 286 ----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 ----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0111112234678999999999999999 566666666543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=297.27 Aligned_cols=222 Identities=23% Similarity=0.286 Sum_probs=175.0
Q ss_pred cccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHh-hccCcceeeeeeeEeec----CCeeeEEEeeccC
Q 036583 498 VKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSII-GSIHHLHLVKLRGFCAE----GTHRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l-~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~ 571 (817)
+.||+|+||.||++.. .+++.||+|++.. ...+.+|+.++ +.++||||+++++++.. ....++||||+++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~ 99 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 99 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence 6699999999999985 5688999999964 35678899888 56699999999999976 6778999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC---CCcEEEeecCCccccCCCCc
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD---NYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~Dfgla~~~~~~~~ 648 (817)
|+|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||++....
T Consensus 100 ~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---- 171 (299)
T 3m2w_A 100 GELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---- 171 (299)
T ss_dssp CBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----
T ss_pred CcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccccccc----
Confidence 999999986542 268999999999999999999999 89999999999999998 7899999999986432
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
+..++.++|||||||++|||++|+.||......... ......+.......
T Consensus 172 -------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~~~~~~~~~~ 221 (299)
T 3m2w_A 172 -------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKTRIRMGQYEF 221 (299)
T ss_dssp -------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSCTTCCSS
T ss_pred -------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHHHHhhccccC
Confidence 235678999999999999999999999654322100 00000111111111
Q ss_pred ccc--HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 729 DEQ--SDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 729 ~~~--~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+.. ......+.+++.+||+.||.+|||++|+++
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 100 122456889999999999999999999998
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=312.94 Aligned_cols=236 Identities=16% Similarity=0.102 Sum_probs=175.5
Q ss_pred cccccCCCcceeEEEEE-cCCCcEEEEEEeccC----CcCHHHHHHHHHHhhccCc-ceee---------------ee--
Q 036583 496 FSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHH-LHLV---------------KL-- 552 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~-~~~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h-~niv---------------~l-- 552 (817)
..+.||+|+||+||+|+ ..+|+.||||++... ....+.+.+|+.++..++| +|.. .+
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 34689999999999999 557999999998733 2235789999999999977 2211 11
Q ss_pred ----eeEeec-----CCeeeEEEeeccCCChhhhhhhc----ccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCC
Q 036583 553 ----RGFCAE-----GTHRLLAYEFMANGSLDKWIFKK----NQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDI 619 (817)
Q Consensus 553 ----~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dl 619 (817)
..++.. ....+++|+++ +++|.+++... .....+++..++.++.||++||+|||+ .+|+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCC
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCc
Confidence 111111 12345666654 57999888521 123368999999999999999999999 99999999
Q ss_pred CCCCeEecCCCcEEEeecCCccccCCCCceeeeeccCCCCccCcccc----------ccCccCccccccchhhhHHHhhh
Q 036583 620 KPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI----------TNYAISEKSDVYSYGMVLLEIIG 689 (817)
Q Consensus 620 k~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwS~Gvvl~ellt 689 (817)
||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|||++
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 999999999999999999998865432 344567 999999999 55568889999999999999999
Q ss_pred CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 690 GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 690 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
|+.||........ ...++..... .+..+.+++.+||+.||++||++.|+++
T Consensus 313 g~~Pf~~~~~~~~---------------~~~~~~~~~~------~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 313 ADLPNTDDAALGG---------------SEWIFRSCKN------IPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp SSCCCCTTGGGSC---------------SGGGGSSCCC------CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCcchhhh---------------HHHHHhhccc------CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999965432211 1111111111 1246889999999999999999777653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=305.35 Aligned_cols=240 Identities=18% Similarity=0.183 Sum_probs=181.4
Q ss_pred HHhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCC---------cCHHHHHHHHHHhhccC---------cceeeee
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIG---------QGKKEFRAEVSIIGSIH---------HLHLVKL 552 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~---------~~~~~~~~Ev~~l~~l~---------h~niv~l 552 (817)
...+.+.++||+|+||+||+|+. +|+.||||++.... ...+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45577788999999999999998 78999999996532 22378999999998886 5555555
Q ss_pred -----------------eeEeec-------------CCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHH
Q 036583 553 -----------------RGFCAE-------------GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKG 602 (817)
Q Consensus 553 -----------------~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~ 602 (817)
++++.+ ....++||||+++|++.+.+.+. .+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~----~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT----CCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc----CCCHHHHHHHHHHHHHH
Confidence 444443 67899999999999777766442 57899999999999999
Q ss_pred HHHHH-hcCCCceeecCCCCCCeEecCCC--------------------cEEEeecCCccccCCCCceeeeeccCCCCcc
Q 036583 603 LAYLH-EDCDQRIIHCDIKPENVLLDDNY--------------------HAKVSDFGLAKLMTREQSHVFTTLRGTRGYL 661 (817)
Q Consensus 603 l~~LH-~~~~~~ivH~Dlk~~NIll~~~~--------------------~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~ 661 (817)
|+||| + .+|+||||||+|||++.++ .+||+|||+++..... ...||+.|+
T Consensus 174 L~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~ 244 (336)
T 2vuw_A 174 LAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM 244 (336)
T ss_dssp HHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred HHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence 99999 8 8999999999999999887 9999999999876432 347899999
Q ss_pred CccccccCccCccccccchhhh-HHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhh-cccccCCcccHHHHHHHH
Q 036583 662 APEWITNYAISEKSDVYSYGMV-LLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI-LDSRLNIDEQSDRVFTAV 739 (817)
Q Consensus 662 aPE~~~~~~~~~~~DvwS~Gvv-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~d~~~~~~~~~~~~~~~~ 739 (817)
|||++.+.. +.++||||++++ .+++++|..||... .|. ....+...... ................+.
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWL-HYLTDKMLKQMTFKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHH-HHHHHHHHHTCCCSSCCCSHHHHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhh-hHHHHhhhhhhccCcccchhhhhhcCHHHH
Confidence 999998766 889999998776 78888899888310 000 00111101000 011111122334567899
Q ss_pred HHHHhccccCCCCCCCHHHHH
Q 036583 740 KVALWCVQEDMSLRPSMTKVV 760 (817)
Q Consensus 740 ~l~~~cl~~dp~~RPt~~evl 760 (817)
+|+.+||+.| |++|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 9999999966 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-28 Score=281.03 Aligned_cols=185 Identities=18% Similarity=0.093 Sum_probs=131.0
Q ss_pred cccCCCcceeEEEEE-cCCCcEEEEEEeccCC-----------cCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeE
Q 036583 498 VKLGQGGFGSVYQGV-LPDGTRLAVKKLEGIG-----------QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLL 564 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~-~~~g~~vavK~l~~~~-----------~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~l 564 (817)
...+.|++|.+..++ .--|+.+++|.+.... ...++|.+|+++|+++ +|+||++++++++++...||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 456778888777655 2348889999996531 1235799999999999 79999999999999999999
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
||||++|++|.++|.+.. +++.. +|+.||+.||+|||+ ++||||||||+||||++++++||+|||+|+...
T Consensus 320 VMEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EEecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 999999999999997654 45433 589999999999999 999999999999999999999999999998765
Q ss_pred CCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCC
Q 036583 645 REQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKN 693 (817)
Q Consensus 645 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p 693 (817)
.... ......||+.|||||.+.+ .+..++|+||+|++++++.++..+
T Consensus 391 ~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 4322 2234689999999999976 456789999999999988766543
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=236.56 Aligned_cols=206 Identities=16% Similarity=0.226 Sum_probs=133.8
Q ss_pred ccccCCccccceeeecCCCCEEEeCCCeeEEeeecCCCCCceEEEEEEecCCceEEEEcCCCCCCCCCCCcEEecCceEE
Q 036583 32 GKILPGFQGAQMTFIDKNGLFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVS 111 (817)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~~~~lvs~~g~f~~gf~~~~~~~~~y~~i~~~~~~~t~vWvAnr~~Pi~~~~~~~~~~~g~l~ 111 (817)
+.+.+|.+++ .|++| ++|.|+|||+.+++ +.+|. . +|+||+|||+.| ....+.|+.||+||
T Consensus 9 ~~i~~g~~L~-------~g~~l--~~g~f~l~f~~~gn-----l~ly~-~--~~~vW~an~~~~--~~~~l~l~~dGnLv 69 (236)
T 1dlp_A 9 HEGSHPQTLH-------AAQSL--ELSSFRFTMQSDCN-----LVLFD-S--DVRVWASNTAGA--TGCRAVLQSDGLLV 69 (236)
T ss_dssp SSSCSCSCCC-------TTCEE--CSTTEEEEECTTSC-----EEEEE-S--SSEEECCCCCSC--SCCBCCBCSSSCBC
T ss_pred ceeCCCCEEC-------CCCEE--EcCCEEEEECCCCc-----EEEEE-C--CEEEEECCCCCC--CCeEEEEcCCCcEE
Confidence 4555554444 38888 59999999987765 33333 2 699999999998 55678899999999
Q ss_pred E-ecCCeEEEEeCCCCC-ceeEEEEecCCCEEEEccCCccccccccCCCccc-ccCC---ccCCCc-------eeec--C
Q 036583 112 L-QKGGSVVWSVNPSGA-SVSAMELRDSGNLVLLGNDNKVLWQSFSHPTDTL-ISNQ---DFTQGM-------KLVS--A 176 (817)
Q Consensus 112 l-~~~~~~vWstn~~~~-~~~~a~LldsGNLVL~~~~~~~lWQSFd~PtDTl-LP~~---~l~~~~-------kl~s--~ 176 (817)
| +.+|++||+++.... ....|+|+|+|||||++. ++||||||||||+ ||+| +|.+|. +|.+ +
T Consensus 70 l~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s~~d 146 (236)
T 1dlp_A 70 ILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQS 146 (236)
T ss_dssp CBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS---EEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECSSCC
T ss_pred EEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEecC---CEEECCCCCCcccccCCccceEEecCCcCCCccceEEcCcE
Confidence 8 677899999997643 335789999999999954 8999999999776 4432 234444 5544 6
Q ss_pred CCCCCccEEEEEecCceEEecCCCCCCcccccCccccccccCCCcceeeeccCCCeeeeecCCcceEEEEEEecCCCcce
Q 036583 177 PSTNNLSYVLEIKSGDVVLSAGFPTPQPYWSMGREERKTINKGGGEVTSASLSANSWRFYDNNKIFLWQFIFSDNTDGNA 256 (817)
Q Consensus 177 ~s~g~~s~~~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~ 256 (817)
|++|.+++.++. .++.+++.. ..+||+++++... + .+.+.... ..+-+.+..+.+++..+|... . ..
T Consensus 147 ~s~G~~~l~l~~-dG~LvL~~~---~~~~W~s~~~~~~-~---~~~~~L~~-~Gnl~ly~~~~~~vw~s~~~~--~-~~- 213 (236)
T 1dlp_A 147 LQLSPYRLSMET-DCNLVLFDR---DDRVWSTNTAGKG-T---GCRAVLQP-NGRMDVLTNQNIAVWTSGNSR--S-AG- 213 (236)
T ss_dssp CBCSSCEEEEET-TTEEEEEBT---TBCCSCCCCCSSC-S---SCEEEEET-TTEEEEEETTTEEEEECCCCC--S-SS-
T ss_pred eecCcEEEEECC-CCcEEEEcC---CEeEEeCCCcCCC-C---ceEEEECC-CCcEEEEeCCCcEEEEeCCCC--C-CC-
Confidence 777877777653 345666543 3589998877422 1 12222211 111122222222333322211 1 12
Q ss_pred EEEEEECCCceEEEEE
Q 036583 257 TWIAVLANDGFISFYN 272 (817)
Q Consensus 257 ~~~~~l~~~g~l~~~~ 272 (817)
.+|++|+++|++++|.
T Consensus 214 ~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 214 RYVFVLQPDRNLAIYG 229 (236)
T ss_dssp CCEEEECSSSCEEEEC
T ss_pred CEEEEEcCCCcEEEeC
Confidence 3569999999999984
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4e-25 Score=254.13 Aligned_cols=181 Identities=15% Similarity=0.195 Sum_probs=146.8
Q ss_pred ccccCCCcceeEEEEEcCCCcEEEEEEeccCCc---------CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 497 SVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQ---------GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 497 ~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~---------~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
.+.||+|+||+||++.. .++.+++|+...... ..+.+.+|++++++++||||+++..++...++.++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 35799999999999965 678899998744221 12458999999999999999977777778888899999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+++++|.+++.. +..++.||++||+|||+ .+|+||||||+|||+++ .+||+|||+++......
T Consensus 420 ~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 420 YINGKLAKDVIED-----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp CCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred CCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 9999999999865 45799999999999999 89999999999999999 99999999999875532
Q ss_pred cee------eeeccCCCCccCcccccc--CccCccccccchhhhHHHhhhCCCCC
Q 036583 648 SHV------FTTLRGTRGYLAPEWITN--YAISEKSDVYSYGMVLLEIIGGRKNF 694 (817)
Q Consensus 648 ~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~pf 694 (817)
... .....||+.|||||++.. ..|+.+.|+|+..+-.++-+.++.+|
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 211 124679999999999987 67888999999999988888877766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.3e-21 Score=206.04 Aligned_cols=141 Identities=15% Similarity=0.081 Sum_probs=115.9
Q ss_pred cccccCCCcceeEEEEEcCCCcEEEEEEeccCCc-------------------CHHHHHHHHHHhhccCcceeeeeeeEe
Q 036583 496 FSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQ-------------------GKKEFRAEVSIIGSIHHLHLVKLRGFC 556 (817)
Q Consensus 496 ~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~-------------------~~~~~~~Ev~~l~~l~h~niv~l~~~~ 556 (817)
+.+.||+|+||.||+|...+|+.||||.++.... ....+.+|+.++.+++ | +++.+++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence 3478999999999999997799999999964211 2356899999999999 5 6677755
Q ss_pred ecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEee
Q 036583 557 AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSD 636 (817)
Q Consensus 557 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D 636 (817)
.. +..++||||+++++|.+ +.. .....++.||+.||.|||+ .+|+||||||+|||++ ++.+||+|
T Consensus 171 ~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 171 AW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp EE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEECC
T ss_pred ec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 44 56699999999999988 421 2344699999999999999 9999999999999999 99999999
Q ss_pred cCCccccCCCCceeeeeccCCCCccCcccccc
Q 036583 637 FGLAKLMTREQSHVFTTLRGTRGYLAPEWITN 668 (817)
Q Consensus 637 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 668 (817)
||+++. +..++|||++..
T Consensus 236 FG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 236 FPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp CTTCEE--------------TTSTTHHHHHHH
T ss_pred CCCCeE--------------CCCCCHHHHHHH
Confidence 999873 335789998854
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.9e-18 Score=150.40 Aligned_cols=91 Identities=23% Similarity=0.460 Sum_probs=77.4
Q ss_pred CCEEEeCCCeeEEeeecCCCCCceEEEEEEecCCceEEEEcCCCCCCCCCCCcEEecCceEEE-ecCCeEEEEeCCCCC-
Q 036583 50 GLFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVSL-QKGGSVVWSVNPSGA- 127 (817)
Q Consensus 50 ~~~lvs~~g~f~~gf~~~~~~~~~y~~i~~~~~~~t~vWvAnr~~Pi~~~~~~~~~~~g~l~l-~~~~~~vWstn~~~~- 127 (817)
|++|+| |.|.|.|+..++ +.++.. .++||+|||++|..+...+.|..||+|+| +.++++||+|+++..
T Consensus 13 g~~L~s--g~y~l~~q~DgN-----Lvly~~---~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~t~~~~ 82 (105)
T 4h3o_A 13 GQSLDV--EPYHFIMQDDCN-----LVLYDH---STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASHSTRGS 82 (105)
T ss_dssp TCEEEE--TTEEEEECTTSC-----EEEEET---TEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECCCCCCS
T ss_pred CCEEEE--CCEEEEECCCCe-----EEEEEC---CEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEecCCCCC
Confidence 899987 889999998887 666543 49999999999998888889999999998 678899999997643
Q ss_pred ceeEEEEecCCCEEEEccCCcccccc
Q 036583 128 SVSAMELRDSGNLVLLGNDNKVLWQS 153 (817)
Q Consensus 128 ~~~~a~LldsGNLVL~~~~~~~lWQS 153 (817)
....|+|+|+|||||++. .||||
T Consensus 83 ~~~~l~L~ddGNlVly~~---~~W~S 105 (105)
T 4h3o_A 83 GNYILILQDDGNVIIYGS---DIWST 105 (105)
T ss_dssp SCEEEEECTTSCEEEEES---EEEEC
T ss_pred CCEEEEEeCCCeEEEECC---cEecC
Confidence 445789999999999964 69998
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=4.3e-18 Score=176.97 Aligned_cols=134 Identities=17% Similarity=0.128 Sum_probs=105.5
Q ss_pred ccccccCCCcceeEEEEEc-CCCcE--EEEEEeccCCcC-------------------------HHHHHHHHHHhhccCc
Q 036583 495 NFSVKLGQGGFGSVYQGVL-PDGTR--LAVKKLEGIGQG-------------------------KKEFRAEVSIIGSIHH 546 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~-~~g~~--vavK~l~~~~~~-------------------------~~~~~~Ev~~l~~l~h 546 (817)
.+.+.||+|+||.||+|.. .+|+. ||||+++..... ...+.+|+.++.+++|
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 3557899999999999997 68888 999987543111 1367899999999988
Q ss_pred cee--eeeeeEeecCCeeeEEEeeccC-C----ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHH-hcCCCceeecC
Q 036583 547 LHL--VKLRGFCAEGTHRLLAYEFMAN-G----SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLH-EDCDQRIIHCD 618 (817)
Q Consensus 547 ~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH-~~~~~~ivH~D 618 (817)
+++ ..++.. ...+|||||+.+ | +|.++... .++..+..++.||+.+|.||| + .+|+|||
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~---~givHrD 196 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQE---AELVHAD 196 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHT---SCEECSS
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHH---CCEEeCC
Confidence 854 344432 356899999953 4 56555422 235577889999999999999 7 8999999
Q ss_pred CCCCCeEecCCCcEEEeecCCcccc
Q 036583 619 IKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 619 lk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
|||+|||+++ .++|+|||++...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999764
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.71 E-value=5.9e-17 Score=145.59 Aligned_cols=104 Identities=22% Similarity=0.310 Sum_probs=81.7
Q ss_pred ccccCCccccceeeecCCCCEEE--eCCCeeEEeeecCCCCCceEEEEEEecCCceEEEEcCCCCCCCCCCCcEEecCce
Q 036583 32 GKILPGFQGAQMTFIDKNGLFLL--SNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGE 109 (817)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~~~~lv--s~~g~f~~gf~~~~~~~~~y~~i~~~~~~~t~vWvAnr~~Pi~~~~~~~~~~~g~ 109 (817)
+.+.+|.++. .|++|+ |++|.|+|+|+.+++ + +||++ +++||+|||+.| ..+..+.|..|||
T Consensus 9 ~~l~~g~~L~-------~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~--~~~vW~sn~~~~-~~~~~l~l~~dGN 72 (119)
T 1b2p_A 9 PDDNHPQILH-------ATESLEILFGTHVYRFIMQTDCN-----L-VLYDN--NNPIWATNTGGL-GNGCRAVLQPDGV 72 (119)
T ss_dssp SSSCCCCEEE-------TTCEEEEEETTEEEEEEECTTSC-----E-EEEET--TEEEEECCCTTS-CSSCEEEECTTSC
T ss_pred cccCCCCEEc-------CCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC--CEEEEeCCCccC-CCceEEEEccCCE
Confidence 4455554443 489999 999999999999876 2 36665 799999999977 2335678999999
Q ss_pred EEE-ecCCeEEEEeCCCCC-ceeEEEEecCCCEEEEccCCccccccc
Q 036583 110 VSL-QKGGSVVWSVNPSGA-SVSAMELRDSGNLVLLGNDNKVLWQSF 154 (817)
Q Consensus 110 l~l-~~~~~~vWstn~~~~-~~~~a~LldsGNLVL~~~~~~~lWQSF 154 (817)
||| +.++++||+++.... ....++|+|+|||||++ .++|||-
T Consensus 73 LVl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~---~~~W~Sg 116 (119)
T 1b2p_A 73 LVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQ 116 (119)
T ss_dssp EEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECC
T ss_pred EEEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC---ccEeCCC
Confidence 998 567899999986633 34578999999999997 3899983
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=7e-17 Score=143.27 Aligned_cols=97 Identities=21% Similarity=0.463 Sum_probs=78.7
Q ss_pred CCCEEEeCCCeeEEeeecCCCCCceEEEEEEecCCceEEEEcCCCCCCCCCCCcEEecCceEEE-ecCCeEEEEeCCCCC
Q 036583 49 NGLFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVSL-QKGGSVVWSVNPSGA 127 (817)
Q Consensus 49 ~~~~lvs~~g~f~~gf~~~~~~~~~y~~i~~~~~~~t~vWvAnr~~Pi~~~~~~~~~~~g~l~l-~~~~~~vWstn~~~~ 127 (817)
.|++|+ ++|.|+|+|+.+++ + ++|+ ..++||.||++.|- ....+.|..|||||| +.++++||+++....
T Consensus 12 ~g~~l~-~~~~~~l~~~~dGn-----l-vl~~--~~~~vW~sn~~~~~-~~~~l~l~~dGNLVl~~~~~~~~W~S~t~~~ 81 (110)
T 3a0c_A 12 TGHSLE-VGPSYRLIMQGDCN-----F-VLYD--SGKPVWASNTGGLG-SGCRLTLHNNGNLVIYDQSNRVIWQTKTNGK 81 (110)
T ss_dssp TTCEEE-ETTTEEEEECTTSC-----E-EEEE--TTEEEEECCCTTSC-SSCEEEECTTSCEEEECTTCCEEEECCCCCS
T ss_pred CCCEEE-ECCCEEEEEcCCCc-----E-EEEE--CCEEEEECCCCCCC-CcEEEEEeCCCCEEEECCCCcEEEecCCCCC
Confidence 489999 99999999998876 3 4555 37999999998773 334578999999999 567899999987643
Q ss_pred -ceeEEEEecCCCEEEEccCCccccccccCCC
Q 036583 128 -SVSAMELRDSGNLVLLGNDNKVLWQSFSHPT 158 (817)
Q Consensus 128 -~~~~a~LldsGNLVL~~~~~~~lWQSFd~Pt 158 (817)
....++|+|+|||||++. ++||||+||.
T Consensus 82 ~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~ 110 (110)
T 3a0c_A 82 EDHYVLVLQQDRNVVIYGP---VVWATGSGPA 110 (110)
T ss_dssp SSCCEEEECTTSCEEEECS---EEEECSCCC-
T ss_pred CCCEEEEEeCCccEEEECC---CEecCCCcCC
Confidence 334789999999999875 7999999983
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=2.7e-16 Score=140.88 Aligned_cols=107 Identities=20% Similarity=0.343 Sum_probs=82.2
Q ss_pred ccccCCccccceeeecCCCCEEEeCCCeeEEeeecCCCCCceEEEEEEecCCceEEEEcCCCCCCCCCCCcEEecCceEE
Q 036583 32 GKILPGFQGAQMTFIDKNGLFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVS 111 (817)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~~~~lvs~~g~f~~gf~~~~~~~~~y~~i~~~~~~~t~vWvAnr~~Pi~~~~~~~~~~~g~l~ 111 (817)
++|.+|+.+. .|++|+ +|.|+|+|+.+++ +. +|+ ..++||+|||+.|. .+..+.|..||||+
T Consensus 3 dtl~~gq~L~-------~g~~L~--~g~~~L~~~~dgn-----lv-ly~--~~~~vW~sn~~~~~-~~~~l~l~~~GnLv 64 (115)
T 2dpf_A 3 NVLLSGQTLH-------ADHSLQ--AGAYTLTIQNKCN-----LV-KYQ--NGRQIWASNTDRRG-SGCRLTLLSDGNLV 64 (115)
T ss_dssp CEEETTCEEE-------TTEEEE--ETTEEEEECTTSC-----EE-EEE--TTEEEEECSCTTSC-SSCEEEECTTSCEE
T ss_pred CEeCCCCEEC-------CCCEEE--CCCEEEEEcCCCc-----EE-EEe--CCEEEEeCCCCCCC-CceEEEECCCCcEE
Confidence 4455554443 388888 7999999988776 22 244 47999999999884 34567899999999
Q ss_pred E-ecCCeEEEEeCCCCC-ceeEEEEecCCCEEEEccCCccccccccCCCc
Q 036583 112 L-QKGGSVVWSVNPSGA-SVSAMELRDSGNLVLLGNDNKVLWQSFSHPTD 159 (817)
Q Consensus 112 l-~~~~~~vWstn~~~~-~~~~a~LldsGNLVL~~~~~~~lWQSFd~PtD 159 (817)
| +.++++||+++.... ....++|+|+|||||++. ++||||.++..
T Consensus 65 l~d~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 65 IYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGP---VLWSLGPNGCR 111 (115)
T ss_dssp EECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEECSSTTCBC
T ss_pred EECCCceEEEEcCCCCCCCCEEEEEeCCCeEEEECC---CEEECCCCCCc
Confidence 8 567889999987533 345789999999999964 89999988654
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.64 E-value=6.8e-16 Score=137.62 Aligned_cols=108 Identities=19% Similarity=0.418 Sum_probs=82.2
Q ss_pred ccccCCccccceeeecCCCCEEEeCCCeeEEeeecCCCCCceEEEEEEecCCceEEEEcCCCCCCCCCCCcEEecCceEE
Q 036583 32 GKILPGFQGAQMTFIDKNGLFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVS 111 (817)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~~~~lvs~~g~f~~gf~~~~~~~~~y~~i~~~~~~~t~vWvAnr~~Pi~~~~~~~~~~~g~l~ 111 (817)
++|.+|+.+. .|+.| ++|.|+|+|+.+++ +. +|+. +++||+||++.+ ..+..+.|..+||||
T Consensus 2 dtl~~gq~L~-------~g~~L--~~~~~~L~~~~dgn-----lv-l~~~--~~~vW~sn~~~~-~~~~~l~l~~~GNLv 63 (112)
T 1xd5_A 2 DRLNSGHQLD-------TGGSL--AEGGYLFIIQNDCN-----LV-LYDN--NRAVWASGTNGK-ASGCVLKMQNDGNLV 63 (112)
T ss_dssp CEEETTEEEC-------TTCEE--EETTEEEEECTTSC-----EE-EEET--TEEEEECCCTTS-CSSEEEEECTTSCEE
T ss_pred CCCCCCCEEC-------CCCEE--eCCCEEEEEcCCCc-----EE-EEEC--CEEEEeCCCcCC-CCCEEEEEeCCCCEE
Confidence 3455554443 38888 58999999999887 32 4554 699999999864 223457799999999
Q ss_pred EecCCeEEEEeCCCCC-ceeEEEEecCCCEEEEccCCccccccccCC
Q 036583 112 LQKGGSVVWSVNPSGA-SVSAMELRDSGNLVLLGNDNKVLWQSFSHP 157 (817)
Q Consensus 112 l~~~~~~vWstn~~~~-~~~~a~LldsGNLVL~~~~~~~lWQSFd~P 157 (817)
|..++.+||+++.... ....++|+++|||||++.++.++||||++.
T Consensus 64 l~d~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 64 IYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110 (112)
T ss_dssp EEETTEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred EEcCCEEEEECCccCCCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence 8337889999986533 335689999999999987788999999974
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.60 E-value=6.8e-16 Score=166.61 Aligned_cols=138 Identities=9% Similarity=0.036 Sum_probs=98.9
Q ss_pred hccccccCCCcceeEEEEEcCCCcEEEEEEeccCC---------------cCHHHHHHHHHHhhccCcceeeeeeeEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIG---------------QGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~---------------~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~ 558 (817)
+.+..+||+|+||.||+|...+|+.||||+++... ......+.++++.....|+|+.+++.....
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 45668899999999999999899999999875321 111233334444334445555444332111
Q ss_pred ------CCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC--
Q 036583 559 ------GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY-- 630 (817)
Q Consensus 559 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-- 630 (817)
....+|||||+++++|..+... .....++.||+.+|.|||+ .+||||||||.|||+++++
T Consensus 177 vp~p~~~~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 177 VPEPIAQSRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CCCEEEEETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEECS
T ss_pred CCeeeeccCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCCCc
Confidence 1223799999999888665421 2345688999999999999 8999999999999998776
Q ss_pred --------cEEEeecCCcccc
Q 036583 631 --------HAKVSDFGLAKLM 643 (817)
Q Consensus 631 --------~~ki~Dfgla~~~ 643 (817)
.+.|+||+-+...
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEET
T ss_pred ccccccccceEEEEeCCcccC
Confidence 4899999987654
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=7e-15 Score=130.20 Aligned_cols=101 Identities=22% Similarity=0.425 Sum_probs=77.3
Q ss_pred cccCCccccceeeecCCCCEEEeCCCeeEEeeecCCCCCceEEEEEEecCCceEEEEcCCCCCCCCCCCcEEecCceEEE
Q 036583 33 KILPGFQGAQMTFIDKNGLFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVSL 112 (817)
Q Consensus 33 ~~~~~~~~~~~~~~~~~~~~lvs~~g~f~~gf~~~~~~~~~y~~i~~~~~~~t~vWvAnr~~Pi~~~~~~~~~~~g~l~l 112 (817)
.|.||+.+. .|++|+ +|.|+|+|+.+++ +.+ |.. .++||+||++.+ ..+..+.|..||||+|
T Consensus 3 tL~~gq~L~-------~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~--~~~vW~snt~~~-~~~~~l~l~~dGNLvl 64 (109)
T 3dzw_A 3 ILYSGETLS-------PGEFLN--NGRYVFIMQEDCN-----LVL-YDV--DKPIWATNTGGL-DRRCHLSMQSDGNLVV 64 (109)
T ss_dssp EEETTEEEC-------TTCEEE--ETTEEEEECTTSC-----EEE-EET--TEEEEECCCTTS-SSSCEEEECTTSCEEE
T ss_pred CcCCCCEeC-------CCCEEE--CCCEEEEEcCCCc-----EEE-EeC--CEEEEECCcccC-CCCEEEEEeCCCCEEE
Confidence 355555443 388886 7999999998876 333 443 599999999876 2334578999999998
Q ss_pred -ecCCeEEEEeCCCCCc-eeEEEEecCCCEEEEccCCccccccc
Q 036583 113 -QKGGSVVWSVNPSGAS-VSAMELRDSGNLVLLGNDNKVLWQSF 154 (817)
Q Consensus 113 -~~~~~~vWstn~~~~~-~~~a~LldsGNLVL~~~~~~~lWQSF 154 (817)
+.+++++|++++.... ...|+|+|+|||||++. ++|||-
T Consensus 65 ~~~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---~~W~s~ 105 (109)
T 3dzw_A 65 YSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGT---ARWATG 105 (109)
T ss_dssp ECTTSCEEEECCCCCSSSCEEEEECTTSCEEEEES---CCCCCC
T ss_pred ECCCCCEEEECCCCCCCCCEEEEEeCCCEEEEECC---CEEeCC
Confidence 5678899999876433 35789999999999974 899994
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.44 E-value=5.1e-13 Score=118.83 Aligned_cols=103 Identities=17% Similarity=0.307 Sum_probs=78.5
Q ss_pred ccccCCccccceeeecCCCCEEEeCCCeeEEeeecCCCCCceEEEEEEecCCceEEEEcCCCCCCCCCCCcEEecCceEE
Q 036583 32 GKILPGFQGAQMTFIDKNGLFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVS 111 (817)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~~~~lvs~~g~f~~gf~~~~~~~~~y~~i~~~~~~~t~vWvAnr~~Pi~~~~~~~~~~~g~l~ 111 (817)
+.|.+|+.+.. |+.|. +|.|.|-|...++ +.++. ....++||.+|+..+- ....+.|..|||||
T Consensus 7 ~tL~~gq~L~~-------g~~L~--~g~~~L~~q~dGN-----LvL~~-~~~~~~vWssnt~~~~-~~~~l~l~~dGNLV 70 (113)
T 3mez_B 7 NVLFSSQVMYD-------NAQLA--TRDYSLVMRDDCN-----LVLTK-GSKTNIVWESGTSGRG-QHCFMRLGHSGELD 70 (113)
T ss_dssp SEEETTCEEET-------TCEEE--ETTEEEEECTTSC-----EEEEE-TTTTEEEEECCCTTSC-SSCEEEECTTSCEE
T ss_pred CEeCCCCEECC-------CCEeE--cCCEEEEEcCCCE-----EEEEE-CCCCEEEEECCcccCC-cCEEEEEeCCCcEE
Confidence 56677765544 77876 4889999988776 55543 2247899999998763 23457799999999
Q ss_pred E-ecCCeEEEEeCCCCC-ceeEEEEecCCCEEEEccCCcccccc
Q 036583 112 L-QKGGSVVWSVNPSGA-SVSAMELRDSGNLVLLGNDNKVLWQS 153 (817)
Q Consensus 112 l-~~~~~~vWstn~~~~-~~~~a~LldsGNLVL~~~~~~~lWQS 153 (817)
+ +.+++++|++++... ....|+|+|+|||||++ ..+|+|
T Consensus 71 l~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---~~~W~s 111 (113)
T 3mez_B 71 ITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---PAVWST 111 (113)
T ss_dssp EECTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred EECCCCCEEEECCCcCCCCCEEEEEcCCceEEEec---CCEecC
Confidence 8 567889999997543 33578999999999997 689998
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.42 E-value=3.4e-13 Score=119.24 Aligned_cols=101 Identities=16% Similarity=0.234 Sum_probs=75.8
Q ss_pred hccccCCccccceeeecCCCCEEEeCCCeeEEeeecCCCCCceEEEEEEecCCceEEEEcCCCCCCCCCCCcEEecCceE
Q 036583 31 IGKILPGFQGAQMTFIDKNGLFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEV 110 (817)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~lvs~~g~f~~gf~~~~~~~~~y~~i~~~~~~~t~vWvAnr~~Pi~~~~~~~~~~~g~l 110 (817)
.+.|.+|+.+.. |+.|+| |.|+|-|...++ +.+ |.. ++||.+|++.. .....+.|..||||
T Consensus 6 ~dtL~~gq~L~~-------g~~L~s--g~~~L~~q~dGn-----Lvl-~~~---~~vW~snt~~~-~~~~~l~l~~dGNL 66 (110)
T 3r0e_B 6 NNLLFSGQVLYG-------DGRLTA--KNHQLVMQGDCN-----LVL-YGG---KYGWQSNTHGN-GEHCFLRLNHKGEL 66 (110)
T ss_dssp TTEEETTCEEET-------TEEEEC--SSCEEEECTTSC-----EEE-ECS---SSCEECCCTTS-SSSCEEEECTTSCE
T ss_pred cCEECCCCEecC-------CCEEEe--CCEEEEEcCCCe-----EEE-ECC---eEEEECCCcCC-CcCEEEEEeCCCcE
Confidence 366777766554 889987 569998876665 444 443 58999999863 22345779999999
Q ss_pred EE-ecCCeEEEEeCCCCC-ceeEEEEecCCCEEEEccCCcccccc
Q 036583 111 SL-QKGGSVVWSVNPSGA-SVSAMELRDSGNLVLLGNDNKVLWQS 153 (817)
Q Consensus 111 ~l-~~~~~~vWstn~~~~-~~~~a~LldsGNLVL~~~~~~~lWQS 153 (817)
++ +.+++++|++++... ....|+|+|+|||||++ ..+|+|
T Consensus 67 vl~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---~~~W~t 108 (110)
T 3r0e_B 67 IIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---PAIFET 108 (110)
T ss_dssp EEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred EEEeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---CCEecC
Confidence 98 567899999987533 33578999999999998 489998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=1.8e-12 Score=114.81 Aligned_cols=57 Identities=32% Similarity=0.615 Sum_probs=47.7
Q ss_pred CCCcEEecCceEEEecCCeEEEEeCCCCC-ceeEEEEecCCCEEEEccCCcccccccc
Q 036583 99 SDNFVFKKDGEVSLQKGGSVVWSVNPSGA-SVSAMELRDSGNLVLLGNDNKVLWQSFS 155 (817)
Q Consensus 99 ~~~~~~~~~g~l~l~~~~~~vWstn~~~~-~~~~a~LldsGNLVL~~~~~~~lWQSFd 155 (817)
...+.|..||+|+|...+++||+||+... ....++|+++|||||++.++.++||||.
T Consensus 21 ~~~l~~~~dGnlvl~~~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W~S~t 78 (110)
T 3a0c_A 21 SYRLIMQGDCNFVLYDSGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTKT 78 (110)
T ss_dssp TEEEEECTTSCEEEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECCC
T ss_pred CEEEEEcCCCcEEEEECCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEEecCC
Confidence 34577889999998546899999998643 3457899999999999988999999994
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.30 E-value=4.2e-12 Score=112.00 Aligned_cols=98 Identities=21% Similarity=0.390 Sum_probs=74.5
Q ss_pred ccccCCccccceeeecCCCCEEEeCCCeeEEeeecCCCCCceEEEEEEecCCceEEEEcCCCCCCCCCCCcEEecCceEE
Q 036583 32 GKILPGFQGAQMTFIDKNGLFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVS 111 (817)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~~~~lvs~~g~f~~gf~~~~~~~~~y~~i~~~~~~~t~vWvAnr~~Pi~~~~~~~~~~~g~l~ 111 (817)
++|.||+.+.. |+.| .+|.|.|.|...++ +.+ |.. +|.+|+..+ ..+..+.|..||+|+
T Consensus 4 dtL~~gq~L~~-------g~~L--~~g~~~L~~q~dGN-----Lvl-~~~-----~Wssnt~~~-~~~~~l~l~~dGnLv 62 (109)
T 3r0e_A 4 NYLLSGQTLDT-------EGHL--KNGDFDLVMQDDCN-----LVL-YNG-----NWQSNTANN-GRDCKLTLTDYGELV 62 (109)
T ss_dssp SEEETTCEECT-------TCEE--EETTEEEEECTTSC-----EEE-ETT-----TEECCCTTS-CSSCEEEECTTSCEE
T ss_pred CCcCCCCCcCC-------CCEe--ECCCEEEEEecCCe-----EEE-EeC-----eEEcCCCCC-CCcEEEEEcCCCeEE
Confidence 56777766544 7887 47999999988776 333 322 699998865 234557789999999
Q ss_pred E-ecCCeEEEEeCCCCC-ceeEEEEecCCCEEEEccCCcccccc
Q 036583 112 L-QKGGSVVWSVNPSGA-SVSAMELRDSGNLVLLGNDNKVLWQS 153 (817)
Q Consensus 112 l-~~~~~~vWstn~~~~-~~~~a~LldsGNLVL~~~~~~~lWQS 153 (817)
+ +.+++++|++++... ....|+|+|+|||||++ ..+|+|
T Consensus 63 l~d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---~~~W~s 103 (109)
T 3r0e_A 63 IKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---PSVFKI 103 (109)
T ss_dssp EECTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC---SEEEEE
T ss_pred EEeCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---cCEECC
Confidence 8 567889999987643 33578999999999997 689999
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.24 E-value=1e-11 Score=111.29 Aligned_cols=83 Identities=24% Similarity=0.494 Sum_probs=61.1
Q ss_pred CcEEecCceEEEecCCeEEEEeCCCCC-ceeEEEEecCCCEEEEccCCccccccccCCCcccccCCccCCCceeecCCCC
Q 036583 101 NFVFKKDGEVSLQKGGSVVWSVNPSGA-SVSAMELRDSGNLVLLGNDNKVLWQSFSHPTDTLISNQDFTQGMKLVSAPST 179 (817)
Q Consensus 101 ~~~~~~~g~l~l~~~~~~vWstn~~~~-~~~~a~LldsGNLVL~~~~~~~lWQSFd~PtDTlLP~~~l~~~~kl~s~~s~ 179 (817)
.+.|..||+|++...+++||+||+... ....++|+|+|||||+|.+++++||||.. +++
T Consensus 33 ~L~~~~dgnlvly~~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~~~lW~S~~~--------------------~~~ 92 (119)
T 1b2p_A 33 RFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVA--------------------GKA 92 (119)
T ss_dssp EEEECTTSCEEEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECSCC--------------------CCS
T ss_pred EEEEecCCCEEEEECCEEEEeCCCccCCCceEEEEccCCEEEEEeCCCcEEEcCCCC--------------------CCC
Confidence 466888999998545899999997643 34678999999999999989999999943 344
Q ss_pred CCccEEEEEec-CceEEecCCCCCCcccccCc
Q 036583 180 NNLSYVLEIKS-GDVVLSAGFPTPQPYWSMGR 210 (817)
Q Consensus 180 g~~s~~~~~~~-~~~~~~~~~~~~~~y~~~~~ 210 (817)
|.+ .+.+++ +..+++. .+||++++
T Consensus 93 g~~--~l~l~~~Gnlvl~~-----~~~W~Sg~ 117 (119)
T 1b2p_A 93 GHY--VLVLQPDRNVVIYG-----DALWATQT 117 (119)
T ss_dssp SCE--EEEECTTSCEEEEE-----SEEEECCC
T ss_pred CCE--EEEEECCCcEEEEC-----ccEeCCCC
Confidence 544 444443 4456653 27898764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.24 E-value=1.9e-11 Score=108.70 Aligned_cols=88 Identities=20% Similarity=0.470 Sum_probs=63.7
Q ss_pred CCcEEecCceEEEecCCeEEEEeCCCCC-ceeEEEEecCCCEEEEccCCccccccccCCCcccccCCccCCCceeecCCC
Q 036583 100 DNFVFKKDGEVSLQKGGSVVWSVNPSGA-SVSAMELRDSGNLVLLGNDNKVLWQSFSHPTDTLISNQDFTQGMKLVSAPS 178 (817)
Q Consensus 100 ~~~~~~~~g~l~l~~~~~~vWstn~~~~-~~~~a~LldsGNLVL~~~~~~~lWQSFd~PtDTlLP~~~l~~~~kl~s~~s 178 (817)
..|.|..||+|+|...+++||+||+... ....|+|+++|||||+| ++.++||||+.| +
T Consensus 21 ~~L~~~~dgnlvl~~~~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W~S~~~~--------------------~ 79 (112)
T 1xd5_A 21 YLFIIQNDCNLVLYDNNRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNTNR--------------------Q 79 (112)
T ss_dssp EEEEECTTSCEEEEETTEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEEECCCCC--------------------S
T ss_pred EEEEEcCCCcEEEEECCEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEEECCccC--------------------C
Confidence 3467889999998545899999997643 34678999999999999 788999999543 3
Q ss_pred CCCccEEEEEec-CceEEecCCCCCCcccccCccc
Q 036583 179 TNNLSYVLEIKS-GDVVLSAGFPTPQPYWSMGREE 212 (817)
Q Consensus 179 ~g~~s~~~~~~~-~~~~~~~~~~~~~~y~~~~~~~ 212 (817)
+|.++ +.+++ +..+++.. ...+||.++.+.
T Consensus 80 ~g~~~--l~l~~dGnlvl~~~--~~~~~W~S~~~~ 110 (112)
T 1xd5_A 80 NGNYY--LILQRDRNVVIYDN--SNNAIWATHTNV 110 (112)
T ss_dssp CCCCE--EEECTTSCEEEECT--TSCEEEECCCCC
T ss_pred CCCEE--EEEeCCCcEEEECC--CCceEEECCCcc
Confidence 44444 44443 45666542 346899988763
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=2.2e-11 Score=108.83 Aligned_cols=87 Identities=21% Similarity=0.419 Sum_probs=63.9
Q ss_pred CCcEEecCceEEEecCCeEEEEeCCCCC-ceeEEEEecCCCEEEEccCCccccccccCCCcccccCCccCCCceeecCCC
Q 036583 100 DNFVFKKDGEVSLQKGGSVVWSVNPSGA-SVSAMELRDSGNLVLLGNDNKVLWQSFSHPTDTLISNQDFTQGMKLVSAPS 178 (817)
Q Consensus 100 ~~~~~~~~g~l~l~~~~~~vWstn~~~~-~~~~a~LldsGNLVL~~~~~~~lWQSFd~PtDTlLP~~~l~~~~kl~s~~s 178 (817)
..+.+..||+|+|...+++||+||+... ....++|+++|||||+|.++.++||||++| +
T Consensus 22 ~~L~~~~dgnlvly~~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~~--------------------~ 81 (115)
T 2dpf_A 22 YTLTIQNKCNLVKYQNGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACWG--------------------D 81 (115)
T ss_dssp EEEEECTTSCEEEEETTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCCC--------------------S
T ss_pred EEEEEcCCCcEEEEeCCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCCC--------------------C
Confidence 4466888999998556899999997643 346789999999999998889999999973 2
Q ss_pred CCCccEEEEEec-CceEEecCCCCCCcccccCcccc
Q 036583 179 TNNLSYVLEIKS-GDVVLSAGFPTPQPYWSMGREER 213 (817)
Q Consensus 179 ~g~~s~~~~~~~-~~~~~~~~~~~~~~y~~~~~~~~ 213 (817)
++.++ +.+++ |..+++.. +||.+++|..
T Consensus 82 ~g~~~--l~l~~dGnlvl~~~-----~~W~S~~~~~ 110 (115)
T 2dpf_A 82 NGKYA--LVLQKDGRFVIYGP-----VLWSLGPNGC 110 (115)
T ss_dssp SSCCE--EEECTTSCEEEECS-----EEECSSTTCB
T ss_pred CCCEE--EEEeCCCeEEEECC-----CEEECCCCCC
Confidence 33333 44433 45556532 7999988743
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.14 E-value=6.2e-11 Score=104.85 Aligned_cols=101 Identities=16% Similarity=0.223 Sum_probs=73.3
Q ss_pred ccccCCccccceeeecCCCCEEEeCCCeeEEeeecCCCCCceEEEEEEecCCceEEEEcCCCCCCCCCCCcEEecCceEE
Q 036583 32 GKILPGFQGAQMTFIDKNGLFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVS 111 (817)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~~~~lvs~~g~f~~gf~~~~~~~~~y~~i~~~~~~~t~vWvAnr~~Pi~~~~~~~~~~~g~l~ 111 (817)
+.|.+|+.+.. |+.| .+|.|.|-|...++ +.+ |.. . . ||.+|+..+- ....+.|..|||||
T Consensus 3 ~~l~~gq~L~~-------g~~L--~~g~~~L~~q~dGn-----Lvl-~~~-~-~-vW~snt~~~~-~~~~l~l~~dGNLV 63 (111)
T 3mez_A 3 NVLLTGDVIHT-------DNQL--SYESAAFVMQGDCN-----LVL-YNE-A-G-GFQSNTHGRG-VDCTLRLNNRGQLE 63 (111)
T ss_dssp TEEETTCEECT-------TCEE--EETTEEEEECTTSC-----EEE-ECS-S-C-CEECCCTTSC-SSCEEEECTTSCEE
T ss_pred CEeCCCCEeCC-------CCEE--ecCCEEEEEccCCe-----EEE-ECC-C-C-EEECCcccCC-cCEEEEEcCCCcEE
Confidence 45666655544 7887 37899999988777 444 332 2 3 9999998762 23567799999999
Q ss_pred E-ecCCe-EEEEeCCC--C-CceeEEEEecCCCEEEEccCCccccccc
Q 036583 112 L-QKGGS-VVWSVNPS--G-ASVSAMELRDSGNLVLLGNDNKVLWQSF 154 (817)
Q Consensus 112 l-~~~~~-~vWstn~~--~-~~~~~a~LldsGNLVL~~~~~~~lWQSF 154 (817)
+ +.++. +||++++. . .....+.|+++|||||++ ..+|+|-
T Consensus 64 l~~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---~~~W~s~ 108 (111)
T 3mez_A 64 IHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---PAIWSTP 108 (111)
T ss_dssp EECSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---SEEEECC
T ss_pred EEeCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec---cCEEccC
Confidence 9 55554 69999853 1 234578999999999997 7899983
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=3.2e-10 Score=117.70 Aligned_cols=139 Identities=14% Similarity=0.033 Sum_probs=109.4
Q ss_pred hccccccCCCcceeEEEEEcCCCcEEEEEEeccCC-cCHHHHHHHHHHhhccC-cceeeeeeeEeecCCeeeEEEeeccC
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIH-HLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+.+...++.|+.+.||+.... ++.+++|+..... .....+.+|+++++.+. |..+.++++++.+.+..++||||++|
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 94 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence 344566788888999999864 6889999986431 23446899999999884 67888999999988899999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED------------------------------------------ 609 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~------------------------------------------ 609 (817)
.+|.+.+. +......++.+++++|+.||+.
T Consensus 95 ~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 95 VLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp EEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred eehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 99877532 1123457889999999999981
Q ss_pred --------------CCCceeecCCCCCCeEecCCCcEEEeecCCcc
Q 036583 610 --------------CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK 641 (817)
Q Consensus 610 --------------~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 641 (817)
....++|+|+++.||+++++..+.|+||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01458999999999999876667799998765
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.99 E-value=9.6e-10 Score=113.68 Aligned_cols=130 Identities=15% Similarity=0.054 Sum_probs=98.3
Q ss_pred ccC-CCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcce--eeeeeeEeecCCeeeEEEeeccCCChh
Q 036583 499 KLG-QGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLH--LVKLRGFCAEGTHRLLAYEFMANGSLD 575 (817)
Q Consensus 499 ~lG-~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~ 575 (817)
.++ .|..+.||+....+|+.+++|..... ....+..|+++++.+++.+ +.+++++...++..++||||++|.+|.
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 344 55669999999877888999997643 3356789999999886444 566888888888889999999998884
Q ss_pred hhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 036583 576 KWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC--------------------------------------------- 610 (817)
Q Consensus 576 ~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~--------------------------------------------- 610 (817)
... . ....++.++++.|+.||+..
T Consensus 104 --~~~------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 --SSH------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp --TSC------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred --cCc------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 211 1 12356777778888888621
Q ss_pred ----------CCceeecCCCCCCeEecCCCcEEEeecCCcc
Q 036583 611 ----------DQRIIHCDIKPENVLLDDNYHAKVSDFGLAK 641 (817)
Q Consensus 611 ----------~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 641 (817)
...++|+|++|.||+++++..++|+||+.+.
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999887667899999875
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=98.90 E-value=2.5e-09 Score=110.66 Aligned_cols=114 Identities=20% Similarity=0.408 Sum_probs=76.3
Q ss_pred hccccCCccccceeeecCCCCEEEeCCCeeEEeeecCC--CCCceEEEEEEecCCceEEEEcCCCCCCCCCCCcEEecCc
Q 036583 31 IGKILPGFQGAQMTFIDKNGLFLLSNNSDFAFGFRTTE--NDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDG 108 (817)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~lvs~~g~f~~gf~~~~--~~~~~y~~i~~~~~~~t~vWvAnr~~Pi~~~~~~~~~~~g 108 (817)
.++++|+..... .-..|+.|+| +..++.|+|... ...+.+ + |+ ...+++|.+++.++- ...+.+..+|
T Consensus 136 tdtlLpg~~~~~---~l~~g~~L~S-~~dps~G~fsl~l~~dGnlv--L-y~-~~~~~yW~Sgt~~~~--~~~l~l~~dG 205 (276)
T 3m7h_A 136 AIPLVPGAIDSL---LLAPGSELVQ-GVVYGAGASKLVFQGDGNLV--A-YG-PNGAATWNAGTQGKG--AVRAVFQGDG 205 (276)
T ss_dssp TSCCCCSCTTCE---EECSSEEECT-TCEEEETTEEEEECTTSCEE--E-EC-TTSSEEEECCCTTTT--CCEEEECTTS
T ss_pred cccccccccccc---ccccCccccc-CCCCCCceEEEeecCCceEE--E-Ee-CCCeEEEECCCCCCc--cEEEEEcCCC
Confidence 356666643110 1133666654 345666655432 222322 2 32 236899999998762 2456788999
Q ss_pred eEEE-ecCCeEEEEeCCCCCceeEEEEecCCCEEEEccCCccccccccC
Q 036583 109 EVSL-QKGGSVVWSVNPSGASVSAMELRDSGNLVLLGNDNKVLWQSFSH 156 (817)
Q Consensus 109 ~l~l-~~~~~~vWstn~~~~~~~~a~LldsGNLVL~~~~~~~lWQSFd~ 156 (817)
+|++ +.++.++|+++........++|.++|||||++. +++|||||+
T Consensus 206 nLvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~ 252 (276)
T 3m7h_A 206 NLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE--KPVWARFGF 252 (276)
T ss_dssp CEEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred eEEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence 9998 566789999987644456789999999999976 689999998
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.86 E-value=7e-09 Score=112.84 Aligned_cols=139 Identities=15% Similarity=0.217 Sum_probs=105.3
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEec--cCC--cCHHHHHHHHHHhhccC--cceeeeeeeEeecC---CeeeEEEee
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLE--GIG--QGKKEFRAEVSIIGSIH--HLHLVKLRGFCAEG---THRLLAYEF 568 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~--~~~--~~~~~~~~Ev~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e~ 568 (817)
+.|+.|.++.||+....+ ..+++|+.. ... .....+.+|+.+++.++ +..+.+++.++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 468999999999998854 578888776 322 23457888999999996 45688999988776 347999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC-------------------------------------- 610 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~-------------------------------------- 610 (817)
+++..+.+.... .++...+..++.++++.|+.||+..
T Consensus 123 v~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 123 VSGRVLWDQSLP-----GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCCBCCCCTTCT-----TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred cCCeecCCCccc-----cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 999877542211 3566778889999999999999720
Q ss_pred -----------------CCceeecCCCCCCeEecCCCc--EEEeecCCccc
Q 036583 611 -----------------DQRIIHCDIKPENVLLDDNYH--AKVSDFGLAKL 642 (817)
Q Consensus 611 -----------------~~~ivH~Dlk~~NIll~~~~~--~ki~Dfgla~~ 642 (817)
...++|+|+++.||+++.++. +.|.||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997653 68999998864
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.74 E-value=7.6e-09 Score=91.74 Aligned_cols=63 Identities=22% Similarity=0.376 Sum_probs=48.9
Q ss_pred CCCCCCC-CCcEEecCceEEE-ec-CCeEEEEeCCCCC-ceeEEEEecCCCEEEEccCCcccccccc
Q 036583 93 GSPVANS-DNFVFKKDGEVSL-QK-GGSVVWSVNPSGA-SVSAMELRDSGNLVLLGNDNKVLWQSFS 155 (817)
Q Consensus 93 ~~Pi~~~-~~~~~~~~g~l~l-~~-~~~~vWstn~~~~-~~~~a~LldsGNLVL~~~~~~~lWQSFd 155 (817)
++|+.+. ..+.+..||+|+| +. .+++||++|+... ....++|+++|||||+|.++.++|||..
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~t 84 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNT 84 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECSC
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECCC
Confidence 4455433 3467889999999 44 4799999997643 3457899999999999988899999943
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.65 E-value=8.7e-09 Score=109.30 Aligned_cols=181 Identities=18% Similarity=0.223 Sum_probs=119.3
Q ss_pred ccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccC-cce--eeeeeeEeecCC---eeeEEEeeccCC
Q 036583 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH-HLH--LVKLRGFCAEGT---HRLLAYEFMANG 572 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~~~g 572 (817)
.++.|....||+.. +.+++|+.... .....+.+|.+++..+. +.. +.+++....... ..++|||+++|.
T Consensus 27 ~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~ 101 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGV 101 (304)
T ss_dssp EEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCE
T ss_pred ecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCe
Confidence 47889999999864 45888886532 23467899999998873 332 445555443333 347899999998
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED------------------------------------------- 609 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~------------------------------------------- 609 (817)
+|.+.... .++..++..++.++++.++.||+.
T Consensus 102 ~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 102 PLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp ECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred ECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 88654321 355667777888888888888851
Q ss_pred ------------CCCceeecCCCCCCeEecC--CCcEEEeecCCccccCCCCceeeeeccCCCCc---cCcccccc----
Q 036583 610 ------------CDQRIIHCDIKPENVLLDD--NYHAKVSDFGLAKLMTREQSHVFTTLRGTRGY---LAPEWITN---- 668 (817)
Q Consensus 610 ------------~~~~ivH~Dlk~~NIll~~--~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y---~aPE~~~~---- 668 (817)
....++|+|+++.||++++ ...+.|+||+.+....+... ....... ..|+....
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-----l~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-----FISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-----HHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-----HHHHHhhccccCHHHHHHHHHH
Confidence 1245899999999999998 56689999998875432110 0000111 22322210
Q ss_pred C----------ccCccccccchhhhHHHhhhCCCCC
Q 036583 669 Y----------AISEKSDVYSYGMVLLEIIGGRKNF 694 (817)
Q Consensus 669 ~----------~~~~~~DvwS~Gvvl~elltg~~pf 694 (817)
. ......+.|+++.+++++.+|..+|
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 0112258999999999999998765
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=4.6e-08 Score=86.15 Aligned_cols=56 Identities=23% Similarity=0.502 Sum_probs=46.2
Q ss_pred CCcEEecCceEEEecCCeEEEEeCCCCC-ceeEEEEecCCCEEEEccCCcccccccc
Q 036583 100 DNFVFKKDGEVSLQKGGSVVWSVNPSGA-SVSAMELRDSGNLVLLGNDNKVLWQSFS 155 (817)
Q Consensus 100 ~~~~~~~~g~l~l~~~~~~vWstn~~~~-~~~~a~LldsGNLVL~~~~~~~lWQSFd 155 (817)
..+.|..||+|+|...+++||++|+... ....++|+++|||||+|.++.++|||..
T Consensus 21 ~~L~~q~dGnLvly~~~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t 77 (109)
T 3dzw_A 21 YVFIMQEDCNLVLYDVDKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNT 77 (109)
T ss_dssp EEEEECTTSCEEEEETTEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCC
T ss_pred EEEEEcCCCcEEEEeCCEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCC
Confidence 3467889999999655899999997643 3457899999999999988899999953
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.59 E-value=5.3e-08 Score=84.92 Aligned_cols=54 Identities=24% Similarity=0.503 Sum_probs=45.9
Q ss_pred CcEEecCceEEEecCCeEEEEeCCCCC--ceeEEEEecCCCEEEEccCCccccccc
Q 036583 101 NFVFKKDGEVSLQKGGSVVWSVNPSGA--SVSAMELRDSGNLVLLGNDNKVLWQSF 154 (817)
Q Consensus 101 ~~~~~~~g~l~l~~~~~~vWstn~~~~--~~~~a~LldsGNLVL~~~~~~~lWQSF 154 (817)
.+.+..||||||...+++||+||+... ....++|.++|||||+|.+++++|+|.
T Consensus 22 ~l~~q~DgNLvly~~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~ 77 (105)
T 4h3o_A 22 HFIMQDDCNLVLYDHSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASH 77 (105)
T ss_dssp EEEECTTSCEEEEETTEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECC
T ss_pred EEEECCCCeEEEEECCEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEec
Confidence 466889999999777899999997633 345788999999999999999999984
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.58 E-value=1.4e-07 Score=83.21 Aligned_cols=53 Identities=19% Similarity=0.357 Sum_probs=42.3
Q ss_pred CcEEecCceEEEecCCeEEEEeCCCCC-ceeEEEEecCCCEEEEccCCc-cccccc
Q 036583 101 NFVFKKDGEVSLQKGGSVVWSVNPSGA-SVSAMELRDSGNLVLLGNDNK-VLWQSF 154 (817)
Q Consensus 101 ~~~~~~~g~l~l~~~~~~vWstn~~~~-~~~~a~LldsGNLVL~~~~~~-~lWQSF 154 (817)
.+.+..||||||...+. ||++|+... ....++|+++|||||++.+++ ++|||.
T Consensus 23 ~L~~q~dGnLvl~~~~~-vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~ 77 (111)
T 3mez_A 23 AFVMQGDCNLVLYNEAG-GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYP 77 (111)
T ss_dssp EEEECTTSCEEEECSSC-CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEES
T ss_pred EEEEccCCeEEEECCCC-EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEec
Confidence 46788999999954334 999997643 336789999999999998776 599996
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.43 E-value=1.4e-07 Score=82.99 Aligned_cols=55 Identities=27% Similarity=0.514 Sum_probs=44.6
Q ss_pred CCcEEecCceEEEecCCeEEEEeCCCCC-ceeEEEEecCCCEEEEccCCcccccccc
Q 036583 100 DNFVFKKDGEVSLQKGGSVVWSVNPSGA-SVSAMELRDSGNLVLLGNDNKVLWQSFS 155 (817)
Q Consensus 100 ~~~~~~~~g~l~l~~~~~~vWstn~~~~-~~~~a~LldsGNLVL~~~~~~~lWQSFd 155 (817)
-.+.+..||+|+|... ++||++|+... ....++|+++|||||+|.++.++|||..
T Consensus 26 ~~L~~q~dGnLvl~~~-~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t 81 (110)
T 3r0e_B 26 HQLVMQGDCNLVLYGG-KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRS 81 (110)
T ss_dssp CEEEECTTSCEEEECS-SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCC
T ss_pred EEEEEcCCCeEEEECC-eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCC
Confidence 4567889999999544 68999997643 3357899999999999988899999954
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.32 E-value=9.6e-07 Score=77.51 Aligned_cols=59 Identities=25% Similarity=0.471 Sum_probs=44.6
Q ss_pred CCCCCCC-CCcEEecCceEEEecCCeEEEEeCCCCC-ceeEEEEecCCCEEEEccCCccccccc
Q 036583 93 GSPVANS-DNFVFKKDGEVSLQKGGSVVWSVNPSGA-SVSAMELRDSGNLVLLGNDNKVLWQSF 154 (817)
Q Consensus 93 ~~Pi~~~-~~~~~~~~g~l~l~~~~~~vWstn~~~~-~~~~a~LldsGNLVL~~~~~~~lWQSF 154 (817)
++|+.+. -.+.+..||||||... +|+||+... ....++|.++|||||+|.++.++|+|.
T Consensus 15 g~~L~~g~~~L~~q~dGNLvl~~~---~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWss~ 75 (109)
T 3r0e_A 15 EGHLKNGDFDLVMQDDCNLVLYNG---NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSG 75 (109)
T ss_dssp TCEEEETTEEEEECTTSCEEEETT---TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECC
T ss_pred CCEeECCCEEEEEecCCeEEEEeC---eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEcCC
Confidence 3444333 2466889999999643 799997643 346789999999999998889999873
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=7.5e-06 Score=84.81 Aligned_cols=135 Identities=17% Similarity=0.162 Sum_probs=96.8
Q ss_pred ccCCCcce-eEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhccC-cceeeeeeeEeecCCeeeEEEeeccCCChh
Q 036583 499 KLGQGGFG-SVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH-HLHLVKLRGFCAEGTHRLLAYEFMANGSLD 575 (817)
Q Consensus 499 ~lG~G~fG-~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 575 (817)
.+..|..| .||+.... ++..++||+-... ...++.+|..+|+.+. +--+.++++++.+++..++|||++++.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 34445555 68987754 4667888886532 2456888999988874 445778899999999999999999998877
Q ss_pred hhhhhcccccchhhhHHHHHHHHHHHHHHHHHhc----------------------------------------------
Q 036583 576 KWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED---------------------------------------------- 609 (817)
Q Consensus 576 ~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~---------------------------------------------- 609 (817)
+..... ......+..+++..|+-||..
T Consensus 109 ~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 109 QVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 654321 123344566666666666641
Q ss_pred ---------CCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 610 ---------CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 610 ---------~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
....++|+|+.+.||++++++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012379999999999999887778999988753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=9.3e-06 Score=85.85 Aligned_cols=134 Identities=18% Similarity=0.203 Sum_probs=89.5
Q ss_pred ccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcc---eeeeeeeEee-cCCeeeEEEeeccCCCh
Q 036583 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHL---HLVKLRGFCA-EGTHRLLAYEFMANGSL 574 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~gsL 574 (817)
.++.|....||+. ++.++||+-.. ......+..|.+++..+.+. .+.+++.+.. ..+..++||||++|..|
T Consensus 26 ~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l 100 (306)
T 3tdw_A 26 SLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQIL 100 (306)
T ss_dssp EEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEEC
T ss_pred ecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeEC
Confidence 4778888899987 56688887532 22346789999999999642 3566666664 44567899999999887
Q ss_pred hhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 036583 575 DKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED--------------------------------------------- 609 (817)
Q Consensus 575 ~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~--------------------------------------------- 609 (817)
.+.... .++...+..++.++++.|+.||+.
T Consensus 101 ~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 101 GEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp HHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred chhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 653211 122233334444444444444431
Q ss_pred ------------CCCceeecCCCCCCeEecC---CCc-EEEeecCCccc
Q 036583 610 ------------CDQRIIHCDIKPENVLLDD---NYH-AKVSDFGLAKL 642 (817)
Q Consensus 610 ------------~~~~ivH~Dlk~~NIll~~---~~~-~ki~Dfgla~~ 642 (817)
....++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2346799999999999987 455 58999998764
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.04 E-value=1.1e-06 Score=88.94 Aligned_cols=57 Identities=28% Similarity=0.461 Sum_probs=47.1
Q ss_pred CCcEEecCceEEEecCCeEEEEeCCCCCceeEEEEecCCCEEEEccCCccccccccC
Q 036583 100 DNFVFKKDGEVSLQKGGSVVWSVNPSGASVSAMELRDSGNLVLLGNDNKVLWQSFSH 156 (817)
Q Consensus 100 ~~~~~~~~g~l~l~~~~~~vWstn~~~~~~~~a~LldsGNLVL~~~~~~~lWQSFd~ 156 (817)
..+.+..||++++-..+++||+||+.......++|.++|||||+|.+++++|+|+++
T Consensus 28 f~l~f~~~gnl~ly~~~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW~s~~~ 84 (236)
T 1dlp_A 28 FRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTK 84 (236)
T ss_dssp EEEEECTTSCEEEEESSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCC
T ss_pred EEEEECCCCcEEEEECCEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEEeCCcc
Confidence 345577889988855589999999875555678899999999999999999999865
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.87 E-value=2e-05 Score=85.17 Aligned_cols=79 Identities=6% Similarity=0.048 Sum_probs=56.3
Q ss_pred ccc-CCCcceeEEEEEcC-------CCcEEEEEEeccCC---c-CHHHHHHHHHHhhccCc---ceeeeeeeEeecC---
Q 036583 498 VKL-GQGGFGSVYQGVLP-------DGTRLAVKKLEGIG---Q-GKKEFRAEVSIIGSIHH---LHLVKLRGFCAEG--- 559 (817)
Q Consensus 498 ~~l-G~G~fG~Vy~g~~~-------~g~~vavK~l~~~~---~-~~~~~~~Ev~~l~~l~h---~niv~l~~~~~~~--- 559 (817)
+.| +.|....+|+.... +++.+++|+..... . ....+.+|+.+++.+.. ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 346 88989999998764 26678888765422 1 23467889999988853 3577788887665
Q ss_pred CeeeEEEeeccCCChhh
Q 036583 560 THRLLAYEFMANGSLDK 576 (817)
Q Consensus 560 ~~~~lv~e~~~~gsL~~ 576 (817)
...++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999876643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.73 E-value=8.5e-05 Score=79.54 Aligned_cols=139 Identities=13% Similarity=0.202 Sum_probs=81.3
Q ss_pred ccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCc--ceeeeeee------EeecCCeeeEEEeecc
Q 036583 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHH--LHLVKLRG------FCAEGTHRLLAYEFMA 570 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~~~ 570 (817)
.|+.|..+.||+....+| .+++|+... ...++..|+.++..+.. -.+.+++. +....+..+++|||++
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~ 114 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHR---PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE 114 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECS---CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCC---CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence 466677899999987555 488998875 23455566666666642 12344443 1234567899999999
Q ss_pred CCChh-----------h---hhhhccccc-----------chhhhHH-------------------------------HH
Q 036583 571 NGSLD-----------K---WIFKKNQEF-----------LLDWETR-------------------------------FN 594 (817)
Q Consensus 571 ~gsL~-----------~---~l~~~~~~~-----------~l~~~~~-------------------------------~~ 594 (817)
|..+. . .|+...... ...|... ..
T Consensus 115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (346)
T 2q83_A 115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG 194 (346)
T ss_dssp CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence 86542 0 111110000 0112110 01
Q ss_pred HHHHHHHHHHHHHh----------cCCCceeecCCCCCCeEecCCCcEEEeecCCcc
Q 036583 595 IALGTAKGLAYLHE----------DCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK 641 (817)
Q Consensus 595 i~~qia~~l~~LH~----------~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 641 (817)
+..++.+++.+|++ .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11223445666653 124789999999999999888899999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.67 E-value=8.2e-05 Score=81.68 Aligned_cols=73 Identities=12% Similarity=0.049 Sum_probs=49.1
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccCC--------cCHHHHHHHHHHhhccCc--c-eeeeeeeEeecCCeeeEE
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--------QGKKEFRAEVSIIGSIHH--L-HLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--------~~~~~~~~Ev~~l~~l~h--~-niv~l~~~~~~~~~~~lv 565 (817)
+.||.|.++.||++... +++.++||...... .....+..|.+++..+.+ + .+.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46899999999999864 46789999764321 123456789888887742 3 34455544 34556899
Q ss_pred EeeccCC
Q 036583 566 YEFMANG 572 (817)
Q Consensus 566 ~e~~~~g 572 (817)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00062 Score=71.63 Aligned_cols=74 Identities=19% Similarity=0.180 Sum_probs=60.3
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccC---cceeeeeeeEeecCCeeeEEEeeccCCCh
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH---HLHLVKLRGFCAEGTHRLLAYEFMANGSL 574 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~gsL 574 (817)
+.|+.|....+|+... +++.++||+.... ....+..|.+.|+.+. ...+.+++.++...+..++||||+++..+
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 4589999999999987 5678889987642 3567889999998884 35788899988888889999999998765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0017 Score=71.65 Aligned_cols=80 Identities=13% Similarity=0.010 Sum_probs=47.0
Q ss_pred CCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeeeccCCCCccCccccccC---ccCccccccchhhhHHHh
Q 036583 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNY---AISEKSDVYSYGMVLLEI 687 (817)
Q Consensus 611 ~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwS~Gvvl~el 687 (817)
...++|+|+++.|||++.++ ++|.||+.+..-.....-......-...|++|+..... ......++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 47899999999999998876 99999998875432110000000001235555544311 111234555777777777
Q ss_pred hhCC
Q 036583 688 IGGR 691 (817)
Q Consensus 688 ltg~ 691 (817)
+.++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0012 Score=68.83 Aligned_cols=73 Identities=26% Similarity=0.265 Sum_probs=53.6
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccCC-cCHHHHHHHHHHhhccCc---ceeeeeeeEeecCCeeeEEEeeccCCC
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHH---LHLVKLRGFCAEGTHRLLAYEFMANGS 573 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h---~niv~l~~~~~~~~~~~lv~e~~~~gs 573 (817)
+.+|.|..+.||+.++.||+.+.||+-.... .....|..|.+.|+.|.. -.+.+++++. ..++||||++.+.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 5689999999999999999999999875432 334568899999888742 2344555442 3478999988764
Q ss_pred h
Q 036583 574 L 574 (817)
Q Consensus 574 L 574 (817)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0013 Score=68.90 Aligned_cols=70 Identities=6% Similarity=0.023 Sum_probs=43.6
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCccee-eeeeeEeecCCeeeEEEeec-cCCCh
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHL-VKLRGFCAEGTHRLLAYEFM-ANGSL 574 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gsL 574 (817)
+.|+.|....+|+. +.+++|+............+|+.++..+....+ .+++++ +.+..++++||+ ++.+|
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 45888999999998 458888876432211223568888777753333 455544 344457899999 65444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0023 Score=69.22 Aligned_cols=139 Identities=17% Similarity=0.168 Sum_probs=82.3
Q ss_pred ccCCCcceeEEEEEcCC--------CcEEEEEEeccCCcCHHHHHHHHHHhhccC-cceeeeeeeEeecCCeeeEEEeec
Q 036583 499 KLGQGGFGSVYQGVLPD--------GTRLAVKKLEGIGQGKKEFRAEVSIIGSIH-HLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~~--------g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
.|..|-...+|+....+ ++.+++|+..........+.+|..+++.+. +.-..++++.+.++ +||||+
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~i 132 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQYI 132 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEECC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEEe
Confidence 46667788899988752 478888886443345567779999998884 33345667666542 899999
Q ss_pred cCCChhhh--------------h---hhcc---cccch-hhhHHHHHHHHHHH-------------------HHHHHHh-
Q 036583 570 ANGSLDKW--------------I---FKKN---QEFLL-DWETRFNIALGTAK-------------------GLAYLHE- 608 (817)
Q Consensus 570 ~~gsL~~~--------------l---~~~~---~~~~l-~~~~~~~i~~qia~-------------------~l~~LH~- 608 (817)
+|..|..- | +... ...+. -|.+..++..++.. .+..|.+
T Consensus 133 ~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~ 212 (379)
T 3feg_A 133 PSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKL 212 (379)
T ss_dssp SEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHH
T ss_pred cCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHH
Confidence 98655311 1 1100 00011 23444444433321 2233321
Q ss_pred ----cCCCceeecCCCCCCeEecCC----CcEEEeecCCcc
Q 036583 609 ----DCDQRIIHCDIKPENVLLDDN----YHAKVSDFGLAK 641 (817)
Q Consensus 609 ----~~~~~ivH~Dlk~~NIll~~~----~~~ki~Dfgla~ 641 (817)
.....++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 213 L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 213 LESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 123578999999999999876 789999998775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0019 Score=71.33 Aligned_cols=72 Identities=17% Similarity=0.205 Sum_probs=50.2
Q ss_pred cccCCCcceeEEEEEcCC--------CcEEEEEEeccCCcCHHHHHHHHHHhhccCccee-eeeeeEeecCCeeeEEEee
Q 036583 498 VKLGQGGFGSVYQGVLPD--------GTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHL-VKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~--------g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 568 (817)
+.|+.|....||+....+ ++.+++|+.... .....+..|..++..+...++ .++++.+.+ .+|+||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 457888889999998753 478889988432 222567789999988853333 566766543 289999
Q ss_pred ccCCCh
Q 036583 569 MANGSL 574 (817)
Q Consensus 569 ~~~gsL 574 (817)
+++.+|
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0057 Score=64.74 Aligned_cols=141 Identities=13% Similarity=0.079 Sum_probs=83.3
Q ss_pred ccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcc--eeeeeeeE-----eecCCeeeEEEeeccC
Q 036583 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHL--HLVKLRGF-----CAEGTHRLLAYEFMAN 571 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~~~ 571 (817)
.|+ |....||+....+|+.+++|...........+..|..++..+... .+.+++.. ...++..+++||+++|
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 356 788899998887787899999875434567788899888887422 24444443 1224456789999988
Q ss_pred CChhh-----------h---hhhccc------ccchhhhHH----HHH---------------HHHHHHHHHHHHhc---
Q 036583 572 GSLDK-----------W---IFKKNQ------EFLLDWETR----FNI---------------ALGTAKGLAYLHED--- 609 (817)
Q Consensus 572 gsL~~-----------~---l~~~~~------~~~l~~~~~----~~i---------------~~qia~~l~~LH~~--- 609 (817)
..+.. . ++.... ....++... ..+ ...+.+.++.+.+.
T Consensus 112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 191 (328)
T 1zyl_A 112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 191 (328)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 54321 1 111000 001111110 000 11111222333221
Q ss_pred -CCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 610 -CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 610 -~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 236789999999999999 4 899999987753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0045 Score=65.40 Aligned_cols=142 Identities=13% Similarity=0.103 Sum_probs=81.0
Q ss_pred cccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcce--eeeeeeE------eecCCeeeEEEeec
Q 036583 498 VKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLH--LVKLRGF------CAEGTHRLLAYEFM 569 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e~~ 569 (817)
+.|+.|....+|+....+| .+++|+.... ...+++..|+.++..+.... +.+++.. ....+..+++++|+
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 3477788899999987666 5788888652 12345667888877774222 3333321 12235678999999
Q ss_pred cCCChhh--------------hhhhcccc---------cchhhhHHHH------------HHHHHHHHHHHHHhc----C
Q 036583 570 ANGSLDK--------------WIFKKNQE---------FLLDWETRFN------------IALGTAKGLAYLHED----C 610 (817)
Q Consensus 570 ~~gsL~~--------------~l~~~~~~---------~~l~~~~~~~------------i~~qia~~l~~LH~~----~ 610 (817)
+|..+.. .++..... ....|..... +...+.+.++.+++. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 9865421 01111000 0122322111 011234455555532 2
Q ss_pred CCceeecCCCCCCeEecCCCcEEEeecCCcc
Q 036583 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAK 641 (817)
Q Consensus 611 ~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 641 (817)
...++|+|+++.||+++++..+.|+||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3579999999999999987666899998765
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0048 Score=68.50 Aligned_cols=73 Identities=12% Similarity=-0.005 Sum_probs=46.9
Q ss_pred cccCCCcceeEEEEEcCC-CcEEEEEEeccCCcCHHHHHHHHHHhhccCccee-eeeeeEeecCCeeeEEEeeccCCCh
Q 036583 498 VKLGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHL-VKLRGFCAEGTHRLLAYEFMANGSL 574 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL 574 (817)
+.|+.|-...+|+....+ +..+++|+........-+...|..++..+...++ .++++.+.. .+||||+++..|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 457888889999998765 4778888874322211122578888888864444 567776632 259999987544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.60 E-value=0.016 Score=61.41 Aligned_cols=141 Identities=18% Similarity=0.126 Sum_probs=73.0
Q ss_pred ccCCCccee-EEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCc--ceeeeeeeEeecCCeeeEEEeeccCCChh
Q 036583 499 KLGQGGFGS-VYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHH--LHLVKLRGFCAEGTHRLLAYEFMANGSLD 575 (817)
Q Consensus 499 ~lG~G~fG~-Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 575 (817)
.|+.|.... +|+....+++.+++|...... ..++..|+.++..+.. -.+.+++.+..+. .+++||++.+..+.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l~ 100 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALFT 100 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBHH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcchH
Confidence 355554443 667766446677777654322 1334567777766642 2355666654333 37899999876665
Q ss_pred hhhhhccc----------------------cc-chhhhHH---------------H-----HHHHHHHHHHHHHH---hc
Q 036583 576 KWIFKKNQ----------------------EF-LLDWETR---------------F-----NIALGTAKGLAYLH---ED 609 (817)
Q Consensus 576 ~~l~~~~~----------------------~~-~l~~~~~---------------~-----~i~~qia~~l~~LH---~~ 609 (817)
+++..... .. ..+.... . .....+...+..+. ..
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 44321100 00 0000000 0 00011112222221 11
Q ss_pred CCCceeecCCCCCCeEecCC----CcEEEeecCCcccc
Q 036583 610 CDQRIIHCDIKPENVLLDDN----YHAKVSDFGLAKLM 643 (817)
Q Consensus 610 ~~~~ivH~Dlk~~NIll~~~----~~~ki~Dfgla~~~ 643 (817)
....++|+|+.+.||+++.+ ..+.|.||+.+..-
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 24689999999999999874 68999999988643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.36 E-value=0.0039 Score=67.43 Aligned_cols=73 Identities=11% Similarity=0.047 Sum_probs=43.7
Q ss_pred cccCCCcceeEEEEEcCC---------CcEEEEEEeccCCcCHHHHHHHHHHhhccCcce-eeeeeeEeecCCeeeEEEe
Q 036583 498 VKLGQGGFGSVYQGVLPD---------GTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLH-LVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~---------g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e 567 (817)
+.|+.|....+|+....+ ++.+++|+.........+...|.+++..+...+ ..++++... -.+|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEEE
Confidence 347778888999988754 267888876543221112467888888775333 346665441 368999
Q ss_pred eccCCCh
Q 036583 568 FMANGSL 574 (817)
Q Consensus 568 ~~~~gsL 574 (817)
|+++..+
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.32 E-value=0.011 Score=57.65 Aligned_cols=101 Identities=12% Similarity=0.052 Sum_probs=65.4
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
-+|.++|...+. +++.++++.++.|.+.+|.-+-.. ..-..+=+.|..|++..+|.+...+ ..+.
T Consensus 33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc----------
Confidence 378999976554 899999999999999998766210 1111333456889999999988764 1110
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCC
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGR 691 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~ 691 (817)
.....+.|||... ...+.+.=|||+|+++|.-+--.
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 1123466888763 34467788999999999998644
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.01 E-value=0.024 Score=60.27 Aligned_cols=68 Identities=18% Similarity=0.163 Sum_probs=44.4
Q ss_pred CCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCc---ceeeeeeeE------eecCCeeeEEEeeccC
Q 036583 501 GQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHH---LHLVKLRGF------CAEGTHRLLAYEFMAN 571 (817)
Q Consensus 501 G~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h---~niv~l~~~------~~~~~~~~lv~e~~~~ 571 (817)
|.|....||+....+| .+++|+...... ..|+.++..|.. |++.+++.. ...++..+++|+|++|
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 4455789999998777 899998765432 345566655531 224444432 2345677999999998
Q ss_pred CCh
Q 036583 572 GSL 574 (817)
Q Consensus 572 gsL 574 (817)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.25 E-value=0.32 Score=53.11 Aligned_cols=73 Identities=8% Similarity=0.014 Sum_probs=46.9
Q ss_pred cccCCCcceeEEEEEcCC--------CcEEEEEEeccCCcCHHHHHHHHHHhhccCc-ceeeeeeeEeecCCeeeEEEee
Q 036583 498 VKLGQGGFGSVYQGVLPD--------GTRLAVKKLEGIGQGKKEFRAEVSIIGSIHH-LHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~--------g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.|..|-...+|+....+ ++.+++|+........-+..+|..+++.+.. .-..++++.+. -.+||||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence 356778888999988753 5778888864432222234578888887742 22345555332 3789999
Q ss_pred ccCCCh
Q 036583 569 MANGSL 574 (817)
Q Consensus 569 ~~~gsL 574 (817)
+++..|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998654
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=92.31 E-value=0.14 Score=41.30 Aligned_cols=36 Identities=19% Similarity=0.454 Sum_probs=31.8
Q ss_pred ccChhhHHHHhhccCceeeEeeccCCCceEEEeccc
Q 036583 357 KADLNGCKKACLGNCSCLAMFFQNSSGNCFLFDRIG 392 (817)
Q Consensus 357 ~~~~~~C~~~Cl~nCsC~Ay~~~~~~g~C~~~~~~~ 392 (817)
.+++++|+..|+.+=.|.||.|+..+..|+++....
T Consensus 29 ~~sl~~Cq~aC~a~~~C~aFTyN~~s~~CflKs~~~ 64 (82)
T 2ll3_A 29 ASSLSECRARCQAEKECSHYTYNVKSGLCYPKRGKP 64 (82)
T ss_dssp CSSHHHHHHHHHHCTTEEEEEEETTTTEEEEEESSC
T ss_pred CCCHHHHHHHhhccCCCCeEEeccCCCceEcccCCC
Confidence 458999999999999999999998888999996543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.35 E-value=1.5 Score=47.38 Aligned_cols=30 Identities=23% Similarity=0.370 Sum_probs=25.0
Q ss_pred ceeecCCCCCCeEe------cCCCcEEEeecCCccc
Q 036583 613 RIIHCDIKPENVLL------DDNYHAKVSDFGLAKL 642 (817)
Q Consensus 613 ~ivH~Dlk~~NIll------~~~~~~ki~Dfgla~~ 642 (817)
.++|+|+.+.||++ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567899999988753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 817 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-69 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-67 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-66 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-61 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-50 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-42 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-22 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 3e-12 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 8e-12 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 8e-11 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 1e-05 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 1e-09 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 1e-05 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 3e-05 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 7e-05 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 6e-69
Identities = 68/274 (24%), Positives = 125/274 (45%), Gaps = 24/274 (8%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGI-GQGKKEFRAEVSIIGSIHHLHLVKLRGFCA 557
++G G FG+VY+G + + + Q + F+ EV ++ H++++ G+
Sbjct: 15 RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 73
Query: 558 EGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHC 617
+ ++ SL + +F + +IA TA+G+ YLH + IIH
Sbjct: 74 TAPQLAIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 618 DIKPENVLLDDNYHAKVSDFGLAKLMTR-EQSHVFTTLRGTRGYLAPEWITNY---AISE 673
D+K N+ L ++ K+ DFGLA + +R SH F L G+ ++APE I S
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 674 KSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS-RLNIDEQS 732
+SDVY++G+VL E++ G+ + D+ M+ G L L R N +
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYLSPDLSKVRSNCPKA- 241
Query: 733 DRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
++ C+++ RP +++ +E +
Sbjct: 242 -----MKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (568), Expect = 1e-67
Identities = 68/273 (24%), Positives = 123/273 (45%), Gaps = 20/273 (7%)
Query: 495 NFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRG 554
F ++G G FG V+ G + ++A+K + +++F E ++ + H LV+L G
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
C E L +EFM +G L ++ + L ET + L +G+AYL + +
Sbjct: 68 VCLEQAPICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYL---EEACV 122
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEK 674
IH D+ N L+ +N KVSDFG+ + + +Q T + + +PE + S K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 675 SDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDR 734
SDV+S+G+++ E+ K N + S + + G + RL
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDISTGF--RLYKPRLASTH---- 230
Query: 735 VFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767
++ C +E RP+ +++++ L I
Sbjct: 231 ---VYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 5e-67
Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 20/268 (7%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558
+LG G FG V+ G T++AVK L+ F AE +++ + H LV+L +
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 559 GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCD 618
+ E+M NGSL ++ K L ++A A+G+A++ E IH D
Sbjct: 80 E-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRD 134
Query: 619 IKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVY 678
++ N+L+ D K++DFGLA+L+ + + + APE I + KSDV+
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 679 SYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTA 738
S+G++L EI+ + P T+ + + +E G R+ +
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPE------VIQNLERGY-------RMVRPDNCPE--EL 239
Query: 739 VKVALWCVQEDMSLRPSMTKVVQMLEGI 766
++ C +E RP+ + +LE
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 220 bits (560), Expect = 4e-66
Identities = 77/308 (25%), Positives = 132/308 (42%), Gaps = 41/308 (13%)
Query: 484 FTYRDLQTATNNFSV-----------KLGQGGFGSVYQGVLPDGTRL----AVKKL--EG 526
FT+ D A F+ +G G FG V G L + A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 527 IGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFL 586
+ +++F +E SI+G H +++ L G + T ++ EFM NGSLD ++ + + +F
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 587 LDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646
+ G A G+ YL D +H D+ N+L++ N KVSDFGL++ + +
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 647 QSHVFTT----LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDK 702
S T + + APE I + SDV+SYG+V+ E++ +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231
Query: 703 AHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762
+ M + N ++ + D ++ L C Q+D + RP ++V
Sbjct: 232 -----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 763 LEGICPVP 770
L+ + P
Sbjct: 287 LDKMIRNP 294
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 4e-65
Identities = 66/275 (24%), Positives = 120/275 (43%), Gaps = 20/275 (7%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558
KLGQG FG V+ G TR+A+K L+ + F E ++ + H LV+L +E
Sbjct: 24 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 83
Query: 559 GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCD 618
+ E+M+ GSL ++ + ++L ++A A G+AY+ +H D
Sbjct: 84 E-PIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE---RMNYVHRD 138
Query: 619 IKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVY 678
++ N+L+ +N KV+DFGLA+L+ + + + APE + KSDV+
Sbjct: 139 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 198
Query: 679 SYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTA 738
S+G++L E+ + P + + +E G R+ + +
Sbjct: 199 SFGILLTELTTKGRVPYPGMVNRE------VLDQVERGY-------RMPCPPECPE--SL 243
Query: 739 VKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQPP 773
+ C +++ RP+ + LE +P
Sbjct: 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 6e-65
Identities = 57/275 (20%), Positives = 113/275 (41%), Gaps = 22/275 (8%)
Query: 494 NNFSV--KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVK 551
+ + +LG G FG V G +A+K ++ + EF E ++ ++ H LV+
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 552 LRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCD 611
L G C + + E+MANG L ++ + F + + + + YL
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRF--QTQQLLEMCKDVCEAMEYLE---S 118
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAI 671
++ +H D+ N L++D KVSDFGL++ + ++ + + PE +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 672 SEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731
S KSD++++G+++ EI K T+ + + + +G RL
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGL-------RLYRPHL 225
Query: 732 SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
+ + C E RP+ ++ + +
Sbjct: 226 ASE--KVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 216 bits (551), Expect = 7e-65
Identities = 70/289 (24%), Positives = 129/289 (44%), Gaps = 22/289 (7%)
Query: 481 PVRFTYRDLQTATNNFSV--KLGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQGKKEFRAE 537
P Y + + ++ KLG G +G VY+GV +AVK L+ +EF E
Sbjct: 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 63
Query: 538 VSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIAL 597
+++ I H +LV+L G C + EFM G+L ++ + N++ + +A
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMAT 122
Query: 598 GTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGT 657
+ + YL + + IH D+ N L+ +N+ KV+DFGL++LMT + +
Sbjct: 123 QISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179
Query: 658 RGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGK 717
+ APE + S KSDV+++G++L EI + + ++ +
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQ 224
Query: 718 LRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
+ +L+ ++ ++ C Q + S RPS ++ Q E +
Sbjct: 225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 5e-64
Identities = 60/291 (20%), Positives = 116/291 (39%), Gaps = 28/291 (9%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558
+G+G FG V++G G +AVK + AE+ + H +++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 559 G----THRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC---- 610
T L ++ +GSL ++ + + E +AL TA GLA+LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 611 -DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF---TTLRGTRGYLAPEWI 666
I H D+K +N+L+ N ++D GLA + GT+ Y+APE +
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 667 ------TNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHF----PSYAFKMMEEG 716
++ +++D+Y+ G+V EI +E ++ + + M +
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 717 KLRNILDSRLNIDEQSDRVFTAV-KVALWCVQEDMSLRPSMTKVVQMLEGI 766
L + QS + K+ C + + R + ++ + L +
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 212 bits (540), Expect = 4e-63
Identities = 70/314 (22%), Positives = 129/314 (41%), Gaps = 50/314 (15%)
Query: 486 YRDLQTATNNFSV--KLGQGGFGSVYQGVLP------DGTRLAVKKL--EGIGQGKKEFR 535
L+ NN +G+G FG V+Q P T +AVK L E + +F+
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 536 AEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFL--------- 586
E +++ + ++VKL G CA G L +E+MA G L++++ + +
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 587 ------------LDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKV 634
L + IA A G+AYL E ++ +H D+ N L+ +N K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181
Query: 635 SDFGLAKLM-TREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKN 693
+DFGL++ + + + ++ PE I + +SDV++YG+VL EI
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 694 FDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLR 753
++ + +G + + N + + C + + R
Sbjct: 242 PYYGMAHEE------VIYYVRDGNILACPE---NCPLE------LYNLMRLCWSKLPADR 286
Query: 754 PSMTKVVQMLEGIC 767
PS + ++L+ +C
Sbjct: 287 PSFCSIHRILQRMC 300
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 4e-62
Identities = 72/269 (26%), Positives = 120/269 (44%), Gaps = 26/269 (9%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE 558
+G+G FG V G G ++AVK ++ + F AE S++ + H +LV+L G E
Sbjct: 14 TIGKGEFGDVMLGDY-RGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 559 GTHRL-LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHC 617
L + E+MA GSL ++ + + L + +L + + YL +H
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYLEG---NNFVHR 127
Query: 618 DIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDV 677
D+ NVL+ ++ AKVSDFGL K + Q T + + APE + S KSDV
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDV 183
Query: 678 YSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFT 737
+S+G++L EI + P +E+G +++ +
Sbjct: 184 WSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGY-------KMDAPDGCPP--A 228
Query: 738 AVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
+V C D ++RPS ++ + LE I
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 9e-62
Identities = 69/291 (23%), Positives = 120/291 (41%), Gaps = 33/291 (11%)
Query: 487 RDLQTATNNFSV---KLGQGGFGSVYQGVL---PDGTRLAVKKL--EGIGQGKKEFRAEV 538
+ L +N + +LG G FGSV QGV +A+K L +E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 539 SIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALG 598
I+ + + ++V+L G C + +L E G L K++ K +E + +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQ 117
Query: 599 TAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH--VFTTLRG 656
+ G+ YL ++ +H D+ NVLL + ++AK+SDFGL+K + + S+ + +
Sbjct: 118 VSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 657 TRGYLAPEWITNYAISEKSDVYSYGMVLLEII-GGRKNFDPNETSDKAHFPSYAFKMMEE 715
+ APE I S +SDV+SYG+ + E + G+K + + + +E+
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQ 227
Query: 716 GKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
GK + + C RP V Q +
Sbjct: 228 GKRMECPP---ECPPE------LYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 1e-61
Identities = 61/305 (20%), Positives = 121/305 (39%), Gaps = 40/305 (13%)
Query: 489 LQTATNNFSV--KLGQGGFGSVYQGV-LPDGTRLAVKKL--EGIGQGKKEFRAEVSIIGS 543
++ ++F +LG G G V++ P G +A K + E + + E+ ++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 544 IHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGL 603
+ ++V G + E M GSLD+ + K + + + +++ KGL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117
Query: 604 AYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAP 663
YL E +I+H D+KP N+L++ K+ DFG++ + + + GTR Y++P
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSP 172
Query: 664 EWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSD---------------------- 701
E + S +SD++S G+ L+E+ GR P + +
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 702 -KAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFT----AVKVALWCVQEDMSLRPSM 756
SY + +LD +N C+ ++ + R +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 757 TKVVQ 761
+++
Sbjct: 293 KQLMV 297
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 1e-60
Identities = 73/324 (22%), Positives = 140/324 (43%), Gaps = 37/324 (11%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVK------KLEGIGQGKKEFRAEVSIIGSIHHLHLVK 551
LG G FG+VY+G+ +P+G ++ + + + KE E ++ S+ + H+ +
Sbjct: 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 552 LRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCD 611
L G C T +L+ + M G L ++ + + N + AKG+ YL D
Sbjct: 76 LLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNYL---ED 129
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM-TREQSHVFTTLRGTRGYLAPEWITNYA 670
+R++H D+ NVL+ H K++DFGLAKL+ E+ + + ++A E I +
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 671 ISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730
+ +SDV+SYG+ + E++ + + ++ +IL+ + +
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSKP---------------YDGIPASEISSILEKGERLPQ 234
Query: 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQ------PPTCSPLGARLYS 784
+ + C D RP +++ + PQ L + S
Sbjct: 235 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDS 294
Query: 785 SFFRSISEEGTSSGPSDCNSDAYL 808
+F+R++ +E D +D YL
Sbjct: 295 NFYRALMDEEDMDDVVD--ADEYL 316
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 2e-60
Identities = 68/293 (23%), Positives = 118/293 (40%), Gaps = 42/293 (14%)
Query: 499 KLGQGGFGSVYQGVL------PDGTRLAVKKL--EGIGQGKKEFRAEVSIIGSI-HHLHL 549
LG G FG V + +AVK L ++ +E+ ++ + +H+++
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 550 VKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFL---------------LDWETRFN 594
V L G C G L+ E+ G L ++ +K F+ LD E +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 595 IALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT- 653
+ AKG+A+L + IH D+ N+LL K+ DFGLA+ + + ++V
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 654 LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMM 713
R ++APE I N + +SDV+SYG+ L E+ + P M
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG--------------MP 252
Query: 714 EEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
+ K ++ + + C D RP+ ++VQ++E
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-58
Identities = 66/280 (23%), Positives = 131/280 (46%), Gaps = 29/280 (10%)
Query: 500 LGQGGFGSVYQGVLPDGTR-----LAVKKL--EGIGQGKKEFRAEVSIIGSIHHLHLVKL 552
+G G FG VY+G+L + +A+K L + + +F E I+G H ++++L
Sbjct: 15 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
G ++ ++ E+M NG+LDK++ +K+ EF + G A G+ YL
Sbjct: 75 EGVISKYKPMMIITEYMENGALDKFLREKDGEF--SVLQLVGMLRGIAAGMKYLAN---M 129
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT--LRGTRGYLAPEWITNYA 670
+H D+ N+L++ N KVSDFGL++++ + +TT + + APE I+
Sbjct: 130 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 189
Query: 671 ISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730
+ SDV+S+G+V+ E++ + + + ++ ++ +
Sbjct: 190 FTSASDVWSFGIVMWEVMTYGERP---------------YWELSNHEVMKAINDGFRLPT 234
Query: 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVP 770
D ++ + C Q++ + RP +V +L+ + P
Sbjct: 235 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 6e-58
Identities = 69/282 (24%), Positives = 118/282 (41%), Gaps = 30/282 (10%)
Query: 495 NFSVKLGQGGFGSVYQGVLPD----GTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLH 548
+F+ +G+G FG VY G L D AVK L I +F E I+ H +
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 549 LVKLRGFCAEG-THRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLH 607
++ L G C L+ +M +G L +I + + L AKG+
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGM---K 144
Query: 608 EDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ---SHVFTTLRGTRGYLAPE 664
++ +H D+ N +LD+ + KV+DFGLA+ M ++ H T + ++A E
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 665 WITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724
+ + KSDV+S+G++L E++ P+ + + +G+
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYLLQGR------- 251
Query: 725 RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
RL E +V L C +RPS +++V + I
Sbjct: 252 RLLQPEYCPDPL--YEVMLKCWHPKAEMRPSFSELVSRISAI 291
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 7e-58
Identities = 64/272 (23%), Positives = 112/272 (41%), Gaps = 26/272 (9%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL---EGIGQGKKEFRAEVSIIGSIHHLHLVKLRG 554
+G G +G + DG L K+L K+ +EV+++ + H ++V+
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 555 FCAEGTHRLL--AYEFMANGSLDKWIFKKNQEF-LLDWETRFNIALGTAKGLAYLHE--D 609
+ T+ L E+ G L I K +E LD E + L H D
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNY 669
++H D+KP NV LD + K+ DFGLA+++ + S GT Y++PE +
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA-KAFVGTPYYMSPEQMNRM 189
Query: 670 AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729
+ +EKSD++S G +L E+ F + + EGK R I
Sbjct: 190 SYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFRRIPY---RYS 239
Query: 730 EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761
++ ++ + RPS+ ++++
Sbjct: 240 DE------LNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-57
Identities = 65/274 (23%), Positives = 116/274 (42%), Gaps = 30/274 (10%)
Query: 499 KLGQGGFGSVYQGVLPD---GTRLAVKKLE---GIGQGKKEFRAEVSIIGSIHHLHLVKL 552
+LG G FG+V +G +AVK L+ K E AE +++ + + ++V++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
G C E +L E G L+K++ + + + + + G+ YL +
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE---ES 126
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT--LRGTRGYLAPEWITNYA 670
+H D+ NVLL ++AK+SDFGL+K + ++++ + + APE I Y
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 671 ISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730
S KSDV+S+G+++ E + + M+E+G+ R+
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKGE-------RMGCPA 233
Query: 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764
R + C D+ RP V L
Sbjct: 234 GCPR--EMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-57
Identities = 66/296 (22%), Positives = 110/296 (37%), Gaps = 47/296 (15%)
Query: 499 KLGQGGFGSVYQGVLPDGTRL------AVKKL--EGIGQGKKEFRAEVSIIGSI-HHLHL 549
LG G FG V ++ AVK L + ++ +E+ ++ + H ++
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 550 VKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEF--------------------LLDW 589
V L G C L +E+ G L ++ K ++F +L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 590 ETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK-LMTREQS 648
E A AKG+ +L + +H D+ NVL+ K+ DFGLA+ +M+
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSY 708
V R ++APE + + KSDV+SYG++L EI N P D
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN----- 275
Query: 709 AFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764
++ + +D+ + C D RPS + L
Sbjct: 276 ---------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 3e-57
Identities = 53/275 (19%), Positives = 113/275 (41%), Gaps = 31/275 (11%)
Query: 496 FSVKLGQGGFGSVYQGVLPD-GTRLAVKKL---EGIGQGKKEFRAEVSIIGSIHHLHLVK 551
F +++G+G F +VY+G+ + +A +L + ++ F+ E ++ + H ++V+
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 552 LRGFCAE----GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLH 607
+L E M +G+L ++ + + + + KGL +LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLH 129
Query: 608 EDCDQRIIHCDIKPENVLLDD-NYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI 666
IIH D+K +N+ + K+ D GLA L ++ + GT ++APE
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMY 185
Query: 667 TNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726
E DVY++GM +LE+ + + + ++ + G D
Sbjct: 186 EE-KYDESVDVYAFGMCMLEMATSEYPY------SECQNAAQIYRRVTSGVKPASFDKVA 238
Query: 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761
+ ++ C++++ R S+ ++
Sbjct: 239 IPE--------VKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 3e-57
Identities = 69/333 (20%), Positives = 136/333 (40%), Gaps = 45/333 (13%)
Query: 481 PVRFTYRDLQTATNNFSV--KLGQGGFGSVYQGVLPDGTRL---AVKKLEGIG--QGKKE 533
P + D N+ +G+G FG V + + A+K+++ ++
Sbjct: 1 PTIYPVLDW----NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 534 FRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFL------ 586
F E+ ++ + HH +++ L G C + LA E+ +G+L ++ K
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116
Query: 587 -------LDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGL 639
L + + A A+G+ YL + ++ IH D+ N+L+ +NY AK++DFGL
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 173
Query: 640 AKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNET 699
++ T R ++A E + + SDV+SYG++L EI+ T
Sbjct: 174 SRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231
Query: 700 SDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKV 759
+ ++ + +G L+ LN D++ + C +E RPS ++
Sbjct: 232 CAE------LYEKLPQGY---RLEKPLNCDDE------VYDLMRQCWREKPYERPSFAQI 276
Query: 760 VQMLEGICPVPQPPTCSPLGARLYSSFFRSISE 792
+ L + + + L + + +E
Sbjct: 277 LVSLNRMLEERKTYVNTTLYEKFTYAGIDCSAE 309
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (494), Expect = 2e-56
Identities = 61/271 (22%), Positives = 104/271 (38%), Gaps = 34/271 (12%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL----EGIGQGKKEFRAEVSIIGSIHHLHLVKLR 553
++G G FG+VY + + +A+KK+ + + ++ EV + + H + ++ R
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
G L E+ + D K L + G +GLAYLH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHS---HN 135
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNY---A 670
+IH D+K N+LL + K+ DFG A +M S V GT ++APE I
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQ 190
Query: 671 ISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730
K DV+S G+ +E+ + F M L +I + +
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPL---------------FNMNAMSALYHIAQNESPALQ 235
Query: 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761
C+Q+ RP+ +++
Sbjct: 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 8e-56
Identities = 67/268 (25%), Positives = 113/268 (42%), Gaps = 31/268 (11%)
Query: 499 KLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG----QGKKEFRAEVSIIGSIHHLHLVKLR 553
LG+G FG+VY LA+K L + + R EV I + H ++++L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
G+ + T L E+ G++ + + K ++ D + A L+Y H +R
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHS---KR 126
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISE 673
+IH DIKPEN+LL K++DFG + + TL GT YL PE I E
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEGRMHDE 183
Query: 674 KSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSD 733
K D++S G++ E + G+ F+ N + + I +
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQE---------------TYKRISRVEFTFPDFVT 228
Query: 734 RVFTAVKVALWCVQEDMSLRPSMTKVVQ 761
A + ++ + S RP + +V++
Sbjct: 229 E--GARDLISRLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 5e-55
Identities = 61/271 (22%), Positives = 111/271 (40%), Gaps = 29/271 (10%)
Query: 499 KLGQGGFGSVYQGVLPD-GTRLAVKKLE-GIGQGKKEFRAEVSIIGSIHHLHLVKLRGFC 556
+LG G FG VY+ + A K ++ + +++ E+ I+ S H ++VKL
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 557 AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIH 616
+ + EF A G++D + + + L + T L YLH+ +IIH
Sbjct: 79 YYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHD---NKIIH 133
Query: 617 CDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYA-----I 671
D+K N+L + K++DFG++ TR + GT ++APE +
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-RDSFIGTPYWMAPEVVMCETSKDRPY 192
Query: 672 SEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731
K+DV+S G+ L+E+ L I S Q
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHELNPMR---------------VLLKIAKSEPPTLAQ 237
Query: 732 SDRVFTAVK-VALWCVQEDMSLRPSMTKVVQ 761
R + K C+++++ R + ++++Q
Sbjct: 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-54
Identities = 63/274 (22%), Positives = 106/274 (38%), Gaps = 27/274 (9%)
Query: 499 KLGQGGFGSVYQGVLPD----GTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKL 552
+G+G FG V+QG+ +A+K + +++F E + H H+VKL
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 553 RGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQ 612
G E + E G L ++ + LD + A + LAYL +
Sbjct: 74 IGVITEN-PVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLES---K 127
Query: 613 RIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAIS 672
R +H DI NVL+ N K+ DFGL++ M + + + ++APE I +
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 673 EKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQS 732
SDV+ +G+ + EI+ ++ +E G+ + N
Sbjct: 188 SASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLPMPP---NCPPT- 237
Query: 733 DRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
+ C D S RP T++ L I
Sbjct: 238 -----LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-54
Identities = 64/276 (23%), Positives = 104/276 (37%), Gaps = 30/276 (10%)
Query: 499 KLGQGGFGSVYQGVLP----DGTRLAVKKLE----GIGQGKKEFRAEVSIIGSIHHLHLV 550
KLG G FG V +G +AVK L+ + +F EV+ + S+ H +L+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC 610
+L G +++ E GSL + K FLL +R A+ A+G+ YL
Sbjct: 75 RLYGVVLTPPMKMV-TELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLES-- 129
Query: 611 DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH--VFTTLRGTRGYLAPEWITN 668
+R IH D+ N+LL K+ DFGL + + + H + + + APE +
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 669 YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728
S SD + +G+ L E+ + + L I +
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--------------LHKIDKEGERL 234
Query: 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764
D V + C RP+ + L
Sbjct: 235 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 9e-54
Identities = 68/268 (25%), Positives = 113/268 (42%), Gaps = 25/268 (9%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL--EGIGQGKKEFRAEVSIIGSIHHLHLVKLRGF 555
LG+G +G V V +AVK + + + + E+ I ++H ++VK G
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
EG + L E+ + G L I + G+ YLH I
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG---IGIT 125
Query: 616 HCDIKPENVLLDDNYHAKVSDFGLAKLMTR-EQSHVFTTLRGTRGYLAPEWITNYAI-SE 673
H DIKPEN+LLD+ + K+SDFGLA + + + + GT Y+APE + +E
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 674 KSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSD 733
DV+S G+VL ++ G +D S + + +E K L+ ID
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWKEKKTY--LNPWKKIDSA-- 235
Query: 734 RVFTAVKVALWCVQEDMSLRPSMTKVVQ 761
+ + + E+ S R ++ + +
Sbjct: 236 ----PLALLHKILVENPSARITIPDIKK 259
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-53
Identities = 62/284 (21%), Positives = 122/284 (42%), Gaps = 34/284 (11%)
Query: 499 KLGQGGFGSVYQGVL------PDGTRLAVKKL--EGIGQGKKEFRAEVSIIGSIHHLHLV 550
+LGQG FG VY+GV TR+A+K + + + EF E S++ + H+V
Sbjct: 27 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 86
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFL-------LDWETRFNIALGTAKGL 603
+L G ++G L+ E M G L ++ +A A G+
Sbjct: 87 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146
Query: 604 AYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR-EQSHVFTTLRGTRGYLA 662
AYL+ + +H D+ N ++ +++ K+ DFG+ + + + +++
Sbjct: 147 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 203
Query: 663 PEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722
PE + + + SDV+S+G+VL EI + ++++ + + EG L +
Sbjct: 204 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------VLRFVMEGGLLDKP 257
Query: 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
D N + ++ C Q + +RPS +++ ++
Sbjct: 258 D---NCPDM------LFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 3e-53
Identities = 63/265 (23%), Positives = 115/265 (43%), Gaps = 24/265 (9%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKE-FRAEVSIIGSIHHLHLVKLRGFC 556
K+GQG G+VY + + G +A++++ Q KKE E+ ++ + ++V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 557 AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIH 616
G + E++A GSL + + D + + L +LH ++IH
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS---NQVIH 139
Query: 617 CDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSD 676
DIK +N+LL + K++DFG +T EQS +T+ GT ++APE +T A K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 677 VYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVF 736
++S G++ +E+I G + + + G L + +
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTPE--LQNPEKLSAI----- 245
Query: 737 TAVKVALWCVQEDMSLRPSMTKVVQ 761
C+ D+ R S +++Q
Sbjct: 246 -FRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 1e-52
Identities = 66/293 (22%), Positives = 127/293 (43%), Gaps = 43/293 (14%)
Query: 499 KLGQGGFGSVYQGVLP--------DGTRLAVKKL--EGIGQGKKEFRAEVSIIGSI-HHL 547
LG+G FG V T++AVK L + + + +E+ ++ I H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 548 HLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKK-------------NQEFLLDWETRFN 594
+++ L G C + + E+ + G+L +++ + N E L + +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 595 IALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT-T 653
A A+G+ YL ++ IH D+ NVL+ ++ K++DFGLA+ + + T
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 654 LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMM 713
R ++APE + + + +SDV+S+G++L EI + P ++ FK++
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLL 250
Query: 714 EEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
+EG R++ + C S RP+ ++V+ L+ I
Sbjct: 251 KEGH-------RMDKPSNCTN--ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-52
Identities = 72/292 (24%), Positives = 127/292 (43%), Gaps = 41/292 (14%)
Query: 499 KLGQGGFGSVYQGV------LPDGTRLAVKKL--EGIGQGKKEFRAEVSIIGSI-HHLHL 549
LG+G FG V + +AVK L + +E+ I+ I HHL++
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 550 VKLRGFCAE-GTHRLLAYEFMANGSLDKWIFKKNQEFL-------------LDWETRFNI 595
V L G C + G ++ EF G+L ++ K EF+ L E
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 596 ALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT-L 654
+ AKG+ +L ++ IH D+ N+LL + K+ DFGLA+ + ++ +V
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 655 RGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMME 714
R ++APE I + + +SDV+S+G++L EI + P D+ + ++
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FCRRLK 251
Query: 715 EGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766
EG R+ + + + L C + S RP+ +++V+ L +
Sbjct: 252 EGT-------RMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 179 bits (454), Expect = 1e-50
Identities = 57/269 (21%), Positives = 108/269 (40%), Gaps = 28/269 (10%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL-EGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFC 556
+LG G FG V++ G A K + K+ R E+ + + H LV L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 557 AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIH 616
+ ++ YEFM+ G L + + ++ + + + KGL ++HE +H
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHE---NNYVH 147
Query: 617 CDIKPENVLL--DDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEK 674
D+KPEN++ + K+ DFGL + +QS GT + APE +
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTAEFAAPEVAEGKPVGYY 205
Query: 675 SDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDR 734
+D++S G++ ++ G F + LRN+ N+D+ +
Sbjct: 206 TDMWSVGVLSYILLSGLSPFGGENDDE---------------TLRNVKSCDWNMDDSAFS 250
Query: 735 VFT--AVKVALWCVQEDMSLRPSMTKVVQ 761
+ + D + R ++ + ++
Sbjct: 251 GISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 5e-47
Identities = 51/268 (19%), Positives = 108/268 (40%), Gaps = 27/268 (10%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCA 557
LG+G FG V++ V K ++ G + + E+SI+ H +++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 558 EGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHC 617
++ +EF++ + + I F L+ + + L +LH I H
Sbjct: 72 SMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHF 126
Query: 618 DIKPENVLLD--DNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKS 675
DI+PEN++ + K+ +FG A+ + + L Y APE + +S +
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 676 DVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRV 735
D++S G ++ ++ G F + NI+++ DE++ +
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQ---------------IIENIMNAEYTFDEEAFKE 229
Query: 736 FT--AVKVALWCVQEDMSLRPSMTKVVQ 761
+ A+ + ++ R + ++ +Q
Sbjct: 230 ISIEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 6e-47
Identities = 59/272 (21%), Positives = 106/272 (38%), Gaps = 29/272 (10%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLE----GIGQGKKEFRAEVSIIGSIHHLHLVKLR 553
LG+G F +V L A+K LE E ++ + H VKL
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 554 GFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR 613
+ + NG L K+I K D TA+ ++ L +
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETC---TRFYTAEIVSALEYLHGKG 128
Query: 614 IIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS-HVFTTLRGTRGYLAPEWITNYAIS 672
IIH D+KPEN+LL+++ H +++DFG AK+++ E + GT Y++PE +T +
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188
Query: 673 EKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQS 732
+ SD+++ G ++ +++ G F E + I+ + E+
Sbjct: 189 KSSDLWALGCIIYQLVAGLPPFRAGN---------------EYLIFQKIIKLEYDFPEKF 233
Query: 733 DRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764
A + + D + R ++
Sbjct: 234 FP--KARDLVEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 168 bits (426), Expect = 9e-47
Identities = 56/267 (20%), Positives = 111/267 (41%), Gaps = 24/267 (8%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLE-GIGQGKKEFRAEVSIIGSIHHLHLVKLRGFC 556
+LG G FG V++ V G K + K + E+SI+ +HH L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 557 AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIH 616
+ +L EF++ G L I ++ + + N +GL ++HE I+H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMHE---HSIVH 150
Query: 617 CDIKPENVLLD--DNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEK 674
DIKPEN++ + K+ DFGLA + ++ TT T + APE + +
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGFY 208
Query: 675 SDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDR 734
+D+++ G++ ++ G F + + + ++ D+ ++ +
Sbjct: 209 TDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDWEFDEDAFSSVSPE--- 258
Query: 735 VFTAVKVALWCVQEDMSLRPSMTKVVQ 761
A +Q++ R ++ ++
Sbjct: 259 ---AKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 160 bits (406), Expect = 7e-45
Identities = 55/281 (19%), Positives = 111/281 (39%), Gaps = 39/281 (13%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL----------EGIGQGKKEFRAEVSIIGSIH-H 546
LG+G V + + P AVK + E + + ++ EV I+ + H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 547 LHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYL 606
++++L+ T L ++ M G L ++ +K L + I + + L
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICAL 126
Query: 607 HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI 666
H+ I+H D+KPEN+LLDD+ + K++DFG + + + + GT YLAPE I
Sbjct: 127 HK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAPEII 181
Query: 667 T------NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRN 720
+ ++ D++S G+++ ++ G F + +M+ G +
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRMIMSGNYQF 234
Query: 721 ILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761
+ + + + R + + +
Sbjct: 235 GSPEWDDYSDT------VKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 161 bits (409), Expect = 2e-44
Identities = 66/253 (26%), Positives = 111/253 (43%), Gaps = 26/253 (10%)
Query: 494 NNFSV--KLGQGGFGSVYQGVLPD-GTRLAVKKLE----GIGQGKKEFRAEV---SIIGS 543
N+FSV +G+GGFG VY D G A+K L+ + QG+ E S++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 544 IHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGL 603
+V + + M G L + + A GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---EADMRFYAAEIILGL 120
Query: 604 AYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAP 663
++H + +++ D+KP N+LLD++ H ++SD GLA ++++ H GT GY+AP
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAP 174
Query: 664 EWI-TNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEE------G 716
E + A +D +S G +L +++ G F ++T DK M E
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234
Query: 717 KLRNILDSRLNID 729
+LR++L+ L D
Sbjct: 235 ELRSLLEGLLQRD 247
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (404), Expect = 3e-44
Identities = 58/284 (20%), Positives = 113/284 (39%), Gaps = 29/284 (10%)
Query: 486 YRDLQTATNNFSV--KLGQGGFGSVYQGV-LPDGTRLAVKKL--EGIGQGKKEFRAEVSI 540
++ + + + LG G F V +A+K + + + + E+++
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 541 IGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTA 600
+ I H ++V L G H L + ++ G L I +K +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVL 117
Query: 601 KGLAYLHEDCDQRIIHCDIKPENVLL---DDNYHAKVSDFGLAKLMTREQSHVFTTLRGT 657
+ YLH+ I+H D+KPEN+L D++ +SDFGL+K+ + V +T GT
Sbjct: 118 DAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGT 172
Query: 658 RGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGK 717
GY+APE + S+ D +S G++ ++ G F + F+ + + +
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-------LFEQILKAE 225
Query: 718 LRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761
+I + A +++D R + + +Q
Sbjct: 226 YEFDSPYWDDISDS------AKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 8e-44
Identities = 64/308 (20%), Positives = 113/308 (36%), Gaps = 28/308 (9%)
Query: 500 LGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFC-- 556
LG G G V Q + A+K L+ + ++E H+V++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRAS---QCPHIVRIVDVYEN 76
Query: 557 --AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
A L+ E + G L I + + I + + YLH I
Sbjct: 77 LYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYLHS---INI 132
Query: 615 IHCDIKPENVLLD---DNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAI 671
H D+KPEN+L N K++DFG AK T S TT T Y+APE +
Sbjct: 133 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTPYYVAPEVLGPEKY 190
Query: 672 SEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731
+ D++S G+++ ++ G F N + + G+ + E+
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQYEFPNPEWSEVSEE 247
Query: 732 SDRVFTAVKVALWCVQEDMSLRPSMTKVVQM--LEGICPVPQPPTCSPLGARLYSSFFRS 789
+ ++ + + R ++T+ + + VPQ P + + +
Sbjct: 248 ------VKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWED 301
Query: 790 ISEEGTSS 797
+ EE TS+
Sbjct: 302 VKEEMTSA 309
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (398), Expect = 1e-43
Identities = 54/278 (19%), Positives = 100/278 (35%), Gaps = 29/278 (10%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFC 556
K+G G FG +Y G + G +A+K + + E I + + + +R
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 557 AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIH 616
AEG + ++ E + D + F + +T +A + Y+H + IH
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHS---KNFIH 126
Query: 617 CDIKPENVL---LDDNYHAKVSDFGLAKLMTREQSHVF------TTLRGTRGYLAPEWIT 667
D+KP+N L + DFGLAK ++H L GT Y +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 668 NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL- 726
S + D+ S G VL+ G + + + K ++ + E K+ ++
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ----KYERISEKKMSTPIEVLCK 242
Query: 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764
+ +C +P + + Q+
Sbjct: 243 GYPSE------FATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 4e-42
Identities = 51/283 (18%), Positives = 105/283 (37%), Gaps = 23/283 (8%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGK--KEFRAEVSIIGSIHHLHLVKLRGF 555
+G+G +G V + R+A+KK+ + E+ I+ H +++ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
T + ++ + ++K + L + +GL Y+H ++
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 131
Query: 616 HCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH--VFTTLRGTRGYLAPEWITN-YAIS 672
H D+KP N+LL+ K+ DFGLA++ + H T TR Y APE + N +
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 191
Query: 673 EKSDVYSYGMVLLEIIGGRKNFDPNETSD-------------KAHFPSYAFKMMEEGKLR 719
+ D++S G +L E++ R F D + L
Sbjct: 192 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 251
Query: 720 NILDSRLNIDEQSDRVFT-AVKVALWCVQEDMSLRPSMTKVVQ 761
+++ + + A+ + + + R + + +
Sbjct: 252 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 8e-42
Identities = 60/290 (20%), Positives = 111/290 (38%), Gaps = 46/290 (15%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL-------EGIGQGKKEFRAEVSIIGSIHHLH-- 548
LG GGFGSVY G+ + D +A+K + G EV ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 549 LVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHE 608
+++L + +L E + L E + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHN 128
Query: 609 DCDQRIIHCDIKPENVLLD-DNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI- 666
++H DIK EN+L+D + K+ DFG L+ + V+T GTR Y PEWI
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 182
Query: 667 TNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726
+ + V+S G++L +++ G F+ +E I+ ++
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIRGQV 221
Query: 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM--LEGICPVPQPPT 774
++ + WC+ S RP+ ++ ++ + +PQ
Sbjct: 222 FFRQRVSS--ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV-LLPQETA 268
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 151 bits (383), Expect = 8e-42
Identities = 55/280 (19%), Positives = 98/280 (35%), Gaps = 31/280 (11%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL----EGIGQGKKEFRAEVSIIGSIHHLHLVKLR 553
LG GG V+ L +AVK L FR E +++H +V +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 554 GFCAE----GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED 609
G + E++ +L + + + + + + L + H+
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQ- 129
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV--FTTLRGTRGYLAPEWIT 667
IIH D+KP N+++ KV DFG+A+ + + V + GT YL+PE
Sbjct: 130 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187
Query: 668 NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727
++ +SDVYS G VL E++ G F +
Sbjct: 188 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-------VAYQHVREDPIPPSARHEG 240
Query: 728 IDEQSDRVFTAVKVALWCVQEDMSLRP-SMTKVVQMLEGI 766
+ V L + ++ R + ++ L +
Sbjct: 241 LSAD------LDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 151 bits (381), Expect = 2e-41
Identities = 45/283 (15%), Positives = 91/283 (32%), Gaps = 31/283 (10%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFC 556
++G+G FG +++G L + ++A+K + R E + + + F
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEP-RRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 557 AEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIH 616
EG H +L + + +T A + +HE + +++
Sbjct: 71 QEGLHNVLVIDLLGP---SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVY 124
Query: 617 CDIKPENVLLDDNY-----HAKVSDFGLAKLMTREQSHVF------TTLRGTRGYLAPEW 665
DIKP+N L+ V DFG+ K + L GT Y++
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 666 ITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725
S + D+ + G V + + G + + + ++ + E K L
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ----KYERIGEKKQSTPLREL 240
Query: 726 L-NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767
E+ K + P + + +
Sbjct: 241 CAGFPEE------FYKYMHYARNLAFDATPDYDYLQGLFSKVL 277
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-40
Identities = 76/349 (21%), Positives = 129/349 (36%), Gaps = 56/349 (16%)
Query: 481 PVRFTYRDLQTATNNFSVKLGQGGFGSVYQGVLPD-GTRLAVKKLEGIGQGKKEFRAEVS 539
P +Y D + +G G FG VYQ L D G +A+KK+ Q K+ E+
Sbjct: 17 PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFKNRELQ 65
Query: 540 IIGSIHHLHLVKLRGFCAEG------THRLLAYEFMANGSLDKWIFKKNQEFLLDWETRF 593
I+ + H ++V+LR F + L +++ + L
Sbjct: 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 594 NIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD-DNYHAKVSDFGLAKLMTREQSHVFT 652
+ LAY+H I H DIKP+N+LLD D K+ DFG AK + R + +
Sbjct: 126 LYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--V 180
Query: 653 TLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSD---------- 701
+ +R Y APE I + DV+S G VL E++ G+ F + D
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 240
Query: 702 ----------KAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMS 751
++ + F ++ + R + A+ + ++ +
Sbjct: 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPE--------AIALCSRLLEYTPT 292
Query: 752 LRPSMTKVVQMLEGICPVPQPPTCSPLGARLYSSFFRSISEEGTSSGPS 800
R + + + P P G + F + + + SS P
Sbjct: 293 ARLTPLEACAH-SFFDELRDPNVKLPNGRDTPALF--NFTTQELSSNPP 338
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-40
Identities = 58/293 (19%), Positives = 120/293 (40%), Gaps = 28/293 (9%)
Query: 492 ATNNFSV--KLGQGGFGSVYQG--VLPDGTRLAVKKL------EGIGQGKKEFRAEVSII 541
A + ++G+G +G V++ + G +A+K++ EG+ A + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 542 GSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKW---IFKKNQEFLLDWETRFNIALG 598
+ H ++V+L C + +D+ K E + ET ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 599 TAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTR 658
+GL +LH R++H D+KP+N+L+ + K++DFGLA++ + + + T++ T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179
Query: 659 GYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDK-AHFPSYAFKMMEEGK 717
Y APE + + + D++S G + E+ + F + D+ EE
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 718 LRNILDSRLNIDEQSDRVFT---------AVKVALWCVQEDMSLRPSMTKVVQ 761
R++ R +S + + L C+ + + R S +
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 149 bits (376), Expect = 2e-40
Identities = 73/325 (22%), Positives = 131/325 (40%), Gaps = 30/325 (9%)
Query: 494 NNFSV--KLGQGGFGSVYQGV-LPDGTRLAVKKLE----GIGQGKKEFRAEVSIIGSIHH 546
+F + LG G FG V+ +G A+K L+ + + E ++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 547 LHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYL 606
++++ G + + +++ G L + K A+ L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLAL 117
Query: 607 HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI 666
+ II+ D+KPEN+LLD N H K++DFG AK + V TL GT Y+APE +
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVV 173
Query: 667 TNYAISEKSDVYSYGMVLLEIIGGRKNF---DPNETSDKAHFPSYAFKMMEEGKLRNILD 723
+ ++ D +S+G+++ E++ G F + +T +K F ++++L
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS 233
Query: 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVV--QMLEGICPVPQPPTCSPLGAR 781
+ D S R+ ED+ P +VV ++L P P +
Sbjct: 234 RLITRD-LSQRLGNLQNGT-----EDVKNHPWFKEVVWEKLLSRNIETPYEPPIQ--QGQ 285
Query: 782 LYSSFFRSISEEGTSSGPSDCNSDA 806
+S F EE + G + A
Sbjct: 286 GDTSQFDKYPEEDINYGVQGEDPYA 310
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 4e-40
Identities = 54/247 (21%), Positives = 100/247 (40%), Gaps = 18/247 (7%)
Query: 494 NNFSV--KLGQGGFGSVYQGV-LPDGTRLAVKKLE----GIGQGKKEFRAEVSIIG-SIH 545
+F + LG+G FG V+ A+K L+ + + E ++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 546 HLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAY 605
H L + + E++ G L I ++ D A GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 606 LHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEW 665
LH + I++ D+K +N+LLD + H K++DFG+ K + T GT Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFCGTPDYIAPEI 174
Query: 666 ITNYAISEKSDVYSYGMVLLEIIGGRKNF---DPNETSDKAHFPSYAFKMMEEGKLRNIL 722
+ + D +S+G++L E++ G+ F D E + + E + +++L
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL 234
Query: 723 DSRLNID 729
+
Sbjct: 235 VKLFVRE 241
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 5e-40
Identities = 61/299 (20%), Positives = 116/299 (38%), Gaps = 28/299 (9%)
Query: 495 NFSV--KLGQGGFGSVYQGV-LPDGTRLAVKKL---EGIGQGKKEFRAEVSIIGSIHHLH 548
NF K+G+G +G VY+ G +A+KK+ E+S++ ++H +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 549 LVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHE 608
+VKL L +EF+ + + + +GLA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 609 DCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITN 668
R++H D+KP+N+L++ K++DFGLA+ +T T Y APE +
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLG 176
Query: 669 Y-AISEKSDVYSYGMVLLEIIGGRKNF---DPNETSDKAHFPSYAFKMMEEGKLRNILDS 724
S D++S G + E++ R F + + + + ++ D
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 725 RLNIDEQSDRVFTAVKVAL---------WCVQEDMSLRPSMTKVVQM--LEGI-CPVPQ 771
+ + + + + F+ V L + D + R S + + + PVP
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 295
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 146 bits (370), Expect = 6e-40
Identities = 51/278 (18%), Positives = 106/278 (38%), Gaps = 21/278 (7%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGK---KEFRAEVSIIGSIHHLHLVKLRGF 555
K+G+G +G VY+ G A+KK+ + + E+SI+ + H ++VKL
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRII 615
+L +E + + L+ T + L G+AY H+ +R++
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 616 HCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKS 675
H D+KP+N+L++ K++DFGLA+ + + + S
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 676 DVYSYGMVLLEIIGGRKNFDPNETSD--------KAHFPSYAFKMMEEGKLRNILDSRLN 727
D++S G + E++ G F +D S + + E + +
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 728 IDEQSDRVFTAVKVAL----WCVQEDMSLRPSMTKVVQ 761
+ + + ++ D + R + + ++
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-39
Identities = 61/301 (20%), Positives = 115/301 (38%), Gaps = 34/301 (11%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL------EGIGQGKKEFRAEVSIIGSIHHLHLVK 551
LG+G F +VY+ +A+KK+ E + E+ ++ + H +++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 552 LRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCD 611
L ++ L ++FM + +L L T +GL YLH+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNY-A 670
I+H D+KP N+LLD+N K++DFGLAK +T TR Y APE +
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARM 177
Query: 671 ISEKSDVYSYGMVLLEIIGGRKNFDPNETSD------KAHFPSYAFKMMEEGKLRNILDS 724
D+++ G +L E++ + D + + + L + +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 725 RLNIDEQSDRVFT-----AVKVALWCVQEDMSLRPSMTKVVQM--------LEGICPVPQ 771
+ +F+ + + + R + T+ ++M C +P+
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 297
Query: 772 P 772
P
Sbjct: 298 P 298
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 3e-39
Identities = 60/275 (21%), Positives = 105/275 (38%), Gaps = 33/275 (12%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKL-------EGIGQGKKEFRAEVSIIGSIHHLHLV 550
+LG G F V + G + A K + G +++ EVSI+ I H +++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 551 KLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC 610
L T +L E +A G L ++ +K L E G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHS-- 131
Query: 611 DQRIIHCDIKPENVLLDDN----YHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI 666
+I H D+KPEN++L D K+ DFGLA + + + F + GT ++APE +
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEIV 188
Query: 667 TNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726
+ ++D++S G++ ++ G F + +
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFL-------GDTKQETLANVSAVNYEFEDEYFS 241
Query: 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761
N A + +D R ++ +Q
Sbjct: 242 NTSAL------AKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 1e-36
Identities = 57/246 (23%), Positives = 97/246 (39%), Gaps = 17/246 (6%)
Query: 494 NNFSV--KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKE----FRAEVSIIGSIHH 546
N+F LG+G FG V G A+K L K+ E ++ + H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 547 LHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYL 606
L L+ E+ G L + ++ + E A+ ++ L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYG---AEIVSAL 118
Query: 607 HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWI 666
+ +++ DIK EN++LD + H K++DFGL K + + + T GT YLAPE +
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-TFCGTPEYLAPEVL 177
Query: 667 TNYAISEKSDVYSYGMVLLEIIGGRKNF---DPNETSDKAHFPSYAFKMMEEGKLRNILD 723
+ D + G+V+ E++ GR F D + F + +++L
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA 237
Query: 724 SRLNID 729
L D
Sbjct: 238 GLLKKD 243
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 1e-36
Identities = 73/324 (22%), Positives = 129/324 (39%), Gaps = 47/324 (14%)
Query: 482 VRFTYRDLQTATNNFSVKLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGK---KEFRAE 537
VR YRDLQ +G G +G+V V G ++A+KKL Q + K E
Sbjct: 16 VRAVYRDLQ--------PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE 67
Query: 538 VSIIGSIHHLHLVKLRGFCAEG------THRLLAYEFMANGSLDKWIFKKNQEFLLDWET 591
+ ++ + H +++ L T L FM G+ + K + L +
Sbjct: 68 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK---LGEDR 122
Query: 592 RFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651
+ KGL Y+H IIH D+KP N+ ++++ K+ DFGLA+ E
Sbjct: 123 IQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----M 175
Query: 652 TTLRGTRGYLAPEWITNYA-ISEKSDVYSYGMVLLEIIGGRKNFDPNETSD--------K 702
T TR Y APE I N+ ++ D++S G ++ E+I G+ F ++ D
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235
Query: 703 AHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFT------AVKVALWCVQEDMSLRPSM 756
P+ + ++ + +N + ++++ AV + + D R +
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295
Query: 757 TKVVQM--LEGICPVPQPPTCSPL 778
+ + E + P
Sbjct: 296 GEALAHPYFESLHDTEDEPQVQKY 319
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (342), Expect = 2e-35
Identities = 64/283 (22%), Positives = 117/283 (41%), Gaps = 25/283 (8%)
Query: 462 ESPQETSEEDNFLENLSGMPVRFTYRDLQTATNNFSV-------KLGQGGFGSVYQGV-L 513
+ ++ SE+++ E L+ F + + N + LG G FG V
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK 63
Query: 514 PDGTRLAVKKLE----GIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569
G A+K L+ + + E I+ +++ LVKL + ++ + E++
Sbjct: 64 ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDN 629
A G + + + + A YLH +I+ D+KPEN+L+D
Sbjct: 124 AGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQ 177
Query: 630 YHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG 689
+ +V+DFG AK + TL GT LAPE I + ++ D ++ G+++ E+
Sbjct: 178 GYIQVTDFGFAKRVK----GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 690 GRKNF---DPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729
G F P + +K F L+++L + L +D
Sbjct: 234 GYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-34
Identities = 52/294 (17%), Positives = 101/294 (34%), Gaps = 37/294 (12%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGK---KEFRAEVSIIGSIHHLHLVKLRG 554
K+GQG FG V++ G ++A+KK+ + + E+ I+ + H ++V L
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 555 FCAEGTHR--------LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYL 606
C L ++F + +F L R L L L
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQML-----LNGL 130
Query: 607 HEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS---HVFTTLRGTRGYLAP 663
+ +I+H D+K NVL+ + K++DFGLA+ + ++ + +T T Y P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 664 EWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSD--------KAHFPSYAFKMME 714
E + D++ G ++ E+ N + ++
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250
Query: 715 EGKLRNILDSRLNIDEQSDRVF-------TAVKVALWCVQEDMSLRPSMTKVVQ 761
+L L+ + A+ + + D + R +
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-34
Identities = 43/280 (15%), Positives = 96/280 (34%), Gaps = 23/280 (8%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGK---KEFRAEVSIIGSIHHLHLVKLRG 554
K+G+G +G+V++ +A+K++ + E+ ++ + H ++V+L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 555 FCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRI 614
L +EF + E + KGL + H + +
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCH---SRNV 122
Query: 615 IHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEK 674
+H D+KP+N+L++ N K+++FGLA+ + S
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 675 SDVYSYGMVLLEIIGGRKNF----DPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730
D++S G + E+ + D ++ + + + + D +
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242
Query: 731 QSDRVFTAVKVAL---------WCVQEDMSLRPSMTKVVQ 761
+ V L ++ + R S + +Q
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 3e-33
Identities = 53/241 (21%), Positives = 95/241 (39%), Gaps = 27/241 (11%)
Query: 475 ENLSGMPVRFTYRDLQTATNNFSV--KLGQGGFGSVYQGVL----PDGTRLAVKKL---- 524
NL+G + NF + LG G +G V+ G A+K L
Sbjct: 12 ANLTGHAEKVG-------IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKAT 64
Query: 525 -EGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKN 582
+ + R E ++ I LV L T L +++ G L + ++
Sbjct: 65 IVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE 124
Query: 583 QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642
+ + + + + L II+ DIK EN+LLD N H ++DFGL+K
Sbjct: 125 RFTEHEVQIYV------GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178
Query: 643 MTREQSHVFTTLRGTRGYLAPEWI--TNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETS 700
+++ GT Y+AP+ + + + D +S G+++ E++ G F +
Sbjct: 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 238
Query: 701 D 701
+
Sbjct: 239 N 239
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (316), Expect = 3e-32
Identities = 51/311 (16%), Positives = 115/311 (36%), Gaps = 28/311 (9%)
Query: 494 NNFSV--KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHL 549
+++ + KLG+G + V++ + + + ++ VK L+ + KK+ + E+ I+ ++ ++
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNI 92
Query: 550 VKLRGFCAEGTHRLLA--YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLH 607
+ L + R A +E + N + L K L Y H
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCH 146
Query: 608 EDCDQRIIHCDIKPENVLLD-DNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPE-W 665
I+H D+KP NV++D ++ ++ D+GLA+ Q + +R + PE
Sbjct: 147 S---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELL 201
Query: 666 ITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725
+ D++S G +L +I ++ F + A + E I
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVPQP---PTCSPLGARL 782
+ +D + + + W + ++ T +
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA---M 317
Query: 783 YSSFFRSISEE 793
+F ++ ++
Sbjct: 318 EHPYFYTVVKD 328
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-31
Identities = 53/234 (22%), Positives = 90/234 (38%), Gaps = 29/234 (12%)
Query: 486 YRDLQTATNNFSV--------KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGK---KE 533
+ ++ + F+V +G G G V +A+KKL Q + K
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR 62
Query: 534 FRAEVSIIGSIHHLHLVKLRGFCA------EGTHRLLAYEFMANGSLDKWIFKKNQEFLL 587
E+ ++ ++H +++ L E L E M +
Sbjct: 63 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------ 116
Query: 588 DWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647
D E + G+ +LH IIH D+KP N+++ + K+ DFGLA+
Sbjct: 117 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GT 171
Query: 648 SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSD 701
S + T TR Y APE I E D++S G ++ E++ + F + D
Sbjct: 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (305), Expect = 1e-30
Identities = 52/232 (22%), Positives = 92/232 (39%), Gaps = 18/232 (7%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCA 557
KLG G F +V+ + + T +A+K + G + E+ ++ ++ K A
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 558 EGTHRLLAY-------------EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLA 604
+LL + F G + KK + + I+ GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 605 YLHEDCDQRIIHCDIKPENVLLD-DNYHAKVSDFGLAKLMT-REQSHVFTTLRGTRGYLA 662
Y+H IIH DIKPENVL++ + + +A L +T TR Y +
Sbjct: 140 YMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 663 PEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMME 714
PE + +D++S ++ E+I G F+P+E + +++E
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 4e-29
Identities = 64/306 (20%), Positives = 114/306 (37%), Gaps = 37/306 (12%)
Query: 499 KLGQGGFGSVYQGV-LPDGTRLAVKKLEGIGQG---KKEFRAEVSIIGSIHHLHLVKLRG 554
+G G +GSV G R+AVKKL Q K E+ ++ + H +++ L
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 555 FCAEGT-----HRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHED 609
+ + + L+ + + L + + +GL Y+H
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----LTDDHVQFLIYQILRGLKYIHS- 139
Query: 610 CDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNY 669
IIH D+KP N+ ++++ K+ DFGLA+ T TR Y APE + N+
Sbjct: 140 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNW 193
Query: 670 A-ISEKSDVYSYGMVLLEIIGGRKNFDPNETSD--------KAHFPSYAFKMMEEGKLRN 720
++ D++S G ++ E++ GR F + D + K + RN
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 721 ILDSRLNIDEQS-DRVFT-----AVKVALWCVQEDMSLRPSMTKVVQM--LEGICPVPQP 772
+ S + + + VF AV + + D R + + +
Sbjct: 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 313
Query: 773 PTCSPL 778
P P
Sbjct: 314 PVADPY 319
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.8 bits (227), Expect = 7e-22
Identities = 31/199 (15%), Positives = 57/199 (28%), Gaps = 25/199 (12%)
Query: 499 KLGQGGFGSVYQGVLPDGTRLAVKKLE-----------GIGQGKKEFRAEVSIIGSIHHL 547
+G+G +V+ VK + G F
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 548 HLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLH 607
L KL+G Y + N L + I K + + + +A +
Sbjct: 67 ALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKFY 120
Query: 608 EDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWIT 667
I+H D+ NVL+ + + DF + + E L + +
Sbjct: 121 HRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREI--LERDVRNIITYFSR 174
Query: 668 NYAISEKSDVYSYGMVLLE 686
Y + D+ S +L+
Sbjct: 175 TYRT--EKDINSAIDRILQ 191
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 61.9 bits (150), Expect = 3e-12
Identities = 18/77 (23%), Positives = 30/77 (38%), Gaps = 1/77 (1%)
Query: 81 KASSTIIWTANRGSPVANSD-NFVFKKDGEVSLQKGGSVVWSVNPSGASVSAMELRDSGN 139
+ T + + S F + D + L VW+ N +GA+ L+ G
Sbjct: 8 SHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVLQSDGL 67
Query: 140 LVLLGNDNKVLWQSFSH 156
LV+L N + W S +
Sbjct: 68 LVILTAQNTIRWSSGTK 84
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 60.4 bits (146), Expect = 8e-12
Identities = 22/103 (21%), Positives = 42/103 (40%), Gaps = 13/103 (12%)
Query: 56 NNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVSLQ-K 114
+ + F + D L L ST +W +N G V + DG +
Sbjct: 17 DVEPYHFIMQ---EDCNLVL-----YDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDA 68
Query: 115 GGSVVWSVN-PSGASVSAMELRDSGNLVLLGNDNKVLWQSFSH 156
G +W+ + G + L++ GN+V+ G+D +W + ++
Sbjct: 69 EGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD---IWSTGTY 108
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 58.0 bits (140), Expect = 8e-11
Identities = 17/86 (19%), Positives = 29/86 (33%), Gaps = 4/86 (4%)
Query: 85 TIIWTANRGSPVANSD-NFVFKKDGEVSLQKGGSVVWSVNPSGASVSA-MELRDSGNLVL 142
T + + S + D + L VWS N +G L+ +G + +
Sbjct: 21 NHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQPNGRMDV 80
Query: 143 LGNDNKVLWQSFS--HPTDTLISNQD 166
L N N +W S + + Q
Sbjct: 81 LTNQNIAVWTSGNSRSAGRYVFVLQP 106
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 43.0 bits (101), Expect = 1e-05
Identities = 29/139 (20%), Positives = 45/139 (32%), Gaps = 29/139 (20%)
Query: 138 GNLVLLGNDNKVLW--QSFSHPTDTLISNQDFTQGMKLVSAPSTNNLSYVLEI-KSGDVV 194
G++V+ N N +L+ Q + TL + Q Y L + ++V
Sbjct: 1 GSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLS------------PYRLSMETDCNLV 48
Query: 195 LSAGFPTPQPYWSMGREERKTINKGGGEVTSASL-SANSWRFYDNNKIFLWQFIFSDNTD 253
L F WS G G A L N I +W S N+
Sbjct: 49 L---FDRDDRVWSTN-------TAGKGTGCRAVLQPNGRMDVLTNQNIAVWT---SGNSR 95
Query: 254 GNATWIAVLANDGFISFYN 272
++ VL D ++ Y
Sbjct: 96 SAGRYVFVLQPDRNLAIYG 114
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 54.4 bits (130), Expect = 1e-09
Identities = 15/104 (14%), Positives = 37/104 (35%), Gaps = 10/104 (9%)
Query: 57 NSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVSLQKGG 116
+ F + N V ++ +W + + + DG + + G
Sbjct: 18 EGGYLFIIQNDCNLVLYD--------NNRAVWASGTNGKASGC-VLKMQNDGNLVIYSGS 68
Query: 117 SVVWSVNPS-GASVSAMELRDSGNLVLLGNDNKVLWQSFSHPTD 159
+W+ N + + L+ N+V+ N N +W + ++ +
Sbjct: 69 RAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 42.7 bits (100), Expect = 1e-05
Identities = 21/102 (20%), Positives = 35/102 (34%), Gaps = 12/102 (11%)
Query: 56 NNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVSLQKG 115
N F F + N LV+ IW N G + + V
Sbjct: 17 NYGSFVFIMQEDCN------LVLYD--VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPS 68
Query: 116 GSVVWSVNPSGASVSAM-ELRDSGNLVLLGNDNKVLWQSFSH 156
+W+ N G + + + L+ N+V+ G D W + +H
Sbjct: 69 NKPIWASNTGGQNGNYVCILQKDRNVVIYGTD---RWATGTH 107
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 41.9 bits (98), Expect = 3e-05
Identities = 15/56 (26%), Positives = 26/56 (46%), Gaps = 1/56 (1%)
Query: 102 FVFKKDGEVSLQKGGSVVWSVNPSGASVSA-MELRDSGNLVLLGNDNKVLWQSFSH 156
F+ + D + L + +W+ N G L+ G LV++ N+N +WQS
Sbjct: 34 FIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVA 89
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 40.8 bits (95), Expect = 7e-05
Identities = 23/107 (21%), Positives = 41/107 (38%), Gaps = 14/107 (13%)
Query: 51 LFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEV 110
L +L + F +T N LV+ ++ IW N G V + DG +
Sbjct: 23 LEILFGTHVYRFIMQTDCN------LVLYD--NNNPIWATNTGGLGNGC-RAVLQPDGVL 73
Query: 111 SLQKG-GSVVWSVNPSGAS-VSAMELRDSGNLVLLGNDNKVLWQSFS 155
+ VW +G + + L+ N+V+ G+ LW + +
Sbjct: 74 VVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGD---ALWATQT 117
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 36.5 bits (84), Expect = 0.002
Identities = 23/142 (16%), Positives = 43/142 (30%), Gaps = 27/142 (19%)
Query: 147 NKVL--WQSFSHPTDTLISNQDFTQGMKLVSAPSTNNLSYVLEIKSGDVVLSAGFPTPQP 204
N ++ Q + L + + T+ ++++ ++VL P
Sbjct: 1 NNIIFSKQPDDNHPQILHATESLE------ILFGTHVYRFIMQ-TDCNLVLYDN---NNP 50
Query: 205 YWSMGREERKTINKGGGEVTSASL-SANSWRFYDNNKIFLWQFIFSDNTDGNATWIAVLA 263
W+ G G A L N + +WQ S ++ VL
Sbjct: 51 IWATN-------TGGLGNGCRAVLQPDGVLVVITNENVTVWQ---SPVAGKAGHYVLVLQ 100
Query: 264 NDGFISFYNLQDGEPSTASNTK 285
D + Y G+ A+ T
Sbjct: 101 PDRNVVIY----GDALWATQTV 118
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 817 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.75 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.72 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.69 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.4 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.35 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.31 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 98.99 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.69 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.43 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.4 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.37 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.01 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 97.89 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.8 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.16 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.13 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.8 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.06 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=419.06 Aligned_cols=252 Identities=26% Similarity=0.433 Sum_probs=200.5
Q ss_pred hccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCC
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGS 573 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 573 (817)
+.+.++||+|+||+||+|++.+++.||||+++......++|.+|++++++++||||++++|+|.+++..++||||+++|+
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~ 86 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence 45668899999999999999888999999998777778899999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeee
Q 036583 574 LDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTT 653 (817)
Q Consensus 574 L~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 653 (817)
|.+++..... .+++..++.++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++............
T Consensus 87 L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 87 LSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp HHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred HHHHhhcccc--CCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence 9999876543 68899999999999999999999 999999999999999999999999999998776544433344
Q ss_pred ccCCCCccCccccccCccCccccccchhhhHHHhhhCC-CCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccH
Q 036583 654 LRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGR-KNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQS 732 (817)
Q Consensus 654 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 732 (817)
..||+.|+|||++.+..++.++|||||||++|||+|+. +||.... .......+..+.. ...+.
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-------~~~~~~~i~~~~~---------~~~p~ 225 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTGFR---------LYKPR 225 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-------HHHHHHHHHHTCC---------CCCCT
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-------HHHHHHHHHhcCC---------CCCcc
Confidence 67899999999999999999999999999999999954 4443211 1112222222211 11111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 733 DRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 733 ~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
....++.+++.+||+.||++||||+||+++|+++
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 2234688999999999999999999999999876
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-50 Score=417.93 Aligned_cols=255 Identities=27% Similarity=0.415 Sum_probs=210.5
Q ss_pred HhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
..+.+.++||+|+||+||+|++++++.||||+++......++|.+|++++.+++|||||++++++.+ +..++||||+++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCC
Confidence 3456678899999999999999888999999998777778899999999999999999999998865 567999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
|+|.+++..... ..+++..+++|+.||++||.|||+ ++|+||||||+||||++++.+||+|||+|+..........
T Consensus 92 g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 92 GSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp CBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 999998865432 258999999999999999999999 8999999999999999999999999999998765544444
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
....||+.|||||++.+..++.++|||||||++|||+||..|+..... .......+..+. ....+
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~------~~~~~~~i~~~~---------~~~~p 232 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT------NPEVIQNLERGY---------RMVRP 232 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHHHHHTTC---------CCCCC
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC------HHHHHHHHHhcC---------CCCCc
Confidence 456789999999999999999999999999999999997665532211 111222232221 11111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
......+.+++.+||+.||++||||+||+++|+..
T Consensus 233 ~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 12334688999999999999999999999999853
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-49 Score=419.63 Aligned_cols=260 Identities=27% Similarity=0.396 Sum_probs=216.8
Q ss_pred HHHHhhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 489 LQTATNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 489 l~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
+....+.+.++||+|+||+||+|++. +++.||||+++......++|.+|++++++++|||||+++++|.+++..++|||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 33445666789999999999999965 58899999998777778899999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+++|+|.+++..... ..+++..++.++.||++||+|||+ ++|+||||||+||||++++.+||+|||+++......
T Consensus 94 ~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 94 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred cccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 9999999999976433 268999999999999999999999 899999999999999999999999999999876655
Q ss_pred ceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
........|++.|+|||++.+..++.++|||||||++|||++|..||..... .......+..+ ..
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~------~~~~~~~i~~~---------~~ 234 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLEKD---------YR 234 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHHHHHHHHTT---------CC
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch------HHHHHHHHhcC---------CC
Confidence 4444446789999999999999999999999999999999997776643221 11122222222 11
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
.+.+......+.+++.+||+.||++||||+||++.|+.+.
T Consensus 235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1222223457889999999999999999999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.1e-50 Score=423.99 Aligned_cols=265 Identities=28% Similarity=0.472 Sum_probs=204.3
Q ss_pred ccCHHHHHHHhhccc-----------cccCCCcceeEEEEEcCC-C---cEEEEEEeccCC--cCHHHHHHHHHHhhccC
Q 036583 483 RFTYRDLQTATNNFS-----------VKLGQGGFGSVYQGVLPD-G---TRLAVKKLEGIG--QGKKEFRAEVSIIGSIH 545 (817)
Q Consensus 483 ~~~~~~l~~~~~~~~-----------~~lG~G~fG~Vy~g~~~~-g---~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~ 545 (817)
+++|+++..++.+|. ++||+|+||+||+|++.. + ..||||++.... ...++|.+|++++++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 466777777776663 569999999999999643 3 258899886542 23568999999999999
Q ss_pred cceeeeeeeEeecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeE
Q 036583 546 HLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVL 625 (817)
Q Consensus 546 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIl 625 (817)
|||||+++|+|.+++..++|||||++|+|.+++..... .+++.+++.++.||++||+|||+ ++|+||||||+|||
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NIL 160 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNIL 160 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEE
Confidence 99999999999999999999999999999998876543 58999999999999999999999 99999999999999
Q ss_pred ecCCCcEEEeecCCccccCCCCcee----eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCC
Q 036583 626 LDDNYHAKVSDFGLAKLMTREQSHV----FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETS 700 (817)
Q Consensus 626 l~~~~~~ki~Dfgla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~ 700 (817)
|+.++.+||+|||+++......... .....||+.|||||.+.+..++.++|||||||++|||+| |+.||.....
T Consensus 161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~- 239 (299)
T d1jpaa_ 161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN- 239 (299)
T ss_dssp ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-
T ss_pred ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-
Confidence 9999999999999999775433221 112457899999999999999999999999999999998 8999964321
Q ss_pred CCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 701 DKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
..+...+.++ ...+.+...+..+.+++.+||+.||++||||+||++.|+++.+
T Consensus 240 ------~~~~~~i~~~---------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 240 ------QDVINAIEQD---------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ------HHHHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------HHHHHHHHcC---------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1122222222 1112222344578899999999999999999999999988643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=407.26 Aligned_cols=251 Identities=22% Similarity=0.381 Sum_probs=214.0
Q ss_pred ccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCCh
Q 036583 495 NFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGSL 574 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 574 (817)
.|.++||+|+||+||+|++++++.||||+++......++|.+|++++.+++||||++++|+|.+++..++||||+++|+|
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l 86 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 86 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence 46688999999999999998888999999988777788999999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeeeec
Q 036583 575 DKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTL 654 (817)
Q Consensus 575 ~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~ 654 (817)
.+++..... .+++..+++++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++.............
T Consensus 87 ~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 161 (258)
T d1k2pa_ 87 LNYLREMRH--RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 161 (258)
T ss_dssp HHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCS
T ss_pred HHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCceeeccc
Confidence 999876544 58889999999999999999999 8999999999999999999999999999987765544444456
Q ss_pred cCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcccHH
Q 036583 655 RGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSD 733 (817)
Q Consensus 655 ~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 733 (817)
.||+.|+|||.+.+..++.++|||||||++|||+| |+.||+.... ......+.++.. ...+..
T Consensus 162 ~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-------~~~~~~i~~~~~---------~~~p~~ 225 (258)
T d1k2pa_ 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-------SETAEHIAQGLR---------LYRPHL 225 (258)
T ss_dssp CCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------HHHHHHHHTTCC---------CCCCTT
T ss_pred CCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-------HHHHHHHHhCCC---------CCCccc
Confidence 78999999999999999999999999999999998 8999964431 122233333211 111122
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 734 RVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 734 ~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
....+.+++.+||+.||++||||+|+++.|..+
T Consensus 226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 226 ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 334688999999999999999999999999753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=407.01 Aligned_cols=256 Identities=27% Similarity=0.458 Sum_probs=200.7
Q ss_pred hhccccccCCCcceeEEEEEcCCCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
.+.+.++||+|+||+||+|++++ .||||+++.. ....+.|.+|++++.+++|||||++++++.+ +..++||||+
T Consensus 9 ~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~ 85 (276)
T d1uwha_ 9 QITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWC 85 (276)
T ss_dssp CCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred cEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecC
Confidence 34566889999999999998743 5999999654 2335789999999999999999999999865 5689999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc-
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS- 648 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~- 648 (817)
++|+|.+++..... .+++..++.++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++.......
T Consensus 86 ~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 86 EGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999999976543 58999999999999999999999 8999999999999999999999999999987654322
Q ss_pred eeeeeccCCCCccCcccccc---CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccc
Q 036583 649 HVFTTLRGTRGYLAPEWITN---YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSR 725 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 725 (817)
.......||+.|||||++.+ ..++.++|||||||+||||+||+.||..... .......+..+.....+.
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~------~~~~~~~~~~~~~~p~~~-- 232 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN------RDQIIFMVGRGYLSPDLS-- 232 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC------HHHHHHHHHHTSCCCCGG--
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh------HHHHHHHHhcCCCCCcch--
Confidence 23345789999999999964 3578999999999999999999999964322 112222233322111111
Q ss_pred cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 726 LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 726 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
......+..+.+++.+||+.||++||||+||++.|+.+.
T Consensus 233 ---~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 233 ---KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp ---GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111122346889999999999999999999999998763
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=409.29 Aligned_cols=259 Identities=25% Similarity=0.382 Sum_probs=206.7
Q ss_pred HhhccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
..+.+.++||+|+||+||+|+++++++||||++.......+.|.+|+.++.+++|||||+++++|.+ +..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 3466778999999999999999888899999998777778899999999999999999999999865 567999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
|+|..++...... .++|..++.++.||+.||+|||+ .+|+||||||+||||+.++++||+|||+++..........
T Consensus 96 g~l~~~~~~~~~~-~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 96 GSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp CBHHHHHSHHHHT-TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred Cchhhhhhhcccc-cchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 9999988764332 58999999999999999999999 8999999999999999999999999999987765544444
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
....||+.|+|||++.+..++.++|||||||++|||++|..|+...... ......+..+. ..+..
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~------~~~~~~i~~~~---------~~~~~ 236 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVERGY---------RMPCP 236 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTC---------CCCCC
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH------HHHHHHHHhcC---------CCCCC
Confidence 4577999999999999999999999999999999999977666432211 11222222221 11122
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCCC
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICPVP 770 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 770 (817)
......+.+++.+||+.||++||||++|+++|+......
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 223446889999999999999999999999999875443
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-48 Score=401.03 Aligned_cols=248 Identities=26% Similarity=0.362 Sum_probs=200.6
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
+.+.++||+|+||+||+|+. .+|+.||||++... .+..+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 45668999999999999996 46899999998654 2335679999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce-
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH- 649 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~- 649 (817)
+|+|.++|.... .+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+........
T Consensus 87 gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 87 GGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp TEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999999997543 68999999999999999999999 99999999999999999999999999999987544322
Q ss_pred eeeeccCCCCccCccccccCcc-CccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 650 VFTTLRGTRGYLAPEWITNYAI-SEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
......||+.|||||++.+..+ +.++|||||||++|||++|+.||....... ........... ..
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~~~~~~~~~~--------~~ 226 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QEYSDWKEKKT--------YL 226 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS------HHHHHHHTTCT--------TS
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH------HHHHHHhcCCC--------CC
Confidence 2345789999999999988776 578999999999999999999996543221 01111111111 11
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.........+.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111122346778999999999999999999876
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-48 Score=402.38 Aligned_cols=245 Identities=27% Similarity=0.423 Sum_probs=199.0
Q ss_pred cccCCCcceeEEEEEcCC---CcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 498 VKLGQGGFGSVYQGVLPD---GTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~---g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
++||+|+||+||+|.+++ ++.||||+++.... ..++|.+|++++++++|||||+++++|.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998543 46899999965322 24679999999999999999999999965 467899999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
|+|.+++.+.. .+++..++.++.||++||+|||+ .+|+||||||+||||+.++.+||+|||+++..........
T Consensus 92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999997654 58999999999999999999999 8999999999999999999999999999998765433322
Q ss_pred --eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 652 --TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 652 --~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
....||+.|||||.+.+..++.++|||||||++|||++ |+.||..... ..+...+.++.. .
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-------~~~~~~i~~~~~---------~ 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SEVTAMLEKGER---------M 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCC---------C
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-------HHHHHHHHcCCC---------C
Confidence 23678999999999999999999999999999999998 8999964321 122233333321 1
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEG 765 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~ 765 (817)
+.+...+..+.+++.+||+.||++||||+||+++|+.
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 1112234568899999999999999999999998875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=403.03 Aligned_cols=246 Identities=27% Similarity=0.402 Sum_probs=202.4
Q ss_pred ccCCCcceeEEEEEcC---CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccCCC
Q 036583 499 KLGQGGFGSVYQGVLP---DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMANGS 573 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~---~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 573 (817)
+||+|+||+||+|.++ ++..||||+++... ...++|.+|++++.+++|||||+++|+|.+ +..++||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 5999999999999753 35579999997543 235789999999999999999999999865 56899999999999
Q ss_pred hhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee--
Q 036583 574 LDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF-- 651 (817)
Q Consensus 574 L~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~-- 651 (817)
|.+++..... .+++..+.+++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++.+........
T Consensus 95 L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 169 (285)
T d1u59a_ 95 LHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169 (285)
T ss_dssp HHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred HHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccccccccc
Confidence 9999865443 58999999999999999999999 8999999999999999999999999999998765433222
Q ss_pred eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 652 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
....||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+...+.++...+ .
T Consensus 170 ~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-------~~~~~i~~~~~~~---------~ 233 (285)
T d1u59a_ 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQGKRME---------C 233 (285)
T ss_dssp CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------HHHHHHHTTCCCC---------C
T ss_pred cccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCC---------C
Confidence 23568899999999999999999999999999999998 89999644321 1233333332111 1
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
+...+..+.+++.+||+.||++||||.+|++.|+..
T Consensus 234 p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 122335688999999999999999999999998753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=407.35 Aligned_cols=255 Identities=25% Similarity=0.437 Sum_probs=199.4
Q ss_pred hccccccCCCcceeEEEEEcCCC-----cEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPDG-----TRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~g-----~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
+.+.+.||+|+||+||+|.++.. ..||||++.... ...++|.+|++++.+++|||||+++|++.+.+..++||
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence 34567899999999999986532 369999996542 23457999999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
||+.+++|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++.....
T Consensus 89 e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 89 EYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp ECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999998876543 68999999999999999999999 99999999999999999999999999999876543
Q ss_pred Ccee--eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccc
Q 036583 647 QSHV--FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724 (817)
Q Consensus 647 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 724 (817)
.... .....||+.|||||++.+..++.++|||||||++|||+++..|+..... ...+...+.++
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~------~~~~~~~i~~~-------- 229 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS------NHEVMKAINDG-------- 229 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTT--------
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC------HHHHHHHHhcc--------
Confidence 3222 2235689999999999999999999999999999999997666543211 11122222222
Q ss_pred ccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 725 RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 725 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
...+.+...+..+.+++.+||+.||++||||+||+++|+.+..
T Consensus 230 -~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 230 -FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 1122222334578899999999999999999999999998754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-47 Score=393.07 Aligned_cols=242 Identities=28% Similarity=0.405 Sum_probs=204.5
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.++||+|+||+||+|+.. +++.||+|++... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 566789999999999999964 6889999998642 34567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++|+|.+++.+.. .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 88 ~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 88 APLGTVYRELQKLS---KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred cCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 99999999997654 58999999999999999999999 999999999999999999999999999998765432
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
.....||+.|||||++.+..++.++|||||||++|||++|+.||..... ......+.++. ...
T Consensus 161 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~--------~~~ 223 (263)
T d2j4za1 161 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QETYKRISRVE--------FTF 223 (263)
T ss_dssp --CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTC--------CCC
T ss_pred --ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCC--------CCC
Confidence 2356899999999999999999999999999999999999999964321 11222222221 111
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+......+.+++.+||+.||++|||++|+++
T Consensus 224 --p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 --PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1112346789999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=410.28 Aligned_cols=256 Identities=25% Similarity=0.401 Sum_probs=206.1
Q ss_pred HHhhccccccCCCcceeEEEEEcCC------CcEEEEEEeccC--CcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCe
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLPD------GTRLAVKKLEGI--GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTH 561 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~--~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~ 561 (817)
...+.+.++||+|+||+||+|+... ...||||++... ......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3455677899999999999998532 236999998653 33457899999999998 89999999999999999
Q ss_pred eeEEEeeccCCChhhhhhhccc--------------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCC
Q 036583 562 RLLAYEFMANGSLDKWIFKKNQ--------------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKP 621 (817)
Q Consensus 562 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~ 621 (817)
.++||||+++|+|.++|..... ...+++..++.++.||++||+|||+ ++|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCch
Confidence 9999999999999999976432 1258999999999999999999999 8999999999
Q ss_pred CCeEecCCCcEEEeecCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCC
Q 036583 622 ENVLLDDNYHAKVSDFGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNET 699 (817)
Q Consensus 622 ~NIll~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~ 699 (817)
+|||++.++.+||+|||+|+......... .....||+.|||||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998765543332 234678999999999999999999999999999999998 8999964432
Q ss_pred CCCCcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 036583 700 SDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLE 764 (817)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~ 764 (817)
. ......+..+. ..+.+......+.+++.+||+.||++||||+||+++|.
T Consensus 273 ~------~~~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 D------ANFYKLIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp S------HHHHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H------HHHHHHHhcCC---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 2 11222222221 11122223457889999999999999999999999995
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=394.90 Aligned_cols=247 Identities=24% Similarity=0.365 Sum_probs=204.9
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccC-CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI-GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.+.+.++||+|+||+||+|+. .+|+.||||++... ....+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 356678899999999999985 56999999999754 3456789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
+|+|.+++.+. .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.+..... .
T Consensus 101 gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~ 172 (293)
T d1yhwa1 101 GGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (293)
T ss_dssp TCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-c
Confidence 99999987643 48899999999999999999999 9999999999999999999999999999997754332 2
Q ss_pred eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCcc
Q 036583 651 FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDE 730 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 730 (817)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..........+. .....
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~~~~~~~--------~~~~~ 238 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGT--------PELQN 238 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCS--------CCCSS
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCC--------CCCCC
Confidence 2456799999999999999999999999999999999999999964321 111112221111 01111
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 731 QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 731 ~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.......+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1223456889999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=389.61 Aligned_cols=243 Identities=21% Similarity=0.406 Sum_probs=196.2
Q ss_pred ccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeec----CCeeeEEE
Q 036583 495 NFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAE----GTHRLLAY 566 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 566 (817)
.|.++||+|+||+||+|+.. +++.||+|++..... ..+.|.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45678999999999999964 688999999865432 34578999999999999999999999865 34579999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCc--eeecCCCCCCeEec-CCCcEEEeecCCcccc
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQR--IIHCDIKPENVLLD-DNYHAKVSDFGLAKLM 643 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~--ivH~Dlk~~NIll~-~~~~~ki~Dfgla~~~ 643 (817)
||+++|+|.+++.+.. .+++..++.++.||++||+|||+ ++ |+||||||+|||++ +++.+||+|||+++..
T Consensus 92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 9999999999997654 58899999999999999999998 66 99999999999996 5789999999999865
Q ss_pred CCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
.... .....||+.|||||++.+ .++.++|||||||++|||++|+.||..... .......+..+.....
T Consensus 166 ~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~------~~~~~~~i~~~~~~~~-- 233 (270)
T d1t4ha_ 166 RASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVKPAS-- 233 (270)
T ss_dssp CTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHHHHTTTCCCGG--
T ss_pred cCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc------HHHHHHHHHcCCCCcc--
Confidence 4432 235689999999999876 599999999999999999999999964321 1122223322211111
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.......++.+++.+||+.||++|||++|+++
T Consensus 234 ------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 ------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11112235789999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-47 Score=394.22 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=191.5
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc---CHHHHHHHHHHhhccCcceeeeeeeEeec--CCeeeEEEe
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ---GKKEFRAEVSIIGSIHHLHLVKLRGFCAE--GTHRLLAYE 567 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~---~~~~~~~Ev~~l~~l~h~niv~l~~~~~~--~~~~~lv~e 567 (817)
+++.++||+|+||+||+|+. .+|+.||||++..... ..+.+.+|++++++++||||+++++++.+ ....++|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 45668899999999999985 5689999999976532 24568999999999999999999999865 456799999
Q ss_pred eccCCChhhhhhhcc-cccchhhhHHHHHHHHHHHHHHHHHhcC--CCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 568 FMANGSLDKWIFKKN-QEFLLDWETRFNIALGTAKGLAYLHEDC--DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~l~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
|+++|+|.+++.+.. ....+++..++.++.||+.||+|||+.. ..+|+||||||+||||+.++.+||+|||+++...
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence 999999999987532 2336899999999999999999999831 1359999999999999999999999999999875
Q ss_pred CCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccc
Q 036583 645 REQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724 (817)
Q Consensus 645 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 724 (817)
.... ......||+.|||||++.+..++.++|||||||++|||++|+.||..... ......+.++....+
T Consensus 166 ~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-------~~~~~~i~~~~~~~~--- 234 (269)
T d2java1 166 HDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAGKIREGKFRRI--- 234 (269)
T ss_dssp -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTCCCCC---
T ss_pred cCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-------HHHHHHHHcCCCCCC---
Confidence 4322 23457899999999999999999999999999999999999999964321 122333333332211
Q ss_pred ccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 725 RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 725 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+......+.+++.+||+.||.+|||++|+++
T Consensus 235 ------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 ------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1122346889999999999999999999976
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=394.44 Aligned_cols=248 Identities=23% Similarity=0.327 Sum_probs=202.5
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccC-CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI-GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
+.+.++||+|+||+||+|+. .+++.||||++... ....+.+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 45668899999999999995 46899999999754 34457899999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceee
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVF 651 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 651 (817)
|+|.+++.+... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 94 g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~~ 167 (288)
T d2jfla1 94 GAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR 167 (288)
T ss_dssp EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-HH
T ss_pred CcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc-cc
Confidence 999999875433 68999999999999999999999 9999999999999999999999999999976533211 12
Q ss_pred eeccCCCCccCccccc-----cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 652 TTLRGTRGYLAPEWIT-----NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 652 ~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
....||+.|+|||++. +..++.++|||||||++|||++|+.||....... ....+..+... .
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-------~~~~i~~~~~~-----~- 234 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-------VLLKIAKSEPP-----T- 234 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-------HHHHHHHSCCC-----C-
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCCC-----C-
Confidence 3467999999999984 4568899999999999999999999996543211 11222222111 1
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
..........+.+++.+||+.||++|||++|+++
T Consensus 235 -~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 -LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111223456889999999999999999999976
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-47 Score=404.60 Aligned_cols=261 Identities=21% Similarity=0.313 Sum_probs=201.1
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
.+.+.++||+|+||+||+|+. .+|+.||+|+++... ...+.+.+|+.++++++|||||+++++|.+..+.++||||+
T Consensus 7 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~ 86 (322)
T d1s9ja_ 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 86 (322)
T ss_dssp GEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 455668899999999999995 468999999997542 23568999999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
++|+|.+++.+.. .+++..+..++.||+.||.|||+. ++|+||||||+||||++++.+||+|||+|+......
T Consensus 87 ~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 159 (322)
T d1s9ja_ 87 DGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 159 (322)
T ss_dssp TTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT--
T ss_pred CCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc--
Confidence 9999999997654 589999999999999999999971 489999999999999999999999999998764322
Q ss_pred eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcc---------hH------HHHHHhh
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHF---------PS------YAFKMME 714 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~---------~~------~~~~~~~ 714 (817)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||........... .. .......
T Consensus 160 -~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
T d1s9ja_ 160 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238 (322)
T ss_dssp -C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred -cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence 2346899999999999999999999999999999999999999975432210000 00 0000000
Q ss_pred h--------cc----hhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 715 E--------GK----LRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 715 ~--------~~----~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
. .. ...+...............++.+++.+||+.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0 00 00000000000001112346789999999999999999999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=392.75 Aligned_cols=245 Identities=24% Similarity=0.355 Sum_probs=201.8
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.+.||+|+||+||+|+. .+|+.||||++... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 56778999999999999996 46899999998642 34567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.+.....
T Consensus 90 ~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 90 AKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999999987654 58999999999999999999999 9999999999999999999999999999998754332
Q ss_pred -eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 649 -HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 649 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.++.. .
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~~i~~~~~--------~ 228 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------YLIFQKIIKLEY--------D 228 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHTTCC--------C
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-------HHHHHHHHcCCC--------C
Confidence 223446899999999999999999999999999999999999999964321 112222222221 1
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
. +......+.+++.+||+.||++|||++|+++
T Consensus 229 ~--p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 229 F--PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp C--CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred C--CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1 1122346789999999999999999998743
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=389.28 Aligned_cols=247 Identities=30% Similarity=0.455 Sum_probs=195.9
Q ss_pred hccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeec-CCeeeEEEeeccCC
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE-GTHRLLAYEFMANG 572 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~~g 572 (817)
..|.++||+|+||.||+|++ .|+.||||+++.. ...++|.+|++++++++||||++++|+|.+ .+..++||||+++|
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g 86 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred eEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence 45668899999999999998 5789999999753 446789999999999999999999999965 45689999999999
Q ss_pred ChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCceeee
Q 036583 573 SLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFT 652 (817)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 652 (817)
+|.++|..... ..++|..+++++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 87 ~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~----~ 158 (262)
T d1byga_ 87 SLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----D 158 (262)
T ss_dssp EHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred CHHHHHHhcCC-CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC----c
Confidence 99999976432 268999999999999999999999 899999999999999999999999999998654322 3
Q ss_pred eccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCccc
Q 036583 653 TLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNIDEQ 731 (817)
Q Consensus 653 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 731 (817)
...++..|+|||++.+..+++++|||||||++|||+| |+.||....... +...+.++.. .+.+
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~-------~~~~i~~~~~---------~~~~ 222 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYK---------MDAP 222 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-------HHHHHTTTCC---------CCCC
T ss_pred cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCC---------CCCC
Confidence 3567899999999999999999999999999999998 677775432211 2222322211 1112
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 732 SDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 732 ~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.....++.+++.+||+.||.+||||+|++++|+.+
T Consensus 223 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 22334688999999999999999999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.4e-46 Score=393.54 Aligned_cols=243 Identities=24% Similarity=0.332 Sum_probs=199.1
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc----CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ----GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~----~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
.+...++||+|+||+||+|+. .+++.||||++..... ..+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 456668999999999999985 5688999999975432 23568999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+++|+|..++.... .+++..++.++.||+.||.|||+ ++|+||||||+||||++++.+||+|||+++.....
T Consensus 96 ~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp CCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 999999987765443 68999999999999999999999 99999999999999999999999999999865432
Q ss_pred ceeeeeccCCCCccCcccccc---CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccc
Q 036583 648 SHVFTTLRGTRGYLAPEWITN---YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 724 (817)
....||+.|||||++.+ ..|+.++|||||||++|||++|+.||..... .. ....+..+.....
T Consensus 169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~-~~~~i~~~~~~~~--- 234 (309)
T d1u5ra_ 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MS-ALYHIAQNESPAL--- 234 (309)
T ss_dssp ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HH-HHHHHHHSCCCCC---
T ss_pred ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HH-HHHHHHhCCCCCC---
Confidence 34579999999999864 4689999999999999999999999964321 11 1111112111111
Q ss_pred ccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 725 RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 725 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
........+.+++.+||+.||++|||++|+++
T Consensus 235 -----~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 -----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11122346889999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-46 Score=398.02 Aligned_cols=255 Identities=25% Similarity=0.428 Sum_probs=206.7
Q ss_pred hccccccCCCcceeEEEEEcC------CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP------DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv 565 (817)
+.+.++||+|+||+||+|+.. +++.||||++.... +..++|.+|++++++++||||++++++|.+....+++
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence 445689999999999999853 45789999997543 2356799999999999999999999999999999999
Q ss_pred EeeccCCChhhhhhhccc---------------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 036583 566 YEFMANGSLDKWIFKKNQ---------------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENV 624 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NI 624 (817)
|||+++|+|.++|..... ...+++..++.|+.||+.||+|||+ .+|+||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccce
Confidence 999999999999975321 1248899999999999999999999 9999999999999
Q ss_pred EecCCCcEEEeecCCccccCCCCc-eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCC-CCCCCCCCCCC
Q 036583 625 LLDDNYHAKVSDFGLAKLMTREQS-HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGR-KNFDPNETSDK 702 (817)
Q Consensus 625 ll~~~~~~ki~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~-~pf~~~~~~~~ 702 (817)
|||.++.+||+|||+++....... .......|++.|+|||.+.+..++.++|||||||++|||++|. +||.....
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~--- 248 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH--- 248 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH---
Confidence 999999999999999987654332 2234467889999999999999999999999999999999986 56653321
Q ss_pred CcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 703 AHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
......+.++....+ +...+.++.+++.+||+.||++||||.||+++|++++
T Consensus 249 ----~e~~~~v~~~~~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 249 ----EEVIYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp ----HHHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ----HHHHHHHHcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 122233333332211 1122346889999999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=391.44 Aligned_cols=253 Identities=26% Similarity=0.363 Sum_probs=195.1
Q ss_pred HhhccccccCCCcceeEEEEEcCC----CcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEE
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLPD----GTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv 565 (817)
..+.+.++||+|+||+||+|+... +..||||+++.... ..+.|.+|+.++++++||||+++++++.+ +..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence 356677899999999999998643 34689999865432 34679999999999999999999999964 678999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|||+++|+|.+++..... .+++..++.++.||++||.|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 86 ~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999998865443 58999999999999999999999 9999999999999999999999999999987765
Q ss_pred CCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccc
Q 036583 646 EQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 724 (817)
..........||+.|+|||.+.+..++.++|||||||++|||++ |++||...... .+...+.++....
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-------~~~~~i~~~~~~~---- 229 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-------DVIGRIENGERLP---- 229 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-------GHHHHHHTTCCCC----
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCCCC----
Confidence 44444445678999999999999999999999999999999998 89899654322 1223333332111
Q ss_pred ccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 725 RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 725 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
.+...+..+.+++.+||+.||++|||++||++.|+.+
T Consensus 230 -----~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 230 -----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1122334688999999999999999999999999865
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-45 Score=390.19 Aligned_cols=249 Identities=23% Similarity=0.359 Sum_probs=189.2
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
.+.+.++||+|+||+||+|+.. +++.||||++.... ...+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4667789999999999999964 68999999996542 33467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec---CCCcEEEeecCCccccCCC
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD---DNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~ki~Dfgla~~~~~~ 646 (817)
++|+|.++|.+.. .+++..+..++.||+.||+|||+ ++|+||||||+|||+. +++.+||+|||+++.....
T Consensus 90 ~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 90 SGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred CCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 9999999997654 68999999999999999999999 9999999999999994 5789999999999876433
Q ss_pred CceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccccc
Q 036583 647 QSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRL 726 (817)
Q Consensus 647 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 726 (817)
. ......||+.|||||++.+..++.++|||||||++|||++|+.||..... ......+..+... .
T Consensus 164 ~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~~i~~~~~~------~ 228 (307)
T d1a06a_ 164 S--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-------AKLFEQILKAEYE------F 228 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHTTCCC------C
T ss_pred C--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-------HHHHHHHhccCCC------C
Confidence 2 23456799999999999999999999999999999999999999964321 1122222222111 1
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 727 NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 727 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
..+........+.+++.+||+.||++|||++|+++.
T Consensus 229 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 229 DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 111111233468899999999999999999999983
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=391.59 Aligned_cols=264 Identities=22% Similarity=0.286 Sum_probs=201.2
Q ss_pred hccccccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCC----eeeEEEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT----HRLLAYEFM 569 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~ 569 (817)
+.+.++||+|+||+||+|++ +|+.||||+++........+..|+..+.+++||||++++++|.+.+ ..++|||||
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~ 83 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecc
Confidence 44567899999999999997 6889999999754332233445566667889999999999997644 579999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcC-----CCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDC-----DQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~-----~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
++|+|.++|.+. .++|..+++++.|+|.||+|||+.. .++|+||||||+||||+.++.+||+|||+++...
T Consensus 84 ~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 84 EHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp TTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred cCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence 999999999764 4899999999999999999999621 3699999999999999999999999999999775
Q ss_pred CCCce---eeeeccCCCCccCccccccC------ccCccccccchhhhHHHhhhCCCCCCCCCCCCCC--------cchH
Q 036583 645 REQSH---VFTTLRGTRGYLAPEWITNY------AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA--------HFPS 707 (817)
Q Consensus 645 ~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~--------~~~~ 707 (817)
..... ......||+.|+|||++.+. .++.++|||||||+||||+||..||......... ....
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T d1vjya_ 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence 54322 22346799999999998754 3677999999999999999999888644332211 1111
Q ss_pred HHHHHhhhcchhhhcccccCC-cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 708 YAFKMMEEGKLRNILDSRLNI-DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 708 ~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
........+. ..+.+.. ....+....+.+++.+||+.||++||||.||++.|+++
T Consensus 240 ~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 240 EMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 2222222221 1121111 12334566788999999999999999999999999876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=393.70 Aligned_cols=251 Identities=26% Similarity=0.457 Sum_probs=200.2
Q ss_pred hccccccCCCcceeEEEEEcC-CCc----EEEEEEeccC--CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGT----RLAVKKLEGI--GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAY 566 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~----~vavK~l~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~ 566 (817)
+.+.++||+|+||+||+|+.. +|+ +||+|+++.. .+..++|.+|++++++++|||||+++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 455688999999999999854 444 5899998653 34578899999999999999999999999875 567889
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
||+.+|+|.+++..... .+++..+++++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 90 e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp ECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 99999999998876543 68999999999999999999999 89999999999999999999999999999987654
Q ss_pred Ccee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccc
Q 036583 647 QSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724 (817)
Q Consensus 647 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 724 (817)
.... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||+...... +...+..+.
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-------~~~~i~~~~------- 230 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGE------- 230 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-------HHHHHHHTC-------
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCC-------
Confidence 3332 233578999999999999999999999999999999998 788886443211 222232221
Q ss_pred ccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 725 RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 725 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
..+.+......+.+++.+||+.||.+||||+||++.|+.+
T Consensus 231 --~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 231 --RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp --CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 1111122334688999999999999999999999998765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=390.38 Aligned_cols=255 Identities=26% Similarity=0.422 Sum_probs=202.9
Q ss_pred hccccccCCCcceeEEEEEcCCC----cEEEEEEeccCC--cCHHHHHHHHHHhhccCcceeeeeeeEeec-CCeeeEEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPDG----TRLAVKKLEGIG--QGKKEFRAEVSIIGSIHHLHLVKLRGFCAE-GTHRLLAY 566 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~g----~~vavK~l~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 566 (817)
.+|.++||+|+||+||+|++.++ ..||||+++... ...++|.+|++++++++||||++++|++.+ +...++||
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 45677899999999999996442 258999997532 234789999999999999999999999875 45789999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
|||++|+|.+++..... .+++..+++++.|+++||.|||+ .+|+||||||+||||++++.+||+|||+++.....
T Consensus 109 E~~~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp ECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred EEeecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 99999999999876543 57788899999999999999999 99999999999999999999999999999976543
Q ss_pred Ccee---eeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 647 QSHV---FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 647 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .. ...+..+.-
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~----~~~i~~g~~----- 252 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DI----TVYLLQGRR----- 252 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------C----HHHHHTTCC-----
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HH----HHHHHcCCC-----
Confidence 3221 123568999999999999999999999999999999999888885432211 11 112222211
Q ss_pred cccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 724 SRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 724 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
... +......+.+++.+||+.||++||+|.||++.|+.+..
T Consensus 253 --~~~--p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 253 --LLQ--PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp --CCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCC--cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111 11123468899999999999999999999999998743
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=383.49 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=194.8
Q ss_pred hccccccCCCcceeEEEEEcC--CC--cEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP--DG--TRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~--~g--~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv 565 (817)
+.+.++||+|+||+||+|++. ++ ..||||++... .+..++|.+|++++++++||||++++|+|.+ ...++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence 456788999999999999853 23 36899998653 2234689999999999999999999999976 467899
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|||+++|+|.+++..... .+++..++.++.||++||.|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 89 ~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999999998876543 58999999999999999999999 8999999999999999999999999999998765
Q ss_pred CCceee--eeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcchHHHHHHhhhcchhhhc
Q 036583 646 EQSHVF--TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHFPSYAFKMMEEGKLRNIL 722 (817)
Q Consensus 646 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (817)
...... ....|+..|+|||.+.+..++.++|||||||++|||+| |+.||..... ..........+
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~------~~~~~~i~~~~------ 231 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEG------ 231 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSC------
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH------HHHHHHHHhCC------
Confidence 433322 23567889999999999999999999999999999998 8999964321 11111111221
Q ss_pred ccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 723 DSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 723 d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
...+.....+..+.+++.+||+.||++||||+||+++|++.
T Consensus 232 ---~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 ---ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11111122234688999999999999999999999999763
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-44 Score=382.83 Aligned_cols=241 Identities=24% Similarity=0.355 Sum_probs=202.7
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.++||+|+||+||+++. .+|+.||||+++.. ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 55678999999999999996 46899999999642 34567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++|+|..++.... .+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+......
T Consensus 86 ~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~- 158 (316)
T d1fota_ 86 IEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT- 158 (316)
T ss_dssp CCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred cCCccccccccccc---cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecccc-
Confidence 99999999887655 57788888999999999999999 999999999999999999999999999998765432
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
....||+.|||||++.+..++.++|||||||++|||++|+.||..... ......+.++. ...
T Consensus 159 ---~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~i~~~~--------~~~ 220 (316)
T d1fota_ 159 ---YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MKTYEKILNAE--------LRF 220 (316)
T ss_dssp ---CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHCC--------CCC
T ss_pred ---ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-------HHHHHHHHcCC--------CCC
Confidence 346899999999999999999999999999999999999999964321 11222222221 111
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRP-----SMTKVVQ 761 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~evl~ 761 (817)
+ ......+.+++.+||+.||.+|| |++|+++
T Consensus 221 p--~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 221 P--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp C--TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred C--CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1 11234678999999999999996 8999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.9e-45 Score=393.23 Aligned_cols=250 Identities=21% Similarity=0.336 Sum_probs=205.7
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.+.+.++||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+.++.+++|||||++++++.+++..++|||||+
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 466778999999999999985 468999999997543 335678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec--CCCcEEEeecCCccccCCCCc
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD--DNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+|+|.+++.+... .+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+++.+.....
T Consensus 107 gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 107 GGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp SCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 9999999965433 58999999999999999999999 9999999999999996 468899999999997755433
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
.....||+.|||||++.+..++.++|||||||++|||++|+.||..... ......+...... ...
T Consensus 182 --~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~------~~~ 246 (350)
T d1koaa2 182 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-------DETLRNVKSCDWN------MDD 246 (350)
T ss_dssp --EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCC------SCC
T ss_pred --cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCC------CCc
Confidence 3457899999999999999999999999999999999999999964321 1122222222110 011
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.........+.+++.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111223467899999999999999999999984
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=390.69 Aligned_cols=260 Identities=27% Similarity=0.452 Sum_probs=210.1
Q ss_pred HHHHhhccccccCCCcceeEEEEEc------CCCcEEEEEEeccCCc--CHHHHHHHHHHhhcc-CcceeeeeeeEeecC
Q 036583 489 LQTATNNFSVKLGQGGFGSVYQGVL------PDGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSI-HHLHLVKLRGFCAEG 559 (817)
Q Consensus 489 l~~~~~~~~~~lG~G~fG~Vy~g~~------~~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~ 559 (817)
+....+.+.++||+|+||.||+|++ ..++.||||+++.... ...+|.+|+.++.++ +|||||+++++|.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 4445667788999999999999974 3467899999976432 345799999999999 699999999999999
Q ss_pred CeeeEEEeeccCCChhhhhhhccc---------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 036583 560 THRLLAYEFMANGSLDKWIFKKNQ---------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENV 624 (817)
Q Consensus 560 ~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NI 624 (817)
...++||||+++|+|.++++.... ...+++..+..++.||++||+|||+ ++|+||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccc
Confidence 999999999999999999976431 2258899999999999999999999 8999999999999
Q ss_pred EecCCCcEEEeecCCccccCCCCceee-eeccCCCCccCccccccCccCccccccchhhhHHHhhhC-CCCCCCCCCCCC
Q 036583 625 LLDDNYHAKVSDFGLAKLMTREQSHVF-TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGG-RKNFDPNETSDK 702 (817)
Q Consensus 625 ll~~~~~~ki~Dfgla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg-~~pf~~~~~~~~ 702 (817)
+++.++.+||+|||+++.......... ....||+.|+|||.+.+..++.++|||||||++|||+|+ .+||......
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-- 254 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-- 254 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999998765443332 346889999999999999999999999999999999995 5555432221
Q ss_pred CcchHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 703 AHFPSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
......+..+. ....+......+.+|+.+||+.||++||||+||+++|++.
T Consensus 255 ----~~~~~~i~~~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 255 ----SKFYKMIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp ----HHHHHHHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHhcCC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11222222221 1111122335688999999999999999999999999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=380.36 Aligned_cols=248 Identities=24% Similarity=0.347 Sum_probs=203.9
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC-------cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG-------QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLL 564 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~-------~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 564 (817)
.+.+.++||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+.++++++|||||++++++.+.+..+|
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 466778999999999999996 468999999986431 235789999999999999999999999999999999
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC----cEEEeecCCc
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY----HAKVSDFGLA 640 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~ki~Dfgla 640 (817)
||||+++|+|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||++
T Consensus 91 v~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhh
Confidence 999999999999997654 58999999999999999999999 9999999999999998776 5999999999
Q ss_pred cccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhh
Q 036583 641 KLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRN 720 (817)
Q Consensus 641 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (817)
+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+...
T Consensus 165 ~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~~i~~~~~~- 234 (293)
T d1jksa_ 165 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANVSAVNYE- 234 (293)
T ss_dssp EECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHTTCCC-
T ss_pred hhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH-------HHHHHHHHhcCCC-
Confidence 87654332 2346789999999999999999999999999999999999999964321 1112222222110
Q ss_pred hcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 721 ILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 721 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
............+.+++.+||+.||++|||++|+++
T Consensus 235 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 -----FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -----CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000011122346789999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=390.29 Aligned_cols=259 Identities=25% Similarity=0.380 Sum_probs=197.2
Q ss_pred HHhhccccccCCCcceeEEEEEcC------CCcEEEEEEeccCC--cCHHHHHHHHHHhhcc-CcceeeeeeeEeecC-C
Q 036583 491 TATNNFSVKLGQGGFGSVYQGVLP------DGTRLAVKKLEGIG--QGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEG-T 560 (817)
Q Consensus 491 ~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~--~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~-~ 560 (817)
...+.+.++||+|+||.||+|+.. +++.||||+++... ...+.+.+|+.++.++ +|+||+.+++++.+. .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 345667789999999999999842 35689999997542 2356788888888777 799999999998664 4
Q ss_pred eeeEEEeeccCCChhhhhhhccc-------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec
Q 036583 561 HRLLAYEFMANGSLDKWIFKKNQ-------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD 627 (817)
Q Consensus 561 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~ 627 (817)
..++||||+++|+|.++|..... ...+++..++.++.||++||+|||+ ++|+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeEC
Confidence 68999999999999999975432 2258899999999999999999999 9999999999999999
Q ss_pred CCCcEEEeecCCccccCCCCce-eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCC-CCCCCCCCCCCCcc
Q 036583 628 DNYHAKVSDFGLAKLMTREQSH-VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGR-KNFDPNETSDKAHF 705 (817)
Q Consensus 628 ~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~-~pf~~~~~~~~~~~ 705 (817)
+++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|. .||......
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~----- 243 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----- 243 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-----
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-----
Confidence 9999999999999876544332 223467999999999999999999999999999999999875 577533221
Q ss_pred hHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 706 PSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 706 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
......+.++..... +.....++.+++.+||+.||++||||+||+++|+.+.
T Consensus 244 -~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 244 -EEFCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp -HHHHHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHHHhcCCCCCC---------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 222333333321111 1122346889999999999999999999999998753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.2e-44 Score=388.98 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=207.4
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC-cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.+.+.++||+|+||+||+|+. .+|+.||||++.... ...+.+.+|++++++++|||||++++++.+++..++||||++
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 466778999999999999995 569999999997643 335678899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec--CCCcEEEeecCCccccCCCCc
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD--DNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+|+|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+||||+ .++.+||+|||+|+.......
T Consensus 110 gg~L~~~~~~~~~--~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 110 GGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CChHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 9999988765433 58999999999999999999999 9999999999999998 678999999999998765432
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+... ...
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~~~------~~~ 249 (352)
T d1koba_ 185 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ETLQNVKRCDWE------FDE 249 (352)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHHCCCC------CCS
T ss_pred --eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCC------CCc
Confidence 34568999999999999999999999999999999999999999643211 112222222111 111
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhc
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM--LEG 765 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~--L~~ 765 (817)
.........+.+|+.+||+.||.+|||++|+++. +++
T Consensus 250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 1111223467899999999999999999999884 544
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-44 Score=382.89 Aligned_cols=244 Identities=23% Similarity=0.312 Sum_probs=204.7
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEee
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 568 (817)
+.+.++||+|+||.||+++. .+|+.||||++.+. ....+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 55678999999999999995 57999999999643 34567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCc
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQS 648 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 648 (817)
+++|+|.+++.+.. .+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 87 ~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 87 ANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp CTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred cCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 99999999998755 58889999999999999999999 9999999999999999999999999999987644322
Q ss_pred eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCC
Q 036583 649 HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNI 728 (817)
Q Consensus 649 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 728 (817)
......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+..+.. ..
T Consensus 161 -~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-------~~~~~~i~~~~~--------~~ 224 (337)
T d1o6la_ 161 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELILMEEI--------RF 224 (337)
T ss_dssp -CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCC--------CC
T ss_pred -ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-------HHHHHHHhcCCC--------CC
Confidence 23457899999999999999999999999999999999999999975431 112222222221 11
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 036583 729 DEQSDRVFTAVKVALWCVQEDMSLRPS-----MTKVVQ 761 (817)
Q Consensus 729 ~~~~~~~~~~~~l~~~cl~~dp~~RPt-----~~evl~ 761 (817)
+ ......+.+++.+||+.||.+||+ ++|+++
T Consensus 225 p--~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 225 P--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp C--TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C--ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1 122346789999999999999994 888886
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=386.16 Aligned_cols=254 Identities=24% Similarity=0.410 Sum_probs=201.7
Q ss_pred hccccccCCCcceeEEEEEcCC-Cc--EEEEEEeccC--CcCHHHHHHHHHHhhcc-CcceeeeeeeEeecCCeeeEEEe
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPD-GT--RLAVKKLEGI--GQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~-g~--~vavK~l~~~--~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 567 (817)
..+.++||+|+||+||+|++.+ |. .||||++... ....++|.+|++++.++ +||||++++++|.+++..++|||
T Consensus 12 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e 91 (309)
T d1fvra_ 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 91 (309)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEE
Confidence 3456889999999999999754 43 4788888643 33456899999999999 79999999999999999999999
Q ss_pred eccCCChhhhhhhcc-------------cccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEE
Q 036583 568 FMANGSLDKWIFKKN-------------QEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKV 634 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki 634 (817)
|+++|+|.++|+... ....+++..+.+++.||++||.|||+ .+|+||||||+|||++.++.+||
T Consensus 92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEE
T ss_pred ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceEE
Confidence 999999999997541 23468999999999999999999999 89999999999999999999999
Q ss_pred eecCCccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCC-CCCCCCCCCCCcchHHHHHHh
Q 036583 635 SDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRK-NFDPNETSDKAHFPSYAFKMM 713 (817)
Q Consensus 635 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~-pf~~~~~~~~~~~~~~~~~~~ 713 (817)
+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||.... ...+...+
T Consensus 169 ~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-------~~~~~~~i 239 (309)
T d1fvra_ 169 ADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELYEKL 239 (309)
T ss_dssp CCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHG
T ss_pred cccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-------HHHHHHHH
Confidence 99999986543221 123568999999999999999999999999999999999765 564322 11122223
Q ss_pred hhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 714 EEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 714 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
.++. ..+.+......+.+++.+||+.||++||||+||++.|+++..
T Consensus 240 ~~~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 240 PQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp GGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 2221 111122234578899999999999999999999999988743
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-45 Score=387.50 Aligned_cols=257 Identities=26% Similarity=0.393 Sum_probs=204.2
Q ss_pred HhhccccccCCCcceeEEEEEcC--------CCcEEEEEEeccCCc--CHHHHHHHHHHhhcc-CcceeeeeeeEeecCC
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP--------DGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSI-HHLHLVKLRGFCAEGT 560 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~--------~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~ 560 (817)
..+.+.++||+|+||.||+|+.. ++..||||+++.... ...++.+|+..+.++ +|||||+++++|.++.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 34556789999999999999842 235799999976432 347889999999888 8999999999999999
Q ss_pred eeeEEEeeccCCChhhhhhhccc-------------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec
Q 036583 561 HRLLAYEFMANGSLDKWIFKKNQ-------------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD 627 (817)
Q Consensus 561 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~ 627 (817)
..++||||+++|+|.++|..... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeec
Confidence 99999999999999999975431 2358999999999999999999999 9999999999999999
Q ss_pred CCCcEEEeecCCccccCCCCcee-eeeccCCCCccCccccccCccCccccccchhhhHHHhhh-CCCCCCCCCCCCCCcc
Q 036583 628 DNYHAKVSDFGLAKLMTREQSHV-FTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIG-GRKNFDPNETSDKAHF 705 (817)
Q Consensus 628 ~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~pf~~~~~~~~~~~ 705 (817)
.++.+||+|||+++......... .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~------ 243 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 243 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH------
Confidence 99999999999999775543322 233678999999999999999999999999999999998 6888854321
Q ss_pred hHHHHHHhhhcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 036583 706 PSYAFKMMEEGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGIC 767 (817)
Q Consensus 706 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 767 (817)
..+...+.++... +.+......+.+++.+||+.||++||||.||+++|+++.
T Consensus 244 -~~~~~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 244 -EELFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp -HHHHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHHHHcCCCC---------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 2233333333211 111122346889999999999999999999999998863
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-45 Score=386.85 Aligned_cols=258 Identities=24% Similarity=0.394 Sum_probs=207.7
Q ss_pred HhhccccccCCCcceeEEEEEcC------CCcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCCeee
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVLP------DGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 563 (817)
....+.++||+|+||+||+|.+. +++.||||+++.... ....|.+|++++++++||||++++++|......+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 34556788999999999999863 357899999975432 2356899999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhhhccc-------ccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEee
Q 036583 564 LAYEFMANGSLDKWIFKKNQ-------EFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSD 636 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D 636 (817)
+||||+++|+|.+++..... ...+++..+.+++.|+++||.|||+ ++|+||||||+|||+++++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEee
Confidence 99999999999999875421 1246888999999999999999999 8999999999999999999999999
Q ss_pred cCCccccCCCCceee-eeccCCCCccCccccccCccCccccccchhhhHHHhhhCC-CCCCCCCCCCCCcchHHHHHHhh
Q 036583 637 FGLAKLMTREQSHVF-TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGR-KNFDPNETSDKAHFPSYAFKMME 714 (817)
Q Consensus 637 fgla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~-~pf~~~~~~~~~~~~~~~~~~~~ 714 (817)
||+++.......... ....||+.|+|||.+.+..++.++||||||+++|||+||. .||..... ......+.
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-------~~~~~~i~ 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------EQVLRFVM 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-------HHHHHHHH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHH
Confidence 999987754433222 2346899999999999999999999999999999999985 56643211 11222233
Q ss_pred hcchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 036583 715 EGKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGICP 768 (817)
Q Consensus 715 ~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 768 (817)
++..... .......+.+++.+||+.||++||||+||+++|++..+
T Consensus 250 ~~~~~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 EGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred hCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 3221111 11223468899999999999999999999999998744
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-43 Score=379.96 Aligned_cols=242 Identities=24% Similarity=0.293 Sum_probs=203.6
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccC----CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEe
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI----GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
.+.+.++||+|+||+||+++. .+|+.||||++... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 355668999999999999986 46999999998642 3456789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+.+|+|..++.+.. .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++......
T Consensus 122 ~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp CCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred cccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence 999999999997654 58999999999999999999999 999999999999999999999999999999775432
Q ss_pred ceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
....||+.|||||++.+..++.++|||||||++|||++|+.||..... ......+..+.. .
T Consensus 196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~i~~~~~--------~ 256 (350)
T d1rdqe_ 196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIYEKIVSGKV--------R 256 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCC--------C
T ss_pred ----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-------HHHHHHHhcCCC--------C
Confidence 346799999999999999999999999999999999999999964321 112222222211 1
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRP-----SMTKVVQ 761 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~evl~ 761 (817)
. +......+.+++.+||+.||.+|+ |++|+++
T Consensus 257 ~--p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 F--PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp C--CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred C--CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1 112234678999999999999994 8999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2e-43 Score=368.95 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=202.9
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc---C-------HHHHHHHHHHhhccC-cceeeeeeeEeecCCe
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ---G-------KKEFRAEVSIIGSIH-HLHLVKLRGFCAEGTH 561 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~---~-------~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~ 561 (817)
+.+.++||+|+||+||+++. .+|+.+|||++..... . .+.+.+|+.++.+++ ||||+++++++.+++.
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 84 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence 55678999999999999995 5789999999965421 1 235889999999997 9999999999999999
Q ss_pred eeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcc
Q 036583 562 RLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAK 641 (817)
Q Consensus 562 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 641 (817)
.+|||||+++|+|.++|.... .+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 85 ~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhee
Confidence 999999999999999997654 68999999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCceeeeeccCCCCccCcccccc------CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhh
Q 036583 642 LMTREQSHVFTTLRGTRGYLAPEWITN------YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEE 715 (817)
Q Consensus 642 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 715 (817)
....... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ......+.+
T Consensus 159 ~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-------~~~~~~i~~ 229 (277)
T d1phka_ 159 QLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-------MLMLRMIMS 229 (277)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHH
T ss_pred EccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH-------HHHHHHHHh
Confidence 8755332 244679999999999864 3467899999999999999999999964321 222233333
Q ss_pred cchhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 716 GKLRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 716 ~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
+... ...+.......++.+++.+||+.||++|||++||++.
T Consensus 230 ~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 230 GNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2211 1111122334578899999999999999999999763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=378.83 Aligned_cols=247 Identities=20% Similarity=0.307 Sum_probs=204.8
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeeccC
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMAN 571 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 571 (817)
.|.+.++||+|+||+||+|... +++.||||.++........+.+|+++|++++||||+++++++.+++..+|||||+++
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g 85 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence 3567789999999999999964 688999999987655566789999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC--CCcEEEeecCCccccCCCCce
Q 036583 572 GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD--NYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 572 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~ki~Dfgla~~~~~~~~~ 649 (817)
|+|.+++..... .+++.++..++.||+.||+|||+ .+|+||||||+|||++. ...+||+|||+++.......
T Consensus 86 g~L~~~i~~~~~--~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~- 159 (321)
T d1tkia_ 86 LDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN- 159 (321)
T ss_dssp CBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE-
T ss_pred CcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCCc-
Confidence 999999976432 58999999999999999999999 99999999999999984 45899999999987654432
Q ss_pred eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccCCc
Q 036583 650 VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLNID 729 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 729 (817)
.....+|+.|+|||.+.+..++.++||||+||++|||++|+.||..... ......+.++. ...+
T Consensus 160 -~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-------~~~~~~i~~~~--------~~~~ 223 (321)
T d1tkia_ 160 -FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------QQIIENIMNAE--------YTFD 223 (321)
T ss_dssp -EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTC--------CCCC
T ss_pred -ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC--------CCCC
Confidence 3456789999999999999999999999999999999999999965421 11222222221 1111
Q ss_pred cc--HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 730 EQ--SDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 730 ~~--~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.. .....++.+++.+||+.||++|||++|+++
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10 012346789999999999999999999998
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-43 Score=370.16 Aligned_cols=255 Identities=22% Similarity=0.304 Sum_probs=198.7
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc----CHHHHHHHHHHhhccCcceeeeeeeEeecCC----eee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ----GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT----HRL 563 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~----~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~----~~~ 563 (817)
.+.+.+.||+|+||+||+|+. .+|+.||||+++.... ..+.|.+|++++++++||||+++++++...+ ..+
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 356778999999999999985 5799999999975422 2357899999999999999999999997644 378
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+||||+++++|.+++.... .+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++..+|+|||.+...
T Consensus 88 lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhh
Confidence 9999999999999887654 58999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc--eeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhh
Q 036583 644 TREQS--HVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721 (817)
Q Consensus 644 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (817)
..... .......||+.|+|||++.+..+++++|||||||++|||++|+.||..... .......+..+.....
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~~~~ 235 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIPPS 235 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCCGG
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCCCCc
Confidence 43322 223346799999999999999999999999999999999999999964321 1222222222211100
Q ss_pred cccccCCcccHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcC
Q 036583 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRP-SMTKVVQMLEGI 766 (817)
Q Consensus 722 ~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-t~~evl~~L~~~ 766 (817)
......+..+.+++.+||+.||++|| |++|+++.|.++
T Consensus 236 -------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 236 -------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp -------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 00111234688999999999999999 899999988765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-43 Score=376.91 Aligned_cols=247 Identities=24% Similarity=0.275 Sum_probs=196.7
Q ss_pred hcccc-ccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhcc-CcceeeeeeeEeec----CCeeeEEE
Q 036583 494 NNFSV-KLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSI-HHLHLVKLRGFCAE----GTHRLLAY 566 (817)
Q Consensus 494 ~~~~~-~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~----~~~~~lv~ 566 (817)
+.+.. .||+|+||+||+|+. .+++.||||+++. .+.+.+|++++.++ +||||+++++++.+ ....++||
T Consensus 13 y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivm 88 (335)
T d2ozaa1 13 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 88 (335)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEE
Confidence 44544 599999999999985 5689999999964 35678899987655 89999999999865 45689999
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC---CCcEEEeecCCcccc
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD---NYHAKVSDFGLAKLM 643 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~Dfgla~~~ 643 (817)
|||++|+|.++|.+... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+++ .+.+||+|||+++..
T Consensus 89 Ey~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 89 ECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp ECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeeec
Confidence 99999999999976432 269999999999999999999999 99999999999999985 567999999999876
Q ss_pred CCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcc
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILD 723 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 723 (817)
..... .....||+.|||||++.+..++.++|||||||++|||++|+.||.......... .+ ...+..
T Consensus 165 ~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~-------~~----~~~i~~ 231 (335)
T d2ozaa1 165 TSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------GM----KTRIRM 231 (335)
T ss_dssp CCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------CCCS
T ss_pred cCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH-------HH----HHHHhc
Confidence 54432 245689999999999999999999999999999999999999996543322100 00 001111
Q ss_pred cccCCc--ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 724 SRLNID--EQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 724 ~~~~~~--~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
.....+ .......++.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 232 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111111 11233457889999999999999999999998
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-42 Score=377.05 Aligned_cols=245 Identities=24% Similarity=0.336 Sum_probs=196.6
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccC----CcCHHHHHHH---HHHhhccCcceeeeeeeEeecCCeeeEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI----GQGKKEFRAE---VSIIGSIHHLHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~----~~~~~~~~~E---v~~l~~l~h~niv~l~~~~~~~~~~~lv 565 (817)
+.+.++||+|+||+||+|+. .+|+.||||++... ......+.+| +++++.++||||+++++++.+.+..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 45668899999999999995 46899999998642 2334445444 6777788899999999999999999999
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 645 (817)
|||+++|+|.++|.+.. .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 mE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp ECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999999997654 57889999999999999999999 9999999999999999999999999999997654
Q ss_pred CCceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccc
Q 036583 646 EQSHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS 724 (817)
Q Consensus 646 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 724 (817)
.. .....||+.|+|||++.. ..++.++|||||||+||||++|+.||........ ...... ....
T Consensus 160 ~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----~~~~~~--------~~~~ 224 (364)
T d1omwa3 160 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRM--------TLTM 224 (364)
T ss_dssp SC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH----HHHHHH--------SSSC
T ss_pred Cc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHh--------cccC
Confidence 43 234679999999999974 5689999999999999999999999975433220 011111 1111
Q ss_pred ccCCcccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 036583 725 RLNIDEQSDRVFTAVKVALWCVQEDMSLRPS-----MTKVVQ 761 (817)
Q Consensus 725 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt-----~~evl~ 761 (817)
.... .......+.+++.+||+.||++||| ++|+++
T Consensus 225 ~~~~--~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 AVEL--PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCC--CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCC--CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1111 1112346789999999999999999 688875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=375.92 Aligned_cols=244 Identities=22% Similarity=0.292 Sum_probs=201.2
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccC----CcCHHHHHHHHHHhh-ccCcceeeeeeeEeecCCeeeEEEe
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGI----GQGKKEFRAEVSIIG-SIHHLHLVKLRGFCAEGTHRLLAYE 567 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~~~~~~~~Ev~~l~-~l~h~niv~l~~~~~~~~~~~lv~e 567 (817)
+.+.++||+|+||+||+|+.. +|+.||||++++. ....+.+..|..++. .++||||+++++++.+++..++|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 556789999999999999964 6899999999643 345567777877765 6899999999999999999999999
Q ss_pred eccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCC
Q 036583 568 FMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 647 (817)
|+++|+|.+++.... .++...+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 84 y~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 84 YLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred ecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 999999999997655 57889999999999999999999 899999999999999999999999999998765433
Q ss_pred ceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhcccccC
Q 036583 648 SHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDSRLN 727 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 727 (817)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+.. .
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~~i~~~~~--------~ 221 (320)
T d1xjda_ 158 A-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------EELFHSIRMDNP--------F 221 (320)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCC--------C
T ss_pred c-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCC--------C
Confidence 2 23446899999999999999999999999999999999999999964321 222333322211 1
Q ss_pred CcccHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 036583 728 IDEQSDRVFTAVKVALWCVQEDMSLRPSMT-KVVQ 761 (817)
Q Consensus 728 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~-evl~ 761 (817)
.+ ......+.+|+.+||+.||++||++. |+++
T Consensus 222 ~p--~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 YP--RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CC--TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CC--ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11 11234678999999999999999995 7764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=374.53 Aligned_cols=254 Identities=22% Similarity=0.247 Sum_probs=193.0
Q ss_pred cccCCCcceeEEEEEcC-CCcEEEEEEeccCCc------CHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 498 VKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQ------GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~------~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
+.||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|+.++++++|||||++++++.++++.++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 57999999999999964 589999999864321 13468999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
++++..++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 84 ~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~- 156 (299)
T d1ua2a_ 84 TDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA- 156 (299)
T ss_dssp EEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-
T ss_pred chHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCccc-
Confidence 987776654333 58889999999999999999999 99999999999999999999999999999876543322
Q ss_pred eeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhhccc-----
Q 036583 651 FTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNILDS----- 724 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~----- 724 (817)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||......+ ......+...........+.
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhccch
Confidence 234679999999999875 467999999999999999999999996543211 00000111000000000000
Q ss_pred --ccC--Cccc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 725 --RLN--IDEQ-----SDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 725 --~~~--~~~~-----~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
... .... ......+.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000 0000 012346889999999999999999999997
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-42 Score=364.39 Aligned_cols=261 Identities=22% Similarity=0.291 Sum_probs=197.6
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
+.+.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|++++++++||||+++++++.++.+.++||||+
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence 44568899999999999995 578999999996542 23578999999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
.++.+ +++.... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~~~~-~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~- 157 (298)
T d1gz8a_ 84 HQDLK-KFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 157 (298)
T ss_dssp SEEHH-HHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred CCchh-hhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence 86544 4443322 2268999999999999999999999 9999999999999999999999999999987654322
Q ss_pred eeeeccCCCCccCccccccCc-cCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhh-cch--------h
Q 036583 650 VFTTLRGTRGYLAPEWITNYA-ISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEE-GKL--------R 719 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~--------~ 719 (817)
......||+.|+|||.+.... ++.++|||||||++|||++|+.||...... ......... +.. .
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~------~~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI------DQLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHCCCCTTTSTTGG
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH------HHHHHHHHhcCCCchhhccccc
Confidence 223467999999999987655 478999999999999999999999644211 111111100 000 0
Q ss_pred hhccccc------CCcc---cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcC
Q 036583 720 NILDSRL------NIDE---QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM--LEGI 766 (817)
Q Consensus 720 ~~~d~~~------~~~~---~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~--L~~~ 766 (817)
...+... .... .......+.+++.+||+.||++|||++|+++. ++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0000000 0000 00123467899999999999999999999984 6554
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-43 Score=364.05 Aligned_cols=237 Identities=25% Similarity=0.408 Sum_probs=193.9
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC-------cCHHHHHHHHHHhhccC--cceeeeeeeEeecCCee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG-------QGKKEFRAEVSIIGSIH--HLHLVKLRGFCAEGTHR 562 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~-------~~~~~~~~Ev~~l~~l~--h~niv~l~~~~~~~~~~ 562 (817)
.+.+.++||+|+||+||+|+. .+|+.||||++.... .....+.+|+.++++++ ||||+++++++.+.+..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 466778999999999999995 578999999986431 12245778999999996 89999999999999999
Q ss_pred eEEEeeccC-CChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC-CCcEEEeecCCc
Q 036583 563 LLAYEFMAN-GSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD-NYHAKVSDFGLA 640 (817)
Q Consensus 563 ~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~Dfgla 640 (817)
++||||+.+ +++.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||++
T Consensus 85 ~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccc
Confidence 999999976 67888876544 58999999999999999999999 99999999999999985 579999999999
Q ss_pred cccCCCCceeeeeccCCCCccCccccccCcc-CccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchh
Q 036583 641 KLMTREQSHVFTTLRGTRGYLAPEWITNYAI-SEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLR 719 (817)
Q Consensus 641 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (817)
+...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .+..+.
T Consensus 159 ~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------------~i~~~~-- 220 (273)
T d1xwsa_ 159 ALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIRGQ-- 220 (273)
T ss_dssp EECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHHCC--
T ss_pred eeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------HHhhcc--
Confidence 8754432 245689999999999987765 577999999999999999999995321 111111
Q ss_pred hhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 720 NILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 720 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
...+ .....++.+++.+||+.||++|||++|+++
T Consensus 221 ------~~~~--~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 ------VFFR--QRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ------CCCS--SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------cCCC--CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0010 112346789999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-41 Score=358.72 Aligned_cols=258 Identities=22% Similarity=0.311 Sum_probs=196.0
Q ss_pred hccccccCCCcceeEEEEEcCCCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeecc
Q 036583 494 NNFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
+.+.++||+|+||+||+|+.++|+.||||++... ....+.+.+|+.++++++||||+++++++.+.+..++++||+.
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~ 83 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred ceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeeh
Confidence 4556889999999999999989999999999654 2335789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCcee
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHV 650 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 650 (817)
++.+..+..... .++...+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........ .
T Consensus 84 ~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~ 156 (286)
T d1ob3a_ 84 QDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (286)
T ss_dssp EEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred hhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCcc-c
Confidence 877766655433 68999999999999999999999 8999999999999999999999999999987654322 2
Q ss_pred eeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcc------hhhhc-
Q 036583 651 FTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGK------LRNIL- 722 (817)
Q Consensus 651 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~~- 722 (817)
.....+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+ .+ ........... .....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--~~-~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QL-MRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HH-HHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--HH-HHHHHhhCCCChhhccchhhhhh
Confidence 2345689999999999754 56899999999999999999999996543111 00 00001000000 00000
Q ss_pred -cccc----CC---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 723 -DSRL----NI---DEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 723 -d~~~----~~---~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+... .. .........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00 000112346789999999999999999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-41 Score=358.75 Aligned_cols=260 Identities=20% Similarity=0.301 Sum_probs=192.7
Q ss_pred hhccccccCCCcceeEEEEEc-CC-CcEEEEEEeccC---CcCHHHHHHHHHHhhcc---CcceeeeeeeEeec-----C
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PD-GTRLAVKKLEGI---GQGKKEFRAEVSIIGSI---HHLHLVKLRGFCAE-----G 559 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~-g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l---~h~niv~l~~~~~~-----~ 559 (817)
.+.+.++||+|+||+||+|+. .+ ++.||||+++.. ......+.+|+.+++.+ +||||++++++|.. .
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~ 87 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 87 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence 456678999999999999985 34 567999998643 22234567888887766 79999999999853 3
Q ss_pred CeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCC
Q 036583 560 THRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGL 639 (817)
Q Consensus 560 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl 639 (817)
...+++|||++++.+......... .+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+
T Consensus 88 ~~~~~~~e~~~~~~~~~~~~~~~~--~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 88 TKLTLVFEHVDQDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp EEEEEEEECCSCBHHHHHHHSCTT--CSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred ceEEEEEEeccCCchhhhhhccCC--CCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhh
Confidence 467999999999877655443332 58889999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchh
Q 036583 640 AKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLR 719 (817)
Q Consensus 640 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (817)
++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+ .............
T Consensus 163 ~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~-~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 163 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QL-GKILDVIGLPGEE 237 (305)
T ss_dssp CCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HH-HHHHHHHCCCCGG
T ss_pred hhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH--HH-HHHHHhhCCCchh
Confidence 98654332 2345789999999999999999999999999999999999999996543211 00 0000000000000
Q ss_pred h----------hcccccC---CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 720 N----------ILDSRLN---IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 720 ~----------~~d~~~~---~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
. ....... ..........+.+|+.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 0000000 00011123467789999999999999999999873
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=360.98 Aligned_cols=263 Identities=23% Similarity=0.274 Sum_probs=192.8
Q ss_pred hhccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceeeeeeeEeecC------CeeeEE
Q 036583 493 TNNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLRGFCAEG------THRLLA 565 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~------~~~~lv 565 (817)
+++..++||+|+||+||+|+.. +|+.||||++..... ...+|++++++++||||++++++|... .+.+||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 3445578999999999999964 689999999975432 234799999999999999999998542 357899
Q ss_pred EeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC-cEEEeecCCccccC
Q 036583 566 YEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY-HAKVSDFGLAKLMT 644 (817)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Dfgla~~~~ 644 (817)
|||++++.+..+.........+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++...
T Consensus 98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 9999876544444333333468999999999999999999998 9999999999999999765 89999999998765
Q ss_pred CCCceeeeeccCCCCccCcccccc-CccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHH----------HHHHh
Q 036583 645 REQSHVFTTLRGTRGYLAPEWITN-YAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSY----------AFKMM 713 (817)
Q Consensus 645 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~----------~~~~~ 713 (817)
.... .....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. +... .+...
T Consensus 175 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 175 RGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp TTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHH
T ss_pred CCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHHHHhCCChHHhhhhh
Confidence 4332 234679999999998875 5789999999999999999999999965432110 0000 00000
Q ss_pred hhcchhhhcccccC-----CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcC
Q 036583 714 EEGKLRNILDSRLN-----IDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM--LEGI 766 (817)
Q Consensus 714 ~~~~~~~~~d~~~~-----~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~--L~~~ 766 (817)
... .....-+... ..........+.+|+.+||+.||++|||++|+++. ++.+
T Consensus 251 ~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 251 NPN-YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CC----CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred ccc-hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 000 0000000000 00011223467899999999999999999999973 5544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.4e-40 Score=347.42 Aligned_cols=258 Identities=20% Similarity=0.260 Sum_probs=194.4
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcceee-eeeeEeecCCeeeEEEeecc
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLV-KLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~ 570 (817)
++.+.++||+|+||+||+|+. .+|+.||||++.... ..+++..|++++++++|+|++ .+..+..+++..++||||+.
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~ 86 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence 366778999999999999985 568999999886532 334688999999999877655 45555677888999999995
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEec---CCCcEEEeecCCccccCCCC
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLD---DNYHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~ki~Dfgla~~~~~~~ 647 (817)
++|...+..... .+++..+..++.|++.||+|||+ ++|+||||||+|||++ .+..+||+|||+|+......
T Consensus 87 -~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 87 -PSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp -CBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred -CchhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 466666654433 58999999999999999999999 9999999999999986 45679999999999875433
Q ss_pred ce------eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhh
Q 036583 648 SH------VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721 (817)
Q Consensus 648 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (817)
.. ......||+.|||||.+.+..++.++|||||||++|||++|+.||..........................+
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence 21 223467999999999999999999999999999999999999999765433221111100000000000101
Q ss_pred cccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 722 ~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
. ...+.++.+++..||+.+|++||+++++.+.|+..
T Consensus 241 -----~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 241 -----C----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp -----T----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred -----c----cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0 01224678999999999999999999999988764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-40 Score=355.26 Aligned_cols=262 Identities=19% Similarity=0.217 Sum_probs=191.9
Q ss_pred HhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccC---CcCHHHHHHHHHHhhccCcceeeeeeeEeec--------C
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGI---GQGKKEFRAEVSIIGSIHHLHLVKLRGFCAE--------G 559 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~--------~ 559 (817)
..+.+.++||+|+||+||+|+. .+|+.||||++... ....+.+.+|++++++++|||++++++.+.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 3456678999999999999995 57999999998543 2345788999999999999999999999855 3
Q ss_pred CeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCC
Q 036583 560 THRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGL 639 (817)
Q Consensus 560 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl 639 (817)
.+.++||||++++.+..+..... .++......++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecce
Confidence 46799999999887765544333 57778889999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCce---eeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhh
Q 036583 640 AKLMTREQSH---VFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEE 715 (817)
Q Consensus 640 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 715 (817)
++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~---~~~~i~~~~~~ 240 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCGS 240 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH---HHHHHHHhcCC
Confidence 9876543221 12235799999999998765 68999999999999999999999997533211 00000010000
Q ss_pred c-----------chhhhcccccCCcccH-------HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 716 G-----------KLRNILDSRLNIDEQS-------DRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 716 ~-----------~~~~~~d~~~~~~~~~-------~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
. ................ .....+.+|+.+||+.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0 0000000000001111 112356789999999999999999999973
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=351.38 Aligned_cols=263 Identities=21% Similarity=0.314 Sum_probs=193.8
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCc--CHHHHHHHHHHhhccCcceeeeeeeEeecCC----eeeEEE
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQ--GKKEFRAEVSIIGSIHHLHLVKLRGFCAEGT----HRLLAY 566 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 566 (817)
+.+.++||+|+||+||+|+. .+|+.||||++..... ..+.+++|+.+|++++||||+++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 55668999999999999984 5799999999975432 3467899999999999999999999996543 335556
Q ss_pred eeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCC
Q 036583 567 EFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTRE 646 (817)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 646 (817)
+|+.+|+|.+++... .+++..++.++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 90 ~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 90 THLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 777899999999653 48899999999999999999999 99999999999999999999999999999876543
Q ss_pred Cce--eeeeccCCCCccCccccc-cCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcc------
Q 036583 647 QSH--VFTTLRGTRGYLAPEWIT-NYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGK------ 717 (817)
Q Consensus 647 ~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~------ 717 (817)
... ......||+.|+|||++. +..++.++||||+||+++||++|+.||......+. ............
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQEDLNC 239 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHHHT
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH---HHHHhhhccCCChhhhhh
Confidence 222 123467999999999985 45678999999999999999999999965432110 000000000000
Q ss_pred -----hhhhc--ccccC-Cccc---HHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcC
Q 036583 718 -----LRNIL--DSRLN-IDEQ---SDRVFTAVKVALWCVQEDMSLRPSMTKVVQM--LEGI 766 (817)
Q Consensus 718 -----~~~~~--d~~~~-~~~~---~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~--L~~~ 766 (817)
..... .+... .+.. .....++.+++.+||+.||++|||++|+++. |+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 00000 00000 0000 0112367899999999999999999999984 5543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-39 Score=343.17 Aligned_cols=258 Identities=18% Similarity=0.250 Sum_probs=202.0
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhccCc-ceeeeeeeEeecCCeeeEEEeecc
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHH-LHLVKLRGFCAEGTHRLLAYEFMA 570 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~ 570 (817)
.+.+.++||+|+||+||+|+. .+|+.||||++... ...+.+.+|++++..++| +|++.+++++.++...++||||+
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc-cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence 456778999999999999995 46899999988643 233457889999999965 89999999999999999999998
Q ss_pred CCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecC-----CCcEEEeecCCccccCC
Q 036583 571 NGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDD-----NYHAKVSDFGLAKLMTR 645 (817)
Q Consensus 571 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~ki~Dfgla~~~~~ 645 (817)
+++|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++....
T Consensus 84 ~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 84 GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 6799998876543 58889999999999999999999 99999999999999974 57899999999997654
Q ss_pred CCce------eeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchh
Q 036583 646 EQSH------VFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLR 719 (817)
Q Consensus 646 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (817)
.... ......||+.|||||.+.+..++.++|||||||++|||++|+.||......... .....+......
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~----~~~~~i~~~~~~ 234 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK----QKYERIGEKKQS 234 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH----HHHHHHHHHHHH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH----HHHHHHHhccCC
Confidence 3211 123467999999999999999999999999999999999999999754433211 111111111110
Q ss_pred hhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 036583 720 NILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQMLEGI 766 (817)
Q Consensus 720 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~L~~~ 766 (817)
..+ +.+.. ..+.++.+++..|++.+|++||+++.+.+.|+.+
T Consensus 235 ~~~-~~l~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 235 TPL-RELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp SCH-HHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCh-HHhcC----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 000 00100 1123578889999999999999999999888765
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-39 Score=350.39 Aligned_cols=263 Identities=24% Similarity=0.341 Sum_probs=191.2
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcC---HHHHHHHHHHhhccCcceeeeeeeEeecCC------ee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQG---KKEFRAEVSIIGSIHHLHLVKLRGFCAEGT------HR 562 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~---~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~------~~ 562 (817)
++.+.++||+|+||+||+|+. .+|+.||||+++..... .+.+.+|+++|++++|||||+++++|...+ +.
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 455668899999999999995 56999999999754322 457889999999999999999999997654 56
Q ss_pred eEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 563 LLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 563 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
++||||+ +.+|..++... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||+++.
T Consensus 99 ~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp EEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceec
Confidence 9999999 45777766432 58999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCceeeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCC--------cchHHHHHHh
Q 036583 643 MTREQSHVFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA--------HFPSYAFKMM 713 (817)
Q Consensus 643 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~--------~~~~~~~~~~ 713 (817)
..... ....||+.|+|||.+.+. .++.++||||+||++|||++|+.||......... ..+.......
T Consensus 171 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 171 ADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 65432 346799999999998764 5689999999999999999999999754321100 0000000000
Q ss_pred hhcc-------hhhhcccccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcCCC
Q 036583 714 EEGK-------LRNILDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM--LEGICP 768 (817)
Q Consensus 714 ~~~~-------~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~--L~~~~~ 768 (817)
.... +.+.....+. .........+.+|+.+||+.||++|||++|+++. ++.+.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred cchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 0000 0000000000 0001122457799999999999999999999984 666543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-40 Score=349.64 Aligned_cols=249 Identities=21% Similarity=0.268 Sum_probs=200.5
Q ss_pred hccccccCCCcceeEEEEEc----CCCcEEEEEEeccC-----CcCHHHHHHHHHHhhccCc-ceeeeeeeEeecCCeee
Q 036583 494 NNFSVKLGQGGFGSVYQGVL----PDGTRLAVKKLEGI-----GQGKKEFRAEVSIIGSIHH-LHLVKLRGFCAEGTHRL 563 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~----~~g~~vavK~l~~~-----~~~~~~~~~Ev~~l~~l~h-~niv~l~~~~~~~~~~~ 563 (817)
+.+.++||+|+||+||+|+. .+|+.||||++... ....+.+.+|++++.+++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 67778999999999999974 24789999998542 2345678999999999966 89999999999999999
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
++|||+.+|+|.+++.... .+.......++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+
T Consensus 106 ~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 9999999999999997665 46678888999999999999999 99999999999999999999999999999877
Q ss_pred CCCCceeeeeccCCCCccCccccccC--ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcchhhh
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITNY--AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGKLRNI 721 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (817)
............|++.|+|||.+.+. .++.++|||||||+||||++|+.||....... ............
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~---~~~~i~~~~~~~----- 251 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISRRILKS----- 251 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC---CHHHHHHHHHHC-----
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcccC-----
Confidence 55444444557899999999999754 46789999999999999999999997654332 111111111111
Q ss_pred cccccCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 036583 722 LDSRLNIDEQSDRVFTAVKVALWCVQEDMSLRP-----SMTKVVQ 761 (817)
Q Consensus 722 ~d~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~evl~ 761 (817)
... ........+.+++.+||+.||++|| |++|+++
T Consensus 252 ---~~~--~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 ---EPP--YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ---CCC--CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ---CCC--CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111 1112345788999999999999999 4889986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=344.65 Aligned_cols=259 Identities=19% Similarity=0.262 Sum_probs=198.3
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccCC---cCHHHHHHHHHHhhccCcceeeeeeeEeecCCeeeEEEeec
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIG---QGKKEFRAEVSIIGSIHHLHLVKLRGFCAEGTHRLLAYEFM 569 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 569 (817)
+.+.++||+|+||+||+|+. .+++.||||+++... ...+.+.+|+.++++++||||+++++++.+....++|+|++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 45668999999999999995 578899999996542 22578899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccCCCCce
Q 036583 570 ANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMTREQSH 649 (817)
Q Consensus 570 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 649 (817)
.+++|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||.++.......
T Consensus 84 ~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~- 156 (292)
T d1unla_ 84 DQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp SEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred ccccccccccccc---ccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence 9999988776544 57889999999999999999999 9999999999999999999999999999987654332
Q ss_pred eeeeccCCCCccCccccccCc-cCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhhcc------hhhhc
Q 036583 650 VFTTLRGTRGYLAPEWITNYA-ISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEEGK------LRNIL 722 (817)
Q Consensus 650 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 722 (817)
......+++.|+|||.+.... ++.++|||||||++|||++|+.||........ ....+........ .....
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCCCChhhhhhhhhcc
Confidence 223356778899999987654 68999999999999999999999753322110 0000000000000 00000
Q ss_pred cc---------ccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 723 DS---------RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 723 d~---------~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
+. .............+.+|+.+|++.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000111122346788999999999999999999987
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.9e-39 Score=345.74 Aligned_cols=254 Identities=20% Similarity=0.313 Sum_probs=194.5
Q ss_pred hhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhccC-cceeeeeeeEeec--CCeeeEEEee
Q 036583 493 TNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH-HLHLVKLRGFCAE--GTHRLLAYEF 568 (817)
Q Consensus 493 ~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~--~~~~~lv~e~ 568 (817)
.+.+.++||+|+||+||+|+. .+|+.||||+++. ...+++.+|+++|.+++ ||||+++++++.. ....++||||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~--~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH--HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 466778999999999999995 5689999999974 34678999999999995 9999999999974 4568999999
Q ss_pred ccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCC-CcEEEeecCCccccCCCC
Q 036583 569 MANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDN-YHAKVSDFGLAKLMTREQ 647 (817)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~Dfgla~~~~~~~ 647 (817)
+++++|..+.. .++...+..++.||+.||+|||+ ++|+||||||+|||++.+ ..+||+|||+++......
T Consensus 114 ~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 114 VNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp CCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred cCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 99999977642 47889999999999999999999 999999999999999865 469999999998765443
Q ss_pred ceeeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHH---------hhhcc
Q 036583 648 SHVFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKM---------MEEGK 717 (817)
Q Consensus 648 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~---------~~~~~ 717 (817)
. .....+|+.|+|||.+.+. .++.++||||+||+++||++|+.||......... ....... .....
T Consensus 185 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~--~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 185 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ--LVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH--HHHHHHHHCHHHHHHHHHHTT
T ss_pred c--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHH--HHHHHHHHCCchhhhhhhhcc
Confidence 2 2446789999999998765 5789999999999999999999999654322110 0000000 00000
Q ss_pred h------hhhccc--------ccCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 036583 718 L------RNILDS--------RLNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ 761 (817)
Q Consensus 718 ~------~~~~d~--------~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~ 761 (817)
. ...... ............++.+|+.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000 0001111122346789999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-38 Score=339.73 Aligned_cols=258 Identities=23% Similarity=0.264 Sum_probs=185.3
Q ss_pred hccccccCCCcceeEEEEEcC-CCcEEEEEEeccCCcC---HHHHHHHHHHhhccCcceeeeeeeEeec------CCeee
Q 036583 494 NNFSVKLGQGGFGSVYQGVLP-DGTRLAVKKLEGIGQG---KKEFRAEVSIIGSIHHLHLVKLRGFCAE------GTHRL 563 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~---~~~~~~Ev~~l~~l~h~niv~l~~~~~~------~~~~~ 563 (817)
+.+.++||+|+||+||+|+.. +|+.||||++...... .+.+.+|+.++++++||||++++++|.. ..+.|
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 455679999999999999954 6999999999754322 3568899999999999999999999963 46889
Q ss_pred EEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCcccc
Q 036583 564 LAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLM 643 (817)
Q Consensus 564 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 643 (817)
+||||+.++.+. .+.. .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||+++..
T Consensus 99 iv~Ey~~~~l~~-~~~~-----~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 99 LVMELMDANLCQ-VIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEECCSEEHHH-HHTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeccchHHHH-hhhc-----CCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhcc
Confidence 999999775544 4422 47889999999999999999999 99999999999999999999999999998866
Q ss_pred CCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCC---------cchH-------
Q 036583 644 TREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKA---------HFPS------- 707 (817)
Q Consensus 644 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~---------~~~~------- 707 (817)
.... ......+|+.|+|||++.+..+++++||||+||+++||++|+.||......... ..++
T Consensus 170 ~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 170 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred cccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 4432 224467899999999999999999999999999999999999999644311100 0000
Q ss_pred HHHHHhhhcc------hhhhccccc---CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 036583 708 YAFKMMEEGK------LRNILDSRL---NIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVVQM 762 (817)
Q Consensus 708 ~~~~~~~~~~------~~~~~d~~~---~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~~ 762 (817)
.......... ......... ...........+.+|+.+|++.||++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000000 000000000 011122345678899999999999999999999873
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-38 Score=341.06 Aligned_cols=260 Identities=23% Similarity=0.328 Sum_probs=192.5
Q ss_pred hccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcC---HHHHHHHHHHhhccCcceeeeeeeEeecC-----CeeeE
Q 036583 494 NNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQG---KKEFRAEVSIIGSIHHLHLVKLRGFCAEG-----THRLL 564 (817)
Q Consensus 494 ~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~---~~~~~~Ev~~l~~l~h~niv~l~~~~~~~-----~~~~l 564 (817)
|.+.++||+|+||+||+|+. .+|+.||||++...... .+.+.+|++++++++|||++++++++... ...++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence 55668899999999999994 57999999999765333 35688999999999999999999998643 34577
Q ss_pred EEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEeecCCccccC
Q 036583 565 AYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVSDFGLAKLMT 644 (817)
Q Consensus 565 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 644 (817)
+++|+.+|+|.+++... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++....
T Consensus 100 i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 100 LVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp EEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred EEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcccC
Confidence 78888999999998643 48999999999999999999999 999999999999999999999999999997654
Q ss_pred CCCceeeeeccCCCCccCccccccC-ccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHHHhhh--------
Q 036583 645 REQSHVFTTLRGTRGYLAPEWITNY-AISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFKMMEE-------- 715 (817)
Q Consensus 645 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-------- 715 (817)
.. .....|++.|+|||.+.+. .++.++|||||||++|||++|+.||........ ..........
T Consensus 173 ~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~---~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 173 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTPGAELLKK 245 (348)
T ss_dssp GG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCHHHHTT
T ss_pred cc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCChHHhhh
Confidence 32 2345788999999987765 468899999999999999999999965432110 0000000000
Q ss_pred ---cchhhhcccccC---Ccc---cHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcCC
Q 036583 716 ---GKLRNILDSRLN---IDE---QSDRVFTAVKVALWCVQEDMSLRPSMTKVVQ--MLEGIC 767 (817)
Q Consensus 716 ---~~~~~~~d~~~~---~~~---~~~~~~~~~~l~~~cl~~dp~~RPt~~evl~--~L~~~~ 767 (817)
............ ... .......+.+|+.+||+.||.+|||++|+++ .+.+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 000000000000 000 0012345789999999999999999999998 455543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.3e-35 Score=317.73 Aligned_cols=265 Identities=24% Similarity=0.263 Sum_probs=191.8
Q ss_pred HhhccccccCCCcceeEEEEEc-CCCcEEEEEEeccCCcCHHHHHHHHHHhhccC-----------cceeeeeeeEeec-
Q 036583 492 ATNNFSVKLGQGGFGSVYQGVL-PDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH-----------HLHLVKLRGFCAE- 558 (817)
Q Consensus 492 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~-----------h~niv~l~~~~~~- 558 (817)
.+|.+.++||+|+||+||+|+. .+|+.||||+++......+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4477889999999999999995 57999999999865444567889999988875 5789999998864
Q ss_pred -CCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCC------c
Q 036583 559 -GTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNY------H 631 (817)
Q Consensus 559 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~------~ 631 (817)
....+++++++..+..............++...+..++.||+.||+|||+ ..+|+||||||+||||+.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence 34566777776665444433333333467888999999999999999997 37899999999999998654 4
Q ss_pred EEEeecCCccccCCCCceeeeeccCCCCccCccccccCccCccccccchhhhHHHhhhCCCCCCCCCCCCCCcchHHHHH
Q 036583 632 AKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNFDPNETSDKAHFPSYAFK 711 (817)
Q Consensus 632 ~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 711 (817)
+|++|||.+....... ....||+.|+|||.+.+..++.++||||+||+++||++|+.||.................
T Consensus 171 ~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 9999999998654322 346799999999999999999999999999999999999999976543322111111111
Q ss_pred Hhh-----------hcc-hhhhccc----------c---------cCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 036583 712 MME-----------EGK-LRNILDS----------R---------LNIDEQSDRVFTAVKVALWCVQEDMSLRPSMTKVV 760 (817)
Q Consensus 712 ~~~-----------~~~-~~~~~d~----------~---------~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~evl 760 (817)
.+. ... .....+. . ............+.+|+.+|++.||.+|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 100 000 0000000 0 01112234567889999999999999999999999
Q ss_pred HH
Q 036583 761 QM 762 (817)
Q Consensus 761 ~~ 762 (817)
+.
T Consensus 327 ~H 328 (362)
T d1q8ya_ 327 NH 328 (362)
T ss_dssp TC
T ss_pred cC
Confidence 84
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=6.2e-22 Score=193.83 Aligned_cols=162 Identities=15% Similarity=0.130 Sum_probs=120.5
Q ss_pred ccccccCCCcceeEEEEEcCCCcEEEEEEeccCCc------C-------------HHHHHHHHHHhhccCcceeeeeeeE
Q 036583 495 NFSVKLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQ------G-------------KKEFRAEVSIIGSIHHLHLVKLRGF 555 (817)
Q Consensus 495 ~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~------~-------------~~~~~~Ev~~l~~l~h~niv~l~~~ 555 (817)
.+.++||+|+||+||+|+..+|++||||+++.... . ......|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35678999999999999988999999998753210 0 1234568889999999999988766
Q ss_pred eecCCeeeEEEeeccCCChhhhhhhcccccchhhhHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEecCCCcEEEe
Q 036583 556 CAEGTHRLLAYEFMANGSLDKWIFKKNQEFLLDWETRFNIALGTAKGLAYLHEDCDQRIIHCDIKPENVLLDDNYHAKVS 635 (817)
Q Consensus 556 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~ 635 (817)
. ..+++|||+++..+.. ++......++.|++++|+|||+ .+|+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEE
Confidence 3 2379999998865432 3445567899999999999999 999999999999999965 58999
Q ss_pred ecCCccccCCCCceeeeeccCCCCccCc------cccccCccCccccccchhhhH
Q 036583 636 DFGLAKLMTREQSHVFTTLRGTRGYLAP------EWITNYAISEKSDVYSYGMVL 684 (817)
Q Consensus 636 Dfgla~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DvwS~Gvvl 684 (817)
|||+|......... .|... |.+ .+.|..++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 99999866433211 11111 111 35678899999965433
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.75 E-value=2.3e-18 Score=151.36 Aligned_cols=110 Identities=17% Similarity=0.388 Sum_probs=88.8
Q ss_pred ccccCCccccceeeecCCCCEEEeCCCeeEEeeecCCCCCceEEEEEEecCCceEEEEcCCCCCCCCCCCcEEecCceEE
Q 036583 32 GKILPGFQGAQMTFIDKNGLFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVS 111 (817)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~~~~lvs~~g~f~~gf~~~~~~~~~y~~i~~~~~~~t~vWvAnr~~Pi~~~~~~~~~~~g~l~ 111 (817)
|+|.||+.+.. |++|+| |.|+|+|+.+++ +.+++. .++||.||++.|... ..+.|..||+|+
T Consensus 2 DtL~~gq~L~~-------g~~l~~--g~~~l~~q~DGN-----Lvly~~---~~~vW~s~~~~~~~~-~~l~l~~dGnLv 63 (112)
T d1xd5a_ 2 DRLNSGHQLDT-------GGSLAE--GGYLFIIQNDCN-----LVLYDN---NRAVWASGTNGKASG-CVLKMQNDGNLV 63 (112)
T ss_dssp CEEETTEEECT-------TCEEEE--TTEEEEECTTSC-----EEEEET---TEEEEECCCTTSCSS-EEEEECTTSCEE
T ss_pred CEecCCCEecC-------CCEEEE--CCEEEEEcCCCC-----EEEEcC---CcEEEEccCccCCCC-cEEEEeccccEE
Confidence 56777766655 899974 999999999887 555543 589999999988543 457899999999
Q ss_pred EecCCeEEEEeCCCCC-ceeEEEEecCCCEEEEccCCccccccccCCCc
Q 036583 112 LQKGGSVVWSVNPSGA-SVSAMELRDSGNLVLLGNDNKVLWQSFSHPTD 159 (817)
Q Consensus 112 l~~~~~~vWstn~~~~-~~~~a~LldsGNLVL~~~~~~~lWQSFd~PtD 159 (817)
|..++.++|+++.+.. ....|+|+|+|||||++.+++++|||+.+|+|
T Consensus 64 l~~~~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 64 IYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp EEETTEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred EEecCCeEEEEeeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence 9556778888876533 44578999999999999999999999999975
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.72 E-value=1.3e-17 Score=144.89 Aligned_cols=94 Identities=22% Similarity=0.416 Sum_probs=77.9
Q ss_pred CCEEEeCCCeeEEeeecCCCCCceEEEEEEecCCceEEEEcCCCCCCCCCCCcEEecCceEEE-ecCCeEEEEeCCCC-C
Q 036583 50 GLFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVSL-QKGGSVVWSVNPSG-A 127 (817)
Q Consensus 50 ~~~lvs~~g~f~~gf~~~~~~~~~y~~i~~~~~~~t~vWvAnr~~Pi~~~~~~~~~~~g~l~l-~~~~~~vWstn~~~-~ 127 (817)
|++|. +|.|.|+|+..++ +.++. ..++||+||++.|......+.|..||+|+| +.+|++||+++++. .
T Consensus 13 g~~l~--~g~~~l~~q~dgn-----Lvl~~---~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s~t~~~~ 82 (109)
T d1kj1a_ 13 GQSLD--VEPYHFIMQEDCN-----LVLYD---HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGN 82 (109)
T ss_dssp TCEEE--ETTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEECCCCCCS
T ss_pred CCEEE--eCCEEEEecCCCe-----EEEEe---CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEEeeECCC
Confidence 88886 4899999998877 55543 348999999999998878888999999998 67899999998763 3
Q ss_pred ceeEEEEecCCCEEEEccCCccccccccC
Q 036583 128 SVSAMELRDSGNLVLLGNDNKVLWQSFSH 156 (817)
Q Consensus 128 ~~~~a~LldsGNLVL~~~~~~~lWQSFd~ 156 (817)
....|.|+|+|||||+++ .+|||+-|
T Consensus 83 ~~~~l~L~ddGNlvly~~---~~W~S~t~ 108 (109)
T d1kj1a_ 83 GNYVLVLQEDGNVVIYGS---DIWSTGTY 108 (109)
T ss_dssp SCCEEEECTTSCEEEECC---EEEECCCC
T ss_pred CCEEEEEeCCCcEEEECC---CEecCCCc
Confidence 445789999999999964 59999865
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.69 E-value=3.3e-17 Score=142.41 Aligned_cols=103 Identities=23% Similarity=0.400 Sum_probs=80.4
Q ss_pred cccCCccccceeeecCCCCEEEeCCCeeEEeeecCCCCCceEEEEEEecCCceEEEEcCCCCCCCCCCCcEEecCceEEE
Q 036583 33 KILPGFQGAQMTFIDKNGLFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVSL 112 (817)
Q Consensus 33 ~~~~~~~~~~~~~~~~~~~~lvs~~g~f~~gf~~~~~~~~~y~~i~~~~~~~t~vWvAnr~~Pi~~~~~~~~~~~g~l~l 112 (817)
.|.+|+.+.. |++|. +|.|+|.|+.+|+ +.++.. .++||.||++.|-. ...+.+..+|+|+|
T Consensus 3 ~L~~g~~L~~-------G~~l~--ng~~~l~~q~DGN-----Lvly~~---~~~vW~s~~~~~~~-~~~l~l~~~Gnlvl 64 (108)
T d1jpca_ 3 ILYSGETLST-------GEFLN--YGSFVFIMQEDCN-----LVLYDV---DKPIWATNTGGLSR-SCFLSMQTDGNLVV 64 (108)
T ss_dssp EEETTEEECT-------TCEEE--ETTEEEEECTTSC-----EEEEET---TEEEEECCCTTSCS-SCEEEECTTSCEEE
T ss_pred CccCCCEecC-------CCEEE--cCCEEEEECCCCe-----EEEEeC---CceeeEeCCCCCCC-ccEEEEeccceEEE
Confidence 4555655443 89985 6999999999988 556543 48999999998743 34578999999998
Q ss_pred -ecCCeEEEEeCCCCC-ceeEEEEecCCCEEEEccCCccccccccC
Q 036583 113 -QKGGSVVWSVNPSGA-SVSAMELRDSGNLVLLGNDNKVLWQSFSH 156 (817)
Q Consensus 113 -~~~~~~vWstn~~~~-~~~~a~LldsGNLVL~~~~~~~lWQSFd~ 156 (817)
+.+|++||++++... ....|+|+|+|||||++. .+||||+|
T Consensus 65 ~~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~---~~W~S~t~ 107 (108)
T d1jpca_ 65 YNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH 107 (108)
T ss_dssp ECTTCCEEEECCCCCSCSCEEEEECTTSCEEEEEC---CCCCCCCC
T ss_pred ECCCccceEEccccCCCCcEEEEEcCCCCEEEeCC---CcccCCCC
Confidence 678999999986533 334688999999999953 59999987
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.40 E-value=4.3e-14 Score=124.44 Aligned_cols=79 Identities=20% Similarity=0.308 Sum_probs=66.1
Q ss_pred EEEecCC-ceEEEEcCCCCCCCCCC-CcEEecCceEEEecCCeEEEEeCCCCC-ceeEEEEecCCCEEEEccCCcccccc
Q 036583 77 VIMHKAS-STIIWTANRGSPVANSD-NFVFKKDGEVSLQKGGSVVWSVNPSGA-SVSAMELRDSGNLVLLGNDNKVLWQS 153 (817)
Q Consensus 77 i~~~~~~-~t~vWvAnr~~Pi~~~~-~~~~~~~g~l~l~~~~~~vWstn~~~~-~~~~a~LldsGNLVL~~~~~~~lWQS 153 (817)
|||.+++ ++++|++|++.|+.... .+.+..||||+|...+.+||+++.... ....++|+++|||||+|.++++||||
T Consensus 12 il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW~S 91 (120)
T d1dlpa2 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTS 91 (120)
T ss_dssp ECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBTTBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEEC
T ss_pred EEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecCCcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEEEEe
Confidence 6666555 89999999999998765 688999999999777889999987644 44678999999999999999999999
Q ss_pred cc
Q 036583 154 FS 155 (817)
Q Consensus 154 Fd 155 (817)
+.
T Consensus 92 ~t 93 (120)
T d1dlpa2 92 GN 93 (120)
T ss_dssp CC
T ss_pred CC
Confidence 84
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.35 E-value=2e-12 Score=113.20 Aligned_cols=91 Identities=23% Similarity=0.440 Sum_probs=71.8
Q ss_pred EEeCCCeeEEeeecCCCCCceEEEEEEecCCceEEEEcCCCCCCCCCCCcEEecCceEEE-ecCCeEEEEeCCCCC-cee
Q 036583 53 LLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVSL-QKGGSVVWSVNPSGA-SVS 130 (817)
Q Consensus 53 lvs~~g~f~~gf~~~~~~~~~y~~i~~~~~~~t~vWvAnr~~Pi~~~~~~~~~~~g~l~l-~~~~~~vWstn~~~~-~~~ 130 (817)
+++..|.|.|.|+.+|+ +.++ + ..++||.||+..|..+ ..+.|..||+|+| +.+|.+||++++... ...
T Consensus 25 ~~~~~~~y~l~mQ~DGN-----LVLy-~--~~~~vWssnt~~~~~~-~~l~l~~dGnLvL~d~~g~~vWsS~t~~~~~~~ 95 (119)
T d1b2pa_ 25 ILFGTHVYRFIMQTDCN-----LVLY-D--NNNPIWATNTGGLGNG-CRAVLQPDGVLVVITNENVTVWQSPVAGKAGHY 95 (119)
T ss_dssp EEETTEEEEEEECTTSC-----EEEE-E--TTEEEEECCCTTSCSS-CEEEECTTSCEEEECTTCCEEEECSCCCCSSCE
T ss_pred EecCCceEEEEECCCCc-----EEEE-E--CCeEEEEecCCCCCcc-eEEEEEeCCCEEEECCCCcEEEECCCcCCCCce
Confidence 36679999999999998 4443 2 2589999999877433 4578999999998 678899999987643 334
Q ss_pred EEEEecCCCEEEEccCCcccccccc
Q 036583 131 AMELRDSGNLVLLGNDNKVLWQSFS 155 (817)
Q Consensus 131 ~a~LldsGNLVL~~~~~~~lWQSFd 155 (817)
.|+|+|+|||||++ .++|||..
T Consensus 96 ~l~Lq~DGNlvlYg---~~~W~S~T 117 (119)
T d1b2pa_ 96 VLVLQPDRNVVIYG---DALWATQT 117 (119)
T ss_dssp EEEECTTSCEEEEE---SEEEECCC
T ss_pred EEEEcCCCCEEEEC---CCEeccCC
Confidence 68899999999995 47999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.31 E-value=1.9e-13 Score=118.88 Aligned_cols=79 Identities=23% Similarity=0.368 Sum_probs=66.3
Q ss_pred EEEecC-CceEEEEcCCCCCCCCCC-CcEEecCceEEEecCCeEEEEeCCCCCceeEEEEecCCCEEEEccCCccccccc
Q 036583 77 VIMHKA-SSTIIWTANRGSPVANSD-NFVFKKDGEVSLQKGGSVVWSVNPSGASVSAMELRDSGNLVLLGNDNKVLWQSF 154 (817)
Q Consensus 77 i~~~~~-~~t~vWvAnr~~Pi~~~~-~~~~~~~g~l~l~~~~~~vWstn~~~~~~~~a~LldsGNLVL~~~~~~~lWQSF 154 (817)
|||... ..+..|..+.+++|.+.. .+.+..||||+|..++.+||++++.+.....+.|+++|||||++.++++||||+
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vWsS~ 82 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSG 82 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEESSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCC
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEcCCeeEEEcccCCCCceEEEEeccCCEEEEccCCCEEEEcC
Confidence 455443 367789999999997654 577999999999767889999998766677889999999999999999999997
Q ss_pred c
Q 036583 155 S 155 (817)
Q Consensus 155 d 155 (817)
.
T Consensus 83 t 83 (115)
T d1dlpa1 83 T 83 (115)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.99 E-value=2e-10 Score=99.45 Aligned_cols=91 Identities=22% Similarity=0.423 Sum_probs=70.3
Q ss_pred CCEEEeCCCeeEEeeecCCCCCceEEEEEEecCCceEEEEcCCCCCCCCCCCcEEecCceEEE-ecCCeEEEEeCCCCC-
Q 036583 50 GLFLLSNNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVSL-QKGGSVVWSVNPSGA- 127 (817)
Q Consensus 50 ~~~lvs~~g~f~~gf~~~~~~~~~y~~i~~~~~~~t~vWvAnr~~Pi~~~~~~~~~~~g~l~l-~~~~~~vWstn~~~~- 127 (817)
++.| .+|.|.|.|..+|+ |.++. ..++||.+|...+ ....+.|..||+|++ +.++++||+++....
T Consensus 20 ~~~l--~~g~~~l~~q~DGN-----LvL~~---~~~~vW~s~t~~~--~~~~l~l~~dGNLvl~d~~~~~vWsS~t~~~~ 87 (115)
T d1dlpa1 20 AQSL--ELSSFRFTMQSDCN-----LVLFD---SDVRVWASNTAGA--TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSI 87 (115)
T ss_dssp TCEE--CSTTEEEEECTTSC-----EEEEE---SSSEEECCCCCSC--SCCBCCBCSSSCBCCBCTTTCCSCCCCCCCCS
T ss_pred CCcE--EcCCEEEEECCCCe-----EEEEc---CCeeEEEcccCCC--CceEEEEeccCCEEEEccCCCEEEEcCCCCCC
Confidence 6777 57889999999988 65554 3478999996542 345677899999998 678899999987633
Q ss_pred ceeEEEEecCCCEEEEccCCcccccccc
Q 036583 128 SVSAMELRDSGNLVLLGNDNKVLWQSFS 155 (817)
Q Consensus 128 ~~~~a~LldsGNLVL~~~~~~~lWQSFd 155 (817)
....++|.++|||||++ ..+|+|..
T Consensus 88 g~y~l~Lq~DGNlvlY~---~~~Wssgt 112 (115)
T d1dlpa1 88 GNYVLVLQPDRTVTIYG---PGLWDSGT 112 (115)
T ss_dssp SCCEEEECSSSCEEEEC---SEEEECSC
T ss_pred CCEEEEECCCCcEEEeC---CCeecCCC
Confidence 33468899999999994 47999853
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.69 E-value=1.3e-08 Score=88.70 Aligned_cols=86 Identities=20% Similarity=0.423 Sum_probs=62.5
Q ss_pred CCCeeEEeeecCCCCCceEEEEEEecCCceEEEEcCCCCCCCCCCCcEEecCceEEE-ecCCeEEEEeCCCCC-ceeEEE
Q 036583 56 NNSDFAFGFRTTENDVTLFLLVIMHKASSTIIWTANRGSPVANSDNFVFKKDGEVSL-QKGGSVVWSVNPSGA-SVSAME 133 (817)
Q Consensus 56 ~~g~f~~gf~~~~~~~~~y~~i~~~~~~~t~vWvAnr~~Pi~~~~~~~~~~~g~l~l-~~~~~~vWstn~~~~-~~~~a~ 133 (817)
..|.|.|.|...|+ |.++. ...+||.+|-... .....+.|..+|||+| +.++++||+++.... ....+.
T Consensus 33 ~~g~y~L~~q~DGN-----LvL~~---~~~~vW~s~t~~~-~~~~~~~l~~~GnLvl~d~~~~~lW~S~t~~~~~~~~l~ 103 (120)
T d1dlpa2 33 QLSPYRLSMETDCN-----LVLFD---RDDRVWSTNTAGK-GTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFV 103 (120)
T ss_dssp BCSSCEEEEETTTE-----EEEEB---TTBCCSCCCCCSS-CSSCEEEEETTTEEEEEETTTEEEEECCCCCSSSCCEEE
T ss_pred EcCCEEEEEcCCCc-----EEEec---CCcEEEEEccccC-CCcEEEEEeCCeeEEEEcCCCCEEEEeCCCCCCCcEEEE
Confidence 35778888887776 55443 2477899884322 1234567889999998 678999999987533 334688
Q ss_pred EecCCCEEEEccCCcccccc
Q 036583 134 LRDSGNLVLLGNDNKVLWQS 153 (817)
Q Consensus 134 LldsGNLVL~~~~~~~lWQS 153 (817)
|.++|||||++ ..+|.|
T Consensus 104 Lq~DGnlvlY~---~~~W~t 120 (120)
T d1dlpa2 104 LQPDRNLAIYG---GALWTT 120 (120)
T ss_dssp ECSSSCEEEEC---CCCCBC
T ss_pred ECCCCcEEEeC---CCcccC
Confidence 99999999994 468986
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.43 E-value=1.2e-07 Score=81.06 Aligned_cols=53 Identities=25% Similarity=0.518 Sum_probs=45.2
Q ss_pred CcEEecCceEEEecCCeEEEEeCCCC--CceeEEEEecCCCEEEEccCCcccccc
Q 036583 101 NFVFKKDGEVSLQKGGSVVWSVNPSG--ASVSAMELRDSGNLVLLGNDNKVLWQS 153 (817)
Q Consensus 101 ~~~~~~~g~l~l~~~~~~vWstn~~~--~~~~~a~LldsGNLVL~~~~~~~lWQS 153 (817)
.+.+..||||++..++++||++|+.. .....+.|.++|||||++.++.++|+|
T Consensus 22 ~l~~q~dgnLvl~~~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s 76 (109)
T d1kj1a_ 22 HFIMQEDCNLVLYDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWAS 76 (109)
T ss_dssp EEEECTTSCEEEEETTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEEC
T ss_pred EEEecCCCeEEEEeCCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEE
Confidence 45678999999987889999999763 234568899999999999999999998
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.40 E-value=1.5e-07 Score=81.67 Aligned_cols=53 Identities=28% Similarity=0.562 Sum_probs=45.5
Q ss_pred cEEecCceEEEecCCeEEEEeCCCCC-ceeEEEEecCCCEEEEccCCccccccc
Q 036583 102 FVFKKDGEVSLQKGGSVVWSVNPSGA-SVSAMELRDSGNLVLLGNDNKVLWQSF 154 (817)
Q Consensus 102 ~~~~~~g~l~l~~~~~~vWstn~~~~-~~~~a~LldsGNLVL~~~~~~~lWQSF 154 (817)
+.+..||||||...+.+||+++..+. ....+.|.++|||||+|.++.++|+|.
T Consensus 34 l~mQ~DGNLVLy~~~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~ 87 (119)
T d1b2pa_ 34 FIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP 87 (119)
T ss_dssp EEECTTSCEEEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECS
T ss_pred EEECCCCcEEEEECCeEEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEECC
Confidence 56889999999777889999997644 346789999999999999999999974
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.37 E-value=1.8e-07 Score=79.87 Aligned_cols=53 Identities=26% Similarity=0.572 Sum_probs=45.8
Q ss_pred CcEEecCceEEEecCCeEEEEeCCCCC-ceeEEEEecCCCEEEEccCCcccccc
Q 036583 101 NFVFKKDGEVSLQKGGSVVWSVNPSGA-SVSAMELRDSGNLVLLGNDNKVLWQS 153 (817)
Q Consensus 101 ~~~~~~~g~l~l~~~~~~vWstn~~~~-~~~~a~LldsGNLVL~~~~~~~lWQS 153 (817)
.+.+..||||+|...+++||+||+.+. ....+.|.++|||||++.+++++|+|
T Consensus 22 ~l~~q~DGNLvly~~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS 75 (108)
T d1jpca_ 22 VFIMQEDCNLVLYDVDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWAS 75 (108)
T ss_dssp EEEECTTSCEEEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEEC
T ss_pred EEEECCCCeEEEEeCCceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEc
Confidence 466889999999778899999997654 34578899999999999999999998
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.01 E-value=1.8e-05 Score=79.01 Aligned_cols=130 Identities=15% Similarity=0.072 Sum_probs=90.4
Q ss_pred CcceeEEEEEcCCCcEEEEEEeccC-CcCHHHHHHHHHHhhccC-cceeeeeeeEeecCCeeeEEEeeccCCChhhhhhh
Q 036583 503 GGFGSVYQGVLPDGTRLAVKKLEGI-GQGKKEFRAEVSIIGSIH-HLHLVKLRGFCAEGTHRLLAYEFMANGSLDKWIFK 580 (817)
Q Consensus 503 G~fG~Vy~g~~~~g~~vavK~l~~~-~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 580 (817)
+....||+... +++.++||+.... ......+.+|..++..+. +--+.+++.+..+++..++||+++++..+.+....
T Consensus 25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 25 MSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp CSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence 33468999876 5566788887644 233446788888887774 44467888888888899999999999887654322
Q ss_pred cccccchhhhHHHHHHHHHHHHHHHHHhcC--------------------------------------------------
Q 036583 581 KNQEFLLDWETRFNIALGTAKGLAYLHEDC-------------------------------------------------- 610 (817)
Q Consensus 581 ~~~~~~l~~~~~~~i~~qia~~l~~LH~~~-------------------------------------------------- 610 (817)
. .....++.++++.++.||+..
T Consensus 104 ~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (263)
T d1j7la_ 104 E--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK 175 (263)
T ss_dssp C--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHH
T ss_pred c--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHH
Confidence 1 122334555555555555310
Q ss_pred ------CCceeecCCCCCCeEecCCCcEEEeecCCcc
Q 036583 611 ------DQRIIHCDIKPENVLLDDNYHAKVSDFGLAK 641 (817)
Q Consensus 611 ------~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 641 (817)
...++|+|+.|.||+++++..+-|.||+.+.
T Consensus 176 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987777899998775
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=97.89 E-value=6.1e-06 Score=70.71 Aligned_cols=53 Identities=26% Similarity=0.616 Sum_probs=42.8
Q ss_pred CCcEEecCceEEEecCCeEEEEeCCCC-CceeEEEEecCCCEEEEccCCcccccc
Q 036583 100 DNFVFKKDGEVSLQKGGSVVWSVNPSG-ASVSAMELRDSGNLVLLGNDNKVLWQS 153 (817)
Q Consensus 100 ~~~~~~~~g~l~l~~~~~~vWstn~~~-~~~~~a~LldsGNLVL~~~~~~~lWQS 153 (817)
-.+.+..||||+|...+++||++++.. ...+.+.|..+|||||++. ++.+|.|
T Consensus 21 ~~l~~q~DGNLvly~~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~-~~~~w~s 74 (112)
T d1xd5a_ 21 YLFIIQNDCNLVLYDNNRAVWASGTNGKASGCVLKMQNDGNLVIYSG-SRAIWAS 74 (112)
T ss_dssp EEEEECTTSCEEEEETTEEEEECCCTTSCSSEEEEECTTSCEEEEET-TEEEEEC
T ss_pred EEEEEcCCCCEEEEcCCcEEEEccCccCCCCcEEEEeccccEEEEec-CCeEEEE
Confidence 346688999999987889999999764 3446788999999999986 4567766
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.80 E-value=2.9e-05 Score=76.95 Aligned_cols=74 Identities=14% Similarity=0.036 Sum_probs=53.8
Q ss_pred cCCCcc-eeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccC--cceeeeeeeEeecCCeeeEEEeeccCCChh
Q 036583 500 LGQGGF-GSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIH--HLHLVKLRGFCAEGTHRLLAYEFMANGSLD 575 (817)
Q Consensus 500 lG~G~f-G~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 575 (817)
+..|.. ..||+...+++..+++|.-.... ...+..|...++.+. .-.+.+++.+..+++..++||+++++.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 444543 57999998888888899865432 234677888777663 334677888888888899999999886653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.16 E-value=0.00091 Score=70.42 Aligned_cols=74 Identities=14% Similarity=0.077 Sum_probs=48.0
Q ss_pred cccCCCcceeEEEEEcCC-CcEEEEEEeccC--------CcCHHHHHHHHHHhhccC-c--ceeeeeeeEeecCCeeeEE
Q 036583 498 VKLGQGGFGSVYQGVLPD-GTRLAVKKLEGI--------GQGKKEFRAEVSIIGSIH-H--LHLVKLRGFCAEGTHRLLA 565 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--------~~~~~~~~~Ev~~l~~l~-h--~niv~l~~~~~~~~~~~lv 565 (817)
++||.|....||+....+ ++.++||.-... .........|.+.|..+. + ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 469999999999998765 678899965321 112234556888777663 2 345556554 45566899
Q ss_pred EeeccCCC
Q 036583 566 YEFMANGS 573 (817)
Q Consensus 566 ~e~~~~gs 573 (817)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.13 E-value=0.00052 Score=70.41 Aligned_cols=136 Identities=13% Similarity=0.076 Sum_probs=81.1
Q ss_pred ceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCccee--eeeee-----EeecCCeeeEEEeeccCCChhh-
Q 036583 505 FGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHL--VKLRG-----FCAEGTHRLLAYEFMANGSLDK- 576 (817)
Q Consensus 505 fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL~~- 576 (817)
.-.||+...++|+.+++|..+......+++..|...+..|....+ +..+. .+..+...+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 458999999999999999987766667889999999888753222 11111 2234556788999988743210
Q ss_pred ----------h---hhhc------ccccc-------------------hhhhHHHHHHHHHHHHHHHHHh----cCCCce
Q 036583 577 ----------W---IFKK------NQEFL-------------------LDWETRFNIALGTAKGLAYLHE----DCDQRI 614 (817)
Q Consensus 577 ----------~---l~~~------~~~~~-------------------l~~~~~~~i~~qia~~l~~LH~----~~~~~i 614 (817)
. ++.. ..... ++...+..+...+.+.++.+.. ....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 0100 00001 1111111122222233333322 234678
Q ss_pred eecCCCCCCeEecCCCcEEEeecCCccc
Q 036583 615 IHCDIKPENVLLDDNYHAKVSDFGLAKL 642 (817)
Q Consensus 615 vH~Dlk~~NIll~~~~~~ki~Dfgla~~ 642 (817)
+|+|+.+.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45889987763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.80 E-value=0.012 Score=61.54 Aligned_cols=72 Identities=15% Similarity=0.148 Sum_probs=49.1
Q ss_pred cccCCCcceeEEEEEcCCC--------cEEEEEEeccCCcCHHHHHHHHHHhhccCcce-eeeeeeEeecCCeeeEEEee
Q 036583 498 VKLGQGGFGSVYQGVLPDG--------TRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLH-LVKLRGFCAEGTHRLLAYEF 568 (817)
Q Consensus 498 ~~lG~G~fG~Vy~g~~~~g--------~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~ 568 (817)
+.|+.|---.+|+...+++ +.|.+++.. .....-...+|..+++.+.-.+ ..++++++.+ .+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 4577788889999886543 456666654 3344456678999998885334 4577777754 588999
Q ss_pred ccCCCh
Q 036583 569 MANGSL 574 (817)
Q Consensus 569 ~~~gsL 574 (817)
+++..|
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.06 E-value=0.16 Score=50.59 Aligned_cols=141 Identities=13% Similarity=0.007 Sum_probs=72.4
Q ss_pred ccCCCcceeEEEEEcCCCcEEEEEEeccCCcCHHHHHHHHHHhhccCcce--eeeeeeE------eecCCeeeEEEeecc
Q 036583 499 KLGQGGFGSVYQGVLPDGTRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLH--LVKLRGF------CAEGTHRLLAYEFMA 570 (817)
Q Consensus 499 ~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~Ev~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e~~~ 570 (817)
.|..|---+.|+.+..+|+ .++|+.+.. ...+++..|++++..+.+.+ +...+.. .........++.+..
T Consensus 25 ~i~~G~~N~ny~v~t~~g~-yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~ 102 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTTKDP-LILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 102 (316)
T ss_dssp EECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred cCCCCcccCeEEEEECCCc-EEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecc
Confidence 3566777889999986665 888988653 23345566777777774322 1111111 122334556666665
Q ss_pred CCChhh--------------hhhhccc--------cc----------------chhhhHHHHHHHHHHHHHHHHH-hcCC
Q 036583 571 NGSLDK--------------WIFKKNQ--------EF----------------LLDWETRFNIALGTAKGLAYLH-EDCD 611 (817)
Q Consensus 571 ~gsL~~--------------~l~~~~~--------~~----------------~l~~~~~~~i~~qia~~l~~LH-~~~~ 611 (817)
+..... .++.... .. ..........+..+...+.-.+ ....
T Consensus 103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~ 182 (316)
T d2ppqa1 103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 182 (316)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred cccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccc
Confidence 532211 0000000 00 0011111222222222222222 1235
Q ss_pred CceeecCCCCCCeEecCCCcEEEeecCCcc
Q 036583 612 QRIIHCDIKPENVLLDDNYHAKVSDFGLAK 641 (817)
Q Consensus 612 ~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 641 (817)
.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 689999999999999998777899999875
|